{"meta":{"query_hash":"73fff1a721b8","filters":{"venue":"Journal of the American Academy of Dermatology"},"cohort_total":1255,"direct_labels_cover":0,"predictions_cover":1255,"exported":1255,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/73fff1a721b8","api":"https://metacan.xera.ac/api/v1/cohort?venue=Journal+of+the+American+Academy+of+Dermatology"},"results":[{"id":"W128875354","doi":"10.1016/j.jaad.2009.04.055","title":"Patient safety","year":2009,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Patient Safety and Medication Errors","field":"Health Professions","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Medical Protective Association; University of Ottawa","funders":"","keywords":"Blame; Patient safety; Medicine; Shame; Harm; Root cause analysis; Quality management; Quality (philosophy); Health care; Human error; Medical emergency; Nursing; Medical education; Management system; Risk analysis (engineering); Psychiatry; Psychology; Operations management","score_opus":0.08856810986094747,"score_gpt":0.4781863673339046,"score_spread":0.38961825747295714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W128875354","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00044807742,0.9587604,0.001100418,0.0046638027,0.0029900188,0.000112047455,0.00018147129,0.00010974277,0.031634014],"genre_scores_gemma":[0.007885398,0.9550583,0.0022347628,0.0072801397,0.002037678,0.00010473727,0.0004629668,0.000017336759,0.024918778],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99813074,0.00040602867,0.00027161514,0.00019559936,0.00086088554,0.00013515116],"domain_scores_gemma":[0.9961785,0.0011145603,0.000716714,0.00017928028,0.0015653884,0.00024554585],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021838206,0.00095520983,0.001068028,0.0029792322,0.00079638493,0.0016563468,0.0009625504,0.0023074853,0.027658952],"category_scores_gemma":[0.0065156585,0.00035757164,0.00086045574,0.0021060659,0.0005833546,0.0015660505,0.0018155186,0.00201523,0.009378987],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031898267,0.000060565762,0.00027174773,0.0060336837,0.000052448555,0.000052323507,0.00007107037,0.000038185823,0.00035111106,0.0011194004,0.10651924,0.8853984],"study_design_scores_gemma":[0.000028099414,0.00006838197,0.0017107406,0.010016615,0.00011546288,0.0006774613,0.00008452328,0.000042137064,0.0003346825,0.0006053695,0.98630387,0.000012616706],"about_ca_topic_score_codex":0.0026131559,"about_ca_topic_score_gemma":0.005257567,"teacher_disagreement_score":0.027658952,"about_ca_system_score_codex":0.0010862708,"about_ca_system_score_gemma":0.003926766,"threshold_uncertainty_score":0.09252834},"labels":[],"label_agreement":null},{"id":"W1651325956","doi":"10.1016/j.jaad.2009.10.032","title":"Alopecia areata update","year":2010,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":729,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health; Quest University Canada; University of British Columbia","funders":"","keywords":"Medicine; Alopecia areata; Dermatology","score_opus":0.00922601807538087,"score_gpt":0.2994972851285738,"score_spread":0.29027126705319295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1651325956","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.022710666,0.82612014,0.0023834836,0.043296505,0.020999681,0.0001042749,0.00087040354,0.0005464073,0.08296846],"genre_scores_gemma":[0.14223194,0.6803287,0.005151602,0.04386937,0.06566194,0.0001253058,0.0026934794,0.00007995074,0.05985774],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999708,0.000036536192,0.000057696543,0.00003566581,0.000097644246,0.00006452531],"domain_scores_gemma":[0.99917835,0.00023327829,0.00012023217,0.000036507503,0.00030216307,0.00012951762],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005407672,0.0005471016,0.00080566434,0.002035702,0.00042383122,0.0010187309,0.000565986,0.0018826732,0.0059260475],"category_scores_gemma":[0.0014463858,0.00016496553,0.0005333831,0.00089060894,0.0002502292,0.0012654883,0.000498626,0.0014976441,0.002177443],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020616999,0.00019261833,0.007501003,0.0013545598,0.00007417181,0.016656639,0.000091812006,0.00019425667,0.0012268107,0.0012945753,0.22996649,0.7412409],"study_design_scores_gemma":[0.00008742277,0.0001484725,0.013909314,0.0013584701,0.00026922152,0.08521922,0.00019217397,0.00030155148,0.00044135842,0.00083776045,0.897214,0.000021008495],"about_ca_topic_score_codex":0.0017176928,"about_ca_topic_score_gemma":0.006112732,"teacher_disagreement_score":0.0059260475,"about_ca_system_score_codex":0.00044556233,"about_ca_system_score_gemma":0.0005656225,"threshold_uncertainty_score":0.019824564},"labels":[],"label_agreement":null},{"id":"W178679796","doi":"10.1016/j.jaad.2013.07.048","title":"Diabetic foot ulcers","year":2013,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Diabetic Foot Ulcer Assessment and Management","field":"Medicine","cited_by":267,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Women's College Hospital; University of Toronto","funders":"","keywords":"Medicine; Diabetic foot; Diabetic ulcers; Wound care; Amputation; Intensive care medicine; Diabetes mellitus; Foot (prosody); Surgery; Diabetic foot ulcer","score_opus":0.013003335526729146,"score_gpt":0.29706953880044384,"score_spread":0.2840662032737147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W178679796","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19714205,0.056612242,0.002465675,0.010867309,0.0037552868,0.00042862288,0.0019236823,0.00035921898,0.726446],"genre_scores_gemma":[0.76803464,0.02993404,0.0027815676,0.00967644,0.0026810747,0.00016476777,0.0022609737,0.000045081404,0.18442138],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99960357,0.00004675156,0.000034009143,0.000030215548,0.00015605878,0.0001294027],"domain_scores_gemma":[0.9995875,0.000046904788,0.000078117744,0.000024212031,0.0001374363,0.00012590882],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028050365,0.00031308975,0.00036867452,0.001207429,0.0008248142,0.000997579,0.00028162455,0.00054018764,0.03424214],"category_scores_gemma":[0.0011766439,0.00010577366,0.00045619046,0.00096128933,0.00013057579,0.00025629438,0.0003770088,0.00087121583,0.0041693375],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007323127,0.0016982313,0.08894287,0.00083622715,0.00014608107,0.017490042,0.0002431078,0.00007180149,0.0043061613,0.0035983392,0.13128348,0.75065136],"study_design_scores_gemma":[0.00026428627,0.001007909,0.28876153,0.0018918228,0.0003357837,0.09107885,0.0011120428,0.0005300766,0.0036227722,0.0029200825,0.6084223,0.000052622167],"about_ca_topic_score_codex":0.002021294,"about_ca_topic_score_gemma":0.002958886,"teacher_disagreement_score":0.03424214,"about_ca_system_score_codex":0.0003985792,"about_ca_system_score_gemma":0.0005218091,"threshold_uncertainty_score":0.114551306},"labels":[],"label_agreement":null},{"id":"W1810069629","doi":"10.1016/j.jaad.2015.04.023","title":"Adverse events resulting in withdrawal of biologic therapy for psoriasis in real-world clinical practice: A Canadian multicenter retrospective study","year":2015,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre; University of Ottawa; Public Health Ontario; University of Toronto; Women's College Hospital; McMaster University","funders":"","keywords":"Medicine; Ustekinumab; Adalimumab; Etanercept; Infliximab; Adverse effect; Psoriasis; Internal medicine; Incidence (geometry); Discontinuation; Clinical trial; Population; Retrospective cohort study; Confidence interval; Hazard ratio; Dermatology; Disease; Rheumatoid arthritis","score_opus":0.053207852357666036,"score_gpt":0.3817297459648518,"score_spread":0.32852189360718576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1810069629","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945543,0.002225313,0.00013682437,0.00019885192,0.000018387665,0.00017936649,0.0010926265,0.0000069340704,0.0015874221],"genre_scores_gemma":[0.9976768,0.0009412298,0.00015107974,0.00022724009,0.000026261636,0.00004666198,0.0007400067,0.0000058029113,0.00018493351],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.994562,0.0008486352,0.0007229049,0.0008456855,0.0020383606,0.0009824715],"domain_scores_gemma":[0.9826968,0.0022394373,0.008054509,0.0007069915,0.003962861,0.002339498],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002626881,0.0006595348,0.0010820925,0.0021465884,0.0022739042,0.0020913589,0.0014609263,0.0012256515,0.0018669829],"category_scores_gemma":[0.011531194,0.0006395534,0.0016572034,0.0050128736,0.0015113415,0.0006676733,0.0010533966,0.0014670031,0.00018314327],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044599935,0.000079080615,0.9963644,0.000084918254,0.00019735294,0.00024281819,0.00038117656,0.000048451042,0.00009676176,0.00005435737,0.00023046198,0.0017743177],"study_design_scores_gemma":[0.00006828172,0.00017931376,0.9978356,0.000043975553,0.00014091085,0.0004454993,0.00062659365,0.00010437049,0.000033024833,0.000015735393,0.0004830507,0.000023683835],"about_ca_topic_score_codex":0.71881074,"about_ca_topic_score_gemma":0.703989,"teacher_disagreement_score":0.28118926,"about_ca_system_score_codex":0.016154198,"about_ca_system_score_gemma":0.018500155,"threshold_uncertainty_score":0.56569046},"labels":[],"label_agreement":null},{"id":"W1842534514","doi":"10.1016/j.jaad.2015.07.002","title":"Ustekinumab in adolescent patients age 12 to 17 years with moderate-to-severe plaque psoriasis: Results of the randomized phase 3 CADMUS study","year":2015,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":224,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"Biogen; Janssen Scientific Affairs; Pfizer; Eli Lilly and Company","keywords":"Medicine; Ustekinumab; Placebo; Psoriasis; Dosing; Psoriasis Area and Severity Index; Adverse effect; Internal medicine; Gastroenterology; Crossover study; Randomized controlled trial; Randomization; Dermatology; Adalimumab; Pathology","score_opus":0.02644487551324075,"score_gpt":0.2893892750184099,"score_spread":0.2629443995051691,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1842534514","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945478,0.003139289,0.00016318195,0.00029941023,0.00008389359,0.0007969298,0.0003396411,0.000017653154,0.0006121129],"genre_scores_gemma":[0.9922742,0.0032527098,0.0008541127,0.0008229862,0.00017502629,0.0013242477,0.0005179171,0.000008418657,0.0007702935],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99955004,0.00027753387,0.000023415994,0.00003780269,0.000050295715,0.000060817325],"domain_scores_gemma":[0.9992649,0.00014849621,0.00019125167,0.000033493012,0.000049389648,0.00031231862],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013122982,0.00048995076,0.0012829235,0.00018589721,0.00022522171,0.00049062463,0.00033913428,0.0006269203,0.002804048],"category_scores_gemma":[0.0010453237,0.0002787343,0.0010108063,0.00019725515,0.00042902888,0.0003667369,0.00021352404,0.0015074672,0.00030775773],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8253782,0.025966547,0.029872837,0.0008563519,0.0018189637,0.00023250713,0.0002357017,0.0005141344,0.00945111,0.00026626608,0.0030157464,0.10239164],"study_design_scores_gemma":[0.7640112,0.18322995,0.04586466,0.0001250015,0.0010894879,0.0003349399,0.00011557905,0.0006062748,0.0012214878,0.00014621197,0.0032369613,0.000018132028],"about_ca_topic_score_codex":0.0006871141,"about_ca_topic_score_gemma":0.0022130453,"teacher_disagreement_score":0.002804048,"about_ca_system_score_codex":0.00042198197,"about_ca_system_score_gemma":0.0009071412,"threshold_uncertainty_score":0.00938046},"labels":[],"label_agreement":null},{"id":"W1889380822","doi":"10.1016/j.jaad.2003.10.247","title":"Pimecrolimus cream 1% provides effective long-term control of atopic dermatitis in infants","year":2004,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Medicine; Pimecrolimus; Atopic dermatitis; Dermatology; Term (time); Calcineurin; Surgery","score_opus":0.0072803056685046144,"score_gpt":0.29354832123622576,"score_spread":0.28626801556772113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1889380822","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99019814,0.007831763,0.00026379756,0.00015132505,0.00005149528,0.000015021753,0.0000789283,0.000053254,0.0013564224],"genre_scores_gemma":[0.99650335,0.002125248,0.00030156458,0.00009153597,0.00005673725,0.0000139686545,0.00012114478,0.000008968751,0.0007774394],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9998969,0.00003437764,0.0000092689825,0.000009433229,0.000021006037,0.000028979624],"domain_scores_gemma":[0.9998423,0.00005041561,0.000030392368,0.000009711836,0.0000118471025,0.00005540468],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022920078,0.00024597943,0.0005475218,0.0001470144,0.00023918485,0.0001808866,0.00030225242,0.00035223004,0.00082687003],"category_scores_gemma":[0.0006180701,0.00007440473,0.00028327477,0.000091614216,0.000114732546,0.00019334807,0.000116713156,0.0005002834,0.00018315899],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04391004,0.006520633,0.0439794,0.0019137836,0.0004369198,0.017575305,0.0004528643,0.00067933666,0.29213426,0.00058963953,0.005895622,0.5859123],"study_design_scores_gemma":[0.004200466,0.0669565,0.70965296,0.00048049237,0.0013025232,0.046679083,0.0006259497,0.0025205838,0.14536552,0.00034745954,0.021805057,0.0000634931],"about_ca_topic_score_codex":0.00046629482,"about_ca_topic_score_gemma":0.0009932134,"teacher_disagreement_score":0.00082687003,"about_ca_system_score_codex":0.00018164692,"about_ca_system_score_gemma":0.00014805318,"threshold_uncertainty_score":0.0027661324},"labels":[],"label_agreement":null},{"id":"W189068515","doi":"10.1016/j.jaad.2014.03.030","title":"Guidelines of care for the management of atopic dermatitis","year":2014,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":871,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institute for Health and Care Research","keywords":"Medicine; Atopic dermatitis; Guideline; Dermatology; Intensive care medicine; Pathology","score_opus":0.02141403959256145,"score_gpt":0.34237505895062886,"score_spread":0.3209610193580674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W189068515","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009828571,0.33969197,0.0595343,0.3311118,0.02298874,0.0041313013,0.003841223,0.0015432761,0.2273289],"genre_scores_gemma":[0.0828674,0.32601583,0.38762647,0.116758235,0.015125565,0.0078016534,0.012562115,0.00045157326,0.050791178],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.994803,0.0018964538,0.0013515241,0.00015492678,0.0014521,0.00034192437],"domain_scores_gemma":[0.98933196,0.002250899,0.0012573614,0.00020932811,0.006003411,0.0009470596],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041489047,0.0011646859,0.0014462625,0.0034568696,0.0016257261,0.0021952842,0.0035822578,0.005520674,0.005392168],"category_scores_gemma":[0.014274807,0.00042280622,0.0024264245,0.0015615856,0.00081509334,0.0011770312,0.0015090312,0.00699093,0.0030174472],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013400878,0.00064115546,0.0059110895,0.0023775152,0.00017129426,0.0018662399,0.00046266837,0.0017484766,0.0010573317,0.010082252,0.5854093,0.39013866],"study_design_scores_gemma":[0.00034958211,0.00028028458,0.016984046,0.024247648,0.00036055522,0.0058730203,0.0006393256,0.0016398004,0.00077417627,0.013106323,0.93562186,0.00012333563],"about_ca_topic_score_codex":0.0142362835,"about_ca_topic_score_gemma":0.03402326,"teacher_disagreement_score":0.0142362835,"about_ca_system_score_codex":0.0025158883,"about_ca_system_score_gemma":0.00932964,"threshold_uncertainty_score":0.028306842},"labels":[],"label_agreement":null},{"id":"W1895056291","doi":"10.1016/j.jaad.2015.07.049","title":"Scientific evidence for the use of current traditional systemic therapies in patients with hidradenitis suppurativa","year":2015,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Hidradenitis suppurativa; Systemic therapy; Intensive care medicine; Antibiotics; Antiandrogens; Systemic antibiotics; Clostridium difficile; Dermatology; Cancer; Internal medicine; Prostate cancer; Disease","score_opus":0.30647348811131836,"score_gpt":0.4171710504866065,"score_spread":0.11069756237528816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1895056291","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007696596,0.99961936,0.000015488999,0.000085041516,0.00005044293,0.0000030216154,0.000014341124,6.7771197e-7,0.00013473249],"genre_scores_gemma":[0.0016182528,0.9979157,0.000099470686,0.00021290669,0.000087364984,0.000005487891,0.000021229045,4.575788e-7,0.00003911357],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990345,0.00025462575,0.00028895886,0.00011479498,0.00026913287,0.000038027272],"domain_scores_gemma":[0.9958851,0.003060165,0.00066267175,0.000044138378,0.00029052037,0.0000574094],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002030047,0.0007016808,0.002884195,0.0029281417,0.00031225898,0.0013338139,0.0012345115,0.0014863337,0.005142474],"category_scores_gemma":[0.0052838447,0.00034126738,0.0025891205,0.002455726,0.0006440958,0.0011172205,0.00067538023,0.0018545028,0.00039540912],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00063027954,0.00010144691,0.00079850736,0.33365536,0.0032971306,0.00023194563,0.00011763885,0.00019072466,0.00082894677,0.0013546181,0.00997813,0.64881533],"study_design_scores_gemma":[0.0010497085,0.0008060507,0.0138378125,0.41905782,0.03284074,0.0031366325,0.0005193731,0.00029844773,0.0011907438,0.0033628892,0.523772,0.00012782219],"about_ca_topic_score_codex":0.0020516054,"about_ca_topic_score_gemma":0.004106917,"teacher_disagreement_score":0.005142474,"about_ca_system_score_codex":0.0006881603,"about_ca_system_score_gemma":0.0017040637,"threshold_uncertainty_score":0.017203331},"labels":[],"label_agreement":null},{"id":"W1913569983","doi":"10.1016/j.jaad.2015.07.051","title":"Hidradenitis suppurativa in the pediatric population","year":2015,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children; SickKids Foundation","funders":"","keywords":"Medicine; Hidradenitis suppurativa; Intertriginous; Dermatology; Disease; Scars; Quality of life (healthcare); Population; Muscle contracture; Pediatrics; Hormonal therapy; Antibiotics; Surgery; Internal medicine","score_opus":0.06430126920018192,"score_gpt":0.40849833027585214,"score_spread":0.3441970610756702,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1913569983","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007513644,0.9995896,0.00001576991,0.00006745247,0.000048352198,0.000002020372,0.0000097993925,0.0000011610632,0.00019061903],"genre_scores_gemma":[0.0007204836,0.99896324,0.000056357556,0.0000891772,0.00008973266,0.0000023083712,0.000012265777,3.050549e-7,0.00006623915],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99975985,0.000042984448,0.00006442234,0.000040596464,0.000070872346,0.000021222182],"domain_scores_gemma":[0.99916446,0.0004960064,0.00020720824,0.000011467612,0.00008295783,0.000037882717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054662855,0.00069134455,0.0016001062,0.0027211795,0.0003151781,0.0010525971,0.00066278334,0.0008543872,0.0031589111],"category_scores_gemma":[0.0012793185,0.00030279206,0.00080498785,0.0023823006,0.00044029873,0.0011927311,0.0006651078,0.0013981296,0.0005294868],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000106957654,0.00009409465,0.0010530762,0.06361865,0.00032362208,0.0005299072,0.00007868421,0.00021975167,0.00048527156,0.0011114976,0.017260972,0.91511756],"study_design_scores_gemma":[0.00011210029,0.0002269731,0.010039218,0.06697115,0.0021416538,0.012289438,0.00041015903,0.00020885529,0.00052112265,0.002179818,0.9048271,0.00007232412],"about_ca_topic_score_codex":0.001745139,"about_ca_topic_score_gemma":0.004069525,"teacher_disagreement_score":0.0031589111,"about_ca_system_score_codex":0.00045515815,"about_ca_system_score_gemma":0.0011606468,"threshold_uncertainty_score":0.010567546},"labels":[],"label_agreement":null},{"id":"W1919283206","doi":"10.1016/j.jaad.2015.03.049","title":"Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor, in patients with moderate to severe plaque psoriasis: Results of a phase III, randomized, controlled trial (Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis [ESTEEM] 1)","year":2015,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":669,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Probity Medical Research","funders":"Ortho-McNeil Pharmaceutical; Janssen Pharmaceuticals; Johnson and Johnson; Janssen Biotech; 3M; Merck Sharp and Dohme; Biogen Idec; Genentech; LEO Pharma; Abbott Laboratories; National Institute for Health and Care Research; Sandoz; Novartis; Celgene; Merck; GlaxoSmithKline; Astellas Pharma US; Galderma; Eli Lilly and Company; Pfizer; Amgen; AbbVie; Society of Daughters of the United States Army; Allergan; Merz Therapeutics","keywords":"Apremilast; Medicine; Psoriasis; Plaque psoriasis; Randomized controlled trial; Dermatology; Phosphodiesterase inhibitor; Phosphodiesterase; Internal medicine; Pharmacology; Clinical trial; Psoriatic arthritis; Enzyme","score_opus":0.01953649670246773,"score_gpt":0.30237140756684366,"score_spread":0.28283491086437595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1919283206","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98064697,0.011288699,0.00070767617,0.000920249,0.0003169799,0.0032801318,0.00080405246,0.000108389846,0.0019269158],"genre_scores_gemma":[0.98399645,0.0054473747,0.00258158,0.0012995349,0.00073340937,0.0029534856,0.0012576396,0.00001962254,0.0017110131],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9989214,0.0006895685,0.00007928204,0.00012774397,0.00010192975,0.0000800613],"domain_scores_gemma":[0.9987326,0.00037125888,0.00033424183,0.00007246812,0.000077736564,0.00041165255],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036961124,0.0010257136,0.0021936682,0.00032857925,0.00033060345,0.000756355,0.00055563904,0.0012701234,0.0038160835],"category_scores_gemma":[0.002317092,0.0004619915,0.0014034162,0.00036699956,0.0006560154,0.0006535869,0.00027493498,0.0022957067,0.00052095554],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.93235844,0.01379126,0.0022341106,0.0010868303,0.00118687,0.00008118721,0.00007729654,0.0003244651,0.0076006716,0.00008292186,0.0013586072,0.039817322],"study_design_scores_gemma":[0.89749455,0.095849715,0.004891492,0.00003922493,0.00041875153,0.000086565415,0.000014289813,0.00017354815,0.0004975798,0.000056928537,0.00046798962,0.000009363332],"about_ca_topic_score_codex":0.00033250664,"about_ca_topic_score_gemma":0.00082884135,"teacher_disagreement_score":0.0038160835,"about_ca_system_score_codex":0.00038411716,"about_ca_system_score_gemma":0.0009287206,"threshold_uncertainty_score":0.019547164},"labels":[],"label_agreement":null},{"id":"W1931504381","doi":"10.1016/j.jaad.2015.09.014","title":"A retrospective, multicenter analysis of the predictive value of mitotic rate for sentinel lymph node (SLN) positivity in thin melanomas","year":2015,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Sentinel lymph node; Predictive value; Retrospective cohort study; Multicenter study; Oncology; Internal medicine; Cancer","score_opus":0.01442131603697651,"score_gpt":0.2904772554403592,"score_spread":0.2760559394033827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1931504381","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995183,0.00012072182,0.00005218337,0.0000071410504,0.0000035732996,0.0000069622693,0.00013819366,0.0000016918799,0.00015122484],"genre_scores_gemma":[0.99955815,0.00003801768,0.0000742341,0.000013734887,0.000008007487,0.000007546265,0.0002500472,0.0000023295047,0.000048051974],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993536,0.00019990928,0.000093375886,0.00019423715,0.00009035133,0.00006854988],"domain_scores_gemma":[0.99662846,0.0009459895,0.0012659347,0.0004246981,0.0003622779,0.000372678],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012125554,0.00027750237,0.00039915487,0.00069222663,0.00038867848,0.00065974257,0.00040422266,0.0003183596,0.0011702669],"category_scores_gemma":[0.003356202,0.0003844064,0.00045749338,0.0006842646,0.00039525176,0.00046411215,0.00035961883,0.00036230258,0.00021962855],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006184482,0.00004332441,0.99755836,0.000009751521,0.00008500728,0.00011783469,0.000047512403,0.000028286147,0.0005186284,0.000013140076,0.000045364333,0.00091424567],"study_design_scores_gemma":[0.00004515854,0.00038175087,0.9978461,0.000008139829,0.00016143497,0.000656922,0.00016231755,0.00023693564,0.00023787204,0.000016946717,0.00024104305,0.0000053757385],"about_ca_topic_score_codex":0.002028663,"about_ca_topic_score_gemma":0.0021165,"teacher_disagreement_score":0.002028663,"about_ca_system_score_codex":0.00031032338,"about_ca_system_score_gemma":0.00034714057,"threshold_uncertainty_score":0.006412685},"labels":[],"label_agreement":null},{"id":"W193413860","doi":"10.1016/j.jaad.2014.04.070","title":"Evaluation and diagnosis of the hair loss patient","year":2014,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":127,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Hair loss; Dermatology; Alopecia areata; Scarring alopecia; Differential diagnosis; Distress; Cabello; Hair disease; Scalp; Pathology","score_opus":0.03234554808936918,"score_gpt":0.3719685641445745,"score_spread":0.33962301605520534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W193413860","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011467998,0.9703076,0.0018710684,0.0038261125,0.0009082503,0.000049501203,0.000121664816,0.00007435824,0.011373443],"genre_scores_gemma":[0.113666646,0.871739,0.0037776702,0.0043476466,0.0025739323,0.000025934767,0.00044127356,0.000016096814,0.0034117212],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99977475,0.000034425084,0.000037184178,0.00004171625,0.0000791276,0.000032792053],"domain_scores_gemma":[0.99975103,0.000104294064,0.00003638761,0.00001009005,0.000054378273,0.000043886314],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026223934,0.0007104909,0.0008317877,0.0021519638,0.00048241016,0.00078011764,0.00091401825,0.0014100081,0.0017854568],"category_scores_gemma":[0.0011290804,0.00025980445,0.00048175143,0.0008634498,0.00041102857,0.0009899229,0.0005217338,0.001272342,0.00087209826],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015424014,0.00022894629,0.014643924,0.0045741247,0.000120436416,0.20057464,0.00028631676,0.00040374848,0.0067609954,0.0016716612,0.03605439,0.7345266],"study_design_scores_gemma":[0.000028521588,0.000087587396,0.014148082,0.0047438117,0.00020055858,0.8619201,0.00061590504,0.00036500668,0.002094121,0.002184829,0.11355832,0.00005319537],"about_ca_topic_score_codex":0.0011231856,"about_ca_topic_score_gemma":0.0019105596,"teacher_disagreement_score":0.0021519638,"about_ca_system_score_codex":0.0003418263,"about_ca_system_score_gemma":0.00065216667,"threshold_uncertainty_score":0.005972922},"labels":[],"label_agreement":null},{"id":"W1953606094","doi":"10.1016/j.jaad.2015.07.054","title":"The psychosocial impact of hidradenitis suppurativa","year":2015,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; SKiN Health","funders":"","keywords":"Hidradenitis suppurativa; Medicine; Psychosocial; Quality of life (healthcare); Psychological intervention; Disease; Adverse effect; Psychiatry; Pathology; Internal medicine; Nursing","score_opus":0.05794548246555467,"score_gpt":0.44866979477418073,"score_spread":0.39072431230862603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1953606094","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010551997,0.9995797,0.000007756191,0.0000794337,0.000048050908,0.0000016290281,0.000007176034,4.4449908e-7,0.00017030082],"genre_scores_gemma":[0.0018961863,0.9976857,0.000041395346,0.00015331239,0.00013663717,0.0000028833435,0.000012947525,2.5442978e-7,0.00007077085],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996823,0.00008630317,0.000056697536,0.000040508734,0.00010569618,0.000028524377],"domain_scores_gemma":[0.9991352,0.00056917325,0.00017397261,0.0000089621135,0.00008122802,0.00003144907],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006529652,0.00065887545,0.0013894975,0.0017571853,0.00029744784,0.001063557,0.0005650987,0.0009747824,0.002527471],"category_scores_gemma":[0.0017555786,0.00023982949,0.0008533559,0.0018473732,0.00044085222,0.0009155868,0.00067953847,0.0011677508,0.00029087102],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001635104,0.00011807159,0.0019088046,0.08165481,0.0008654531,0.00036409977,0.0001537294,0.00018513743,0.00042158607,0.0012161953,0.013357797,0.8995909],"study_design_scores_gemma":[0.00019935853,0.0004324041,0.03552372,0.12178928,0.005149174,0.008511754,0.0010391524,0.00030142828,0.000553896,0.0032415516,0.82311994,0.00013830209],"about_ca_topic_score_codex":0.0018187758,"about_ca_topic_score_gemma":0.004063089,"teacher_disagreement_score":0.002527471,"about_ca_system_score_codex":0.00042815477,"about_ca_system_score_gemma":0.0009672942,"threshold_uncertainty_score":0.0084552765},"labels":[],"label_agreement":null},{"id":"W1963516566","doi":"10.1016/j.jaad.2003.01.002","title":"Contact dermatitis: A quarter century perspective","year":2004,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Contact Dermatitis and Allergies","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Quarter (Canadian coin); Hubris; Dermatology; Allergic contact dermatitis; Contact dermatitis; Allergy; Classics; Immunology; History","score_opus":0.021378255181425214,"score_gpt":0.34609147601619294,"score_spread":0.3247132208347677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1963516566","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003753575,0.99743915,0.000037521,0.0007564038,0.0011244884,0.0000015627534,0.000008419154,0.0000034786392,0.0005914121],"genre_scores_gemma":[0.00037912675,0.99611074,0.0000947825,0.0011280756,0.0015712554,0.0000030500519,0.000015136359,0.0000010228073,0.00069669296],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995158,0.00008286259,0.000087913846,0.000091182235,0.00017792244,0.000044355096],"domain_scores_gemma":[0.99844724,0.0006060258,0.00023148597,0.000041108637,0.00051108765,0.00016304525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014280792,0.0014131315,0.0023378804,0.004786269,0.00059407746,0.0024289098,0.0010981074,0.0029007723,0.006113998],"category_scores_gemma":[0.0021772005,0.00053431484,0.0006172639,0.0054051233,0.00085775065,0.0046064537,0.0013042378,0.0031759238,0.0028866287],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018354398,0.00013088231,0.00051619584,0.022450961,0.00012732527,0.00063993107,0.00013008466,0.00029223532,0.0009884562,0.0042004585,0.16312167,0.8072183],"study_design_scores_gemma":[0.000026629,0.000066404755,0.0009079627,0.0070730587,0.00013370054,0.0016474911,0.00013058668,0.000058417518,0.0000949839,0.0010960496,0.9887481,0.000016683149],"about_ca_topic_score_codex":0.0021084654,"about_ca_topic_score_gemma":0.005871857,"teacher_disagreement_score":0.006113998,"about_ca_system_score_codex":0.0013594953,"about_ca_system_score_gemma":0.0018563273,"threshold_uncertainty_score":0.020453393},"labels":[],"label_agreement":null},{"id":"W1963766950","doi":"10.1067/mjd.2001.112579","title":"Actinic prurigo: Clinical features and HLA associations in a Canadian Inuit population","year":2001,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Skin Protection and Aging","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; Research Manitoba","funders":"","keywords":"Medicine; Odds ratio; Photosensitivity; Dermatology; Population; Human leukocyte antigen; Typing; Polymerase chain reaction; Immunology; Internal medicine; Genetics; Antigen; Biology; Gene","score_opus":0.027828601535881882,"score_gpt":0.38114109851916467,"score_spread":0.35331249698328276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1963766950","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980248,0.00014758584,0.000058303933,0.00009819428,0.0000047191675,0.000021372656,0.00019352305,0.000004302559,0.0014470216],"genre_scores_gemma":[0.9987931,0.00018915729,0.00010029068,0.00006903192,0.000006736932,0.000007531289,0.0001301822,0.0000047519275,0.0006989856],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995003,0.000038316415,0.000027076432,0.00008682201,0.0001380946,0.0002094248],"domain_scores_gemma":[0.99945503,0.000046352103,0.000073379735,0.000014059941,0.00020392126,0.00020716376],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032214922,0.0006577195,0.00047620188,0.0017083448,0.0057574753,0.0010766556,0.0010565716,0.00063529995,0.0034313009],"category_scores_gemma":[0.001212612,0.0003887674,0.0003353332,0.0027162472,0.0009107001,0.0003700206,0.00064090925,0.00056851114,0.000322909],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028374678,0.00037196503,0.97694004,0.00004311256,0.000053959768,0.00596489,0.0066730403,0.000087446635,0.0021383266,0.0003096426,0.00086930406,0.00626451],"study_design_scores_gemma":[0.000021156682,0.000179108,0.9856435,0.00001915272,0.000057488993,0.005189324,0.00731812,0.0002772862,0.00011273276,0.00007712241,0.0010795493,0.000025331983],"about_ca_topic_score_codex":0.94173497,"about_ca_topic_score_gemma":0.944047,"teacher_disagreement_score":0.05826503,"about_ca_system_score_codex":0.005613634,"about_ca_system_score_gemma":0.00557286,"threshold_uncertainty_score":0.11721629},"labels":[],"label_agreement":null},{"id":"W1964184432","doi":"10.1016/j.jaad.2010.07.026","title":"Assessment of the long-term safety and effectiveness of etanercept for the treatment of psoriasis in an adult population","year":2010,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":100,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"XLV Diagnostics (Canada); Innovation Initiatives Ontario North; Moncton Hospital; Amgen (Canada); Innovaderm (Canada); Centre de Recherche Dermatologique du Québec Métropolitain; Probity Medical Research","funders":"","keywords":"Medicine; Etanercept; Dermatology Life Quality Index; Adverse effect; Psoriasis; Confidence interval; Psoriasis Area and Severity Index; Population; Internal medicine; Quality of life (healthcare); Surgery; Dermatology","score_opus":0.013176974594710403,"score_gpt":0.3136862525341223,"score_spread":0.3005092779394119,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964184432","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99614835,0.0022413195,0.00025500223,0.00018135748,0.000020162634,0.00002815736,0.0001910671,0.0000058753826,0.00092876505],"genre_scores_gemma":[0.9985123,0.00056447263,0.00015527756,0.00016606759,0.000082408485,0.000014951644,0.00023877955,0.0000015717296,0.0002641519],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99855,0.00053033495,0.00020939157,0.00014851782,0.00044411005,0.00011763256],"domain_scores_gemma":[0.99528533,0.0018410766,0.0014026598,0.0002579427,0.00081844867,0.00039464876],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004580123,0.00022428503,0.00060259673,0.00042663206,0.00039298227,0.000563232,0.00024061213,0.0007064615,0.0010050002],"category_scores_gemma":[0.006622667,0.0001268179,0.0007074947,0.00036795347,0.0003199598,0.0006867746,0.00020465945,0.0006996911,0.00020548362],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028000072,0.0025336854,0.88105434,0.00020829517,0.0009213414,0.00042262636,0.00029883237,0.0004043946,0.004810122,0.00013737121,0.00040678598,0.080802195],"study_design_scores_gemma":[0.00095165265,0.033936862,0.95941824,0.000035669473,0.00071001746,0.0011995471,0.00021551855,0.0009750892,0.001236777,0.00012215483,0.0011720251,0.000026495649],"about_ca_topic_score_codex":0.0009002721,"about_ca_topic_score_gemma":0.0008756867,"teacher_disagreement_score":0.004580123,"about_ca_system_score_codex":0.0003597162,"about_ca_system_score_gemma":0.00037727505,"threshold_uncertainty_score":0.024222314},"labels":[],"label_agreement":null},{"id":"W1965125798","doi":"10.1016/j.jaad.2006.05.005","title":"Childhood acquired lipodystrophy: A retrospective study","year":2006,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Nuclear Structure and Function","field":"Biochemistry, Genetics and Molecular Biology","cited_by":67,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Retrospective cohort study; Pediatrics; Juvenile dermatomyositis; Context (archaeology); Hyperpigmentation; Lipodystrophy; Surgery; Dermatomyositis; Dermatology; Immunology","score_opus":0.00388273855054041,"score_gpt":0.23858634807218143,"score_spread":0.23470360952164102,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965125798","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987165,0.00025857586,0.00010525936,0.000022341144,0.0000047469434,0.000009427,0.00015625822,0.0000065770037,0.00072033354],"genre_scores_gemma":[0.99924314,0.00024352764,0.000072910385,0.000024015977,0.000012533618,0.0000055229,0.00019785465,0.000006034193,0.00019448332],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99924064,0.00012314286,0.000091507114,0.00022739559,0.00011589844,0.0002015038],"domain_scores_gemma":[0.99738187,0.0006974344,0.00083389453,0.00038461346,0.00023387707,0.00046824978],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004585622,0.0007523363,0.00080008205,0.0021366482,0.0015168043,0.0010022579,0.00059301825,0.0009327289,0.0034721226],"category_scores_gemma":[0.0018930943,0.0009335335,0.000562434,0.0018737343,0.0014325863,0.0009249908,0.00081562746,0.0008019166,0.00077808567],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019750455,0.00011332693,0.97407407,0.000015522213,0.000035613954,0.0230199,0.00032119267,0.000049559276,0.0009758102,0.00008052838,0.00006810697,0.0010488554],"study_design_scores_gemma":[0.000031050473,0.00058987347,0.8414661,0.000021408008,0.00015154536,0.15386124,0.0018141714,0.00022159297,0.0007861639,0.000079226826,0.0009472182,0.00003028177],"about_ca_topic_score_codex":0.003451955,"about_ca_topic_score_gemma":0.0023171613,"teacher_disagreement_score":0.0034721226,"about_ca_system_score_codex":0.00054803764,"about_ca_system_score_gemma":0.00077082444,"threshold_uncertainty_score":0.011615396},"labels":[],"label_agreement":null},{"id":"W1965684159","doi":"10.1067/mjd.2000.109069","title":"Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States","year":2000,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; Sunnybrook Health Science Centre","funders":"","keywords":"Itraconazole; Griseofulvin; Medicine; Dermatophyte; Terbinafine; Fluconazole; Dermatology; Nail (fastener); Antifungal","score_opus":0.052516668633946134,"score_gpt":0.39685086429807964,"score_spread":0.3443341956641335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965684159","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0035770233,0.9949334,0.000083548955,0.00020326486,0.000056675854,0.000022857485,0.000066118635,0.0000051756765,0.0010519414],"genre_scores_gemma":[0.013305438,0.9849416,0.00031924277,0.00039584044,0.00009334838,0.000024255287,0.000106391075,0.0000012990827,0.00081254187],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99975044,0.00005532889,0.000043375825,0.000025496607,0.00010951193,0.000015872216],"domain_scores_gemma":[0.9997009,0.00012665924,0.00008761071,0.0000054959264,0.00006286277,0.000016519076],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005256998,0.0004049439,0.0013382827,0.001396667,0.00015014719,0.00040342848,0.0005682137,0.0005444797,0.0019182282],"category_scores_gemma":[0.0005772697,0.0001343881,0.000618251,0.0015784514,0.00015582716,0.0002974776,0.00015067714,0.0003484006,0.00033170497],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001097499,0.00032127107,0.0008307103,0.022236189,0.00047779715,0.0008042802,0.000052509764,0.0002885334,0.0033741207,0.00040647318,0.00821091,0.9618997],"study_design_scores_gemma":[0.0021314314,0.007640655,0.05819647,0.012894234,0.008408573,0.014894995,0.0004859341,0.0010905542,0.009930594,0.0012354363,0.8829658,0.00012517975],"about_ca_topic_score_codex":0.0024862576,"about_ca_topic_score_gemma":0.007251534,"teacher_disagreement_score":0.0024862576,"about_ca_system_score_codex":0.00052757043,"about_ca_system_score_gemma":0.000880639,"threshold_uncertainty_score":0.0064170957},"labels":[],"label_agreement":null},{"id":"W1965908002","doi":"10.1016/j.jaad.2008.11.021","title":"Eruptive pyogenic granulomas developing after drug hypersensitivity reaction","year":2009,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Vascular Malformations and Hemangiomas","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Pyogenic granuloma; Medicine; Capillary hemangioma; Hypersensitivity reaction; Dermatology; Hemangioma; Granuloma; Pathology; Immunology; Lesion","score_opus":0.012658765727380882,"score_gpt":0.2934708933196761,"score_spread":0.2808121275922952,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965908002","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96145374,0.0033300496,0.0045479,0.00069085695,0.0002530379,0.0002376901,0.00015705277,0.00043196167,0.028897697],"genre_scores_gemma":[0.99816567,0.00029297033,0.00027481103,0.00021116214,0.000115186216,0.000012520915,0.00003067629,0.000010735803,0.0008863131],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99922574,0.00015123047,0.000057860525,0.00009465847,0.0001569875,0.0003134961],"domain_scores_gemma":[0.9977447,0.001032896,0.00040438297,0.00040680284,0.00010896958,0.00030235053],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069102895,0.00081925455,0.00073306554,0.0012227318,0.00096632284,0.0008015686,0.00059608783,0.0020293118,0.0026196763],"category_scores_gemma":[0.0033925746,0.00051471393,0.0008801453,0.00056504435,0.0008501116,0.0010631249,0.00065713236,0.0023602578,0.0007586704],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004956363,0.00022793008,0.015507496,0.00006628629,0.00003221942,0.9721013,0.00020176375,0.00014543449,0.0038706919,0.0006349744,0.0004166031,0.0062998217],"study_design_scores_gemma":[0.00013984556,0.0005415662,0.041255083,0.000020215082,0.000059707676,0.9494244,0.000101575475,0.0008807072,0.005291404,0.00033481157,0.0019342513,0.000016458978],"about_ca_topic_score_codex":0.00063686277,"about_ca_topic_score_gemma":0.0005762104,"teacher_disagreement_score":0.0026196763,"about_ca_system_score_codex":0.00058373174,"about_ca_system_score_gemma":0.00030888442,"threshold_uncertainty_score":0.0087637305},"labels":[],"label_agreement":null},{"id":"W1966842773","doi":"10.1016/j.jaad.2003.10.159","title":"Acneiform eruptions caused by an epidermal growth factor receptor-tyrosine kinase inhibitor ZD 1839","year":2004,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Systems, Applications & Products in Data Processing (Canada)","funders":"","keywords":"Medicine; Tyrosine-kinase inhibitor; Tyrosine kinase; Dermatology; Epidermal growth factor receptor; Cancer research; Receptor; Internal medicine; Cancer","score_opus":0.02426059917868966,"score_gpt":0.33379022692651306,"score_spread":0.3095296277478234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966842773","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9873481,0.0024502003,0.0013466808,0.00038882194,0.00012655076,0.00012140441,0.00016604764,0.0002619868,0.0077903233],"genre_scores_gemma":[0.99830973,0.00034628846,0.00016647643,0.000060080412,0.00002174738,0.000008557347,0.00006557721,0.0000056041517,0.0010159008],"study_design_codex":"bench_or_experimental","study_design_gemma":"case_report","domain_scores_codex":[0.99983966,0.000045092773,0.0000104285355,0.000016502332,0.000034413464,0.00005386861],"domain_scores_gemma":[0.99987864,0.000044426582,0.000028661863,0.000015167367,0.00000750137,0.000025571766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022724761,0.0004022248,0.00073246425,0.0002746099,0.00032096772,0.00023105615,0.00026647482,0.00047487282,0.0016721857],"category_scores_gemma":[0.00031679188,0.00022375234,0.0003488955,0.00016517848,0.00023689734,0.00017488352,0.00010839941,0.0013249429,0.00029585132],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021155382,0.0032623478,0.013484104,0.00046662433,0.00031561972,0.058989737,0.00013374609,0.0018325914,0.78594774,0.0014637624,0.0048360834,0.1081123],"study_design_scores_gemma":[0.019774968,0.029456407,0.22029121,0.000054258377,0.0008491737,0.17775236,0.00018321742,0.018820314,0.4912835,0.00072883925,0.0407271,0.00007860335],"about_ca_topic_score_codex":0.001133663,"about_ca_topic_score_gemma":0.001951551,"teacher_disagreement_score":0.0016721857,"about_ca_system_score_codex":0.00039898828,"about_ca_system_score_gemma":0.00020383354,"threshold_uncertainty_score":0.005594015},"labels":[],"label_agreement":null},{"id":"W1967172126","doi":"10.1016/j.jaad.2013.01.046","title":"Treatment of mucous membrane pemphigoid with rituximab","year":2013,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Autoimmune Bullous Skin Diseases","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Rituximab; Medicine; Dermatology; Refractory (planetary science); Pemphigoid; Cicatricial pemphigoid; Antibody; Internal medicine; Immunology; Bullous pemphigoid","score_opus":0.013803675498207359,"score_gpt":0.2785170180046684,"score_spread":0.264713342506461,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967172126","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3492441,0.05695258,0.008366826,0.425038,0.021427276,0.00055480323,0.00029089148,0.0006894412,0.13743602],"genre_scores_gemma":[0.89672685,0.008640493,0.0021904628,0.06290692,0.017256537,0.00015930575,0.00013461693,0.00004336022,0.011941467],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9989718,0.0003043725,0.00011980528,0.00010277868,0.00022651032,0.00027477212],"domain_scores_gemma":[0.9993967,0.00032718235,0.000059003825,0.000044025663,0.000056958503,0.00011622937],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009630374,0.0008206227,0.0010881372,0.00073765736,0.0018076951,0.0009720243,0.0010045785,0.008367272,0.0015138505],"category_scores_gemma":[0.0038011703,0.00039851936,0.0017463047,0.0004024724,0.0010210298,0.0013020608,0.00051783485,0.005535892,0.00083073427],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074697286,0.00040270807,0.009610013,0.0003039955,0.00015417663,0.89986384,0.00020801096,0.0008598933,0.00371549,0.0028787276,0.04381965,0.037436537],"study_design_scores_gemma":[0.0012695765,0.0010369787,0.014770127,0.00037291646,0.00019218735,0.8997983,0.00019801006,0.0046770326,0.0026108567,0.004626433,0.07037832,0.000069294285],"about_ca_topic_score_codex":0.0014546105,"about_ca_topic_score_gemma":0.0020845921,"teacher_disagreement_score":0.008367272,"about_ca_system_score_codex":0.0019820274,"about_ca_system_score_gemma":0.000727628,"threshold_uncertainty_score":0.014380753},"labels":[],"label_agreement":null},{"id":"W1967601044","doi":"10.1016/j.jaad.2009.05.054","title":"Iron deficiency and diffuse nonscarring scalp alopecia in women: More pieces to the puzzle","year":2010,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Scalp; Hair loss; Iron deficiency; Medicine; Dermatology; Hair follicle; Alopecia areata; Physiology; Internal medicine; Anemia","score_opus":0.01702565376393845,"score_gpt":0.3368630190970625,"score_spread":0.31983736533312407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967601044","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001118949,0.99919873,0.000020806097,0.00028529306,0.00011283952,0.000001024273,0.0000067054457,0.0000020658292,0.00026066386],"genre_scores_gemma":[0.00083550054,0.99806696,0.000056243127,0.000333623,0.0003729606,0.0000013901245,0.00001640663,6.816468e-7,0.00031613975],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99986243,0.000021811597,0.000023106946,0.000025916639,0.000053060823,0.000013646498],"domain_scores_gemma":[0.9997265,0.00012901762,0.000056296685,0.0000062864524,0.00005716742,0.00002469093],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032737324,0.00068175467,0.0018478876,0.0015714017,0.0001845122,0.00077671657,0.0006493986,0.0010138144,0.0026353311],"category_scores_gemma":[0.0005816086,0.0002008015,0.00044002495,0.0015468325,0.00033254657,0.0010287885,0.00038535026,0.0011370428,0.0007975473],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014385076,0.000071722934,0.000923601,0.0155441435,0.00017747805,0.0010611023,0.00006269816,0.00011374097,0.000997859,0.0007374003,0.061910808,0.91825557],"study_design_scores_gemma":[0.00016410052,0.00015703129,0.011146364,0.013879199,0.0008512436,0.019445203,0.00034995642,0.00020366798,0.00033373226,0.0021111283,0.95129937,0.000059039125],"about_ca_topic_score_codex":0.0018726082,"about_ca_topic_score_gemma":0.0045430115,"teacher_disagreement_score":0.0026353311,"about_ca_system_score_codex":0.00032979096,"about_ca_system_score_gemma":0.0006691208,"threshold_uncertainty_score":0.008816063},"labels":[],"label_agreement":null},{"id":"W1968055097","doi":"10.1016/j.jaad.2006.02.009","title":"The treatment of melasma: A review of clinical trials","year":2006,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Dermatologic Treatments and Research","field":"Medicine","cited_by":469,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; Mediprobe Research (Canada); Sunnybrook Health Science Centre","funders":"","keywords":"Melasma; Dermatology; Medicine; Azelaic acid; Tretinoin; Keratolytic; Hyperpigmentation; Retinoic acid","score_opus":0.3126494059244671,"score_gpt":0.5906454503965518,"score_spread":0.2779960444720847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968055097","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014735296,0.99953175,0.00004927443,0.00006782896,0.000041502728,0.000016992884,0.000026178886,0.0000027930694,0.00011621248],"genre_scores_gemma":[0.0013747723,0.9980426,0.00021293925,0.00021527412,0.000044613596,0.000015515487,0.000029210078,0.0000011737537,0.000063993175],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9994886,0.00012260034,0.00014231955,0.000080463324,0.00014035194,0.000025706368],"domain_scores_gemma":[0.9982323,0.0012258932,0.0003133897,0.000026799034,0.00014695454,0.00005461302],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015900097,0.0010999202,0.004703102,0.002430034,0.0002673408,0.001014597,0.0018470593,0.0012308114,0.0040056584],"category_scores_gemma":[0.0030321016,0.00042343422,0.0021988405,0.00280617,0.00049780245,0.0011293268,0.0005146018,0.0012830757,0.00047175612],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013558348,0.00018766579,0.00040158993,0.2406136,0.00248551,0.00023623322,0.000073349256,0.00044421,0.0012208018,0.0005621936,0.012127799,0.7402911],"study_design_scores_gemma":[0.00468031,0.004168043,0.012769315,0.23987377,0.038572922,0.0057655494,0.0005843253,0.0009444181,0.0022913374,0.002808257,0.68729484,0.00024692318],"about_ca_topic_score_codex":0.0016840061,"about_ca_topic_score_gemma":0.0051741158,"teacher_disagreement_score":0.004703102,"about_ca_system_score_codex":0.0006250526,"about_ca_system_score_gemma":0.0012004903,"threshold_uncertainty_score":0.013400316},"labels":[],"label_agreement":null},{"id":"W1968080786","doi":"10.1016/j.jaad.2014.07.030","title":"Diameter of dysplastic nevi is a more robust biomarker of increased melanoma risk than degree of histologic dysplasia: A case-control study","year":2014,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; University of Calgary","funders":"","keywords":"Medicine; Dysplastic nevus; Grading (engineering); Dysplasia; Melanoma; Dermatology; Pathology; Nevus","score_opus":0.029354806909406294,"score_gpt":0.278089042467406,"score_spread":0.24873423555799973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968080786","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97977954,0.0022802856,0.0012839425,0.01190938,0.0008962829,0.00006208086,0.00051683455,0.00003254475,0.0032390573],"genre_scores_gemma":[0.9919778,0.00051888096,0.00067600276,0.003986234,0.0016513438,0.00002702116,0.00013532593,0.000010564477,0.0010167444],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981287,0.0006630173,0.00029000212,0.00046671255,0.00032936496,0.00012230106],"domain_scores_gemma":[0.9899136,0.005708041,0.001477362,0.0012422882,0.0011187996,0.0005399102],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028837163,0.0005473452,0.0008107844,0.00075716124,0.0007029695,0.0012371842,0.00078939117,0.0037525943,0.0019313544],"category_scores_gemma":[0.013347147,0.0006130145,0.0007383505,0.00081512786,0.0007238587,0.00083355355,0.00030337603,0.0018025674,0.00030984476],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00097124884,0.00021187466,0.9746966,0.00007550244,0.00046493023,0.011151736,0.0003540165,0.000042900203,0.001727857,0.00022145483,0.0036108578,0.0064710598],"study_design_scores_gemma":[0.00031967065,0.000996628,0.9277025,0.00007491099,0.00082848116,0.061272856,0.000554293,0.0013319204,0.00048076565,0.00074687606,0.0056312173,0.000059978705],"about_ca_topic_score_codex":0.0022386974,"about_ca_topic_score_gemma":0.0031920872,"teacher_disagreement_score":0.0037525943,"about_ca_system_score_codex":0.00036389177,"about_ca_system_score_gemma":0.00026876354,"threshold_uncertainty_score":0.015250742},"labels":[],"label_agreement":null},{"id":"W1968296917","doi":"10.1016/j.jaad.2006.01.016","title":"Dermatophytes: Diagnosis and treatment","year":2006,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; Mediprobe Research (Canada); Sunnybrook Health Science Centre","funders":"","keywords":"Dermatophyte; Medicine; Limiting; Dermatology; Presentation (obstetrics); Pathology; Surgery","score_opus":0.015294004904793415,"score_gpt":0.30648761097390015,"score_spread":0.2911936060691067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968296917","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.026597634,0.86214495,0.012884605,0.04886363,0.0034552536,0.00012768009,0.00017754963,0.00019542925,0.04555336],"genre_scores_gemma":[0.2613806,0.68057096,0.015593111,0.0076623424,0.011827642,0.00008600981,0.00038871044,0.0000325684,0.0224581],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99943596,0.00011939911,0.00007239492,0.00004818284,0.000249779,0.00007422913],"domain_scores_gemma":[0.9997147,0.000056369732,0.000051328163,0.000017370246,0.000095046445,0.00006514467],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006497255,0.0005631762,0.00067855703,0.0013614849,0.00051948405,0.0013242711,0.00049040234,0.0017497028,0.0026445566],"category_scores_gemma":[0.0011759289,0.00021902692,0.0003815528,0.00068833877,0.00066929945,0.0010627442,0.00067533454,0.001726413,0.0018338994],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003224575,0.0005761829,0.014334334,0.001137506,0.0000372471,0.018726606,0.00023697372,0.00037969623,0.010181714,0.008911878,0.07487853,0.8702768],"study_design_scores_gemma":[0.00012806659,0.0005551559,0.031512417,0.0018170029,0.00013501602,0.25331348,0.0011128979,0.00097503635,0.009099383,0.01814388,0.6831333,0.00007436515],"about_ca_topic_score_codex":0.000745274,"about_ca_topic_score_gemma":0.0012472568,"teacher_disagreement_score":0.0026445566,"about_ca_system_score_codex":0.00063940434,"about_ca_system_score_gemma":0.0012238765,"threshold_uncertainty_score":0.008846939},"labels":[],"label_agreement":null},{"id":"W1968405676","doi":"10.1016/j.jaad.2013.07.023","title":"Prevalence of rheumatologist-diagnosed psoriatic arthritis in patients with psoriasis in European/North American dermatology clinics","year":2013,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":509,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland; Probity Medical Research; University of Toronto","funders":"","keywords":"Medicine; Psoriatic arthritis; Psoriasis; Dermatology; Physical examination; Medical history; Internal medicine; Arthritis; Rheumatology","score_opus":0.009897535843477008,"score_gpt":0.26665756745459707,"score_spread":0.25676003161112004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968405676","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980751,0.00065233686,0.000021793256,0.00008791306,0.000006688203,0.000004499738,0.00024091451,0.000004086931,0.0009066791],"genre_scores_gemma":[0.9995735,0.00017198593,0.000022553988,0.000044034798,0.000010915865,0.0000023941748,0.000090207606,0.0000010367792,0.00008328133],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991731,0.00025772242,0.00014027955,0.00014639024,0.00015472894,0.00012774035],"domain_scores_gemma":[0.9984511,0.00030762047,0.0007269155,0.000042908203,0.0001693234,0.00030209697],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053242105,0.00016617596,0.0003010087,0.001561811,0.000541222,0.0008160244,0.00037473562,0.00062494806,0.0028525982],"category_scores_gemma":[0.0022696715,0.00025547537,0.00039249499,0.0014213008,0.0002946252,0.0005639948,0.0004005225,0.00039630476,0.0002464287],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005069324,0.00003715849,0.9985783,0.0000110799165,0.00002471779,0.00010120145,0.00013084168,0.000008883091,0.0001650225,0.000011015206,0.00009028012,0.0007908724],"study_design_scores_gemma":[0.0000042914576,0.000026035477,0.99887043,0.000007088345,0.000012306923,0.00045351262,0.0004984794,0.000034884466,0.000016409287,0.00000585932,0.000068858804,0.0000019643603],"about_ca_topic_score_codex":0.010947587,"about_ca_topic_score_gemma":0.014636726,"teacher_disagreement_score":0.010947587,"about_ca_system_score_codex":0.0003535218,"about_ca_system_score_gemma":0.0003627868,"threshold_uncertainty_score":0.021767735},"labels":[],"label_agreement":null},{"id":"W1968430532","doi":"10.1016/s0190-9622(03)02121-2","title":"Coexistence of erythromelalgia and Raynaud's phenomenon","year":2004,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Sympathectomy and Hyperhidrosis Treatments","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Erythromelalgia; Pallor; Medicine; Pathophysiology; Dermatology; RAYNAUD DISEASE; Presentation (obstetrics); Disease; Phenomenon; Surgery; Pathology","score_opus":0.0445274695121092,"score_gpt":0.37282410211891953,"score_spread":0.3282966326068103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968430532","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00038982838,0.9986363,0.000097251635,0.000121756566,0.000080423924,0.0000020249272,0.000008030195,0.0000053079034,0.00065910583],"genre_scores_gemma":[0.0043992074,0.9943083,0.0002460596,0.00019628192,0.00037778026,0.000004038119,0.000036296213,0.0000013592692,0.00043071466],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997209,0.000045517554,0.000058823367,0.000060421968,0.000091450216,0.00002287671],"domain_scores_gemma":[0.99952686,0.00024357982,0.00012067601,0.000012102459,0.0000679493,0.00002885695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040139072,0.00081511587,0.0020096495,0.0030429359,0.00026655867,0.0008584633,0.00096371904,0.0011243048,0.0019781112],"category_scores_gemma":[0.00089537754,0.00031989272,0.00045148877,0.0022925276,0.0004736037,0.0012196794,0.00040952238,0.0010528734,0.0009162762],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015346079,0.00010293796,0.0024520531,0.013046724,0.0002134108,0.008570701,0.00005404481,0.00023593874,0.0017994737,0.00077978976,0.013503842,0.9590876],"study_design_scores_gemma":[0.00019349011,0.00032619137,0.021583479,0.009617578,0.0016590202,0.1877199,0.0004103415,0.0005186468,0.0020958434,0.0025458853,0.7732247,0.000104956445],"about_ca_topic_score_codex":0.0013058946,"about_ca_topic_score_gemma":0.0026712776,"teacher_disagreement_score":0.0030429359,"about_ca_system_score_codex":0.00037322467,"about_ca_system_score_gemma":0.00084806624,"threshold_uncertainty_score":0.006617427},"labels":[],"label_agreement":null},{"id":"W1968892592","doi":"10.1016/j.jaad.2006.04.084","title":"Systematic review of rosacea treatments","year":2006,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mediprobe Research (Canada); Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Rosacea; Dermatology","score_opus":0.02456842003084935,"score_gpt":0.3774730762208786,"score_spread":0.35290465619002925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968892592","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011306423,0.9973109,0.000121775534,0.0001379878,0.00012406168,0.0003836847,0.00038934645,0.000009525315,0.00039211134],"genre_scores_gemma":[0.023637343,0.9738511,0.00090913795,0.00058031763,0.00007725263,0.00047873677,0.00020882292,0.00000634927,0.00025097447],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99323505,0.002576426,0.002394139,0.00048271538,0.0010757116,0.00023600094],"domain_scores_gemma":[0.98858196,0.006526911,0.0034799324,0.00022220933,0.0009693097,0.0002197523],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0065349387,0.0017866632,0.010672757,0.008315527,0.0005820972,0.0019635116,0.0020368746,0.0018433945,0.007579938],"category_scores_gemma":[0.021796042,0.0014461983,0.007671343,0.0077606975,0.00084893696,0.0016573399,0.0017995352,0.0013004495,0.00040640513],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004168873,0.000020677351,0.00035598307,0.95450956,0.01964851,0.00010267106,0.00012392989,0.000089801186,0.0001473136,0.000105490544,0.001532764,0.022946464],"study_design_scores_gemma":[0.0021593194,0.00056543935,0.006727857,0.6469316,0.30790114,0.0006396171,0.00028598733,0.00010525097,0.00032253578,0.00031796095,0.03397967,0.00006353287],"about_ca_topic_score_codex":0.010489685,"about_ca_topic_score_gemma":0.041455764,"teacher_disagreement_score":0.010672757,"about_ca_system_score_codex":0.003118671,"about_ca_system_score_gemma":0.007202849,"threshold_uncertainty_score":0.034560442},"labels":[],"label_agreement":null},{"id":"W1968962609","doi":"10.1016/j.jaad.2005.08.041","title":"A comparative study of two Congo red stains for the detection of primary cutaneous amyloidosis","year":2006,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Skin and Cellular Biology Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"","keywords":"Congo red; Amyloidosis; Medicine; Amyloid (mycology); Pathology; Stain; Staining; Gold standard (test); Dermatology; Internal medicine; Chemistry","score_opus":0.023791466534048455,"score_gpt":0.32231064444392743,"score_spread":0.298519177909879,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968962609","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9518314,0.018343532,0.01153583,0.004471828,0.0016835142,0.00018698473,0.00018789638,0.0003012862,0.011457705],"genre_scores_gemma":[0.9838847,0.0034021782,0.009042138,0.0010906225,0.00044991076,0.0000607975,0.00028794355,0.000060017483,0.0017216523],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99925774,0.00028154821,0.00009314682,0.00010024474,0.00015216398,0.0001151407],"domain_scores_gemma":[0.9972952,0.0015161,0.00009895736,0.0002881682,0.0006529311,0.0001487332],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002453985,0.0006221733,0.00047513566,0.0015878689,0.00046159994,0.0005992759,0.00081115216,0.0016753776,0.002049489],"category_scores_gemma":[0.0031986206,0.00043827947,0.0007805006,0.0004194935,0.0007681439,0.0009563668,0.00031510388,0.001053505,0.00086318253],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005042677,0.00051876693,0.014000631,0.00089265674,0.00026062338,0.020307157,0.000577112,0.00011776492,0.9010204,0.0011268635,0.0032279473,0.052907467],"study_design_scores_gemma":[0.0011745848,0.0063723996,0.11827948,0.00026687,0.0014763345,0.21660854,0.0010471257,0.003398728,0.6006566,0.0017802492,0.04880098,0.00013810245],"about_ca_topic_score_codex":0.00082523003,"about_ca_topic_score_gemma":0.0012619796,"teacher_disagreement_score":0.002453985,"about_ca_system_score_codex":0.0005719954,"about_ca_system_score_gemma":0.0001486626,"threshold_uncertainty_score":0.012978077},"labels":[],"label_agreement":null},{"id":"W1969405459","doi":"10.1016/j.jaad.2003.10.457","title":"Neurofibromatosis type 1, mastocytoma and autism","year":2004,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Neurofibromatosis and Schwannoma Cases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Neurofibromatosis; Autism; Dermatology; Pathology; Psychiatry","score_opus":0.019235796157829034,"score_gpt":0.29362020300798014,"score_spread":0.2743844068501511,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969405459","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9555162,0.0034092206,0.0005988235,0.0016179804,0.00019264274,0.0000709629,0.0002247557,0.000121251454,0.038248226],"genre_scores_gemma":[0.995574,0.0006950093,0.0005528827,0.00022557913,0.0002441722,0.000027762708,0.000058095015,0.000014179614,0.002608335],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9995065,0.000044721834,0.000076037046,0.000078013894,0.00011105239,0.00018377334],"domain_scores_gemma":[0.9990029,0.00037781097,0.00028037262,0.00005983008,0.00005159874,0.00022762481],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043493783,0.0013744347,0.0004730336,0.0028768007,0.0028095895,0.001073042,0.00096072635,0.0031497092,0.004712607],"category_scores_gemma":[0.0032624046,0.00074025133,0.0005343444,0.0012216427,0.0017713938,0.0012888341,0.0013043246,0.0010703916,0.00073407433],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008834605,0.000028378585,0.022629574,0.00003391711,0.000011658338,0.9720386,0.00028810246,0.00009220733,0.0017274184,0.0007413549,0.00036782245,0.0019526017],"study_design_scores_gemma":[0.000015025211,0.0000332576,0.019192798,0.000009000655,0.000012850641,0.97898805,0.00019007227,0.000117189404,0.00041226204,0.00039673064,0.00062528497,0.0000075685775],"about_ca_topic_score_codex":0.004751135,"about_ca_topic_score_gemma":0.009308429,"teacher_disagreement_score":0.004751135,"about_ca_system_score_codex":0.0012060094,"about_ca_system_score_gemma":0.0008021837,"threshold_uncertainty_score":0.01576525},"labels":[],"label_agreement":null},{"id":"W1970753372","doi":"10.1016/j.jaad.2006.09.025","title":"A randomized bilateral vehicle-controlled study of eflornithine cream combined with laser treatment versus laser treatment alone for facial hirsutism in women","year":2007,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":133,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health Research Institute; University of British Columbia; Vancouver Coastal Health","funders":"","keywords":"Medicine; Eflornithine; hirsutism; Dermatology; Laser treatment; Randomized controlled trial; Surgery; Laser; Internal medicine","score_opus":0.0164096658968434,"score_gpt":0.30759559161402766,"score_spread":0.29118592571718427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970753372","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915916,0.0020984935,0.00047458455,0.0004678716,0.00080844277,0.0022320363,0.0005550639,0.00008612245,0.0016858001],"genre_scores_gemma":[0.98845714,0.0019496279,0.0013762672,0.00070312596,0.00073655637,0.0027728626,0.00044073616,0.000026339263,0.0035373606],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99896514,0.00044842972,0.00008397652,0.00021100021,0.00008530156,0.00020621266],"domain_scores_gemma":[0.998803,0.00045399563,0.0001692113,0.00011427592,0.00007731115,0.00038225894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016152128,0.0016605676,0.005322672,0.00091579964,0.0009082369,0.0009434134,0.0016430332,0.0025320589,0.0116641475],"category_scores_gemma":[0.0023357293,0.0012393761,0.0016785525,0.0006889379,0.002040777,0.0015884498,0.0005897122,0.0030492742,0.0013787256],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.984397,0.008793393,0.0001411939,0.00016739692,0.00024670112,0.000022483468,0.000023153012,0.000059142745,0.001557646,0.000038209288,0.0001171338,0.004436451],"study_design_scores_gemma":[0.92538065,0.072737515,0.0008742209,0.000013027865,0.00032425817,0.000012847249,0.000027525546,0.000119350894,0.00024400045,0.000058754827,0.00019775688,0.0000101106625],"about_ca_topic_score_codex":0.0031906127,"about_ca_topic_score_gemma":0.0057547847,"teacher_disagreement_score":0.0116641475,"about_ca_system_score_codex":0.0010615521,"about_ca_system_score_gemma":0.0013339168,"threshold_uncertainty_score":0.03902048},"labels":[],"label_agreement":null},{"id":"W1970799293","doi":"10.1016/j.jaad.2014.09.048","title":"Acral localized acquired cutis laxa: Report of a case associated with inflammatory arthritis","year":2014,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Skin Diseases and Diabetes","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Calgary","funders":"","keywords":"Medicine; Cutis laxa; Dermatology; Erythema; Rheumatoid arthritis; Arthritis; Physical examination; Cutis; Surgery; Internal medicine","score_opus":0.013095336881550542,"score_gpt":0.27947612318053766,"score_spread":0.2663807862989871,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970799293","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8463187,0.06314517,0.007926413,0.037740238,0.0145808235,0.00048577026,0.000606564,0.0008104658,0.028385889],"genre_scores_gemma":[0.9583011,0.008926774,0.0026723365,0.005468035,0.020725613,0.000081543985,0.00016457749,0.00006927561,0.0035907459],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99821556,0.00023967988,0.0002186708,0.00042682842,0.000247619,0.0006515734],"domain_scores_gemma":[0.99514836,0.0016343807,0.0010788728,0.00034241218,0.00046471672,0.0013313056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010648211,0.0031644837,0.0026477391,0.004162886,0.003045991,0.0031527816,0.0025092212,0.010274473,0.00401611],"category_scores_gemma":[0.005411143,0.0019035699,0.0017828743,0.0030125855,0.0022688597,0.0034548517,0.002469135,0.0050782226,0.0018666054],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021634549,0.000027987788,0.0017618875,0.00007052629,0.000011350193,0.9958312,0.00010544697,0.000022694705,0.00032501487,0.000094657,0.00092503836,0.0008025985],"study_design_scores_gemma":[0.00001796213,0.00003362097,0.0017967768,0.000027756398,0.000021290276,0.9962423,0.00011776781,0.0001514677,0.00012327067,0.0000736193,0.0013834321,0.000010814761],"about_ca_topic_score_codex":0.0017505459,"about_ca_topic_score_gemma":0.0021110123,"teacher_disagreement_score":0.010274473,"about_ca_system_score_codex":0.0016696363,"about_ca_system_score_gemma":0.0007871857,"threshold_uncertainty_score":0.013435185},"labels":[],"label_agreement":null},{"id":"W1970993308","doi":"10.1016/j.jaad.2004.08.046","title":"Long-term treatment of atopic dermatitis with pimecrolimus cream 1% in infants does not interfere with the development of protective antibodies after vaccination","year":2005,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Pimecrolimus; Medicine; Atopic dermatitis; Measles; Vaccination; Dermatology; Diphtheria; Rubella; Tetanus; Atopy; Immunology; Pediatrics; Allergy; Calcineurin; Internal medicine","score_opus":0.010054581319521359,"score_gpt":0.2903227321416454,"score_spread":0.28026815082212403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970993308","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974349,0.001608852,0.00014663563,0.00006618809,0.000037305406,0.0000124017915,0.000030722695,0.00001694419,0.00064603117],"genre_scores_gemma":[0.9989718,0.00038031,0.00011098472,0.000052444626,0.000025672307,0.000011849506,0.00007357993,0.000004863223,0.00036849835],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.999665,0.00012871831,0.000023228886,0.000025006042,0.000053057174,0.00010496769],"domain_scores_gemma":[0.99953973,0.00021137338,0.0000794894,0.000058809794,0.000031255277,0.00007941492],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049904676,0.0002806112,0.0006915725,0.0001468673,0.00028708033,0.00022995508,0.00035094947,0.00061540765,0.0007894615],"category_scores_gemma":[0.0011513716,0.00014214219,0.00038355828,0.00008736226,0.00022127309,0.0002646546,0.00014118553,0.0011140221,0.00021208789],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029541243,0.0074427333,0.041189972,0.00073131523,0.0003388188,0.0041945246,0.00041902345,0.00044767137,0.78558487,0.0004763529,0.0023108332,0.12732275],"study_design_scores_gemma":[0.0013019562,0.08644236,0.47307828,0.00021033607,0.0006931235,0.01314219,0.0003601075,0.0016815938,0.41342372,0.00025672768,0.009370728,0.000038916874],"about_ca_topic_score_codex":0.00049558224,"about_ca_topic_score_gemma":0.000795002,"teacher_disagreement_score":0.0007894615,"about_ca_system_score_codex":0.00019629268,"about_ca_system_score_gemma":0.00019647318,"threshold_uncertainty_score":0.0026410222},"labels":[],"label_agreement":null},{"id":"W1971186170","doi":"10.1067/mjd.2001.112400","title":"Intermittent short courses of cyclosporine microemulsion for the long-term management of psoriasis: A 2-year cohort study","year":2001,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":139,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Medicine; Randomization; Psoriasis; Randomized controlled trial; Cohort; Surgery; Creatinine; Multicenter trial; Renal function; Cohort study; Internal medicine; Multicenter study; Dermatology","score_opus":0.020096104883756526,"score_gpt":0.30287955544452655,"score_spread":0.28278345056077003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971186170","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99941266,0.00018594593,0.000052462863,0.00003465061,0.000011745286,0.00001712368,0.000116691706,0.0000025163615,0.00016621161],"genre_scores_gemma":[0.9990422,0.00017531074,0.000053896947,0.0000696472,0.000032661574,0.000023415103,0.00027999913,0.0000033885938,0.00031941672],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99905473,0.00021971477,0.00008245333,0.0002406685,0.0001389637,0.00026344534],"domain_scores_gemma":[0.99759406,0.00032387886,0.0007267481,0.0003199426,0.00027606537,0.00075936853],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013500005,0.0008432974,0.001149691,0.00082931895,0.0014705985,0.0012769111,0.00075299287,0.0016962134,0.0016467214],"category_scores_gemma":[0.0022018598,0.0009340753,0.0015682188,0.0012283145,0.00062844757,0.0012828527,0.0005777117,0.0019585777,0.00041079862],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0075208102,0.0018753388,0.9846674,0.00002181514,0.0005746759,0.00064244564,0.000370388,0.000050051207,0.0012550198,0.000033036176,0.00018008395,0.0028090645],"study_design_scores_gemma":[0.0003596224,0.004175438,0.9937396,0.000007781683,0.00027177026,0.0005659088,0.0003701605,0.00015314644,0.00009575601,0.000025031197,0.00021379518,0.000022004544],"about_ca_topic_score_codex":0.009216299,"about_ca_topic_score_gemma":0.006768328,"teacher_disagreement_score":0.009216299,"about_ca_system_score_codex":0.00060909597,"about_ca_system_score_gemma":0.0007437195,"threshold_uncertainty_score":0.018325329},"labels":[],"label_agreement":null},{"id":"W1972194503","doi":"10.1016/j.jaad.2007.08.030","title":"From the Medical Board of the National Psoriasis Foundation: Monitoring and vaccinations in patients treated with biologics for psoriasis","year":2007,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":119,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University Health Network","funders":"","keywords":"Medicine; Psoriasis; Foundation (evidence); Dermatology; Vaccination; Family medicine; Immunology","score_opus":0.020526556638649704,"score_gpt":0.29358086557537555,"score_spread":0.27305430893672583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972194503","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.075732686,0.033693537,0.0015225355,0.7572138,0.06539068,0.00081985263,0.0067182695,0.00037618086,0.058532555],"genre_scores_gemma":[0.46574324,0.027756909,0.008135202,0.27329016,0.11984806,0.0011722613,0.013150139,0.00046903495,0.090435006],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.995074,0.0018802525,0.0010484395,0.0003681215,0.001159241,0.00046994298],"domain_scores_gemma":[0.97582257,0.0052141505,0.0037674373,0.0011209059,0.007020995,0.007053813],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0053947335,0.00053229043,0.0007621616,0.0010037228,0.0012163891,0.0010317646,0.000971733,0.0060484563,0.013584347],"category_scores_gemma":[0.025848748,0.00048754545,0.00045325438,0.0010484003,0.00048139473,0.0008738571,0.00097390375,0.0031645799,0.0033186215],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00096722855,0.0004607771,0.07190532,0.00032423908,0.00008542729,0.00081390183,0.00013455476,0.00017121743,0.00076808635,0.00037369996,0.8253173,0.098678224],"study_design_scores_gemma":[0.0013344146,0.0006955444,0.47605833,0.0010351334,0.0002422329,0.002322043,0.00032428952,0.0010276177,0.0011302292,0.00040927064,0.5153332,0.000087669636],"about_ca_topic_score_codex":0.006021201,"about_ca_topic_score_gemma":0.009869748,"teacher_disagreement_score":0.013584347,"about_ca_system_score_codex":0.001386697,"about_ca_system_score_gemma":0.003984016,"threshold_uncertainty_score":0.04544419},"labels":[],"label_agreement":null},{"id":"W1972297339","doi":"10.1016/j.jaad.2010.12.022","title":"Positive patch test reactions in older individuals: Retrospective analysis from the North American Contact Dermatitis Group, 1994-2008","year":2011,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Contact Dermatitis and Allergies","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Royal Victoria Hospital; University of Ottawa","funders":"","keywords":"Medicine; Patch test; Contact dermatitis; Thimerosal; Retrospective cohort study; Population; Allergic contact dermatitis; Epidemiology; Pediatrics; Dermatology; Surgery; Allergy; Internal medicine; Immunology; Environmental health","score_opus":0.013586318998000354,"score_gpt":0.2682522589172399,"score_spread":0.2546659399192396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972297339","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988757,0.00033654194,0.00003953616,0.000014239642,0.0000044577546,0.000005640679,0.00022836767,0.000002784754,0.00049269217],"genre_scores_gemma":[0.99931157,0.00017992254,0.00003068703,0.000026030584,0.000009282977,0.000005063744,0.0002698321,0.0000019989056,0.00016555667],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995117,0.000075665565,0.00006738774,0.00012119445,0.00013781634,0.00008607334],"domain_scores_gemma":[0.9985494,0.00019858786,0.0006724885,0.00010594808,0.00025235376,0.00022123379],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044518764,0.00034610956,0.00038044137,0.0012128488,0.000554314,0.00054233125,0.00033132223,0.0004973839,0.0013562752],"category_scores_gemma":[0.0014197322,0.00029901764,0.00044861078,0.0011793599,0.0003047225,0.0005387494,0.0003689908,0.00044022297,0.0002824121],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052228046,0.000017920103,0.9989298,0.0000051981165,0.000018076646,0.0001317319,0.000062236,0.000006544093,0.000092193484,0.0000032321702,0.00006253604,0.0006182481],"study_design_scores_gemma":[0.0000018174028,0.0000426419,0.9991301,0.0000030050414,0.000017819475,0.00050268596,0.00015284025,0.000018591933,0.000022899456,0.000002398848,0.00010403961,0.0000012111882],"about_ca_topic_score_codex":0.0136408,"about_ca_topic_score_gemma":0.01850238,"teacher_disagreement_score":0.0136408,"about_ca_system_score_codex":0.00042911601,"about_ca_system_score_gemma":0.0002988794,"threshold_uncertainty_score":0.027122796},"labels":[],"label_agreement":null},{"id":"W1972546324","doi":"10.1016/j.jaad.2003.10.074","title":"Effects of oral tazarotene on health-related quality of life in patients with severe nodulocystic acne: results from a phase ii dose-ranging study","year":2004,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Windsor Clinical Research","funders":"","keywords":"Medicine; Tazarotene; Acne; Dermatology; Quality of life (healthcare); Dose-ranging study; Pathology; Alternative medicine","score_opus":0.010032538625021818,"score_gpt":0.2914824447477195,"score_spread":0.2814499061226977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972546324","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967931,0.002124675,0.00015869783,0.00010765388,0.000030126052,0.00017275348,0.00017750531,0.000020841155,0.00041455438],"genre_scores_gemma":[0.99674916,0.0016731666,0.00032257297,0.00017090811,0.000076332784,0.00019195056,0.0003127728,0.0000073563497,0.0004958639],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99961,0.00018346473,0.00003140628,0.00004971857,0.00004818599,0.000077262426],"domain_scores_gemma":[0.9992323,0.00026855385,0.00015011756,0.00008134692,0.00004347548,0.00022428735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009197692,0.0011071033,0.002485976,0.0003776192,0.00041643198,0.0005546059,0.0005536492,0.0007830111,0.001395097],"category_scores_gemma":[0.00085538253,0.00038662582,0.0015742682,0.00048724603,0.0007364047,0.0006362246,0.00020034137,0.0021648933,0.00028523634],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7314345,0.03993547,0.0260296,0.0010654407,0.0034972976,0.00039155062,0.00030831638,0.002201624,0.060737215,0.00012813539,0.0008927055,0.13337822],"study_design_scores_gemma":[0.35096598,0.54637486,0.09280528,0.000052673036,0.0020838075,0.0004221455,0.00015049134,0.0010614913,0.0046482906,0.00011017691,0.0012730851,0.000051689083],"about_ca_topic_score_codex":0.0010705134,"about_ca_topic_score_gemma":0.001984095,"teacher_disagreement_score":0.002485976,"about_ca_system_score_codex":0.00040438608,"about_ca_system_score_gemma":0.0005336193,"threshold_uncertainty_score":0.0048642755},"labels":[],"label_agreement":null},{"id":"W1972578535","doi":"10.1016/j.jaad.2010.01.047","title":"The efficacy of trimethoprim in wound healing of patients with epidermolysis bullosa: A feasibility trial","year":2011,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Skin and Cellular Biology Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; Hospital for Sick Children","funders":"","keywords":"Medicine; Epidermolysis bullosa; Placebo; Statistical significance; Crossover study; Quality of life (healthcare); Surgery; Wound healing; Epidermolysis bullosa dystrophica; Clinical trial; Dermatology; Randomized controlled trial; Internal medicine; Pathology; Nursing","score_opus":0.03297571265824945,"score_gpt":0.3272180582695546,"score_spread":0.29424234561130513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972578535","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936905,0.002870334,0.00025403243,0.0007160553,0.00015303055,0.0013182544,0.00016182725,0.000016937249,0.0008190564],"genre_scores_gemma":[0.99445194,0.0016152133,0.0006620912,0.00064438814,0.00029394467,0.0014218126,0.00021578607,0.0000063542257,0.0006883595],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9986999,0.00081043324,0.0000812994,0.00013253302,0.00009648025,0.00017938028],"domain_scores_gemma":[0.99787724,0.0010063977,0.00033050994,0.00019783476,0.00011497593,0.00047301888],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026815378,0.00097457017,0.0026226705,0.00037706326,0.00067130086,0.0009325432,0.0011056009,0.0028895247,0.003587028],"category_scores_gemma":[0.0036139847,0.0006548233,0.0022016326,0.00046955756,0.0014089282,0.0012286116,0.0004905788,0.0036799128,0.0006440983],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9549625,0.014190452,0.0021823645,0.00044567598,0.00059684576,0.00014215252,0.00012270827,0.00023007535,0.003034295,0.00010555046,0.0002600039,0.023727465],"study_design_scores_gemma":[0.7204425,0.2728731,0.0045588235,0.000057170553,0.00045301282,0.00008047975,0.00008129628,0.0003288157,0.00052443874,0.00010429624,0.00047917396,0.00001698901],"about_ca_topic_score_codex":0.0009162107,"about_ca_topic_score_gemma":0.0010288444,"teacher_disagreement_score":0.003587028,"about_ca_system_score_codex":0.00083198113,"about_ca_system_score_gemma":0.0013389444,"threshold_uncertainty_score":0.014181495},"labels":[],"label_agreement":null},{"id":"W1972980827","doi":"10.1067/mjd.2000.109297","title":"The use of plasmapheresis and immunosuppression in the treatment of pemphigus vulgaris","year":2000,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Autoimmune Bullous Skin Diseases","field":"Medicine","cited_by":104,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Plasmapheresis; Pemphigus vulgaris; Medicine; Immunosuppression; Pemphigus; Autoimmune disease; Paraneoplastic pemphigus; Disease; Dermatology; Immunology; Internal medicine; Autoantibody; Antibody","score_opus":0.025915672733325897,"score_gpt":0.30317667898240647,"score_spread":0.27726100624908057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972980827","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6305846,0.33672342,0.0019876312,0.007486627,0.0018604274,0.00006515737,0.00007118123,0.00007969677,0.021141263],"genre_scores_gemma":[0.9570551,0.037851434,0.00077247876,0.0009034249,0.0022841073,0.000027999398,0.00002849454,0.000009255296,0.0010676846],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9996371,0.0001534149,0.00004457434,0.00002655459,0.00009766293,0.000040664083],"domain_scores_gemma":[0.9996172,0.00022887922,0.000044506804,0.000021282303,0.000023214001,0.00006494039],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008278212,0.00024948336,0.00064676744,0.0006212883,0.00061032554,0.000527441,0.00040225644,0.00076343416,0.00085060217],"category_scores_gemma":[0.0015393647,0.00012073987,0.0006060133,0.00034667325,0.0005820803,0.00046958713,0.00021300004,0.0016118867,0.00017428175],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022824503,0.002052927,0.012977489,0.001293728,0.00078469765,0.014520377,0.0003226376,0.0016239524,0.029011717,0.0033748476,0.005080471,0.90613264],"study_design_scores_gemma":[0.020581368,0.05995181,0.42907515,0.001454213,0.0031764656,0.1791581,0.0012914969,0.0073105334,0.045336574,0.009580172,0.24279976,0.0002843614],"about_ca_topic_score_codex":0.0007193448,"about_ca_topic_score_gemma":0.0013344352,"teacher_disagreement_score":0.00085060217,"about_ca_system_score_codex":0.0004056755,"about_ca_system_score_gemma":0.0005135904,"threshold_uncertainty_score":0.004377961},"labels":[],"label_agreement":null},{"id":"W1973861878","doi":"10.1067/mjd.2001.112219","title":"Recurrent erythema nodosum associated with echinacea herbal therapy","year":2001,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Herbal Medicine Research Studies","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Dalhousie University","funders":"","keywords":"Medicine; Echinacea (animal); Immunostimulant; Adverse effect; Erythema nodosum; Immune system; Dermatology; Traditional medicine; Clinical trial; Immunology; Pharmacology; Disease; Internal medicine","score_opus":0.037178357885100745,"score_gpt":0.36084826240004547,"score_spread":0.3236699045149447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973861878","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9645547,0.010497731,0.0010453534,0.00077533664,0.00012108728,0.00016683468,0.0000935756,0.00016502914,0.022580264],"genre_scores_gemma":[0.99735403,0.00091113587,0.000117652686,0.00022700349,0.00009584837,0.000009924404,0.00003626777,0.0000072686853,0.0012408748],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9992968,0.0002152509,0.00007141787,0.000075366006,0.00014442638,0.00019671473],"domain_scores_gemma":[0.998594,0.00057160796,0.0003451642,0.0002259208,0.00009804286,0.00016511104],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000634149,0.0005595722,0.001163374,0.00078961987,0.00096973486,0.0004110607,0.000549575,0.0016256324,0.0029207298],"category_scores_gemma":[0.0031786843,0.00024468265,0.0010125422,0.00053733477,0.0005021553,0.00049640296,0.00042302435,0.0014253992,0.00063864916],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003695367,0.002356013,0.077582344,0.0010939674,0.00048320636,0.8088832,0.0011137815,0.0003473627,0.027416961,0.0012166181,0.0023039165,0.0735073],"study_design_scores_gemma":[0.00075941044,0.0039650993,0.18230514,0.000112500195,0.00046360752,0.79423136,0.000446797,0.0009442669,0.0072567705,0.00045485346,0.009023113,0.000037049376],"about_ca_topic_score_codex":0.0012855969,"about_ca_topic_score_gemma":0.001036771,"teacher_disagreement_score":0.0029207298,"about_ca_system_score_codex":0.00044913197,"about_ca_system_score_gemma":0.00020595791,"threshold_uncertainty_score":0.009770751},"labels":[],"label_agreement":null},{"id":"W1975463338","doi":"10.1016/j.jaad.2006.07.017","title":"A randomized comparison of continuous vs. intermittent infliximab maintenance regimens over 1 year in the treatment of moderate-to-severe plaque psoriasis","year":2006,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":517,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Medicine; Infliximab; Maintenance therapy; Psoriasis; Maintenance dose; Placebo; Randomized controlled trial; Internal medicine; Surgery; Gastroenterology; Chemotherapy; Dermatology; Tumor necrosis factor alpha","score_opus":0.014818830194803984,"score_gpt":0.280921689709543,"score_spread":0.266102859514739,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975463338","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910869,0.005007771,0.00040165914,0.00047021563,0.0007447867,0.0010532325,0.00035576525,0.00005849542,0.00082112395],"genre_scores_gemma":[0.99342597,0.0020031347,0.0008600213,0.00053392875,0.00061053975,0.0010592369,0.00034827474,0.00001248592,0.0011465249],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9987373,0.00056509726,0.00013744232,0.0002556691,0.00009862113,0.00020605436],"domain_scores_gemma":[0.99769044,0.0009179726,0.00043829557,0.00022580767,0.00012116169,0.0006063674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018437173,0.001266985,0.0056143687,0.0006967636,0.00057585933,0.0012558086,0.0017411346,0.0029561454,0.0071147527],"category_scores_gemma":[0.0030616843,0.0010011914,0.0024695047,0.0007622369,0.0014992844,0.0014594287,0.0006089755,0.0037043288,0.0007331036],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.99023926,0.0028841356,0.00015687018,0.0001553374,0.00038752405,0.000013344001,0.000016310025,0.000078979465,0.00055223407,0.000030585998,0.00009375395,0.005391626],"study_design_scores_gemma":[0.9282833,0.06892858,0.0016272241,0.0000283778,0.0005548561,0.000015896932,0.000019395511,0.0002103074,0.000113777176,0.000062713094,0.00014439103,0.000011236612],"about_ca_topic_score_codex":0.0021080743,"about_ca_topic_score_gemma":0.0030553509,"teacher_disagreement_score":0.0071147527,"about_ca_system_score_codex":0.0011088907,"about_ca_system_score_gemma":0.0010070556,"threshold_uncertainty_score":0.023801148},"labels":[],"label_agreement":null},{"id":"W1975592271","doi":"10.1016/j.jaad.2005.10.032","title":"Efalizumab retreatment in patients with moderate to severe chronic plaque psoriasis","year":2006,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Medicine; Efalizumab; Plaque psoriasis; Dermatology; Psoriasis","score_opus":0.006745783155185325,"score_gpt":0.22889915669201263,"score_spread":0.22215337353682732,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975592271","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939812,0.003814196,0.00009383328,0.00036005635,0.000059661015,0.000026552294,0.000052706728,0.000013702092,0.00159793],"genre_scores_gemma":[0.9986608,0.0006402659,0.000094641226,0.00022773726,0.00006975653,0.000010355841,0.000060115475,0.0000017668834,0.00023458422],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99974555,0.000066335866,0.00003881126,0.00003116152,0.00004973683,0.00006841255],"domain_scores_gemma":[0.99962497,0.00014089093,0.00007245288,0.000013250095,0.000026685693,0.0001217362],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041483383,0.00029698937,0.0010506054,0.00033033724,0.0005319432,0.00035914622,0.00017824411,0.00046831023,0.00090636325],"category_scores_gemma":[0.00145195,0.00016440947,0.00048589954,0.0003492531,0.0001994566,0.00035230996,0.00015687925,0.00061411125,0.000114731454],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.039095476,0.0022376291,0.73325986,0.00049696077,0.00071302993,0.012197551,0.0006968442,0.00062481576,0.010373778,0.00017062461,0.0034038515,0.19672957],"study_design_scores_gemma":[0.0017986187,0.0070632044,0.9733968,0.000056871362,0.00048562267,0.01269881,0.00036628923,0.0009896277,0.00057630386,0.00013369112,0.0024083012,0.000025797903],"about_ca_topic_score_codex":0.0018490419,"about_ca_topic_score_gemma":0.0038212475,"teacher_disagreement_score":0.0018490419,"about_ca_system_score_codex":0.0003220402,"about_ca_system_score_gemma":0.00034153054,"threshold_uncertainty_score":0.0036765933},"labels":[],"label_agreement":null},{"id":"W1976247368","doi":"10.1016/j.jaad.2014.08.053","title":"Commenting on: “Duration of efficacy increases with the repetition of botulinum toxin A injections in primary palmar hyperhidrosis”","year":2014,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Sympathectomy and Hyperhidrosis Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Regional Municipality of Niagara","funders":"","keywords":"Medicine; Hyperhidrosis; Botulinum toxin; Dermatology; Palmar hyperhidrosis; Repetition (rhetorical device); Duration (music); Anesthesia","score_opus":0.018003779406311465,"score_gpt":0.28184130188285755,"score_spread":0.26383752247654607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976247368","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013192891,0.00048598918,0.00008886062,0.98419535,0.011355892,0.000015189218,0.000083129264,0.00003219209,0.00242412],"genre_scores_gemma":[0.008199407,0.00043142328,0.00016806243,0.96647936,0.020101016,0.00003079335,0.000029335619,0.000016486329,0.0045441226],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99728084,0.00058094994,0.00040183548,0.00046481536,0.00071954605,0.00055207615],"domain_scores_gemma":[0.99280953,0.003914396,0.0008928904,0.00016280418,0.0014291812,0.00079116947],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019323078,0.0006580192,0.001252792,0.0006488508,0.0035680418,0.0024102046,0.0019866508,0.053153913,0.0051599364],"category_scores_gemma":[0.02153682,0.00076358113,0.0013772859,0.0008224334,0.0018968811,0.0023561006,0.00084942573,0.027109219,0.004093412],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023997747,0.00010462802,0.0027851057,0.000075905315,0.00004664236,0.00668528,0.000343247,0.00016335367,0.0004460646,0.0016505895,0.97966385,0.0077953315],"study_design_scores_gemma":[0.0006485889,0.00051584264,0.014994929,0.00062747335,0.00028157872,0.011740905,0.0020004376,0.0022633343,0.00177059,0.007914163,0.9569516,0.0002905065],"about_ca_topic_score_codex":0.015283287,"about_ca_topic_score_gemma":0.023835141,"teacher_disagreement_score":0.053153913,"about_ca_system_score_codex":0.0060499273,"about_ca_system_score_gemma":0.004498427,"threshold_uncertainty_score":0.043895543},"labels":[],"label_agreement":null},{"id":"W1976943112","doi":"10.1016/j.jaad.2011.10.008","title":"Recommendations and current practices for the reconstitution and storage of botulinum toxin type A","year":2011,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Botulinum Toxin and Related Neurological Disorders","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Vial; Medicaid; Disease control; Botulinum toxin; Family medicine; Surgery; Environmental health; Health care","score_opus":0.09810013717928978,"score_gpt":0.3700542199206942,"score_spread":0.2719540827414044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976943112","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.018787893,0.11524014,0.06363411,0.6840704,0.014919669,0.002164086,0.0012016408,0.0014556976,0.098526366],"genre_scores_gemma":[0.11992253,0.1591035,0.49442697,0.16021512,0.013948898,0.0057891523,0.0028781511,0.00063994183,0.043075807],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9847083,0.005237152,0.004077837,0.0007331669,0.0045781615,0.00066527573],"domain_scores_gemma":[0.95973074,0.012483647,0.0040106005,0.0018773049,0.019698348,0.0021993616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018292228,0.00086316885,0.0011005973,0.0038175012,0.0029708743,0.0034497937,0.0041132583,0.009329296,0.0082816295],"category_scores_gemma":[0.050625656,0.0005381977,0.0021697145,0.0022408254,0.0023770719,0.0036654007,0.0018524473,0.008628884,0.004646671],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056261255,0.001742792,0.015243594,0.0030342638,0.00018851973,0.0030616135,0.0014437798,0.00167219,0.003937108,0.011464905,0.34473735,0.6129114],"study_design_scores_gemma":[0.00078410195,0.0007638516,0.021771658,0.017232288,0.00064909493,0.008729314,0.005385319,0.0025440932,0.0055446113,0.01866128,0.9176651,0.0002692374],"about_ca_topic_score_codex":0.011287727,"about_ca_topic_score_gemma":0.01473647,"teacher_disagreement_score":0.018292228,"about_ca_system_score_codex":0.0022481391,"about_ca_system_score_gemma":0.008266866,"threshold_uncertainty_score":0.09673971},"labels":[],"label_agreement":null},{"id":"W1977191029","doi":"10.1016/j.jaad.2008.07.056","title":"Allergic patch test reactions associated with cosmetics: Retrospective analysis of cross-sectional data from the North American Contact Dermatitis Group, 2001-2004","year":2008,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Contact Dermatitis and Allergies","field":"Medicine","cited_by":106,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Royal Victoria Hospital; University of Ottawa","funders":"","keywords":"Medicine; Patch test; Allergic contact dermatitis; Cosmetics; Allergy; Dermatology; Cross-sectional study; Confidence interval; Retrospective cohort study; Contact dermatitis; Cross reactions; Surgery; Internal medicine; Immunology; Pathology; Antibody","score_opus":0.03522041434708817,"score_gpt":0.3130760623691829,"score_spread":0.2778556480220947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977191029","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987446,0.00027410977,0.000058467635,0.000010263752,0.0000039953206,0.000011166642,0.00052682706,0.00000417587,0.0003663792],"genre_scores_gemma":[0.99876875,0.0001893785,0.00005764893,0.000024398109,0.0000061973474,0.000011903088,0.00078882574,0.0000030012948,0.0001499006],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99902487,0.00025593038,0.00013533428,0.00022816536,0.0002353742,0.00012040658],"domain_scores_gemma":[0.9969989,0.0004972625,0.0014297577,0.00028094044,0.0004896024,0.00030361817],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080282224,0.0004335879,0.00045825698,0.0013430351,0.0005292451,0.00060747523,0.00047578558,0.0006027725,0.0012637904],"category_scores_gemma":[0.0018432329,0.0005015748,0.0005821782,0.0019483032,0.0003417199,0.00073880935,0.00043046148,0.00053627207,0.00033601292],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000076133925,0.000039836443,0.9989586,0.000008045798,0.00003707712,0.00008390536,0.000064654516,0.000013896497,0.00015232239,0.0000034394798,0.00006674493,0.0004953701],"study_design_scores_gemma":[0.0000025018855,0.000060564755,0.9993197,0.0000026636399,0.000021141806,0.00032139712,0.00012153629,0.000028860546,0.00003476522,0.0000019154031,0.00008348512,0.0000015208939],"about_ca_topic_score_codex":0.015320015,"about_ca_topic_score_gemma":0.017875314,"teacher_disagreement_score":0.015320015,"about_ca_system_score_codex":0.00057399564,"about_ca_system_score_gemma":0.0004275817,"threshold_uncertainty_score":0.030461669},"labels":[],"label_agreement":null},{"id":"W1977897321","doi":"10.1016/j.jaad.2007.12.021","title":"Stem cell transplantation in advanced cutaneous T-cell lymphoma","year":2008,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Transplantation; Lymphoma; Stem cell; Pathology; Dermatology; Surgery; Cell biology","score_opus":0.028992934718060075,"score_gpt":0.35331772984046317,"score_spread":0.3243247951224031,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977897321","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00026153817,0.998754,0.000101156525,0.00010832782,0.00015099686,0.0000026387613,0.0000075810476,0.000004340321,0.0006094843],"genre_scores_gemma":[0.0024211048,0.99605846,0.00021840687,0.0002905208,0.00035490934,0.0000059041886,0.000029105728,0.0000013488701,0.0006202434],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998834,0.000021094605,0.00002024833,0.000021268816,0.00004447957,0.0000095051555],"domain_scores_gemma":[0.99974424,0.00014106034,0.000042326337,0.0000071919744,0.00004480326,0.000020337433],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045998878,0.00048762097,0.0013711237,0.0015920913,0.00015991955,0.0005956273,0.0006505505,0.0007195718,0.0021655487],"category_scores_gemma":[0.0005376616,0.0001640543,0.00033200518,0.001482318,0.0003341247,0.0007961467,0.00033435476,0.0010285352,0.001074006],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000097548684,0.00006365364,0.00028179013,0.006394908,0.00007540148,0.00057681755,0.00002442553,0.00022086746,0.0010451771,0.00088213204,0.018427115,0.9719101],"study_design_scores_gemma":[0.00014374548,0.00029390593,0.0029930642,0.004381567,0.00047279737,0.0110223405,0.000097823424,0.00026069809,0.001231087,0.001603826,0.9774679,0.000031248954],"about_ca_topic_score_codex":0.00044706694,"about_ca_topic_score_gemma":0.0010357093,"teacher_disagreement_score":0.0021655487,"about_ca_system_score_codex":0.0002681214,"about_ca_system_score_gemma":0.00042620095,"threshold_uncertainty_score":0.0072445273},"labels":[],"label_agreement":null},{"id":"W1978594041","doi":"10.1067/mjd.2000.103980","title":"Screening for azathioprine toxicity: A pharmacoeconomic analysis based on a target case","year":2000,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Autoimmune Bullous Skin Diseases","field":"Medicine","cited_by":95,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Thiopurine methyltransferase; Azathioprine; Medicine; Population; Internal medicine; Pharmacology; Disease","score_opus":0.018557500367194744,"score_gpt":0.3318358612309653,"score_spread":0.3132783608637706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978594041","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98988897,0.00031223998,0.0012235742,0.0017445984,0.000027838618,0.00008469422,0.00013426137,0.000020786312,0.0065630637],"genre_scores_gemma":[0.9988104,0.00011394321,0.0005128741,0.00025959202,0.000024243558,0.000008415202,0.000043406635,0.0000091888205,0.00021783983],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.99935526,0.00013192343,0.000076540964,0.00012759853,0.00019024893,0.0001185033],"domain_scores_gemma":[0.99871266,0.000743951,0.000120984325,0.00006536013,0.00017335032,0.00018376984],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035954363,0.00057452684,0.0004860559,0.0016942427,0.0015368821,0.0006332844,0.00058683835,0.0013823766,0.0026226516],"category_scores_gemma":[0.004289002,0.00024166903,0.00069882185,0.0007586422,0.0006564855,0.00044594132,0.0003431058,0.0007832447,0.00028660148],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007359876,0.00078898564,0.37401822,0.000068049776,0.0000975074,0.5952142,0.00076829037,0.00085731054,0.009187514,0.0009914546,0.0008830656,0.016389465],"study_design_scores_gemma":[0.000087945235,0.0010985734,0.17710368,0.000056524692,0.00030905308,0.7982361,0.0008526709,0.0066933422,0.012575679,0.00078946113,0.0021620605,0.000034963985],"about_ca_topic_score_codex":0.0038706227,"about_ca_topic_score_gemma":0.00272247,"teacher_disagreement_score":0.0038706227,"about_ca_system_score_codex":0.00089644635,"about_ca_system_score_gemma":0.0005433529,"threshold_uncertainty_score":0.0087736845},"labels":[],"label_agreement":null},{"id":"W1978629280","doi":"10.1016/j.jaad.2003.10.350","title":"Efficacy and safety of intermittent terbinafine therapy to treat dermatophyte toenail onychomycosis","year":2004,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Terbinafine; Medicine; Dermatophyte; Regimen; Adverse effect; Itraconazole; Randomized controlled trial; Pharmacotherapy; Surgery; Internal medicine; Dermatology; Antifungal","score_opus":0.01520029522886556,"score_gpt":0.3129809085697583,"score_spread":0.29778061334089273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978629280","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939758,0.004469439,0.0002579234,0.00010216709,0.000039833692,0.00004486142,0.00008079215,0.00002473361,0.0010044189],"genre_scores_gemma":[0.99877447,0.00067468046,0.00010623504,0.000039794817,0.000060131202,0.000016966786,0.000057462967,0.0000035266794,0.00026665113],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99973613,0.00011052115,0.000027799151,0.00003306357,0.00004059,0.00005187284],"domain_scores_gemma":[0.99927753,0.00031276786,0.00016197565,0.00009156444,0.000042689822,0.00011348354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046333837,0.0002801175,0.0011376288,0.00026518502,0.0002507343,0.00030796908,0.00035271878,0.00047105647,0.0016579601],"category_scores_gemma":[0.0013625323,0.00010258197,0.000366109,0.00021892379,0.00028716328,0.00037800297,0.000116250754,0.0011073141,0.0002233431],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2590474,0.013464791,0.015715225,0.00097513205,0.0009826582,0.001042396,0.00028447137,0.001687417,0.081235185,0.00039103423,0.0010058999,0.6241685],"study_design_scores_gemma":[0.08924098,0.5231832,0.28073207,0.00039581538,0.0028712833,0.007900602,0.00036586245,0.008223611,0.07738177,0.0009599735,0.0086326245,0.00011219497],"about_ca_topic_score_codex":0.00043489094,"about_ca_topic_score_gemma":0.00048726107,"teacher_disagreement_score":0.0016579601,"about_ca_system_score_codex":0.00025218216,"about_ca_system_score_gemma":0.00019951709,"threshold_uncertainty_score":0.0055464506},"labels":[],"label_agreement":null},{"id":"W1978910356","doi":"10.1067/mjd.2002.121356","title":"A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines","year":2002,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Botulinum Toxin and Related Neurological Disorders","field":"Medicine","cited_by":429,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital","funders":"","keywords":"Medicine; Placebo; Botulinum toxin; Adverse effect; Wrinkle; Surgery; Randomized controlled trial; Multicenter study; Internal medicine","score_opus":0.032273745907084164,"score_gpt":0.3156331382727708,"score_spread":0.28335939236568664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978910356","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9863344,0.0036539256,0.001048091,0.00077332807,0.0010875389,0.0048917853,0.0007533484,0.00015476352,0.0013028902],"genre_scores_gemma":[0.98405737,0.0025936232,0.0022499464,0.0016776222,0.0014522473,0.0047407434,0.00089318096,0.000051126077,0.0022839706],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99796754,0.0010363013,0.00017906849,0.00037419636,0.00018370559,0.00025918675],"domain_scores_gemma":[0.9966378,0.0011856079,0.0006208732,0.00034525784,0.0002574782,0.0009529334],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041797506,0.0027110002,0.005640555,0.0010697875,0.0013612612,0.0014180858,0.0018799073,0.004534381,0.0064483318],"category_scores_gemma":[0.0049865525,0.001577293,0.002253445,0.0007424718,0.004044897,0.0022832148,0.0007336585,0.0049083764,0.0011272465],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97916836,0.013085673,0.00017650105,0.0002770094,0.00042044075,0.000027801601,0.000042772117,0.00008109001,0.0025076065,0.00005553381,0.00022263447,0.0039345133],"study_design_scores_gemma":[0.9440263,0.054947343,0.00042458798,0.0000076797205,0.00015100004,0.000009658524,0.000007339538,0.000075682794,0.00020209486,0.000034462362,0.00010632419,0.0000075231706],"about_ca_topic_score_codex":0.0016503314,"about_ca_topic_score_gemma":0.002144503,"teacher_disagreement_score":0.0064483318,"about_ca_system_score_codex":0.000964158,"about_ca_system_score_gemma":0.0021750426,"threshold_uncertainty_score":0.02210486},"labels":[],"label_agreement":null},{"id":"W1979929645","doi":"10.1016/j.jaad.2005.10.029","title":"Relapse, rebound, and psoriasis adverse events: An advisory group report","year":2006,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":150,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Royal Victoria Hospital","funders":"","keywords":"Efalizumab; Medicine; Psoriasis; Adverse effect; Clinical trial; Disease; Dermatology; Internal medicine; Plaque psoriasis","score_opus":0.027237259942385166,"score_gpt":0.3133963137695004,"score_spread":0.2861590538271152,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979929645","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006091128,0.9823893,0.00048263112,0.0064617344,0.004874065,0.0000632168,0.0001758345,0.00004807685,0.0048961146],"genre_scores_gemma":[0.0054155015,0.97559494,0.00095131155,0.0054993564,0.0066903713,0.00007552412,0.00039866965,0.000010844801,0.005363546],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99923766,0.0001272945,0.00011585533,0.000073858966,0.0003830717,0.00006216719],"domain_scores_gemma":[0.9975169,0.0007912766,0.0005060448,0.000045630284,0.0009146943,0.00022547488],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002283106,0.0008406682,0.001956666,0.0012153665,0.0003598277,0.00091378926,0.0016023611,0.003278388,0.004117112],"category_scores_gemma":[0.00245251,0.00027585134,0.0008629342,0.0013564948,0.00032263147,0.0009742564,0.0005103413,0.002490624,0.00220217],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002505961,0.00012445671,0.00047608375,0.0039405357,0.00008395783,0.00027627233,0.000022344864,0.00011112203,0.00060439116,0.0006302088,0.2134113,0.7800688],"study_design_scores_gemma":[0.00030025982,0.00034373126,0.004827714,0.0041004075,0.00047766982,0.0026306428,0.000047626218,0.00022796274,0.00058629515,0.0007786491,0.98564863,0.00003041765],"about_ca_topic_score_codex":0.0016046361,"about_ca_topic_score_gemma":0.003659483,"teacher_disagreement_score":0.004117112,"about_ca_system_score_codex":0.0006514439,"about_ca_system_score_gemma":0.0014783011,"threshold_uncertainty_score":0.013773084},"labels":[],"label_agreement":null},{"id":"W1980381087","doi":"10.1016/j.jaad.2014.10.025","title":"WITHDRAWN: Experience with ustekinumab in patients with psoriasis enrolled in a large, multicenter, prospective, disease-based registry (Psoriasis Longitudinal Assessment and Registry [PSOLAR])","year":2015,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Probity Medical Research","funders":"","keywords":"Ustekinumab; Medicine; Psoriasis; Multicenter study; Dermatology; Disease; Surgery; Internal medicine; Randomized controlled trial","score_opus":0.013856139154407254,"score_gpt":0.2775879553469565,"score_spread":0.26373181619254926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980381087","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97053593,0.008767027,0.0008063119,0.0064002145,0.00051390496,0.00010667396,0.002385249,0.000079131416,0.010405401],"genre_scores_gemma":[0.99122846,0.001312818,0.00020999917,0.0037316512,0.00039772553,0.000024021148,0.0014474771,0.000018970966,0.0016288382],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982664,0.0007321628,0.00021484242,0.00014649332,0.0004618142,0.00017828873],"domain_scores_gemma":[0.9931472,0.0021577545,0.0020198498,0.0004071456,0.0010751232,0.0011928958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026722753,0.00016666105,0.00042474852,0.00020934467,0.00066006614,0.0014738531,0.000372521,0.00069932145,0.003801152],"category_scores_gemma":[0.011303485,0.00009694997,0.00047222606,0.0007300705,0.0002828028,0.0007840568,0.00040231223,0.0010742213,0.0008134003],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00560294,0.00063140586,0.8444788,0.0002378639,0.0002757978,0.0011484076,0.00052547874,0.00015477776,0.0021277885,0.00035201915,0.011465407,0.13299935],"study_design_scores_gemma":[0.001625447,0.0044554747,0.9565267,0.00020374844,0.0006313102,0.006593616,0.00093089003,0.00096815947,0.0017967314,0.00036846573,0.025860555,0.00003879787],"about_ca_topic_score_codex":0.0024712414,"about_ca_topic_score_gemma":0.0027517213,"teacher_disagreement_score":0.003801152,"about_ca_system_score_codex":0.00048653476,"about_ca_system_score_gemma":0.000997369,"threshold_uncertainty_score":0.0141325},"labels":[],"label_agreement":null},{"id":"W1980470859","doi":"10.1016/j.jaad.2003.10.268","title":"Malignant melanoma epidemiology-greater victoria area 1993–96","year":2004,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Epidemiology; Melanoma; Population; Breslow Thickness; Demography; Incidence (geometry); Pathology; Cancer; Environmental health; Internal medicine","score_opus":0.02791169288208212,"score_gpt":0.3025031138717505,"score_spread":0.2745914209896684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980470859","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9884319,0.0010403771,0.00011000242,0.0004239837,0.000022022734,0.0000946753,0.0060212007,0.000012382072,0.0038434495],"genre_scores_gemma":[0.9897333,0.0011497963,0.00024654868,0.00021533313,0.00001711888,0.00008121145,0.0025346808,0.000009150666,0.0060128723],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994766,0.000054054966,0.000062479456,0.00007048685,0.0001597625,0.00017666027],"domain_scores_gemma":[0.9987435,0.000053973505,0.0004776972,0.00003464366,0.0003859905,0.00030424894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031110455,0.00022242039,0.0002338041,0.0016465607,0.0008906225,0.0006655517,0.0008366442,0.00057851255,0.0019985694],"category_scores_gemma":[0.0016640549,0.00056037924,0.00036953908,0.0033109982,0.00020256064,0.0004853281,0.0010665176,0.0005611722,0.00045642597],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013259143,0.00006767834,0.9833909,0.00018224439,0.00006789723,0.0007204033,0.001379341,0.00027785002,0.0008122946,0.000081554645,0.003026865,0.009860343],"study_design_scores_gemma":[0.000004791883,0.00002022864,0.9972939,0.00003532688,0.000008237409,0.00028421363,0.00064455584,0.00011677059,0.000037221387,0.000008157823,0.001542135,0.0000044240096],"about_ca_topic_score_codex":0.8488703,"about_ca_topic_score_gemma":0.93848157,"teacher_disagreement_score":0.8488703,"about_ca_system_score_codex":0.0076692165,"about_ca_system_score_gemma":0.0060646236,"threshold_uncertainty_score":0.30403948},"labels":[],"label_agreement":null},{"id":"W1981277011","doi":"10.1016/j.jaad.2003.10.454","title":"Pyoderma gangrenosum involving labia minora","year":2004,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Autoimmune and Inflammatory Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Labia minora; Pyoderma gangrenosum; Labia; Labia majora; Papule; Leukocytosis; Dermatology; Surgery; Pathology; Vulva","score_opus":0.01295541177005127,"score_gpt":0.28850643783792246,"score_spread":0.2755510260678712,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981277011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9422137,0.0056087975,0.0038694227,0.0015976629,0.00017419335,0.0002072098,0.00024978165,0.00048409155,0.045595117],"genre_scores_gemma":[0.9972146,0.000525847,0.00036202546,0.00023787208,0.00009279596,0.000014766665,0.000025485813,0.000012313478,0.0015143158],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99943966,0.00011327833,0.000041822706,0.000083639236,0.00009659473,0.00022501698],"domain_scores_gemma":[0.99935216,0.00022437949,0.0001147718,0.00013322615,0.000045683813,0.00012983166],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036425272,0.0012690297,0.0006693868,0.0014282975,0.0017232914,0.00086191803,0.0007883782,0.0013777529,0.0024559526],"category_scores_gemma":[0.0028986463,0.00059875066,0.0005833469,0.00078171084,0.0010713537,0.0012435179,0.0008173426,0.0012820667,0.00057735114],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007085615,0.0002699165,0.028199982,0.00026729066,0.000063278,0.93642545,0.00045020744,0.00030755487,0.00877582,0.0018352142,0.000733798,0.021962902],"study_design_scores_gemma":[0.00013657664,0.0003937616,0.041587852,0.000025688436,0.000058537098,0.9513026,0.00017414425,0.0006874857,0.002956085,0.00083882076,0.0018187267,0.000019767138],"about_ca_topic_score_codex":0.0013174,"about_ca_topic_score_gemma":0.0013006954,"teacher_disagreement_score":0.0024559526,"about_ca_system_score_codex":0.00062519324,"about_ca_system_score_gemma":0.00041570433,"threshold_uncertainty_score":0.008215964},"labels":[],"label_agreement":null},{"id":"W1981500268","doi":"10.1016/j.jaad.2011.10.010","title":"Stability of sunscreens and sunblocks following exposure to extreme temperatures","year":2012,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Greenhouse Technology and Climate Control","field":"Agricultural and Biological Sciences","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Dermatology","score_opus":0.02743914394286152,"score_gpt":0.2480159425296423,"score_spread":0.22057679858678078,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981500268","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.53967226,0.012553301,0.0025347508,0.38935852,0.011522073,0.0001417694,0.00036098537,0.00019163007,0.04366474],"genre_scores_gemma":[0.9169544,0.0014111305,0.00053211546,0.068040006,0.0072502606,0.000023834058,0.00008562176,0.00002607071,0.0056765396],"study_design_codex":"case_report","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993704,0.00016174326,0.000082806306,0.0000674304,0.00019697064,0.00012074841],"domain_scores_gemma":[0.99693274,0.001642029,0.00060791936,0.00019967128,0.00032026882,0.00029733856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00082983234,0.00021526364,0.0005142047,0.00034966605,0.0011962691,0.0008786107,0.00046004183,0.005290488,0.0013345617],"category_scores_gemma":[0.010626355,0.00016954794,0.0007131542,0.00035716756,0.0005458544,0.00059049006,0.0003559276,0.0047199796,0.00045281393],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006792989,0.00086198846,0.1971271,0.00041421456,0.00041109306,0.42523068,0.0035413688,0.00078910554,0.011609706,0.005459814,0.19139446,0.1563675],"study_design_scores_gemma":[0.0004594459,0.0030572088,0.29102895,0.0004758277,0.00056439015,0.3887052,0.0040925504,0.004594509,0.009569398,0.008704133,0.2885925,0.00015587408],"about_ca_topic_score_codex":0.0027760947,"about_ca_topic_score_gemma":0.005860411,"teacher_disagreement_score":0.005290488,"about_ca_system_score_codex":0.0015431688,"about_ca_system_score_gemma":0.00039458973,"threshold_uncertainty_score":0.011196494},"labels":[],"label_agreement":null},{"id":"W1982551557","doi":"10.1067/mjd.2001.114750","title":"Patch testing discordance alert: False-negative findings with rubber additives and fragrances","year":2001,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Contact Dermatitis and Allergies","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Patch testing; Contact dermatitis; Patch test; Allergen; Dermatology; Allergic contact dermatitis; Natural rubber; False Negative Reactions; Allergy; Immunology; Composite material; Internal medicine","score_opus":0.01650673949767841,"score_gpt":0.28208451671657486,"score_spread":0.26557777721889647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982551557","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91893286,0.005940759,0.008708448,0.0205997,0.0037765757,0.00030522177,0.00041933387,0.001238181,0.04007907],"genre_scores_gemma":[0.9873936,0.00079751783,0.0035916585,0.0048902975,0.0009915318,0.00002989849,0.00016240768,0.00009606209,0.002047089],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.9974433,0.0005125075,0.00041197165,0.00029929786,0.00092348055,0.0004093274],"domain_scores_gemma":[0.9935545,0.0032491693,0.00070849364,0.0005078074,0.0011860317,0.00079402555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019524186,0.0017080333,0.0010985845,0.0020070872,0.0009878286,0.0009848643,0.0017874415,0.0060127196,0.004934404],"category_scores_gemma":[0.017371569,0.0005780777,0.0012192769,0.0005901874,0.0009861506,0.0016896091,0.00055033696,0.0024666556,0.0024463697],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021064018,0.0006437778,0.18320969,0.00042518807,0.00013181262,0.7291781,0.00075304013,0.00021925369,0.016087618,0.0005629207,0.02401151,0.042670824],"study_design_scores_gemma":[0.00018957691,0.00117114,0.072563514,0.00030238408,0.00041899158,0.8709988,0.0009034183,0.0042449655,0.031747054,0.0007923581,0.016602771,0.00006508303],"about_ca_topic_score_codex":0.0010628363,"about_ca_topic_score_gemma":0.0012893577,"teacher_disagreement_score":0.0060127196,"about_ca_system_score_codex":0.00055955246,"about_ca_system_score_gemma":0.0003987483,"threshold_uncertainty_score":0.016507208},"labels":[],"label_agreement":null},{"id":"W1983289252","doi":"10.1016/j.jaad.2013.04.028","title":"Zinc deficiency and its management in the pediatric population: A literature review and proposed etiologic classification","year":2013,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Trace Elements in Health","field":"Nursing","cited_by":102,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Zinc deficiency (plant disorder); MEDLINE; Intensive care medicine; Zinc; Pediatrics; Dermatology; Pathology; Micronutrient; Biochemistry","score_opus":0.057265594313487676,"score_gpt":0.39814641918149324,"score_spread":0.3408808248680056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983289252","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00033285617,0.9990402,0.00006145428,0.00028584118,0.000068687375,0.000005990108,0.000018987172,0.0000021934602,0.00018379695],"genre_scores_gemma":[0.002121835,0.99728847,0.00024099475,0.00015541862,0.000113712435,0.000006659722,0.000025383757,4.6175592e-7,0.000047057194],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.999408,0.000083726445,0.00025087688,0.000088997745,0.00013179546,0.000036549478],"domain_scores_gemma":[0.9985501,0.0007106686,0.0004381711,0.000015999714,0.00023399765,0.00005101845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010588559,0.0009759189,0.0024932327,0.005510858,0.0004821688,0.0013955568,0.0014969134,0.001203369,0.0016257046],"category_scores_gemma":[0.002488985,0.0003923536,0.0012127524,0.0046253386,0.00077206385,0.001680081,0.0009075078,0.001177233,0.00029361714],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028169557,0.00023266066,0.011436707,0.10561644,0.00075326575,0.0040347567,0.00034759095,0.00045177844,0.00076859305,0.002956017,0.020520467,0.85260004],"study_design_scores_gemma":[0.00030566775,0.0005770264,0.04536451,0.21180102,0.009586116,0.07092239,0.0027076132,0.0013388224,0.0013963208,0.0072511677,0.6484835,0.00026586826],"about_ca_topic_score_codex":0.0032667862,"about_ca_topic_score_gemma":0.0059544635,"teacher_disagreement_score":0.005510858,"about_ca_system_score_codex":0.00086813484,"about_ca_system_score_gemma":0.0029972768,"threshold_uncertainty_score":0.0064955354},"labels":[],"label_agreement":null},{"id":"W1984048395","doi":"10.1067/mjd.2003.107","title":"Lupus-associated toxic epidermal necrolysis: A novel manifestation of lupus?","year":2003,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Toxic epidermal necrolysis; Mucocutaneous zone; Medicine; Dermatology; Systemic lupus erythematosus; Lupus erythematosus; Ingestion; Sloughing; Drug; Connective tissue disease; Pathology; Immunology; Disease; Autoimmune disease; Internal medicine; Antibody","score_opus":0.023655128857255424,"score_gpt":0.31117685945997053,"score_spread":0.28752173060271513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984048395","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.905826,0.019208124,0.0059322766,0.009490357,0.0007634117,0.00016489699,0.0003667234,0.00048378852,0.057764504],"genre_scores_gemma":[0.9928878,0.0024026632,0.00089856907,0.001227827,0.00077007624,0.000010949979,0.00007612066,0.000015600877,0.0017104142],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9995902,0.00007322892,0.000052234078,0.000092242124,0.00006990412,0.00012221737],"domain_scores_gemma":[0.9991757,0.00021504836,0.00025106696,0.00010541769,0.0000794078,0.00017328915],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003882539,0.0008360748,0.00081566826,0.00077724044,0.00067415426,0.0013560861,0.00064618606,0.0028070281,0.0031226864],"category_scores_gemma":[0.0021001427,0.0003095138,0.00047270008,0.00075257214,0.0007423349,0.0013860209,0.00063603994,0.0014621232,0.0011418142],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002983194,0.00011855796,0.02178424,0.00010488338,0.000023987983,0.9576373,0.00014799421,0.00009078406,0.005968409,0.0011314945,0.0013511566,0.011342892],"study_design_scores_gemma":[0.00003047389,0.00012419652,0.0059695006,0.000014131511,0.000020850352,0.9902823,0.00008374763,0.00023794154,0.0008223044,0.00037028868,0.002037159,0.0000071022127],"about_ca_topic_score_codex":0.000388233,"about_ca_topic_score_gemma":0.0004070237,"teacher_disagreement_score":0.0031226864,"about_ca_system_score_codex":0.0004197127,"about_ca_system_score_gemma":0.000286897,"threshold_uncertainty_score":0.010446429},"labels":[],"label_agreement":null},{"id":"W1984373713","doi":"10.1016/j.jaad.2011.04.038","title":"Melanoma in adolescents and young adults (ages 15-39 years): United States, 1999-2006","year":2011,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":181,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario","funders":"National Cancer Institute","keywords":"Medicine; Young adult; Demography; Pediatrics; Gerontology","score_opus":0.01223048485009539,"score_gpt":0.2549558783804142,"score_spread":0.24272539353031883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984373713","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9796911,0.0020458538,0.00012153304,0.00041730914,0.000079748635,0.000047918977,0.014793477,0.000018729708,0.002784259],"genre_scores_gemma":[0.9891566,0.0018801052,0.00017954902,0.00027869234,0.00003980543,0.00004747699,0.007132785,0.0000066218427,0.0012782032],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99967504,0.000031310734,0.000074847696,0.000061802115,0.00009008419,0.00006690468],"domain_scores_gemma":[0.9987538,0.00007331531,0.00064100587,0.000020313582,0.00025165957,0.00025983213],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003995369,0.00027727996,0.00032711835,0.0012406388,0.00044805455,0.00074355083,0.00050869444,0.00055381784,0.0012924242],"category_scores_gemma":[0.0013846753,0.00030340033,0.00046609505,0.0018421963,0.00015264006,0.0007643455,0.00055254897,0.0008175264,0.00028146405],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000037946207,0.000035877954,0.996997,0.000024506291,0.000028258964,0.00006414654,0.000107339925,0.000018988878,0.000044986537,0.000010401534,0.00092444645,0.0017061201],"study_design_scores_gemma":[0.000003392064,0.000025030327,0.99837863,0.000027456586,0.00002373015,0.00020541697,0.00040290077,0.000036994086,0.00002610797,0.000004936978,0.0008636781,0.0000017682028],"about_ca_topic_score_codex":0.08620354,"about_ca_topic_score_gemma":0.20386367,"teacher_disagreement_score":0.08620354,"about_ca_system_score_codex":0.0008108794,"about_ca_system_score_gemma":0.0009054879,"threshold_uncertainty_score":0.17140359},"labels":[],"label_agreement":null},{"id":"W1984874852","doi":"10.1067/mjd.2003.445","title":"Repeated exposure to blue light does not improve psoriasis","year":2003,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Psoriasis; Medicine; Blue light; Protoporphyrin IX; Photobleaching; Dermatology; Plaque psoriasis; In vivo; Endogeny; Photodynamic therapy; Pathology; Fluorescence; Internal medicine; Optics; Chemistry","score_opus":0.010627363461646529,"score_gpt":0.2530564022201959,"score_spread":0.24242903875854935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984874852","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9852722,0.0068094535,0.0009567022,0.0009302476,0.00060663145,0.00006302662,0.00015527061,0.00043104368,0.004775418],"genre_scores_gemma":[0.99472564,0.0010842597,0.00029304327,0.00023973375,0.00026126968,0.000017858936,0.00012626204,0.000056799712,0.0031951107],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9996916,0.0000803172,0.000015759626,0.000047874222,0.000076429584,0.00008812811],"domain_scores_gemma":[0.9992046,0.0002984479,0.00008685884,0.0001461676,0.000046822654,0.00021713562],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000311553,0.00043004865,0.0014256835,0.00027044202,0.00035059365,0.00029517178,0.00043464647,0.0009876399,0.006312432],"category_scores_gemma":[0.00088296045,0.00017688457,0.0006405163,0.00016180711,0.00038551213,0.00042759822,0.00022251393,0.0014967032,0.0009724401],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03653823,0.010043803,0.0056072664,0.00066329405,0.000807041,0.0013254089,0.00022948728,0.00049409684,0.75895596,0.0002758426,0.0053821444,0.17967735],"study_design_scores_gemma":[0.013271108,0.2933235,0.21346536,0.0003028596,0.0021148846,0.013440311,0.0006877821,0.0028893126,0.42278683,0.0012421577,0.036317818,0.00015805296],"about_ca_topic_score_codex":0.0008680931,"about_ca_topic_score_gemma":0.0012692357,"teacher_disagreement_score":0.006312432,"about_ca_system_score_codex":0.00018269746,"about_ca_system_score_gemma":0.00026929218,"threshold_uncertainty_score":0.02111721},"labels":[],"label_agreement":null},{"id":"W1985886453","doi":"10.1016/j.jaad.2011.06.035","title":"Underdiagnosis and undertreatment of cardiovascular risk factors in patients with moderate to severe psoriasis","year":2011,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":128,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Psoriasis; Hyperlipidemia; Diabetes mellitus; Framingham Risk Score; Internal medicine; Population; Blood pressure; Risk factor; Disease; Endocrinology; Dermatology","score_opus":0.01704995357881962,"score_gpt":0.22461067678834515,"score_spread":0.20756072320952554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985886453","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956232,0.001988921,0.00012380676,0.0007869055,0.000046054945,0.0000064080477,0.00012373005,0.000006162841,0.0012947273],"genre_scores_gemma":[0.9994116,0.0002745666,0.000059924238,0.0001226131,0.000047247137,0.000001419617,0.00004743644,0.0000010185643,0.000034177716],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980584,0.00085175876,0.00023564218,0.00018122586,0.00041518867,0.0002576901],"domain_scores_gemma":[0.98869413,0.0058780564,0.0033950447,0.0006607909,0.0007174486,0.00065464794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001315919,0.00021974082,0.00056902535,0.0008983065,0.00047211535,0.0012420411,0.00037674722,0.0008891599,0.0009003421],"category_scores_gemma":[0.021341315,0.00030543687,0.00047484977,0.0013259047,0.00042661437,0.0007653612,0.000466859,0.0013928475,0.000101280006],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001842241,0.000036831538,0.9949195,0.000015504918,0.0000353772,0.00022568811,0.00009407416,0.000030650477,0.00008037562,0.0000312172,0.00012209598,0.0042245355],"study_design_scores_gemma":[0.00001413252,0.00008358501,0.9970625,0.000017688695,0.000098141994,0.0015359671,0.0003490711,0.00045530885,0.000079359874,0.00012547823,0.00017232112,0.000006392427],"about_ca_topic_score_codex":0.005928697,"about_ca_topic_score_gemma":0.0067167548,"teacher_disagreement_score":0.005928697,"about_ca_system_score_codex":0.00039025268,"about_ca_system_score_gemma":0.0006172571,"threshold_uncertainty_score":0.011788368},"labels":[],"label_agreement":null},{"id":"W1986030150","doi":"10.1016/j.jaad.2014.05.044","title":"Reliability of Clinician Erythema Assessment grading scale","year":2014,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":136,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Windsor Clinical Research; University of Windsor; Western University","funders":"","keywords":"Medicine; Erythema; Intraclass correlation; Inter-rater reliability; Rosacea; Dermatology; Intra-rater reliability; Statistic; Grading (engineering); Reliability (semiconductor); Rating scale; Physical therapy; Confidence interval; Psychometrics; Internal medicine; Psychology; Clinical psychology; Statistics","score_opus":0.014234325597387893,"score_gpt":0.3509681963224041,"score_spread":0.3367338707250162,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986030150","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9627217,0.0012410639,0.010866674,0.0004359572,0.00074437354,0.0009942147,0.0010232301,0.0002247777,0.021748044],"genre_scores_gemma":[0.99116737,0.00018001269,0.005982641,0.00017685126,0.000073479714,0.00033030493,0.00042788195,0.000051345465,0.0016100687],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9786997,0.008530322,0.002687511,0.0021233286,0.007423815,0.0005353087],"domain_scores_gemma":[0.926242,0.032371372,0.0063310815,0.0060978597,0.027809339,0.0011483426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015143659,0.00037975836,0.00072249,0.0016292344,0.00071041,0.00092637993,0.000611377,0.0007045107,0.0030615998],"category_scores_gemma":[0.07121047,0.00029882757,0.0010610218,0.00074672716,0.0005614525,0.00092578266,0.0012736729,0.00090550387,0.0012167838],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013490198,0.00041448846,0.923308,0.00025992934,0.00037453588,0.0001505188,0.0025654975,0.0006147492,0.0048596566,0.0006274536,0.0049545434,0.060521554],"study_design_scores_gemma":[0.00017457276,0.0012704565,0.9723355,0.00019805999,0.0002717472,0.0010141538,0.0015470221,0.006739809,0.0043101674,0.00065471313,0.011388917,0.000094764335],"about_ca_topic_score_codex":0.0016160966,"about_ca_topic_score_gemma":0.0024248934,"teacher_disagreement_score":0.015143659,"about_ca_system_score_codex":0.0007391805,"about_ca_system_score_gemma":0.0009086229,"threshold_uncertainty_score":0.08008832},"labels":[],"label_agreement":null},{"id":"W1986087084","doi":"10.1016/j.jaad.2010.05.001","title":"Comparison of patients' and providers' severity evaluation of oral mucosal conditions","year":2011,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Oral Health Pathology and Treatment","field":"Dentistry","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Alexithymia; Concordance; Toronto Alexithymia Scale; Quality of life (healthcare); Oral health; Feeling; Severity of illness; Disease; Family medicine; Psychiatry; Internal medicine; Nursing","score_opus":0.08524544524980744,"score_gpt":0.4219373257595972,"score_spread":0.33669188050978976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986087084","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99751127,0.00014435624,0.00007160293,0.00010412038,0.000010910988,0.000021278052,0.0002050374,0.0000029321916,0.0019285755],"genre_scores_gemma":[0.9995184,0.000057063746,0.00009953072,0.000033934324,0.0000068364166,0.000010342715,0.0001367788,0.0000016030884,0.00013563132],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965179,0.0014705452,0.0005739893,0.00021535807,0.0008220354,0.0004001727],"domain_scores_gemma":[0.986155,0.0066273855,0.0028423937,0.00034441677,0.0030873998,0.00094347243],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027328988,0.00013599121,0.0003400414,0.001286812,0.00052016386,0.0006634507,0.00028919973,0.0004046568,0.0040460285],"category_scores_gemma":[0.023187604,0.00016032124,0.00051100797,0.00070320704,0.00026843318,0.00068182935,0.00085679535,0.0004107021,0.00029203919],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010087794,0.00018940345,0.9847184,0.00006139894,0.00007122796,0.00012210672,0.0019940373,0.00007415865,0.0003734186,0.00010566217,0.00039897618,0.0108824195],"study_design_scores_gemma":[0.00005012761,0.00055267493,0.9928877,0.000028141523,0.00007264251,0.0005312388,0.0044024633,0.00033635527,0.00025205352,0.000059171376,0.0008140197,0.000013452644],"about_ca_topic_score_codex":0.0027876745,"about_ca_topic_score_gemma":0.0046693934,"teacher_disagreement_score":0.0040460285,"about_ca_system_score_codex":0.0007757983,"about_ca_system_score_gemma":0.00059168215,"threshold_uncertainty_score":0.014453173},"labels":[],"label_agreement":null},{"id":"W1987243938","doi":"10.1016/j.jaad.2009.12.017","title":"Differentiation of vascular tumors from vascular malformations by expression of Wilms tumor 1 gene: Evaluation of 126 cases","year":2010,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Vascular Malformations and Hemangiomas","field":"Medicine","cited_by":92,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Pathology; Hemangioma; Wilms' tumor; Vascular malformation; Angioma; Vascular Tumors; Vascular anomaly; Vascular disease; Radiology; Internal medicine","score_opus":0.016833121386574564,"score_gpt":0.2974173544478039,"score_spread":0.28058423306122937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987243938","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99745995,0.0005793564,0.00057628454,0.000019983278,0.000008978953,0.000045539826,0.00011149615,0.000011175809,0.0011872791],"genre_scores_gemma":[0.99877864,0.0002932098,0.0004935815,0.000009795186,0.000016929213,0.000021112131,0.00015910358,0.000006976744,0.00022067553],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991516,0.00009249192,0.00015061119,0.00020755523,0.00022348715,0.00017435999],"domain_scores_gemma":[0.99863005,0.00053103437,0.00024240163,0.0001679823,0.00013269119,0.00029588482],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063083536,0.00068308134,0.00060603296,0.0035512487,0.0012751811,0.0005274955,0.00078736467,0.0006819665,0.0013509291],"category_scores_gemma":[0.002622184,0.0009400993,0.00061417714,0.0015003078,0.0014920294,0.0004808226,0.001034514,0.00035840177,0.00039743297],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010540037,0.00035334393,0.6302208,0.0002605211,0.00013364463,0.31108224,0.0028410566,0.00059887714,0.0336431,0.00031841922,0.00037196334,0.019121997],"study_design_scores_gemma":[0.000118348085,0.00093000574,0.55062497,0.000047501882,0.00029741426,0.42338243,0.0019606536,0.0014056675,0.017641522,0.00032928624,0.0031755364,0.0000868208],"about_ca_topic_score_codex":0.001620066,"about_ca_topic_score_gemma":0.001698086,"teacher_disagreement_score":0.0035512487,"about_ca_system_score_codex":0.00057765853,"about_ca_system_score_gemma":0.00054131227,"threshold_uncertainty_score":0.0045193434},"labels":[],"label_agreement":null},{"id":"W1987651671","doi":"10.1067/mjd.2000.109299","title":"Comparison of UVA protection afforded by high sun protection factor sunscreens","year":2000,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Skin Protection and Aging","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Sun protection factor; Sun protection; Medicine; Sunscreening Agents; Radiation protection; Dermatology; Ultraviolet radiation; Sun exposure; Toxicology; Internal medicine; Skin cancer; Nuclear medicine","score_opus":0.03396587361558961,"score_gpt":0.33911002947779945,"score_spread":0.30514415586220983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987651671","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930455,0.005182361,0.00020794319,0.000046393754,0.00003878843,0.000016431199,0.0002415072,0.000011911129,0.0012089637],"genre_scores_gemma":[0.9978842,0.0011915053,0.00024550344,0.000029379986,0.0000229921,0.000007516231,0.00014820763,0.000004713919,0.0004659245],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99963284,0.00012956592,0.000032957218,0.00004798019,0.00007234456,0.00008427148],"domain_scores_gemma":[0.9991196,0.0005159594,0.0000875525,0.00006403567,0.000093975556,0.00011889052],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049230555,0.00026676562,0.00044669054,0.00055110623,0.00022246683,0.00034022835,0.00019212873,0.00035224782,0.004272535],"category_scores_gemma":[0.00090832,0.00012161724,0.00063525815,0.000352425,0.00021592615,0.00041280244,0.00019994938,0.00044652366,0.00019208605],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.24071772,0.0052359337,0.021514785,0.0020466223,0.0008482152,0.0002565697,0.0003900977,0.0018857155,0.5704261,0.0010700146,0.0009877301,0.15462044],"study_design_scores_gemma":[0.004037493,0.25056386,0.2574304,0.00021291671,0.001793562,0.0010571677,0.0011755055,0.0012921204,0.4676389,0.0009016626,0.0138201285,0.00007626008],"about_ca_topic_score_codex":0.0007945679,"about_ca_topic_score_gemma":0.0007911327,"teacher_disagreement_score":0.004272535,"about_ca_system_score_codex":0.00017165024,"about_ca_system_score_gemma":0.0001913968,"threshold_uncertainty_score":0.014293015},"labels":[],"label_agreement":null},{"id":"W1987827452","doi":"10.1016/j.jaad.2014.06.037","title":"Extragenital bullous lichen sclerosus","year":2014,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Genital Health and Disease","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Lichen sclerosus; Medicine; Dermatology; Papillary dermis; Dermis; Pathology","score_opus":0.05024327893964109,"score_gpt":0.3995990529783177,"score_spread":0.3493557740386766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987827452","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012279736,0.99897754,0.00004703617,0.00011512939,0.00012192032,0.0000029075293,0.000013094686,0.0000040607943,0.000595525],"genre_scores_gemma":[0.001323777,0.99757034,0.00010859453,0.0002298808,0.00022599053,0.000003052279,0.00003064505,0.000001149032,0.00050647726],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99968195,0.00004696455,0.00006512005,0.000052671992,0.0001185147,0.000034922465],"domain_scores_gemma":[0.9994369,0.0002578426,0.0001445031,0.000015348534,0.000100054,0.00004522178],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000540286,0.00076913467,0.001856581,0.0042712204,0.00039230383,0.0012807833,0.00083675544,0.00084787875,0.005387776],"category_scores_gemma":[0.00108806,0.00031992656,0.0004995565,0.0032612632,0.0005224491,0.0016507503,0.0009609807,0.0013780737,0.001279037],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000059183534,0.0000695841,0.0007232549,0.026022619,0.00015441899,0.00088416506,0.000060497245,0.00016510022,0.00059973437,0.00079540256,0.02521535,0.94525075],"study_design_scores_gemma":[0.00007264369,0.00011455519,0.0049753175,0.017961895,0.00091243646,0.018136526,0.00024492198,0.00013434073,0.0004997692,0.0011495311,0.9557527,0.000045425022],"about_ca_topic_score_codex":0.0014907746,"about_ca_topic_score_gemma":0.0042554294,"teacher_disagreement_score":0.005387776,"about_ca_system_score_codex":0.00044453077,"about_ca_system_score_gemma":0.0010173795,"threshold_uncertainty_score":0.018023908},"labels":[],"label_agreement":null},{"id":"W1988216288","doi":"10.1016/j.jaad.2011.09.005","title":"Acne severity grading: Determining essential clinical components and features using a Delphi consensus","year":2011,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Windsor; Western University","funders":"","keywords":"Acne; Medicine; Grading (engineering); Delphi method; Categorization; Grading scale; Delphi; Medical physics; Dermatology; Surgery; Artificial intelligence; Computer science","score_opus":0.08468723462818897,"score_gpt":0.3836153987262778,"score_spread":0.29892816409808887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988216288","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6924099,0.0029059246,0.13659362,0.014872279,0.0009927439,0.060344953,0.001870184,0.00041358513,0.08959676],"genre_scores_gemma":[0.71955186,0.0015702386,0.24043608,0.0019652343,0.00017740559,0.029483892,0.0013375826,0.0001346437,0.005343054],"study_design_codex":"design_other","study_design_gemma":"qualitative","domain_scores_codex":[0.95705223,0.0244517,0.00931358,0.0013046485,0.0055307075,0.0023470998],"domain_scores_gemma":[0.9614685,0.012046336,0.002084523,0.0015844807,0.021101944,0.0017141938],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.067446604,0.0008610422,0.0011344402,0.0045672017,0.0022816707,0.0014648297,0.001655662,0.0013017018,0.004452009],"category_scores_gemma":[0.04931239,0.00071117136,0.0020864776,0.0016048935,0.001535306,0.0020602765,0.005920306,0.0018630967,0.0012703248],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032732792,0.0016755201,0.13909774,0.007276385,0.00082773966,0.0013520296,0.10822369,0.0028599387,0.03704676,0.017703071,0.051817097,0.62884676],"study_design_scores_gemma":[0.002422879,0.004702272,0.3327319,0.013099605,0.0019004396,0.011192307,0.20637988,0.044489276,0.027395094,0.047826096,0.3063062,0.0015540037],"about_ca_topic_score_codex":0.0020598588,"about_ca_topic_score_gemma":0.003789691,"teacher_disagreement_score":0.067446604,"about_ca_system_score_codex":0.0035474875,"about_ca_system_score_gemma":0.009640583,"threshold_uncertainty_score":0.356696},"labels":[],"label_agreement":null},{"id":"W1988429285","doi":"10.1016/j.jaad.2003.10.546","title":"The value of persistent treatment of psoriasis with etanercept","year":2004,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Biogen; Genentech; Amgen","keywords":"Medicine; Etanercept; Placebo; Psoriasis; Internal medicine; Clinical trial; Gastroenterology; Dermatology; Tumor necrosis factor alpha","score_opus":0.0401629159775974,"score_gpt":0.36699750430040634,"score_spread":0.3268345883228089,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988429285","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6643378,0.26824385,0.0015427463,0.037237734,0.0018390586,0.000049008646,0.0008480861,0.00007722667,0.025824426],"genre_scores_gemma":[0.9723961,0.021801729,0.0005148806,0.001875254,0.0013370037,0.000012103584,0.00016477058,0.000012122841,0.001886095],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9986247,0.000660663,0.00015848746,0.000120967314,0.00030142794,0.00013377915],"domain_scores_gemma":[0.9860199,0.009134092,0.0016202831,0.0007571089,0.0011356266,0.0013329235],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026186386,0.0002982842,0.0010869147,0.00042086456,0.00064615894,0.0015835515,0.00056360284,0.0010236645,0.0041061],"category_scores_gemma":[0.014090689,0.0001101904,0.00082602113,0.00040756146,0.0007234456,0.0018248084,0.0004936619,0.0021637278,0.0003500027],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03297204,0.0009463123,0.069717035,0.0013582784,0.00094973255,0.0008788516,0.00036974635,0.00052747753,0.0026184958,0.0028100063,0.0061799274,0.8806721],"study_design_scores_gemma":[0.007149742,0.038563546,0.78514457,0.005148094,0.008972038,0.016711885,0.004651073,0.0065644113,0.0061558005,0.023155212,0.097547635,0.0002360179],"about_ca_topic_score_codex":0.002070669,"about_ca_topic_score_gemma":0.0047183135,"teacher_disagreement_score":0.0041061,"about_ca_system_score_codex":0.0012564415,"about_ca_system_score_gemma":0.0016095426,"threshold_uncertainty_score":0.013848841},"labels":[],"label_agreement":null},{"id":"W1988845586","doi":"10.1016/j.jaad.2003.10.497","title":"A new anti-psoriatic ointment yields high efficacy irrespective of initial disease levels","year":2004,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Galderma","keywords":"Medicine; Psoriasis; Psoriasis Area and Severity Index; Clinical trial; Internal medicine; Plaque psoriasis; Dermatology; Betamethasone dipropionate; Disease; Betamethasone","score_opus":0.022601719317820998,"score_gpt":0.30690558313449534,"score_spread":0.28430386381667433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988845586","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9805617,0.0095443195,0.002156469,0.00029300302,0.0003250887,0.0001348901,0.0002613078,0.00026295346,0.006460252],"genre_scores_gemma":[0.9931473,0.0021465004,0.0010829534,0.00012361967,0.00020154113,0.00002455086,0.00025302602,0.00003340844,0.0029871957],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997551,0.000046298854,0.000013634573,0.000036553385,0.000068221845,0.00008028393],"domain_scores_gemma":[0.9995726,0.00016435243,0.000040463558,0.00005325128,0.000040968454,0.00012831642],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039964507,0.00044685497,0.0009390957,0.00053939247,0.0002596393,0.00046355926,0.00021627582,0.000513016,0.0022617886],"category_scores_gemma":[0.0004581321,0.00015266043,0.0003866188,0.00024628403,0.00022156443,0.00031558762,0.00015145123,0.0010509824,0.0006383729],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035890858,0.0022106993,0.0009869625,0.00016208115,0.00005484089,0.0003077893,0.00004600654,0.00025778587,0.92107,0.00016165632,0.0008521172,0.070301116],"study_design_scores_gemma":[0.0017549993,0.053412173,0.044300858,0.00005093583,0.00039019663,0.0021888015,0.00007519813,0.0014818077,0.88684195,0.0002100551,0.009251183,0.00004193173],"about_ca_topic_score_codex":0.000413351,"about_ca_topic_score_gemma":0.0008552024,"teacher_disagreement_score":0.0022617886,"about_ca_system_score_codex":0.00010833203,"about_ca_system_score_gemma":0.00018321628,"threshold_uncertainty_score":0.007566452},"labels":[],"label_agreement":null},{"id":"W1989586093","doi":"10.1016/j.jaad.2003.10.347","title":"Ciclopirox shampoo: an overview","year":2004,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Shampoo; Medicine; Dermatology; Scalp; Adverse effect; Pharmacology; Pathology","score_opus":0.0418395794806007,"score_gpt":0.3799738916837757,"score_spread":0.338134312203175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989586093","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009165577,0.99601585,0.00068080827,0.0008422927,0.00016407714,0.0000128041465,0.000023582885,0.000016891307,0.0013271772],"genre_scores_gemma":[0.0059283013,0.98855513,0.0015336752,0.0014136959,0.0013360021,0.000031499894,0.00007331513,0.000009685875,0.0011187675],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99935,0.00010771163,0.0001278244,0.00016195296,0.0002003569,0.000052125597],"domain_scores_gemma":[0.99909306,0.0005479542,0.00013258317,0.000019794088,0.00014322663,0.00006331644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012048681,0.0014057825,0.002901128,0.0034103084,0.00058625446,0.0017814516,0.00096343533,0.0020517597,0.0018415116],"category_scores_gemma":[0.0008999955,0.0005752202,0.001219241,0.0017522116,0.0006025508,0.0027381086,0.00065262953,0.0024576378,0.0011379686],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007494536,0.0003875045,0.0014344088,0.0067360476,0.00022998743,0.0012623202,0.00006908453,0.00033668612,0.00169499,0.0018305648,0.010479958,0.9747891],"study_design_scores_gemma":[0.00073100266,0.0041802055,0.0219042,0.010427825,0.0021776431,0.05315175,0.0005784971,0.0018437178,0.0036745612,0.009840155,0.8912591,0.00023137589],"about_ca_topic_score_codex":0.001095343,"about_ca_topic_score_gemma":0.0031944518,"teacher_disagreement_score":0.0034103084,"about_ca_system_score_codex":0.0012193159,"about_ca_system_score_gemma":0.0010779457,"threshold_uncertainty_score":0.008846819},"labels":[],"label_agreement":null},{"id":"W1989702104","doi":"10.1016/j.jaad.2011.06.041","title":"Long-term safety experience of ustekinumab in patients with moderate to severe psoriasis (Part II of II): Results from analyses of infections and malignancy from pooled phase II and III clinical trials","year":2011,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":140,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Dalhousie University; Probity Medical Research","funders":"","keywords":"Ustekinumab; Medicine; Placebo; Psoriasis; Internal medicine; Population; Epidemiology; Confidence interval; Clinical trial; Randomized controlled trial; Dermatology; Disease; Pathology","score_opus":0.07938100106568033,"score_gpt":0.36741952211894696,"score_spread":0.28803852105326666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989702104","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94055563,0.052719943,0.0014679658,0.0008219682,0.00017801857,0.0003466873,0.0015111129,0.0000758646,0.0023227122],"genre_scores_gemma":[0.988576,0.007663589,0.00040635484,0.00086002436,0.00031969248,0.00013867242,0.0015351513,0.000024352614,0.00047610924],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99623495,0.0024186075,0.0002832039,0.00035086882,0.00041215945,0.00030009096],"domain_scores_gemma":[0.99348044,0.0027306562,0.0020653969,0.0006234369,0.00047129637,0.00062879047],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010854216,0.0010684237,0.003608064,0.00045715662,0.00049425074,0.0019188584,0.00064259826,0.0011264059,0.00133582],"category_scores_gemma":[0.005917899,0.0005376347,0.004753925,0.00079682795,0.00095204747,0.0015121648,0.0005330993,0.0026039071,0.00031767957],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.63598424,0.0039466843,0.07334671,0.0030114765,0.05248486,0.00025001698,0.00053898344,0.0034129955,0.018333906,0.00037914517,0.004647092,0.20366386],"study_design_scores_gemma":[0.24414998,0.32520494,0.34429944,0.000641408,0.058471773,0.0017619136,0.0004279878,0.0020483055,0.008876761,0.0012732531,0.012639147,0.00020503475],"about_ca_topic_score_codex":0.00046987634,"about_ca_topic_score_gemma":0.0009973367,"teacher_disagreement_score":0.010854216,"about_ca_system_score_codex":0.0006566056,"about_ca_system_score_gemma":0.0007806233,"threshold_uncertainty_score":0.057403266},"labels":[],"label_agreement":null},{"id":"W1989954587","doi":"10.1016/j.jaad.2006.04.048","title":"Toxic epidermal necrolysis","year":2007,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":379,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"","keywords":"Medicine; Toxic epidermal necrolysis; Etiology; Discontinuation; Perforin; Retrospective cohort study; Intensive care medicine; Dermatology; Immunology; Internal medicine; Immune system; CD8","score_opus":0.07644439473627122,"score_gpt":0.42189287355115285,"score_spread":0.3454484788148816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989954587","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002415011,0.9950368,0.0002371969,0.000133408,0.00044325247,0.000014730228,0.00003049576,0.000022643362,0.0038399396],"genre_scores_gemma":[0.0026322645,0.9925351,0.00044344924,0.0003884268,0.0004869973,0.000013609903,0.000102656115,0.0000031200132,0.003394377],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996995,0.00004012796,0.00005639436,0.00004675912,0.00012728207,0.000030050585],"domain_scores_gemma":[0.99962854,0.00009166074,0.000122058176,0.00002027584,0.00010767509,0.000029775372],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035596322,0.0009775017,0.001290335,0.0035198191,0.0003584529,0.00097129383,0.000729463,0.00081899116,0.006271207],"category_scores_gemma":[0.0006276093,0.0002565907,0.0004952241,0.0025188962,0.00036174798,0.0009111502,0.000716725,0.0012287169,0.0038877456],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004322252,0.00008291624,0.0002570869,0.0070048007,0.00006267561,0.0004565156,0.000019483477,0.00011808927,0.0014529414,0.0004730834,0.033865225,0.95616406],"study_design_scores_gemma":[0.000038995284,0.00013144464,0.0022395095,0.0040950105,0.0002207382,0.010336551,0.000043450145,0.00011604143,0.0013897158,0.0007868855,0.9805791,0.000022542841],"about_ca_topic_score_codex":0.0008887554,"about_ca_topic_score_gemma":0.0020858708,"teacher_disagreement_score":0.006271207,"about_ca_system_score_codex":0.00036804803,"about_ca_system_score_gemma":0.00063162495,"threshold_uncertainty_score":0.020979285},"labels":[],"label_agreement":null},{"id":"W1990318779","doi":"10.1016/j.jaad.2005.08.015","title":"Infectious occupational exposures in dermatology–A review of risks and prevention measures","year":2005,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"","keywords":"Medicine; Dermabrasion; Occupational exposure; Dermatology; Cryotherapy; Intensive care medicine; Surgery; Environmental health","score_opus":0.10754096973042207,"score_gpt":0.45192856629402206,"score_spread":0.34438759656359996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990318779","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000058407666,0.99974805,0.00002135497,0.000049151084,0.000029493673,0.0000043275127,0.00001339762,9.893657e-7,0.00007481049],"genre_scores_gemma":[0.00037412986,0.99942446,0.00008608725,0.000045878754,0.000031654934,0.0000036288736,0.0000104583405,2.2913719e-7,0.000023590472],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9991326,0.00018153737,0.00028256598,0.000110683024,0.00026335308,0.000029343722],"domain_scores_gemma":[0.9970366,0.0021093367,0.0005103981,0.00003933175,0.00025708892,0.000047300837],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018366659,0.0011190914,0.0038718453,0.004607118,0.0003283012,0.0012277161,0.0013264271,0.0013347492,0.002600547],"category_scores_gemma":[0.0033479056,0.00064153253,0.0017104759,0.005340439,0.0005135018,0.0014183228,0.00067545107,0.0010205042,0.00042917757],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001917556,0.00012896607,0.0010562941,0.2202514,0.0014320294,0.00021307245,0.00009683629,0.00032269637,0.0004194095,0.0009295144,0.010338758,0.76461935],"study_design_scores_gemma":[0.0003668298,0.0007964699,0.019616757,0.2865033,0.015196327,0.004205329,0.0007102529,0.00043061166,0.0010328813,0.003310438,0.6676615,0.00016931337],"about_ca_topic_score_codex":0.0042028604,"about_ca_topic_score_gemma":0.009477916,"teacher_disagreement_score":0.004607118,"about_ca_system_score_codex":0.0007797925,"about_ca_system_score_gemma":0.0020743397,"threshold_uncertainty_score":0.009713352},"labels":[],"label_agreement":null},{"id":"W1990396596","doi":"10.1016/j.jaad.2005.04.075","title":"A systematic review of contact dermatitis treatment and prevention","year":2005,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Contact Dermatitis and Allergies","field":"Medicine","cited_by":158,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Dermatology; Contact dermatitis; MEDLINE; Allergy; Immunology","score_opus":0.03153825801324351,"score_gpt":0.37187433207559695,"score_spread":0.34033607406235344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990396596","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008691571,0.99814487,0.000086487235,0.00012815905,0.00010341063,0.00023806583,0.00019594697,0.000006116097,0.00022780485],"genre_scores_gemma":[0.017415652,0.98078316,0.00075518084,0.00044223608,0.00007005531,0.00027473862,0.00011731697,0.000003880104,0.00013767587],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.992773,0.0027742719,0.0025950936,0.0005053698,0.001147852,0.00020436397],"domain_scores_gemma":[0.9842622,0.00996325,0.0038401457,0.00023156656,0.0014228811,0.00027989427],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0067377454,0.0015367892,0.010650326,0.007697898,0.000618261,0.0021447479,0.0020563253,0.0019316698,0.0057512037],"category_scores_gemma":[0.028267527,0.0013024675,0.0064902524,0.008260199,0.00080415374,0.001868978,0.0015257776,0.0013402834,0.00030636514],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032708864,0.00002790102,0.00063207827,0.94696134,0.017980259,0.000104754385,0.00014813339,0.0001007074,0.00011837704,0.00012095161,0.0015161077,0.031962298],"study_design_scores_gemma":[0.0013674655,0.00049860805,0.0072598234,0.742231,0.22311534,0.0006382463,0.00029267775,0.00012361228,0.00017072637,0.00028896643,0.023961129,0.000052449755],"about_ca_topic_score_codex":0.015113541,"about_ca_topic_score_gemma":0.05468308,"teacher_disagreement_score":0.015113541,"about_ca_system_score_codex":0.003512114,"about_ca_system_score_gemma":0.009405412,"threshold_uncertainty_score":0.035632968},"labels":[],"label_agreement":null},{"id":"W1993332228","doi":"10.1016/j.jaad.2003.10.062","title":"The canadian acne epidemiological survey: baseline demographics and interim analysis","year":2004,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Windsor; Western University","funders":"","keywords":"Medicine; Acne; Epidemiology; Demographics; Family medicine; Interim; Informed consent; Population; Pediatrics; Demography; Alternative medicine; Dermatology; Environmental health; Internal medicine; Pathology","score_opus":0.03312890096468202,"score_gpt":0.3485382619621448,"score_spread":0.3154093609974628,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993332228","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85679364,0.0008095809,0.0013019732,0.00049253664,0.00008516562,0.0011923867,0.1282339,0.0001086318,0.010982069],"genre_scores_gemma":[0.87766343,0.0006240316,0.0012941468,0.00028600043,0.000042200678,0.0010246377,0.110096864,0.000042041283,0.008926665],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99729425,0.00022988119,0.00014585935,0.00025780802,0.0011618661,0.00091034564],"domain_scores_gemma":[0.9974648,0.00008676841,0.00019177866,0.00017314444,0.001764013,0.00031955322],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022800409,0.00074217183,0.0010376266,0.0028891263,0.0021750221,0.0009865228,0.0016190391,0.0008349602,0.003952241],"category_scores_gemma":[0.004547124,0.000579704,0.0014983816,0.0046839095,0.00046545258,0.0008086883,0.0009263045,0.0012576069,0.00087906624],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013129006,0.00029619675,0.9786275,0.00004304057,0.00022466939,0.00013450264,0.00020729953,0.00047602513,0.00024642417,0.00012464884,0.009388293,0.008918465],"study_design_scores_gemma":[0.000038331083,0.0000969396,0.9967154,0.000006973396,0.00005816894,0.00004731312,0.00024732845,0.00021242602,0.00008559369,0.000028036106,0.0024463907,0.000017026487],"about_ca_topic_score_codex":0.944568,"about_ca_topic_score_gemma":0.940868,"teacher_disagreement_score":0.05543202,"about_ca_system_score_codex":0.012515126,"about_ca_system_score_gemma":0.02252485,"threshold_uncertainty_score":0.11151689},"labels":[],"label_agreement":null},{"id":"W1993553749","doi":"10.1016/j.jaad.2007.01.048","title":"A pilot quality-of-life instrument for acne rosacea","year":2007,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":106,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","keywords":"Rosacea; Medicine; Intraclass correlation; Discriminant validity; Cronbach's alpha; Reliability (semiconductor); Quality of life (healthcare); Construct validity; Acne; Physical therapy; Dermatology; Psychometrics; Clinical psychology; Internal consistency","score_opus":0.058105085620273285,"score_gpt":0.3868799754731469,"score_spread":0.3287748898528736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993553749","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9832213,0.00030745668,0.003053162,0.0005058139,0.00011935523,0.005946126,0.0030947528,0.0001223594,0.0036297226],"genre_scores_gemma":[0.9682846,0.0002581656,0.016852574,0.0004390397,0.00005860867,0.007813671,0.0041575516,0.000059494625,0.0020762645],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977203,0.00088174583,0.00042735084,0.00018008097,0.000563171,0.00022737811],"domain_scores_gemma":[0.99209654,0.0027660287,0.0016469046,0.00042456755,0.0019520543,0.0011140172],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005462991,0.0006209192,0.0010004372,0.001104325,0.0008540387,0.0008895955,0.00075163215,0.0008554493,0.004026379],"category_scores_gemma":[0.0099085225,0.0003643519,0.0019965027,0.0007596724,0.00041755394,0.0012878102,0.001539564,0.0017307296,0.0007135532],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009037822,0.013776381,0.7704836,0.0006937718,0.0007909488,0.000307722,0.0027743622,0.0022737698,0.004272014,0.00077613146,0.009012345,0.18580097],"study_design_scores_gemma":[0.0012187666,0.007838125,0.98180765,0.00007826778,0.00015006698,0.00029626227,0.00083176093,0.0024179805,0.00089131284,0.00027010613,0.004134244,0.00006537117],"about_ca_topic_score_codex":0.00146891,"about_ca_topic_score_gemma":0.00249889,"teacher_disagreement_score":0.005462991,"about_ca_system_score_codex":0.000983655,"about_ca_system_score_gemma":0.001118191,"threshold_uncertainty_score":0.028891385},"labels":[],"label_agreement":null},{"id":"W1993862203","doi":"10.1067/mjd.2000.101448","title":"The value of positron emission tomography scanning in the detection of subclinical metastatic melanoma","year":2000,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Positron emission tomography; Stage (stratigraphy); Subclinical infection; Melanoma; Radiology; Nuclear medicine; Histology; Pathology","score_opus":0.013546286659555516,"score_gpt":0.30938543157776377,"score_spread":0.29583914491820823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993862203","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9037482,0.074922994,0.0033407968,0.0035287766,0.0003147146,0.000043302425,0.00012443577,0.000108981636,0.013867915],"genre_scores_gemma":[0.99050385,0.007278544,0.0011616746,0.0003119269,0.00028645378,0.0000069685816,0.00004357802,0.000009960654,0.00039707104],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99953556,0.00022089481,0.0000499233,0.000038208807,0.00010659275,0.000048838494],"domain_scores_gemma":[0.99562186,0.0031765993,0.00028767646,0.00014295228,0.0005391543,0.0002316504],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018643518,0.00065939245,0.0006551439,0.0014293069,0.00028837073,0.0009341973,0.00058385637,0.001337685,0.0009869674],"category_scores_gemma":[0.014478071,0.0003867598,0.0003558463,0.00046401104,0.00088531134,0.0011420383,0.00022506028,0.0012452203,0.00033070717],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048890444,0.00019302082,0.8350812,0.00032793547,0.00015237609,0.010871358,0.00010274004,0.0014452933,0.0136513,0.0005955714,0.0012170798,0.13147303],"study_design_scores_gemma":[0.0004460286,0.00585092,0.81746346,0.0006473389,0.0013645681,0.09724171,0.00072389917,0.033112336,0.030686963,0.0028840534,0.009454535,0.00012428599],"about_ca_topic_score_codex":0.0025805924,"about_ca_topic_score_gemma":0.002919394,"teacher_disagreement_score":0.0025805924,"about_ca_system_score_codex":0.0005805585,"about_ca_system_score_gemma":0.0006372839,"threshold_uncertainty_score":0.0098598},"labels":[],"label_agreement":null},{"id":"W1994027238","doi":"10.1067/mjd.2000.103987","title":"Vertex balding, plasma insulin-like growth factor 1, and insulin-like growth factor binding protein 3","year":2000,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute; National Institutes of Health; Jewish General Hospital","keywords":"Medicine; Insulin; Internal medicine; Insulin-like growth factor; Endocrinology; Growth factor; Receptor","score_opus":0.013730462323253595,"score_gpt":0.2683984681105407,"score_spread":0.2546680057872871,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994027238","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99137574,0.0065162648,0.00047953072,0.00028822583,0.000038376817,0.000006916624,0.0002670549,0.00002679982,0.0010011701],"genre_scores_gemma":[0.99863523,0.0007105604,0.00021818539,0.00003973114,0.000032723423,0.0000018477426,0.00009749752,0.000001838227,0.0002623281],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99976104,0.00006258092,0.000017837245,0.00004644237,0.00007588688,0.000036119956],"domain_scores_gemma":[0.9977082,0.0006378253,0.0011322534,0.00007163887,0.00013876423,0.0003112361],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004204017,0.0003611651,0.00018512247,0.00055002334,0.00016583041,0.00044046663,0.00022739933,0.0003481408,0.0027267481],"category_scores_gemma":[0.0028033853,0.00015802433,0.000372132,0.00056507613,0.0003024026,0.0002159284,0.00021392122,0.0004495487,0.00021004445],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002531171,0.000017073602,0.99472564,0.000029042178,0.00007769103,0.00015630433,0.000022605218,0.000069785325,0.0004705753,0.000021677159,0.00012425322,0.0040321285],"study_design_scores_gemma":[0.000009537366,0.000081299964,0.99832124,0.000015129335,0.00006992759,0.00079674425,0.000035338828,0.0002661382,0.000120052304,0.00007486597,0.00020680425,0.0000029123325],"about_ca_topic_score_codex":0.004580178,"about_ca_topic_score_gemma":0.00240685,"teacher_disagreement_score":0.004580178,"about_ca_system_score_codex":0.00017127633,"about_ca_system_score_gemma":0.00019208422,"threshold_uncertainty_score":0.009121835},"labels":[],"label_agreement":null},{"id":"W1995719342","doi":"10.1067/mjd.2002.118559","title":"Surgical Pearl: Removing skin-colored cosmetic tattoos with carbon dioxide resurfacing lasers","year":2002,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatologic Treatments and Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Vancouver Hospital and Health Sciences Centre","funders":"","keywords":"Medicine; Pearl; Carbon dioxide laser; Surgery; Colored; Dermatology; Laser; Laser surgery; Optics; Composite material","score_opus":0.023818698421698488,"score_gpt":0.30784541378570834,"score_spread":0.28402671536400986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995719342","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85423887,0.014013188,0.06926971,0.009817512,0.0032833593,0.00032751157,0.00020498103,0.004403474,0.04444136],"genre_scores_gemma":[0.93980455,0.0031080004,0.034960374,0.0025199219,0.0007658871,0.00005880063,0.000102047205,0.00029598142,0.018384514],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.99978775,0.000026082012,0.00001784633,0.000033623957,0.000096119016,0.000038605944],"domain_scores_gemma":[0.99981636,0.000067668625,0.000027526874,0.000032916712,0.000022299788,0.0000332607],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034667028,0.00077553286,0.000302586,0.0007950466,0.0010233661,0.00057528465,0.0006530371,0.0016271974,0.005062572],"category_scores_gemma":[0.0009644222,0.00026617342,0.00061073725,0.00029344473,0.0006466114,0.0010488554,0.00050421216,0.0011004558,0.0014799639],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002626123,0.0011120887,0.011337201,0.0007818248,0.00016851869,0.10457138,0.0005551089,0.0006971276,0.27960443,0.002529887,0.024227936,0.5717884],"study_design_scores_gemma":[0.00043514813,0.0026476842,0.03244857,0.00010751404,0.0002605049,0.69496244,0.0008044834,0.009083033,0.20348836,0.0027137415,0.052857935,0.00019049914],"about_ca_topic_score_codex":0.00065433455,"about_ca_topic_score_gemma":0.0015333688,"teacher_disagreement_score":0.005062572,"about_ca_system_score_codex":0.00024172157,"about_ca_system_score_gemma":0.00032938374,"threshold_uncertainty_score":0.016936004},"labels":[],"label_agreement":null},{"id":"W1995842973","doi":"10.1016/j.jaad.2004.12.048","title":"Progression of classic Kaposi's sarcoma with rituximab","year":2005,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"","keywords":"Rituximab; Medicine; CD20; Autoimmune hemolytic anemia; Immunology; Monoclonal antibody; Antibody; Sarcoma; Monoclonal; Pathology","score_opus":0.010994072521095242,"score_gpt":0.31189233928827526,"score_spread":0.30089826676718,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995842973","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9305622,0.02341173,0.0053552114,0.0021013878,0.00045670985,0.000420742,0.00042695508,0.0005162593,0.03674873],"genre_scores_gemma":[0.99551755,0.0011571327,0.0006058956,0.00044944053,0.00013072781,0.000028835864,0.00012288263,0.000015089163,0.001972355],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.999701,0.000085165666,0.000034115696,0.000049453396,0.000045217257,0.00008510355],"domain_scores_gemma":[0.9991917,0.00036329834,0.00010797305,0.0001389891,0.000073571915,0.00012449412],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072106754,0.00043028608,0.00060410216,0.00062838144,0.00041857857,0.000417806,0.00049407664,0.0007870995,0.0017540315],"category_scores_gemma":[0.0020146728,0.00018858138,0.00069513806,0.00031741377,0.00033591568,0.0005558835,0.0002683032,0.0013619809,0.00054894073],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018064434,0.0036057257,0.037512615,0.0015098026,0.0009191264,0.16959491,0.0013184209,0.005194424,0.112641625,0.004591363,0.01099904,0.6340485],"study_design_scores_gemma":[0.010086307,0.047666796,0.22926061,0.00044794226,0.0020643927,0.50739473,0.0004180002,0.015417479,0.090153314,0.0056674723,0.09124089,0.00018211633],"about_ca_topic_score_codex":0.0013845909,"about_ca_topic_score_gemma":0.0015417578,"teacher_disagreement_score":0.0017540315,"about_ca_system_score_codex":0.00059868104,"about_ca_system_score_gemma":0.00034702208,"threshold_uncertainty_score":0.005867839},"labels":[],"label_agreement":null},{"id":"W1996022559","doi":"10.1016/j.jaad.2003.10.443","title":"Single-blind, randomized controlled trial to evaluate the efficacy and safety of photodynamic therapy using aminolevulinic acid versus 5-fluorouracil in the management of actinic keratosis","year":2004,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Actinic keratosis; Photodynamic therapy; Dermatology; Keratosis; Scalp; Fluorouracil; Randomized controlled trial; Itching; Single Center; Adverse effect; Surgery; Internal medicine; Chemotherapy","score_opus":0.051115305554765685,"score_gpt":0.3681841025308011,"score_spread":0.3170687969760354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996022559","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97407496,0.010299353,0.0017296888,0.0014003373,0.003189943,0.0057373075,0.0010648237,0.00024915845,0.0022544211],"genre_scores_gemma":[0.98353356,0.003017881,0.0024089792,0.0012212794,0.001379328,0.0051103346,0.00069320697,0.000029776666,0.0026057016],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9974043,0.0014799831,0.00025306226,0.00046090057,0.00017098995,0.00023081827],"domain_scores_gemma":[0.9952865,0.002309077,0.0009147404,0.00039023376,0.00028109358,0.0008183817],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0043404507,0.002297994,0.0077113896,0.0007801001,0.00094513496,0.0015465851,0.002095493,0.0041538724,0.009508603],"category_scores_gemma":[0.006458405,0.0013835569,0.003194857,0.0007439712,0.0031453138,0.0019444748,0.00067052466,0.0053356485,0.001220401],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9956195,0.0014695654,0.000069479574,0.00024607175,0.00044463895,0.000009147374,0.000011277687,0.000059507525,0.00033825188,0.000041589883,0.00010748346,0.0015835144],"study_design_scores_gemma":[0.9858942,0.013375496,0.00016344694,0.000014030156,0.00025055924,0.0000051248644,0.0000048346,0.0001188256,0.00007228918,0.00003584045,0.00006091336,0.0000044891376],"about_ca_topic_score_codex":0.0023637367,"about_ca_topic_score_gemma":0.0031017943,"teacher_disagreement_score":0.009508603,"about_ca_system_score_codex":0.0015453118,"about_ca_system_score_gemma":0.0021225954,"threshold_uncertainty_score":0.03180945},"labels":[],"label_agreement":null},{"id":"W1996401577","doi":"10.1016/j.jaad.2003.12.017","title":"Klippel-Trénaunay syndrome: The importance of “geographic stains” in identifying lymphatic disease and risk of complications","year":2004,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Vascular Malformations and Hemangiomas","field":"Medicine","cited_by":118,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Lymphatic system; Stain; Port-wine stain; Vascular anomaly; Pathology; Lymphatic Endothelium; Disease; Klippel-Trenaunay syndrome; Vascular disease; Dermatology; Internal medicine; Soft tissue; Surgery; Staining","score_opus":0.028111456307899147,"score_gpt":0.34814202555357626,"score_spread":0.32003056924567713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996401577","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00040426894,0.9980118,0.0002823823,0.00029445277,0.00012061624,0.0000031785721,0.000013966471,0.000010347591,0.0008588822],"genre_scores_gemma":[0.0031194084,0.99547523,0.00040551112,0.00023310096,0.00021938424,0.0000035243613,0.000032420892,0.0000023062307,0.0005090029],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99977213,0.000038709968,0.0000438184,0.000044365454,0.000082791026,0.000018115405],"domain_scores_gemma":[0.9994635,0.0002833286,0.00010851762,0.000012755315,0.000096435586,0.00003550107],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042033393,0.0008517523,0.0017510984,0.0034615085,0.0002248625,0.00067240186,0.0010548542,0.00097191037,0.0015819097],"category_scores_gemma":[0.0010309868,0.00025740298,0.00034404063,0.0026179985,0.00054847635,0.0011512416,0.000473911,0.0012942977,0.00082340854],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000059039263,0.00005043408,0.0017805707,0.0059158104,0.00014004685,0.004370944,0.000055930952,0.00029215225,0.0011314608,0.001021168,0.02011197,0.9650705],"study_design_scores_gemma":[0.00006681073,0.00011288238,0.009578807,0.007727472,0.0007342529,0.10702359,0.00028486765,0.00044298664,0.0016886472,0.00280616,0.8694539,0.000079589794],"about_ca_topic_score_codex":0.0018520365,"about_ca_topic_score_gemma":0.0029947248,"teacher_disagreement_score":0.0034615085,"about_ca_system_score_codex":0.00045109063,"about_ca_system_score_gemma":0.0007788453,"threshold_uncertainty_score":0.0052919984},"labels":[],"label_agreement":null},{"id":"W1997452543","doi":"10.1067/mjd.2000.109068","title":"Ciclopirox nail lacquer solution 8% in the 21st century","year":2000,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Lacquer; Medicine; Dermatology; Onycholysis; Nail (fastener); Antifungal; Adverse effect; Dermatophyte; Pharmacology; Paronychia; Nanotechnology","score_opus":0.033549461860200865,"score_gpt":0.36740866945300904,"score_spread":0.3338592075928082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997452543","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00020187358,0.9985133,0.000049872997,0.00016894247,0.00019110016,0.0000034877364,0.000008961798,0.000006145178,0.00085640216],"genre_scores_gemma":[0.0009891567,0.99654514,0.0001573198,0.00035341823,0.0002562469,0.0000066316716,0.000031342217,0.0000017086887,0.0016590181],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997886,0.000025714919,0.00003476767,0.00004003811,0.00009407678,0.000016809132],"domain_scores_gemma":[0.999726,0.00010267584,0.000054955748,0.0000064898018,0.000079987214,0.0000299276],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006253628,0.0007797817,0.0018004819,0.002203525,0.00036633905,0.00076781464,0.00079576176,0.0010781095,0.004602969],"category_scores_gemma":[0.00063860137,0.00023091014,0.00032885847,0.002185018,0.0004138381,0.0011591447,0.0004991693,0.0012178916,0.0024509472],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018518508,0.00008754926,0.0001779787,0.008899712,0.00004290342,0.00024867553,0.000034842466,0.00009141642,0.0011175111,0.0006586823,0.021807363,0.9666482],"study_design_scores_gemma":[0.00012133346,0.00024220232,0.002159944,0.0027792067,0.00019880789,0.0029830502,0.000080095095,0.00011061074,0.0008486479,0.0007118145,0.9897418,0.000022420643],"about_ca_topic_score_codex":0.0025350126,"about_ca_topic_score_gemma":0.0061810245,"teacher_disagreement_score":0.004602969,"about_ca_system_score_codex":0.00055593543,"about_ca_system_score_gemma":0.0010863635,"threshold_uncertainty_score":0.015398443},"labels":[],"label_agreement":null},{"id":"W1997702985","doi":"10.1016/j.jaad.2003.10.281","title":"Proteus syndrome and tuberous sclerosis: any genetic association?","year":2004,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Vascular Malformations and Hemangiomas","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Tuberous sclerosis; Macrocephaly; Pathology; TSC1; Dermatology; Genetics; Biology","score_opus":0.011764306098457265,"score_gpt":0.26170461005452234,"score_spread":0.24994030395606506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997702985","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85816926,0.05100474,0.001987016,0.060454477,0.0018030745,0.00002450479,0.00056442886,0.00022929093,0.025763225],"genre_scores_gemma":[0.96670514,0.015091246,0.0015011573,0.0047684573,0.008945271,0.000023763414,0.0003640186,0.000027964412,0.0025730154],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99905187,0.00022740489,0.00013392293,0.00019255241,0.00022728804,0.00016704453],"domain_scores_gemma":[0.9957488,0.0023748404,0.00097032887,0.00024102254,0.00027652798,0.00038844923],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010076766,0.0013137751,0.0014807958,0.0024407941,0.0011035096,0.0015259753,0.0022741205,0.009936245,0.0144219715],"category_scores_gemma":[0.00993722,0.00067002734,0.0008577801,0.0028004702,0.0021666319,0.0029740399,0.0008484914,0.0021647266,0.0015415752],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003257043,0.0010691452,0.5782656,0.00080336485,0.0020929573,0.28384867,0.0012702857,0.00065872015,0.0077920845,0.018454542,0.020445162,0.08204243],"study_design_scores_gemma":[0.0007754468,0.00054735626,0.28538996,0.00095866347,0.0028160524,0.6340556,0.0032908516,0.0022818097,0.0019061053,0.03784299,0.029879661,0.0002554179],"about_ca_topic_score_codex":0.0012585692,"about_ca_topic_score_gemma":0.0015466175,"teacher_disagreement_score":0.0144219715,"about_ca_system_score_codex":0.00038364364,"about_ca_system_score_gemma":0.00073540397,"threshold_uncertainty_score":0.048246324},"labels":[],"label_agreement":null},{"id":"W1998560367","doi":"10.1016/j.jaad.2003.12.034","title":"Skin diseases associated with Malassezia species","year":2004,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":520,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Malassezia; Seborrheic dermatitis; Pityriasis; Seborrhoeic dermatitis; Folliculitis; Dermatology; Dandruff; Atopic dermatitis; Medicine; Psoriasis; Fastidious organism; Tinea versicolor; Biology; Pathology","score_opus":0.028065234787954873,"score_gpt":0.34651058925876255,"score_spread":0.3184453544708077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998560367","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021646854,0.9986089,0.00009989258,0.00013003449,0.00012374688,0.000002876902,0.000011432548,0.000005879148,0.0008007851],"genre_scores_gemma":[0.0012157701,0.9976221,0.00018088147,0.00013717182,0.00018538635,0.0000028925704,0.000027921327,0.0000010550741,0.00062688213],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998004,0.000029949215,0.00004155294,0.000034740802,0.00007540025,0.000017853876],"domain_scores_gemma":[0.9996593,0.00014412015,0.000092772374,0.000010863782,0.00006768781,0.000025312633],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037202894,0.0009148469,0.0016098729,0.00265443,0.000271129,0.00086684077,0.00068885554,0.00081538776,0.0032948847],"category_scores_gemma":[0.0005847279,0.00027765904,0.00042050146,0.0026772616,0.0004206951,0.0011676947,0.00054066203,0.001007405,0.0014694988],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011173656,0.000099124045,0.0007123498,0.013739456,0.00012669674,0.00083658536,0.000036967784,0.00018196338,0.0016814334,0.00074990024,0.018968103,0.96275574],"study_design_scores_gemma":[0.000055064917,0.0001746485,0.004467679,0.005095549,0.00049557316,0.014727567,0.00015186261,0.00014752518,0.0014349421,0.000918899,0.97230005,0.000030729578],"about_ca_topic_score_codex":0.0011138842,"about_ca_topic_score_gemma":0.002560295,"teacher_disagreement_score":0.0032948847,"about_ca_system_score_codex":0.0003649858,"about_ca_system_score_gemma":0.0005846429,"threshold_uncertainty_score":0.011022508},"labels":[],"label_agreement":null},{"id":"W1998564443","doi":"10.1016/j.jaad.2007.09.009","title":"A comparison of disease severity among affected male versus female patients with PHACE syndrome","year":2007,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Vascular Malformations and Hemangiomas","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; BC Children's Hospital; University of Toronto","funders":"","keywords":"Medicine; Pathogenesis; Mendelian inheritance; Disease; OMIM : Online Mendelian Inheritance in Man; Pediatrics; Internal medicine; Genetics","score_opus":0.016305319762747295,"score_gpt":0.3220342638488889,"score_spread":0.3057289440861416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998564443","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999448,0.000052193434,0.00002751634,0.000010305283,0.000002261599,0.0000024506294,0.0000483288,0.0000012569761,0.0004075665],"genre_scores_gemma":[0.99981815,0.00002697649,0.000017558423,0.000008417622,0.0000062022023,0.0000013948721,0.000063031745,0.0000012127172,0.000057112444],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999701,0.000070513306,0.000044697706,0.000054616856,0.00006118034,0.00006801463],"domain_scores_gemma":[0.99874663,0.00042314475,0.00031448013,0.00004415415,0.00010188607,0.00036971687],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026883325,0.00028361526,0.00042136214,0.0012327924,0.00038748092,0.00044334796,0.0001759352,0.0003549564,0.0029482855],"category_scores_gemma":[0.0019900762,0.00015402447,0.00030614441,0.0005587651,0.0002792711,0.0004299378,0.0003743639,0.00028037478,0.00028895392],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011096807,0.000060891987,0.9912717,0.000010338293,0.000062433384,0.0013539795,0.00016422644,0.000048987422,0.0029712205,0.0000447218,0.000063953456,0.0028378272],"study_design_scores_gemma":[0.000018526996,0.00030925838,0.99621034,0.0000023726634,0.000030162126,0.0028591729,0.00020467298,0.000100090496,0.00017888329,0.000020167832,0.000062449595,0.0000039830843],"about_ca_topic_score_codex":0.0011522115,"about_ca_topic_score_gemma":0.00096298935,"teacher_disagreement_score":0.0029482855,"about_ca_system_score_codex":0.00018185089,"about_ca_system_score_gemma":0.00014368465,"threshold_uncertainty_score":0.009863019},"labels":[],"label_agreement":null},{"id":"W1998564917","doi":"10.1016/j.jaad.2013.05.034","title":"Update on necrobiosis lipoidica: A review of etiology, diagnosis, and treatment options","year":2013,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Skin Diseases and Diabetes","field":"Medicine","cited_by":199,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"","keywords":"Necrobiosis lipoidica; Medicine; Etiology; Dermatology; Diabetes mellitus; Pathology","score_opus":0.04864693828826291,"score_gpt":0.3824298976222042,"score_spread":0.3337829593339413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998564917","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008273381,0.9989116,0.000065925735,0.00034457975,0.0002988878,0.0000035712976,0.000026988195,0.000005768949,0.000259927],"genre_scores_gemma":[0.000431355,0.9979455,0.00022816002,0.0005329414,0.0006243869,0.0000041879566,0.00005291729,0.0000011305957,0.00017944984],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996418,0.00006391546,0.000099100376,0.000051948336,0.00011535271,0.000027850843],"domain_scores_gemma":[0.9987921,0.00057331106,0.00027355063,0.000018576782,0.0002514917,0.00009101479],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077764574,0.0009114684,0.002327036,0.0042427774,0.00030009204,0.0012403358,0.0010892173,0.0012886286,0.004107545],"category_scores_gemma":[0.0017540533,0.00038635998,0.0009322962,0.003006166,0.0004326977,0.0022114632,0.00077053136,0.002019231,0.0015249889],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001678631,0.000111732435,0.0006697844,0.036272082,0.0002535738,0.0009721269,0.00008291871,0.00026107498,0.001301342,0.0009808718,0.108707316,0.8502193],"study_design_scores_gemma":[0.00007799007,0.0001636237,0.002414838,0.016567636,0.000820583,0.008974514,0.00015223854,0.00016674303,0.00030404923,0.0011726682,0.96912795,0.000057102956],"about_ca_topic_score_codex":0.0014322296,"about_ca_topic_score_gemma":0.0038147166,"teacher_disagreement_score":0.0042427774,"about_ca_system_score_codex":0.0005860078,"about_ca_system_score_gemma":0.001389352,"threshold_uncertainty_score":0.013741076},"labels":[],"label_agreement":null},{"id":"W1998604091","doi":"10.1067/mjd.2001.116215","title":"Clinical efficacy of topical docosanol 10% cream for herpes simplex labialis: A multicenter, randomized, placebo-controlled trial","year":2001,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":105,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Placebo; Surgery; Herpes Labialis; Population; Randomized controlled trial; Erythema; Confidence interval; Internal medicine; Odds ratio; Dermatology; Herpes simplex virus","score_opus":0.036557601592666765,"score_gpt":0.4032126080036271,"score_spread":0.3666550064109604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998604091","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96837693,0.020602772,0.00092928665,0.0010164721,0.0015566943,0.004390462,0.0008713413,0.00015033755,0.0021056668],"genre_scores_gemma":[0.9803279,0.009534931,0.0013898615,0.0012216769,0.00095826574,0.0032656672,0.0007128456,0.000026525742,0.0025622665],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99891055,0.0005018702,0.00009519187,0.00021050974,0.00010018144,0.00018177244],"domain_scores_gemma":[0.9988846,0.00042148156,0.00021851041,0.000077237724,0.00008573393,0.00031246128],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002146985,0.001935367,0.0057757623,0.00064125715,0.0006701493,0.0012933151,0.0012040959,0.0027059475,0.0060524885],"category_scores_gemma":[0.002321946,0.0010633391,0.00213151,0.000593425,0.0018480909,0.0011604219,0.0004351,0.0027504037,0.0010839156],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98433244,0.0035190454,0.00027238147,0.0008256357,0.00071645336,0.00003666029,0.000030975545,0.0000814642,0.0022900112,0.000045618897,0.0002558365,0.0075933784],"study_design_scores_gemma":[0.95660305,0.041547287,0.00066842564,0.000034398017,0.00052375393,0.00001385794,0.000016383503,0.00010713342,0.00021919505,0.000037065438,0.00021936382,0.000010088685],"about_ca_topic_score_codex":0.0011155604,"about_ca_topic_score_gemma":0.001791754,"teacher_disagreement_score":0.0060524885,"about_ca_system_score_codex":0.00074449065,"about_ca_system_score_gemma":0.0012079518,"threshold_uncertainty_score":0.020247638},"labels":[],"label_agreement":null},{"id":"W1998652494","doi":"10.1016/j.jaad.2014.07.046","title":"Assessing adherence with phototherapy protocols","year":2014,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; Centre for Advancing Health Outcomes; University of British Columbia; Vancouver Coastal Health","funders":"","keywords":"Medicine; MEDLINE; Dermatology; Intensive care medicine","score_opus":0.0289464904360851,"score_gpt":0.3254488855279885,"score_spread":0.2965023950919034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998652494","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97200656,0.0010233808,0.004159988,0.0013092573,0.0001951976,0.0019666862,0.00060610386,0.0001132997,0.018619537],"genre_scores_gemma":[0.9783644,0.00096898293,0.013532267,0.0006757838,0.00010742042,0.0014944809,0.00071438274,0.000037073263,0.0041052927],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9741391,0.0096294,0.005110129,0.0011259905,0.00896395,0.0010314881],"domain_scores_gemma":[0.96017617,0.01353971,0.012706577,0.0037993684,0.008070316,0.0017078808],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014128801,0.0003575752,0.0006375478,0.0013601586,0.0012855326,0.0013759382,0.0011411068,0.0010125658,0.0033358478],"category_scores_gemma":[0.060862266,0.00027087066,0.0010958883,0.00089733384,0.00038959013,0.0011185138,0.001348284,0.0017754938,0.0006756848],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015033841,0.0044929753,0.7408125,0.0006109266,0.000608233,0.0002252602,0.0051865955,0.00081770273,0.0020410144,0.0005747513,0.0031106474,0.24001607],"study_design_scores_gemma":[0.00012374314,0.005237952,0.9572734,0.000908719,0.00058731204,0.0008686651,0.007350639,0.0041939435,0.0046270345,0.0010645025,0.017660284,0.000103809296],"about_ca_topic_score_codex":0.005308966,"about_ca_topic_score_gemma":0.0063102194,"teacher_disagreement_score":0.014128801,"about_ca_system_score_codex":0.001433111,"about_ca_system_score_gemma":0.0024612867,"threshold_uncertainty_score":0.07472116},"labels":[],"label_agreement":null},{"id":"W1998912255","doi":"10.1016/j.jaad.2010.02.061","title":"Recognizing psoriatic arthritis in the dermatology clinic","year":2010,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"","keywords":"Psoriatic arthritis; Medicine; Psoriasis; Dermatology; Arthritis; Rheumatoid arthritis; Physical therapy; Internal medicine","score_opus":0.021552988312706127,"score_gpt":0.3314556653927374,"score_spread":0.3099026770800313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998912255","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8342265,0.032935455,0.0010460933,0.056845136,0.0020706586,0.0004957035,0.00033422938,0.00013112475,0.07191499],"genre_scores_gemma":[0.97162545,0.011455528,0.0018776334,0.010056538,0.0022557238,0.00007977689,0.00015279572,0.000017138791,0.002479358],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976654,0.00069595873,0.0003035564,0.00012949959,0.000542602,0.00066304085],"domain_scores_gemma":[0.99692446,0.00085135957,0.00050951506,0.000050548362,0.00057993096,0.0010842067],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013619952,0.00032762616,0.0007219294,0.0019843217,0.0021038114,0.0021807803,0.0007058336,0.002198074,0.0046407226],"category_scores_gemma":[0.0072734095,0.0005201217,0.0003410145,0.00078769895,0.0004369321,0.0016403587,0.0009472851,0.0024085783,0.00086241175],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002709598,0.0013383436,0.8418765,0.0003376017,0.000048128313,0.0367592,0.0016306819,0.00013708009,0.002537321,0.00036313484,0.028169172,0.08653191],"study_design_scores_gemma":[0.00016056567,0.0010280943,0.791073,0.0018066586,0.0002221212,0.15218155,0.019283822,0.0012151302,0.0015601574,0.0011786186,0.030203372,0.000086982676],"about_ca_topic_score_codex":0.010454183,"about_ca_topic_score_gemma":0.024218656,"teacher_disagreement_score":0.010454183,"about_ca_system_score_codex":0.0014010892,"about_ca_system_score_gemma":0.0031079296,"threshold_uncertainty_score":0.020786643},"labels":[],"label_agreement":null},{"id":"W1998981123","doi":"10.1016/j.jaad.2009.01.005","title":"A single-center, dose-comparison, pilot study of botulinum neurotoxin type A in female patients with upper facial rhytids: Safety and efficacy","year":2009,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Botulinum Toxin and Related Neurological Disorders","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Adverse effect; Single Center; Botulinum neurotoxin; Internal medicine; Randomized controlled trial; Surgery","score_opus":0.027169248506506753,"score_gpt":0.2990249963900844,"score_spread":0.27185574788357764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998981123","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971854,0.00031819456,0.00047286184,0.00010440121,0.00007358086,0.0009719674,0.00026804025,0.00003992819,0.0005656188],"genre_scores_gemma":[0.99648726,0.00032568185,0.00094194326,0.0003135976,0.00018226616,0.00071977853,0.00034911733,0.000024057745,0.00065644394],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99821043,0.0009415846,0.00011921859,0.00035624407,0.00015516327,0.00021740004],"domain_scores_gemma":[0.99752074,0.000842926,0.00039351956,0.00047574294,0.00021330034,0.00055376097],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002574152,0.0018849191,0.0033184686,0.0007162545,0.0010679517,0.0010228374,0.0014205573,0.0015644402,0.0050918427],"category_scores_gemma":[0.0029118946,0.0010080726,0.0021659897,0.0005660998,0.002027092,0.0017118558,0.0005498367,0.0026847406,0.0011711835],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8670051,0.08488854,0.0045012496,0.00020929091,0.00089130906,0.0002100824,0.0002852356,0.000672796,0.017690485,0.00012237928,0.00048411224,0.023039464],"study_design_scores_gemma":[0.38984424,0.59820056,0.00889755,0.000009972156,0.0004120187,0.00017919033,0.00009353053,0.00056119496,0.0013827465,0.0000782168,0.00030969907,0.00003102822],"about_ca_topic_score_codex":0.0014056654,"about_ca_topic_score_gemma":0.001861116,"teacher_disagreement_score":0.0050918427,"about_ca_system_score_codex":0.0011579853,"about_ca_system_score_gemma":0.00136145,"threshold_uncertainty_score":0.017033935},"labels":[],"label_agreement":null},{"id":"W1999922931","doi":"10.1067/mjd.2000.105558","title":"Vulvitis circumscripta plasmacellularis mimicking child abuse","year":2000,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Genital Health and Disease","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Vulvitis; Lichen sclerosus; Dermatology; Biopsy; Vulva; Girl; Basal cell; Pathology; Gynecology; Vaginitis","score_opus":0.013225983048259856,"score_gpt":0.29238352622598945,"score_spread":0.2791575431777296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999922931","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91314894,0.006372776,0.0033951625,0.0036166173,0.00042992368,0.0003956948,0.00062138244,0.00036203495,0.071657516],"genre_scores_gemma":[0.9943969,0.0013779767,0.0007660849,0.00066817354,0.00022772801,0.000025890415,0.00006998444,0.000027625332,0.0024395622],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9992211,0.000114323855,0.000039802322,0.00017511535,0.00013122991,0.0003184482],"domain_scores_gemma":[0.99856395,0.0004988942,0.00039851153,0.00022170632,0.000082293125,0.00023465164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039769543,0.0019910384,0.0005922655,0.0032997648,0.0029175805,0.0014456772,0.0016747739,0.0033053854,0.00442043],"category_scores_gemma":[0.0038400097,0.0010421774,0.0006767952,0.0020299552,0.0027523322,0.0016898128,0.0017485322,0.0035229581,0.0008366183],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044876455,0.000047777292,0.008684035,0.00004052452,0.0000067382603,0.9873834,0.00024118042,0.0001290334,0.00061594654,0.00094913034,0.00026673026,0.0015905639],"study_design_scores_gemma":[0.000009610871,0.000036649177,0.00811689,0.000021916658,0.000007969333,0.9897932,0.00025626994,0.00022816697,0.00059648,0.00024782767,0.00067936705,0.000005699701],"about_ca_topic_score_codex":0.0054168277,"about_ca_topic_score_gemma":0.006529499,"teacher_disagreement_score":0.0054168277,"about_ca_system_score_codex":0.0015830623,"about_ca_system_score_gemma":0.00086606643,"threshold_uncertainty_score":0.014787793},"labels":[],"label_agreement":null},{"id":"W2000142077","doi":"10.1067/mjd.2003.130","title":"Early onset of action and efficacy of a combination of calcipotriene and betamethasone dipropionate in the treatment of psoriasis","year":2003,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":165,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Betamethasone dipropionate; Medicine; Psoriasis; Dermatology; Betamethasone; Combination therapy; Onset of action; Pharmacology; Internal medicine","score_opus":0.02503805519354295,"score_gpt":0.29499881826161783,"score_spread":0.26996076306807487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000142077","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9838933,0.013196838,0.00030417953,0.00018780013,0.00013795398,0.000069371185,0.00009531454,0.000027082126,0.0020881873],"genre_scores_gemma":[0.9975865,0.0013368857,0.000185244,0.00007499803,0.00013381503,0.0000124406615,0.000082489816,0.000005176246,0.0005824949],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99952626,0.00012519397,0.000043365435,0.000047916546,0.00015141856,0.00010584176],"domain_scores_gemma":[0.9993718,0.0002621673,0.000071908624,0.000036892146,0.000064051834,0.0001930431],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006631716,0.00032582422,0.0010408985,0.00048907235,0.00024410873,0.00038798878,0.00035494845,0.0006149849,0.0013343648],"category_scores_gemma":[0.0011565076,0.0002053007,0.0004695976,0.0002722932,0.00026989056,0.0003410332,0.00013971319,0.0012863465,0.00022740885],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16943298,0.013116737,0.024443742,0.00064342766,0.00053458323,0.0030872957,0.00025757277,0.0013700746,0.5054758,0.00033648845,0.0011681912,0.28013304],"study_design_scores_gemma":[0.027892083,0.36709446,0.41707006,0.0002161997,0.0021591154,0.0136313215,0.00036055368,0.0029199657,0.15543275,0.00032684306,0.012779514,0.00011714153],"about_ca_topic_score_codex":0.0009948479,"about_ca_topic_score_gemma":0.0022078634,"teacher_disagreement_score":0.0013343648,"about_ca_system_score_codex":0.00030032016,"about_ca_system_score_gemma":0.0004236363,"threshold_uncertainty_score":0.004463911},"labels":[],"label_agreement":null},{"id":"W2002045980","doi":"10.1016/s0190-9622(00)90266-4","title":"Pseudopelade of Brocq in beard area","year":2000,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Scalp; Medicine; Dermatology; Scarring alopecia; Vertex (graph theory); Combinatorics","score_opus":0.012257963889681688,"score_gpt":0.2914859716505163,"score_spread":0.2792280077608346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002045980","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9783257,0.0015374036,0.0037187873,0.0019573912,0.00051699224,0.00020391203,0.0003377762,0.00039637907,0.013005642],"genre_scores_gemma":[0.9949303,0.00016936974,0.0007968703,0.00052156096,0.00015400111,0.000015315449,0.0000998607,0.00005286766,0.003259851],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99935204,0.000044576547,0.000027483198,0.00018666594,0.000119579265,0.0002696272],"domain_scores_gemma":[0.9986284,0.000312891,0.00030143393,0.00025538247,0.00013449218,0.00036748007],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027383157,0.00077047007,0.00067766616,0.0021494657,0.002044064,0.00086011144,0.0013659338,0.0029834232,0.007328639],"category_scores_gemma":[0.0021151186,0.00056598056,0.0009680493,0.00076897343,0.0018291335,0.0010474793,0.0012174364,0.0024832238,0.001534004],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003288592,0.00008544381,0.005762136,0.00002616742,0.000019865969,0.98114794,0.000119510885,0.00006899985,0.008287752,0.00063225924,0.0006389868,0.0028821328],"study_design_scores_gemma":[0.00006355141,0.00011612859,0.011189311,0.000012011689,0.000027885699,0.98299134,0.00018337496,0.0005844313,0.0031779103,0.00037405154,0.0012636562,0.000016391876],"about_ca_topic_score_codex":0.0057423594,"about_ca_topic_score_gemma":0.0038503911,"teacher_disagreement_score":0.007328639,"about_ca_system_score_codex":0.0009742685,"about_ca_system_score_gemma":0.00058912346,"threshold_uncertainty_score":0.024516702},"labels":[],"label_agreement":null},{"id":"W2003280996","doi":"10.1067/mjd.2000.107808","title":"Immunomodulatory and pharmacologic properties of imiquimod","year":2000,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":254,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Imiquimod; Medicine; Immune system; Immunology; Herpes simplex virus; Cytokine; In vivo; Innate immune system; Virus; Biology","score_opus":0.03843621876529588,"score_gpt":0.32243001904502805,"score_spread":0.28399380027973214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003280996","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001459782,0.9937582,0.00043476035,0.00029540632,0.00042476467,0.000019693069,0.00004292588,0.000021142978,0.0035434023],"genre_scores_gemma":[0.0056777797,0.9871078,0.0009502523,0.00055918976,0.0008538213,0.000033965043,0.0001418905,0.0000040381537,0.004671223],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99990094,0.000012703415,0.000014744654,0.000016589722,0.000042869247,0.000012036234],"domain_scores_gemma":[0.9999155,0.00003329167,0.00001693701,0.0000034872692,0.000022210159,0.000008681993],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033750403,0.0007730176,0.000998694,0.0012262972,0.00025894065,0.00053687557,0.0006064666,0.0006001453,0.0021516525],"category_scores_gemma":[0.0002495276,0.00020695121,0.000308548,0.00076242466,0.00035697594,0.00068330305,0.00025785467,0.0010811259,0.0013642112],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021704177,0.00015830429,0.00023362858,0.0043065683,0.00004014134,0.00049053406,0.000045452667,0.0003522133,0.018140454,0.0014449629,0.015716866,0.9588539],"study_design_scores_gemma":[0.000102174534,0.00048415025,0.0028039042,0.0007520408,0.00013328284,0.005161329,0.000050999624,0.00022128776,0.011181233,0.00095568644,0.9781285,0.000025362335],"about_ca_topic_score_codex":0.00080124213,"about_ca_topic_score_gemma":0.0019110534,"teacher_disagreement_score":0.0021516525,"about_ca_system_score_codex":0.00046424623,"about_ca_system_score_gemma":0.0004007824,"threshold_uncertainty_score":0.007197976},"labels":[],"label_agreement":null},{"id":"W2003335263","doi":"10.1016/j.jaad.2006.04.012","title":"Diffuse dermatitis: An unexpected initial presentation of cystic fibrosis","year":2008,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Cystic fibrosis; Rash; Presentation (obstetrics); Histopathology; Dermatology; Multisystem disease; Disease; Malnutrition; Pathology; Fibrosis; Pathophysiology; Internal medicine; Surgery","score_opus":0.025834267051829545,"score_gpt":0.35813731090107626,"score_spread":0.3323030438492467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003335263","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9153397,0.008853835,0.00769858,0.011235481,0.0013618179,0.00073663844,0.00088698504,0.0009033848,0.052983608],"genre_scores_gemma":[0.99282724,0.0015533034,0.0015062651,0.0013621371,0.0013554952,0.00003606097,0.00014767228,0.00005014359,0.0011616836],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9987816,0.00016773693,0.000103529615,0.00027974838,0.00022134391,0.0004459627],"domain_scores_gemma":[0.9960944,0.0015405939,0.000327515,0.00039090528,0.00032292047,0.0013237378],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008860915,0.0032631473,0.0023216633,0.0033672175,0.0019902808,0.0021062144,0.0020460335,0.007193488,0.0034272694],"category_scores_gemma":[0.0067574917,0.0014950766,0.0013798,0.001435528,0.0016265985,0.0029675544,0.0016800025,0.005144487,0.0018541057],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006819589,0.000036405185,0.0034033218,0.00003061907,0.0000042139286,0.9945657,0.000045791894,0.000034822053,0.00047839386,0.00011969003,0.00027588406,0.0009369151],"study_design_scores_gemma":[0.000033954777,0.00009667088,0.0047914973,0.000015091673,0.000012386068,0.99406356,0.00006676512,0.00023250573,0.00029388757,0.00010953327,0.0002752776,0.000008895828],"about_ca_topic_score_codex":0.0016820737,"about_ca_topic_score_gemma":0.0019438714,"teacher_disagreement_score":0.007193488,"about_ca_system_score_codex":0.0013844847,"about_ca_system_score_gemma":0.0006381566,"threshold_uncertainty_score":0.011465371},"labels":[],"label_agreement":null},{"id":"W2003808969","doi":"10.1016/j.jaad.2013.11.002","title":"Development of a disease severity score for newborns with collodion membrane","year":2013,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Skin and Cellular Biology Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Collodion; Lamellar ichthyosis; Ichthyosis; Retrospective cohort study; Cohort; Disease; Severity of illness; Cohort study; Prospective cohort study; Pediatrics; Dermatology; Internal medicine; Membrane","score_opus":0.01577549686011328,"score_gpt":0.2866528539095331,"score_spread":0.27087735704941984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003808969","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9868515,0.0006154283,0.0031702158,0.00048301052,0.00011532136,0.00016871374,0.0013230785,0.00010445597,0.0071682315],"genre_scores_gemma":[0.98953104,0.00036655212,0.00702939,0.0000585358,0.000037510283,0.00016181995,0.0017135307,0.000018779132,0.0010828096],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99943835,0.000103934835,0.00010883545,0.00008226094,0.00016776976,0.00009885709],"domain_scores_gemma":[0.99828666,0.00021387306,0.00063029473,0.00003613479,0.00048466222,0.000348389],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00090036896,0.00091205817,0.00052906177,0.0023939735,0.0004287993,0.0008618359,0.00044497318,0.0004637606,0.0014839408],"category_scores_gemma":[0.0035655792,0.00018731083,0.000896422,0.00076408224,0.00025747906,0.0005572604,0.00079877145,0.0007844308,0.00034092416],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027979448,0.00010719958,0.9730429,0.000052800588,0.00008388832,0.0005487684,0.00016787098,0.0003204884,0.002738146,0.00023157407,0.0012707418,0.021155832],"study_design_scores_gemma":[0.000022104825,0.00054731715,0.9900748,0.000100386744,0.00009152659,0.0020127,0.0003824721,0.0025752906,0.0024152887,0.00022232787,0.0015277974,0.000027864033],"about_ca_topic_score_codex":0.003120265,"about_ca_topic_score_gemma":0.0030990369,"teacher_disagreement_score":0.003120265,"about_ca_system_score_codex":0.00074115756,"about_ca_system_score_gemma":0.0008403543,"threshold_uncertainty_score":0.0062042475},"labels":[],"label_agreement":null},{"id":"W2004345862","doi":"10.1067/mjd.2001.113715","title":"Retinoic acid metabolism","year":2001,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":73,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Catabolism; Retinoic acid; Enzyme; Medicine; Metabolism; Tretinoin; Biochemistry; Internal medicine; Biology; Gene","score_opus":0.02149562487596213,"score_gpt":0.3317095293611105,"score_spread":0.31021390448514835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004345862","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016297672,0.9231214,0.005318928,0.0013372783,0.0032020775,0.000060881655,0.0004231301,0.00023815819,0.06466841],"genre_scores_gemma":[0.012548265,0.832172,0.003572913,0.00069775805,0.0010549601,0.00006589917,0.0011452216,0.000030760686,0.14871232],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999038,0.00000889899,0.000011663459,0.000028196531,0.000033266242,0.000014119032],"domain_scores_gemma":[0.99994314,0.0000051864304,0.000007842218,0.00000884253,0.00002344847,0.000011478487],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002184838,0.00089709484,0.0006909098,0.0013130227,0.0005103739,0.0012774166,0.0006540605,0.00078835303,0.014870913],"category_scores_gemma":[0.0001469739,0.00036898337,0.00029205283,0.0013029495,0.00045214663,0.00082839763,0.00085907907,0.0011738793,0.019714326],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001781147,0.00007178574,0.0001870404,0.001928637,0.00003767678,0.00029756944,0.000050140337,0.00021509788,0.056024857,0.007519889,0.061426964,0.8720622],"study_design_scores_gemma":[0.00000783866,0.000024199222,0.00036003356,0.0001318292,0.00001640676,0.0006685307,0.000016505568,0.000034222554,0.007904825,0.00078337884,0.99004537,0.0000067754736],"about_ca_topic_score_codex":0.0012133486,"about_ca_topic_score_gemma":0.0021583657,"teacher_disagreement_score":0.014870913,"about_ca_system_score_codex":0.0007480828,"about_ca_system_score_gemma":0.00076376955,"threshold_uncertainty_score":0.049748182},"labels":[],"label_agreement":null},{"id":"W2004570679","doi":"10.1067/mjd.2001.117850","title":"The treatment of moderate to severe psoriasis with a new anti-CD11a monoclonal antibody","year":2001,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":176,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Probity Medical Research","funders":"","keywords":"Medicine; Placebo; Psoriasis Area and Severity Index; Psoriasis; Adverse effect; Internal medicine; Gastroenterology; White blood cell; Surgery; Immunology; Pathology","score_opus":0.017956186068602137,"score_gpt":0.28486302243096984,"score_spread":0.26690683636236767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004570679","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94705224,0.036315974,0.004252498,0.0016180333,0.0010118323,0.00019333241,0.00009318804,0.00013246537,0.009330499],"genre_scores_gemma":[0.9768975,0.014509292,0.0019368788,0.0007020529,0.00036423845,0.0000796498,0.00017300346,0.000009658343,0.005327593],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9998877,0.000024515146,0.0000087245635,0.0000099840145,0.000029699024,0.000039426544],"domain_scores_gemma":[0.99994624,0.00001438859,0.000010296898,0.0000045584925,0.000008319395,0.000016161319],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002970837,0.00023029318,0.00041332337,0.00024277528,0.00023760063,0.00021160411,0.0002288911,0.00032100873,0.0007152427],"category_scores_gemma":[0.00019761358,0.00010473096,0.00033438855,0.00015534027,0.00014899198,0.00015144372,0.00015165542,0.0008583802,0.00020691709],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008547574,0.0036417274,0.0056031244,0.0006256846,0.00028020723,0.0029785167,0.00012923374,0.0010377838,0.33148947,0.001322623,0.007308897,0.6370352],"study_design_scores_gemma":[0.029550362,0.12242056,0.18236853,0.00036859416,0.0015600354,0.05274133,0.00029002642,0.0064298464,0.3005407,0.0015834188,0.30199182,0.00015481743],"about_ca_topic_score_codex":0.00039176157,"about_ca_topic_score_gemma":0.0013802915,"teacher_disagreement_score":0.0007152427,"about_ca_system_score_codex":0.00015526681,"about_ca_system_score_gemma":0.0001687602,"threshold_uncertainty_score":0.0023927689},"labels":[],"label_agreement":null},{"id":"W2004741559","doi":"10.1016/j.jaad.2014.07.029","title":"Quality of life in pediatric patients before and after cosmetic camouflage of visible skin conditions","year":2014,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Skin Protection and Aging","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine; Children's Hospital of Eastern Ontario","funders":"","keywords":"Medicine; Camouflage; Dermatology Life Quality Index; Quality of life (healthcare); Dermatology; Population","score_opus":0.010503831650491765,"score_gpt":0.30893461078444234,"score_spread":0.29843077913395055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004741559","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99870825,0.00047367293,0.00001839369,0.00009042189,0.000014891501,0.0000058264095,0.00027379466,0.000001470138,0.000413379],"genre_scores_gemma":[0.9992322,0.00022192663,0.000027275077,0.00003957468,0.000011768031,0.000005704515,0.00035324588,0.0000012009551,0.00010725061],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99962556,0.00006365614,0.000026110678,0.00005446912,0.000057620193,0.00017253654],"domain_scores_gemma":[0.9985311,0.00025176618,0.0005504765,0.00002837125,0.00013569107,0.0005025607],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003521048,0.00026126727,0.0005971498,0.0005605892,0.0005299978,0.0007475473,0.00025260303,0.00056515983,0.0015905353],"category_scores_gemma":[0.0028787353,0.00013753366,0.0009280263,0.00077642244,0.00032817165,0.00060687104,0.00050726894,0.0010845435,0.00017052657],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035398034,0.0001692618,0.99489284,0.000021412689,0.000058225487,0.00034715992,0.0002792343,0.00006942456,0.00010011649,0.000027962162,0.0002092308,0.0034711952],"study_design_scores_gemma":[0.00000971951,0.00043791052,0.99812955,0.000011701046,0.000037738457,0.00039174667,0.0006383904,0.000081699436,0.000036979916,0.00001931087,0.00019834503,0.000006888419],"about_ca_topic_score_codex":0.0078282785,"about_ca_topic_score_gemma":0.009316859,"teacher_disagreement_score":0.0078282785,"about_ca_system_score_codex":0.00094637927,"about_ca_system_score_gemma":0.0005403285,"threshold_uncertainty_score":0.015565395},"labels":[],"label_agreement":null},{"id":"W2005618682","doi":"10.1016/j.jaad.2003.10.548","title":"Oral tazarotene improves scalp psoriasis","year":2004,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre de Recherche Dermatologique du Québec Métropolitain","funders":"","keywords":"Tazarotene; Medicine; Psoriasis; Placebo; Dermatology; Scalp; Pathology","score_opus":0.014579817447976245,"score_gpt":0.26943845640454794,"score_spread":0.2548586389565717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005618682","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95081574,0.03039751,0.0011473242,0.0013403655,0.0010164428,0.00010952694,0.00044099768,0.00072785583,0.014004289],"genre_scores_gemma":[0.9805619,0.010580557,0.0006303886,0.0003678613,0.00038106463,0.000024271993,0.00038198192,0.00004119358,0.007030733],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9999062,0.000019806663,0.0000096662725,0.00001073483,0.000023830937,0.000029728706],"domain_scores_gemma":[0.9998647,0.00003108859,0.000023077642,0.000021484426,0.000017938964,0.00004157194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013602454,0.00047659833,0.0007038453,0.00031934545,0.0002783978,0.0002735383,0.0003483365,0.0003952832,0.006480485],"category_scores_gemma":[0.0003502975,0.00013399655,0.00033378307,0.00021312172,0.0001739424,0.00029244903,0.0000923098,0.0011222226,0.0010855136],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.039135303,0.0051184255,0.0032028288,0.0014541362,0.0004702493,0.0020169595,0.00010805063,0.0004363971,0.43002948,0.00051079533,0.007752169,0.5097652],"study_design_scores_gemma":[0.058553964,0.11724093,0.29526338,0.00057819596,0.0052010003,0.029791206,0.00063475757,0.003961315,0.35350636,0.0023600734,0.13274221,0.00016671221],"about_ca_topic_score_codex":0.0011696517,"about_ca_topic_score_gemma":0.002195046,"teacher_disagreement_score":0.006480485,"about_ca_system_score_codex":0.0001262164,"about_ca_system_score_gemma":0.00022344792,"threshold_uncertainty_score":0.021679401},"labels":[],"label_agreement":null},{"id":"W2006342158","doi":"10.1016/j.jaad.2014.02.019","title":"A double-blind, randomized prospective study evaluating topical clobetasol propionate 0.05% versus topical tacrolimus 0.1% in patients with vulvar lichen sclerosus","year":2014,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Genital Health and Disease","field":"Medicine","cited_by":95,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université de Montréal","funders":"","keywords":"Lichen sclerosus; Medicine; Clobetasol propionate; Dermatology; Tacrolimus; Vulva; Randomized controlled trial; Testosterone propionate; Surgery; Androgen; Internal medicine; Psoriasis; Transplantation","score_opus":0.03595892790140078,"score_gpt":0.3660825810869773,"score_spread":0.3301236531855765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006342158","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9873104,0.005404419,0.0007811641,0.0005722056,0.0011340622,0.0027973775,0.0004949054,0.00009372892,0.0014117468],"genre_scores_gemma":[0.9880733,0.0029762057,0.001537489,0.0011920319,0.0008657045,0.002734629,0.00047894212,0.000023724338,0.002117912],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99880576,0.00062128453,0.00012127736,0.0002168344,0.00007912302,0.00015563473],"domain_scores_gemma":[0.9976295,0.000995885,0.0003952928,0.00020680568,0.00017860506,0.000593839],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019749196,0.001812683,0.005937041,0.0006637233,0.0007185617,0.0013442893,0.0012619572,0.0024026907,0.0061109914],"category_scores_gemma":[0.0028591757,0.0011568266,0.002126939,0.0006977082,0.0021685276,0.0016344618,0.0004802473,0.0033531634,0.0013537735],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9895433,0.0048398385,0.00020210333,0.00026234228,0.00038052016,0.000017962735,0.000021409678,0.00007648821,0.0012591949,0.000032959753,0.00011747306,0.0032462105],"study_design_scores_gemma":[0.92940235,0.069124445,0.0006523502,0.00001545334,0.00032398853,0.000012010525,0.000018599534,0.00012809175,0.00014856196,0.000044406683,0.0001202355,0.000009585585],"about_ca_topic_score_codex":0.0013493359,"about_ca_topic_score_gemma":0.0023187338,"teacher_disagreement_score":0.0061109914,"about_ca_system_score_codex":0.00078891404,"about_ca_system_score_gemma":0.0014453139,"threshold_uncertainty_score":0.02044332},"labels":[],"label_agreement":null},{"id":"W2006458564","doi":"10.1016/j.jaad.2010.07.031","title":"p16 Expression: A marker of differentiation between childhood malignant melanomas and Spitz nevi","year":2011,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":101,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Université de Montréal","funders":"","keywords":"Medicine; Spitz nevus; Dermatology; Melanoma; Nevus; Pathology; Cancer research","score_opus":0.019090126402283154,"score_gpt":0.2610830089601394,"score_spread":0.24199288255785625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006458564","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99773103,0.000543386,0.00030240527,0.000017624554,0.0000032546322,0.00000617613,0.00006092594,0.000014952986,0.0013203607],"genre_scores_gemma":[0.9989858,0.000216705,0.0005144878,0.000003975095,0.000004308333,0.000005075324,0.00008691886,0.0000043662862,0.00017841397],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999762,0.000036091165,0.00003779546,0.00004327955,0.00005740065,0.00006341826],"domain_scores_gemma":[0.9992379,0.0002109902,0.00028845074,0.00003578904,0.00011806166,0.000108785185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044268434,0.00020578557,0.00019576988,0.0019847853,0.00031744855,0.0005781284,0.00024138279,0.0002712937,0.0011467879],"category_scores_gemma":[0.0014939593,0.00021844672,0.00014420788,0.0006632291,0.0004491977,0.0006185032,0.00032719635,0.0003646589,0.00025175358],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071402383,0.000024610119,0.9202602,0.000065013446,0.000028380775,0.0026944731,0.00030292867,0.00017270498,0.06177281,0.00019759827,0.00012601793,0.01364126],"study_design_scores_gemma":[0.00001140363,0.00026026054,0.949881,0.00002397821,0.000047987363,0.02031176,0.0005032509,0.0008829549,0.026804045,0.00014978052,0.0011149839,0.000008551243],"about_ca_topic_score_codex":0.0018047857,"about_ca_topic_score_gemma":0.002465418,"teacher_disagreement_score":0.0019847853,"about_ca_system_score_codex":0.00043367266,"about_ca_system_score_gemma":0.00032180327,"threshold_uncertainty_score":0.0038363934},"labels":[],"label_agreement":null},{"id":"W2007202911","doi":"10.1016/j.jaad.2005.07.013","title":"Malignant melanoma in childhood and adolescence: Report of 13 cases","year":2005,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Xeroderma pigmentosum; Incidence (geometry); Pyogenic granuloma; Pediatrics; Melanoma; Dermatology; Differential diagnosis; Nevus; Lesion; Medical record; Surgery; Pathology","score_opus":0.011212016643999815,"score_gpt":0.28268204160321175,"score_spread":0.27147002495921196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007202911","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888672,0.0030833185,0.0012452322,0.00029733294,0.000074542724,0.00012775039,0.0001585204,0.000058579717,0.006087529],"genre_scores_gemma":[0.9958936,0.0017781695,0.0008836149,0.00014125046,0.00014105301,0.000049550916,0.00013811202,0.000024616944,0.0009501187],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9989919,0.00009919844,0.00014734236,0.0001874995,0.00013157699,0.00044247732],"domain_scores_gemma":[0.99788207,0.0005710825,0.0004798433,0.00019228588,0.00020259467,0.00067208585],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005456993,0.0022913716,0.0012073237,0.002769684,0.0038998707,0.001614743,0.0013866719,0.0027948217,0.002440752],"category_scores_gemma":[0.0030001923,0.001468347,0.0010943578,0.001842846,0.0021500937,0.0011950589,0.0017897708,0.0015525536,0.0011443583],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009511292,0.00027783331,0.14661756,0.00006171423,0.000030801704,0.8454391,0.0008850792,0.00013421185,0.0011318986,0.00011586236,0.00032700633,0.0048839324],"study_design_scores_gemma":[0.000024048595,0.00021267617,0.06627052,0.000036750807,0.000055949276,0.92981124,0.0011105286,0.00020092692,0.0010004031,0.000104086146,0.0011515738,0.00002126641],"about_ca_topic_score_codex":0.0039698575,"about_ca_topic_score_gemma":0.006857247,"teacher_disagreement_score":0.0039698575,"about_ca_system_score_codex":0.0010743283,"about_ca_system_score_gemma":0.0011133283,"threshold_uncertainty_score":0.008165121},"labels":[],"label_agreement":null},{"id":"W2008192281","doi":"10.1016/j.jaad.2006.10.005","title":"Two randomized studies demonstrate the efficacy and safety of dapsone gel, 5% for the treatment of acne vulgaris","year":2007,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":127,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lynde Centre for Dermatology; Guenther Dermatology Research Centre","funders":"","keywords":"Medicine; Dapsone; Acne; Dermatology; Randomized controlled trial; Surgery","score_opus":0.027942587928669195,"score_gpt":0.3730086703812019,"score_spread":0.3450660824525327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008192281","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8589412,0.10167771,0.007310599,0.006201737,0.0036635639,0.00888229,0.0046296725,0.00035411643,0.008339151],"genre_scores_gemma":[0.96914715,0.016761415,0.004549423,0.0026886691,0.001114679,0.002117899,0.0016474092,0.00005106047,0.0019223179],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99450314,0.0034179587,0.0007852613,0.00052379136,0.0004982921,0.00027150562],"domain_scores_gemma":[0.9780489,0.014978945,0.004037869,0.0012576354,0.0009726839,0.0007040121],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007020662,0.0013719988,0.004854979,0.0007995977,0.0007219869,0.0012083978,0.0010043125,0.0040870155,0.005115976],"category_scores_gemma":[0.019746162,0.0005912523,0.004815988,0.0008630328,0.0016667054,0.0009078624,0.00052402035,0.0031211255,0.0006067473],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9102777,0.0050478564,0.002274171,0.006786355,0.01208193,0.00012682009,0.00010029185,0.00033316197,0.003205297,0.00036786133,0.0015219651,0.057876624],"study_design_scores_gemma":[0.9145106,0.063468,0.006990142,0.00046140354,0.009392581,0.00020253671,0.000045360575,0.00030264547,0.0017219569,0.00037012747,0.0024932346,0.000041449915],"about_ca_topic_score_codex":0.0010738913,"about_ca_topic_score_gemma":0.0022196465,"teacher_disagreement_score":0.007020662,"about_ca_system_score_codex":0.0010388389,"about_ca_system_score_gemma":0.0012391869,"threshold_uncertainty_score":0.037129283},"labels":[],"label_agreement":null},{"id":"W2008716526","doi":"10.1016/j.jaad.2006.05.027","title":"Clinical response to adalimumab treatment in patients with moderate to severe psoriasis: Double-blind, randomized controlled trial and open-label extension study","year":2006,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":507,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Dalhousie University","funders":"","keywords":"Medicine; Adalimumab; Open label; Psoriasis; Randomized controlled trial; Double blind; Dermatology; Surgery; Internal medicine; Placebo; Alternative medicine; Tumor necrosis factor alpha","score_opus":0.03691857886856944,"score_gpt":0.3417004839563627,"score_spread":0.3047819050877933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008716526","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98184144,0.0058971155,0.0011535817,0.0008666177,0.0012192765,0.0048310775,0.0016614443,0.00024608555,0.0022832947],"genre_scores_gemma":[0.9806608,0.0028174305,0.002124923,0.0014815048,0.0013715427,0.006014526,0.0015107896,0.000049124646,0.0039693527],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99817836,0.0009117485,0.0001329574,0.00036010725,0.00014013989,0.0002766605],"domain_scores_gemma":[0.9976254,0.0006797655,0.00048330348,0.00028861625,0.0001973097,0.00072557013],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031628609,0.0030761857,0.009487017,0.00074661255,0.0009714035,0.0019126938,0.0016606476,0.0031337095,0.008470405],"category_scores_gemma":[0.0027737103,0.001451218,0.0034923742,0.0008068337,0.0024872913,0.0019253202,0.0007255096,0.004574047,0.0016496958],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9942179,0.0020692397,0.00018162905,0.0002589616,0.0003753321,0.00001034415,0.000016642414,0.00006715104,0.00056546426,0.00002120412,0.00015467021,0.0020614201],"study_design_scores_gemma":[0.9810923,0.017461069,0.0008103645,0.000011067579,0.00025961333,0.000008325543,0.00000726626,0.00012384697,0.000071855284,0.000033366927,0.000112511836,0.000008408448],"about_ca_topic_score_codex":0.0012558457,"about_ca_topic_score_gemma":0.0016155035,"teacher_disagreement_score":0.009487017,"about_ca_system_score_codex":0.0009341478,"about_ca_system_score_gemma":0.0012225365,"threshold_uncertainty_score":0.028336346},"labels":[],"label_agreement":null},{"id":"W2010044260","doi":"10.1067/mjd.2000.107754","title":"A large-scale North American study of fungal isolates from nails: The frequency of onychomycosis, fungal distribution, and antifungal susceptibility patterns","year":2000,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":535,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Dermatophyte; Medicine; Incidence (geometry); Nail (fastener); Nail disease; Mycosis; Trichophyton rubrum; Fluconazole; Dermatology; Antifungal; Veterinary medicine; Microbiology; Biology; Surgery; Paronychia","score_opus":0.010021031842006643,"score_gpt":0.28497348790437144,"score_spread":0.2749524560623648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010044260","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993654,0.000070691916,0.0001102343,0.000020862464,0.000002729379,0.000014496542,0.00014263774,0.00000193959,0.00027108754],"genre_scores_gemma":[0.99912137,0.00014785795,0.00019738746,0.00007086282,0.000008340445,0.000015448672,0.0002298236,0.0000038013227,0.00020511645],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993362,0.00021151706,0.00004742974,0.00017650375,0.00013919944,0.00008922308],"domain_scores_gemma":[0.9989434,0.00021875222,0.00016549474,0.00014294102,0.00028626056,0.0002431017],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005122181,0.00040095,0.0003899353,0.0008674138,0.001092804,0.00064250303,0.0003446361,0.00049693865,0.0008702998],"category_scores_gemma":[0.00090470014,0.00047587746,0.0002850607,0.0012460983,0.0006392648,0.0005246106,0.00064157107,0.0006076857,0.00027151525],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014962259,0.00022854876,0.99203205,0.000018247501,0.00006987268,0.00030553088,0.0011377357,0.000022120408,0.0035710267,0.000018623841,0.00016766669,0.0022788353],"study_design_scores_gemma":[0.0000074297013,0.00009688915,0.99774086,0.0000036627985,0.000027926755,0.00062663935,0.0010110154,0.00005075924,0.00015832015,0.000008279859,0.00026407724,0.0000042481674],"about_ca_topic_score_codex":0.023184933,"about_ca_topic_score_gemma":0.039935824,"teacher_disagreement_score":0.023184933,"about_ca_system_score_codex":0.00041327396,"about_ca_system_score_gemma":0.00045828734,"threshold_uncertainty_score":0.04609996},"labels":[],"label_agreement":null},{"id":"W2010098840","doi":"10.1016/j.jaad.2014.01.903","title":"Inherited epidermolysis bullosa: Updated recommendations on diagnosis and classification","year":2014,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Skin and Cellular Biology Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":933,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Epidermolysis bullosa; Medicine; Classification scheme; Computational biology; Mutation; Bioinformatics; Gene; Genetics; Dermatology; Data science; Biology; Computer science","score_opus":0.055508899451133485,"score_gpt":0.38325801081690103,"score_spread":0.32774911136576756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010098840","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002998788,0.9829625,0.0017650313,0.007705734,0.004340722,0.000050488085,0.0003251272,0.00008386916,0.0024665946],"genre_scores_gemma":[0.002572681,0.9755495,0.007240001,0.0063991575,0.0043534916,0.00009497444,0.0013489639,0.00002317124,0.002417948],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99822,0.0003542181,0.00049152283,0.00022947311,0.0005446476,0.00016000094],"domain_scores_gemma":[0.9972011,0.00082086946,0.0004050826,0.00006888646,0.0013103479,0.00019369609],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003288222,0.0017988536,0.0032992896,0.0066450112,0.0006021148,0.002058051,0.0028498026,0.0028739788,0.0044784965],"category_scores_gemma":[0.0048926272,0.0005758922,0.0018288237,0.0030314948,0.0012668286,0.002476114,0.0013952166,0.004395764,0.003075098],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014044174,0.00008552075,0.0021123497,0.006645358,0.00018455526,0.0012322948,0.000118210126,0.00055923034,0.0008624187,0.0035373797,0.31163982,0.67288244],"study_design_scores_gemma":[0.00011621499,0.000067576344,0.004017191,0.01367058,0.0005106111,0.008633935,0.00019178694,0.00027204273,0.00032541182,0.0044458103,0.9676673,0.00008143291],"about_ca_topic_score_codex":0.0062863026,"about_ca_topic_score_gemma":0.007911172,"teacher_disagreement_score":0.0066450112,"about_ca_system_score_codex":0.0020874636,"about_ca_system_score_gemma":0.004034399,"threshold_uncertainty_score":0.017390013},"labels":[],"label_agreement":null},{"id":"W2011424039","doi":"10.1016/j.jaad.2014.11.026","title":"The “pinch and slide” suture technique","year":2015,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Surgical Sutures and Adhesives","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Wound closure; Knot (papermaking); Apposition; Surgery; Anatomy; Fibrous joint; Wound healing","score_opus":0.020305140436022873,"score_gpt":0.32364061784811565,"score_spread":0.30333547741209277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011424039","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2853722,0.011753277,0.5500775,0.0072352015,0.008539801,0.0011261287,0.00058831077,0.0063897907,0.12891783],"genre_scores_gemma":[0.6070005,0.0071098893,0.31683528,0.004908505,0.004418697,0.00054504885,0.00052275154,0.00068229676,0.05797706],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990017,0.00019668402,0.00010074322,0.00021224105,0.0003688573,0.00011977664],"domain_scores_gemma":[0.99934953,0.00020061071,0.00011899787,0.00017632845,0.000078989324,0.00007546579],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00094368804,0.00062071683,0.00043621505,0.0012394553,0.0008811598,0.0006549537,0.0006454752,0.0009080376,0.0077121854],"category_scores_gemma":[0.0024280907,0.00025083497,0.0009213599,0.00074088114,0.0009478276,0.0013440716,0.0011274322,0.002340755,0.0023632094],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011664513,0.00042319173,0.008111329,0.0009386532,0.00032496516,0.0049620196,0.00037587096,0.0008660769,0.07548242,0.01276317,0.03185775,0.86272806],"study_design_scores_gemma":[0.00097108184,0.0062756827,0.08063187,0.0010211285,0.0011845246,0.2875576,0.0006798239,0.010043192,0.15034412,0.015910171,0.44488618,0.0004945956],"about_ca_topic_score_codex":0.00027367417,"about_ca_topic_score_gemma":0.00084038585,"teacher_disagreement_score":0.0077121854,"about_ca_system_score_codex":0.0001823101,"about_ca_system_score_gemma":0.0007070124,"threshold_uncertainty_score":0.02579981},"labels":[],"label_agreement":null},{"id":"W2012188315","doi":"10.1016/j.jaad.2014.07.016","title":"Retrospective review of Stevens-Johnson syndrome/toxic epidermal necrolysis treatment comparing intravenous immunoglobulin with cyclosporine","year":2014,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":187,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Child and Family Research Institute; University of British Columbia","funders":"","keywords":"Toxic epidermal necrolysis; Medicine; Mucocutaneous zone; Retrospective cohort study; Cohort; Dermatology; Pediatrics; Internal medicine; Disease","score_opus":0.015184668106682812,"score_gpt":0.29313020943124707,"score_spread":0.2779455413245643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012188315","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9856237,0.012874217,0.00012057837,0.00003409786,0.000021284806,0.00006656532,0.00029941616,0.0000036582967,0.0009563889],"genre_scores_gemma":[0.99739134,0.0018662201,0.0001542524,0.00010016969,0.000038417296,0.00002331652,0.0003220014,0.000004164874,0.00009997395],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976792,0.00072487054,0.00081698527,0.0003375555,0.00030426402,0.00013720494],"domain_scores_gemma":[0.9950918,0.001858707,0.0021233794,0.00025062208,0.0004667458,0.00020869485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011802067,0.00020307853,0.00082110177,0.0009505701,0.00041939673,0.0006129161,0.00037461988,0.00045246334,0.0015622169],"category_scores_gemma":[0.004496407,0.00018306087,0.000988144,0.0015897319,0.00034750116,0.00031077518,0.00025930826,0.00033598088,0.0002049379],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006655929,0.0003626489,0.9517936,0.0017681842,0.0016232628,0.010662565,0.00034374977,0.000102214435,0.0029501205,0.0001305739,0.00042894104,0.023178263],"study_design_scores_gemma":[0.00057986425,0.005838295,0.9456092,0.00052453455,0.0041618207,0.03530697,0.0011169984,0.00016079047,0.002229541,0.00008122675,0.0043581063,0.00003263611],"about_ca_topic_score_codex":0.0012921497,"about_ca_topic_score_gemma":0.0015783372,"teacher_disagreement_score":0.0015622169,"about_ca_system_score_codex":0.0006867455,"about_ca_system_score_gemma":0.00067451247,"threshold_uncertainty_score":0.00624156},"labels":[],"label_agreement":null},{"id":"W2012677700","doi":"10.1016/j.jaad.2011.02.038","title":"Systematic review of nondermatophyte mold onychomycosis: Diagnosis, clinical types, epidemiology, and treatment","year":2011,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":247,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada); University of Toronto","funders":"","keywords":"Medicine; Dermatology; Nail (fastener); Isolation (microbiology); Nail disease; Terbinafine; Dermatophyte; Nail plate; Microbiology; Biology; Itraconazole; Antifungal","score_opus":0.11823851612222527,"score_gpt":0.455378848726962,"score_spread":0.33714033260473675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012677700","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000748443,0.9985753,0.00006813855,0.00007112971,0.000058495647,0.000094712486,0.00027397057,0.0000035965522,0.00010608014],"genre_scores_gemma":[0.009089829,0.9899573,0.0003180613,0.0002174022,0.000044015294,0.00011325575,0.00017476856,0.000002272832,0.000083106985],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9967818,0.0010279175,0.001277788,0.00030927025,0.00047941162,0.00012379266],"domain_scores_gemma":[0.9922466,0.0046222317,0.002067407,0.00012619517,0.00078748865,0.00014995024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036043392,0.0014921381,0.009023528,0.0059084552,0.00043379152,0.0015442146,0.0018225905,0.0012171941,0.0041291732],"category_scores_gemma":[0.013899176,0.00088720495,0.0067245527,0.008077485,0.0006037482,0.0014213095,0.0013236671,0.0009283822,0.00030829222],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003103094,0.000026693091,0.00093869853,0.9404388,0.021009307,0.00011520165,0.00008787253,0.000099790224,0.00015239502,0.00010580838,0.0020629638,0.03465218],"study_design_scores_gemma":[0.0011173448,0.00053091947,0.0125955455,0.59982413,0.35196677,0.0009222988,0.000315057,0.00012332546,0.0002604569,0.00039423368,0.03187051,0.00007939688],"about_ca_topic_score_codex":0.0114168,"about_ca_topic_score_gemma":0.039148204,"teacher_disagreement_score":0.0114168,"about_ca_system_score_codex":0.00208114,"about_ca_system_score_gemma":0.0070775677,"threshold_uncertainty_score":0.022700667},"labels":[],"label_agreement":null},{"id":"W2012715950","doi":"10.1016/j.jaad.2010.12.005","title":"Long-term efficacy and safety of adalimumab in patients with moderate to severe psoriasis treated continuously over 3 years: Results from an open-label extension study for patients from REVEAL","year":2011,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":177,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre de Recherche Dermatologique du Québec Métropolitain; Probity Medical Research","funders":"","keywords":"Adalimumab; Medicine; Psoriasis Area and Severity Index; Psoriasis; Adverse effect; Placebo; Internal medicine; Open label; Clinical trial; Randomized controlled trial; Severity of illness; Surgery; Dermatology; Disease","score_opus":0.027432609005187077,"score_gpt":0.2852208799279339,"score_spread":0.2577882709227468,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012715950","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985317,0.0007633468,0.00008396627,0.0000548622,0.000024676903,0.00008200492,0.00021000947,0.000010182379,0.00023929687],"genre_scores_gemma":[0.998315,0.0003508486,0.00018478038,0.0001281798,0.000075134296,0.00011076229,0.00041744203,0.000005919489,0.00041197732],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99916065,0.0003481893,0.000067159956,0.00013068198,0.000103024424,0.00019026849],"domain_scores_gemma":[0.9985312,0.00035979165,0.00039719784,0.0001750028,0.00010248636,0.0004342143],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023598627,0.0009250979,0.001982264,0.00041388386,0.0006278136,0.0010149804,0.0005010818,0.0010164798,0.0014284335],"category_scores_gemma":[0.0016269494,0.00045017095,0.002059109,0.0004349254,0.00076936703,0.0011401327,0.00036080374,0.0023054234,0.00040410573],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8535629,0.019011535,0.059797067,0.00037448425,0.0021974973,0.00022467482,0.00041483625,0.0006417782,0.015770502,0.00007703754,0.0006816858,0.04724599],"study_design_scores_gemma":[0.30437696,0.3611154,0.32281056,0.000068848756,0.003990467,0.0004829944,0.00029366478,0.0013625172,0.0032628393,0.00016408839,0.0019746695,0.00009702585],"about_ca_topic_score_codex":0.0011090687,"about_ca_topic_score_gemma":0.0015670656,"teacher_disagreement_score":0.0023598627,"about_ca_system_score_codex":0.00054024346,"about_ca_system_score_gemma":0.00057533756,"threshold_uncertainty_score":0.012480319},"labels":[],"label_agreement":null},{"id":"W2012980289","doi":"10.1067/mjd.2002.127247","title":"A randomized, double-blind, placebo-controlled phase III study evaluating efficacy and tolerability of 2 courses of alefacept in patients with chronic plaque psoriasis","year":2002,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":347,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Medicine; Tolerability; Psoriasis Area and Severity Index; Psoriasis; Placebo; Plaque psoriasis; Adverse effect; Dermatology; Surgery; Anesthesia; Internal medicine","score_opus":0.030223057427708658,"score_gpt":0.320761134649429,"score_spread":0.29053807722172037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012980289","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904359,0.0019230617,0.0008044897,0.00053318805,0.00049804774,0.0035935096,0.00070574565,0.00015859332,0.0013474666],"genre_scores_gemma":[0.9856579,0.0016257345,0.001820237,0.0013612893,0.00074397336,0.004985723,0.0011116258,0.000044343684,0.0026491224],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9992749,0.0002915062,0.000046776764,0.00015237338,0.00006119983,0.0001731988],"domain_scores_gemma":[0.99850875,0.00041213923,0.0002215212,0.00016626492,0.00008683387,0.0006043939],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016737737,0.0023900305,0.0056691826,0.00067655044,0.0008315361,0.0011027151,0.0013096792,0.002856996,0.0060346634],"category_scores_gemma":[0.0020245018,0.0012553767,0.0019821075,0.0005487974,0.002132352,0.001617044,0.0005255545,0.00447953,0.0013134999],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9775368,0.011999747,0.00035133088,0.00017157939,0.00031959795,0.000033485354,0.000043011383,0.00016599527,0.0028366935,0.00004002401,0.00023876387,0.0062629143],"study_design_scores_gemma":[0.94768435,0.051099017,0.00066701503,0.000004744792,0.00010908433,0.000012409223,0.000008344166,0.00009078094,0.00016750647,0.00003138619,0.000118843214,0.0000064826654],"about_ca_topic_score_codex":0.0011478487,"about_ca_topic_score_gemma":0.0020214182,"teacher_disagreement_score":0.0060346634,"about_ca_system_score_codex":0.00074475893,"about_ca_system_score_gemma":0.0014052311,"threshold_uncertainty_score":0.020187974},"labels":[],"label_agreement":null},{"id":"W2013374458","doi":"10.1067/s0190-9622(03)00800-4","title":"Topical nitrogen mustard in the treatment of alopecia areata: a bilateral comparison study","year":2003,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Vancouver General Hospital","funders":"","keywords":"Alopecia areata; Nitrogen mustard; Medicine; Scalp; Dermatology; Surgery; Chemotherapy; Cyclophosphamide","score_opus":0.03102993186443124,"score_gpt":0.3486541609394197,"score_spread":0.31762422907498844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013374458","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99729186,0.0015298238,0.000059974926,0.000041176474,0.000030068779,0.000092597424,0.00007582199,0.00000328302,0.00087541656],"genre_scores_gemma":[0.9981456,0.0010284985,0.00009042543,0.000054205793,0.000088235,0.0000640738,0.00008390674,0.0000020443672,0.0004430175],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99912447,0.00040661474,0.00007837947,0.00011417781,0.00015888888,0.00011754308],"domain_scores_gemma":[0.999244,0.00028629208,0.00015927704,0.00006889829,0.000078812445,0.00016269661],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008631106,0.0007365914,0.0019441167,0.0005002071,0.00042486194,0.00038519566,0.00054082985,0.0007813065,0.0033680787],"category_scores_gemma":[0.0012728694,0.00025336668,0.00086728536,0.00049370545,0.000651123,0.00058016606,0.0003095312,0.00080357766,0.00029056723],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.839951,0.04115165,0.014312819,0.0011437136,0.002613601,0.00066126883,0.0002934757,0.0005124899,0.041832175,0.00021725583,0.00036908526,0.05694158],"study_design_scores_gemma":[0.26108867,0.5498488,0.17170909,0.000093612725,0.0049282317,0.0011739467,0.00060820865,0.0010516879,0.0068638306,0.00024043009,0.0023290263,0.00006448903],"about_ca_topic_score_codex":0.002826954,"about_ca_topic_score_gemma":0.003770187,"teacher_disagreement_score":0.0033680787,"about_ca_system_score_codex":0.00083845906,"about_ca_system_score_gemma":0.0005509718,"threshold_uncertainty_score":0.011267364},"labels":[],"label_agreement":null},{"id":"W2013575934","doi":"10.1016/j.jaad.2009.02.048","title":"Amniotic membrane grafting in patients with epidermolysis bullosa with chronic wounds","year":2010,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Skin and Cellular Biology Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Epidermolysis bullosa; Retrospective cohort study; Visual analogue scale; Adverse effect; Amnion; Surgery; Wound healing; Dermatology; Internal medicine; Pregnancy; Fetus","score_opus":0.005298187105687921,"score_gpt":0.25399146933348804,"score_spread":0.24869328222780013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013575934","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971584,0.0011839983,0.0000955311,0.00017059114,0.000034081284,0.000009534911,0.000035262037,0.000008508628,0.0013040841],"genre_scores_gemma":[0.9993774,0.00032278203,0.000041820902,0.000045592526,0.000041819065,0.000004904272,0.000028354327,0.000001741951,0.00013555543],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999729,0.000050201008,0.000039029008,0.00003542286,0.000044719975,0.000101725855],"domain_scores_gemma":[0.9991666,0.00028515715,0.00023662619,0.00004012279,0.000024876485,0.00024660554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037331556,0.00043334716,0.00065925013,0.00087148073,0.0014002717,0.00083034567,0.00034364712,0.0011438918,0.0021361704],"category_scores_gemma":[0.00236241,0.00028567613,0.00044080938,0.00064114376,0.0007747274,0.00059921853,0.00046098104,0.0009279197,0.00022811288],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023282561,0.00044092268,0.7560328,0.00011445753,0.00010871463,0.22378558,0.0007938702,0.00022246735,0.003711534,0.00035100826,0.00040175422,0.011708625],"study_design_scores_gemma":[0.00023860336,0.0019459164,0.5167932,0.00010199942,0.00022429347,0.4744885,0.002472197,0.0008772242,0.0013508548,0.0004409858,0.0010312177,0.00003490453],"about_ca_topic_score_codex":0.0010493022,"about_ca_topic_score_gemma":0.00089793676,"teacher_disagreement_score":0.0021361704,"about_ca_system_score_codex":0.00036210698,"about_ca_system_score_gemma":0.0004771472,"threshold_uncertainty_score":0.0071461797},"labels":[],"label_agreement":null},{"id":"W2013748670","doi":"10.1016/j.jaad.2003.10.625","title":"Minocycline-tetracycline-induced severe hypertriglyceridemia in an HIV-positive patient receiving combination antiretroviral therapy","year":2004,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Lipid metabolism and disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Minocycline; Hypertriglyceridemia; Discontinuation; Lipodystrophy; Adverse effect; Pancreatitis; Internal medicine; Ritonavir; Tetracycline; Gastroenterology; Triglyceride; Pharmacology; Viral load; Immunology; Antiretroviral therapy; Cholesterol; Human immunodeficiency virus (HIV); Antibiotics","score_opus":0.018912441555829086,"score_gpt":0.3114817473830872,"score_spread":0.2925693058272581,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013748670","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9816285,0.0011901049,0.00083836017,0.00413539,0.00034556512,0.00013149976,0.00015758707,0.00009504201,0.0114779575],"genre_scores_gemma":[0.99712294,0.00042217795,0.00026912638,0.000990793,0.0003625078,0.000009004985,0.000047853788,0.000014546279,0.00076099037],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9995788,0.00006411111,0.000060622417,0.00007519283,0.00008732159,0.00013390234],"domain_scores_gemma":[0.99874854,0.000456303,0.00018742468,0.000060710685,0.00007944511,0.0004675603],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002696881,0.0013376742,0.0008588609,0.0015015911,0.0025544588,0.0009618061,0.00094612286,0.0039402964,0.001763782],"category_scores_gemma":[0.0025707323,0.000853588,0.0010722455,0.00078908436,0.00094445393,0.00095491635,0.00055187655,0.0038453084,0.0005573892],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000269113,0.00016154085,0.017134286,0.000022481467,0.000016636373,0.979455,0.0001414584,0.00009041326,0.0011544689,0.00009507289,0.00024108088,0.0012184043],"study_design_scores_gemma":[0.00010078965,0.0010184075,0.047337115,0.00003316275,0.00010576132,0.9468007,0.00046256633,0.0014975739,0.001577384,0.00021188069,0.0008178282,0.000036909943],"about_ca_topic_score_codex":0.0057664434,"about_ca_topic_score_gemma":0.00899387,"teacher_disagreement_score":0.0057664434,"about_ca_system_score_codex":0.001457118,"about_ca_system_score_gemma":0.0010240991,"threshold_uncertainty_score":0.011465788},"labels":[],"label_agreement":null},{"id":"W2014410210","doi":"10.1016/j.jaad.2009.01.047","title":"A population-based study of cutaneous melanoma in Alberta, Canada (1993-2002)","year":2009,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Health Services; University of Alberta","funders":"","keywords":"Medicine; Melanoma; Incidence (geometry); Demography; Breslow Thickness; Population; Head and neck; Confidence interval; Univariate analysis; Multivariate analysis; Surgery; Cancer; Internal medicine; Sentinel lymph node","score_opus":0.00910621617381456,"score_gpt":0.2684462748262491,"score_spread":0.25934005865243454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014410210","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99183744,0.0011001213,0.00015706927,0.00039117047,0.000039462044,0.00009491583,0.0039511453,0.000018936911,0.0024096407],"genre_scores_gemma":[0.9953157,0.0006205677,0.0002600196,0.0002240233,0.000014262409,0.000027852127,0.0015458633,0.0000071391564,0.001984692],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989631,0.00008202885,0.000072982744,0.00018078431,0.00037285042,0.00032822776],"domain_scores_gemma":[0.99816966,0.00006462465,0.0002624004,0.000067053435,0.0009197695,0.0005164283],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075989426,0.00068959343,0.0006742442,0.0017675009,0.0034093698,0.001957466,0.0020296643,0.0011284981,0.0018481094],"category_scores_gemma":[0.0016246476,0.00078055676,0.00081481296,0.005989149,0.00076851924,0.00055707165,0.00089239836,0.0012136798,0.0003985847],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013170856,0.00007925566,0.9952121,0.00002870617,0.000084769985,0.00028784643,0.00060173986,0.00006804889,0.00020191622,0.000068287154,0.0011439289,0.0020916993],"study_design_scores_gemma":[0.000018065259,0.00003274448,0.9975278,0.000023320285,0.000061750456,0.0001636453,0.0013503848,0.00011995871,0.000030557592,0.0000139373215,0.0006484508,0.00000947545],"about_ca_topic_score_codex":0.9952284,"about_ca_topic_score_gemma":0.9969091,"teacher_disagreement_score":0.027156621,"about_ca_system_score_codex":0.027156621,"about_ca_system_score_gemma":0.024199395,"threshold_uncertainty_score":0.19703603},"labels":[],"label_agreement":null},{"id":"W2015265198","doi":"10.1016/j.jaad.2014.04.034","title":"Eruptive disseminated porokeratosis: A new classification system","year":2014,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Genetic and rare skin diseases.","field":"Biochemistry, Genetics and Molecular Biology","cited_by":46,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Porokeratosis; Dermatology","score_opus":0.020574287266529358,"score_gpt":0.3381056995754382,"score_spread":0.3175314123089088,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015265198","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011706459,0.98931366,0.0023492419,0.0024396263,0.0013182741,0.00003269324,0.0001239179,0.000085570195,0.003166342],"genre_scores_gemma":[0.011395211,0.97655904,0.0047658654,0.0019201245,0.0026575625,0.000047969337,0.0005669356,0.00001935351,0.0020679322],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99954766,0.00008988375,0.00008930744,0.00008683009,0.0001332564,0.000052988653],"domain_scores_gemma":[0.999295,0.00023279613,0.00012929788,0.000027730684,0.00022417697,0.000091034824],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009504551,0.0011649112,0.0023679943,0.006168185,0.0005039957,0.0014422038,0.0017788268,0.0009556013,0.002441881],"category_scores_gemma":[0.0010607565,0.00024735028,0.00066191313,0.0029220881,0.0016543815,0.0018674905,0.0010884482,0.0033202623,0.0014075347],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009051898,0.000060067116,0.0022167426,0.0052471342,0.0001308409,0.002292099,0.00015055487,0.00054733624,0.0015429541,0.009773123,0.08272748,0.8952212],"study_design_scores_gemma":[0.00008862865,0.00008818299,0.005497028,0.0051753,0.00034776216,0.067874394,0.00040904983,0.00068888103,0.000541358,0.015828112,0.903388,0.00007338987],"about_ca_topic_score_codex":0.0010986719,"about_ca_topic_score_gemma":0.0017262264,"teacher_disagreement_score":0.006168185,"about_ca_system_score_codex":0.0010634541,"about_ca_system_score_gemma":0.0013120015,"threshold_uncertainty_score":0.008168936},"labels":[],"label_agreement":null},{"id":"W2015828565","doi":"10.1016/j.jaad.2005.08.057","title":"Defining early mycosis fungoides","year":2005,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":543,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","keywords":"Mycosis fungoides; Medicine; Dermatology; Histopathology; Epidemiology; Lymphoma; Cutaneous T-cell lymphoma; Pathology","score_opus":0.047336051677437145,"score_gpt":0.4172516932246067,"score_spread":0.36991564154716955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015828565","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000097497905,0.9993079,0.00006274529,0.00013275757,0.0001496352,0.0000019550666,0.00000436999,0.0000018524908,0.00024133701],"genre_scores_gemma":[0.0012259062,0.99772376,0.00021267885,0.00029412616,0.0002915507,0.0000034416914,0.000017158442,7.633887e-7,0.00023064],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99966884,0.00007646706,0.00006989735,0.00005275108,0.00010211123,0.000029870773],"domain_scores_gemma":[0.9991774,0.00041853284,0.00015605535,0.000019608131,0.00018403567,0.000044363343],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010316111,0.00085096975,0.0020867407,0.003015186,0.00025796975,0.0012644804,0.0010292071,0.0013215899,0.0013406472],"category_scores_gemma":[0.0013475739,0.0004129221,0.00038109516,0.001986838,0.0007704599,0.0021661867,0.00074984756,0.0016767508,0.0008058774],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010827765,0.000049967028,0.00071131444,0.017781468,0.00008532399,0.00091717904,0.00007571415,0.00020191423,0.0012740863,0.001935493,0.019379126,0.95748013],"study_design_scores_gemma":[0.00006882737,0.00012348915,0.003265069,0.01085411,0.0003477153,0.009454438,0.00016799908,0.00014450902,0.00077280833,0.001981857,0.97278285,0.00003629249],"about_ca_topic_score_codex":0.0012479911,"about_ca_topic_score_gemma":0.002611594,"teacher_disagreement_score":0.003015186,"about_ca_system_score_codex":0.000613678,"about_ca_system_score_gemma":0.0010304345,"threshold_uncertainty_score":0.0054557323},"labels":[],"label_agreement":null},{"id":"W2015841617","doi":"10.1016/j.jaad.2006.08.001","title":"Acremonium mycetoma in a heart transplant recipient","year":2006,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Actinomycetales infections and treatment","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"","keywords":"Medicine; Population; Mycetoma; Acremonium; Incidence (geometry); Microbiology; Dermatology; Biology","score_opus":0.010475027141998694,"score_gpt":0.2945500130709072,"score_spread":0.2840749859289085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015841617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.985849,0.0006980272,0.0007737606,0.0022025295,0.00027986575,0.00011206193,0.000171087,0.00010913111,0.009804576],"genre_scores_gemma":[0.9971257,0.0003374194,0.00025271715,0.00047035314,0.00042576817,0.000010767866,0.0000696062,0.000013773809,0.0012938592],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9995148,0.000053987533,0.000050215152,0.000102784936,0.00007159523,0.00020661183],"domain_scores_gemma":[0.9987326,0.00032830477,0.00019114379,0.00008852989,0.000076040444,0.00058337743],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034794435,0.0014648123,0.0009085403,0.0024719785,0.00329939,0.0013759139,0.0013886238,0.003985227,0.004479441],"category_scores_gemma":[0.0022646238,0.0008899922,0.00091835856,0.00090196135,0.0010252642,0.00135648,0.0010226708,0.0032092931,0.0011680741],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019169872,0.0002613672,0.01692581,0.000016587916,0.000010175961,0.98016745,0.00011821844,0.000075698124,0.0007981546,0.00012952306,0.00019910409,0.0011062742],"study_design_scores_gemma":[0.0000679742,0.0005236018,0.03551344,0.000016948234,0.00004434219,0.9614026,0.00045233968,0.0007134894,0.00065686274,0.00018957161,0.00039900112,0.000019797926],"about_ca_topic_score_codex":0.0031296173,"about_ca_topic_score_gemma":0.00310248,"teacher_disagreement_score":0.004479441,"about_ca_system_score_codex":0.0012690006,"about_ca_system_score_gemma":0.00079644145,"threshold_uncertainty_score":0.014985204},"labels":[],"label_agreement":null},{"id":"W2018438415","doi":"10.1016/j.jaad.2005.10.054","title":"Patients with psoriasis respond to continuous open-label etanercept treatment after initial incomplete response in a randomized, placebo-controlled trial","year":2006,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":50,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Medicine; Etanercept; Psoriasis; Placebo; Randomized controlled trial; Open label; Dermatology; Internal medicine; Alternative medicine; Tumor necrosis factor alpha","score_opus":0.015428633258825881,"score_gpt":0.28942460871081427,"score_spread":0.2739959754519884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018438415","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9831819,0.0064197797,0.0010794953,0.0010506756,0.0010674612,0.0036943632,0.0011682176,0.00022516266,0.0021129504],"genre_scores_gemma":[0.98772997,0.002158488,0.0013749464,0.0011612409,0.0008336364,0.0032318905,0.0010127227,0.000036385583,0.002460697],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9983171,0.0008295948,0.00012958123,0.0003369572,0.00010738421,0.00027943487],"domain_scores_gemma":[0.99725693,0.0010716082,0.0005704865,0.0002860737,0.00015986532,0.00065499224],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031461453,0.0021178902,0.0067166495,0.0005161372,0.00087237667,0.0017951014,0.0014444422,0.003274898,0.0093429675],"category_scores_gemma":[0.0034586755,0.001090526,0.0029574316,0.0005619903,0.0020543984,0.0020358602,0.0006045572,0.0046855747,0.0017213164],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9932099,0.0017509004,0.0002064871,0.00022308402,0.00040426396,0.000017155535,0.000020729396,0.000056574223,0.0005209598,0.000025140836,0.0001928719,0.0033720275],"study_design_scores_gemma":[0.9808785,0.01764816,0.0008226331,0.000015492049,0.00023600929,0.000011720016,0.000008757968,0.000095333366,0.00007637624,0.00003525835,0.00016460351,0.00000724453],"about_ca_topic_score_codex":0.00087059254,"about_ca_topic_score_gemma":0.0013678435,"teacher_disagreement_score":0.0093429675,"about_ca_system_score_codex":0.00088542595,"about_ca_system_score_gemma":0.00097185984,"threshold_uncertainty_score":0.031255364},"labels":[],"label_agreement":null},{"id":"W2019994046","doi":"10.1016/j.jaad.2003.10.309","title":"IgA mucous membrane pemphigoid in a patient with common variable immunodeficiency","year":2004,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Autoimmune Bullous Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Common variable immunodeficiency; Immunology; Autoimmune disease; Lymphoid hyperplasia; Dermatology; Autoimmune hemolytic anemia; Lymphoma; Antibody","score_opus":0.006649806418184293,"score_gpt":0.2605648317642623,"score_spread":0.253915025346078,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019994046","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9797401,0.0021811472,0.0006219721,0.0023276191,0.00028407088,0.00012491723,0.00021415124,0.00011698172,0.014389026],"genre_scores_gemma":[0.9974833,0.00043087426,0.0002565784,0.000566891,0.0003852231,0.000010614157,0.000050469735,0.000012625678,0.00080349424],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9993467,0.00007165544,0.00007931345,0.00016648842,0.00008014551,0.0002556144],"domain_scores_gemma":[0.99852955,0.0005964667,0.00018182326,0.000112691494,0.00009756115,0.00048185603],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053739344,0.002513219,0.0012151067,0.0026935658,0.003622167,0.0014636981,0.0013592559,0.0055940775,0.002593919],"category_scores_gemma":[0.0035096148,0.001159865,0.0012194077,0.0015017163,0.0016062893,0.0015474698,0.0012794532,0.003040138,0.00061383477],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010728831,0.00005940877,0.013261182,0.000025229327,0.000012361504,0.9846927,0.00015927112,0.000055093562,0.0005909958,0.00010108057,0.0001755754,0.0007598371],"study_design_scores_gemma":[0.00004874436,0.0002377173,0.029505823,0.000019393605,0.000056108212,0.9685336,0.00024648727,0.00038597436,0.00033275166,0.00014696407,0.0004682787,0.000018189943],"about_ca_topic_score_codex":0.0050850427,"about_ca_topic_score_gemma":0.0045782365,"teacher_disagreement_score":0.0055940775,"about_ca_system_score_codex":0.0016388787,"about_ca_system_score_gemma":0.0008024269,"threshold_uncertainty_score":0.011890948},"labels":[],"label_agreement":null},{"id":"W2021042136","doi":"10.1067/mjd.2000.105507","title":"Measuring quality of life in people referred for specialist care of acne: Comparing generic and disease-specific measures","year":2000,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":136,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Advancing Health Outcomes; University of British Columbia","funders":"","keywords":"Medicine; Acne; Quality of life (healthcare); Anxiety; Disease; Dermatology Life Quality Index; Depression (economics); Normative; Population; Physical therapy; Sample (material); Family medicine; Psychiatry; Dermatology; Internal medicine; Environmental health; Nursing","score_opus":0.09453868950293735,"score_gpt":0.3356033373460015,"score_spread":0.24106464784306414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021042136","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989973,0.00042826115,0.00005777849,0.000053523938,0.000012981495,0.00002566591,0.00013607249,0.0000016931441,0.0002868078],"genre_scores_gemma":[0.99927896,0.00016803938,0.00018530698,0.00006977753,0.000010495823,0.000027286369,0.00019995154,0.0000013102954,0.000058989222],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99802446,0.0007934071,0.0003106467,0.00018871976,0.0004540878,0.00022861543],"domain_scores_gemma":[0.9963403,0.0014715027,0.0010746085,0.00014758173,0.00052959146,0.0004364303],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034982304,0.00033939173,0.0011559938,0.0010576104,0.000580327,0.0009170666,0.0004977548,0.0011863512,0.0008726569],"category_scores_gemma":[0.009303932,0.0003094312,0.0018595913,0.0014114152,0.00047428746,0.001016614,0.0010153301,0.001100157,0.00016529368],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027025768,0.00039824977,0.9835739,0.00017231941,0.0008817984,0.00004669242,0.00085105264,0.00011299777,0.00023667047,0.000041299587,0.00020900962,0.01077332],"study_design_scores_gemma":[0.00021883198,0.002127067,0.99560153,0.000032140135,0.00033208332,0.00014240618,0.00083194964,0.00033037222,0.00009454253,0.000055222372,0.00022016875,0.000013660847],"about_ca_topic_score_codex":0.004340228,"about_ca_topic_score_gemma":0.0063881483,"teacher_disagreement_score":0.004340228,"about_ca_system_score_codex":0.0009332271,"about_ca_system_score_gemma":0.0004123932,"threshold_uncertainty_score":0.018500626},"labels":[],"label_agreement":null},{"id":"W2022235333","doi":"10.1016/j.jaad.2010.08.008","title":"Recurrent Gianotti-Crosti syndrome","year":2011,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Parvovirus B19 Infection Studies","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Buttocks; Hepatosplenomegaly; Dermatology; Leukocytosis; Pathology; Immunology; Surgery","score_opus":0.044086596795207426,"score_gpt":0.332378460823647,"score_spread":0.2882918640284396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022235333","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6002093,0.020814246,0.0019428177,0.16067566,0.005607117,0.00021814634,0.00049502036,0.00068311073,0.20935458],"genre_scores_gemma":[0.9650887,0.0036873522,0.00076966576,0.017019065,0.0058430447,0.000042441647,0.00011163217,0.000063697815,0.007374451],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99914455,0.000210243,0.00008174447,0.00016935506,0.00019242633,0.00020161417],"domain_scores_gemma":[0.9973322,0.0013268891,0.00037336786,0.00026253704,0.00020931319,0.000495672],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076875795,0.0017708037,0.0010134879,0.0021905464,0.0023742567,0.0014473095,0.0012450675,0.008512177,0.0067274584],"category_scores_gemma":[0.008938082,0.000616769,0.0007524538,0.0010812202,0.0016733418,0.0024618078,0.00089713413,0.004649828,0.0012905219],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006938379,0.000082616156,0.017302101,0.00004361661,0.00002383897,0.9715811,0.00019800977,0.0000518174,0.0006635888,0.0011743988,0.006035296,0.0027742404],"study_design_scores_gemma":[0.00006750068,0.00006803756,0.010327443,0.00007721343,0.000033760625,0.9831246,0.00016615266,0.00029754225,0.00028875607,0.0007674418,0.004768378,0.0000131921115],"about_ca_topic_score_codex":0.002675588,"about_ca_topic_score_gemma":0.0018740918,"teacher_disagreement_score":0.008512177,"about_ca_system_score_codex":0.0012758414,"about_ca_system_score_gemma":0.0007981376,"threshold_uncertainty_score":0.022505581},"labels":[],"label_agreement":null},{"id":"W2023039127","doi":"10.1016/j.jaad.2011.07.034","title":"Moderate to severe plaque psoriasis with scalp involvement: A randomized, double-blind, placebo-controlled study of etanercept","year":2011,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":104,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Lynde Centre for Dermatology","funders":"","keywords":"Medicine; Etanercept; Scalp; Placebo; Dermatology Life Quality Index; Psoriasis; Internal medicine; Randomized controlled trial; Adverse effect; Surgery; Clinical endpoint; Dermatology; Gastroenterology; Tumor necrosis factor alpha; Pathology","score_opus":0.03386156533134699,"score_gpt":0.27507144587953,"score_spread":0.241209880548183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023039127","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99002576,0.0037904338,0.00074157194,0.00043016663,0.0005805049,0.0023139697,0.0004668266,0.00013364243,0.001517029],"genre_scores_gemma":[0.9897535,0.002843825,0.00092613976,0.0008026312,0.00057281874,0.0019851883,0.00044193535,0.000024842217,0.0026491454],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9992143,0.00032070896,0.000071560586,0.00014392841,0.00007189591,0.00017749004],"domain_scores_gemma":[0.99926704,0.00022036566,0.00010672928,0.0000766712,0.00004748149,0.00028163142],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019064277,0.0017872908,0.0049394215,0.00066305907,0.0006468552,0.0010984584,0.0011271626,0.0023218563,0.0077238097],"category_scores_gemma":[0.0015998572,0.0011246599,0.0018132973,0.00053561945,0.0017099727,0.0014626518,0.00039241064,0.00293117,0.00093913503],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98311424,0.007080045,0.00024182122,0.0003816898,0.00048364274,0.00003864441,0.000024318073,0.000094870215,0.002560861,0.00004357253,0.00020378678,0.005732422],"study_design_scores_gemma":[0.9692058,0.0291336,0.00088614493,0.000009696656,0.00025623618,0.000022691129,0.000010349063,0.00010035712,0.00016556417,0.00004171846,0.00015994378,0.000007846752],"about_ca_topic_score_codex":0.0011511226,"about_ca_topic_score_gemma":0.0021519165,"teacher_disagreement_score":0.0077238097,"about_ca_system_score_codex":0.0005481296,"about_ca_system_score_gemma":0.0009351786,"threshold_uncertainty_score":0.025838733},"labels":[],"label_agreement":null},{"id":"W2026261818","doi":"10.1016/j.jaad.2006.09.002","title":"A randomized, open-label trial of continuous versus interrupted etanercept therapy in the treatment of psoriasis","year":2006,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":156,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"Allergan; 3M; Astellas Pharma US; Amgen; Biogen; Abbott Laboratories","keywords":"Medicine; Etanercept; Discontinuation; Clinical endpoint; Psoriasis; Randomized controlled trial; Psoriasis Area and Severity Index; Dermatology Life Quality Index; Surgery; Internal medicine; Dermatology","score_opus":0.04710496800482027,"score_gpt":0.33180287935337477,"score_spread":0.2846979113485545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026261818","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899255,0.0032713197,0.00084525597,0.00056214625,0.0010630548,0.0019352993,0.00064265245,0.00012218351,0.0016324876],"genre_scores_gemma":[0.9888516,0.0016483176,0.0016434031,0.00082091126,0.00091461616,0.0024980616,0.0006103334,0.0000324426,0.002980208],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9987147,0.000627286,0.0000973477,0.00026994105,0.000091241156,0.00019954004],"domain_scores_gemma":[0.9975025,0.0009913736,0.00035691352,0.00033529272,0.00011975371,0.00069416186],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021894274,0.001738861,0.005816189,0.00051847694,0.0005660763,0.0016093855,0.0016225638,0.0027275418,0.010005656],"category_scores_gemma":[0.0030092057,0.0010803918,0.0018688882,0.00053332315,0.002263399,0.0021798874,0.00063058984,0.005131306,0.0013923913],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.99402314,0.002415749,0.00008429761,0.00009915376,0.00019159562,0.000008706118,0.000012738803,0.000074455056,0.00045458807,0.000030576404,0.000082836115,0.002522205],"study_design_scores_gemma":[0.9728923,0.026098115,0.0003950402,0.000009293902,0.00014139859,0.000010053092,0.000009931006,0.0001683479,0.00008707834,0.00006345599,0.00011781462,0.0000071405484],"about_ca_topic_score_codex":0.0010539241,"about_ca_topic_score_gemma":0.0012047752,"teacher_disagreement_score":0.010005656,"about_ca_system_score_codex":0.0008131783,"about_ca_system_score_gemma":0.0009045558,"threshold_uncertainty_score":0.03347224},"labels":[],"label_agreement":null},{"id":"W2026300910","doi":"10.1016/j.jaad.2014.06.013","title":"Efficacy of oral retinoids in treatment-resistant lichen planopilaris","year":2014,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"START Clinic; Women's College Hospital; University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Dermatology; Scarring alopecia; Concomitant; Internal medicine; Scalp","score_opus":0.021529851359736528,"score_gpt":0.3105125318843925,"score_spread":0.288982680524656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026300910","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8727724,0.05405425,0.00054535834,0.0345456,0.0017279912,0.00023029179,0.0003047117,0.0001333638,0.035686158],"genre_scores_gemma":[0.9873904,0.0052619292,0.00024954267,0.003066354,0.0011660826,0.000046297646,0.00011732305,0.000010062844,0.002691971],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.9996847,0.00014353891,0.000031788135,0.000024797975,0.000067835055,0.00004739283],"domain_scores_gemma":[0.99923766,0.0005243505,0.000053637137,0.000048751404,0.00004620363,0.00008939782],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059814606,0.00019385552,0.0010283446,0.0003281917,0.00045211345,0.0004286561,0.0003929611,0.0013055123,0.0017405776],"category_scores_gemma":[0.0017259446,0.000082489765,0.0005630264,0.0002634575,0.00034958989,0.00030996,0.0001305951,0.0016489115,0.00036556806],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.060796577,0.007399107,0.02611388,0.0021415479,0.00084806664,0.069142684,0.00075903506,0.0018152335,0.042321708,0.0049551334,0.03692729,0.74677974],"study_design_scores_gemma":[0.09129414,0.13163099,0.26549938,0.0018266331,0.004312219,0.15593994,0.0014448052,0.011931898,0.059289005,0.008415702,0.2681392,0.00027606834],"about_ca_topic_score_codex":0.0010349286,"about_ca_topic_score_gemma":0.0013150051,"teacher_disagreement_score":0.0017405776,"about_ca_system_score_codex":0.0007826419,"about_ca_system_score_gemma":0.00028384628,"threshold_uncertainty_score":0.0058227777},"labels":[],"label_agreement":null},{"id":"W2026691829","doi":"10.1016/j.jaad.2014.02.015","title":"Reactive hemophagocytic syndrome in a patient with adult-onset Still disease","year":2014,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Adult-onset Still's disease; Disease; Hemophagocytic lymphohistiocytosis; Pediatrics; Dermatology; Pathology","score_opus":0.012498524050752156,"score_gpt":0.28672433369276734,"score_spread":0.2742258096420152,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026691829","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8544124,0.051881,0.00574103,0.051768374,0.017554753,0.00026886156,0.00058062497,0.0006373571,0.017155675],"genre_scores_gemma":[0.9550367,0.0074540153,0.0014593814,0.009094083,0.025106557,0.00002555163,0.00015318133,0.000049834478,0.0016206421],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99936455,0.000109444816,0.000120022225,0.00015227373,0.00009678738,0.0001570815],"domain_scores_gemma":[0.9979352,0.00081333274,0.00034964608,0.00012838251,0.00024005651,0.00053343194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00084655883,0.0015512679,0.001523349,0.0016411665,0.0010258816,0.0014653006,0.0012399654,0.0055065523,0.0021216946],"category_scores_gemma":[0.0039189425,0.00075833243,0.0006733378,0.0011597014,0.0010588458,0.0020752817,0.00091856206,0.002860821,0.0007818241],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010800941,0.000043031614,0.014825117,0.00016506687,0.000039302322,0.9754313,0.00022817474,0.000057300982,0.0007786518,0.00018498431,0.0057468032,0.0023922499],"study_design_scores_gemma":[0.000055538458,0.00010996951,0.009819986,0.00012194394,0.00007893132,0.9808719,0.00033282436,0.00073336746,0.00039086005,0.00035092531,0.007110058,0.000023686578],"about_ca_topic_score_codex":0.00059202424,"about_ca_topic_score_gemma":0.00081406644,"teacher_disagreement_score":0.0055065523,"about_ca_system_score_codex":0.00061202585,"about_ca_system_score_gemma":0.00036878858,"threshold_uncertainty_score":0.007097721},"labels":[],"label_agreement":null},{"id":"W2027939191","doi":"10.1016/j.jaad.2005.03.060","title":"Botulinum toxin type A","year":2005,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Botulinum Toxin and Related Neurological Disorders","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Glabella; Botulinum toxin; Rejuvenation; Facial rejuvenation; Strabismus; Intensive care medicine; Surgery; Forehead","score_opus":0.018202089869719777,"score_gpt":0.312201824177715,"score_spread":0.29399973430799525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027939191","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19288565,0.06256327,0.0054268604,0.022200244,0.0072092847,0.00028165444,0.0013082301,0.00083939946,0.70728534],"genre_scores_gemma":[0.6491274,0.019448144,0.0017456735,0.011386837,0.0013912485,0.00006447075,0.0010383759,0.00006315188,0.31573468],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99980706,0.000021074939,0.000014038534,0.000021664035,0.00006604029,0.00007010022],"domain_scores_gemma":[0.9998318,0.000025142801,0.000026319667,0.000017482404,0.000053411073,0.000045858644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002207166,0.00028955122,0.00021163339,0.0006711892,0.00076534733,0.00049541245,0.00028040473,0.0008986613,0.021472385],"category_scores_gemma":[0.0007448636,0.000084792446,0.00027293782,0.00038458436,0.00026445813,0.00030404693,0.00028685352,0.00064613,0.0069928234],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001525174,0.00075320643,0.028737795,0.00066533824,0.0001550319,0.083740234,0.0002963805,0.00016310203,0.08964197,0.01112238,0.22831286,0.5548866],"study_design_scores_gemma":[0.00013262477,0.00048750185,0.04575924,0.00031159824,0.00009772817,0.19648261,0.0001503634,0.00025250702,0.013233577,0.0018334363,0.7412333,0.000025437015],"about_ca_topic_score_codex":0.0030816537,"about_ca_topic_score_gemma":0.0036716524,"teacher_disagreement_score":0.021472385,"about_ca_system_score_codex":0.0007732088,"about_ca_system_score_gemma":0.00079902605,"threshold_uncertainty_score":0.0718323},"labels":[],"label_agreement":null},{"id":"W2028269844","doi":"10.1016/j.jaad.2005.03.015","title":"Sunlight, tanning booths, and vitamin D","year":2005,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Vitamin D Research Studies","field":"Medicine","cited_by":86,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Vitamin D and neurology; Ultraviolet radiation; Dermatology; Sunlight; Miller; Library science; Vitamin; Gerontology; Environmental health; Internal medicine; Optics; Computer science; Biology; Physics","score_opus":0.01819430905100439,"score_gpt":0.34374319396509057,"score_spread":0.3255488849140862,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028269844","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9386966,0.052422296,0.00008120007,0.0012007674,0.00015725066,0.00002640236,0.0002280007,0.000005732598,0.00718172],"genre_scores_gemma":[0.9848483,0.011646604,0.0001268065,0.000288707,0.00012488317,0.000008369635,0.00010886585,0.00000261988,0.0028447562],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99908423,0.000536335,0.00005877862,0.000083689345,0.00014898992,0.00008790741],"domain_scores_gemma":[0.9970071,0.0015931114,0.0006660358,0.00017959187,0.00020753582,0.00034666597],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010324725,0.00027639547,0.00033813814,0.0010947316,0.00081876013,0.0012440562,0.00035208146,0.00065819477,0.0057902765],"category_scores_gemma":[0.004831409,0.00030160218,0.0004717125,0.0010500601,0.00046117662,0.0004605578,0.00038879277,0.0006214349,0.00026569498],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02071945,0.0045673214,0.8691158,0.0010868645,0.0017952877,0.00041195482,0.0010156801,0.00012652579,0.003634728,0.0021434752,0.0028966393,0.09248619],"study_design_scores_gemma":[0.00060125196,0.0043961187,0.9776774,0.00035386704,0.0012813485,0.00057709456,0.002003574,0.000097354794,0.0013516692,0.0013826988,0.010251775,0.000025865258],"about_ca_topic_score_codex":0.010637692,"about_ca_topic_score_gemma":0.0194775,"teacher_disagreement_score":0.010637692,"about_ca_system_score_codex":0.00049514597,"about_ca_system_score_gemma":0.00063738774,"threshold_uncertainty_score":0.021151543},"labels":[],"label_agreement":null},{"id":"W2030354062","doi":"10.1016/j.jaad.2008.07.004","title":"The EuroSCAR study: Cannot agree with the conclusions","year":2008,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Toxic epidermal necrolysis; Medicine; Prednisone; Retrospective cohort study; Dermatology; Odds ratio; Prospective cohort study; Pediatrics; Surgery; Internal medicine","score_opus":0.023739157185462198,"score_gpt":0.3094375850664679,"score_spread":0.2856984278810057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030354062","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011250613,0.0015448356,0.000116564835,0.98365396,0.010492612,0.000015590254,0.0001346389,0.000013516014,0.002903275],"genre_scores_gemma":[0.011674681,0.0010604669,0.00025998318,0.9580033,0.02721134,0.000050643117,0.00008121299,0.000020112057,0.0016383055],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9849857,0.006175709,0.002582835,0.0015280537,0.0036173721,0.0011103757],"domain_scores_gemma":[0.9424228,0.03663797,0.005942555,0.0018338342,0.008365302,0.004797586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017716365,0.00073694595,0.0033998678,0.0012978035,0.0034090702,0.0047732713,0.005405054,0.06292385,0.01213584],"category_scores_gemma":[0.08512949,0.0007547778,0.0023274391,0.00195707,0.00313896,0.004808865,0.0019116912,0.038639843,0.009356881],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017358518,0.00018631427,0.008142138,0.00041625273,0.000530686,0.00248191,0.00023687528,0.00020978703,0.00030067057,0.006193376,0.9563521,0.02321413],"study_design_scores_gemma":[0.0062354673,0.00076696347,0.013466934,0.0027409904,0.0017362443,0.0039060914,0.0018920935,0.002388338,0.001438918,0.048038956,0.9169103,0.0004786558],"about_ca_topic_score_codex":0.0029955148,"about_ca_topic_score_gemma":0.005360051,"teacher_disagreement_score":0.06292385,"about_ca_system_score_codex":0.0033051325,"about_ca_system_score_gemma":0.003964759,"threshold_uncertainty_score":0.09369421},"labels":[],"label_agreement":null},{"id":"W2030671146","doi":"10.1067/mjd.2002.120927","title":"Three-dimensional analysis of a calciphylaxis plaque: Clues to pathogenesis","year":2002,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Parathyroid Disorders and Treatments","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Calciphylaxis; Medicine; Calcification; Pathology; Thrombosis; Pathogenesis; Lesion; Surgery","score_opus":0.02569818159382721,"score_gpt":0.3176850911558554,"score_spread":0.2919869095620282,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030671146","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8918092,0.010505323,0.06770739,0.003871805,0.00028225,0.00012128763,0.0003920715,0.00049429486,0.024816254],"genre_scores_gemma":[0.970272,0.0025759758,0.024798116,0.00026413763,0.00019711658,0.00003541879,0.00016419035,0.000034042594,0.0016589677],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99985445,0.000026864658,0.00001399143,0.00001475117,0.000053807697,0.00003626679],"domain_scores_gemma":[0.99974734,0.00006360594,0.000039351184,0.000050048868,0.000059755497,0.000039921353],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027074903,0.0003709136,0.00024466586,0.0021882702,0.00043748453,0.0013532689,0.0004462922,0.0011759206,0.0022847608],"category_scores_gemma":[0.00063724257,0.00034916386,0.00039547792,0.00062369823,0.00071506004,0.00072430924,0.0004818706,0.0009191178,0.00064505445],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00083796703,0.00018811702,0.029625345,0.00035572355,0.0000931133,0.050624117,0.0009991695,0.0023139662,0.8495085,0.01212195,0.0035565891,0.049775448],"study_design_scores_gemma":[0.00012777917,0.00041401596,0.1424904,0.00021419585,0.0003450768,0.4352434,0.0031164316,0.04471813,0.29178706,0.028084515,0.053212494,0.00024645377],"about_ca_topic_score_codex":0.000669457,"about_ca_topic_score_gemma":0.00041975713,"teacher_disagreement_score":0.0022847608,"about_ca_system_score_codex":0.00022034043,"about_ca_system_score_gemma":0.00024157598,"threshold_uncertainty_score":0.0076432824},"labels":[],"label_agreement":null},{"id":"W2032020701","doi":"10.1016/j.jaad.2003.10.626","title":"Skin penetration and systemic absorption of sunscreens after topical application","year":2004,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Skin Protection and Aging","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Stratum corneum; Medicine; Urine; Penetration (warfare); Chromatography; Absorption (acoustics); High-performance liquid chromatography; Salicylic acid; Dermatology; Chemistry; Materials science; Pathology; Internal medicine","score_opus":0.009343720311143642,"score_gpt":0.285439412541606,"score_spread":0.2760956922304623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032020701","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963019,0.0013314855,0.00033611106,0.000025275709,0.00002833157,0.000021976344,0.00015237085,0.00001722068,0.0017851508],"genre_scores_gemma":[0.99650526,0.0005543916,0.00017387829,0.00004428628,0.000024583975,0.000016081656,0.00021093678,0.000013491194,0.0024571016],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997682,0.00006403313,0.0000099693025,0.000036807058,0.000050071205,0.000070903974],"domain_scores_gemma":[0.999617,0.00016938166,0.000055988137,0.000037540365,0.000063580126,0.000056479694],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025464708,0.0002656547,0.00038432635,0.00023156803,0.0002258268,0.0003168952,0.00012560732,0.0003986432,0.006011577],"category_scores_gemma":[0.0005812149,0.00019645444,0.0006359472,0.00020763963,0.00020019531,0.000541471,0.00014548696,0.00078856,0.000688505],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.048757296,0.0013832548,0.024402384,0.00033308347,0.00026470568,0.0012917757,0.00042961424,0.00048622704,0.88874084,0.00024345469,0.00061700307,0.033050377],"study_design_scores_gemma":[0.00029010142,0.03022958,0.45343402,0.000043805907,0.0005042303,0.003145295,0.00070769986,0.0029633213,0.5056351,0.00023221275,0.0027650893,0.00004955327],"about_ca_topic_score_codex":0.0016268517,"about_ca_topic_score_gemma":0.0011713951,"teacher_disagreement_score":0.006011577,"about_ca_system_score_codex":0.00021151677,"about_ca_system_score_gemma":0.00022746655,"threshold_uncertainty_score":0.020110726},"labels":[],"label_agreement":null},{"id":"W2033181814","doi":"10.1067/mjd.2001.117527","title":"A psychometric study of patients with nail dystrophies","year":2001,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Body Image and Dysmorphia Studies","field":"Psychology","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"","keywords":"Medicine; Nail (fastener); Dermatology; Nail disease; Paronychia","score_opus":0.02059211698670773,"score_gpt":0.3179843246700717,"score_spread":0.297392207683364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033181814","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99927527,0.000052128362,0.000028161372,0.00003282049,0.000006247911,0.000013397198,0.0000318465,0.0000010661042,0.00055898906],"genre_scores_gemma":[0.9996494,0.00004682434,0.000033609722,0.00004268075,0.000005280277,0.000010988578,0.000078360696,0.0000012457539,0.00013160682],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99871886,0.00047872344,0.00017433184,0.000119274526,0.0002755408,0.00023339283],"domain_scores_gemma":[0.9945766,0.0019460904,0.001434626,0.00028171614,0.0009013498,0.0008596419],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018140579,0.00049734005,0.0006614963,0.0015939061,0.0011718046,0.0011668596,0.00034999038,0.00067475036,0.0013264946],"category_scores_gemma":[0.014082245,0.00031547179,0.0005643134,0.0014232689,0.0009669247,0.0007509685,0.0009881279,0.000969243,0.00036249208],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020490482,0.0004507227,0.99329424,0.0000140846805,0.00003316531,0.00031518628,0.0020578045,0.000032463624,0.00035483373,0.000053477295,0.000110968795,0.0030781778],"study_design_scores_gemma":[0.000026510976,0.0009420023,0.9943178,0.000009526864,0.00002228245,0.0009049529,0.0032756003,0.00008629477,0.0000683303,0.000049538943,0.00028657998,0.00001046044],"about_ca_topic_score_codex":0.0039854697,"about_ca_topic_score_gemma":0.0032377492,"teacher_disagreement_score":0.0039854697,"about_ca_system_score_codex":0.0006849095,"about_ca_system_score_gemma":0.00060562533,"threshold_uncertainty_score":0.009593725},"labels":[],"label_agreement":null},{"id":"W2033881749","doi":"10.1016/j.jaad.2014.08.039","title":"Safety and efficacy of brodalumab for psoriasis after 120 weeks of treatment","year":2014,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":114,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"Amgen","keywords":"Medicine; Psoriasis Area and Severity Index; Psoriasis; Adverse effect; Internal medicine; Dermatology Life Quality Index; Placebo; Interim analysis; Clinical trial; Gastroenterology; Dermatology","score_opus":0.012164301127651758,"score_gpt":0.2660242826918065,"score_spread":0.25385998156415474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033881749","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9794775,0.013903973,0.00035438154,0.0004659017,0.00026708088,0.00022526806,0.000713257,0.00010163393,0.0044908756],"genre_scores_gemma":[0.99648076,0.0009569243,0.00013380445,0.00032714216,0.00011653971,0.00007925989,0.0004736651,0.000012881472,0.0014190953],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99917066,0.00020761917,0.0000676506,0.00014170798,0.0002200286,0.00019242568],"domain_scores_gemma":[0.99838614,0.00047129413,0.00038828835,0.00018177424,0.00024594946,0.00032655586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001650398,0.0004840292,0.0017980533,0.00045436787,0.0005590738,0.0009379159,0.000575698,0.0011985251,0.0022694836],"category_scores_gemma":[0.0022451484,0.00024624905,0.0015050045,0.000279105,0.00041977453,0.0005856206,0.00017311922,0.002357151,0.0010606595],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.52890587,0.014988739,0.055215888,0.001388721,0.0022093728,0.0017639358,0.0003485662,0.0017478011,0.08452304,0.0003877901,0.004171578,0.3043487],"study_design_scores_gemma":[0.05747084,0.26498118,0.6081894,0.00048071466,0.0033046785,0.005346,0.0003747294,0.0036905226,0.035670694,0.0007299862,0.01951387,0.0002473701],"about_ca_topic_score_codex":0.0006693189,"about_ca_topic_score_gemma":0.00082046277,"teacher_disagreement_score":0.0022694836,"about_ca_system_score_codex":0.000692383,"about_ca_system_score_gemma":0.0004468505,"threshold_uncertainty_score":0.008728206},"labels":[],"label_agreement":null},{"id":"W2034319369","doi":"10.1016/j.jaad.2011.07.023","title":"Teaching empathy to undergraduate medical students using a temporary tattoo simulating psoriasis","year":2011,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Empathy and Medical Education","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Psoriasis; Medicine; Depression (economics); Psoriatic arthritis; Empathy; Visual analogue scale; Physical therapy; Mental health; Quality of life (healthcare); Dermatology; Psychiatry","score_opus":0.04991960939072102,"score_gpt":0.3928771643822015,"score_spread":0.34295755499148045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034319369","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96816504,0.0004949155,0.009575272,0.0035175234,0.00091410807,0.00042437343,0.000024891671,0.00019414043,0.016689762],"genre_scores_gemma":[0.9787759,0.0010176147,0.011081542,0.001334623,0.00019015273,0.0001729324,0.000023571605,0.000025128338,0.007378555],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995592,0.0001769681,0.000017625236,0.000035709476,0.00007526783,0.00013515214],"domain_scores_gemma":[0.9990396,0.00039157362,0.00009051515,0.00006109166,0.00007011699,0.00034704088],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009446991,0.0007369551,0.0003018657,0.00024005782,0.00094996527,0.0010193688,0.0005032324,0.0014747734,0.009440846],"category_scores_gemma":[0.0035558105,0.00024741492,0.00061265356,0.00010245528,0.000712665,0.0006068835,0.0019694571,0.001700864,0.0014319359],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003517852,0.05998441,0.046360373,0.0020285673,0.0001576757,0.017691065,0.07038951,0.009832695,0.13639322,0.010817464,0.06120794,0.5816193],"study_design_scores_gemma":[0.003520005,0.1239111,0.105064,0.0037582333,0.0007402228,0.11197585,0.13254169,0.04132902,0.13211854,0.033207625,0.31112254,0.00071120815],"about_ca_topic_score_codex":0.00024274958,"about_ca_topic_score_gemma":0.0009454357,"teacher_disagreement_score":0.009440846,"about_ca_system_score_codex":0.0004369431,"about_ca_system_score_gemma":0.0010343662,"threshold_uncertainty_score":0.031582773},"labels":[],"label_agreement":null},{"id":"W2034868754","doi":"10.1016/j.jaad.2010.04.040","title":"Immune response to pneumococcal polysaccharide vaccine in adults with chronic plaque psoriasis treated with alefacept","year":2011,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lynde Centre for Dermatology","funders":"Astellas Pharma","keywords":"Medicine; Plaque psoriasis; Psoriasis; Immune system; Dermatology; Immunology","score_opus":0.01081404379905381,"score_gpt":0.23785209298034796,"score_spread":0.22703804918129414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034868754","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99796605,0.0005927875,0.00003975089,0.0001862022,0.000029472145,0.000017852351,0.00009013214,0.0000065084046,0.0010712284],"genre_scores_gemma":[0.99927455,0.00013428072,0.000027446129,0.00015493219,0.000048334747,0.000009211134,0.000089952235,0.0000010856644,0.00026012707],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99971145,0.000072176874,0.00003511084,0.000051398434,0.000049589547,0.00008025976],"domain_scores_gemma":[0.99952185,0.00015307775,0.00012545194,0.000019809175,0.000057158933,0.00012262078],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035582224,0.0003305505,0.00064060325,0.00030820083,0.00044374436,0.00039835036,0.00016315046,0.000823516,0.001197153],"category_scores_gemma":[0.0014885531,0.00017918748,0.00047834194,0.00027663275,0.00020681473,0.0003396115,0.00015852794,0.00085965305,0.00021247084],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0097998865,0.0012529887,0.9569532,0.00008636187,0.00021205131,0.005272426,0.0004183019,0.00014936487,0.0059434604,0.000054956385,0.00083370943,0.019023273],"study_design_scores_gemma":[0.00038597107,0.0058825533,0.9862531,0.000018907669,0.00022841906,0.005219958,0.0002979189,0.0003697586,0.0005014788,0.000042695323,0.00078931276,0.00000991736],"about_ca_topic_score_codex":0.0019319693,"about_ca_topic_score_gemma":0.0019442424,"teacher_disagreement_score":0.0019319693,"about_ca_system_score_codex":0.0003326106,"about_ca_system_score_gemma":0.00023320454,"threshold_uncertainty_score":0.0040048957},"labels":[],"label_agreement":null},{"id":"W2035059473","doi":"10.1016/j.jaad.2005.07.073","title":"Psoriasis of the nail: Anatomy, pathology, clinical presentation, and a review of the literature on therapy","year":2007,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":419,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McMaster University; University of Toronto","funders":"","keywords":"Medicine; Psoriasis; Nail (fastener); Dermatology; Disease; Nail disease; Presentation (obstetrics); Intensive care medicine; Surgery; Pathology","score_opus":0.06351650013251874,"score_gpt":0.47530048933442687,"score_spread":0.4117839892019081,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035059473","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017480955,0.999065,0.0000839512,0.00010071176,0.00008238014,0.00000402156,0.000013413655,0.000004039126,0.00047167664],"genre_scores_gemma":[0.0008404004,0.99853635,0.00016577773,0.00010967412,0.00013129429,0.0000030496165,0.000019056395,6.9742237e-7,0.0001936505],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99968183,0.00004085693,0.0000847193,0.000057014866,0.00011364721,0.000021948219],"domain_scores_gemma":[0.9995401,0.00023028466,0.000109054025,0.000012048734,0.00007937655,0.000029175671],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043871923,0.0010253033,0.002062973,0.0052441917,0.00036300806,0.0009719363,0.0009892908,0.0009926576,0.0027798302],"category_scores_gemma":[0.0007043291,0.0004155102,0.0006491474,0.0048443866,0.0006025864,0.0017184664,0.0006029417,0.0011631974,0.0013351572],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009089619,0.00011937202,0.00066662836,0.027753748,0.00012301432,0.0016007405,0.000081587445,0.00030197046,0.0019268038,0.0008682814,0.021337291,0.9451296],"study_design_scores_gemma":[0.00007698532,0.00027920515,0.010231062,0.020665577,0.0008894144,0.06079845,0.000553421,0.00035046967,0.0013997526,0.002831014,0.9018215,0.00010309676],"about_ca_topic_score_codex":0.001410425,"about_ca_topic_score_gemma":0.003297305,"teacher_disagreement_score":0.0052441917,"about_ca_system_score_codex":0.00044239702,"about_ca_system_score_gemma":0.00091396726,"threshold_uncertainty_score":0.009299517},"labels":[],"label_agreement":null},{"id":"W2035553110","doi":"10.1016/j.jaad.2006.05.042","title":"Orbit and eyelid hemangiomas: Is there a relationship between location and ocular problems?","year":2006,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Vascular Malformations and Hemangiomas","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Palpebral fissure; Medicine; Eyelid; Orbit (dynamics); Magnetic resonance imaging; Lesion; Astigmatism; Hemangioma; Radiology; Ophthalmology; Surgery","score_opus":0.02044411767459979,"score_gpt":0.2913255266500829,"score_spread":0.2708814089754831,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035553110","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9718237,0.009408616,0.0008688491,0.0034282976,0.00014823712,0.000014429858,0.00011774192,0.000045198645,0.014144872],"genre_scores_gemma":[0.99650097,0.0017317669,0.0003211193,0.00022100515,0.00050337275,0.0000052013856,0.000032571937,0.000006684351,0.0006772994],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99944764,0.00013687796,0.00008449994,0.00006736633,0.00011689829,0.00014674712],"domain_scores_gemma":[0.99123234,0.004577101,0.0030446628,0.0003522534,0.00034142288,0.00045227734],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068751007,0.0004965764,0.0005879965,0.0019712716,0.00067793106,0.0009841518,0.0008849309,0.0031702814,0.010942136],"category_scores_gemma":[0.009352621,0.00047721548,0.00048072415,0.0023316958,0.0016209092,0.0032284202,0.00062982907,0.0012260099,0.0011546166],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000531914,0.00026255898,0.7469015,0.00019972968,0.000101520076,0.21826565,0.00038692515,0.00022813673,0.0018513518,0.0018447672,0.00086845126,0.02855736],"study_design_scores_gemma":[0.000088786815,0.00035853262,0.2653365,0.00012635987,0.00018213183,0.7267499,0.0013612044,0.00074611465,0.0006377014,0.0025809046,0.0017836082,0.000048328933],"about_ca_topic_score_codex":0.0010572909,"about_ca_topic_score_gemma":0.0014008498,"teacher_disagreement_score":0.010942136,"about_ca_system_score_codex":0.00033256656,"about_ca_system_score_gemma":0.0004989716,"threshold_uncertainty_score":0.03660506},"labels":[],"label_agreement":null},{"id":"W2035770770","doi":"10.1016/j.jaad.2006.06.011","title":"Topical imiquimod in the treatment of infantile hemangiomas: A retrospective study","year":2006,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Vascular Malformations and Hemangiomas","field":"Medicine","cited_by":106,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Imiquimod; Retrospective cohort study; Hemangioma; Surgery; Dermatology","score_opus":0.013090790316883167,"score_gpt":0.3091578133568312,"score_spread":0.29606702303994803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035770770","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975318,0.0016253684,0.00014665561,0.000016047057,0.0000056982076,0.000026621892,0.00007219533,0.0000022113334,0.00057344855],"genre_scores_gemma":[0.999076,0.0005807981,0.00008065162,0.000026020627,0.000016801972,0.00001624585,0.00008731022,0.0000020329255,0.000114071154],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995758,0.000105581865,0.000075081545,0.0000864325,0.00008707451,0.000070029215],"domain_scores_gemma":[0.9990625,0.0002640075,0.00040510885,0.00008423071,0.000102527396,0.00008173136],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035163382,0.00027281267,0.00060193316,0.00056108285,0.00040509365,0.0003918611,0.00021344221,0.00049845176,0.0009627596],"category_scores_gemma":[0.0012917393,0.00023693258,0.000514989,0.0008149345,0.00037069144,0.00029226815,0.00015593268,0.00039502687,0.00020571022],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033045686,0.0006951058,0.96434736,0.0001754905,0.0003405169,0.009127992,0.00038510517,0.00018087891,0.0056190067,0.00010182759,0.00019503696,0.015527091],"study_design_scores_gemma":[0.00019925885,0.0080983825,0.9506758,0.00006159914,0.0008917685,0.03254006,0.0011235189,0.00051225227,0.0027316536,0.00006237644,0.0030645968,0.00003864349],"about_ca_topic_score_codex":0.0011127377,"about_ca_topic_score_gemma":0.00087783416,"teacher_disagreement_score":0.0011127377,"about_ca_system_score_codex":0.00035915154,"about_ca_system_score_gemma":0.00033777521,"threshold_uncertainty_score":0.003220737},"labels":[],"label_agreement":null},{"id":"W2036488279","doi":"10.1016/j.jaad.2004.09.029","title":"Extended efalizumab therapy improves chronic plaque psoriasis: Results from a randomized phase III trial","year":2005,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":213,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Efalizumab; Medicine; Psoriasis; Psoriasis Area and Severity Index; Placebo; Randomized controlled trial; Dermatology; Plaque psoriasis; Internal medicine; Pathology","score_opus":0.01780253160628653,"score_gpt":0.29822210374410896,"score_spread":0.2804195721378224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036488279","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97942585,0.012719944,0.0008606408,0.0011617803,0.0004966132,0.0014818576,0.0014460065,0.00014091749,0.002266503],"genre_scores_gemma":[0.98420113,0.0056602703,0.0016880992,0.0017347346,0.000535003,0.0018226231,0.0018817647,0.00003475319,0.0024415713],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99909925,0.0004041174,0.00005293741,0.00016303273,0.00007377328,0.00020699936],"domain_scores_gemma":[0.99858,0.00043289587,0.000290724,0.0001967591,0.000083791696,0.00041584403],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025551843,0.0019302497,0.0046398067,0.0003852794,0.0006061026,0.001321084,0.0010689574,0.0017776468,0.0059666065],"category_scores_gemma":[0.0019493502,0.00069921324,0.0027549851,0.00060009153,0.0013871758,0.0015844075,0.00048927753,0.0038673314,0.0009304668],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9739397,0.0032431865,0.0007411203,0.00052201975,0.0026358059,0.000047712092,0.00004657654,0.00031968005,0.0017802118,0.00007378273,0.000769218,0.01588098],"study_design_scores_gemma":[0.97295195,0.021770062,0.0032610695,0.000034451015,0.0009904917,0.000041404626,0.000018886441,0.000141904,0.00017333048,0.000120531855,0.00048250786,0.0000134657475],"about_ca_topic_score_codex":0.0010621895,"about_ca_topic_score_gemma":0.002034208,"teacher_disagreement_score":0.0059666065,"about_ca_system_score_codex":0.0008432841,"about_ca_system_score_gemma":0.00079568144,"threshold_uncertainty_score":0.019960284},"labels":[],"label_agreement":null},{"id":"W2036509682","doi":"10.1016/j.jaad.2004.11.054","title":"Surgical Pearl: Use of needle-free anesthesia in the treatment of palmar hyperhidrosis with botulinum A toxin","year":2005,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Sympathectomy and Hyperhidrosis Treatments","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Lidocaine; Hyperhidrosis; Anesthesia; Botulinum toxin; Local anesthetic; Palmar hyperhidrosis; Surgery","score_opus":0.02965959614967915,"score_gpt":0.29630940247515475,"score_spread":0.2666498063254756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036509682","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92109436,0.018020678,0.017039392,0.006927481,0.00087820494,0.00027700994,0.00022033362,0.0008536511,0.0346889],"genre_scores_gemma":[0.98396367,0.0031860827,0.005980039,0.0022510244,0.0005310118,0.000046538134,0.00009840038,0.000050483915,0.0038927535],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.9998419,0.00002860857,0.000023712973,0.000019742689,0.000060284685,0.000025692878],"domain_scores_gemma":[0.999778,0.00007019512,0.000057013774,0.000018717707,0.000018274088,0.000057897418],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003261502,0.0003646869,0.00036157886,0.00045483286,0.00055403163,0.00044527507,0.0005144363,0.0009278971,0.0020301957],"category_scores_gemma":[0.0010164576,0.00009564949,0.00040182486,0.0002699909,0.00037691515,0.000593932,0.0003109889,0.0011899377,0.00053398364],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009478229,0.00226501,0.018907463,0.0012040004,0.00034305733,0.14307988,0.00049375993,0.0011938496,0.08645093,0.0029218944,0.0121503975,0.72151154],"study_design_scores_gemma":[0.003898159,0.028410494,0.14953579,0.00049810804,0.00052778795,0.66407955,0.00051012245,0.009991952,0.078325875,0.0033452446,0.060682707,0.00019420584],"about_ca_topic_score_codex":0.00046900153,"about_ca_topic_score_gemma":0.001072857,"teacher_disagreement_score":0.0020301957,"about_ca_system_score_codex":0.00023143296,"about_ca_system_score_gemma":0.00047181212,"threshold_uncertainty_score":0.0067916512},"labels":[],"label_agreement":null},{"id":"W2036905374","doi":"10.1016/j.jaad.2009.01.020","title":"Incidence and anatomic presentation of cutaneous malignant melanoma in central Canada during a 50-year period: 1956 to 2005","year":2009,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"CancerCare Manitoba; University of Alberta; University of Manitoba","funders":"","keywords":"Medicine; Incidence (geometry); Population; Trunk; Demography; Epidemiology; Melanoma; Surgery; Internal medicine","score_opus":0.005933242089275164,"score_gpt":0.2577599056091233,"score_spread":0.25182666351984817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036905374","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9843286,0.002326932,0.00008312442,0.00022686335,0.000026816942,0.00003171304,0.008798709,0.000025982354,0.004151219],"genre_scores_gemma":[0.9954717,0.0010686518,0.00008028483,0.000075095566,0.0000093155795,0.000006026814,0.002047472,0.0000035974676,0.0012377943],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99962616,0.000013903993,0.00003420266,0.000049527756,0.00012338966,0.0001528692],"domain_scores_gemma":[0.9989662,0.000031514453,0.00022943012,0.00001716828,0.000481234,0.00027434534],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019566088,0.0002790039,0.00024497558,0.0024370237,0.001220414,0.0010233184,0.00084574736,0.00050663715,0.001735397],"category_scores_gemma":[0.0008849638,0.00022786834,0.0004214186,0.0041997624,0.00043590326,0.00037190467,0.00055643165,0.0004896568,0.00023540996],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005280201,0.000018618728,0.99618655,0.00002520349,0.000031634845,0.00020004177,0.00019852478,0.00008100491,0.00013693189,0.000036900085,0.0008038119,0.0022279304],"study_design_scores_gemma":[0.0000021644753,0.000014877749,0.9981256,0.000019020004,0.000015082724,0.00024620228,0.0005388844,0.000108397675,0.000046356978,0.0000065648305,0.00087190693,0.0000048772463],"about_ca_topic_score_codex":0.9808359,"about_ca_topic_score_gemma":0.98705935,"teacher_disagreement_score":0.019164085,"about_ca_system_score_codex":0.012427753,"about_ca_system_score_gemma":0.011811639,"threshold_uncertainty_score":0.090170026},"labels":[],"label_agreement":null},{"id":"W2036918038","doi":"10.1016/s0190-9622(03)00853-3","title":"Ultraviolet autorepigmentation in scleroderma","year":2003,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Medicine; Dermatology; Scleroderma (fungus); Immunology","score_opus":0.02365797690649265,"score_gpt":0.30722032554836814,"score_spread":0.2835623486418755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036918038","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.048908893,0.0359374,0.00095295394,0.80162907,0.033357542,0.00007169252,0.00006348625,0.0001624698,0.07891655],"genre_scores_gemma":[0.4217632,0.018627262,0.0011035288,0.37612668,0.13809413,0.00010655989,0.000067497705,0.000067547546,0.044043597],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9993174,0.0002579908,0.00008696248,0.00004633414,0.00016015377,0.00013117437],"domain_scores_gemma":[0.9984107,0.001072492,0.00012428014,0.000063612984,0.00014642047,0.00018256747],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00090952776,0.00046837737,0.0009370548,0.0005965215,0.0019313653,0.0012035766,0.0007466321,0.01647726,0.0025934735],"category_scores_gemma":[0.005444643,0.00029339184,0.0007595754,0.00042921604,0.0011646725,0.0012591651,0.00053295546,0.0068329936,0.0011955537],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00078712887,0.00030250102,0.013124498,0.00044888517,0.000087000066,0.52094495,0.00075755984,0.0005133428,0.0018961233,0.008710725,0.40038875,0.05203853],"study_design_scores_gemma":[0.00087273953,0.00050555565,0.02103338,0.0008358754,0.00020149648,0.5434586,0.0011930391,0.0029933848,0.0014127308,0.016774414,0.4106468,0.00007203446],"about_ca_topic_score_codex":0.0019597588,"about_ca_topic_score_gemma":0.0043073315,"teacher_disagreement_score":0.01647726,"about_ca_system_score_codex":0.0021267787,"about_ca_system_score_gemma":0.0006899248,"threshold_uncertainty_score":0.015430987},"labels":[],"label_agreement":null},{"id":"W2037227811","doi":"10.1016/j.jaad.2007.05.044","title":"In vivo reflectance confocal microscopy imaging of melanocytic skin lesions: Consensus terminology glossary and illustrative images","year":2007,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":192,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Dalhousie University","funders":"","keywords":"Terminology; Glossary; Medicine; Lesion; Pathology; Confocal; Confocal microscopy; Standardization; Dermatology; Computer science; Biology; Optics; Linguistics","score_opus":0.01508693092603388,"score_gpt":0.3350459241154863,"score_spread":0.3199589931894524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037227811","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.035903867,0.18601243,0.43359387,0.10912532,0.033447698,0.0049663964,0.006375647,0.006538333,0.18403643],"genre_scores_gemma":[0.23432854,0.15358393,0.48362085,0.045685925,0.017397588,0.0044913352,0.009404261,0.0020355212,0.04945205],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99782276,0.00053874945,0.0006860273,0.00020062177,0.00060431653,0.00014769168],"domain_scores_gemma":[0.9963877,0.0010796104,0.00038550518,0.00046126742,0.001517506,0.00016835614],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0039240443,0.0010706104,0.0013739086,0.0045403405,0.0011870792,0.0017155184,0.003053469,0.004327245,0.008565726],"category_scores_gemma":[0.0076379506,0.0005457618,0.0011931339,0.0021451705,0.0016823378,0.0019830056,0.0015173062,0.0037068268,0.0052693505],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009021656,0.00018620986,0.0016711575,0.0066136387,0.00013028797,0.006494781,0.0005308208,0.0007612556,0.054523736,0.012931229,0.42012426,0.49513045],"study_design_scores_gemma":[0.00019658526,0.00046404699,0.0126465615,0.006184535,0.00035623994,0.07484338,0.0009488223,0.0026876477,0.031081589,0.01410949,0.8561901,0.00029108083],"about_ca_topic_score_codex":0.0016484658,"about_ca_topic_score_gemma":0.0021976451,"teacher_disagreement_score":0.008565726,"about_ca_system_score_codex":0.00085389684,"about_ca_system_score_gemma":0.0011449591,"threshold_uncertainty_score":0.028655171},"labels":[],"label_agreement":null},{"id":"W2037946873","doi":"10.1016/j.jaad.2014.06.021","title":"Painful localized scalp swelling in a returning traveler","year":2014,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Forensic Entomology and Diptera Studies","field":"Agricultural and Biological Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Scalp; Medicine; Rhipicephalus sanguineus; Forehead; Myiasis; Dermatology; Surgery; Tick; Anatomy; Veterinary medicine; Ixodidae; Biology; Larva","score_opus":0.014645103210608927,"score_gpt":0.25428049093254973,"score_spread":0.2396353877219408,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037946873","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96924925,0.0033866835,0.00092407526,0.0069421944,0.0006743557,0.00023961798,0.00035441486,0.00025315146,0.017976237],"genre_scores_gemma":[0.99458575,0.0008850373,0.00033984813,0.0013682211,0.0004902567,0.0000141880355,0.00007519578,0.000015891816,0.0022255129],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99948895,0.00006536803,0.000046819416,0.00011424669,0.00007219012,0.00021240594],"domain_scores_gemma":[0.9989812,0.00024130827,0.00020138713,0.00008634335,0.00009351787,0.0003962427],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037778987,0.0017127816,0.00093724893,0.0020190736,0.0027259714,0.0014093885,0.0019662702,0.006959362,0.005357914],"category_scores_gemma":[0.0028457649,0.0010479235,0.0012111294,0.00117763,0.0015744338,0.0018218264,0.0010845202,0.0039135967,0.0014709445],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003510802,0.00009682889,0.005347538,0.000024676923,0.0000063611733,0.9930397,0.00022387819,0.000032673284,0.00023255928,0.00004527787,0.0003465964,0.0005687885],"study_design_scores_gemma":[0.000030776584,0.00037142079,0.026020773,0.000050335704,0.00002440265,0.97026944,0.0016053759,0.00031197225,0.00022635618,0.00015599573,0.00090959884,0.000023520992],"about_ca_topic_score_codex":0.007256791,"about_ca_topic_score_gemma":0.008881637,"teacher_disagreement_score":0.007256791,"about_ca_system_score_codex":0.0021697269,"about_ca_system_score_gemma":0.0008443,"threshold_uncertainty_score":0.01792401},"labels":[],"label_agreement":null},{"id":"W2039494835","doi":"10.1016/j.jaad.2003.10.462","title":"Surprising case of generalized alopecia in an infant","year":2004,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Children's Hospital","funders":"","keywords":"Scalp; Medicine; Dermatology; Dermatophyte; Trichosporon; Trichophyton; Population; Biology; Antifungal","score_opus":0.02065729913390839,"score_gpt":0.3540848762227833,"score_spread":0.3334275770888749,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039494835","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9717933,0.0036632793,0.0026138725,0.0047733285,0.00063452625,0.00013918434,0.00033550037,0.0004691276,0.015577909],"genre_scores_gemma":[0.9945998,0.0009197666,0.0010720348,0.00087828503,0.00072912616,0.00001948553,0.0000738222,0.00005041328,0.0016571705],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99947363,0.00007797533,0.000043940126,0.0001398963,0.000078943856,0.00018558875],"domain_scores_gemma":[0.99804604,0.0007219816,0.00032256023,0.00025322218,0.00012629578,0.00052990427],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030899988,0.0019146522,0.0014592508,0.0013644821,0.0014530096,0.0012117358,0.001070979,0.0044475663,0.0018132292],"category_scores_gemma":[0.004436873,0.0009262357,0.001023139,0.00060969853,0.0014815694,0.0010874579,0.0010631583,0.0029331201,0.0005497985],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019508465,0.000014184863,0.0013065703,0.000010119827,0.000002159484,0.99746525,0.000034702956,0.000021547125,0.0004661315,0.000068399146,0.0001177792,0.00047362735],"study_design_scores_gemma":[0.000012321662,0.000074899086,0.0044851275,0.0000068055247,0.0000096635285,0.9945427,0.00004969325,0.00015117657,0.00031912464,0.000108350985,0.00023433876,0.000005689158],"about_ca_topic_score_codex":0.0013918703,"about_ca_topic_score_gemma":0.0014119329,"teacher_disagreement_score":0.0044475663,"about_ca_system_score_codex":0.0009812036,"about_ca_system_score_gemma":0.00038530544,"threshold_uncertainty_score":0.007119119},"labels":[],"label_agreement":null},{"id":"W2040896168","doi":"10.1016/s0190-9622(03)02141-8","title":"Restoration of hair growth with topical diphencyprone in mouse and rat models of alopecia areata","year":2003,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Hospital and Health Sciences Centre; University of British Columbia","funders":"National Cancer Institute","keywords":"Alopecia areata; Medicine; Hair growth; Dermatology; Cabello; Hair disease; Hair loss; Physiology; Scalp","score_opus":0.015477731958028382,"score_gpt":0.26893460362687394,"score_spread":0.25345687166884556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040896168","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99331784,0.001871132,0.001885972,0.00027696055,0.00012950882,0.00013376815,0.0003813896,0.0002434363,0.0017599883],"genre_scores_gemma":[0.9937714,0.0015247868,0.0011697137,0.00005364921,0.000032644548,0.000119906326,0.00019115821,0.00002502622,0.0031117164],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99948907,0.00011141398,0.000040502102,0.000074580064,0.00012526229,0.00015918184],"domain_scores_gemma":[0.99939215,0.00009466204,0.00015757873,0.00013731317,0.000042812877,0.00017544559],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005284517,0.0011921432,0.0004893267,0.0020893337,0.00048255452,0.0004870338,0.00058293866,0.0010325881,0.0018267679],"category_scores_gemma":[0.00036336313,0.0004910914,0.0009879062,0.00044467888,0.0009456375,0.00088610675,0.0002962106,0.0025903743,0.000493873],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019680469,0.0011081862,0.00034095708,0.00010451396,0.000021852082,0.00044888948,0.000072006216,0.00022902894,0.9914596,0.00042787526,0.00016016176,0.0036589003],"study_design_scores_gemma":[0.00043525343,0.010976054,0.004971257,0.000032212283,0.00009710862,0.0010422185,0.00018755934,0.0014507576,0.97927696,0.00024643916,0.0012626116,0.000021515241],"about_ca_topic_score_codex":0.0017026748,"about_ca_topic_score_gemma":0.0022699968,"teacher_disagreement_score":0.0020893337,"about_ca_system_score_codex":0.00040572963,"about_ca_system_score_gemma":0.0006390775,"threshold_uncertainty_score":0.006111145},"labels":[],"label_agreement":null},{"id":"W2042638001","doi":"10.1016/j.jaad.2010.02.060","title":"Patient-reported outcomes in pediatric patients with psoriasis undergoing etanercept treatment: 12-week results from a phase III randomized controlled trial","year":2010,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":79,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Etanercept; Randomized controlled trial; Psoriasis; Dermatology; Physical therapy; Surgery; Internal medicine; Tumor necrosis factor alpha","score_opus":0.012531557788304871,"score_gpt":0.26473916223222793,"score_spread":0.25220760444392304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042638001","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9884608,0.008374448,0.00044302706,0.00039786665,0.00018822089,0.0007614064,0.0006698699,0.000043788485,0.00066052435],"genre_scores_gemma":[0.98970336,0.0050039454,0.001126066,0.0006804761,0.000309599,0.0017804627,0.0007528173,0.000016997752,0.00062619505],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9986129,0.0007598197,0.00012295734,0.00023095476,0.00012896316,0.00014447611],"domain_scores_gemma":[0.9974336,0.0009767078,0.00091135973,0.00017762666,0.00012196429,0.00037874174],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021637175,0.0011998374,0.004174718,0.00028268178,0.0004140676,0.001025501,0.0009719835,0.0020155495,0.0028963732],"category_scores_gemma":[0.0028654332,0.0006010239,0.0032880534,0.0005291006,0.0009709459,0.0009883444,0.00037007756,0.0032028744,0.00033501396],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9602296,0.0053491853,0.004901952,0.001276544,0.0044803433,0.00010110484,0.00006894534,0.00047899695,0.0017165658,0.00008820741,0.0006649095,0.020643672],"study_design_scores_gemma":[0.9328294,0.051792916,0.011342321,0.000102380036,0.0026251266,0.00009547393,0.000041614196,0.0003197978,0.0003672074,0.00008134775,0.0003824709,0.000020056368],"about_ca_topic_score_codex":0.0008972184,"about_ca_topic_score_gemma":0.001386048,"teacher_disagreement_score":0.004174718,"about_ca_system_score_codex":0.0007026648,"about_ca_system_score_gemma":0.0009219161,"threshold_uncertainty_score":0.011443019},"labels":[],"label_agreement":null},{"id":"W2042922586","doi":"10.1016/j.jaad.2003.10.631","title":"Dry skin improvement by an oleosome emulsion as a carrier for sphingolipid","year":2004,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Advancements in Transdermal Drug Delivery","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Emulsion; Sphingolipid; Medicine; Dry skin; Transepidermal water loss; Dryness; Penetration (warfare); Dermatology; Chromatography; Surgery; Biochemistry; Chemistry; Pathology; Stratum corneum","score_opus":0.0403866174318624,"score_gpt":0.4277098975800991,"score_spread":0.3873232801482367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042922586","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929898,0.0018065069,0.0033116657,0.00012851783,0.00009176964,0.000041639836,0.000027937916,0.00007776238,0.0015245768],"genre_scores_gemma":[0.99526334,0.0007842346,0.0011696441,0.000047087568,0.000024571353,0.000010970391,0.000024429546,0.000018803843,0.0026569043],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999603,0.000006385098,0.0000024589856,0.000008524054,0.000008697316,0.000013535995],"domain_scores_gemma":[0.99997056,0.000007405944,0.0000055074474,0.0000029012053,0.0000045334186,0.000009143856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010988316,0.00025181935,0.00017744524,0.000194328,0.00015017955,0.00012792497,0.0001492966,0.00024388585,0.0018151115],"category_scores_gemma":[0.00010024547,0.00009467128,0.00024206753,0.00006865372,0.00014940454,0.00028530814,0.00015951217,0.00043737362,0.00015586802],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014239078,0.00025624732,0.000101668535,0.000055862023,0.000009432571,0.00028289054,0.000014395908,0.000069931026,0.9912492,0.00007364722,0.00008300587,0.0063797347],"study_design_scores_gemma":[0.00022510643,0.002151793,0.0015369396,0.000004375503,0.000057914745,0.0006419795,0.000015560809,0.0012526293,0.9927328,0.0000428802,0.001332524,0.0000055164514],"about_ca_topic_score_codex":0.00048002994,"about_ca_topic_score_gemma":0.00040528525,"teacher_disagreement_score":0.0018151115,"about_ca_system_score_codex":0.000072887415,"about_ca_system_score_gemma":0.00012719323,"threshold_uncertainty_score":0.0060721636},"labels":[],"label_agreement":null},{"id":"W2043066718","doi":"10.1016/j.jaad.2004.09.003","title":"An American dermatologist goes to Canada: Lessons from a single-payer healthcare system","year":2004,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Medicine and Dermatology Studies History","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Surprise; Medicine; Healthcare system; Health care; Family medicine; Private practice; Political science; Law; Psychology","score_opus":0.030443590589991205,"score_gpt":0.3329201879894707,"score_spread":0.3024765973994795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043066718","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012198068,0.002471883,0.00019797293,0.9667203,0.0016860428,0.000018789364,0.000084503736,0.0000240244,0.016598448],"genre_scores_gemma":[0.31016028,0.007880169,0.0012715606,0.66338,0.0032358936,0.00004882452,0.00013884348,0.00013840628,0.013746053],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9826072,0.0029150287,0.0005791935,0.0010456829,0.0050399997,0.007812806],"domain_scores_gemma":[0.902313,0.011607321,0.0027278233,0.0012256934,0.024100028,0.05802612],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011409762,0.00052167557,0.0009241729,0.0017116341,0.037159383,0.017769244,0.006806513,0.02714725,0.01784252],"category_scores_gemma":[0.049636777,0.0008037201,0.0015832696,0.0031521716,0.017329913,0.008392508,0.0079231495,0.034336697,0.0013387034],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019083495,0.0005016164,0.0456786,0.00021390953,0.00019663523,0.0042845337,0.016941499,0.00086419436,0.0002697057,0.060608815,0.7939073,0.07634226],"study_design_scores_gemma":[0.0004239198,0.00026944414,0.075153194,0.004099816,0.00049242546,0.0028005152,0.16706948,0.0020244806,0.00041887193,0.09897587,0.64766157,0.0006103612],"about_ca_topic_score_codex":0.9709182,"about_ca_topic_score_gemma":0.9918711,"teacher_disagreement_score":0.88887894,"about_ca_system_score_codex":0.11112105,"about_ca_system_score_gemma":0.37846214,"threshold_uncertainty_score":0.8062434},"labels":[],"label_agreement":null},{"id":"W2043442618","doi":"10.1016/j.jaad.2006.08.017","title":"High-potency steroid use in children with vitiligo: A retrospective study","year":2006,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"melanin and skin pigmentation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":82,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; SickKids Foundation; Hospital for Sick Children; University of Ottawa","funders":"","keywords":"Medicine; Potency; Vitiligo; Retrospective cohort study; Family history; Corticosteroid; Confidence interval; Dermatology; Pediatrics; Internal medicine","score_opus":0.005640349645382637,"score_gpt":0.2499058576638149,"score_spread":0.24426550801843228,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043442618","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991584,0.00025394937,0.000038236663,0.00001500998,0.0000030482875,0.0000056749996,0.00011545085,0.0000025992451,0.00040759082],"genre_scores_gemma":[0.9996147,0.00015433993,0.000028667471,0.000016258624,0.000005469592,0.000004045868,0.00011449538,0.0000017161535,0.00006031365],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99934846,0.00013377222,0.00010576179,0.00013551544,0.00012480933,0.00015163829],"domain_scores_gemma":[0.9979365,0.00051030616,0.00083635264,0.00017445745,0.00017700698,0.00036548276],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035114505,0.00037294813,0.00070486194,0.0014143182,0.00077729754,0.00083665736,0.0003786863,0.000656594,0.002266868],"category_scores_gemma":[0.0017386175,0.0004611832,0.00073089503,0.0019158236,0.0006623423,0.00059589045,0.00047761886,0.0007578925,0.00039690573],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007898287,0.000047184378,0.9973591,0.000008072049,0.000023070164,0.0015523712,0.000114023904,0.000013603506,0.000253953,0.000015132092,0.000026543416,0.000508048],"study_design_scores_gemma":[0.000014725887,0.0004089625,0.9848557,0.000012608205,0.00006963573,0.012869535,0.0010697776,0.00008651955,0.0002396866,0.000019977246,0.00034416525,0.00000881242],"about_ca_topic_score_codex":0.0049423473,"about_ca_topic_score_gemma":0.003393408,"teacher_disagreement_score":0.0049423473,"about_ca_system_score_codex":0.00045435748,"about_ca_system_score_gemma":0.00061502267,"threshold_uncertainty_score":0.009827197},"labels":[],"label_agreement":null},{"id":"W2044529237","doi":"10.1067/mjd.2000.104889","title":"Unplanned incomplete Mohs micrographic surgery","year":2000,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Canthus; Mohs surgery; Surgery; Nose; Eyelid; Basal cell; Basal cell carcinoma; Dermatofibrosarcoma protuberans; Retrospective cohort study; Scalp; Dermatology; Pathology","score_opus":0.020444235423305212,"score_gpt":0.3019363485570903,"score_spread":0.2814921131337851,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044529237","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9844593,0.002389406,0.00026309237,0.00047774884,0.00010751707,0.00010560677,0.00050761446,0.000009980523,0.011679848],"genre_scores_gemma":[0.9962075,0.00090017816,0.0001493768,0.00020321502,0.000089661,0.000034511962,0.00026419546,0.0000032627481,0.0021481162],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9990427,0.00019449514,0.00009612335,0.00009612032,0.00021398159,0.0003565358],"domain_scores_gemma":[0.9947072,0.002333399,0.0012100049,0.0004924347,0.00031475088,0.00094226876],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009985955,0.00017412278,0.0002508357,0.00056312943,0.0011258514,0.00044806785,0.00035013922,0.00029161767,0.0057640765],"category_scores_gemma":[0.0043487754,0.0001296134,0.00034644792,0.0004252041,0.0005706936,0.0008220365,0.0005315332,0.00080750545,0.00019520936],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040555275,0.0017799825,0.8480723,0.0006920661,0.00019908791,0.0030474295,0.001986251,0.00130305,0.0027833057,0.0035894192,0.003017423,0.12947413],"study_design_scores_gemma":[0.00012333348,0.009298302,0.95806134,0.00025644572,0.00010970679,0.007254361,0.0034577842,0.00040527634,0.0018326695,0.0010945874,0.018077796,0.000028329987],"about_ca_topic_score_codex":0.007896286,"about_ca_topic_score_gemma":0.014082099,"teacher_disagreement_score":0.007896286,"about_ca_system_score_codex":0.0008534884,"about_ca_system_score_gemma":0.0026968662,"threshold_uncertainty_score":0.019282699},"labels":[],"label_agreement":null},{"id":"W2046376333","doi":"10.1016/s0190-9622(03)00451-1","title":"Hiccups, eructation, and other uncommon prodromal manifestations of herpes zoster","year":2003,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Facial Nerve Paralysis Treatment and Research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McMaster University Medical Centre","funders":"","keywords":"Medicine; Hiccups; Herpes Zoster Ophthalmicus; Presentation (obstetrics); Dermatology; Disease; Pediatrics; Genital herpes; Shingles; Surgery; Internal medicine; Immunology; Virus","score_opus":0.027099988651262733,"score_gpt":0.35432628692388995,"score_spread":0.3272262982726272,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046376333","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9768559,0.0038735704,0.0007832233,0.0003256819,0.00006144944,0.00007860641,0.00019829425,0.00011402208,0.017709129],"genre_scores_gemma":[0.9979462,0.0005753269,0.00023678296,0.00013703959,0.00008004014,0.000010529272,0.00008344857,0.000009463959,0.0009211189],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9996877,0.000036805355,0.0000277725,0.000047695583,0.000050269646,0.00014979148],"domain_scores_gemma":[0.99912435,0.00027402735,0.00026413694,0.00012080368,0.00006076754,0.00015585551],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033895456,0.000990356,0.00046660073,0.0011673983,0.0006886491,0.00052413525,0.00049954746,0.001175116,0.002593128],"category_scores_gemma":[0.0025904262,0.00042872984,0.00031763504,0.0006499769,0.0007173428,0.0010284994,0.00042656172,0.0007648898,0.0006219338],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000991965,0.00034111124,0.20983152,0.00025404157,0.000047535097,0.7476411,0.0005383071,0.00030177177,0.017336536,0.001341481,0.0018334832,0.019541137],"study_design_scores_gemma":[0.00006292733,0.00035742504,0.1645465,0.000027514385,0.000035741767,0.830028,0.00028638335,0.00026651524,0.0026714252,0.00040980548,0.0012917528,0.000016009728],"about_ca_topic_score_codex":0.0018332091,"about_ca_topic_score_gemma":0.0020653787,"teacher_disagreement_score":0.002593128,"about_ca_system_score_codex":0.00029137783,"about_ca_system_score_gemma":0.00031441098,"threshold_uncertainty_score":0.00867486},"labels":[],"label_agreement":null},{"id":"W2046435849","doi":"10.1016/j.jaad.2013.03.025","title":"HIV-associated facial lipoatrophy treated with injectable silicone oil: A pilot study","year":2013,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Facial Rejuvenation and Surgery Techniques","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health; Quest University Canada; University of British Columbia","funders":"","keywords":"Medicine; Lipoatrophy; Adverse effect; Silicone; Lipodystrophy; Patient satisfaction; Surgery; Human immunodeficiency virus (HIV); Population; Internal medicine; Viral load; Antiretroviral therapy","score_opus":0.018377855474429654,"score_gpt":0.28546021937853416,"score_spread":0.2670823639041045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046435849","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989755,0.000120083794,0.00007201843,0.000026489983,0.000012205285,0.0002195501,0.000032726082,0.0000030304384,0.00053834147],"genre_scores_gemma":[0.99910384,0.0002162553,0.00013810224,0.00009035942,0.0000469574,0.00008504501,0.00006072447,0.0000015195521,0.00025729442],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99947566,0.00019974294,0.00003882428,0.00007348643,0.00006596032,0.0001462615],"domain_scores_gemma":[0.99924254,0.00035676514,0.00006853593,0.00007568603,0.00005528069,0.0002012618],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009638687,0.0011251298,0.0010735737,0.000551565,0.001321836,0.0005761758,0.0005601776,0.00128858,0.0027421112],"category_scores_gemma":[0.0012505715,0.00042826906,0.0013430543,0.00037520798,0.001158537,0.0008578067,0.00042926925,0.0011922495,0.0004243024],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.120647565,0.28310147,0.28473365,0.0008815191,0.0011642823,0.15734841,0.0060404646,0.0008270526,0.08535278,0.00090315857,0.00071292405,0.0582867],"study_design_scores_gemma":[0.017497398,0.65090823,0.2844566,0.00009252407,0.0008025636,0.031890627,0.004496111,0.0018102297,0.006119217,0.00031416197,0.001486136,0.00012621048],"about_ca_topic_score_codex":0.001822666,"about_ca_topic_score_gemma":0.0016605004,"teacher_disagreement_score":0.0027421112,"about_ca_system_score_codex":0.0005823081,"about_ca_system_score_gemma":0.0007172313,"threshold_uncertainty_score":0.009173274},"labels":[],"label_agreement":null},{"id":"W2047131982","doi":"10.1016/j.jaad.2004.06.048","title":"Involvement of three mucous membranes in herpes-induced recurrent erythema multiforme","year":2004,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Erythema multiforme; Dermatology; Mucous membrane; Erythema; Pathology","score_opus":0.04185528691411816,"score_gpt":0.31926368357626284,"score_spread":0.2774083966621447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047131982","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9015325,0.007879147,0.0020551896,0.020842286,0.0014339124,0.00022403672,0.00011671323,0.0002827076,0.06563364],"genre_scores_gemma":[0.9937069,0.0008112482,0.00034715986,0.0025430848,0.0006227119,0.000018045248,0.000023018543,0.000011468311,0.0019163179],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9991242,0.00018910022,0.00009101475,0.00009259617,0.0001491753,0.00035394132],"domain_scores_gemma":[0.9988734,0.00052025786,0.00016048219,0.00014186915,0.00010894408,0.00019502324],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000759966,0.0009661438,0.00085537357,0.0007658007,0.001410607,0.0011008417,0.00095630216,0.0069609173,0.002289259],"category_scores_gemma":[0.0047801426,0.00047192888,0.0011292476,0.00038066087,0.0009684441,0.0012913566,0.0006757044,0.0027283304,0.0006887856],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018068914,0.00006645242,0.008846056,0.000058728798,0.000018643223,0.9838696,0.00023224014,0.000083061816,0.001340714,0.0004931824,0.001207216,0.003603404],"study_design_scores_gemma":[0.000120173674,0.00025566827,0.015549279,0.000044408363,0.00005399735,0.9769438,0.00029445963,0.0007759044,0.0011240703,0.00044899862,0.0043729767,0.000016268454],"about_ca_topic_score_codex":0.0021610383,"about_ca_topic_score_gemma":0.0027680814,"teacher_disagreement_score":0.0069609173,"about_ca_system_score_codex":0.0016539769,"about_ca_system_score_gemma":0.00047453665,"threshold_uncertainty_score":0.012000561},"labels":[],"label_agreement":null},{"id":"W2047535890","doi":"10.1067/mjd.2002.126273","title":"Anti-CD20 chimeric monoclonal antibody (rituximab) for the treatment of recalcitrant, life-threatening pemphigus vulgaris with implications in the pathogenesis of the disorder","year":2002,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Autoimmune Bullous Skin Diseases","field":"Medicine","cited_by":124,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Rituximab; Pemphigus vulgaris; Medicine; CD20; Monoclonal antibody; Monoclonal; Immunology; Pemphigus; Refractory (planetary science); Pathogenesis; Antibody; Immunotherapy; Dermatology; Immune system","score_opus":0.02792631682258817,"score_gpt":0.3170234333169194,"score_spread":0.28909711649433123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047535890","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.77777505,0.1855009,0.003462733,0.0068354732,0.0016483162,0.00016429104,0.000060778704,0.00028019916,0.024272298],"genre_scores_gemma":[0.97940433,0.015246262,0.0012430383,0.00087758776,0.00070620136,0.00003160884,0.000052901847,0.000010093932,0.0024278879],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.9998958,0.000030198566,0.0000070766314,0.000007830809,0.000026272648,0.000032854343],"domain_scores_gemma":[0.99991715,0.000032883636,0.000010381157,0.000005033749,0.000006572688,0.00002794681],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003884816,0.0003193077,0.00041053162,0.000364483,0.00047454363,0.0002827203,0.00037307953,0.0010430525,0.0015538039],"category_scores_gemma":[0.00049931987,0.000118258366,0.00032113178,0.00012542742,0.0002934506,0.0002661077,0.00015608933,0.0010465692,0.00026831677],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017537452,0.002440337,0.007641371,0.0013374584,0.0005596828,0.116697356,0.00028752538,0.0018927605,0.12490641,0.0061017447,0.024908993,0.69568884],"study_design_scores_gemma":[0.030782305,0.03542488,0.087173164,0.00059532764,0.0019153119,0.48211733,0.00034147655,0.01073305,0.111113906,0.005109881,0.23451097,0.00018244835],"about_ca_topic_score_codex":0.00043317064,"about_ca_topic_score_gemma":0.00080583786,"teacher_disagreement_score":0.0015538039,"about_ca_system_score_codex":0.00033491783,"about_ca_system_score_gemma":0.00027951962,"threshold_uncertainty_score":0.005198002},"labels":[],"label_agreement":null},{"id":"W2047932221","doi":"10.1016/j.jaad.2012.04.030","title":"Octreotide-responsive necrolytic migratory erythema in a patient with pseudoglucagonoma syndrome","year":2013,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Glucagonoma; Medicine; Scopus; Dermatology; Glucagon; MEDLINE; Pathology; Internal medicine; Gastroenterology; Insulin","score_opus":0.012595378366072977,"score_gpt":0.2888166202673922,"score_spread":0.2762212419013192,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047932221","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.78825015,0.009677285,0.0048151636,0.113835655,0.008121328,0.00041054358,0.00045166793,0.0007208762,0.07371727],"genre_scores_gemma":[0.9793834,0.001405893,0.0012657968,0.009420829,0.0046798526,0.000042330863,0.00007510266,0.00005129113,0.0036754606],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.999172,0.00018499987,0.000096226504,0.00016870488,0.0001411063,0.00023693254],"domain_scores_gemma":[0.9976814,0.0011495923,0.00026085568,0.00014397387,0.00015785072,0.00060638104],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068341737,0.0016342493,0.001174231,0.001277739,0.0019768472,0.0014249865,0.001398242,0.009254651,0.0017591823],"category_scores_gemma":[0.0061829844,0.00073890726,0.0016818125,0.0007147266,0.0015408545,0.001666576,0.0009087342,0.0056293975,0.0008878409],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000051911535,0.000023660587,0.001769051,0.000018452434,0.0000074447576,0.9956191,0.000047565612,0.00007350873,0.00030708397,0.00021927286,0.0011690587,0.00069390325],"study_design_scores_gemma":[0.00007129249,0.00012688152,0.004096165,0.000036453606,0.000035392684,0.9912636,0.00013859174,0.0012731012,0.00043921426,0.0005418638,0.0019621358,0.000015312797],"about_ca_topic_score_codex":0.002299374,"about_ca_topic_score_gemma":0.002753077,"teacher_disagreement_score":0.009254651,"about_ca_system_score_codex":0.002340385,"about_ca_system_score_gemma":0.00086579786,"threshold_uncertainty_score":0.016980827},"labels":[],"label_agreement":null},{"id":"W2049455218","doi":"10.1067/s0190-9622(03)00777-1","title":"The expression of insulin-like growth factor 1 in follicular dermal papillae correlates with therapeutic efficacy of finasteride in androgenetic alopecia","year":2003,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Hospital and Health Sciences Centre; University of British Columbia","funders":"","keywords":"Finasteride; Dihydrotestosterone; Medicine; Testosterone (patch); Internal medicine; Male-pattern baldness; Endocrinology; Insulin-like growth factor; Androgen; Hair follicle; Scalp; Biopsy; Hair loss; Follicular phase; Growth factor; Dermatology; Prostate; Receptor; Hormone","score_opus":0.01098906499689655,"score_gpt":0.2647455723084841,"score_spread":0.25375650731158755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049455218","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977464,0.0006118191,0.00016722463,0.000035959303,0.000008948547,0.000011579927,0.00005861203,0.000013747253,0.0013457075],"genre_scores_gemma":[0.99942964,0.00009699171,0.00006033493,0.0000144571595,0.0000071685827,0.0000036205686,0.00005021667,0.0000019851343,0.00033558733],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998419,0.000033652246,0.000010218245,0.000016154874,0.000045261295,0.000052638534],"domain_scores_gemma":[0.9996438,0.00012238968,0.000075300195,0.000022932303,0.000049223025,0.000086395194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016370742,0.000116728625,0.0002088586,0.00044681705,0.00019068112,0.00029640127,0.00012332683,0.0001923241,0.0010750634],"category_scores_gemma":[0.00076778024,0.00012489561,0.00018389116,0.00026947117,0.00023848623,0.00018346627,0.000089136585,0.0004383641,0.00013106754],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0061362823,0.00047108243,0.07994685,0.00006965979,0.00007493709,0.00079340505,0.00011803152,0.0002748755,0.8896371,0.00013461702,0.00021076218,0.022132307],"study_design_scores_gemma":[0.00012448161,0.002263752,0.8761568,0.000006715742,0.00010622577,0.0018813243,0.00019892331,0.0011586398,0.117140286,0.000121985584,0.0008284674,0.000012315455],"about_ca_topic_score_codex":0.0020726349,"about_ca_topic_score_gemma":0.001980763,"teacher_disagreement_score":0.0020726349,"about_ca_system_score_codex":0.00029680596,"about_ca_system_score_gemma":0.00015039837,"threshold_uncertainty_score":0.0041211247},"labels":[],"label_agreement":null},{"id":"W2050172669","doi":"10.1016/j.jaad.2004.04.012","title":"Evaluating psoriasis with Psoriasis Area and Severity Index, Psoriasis Global Assessment, and Lattice System Physician's Global Assessment","year":2004,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":608,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Psoriasis; Medicine; Psoriasis Area and Severity Index; Inter-rater reliability; Cronbach's alpha; Concordance; Severity of illness; Clinical trial; Physical therapy; Dermatology; Psychometrics; Internal medicine; Rating scale; Statistics; Clinical psychology","score_opus":0.024617126348465305,"score_gpt":0.3342530989070339,"score_spread":0.3096359725585686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050172669","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95962894,0.004062547,0.0061667906,0.000769726,0.00010908429,0.0007712437,0.0020970006,0.00021308534,0.026181461],"genre_scores_gemma":[0.9855117,0.001400898,0.009174881,0.00022477022,0.000074988,0.00021656921,0.0010146243,0.00002352266,0.0023580496],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99883825,0.00038298467,0.00015835845,0.00011168685,0.000416123,0.00009253454],"domain_scores_gemma":[0.998767,0.0002120518,0.00045418585,0.000048943937,0.00034907094,0.00016874126],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014966939,0.00054054975,0.0008557131,0.0016999203,0.0005567237,0.0005368095,0.00033507848,0.0003551817,0.0014939893],"category_scores_gemma":[0.0032384158,0.00013364705,0.00078460126,0.0011466236,0.00023411596,0.00062895066,0.00045738523,0.0005699788,0.0003176429],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010351478,0.00046407766,0.9213033,0.00017164963,0.00042336495,0.00029580548,0.00014588292,0.00073835877,0.0022965318,0.00019536451,0.0028037757,0.07012677],"study_design_scores_gemma":[0.00015835777,0.0012671194,0.9894404,0.000058727645,0.00036628096,0.002153341,0.00024120482,0.0025495351,0.0014560058,0.0004495982,0.0018310215,0.000028358967],"about_ca_topic_score_codex":0.0038233122,"about_ca_topic_score_gemma":0.009134735,"teacher_disagreement_score":0.0038233122,"about_ca_system_score_codex":0.00035528193,"about_ca_system_score_gemma":0.000673384,"threshold_uncertainty_score":0.007915318},"labels":[],"label_agreement":null},{"id":"W2050295697","doi":"10.1016/j.jaad.2005.12.006","title":"The vulvovaginal gingival syndrome: A severe subgroup of lichen planus with characteristic clinical features and a novel association with the class II HLA DQB1∗0201 allele","year":2006,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Oral and gingival health research","field":"Health Professions","cited_by":123,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Allele; Dermatology; Human leukocyte antigen; Genetics; Gene; Immunology; Biology","score_opus":0.03275349376938416,"score_gpt":0.4072678863697104,"score_spread":0.37451439260032626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050295697","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99789447,0.00022125574,0.00030696238,0.00010988578,0.000009641712,0.000023955423,0.00008049826,0.000016166765,0.001337266],"genre_scores_gemma":[0.99946445,0.00006649028,0.0001574722,0.00003250639,0.000033658827,0.000006397495,0.00006484872,0.0000058567693,0.00016826943],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.99960655,0.00006782924,0.000041434523,0.000093803006,0.0000895697,0.000100781246],"domain_scores_gemma":[0.99930966,0.0001890383,0.00019887558,0.00007036319,0.00004100931,0.000191114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019820612,0.0013682989,0.0006547107,0.0013292541,0.0008297241,0.0005837955,0.00040799583,0.00077678025,0.0015214875],"category_scores_gemma":[0.0017592291,0.000355441,0.00036325178,0.0009609835,0.0007411368,0.0003913051,0.00082350767,0.00054108095,0.00022682613],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012194229,0.00030193242,0.41240737,0.00011921779,0.00016253018,0.48806378,0.0013371696,0.00040710994,0.07671409,0.0013344357,0.0010495364,0.016883485],"study_design_scores_gemma":[0.00008110632,0.00042245255,0.33286163,0.000016981541,0.0000830846,0.6617819,0.0006239879,0.00062753627,0.0019371922,0.0005521229,0.0009830375,0.000028927818],"about_ca_topic_score_codex":0.0013490757,"about_ca_topic_score_gemma":0.0012858963,"teacher_disagreement_score":0.0015214875,"about_ca_system_score_codex":0.00022195814,"about_ca_system_score_gemma":0.0003425345,"threshold_uncertainty_score":0.0050899386},"labels":[],"label_agreement":null},{"id":"W2050302920","doi":"10.1016/j.jaad.2004.06.024","title":"Congenital alopecia areata","year":2005,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Alopecia areata; Medicine; Dermatology; Minoxidil; Clobetasol propionate; Hair loss; Vellus hair; Scalp; Psoriasis","score_opus":0.04317954002890827,"score_gpt":0.3823450597364103,"score_spread":0.33916551970750203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050302920","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006036153,0.99555236,0.00024224112,0.00018178839,0.0003534307,0.000006742763,0.000023651577,0.000018236131,0.0030179198],"genre_scores_gemma":[0.006958375,0.988938,0.0004019739,0.00040492928,0.0008135901,0.000007647819,0.00007976785,0.0000045477163,0.0023912357],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998011,0.000025289486,0.00004403315,0.000042549644,0.00006494732,0.000022148735],"domain_scores_gemma":[0.99962425,0.00015645067,0.00009901796,0.00001381774,0.00006975094,0.000036749992],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025023613,0.0007561777,0.0011589188,0.0037326545,0.0003242386,0.0007616448,0.0006963216,0.0006298228,0.0039965636],"category_scores_gemma":[0.0006714221,0.00023577653,0.00031661193,0.002570736,0.0004235277,0.0010294233,0.0005581468,0.0009078667,0.0014904701],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044067074,0.00005500206,0.000901155,0.006733838,0.00006840685,0.0037608726,0.000044909528,0.00016225006,0.0012389546,0.00075041305,0.027085776,0.95915437],"study_design_scores_gemma":[0.000043856864,0.000080064485,0.0058715777,0.004686335,0.00033956912,0.082028806,0.00015093932,0.00017391375,0.0010101249,0.001024539,0.9045584,0.000031914915],"about_ca_topic_score_codex":0.0010795317,"about_ca_topic_score_gemma":0.002613596,"teacher_disagreement_score":0.0039965636,"about_ca_system_score_codex":0.00036017777,"about_ca_system_score_gemma":0.00057312014,"threshold_uncertainty_score":0.013369799},"labels":[],"label_agreement":null},{"id":"W2050596358","doi":"10.1016/j.jaad.2012.01.036","title":"Connective tissue nevi in children: Institutional experience and review","year":2012,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Genetic and rare skin diseases.","field":"Biochemistry, Genetics and Molecular Biology","cited_by":50,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Connective tissue; Dermatology; Connective tissue disease; Pathology; Autoimmune disease","score_opus":0.0078437310139772,"score_gpt":0.29979020987288363,"score_spread":0.29194647885890646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050596358","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5665036,0.4099595,0.0013747851,0.0026143482,0.0003770678,0.00020777063,0.0016809573,0.00006446656,0.017217524],"genre_scores_gemma":[0.640522,0.3536369,0.0016915746,0.0009731392,0.00044586163,0.00007633527,0.001071682,0.000037541893,0.001545023],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991629,0.00013548201,0.00023531311,0.00011881384,0.00023343114,0.000114036375],"domain_scores_gemma":[0.997269,0.0011412555,0.0007237707,0.00012795688,0.0004228878,0.00031520508],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010545101,0.00033828776,0.0005699467,0.0029659616,0.0006555698,0.0010298269,0.0008743136,0.00070846727,0.0015650257],"category_scores_gemma":[0.003212014,0.00022889175,0.00033269657,0.0036089143,0.0010618439,0.0010039642,0.00083021587,0.00044084995,0.0005176298],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022815974,0.00028607767,0.46324396,0.004002068,0.00022455606,0.21457858,0.006106119,0.00032928563,0.0024408456,0.0015450513,0.018329812,0.28868544],"study_design_scores_gemma":[0.000018147957,0.00015452664,0.24110949,0.0025600158,0.00018709338,0.69010407,0.007836264,0.00007455891,0.0009337961,0.0002801852,0.056673553,0.00006828697],"about_ca_topic_score_codex":0.0020457201,"about_ca_topic_score_gemma":0.003981158,"teacher_disagreement_score":0.0029659616,"about_ca_system_score_codex":0.0007974158,"about_ca_system_score_gemma":0.0013138326,"threshold_uncertainty_score":0.0057857037},"labels":[],"label_agreement":null},{"id":"W2051510630","doi":"10.1016/j.jaad.2004.06.054","title":"Paradoxical hypertrichosis after laser epilation","year":2005,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatologic Treatments and Research","field":"Medicine","cited_by":125,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Vancouver Coastal Health Research Institute; Vancouver Coastal Health","funders":"","keywords":"Medicine; Hypertrichosis; Hair removal; Dermatology; Intense pulsed light; Confidence interval; Hyperpigmentation; Hair follicle; Scars; Laser; Single Center; Adverse effect; Surgery; Internal medicine","score_opus":0.020236444216231858,"score_gpt":0.34268686828882844,"score_spread":0.3224504240725966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051510630","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9663367,0.003058194,0.0032868965,0.003488709,0.00070618873,0.00016075939,0.00018579698,0.00037860675,0.022398084],"genre_scores_gemma":[0.9982961,0.00012978727,0.00012534362,0.00043408602,0.000198546,0.0000069676166,0.000022379796,0.000009730017,0.00077725307],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9997267,0.000057072106,0.000023180748,0.000045263634,0.000055462286,0.00009227407],"domain_scores_gemma":[0.99787986,0.00121919,0.00023759554,0.00029838382,0.00006265605,0.00030235288],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003171228,0.0004167934,0.00066297915,0.0006365557,0.0006406371,0.00045771062,0.0006670122,0.0021219573,0.0041908715],"category_scores_gemma":[0.0037829478,0.00021919551,0.0004876393,0.0003350504,0.0010144622,0.00087709125,0.00060060364,0.002596491,0.0006350091],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009118176,0.0005910624,0.01783353,0.00021231653,0.0001529508,0.9065841,0.0005043448,0.00040856373,0.022502895,0.0034321556,0.0015864831,0.037073452],"study_design_scores_gemma":[0.0019118157,0.005835646,0.14106734,0.000060141312,0.0001478185,0.81891245,0.0003977402,0.0041536465,0.0150195155,0.004605288,0.0078067756,0.00008179803],"about_ca_topic_score_codex":0.0008179301,"about_ca_topic_score_gemma":0.00075280666,"teacher_disagreement_score":0.0041908715,"about_ca_system_score_codex":0.0006208527,"about_ca_system_score_gemma":0.00030246458,"threshold_uncertainty_score":0.014019847},"labels":[],"label_agreement":null},{"id":"W2052231731","doi":"10.1067/mjd.2003.68","title":"Summary of North American Hair Research Society (NAHRS)-sponsored Workshop on Cicatricial Alopecia, Duke University Medical Center, February 10 and 11, 2001","year":2003,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":416,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Center (category theory); Dermatology; Family medicine; Library science; Gerontology","score_opus":0.02989421350954823,"score_gpt":0.32975394603322816,"score_spread":0.2998597325236799,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052231731","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01098274,0.10737312,0.0026101773,0.23506019,0.4646212,0.0026800807,0.011284658,0.00054138986,0.16484651],"genre_scores_gemma":[0.023587367,0.073486455,0.00254779,0.041139197,0.11575782,0.0013165678,0.010901383,0.0002618186,0.7310016],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993536,0.000092201815,0.00005703165,0.00008624492,0.000280804,0.0001301229],"domain_scores_gemma":[0.99761367,0.00022525067,0.000111537476,0.000051641615,0.0012711858,0.0007267257],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002260417,0.0013656209,0.00094510923,0.0016034854,0.0014759712,0.0015850079,0.0011778398,0.0027199246,0.04941064],"category_scores_gemma":[0.002069103,0.0003333045,0.00064594595,0.000719208,0.00023649677,0.0007851895,0.0010226532,0.0024127846,0.012357841],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014989317,0.00010963814,0.00046836634,0.00024930298,0.000010072102,0.00008115316,0.000035852598,0.00004153231,0.00034942606,0.000105266365,0.9664642,0.03193533],"study_design_scores_gemma":[0.000121357814,0.00021818964,0.010099586,0.00051582896,0.00004105484,0.00020153531,0.0002669023,0.000106456464,0.00035705903,0.00022449548,0.987827,0.000020634812],"about_ca_topic_score_codex":0.010341594,"about_ca_topic_score_gemma":0.044755477,"teacher_disagreement_score":0.04941064,"about_ca_system_score_codex":0.0011451064,"about_ca_system_score_gemma":0.0026903462,"threshold_uncertainty_score":0.16529506},"labels":[],"label_agreement":null},{"id":"W2052459750","doi":"10.1016/j.jaad.2009.01.006","title":"Uncombable hair syndrome","year":2009,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health; Quest University Canada; University of British Columbia","funders":"","keywords":"Penetrance; Medicine; Hair shaft; Anatomy; Cabello; Dermatology; Internal medicine; Biology; Hair follicle; Genetics; Phenotype","score_opus":0.010477400067804567,"score_gpt":0.29556950718577535,"score_spread":0.2850921071179708,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052459750","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8055262,0.0060166414,0.0043583177,0.0050059776,0.0010818846,0.00022758693,0.0005557403,0.0005501995,0.1766775],"genre_scores_gemma":[0.9874336,0.0009097839,0.00081870594,0.0006741136,0.00023507667,0.000018235658,0.000113460555,0.000032936256,0.00976401],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9997168,0.00002846422,0.000017229158,0.00006496154,0.00009382346,0.00007867787],"domain_scores_gemma":[0.9994655,0.00012665054,0.000079979574,0.000051721,0.00006220089,0.00021392194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013763995,0.001096342,0.00033522738,0.0014795983,0.0011752839,0.00062867405,0.00081155886,0.0011592822,0.0093412595],"category_scores_gemma":[0.0018145285,0.00023231351,0.00034629402,0.00072533434,0.0008267809,0.00073425093,0.000783132,0.0011608497,0.0013525647],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000055748722,0.00006213553,0.012082043,0.000046808156,0.000019077484,0.96449274,0.00015132038,0.00008548223,0.0063256016,0.0024150955,0.0020430102,0.01222092],"study_design_scores_gemma":[0.000011243565,0.00004432626,0.012291089,0.000015741625,0.000009552551,0.9828447,0.00008135086,0.00012716065,0.0007887935,0.0006997156,0.0030794286,0.0000069631355],"about_ca_topic_score_codex":0.0017207651,"about_ca_topic_score_gemma":0.0018078793,"teacher_disagreement_score":0.0093412595,"about_ca_system_score_codex":0.00051902427,"about_ca_system_score_gemma":0.00056894834,"threshold_uncertainty_score":0.031249642},"labels":[],"label_agreement":null},{"id":"W2052609979","doi":"10.1016/j.jaad.2004.08.012","title":"Randomized controlled trial of pimecrolimus 1% cream for treatment of facial acne vulgaris","year":2005,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Windsor; Western University; Windsor Clinical Research","funders":"","keywords":"Pimecrolimus; Medicine; Acne; Dermatology; Adverse effect; Randomized controlled trial; Tacrolimus; Atopic dermatitis; Calcineurin; Randomization; Clinical trial; Surgery; Internal medicine; Transplantation","score_opus":0.01982851633987103,"score_gpt":0.3310486771793467,"score_spread":0.3112201608394757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052609979","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96123713,0.014996894,0.0011789171,0.003506035,0.0045276247,0.005687726,0.0018031712,0.00027439164,0.006788128],"genre_scores_gemma":[0.9786592,0.0051175035,0.0019248496,0.0031115382,0.0012625125,0.0037664177,0.00065639644,0.000031689946,0.0054698456],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99911314,0.0004939372,0.00006886306,0.00013912088,0.000069461625,0.00011556581],"domain_scores_gemma":[0.99907815,0.0004256383,0.00017147204,0.000065978675,0.000051882667,0.00020674091],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017245954,0.0013701917,0.0039610867,0.0004329801,0.0006006108,0.0009939565,0.0011677069,0.002206992,0.012775861],"category_scores_gemma":[0.002420885,0.0008418282,0.0017719902,0.0003723806,0.0009728896,0.0010341633,0.00038084853,0.0038105857,0.0013838466],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9876111,0.0024768584,0.00013503534,0.0006622897,0.0008989033,0.00004217702,0.00002055377,0.00008909788,0.0007143601,0.00008974377,0.00069635076,0.0065635317],"study_design_scores_gemma":[0.9873165,0.011298563,0.00045561008,0.000024221521,0.0003634481,0.00001241575,0.000008503892,0.000116953786,0.00007928642,0.000051073108,0.0002679446,0.000005393096],"about_ca_topic_score_codex":0.0018734345,"about_ca_topic_score_gemma":0.0039916583,"teacher_disagreement_score":0.012775861,"about_ca_system_score_codex":0.0009139164,"about_ca_system_score_gemma":0.0010035369,"threshold_uncertainty_score":0.04273951},"labels":[],"label_agreement":null},{"id":"W2053450751","doi":"10.1067/mjd.2002.126823","title":"Drug interactions: Proteins, pumps, and P-450s","year":2002,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":100,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Computational biology; Drug; Pharmacology; Biology","score_opus":0.1446874382603087,"score_gpt":0.4860916144772223,"score_spread":0.34140417621691366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053450751","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019167282,0.99796826,0.00027814604,0.00030358226,0.00026107978,0.000006273051,0.000015956697,0.00001658142,0.00095841393],"genre_scores_gemma":[0.0010918602,0.99605066,0.0003577077,0.00030976158,0.0005265816,0.00000731566,0.000029802595,0.0000016141273,0.0016247437],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997086,0.00005050183,0.000033516295,0.000050419105,0.00013658426,0.000020367743],"domain_scores_gemma":[0.9995933,0.0001766669,0.00008826369,0.000010537472,0.00009948086,0.000031721334],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004613463,0.0014405224,0.0023731207,0.0022686978,0.00033844827,0.0009668501,0.0009944253,0.001362197,0.0041887746],"category_scores_gemma":[0.00059611624,0.00032142736,0.0005714853,0.0027369498,0.0004985385,0.0012179851,0.00045911002,0.0015170107,0.003144689],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010401993,0.00013336186,0.00040442622,0.0077339513,0.00013054516,0.00055974163,0.000029249733,0.0003641864,0.002273926,0.0011764513,0.040523198,0.94656706],"study_design_scores_gemma":[0.000055794044,0.0002306291,0.0026775436,0.0017726383,0.00025278758,0.0069737304,0.00006567835,0.00033977945,0.0012695341,0.0021735416,0.98415655,0.00003190058],"about_ca_topic_score_codex":0.0013002172,"about_ca_topic_score_gemma":0.0036123765,"teacher_disagreement_score":0.0041887746,"about_ca_system_score_codex":0.0005357075,"about_ca_system_score_gemma":0.00072191696,"threshold_uncertainty_score":0.014012873},"labels":[],"label_agreement":null},{"id":"W2053649186","doi":"10.1016/j.jaad.2013.05.035","title":"Anti-IgE therapy and severe atopic dermatitis: A pediatric perspective","year":2013,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Atopic dermatitis; Immunoglobulin E; Dermatology; Perspective (graphical); Dupilumab; Immunology; Antibody","score_opus":0.01584392889004795,"score_gpt":0.28904436164498715,"score_spread":0.2732004327549392,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053649186","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.038466766,0.15207192,0.0011516165,0.7475842,0.017470255,0.000045968285,0.00015877119,0.000105514366,0.04294495],"genre_scores_gemma":[0.301794,0.22190757,0.0017122356,0.2918531,0.17230356,0.000049570845,0.00016460639,0.000056831625,0.010158548],"study_design_codex":"case_report","study_design_gemma":"not_applicable","domain_scores_codex":[0.999292,0.00019817137,0.00011493774,0.00009634725,0.00015084511,0.00014770096],"domain_scores_gemma":[0.9984464,0.0008263319,0.0002548185,0.000036608802,0.00016051963,0.00027525058],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076201645,0.0009591065,0.0013549706,0.0009208658,0.0013223108,0.0019093753,0.00086678925,0.010562074,0.0025563475],"category_scores_gemma":[0.0043800985,0.00057206355,0.0009651888,0.0007954563,0.0013231037,0.0028614684,0.00072119775,0.012267929,0.00096399913],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015818134,0.000372324,0.031034254,0.00040708543,0.00012952821,0.7296331,0.0005234341,0.0006129281,0.0008166052,0.011892317,0.18372603,0.040694144],"study_design_scores_gemma":[0.000120108656,0.00022341667,0.0125608565,0.0014007766,0.00017708435,0.8370269,0.0009339088,0.0006335759,0.00025328694,0.004368819,0.14225467,0.00004668295],"about_ca_topic_score_codex":0.002653809,"about_ca_topic_score_gemma":0.0043449947,"teacher_disagreement_score":0.010562074,"about_ca_system_score_codex":0.0018016805,"about_ca_system_score_gemma":0.0012567646,"threshold_uncertainty_score":0.013072193},"labels":[],"label_agreement":null},{"id":"W2053944850","doi":"10.1067/mjd.2001.119664","title":"Minocycline, perinuclear antineutrophilic cytoplasmic antibody, and pigment: The biochemical basis","year":2001,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Minocycline; Medicine; Antibody; Cytoplasm; Pigment; Microbiology; Pathology; Immunology; Antibiotics; Biochemistry; Biology","score_opus":0.012622702674865498,"score_gpt":0.2993731074654108,"score_spread":0.2867504047905453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053944850","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.059099182,0.024826068,0.0017817616,0.8644528,0.022034613,0.000083092375,0.00016464063,0.0001386647,0.027419252],"genre_scores_gemma":[0.5048768,0.01819774,0.001800275,0.27670404,0.17641781,0.00012817646,0.00017249097,0.000062522566,0.02164007],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9994772,0.00014897376,0.00007379633,0.00010306188,0.00009992635,0.000097054435],"domain_scores_gemma":[0.9982698,0.0011816272,0.00013916222,0.0000676239,0.00015802415,0.00018373423],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068873406,0.00080834003,0.0011685165,0.00058980915,0.0011211728,0.0011383974,0.0011966047,0.021152927,0.0033856959],"category_scores_gemma":[0.0056580654,0.00050321635,0.0007762519,0.00038897872,0.0016078777,0.0028385376,0.0004608547,0.011215646,0.0011613524],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026852044,0.0006807628,0.020329688,0.0005334815,0.00017764891,0.612126,0.000616285,0.00082845986,0.00416373,0.014170781,0.2908982,0.05278968],"study_design_scores_gemma":[0.0021430193,0.0012467946,0.030461526,0.00061186694,0.0004140812,0.5991548,0.0010452786,0.008138135,0.0042347414,0.031933665,0.320465,0.00015104923],"about_ca_topic_score_codex":0.0018708158,"about_ca_topic_score_gemma":0.0022026561,"teacher_disagreement_score":0.021152927,"about_ca_system_score_codex":0.002116257,"about_ca_system_score_gemma":0.0005734439,"threshold_uncertainty_score":0.015354633},"labels":[],"label_agreement":null},{"id":"W2054099885","doi":"10.1016/j.jaad.2005.11.1098","title":"Melanotic macule of nail unit and its clinicopathologic spectrum","year":2006,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"","keywords":"Medicine; Nail (fastener); Nail matrix; Dermatology; Nail disease; Biopsy; Nail plate; Melanoma; Pathology; Psoriasis","score_opus":0.020408505227303968,"score_gpt":0.32500830637480105,"score_spread":0.3045998011474971,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054099885","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9775712,0.004104024,0.0013024011,0.00027402383,0.00003572539,0.000055699675,0.000128205,0.00006520708,0.016463444],"genre_scores_gemma":[0.99844754,0.00064084504,0.00030209328,0.000043057546,0.00007298272,0.000013046789,0.000034532743,0.000005158134,0.00044072178],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9996643,0.000073311145,0.00004386539,0.00007084017,0.000054500382,0.00009319601],"domain_scores_gemma":[0.99943393,0.00022843125,0.00010457696,0.000060552506,0.00006110109,0.00011133232],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037711608,0.000655786,0.0004081009,0.002410379,0.0009816175,0.00062431226,0.00048251706,0.00080173585,0.0027673682],"category_scores_gemma":[0.0017726471,0.00044446383,0.00027897942,0.00093823444,0.00086044346,0.00086499634,0.00067997735,0.00044919018,0.00047940828],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012641527,0.00023454358,0.2893227,0.00017993426,0.00006681171,0.6541832,0.00084909407,0.00041408837,0.028457524,0.0032201726,0.0010561645,0.020751664],"study_design_scores_gemma":[0.00003776701,0.00019426568,0.16334356,0.000025399526,0.00005002138,0.8314551,0.00046098247,0.00066821993,0.0013733498,0.0009094163,0.0014561482,0.000025740546],"about_ca_topic_score_codex":0.0006171318,"about_ca_topic_score_gemma":0.0008110088,"teacher_disagreement_score":0.0027673682,"about_ca_system_score_codex":0.00024719257,"about_ca_system_score_gemma":0.00019565251,"threshold_uncertainty_score":0.009257734},"labels":[],"label_agreement":null},{"id":"W2055496440","doi":"10.1016/j.jaad.2003.10.229","title":"Alefacept in combination with methotrexate for treatment of active psoriatic arthritis: rationale and design of a randomized, double-blind, placebo-controlled study","year":2004,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Toronto Western Hospital","funders":"","keywords":"Medicine; Psoriatic arthritis; Methotrexate; Psoriasis; Placebo; Arthritis; Psoriasis Area and Severity Index; Internal medicine; Population; Dermatology; Randomization; Randomized controlled trial; Surgery; Gastroenterology; Pathology","score_opus":0.02895944336610945,"score_gpt":0.29690023631253243,"score_spread":0.267940792946423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055496440","genre_codex":"empirical","genre_gemma":"protocol","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"protocol","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8381513,0.015927218,0.009808338,0.0014072102,0.003597329,0.12460861,0.0015211146,0.0004344256,0.004544409],"genre_scores_gemma":[0.85478276,0.008073585,0.016592592,0.0018196837,0.0038943728,0.10993534,0.0007232558,0.00009134665,0.004087169],"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","domain_scores_codex":[0.99305,0.0041039065,0.0007250094,0.00080622546,0.0006278033,0.0006871773],"domain_scores_gemma":[0.9962065,0.0014301612,0.00068553886,0.000501033,0.00043174298,0.0007449264],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009633684,0.0038601737,0.010531541,0.001930463,0.0017661445,0.002048708,0.001918023,0.004885216,0.006758436],"category_scores_gemma":[0.0077122687,0.0022211866,0.003098141,0.0016433296,0.0047992105,0.0020446018,0.0010591651,0.0040048,0.0016236571],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9844946,0.0060183494,0.00027792482,0.00074176636,0.00048009286,0.000025281615,0.00003498929,0.00017048005,0.0024020846,0.00014704051,0.00011650902,0.005090742],"study_design_scores_gemma":[0.9363257,0.06161501,0.00033392783,0.000028175029,0.00057488296,0.000013279451,0.000009516326,0.00015874994,0.0003950574,0.000120561046,0.0004111868,0.000013936775],"about_ca_topic_score_codex":0.00060394045,"about_ca_topic_score_gemma":0.0009975386,"teacher_disagreement_score":0.010531541,"about_ca_system_score_codex":0.0008839407,"about_ca_system_score_gemma":0.0023984085,"threshold_uncertainty_score":0.05094844},"labels":[],"label_agreement":null},{"id":"W2056181342","doi":"10.1067/mjd.2001.111340","title":"Beliefs and perceptions of patients with acne","year":2001,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":173,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; University of Windsor; Windsor Regional Hospital","funders":"","keywords":"Acne; Medicine; Dermatology; Family history; Family medicine; Surgery","score_opus":0.006230840675742155,"score_gpt":0.27664513376112093,"score_spread":0.2704142930853788,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056181342","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964618,0.0002820193,0.000026330179,0.0005899768,0.00001758361,0.000008054656,0.000035992383,0.0000015397965,0.0025766129],"genre_scores_gemma":[0.9994491,0.000107011096,0.000018017525,0.0001888803,0.000010931141,0.0000027659087,0.00001745952,5.495126e-7,0.00020527845],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99862516,0.00059719716,0.00010359407,0.000065585555,0.00032691855,0.00028158876],"domain_scores_gemma":[0.99092335,0.003305945,0.0025328144,0.00016325661,0.00091862906,0.0021560674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014797886,0.00020375135,0.00032236456,0.0008128668,0.0012577459,0.0017099923,0.00025245425,0.0008364023,0.003918198],"category_scores_gemma":[0.013073923,0.00017060807,0.00050841813,0.0004678453,0.0011390737,0.0007160348,0.00085223245,0.001708574,0.00032238456],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000720507,0.000812637,0.95464796,0.00011326283,0.00020937686,0.0005438057,0.02677265,0.00012176013,0.000998383,0.00037906348,0.00081642537,0.013864092],"study_design_scores_gemma":[0.00014271267,0.0014174671,0.90576094,0.0001511113,0.00017708923,0.0017174811,0.08641182,0.0004188427,0.0003541411,0.0004701851,0.0029163365,0.000061876824],"about_ca_topic_score_codex":0.005961467,"about_ca_topic_score_gemma":0.006378482,"teacher_disagreement_score":0.005961467,"about_ca_system_score_codex":0.00077670516,"about_ca_system_score_gemma":0.00061986083,"threshold_uncertainty_score":0.013107717},"labels":[],"label_agreement":null},{"id":"W2056378658","doi":"10.1016/j.jaad.2003.10.370","title":"Unusual cutaneous findings of urticaria pigmentosa and telangiectasia macularis eruptiva perstans associated with marked myelofibrosis","year":2004,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Mast cells and histamine","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Alberta; University of Calgary","funders":"","keywords":"Medicine; Pathology; Systemic mastocytosis; Myelofibrosis; Urticaria pigmentosa; Bone marrow; Biopsy; Cutaneous Mastocytosis; Extramedullary hematopoiesis; Telangiectasia; Mastocytoma; Skin biopsy; Mast cell; Haematopoiesis; Immunology; Stem cell","score_opus":0.006825955693098289,"score_gpt":0.22597307293060664,"score_spread":0.21914711723750835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056378658","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9733142,0.0020923743,0.0025858425,0.000845719,0.00018187161,0.00022057733,0.00028826023,0.00023310367,0.02023805],"genre_scores_gemma":[0.9980002,0.00027767228,0.00060144183,0.00017513274,0.00026047512,0.000018813123,0.000042463686,0.000008873462,0.0006149705],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9994368,0.00009241021,0.00006817295,0.00013819915,0.0000785843,0.00018576076],"domain_scores_gemma":[0.9978676,0.00095504057,0.00030904898,0.00032431856,0.00011733175,0.00042668165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078657945,0.0018926014,0.0007881889,0.0022101873,0.0012203453,0.00081848324,0.001042038,0.002457999,0.003209406],"category_scores_gemma":[0.003596409,0.00090046163,0.00065093936,0.000825816,0.0014077855,0.0011365262,0.00077505014,0.0011653434,0.0006314345],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016982052,0.000053424268,0.009352354,0.0000423099,0.000014186295,0.98648006,0.00008257375,0.000059010603,0.0021646915,0.00022994843,0.0001513033,0.0012002167],"study_design_scores_gemma":[0.000069153255,0.00018225069,0.024340643,0.000009652192,0.000026617487,0.97348815,0.000081322294,0.00031470042,0.00094967696,0.0001644533,0.00036273667,0.000010512005],"about_ca_topic_score_codex":0.0010296322,"about_ca_topic_score_gemma":0.0012246217,"teacher_disagreement_score":0.003209406,"about_ca_system_score_codex":0.00052236125,"about_ca_system_score_gemma":0.00034990095,"threshold_uncertainty_score":0.010736525},"labels":[],"label_agreement":null},{"id":"W2058493564","doi":"10.1016/j.jaad.2003.10.041","title":"Stressful major life events are associated with a higher prevalence of cutaneous sensory symptoms","year":2004,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Itching; Cross-sectional study; Confounding; Marital status; Severity of illness; Rating scale; Scalp; Physical therapy; Dermatology; Psychiatry; Internal medicine; Population","score_opus":0.012132275615262115,"score_gpt":0.2783965610438423,"score_spread":0.2662642854285802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058493564","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99826497,0.0003905959,0.000083641935,0.000046497127,0.000021843349,0.0000051175557,0.00013436709,0.000004411983,0.0010485202],"genre_scores_gemma":[0.99937147,0.00016911265,0.00005019771,0.000023387107,0.000023318935,0.000002915761,0.00015146183,0.0000016202147,0.00020648669],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998173,0.00004361309,0.000017389466,0.00003070965,0.00004100061,0.000050019684],"domain_scores_gemma":[0.99750465,0.00045081397,0.0012015465,0.00008733841,0.00014251875,0.00061309204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015008492,0.00023417511,0.0002768,0.00055284926,0.00037552274,0.0004280256,0.00015972297,0.00033216475,0.005928711],"category_scores_gemma":[0.0016165222,0.00014944715,0.0003802329,0.00044981064,0.0001875403,0.00019821728,0.0002755233,0.0005635472,0.00029024386],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024079232,0.00007156905,0.99538887,0.000024393374,0.000080579586,0.0003695837,0.000071160895,0.000018796334,0.0012835088,0.000013508867,0.0000807088,0.0023565432],"study_design_scores_gemma":[0.0000012377391,0.0000394285,0.9993825,0.000002457771,0.000008228581,0.00039759107,0.00006930274,0.000016039827,0.000031372252,0.000011117312,0.000039153132,0.0000013999417],"about_ca_topic_score_codex":0.0009795532,"about_ca_topic_score_gemma":0.0015417609,"teacher_disagreement_score":0.005928711,"about_ca_system_score_codex":0.00009219376,"about_ca_system_score_gemma":0.00013641303,"threshold_uncertainty_score":0.019833565},"labels":[],"label_agreement":null},{"id":"W2058499720","doi":"10.1016/j.jaad.2009.01.019","title":"New insights into the management of acne: An update from the Global Alliance to Improve Outcomes in Acne Group","year":2009,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":836,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Acne; Medicine; Alliance; Dermatology; Disease; MEDLINE; Acne treatment; Intensive care medicine; Family medicine; Pathology","score_opus":0.019659103395845572,"score_gpt":0.3627392131505955,"score_spread":0.3430801097547499,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058499720","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006344607,0.99852115,0.00006497908,0.0007045605,0.00035012176,0.000005751085,0.000016342121,0.000003670347,0.00027003192],"genre_scores_gemma":[0.0003942821,0.9981629,0.00026724552,0.00062177255,0.0003561198,0.000005855449,0.000029420326,0.0000011746961,0.00016132214],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99936646,0.00011110112,0.0001344126,0.0000633627,0.00027588624,0.00004884747],"domain_scores_gemma":[0.9980521,0.0009675172,0.00024967807,0.00003009813,0.0005802482,0.00012034993],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023726083,0.0009089399,0.0026591972,0.0027826366,0.00027117453,0.0013842474,0.0010677793,0.0016887449,0.0024233714],"category_scores_gemma":[0.0024999494,0.00034993282,0.0011161646,0.0025843817,0.00045031405,0.0020105555,0.00078848004,0.0027873125,0.0009936828],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014159162,0.000084659325,0.00025822822,0.018707803,0.00018188424,0.00015999845,0.000056581932,0.00017245796,0.00050510734,0.0008022798,0.057086326,0.9218431],"study_design_scores_gemma":[0.00022487836,0.0002054757,0.0027729992,0.018108387,0.00072289794,0.0018154476,0.00013033555,0.00016624907,0.00029207996,0.0011171568,0.9744003,0.000043770964],"about_ca_topic_score_codex":0.0028127038,"about_ca_topic_score_gemma":0.0073691383,"teacher_disagreement_score":0.0028127038,"about_ca_system_score_codex":0.00097278715,"about_ca_system_score_gemma":0.0024917638,"threshold_uncertainty_score":0.012547672},"labels":[],"label_agreement":null},{"id":"W2058840547","doi":"10.1016/j.jaad.2003.10.120","title":"Environmental terminology in the language of dermatology","year":2004,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Calgary","funders":"","keywords":"Terminology; Medicine; Dermatology; Pathology; Linguistics","score_opus":0.010073768167647122,"score_gpt":0.2987547719399,"score_spread":0.2886810037722529,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058840547","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.028711652,0.16022007,0.04568388,0.2618041,0.0731297,0.00004088194,0.0005221119,0.00030456984,0.42958307],"genre_scores_gemma":[0.754377,0.0647625,0.024944868,0.06329754,0.0503089,0.00011679472,0.00049592636,0.0007000466,0.040996462],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.993131,0.004338357,0.00091106346,0.00042668363,0.00082470843,0.00036822914],"domain_scores_gemma":[0.99014133,0.00665521,0.0007677147,0.000512785,0.0014795111,0.00044348056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0056304787,0.00043176714,0.00050021475,0.0021967168,0.0025296817,0.006532271,0.0011951255,0.0021647885,0.004152387],"category_scores_gemma":[0.012328747,0.00029127146,0.0003330628,0.0027029777,0.011434293,0.005941351,0.00205642,0.0073260195,0.0012489579],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003572971,0.0000147995215,0.00059452635,0.0002156819,0.000011235961,0.00023556077,0.007356492,0.00011225041,0.00054871046,0.9172866,0.051638126,0.021950308],"study_design_scores_gemma":[0.000012109202,0.00002453476,0.0014376921,0.00059890613,0.000020206971,0.00105294,0.0048479117,0.00022562931,0.00041971187,0.16335818,0.82797337,0.000028742203],"about_ca_topic_score_codex":0.0019130984,"about_ca_topic_score_gemma":0.003106624,"teacher_disagreement_score":0.006532271,"about_ca_system_score_codex":0.0019524177,"about_ca_system_score_gemma":0.0022109952,"threshold_uncertainty_score":0.02977717},"labels":[],"label_agreement":null},{"id":"W2059481764","doi":"10.1016/j.jaad.2005.07.044","title":"CD8+ T lymphocytes reactive against Epstein-Barr virus antigens in skin lesions of a patient with Sézary syndrome","year":2005,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Medicine; Antigen; Lymphoma; CD8; Cutaneous T-cell lymphoma; Immunology; Virus; Epstein–Barr virus; Lytic cycle; Virology; T cell; Epitope; Mycosis fungoides; Human leukocyte antigen; Atypical Lymphocyte; T lymphocyte; Immune system","score_opus":0.013131163272621474,"score_gpt":0.303790466562389,"score_spread":0.2906593032897675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059481764","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962637,0.00027411347,0.0001854564,0.000251235,0.000027242406,0.00002052274,0.000032286123,0.000027738284,0.0029177445],"genre_scores_gemma":[0.99931276,0.00010124392,0.00008996923,0.000109083616,0.000036904392,0.000003739894,0.000019290406,0.000005178092,0.00032186173],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99980706,0.00002855238,0.000028448983,0.000049940663,0.000026480373,0.00005953512],"domain_scores_gemma":[0.9995491,0.00019100218,0.00004788539,0.00003744171,0.000038354334,0.00013617854],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017757692,0.00096329255,0.00049700757,0.0013385059,0.0010316146,0.0005878581,0.0004727465,0.0016263593,0.0021666402],"category_scores_gemma":[0.0011588819,0.0005047014,0.00034043114,0.0004438859,0.00066693075,0.0005728184,0.00032711244,0.00091775577,0.0004458149],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005992148,0.00019564888,0.07937801,0.00006416863,0.000043814616,0.8935908,0.0008938685,0.00020433514,0.020361071,0.00021384833,0.00032892727,0.0041262764],"study_design_scores_gemma":[0.00012611954,0.0007868168,0.10352432,0.00002227223,0.00012429398,0.88725114,0.0007556593,0.0011237944,0.0047589466,0.00028303842,0.0012177181,0.000025984597],"about_ca_topic_score_codex":0.001436447,"about_ca_topic_score_gemma":0.001064815,"teacher_disagreement_score":0.0021666402,"about_ca_system_score_codex":0.00037387953,"about_ca_system_score_gemma":0.00020700037,"threshold_uncertainty_score":0.0072481036},"labels":[],"label_agreement":null},{"id":"W2059501570","doi":"10.1016/j.jaad.2003.11.060","title":"Surgical Pearl: Earlobe repair assisted by guidewire punch technique: A useful method to remove unwanted epithelial tracts caused by body piercing","year":2004,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Tattoo and Body Piercing Complications","field":"Social Sciences","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Earlobe; Medicine; Surgery; Body piercing","score_opus":0.024879823606813706,"score_gpt":0.3732722745904338,"score_spread":0.34839245098362004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059501570","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8530096,0.0047313455,0.12038181,0.0034616154,0.00079643505,0.00022995434,0.00023726701,0.0029624556,0.01418953],"genre_scores_gemma":[0.92223907,0.0014368459,0.063010275,0.0012697746,0.0005330797,0.00005876593,0.00013008965,0.00016871191,0.011153512],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.999819,0.00002860816,0.000023929879,0.00003603349,0.000053923264,0.000038589886],"domain_scores_gemma":[0.999678,0.00007103835,0.000078772115,0.000078153585,0.000029327615,0.00006473329],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003648051,0.0006293493,0.00039795178,0.0006931155,0.0010546457,0.00052334974,0.0006001799,0.001376587,0.0036445872],"category_scores_gemma":[0.000906444,0.00023730313,0.00054306164,0.00044955857,0.0004877739,0.0012345356,0.00066485495,0.0013036584,0.0013523664],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013853568,0.0008087507,0.019200703,0.0010154528,0.00017035946,0.1150503,0.0014507218,0.00041254074,0.33510137,0.002643019,0.011490301,0.51127106],"study_design_scores_gemma":[0.00033525313,0.0030014864,0.057769608,0.00010315533,0.00018675029,0.7709007,0.0006460639,0.002824527,0.12538049,0.0020852364,0.03660575,0.00016091007],"about_ca_topic_score_codex":0.00023592336,"about_ca_topic_score_gemma":0.0006399491,"teacher_disagreement_score":0.0036445872,"about_ca_system_score_codex":0.00012861934,"about_ca_system_score_gemma":0.0004379934,"threshold_uncertainty_score":0.0121923685},"labels":[],"label_agreement":null},{"id":"W2059521082","doi":"10.1067/mjd.2002.120614","title":"The association of Buschke-Ollendorf syndrome and nail-patella syndrome","year":2002,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatological and Skeletal Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cégep de Rivière-du-Loup","funders":"","keywords":"Medicine; Dermatology; Nail (fastener); Nail disease; Patella; Surgery; Psoriasis","score_opus":0.007472236950559684,"score_gpt":0.232608669918556,"score_spread":0.22513643296799632,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059521082","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98209524,0.0030371228,0.0012081536,0.0025676792,0.00020835572,0.000034261342,0.000394236,0.00010965511,0.010345246],"genre_scores_gemma":[0.99798465,0.00039858816,0.00054504373,0.00020770504,0.0001980794,0.000011574917,0.00008815324,0.000009246009,0.0005569794],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9994055,0.00014099252,0.00008088237,0.00012668534,0.00010762356,0.00013829395],"domain_scores_gemma":[0.9972722,0.0013553046,0.0005747284,0.00014359511,0.00018672121,0.00046741441],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040565323,0.001158712,0.00071332575,0.0022884228,0.000982197,0.0007544006,0.0008298513,0.0031695988,0.005595876],"category_scores_gemma":[0.006113682,0.0005396131,0.00036156765,0.0013336455,0.001261169,0.0009697284,0.00081697555,0.0014652307,0.00077776617],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047249245,0.00010808442,0.1534779,0.00007843267,0.00013317121,0.8196724,0.00033923963,0.00027773035,0.0147795845,0.0020764386,0.0016295495,0.0069549065],"study_design_scores_gemma":[0.00008634827,0.000107492604,0.062797025,0.000024444002,0.000097490905,0.9316011,0.0002216663,0.00050483,0.0015633805,0.0011383954,0.0018253573,0.000032455606],"about_ca_topic_score_codex":0.0023390295,"about_ca_topic_score_gemma":0.0026641085,"teacher_disagreement_score":0.005595876,"about_ca_system_score_codex":0.00046450543,"about_ca_system_score_gemma":0.00079672085,"threshold_uncertainty_score":0.01872003},"labels":[],"label_agreement":null},{"id":"W2059619997","doi":"10.1067/mjd.2000.109071","title":"Ciclopirox nail lacquer topical solution 8% in the treatment of toenail onychomycosis","year":2000,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":226,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Nail (fastener); Dermatology; Lacquer; Randomized controlled trial; Dermatophyte; Clinical trial; Dentistry; Surgery; Pathology","score_opus":0.04903528990125822,"score_gpt":0.38860165919996204,"score_spread":0.3395663692987038,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059619997","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006499061,0.9980908,0.00011473839,0.00007292249,0.00013253016,0.00000999883,0.000018413022,0.000009888667,0.0009007977],"genre_scores_gemma":[0.003047939,0.99520314,0.0002848533,0.00016663826,0.00015914084,0.000010654525,0.00005550931,0.0000022392173,0.0010699378],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99984026,0.000025226402,0.00002841316,0.000023595045,0.00006816645,0.000014291463],"domain_scores_gemma":[0.99982244,0.00007389965,0.000034510613,0.0000048486277,0.00004431669,0.000019944033],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037654868,0.00070163835,0.0019018023,0.0020241346,0.00025651805,0.00050757366,0.0009708646,0.00065780565,0.00259077],"category_scores_gemma":[0.00036302448,0.00020120628,0.00044720844,0.0018920935,0.0002945912,0.000535658,0.00029216646,0.0009040401,0.0012950519],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027494424,0.00015469802,0.00015222588,0.014073863,0.00011557543,0.00054327864,0.000040372754,0.00017406078,0.0020017894,0.0003346717,0.014546957,0.9675875],"study_design_scores_gemma":[0.00057353824,0.0012451232,0.0060479785,0.006370172,0.0011937195,0.01135875,0.00020640477,0.0004405452,0.0035166563,0.0010404505,0.96794254,0.00006412478],"about_ca_topic_score_codex":0.0022146832,"about_ca_topic_score_gemma":0.005142425,"teacher_disagreement_score":0.00259077,"about_ca_system_score_codex":0.00028799623,"about_ca_system_score_gemma":0.00057661394,"threshold_uncertainty_score":0.008666992},"labels":[],"label_agreement":null},{"id":"W2060359631","doi":"10.1016/j.jaad.2014.06.011","title":"Managing skin toxicities related to panitumumab","year":2014,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Sunnybrook Hospital; University of Toronto","funders":"","keywords":"Medicine; Panitumumab; Dermatology; Internal medicine; Cetuximab; Cancer; Colorectal cancer","score_opus":0.011641142386273354,"score_gpt":0.3057383189618908,"score_spread":0.29409717657561746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060359631","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6743151,0.19899881,0.010968949,0.019805659,0.0020768947,0.00051074947,0.00016787549,0.0003238444,0.092832156],"genre_scores_gemma":[0.9282815,0.04517492,0.007963903,0.0047790846,0.001599235,0.00010966686,0.00015928473,0.000048705002,0.011883632],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99954283,0.00021054236,0.000065816705,0.000024801033,0.000096261945,0.000059819384],"domain_scores_gemma":[0.99937254,0.00022655647,0.0001834878,0.00003515763,0.000106482505,0.00007575885],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00097171863,0.00019498986,0.00029041796,0.0004509348,0.00051623955,0.0007523305,0.0002190123,0.00031849594,0.0016099832],"category_scores_gemma":[0.0026896514,0.000120360986,0.00040548932,0.00029575403,0.00011754334,0.0005692567,0.00033741392,0.00091170677,0.00036296723],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009696489,0.00057889934,0.028712608,0.0009931523,0.000342573,0.004900853,0.0002759172,0.0005775046,0.010816905,0.0009227537,0.014473659,0.9364355],"study_design_scores_gemma":[0.001578417,0.010627682,0.20537774,0.0033821617,0.0021588728,0.12528327,0.0024843072,0.0063277404,0.060564395,0.005663207,0.5764791,0.00007315703],"about_ca_topic_score_codex":0.00041281543,"about_ca_topic_score_gemma":0.0017881059,"teacher_disagreement_score":0.0016099832,"about_ca_system_score_codex":0.00041302858,"about_ca_system_score_gemma":0.00053919357,"threshold_uncertainty_score":0.0053859353},"labels":[],"label_agreement":null},{"id":"W2060429864","doi":"10.1016/j.jaad.2011.04.005","title":"Atypical Gianotti-Crosti syndrome following administration of the AS03-adjuvanted H1N1 vaccine","year":2011,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Parvovirus B19 Infection Studies","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Dermatology","score_opus":0.030409605302442206,"score_gpt":0.32464082756400797,"score_spread":0.2942312222615658,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060429864","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6070135,0.008506225,0.0030435321,0.26063707,0.01144105,0.0006298606,0.0003891911,0.00045826792,0.107881375],"genre_scores_gemma":[0.9415298,0.0023220568,0.00075112225,0.04039869,0.00738455,0.00006737548,0.0000795842,0.000030400122,0.007436349],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.999086,0.00036249962,0.0000911606,0.000111010755,0.00015802747,0.0001912581],"domain_scores_gemma":[0.9965125,0.0022657719,0.00037067282,0.0001746575,0.00023877108,0.00043771087],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009325334,0.00096928875,0.00090671476,0.0006929808,0.0013494183,0.00089515967,0.0009973518,0.009150044,0.002089282],"category_scores_gemma":[0.009213521,0.00040896566,0.00084039714,0.0004464164,0.0012704537,0.0012553995,0.00040394568,0.0054263566,0.00055284105],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005647183,0.00019843264,0.011169419,0.000096951764,0.000041083917,0.9677959,0.00021320776,0.00015169618,0.0010440085,0.0010606616,0.012625464,0.0050384235],"study_design_scores_gemma":[0.0006296629,0.0014091451,0.032008942,0.0001847454,0.000119937395,0.93595153,0.0004902468,0.0026166737,0.0015121683,0.0021199617,0.0229069,0.000050113536],"about_ca_topic_score_codex":0.004096825,"about_ca_topic_score_gemma":0.0038475539,"teacher_disagreement_score":0.009150044,"about_ca_system_score_codex":0.0024446005,"about_ca_system_score_gemma":0.000876056,"threshold_uncertainty_score":0.017736852},"labels":[],"label_agreement":null},{"id":"W2063627867","doi":"10.1016/j.jaad.2007.09.010","title":"Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial","year":2007,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":883,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Dalhousie University","funders":"","keywords":"Medicine; Adalimumab; Psoriasis; Randomized controlled trial; Dermatology; Physical therapy; Internal medicine; Tumor necrosis factor alpha","score_opus":0.020117108803110594,"score_gpt":0.3155302584066383,"score_spread":0.2954131496035277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063627867","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9530674,0.025083633,0.0023055233,0.00265314,0.0023557448,0.0068590124,0.0023487695,0.00044489928,0.004881801],"genre_scores_gemma":[0.9696732,0.008878431,0.0032072032,0.0032820152,0.0010455439,0.005683529,0.0019365482,0.0000629597,0.0062306034],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.999127,0.0004178561,0.000050262348,0.00016315904,0.000069733134,0.00017213418],"domain_scores_gemma":[0.99904615,0.0002935262,0.0001779766,0.00008705345,0.000065889355,0.00032945495],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024318416,0.0026752686,0.005402266,0.0004582035,0.0008061719,0.0017132848,0.0012926062,0.0021619443,0.007659015],"category_scores_gemma":[0.0018218941,0.0010398711,0.0026249378,0.0005213957,0.0016643228,0.0014243007,0.00052382564,0.0040131453,0.0015440418],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98192364,0.0026861401,0.0003636091,0.0008872365,0.001536583,0.00004177176,0.000041394193,0.00021638822,0.0013532419,0.000109455425,0.0010654927,0.00977507],"study_design_scores_gemma":[0.9886508,0.009636124,0.00061111565,0.000024392693,0.00041928585,0.000020494706,0.000010761858,0.00012175093,0.00007693101,0.00009146925,0.00032963036,0.0000071932545],"about_ca_topic_score_codex":0.0012667611,"about_ca_topic_score_gemma":0.0025768874,"teacher_disagreement_score":0.007659015,"about_ca_system_score_codex":0.0008420451,"about_ca_system_score_gemma":0.0012037124,"threshold_uncertainty_score":0.02562195},"labels":[],"label_agreement":null},{"id":"W2066002096","doi":"10.1016/j.jaad.2009.11.012","title":"Impact of weight on the efficacy and safety of ustekinumab in patients with moderate to severe psoriasis: Rationale for dosing recommendations","year":2010,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":128,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Probity Medical Research; Dalhousie University","funders":"","keywords":"Medicine; Ustekinumab; Psoriasis; Psoriasis Area and Severity Index; Dosing; Body mass index; Placebo; Weight loss; Overweight; Internal medicine; Crossover study; Gastroenterology; Obesity; Dermatology; Infliximab; Disease","score_opus":0.01383228764558732,"score_gpt":0.27610456426620683,"score_spread":0.2622722766206195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066002096","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.39645773,0.24300042,0.045576572,0.20776463,0.008405762,0.0018741235,0.0026397612,0.00067541964,0.09360556],"genre_scores_gemma":[0.9114449,0.027654508,0.03298189,0.020499608,0.0032560423,0.00043630722,0.0006017038,0.00013560454,0.0029895229],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9924233,0.003259091,0.0011941701,0.00038243207,0.0025561156,0.00018482382],"domain_scores_gemma":[0.984233,0.010352683,0.001980974,0.00076251524,0.0021946966,0.00047611663],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008901215,0.00078190304,0.0016005542,0.00083091954,0.0005716643,0.0019426107,0.0011809944,0.0019177428,0.0019649896],"category_scores_gemma":[0.030691117,0.000351834,0.0016977886,0.0007791014,0.0009110599,0.0011078618,0.0006529329,0.004952836,0.00057507254],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015965149,0.0016630432,0.05551532,0.0018123941,0.0034318366,0.00042221788,0.00043176374,0.0052934256,0.009180243,0.011929539,0.034276873,0.86007816],"study_design_scores_gemma":[0.027723331,0.032640785,0.42326006,0.013377608,0.021147152,0.005038082,0.0016250354,0.04228611,0.036264744,0.07370694,0.32226792,0.00066226046],"about_ca_topic_score_codex":0.0010969198,"about_ca_topic_score_gemma":0.0019378333,"teacher_disagreement_score":0.008901215,"about_ca_system_score_codex":0.001137007,"about_ca_system_score_gemma":0.001072034,"threshold_uncertainty_score":0.047074676},"labels":[],"label_agreement":null},{"id":"W2067404826","doi":"10.1016/j.jaad.2010.11.033","title":"Morphea-like skin reactions in patients treated with the cathepsin K inhibitor balicatib","year":2011,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Bone Metabolism and Diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":104,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Morphea; Skin biopsy; Adverse effect; Discontinuation; Dermatology; Scleroderma (fungus); Eosinophilic fasciitis; Clinical trial; Placebo; Internal medicine; Biopsy; Pathology","score_opus":0.00951082568874182,"score_gpt":0.23868868615483618,"score_spread":0.22917786046609437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067404826","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936373,0.0017573755,0.00026255785,0.00020275901,0.000036778147,0.000053923155,0.00006489318,0.000033488417,0.003951076],"genre_scores_gemma":[0.99924004,0.00026039113,0.000052864543,0.00012314443,0.000023725654,0.0000055360556,0.000032283104,0.000002141784,0.0002599564],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997497,0.00008276169,0.000026069232,0.00003913918,0.000044758748,0.000057490448],"domain_scores_gemma":[0.99949086,0.00016034709,0.00014124642,0.000031095704,0.000035609875,0.00014083844],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032858708,0.0004910151,0.0005027077,0.0005773767,0.00056706724,0.0003694998,0.00019323104,0.00069112517,0.0015795729],"category_scores_gemma":[0.0013205003,0.00026203037,0.0005721764,0.00037871028,0.00033255894,0.0002666456,0.00020029955,0.00081245485,0.00020155804],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013531308,0.0014866446,0.7138928,0.00038799256,0.00059276226,0.179046,0.0008736742,0.0003542611,0.03948304,0.0002267987,0.00092743326,0.049197294],"study_design_scores_gemma":[0.00038945136,0.004725659,0.83359563,0.000033117776,0.0004333073,0.15572348,0.00036325812,0.0005957583,0.0021575608,0.000096556665,0.0018601264,0.000026088393],"about_ca_topic_score_codex":0.0011283676,"about_ca_topic_score_gemma":0.0014043709,"teacher_disagreement_score":0.0015795729,"about_ca_system_score_codex":0.00028195826,"about_ca_system_score_gemma":0.00015140387,"threshold_uncertainty_score":0.00528425},"labels":[],"label_agreement":null},{"id":"W2067946670","doi":"10.1067/mjd.2001.110874","title":"Single-blind, randomized, prospective study on terbinafine and itraconazole for treatment of dermatophyte toenail onychomycosis in the elderly","year":2001,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Toronto Western Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Terbinafine; Medicine; Itraconazole; Dermatophyte; Randomized controlled trial; Nail (fastener); Dermatology; Clinical trial; Nail disease; Population; Surgery; Internal medicine; Antifungal; Complication","score_opus":0.029924207018481887,"score_gpt":0.3403536933022848,"score_spread":0.31042948628380296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067946670","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926225,0.0030459077,0.00051757216,0.00031731153,0.00045984986,0.0015345705,0.0005168121,0.00005311503,0.0009323663],"genre_scores_gemma":[0.99162453,0.002309612,0.00083084917,0.00081375055,0.0006109783,0.0016831235,0.0004825754,0.00001533483,0.0016292069],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.998546,0.0007749575,0.00014386137,0.00020500088,0.00009968893,0.00023050955],"domain_scores_gemma":[0.99762934,0.0007936203,0.00039430702,0.0002523459,0.00016027039,0.0007700509],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023886177,0.0014974687,0.005773654,0.00053784,0.000766674,0.0009440108,0.0010572331,0.0022007287,0.0058841445],"category_scores_gemma":[0.0031139276,0.001031114,0.001855664,0.0006169231,0.0018016145,0.0014193077,0.00045921924,0.0029680028,0.0009837371],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.99203604,0.0032304511,0.00030688595,0.00012874507,0.00042727645,0.000016939342,0.000019361894,0.00006637381,0.00068751845,0.000024248042,0.00009349117,0.0029626903],"study_design_scores_gemma":[0.9314036,0.065779716,0.0017838514,0.000014000588,0.00045295525,0.000019066963,0.000020272979,0.00014637933,0.00014693683,0.0000498425,0.00017231883,0.000011010199],"about_ca_topic_score_codex":0.002025666,"about_ca_topic_score_gemma":0.0033850202,"teacher_disagreement_score":0.0058841445,"about_ca_system_score_codex":0.00070603105,"about_ca_system_score_gemma":0.0012016166,"threshold_uncertainty_score":0.019684434},"labels":[],"label_agreement":null},{"id":"W2068089617","doi":"10.1016/j.jaad.2013.12.036","title":"Interleukin 17A: Toward a new understanding of psoriasis pathogenesis","year":2014,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":332,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Novartis (Canada); Dermatrials Research; Centre de Recherche Dermatologique du Québec Métropolitain; Lynde Centre for Dermatology","funders":"","keywords":"Psoriasis; Medicine; Immunology; Pathogenesis; Cytokine; Proinflammatory cytokine; Immune system; Inflammation; Chemokine; Interleukin 17","score_opus":0.07583151560383232,"score_gpt":0.3313353460327577,"score_spread":0.2555038304289254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068089617","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006375177,0.9984053,0.00013804242,0.0007000868,0.00034354758,0.0000022301754,0.000008197017,0.0000052215587,0.00033365496],"genre_scores_gemma":[0.0006912444,0.9976145,0.0002087456,0.00044871823,0.0006451795,0.000004524476,0.00001523004,8.8611506e-7,0.0003709428],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997708,0.000040862786,0.000031846892,0.000033852506,0.000096487136,0.000026091271],"domain_scores_gemma":[0.99950886,0.00020235313,0.00007218716,0.000015342192,0.00014313027,0.000058176855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00085746264,0.0007798081,0.0013963705,0.0015050425,0.00028107013,0.001393503,0.00088643434,0.0013899985,0.0019918582],"category_scores_gemma":[0.00086625543,0.000261272,0.00039259662,0.0015278129,0.0007387443,0.0017328499,0.0009094281,0.003113639,0.0012734903],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012305193,0.000081032194,0.00034430652,0.0073046195,0.00007596468,0.00018643244,0.000055774675,0.00025815642,0.0020802335,0.005783543,0.045117773,0.9385891],"study_design_scores_gemma":[0.000034368688,0.000073473224,0.0007498959,0.002074657,0.00010156386,0.0010836889,0.00008248496,0.00011449118,0.00046992445,0.004031312,0.99116206,0.000021999565],"about_ca_topic_score_codex":0.00090535945,"about_ca_topic_score_gemma":0.0015676281,"teacher_disagreement_score":0.0019918582,"about_ca_system_score_codex":0.0007303934,"about_ca_system_score_gemma":0.0017401129,"threshold_uncertainty_score":0.0066634417},"labels":[],"label_agreement":null},{"id":"W2068401061","doi":"10.1016/j.jaad.2005.12.043","title":"Treatment of solar lentigines","year":2006,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Skin Protection and Aging","field":"Medicine","cited_by":152,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Dermatology","score_opus":0.05158327811901271,"score_gpt":0.3899501833109303,"score_spread":0.3383669051919176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068401061","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00020188314,0.9987596,0.000106717525,0.000087505934,0.00013082389,0.000005344233,0.0000103136945,0.000007865813,0.0006898897],"genre_scores_gemma":[0.0023662853,0.99600357,0.00027394682,0.0002715592,0.00021827866,0.00000902168,0.000039934715,0.000002561545,0.0008147572],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99983513,0.000029296774,0.000024967545,0.000031786672,0.00006066885,0.000018120416],"domain_scores_gemma":[0.99983,0.0000817529,0.00003386023,0.0000061865976,0.00003274555,0.000015388436],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040714713,0.0008348194,0.0018002617,0.002106043,0.00027687763,0.00065577857,0.0009984699,0.00087637035,0.0034189261],"category_scores_gemma":[0.0005455862,0.00024983825,0.0007004848,0.0011694907,0.00036353045,0.0007091164,0.0004339468,0.0016063527,0.0013775345],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014352224,0.00015598992,0.0001336781,0.009710488,0.00013992052,0.00029707883,0.000027175218,0.00019153854,0.0013954893,0.0006652915,0.015925,0.9712147],"study_design_scores_gemma":[0.00029377406,0.00047590103,0.00305283,0.005887173,0.0006424594,0.0066463896,0.00008472812,0.0002783849,0.0016710064,0.001413383,0.97951186,0.00004194106],"about_ca_topic_score_codex":0.0009030277,"about_ca_topic_score_gemma":0.0020269589,"teacher_disagreement_score":0.0034189261,"about_ca_system_score_codex":0.00030845538,"about_ca_system_score_gemma":0.00038299285,"threshold_uncertainty_score":0.011437416},"labels":[],"label_agreement":null},{"id":"W2068616836","doi":"10.1067/s0190-9622(02)61490-2","title":"Surgical Pearl: Accurate documentation of facial lesions using only one landmark","year":2003,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Orthodontics and Dentofacial Orthopedics","field":"Dentistry","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Guenther Dermatology Research Centre","funders":"","keywords":"Nasion; Landmark; Medicine; Orientation (vector space); Face (sociological concept); Horizontal line test; Meatus; Horizontal plane; Pearl; Line (geometry); Orthodontics; Anatomy; Artificial intelligence; Computer science; Geodesy; Geology; Geometry; Mathematics","score_opus":0.04967551594364984,"score_gpt":0.3587559076870325,"score_spread":0.3090803917433827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068616836","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10750575,0.009952219,0.013612636,0.7714839,0.024928657,0.00015235355,0.00018817675,0.0007327016,0.07144374],"genre_scores_gemma":[0.688596,0.009999247,0.016434968,0.20858693,0.046488293,0.00015997986,0.00015988408,0.0002708662,0.029303823],"study_design_codex":"case_report","study_design_gemma":"not_applicable","domain_scores_codex":[0.99846673,0.0004383999,0.00029082387,0.00018572333,0.00036351423,0.0002549122],"domain_scores_gemma":[0.99719596,0.0016444437,0.0002947923,0.0001855533,0.00038516568,0.00029411496],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014587208,0.0006820143,0.000867809,0.0010348349,0.0014091181,0.00147599,0.0012989091,0.020345755,0.0031642444],"category_scores_gemma":[0.01432088,0.0006320224,0.0006775644,0.0005408337,0.0019928995,0.002895353,0.00064981374,0.009555951,0.001801755],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005770257,0.00017488535,0.011790592,0.0003085615,0.000059352576,0.6742471,0.0008489768,0.00052669673,0.0053962735,0.004816556,0.25193664,0.049317393],"study_design_scores_gemma":[0.00015924498,0.00032663735,0.006772044,0.00027662772,0.00008790486,0.8800235,0.0011273229,0.0035971988,0.003290333,0.0056530978,0.09860077,0.00008534841],"about_ca_topic_score_codex":0.0029210518,"about_ca_topic_score_gemma":0.0057613393,"teacher_disagreement_score":0.020345755,"about_ca_system_score_codex":0.0016411586,"about_ca_system_score_gemma":0.0009705215,"threshold_uncertainty_score":0.011907458},"labels":[],"label_agreement":null},{"id":"W2068672299","doi":"10.1016/j.jaad.2013.09.018","title":"Partially involuting congenital hemangiomas: A report of 8 cases and review of the literature","year":2013,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Vascular Malformations and Hemangiomas","field":"Medicine","cited_by":171,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Hemangioma; Involution (esoterism); Lesion; Infantile hemangioma; Radiology; Dermatology; Pathology","score_opus":0.03647301793229579,"score_gpt":0.35213848565502365,"score_spread":0.31566546772272785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068672299","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.057273597,0.93427736,0.0015861186,0.00071697484,0.00030610463,0.00007979607,0.00027190222,0.00009724976,0.0053909756],"genre_scores_gemma":[0.22247915,0.7692512,0.0030039877,0.0012522759,0.001158432,0.00004108075,0.00051890785,0.000037184473,0.0022577753],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99947685,0.000052796804,0.000184215,0.000104894796,0.00010430724,0.00007697943],"domain_scores_gemma":[0.99870133,0.00051547366,0.000451315,0.00007725199,0.00011020929,0.00014434224],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040267117,0.0018522347,0.0015759809,0.006288129,0.0008035701,0.001788467,0.0016578395,0.0018833929,0.002414523],"category_scores_gemma":[0.0015192985,0.0006894279,0.00083345943,0.004813657,0.0014103955,0.0027907463,0.001339572,0.0011009255,0.001150819],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015086409,0.0002086689,0.022488317,0.008010888,0.00038899583,0.67461854,0.001152429,0.0005176609,0.005499256,0.00059614435,0.007592987,0.2787752],"study_design_scores_gemma":[0.000013483238,0.000045781606,0.008346197,0.0012021067,0.00033715396,0.96240765,0.00056091114,0.000100098405,0.000808081,0.00037919098,0.025752727,0.000046607114],"about_ca_topic_score_codex":0.0010691136,"about_ca_topic_score_gemma":0.0021090664,"teacher_disagreement_score":0.006288129,"about_ca_system_score_codex":0.00056189205,"about_ca_system_score_gemma":0.00094646413,"threshold_uncertainty_score":0.008077383},"labels":[],"label_agreement":null},{"id":"W2070862276","doi":"10.1016/j.jaad.2006.04.054","title":"Is melanocytic nevus with focal atypical epithelioid components (clonal nevus) a superficial variant of deep penetrating nevus?","year":2006,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Nevus; Dermatology; Melanocytic nevus; Blue nevus; Congenital melanocytic nevus; Spitz nevus; Melanoma; Cancer research","score_opus":0.014455283461301262,"score_gpt":0.26751789546324645,"score_spread":0.2530626120019452,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070862276","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97959214,0.0038550298,0.0015764503,0.0014517435,0.000099730016,0.00003339897,0.00006878278,0.000058996415,0.013263653],"genre_scores_gemma":[0.9979407,0.00084634847,0.00030026468,0.00022475602,0.00020099712,0.0000038385174,0.000021479638,0.0000033105748,0.00045818402],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.999777,0.000028546347,0.00002500019,0.000039207494,0.000050739818,0.00007948674],"domain_scores_gemma":[0.9994993,0.00016264322,0.00016559898,0.000048081278,0.000048102793,0.000076176075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035755185,0.00042193598,0.0005256835,0.000577342,0.00033042574,0.000813217,0.0006056357,0.0019499524,0.0021436112],"category_scores_gemma":[0.0019878217,0.00021385045,0.0002100701,0.0007443683,0.0010173353,0.0013426809,0.00032179744,0.0004317418,0.0006158624],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004527671,0.00011456745,0.21167769,0.00032267088,0.0000648116,0.7083207,0.0005731438,0.0002758882,0.024290144,0.0031998474,0.0011629331,0.049544957],"study_design_scores_gemma":[0.000016350388,0.0001525921,0.06850282,0.00003787737,0.00004134757,0.9260213,0.0005349337,0.0004248601,0.0011074739,0.0013221769,0.0018241779,0.000014106157],"about_ca_topic_score_codex":0.00063343416,"about_ca_topic_score_gemma":0.001010428,"teacher_disagreement_score":0.0021436112,"about_ca_system_score_codex":0.00019672755,"about_ca_system_score_gemma":0.00020159649,"threshold_uncertainty_score":0.007171154},"labels":[],"label_agreement":null},{"id":"W2071165265","doi":"10.1016/j.jaad.2005.10.014","title":"A survey on the prevalence of orofacial herpes in France: The INSTANT Study","year":2006,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Facial Nerve Paralysis Treatment and Research","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Medicine; Epidemiology; Confidence interval; Quality of life (healthcare); Population; Disease; Cross-sectional study; Pediatrics; Internal medicine; Pathology; Environmental health","score_opus":0.031311186909773116,"score_gpt":0.3562960082437731,"score_spread":0.324984821334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071165265","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977564,0.00031683777,0.0000541486,0.00009731812,0.000005564278,0.000011882352,0.0008545435,0.000005002583,0.00089825894],"genre_scores_gemma":[0.99776864,0.00039535284,0.00009693066,0.00013160412,0.000019486653,0.000023674793,0.0008871281,0.000003725415,0.00067349913],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992889,0.00022845366,0.000072962066,0.000120313845,0.00013799104,0.00015138405],"domain_scores_gemma":[0.9989519,0.00018537004,0.00037412118,0.000059001646,0.00024145312,0.00018799369],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00086260814,0.00040143626,0.00043108937,0.0016166592,0.0005216885,0.0008878891,0.00032040456,0.00083015504,0.0015233046],"category_scores_gemma":[0.0012174903,0.0002397737,0.0005223906,0.001468147,0.00028970282,0.0005921352,0.00044087367,0.00033006366,0.00038583015],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000077448065,0.00006961135,0.9963117,0.000015764525,0.000054017935,0.00014126142,0.0004747546,0.000026127169,0.00035691468,0.000026731255,0.0003417185,0.0021039823],"study_design_scores_gemma":[0.000005857951,0.00009530858,0.99865216,0.0000056261965,0.000017109736,0.00020666241,0.00045332403,0.00002690777,0.000022494787,0.0000039054607,0.00050664606,0.0000039559955],"about_ca_topic_score_codex":0.077216886,"about_ca_topic_score_gemma":0.051125437,"teacher_disagreement_score":0.077216886,"about_ca_system_score_codex":0.0010314398,"about_ca_system_score_gemma":0.00067745405,"threshold_uncertainty_score":0.15353489},"labels":[],"label_agreement":null},{"id":"W2071374810","doi":"10.1016/j.jaad.2010.04.004","title":"Long-term etanercept in pediatric patients with plaque psoriasis","year":2010,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":105,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Etanercept; Psoriasis; Psoriasis Area and Severity Index; Adverse effect; Placebo; Internal medicine; Interim analysis; Dermatology Life Quality Index; Clinical endpoint; Randomized controlled trial; Plaque psoriasis; Dermatology; Tumor necrosis factor alpha","score_opus":0.007928751217707723,"score_gpt":0.24474649434592544,"score_spread":0.2368177431282177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071374810","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99013174,0.007777664,0.00009378418,0.00034171934,0.000027722606,0.000008988031,0.0001370188,0.000010147033,0.0014712382],"genre_scores_gemma":[0.9972366,0.0021452594,0.00008367323,0.00015411468,0.000033180924,0.000008728476,0.00013701388,0.0000025400393,0.00019889844],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99967873,0.00009256049,0.00003976708,0.000039106104,0.0000665091,0.000083270796],"domain_scores_gemma":[0.9992642,0.00028432763,0.00023713027,0.000019915644,0.000048150905,0.00014628899],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036949257,0.00021466882,0.000599964,0.00023629707,0.00033549147,0.00039841374,0.00016103213,0.00041759174,0.00080837513],"category_scores_gemma":[0.0015017034,0.0001165858,0.00040764498,0.00041711712,0.00020848335,0.00044480903,0.00014702968,0.0007142278,0.000113936454],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036518152,0.00048567247,0.92333853,0.00019122548,0.00019837538,0.011524797,0.00042103062,0.00025428433,0.0036829002,0.0001658864,0.0010198809,0.055065546],"study_design_scores_gemma":[0.00034584085,0.0034050038,0.9546083,0.00012123785,0.0004385953,0.03603163,0.00073879753,0.00031092195,0.0010493823,0.0001442177,0.0027883549,0.000017669661],"about_ca_topic_score_codex":0.0017688535,"about_ca_topic_score_gemma":0.003091865,"teacher_disagreement_score":0.0017688535,"about_ca_system_score_codex":0.0004958884,"about_ca_system_score_gemma":0.0006083994,"threshold_uncertainty_score":0.0035979748},"labels":[],"label_agreement":null},{"id":"W2071599182","doi":"10.1016/j.jaad.2013.07.029","title":"Evaluation of essential clinical components and features of current acne global grading scales","year":2013,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Windsor Clinical Research; University of Windsor; Western University","funders":"","keywords":"Medicine; Categorical variable; Acne; Grading (engineering); Subcategory; Grading scale; Statistics; Dermatology; Surgery; Mathematics","score_opus":0.1297352295094553,"score_gpt":0.49430542308506104,"score_spread":0.3645701935756057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071599182","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001785172,0.9958839,0.000462233,0.00020388869,0.00011357047,0.00005043111,0.00013862176,0.000013053761,0.0013490835],"genre_scores_gemma":[0.021215037,0.9741337,0.0026674732,0.00031080455,0.00018241329,0.00007616005,0.0004384786,0.0000050384656,0.0009708638],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99939764,0.000107429005,0.00013418742,0.00007760412,0.00025053642,0.00003262708],"domain_scores_gemma":[0.9987791,0.0005553825,0.0002772976,0.000018516192,0.00033711005,0.00003257282],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016514221,0.00091424375,0.0022844165,0.0033757556,0.00016544883,0.0008099341,0.00097360497,0.00043133946,0.0018107143],"category_scores_gemma":[0.002201291,0.00024927626,0.00127668,0.002160805,0.000344268,0.00084642414,0.00051135366,0.00093240186,0.00037850183],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025809932,0.00010867967,0.004490206,0.02050806,0.00057466334,0.0000896689,0.000066005625,0.00021491792,0.0010195952,0.0006243958,0.0063719843,0.96567374],"study_design_scores_gemma":[0.0006535302,0.0011888896,0.16051635,0.065833226,0.010092261,0.006653315,0.0010352506,0.0023912257,0.005505612,0.0040537342,0.74175906,0.0003175872],"about_ca_topic_score_codex":0.0022609388,"about_ca_topic_score_gemma":0.004947371,"teacher_disagreement_score":0.0033757556,"about_ca_system_score_codex":0.0005251534,"about_ca_system_score_gemma":0.0008988416,"threshold_uncertainty_score":0.00873363},"labels":[],"label_agreement":null},{"id":"W2071745809","doi":"10.1016/j.jaad.2008.04.006","title":"A pilot quality-of-life instrument for pruritus","year":2008,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":221,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","keywords":"Medicine; Cronbach's alpha; Intraclass correlation; Discriminant validity; Construct validity; Quality of life (healthcare); Reliability (semiconductor); Physical therapy; Face validity; Psychometrics; Clinical psychology; Internal consistency","score_opus":0.07489328298359757,"score_gpt":0.3671106187085306,"score_spread":0.292217335724933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071745809","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97009856,0.00068991876,0.004535409,0.0009287059,0.00018715262,0.008712886,0.007389539,0.00024376366,0.0072141006],"genre_scores_gemma":[0.9611496,0.00043431134,0.019643063,0.00065276795,0.00009890207,0.007867989,0.0068796193,0.000064963584,0.0032087285],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969463,0.0011169175,0.00063041685,0.00023340023,0.00078078517,0.00029206544],"domain_scores_gemma":[0.9897685,0.0036791824,0.0026752597,0.00053075096,0.0021515675,0.0011947205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0055062626,0.0006978605,0.0010158506,0.0013751005,0.0006839155,0.0009530435,0.0008156325,0.00080775336,0.0049715913],"category_scores_gemma":[0.011661048,0.00030622003,0.0021318893,0.000871457,0.0003912251,0.0012346567,0.0016673894,0.0016572453,0.0008328584],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007146279,0.008646945,0.75170505,0.00090229977,0.0010556581,0.00024900062,0.002102363,0.0025713332,0.0030005046,0.00084217184,0.0130448835,0.20873351],"study_design_scores_gemma":[0.0009214797,0.0042100153,0.98504156,0.00008563428,0.00018526579,0.00032993322,0.00048134272,0.0019678576,0.0007512053,0.00026574946,0.0056979577,0.00006199936],"about_ca_topic_score_codex":0.0013539282,"about_ca_topic_score_gemma":0.0027766002,"teacher_disagreement_score":0.0055062626,"about_ca_system_score_codex":0.0010715511,"about_ca_system_score_gemma":0.0010222689,"threshold_uncertainty_score":0.029120266},"labels":[],"label_agreement":null},{"id":"W2071780577","doi":"10.1016/j.jaad.2010.01.030","title":"Efficacy and safety of ABT-874, a monoclonal anti–interleukin 12/23 antibody, for the treatment of chronic plaque psoriasis: 36-week observation/retreatment and 60-week open-label extension phases of a randomized phase II trial","year":2010,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Psoriasis; Placebo; Adverse effect; Psoriasis Area and Severity Index; Dosing; Internal medicine; Dose; Gastroenterology; Surgery; Dermatology; Pathology","score_opus":0.04806543979036704,"score_gpt":0.34248805588444153,"score_spread":0.2944226160940745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071780577","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935609,0.0027547986,0.00039980936,0.0003720438,0.00023576203,0.0010674783,0.00048326625,0.000087786175,0.0010380258],"genre_scores_gemma":[0.99188095,0.0018939413,0.0010552098,0.00061103946,0.00043811416,0.0014540616,0.0008989934,0.00003437879,0.0017333684],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99862576,0.00079134223,0.00007739067,0.00017642505,0.000113497495,0.00021571011],"domain_scores_gemma":[0.99834883,0.0005106631,0.00029795663,0.00016388092,0.000111294205,0.00056734314],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033517869,0.0022647628,0.0038653,0.0006615048,0.00063566153,0.0012456124,0.0013487064,0.0023901786,0.0039223633],"category_scores_gemma":[0.0022837352,0.00098634,0.0024374619,0.00052838796,0.002164192,0.001680676,0.0004248352,0.0046973266,0.0012045234],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9677952,0.011271461,0.0006158964,0.00021605703,0.00044596163,0.000021970664,0.00005113709,0.00039465458,0.0029062245,0.00004585871,0.00037376408,0.015861917],"study_design_scores_gemma":[0.8874772,0.10894295,0.0019713645,0.000014219619,0.0003067286,0.000027420618,0.000015937358,0.0004017677,0.0005444768,0.00006647314,0.00021685715,0.00001458359],"about_ca_topic_score_codex":0.0012795591,"about_ca_topic_score_gemma":0.0015996279,"teacher_disagreement_score":0.0039223633,"about_ca_system_score_codex":0.0009683412,"about_ca_system_score_gemma":0.0011668981,"threshold_uncertainty_score":0.017726183},"labels":[],"label_agreement":null},{"id":"W2072087609","doi":"10.1016/j.jaad.2008.09.056","title":"Dental manifestations of dermatologic conditions","year":2008,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Autoimmune and Inflammatory Disorders","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Université de Montréal; University of Toronto","funders":"","keywords":"Medicine; Dermatology; MEDLINE; Dentistry","score_opus":0.03661254928073725,"score_gpt":0.37719905987092706,"score_spread":0.3405865105901898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072087609","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00027305723,0.99796945,0.00015667712,0.00014965955,0.00019574726,0.0000050213957,0.000014066797,0.000009080146,0.001227237],"genre_scores_gemma":[0.0020663594,0.99606055,0.0003271761,0.0003056374,0.0005869727,0.0000045740053,0.00003672792,0.0000017651676,0.0006101621],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995369,0.000071423245,0.00009950551,0.00007939545,0.00017016674,0.000042744006],"domain_scores_gemma":[0.99917823,0.00040220167,0.00017201812,0.00002185541,0.00016045386,0.00006529463],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005823447,0.0011633941,0.002406202,0.0049198978,0.000430617,0.0014349048,0.0011521226,0.0013495616,0.002419575],"category_scores_gemma":[0.0011700763,0.0004589269,0.0007070144,0.003594697,0.0007333646,0.0017595591,0.0009809667,0.001747068,0.0013903083],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007400604,0.00010795228,0.0013993998,0.013283069,0.00012818648,0.0027236445,0.000118260876,0.00021099416,0.0011503384,0.00082851114,0.027752176,0.95222336],"study_design_scores_gemma":[0.000063685955,0.00012293362,0.010875415,0.0131151965,0.000723356,0.053121578,0.00045446423,0.0003277905,0.00062102434,0.0017733948,0.91871405,0.0000870473],"about_ca_topic_score_codex":0.0015113796,"about_ca_topic_score_gemma":0.0038318483,"teacher_disagreement_score":0.0049198978,"about_ca_system_score_codex":0.00046362376,"about_ca_system_score_gemma":0.00092660775,"threshold_uncertainty_score":0.008094251},"labels":[],"label_agreement":null},{"id":"W2073148029","doi":"10.1067/mjd.2000.104794","title":"Prevalence and epidemiology of onychomycosis in patients visiting physicians’ offices: A multicenter Canadian survey of 15,000 patients","year":2000,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":385,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Hospital; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Nail disease; Dermatology; Epidemiology; Dermatophyte; Nail (fastener); Nail plate; Mycosis; Multicenter study; Confidence interval; Surgery; Internal medicine; Paronychia; Randomized controlled trial","score_opus":0.017546279767523067,"score_gpt":0.3044201543200576,"score_spread":0.28687387455253455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073148029","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948931,0.0005888803,0.000050678842,0.00018417266,0.000010459167,0.000045826193,0.00278243,0.000009441216,0.001435049],"genre_scores_gemma":[0.99769896,0.0005391122,0.00013550249,0.0001239465,0.000008470989,0.000017527693,0.0011586705,0.0000048807533,0.00031301175],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984425,0.00011883466,0.000114464325,0.00024243562,0.0005479353,0.0005338057],"domain_scores_gemma":[0.9975459,0.00010769287,0.0005479359,0.000065228516,0.0010742233,0.0006590743],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073605846,0.00071989896,0.00065869646,0.0024968085,0.0027514426,0.0014664495,0.002080334,0.0011730096,0.0015872115],"category_scores_gemma":[0.0019366174,0.0007862261,0.0010184229,0.0057604653,0.0010540622,0.00087039813,0.0010441288,0.0010502707,0.00024401145],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046646244,0.000045922356,0.99820054,0.00001721893,0.000039070965,0.000063440035,0.00036191335,0.000029871593,0.00013394005,0.000020682884,0.00032567943,0.00071514037],"study_design_scores_gemma":[0.000004447039,0.000026932568,0.99881977,0.000010362321,0.000017597087,0.00010991323,0.00074382965,0.000064727945,0.000016565022,0.0000047302333,0.00017394671,0.000007169703],"about_ca_topic_score_codex":0.97768,"about_ca_topic_score_gemma":0.9821792,"teacher_disagreement_score":0.022319973,"about_ca_system_score_codex":0.014927588,"about_ca_system_score_gemma":0.014514249,"threshold_uncertainty_score":0.10830772},"labels":[],"label_agreement":null},{"id":"W2073561686","doi":"10.1016/j.jaad.2010.08.012","title":"Early treatment of cold sores with topical ME-609 decreases the frequency of ulcerative lesions: A randomized, double-blind, placebo-controlled, patient-initiated clinical trial","year":2010,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Placebo; Herpes Labialis; Randomized controlled trial; Lesion; Surgery; Internal medicine; Corticosteroid; Gastroenterology; Dermatology; Herpes simplex virus; Pathology; Virus","score_opus":0.05556703398014337,"score_gpt":0.38086227189742644,"score_spread":0.3252952379172831,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073561686","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9795364,0.0092181275,0.0012742409,0.00084836246,0.0012587268,0.004254743,0.0009614807,0.00030592663,0.002341932],"genre_scores_gemma":[0.9802868,0.0057716076,0.002637339,0.001554827,0.0011405252,0.0041377107,0.00088352006,0.00005122869,0.003536388],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9992048,0.00036567272,0.000063624735,0.00015647782,0.00007190778,0.00013747597],"domain_scores_gemma":[0.9987766,0.00043485465,0.00022142875,0.00009236696,0.000080050384,0.0003946468],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018166146,0.002263751,0.0065323417,0.00074255356,0.0006854362,0.0012851555,0.0015713382,0.0038058336,0.00811355],"category_scores_gemma":[0.0020451488,0.0011251094,0.002381768,0.0005271047,0.0016701302,0.0013016633,0.00045014283,0.004763894,0.0012834222],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98339176,0.0062695397,0.00013528008,0.0005984488,0.0004353465,0.00001970042,0.000022036611,0.00008920514,0.0019044781,0.000045810702,0.0002679174,0.0068204068],"study_design_scores_gemma":[0.96160764,0.037223946,0.00045495175,0.00002217613,0.0001962347,0.000012270565,0.0000072069265,0.00013368792,0.0001768648,0.000033836463,0.00012223805,0.000008944556],"about_ca_topic_score_codex":0.00081227376,"about_ca_topic_score_gemma":0.0013464796,"teacher_disagreement_score":0.00811355,"about_ca_system_score_codex":0.00051165815,"about_ca_system_score_gemma":0.0009899338,"threshold_uncertainty_score":0.027142584},"labels":[],"label_agreement":null},{"id":"W2073746165","doi":"10.1016/j.jaad.2013.07.019","title":"Livedoid vasculopathy: An in-depth analysis using a modified Delphi approach","year":2013,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":133,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Toronto","funders":"","keywords":"Medicine; Livedo reticularis; Context (archaeology); Scars; Chronic venous insufficiency; Dermatology; Pathology; Internal medicine; Disease","score_opus":0.09543194511483541,"score_gpt":0.39356096386870926,"score_spread":0.2981290187538739,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073746165","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14517623,0.8066359,0.016599555,0.006784999,0.00058462267,0.007578939,0.0014976248,0.000037642454,0.015104465],"genre_scores_gemma":[0.33240494,0.6252779,0.031075474,0.0027685342,0.00020553889,0.005080739,0.0010531291,0.000019124585,0.0021146329],"study_design_codex":"design_other","study_design_gemma":"qualitative","domain_scores_codex":[0.9890553,0.006614109,0.0018109226,0.00031854887,0.0018200661,0.00038104915],"domain_scores_gemma":[0.98522896,0.011299249,0.00096221507,0.00019142703,0.0021513794,0.00016667623],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016103992,0.0007345018,0.0015068479,0.0043313643,0.000848854,0.0014281309,0.0008521297,0.0005781556,0.0023383307],"category_scores_gemma":[0.015485855,0.0003332438,0.0012353896,0.0036815947,0.0006546501,0.0014262098,0.0017807074,0.000868556,0.00018574695],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049914303,0.00022840677,0.015113226,0.07837865,0.000980797,0.0013738207,0.019818913,0.00063489185,0.0018499036,0.004406052,0.0089031495,0.86781305],"study_design_scores_gemma":[0.0004877482,0.001628512,0.12715328,0.26761684,0.009219384,0.023250408,0.12259717,0.0023522293,0.003789612,0.011242365,0.43023837,0.00042405893],"about_ca_topic_score_codex":0.001486449,"about_ca_topic_score_gemma":0.004232289,"teacher_disagreement_score":0.016103992,"about_ca_system_score_codex":0.0017479488,"about_ca_system_score_gemma":0.004226329,"threshold_uncertainty_score":0.08516711},"labels":[],"label_agreement":null},{"id":"W2074061573","doi":"10.1016/j.jaad.2010.02.034","title":"Childhood bullous pemphigoid: A rare manifestation of chronic renal allograft rejection","year":2011,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Autoimmune Bullous Skin Diseases","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"British Columbia Children's Hospital","funders":"","keywords":"Medicine; Bullous pemphigoid; Dermatology; Chronic renal failure; Surgery; Immunology","score_opus":0.024007760083725876,"score_gpt":0.3260734038949587,"score_spread":0.3020656438112328,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074061573","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00076726737,0.99790454,0.0001537616,0.00022964201,0.00013734776,0.0000031098662,0.00001696967,0.0000071525737,0.00078013976],"genre_scores_gemma":[0.005592242,0.99289215,0.00022655244,0.0003263351,0.00045683616,0.0000033758886,0.000045775654,0.0000015824372,0.00045514083],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.999772,0.000030846208,0.000049753948,0.000047982798,0.000067382025,0.000032182805],"domain_scores_gemma":[0.9995253,0.000221971,0.00012352473,0.00001205942,0.00007016005,0.000046936686],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035833108,0.0007241067,0.0014543032,0.0021228187,0.00026482096,0.00097479305,0.00075118535,0.0010455641,0.0016419198],"category_scores_gemma":[0.00074600836,0.0002902527,0.0004011891,0.0019047391,0.000424849,0.0014724364,0.00056854065,0.0012694842,0.0007329859],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012514644,0.00009658163,0.00414421,0.016070863,0.00021534692,0.019110238,0.00011560167,0.00036631114,0.0021548693,0.0014580198,0.030675596,0.9254673],"study_design_scores_gemma":[0.00008724356,0.00018410271,0.015997745,0.007437046,0.0008637729,0.26675233,0.0004127079,0.00036105458,0.001320402,0.0017484996,0.7047409,0.00009422149],"about_ca_topic_score_codex":0.001097413,"about_ca_topic_score_gemma":0.0019136027,"teacher_disagreement_score":0.0021228187,"about_ca_system_score_codex":0.00034501828,"about_ca_system_score_gemma":0.0007390432,"threshold_uncertainty_score":0.0054928064},"labels":[],"label_agreement":null},{"id":"W2074849709","doi":"10.1016/j.jaad.2003.10.118","title":"MOHS micrographic surgery: a historical overview","year":2004,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Medicine and Dermatology Studies History","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; University of Calgary","funders":"","keywords":"Medicine; Mohs surgery; Dermatology; Surgery; General surgery","score_opus":0.0388120817933563,"score_gpt":0.3165677404443539,"score_spread":0.27775565865099755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074849709","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00063037133,0.98688763,0.00048243,0.0034523602,0.0019352803,0.000007307921,0.000019156843,0.000011244847,0.0065742545],"genre_scores_gemma":[0.01091335,0.9701362,0.0007951402,0.005088788,0.010994125,0.000029809215,0.000041385716,0.000013414236,0.0019877425],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99908304,0.00026361216,0.00015163691,0.00022389762,0.0001623372,0.00011543917],"domain_scores_gemma":[0.9972631,0.0017002343,0.00022545794,0.00009143809,0.00048103285,0.00023889942],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002483989,0.0010991252,0.0009071425,0.009113069,0.0018228169,0.0036774236,0.0012569532,0.003998726,0.002599308],"category_scores_gemma":[0.0034412027,0.0007198766,0.00065929344,0.005628416,0.006657837,0.0063322634,0.0020013065,0.006893025,0.0012738755],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035040488,0.00056069513,0.007175686,0.010502347,0.00015913714,0.007523942,0.0034051412,0.0011918515,0.0015307434,0.1395096,0.14711502,0.68097544],"study_design_scores_gemma":[0.000017949695,0.00017626512,0.005942836,0.005071384,0.00006565193,0.014128017,0.0012304937,0.00020830719,0.00026805777,0.014139495,0.95866156,0.0000900057],"about_ca_topic_score_codex":0.0029372969,"about_ca_topic_score_gemma":0.0069416515,"teacher_disagreement_score":0.009113069,"about_ca_system_score_codex":0.0041215173,"about_ca_system_score_gemma":0.0025665406,"threshold_uncertainty_score":0.02990383},"labels":[],"label_agreement":null},{"id":"W2075382650","doi":"10.1016/j.jaad.2009.08.040","title":"Efficacy and safety of adalimumab in patients with plaque psoriasis who have shown an unsatisfactory response to etanercept","year":2010,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":48,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lynde Centre for Dermatology; Guenther Dermatology Research Centre; Centre de Recherche Dermatologique du Québec Métropolitain; Innovaderm (Canada)","funders":"","keywords":"Adalimumab; Medicine; Etanercept; Adverse effect; Confidence interval; Internal medicine; Psoriasis; Surgery; Gastroenterology; Dermatology; Tumor necrosis factor alpha","score_opus":0.00841022388969352,"score_gpt":0.2526636037709236,"score_spread":0.2442533798812301,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075382650","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966522,0.002059098,0.00006696605,0.00014254912,0.000031770145,0.000015925503,0.00006771273,0.000010921988,0.00095286535],"genre_scores_gemma":[0.9992797,0.00023575801,0.000054194614,0.00012582527,0.000038905022,0.000007556922,0.00008039504,0.000001966586,0.00017571887],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996518,0.000113841976,0.000053200165,0.000044050597,0.000058710524,0.00007846878],"domain_scores_gemma":[0.9990928,0.000418191,0.00015886658,0.00006304684,0.000075478,0.0001916114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010653295,0.00030926985,0.0011734912,0.0002276705,0.00037696783,0.0005782326,0.00017937603,0.00046456518,0.0009357745],"category_scores_gemma":[0.0019371539,0.00018667501,0.0007288866,0.00021610864,0.00024326511,0.0004114151,0.00013409893,0.0010294027,0.00024436976],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2953546,0.004036965,0.43341744,0.0005155735,0.0020483772,0.0016994913,0.00040734845,0.0019550421,0.025116375,0.0002128971,0.001785005,0.23345086],"study_design_scores_gemma":[0.017082281,0.08302848,0.88031864,0.00008996249,0.00224073,0.004052774,0.00025881303,0.0041433154,0.005265392,0.00021307416,0.0032413197,0.00006527582],"about_ca_topic_score_codex":0.00058422267,"about_ca_topic_score_gemma":0.00082008407,"teacher_disagreement_score":0.0011734912,"about_ca_system_score_codex":0.00036510866,"about_ca_system_score_gemma":0.00020766795,"threshold_uncertainty_score":0.0056340694},"labels":[],"label_agreement":null},{"id":"W2077277924","doi":"10.1016/j.jaad.2005.10.061","title":"A randomized, multicenter, double-blind, placebo-controlled phase 2 trial of ISA247 in patients with chronic plaque psoriasis","year":2006,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":56,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Centre de Recherche Dermatologique du Québec Métropolitain; Probity Medical Research; Innovaderm (Canada)","funders":"","keywords":"Medicine; Psoriasis; Placebo; Psoriasis Area and Severity Index; Body surface area; Internal medicine; Calcineurin; Creatinine; Renal function; Plaque psoriasis; Randomized controlled trial; Clinical endpoint; Gastroenterology; Adverse effect; Urology; Dermatology; Pathology; Transplantation","score_opus":0.013288853269379763,"score_gpt":0.27992318773841834,"score_spread":0.26663433446903856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077277924","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98149616,0.00482704,0.00097046053,0.0013637734,0.0012495243,0.0050239936,0.0011820052,0.0003501576,0.0035368984],"genre_scores_gemma":[0.97883475,0.003615125,0.0017606063,0.0024827037,0.0008046588,0.005415266,0.0015900324,0.00006365019,0.005433201],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9994276,0.00024913435,0.000026820177,0.00010972586,0.000045290155,0.00014143088],"domain_scores_gemma":[0.9993344,0.00018062208,0.00010403231,0.000058034937,0.000058508744,0.000264381],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001493047,0.002367635,0.004706983,0.0007298722,0.0007863202,0.0013991711,0.0012911907,0.002967471,0.0099691395],"category_scores_gemma":[0.0018064531,0.0010729296,0.0018129004,0.0005086409,0.0017835228,0.0016360093,0.0005032996,0.004507723,0.0019662871],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9779114,0.0075387284,0.00025258728,0.00048414248,0.00067185797,0.00003990151,0.000046528476,0.00019178462,0.0020894741,0.00011754278,0.0009081629,0.009747934],"study_design_scores_gemma":[0.97491384,0.024017412,0.00042911933,0.000011279333,0.00014332845,0.000013119615,0.000014983187,0.00009580687,0.00010149464,0.00005560429,0.00019657881,0.000007472659],"about_ca_topic_score_codex":0.0010946149,"about_ca_topic_score_gemma":0.001985422,"teacher_disagreement_score":0.0099691395,"about_ca_system_score_codex":0.00060885854,"about_ca_system_score_gemma":0.0012780945,"threshold_uncertainty_score":0.03335011},"labels":[],"label_agreement":null},{"id":"W2078157933","doi":"10.1016/j.jaad.2005.03.046","title":"Epidemiology of psoriatic arthritis in the population of the United States","year":2005,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":592,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University Health Network; University of Toronto","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","keywords":"Medicine; Psoriatic arthritis; Epidemiology; Dermatology; Population; Arthritis; Psoriasis; Environmental health; Internal medicine","score_opus":0.025612287921444134,"score_gpt":0.33664121485827636,"score_spread":0.3110289269368322,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078157933","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99137294,0.004111927,0.00020510067,0.0004970582,0.000043872995,0.000017014625,0.0019948042,0.000017567088,0.0017397632],"genre_scores_gemma":[0.9978879,0.00118309,0.000094763265,0.00010402171,0.000043267522,0.00000874748,0.00053256477,0.0000015963531,0.0001439438],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989448,0.00035025997,0.00019711089,0.00017628225,0.00024501828,0.00008644419],"domain_scores_gemma":[0.99826884,0.00018493562,0.0008559357,0.0000841744,0.0003047303,0.00030132598],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005720273,0.00020098538,0.0003656979,0.0018404453,0.00041608358,0.00071831106,0.00029392325,0.0006252722,0.0010244006],"category_scores_gemma":[0.0017834591,0.00028731034,0.00055760285,0.0028679604,0.00028444038,0.00061965315,0.0004806265,0.00063178455,0.00015843532],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026832515,0.00002987634,0.9982192,0.000012809168,0.00007107824,0.00002964022,0.000033619235,0.000031740383,0.00009753743,0.000018687064,0.0002454442,0.0011835268],"study_design_scores_gemma":[0.0000017516763,0.000029473435,0.99941266,0.0000066756065,0.000021103646,0.00015391792,0.00013532874,0.00006758159,0.000010841646,0.000015761407,0.00014262939,0.0000022571367],"about_ca_topic_score_codex":0.035136137,"about_ca_topic_score_gemma":0.036520176,"teacher_disagreement_score":0.035136137,"about_ca_system_score_codex":0.000527584,"about_ca_system_score_gemma":0.00060602865,"threshold_uncertainty_score":0.06986326},"labels":[],"label_agreement":null},{"id":"W2078971255","doi":"10.1016/j.jaad.2011.05.025","title":"Targetoid hemosiderotic hemangiomas (hobnail hemangiomas) are vascular lymphatic malformations: A study of 12 pediatric cases","year":2011,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Vascular Malformations and Hemangiomas","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Lymphatic system; Pathology; Hemangioma; Immunostaining; Lymphatic Endothelium; Wilms' tumor; Lymphatic vessel; Lesion; Immunohistochemistry; Internal medicine; Cancer","score_opus":0.04019148258505285,"score_gpt":0.2862178642676446,"score_spread":0.24602638168259178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078971255","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996772,0.00083428284,0.00060655497,0.00003295341,0.000009589376,0.00005537336,0.00010715729,0.000019534044,0.0015625709],"genre_scores_gemma":[0.9983144,0.0006188612,0.00054269924,0.00003587442,0.00003309694,0.0000312601,0.00011309404,0.000017975166,0.00029287205],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9991394,0.000106940715,0.0001673904,0.00018176401,0.00015206863,0.00025237404],"domain_scores_gemma":[0.99802953,0.0007004427,0.00046815097,0.00018278099,0.00019271599,0.00042633884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052780303,0.0012087771,0.0010359467,0.002465288,0.0016594921,0.0009997269,0.0008800158,0.0012535547,0.0024797819],"category_scores_gemma":[0.0025025918,0.0010631199,0.000682769,0.0017849649,0.0014778228,0.0012932405,0.0009810457,0.0007768665,0.0009025412],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045934305,0.000543633,0.37556088,0.00011250569,0.00006372511,0.60400224,0.0023488419,0.00023312475,0.0059255897,0.000253631,0.00025531524,0.010241088],"study_design_scores_gemma":[0.000036229776,0.00060468307,0.21301861,0.000026052683,0.00011638115,0.77888966,0.0021184753,0.00025043334,0.0033989768,0.0001221657,0.0013844699,0.000033889846],"about_ca_topic_score_codex":0.0010186125,"about_ca_topic_score_gemma":0.0013262731,"teacher_disagreement_score":0.0024797819,"about_ca_system_score_codex":0.0005459293,"about_ca_system_score_gemma":0.00052915106,"threshold_uncertainty_score":0.008295715},"labels":[],"label_agreement":null},{"id":"W2079525680","doi":"10.1067/mjd.2000.108320","title":"Tazarotene combination treatments in psoriasis","year":2000,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Tazarotene; Medicine; Tolerability; Psoriasis; Dermatology; Clinical efficacy; Plaque psoriasis; Potency; Combination therapy; Clinical trial; Adjunctive treatment; Pharmacology; Adverse effect; Surgery; Internal medicine","score_opus":0.03183543854003123,"score_gpt":0.3219527245661909,"score_spread":0.29011728602615966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079525680","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00049414666,0.9975924,0.00019149101,0.00020163142,0.00038450464,0.000007635769,0.000015973304,0.00001334014,0.0010988159],"genre_scores_gemma":[0.0028941375,0.994115,0.00037286113,0.0003450379,0.00055931514,0.000012873239,0.000042717867,0.000002673184,0.0016552779],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99984694,0.00002913652,0.000027481,0.000023322667,0.000059375492,0.000013729294],"domain_scores_gemma":[0.99981016,0.00007814491,0.00004370705,0.000006691886,0.000041986827,0.000019349694],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051575806,0.0007401398,0.0016685217,0.001622081,0.00025713095,0.00062337314,0.00081764255,0.0008930179,0.0026763638],"category_scores_gemma":[0.0004104954,0.00025844612,0.000429896,0.0015355393,0.00028033232,0.000694895,0.0002722078,0.0013332976,0.0017982577],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031610797,0.00014282057,0.00020809942,0.0054583703,0.00011284922,0.00043709975,0.000027930011,0.00026280078,0.0022718594,0.00076257216,0.02337976,0.9666197],"study_design_scores_gemma":[0.00037694818,0.00075248315,0.0033155263,0.0019761638,0.00054856675,0.0049960315,0.00005209195,0.00035489883,0.0014019102,0.00104785,0.9851474,0.00003013149],"about_ca_topic_score_codex":0.0009292389,"about_ca_topic_score_gemma":0.0029636966,"teacher_disagreement_score":0.0026763638,"about_ca_system_score_codex":0.00031901587,"about_ca_system_score_gemma":0.00045630918,"threshold_uncertainty_score":0.008953333},"labels":[],"label_agreement":null},{"id":"W2079541867","doi":"10.1016/j.jaad.2011.08.027","title":"Spontaneously resolving eosinophilic annular erythema","year":2012,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Eosinophilic Disorders and Syndromes","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Eosinophilic; Dermatology; Erythema; Pathology","score_opus":0.018630720399162016,"score_gpt":0.2887395836432855,"score_spread":0.2701088632441235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079541867","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.36220673,0.012537967,0.0061250026,0.3619716,0.03715975,0.00047682505,0.00041209158,0.0007988532,0.21831119],"genre_scores_gemma":[0.8366349,0.0032838034,0.0019540945,0.07722634,0.046611466,0.00010033615,0.00018329214,0.00011158677,0.033894178],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99874,0.0003300363,0.00013229033,0.0002253027,0.0002601787,0.0003122293],"domain_scores_gemma":[0.99730396,0.0012315839,0.00037418673,0.00023581283,0.00025917773,0.000595253],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011056804,0.0018846698,0.0014880934,0.001014483,0.0028984617,0.0022343232,0.001277784,0.01345896,0.0035990942],"category_scores_gemma":[0.009405896,0.0008116915,0.0014264956,0.0008027993,0.0016861855,0.0025230509,0.0009275038,0.008906474,0.0016820311],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010182746,0.00011694934,0.0027510868,0.00004857645,0.000017693103,0.9840679,0.000115573945,0.00013641687,0.00033306683,0.0013679429,0.008090229,0.0028527742],"study_design_scores_gemma":[0.0003742155,0.00034975455,0.008495021,0.00012831179,0.00006649405,0.95734113,0.00030509479,0.002671483,0.00068804546,0.0029469032,0.026599932,0.00003359669],"about_ca_topic_score_codex":0.0012194518,"about_ca_topic_score_gemma":0.0017817264,"teacher_disagreement_score":0.01345896,"about_ca_system_score_codex":0.002232947,"about_ca_system_score_gemma":0.00097324373,"threshold_uncertainty_score":0.016201317},"labels":[],"label_agreement":null},{"id":"W2079866318","doi":"10.1016/j.jaad.2004.11.040","title":"Generalized petechial eruption induced by parvovirus B19 infection","year":2005,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Parvovirus B19 Infection Studies","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Parvovirus; Parvoviridae; Petechial rash; Erythema Infectiosum; Virology; Surgery; Virus","score_opus":0.07925941201586559,"score_gpt":0.4259764178119976,"score_spread":0.34671700579613196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079866318","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00056765816,0.9984414,0.00004949963,0.00007167832,0.000058196303,0.0000045163188,0.000011869696,0.0000038286166,0.0007913486],"genre_scores_gemma":[0.004209276,0.99505615,0.00009330692,0.00013530889,0.00015394746,0.0000053166987,0.000021368993,7.8681774e-7,0.00032457706],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99983895,0.000039627837,0.000027549031,0.000029219987,0.000050461524,0.000014276202],"domain_scores_gemma":[0.9996854,0.0001714925,0.00007491753,0.000007674034,0.00004200329,0.000018588184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034235106,0.0006677041,0.0018124473,0.0019684527,0.0002105415,0.0005766104,0.0006194937,0.0005526103,0.0021012963],"category_scores_gemma":[0.00055407366,0.00021021556,0.0004143171,0.0017166766,0.00027818925,0.0007389005,0.00028569985,0.000533373,0.00052068103],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001725629,0.00010653418,0.0020417727,0.026805038,0.000258259,0.00404192,0.00007277704,0.00015671387,0.0021562004,0.00046316604,0.015286215,0.9484389],"study_design_scores_gemma":[0.00026513336,0.00069043605,0.03201593,0.013351051,0.0019994383,0.07768954,0.00054961664,0.0003157002,0.0034082537,0.0013534348,0.8682838,0.000077630655],"about_ca_topic_score_codex":0.00079159485,"about_ca_topic_score_gemma":0.0018840545,"teacher_disagreement_score":0.0021012963,"about_ca_system_score_codex":0.00024883982,"about_ca_system_score_gemma":0.00034966719,"threshold_uncertainty_score":0.0070295334},"labels":[],"label_agreement":null},{"id":"W2080805546","doi":"10.1016/j.jaad.2013.10.045","title":"Hyperpigmented macules on the face of young children: A series of 25 cases","year":2013,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Oral Health Pathology and Treatment","field":"Dentistry","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Hyperpigmentation; Erythema; Dermatology; Forehead; Pediatrics; Nose; Surgery","score_opus":0.023120846340907632,"score_gpt":0.31450750693530627,"score_spread":0.29138666059439866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080805546","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99223936,0.0034715352,0.0005746587,0.00014402531,0.000050222123,0.00007428609,0.00010798094,0.000030668154,0.0033072196],"genre_scores_gemma":[0.9974795,0.0014101132,0.00035695022,0.00008024509,0.00008362699,0.000023311131,0.00006218999,0.0000116523925,0.00049236394],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9990588,0.00011234817,0.00013790124,0.00017527404,0.00019161838,0.00032408602],"domain_scores_gemma":[0.9983369,0.00054711435,0.00039418726,0.00014621431,0.000107718864,0.00046788403],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056072016,0.0024113928,0.0010728447,0.002624371,0.0023468293,0.0014925267,0.001084151,0.0022852763,0.0020287104],"category_scores_gemma":[0.0029672538,0.0012100782,0.0009812322,0.0014963634,0.0024333666,0.0013263759,0.0014721623,0.0011538623,0.00079753436],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000056336172,0.00009513073,0.063232355,0.00006739278,0.00002567784,0.9316806,0.0007063986,0.000097671495,0.0014179582,0.00008824238,0.00022664104,0.002305598],"study_design_scores_gemma":[0.000012536112,0.000094871466,0.047008306,0.000026009659,0.000028632327,0.9507736,0.00091612566,0.000077599936,0.00053850934,0.00006477741,0.00044345198,0.000015558204],"about_ca_topic_score_codex":0.001692368,"about_ca_topic_score_gemma":0.00254756,"teacher_disagreement_score":0.002624371,"about_ca_system_score_codex":0.000954236,"about_ca_system_score_gemma":0.00060712127,"threshold_uncertainty_score":0.0069235563},"labels":[],"label_agreement":null},{"id":"W2081016717","doi":"10.1016/j.jaad.2009.09.014","title":"Ustekinumab significantly improves symptoms of anxiety, depression, and skin-related quality of life in patients with moderate-to-severe psoriasis: Results from a randomized, double-blind, placebo-controlled phase III trial","year":2010,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":216,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Ustekinumab; Dermatology Life Quality Index; Psoriasis; Anxiety; Quality of life (healthcare); Placebo; Depression (economics); Hospital Anxiety and Depression Scale; Randomized controlled trial; Internal medicine; Physical therapy; Dermatology; Psychiatry; Disease; Alternative medicine; Pathology; Nursing","score_opus":0.013777554518188496,"score_gpt":0.2760983433877126,"score_spread":0.2623207888695241,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081016717","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9743353,0.018532963,0.00074673776,0.0009924395,0.00064357254,0.0013898603,0.00076112675,0.00021512673,0.0023828114],"genre_scores_gemma":[0.98665375,0.007911433,0.0008189578,0.0011826284,0.0004465,0.000790383,0.00070515135,0.000021114118,0.0014700738],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99959904,0.00018943273,0.000034413682,0.000060926017,0.00004549725,0.00007070825],"domain_scores_gemma":[0.9993838,0.00022228528,0.00014293983,0.0000387094,0.00003530324,0.00017698109],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013274577,0.0013114993,0.0034444977,0.00037699478,0.0004530615,0.0008191031,0.0007776865,0.0014882847,0.004271902],"category_scores_gemma":[0.0013235265,0.000540768,0.0017437679,0.0004486371,0.001041132,0.0008195915,0.00028571862,0.0025827042,0.0005678477],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9422216,0.0061165807,0.0012768008,0.001910003,0.00297575,0.0000681175,0.00007830488,0.00033392338,0.0045648315,0.00011075073,0.001560687,0.03878269],"study_design_scores_gemma":[0.958288,0.035548653,0.0038371105,0.000055043063,0.0010008661,0.00005205874,0.000025635318,0.00024573356,0.00037238267,0.00011149183,0.000449527,0.000013436397],"about_ca_topic_score_codex":0.0008584572,"about_ca_topic_score_gemma":0.0019127894,"teacher_disagreement_score":0.004271902,"about_ca_system_score_codex":0.00041778488,"about_ca_system_score_gemma":0.0005232268,"threshold_uncertainty_score":0.014290929},"labels":[],"label_agreement":null},{"id":"W2081873265","doi":"10.1016/j.jaad.2003.10.346","title":"Ciclopirox gel: an overview","year":2004,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Seborrheic dermatitis; Dermatology; Antifungal; Microbiology; Biology","score_opus":0.04114730433218826,"score_gpt":0.38092055062790936,"score_spread":0.3397732462957211,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081873265","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00062202144,0.9969258,0.00050305977,0.00062523125,0.00012374762,0.000009001461,0.000019255453,0.00001473149,0.0011571407],"genre_scores_gemma":[0.0039677056,0.9920128,0.0012641576,0.00092309125,0.0008257754,0.000022806911,0.000058310903,0.0000067531773,0.00091855164],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993326,0.00011941591,0.00012908565,0.00014559919,0.00022044277,0.00005286148],"domain_scores_gemma":[0.99914527,0.0005186218,0.000108440654,0.000018659128,0.00015363362,0.00005540398],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012909884,0.0013652608,0.0030100301,0.004117253,0.0005472463,0.0017524501,0.0009975928,0.0021121115,0.0017826511],"category_scores_gemma":[0.0008817137,0.0005869455,0.0010319257,0.0021147835,0.000515687,0.0027938613,0.00062757137,0.0022351174,0.0011373953],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005305391,0.000344436,0.0009782477,0.0068577486,0.00019094527,0.00096338877,0.000060605507,0.00027344056,0.0015598312,0.0014257556,0.011631663,0.9751834],"study_design_scores_gemma":[0.0005006287,0.0033402315,0.014695099,0.009343549,0.0017594037,0.036950547,0.00038422443,0.0013922104,0.0038215988,0.0060541863,0.9215823,0.0001760932],"about_ca_topic_score_codex":0.0013091312,"about_ca_topic_score_gemma":0.003583623,"teacher_disagreement_score":0.004117253,"about_ca_system_score_codex":0.0010998715,"about_ca_system_score_gemma":0.00094758114,"threshold_uncertainty_score":0.007980168},"labels":[],"label_agreement":null},{"id":"W2081998146","doi":"10.1016/j.jaad.2009.03.047","title":"Psoriasis in patients with HIV infection: From the Medical Board of the National Psoriasis Foundation","year":2009,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":157,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Psoriasis; Medicine; Foundation (evidence); Dermatology; Human immunodeficiency virus (HIV); Family medicine","score_opus":0.023893067504284254,"score_gpt":0.33362621030753015,"score_spread":0.3097331428032459,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081998146","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010502421,0.99850595,0.000012146286,0.0008577661,0.00019453937,0.0000027673966,0.000015397001,0.0000014253899,0.0003051144],"genre_scores_gemma":[0.0013348731,0.99751353,0.000056810586,0.0006350859,0.0002640722,0.0000046598557,0.000029954723,5.2921934e-7,0.00016058022],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995577,0.00008596565,0.00010470868,0.000051638526,0.00016924355,0.000030739495],"domain_scores_gemma":[0.99877816,0.0005865432,0.00031580226,0.000019858893,0.0002115147,0.00008824833],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013496451,0.00046233775,0.0013139867,0.0018300252,0.00029421793,0.0009763458,0.0005026423,0.001157499,0.0030983859],"category_scores_gemma":[0.0027564426,0.00025421625,0.0005580479,0.0021852572,0.00032007697,0.0009124754,0.0006546664,0.0013881306,0.00047929288],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018698454,0.000040797986,0.00087227277,0.022201065,0.00018863827,0.00012900317,0.000049076974,0.00006988768,0.00024900158,0.0005818481,0.058356754,0.9170747],"study_design_scores_gemma":[0.0003898673,0.00017597062,0.018477794,0.04967912,0.0014644618,0.0023420854,0.00023024163,0.000088779256,0.00029489692,0.0008383928,0.9259729,0.000045465164],"about_ca_topic_score_codex":0.0040761633,"about_ca_topic_score_gemma":0.011242223,"teacher_disagreement_score":0.0040761633,"about_ca_system_score_codex":0.0006498936,"about_ca_system_score_gemma":0.002123252,"threshold_uncertainty_score":0.010365188},"labels":[],"label_agreement":null},{"id":"W2082486856","doi":"10.1016/s0190-9622(03)00469-9","title":"Fatal squamous cell carcinoma arising from transplant-associated porokeratosis","year":2003,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Genetic and rare skin diseases.","field":"Biochemistry, Genetics and Molecular Biology","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Porokeratosis; Medicine; Malignancy; Immunosuppression; Dermatology; Basal cell; Pathology; Dyskeratosis; Hyperkeratosis; Immunology","score_opus":0.006657067735432831,"score_gpt":0.23272445067628103,"score_spread":0.2260673829408482,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082486856","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9850012,0.0012615613,0.0016825191,0.0008594704,0.00032286468,0.00009804575,0.00027938944,0.00024790544,0.010246997],"genre_scores_gemma":[0.9979949,0.0002478163,0.00015771131,0.00023271753,0.00014490234,0.000007791616,0.00006676994,0.000016600567,0.0011308016],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.999435,0.000056727527,0.000051229457,0.00011196801,0.00011977581,0.0002253129],"domain_scores_gemma":[0.9986051,0.00029948135,0.00022010926,0.0002243602,0.00008468861,0.0005663301],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040115087,0.0015082238,0.0007988673,0.0010439795,0.00226351,0.0014086115,0.00078920653,0.0029269822,0.0021660186],"category_scores_gemma":[0.0026128003,0.0006399363,0.0009147004,0.0006431138,0.0010860898,0.00085652637,0.0009527276,0.0021031648,0.0010652726],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022224142,0.00006404772,0.01156612,0.000028736034,0.000022844606,0.98323613,0.000081400016,0.00016839024,0.0022983064,0.00030744018,0.00033393042,0.0016704294],"study_design_scores_gemma":[0.00005007647,0.00016851047,0.019805672,0.000011540005,0.000034303903,0.97706157,0.000083298924,0.0005497493,0.001446909,0.00028448197,0.00048791282,0.000015963664],"about_ca_topic_score_codex":0.0014126127,"about_ca_topic_score_gemma":0.0015924727,"teacher_disagreement_score":0.0029269822,"about_ca_system_score_codex":0.001337594,"about_ca_system_score_gemma":0.0007254695,"threshold_uncertainty_score":0.0097049475},"labels":[],"label_agreement":null},{"id":"W2084668578","doi":"10.1016/j.jaad.2013.04.067","title":"Current status of surgery in dermatology","year":2013,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Medicine and Dermatology Studies History","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Dermatologic surgery; Medicine; Accreditation; Credentialing; Dermatology; Graduate medical education; Residency training; Medical education; Continuing education","score_opus":0.03577832946277233,"score_gpt":0.33126317853258547,"score_spread":0.29548484906981315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084668578","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019728097,0.90687495,0.0002643379,0.071195,0.009219615,0.0000098378705,0.00012937466,0.000032823533,0.010301234],"genre_scores_gemma":[0.04091932,0.90181184,0.0010661837,0.018628605,0.034861945,0.000031282983,0.0002470984,0.000019084135,0.002414576],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971595,0.00086458685,0.00060656056,0.00036101235,0.00063601317,0.0003724082],"domain_scores_gemma":[0.9623663,0.018591208,0.003851563,0.0007428951,0.0077989027,0.0066491626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009366374,0.0004957734,0.0010002314,0.003910111,0.001938491,0.005264552,0.001673628,0.0040658335,0.019472733],"category_scores_gemma":[0.017284108,0.0003849084,0.00069131184,0.005175584,0.0046631834,0.0064587295,0.0017089426,0.0055934987,0.0025746613],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042894436,0.0003883443,0.009727974,0.009340515,0.00008992517,0.0002775803,0.0004773028,0.00028653097,0.0003712349,0.02399852,0.14965673,0.80495644],"study_design_scores_gemma":[0.000096343676,0.00032152925,0.02199892,0.015541514,0.00022728977,0.00125994,0.0025527,0.00033951027,0.00030248897,0.01197965,0.9452873,0.000092948045],"about_ca_topic_score_codex":0.0048993207,"about_ca_topic_score_gemma":0.012410382,"teacher_disagreement_score":0.019472733,"about_ca_system_score_codex":0.0039143665,"about_ca_system_score_gemma":0.010225778,"threshold_uncertainty_score":0.06514281},"labels":[],"label_agreement":null},{"id":"W2085229314","doi":"10.1067/mjd.2001.110644","title":"Single-blind, randomized, prospective study of sequential itraconazole and terbinafine pulse compared with terbinafine pulse for the treatment of toenail onychomycosis","year":2001,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":100,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto; Women's College Hospital; Sunnybrook Health Science Centre","funders":"","keywords":"Terbinafine; Medicine; Itraconazole; Cure rate; Dermatophyte; Discontinuation; Randomization; Clinical trial; Randomized controlled trial; Adverse effect; Dermatology; Prospective cohort study; Surgery; Internal medicine; Antifungal","score_opus":0.029395532606892077,"score_gpt":0.32320194691325754,"score_spread":0.29380641430636545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085229314","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920744,0.0019941246,0.00085207773,0.00031073167,0.0008052659,0.0022428392,0.0004582003,0.00010095477,0.0011614931],"genre_scores_gemma":[0.9887151,0.0017513179,0.001972782,0.0006700001,0.0009878963,0.0033715225,0.0004899834,0.000032574706,0.00200877],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9980142,0.00094605127,0.0001957355,0.00039097498,0.0001787854,0.0002742243],"domain_scores_gemma":[0.99668366,0.0012590857,0.00053988,0.00037597996,0.00019478935,0.0009466871],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025167046,0.0022366703,0.008306951,0.0008204683,0.0007463824,0.001396288,0.0019379024,0.0027834347,0.007542146],"category_scores_gemma":[0.0037467286,0.0015349677,0.002000263,0.0008558423,0.0025571429,0.0018305889,0.0005805035,0.0047917664,0.0015568228],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98946,0.0055201137,0.00009183687,0.00012041523,0.00028305317,0.000010234494,0.000014444406,0.0000824509,0.0008433898,0.00003515929,0.0000758876,0.0034630706],"study_design_scores_gemma":[0.9115331,0.086871356,0.0006434571,0.000010286138,0.0002796845,0.0000124437465,0.0000103443945,0.00024466624,0.00020688848,0.00006899319,0.00010730429,0.0000114761215],"about_ca_topic_score_codex":0.0015751971,"about_ca_topic_score_gemma":0.002174098,"teacher_disagreement_score":0.008306951,"about_ca_system_score_codex":0.00088888506,"about_ca_system_score_gemma":0.001585002,"threshold_uncertainty_score":0.025230944},"labels":[],"label_agreement":null},{"id":"W2085530247","doi":"10.1016/j.jaad.2008.05.008","title":"The value of patch testing patients with a scattered generalized distribution of dermatitis: Retrospective cross-sectional analyses of North American Contact Dermatitis Group data, 2001 to 2004","year":2008,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Contact Dermatitis and Allergies","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Royal Victoria Hospital; University of Ottawa","funders":"","keywords":"Medicine; Patch testing; Dermatology; Contact dermatitis; Retrospective cohort study; Patch test; Value (mathematics); Cross-sectional study; Distribution (mathematics); Statistics; Surgery; Allergy; Pathology; Mathematics; Immunology; Mathematical analysis","score_opus":0.03878604108368916,"score_gpt":0.3305964632353293,"score_spread":0.29181042215164016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085530247","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99792296,0.00061715476,0.00023275646,0.00008671658,0.00001401895,0.000007210682,0.0003893822,0.000009994928,0.00071979064],"genre_scores_gemma":[0.9995214,0.00007744936,0.00010257125,0.000030274266,0.000009673893,0.000002975837,0.00021368513,0.0000035581172,0.000038522332],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9947437,0.0027502235,0.0006295654,0.0009603206,0.00058939046,0.000326871],"domain_scores_gemma":[0.98023397,0.0077044866,0.0059693316,0.0034025463,0.0016781886,0.001011464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00466743,0.000493166,0.0004824996,0.0013722145,0.0006737258,0.0012696105,0.0011619936,0.0010791636,0.0008222571],"category_scores_gemma":[0.017236056,0.0005455449,0.00084212987,0.0016365469,0.00073567935,0.0017804132,0.0008248522,0.0010410517,0.000140797],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000098212324,0.000009678503,0.9990816,0.0000041845274,0.000055296357,0.00004497367,0.00003994064,0.00005540536,0.00006391688,0.000012272473,0.000045704783,0.0004887121],"study_design_scores_gemma":[0.0000060575926,0.00007814806,0.99838316,0.000009149239,0.00007057673,0.00050936686,0.00024123098,0.00050537765,0.000049268856,0.000025721834,0.000117797455,0.000004099984],"about_ca_topic_score_codex":0.010237502,"about_ca_topic_score_gemma":0.012138545,"teacher_disagreement_score":0.010237502,"about_ca_system_score_codex":0.00045900414,"about_ca_system_score_gemma":0.00050566305,"threshold_uncertainty_score":0.024684012},"labels":[],"label_agreement":null},{"id":"W2085896698","doi":"10.1016/j.jaad.2003.10.154","title":"Use of imiquimod cream in the treatment of localized morphea","year":2004,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Morphea; Medicine; Imiquimod; Localized Scleroderma; Dermatology; Ustekinumab; Fibrosis; Scleroderma (fungus); Pathology; Adalimumab; Tumor necrosis factor alpha; Immunology","score_opus":0.04629129146834173,"score_gpt":0.32235787892227064,"score_spread":0.2760665874539289,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085896698","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9083924,0.06887811,0.0016776348,0.0016480898,0.0011321692,0.00027341043,0.00017583463,0.00014995765,0.017672405],"genre_scores_gemma":[0.98252857,0.012739848,0.00094374595,0.0003419746,0.00044424454,0.000059728314,0.00009844107,0.000011798905,0.0028316483],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.9998634,0.00003883879,0.00001290426,0.00001798924,0.00003519849,0.00003168228],"domain_scores_gemma":[0.9999318,0.000027466695,0.000010496251,0.000005282802,0.00000744733,0.000017521743],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002664408,0.00026022267,0.00082684326,0.0003896423,0.00045180845,0.00020242066,0.0002437666,0.0003685074,0.0015849506],"category_scores_gemma":[0.00039645104,0.000099116434,0.00040722475,0.0002131144,0.00015662143,0.00012739726,0.00014768813,0.0007449204,0.0004128717],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020187564,0.0043986873,0.009282774,0.001718557,0.00041883218,0.008401301,0.00027056373,0.00079055683,0.18613474,0.0005665967,0.0048838966,0.76294595],"study_design_scores_gemma":[0.02640994,0.15725511,0.31566167,0.0013361634,0.003398242,0.06407182,0.0008921303,0.0074245594,0.23766363,0.0011671225,0.18455888,0.0001607202],"about_ca_topic_score_codex":0.0009532243,"about_ca_topic_score_gemma":0.002927702,"teacher_disagreement_score":0.0015849506,"about_ca_system_score_codex":0.00027204514,"about_ca_system_score_gemma":0.00023341454,"threshold_uncertainty_score":0.005302191},"labels":[],"label_agreement":null},{"id":"W2088759836","doi":"10.1067/s0190-9622(03)00428-6","title":"Cutaneous angiosarcoma as a delayed complication of radiation therapy for carcinoma of the breast","year":2003,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Vascular Tumors and Angiosarcomas","field":"Medicine","cited_by":96,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Regional Laboratory Medicine Program; Sunnybrook Health Science Centre; University of Alberta","funders":"","keywords":"Medicine; Angiosarcoma; Radiation therapy; Breast carcinoma; Hemangiosarcoma; Complication; Carcinoma; Surgery; Chemotherapy; Mastectomy; Breast cancer; Adjuvant therapy; Cancer; Pathology; Internal medicine","score_opus":0.02704769538647536,"score_gpt":0.3361984264495244,"score_spread":0.3091507310630491,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088759836","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011575904,0.9974027,0.00015733826,0.0001236203,0.00015142592,0.0000049447967,0.00001524202,0.000007584492,0.0009795538],"genre_scores_gemma":[0.0074122692,0.99100435,0.00016713048,0.00025692387,0.00050819287,0.0000039227916,0.00003438784,0.0000017999525,0.00061101525],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997662,0.000033311117,0.000048732134,0.000050025188,0.00008221592,0.000019568877],"domain_scores_gemma":[0.9993917,0.0002745182,0.0001883024,0.000016080074,0.000089748035,0.000039658604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039733542,0.0006790267,0.001534972,0.0020748284,0.00021470341,0.0009738448,0.00083964353,0.0011800993,0.0013332075],"category_scores_gemma":[0.00088474416,0.00028303775,0.00043089522,0.0019767156,0.00048031783,0.0010632059,0.00035402505,0.0010285547,0.0008625958],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017928968,0.00011628491,0.0036213782,0.015535436,0.0002170262,0.018147985,0.00012577066,0.00045638497,0.0025574923,0.00075543555,0.018821456,0.93946606],"study_design_scores_gemma":[0.00014410322,0.0005588213,0.026343115,0.00796764,0.0015209183,0.31734928,0.00045029295,0.0005167804,0.003108468,0.0015353423,0.64035505,0.00015024573],"about_ca_topic_score_codex":0.0011309157,"about_ca_topic_score_gemma":0.0025919985,"teacher_disagreement_score":0.0020748284,"about_ca_system_score_codex":0.0003844612,"about_ca_system_score_gemma":0.0006411347,"threshold_uncertainty_score":0.0044600368},"labels":[],"label_agreement":null},{"id":"W2088802427","doi":"10.1016/j.jaad.2009.05.042","title":"A randomized, double-blind, placebo-controlled, phase I study of MEDI-545, an anti–interferon-alfa monoclonal antibody, in subjects with chronic psoriasis","year":2010,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":80,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Innovaderm (Canada)","funders":"","keywords":"Medicine; Psoriasis; Placebo; Monoclonal antibody; Interferon alfa; Double blind; Monoclonal; Internal medicine; Placebo-controlled study; Interferon; Antibody; Dermatology; Immunology; Gastroenterology; Alpha interferon; Pathology; Alternative medicine","score_opus":0.020838323158465445,"score_gpt":0.32371114343321705,"score_spread":0.3028728202747516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088802427","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9856045,0.0032589776,0.0010875807,0.00067001826,0.00083198806,0.004781418,0.0009519493,0.00023547087,0.0025780941],"genre_scores_gemma":[0.98462176,0.0026245033,0.001877904,0.0016802612,0.00072497485,0.003956421,0.001091528,0.0000375725,0.003385097],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99951565,0.00020344836,0.00003264382,0.00010856138,0.000040575007,0.00009903346],"domain_scores_gemma":[0.9992698,0.00020210457,0.000113706046,0.00006741905,0.000052333096,0.00029463135],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014097844,0.0018086479,0.0038144053,0.00068327604,0.00081889634,0.000992562,0.0012727233,0.002358102,0.007511285],"category_scores_gemma":[0.0015747225,0.0011941037,0.0015331294,0.00043701916,0.0015971937,0.0011392534,0.00045334213,0.0032012123,0.0015041062],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9790029,0.00927223,0.0002508717,0.00028742262,0.00038174973,0.000020934136,0.00003274317,0.00012454037,0.0034609993,0.000052830408,0.00035293572,0.006759771],"study_design_scores_gemma":[0.9574937,0.040841058,0.00086959987,0.000009623844,0.00019567675,0.000010849372,0.000011898195,0.000117097035,0.00021420642,0.000042541265,0.00018582519,0.000007947638],"about_ca_topic_score_codex":0.0015529284,"about_ca_topic_score_gemma":0.0026715102,"teacher_disagreement_score":0.007511285,"about_ca_system_score_codex":0.0006938041,"about_ca_system_score_gemma":0.0011003236,"threshold_uncertainty_score":0.025127769},"labels":[],"label_agreement":null},{"id":"W2089819419","doi":"10.1016/j.jaad.2011.02.032","title":"Single-blind, randomized controlled trial evaluating the treatment of facial seborrheic dermatitis with hydrocortisone 1% ointment compared with tacrolimus 0.1% ointment in adults","year":2011,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Medicine; Tacrolimus; Seborrheic dermatitis; Adverse effect; Calcineurin; Dermatology; Randomized controlled trial; Hydrocortisone; Corticosteroid; Incidence (geometry); Internal medicine; Transplantation","score_opus":0.03655641551337875,"score_gpt":0.32420363760731036,"score_spread":0.2876472220939316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089819419","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9755284,0.010520143,0.0009803552,0.00096470385,0.0021729749,0.006038471,0.0011373028,0.00019272421,0.0024649026],"genre_scores_gemma":[0.9794754,0.0050273226,0.0023696113,0.0014422894,0.0010499035,0.0064670835,0.0008187276,0.000023126495,0.0033265336],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99915326,0.0003819611,0.000102197075,0.00018780987,0.000061846134,0.00011294882],"domain_scores_gemma":[0.9983621,0.00064125634,0.00035243764,0.00010845139,0.00012648021,0.0004092448],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016950382,0.0018359203,0.0051301112,0.00050536625,0.0006630152,0.0010201854,0.001198282,0.0025919764,0.007938716],"category_scores_gemma":[0.0030481857,0.0008832449,0.0022526958,0.0004735308,0.0014794912,0.0012900254,0.00044053423,0.003209862,0.0010331514],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.99218774,0.0022258947,0.00013085839,0.0006016315,0.000522544,0.000021897054,0.000020798312,0.00007164953,0.0005666671,0.00004622213,0.0002605668,0.0033435258],"study_design_scores_gemma":[0.98079187,0.018119117,0.00044702904,0.000028044333,0.00026700017,0.000009067515,0.000009472164,0.00011179456,0.00007125177,0.00003308655,0.000106787804,0.0000053911135],"about_ca_topic_score_codex":0.002470419,"about_ca_topic_score_gemma":0.0041253064,"teacher_disagreement_score":0.007938716,"about_ca_system_score_codex":0.00076064706,"about_ca_system_score_gemma":0.0013907102,"threshold_uncertainty_score":0.026557624},"labels":[],"label_agreement":null},{"id":"W2090559129","doi":"10.1016/j.jaad.2005.11.1091","title":"A randomized, double-blind, placebo-controlled trial of photopheresis in systemic sclerosis","year":2006,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":124,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Photopheresis; Extracorporeal Photopheresis; Scleroderma (fungus); Placebo; Randomized controlled trial; Clinical trial; Systemic scleroderma; Concomitant; Connective tissue disease; Statistical significance; Surgery; Internal medicine; Dermatology; Disease; Autoimmune disease; Graft-versus-host disease; Pathology","score_opus":0.029257745402188614,"score_gpt":0.30069981285469727,"score_spread":0.27144206745250865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090559129","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9685435,0.011815906,0.001779652,0.0018854177,0.0033104727,0.0077039236,0.0010704957,0.0003747254,0.0035159232],"genre_scores_gemma":[0.97728467,0.005146618,0.0024330085,0.002005597,0.001151812,0.0072019463,0.0006604183,0.000053264223,0.0040626028],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99880135,0.0005857116,0.00010610526,0.00022999619,0.000104486455,0.00017225392],"domain_scores_gemma":[0.9986124,0.00057350204,0.00020837174,0.0001399238,0.000089236215,0.00037650298],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002328754,0.0022762474,0.0070606326,0.0009190465,0.001019941,0.0013963425,0.0015135442,0.003510878,0.009739282],"category_scores_gemma":[0.0034193713,0.0011955918,0.0020877765,0.00067245314,0.0026576624,0.0020493718,0.00065785676,0.004078628,0.001475799],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.99218154,0.002385952,0.00006980867,0.00047951742,0.00042281704,0.000018476214,0.00002136994,0.00007554923,0.0007814094,0.00007612268,0.00026012672,0.003227248],"study_design_scores_gemma":[0.99148977,0.007933528,0.00015224624,0.000011530908,0.000121936355,0.0000063118455,0.0000061805554,0.000068018904,0.00007052371,0.000046830897,0.00008870762,0.000004382896],"about_ca_topic_score_codex":0.0013923064,"about_ca_topic_score_gemma":0.0020433879,"teacher_disagreement_score":0.009739282,"about_ca_system_score_codex":0.00086239656,"about_ca_system_score_gemma":0.0014132337,"threshold_uncertainty_score":0.03258115},"labels":[],"label_agreement":null},{"id":"W2091740233","doi":"10.1016/j.jaad.2013.11.040","title":"Localized bullous fixed drug eruption following yellow fever vaccine","year":2014,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Mosquito-borne diseases and control","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Drug eruption; Dermatology; Drug; Virology; Pharmacology","score_opus":0.010564569428208574,"score_gpt":0.2897615761875752,"score_spread":0.27919700675936665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091740233","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1573978,0.43871376,0.0060807504,0.24528937,0.12274624,0.00036501643,0.0010673582,0.0011142223,0.027225446],"genre_scores_gemma":[0.5374502,0.09890218,0.0019801394,0.111839235,0.22903731,0.00007187845,0.00044744642,0.00015897324,0.020112623],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99920505,0.00017665606,0.00011647936,0.000122008096,0.00022966495,0.00015011634],"domain_scores_gemma":[0.99682474,0.0016876771,0.0007194234,0.00010291432,0.00039933488,0.0002659185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006671784,0.001052519,0.0017307329,0.0014526416,0.0005328869,0.0013673818,0.0014835113,0.00780542,0.0036439607],"category_scores_gemma":[0.004650733,0.00054863817,0.00087874214,0.0008880346,0.0008106414,0.0022995227,0.00061583973,0.004511107,0.0015403411],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020802666,0.00011233933,0.0051945928,0.0019028103,0.00015777521,0.81417835,0.00033679904,0.00024552617,0.0014803226,0.0005869976,0.14629872,0.029297717],"study_design_scores_gemma":[0.00015491771,0.00026617522,0.0073198183,0.0012391986,0.00024060966,0.88575995,0.0005037007,0.0013491882,0.0017403064,0.0006325541,0.10072561,0.00006803945],"about_ca_topic_score_codex":0.0010023176,"about_ca_topic_score_gemma":0.0014664026,"teacher_disagreement_score":0.00780542,"about_ca_system_score_codex":0.0008949536,"about_ca_system_score_gemma":0.0003830938,"threshold_uncertainty_score":0.012190282},"labels":[],"label_agreement":null},{"id":"W2092625384","doi":"10.1016/j.jaad.2005.05.038","title":"Rapp-Hodgkin syndrome: A review of the aspects of hair and hair color","year":2005,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"dental development and anomalies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Children's & Women's Health Centre of British Columbia; Vancouver General Hospital","funders":"","keywords":"Ectodermal dysplasia; Medicine; Hypohidrotic ectodermal dysplasia; Dermatology; Ectrodactyly","score_opus":0.01592271185545306,"score_gpt":0.3188582573053296,"score_spread":0.3029355454498765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092625384","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00020721601,0.9984256,0.00024981654,0.00022872891,0.000322967,0.0000042307547,0.000018646879,0.000013271128,0.00052948203],"genre_scores_gemma":[0.0013660705,0.9964133,0.0005451815,0.00031779177,0.0006571731,0.0000069480584,0.00005811095,0.00000262922,0.00063278334],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999757,0.000035430785,0.000053055275,0.00004535073,0.0000850083,0.000024158886],"domain_scores_gemma":[0.99956936,0.00017945445,0.0000738503,0.000012545101,0.00009446129,0.00007023095],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004805757,0.0012583656,0.0024138098,0.0039681853,0.00026347558,0.00085218454,0.0014867102,0.0012324408,0.0023878408],"category_scores_gemma":[0.0007912468,0.00036120092,0.00043685612,0.003538915,0.0005846569,0.0015195596,0.0007417539,0.001469317,0.0013848974],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001254623,0.000080562495,0.00069786055,0.011409641,0.00015082637,0.0037239927,0.000069428745,0.0004656572,0.001791334,0.0012270239,0.06221966,0.9180386],"study_design_scores_gemma":[0.000059143826,0.00012877093,0.003262928,0.004062774,0.00031812323,0.040792573,0.00017054238,0.00023731809,0.00057901384,0.0017726119,0.9485563,0.000059877424],"about_ca_topic_score_codex":0.0011142524,"about_ca_topic_score_gemma":0.0023166477,"teacher_disagreement_score":0.0039681853,"about_ca_system_score_codex":0.00050296576,"about_ca_system_score_gemma":0.0008607694,"threshold_uncertainty_score":0.007988155},"labels":[],"label_agreement":null},{"id":"W2095093987","doi":"10.1016/j.jaad.2013.12.006","title":"Treatment of notalgia paresthetica with botulinum toxin A: A double-blind randomized controlled trial","year":2014,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Botulinum Toxin and Related Neurological Disorders","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"","keywords":"Medicine; Botulinum toxin; Randomized controlled trial; Placebo; Dermatology; Surgery; Pathology; Alternative medicine","score_opus":0.02692522927142992,"score_gpt":0.3076957314034091,"score_spread":0.2807705021319792,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095093987","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8532162,0.08422579,0.004569988,0.0090644555,0.012778605,0.019926298,0.0042039463,0.000707979,0.0113068335],"genre_scores_gemma":[0.9403953,0.021747004,0.003991598,0.0076134535,0.0036235102,0.013034744,0.0013336362,0.00006724727,0.008193488],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9983558,0.0008731758,0.0001769269,0.0002909946,0.00012127187,0.00018170911],"domain_scores_gemma":[0.9983785,0.0007247076,0.0003736072,0.00011357603,0.0001173183,0.00029219955],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030205287,0.0023113394,0.0063872826,0.000676881,0.00093583326,0.0018109927,0.001574299,0.0049357926,0.013004372],"category_scores_gemma":[0.0039767227,0.0012173257,0.0039930576,0.0007111314,0.0019710963,0.0017959038,0.00058843323,0.0045498936,0.0016261727],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9875688,0.001686818,0.00012765762,0.0021102666,0.0020382167,0.00003640998,0.000024701085,0.00007729384,0.00049793074,0.00010904482,0.00077965355,0.004943155],"study_design_scores_gemma":[0.99517524,0.0036966442,0.00017505186,0.00005150114,0.0005228057,0.000007457729,0.0000056701174,0.00006222945,0.000034320576,0.00006150163,0.00020298957,0.000004630552],"about_ca_topic_score_codex":0.0017915673,"about_ca_topic_score_gemma":0.003118425,"teacher_disagreement_score":0.013004372,"about_ca_system_score_codex":0.001318514,"about_ca_system_score_gemma":0.0013822595,"threshold_uncertainty_score":0.04350394},"labels":[],"label_agreement":null},{"id":"W2095981667","doi":"10.1016/j.jaad.2003.10.537","title":"An open-label extension study evaluating the efficacy and safety of oral tazarotene in plaque psoriasis","year":2004,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Grand River Hospital","funders":"","keywords":"Medicine; Tazarotene; Plaque psoriasis; Psoriasis; Dermatology; Open label; Adverse effect; Pharmacology","score_opus":0.035186304581534274,"score_gpt":0.37683345962443715,"score_spread":0.3416471550429029,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095981667","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99485517,0.0010653737,0.0004394859,0.00020518825,0.00017358224,0.0016125129,0.0004711914,0.00006105607,0.0011163293],"genre_scores_gemma":[0.9930936,0.0012933526,0.0008753603,0.00031027498,0.00037644934,0.0012878913,0.00068988145,0.00002273338,0.0020502997],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9988631,0.00055494264,0.00006157185,0.0001732607,0.00011570901,0.00023136318],"domain_scores_gemma":[0.9973629,0.0007891049,0.00034335765,0.00041627744,0.00017432892,0.0009140082],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027521923,0.0021109942,0.0048260354,0.00080963515,0.0009143972,0.001312547,0.0012810285,0.0022184236,0.00509518],"category_scores_gemma":[0.0022264377,0.0010698431,0.0021848257,0.00068402267,0.0025116843,0.0019092743,0.00052489346,0.006361596,0.0012546082],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9237717,0.04254401,0.00086096185,0.00027868943,0.0004524959,0.00016242376,0.000118829266,0.000403366,0.015469938,0.000101913196,0.00034084936,0.015494736],"study_design_scores_gemma":[0.60359764,0.38946018,0.0037082976,0.000018080194,0.00046096122,0.00009978098,0.00004838391,0.00034128493,0.0016214412,0.00009051157,0.00052936526,0.00002413194],"about_ca_topic_score_codex":0.0020335664,"about_ca_topic_score_gemma":0.002479875,"teacher_disagreement_score":0.00509518,"about_ca_system_score_codex":0.00088055886,"about_ca_system_score_gemma":0.0019372341,"threshold_uncertainty_score":0.01704508},"labels":[],"label_agreement":null},{"id":"W2096686046","doi":"10.1016/j.jaad.2006.11.038","title":"Tea consumption and basal cell and squamous cell skin cancer: Results of a case-control study","year":2007,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Tea Polyphenols and Effects","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences","funders":"National Cancer Institute","keywords":"Medicine; Squamous cell cancer; Basal cell; Dermatology; Skin cancer; Consumption (sociology); Basal cell carcinoma; Cell; Oncology; Internal medicine; Cancer; Genetics","score_opus":0.012831649918509188,"score_gpt":0.3093864274346777,"score_spread":0.2965547775161685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096686046","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989052,0.00043928207,0.00016113125,0.000022913939,0.000016072798,0.000039618288,0.00016489087,0.000005716871,0.00024517477],"genre_scores_gemma":[0.99873954,0.00024356118,0.00019158164,0.000042163556,0.00003404754,0.00003800691,0.0002735652,0.000008591433,0.00042897725],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99732363,0.0009472996,0.00029152163,0.0007339152,0.0003731041,0.00033058246],"domain_scores_gemma":[0.99627066,0.0015272119,0.0005664267,0.0006606959,0.0004157347,0.00055938686],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032116752,0.0014469865,0.0017703883,0.0017252596,0.0021315517,0.0016398475,0.0013834639,0.0020992905,0.0033341995],"category_scores_gemma":[0.005379781,0.0021663888,0.0018973436,0.001941096,0.0017067881,0.0014532877,0.0007350123,0.0014142226,0.0005567956],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022992605,0.004891162,0.95966685,0.00014714334,0.0022915702,0.0012115472,0.0014390264,0.0001264316,0.0041589667,0.00011490165,0.00024320988,0.0027166267],"study_design_scores_gemma":[0.0019496399,0.005125851,0.98724025,0.00001800506,0.0017341655,0.0014725701,0.00093300303,0.00041588565,0.0005232945,0.000083669875,0.00045577588,0.000047824655],"about_ca_topic_score_codex":0.0128561435,"about_ca_topic_score_gemma":0.008456975,"teacher_disagreement_score":0.0128561435,"about_ca_system_score_codex":0.0008314584,"about_ca_system_score_gemma":0.0005201116,"threshold_uncertainty_score":0.025562644},"labels":[],"label_agreement":null},{"id":"W2100107304","doi":"10.1016/j.jaad.2014.10.026","title":"Efficacy and safety of brodalumab in subpopulations of patients with difficult-to-treat moderate-to-severe plaque psoriasis","year":2014,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"Amgen","keywords":"Medicine; Psoriasis; Psoriasis Area and Severity Index; Dermatology Life Quality Index; Discontinuation; Psoriatic arthritis; Secukinumab; Placebo; Internal medicine; Dermatology; Pathology","score_opus":0.008354940819251108,"score_gpt":0.23906012908527388,"score_spread":0.23070518826602276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100107304","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99794275,0.0010171672,0.000058564165,0.00011337034,0.00002364618,0.000027014885,0.00007406361,0.000006384721,0.00073694345],"genre_scores_gemma":[0.99931395,0.00015990202,0.00004939796,0.00010626729,0.000041708157,0.000014875445,0.00009729906,0.000002097349,0.00021454999],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996613,0.00009130117,0.000029855511,0.000078238496,0.00005620585,0.00008302456],"domain_scores_gemma":[0.99950886,0.00016029461,0.00010458321,0.00003855945,0.000058731526,0.00012892594],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006385338,0.0003169949,0.0010035746,0.00021336082,0.0004256145,0.00081097556,0.00021822228,0.00039162737,0.0012630257],"category_scores_gemma":[0.0012921263,0.00014856609,0.0005314438,0.0001439264,0.00022018292,0.000460105,0.00020674078,0.00081933814,0.00023634551],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1884799,0.005939333,0.5438904,0.00040390578,0.00136151,0.000638441,0.0006526295,0.0009942859,0.052468617,0.0002983061,0.0025088578,0.20236379],"study_design_scores_gemma":[0.008749125,0.03037738,0.9483414,0.00006280791,0.0009995835,0.0014685157,0.0005124736,0.0023572946,0.0034865988,0.00034121942,0.0032446757,0.00005888946],"about_ca_topic_score_codex":0.00051785656,"about_ca_topic_score_gemma":0.001018095,"teacher_disagreement_score":0.0012630257,"about_ca_system_score_codex":0.00031491017,"about_ca_system_score_gemma":0.00021264229,"threshold_uncertainty_score":0.004225254},"labels":[],"label_agreement":null},{"id":"W2100961679","doi":"10.1016/j.jaad.2004.10.879","title":"Adapalene gel 0.3% for the treatment of acne vulgaris: A multicenter, randomized, double-blind, controlled, phase III trial","year":2006,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre de Recherche Dermatologique du Québec Métropolitain; Robarts Clinical Trials","funders":"","keywords":"Medicine; Adapalene; Acne; Dermatology; Double blind; Randomized controlled trial; Multicenter study; Internal medicine; Alternative medicine; Placebo; Pathology","score_opus":0.031070397798974157,"score_gpt":0.36324675138303,"score_spread":0.33217635358405584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100961679","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97970116,0.010649834,0.0011806219,0.00058589026,0.00060369197,0.0045073424,0.0007408724,0.00014020085,0.0018903592],"genre_scores_gemma":[0.9794295,0.00817402,0.0023918147,0.0010087197,0.0004872145,0.004583915,0.0006716693,0.00003133658,0.003221769],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9996246,0.000165755,0.000025504634,0.00007331005,0.00004510557,0.00006566384],"domain_scores_gemma":[0.9995198,0.00015386107,0.000085794985,0.000040013874,0.000040638537,0.00015988997],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012349748,0.001543082,0.0030110418,0.00040805462,0.00039304243,0.0007857625,0.0008406446,0.0014776567,0.0040301154],"category_scores_gemma":[0.0010158075,0.00054516154,0.0012949198,0.00044697084,0.0010210862,0.000782885,0.00031950776,0.002068344,0.00065145694],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9505099,0.010246994,0.000490804,0.0013736063,0.0011292777,0.00006902382,0.000090690744,0.00038299168,0.0076563605,0.00016859782,0.00084843126,0.027033402],"study_design_scores_gemma":[0.95538056,0.042395335,0.000852252,0.000029239167,0.00028311004,0.000024481411,0.000016644413,0.00020560506,0.00030912843,0.0000842041,0.00041075688,0.000008679186],"about_ca_topic_score_codex":0.0007496968,"about_ca_topic_score_gemma":0.0016336091,"teacher_disagreement_score":0.0040301154,"about_ca_system_score_codex":0.00040167492,"about_ca_system_score_gemma":0.000840042,"threshold_uncertainty_score":0.013482034},"labels":[],"label_agreement":null},{"id":"W2103273672","doi":"10.1016/j.jaad.2013.11.050","title":"The association of indoor tanning and melanoma in adults: Systematic review and meta-analysis","year":2014,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Skin Protection and Aging","field":"Medicine","cited_by":196,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Confidence interval; Odds ratio; Meta-analysis; Melanoma; Dermatology; Observational study; Environmental health; Internal medicine","score_opus":0.03021202782205293,"score_gpt":0.3584803517502015,"score_spread":0.32826832392814853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103273672","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0072473455,0.9918847,0.00021622889,0.00007301648,0.0000953514,0.0000704197,0.00027674276,0.000012291697,0.00012384955],"genre_scores_gemma":[0.17871764,0.81782126,0.0014206106,0.0007334205,0.0002447099,0.0002134349,0.00047938473,0.0000156216,0.0003539231],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.997747,0.0007415364,0.0007740849,0.00037480288,0.00023067881,0.0001319938],"domain_scores_gemma":[0.99436533,0.0038685738,0.0010735467,0.00020952571,0.0003726354,0.00011033102],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037415703,0.0019889458,0.0104852365,0.0027947489,0.0004993299,0.0017149224,0.0015964935,0.002077657,0.0034531313],"category_scores_gemma":[0.011308561,0.0013767364,0.021210486,0.004089862,0.00053250254,0.0014393739,0.0012904623,0.0016905328,0.00027914572],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028146522,0.000072497154,0.011129262,0.39144123,0.5751737,0.00023044228,0.0001258795,0.00036701545,0.0004300163,0.000097216594,0.00084406266,0.01727399],"study_design_scores_gemma":[0.0005813115,0.00021610035,0.008699535,0.012112633,0.9765205,0.00014904035,0.00006024446,0.00010498156,0.000089929694,0.00010104349,0.0013354828,0.000029269328],"about_ca_topic_score_codex":0.006909545,"about_ca_topic_score_gemma":0.0233638,"teacher_disagreement_score":0.0104852365,"about_ca_system_score_codex":0.0009624665,"about_ca_system_score_gemma":0.0015441146,"threshold_uncertainty_score":0.01978761},"labels":[],"label_agreement":null},{"id":"W2104206044","doi":"10.1016/j.jaad.2005.09.044","title":"Zinc deficiency associated with necrolytic acral erythema","year":2006,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Viral Infections and Immunology Research","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"","keywords":"Medicine; Dermatology; Erythema; Zinc deficiency (plant disorder); Pathology","score_opus":0.015503939504252053,"score_gpt":0.3083465153002867,"score_spread":0.2928425757960347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2104206044","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9859859,0.0016411671,0.0012741218,0.0005901973,0.000079065096,0.000089990855,0.00020602944,0.00019203176,0.009941572],"genre_scores_gemma":[0.99853075,0.00025766974,0.00023865305,0.00007597579,0.00007031988,0.000005590258,0.000049542978,0.000011930683,0.00075957645],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9995555,0.00009641642,0.00006114916,0.000076833734,0.00008282512,0.00012730295],"domain_scores_gemma":[0.998539,0.00045372415,0.00039010725,0.00017068793,0.000118893986,0.0003276753],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041574636,0.0013546242,0.00073107827,0.0015123895,0.0011691337,0.0006375068,0.0007431988,0.0012542325,0.0025660428],"category_scores_gemma":[0.0021136326,0.00055197073,0.00045153828,0.00090132613,0.0009280713,0.00051918015,0.00054844917,0.001409814,0.00058069715],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029157863,0.00024176396,0.048777096,0.00022554702,0.000087671724,0.91465855,0.00021340986,0.00012342137,0.026646715,0.00045658616,0.0006186678,0.0050347704],"study_design_scores_gemma":[0.00021092914,0.00047410067,0.09441199,0.000024363042,0.000108702276,0.8984183,0.00017660046,0.00044945162,0.004165828,0.00027442767,0.0012597551,0.000025639683],"about_ca_topic_score_codex":0.0019836938,"about_ca_topic_score_gemma":0.0017035851,"teacher_disagreement_score":0.0025660428,"about_ca_system_score_codex":0.0004627992,"about_ca_system_score_gemma":0.00037070416,"threshold_uncertainty_score":0.008584261},"labels":[],"label_agreement":null},{"id":"W2106005668","doi":"10.1016/j.jaad.2011.04.031","title":"Guidelines of care for the management of primary cutaneous melanoma","year":2011,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":616,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Primary (astronomy); Primary care; Dermatology; Melanoma; Intensive care medicine; Family medicine; Cancer research","score_opus":0.03826489449961977,"score_gpt":0.3111206311487386,"score_spread":0.27285573664911883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106005668","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0110973045,0.20784189,0.08168244,0.4736734,0.026451623,0.004491917,0.003428905,0.0017468296,0.18958563],"genre_scores_gemma":[0.08192507,0.20248874,0.50346196,0.124435626,0.018242639,0.00881715,0.011122304,0.00053505396,0.048971396],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99425817,0.0020555437,0.0014335903,0.00016314376,0.0017429905,0.00034649603],"domain_scores_gemma":[0.9833363,0.003550359,0.0021406873,0.00027082482,0.0093182605,0.0013834998],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005246899,0.001235589,0.0015745672,0.0037736758,0.0020592767,0.0021234823,0.0040731966,0.007083354,0.004426205],"category_scores_gemma":[0.01849456,0.000558534,0.002630628,0.0018565182,0.000968661,0.0012742633,0.0014907754,0.008544258,0.0025693632],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010286054,0.0005599999,0.006651518,0.0017505564,0.0001735541,0.0015751885,0.0005700916,0.0024750852,0.0010302053,0.008427172,0.6945241,0.28215966],"study_design_scores_gemma":[0.000338483,0.00031462585,0.022108663,0.017987633,0.00041597127,0.0061085415,0.00081015413,0.0033344016,0.0008544037,0.014474937,0.9330948,0.0001574589],"about_ca_topic_score_codex":0.01640574,"about_ca_topic_score_gemma":0.039236914,"teacher_disagreement_score":0.01640574,"about_ca_system_score_codex":0.0029894258,"about_ca_system_score_gemma":0.011629837,"threshold_uncertainty_score":0.03262049},"labels":[],"label_agreement":null},{"id":"W2106027428","doi":"10.1016/j.jaad.2013.02.017","title":"American Academy of Dermatology and Health Volunteers Overseas: A decade of partnership","year":2013,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatological diseases and infestations","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Children's Hospital","funders":"","keywords":"Medicine; Health care; Family medicine; Population; Environmental health; Economic growth","score_opus":0.03910566025033586,"score_gpt":0.3709354628944597,"score_spread":0.3318298026441239,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106027428","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006054364,0.021484686,0.001320063,0.9221158,0.025442481,0.00009875079,0.000056686607,0.000080079044,0.02334726],"genre_scores_gemma":[0.21096125,0.049515538,0.007892686,0.60881984,0.025660256,0.0006484361,0.00034544722,0.00024345843,0.095913105],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.96530396,0.0121986745,0.0015789425,0.0020034767,0.008922958,0.009992038],"domain_scores_gemma":[0.7890821,0.023306664,0.005179212,0.0056616995,0.023509327,0.15326105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.05459055,0.0011419724,0.0014732323,0.0020330206,0.016081274,0.021533877,0.0035450864,0.022044906,0.03756026],"category_scores_gemma":[0.042695023,0.001077962,0.00079067476,0.0025646677,0.012601841,0.01847469,0.03174523,0.034561533,0.0075575775],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022963542,0.0014168518,0.0073629166,0.00058704254,0.00007912371,0.001581033,0.01700037,0.00019521567,0.001135673,0.054446917,0.74003726,0.17592789],"study_design_scores_gemma":[0.00008911832,0.00015342534,0.004866554,0.0011373059,0.000010598489,0.0007818054,0.03162585,0.00021641538,0.00007658259,0.015840191,0.94512445,0.000077734905],"about_ca_topic_score_codex":0.007646174,"about_ca_topic_score_gemma":0.011889102,"teacher_disagreement_score":0.05459055,"about_ca_system_score_codex":0.0056898524,"about_ca_system_score_gemma":0.055763632,"threshold_uncertainty_score":0.2887059},"labels":[],"label_agreement":null},{"id":"W2106192844","doi":"10.1067/mjd.2000.104000","title":"Localized pruritus: A presenting symptom of a spinal cord tumor in a child with features of neurofibromatosis","year":2000,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Neurofibromatosis and Schwannoma Cases","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; Dalhousie University","funders":"","keywords":"Medicine; Spinal cord; Neurofibromatosis; Central nervous system; Pathology; Spinal Cord Neoplasm; Cord; Spinal cord tumor; Surgery; Internal medicine","score_opus":0.011589376614400638,"score_gpt":0.28846808557304754,"score_spread":0.2768787089586469,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106192844","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98210967,0.0026867413,0.0011854192,0.0027460102,0.0002206093,0.00016552208,0.00039121634,0.0002567069,0.0102381455],"genre_scores_gemma":[0.9975164,0.0007050578,0.0005249492,0.0003670331,0.00025300623,0.000017206752,0.00009215615,0.000021454378,0.00050265307],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9993981,0.00007057804,0.000075259726,0.00013730573,0.00009290314,0.0002257752],"domain_scores_gemma":[0.997835,0.00081794395,0.0004240933,0.00009555773,0.00012741548,0.00070006977],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034378734,0.0018926833,0.0012460948,0.0021703513,0.0023623146,0.001249247,0.001369962,0.0044048447,0.0017946212],"category_scores_gemma":[0.005103761,0.0011350239,0.00095173455,0.0015596212,0.0022274759,0.0017874092,0.0011762679,0.002983372,0.0006435387],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029299388,0.00003689297,0.007520205,0.000022860817,0.00000466163,0.9911158,0.00013734776,0.00005132008,0.0004919797,0.0000859857,0.00013358443,0.00037008506],"study_design_scores_gemma":[0.000015123736,0.00014284979,0.019163175,0.000011959616,0.000018570341,0.979645,0.000215545,0.00021379377,0.00027040273,0.00006726614,0.00022580392,0.000010459225],"about_ca_topic_score_codex":0.005877674,"about_ca_topic_score_gemma":0.006037298,"teacher_disagreement_score":0.005877674,"about_ca_system_score_codex":0.0014452911,"about_ca_system_score_gemma":0.0009947338,"threshold_uncertainty_score":0.011686921},"labels":[],"label_agreement":null},{"id":"W2106637550","doi":"10.1016/j.jaad.2015.07.044","title":"Recurrence of hidradenitis suppurativa after surgical management: A systematic review and meta-analysis","year":2015,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":217,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto","funders":"","keywords":"Hidradenitis suppurativa; Medicine; Meta-analysis; Confidence interval; Wide local excision; Surgery; Apocrine; Skin grafting; Systematic review; Odds ratio; Dermatology; Pilonidal disease; MEDLINE; Disease; Randomized controlled trial; Internal medicine; Pathology","score_opus":0.07489976694515861,"score_gpt":0.40202113434096765,"score_spread":0.32712136739580905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106637550","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005776359,0.99344456,0.00016528527,0.00007167901,0.000077079065,0.000090141024,0.00024772418,0.000008061604,0.00011914661],"genre_scores_gemma":[0.19188002,0.80455273,0.0013403604,0.00090375723,0.00019307982,0.00031497373,0.00052960985,0.000016229864,0.00026923334],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99597126,0.0012190952,0.0015536499,0.00058238016,0.00047405972,0.00019946975],"domain_scores_gemma":[0.98991066,0.006756441,0.0022451787,0.00031412218,0.00061768864,0.00015594314],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0055734017,0.0018035054,0.012481232,0.0035166896,0.000506992,0.0021922835,0.0018856685,0.002025983,0.003997963],"category_scores_gemma":[0.015797922,0.0012631702,0.023622328,0.004775481,0.00066200114,0.0018718009,0.0014103841,0.00173771,0.00027847718],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002411705,0.00006427068,0.010835635,0.47549704,0.4921061,0.00025304756,0.00018479997,0.00025308508,0.00025966106,0.00008839427,0.0007697789,0.017276533],"study_design_scores_gemma":[0.00071011356,0.00025908707,0.010425877,0.023195447,0.96282697,0.0002667168,0.00013094931,0.00010715806,0.00008514413,0.000114443676,0.0018359091,0.000042183223],"about_ca_topic_score_codex":0.004631318,"about_ca_topic_score_gemma":0.017930204,"teacher_disagreement_score":0.012481232,"about_ca_system_score_codex":0.0013980303,"about_ca_system_score_gemma":0.0019919798,"threshold_uncertainty_score":0.029475331},"labels":[],"label_agreement":null},{"id":"W2106640409","doi":"10.1016/j.jaad.2005.03.029","title":"Socioeconomic status influences care of patients with acne in Ontario, Canada","year":2006,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Toronto Western Hospital; University of Toronto; University Health Network; Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences","funders":"","keywords":"Medicine; Socioeconomic status; Specialty; Household income; Cohort; Health care; Acne; Population; Family medicine; Cohort study; Environmental health; Dermatology; Pathology","score_opus":0.0038887803576162757,"score_gpt":0.231718135285516,"score_spread":0.2278293549278997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106640409","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9868629,0.0011243155,0.00004764571,0.0027166095,0.000050770468,0.00005723475,0.0016644927,0.0000053877197,0.00747062],"genre_scores_gemma":[0.9974674,0.0005883135,0.000081353544,0.0003536922,0.00001584901,0.000016684713,0.00039816546,0.000005461618,0.0010731645],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984863,0.00020812935,0.00012284411,0.000111099325,0.0003529334,0.0007187009],"domain_scores_gemma":[0.99437284,0.00042877722,0.0013699767,0.00008792389,0.0015815021,0.0021590004],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005485961,0.00020476016,0.00046733872,0.00087695505,0.0055678254,0.002006819,0.0014947584,0.0006452153,0.0057137497],"category_scores_gemma":[0.0046111783,0.00036595023,0.00078979786,0.0036573748,0.00094287744,0.000533193,0.0011757839,0.0011674628,0.0002943262],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012105551,0.0000847247,0.99028206,0.000041966578,0.0000612258,0.00028229988,0.0025795887,0.00011122417,0.00006829117,0.00024049179,0.0025415765,0.0035853083],"study_design_scores_gemma":[0.00002707259,0.000027869439,0.991052,0.00009513452,0.00003626799,0.00012105481,0.006791295,0.00017297294,0.000018759843,0.000068980815,0.001572758,0.000015915868],"about_ca_topic_score_codex":0.995116,"about_ca_topic_score_gemma":0.99814045,"teacher_disagreement_score":0.04472281,"about_ca_system_score_codex":0.04472281,"about_ca_system_score_gemma":0.05165223,"threshold_uncertainty_score":0.32448822},"labels":[],"label_agreement":null},{"id":"W2106849197","doi":"10.1067/mjd.2000.106239","title":"Persistent serpentine supravenous hyperpigmented eruption as an adverse reaction to chemotherapy combining actinomycin and vincristine","year":2000,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Chemotherapy-related skin toxicity","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Vincristine; Hyperpigmentation; Chemotherapy; Drug eruption; Biopsy; Regimen; Forearm; Dermatology; Drug reaction; Adverse effect; Skin biopsy; Surgery; Pathology; Drug; Internal medicine; Pharmacology","score_opus":0.02904670805892959,"score_gpt":0.35528177695360225,"score_spread":0.32623506889467263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106849197","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0025947064,0.99378043,0.00042530254,0.00016746238,0.00021910432,0.0000132173745,0.00003060225,0.000023005083,0.0027460514],"genre_scores_gemma":[0.015616563,0.979955,0.00048769003,0.0004666586,0.000317835,0.00001078324,0.00006913701,0.0000056896993,0.0030707319],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.999863,0.000022613705,0.00002507615,0.000028104425,0.000049642873,0.0000116701485],"domain_scores_gemma":[0.9998282,0.000072985094,0.000046133602,0.000008122039,0.00003047681,0.000014040546],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026001185,0.00057901785,0.0011478584,0.001232732,0.00020380011,0.0005596392,0.00068194314,0.00067100086,0.0016342836],"category_scores_gemma":[0.00031988203,0.00017898512,0.00034703515,0.0012433354,0.00030025374,0.0006054634,0.00023658812,0.000748213,0.0010256252],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016914056,0.00015656317,0.0011465319,0.008961062,0.00013342655,0.007635503,0.00007244003,0.00037453644,0.0058738296,0.00047976064,0.017339362,0.9576579],"study_design_scores_gemma":[0.00013552084,0.00055840705,0.01400963,0.0025954598,0.0007951208,0.109973386,0.00017424238,0.00053997256,0.006610698,0.0008282801,0.86371815,0.00006118752],"about_ca_topic_score_codex":0.0009532629,"about_ca_topic_score_gemma":0.0030453554,"teacher_disagreement_score":0.0016342836,"about_ca_system_score_codex":0.00025997343,"about_ca_system_score_gemma":0.00035739032,"threshold_uncertainty_score":0.0054671764},"labels":[],"label_agreement":null},{"id":"W2107768865","doi":"10.1016/j.jaad.2009.07.032","title":"The safety profile and sustained remission associated with response to multiple courses of intramuscular alefacept for treatment of chronic plaque psoriasis","year":2010,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Windsor Clinical Research","funders":"","keywords":"Medicine; Psoriasis; Plaque psoriasis; Adverse effect; Safety profile; Dermatology; Internal medicine; Clinical trial; Psoriasis Area and Severity Index","score_opus":0.008885098678193015,"score_gpt":0.26615299882690063,"score_spread":0.2572679001487076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107768865","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992467,0.0040723924,0.00089696114,0.00039695395,0.00004554421,0.00007585661,0.00015645994,0.000040188177,0.0018486499],"genre_scores_gemma":[0.99871266,0.00042052378,0.00018197074,0.000115373274,0.00005694547,0.000019401587,0.000111533285,0.000005019531,0.00037673514],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9994649,0.00018004971,0.000054504166,0.00003961441,0.0001582681,0.00010278343],"domain_scores_gemma":[0.99897015,0.00037057349,0.00036082193,0.00009675278,0.00007874802,0.0001229849],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00096687773,0.00027333832,0.0005154904,0.00022983256,0.00024042821,0.00035732304,0.00028091366,0.0005285184,0.0012229122],"category_scores_gemma":[0.001773194,0.00013933973,0.00069393637,0.00023460553,0.00033447528,0.00028613737,0.00014365355,0.0014276536,0.00029556488],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10916189,0.005418457,0.089346625,0.0009342075,0.0010636222,0.003992821,0.0003176381,0.0019193717,0.25682777,0.00051644066,0.0019593625,0.52854186],"study_design_scores_gemma":[0.018885408,0.21162535,0.6644686,0.000137487,0.0018268353,0.020832477,0.00029054,0.004127933,0.065583974,0.0008041894,0.011345205,0.00007201451],"about_ca_topic_score_codex":0.00032840416,"about_ca_topic_score_gemma":0.0006609411,"teacher_disagreement_score":0.0012229122,"about_ca_system_score_codex":0.00033326636,"about_ca_system_score_gemma":0.0003759961,"threshold_uncertainty_score":0.005113423},"labels":[],"label_agreement":null},{"id":"W2108046961","doi":"10.1016/j.jaad.2003.10.010","title":"Efficacy and safety of efalizumab in a large cohort of patients with moderate to severe plaque psoriasis: pooled results from randomized phase III trials","year":2004,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Efalizumab; Medicine; Psoriasis; Psoriasis Area and Severity Index; Placebo; Plaque psoriasis; Internal medicine; Randomized controlled trial; Cohort; Dermatology; Surgery; Pathology","score_opus":0.012879503249499737,"score_gpt":0.278769773733461,"score_spread":0.2658902704839613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2108046961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84653777,0.14221504,0.0031698754,0.0011167197,0.0007410308,0.0015518015,0.0019455118,0.00017236327,0.0025498564],"genre_scores_gemma":[0.97426176,0.019207373,0.0016190137,0.0009842274,0.00056166993,0.0009788956,0.0017754944,0.00003833744,0.00057332165],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99524033,0.002892138,0.00053041143,0.000613855,0.0003843006,0.00033896943],"domain_scores_gemma":[0.9948933,0.0025477982,0.0012997396,0.00057671196,0.00030039187,0.00038201944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012774489,0.002396798,0.009164421,0.00087043084,0.0005797479,0.0018904436,0.0009433316,0.001895753,0.0017999654],"category_scores_gemma":[0.008985921,0.001012521,0.008631258,0.0011619001,0.0011461278,0.0017621642,0.00061151804,0.0024065787,0.00030430735],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8575816,0.0009665694,0.01209964,0.0032777614,0.081052594,0.000097587195,0.00008875185,0.0011932364,0.0026640934,0.00012627518,0.0011429039,0.03970905],"study_design_scores_gemma":[0.77947634,0.048224933,0.05490168,0.00052340614,0.11029934,0.00042076022,0.00011718677,0.0010760219,0.0011165864,0.00085407903,0.0028524469,0.00013720397],"about_ca_topic_score_codex":0.00068286335,"about_ca_topic_score_gemma":0.0013095776,"teacher_disagreement_score":0.012774489,"about_ca_system_score_codex":0.0008279848,"about_ca_system_score_gemma":0.00085622416,"threshold_uncertainty_score":0.067558706},"labels":[],"label_agreement":null},{"id":"W2109449039","doi":"10.1016/j.jaad.2004.08.013","title":"Serious dermatologic reaction associated with valdecoxib: Report of two cases","year":2004,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Rash; Prednisone; Valdecoxib; Gastroenterology; Erythema; Internal medicine; Adverse effect; Anesthesia; Surgery; Dermatology","score_opus":0.027678305703147284,"score_gpt":0.3272721503338169,"score_spread":0.2995938446306696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109449039","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9120829,0.009828809,0.006339873,0.01834902,0.0022301897,0.0005203172,0.00042327796,0.00034380666,0.04988184],"genre_scores_gemma":[0.9838303,0.0024542366,0.001897093,0.0051241424,0.0029816246,0.00007017504,0.00015790468,0.000044413726,0.0034401338],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9981324,0.0003334709,0.00024120467,0.00038533518,0.00023911042,0.0006684484],"domain_scores_gemma":[0.9955649,0.0017458271,0.0007230061,0.0005178077,0.00042718308,0.0010213383],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009944229,0.002909351,0.0014129147,0.0018056836,0.0029598498,0.0024846618,0.0020371752,0.012626785,0.0024462244],"category_scores_gemma":[0.0072240243,0.0014694885,0.0024721725,0.0012250119,0.0019649083,0.0023032068,0.0015965293,0.0050360393,0.0014288586],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000054790085,0.0001152925,0.007377173,0.00002927725,0.000015576947,0.98998255,0.00018978452,0.000054720633,0.00029647554,0.00014664349,0.0006339253,0.0011037418],"study_design_scores_gemma":[0.00005785756,0.00017444482,0.0056621255,0.000019189909,0.000037089696,0.99156624,0.00024783702,0.00025586694,0.00036912644,0.00016251874,0.001432,0.0000155749],"about_ca_topic_score_codex":0.0035644341,"about_ca_topic_score_gemma":0.0042616935,"teacher_disagreement_score":0.012626785,"about_ca_system_score_codex":0.0025323674,"about_ca_system_score_gemma":0.0011283015,"threshold_uncertainty_score":0.018373668},"labels":[],"label_agreement":null},{"id":"W2110643073","doi":"10.1016/j.jaad.2007.04.016","title":"Contact dermatitis of the hands: Cross-sectional analyses of North American Contact Dermatitis Group Data, 1994-2004","year":2007,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Contact Dermatitis and Allergies","field":"Medicine","cited_by":104,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; University of Ottawa","funders":"National Institute of General Medical Sciences","keywords":"Medicine; Contact dermatitis; Cross-sectional study; Dermatology; Allergy; Pathology; Immunology","score_opus":0.03916215046073634,"score_gpt":0.3623251322328145,"score_spread":0.32316298177207814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110643073","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953784,0.0005820829,0.00009513203,0.00003335028,0.000009114816,0.000028544837,0.003141794,0.000008556642,0.0007230992],"genre_scores_gemma":[0.99593973,0.0004549035,0.0001069372,0.000041374013,0.000012865517,0.00003401977,0.0030258996,0.000005237789,0.00037910958],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987876,0.00032722566,0.00018197362,0.00024693343,0.0003109963,0.0001452968],"domain_scores_gemma":[0.99647444,0.0004942669,0.0017223353,0.00030248673,0.00065763603,0.00034885044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012870394,0.0005621267,0.0005688597,0.0017894988,0.0007066834,0.00087708497,0.0008671308,0.0008663309,0.0017192954],"category_scores_gemma":[0.0024721725,0.0007136372,0.00078295736,0.0038476414,0.00036931175,0.00090870913,0.0006665028,0.00078268547,0.00036973553],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012098779,0.000045320863,0.9985813,0.000017156117,0.00012327434,0.000041257914,0.00009658727,0.00003708051,0.00007993655,0.0000073146252,0.00020986475,0.0006400498],"study_design_scores_gemma":[0.0000040184536,0.000027494167,0.99948585,0.0000049079954,0.00003391381,0.00009885471,0.00014116261,0.000036532285,0.000018300832,0.0000028653155,0.00014440189,0.0000016475573],"about_ca_topic_score_codex":0.08210472,"about_ca_topic_score_gemma":0.11348537,"teacher_disagreement_score":0.08210472,"about_ca_system_score_codex":0.0013225701,"about_ca_system_score_gemma":0.0007585786,"threshold_uncertainty_score":0.1632536},"labels":[],"label_agreement":null},{"id":"W2111247729","doi":"10.1016/j.jaad.2011.07.040","title":"Integrated safety analysis: Short- and long-term safety profiles of etanercept in patients with psoriasis","year":2011,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":82,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Etanercept; Medicine; Psoriasis; Tolerability; Adverse effect; Internal medicine; Population; Cumulative incidence; Incidence (geometry); Placebo; Surgery; Dermatology; Cohort; Pathology; Tumor necrosis factor alpha","score_opus":0.023749187184791385,"score_gpt":0.2864853932099048,"score_spread":0.2627362060251134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111247729","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007944688,0.9980185,0.00030103215,0.00028141044,0.00012722252,0.000010653449,0.000047126057,0.000010844421,0.0004087179],"genre_scores_gemma":[0.0073256665,0.9902109,0.00065104454,0.00059750216,0.00044191326,0.000019596107,0.0001723064,0.000004374288,0.00057667476],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99948716,0.00013000894,0.00009193263,0.00006283866,0.00019467057,0.00003324068],"domain_scores_gemma":[0.9987777,0.0006319729,0.0002499325,0.00002617286,0.00025872124,0.00005552157],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017129106,0.00078393985,0.0024168543,0.0009778221,0.00011810544,0.00082428806,0.0010433616,0.0009082487,0.0014044992],"category_scores_gemma":[0.0016456853,0.0001993777,0.0011853386,0.0010465577,0.00023964184,0.0006374135,0.00031723978,0.0013233765,0.00051095826],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056552776,0.000111810965,0.0005345085,0.008792227,0.00046472216,0.00015138181,0.00001908747,0.00035072296,0.0012522372,0.00039742253,0.013006897,0.9743533],"study_design_scores_gemma":[0.0018104697,0.003717793,0.022770328,0.014547879,0.006592347,0.008247915,0.00017641629,0.001687618,0.005697311,0.0042632287,0.93031657,0.00017205685],"about_ca_topic_score_codex":0.0006324219,"about_ca_topic_score_gemma":0.0013274419,"teacher_disagreement_score":0.0024168543,"about_ca_system_score_codex":0.0005371243,"about_ca_system_score_gemma":0.0009939886,"threshold_uncertainty_score":0.009058833},"labels":[],"label_agreement":null},{"id":"W2111467908","doi":"10.1016/j.jaad.2009.02.052","title":"Deep cutaneous fungal infections in immunocompromised children","year":2009,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Fungal Infections and Studies","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Neutropenia; Pediatrics; Dermatology; Medical record; Fluconazole; Internal medicine; Antifungal; Toxicity","score_opus":0.022192007700743543,"score_gpt":0.3492349545659511,"score_spread":0.3270429468652076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111467908","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016641167,0.99948347,0.000017131395,0.00004237175,0.00005167164,0.000002258537,0.000010515274,0.0000013461181,0.00022479925],"genre_scores_gemma":[0.00090938836,0.998816,0.00005982271,0.000052917003,0.00006328198,0.0000018264332,0.000010863296,2.7973783e-7,0.00008568374],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999739,0.000036508132,0.000079092635,0.0000399305,0.000085687534,0.000019794008],"domain_scores_gemma":[0.9993237,0.00032891604,0.00021830812,0.000012299246,0.000076934244,0.000039721923],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048684276,0.00075060397,0.0014789334,0.0036729872,0.00024503353,0.0010269457,0.00063898007,0.0006895626,0.0021858467],"category_scores_gemma":[0.0010476755,0.00030524677,0.00047194862,0.003951847,0.0004730012,0.0011063805,0.0006124148,0.0007602268,0.00043753372],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009538117,0.00006957098,0.0019420366,0.049448032,0.00017209083,0.0010545964,0.0001221258,0.00016507223,0.0008518988,0.00066197047,0.016844047,0.92857313],"study_design_scores_gemma":[0.00009737543,0.00026491686,0.020504791,0.056505624,0.0018923702,0.025346717,0.0007166151,0.00015287052,0.0010364527,0.0011513171,0.8922577,0.000073247145],"about_ca_topic_score_codex":0.0020146756,"about_ca_topic_score_gemma":0.0048142467,"teacher_disagreement_score":0.0036729872,"about_ca_system_score_codex":0.00038373214,"about_ca_system_score_gemma":0.0010573671,"threshold_uncertainty_score":0.007312417},"labels":[],"label_agreement":null},{"id":"W2111754598","doi":"10.1067/s0190-9622(02)61475-6","title":"Efficacy of docosanol","year":2003,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Herpes Labialis; Placebo; Clinical trial; Dermatology; Traditional medicine; Trustworthiness; Alternative medicine; Internal medicine; Herpes simplex virus; Immunology; Pathology; Psychology","score_opus":0.0214571982229174,"score_gpt":0.32821298489109046,"score_spread":0.30675578666817305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111754598","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3208132,0.23118784,0.00072952313,0.25624108,0.017049499,0.00020897223,0.0012391277,0.0002285337,0.17230226],"genre_scores_gemma":[0.86442757,0.024144754,0.0006801641,0.07456394,0.012173593,0.000093642564,0.0005437106,0.00002408548,0.023348542],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993722,0.00027413928,0.0000816199,0.000050417762,0.00011596412,0.00010578146],"domain_scores_gemma":[0.9984124,0.00088016386,0.0001453076,0.0000965946,0.00014179341,0.00032376856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009790577,0.00037975254,0.0014583652,0.00028808578,0.0006236726,0.0008802279,0.00065878156,0.0033920102,0.0035897954],"category_scores_gemma":[0.0035017824,0.00011179031,0.00097300875,0.00023388861,0.0005131963,0.0005105357,0.00018824956,0.0037973335,0.00092046754],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11542831,0.0037529222,0.028300986,0.0019056377,0.0011740148,0.046658367,0.00031187278,0.0005344477,0.016086759,0.009476714,0.091186844,0.6851832],"study_design_scores_gemma":[0.06659928,0.04281443,0.24529462,0.002738055,0.0030984757,0.10223082,0.0009182066,0.0028859787,0.019108837,0.009346991,0.5047152,0.00024908828],"about_ca_topic_score_codex":0.0012028728,"about_ca_topic_score_gemma":0.003042421,"teacher_disagreement_score":0.0035897954,"about_ca_system_score_codex":0.001487907,"about_ca_system_score_gemma":0.0009807079,"threshold_uncertainty_score":0.012009084},"labels":[],"label_agreement":null},{"id":"W2113624410","doi":"10.1067/mjd.2002.123482","title":"Total skin electron radiation in the management of mycosis fungoides: Consensus of the European Organization for Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Project Group","year":2002,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":220,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario","funders":"","keywords":"Mycosis fungoides; Medicine; Radiation therapy; Dermatology; Cancer; Treatment modality; Cutaneous lymphoma; Cutaneous T-cell lymphoma; Lymphoma; Skin cancer; Medical physics; Surgery; Internal medicine","score_opus":0.043022052259848585,"score_gpt":0.36873564796193564,"score_spread":0.3257135957020871,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2113624410","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0155816255,0.6926902,0.007757768,0.25856152,0.012800151,0.00024854398,0.00025249334,0.00008556337,0.012022052],"genre_scores_gemma":[0.23875044,0.6294409,0.037235778,0.06251075,0.024742108,0.0005827811,0.0008248085,0.0001675911,0.005744826],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9943007,0.0018441294,0.0016482356,0.00029164035,0.0016170281,0.00029822803],"domain_scores_gemma":[0.98835844,0.004552772,0.0014416607,0.00040781155,0.0041456344,0.0010936566],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020127349,0.0005209608,0.0018042267,0.0015237639,0.0013355535,0.0020605137,0.0034453378,0.0049811327,0.0009782056],"category_scores_gemma":[0.013766616,0.00038901914,0.0012232873,0.0015893702,0.0016241976,0.0016959397,0.0012861657,0.00837501,0.0005585436],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000969667,0.00036939434,0.010388519,0.0057283896,0.0004987321,0.0018920179,0.0011195433,0.0020920292,0.0037085412,0.004493403,0.13325082,0.8354889],"study_design_scores_gemma":[0.0007934529,0.0010348306,0.042888977,0.017819181,0.0016041662,0.012295441,0.003381219,0.0026827937,0.003770963,0.010291322,0.903252,0.00018562816],"about_ca_topic_score_codex":0.0041564945,"about_ca_topic_score_gemma":0.010131143,"teacher_disagreement_score":0.020127349,"about_ca_system_score_codex":0.0016133853,"about_ca_system_score_gemma":0.0061016353,"threshold_uncertainty_score":0.106444836},"labels":[],"label_agreement":null},{"id":"W2113973541","doi":"10.1016/j.jaad.2004.03.051","title":"Assessing the role of race in quantitative measures of skin pigmentation and clinical assessments of photosensitivity","year":2005,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Skin Protection and Aging","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"","keywords":"Phototype; Medicine; Race (biology); Dark skin; Dermatology; Skin color; Ethnic group; Skin cancer; Sensitive skin; African american; Demography; Cancer; Internal medicine","score_opus":0.06179541084920342,"score_gpt":0.4564267957429483,"score_spread":0.3946313848937449,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2113973541","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940382,0.0005284654,0.0026678143,0.00012577136,0.000051177572,0.000055132616,0.00017030437,0.000011445001,0.0023516272],"genre_scores_gemma":[0.99768925,0.00005885669,0.0013564534,0.000046784295,0.00001999138,0.000035860503,0.00008378932,0.000009651061,0.0006993436],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99229056,0.005347426,0.00040895125,0.00076961453,0.00092499703,0.00025848846],"domain_scores_gemma":[0.9781507,0.013613536,0.0038509306,0.001956264,0.0018119973,0.0006164848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011240781,0.0005277374,0.00043557095,0.00068203505,0.0006006068,0.0014138616,0.0007599298,0.0008082638,0.0012961444],"category_scores_gemma":[0.023616182,0.0003440162,0.000591978,0.0006444778,0.0007145702,0.0012079593,0.00059267326,0.0010583083,0.0003798286],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016852214,0.0003638454,0.98316306,0.000029754494,0.0003668981,0.000046077144,0.00052774453,0.00024669754,0.0031482957,0.00031255072,0.0001455249,0.009964298],"study_design_scores_gemma":[0.000032207918,0.0007675739,0.99350834,0.00001788295,0.00014420127,0.0001976296,0.0002605516,0.0025038298,0.0015998788,0.0003105647,0.0006439683,0.000013402168],"about_ca_topic_score_codex":0.003226604,"about_ca_topic_score_gemma":0.007198779,"teacher_disagreement_score":0.011240781,"about_ca_system_score_codex":0.00047148886,"about_ca_system_score_gemma":0.0005764318,"threshold_uncertainty_score":0.059447646},"labels":[],"label_agreement":null},{"id":"W2114204083","doi":"10.1016/j.jaad.2012.01.016","title":"A consensus approach to wound care in epidermolysis bullosa","year":2012,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Skin and Cellular Biology Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":222,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Hospital for Sick Children; Women's College Hospital; University of Toronto; SickKids Foundation","funders":"National Eye Institute","keywords":"Medicine; Delphi method; Wound care; Epidermolysis bullosa; Cornerstone; Expert opinion; MEDLINE; Delphi; Health care; Nursing; Best practice; Family medicine; Intensive care medicine; Pathology","score_opus":0.018169948821344255,"score_gpt":0.3105134393970779,"score_spread":0.2923434905757336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114204083","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0059575858,0.008152888,0.09856344,0.8519879,0.015817994,0.0009172376,0.00008449609,0.00017858607,0.018339928],"genre_scores_gemma":[0.372047,0.015098046,0.40058434,0.18046555,0.011938019,0.0044070557,0.0007163136,0.00033120756,0.014412452],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9123932,0.05075118,0.012725467,0.0037990175,0.015561162,0.004770039],"domain_scores_gemma":[0.8963349,0.026652377,0.0041686976,0.0034385228,0.04833578,0.021069774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.11148456,0.00088412396,0.0019145365,0.0047301445,0.011103573,0.01070816,0.009878092,0.017624935,0.007289146],"category_scores_gemma":[0.11013295,0.00092918356,0.0024416428,0.0021197875,0.007946,0.006877701,0.019063089,0.029073322,0.0019268896],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002586104,0.0011193816,0.004481228,0.003930953,0.0005170201,0.005101703,0.023520084,0.0048166444,0.0019829983,0.1972493,0.33259752,0.42442456],"study_design_scores_gemma":[0.00047391411,0.00054423825,0.0046858024,0.015485079,0.00031188715,0.0030577832,0.05207857,0.008960944,0.0013667613,0.5078031,0.4047179,0.0005141424],"about_ca_topic_score_codex":0.007086111,"about_ca_topic_score_gemma":0.012236634,"teacher_disagreement_score":0.11148456,"about_ca_system_score_codex":0.012585981,"about_ca_system_score_gemma":0.08039538,"threshold_uncertainty_score":0.58959377},"labels":[],"label_agreement":null},{"id":"W2114677349","doi":"10.1016/j.jaad.2008.01.006","title":"National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening","year":2008,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":431,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University Health Network","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","keywords":"Medicine; Psoriasis; Foundation (evidence); Disease; Intensive care medicine; Population; MEDLINE; Dermatology; Family medicine; Pathology; Environmental health","score_opus":0.13592852914850512,"score_gpt":0.4088836466374366,"score_spread":0.2729551174889315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114677349","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002245525,0.98171437,0.0012230214,0.009698957,0.0025344978,0.00008283814,0.00024607903,0.000046939887,0.004228722],"genre_scores_gemma":[0.0023366336,0.98222834,0.0052283136,0.0057179243,0.001598771,0.00013874231,0.00076992187,0.000011777069,0.0019696264],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983694,0.000348188,0.0003704898,0.00013892281,0.000652114,0.00012088185],"domain_scores_gemma":[0.9962347,0.0011266047,0.0005768527,0.000070957714,0.0017225803,0.00026829774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004495472,0.001110526,0.0027477408,0.005097339,0.0006627928,0.0013361495,0.0025198727,0.0029850677,0.0042399988],"category_scores_gemma":[0.005706681,0.0005105038,0.0015228725,0.0035250427,0.00066341466,0.0014759741,0.0012438234,0.003528158,0.0021026225],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001253277,0.00015409324,0.0009751935,0.008035528,0.00014264756,0.00025282198,0.0000492895,0.00032237,0.0002893205,0.0021820604,0.20816422,0.7793072],"study_design_scores_gemma":[0.00017030553,0.000116395306,0.0057189018,0.0263793,0.0006466921,0.0025988389,0.00018309492,0.0002818773,0.00040691366,0.003812512,0.95962113,0.00006403388],"about_ca_topic_score_codex":0.007339918,"about_ca_topic_score_gemma":0.010379755,"teacher_disagreement_score":0.007339918,"about_ca_system_score_codex":0.0018956601,"about_ca_system_score_gemma":0.006652671,"threshold_uncertainty_score":0.023774624},"labels":[],"label_agreement":null},{"id":"W2116805725","doi":"10.1016/j.jaad.2013.01.031","title":"Visual images for patient skin self-examination and melanoma detection: A systematic review of published studies","year":2013,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Skin cancer; Psychological intervention; Melanoma; Systematic review; Dermatology; MEDLINE; Cancer; Internal medicine; Nursing","score_opus":0.021622385063174248,"score_gpt":0.34940305997647453,"score_spread":0.32778067491330026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116805725","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019568503,0.9973929,0.00004645159,0.000080152844,0.00004324829,0.00008845447,0.00026393932,0.000003268276,0.00012467313],"genre_scores_gemma":[0.038938258,0.95950747,0.00054111803,0.0004833407,0.00006814783,0.00014477326,0.00021917642,0.000004567336,0.00009307458],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9966305,0.001048425,0.0013280562,0.0003686393,0.0005142574,0.00011025812],"domain_scores_gemma":[0.9837869,0.011011387,0.0040635113,0.00016806732,0.0007924358,0.0001776962],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00368827,0.001122878,0.005317653,0.004564489,0.00038958061,0.0017459024,0.0014214335,0.001495461,0.0049813716],"category_scores_gemma":[0.020705102,0.000815842,0.006782749,0.005262787,0.00061387225,0.0016685161,0.001185547,0.0010980411,0.0002002058],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00073175284,0.000055850523,0.0044161687,0.9176164,0.031923503,0.00012694021,0.00022175723,0.00007890606,0.00016987433,0.00008617404,0.0016085273,0.042964153],"study_design_scores_gemma":[0.0015827538,0.0006101015,0.03133278,0.61315143,0.3337567,0.0010150165,0.000712788,0.00015333804,0.00025711197,0.00029711472,0.01702023,0.00011067469],"about_ca_topic_score_codex":0.006545035,"about_ca_topic_score_gemma":0.027274536,"teacher_disagreement_score":0.006545035,"about_ca_system_score_codex":0.0014301962,"about_ca_system_score_gemma":0.002893963,"threshold_uncertainty_score":0.01950568},"labels":[],"label_agreement":null},{"id":"W2117919189","doi":"10.1016/j.jaad.2004.09.016","title":"Long-term control of atopic dermatitis with pimecrolimus cream 1% in infants and young children: A two-year study","year":2005,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":115,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; Probity Medical Research","funders":"","keywords":"Pimecrolimus; Medicine; Atopic dermatitis; Eczema Area and Severity Index; Incidence (geometry); Adverse effect; Dermatology; Calcineurin; Pediatrics; Surgery; Internal medicine; Transplantation","score_opus":0.006339463920536099,"score_gpt":0.28369213926030284,"score_spread":0.27735267533976676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117919189","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99911994,0.00050873193,0.000026345586,0.00002868683,0.00000897454,0.00001299119,0.00005922785,0.0000023022494,0.00023286791],"genre_scores_gemma":[0.99884087,0.00042175117,0.00004756877,0.000061816885,0.000023480616,0.000024673342,0.00018107412,0.000002414311,0.00039636844],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999151,0.00021791764,0.000087984234,0.000113990005,0.00016933434,0.00025967605],"domain_scores_gemma":[0.9982266,0.00040240417,0.00047400713,0.00013075232,0.00022738309,0.00053893763],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012405271,0.00069944013,0.0012770388,0.00081042136,0.0012777172,0.000867301,0.0005591209,0.0015106328,0.000640169],"category_scores_gemma":[0.0024436146,0.0005317884,0.0015118403,0.0008452587,0.0008484873,0.0011790937,0.0005963842,0.0017301299,0.00027923356],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014447717,0.0065608337,0.9587982,0.00012780115,0.00040284565,0.0029947201,0.0017053591,0.00013675138,0.003413282,0.000067897075,0.0002130264,0.011131517],"study_design_scores_gemma":[0.00025404064,0.008578047,0.9885484,0.000012557844,0.00019837945,0.0009263889,0.000687118,0.00007676745,0.00028682305,0.00001972437,0.0003900267,0.000021663129],"about_ca_topic_score_codex":0.010250334,"about_ca_topic_score_gemma":0.0066667935,"teacher_disagreement_score":0.010250334,"about_ca_system_score_codex":0.00088980736,"about_ca_system_score_gemma":0.0005419323,"threshold_uncertainty_score":0.020381331},"labels":[],"label_agreement":null},{"id":"W2117983771","doi":"10.1016/j.jaad.2013.10.010","title":"Guidelines of care for the management of atopic dermatitis","year":2013,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":1257,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health; Quest University Canada; University of British Columbia","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","keywords":"Medicine; Atopic dermatitis; Guideline; Disease; Dermatology; Disease management; Intensive care medicine; MEDLINE; Pathology","score_opus":0.05813627628411073,"score_gpt":0.405380081157618,"score_spread":0.34724380487350726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117983771","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008916926,0.99576795,0.00046203946,0.0011317566,0.0005642549,0.000038525966,0.0000968322,0.000019038102,0.0018303543],"genre_scores_gemma":[0.0010001713,0.99440306,0.0019480784,0.0013923204,0.0003839835,0.000048313992,0.00022157139,0.0000039218494,0.0005986209],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99901414,0.00022064296,0.0002670814,0.000085129635,0.00035509607,0.000057759466],"domain_scores_gemma":[0.9983796,0.00070834265,0.00031617848,0.000029320658,0.0004909221,0.00007552855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001271189,0.0012807869,0.0020223265,0.0039090356,0.00053051586,0.0012448912,0.0022104618,0.0019500692,0.004486851],"category_scores_gemma":[0.003801004,0.00034004738,0.0014824888,0.0025598006,0.0005054966,0.0011168694,0.00085254066,0.0024773402,0.0017688214],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006651001,0.00009566778,0.00042686064,0.029350316,0.00019188058,0.000302294,0.00006240213,0.00033299293,0.00038126943,0.00224254,0.089247696,0.8772996],"study_design_scores_gemma":[0.00011642206,0.00009162461,0.0027056525,0.069127694,0.0010335105,0.0025629015,0.00013525199,0.0002458204,0.0002970674,0.003566805,0.920065,0.000052151347],"about_ca_topic_score_codex":0.0056816437,"about_ca_topic_score_gemma":0.01211408,"teacher_disagreement_score":0.0056816437,"about_ca_system_score_codex":0.0011896993,"about_ca_system_score_gemma":0.0031172333,"threshold_uncertainty_score":0.015010059},"labels":[],"label_agreement":null},{"id":"W2118504352","doi":"10.1016/j.jaad.2010.03.036","title":"The efficacy of adapalene-benzoyl peroxide combination increases with number of acne lesions","year":2011,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre de Recherche Dermatologique du Québec Métropolitain; Windsor Clinical Research; Western University","funders":"","keywords":"Adapalene; Medicine; Benzoyl peroxide; Dermatology; Acne","score_opus":0.036612132210270064,"score_gpt":0.362957882137371,"score_spread":0.32634574992710097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118504352","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009876393,0.99817085,0.00007888916,0.00005602723,0.000048604332,0.00000874303,0.000022945294,0.0000044942253,0.0006217473],"genre_scores_gemma":[0.007355495,0.99145293,0.00023935873,0.000102725164,0.00008307553,0.000011881745,0.000046006076,0.0000014807822,0.00070694514],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999861,0.000022288772,0.00002567223,0.000023798291,0.00005686808,0.0000103590755],"domain_scores_gemma":[0.9998192,0.00008640162,0.00004494991,0.0000047710114,0.000035498066,0.000009140319],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032643919,0.00052824494,0.0014216392,0.0010556082,0.00013635881,0.00043192785,0.0006223619,0.0005061822,0.0028785],"category_scores_gemma":[0.00037466953,0.00021388306,0.00064989144,0.00075006374,0.00019510182,0.00050911185,0.00025443814,0.0007203697,0.00064276945],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004519497,0.0001699283,0.00061942625,0.026464194,0.00035920876,0.00021822723,0.00004293249,0.00017254257,0.0058104037,0.00050038577,0.0054454356,0.95974547],"study_design_scores_gemma":[0.0007215259,0.002587457,0.02401357,0.009141537,0.003914663,0.008011521,0.00023730063,0.00050876,0.012209088,0.0013850965,0.93718415,0.0000853546],"about_ca_topic_score_codex":0.00054920116,"about_ca_topic_score_gemma":0.0015508942,"teacher_disagreement_score":0.0028785,"about_ca_system_score_codex":0.00018671845,"about_ca_system_score_gemma":0.00029299184,"threshold_uncertainty_score":0.009629488},"labels":[],"label_agreement":null},{"id":"W2119535072","doi":"10.1016/j.jaad.2006.06.038","title":"A phase II open-label study of recombinant human interleukin-12 in patients with stage IA, IB, or IIA mycosis fungoides","year":2006,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"National Center for Research Resources","keywords":"Medicine; Mycosis fungoides; Chills; myalgia; Adverse effect; Cutaneous T-cell lymphoma; Internal medicine; Gastroenterology; Surgery; Aldesleukin; Stage (stratigraphy); Lymphoma; Interleukin 2; Cytokine","score_opus":0.042067693453462174,"score_gpt":0.4019044163703511,"score_spread":0.35983672291688895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119535072","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921565,0.0026755068,0.000895511,0.0004772712,0.00034517352,0.0017320113,0.0005428095,0.00008158694,0.0010937102],"genre_scores_gemma":[0.9903233,0.0021484708,0.0015316411,0.0007105699,0.0002776916,0.0023053398,0.0009384967,0.000023259305,0.0017412916],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99953616,0.00022917625,0.000019795465,0.000074726326,0.0000305252,0.0001097226],"domain_scores_gemma":[0.9991565,0.0002362069,0.00010233463,0.00008451295,0.00004262501,0.00037780692],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014702505,0.0016144125,0.003087817,0.00039603852,0.0005085686,0.0011664412,0.0008193893,0.001486408,0.003389682],"category_scores_gemma":[0.0009657494,0.0006809073,0.0015980394,0.0004051304,0.0015997073,0.0011303083,0.00031716723,0.0038255919,0.00089226227],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8677475,0.04628415,0.003367588,0.0006902235,0.000819792,0.00025667655,0.00032294175,0.001539149,0.02855271,0.0002659648,0.0016789483,0.048474368],"study_design_scores_gemma":[0.6773888,0.31671804,0.0030366345,0.000021072176,0.000207525,0.00013309025,0.000066683584,0.00048313467,0.0009636476,0.00009254797,0.0008691106,0.000019701256],"about_ca_topic_score_codex":0.0009907972,"about_ca_topic_score_gemma":0.002103483,"teacher_disagreement_score":0.003389682,"about_ca_system_score_codex":0.0006176873,"about_ca_system_score_gemma":0.0013730283,"threshold_uncertainty_score":0.011339605},"labels":[],"label_agreement":null},{"id":"W2120643746","doi":"10.1016/j.jaad.2013.04.043","title":"Rosacea: Current state of epidemiology","year":2013,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":260,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Windsor","funders":"","keywords":"Rosacea; Epidemiology; Medicine; Standardization; Disease; Population; Demographics; Variety (cybernetics); Dermatology; Intensive care medicine; Environmental health; Pathology; Demography; Computer science; Artificial intelligence","score_opus":0.08662136939120961,"score_gpt":0.4364158867715799,"score_spread":0.34979451738037026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120643746","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000079873076,0.99919575,0.00006525744,0.00030024376,0.00010042856,0.0000038995195,0.00004562782,0.0000030880435,0.00020573927],"genre_scores_gemma":[0.00078942755,0.9986399,0.00014463002,0.00017637723,0.00014551046,0.0000038810485,0.000035722693,6.5565433e-7,0.000063925676],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998887,0.00019737166,0.0003331986,0.00021881454,0.00030026038,0.00006331177],"domain_scores_gemma":[0.993911,0.0037471494,0.0013184362,0.00008478287,0.0007850816,0.00015350759],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023181282,0.00083554076,0.003202838,0.0056855995,0.00041846588,0.0020555572,0.0011757867,0.0014385722,0.0057483194],"category_scores_gemma":[0.0058942167,0.00056131795,0.0013381877,0.00768432,0.00067177956,0.0028715995,0.0010575681,0.0015220062,0.0009528193],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014565873,0.00007891937,0.0030106865,0.08600341,0.00048202687,0.000113730304,0.00009139123,0.0002308108,0.0002770987,0.0017795208,0.018578133,0.8892087],"study_design_scores_gemma":[0.00008896999,0.00022184737,0.016356677,0.13488364,0.0048069595,0.002835203,0.0006798834,0.00038455767,0.00039173066,0.004566838,0.8346727,0.000110975474],"about_ca_topic_score_codex":0.003553755,"about_ca_topic_score_gemma":0.007148821,"teacher_disagreement_score":0.0057483194,"about_ca_system_score_codex":0.0010099814,"about_ca_system_score_gemma":0.0040512527,"threshold_uncertainty_score":0.019230068},"labels":[],"label_agreement":null},{"id":"W2121623213","doi":"10.1016/j.jaad.2015.06.038","title":"Five-year analysis from the ESPRIT 10-year postmarketing surveillance registry of adalimumab treatment for moderate to severe psoriasis","year":2015,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Adalimumab; Medicine; Psoriasis; Observational study; Medical prescription; Confidence interval; Population; Adverse effect; Internal medicine; Dermatology; Disease; Pharmacology","score_opus":0.024680481966402493,"score_gpt":0.28335760386240566,"score_spread":0.25867712189600317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121623213","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98256874,0.0007954583,0.0004160225,0.000098299024,0.00002057624,0.00008959025,0.014946546,0.000026921169,0.0010377452],"genre_scores_gemma":[0.9764683,0.00026634213,0.00031078325,0.00011286232,0.000048609807,0.000109923036,0.022300607,0.00001074223,0.0003717404],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9957141,0.001372882,0.0006968703,0.00094463315,0.0009061631,0.0003652567],"domain_scores_gemma":[0.987405,0.0019052058,0.00760327,0.0011172912,0.0013114902,0.0006577788],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0054163625,0.00045062022,0.0007135556,0.0022993432,0.00036517813,0.0008744756,0.0008381204,0.0006011987,0.0022538172],"category_scores_gemma":[0.00806982,0.0003968496,0.0017384074,0.002215116,0.00020865837,0.0008117077,0.0009377613,0.0009966856,0.00039515248],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008402587,0.0000874496,0.99552995,0.000056232628,0.0005687503,0.00004832577,0.000037756796,0.0001614946,0.00008143585,0.000043545013,0.0011651111,0.0013796587],"study_design_scores_gemma":[0.000114197646,0.0001787157,0.9981818,0.000014154121,0.0002840013,0.00013620591,0.000054282715,0.00057135243,0.000051647577,0.000022063823,0.0003836499,0.000008087788],"about_ca_topic_score_codex":0.008655864,"about_ca_topic_score_gemma":0.010225541,"teacher_disagreement_score":0.008655864,"about_ca_system_score_codex":0.00075040554,"about_ca_system_score_gemma":0.000801995,"threshold_uncertainty_score":0.0286448},"labels":[],"label_agreement":null},{"id":"W2122255161","doi":"10.1016/j.jaad.2003.10.345","title":"The diabetic foot","year":2004,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Diabetic Foot Ulcer Assessment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Amputation; Diabetes mellitus; Diabetic foot; Peripheral neuropathy; Osteomyelitis; Ischemia; Foot (prosody); Vascular disease; Surgery; Complication; Diabetic neuropathy; Disease; Incidence (geometry); Peripheral; Diabetic foot ulcer; Internal medicine; Endocrinology","score_opus":0.01305967120388763,"score_gpt":0.3089031657688823,"score_spread":0.2958434945649947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2122255161","genre_codex":"other","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015701178,0.29207665,0.0018591868,0.124022596,0.059243314,0.00009206306,0.00035578842,0.0002995832,0.5063496],"genre_scores_gemma":[0.1505621,0.20781024,0.0029007792,0.05923342,0.05803584,0.00009759572,0.00061249244,0.00009406156,0.5206536],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996804,0.000055185155,0.000026164558,0.000036816746,0.00012380633,0.000077605204],"domain_scores_gemma":[0.99920577,0.00008423805,0.00007010258,0.000035690242,0.00028732244,0.0003169019],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004512448,0.00048361393,0.0003532855,0.0011002735,0.0008935146,0.0019988662,0.00032169776,0.0012411689,0.027583083],"category_scores_gemma":[0.0014308173,0.00014598349,0.0003244065,0.00048155859,0.0005280866,0.00061809516,0.000786738,0.0022238377,0.00676694],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011835307,0.00011796104,0.0046855216,0.00026636376,0.000023907485,0.0032589415,0.000099802135,0.00004059891,0.0011064365,0.005385088,0.49642557,0.4884715],"study_design_scores_gemma":[0.000029625946,0.00008752775,0.008166958,0.0006048637,0.000024854053,0.013443013,0.00021487444,0.000058512825,0.00025835098,0.0014391656,0.97566277,0.0000095344085],"about_ca_topic_score_codex":0.0022092843,"about_ca_topic_score_gemma":0.0059188944,"teacher_disagreement_score":0.027583083,"about_ca_system_score_codex":0.0007349373,"about_ca_system_score_gemma":0.0013044502,"threshold_uncertainty_score":0.092274666},"labels":[],"label_agreement":null},{"id":"W2123809449","doi":"10.1016/j.jaad.2003.04.001","title":"Primary cicatricial alopecias: clinicopathology of 112 cases","year":2003,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":273,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Medicine; Dermatology; Scarring alopecia; Scalp; Epidemiology; Population; Isotretinoin; Pathology; Acne","score_opus":0.02220987508587945,"score_gpt":0.3295042746923409,"score_spread":0.30729439960646143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123809449","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930814,0.002049548,0.0005561877,0.000056187695,0.000020926782,0.00009206958,0.00017943575,0.00003691111,0.0039272984],"genre_scores_gemma":[0.9977749,0.00087724533,0.00052467803,0.000029831075,0.000048388807,0.000047141697,0.0002198076,0.0000128578195,0.00046505028],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.9993351,0.00007492185,0.0001180082,0.00012762187,0.00015905885,0.0001852672],"domain_scores_gemma":[0.99852705,0.00046083913,0.0002916144,0.00027591252,0.00013376861,0.00031074445],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006646395,0.0009934698,0.0007533729,0.0029761926,0.0015286956,0.00087635155,0.0009541651,0.001165375,0.002233952],"category_scores_gemma":[0.0036141016,0.0010085448,0.00054038595,0.0018568682,0.0013342428,0.0007527891,0.0013711394,0.0005474018,0.00069871],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009946246,0.00032179998,0.46273425,0.00026792192,0.00006309244,0.49931282,0.0034770528,0.00036173835,0.0089749275,0.00024783498,0.0008653281,0.022378588],"study_design_scores_gemma":[0.00012828951,0.0005572393,0.31784257,0.00009189105,0.00011126657,0.6724703,0.0013992405,0.0005677683,0.0019194811,0.00020258347,0.004676559,0.000032922628],"about_ca_topic_score_codex":0.0010399895,"about_ca_topic_score_gemma":0.0012323714,"teacher_disagreement_score":0.0029761926,"about_ca_system_score_codex":0.00047600287,"about_ca_system_score_gemma":0.00032244757,"threshold_uncertainty_score":0.00747329},"labels":[],"label_agreement":null},{"id":"W2124297230","doi":"10.1067/mjd.2002.119202","title":"Surgical Pearl: The use of the Ultra-Fine II short needle 0.3-cc insulin syringe for botulinum toxin injections","year":2002,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Botulinum Toxin and Related Neurological Disorders","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Syringe; Botulinum toxin; Insulin; Surgery; Internal medicine","score_opus":0.06058239788218927,"score_gpt":0.29941415977603775,"score_spread":0.23883176189384847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124297230","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3238014,0.02451402,0.52436864,0.010775779,0.0047772564,0.0009679541,0.0007878588,0.015179507,0.09482754],"genre_scores_gemma":[0.60602355,0.0067036655,0.33547574,0.006028508,0.0013313807,0.00031295072,0.00054045866,0.0012840686,0.04229963],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.9995449,0.00007186129,0.000058774884,0.000059396065,0.00022760546,0.00003746002],"domain_scores_gemma":[0.9992908,0.00024709883,0.0001348113,0.00009248611,0.00011476761,0.00011997241],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012597643,0.00048618982,0.0002829633,0.0009459119,0.0006329224,0.0008427198,0.00066468416,0.0010597,0.0055010403],"category_scores_gemma":[0.0028183134,0.00022631718,0.00045750279,0.00052210584,0.0007877301,0.0014552278,0.0006707921,0.001279706,0.0029059364],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011628837,0.00028323758,0.006897136,0.00068675505,0.00006470466,0.007418572,0.0004206991,0.00038147657,0.08279077,0.0035547728,0.02820784,0.8681312],"study_design_scores_gemma":[0.0007881839,0.0059205866,0.071489766,0.00064550777,0.00028185398,0.4112641,0.00082951336,0.016951924,0.16186145,0.0063122124,0.3231906,0.00046430615],"about_ca_topic_score_codex":0.0004932021,"about_ca_topic_score_gemma":0.0006351244,"teacher_disagreement_score":0.0055010403,"about_ca_system_score_codex":0.00023934021,"about_ca_system_score_gemma":0.0005783336,"threshold_uncertainty_score":0.018402755},"labels":[],"label_agreement":null},{"id":"W2126689331","doi":"10.1016/j.jaad.2012.10.055","title":"OBSERVE-5 interim analysis: An observational postmarketing safety registry of etanercept for the treatment of psoriasis","year":2013,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Janssen Pharmaceuticals; Novartis; Amgen","keywords":"Medicine; Etanercept; Postmarketing surveillance; Observational study; Psoriasis; Interim analysis; Interim; Dermatology; Adverse effect; Clinical trial; Pharmacology; Internal medicine; Tumor necrosis factor alpha","score_opus":0.05944239180353295,"score_gpt":0.3224240746200683,"score_spread":0.26298168281653533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126689331","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.871568,0.0011821244,0.011986688,0.00038318773,0.000102549966,0.0027699983,0.10357158,0.00047789662,0.007957929],"genre_scores_gemma":[0.9017058,0.0002945443,0.0058031324,0.0003088081,0.00016577488,0.003078895,0.08646037,0.00007269743,0.002110094],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9907459,0.0032817817,0.0013218638,0.0013516258,0.0027949666,0.00050381967],"domain_scores_gemma":[0.9672527,0.0046918024,0.017426742,0.0060403347,0.003644795,0.00094365113],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011863792,0.0004509419,0.0008866979,0.001039675,0.00065250706,0.0012861565,0.0011081853,0.0005300587,0.0045059538],"category_scores_gemma":[0.018783385,0.0004044067,0.0011880961,0.0013538303,0.00027743835,0.00087822526,0.0008300478,0.0010313061,0.0010188645],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015338435,0.0015376712,0.93039685,0.00035544543,0.001159529,0.00022788493,0.00018506218,0.0012131426,0.0011805507,0.0008458813,0.015228115,0.0323314],"study_design_scores_gemma":[0.005973053,0.0049357177,0.9584272,0.00012601794,0.0021250285,0.000718941,0.00012303771,0.004659775,0.0032290218,0.00047966617,0.019131705,0.000070796115],"about_ca_topic_score_codex":0.0031954602,"about_ca_topic_score_gemma":0.00407987,"teacher_disagreement_score":0.011863792,"about_ca_system_score_codex":0.0009308064,"about_ca_system_score_gemma":0.003265378,"threshold_uncertainty_score":0.06274253},"labels":[],"label_agreement":null},{"id":"W2127668424","doi":"10.1016/j.jaad.2014.06.030","title":"Quality-of-life impairment in patients with livedoid vasculopathy","year":2014,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Dermatology; Livedo reticularis; Dermatology Life Quality Index; Disease; Quality of life (healthcare); Internal medicine; Psoriasis","score_opus":0.01550310619524893,"score_gpt":0.295280902954505,"score_spread":0.27977779675925607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127668424","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8434169,0.012484332,0.00038670964,0.10451747,0.0016275442,0.000045539597,0.000497331,0.000035331304,0.03698875],"genre_scores_gemma":[0.9883985,0.0011796654,0.00010795121,0.008526408,0.0010008507,0.000010241217,0.000074750584,0.0000024973456,0.0006992166],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995431,0.0001474882,0.00006680169,0.000041668496,0.000084417225,0.00011660947],"domain_scores_gemma":[0.99856997,0.00053218595,0.00029264856,0.000037478236,0.0001919042,0.00037588752],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046811963,0.00018306155,0.000629084,0.00042472527,0.0007933544,0.00078525726,0.00032737356,0.0019665482,0.0022620512],"category_scores_gemma":[0.0043404074,0.00014610827,0.0004908321,0.0007560819,0.00041243056,0.00059839437,0.00036657296,0.0020168724,0.00021398302],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008069534,0.0003171439,0.8647549,0.00024022568,0.00024359133,0.077769525,0.0008260039,0.00044066398,0.00075833156,0.0009353666,0.017516384,0.035390805],"study_design_scores_gemma":[0.0002492601,0.0005574833,0.86725444,0.00040590233,0.0002513167,0.11310398,0.0028446752,0.0018568479,0.00017091953,0.00318647,0.010058032,0.000060726838],"about_ca_topic_score_codex":0.0031931612,"about_ca_topic_score_gemma":0.0059609753,"teacher_disagreement_score":0.0031931612,"about_ca_system_score_codex":0.00082732167,"about_ca_system_score_gemma":0.00040651302,"threshold_uncertainty_score":0.007567346},"labels":[],"label_agreement":null},{"id":"W2127684830","doi":"10.1016/j.jaad.2004.04.031","title":"Melanoma detection in British Columbia, Canada","year":2004,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; University of British Columbia","funders":"","keywords":"Medicine; Melanoma; Breslow Thickness; Melanoma diagnosis; Surgery; Dermatology; Internal medicine; Cancer","score_opus":0.006631299919919362,"score_gpt":0.23674275911986814,"score_spread":0.23011145919994877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127684830","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9556154,0.004913553,0.0003052616,0.006164364,0.00022584393,0.00029193924,0.011401561,0.000104228755,0.020977862],"genre_scores_gemma":[0.9834728,0.002510959,0.00042465865,0.0012598525,0.000034226654,0.00006156339,0.0019107079,0.000034986824,0.010290239],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982437,0.000112808564,0.00012385013,0.00018836935,0.0006035959,0.00072770356],"domain_scores_gemma":[0.9948448,0.00022438033,0.00034147777,0.00006488658,0.0032491768,0.0012752981],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063954364,0.0005714369,0.0006093325,0.003101209,0.006999065,0.0019390908,0.002840768,0.0012258027,0.0047537177],"category_scores_gemma":[0.0031105028,0.00075559673,0.0005517011,0.0054694433,0.0010544342,0.0006262774,0.0013933356,0.0016839739,0.000689419],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002564333,0.00022795038,0.9501717,0.00021536634,0.00008191943,0.0015383445,0.0019294475,0.0003689322,0.00061146263,0.00038413602,0.0190297,0.025184631],"study_design_scores_gemma":[0.000051746265,0.00006914912,0.98490834,0.00022547718,0.000063737134,0.00069893355,0.0068812743,0.00082701625,0.00024512666,0.00010569324,0.005872127,0.00005138526],"about_ca_topic_score_codex":0.9987987,"about_ca_topic_score_gemma":0.9995578,"teacher_disagreement_score":0.06618159,"about_ca_system_score_codex":0.06618159,"about_ca_system_score_gemma":0.09571719,"threshold_uncertainty_score":0.4801833},"labels":[],"label_agreement":null},{"id":"W2128160405","doi":"10.1016/j.jaad.2015.04.049","title":"Benefit of different concentrations of intralesional triamcinolone acetonide in alopecia areata: An intrasubject pilot study","year":2015,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Alopecia areata; Medicine; Triamcinolone acetonide; Dermatology; Placebo; Surgery; Alternative medicine; Pathology","score_opus":0.04955190673641801,"score_gpt":0.33107376445334946,"score_spread":0.28152185771693145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128160405","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99749905,0.00090687635,0.0002560459,0.00024714458,0.00012769195,0.00019560555,0.00008412441,0.000019412098,0.00066397135],"genre_scores_gemma":[0.9983151,0.000478346,0.00020508251,0.00025163734,0.00027061935,0.00010040083,0.000048749145,0.0000065387817,0.00032361262],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99941766,0.00029632665,0.000045029665,0.00008168551,0.0000712904,0.00008800486],"domain_scores_gemma":[0.99874675,0.0006772015,0.00012751913,0.00015206325,0.000064696425,0.00023180884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00090904644,0.0007131059,0.0016560418,0.00023919555,0.00042339912,0.0006249853,0.0005800077,0.001237767,0.0020377822],"category_scores_gemma":[0.0013752837,0.00027608656,0.0007747533,0.0003209821,0.0008181523,0.0007401105,0.00024288779,0.0018754338,0.0004357724],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.64854187,0.099169135,0.005143777,0.00084756454,0.0011183462,0.0028477863,0.000434101,0.00097484235,0.118822254,0.0002688382,0.0014571475,0.12037444],"study_design_scores_gemma":[0.12480914,0.8298554,0.027007254,0.00005326584,0.0012078243,0.0011808858,0.00028664782,0.0017931856,0.011851946,0.00028987037,0.0016015837,0.00006301548],"about_ca_topic_score_codex":0.00064817775,"about_ca_topic_score_gemma":0.0010558149,"teacher_disagreement_score":0.0020377822,"about_ca_system_score_codex":0.0003331212,"about_ca_system_score_gemma":0.00039519602,"threshold_uncertainty_score":0.0068171024},"labels":[],"label_agreement":null},{"id":"W2128228214","doi":"10.1016/j.jaad.2008.11.022","title":"Large congenital melanocytic nevi and neurocutaneous melanocytosis: One pediatric center's experience","year":2009,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Magnetic resonance imaging; Medical record; Dermatology; Retrospective cohort study; Melanocytic nevus; Exact test; Nevus; Radiology; Surgery; Melanoma","score_opus":0.014956702209517324,"score_gpt":0.28456085468754644,"score_spread":0.2696041524780291,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128228214","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99167824,0.0009697934,0.0008104372,0.0010071747,0.000106400345,0.00005733046,0.00012037335,0.000059753133,0.005190393],"genre_scores_gemma":[0.9972046,0.00065504655,0.00077427115,0.00038643548,0.00012731798,0.00001731517,0.00008633781,0.000033093173,0.0007154619],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99946064,0.00007695462,0.00005158587,0.00009513119,0.0001001338,0.00021560218],"domain_scores_gemma":[0.99826163,0.00029157999,0.00026379083,0.00006630964,0.0001462592,0.0009703676],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031785556,0.0011301775,0.00070657796,0.0010032228,0.003230222,0.0011239161,0.00095741526,0.0020100505,0.002166699],"category_scores_gemma":[0.0022864477,0.00065443426,0.0006351474,0.0010935991,0.0011258492,0.0014085008,0.0012343444,0.0020274993,0.0005162875],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000093443094,0.0008008253,0.14201806,0.000047268524,0.000038708175,0.8415324,0.0018145229,0.00043572808,0.0012102512,0.00058247615,0.002104792,0.009321552],"study_design_scores_gemma":[0.000026365737,0.00040623813,0.04101163,0.000026895139,0.000028087601,0.95431626,0.0021854872,0.00029984716,0.00048623906,0.00015018712,0.001027559,0.000035233443],"about_ca_topic_score_codex":0.0033541594,"about_ca_topic_score_gemma":0.008361593,"teacher_disagreement_score":0.0033541594,"about_ca_system_score_codex":0.0012426558,"about_ca_system_score_gemma":0.0011671737,"threshold_uncertainty_score":0.009016097},"labels":[],"label_agreement":null},{"id":"W2129491469","doi":"10.1067/mjd.2000.105556","title":"Melanoma in situ of the oral mucosa in an adolescent with dysplastic nevus syndrome","year":2000,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Cancer and Skin Lesions","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal","funders":"","keywords":"Medicine; Oral mucosa; Dermatology; Melanoma; Nevus; Mouth mucosa; Pathology; Cancer research","score_opus":0.013677046887320493,"score_gpt":0.2953403937565876,"score_spread":0.2816633468692671,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129491469","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940754,0.00048089758,0.00046566493,0.0004244813,0.00005891504,0.000066511195,0.00006286737,0.000049150818,0.004316116],"genre_scores_gemma":[0.99861753,0.00029712217,0.00033588786,0.00009430459,0.0000673771,0.000010663464,0.000020961881,0.0000118282815,0.00054424134],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99946386,0.000057186753,0.000053229236,0.00013584734,0.000119213335,0.00017057105],"domain_scores_gemma":[0.9986168,0.00037894104,0.00032102226,0.00007574503,0.00009251473,0.0005148727],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035956418,0.0017694521,0.0011905546,0.002519078,0.0026035048,0.0013376832,0.0009978898,0.002669849,0.0020867486],"category_scores_gemma":[0.0022955518,0.0010855084,0.0007287796,0.0008282469,0.0012113058,0.0012835396,0.0010261768,0.0021146708,0.00054905383],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000043121618,0.00009079348,0.021085316,0.000028787195,0.000009695227,0.97477186,0.0003102696,0.00007968937,0.0023751343,0.00019176929,0.00008404828,0.000929415],"study_design_scores_gemma":[0.000013798297,0.00018312395,0.02657,0.000016425294,0.00003067119,0.97139525,0.0003950637,0.00030575963,0.00072546245,0.00009702525,0.00025862447,0.000008919536],"about_ca_topic_score_codex":0.0024415152,"about_ca_topic_score_gemma":0.004056948,"teacher_disagreement_score":0.002669849,"about_ca_system_score_codex":0.0007809537,"about_ca_system_score_gemma":0.000808844,"threshold_uncertainty_score":0.006980896},"labels":[],"label_agreement":null},{"id":"W2130184391","doi":"10.1016/j.jaad.2005.01.007","title":"Resolution of acne following therapy with an oral contraceptive in a patient with Apert syndrome","year":2005,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Craniofacial Disorders and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Apert syndrome; Acne; Dermatology; Isotretinoin; Pediatrics; Surgery; Craniosynostosis","score_opus":0.009011446452503088,"score_gpt":0.26564506299083873,"score_spread":0.25663361653833566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130184391","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.82389605,0.0064162966,0.0045239725,0.110670365,0.008495977,0.00027818276,0.00041453599,0.0006177882,0.044686828],"genre_scores_gemma":[0.97957623,0.0011029089,0.001021567,0.008534636,0.005101142,0.00002537733,0.000070410686,0.000054548662,0.0045130705],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9990206,0.00020258882,0.00014451733,0.00018121312,0.0001840886,0.00026701894],"domain_scores_gemma":[0.9944133,0.0035609878,0.00051742437,0.00034228197,0.00029158522,0.0008744308],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00090095046,0.0010913085,0.0015227586,0.0012407558,0.0018430568,0.0013099381,0.0013787827,0.013188317,0.0019362578],"category_scores_gemma":[0.011735085,0.000587606,0.0017749353,0.0006775206,0.0015663048,0.0014209646,0.00067582645,0.0055239787,0.0006858501],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000113124006,0.0000418973,0.0029803938,0.000025575084,0.000015194542,0.992691,0.00018519271,0.00008290043,0.00045377365,0.00031560918,0.0013841935,0.001711235],"study_design_scores_gemma":[0.00013270006,0.00028597304,0.0094990805,0.000026702652,0.000054165746,0.9830608,0.00023200452,0.0011674295,0.0008640725,0.0005781626,0.00407375,0.000025124635],"about_ca_topic_score_codex":0.0032299336,"about_ca_topic_score_gemma":0.0032072025,"teacher_disagreement_score":0.013188317,"about_ca_system_score_codex":0.001791604,"about_ca_system_score_gemma":0.0006836402,"threshold_uncertainty_score":0.012999117},"labels":[],"label_agreement":null},{"id":"W2130212949","doi":"10.1067/mjd.2000.104895","title":"Detection of artificial changes in mole size by skin self-examination","year":2000,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Sunnybrook Health Science Centre","funders":"Medical Research Council Canada","keywords":"Medicine; Confidence interval; Nevus; Mole; Internal medicine; Melanoma","score_opus":0.007594340477394115,"score_gpt":0.26121993911171826,"score_spread":0.25362559863432416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130212949","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98764765,0.00096113613,0.0024581982,0.00023758612,0.00009075565,0.000067788416,0.00008529925,0.00007276659,0.008378911],"genre_scores_gemma":[0.99680626,0.00029734336,0.001712902,0.00008681396,0.000038176277,0.000008857017,0.000054846274,0.000007704905,0.0009872325],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99957544,0.00014484422,0.00003004935,0.0000452731,0.00014954615,0.000054828855],"domain_scores_gemma":[0.9987472,0.00056640094,0.00025565896,0.00009394707,0.00018293911,0.0001538401],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006892538,0.000317477,0.00020685178,0.0011833225,0.0002588577,0.00033440322,0.00026770835,0.00046145977,0.0016229136],"category_scores_gemma":[0.004394345,0.00014302906,0.00021311705,0.00023799218,0.00030331616,0.00054618926,0.00032453422,0.00044145508,0.00035982544],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00087221625,0.00021518949,0.95087564,0.000049838916,0.000036881134,0.005378109,0.00014040354,0.00018666909,0.011113326,0.00017943303,0.0007127466,0.030239401],"study_design_scores_gemma":[0.00003894922,0.0022445088,0.89950615,0.0000618018,0.00008426385,0.064928606,0.0005110013,0.006266044,0.021509426,0.00032803178,0.004495727,0.00002552336],"about_ca_topic_score_codex":0.0006545219,"about_ca_topic_score_gemma":0.00095210236,"teacher_disagreement_score":0.0016229136,"about_ca_system_score_codex":0.00013318358,"about_ca_system_score_gemma":0.00014404625,"threshold_uncertainty_score":0.0054292083},"labels":[],"label_agreement":null},{"id":"W2131117997","doi":"10.1016/j.jaad.2004.12.009","title":"Site-specific protective effect of broad-spectrum sunscreen on nevus development among white schoolchildren in a randomized trial","year":2005,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Skin Protection and Aging","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Nevus; Randomized controlled trial; Dermatology; Melanoma; Melanocytic nevus; Trunk; Skin cancer; Surgery; Cancer; Internal medicine","score_opus":0.009435229562086115,"score_gpt":0.28327408342082433,"score_spread":0.27383885385873824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131117997","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99401194,0.0020668814,0.0004328782,0.0003827171,0.00056375854,0.0014927577,0.0002972845,0.000051902374,0.00069981493],"genre_scores_gemma":[0.9946477,0.0011031706,0.000784326,0.0005505484,0.0003740756,0.0012732409,0.00024258344,0.000013024806,0.0010113274],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9983279,0.0008844656,0.00011957218,0.00034621192,0.00009107457,0.00023076028],"domain_scores_gemma":[0.9980427,0.00074800814,0.00035911615,0.00019114258,0.00011001977,0.00054897944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025487598,0.0017539073,0.004069409,0.00047714132,0.00078748213,0.0012376533,0.0012167373,0.0025004179,0.0057995506],"category_scores_gemma":[0.0032183698,0.0009771228,0.0028829735,0.0005171862,0.0016736287,0.0011564074,0.0006076229,0.0032597356,0.0006487336],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98869693,0.0044057346,0.00093095796,0.0002917031,0.0015664048,0.000029740464,0.00004304086,0.00008201213,0.0006612397,0.000044209577,0.00017824653,0.003069852],"study_design_scores_gemma":[0.9478216,0.04676602,0.0027809138,0.000041201158,0.001877914,0.00001795029,0.000036405072,0.0001737077,0.00019929215,0.000097735094,0.00017379966,0.000013454958],"about_ca_topic_score_codex":0.002154691,"about_ca_topic_score_gemma":0.0031199637,"teacher_disagreement_score":0.0057995506,"about_ca_system_score_codex":0.0007763555,"about_ca_system_score_gemma":0.0011623285,"threshold_uncertainty_score":0.01940149},"labels":[],"label_agreement":null},{"id":"W2131928002","doi":"10.1067/mjd.2003.115","title":"Tinea faciei mimicking cutaneous lupus erythematosus: A histopathologic case report","year":2003,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Histopathology; Spongiosis; Dermatology; Lupus erythematosus; Pathology; Dermatophyte; Discoid lupus erythematosus; Dermatopathology; Cutaneous Lupus Erythematosus; Immunology","score_opus":0.019449559473848285,"score_gpt":0.3104607815608385,"score_spread":0.2910112220869902,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131928002","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88695955,0.009796099,0.009218166,0.0044607287,0.0011377109,0.0010448928,0.0010578192,0.0008288468,0.08549631],"genre_scores_gemma":[0.98972005,0.0015021462,0.0031707466,0.00086329924,0.0016192489,0.000103723134,0.0001636697,0.00006350096,0.0027936173],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9982185,0.0002405854,0.00019495374,0.00053847936,0.00025163937,0.0005558924],"domain_scores_gemma":[0.9964515,0.0013877692,0.00048129781,0.00072088104,0.0002832449,0.0006753708],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010967588,0.0039894544,0.0016688728,0.00491072,0.0044552563,0.002876185,0.003440616,0.008186079,0.0058176536],"category_scores_gemma":[0.0057991245,0.0028291794,0.0013263325,0.00284552,0.0034805536,0.0038295917,0.002429351,0.0030099412,0.0031162289],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046246543,0.000047010224,0.0019540847,0.000032488522,0.0000060957327,0.9963862,0.00008215674,0.000041612424,0.00045518097,0.00012071768,0.00016635162,0.0006618361],"study_design_scores_gemma":[0.00002769912,0.00006234335,0.0037690676,0.000011717355,0.000022540862,0.99448806,0.00013011042,0.00026386825,0.00048028553,0.0001324924,0.0006021321,0.000009794502],"about_ca_topic_score_codex":0.0029613362,"about_ca_topic_score_gemma":0.0046000318,"teacher_disagreement_score":0.008186079,"about_ca_system_score_codex":0.002159737,"about_ca_system_score_gemma":0.0009401046,"threshold_uncertainty_score":0.01946199},"labels":[],"label_agreement":null},{"id":"W2132389332","doi":"10.1016/j.jaad.2005.09.017","title":"Pyoderma gangrenosum associated with isotretinoin therapy","year":2006,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Autoimmune and Inflammatory Disorders","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Pyoderma gangrenosum; Medicine; Isotretinoin; Dermatology; Dermatologic agents; Internal medicine; Acne; Antibiotics; Disease","score_opus":0.013483090448997186,"score_gpt":0.2644626948801341,"score_spread":0.25097960443113687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132389332","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.60675734,0.017254807,0.0069087814,0.15139502,0.00812711,0.00047303876,0.00028790062,0.00078420504,0.20801185],"genre_scores_gemma":[0.9602237,0.0032612681,0.0016963449,0.015679795,0.009527478,0.00005509642,0.00008001328,0.00004183089,0.009434539],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9988564,0.00038296756,0.00013756886,0.00011630532,0.00027214983,0.00023454607],"domain_scores_gemma":[0.9971621,0.001824611,0.0003030863,0.00018572672,0.00014843534,0.00037604047],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000981753,0.0011316711,0.0012648646,0.0010378427,0.0020760421,0.0010861207,0.00089427346,0.008039604,0.002280923],"category_scores_gemma":[0.0066429344,0.00060428766,0.0016928867,0.00076657697,0.0014560216,0.0013678501,0.0007366788,0.006774447,0.000683434],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021344106,0.00008247892,0.0051690564,0.0000659774,0.00003754031,0.9853969,0.000100674166,0.00020425432,0.00057913596,0.00095152407,0.0028756089,0.004323489],"study_design_scores_gemma":[0.00024634102,0.0002806429,0.014498535,0.000091912654,0.00008440326,0.97175467,0.0001459557,0.0021453751,0.0008098221,0.0017818286,0.008137402,0.000023141252],"about_ca_topic_score_codex":0.002071349,"about_ca_topic_score_gemma":0.003572793,"teacher_disagreement_score":0.008039604,"about_ca_system_score_codex":0.0018033964,"about_ca_system_score_gemma":0.00091246853,"threshold_uncertainty_score":0.01308465},"labels":[],"label_agreement":null},{"id":"W2134790121","doi":"10.1067/mjd.2002.124699","title":"Dermatophytoma: Recalcitrance to treatment because of existence of fungal biofilm","year":2002,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":142,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Biofilm; Microbiology; Bacteria; Biology","score_opus":0.03862748819891668,"score_gpt":0.3283036044999312,"score_spread":0.2896761163010145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134790121","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9311145,0.010963542,0.0057945135,0.009816733,0.00087221485,0.0002726319,0.00016102733,0.00038593338,0.0406189],"genre_scores_gemma":[0.9892652,0.0021847899,0.0019917937,0.0015216629,0.0005796052,0.000025238733,0.00006102269,0.000040840507,0.00432984],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.99972886,0.000048392336,0.000028328992,0.000032536267,0.000080468315,0.00008138805],"domain_scores_gemma":[0.9996086,0.00011656541,0.00008237349,0.000038160324,0.000032989374,0.000121421384],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029611768,0.0006824125,0.0006135637,0.0008386528,0.001202402,0.0005625522,0.00038849047,0.0016874768,0.004080166],"category_scores_gemma":[0.0017536067,0.00026948532,0.0005751015,0.00043409909,0.0005011112,0.000582609,0.0004960121,0.0013142438,0.0012752108],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004915029,0.0001842426,0.007824468,0.00024415698,0.000027059072,0.94718045,0.0002055551,0.0001138123,0.018643769,0.0010444372,0.002330541,0.021709882],"study_design_scores_gemma":[0.00012918071,0.00031216937,0.0104698315,0.000047062797,0.0000548515,0.9762965,0.00024382642,0.0006804648,0.005782315,0.00088183564,0.005086686,0.000015357793],"about_ca_topic_score_codex":0.00059770525,"about_ca_topic_score_gemma":0.0010456538,"teacher_disagreement_score":0.004080166,"about_ca_system_score_codex":0.0003049149,"about_ca_system_score_gemma":0.00028999575,"threshold_uncertainty_score":0.013649523},"labels":[],"label_agreement":null},{"id":"W2136517791","doi":"10.1016/j.jaad.2015.04.011","title":"Secukinumab retreatment-as-needed versus fixed-interval maintenance regimen for moderate to severe plaque psoriasis: A randomized, double-blind, noninferiority trial (SCULPTURE)","year":2015,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":206,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"XLV Diagnostics (Canada)","funders":"Novartis Pharmaceuticals Corporation","keywords":"Medicine; Secukinumab; Plaque psoriasis; Randomized controlled trial; Regimen; Double blind; Psoriasis; Dermatology; Surgery; Placebo; Alternative medicine","score_opus":0.0436581266930141,"score_gpt":0.31966165566413257,"score_spread":0.27600352897111846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136517791","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.985015,0.005664319,0.0009954958,0.0008059073,0.0010677362,0.0023950234,0.0010653307,0.0003435732,0.0026478074],"genre_scores_gemma":[0.98543906,0.003052063,0.001645664,0.0010963479,0.0006473489,0.0024337498,0.0008923861,0.00004910928,0.0047442424],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99950624,0.00021453317,0.000028258362,0.00010936559,0.000039424736,0.0001021707],"domain_scores_gemma":[0.999424,0.00015505974,0.000113314374,0.0000681867,0.000033420743,0.00020604154],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014480775,0.0019025448,0.0038913407,0.0005339419,0.00050045224,0.0012667152,0.0011893944,0.0018279447,0.009019819],"category_scores_gemma":[0.0013520683,0.0007526991,0.0021626852,0.00046428075,0.0014155693,0.0015460881,0.00043015776,0.004294565,0.0014452855],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9815886,0.0030241683,0.0002244272,0.00046772504,0.0006234722,0.000021158487,0.00003009551,0.00024487003,0.0015448276,0.00009531608,0.00059249095,0.011542776],"study_design_scores_gemma":[0.973216,0.02488902,0.0007862131,0.000020231695,0.00026065827,0.00001746711,0.000014811059,0.00033717824,0.00016154,0.00009216147,0.0001944171,0.000010358065],"about_ca_topic_score_codex":0.0011430248,"about_ca_topic_score_gemma":0.002397739,"teacher_disagreement_score":0.009019819,"about_ca_system_score_codex":0.00061720534,"about_ca_system_score_gemma":0.000725569,"threshold_uncertainty_score":0.030174315},"labels":[],"label_agreement":null},{"id":"W2138753404","doi":"10.1016/j.jaad.2014.02.017","title":"Differential diagnosis of a pink nodule with a blue globule","year":2014,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Cancer and Skin Lesions","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; University of Ottawa","funders":"","keywords":"Nodule (geology); Medicine; Differential diagnosis; Lesion; Basal cell; Basal cell carcinoma; Pathology; Anatomy; Basal (medicine); Biology; Internal medicine","score_opus":0.011006153671034817,"score_gpt":0.28971285697534044,"score_spread":0.27870670330430564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138753404","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8223449,0.02998805,0.02201477,0.019609472,0.002359701,0.00055281847,0.0010779715,0.0011292886,0.10092307],"genre_scores_gemma":[0.98680985,0.0027846287,0.0045213746,0.0017386843,0.0016296972,0.00003860166,0.00020396379,0.000043781853,0.0022293488],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9993631,0.00007578415,0.00007131887,0.00012589064,0.00017267805,0.00019120281],"domain_scores_gemma":[0.9982729,0.00061055983,0.0002042383,0.0001866421,0.00015831199,0.0005673903],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005884447,0.001954397,0.0010320294,0.0038316865,0.0014470421,0.0013470883,0.0018020313,0.0037677914,0.0057026455],"category_scores_gemma":[0.0048488434,0.000857508,0.00095917645,0.0012954329,0.0013570207,0.002491156,0.0016726116,0.0027657396,0.0024176294],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000104423336,0.00003795255,0.00729617,0.00005758978,0.000010651881,0.9858124,0.000055122982,0.000121635,0.001511627,0.00041277963,0.0008789034,0.0037007257],"study_design_scores_gemma":[0.000018365889,0.00005289247,0.0042622937,0.0000422358,0.00001851117,0.9923206,0.00009982661,0.000694241,0.0008625475,0.00062803604,0.0009918942,0.000008511049],"about_ca_topic_score_codex":0.0012472437,"about_ca_topic_score_gemma":0.0011249476,"teacher_disagreement_score":0.0057026455,"about_ca_system_score_codex":0.0009722062,"about_ca_system_score_gemma":0.00053620513,"threshold_uncertainty_score":0.019077241},"labels":[],"label_agreement":null},{"id":"W2138997157","doi":"10.1016/j.jaad.2004.01.055","title":"Expression of matrix metalloproteinases and their endogenous tissue inhibitors in skin lesions from patients with tuberous sclerosis","year":2004,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Tuberous Sclerosis Complex Research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"","keywords":"Tuberous sclerosis; Matrix metalloproteinase; Gelatinase A; Medicine; Gene expression; Pathology; Lesion; Extracellular matrix; Gelatinase; Reverse transcription polymerase chain reaction; Tissue inhibitor of metalloproteinase; Collagenase; Gene; Biology; Enzyme; Internal medicine; Cell biology","score_opus":0.032993037717177216,"score_gpt":0.289826852929007,"score_spread":0.2568338152118298,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138997157","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987913,0.0005028491,0.00008743972,0.00001915014,0.000006025578,0.000004605441,0.00006428809,0.000004427953,0.0005199656],"genre_scores_gemma":[0.9995173,0.00015223907,0.00006946349,0.000014597697,0.000009991078,0.0000039117226,0.00006839374,0.0000017502716,0.00016233313],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99986184,0.000024129042,0.00002227005,0.000027057235,0.000034026627,0.000030665593],"domain_scores_gemma":[0.99973947,0.00009655269,0.00006142895,0.000012429355,0.0000428705,0.000047297894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012748962,0.00019106222,0.00024545816,0.00072688435,0.00028820033,0.0004893969,0.00014581278,0.00027300234,0.0012064317],"category_scores_gemma":[0.0008134398,0.00015590354,0.00014999865,0.0003428377,0.00018512052,0.00019921863,0.00014588553,0.00030455927,0.0001757315],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038483434,0.0003202289,0.626656,0.00025176944,0.00020466154,0.015556853,0.0013954097,0.00019980829,0.33070627,0.00017948881,0.00046950855,0.020211687],"study_design_scores_gemma":[0.00009186808,0.0005206454,0.9506259,0.000013686679,0.00014995357,0.030416472,0.00087669666,0.000410042,0.015915725,0.00009270737,0.00087567273,0.000010644407],"about_ca_topic_score_codex":0.0006879377,"about_ca_topic_score_gemma":0.00044820108,"teacher_disagreement_score":0.0012064317,"about_ca_system_score_codex":0.00014708648,"about_ca_system_score_gemma":0.00008889272,"threshold_uncertainty_score":0.00403589},"labels":[],"label_agreement":null},{"id":"W2139795636","doi":"10.1016/j.jaad.2008.05.023","title":"Reviewing medical books: A quarter century of observations","year":2008,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Health Sciences Research and Education","field":"Health Professions","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Plea; Medicine; Quarter (Canadian coin); Section (typography); Perspective (graphical); Medical journal; Habit; Medical literature; Classics; Family medicine; History; Psychology; Visual arts; Law; Psychotherapist; Pathology; Advertising","score_opus":0.1910203585809431,"score_gpt":0.4894718004765468,"score_spread":0.2984514418956037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139795636","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006614584,0.45184594,0.0016711549,0.45786574,0.028368203,0.00006799944,0.000627737,0.00023236776,0.05270624],"genre_scores_gemma":[0.0613232,0.46642578,0.0040624877,0.34221122,0.08170344,0.0001665673,0.0012891606,0.00090239884,0.041915752],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.98283124,0.005308698,0.0013955698,0.001293202,0.008527714,0.00064370525],"domain_scores_gemma":[0.84607095,0.087503634,0.0155645665,0.0056455573,0.041343704,0.003871626],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.009589047,0.00065066834,0.0009822662,0.012175985,0.003504684,0.01328121,0.002113375,0.0052133626,0.012056471],"category_scores_gemma":[0.13193597,0.00077325746,0.00065381586,0.016269142,0.0074564423,0.01652734,0.0033728997,0.006509186,0.0066128704],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007001788,0.00004156033,0.0021022,0.0011493356,0.000034746092,0.00020846582,0.005326921,0.000076041244,0.00013966624,0.007998979,0.90358263,0.07926951],"study_design_scores_gemma":[0.000010511166,0.00001310957,0.002456162,0.003191102,0.000023341869,0.00070008816,0.0046539516,0.00006051129,0.00009701277,0.0037589902,0.98500776,0.000027575143],"about_ca_topic_score_codex":0.009204055,"about_ca_topic_score_gemma":0.019234192,"teacher_disagreement_score":0.9904109,"about_ca_system_score_codex":0.005012474,"about_ca_system_score_gemma":0.005145551,"threshold_uncertainty_score":0.050712347},"labels":[],"label_agreement":null},{"id":"W2140085404","doi":"10.1016/j.jaad.2005.03.043","title":"Trends of nonmelanoma skin cancer from 1960 through 2000 in a Canadian population","year":2005,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":150,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre; University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Skin cancer; Basal cell carcinoma; Medicine; Malignancy; Basal cell; Dermatology; Epidemiology; Population; Cancer; Environmental health; Internal medicine","score_opus":0.016045772308887117,"score_gpt":0.32763024749190767,"score_spread":0.31158447518302057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140085404","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97189224,0.002933791,0.000090859896,0.000568493,0.000027789065,0.00003989584,0.018413061,0.000032223244,0.0060017514],"genre_scores_gemma":[0.98671806,0.0025997804,0.00020366862,0.0001508565,0.000012954232,0.000019836834,0.0073381667,0.0000075043454,0.002949187],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99935335,0.000026653164,0.00006149841,0.00009855087,0.00020921396,0.00025077772],"domain_scores_gemma":[0.9983342,0.000059135462,0.00024483143,0.000038410657,0.00096456014,0.00035881822],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052387756,0.00040958522,0.00034409508,0.0039364295,0.0020894264,0.0012260082,0.0013019082,0.0007351811,0.0024112733],"category_scores_gemma":[0.0018665937,0.0003659141,0.0009417143,0.0074745934,0.00052680436,0.0007248762,0.0006398219,0.0008443442,0.00034280273],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022242381,0.000060721984,0.9896569,0.00010547829,0.000104065075,0.00017433538,0.0010798222,0.0001518796,0.00033905476,0.00020796557,0.0022232423,0.005674063],"study_design_scores_gemma":[0.000006266294,0.000022356151,0.9971928,0.000021576932,0.000035638965,0.0000828344,0.0007367918,0.00009451896,0.000045504145,0.000014249992,0.0017379608,0.00000963359],"about_ca_topic_score_codex":0.99485236,"about_ca_topic_score_gemma":0.9959467,"teacher_disagreement_score":0.020240748,"about_ca_system_score_codex":0.020240748,"about_ca_system_score_gemma":0.021512378,"threshold_uncertainty_score":0.14685756},"labels":[],"label_agreement":null},{"id":"W2140375755","doi":"10.1067/mjd.2001.109856","title":"A clinical and histologic comparison of electrosurgical and carbon dioxide laser peels","year":2001,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatologic Treatments and Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Medicine; Hyperpigmentation; Erythema; Carbon dioxide laser; Surgery; Skin biopsy; Laser; Confidence interval; Dermatology; Biopsy; Laser surgery; Pathology; Optics","score_opus":0.04725918557102802,"score_gpt":0.4149969859494127,"score_spread":0.36773780037838466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140375755","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99509335,0.000811716,0.00069515454,0.000047474576,0.000027743721,0.000049939266,0.00006752383,0.000015988911,0.003191155],"genre_scores_gemma":[0.9982389,0.00026913173,0.0005662243,0.000034493274,0.000024279001,0.0000127591165,0.00009149597,0.0000075983394,0.00075502717],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994987,0.00009442382,0.00007871961,0.000095631294,0.00015018137,0.00008236467],"domain_scores_gemma":[0.9966773,0.0014478647,0.00039344115,0.0002671757,0.0009575572,0.0002567567],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009722678,0.0002971695,0.0002816474,0.0021817444,0.000497277,0.00046976598,0.00032848842,0.00053600094,0.003673186],"category_scores_gemma":[0.0028516215,0.00025433916,0.0002233316,0.00064587727,0.00061675167,0.00090341887,0.0003819584,0.00042809293,0.00058542355],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023214212,0.0018728877,0.51822436,0.00046594124,0.00021427115,0.03475414,0.0010602413,0.00032571153,0.3218703,0.0008057364,0.0006613197,0.09653086],"study_design_scores_gemma":[0.00026830507,0.005715725,0.85247153,0.00008547866,0.00018121202,0.08612689,0.0020573656,0.0012985014,0.048064858,0.0005121262,0.0031609363,0.000057025078],"about_ca_topic_score_codex":0.00049009576,"about_ca_topic_score_gemma":0.0008302412,"teacher_disagreement_score":0.003673186,"about_ca_system_score_codex":0.00028245224,"about_ca_system_score_gemma":0.00018928683,"threshold_uncertainty_score":0.012288094},"labels":[],"label_agreement":null},{"id":"W2141931904","doi":"10.1016/j.jaad.2008.10.049","title":"Cystic bone lesions in a boy with Darier disease: A magnetic resonance imaging assessment","year":2009,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Genetic and rare skin diseases.","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Children's Hospital","funders":"","keywords":"Medicine; Magnetic resonance imaging; Asymptomatic; Radiography; Darier's disease; Radiology; Pathology; Disease","score_opus":0.004788885392569318,"score_gpt":0.2736247815140091,"score_spread":0.26883589612143977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141931904","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9813472,0.0023508102,0.0016866671,0.003688762,0.00022156182,0.00015243616,0.00037454706,0.00015572729,0.010022333],"genre_scores_gemma":[0.9951048,0.001206235,0.0016958461,0.00065551687,0.00040333727,0.000020682115,0.00008563812,0.000026760383,0.00080118474],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9993349,0.00005024017,0.00006698948,0.00018420201,0.00014582061,0.00021788542],"domain_scores_gemma":[0.9979169,0.0007898851,0.00028408595,0.0000718042,0.00014241591,0.00079499604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042704362,0.001613466,0.0012460502,0.002990461,0.0019364156,0.0011320102,0.0016280031,0.0045703705,0.0022570065],"category_scores_gemma":[0.0037719412,0.0011059996,0.00082686293,0.0013533765,0.0022224467,0.001693052,0.0013100192,0.0029179826,0.0006796469],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015829914,0.000024962417,0.0035350814,0.000016993336,0.0000033771362,0.9947872,0.000107642474,0.000057214573,0.000761951,0.00013577288,0.00011481605,0.0004391488],"study_design_scores_gemma":[0.000018257579,0.0000659711,0.007442506,0.000016326765,0.000012496624,0.9912744,0.00012755042,0.00022995519,0.00036962028,0.00010508355,0.0003286394,0.000009249244],"about_ca_topic_score_codex":0.0075730323,"about_ca_topic_score_gemma":0.0061692814,"teacher_disagreement_score":0.0075730323,"about_ca_system_score_codex":0.0012300243,"about_ca_system_score_gemma":0.0014619484,"threshold_uncertainty_score":0.015057921},"labels":[],"label_agreement":null},{"id":"W2142327072","doi":"10.1016/j.jaad.2014.03.023","title":"Guidelines of care for the management of atopic dermatitis","year":2014,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":1208,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health; Quest University Canada; University of British Columbia","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","keywords":"Medicine; Atopic dermatitis; Dermatology; MEDLINE","score_opus":0.02141403959256145,"score_gpt":0.34237505895062886,"score_spread":0.3209610193580674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142327072","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009828572,0.3396917,0.059534393,0.3311117,0.022988742,0.0041313036,0.0038412237,0.0015432762,0.22732908],"genre_scores_gemma":[0.08286736,0.3260158,0.38762665,0.1167581,0.015125573,0.007801649,0.012562118,0.0004515737,0.050791197],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.994803,0.0018964519,0.0013515227,0.00015492692,0.0014520993,0.0003419242],"domain_scores_gemma":[0.98933196,0.002250897,0.0012573589,0.00020932793,0.0060034054,0.00094705867],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004148897,0.0011646848,0.0014462611,0.003456868,0.0016257246,0.0021952824,0.0035822557,0.005520674,0.00539217],"category_scores_gemma":[0.014274794,0.0004228056,0.0024264236,0.0015615856,0.00081509334,0.0011770306,0.0015090312,0.006990917,0.0030174488],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013400866,0.00064115465,0.005911085,0.0023775136,0.00017129412,0.0018662384,0.00046266796,0.0017484761,0.0010573309,0.0100822495,0.58540934,0.3901386],"study_design_scores_gemma":[0.000349582,0.00028028435,0.016984032,0.024247605,0.00036055478,0.0058730124,0.00063932413,0.0016397998,0.0007741756,0.013106319,0.935622,0.00012333541],"about_ca_topic_score_codex":0.014236278,"about_ca_topic_score_gemma":0.034023236,"teacher_disagreement_score":0.014236278,"about_ca_system_score_codex":0.0025158871,"about_ca_system_score_gemma":0.009329636,"threshold_uncertainty_score":0.028306842},"labels":[],"label_agreement":null},{"id":"W2143074973","doi":"10.1016/j.jaad.2009.11.693","title":"Central hair loss in African American women: Incidence and potential risk factors","year":2010,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Incidence (geometry); Hair loss; Dermatology; Demography","score_opus":0.004929503236451874,"score_gpt":0.2616646800318455,"score_spread":0.25673517679539365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143074973","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99867237,0.00044138008,0.000038022477,0.000047965732,0.000004833177,0.0000048663483,0.000118532385,0.0000026480316,0.00066936004],"genre_scores_gemma":[0.99934155,0.00035553848,0.000039543094,0.000014144385,0.000018242017,0.000003924815,0.00006789486,0.0000012731731,0.00015784132],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998461,0.00004165149,0.000011920452,0.00002357615,0.00002753993,0.000049241535],"domain_scores_gemma":[0.99959797,0.00009535118,0.000149182,0.0000178457,0.000045994235,0.0000936682],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022849948,0.00025670667,0.00022921061,0.001482455,0.0006594735,0.00043331023,0.0002528071,0.00042168,0.0028536168],"category_scores_gemma":[0.0010319882,0.00029173752,0.00021571894,0.0014483243,0.00026994973,0.0005734788,0.000277948,0.0004018668,0.00026795606],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012508915,0.00006626223,0.99708575,0.00000721496,0.000014965093,0.00040761282,0.00010618243,0.000013635296,0.0003346308,0.000024140427,0.0000939255,0.0017206615],"study_design_scores_gemma":[0.0000037987115,0.000070809016,0.9976774,0.000005530066,0.0000133695,0.0014631428,0.00049545366,0.000084977306,0.000032554955,0.000026691216,0.0001234963,0.000002884395],"about_ca_topic_score_codex":0.0047576153,"about_ca_topic_score_gemma":0.0057583186,"teacher_disagreement_score":0.0047576153,"about_ca_system_score_codex":0.00018072093,"about_ca_system_score_gemma":0.00020494981,"threshold_uncertainty_score":0.00954628},"labels":[],"label_agreement":null},{"id":"W2143380146","doi":"10.1016/j.jaad.2009.05.050","title":"Cutaneous metastases of cervical adenosquamous carcinoma","year":2010,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Cancer Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Adenosquamous carcinoma; Abdomen; Groin; Vaginal vault; Radiology; Biopsy; Carcinoma; Squamous carcinoma; Lymph node; Radiation therapy; Cervical cancer; Surgery; Hysterectomy; Cancer; Adenocarcinoma; Pathology; Internal medicine","score_opus":0.01819738084243559,"score_gpt":0.30267706174697173,"score_spread":0.2844796809045361,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143380146","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.31935978,0.013877634,0.002052622,0.35039988,0.017550562,0.0004305852,0.00061550684,0.00044545069,0.29526803],"genre_scores_gemma":[0.84591436,0.0066721435,0.0011453173,0.077674225,0.022328347,0.00010228166,0.00015891081,0.00007410365,0.04593015],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9995265,0.00007317484,0.000038256185,0.000060169994,0.00014543008,0.000156464],"domain_scores_gemma":[0.9988533,0.0005038635,0.00012978136,0.00007792634,0.00013564996,0.00029947094],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044224187,0.00089997874,0.00087129424,0.0007961436,0.0020231293,0.001333859,0.0008941772,0.010061555,0.0055595627],"category_scores_gemma":[0.0050631585,0.00054614915,0.00094424473,0.0006061756,0.0011709834,0.0012775358,0.00075491227,0.0052820556,0.0017427274],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000119463286,0.000076665325,0.005072653,0.000101368045,0.000023798284,0.96252364,0.00017045824,0.00031199472,0.0014369658,0.0012703111,0.022624638,0.0062680314],"study_design_scores_gemma":[0.00028539193,0.0002786001,0.017347494,0.00024551063,0.000120396224,0.9246705,0.0005072746,0.0036856623,0.0015370647,0.0025071895,0.04876512,0.000049810773],"about_ca_topic_score_codex":0.009233082,"about_ca_topic_score_gemma":0.019552613,"teacher_disagreement_score":0.010061555,"about_ca_system_score_codex":0.0036536842,"about_ca_system_score_gemma":0.0011743949,"threshold_uncertainty_score":0.026509523},"labels":[],"label_agreement":null},{"id":"W2143591146","doi":"10.1016/j.jaad.2012.09.017","title":"A systematic review of patient-reported outcome instruments of nonmelanoma skin cancer in the dermatologic population","year":2012,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Quality of life (healthcare); Skin cancer; CINAHL; Dermatology Life Quality Index; PsycINFO; Population; Dermatology; Patient-reported outcome; Basal cell carcinoma; MEDLINE; Dermatologic surgery; Head and neck cancer; Cancer; Surgery; Basal cell; Internal medicine; Psychological intervention; Psychiatry","score_opus":0.054945559514116046,"score_gpt":0.3917158833313499,"score_spread":0.3367703238172338,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143591146","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0034422195,0.9949049,0.00017811709,0.000118741555,0.00009144642,0.00030093643,0.0007826539,0.0000064250853,0.00017468531],"genre_scores_gemma":[0.059808105,0.93668073,0.0013180283,0.0005310372,0.00006898539,0.0008143103,0.00062936335,0.0000074362533,0.00014198553],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9881324,0.004408707,0.0050201765,0.00091158936,0.0012800687,0.00024703247],"domain_scores_gemma":[0.9714228,0.020651037,0.0058167083,0.0004329721,0.0014452272,0.00023124978],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010083321,0.0016267906,0.009515109,0.006131158,0.0005767876,0.0023731184,0.0017550112,0.0015089033,0.003379502],"category_scores_gemma":[0.04456614,0.00097459566,0.011627808,0.008153182,0.00093804323,0.0018322025,0.0018099869,0.0014967574,0.00020213387],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051254476,0.00002647463,0.003066889,0.90979713,0.066686496,0.00008242023,0.00015037456,0.000099537974,0.000100232304,0.00013443902,0.0007149892,0.018628333],"study_design_scores_gemma":[0.0013614635,0.0004564739,0.01805955,0.40690377,0.5580313,0.00046975055,0.0004194114,0.00012770429,0.00024296554,0.00036488945,0.013476503,0.000086202206],"about_ca_topic_score_codex":0.008150874,"about_ca_topic_score_gemma":0.026757129,"teacher_disagreement_score":0.010083321,"about_ca_system_score_codex":0.0030487492,"about_ca_system_score_gemma":0.006374905,"threshold_uncertainty_score":0.05332631},"labels":[],"label_agreement":null},{"id":"W2145614525","doi":"10.1016/s0190-9622(03)00340-2","title":"Fungus-free versus disease-free nails: Reply","year":2003,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"David Geffen School of Medicine, University of California, Los Angeles; University of California, Los Angeles; University of Toronto","keywords":"Nail (fastener); Medicine; Dermatology; Antifungal; Psoriasis; Nail disease; Disease; Pathology","score_opus":0.022772768710155517,"score_gpt":0.3189613220469427,"score_spread":0.2961885533367872,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2145614525","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011931714,0.004703525,0.000116099145,0.9672348,0.025688427,0.000010331258,0.00012473202,0.000014934739,0.00091394107],"genre_scores_gemma":[0.012880934,0.0044482686,0.000270489,0.92548895,0.054116685,0.000036334717,0.00010592279,0.0000149564285,0.0026374403],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989795,0.000306073,0.00018534476,0.00018883533,0.00019444573,0.00014578279],"domain_scores_gemma":[0.99121606,0.005869952,0.00044281327,0.00021088039,0.0016105716,0.0006497264],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022962585,0.00046622482,0.0013136456,0.00054784206,0.0014647641,0.001624558,0.0013344194,0.017554082,0.008291261],"category_scores_gemma":[0.014074323,0.0004336563,0.0007437124,0.00066149066,0.001948812,0.0028794047,0.0014765552,0.020013,0.0028379438],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003542332,0.000051883893,0.0023442653,0.00018103146,0.000043795826,0.0008367597,0.00023760874,0.000061167055,0.0003056213,0.0019253752,0.9755156,0.018142626],"study_design_scores_gemma":[0.00054206233,0.00023840339,0.010399957,0.00046563102,0.00018525947,0.0056157145,0.0028855659,0.00032420957,0.00083094946,0.012553784,0.9658006,0.00015783763],"about_ca_topic_score_codex":0.0017719951,"about_ca_topic_score_gemma":0.002379055,"teacher_disagreement_score":0.017554082,"about_ca_system_score_codex":0.0013836905,"about_ca_system_score_gemma":0.0013808386,"threshold_uncertainty_score":0.027737081},"labels":[],"label_agreement":null},{"id":"W2146389288","doi":"10.1016/j.jaad.2005.02.035","title":"Infantile pedal papules","year":2005,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dupuytren's Contracture and Treatments","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Clair College; University of Toronto; Hospital for Sick Children; SickKids Foundation","funders":"","keywords":"Medicine; Incidence (geometry); Dermatology; Flesh; Pediatrics","score_opus":0.010550328672181303,"score_gpt":0.3180853500774881,"score_spread":0.3075350214053068,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146389288","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7314129,0.0115113035,0.007969747,0.0030656103,0.0005770302,0.00018874998,0.0008259701,0.0011064793,0.24334234],"genre_scores_gemma":[0.9827549,0.0015390274,0.0010567161,0.00046455194,0.0002331763,0.000016415242,0.000094500945,0.00003505838,0.013805546],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9998042,0.000028601025,0.0000119024135,0.000040069102,0.000050469534,0.00006483502],"domain_scores_gemma":[0.99947935,0.00013832924,0.00012247603,0.00008416666,0.00007105872,0.00010473832],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020620118,0.00068063126,0.0003042218,0.0010043847,0.00067226053,0.00048244442,0.0004270365,0.0008230221,0.008324757],"category_scores_gemma":[0.0017440395,0.0002253508,0.00024634722,0.000351941,0.00043173975,0.00046856588,0.00035944424,0.0009857655,0.0013753112],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028858057,0.00020036726,0.03193179,0.00030017266,0.00005721543,0.8634423,0.0005173269,0.00026983558,0.015617347,0.005944051,0.0069859885,0.07444505],"study_design_scores_gemma":[0.000018665934,0.00019417469,0.03531294,0.00006538866,0.000031744345,0.94542015,0.000110948684,0.00030018634,0.0034419864,0.00043688895,0.014653422,0.000013533368],"about_ca_topic_score_codex":0.0010205071,"about_ca_topic_score_gemma":0.0012310481,"teacher_disagreement_score":0.008324757,"about_ca_system_score_codex":0.00028975666,"about_ca_system_score_gemma":0.00019135774,"threshold_uncertainty_score":0.027849138},"labels":[],"label_agreement":null},{"id":"W2146763960","doi":"10.1016/j.jaad.2010.12.038","title":"Dual mechanism of action of ingenol mebutate gel for topical treatment of actinic keratoses: Rapid lesion necrosis followed by lesion-specific immune response","year":2011,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":158,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Lesion; Dermatology; Skin lesion; Pathology","score_opus":0.13239979905723165,"score_gpt":0.402195160362088,"score_spread":0.2697953613048564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146763960","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00046439117,0.99882287,0.00006827384,0.000064636726,0.000048022855,0.000007790445,0.00001631143,0.0000042302877,0.000503535],"genre_scores_gemma":[0.0029013844,0.99611723,0.00022796149,0.00011619263,0.000052877855,0.000008922261,0.000030057832,0.0000012034168,0.00054419716],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99986076,0.000022633934,0.000028795544,0.000024744297,0.00005026886,0.000012653478],"domain_scores_gemma":[0.9998348,0.00008618176,0.000038123264,0.0000038852327,0.000028203216,0.000008712162],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037816158,0.00063305243,0.0014619464,0.0015054654,0.00017796966,0.0006112084,0.0007091302,0.00065357226,0.0024318045],"category_scores_gemma":[0.0003470216,0.00022460366,0.0006194023,0.00095224887,0.0002753109,0.0006554945,0.00027726227,0.00076300977,0.00076597044],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004212066,0.00023224717,0.0003656222,0.04076953,0.00031091686,0.00045276163,0.000052876054,0.00019141319,0.006009623,0.00092243904,0.0072317505,0.9430395],"study_design_scores_gemma":[0.00044839532,0.001258955,0.00746667,0.010898647,0.0022245017,0.008336698,0.00025521155,0.00025547357,0.009115479,0.0013786282,0.958271,0.00009038079],"about_ca_topic_score_codex":0.00094208535,"about_ca_topic_score_gemma":0.0022369248,"teacher_disagreement_score":0.0024318045,"about_ca_system_score_codex":0.00030274098,"about_ca_system_score_gemma":0.0004664604,"threshold_uncertainty_score":0.0081352},"labels":[],"label_agreement":null},{"id":"W2150049227","doi":"10.1016/j.jaad.2009.08.016","title":"Assessment of recovery time for the collagen products Dermicol-P35 27G and 30G","year":2010,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Facial Rejuvenation and Surgery Techniques","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"","keywords":"Medicine; Adverse effect; Patient satisfaction; Physical therapy; Dentistry; Surgery; Internal medicine","score_opus":0.014522216947237588,"score_gpt":0.3388586890089579,"score_spread":0.3243364720617203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150049227","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939721,0.0013883016,0.0022219794,0.000048377828,0.000022703201,0.0000546579,0.00021352038,0.00003984772,0.002038556],"genre_scores_gemma":[0.99484754,0.00041301158,0.001587726,0.00003659884,0.0000061193546,0.000023990779,0.00034379875,0.000016869224,0.0027242266],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9996996,0.000058575806,0.000012090936,0.00005521675,0.00009932638,0.00007534232],"domain_scores_gemma":[0.9996214,0.00011255927,0.000069470065,0.000034871824,0.00009013788,0.00007162321],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004242753,0.00025723223,0.00016855371,0.0002808269,0.00015106829,0.00018146948,0.0002076915,0.0003449696,0.0029854022],"category_scores_gemma":[0.00057428976,0.00008921422,0.00029646882,0.00014937336,0.00023313385,0.00030196988,0.00013211918,0.00049111946,0.00051246816],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0059574028,0.00036994112,0.0032328132,0.000053504475,0.000025453615,0.0001224474,0.00008831717,0.00019968991,0.97584313,0.0000991944,0.000114394395,0.013893659],"study_design_scores_gemma":[0.000084556865,0.015958872,0.047028206,0.0000148942045,0.00008675579,0.00056016713,0.00023091279,0.002450502,0.9312654,0.00009878424,0.0021999532,0.000021025919],"about_ca_topic_score_codex":0.0022239243,"about_ca_topic_score_gemma":0.0012586621,"teacher_disagreement_score":0.0029854022,"about_ca_system_score_codex":0.00017612806,"about_ca_system_score_gemma":0.00027339644,"threshold_uncertainty_score":0.009987116},"labels":[],"label_agreement":null},{"id":"W2151203335","doi":"10.1016/j.jaad.2003.10.369","title":"Single-blind, randomized, controlled trial to evaluate the efficacy and safety of photodynamic therapy using aminolevulinic acid versusliquid nitrogen cryotherapy in the management of verrucae plantaris","year":2004,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Oral Health Pathology and Treatment","field":"Dentistry","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Cryotherapy; Medicine; Photodynamic therapy; Plantar warts; Randomized controlled trial; Surgery; Dermatology","score_opus":0.04276054856484342,"score_gpt":0.37192828335097783,"score_spread":0.3291677347861344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151203335","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9752552,0.007548764,0.0019945118,0.0015157333,0.003469419,0.0063185166,0.0011706214,0.0003087833,0.0024183865],"genre_scores_gemma":[0.9802694,0.0027632602,0.0028739553,0.0014773059,0.0017844266,0.006777582,0.00077659904,0.00004594429,0.0032317387],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99791604,0.0010190445,0.00020216402,0.000488419,0.00015309207,0.00022122571],"domain_scores_gemma":[0.9958762,0.001928325,0.00079908594,0.00037040788,0.0002386828,0.00078717904],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037187377,0.002542892,0.008589955,0.00086594216,0.0009906504,0.0017110802,0.00223488,0.0042670146,0.0103665525],"category_scores_gemma":[0.0052918657,0.0014690785,0.0028708624,0.00080696633,0.0035258336,0.0022465205,0.00064325175,0.0058796806,0.001655717],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9948744,0.0021756561,0.000054810916,0.00018410265,0.00032482337,0.000009573028,0.00001058572,0.000057889105,0.00047957717,0.000046800156,0.0001115946,0.0016701877],"study_design_scores_gemma":[0.9832255,0.016112303,0.00013944921,0.000011348493,0.00016738135,0.0000058221817,0.00000428149,0.0001350757,0.00008682992,0.000046777706,0.000060102444,0.0000050203266],"about_ca_topic_score_codex":0.0017671603,"about_ca_topic_score_gemma":0.002312392,"teacher_disagreement_score":0.0103665525,"about_ca_system_score_codex":0.0013754043,"about_ca_system_score_gemma":0.0019277995,"threshold_uncertainty_score":0.03467959},"labels":[],"label_agreement":null},{"id":"W2151974389","doi":"10.1016/j.jaad.2013.08.058","title":"Comment on ‘A double-blind, randomized, placebo-controlled trial of adalimumab in the treatment of cutaneous sarcoidosis’","year":2014,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Sarcoidosis and Beryllium Toxicity Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"","keywords":"Medicine; Adalimumab; Sarcoidosis; Randomized controlled trial; Double blind; Cutaneous Sarcoidosis; Dermatology; Placebo; Surgery; Internal medicine; Alternative medicine; Pathology; Disease","score_opus":0.052467464112540406,"score_gpt":0.36331570574409233,"score_spread":0.31084824163155195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151974389","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009180911,0.0014607719,0.00021707498,0.95705354,0.038146265,0.00006194872,0.0003867723,0.0001170229,0.0016383913],"genre_scores_gemma":[0.0026306582,0.0003179851,0.00027721195,0.96824753,0.026127657,0.000082477214,0.000051858085,0.000024223642,0.0022404168],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9916859,0.0031608264,0.001084967,0.0013364573,0.001959459,0.00077231496],"domain_scores_gemma":[0.9730172,0.019221371,0.002313045,0.00072594266,0.002920112,0.0018023398],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012774014,0.0012141532,0.0035495076,0.0011213821,0.0034490498,0.0031591377,0.0037774674,0.06757,0.0071745785],"category_scores_gemma":[0.049605474,0.0013298145,0.003236374,0.0012131626,0.0041519003,0.0033025104,0.0010909947,0.03509051,0.008366496],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017825501,0.00009357343,0.0006363654,0.00023316727,0.00014726853,0.0007739151,0.00010575961,0.000097224074,0.00035256366,0.0015159018,0.98601377,0.00824787],"study_design_scores_gemma":[0.0069075185,0.0012036695,0.005406506,0.0012872923,0.0007934144,0.0017413776,0.00035797752,0.0016367062,0.0020366905,0.011457952,0.9668746,0.0002962303],"about_ca_topic_score_codex":0.007153171,"about_ca_topic_score_gemma":0.009445494,"teacher_disagreement_score":0.06757,"about_ca_system_score_codex":0.0062231263,"about_ca_system_score_gemma":0.0048114373,"threshold_uncertainty_score":0.06755626},"labels":[],"label_agreement":null},{"id":"W2152129288","doi":"10.1016/j.jaad.2014.05.010","title":"Comparative performance of psoriatic arthritis screening tools in patients with psoriasis in European/North American dermatology clinics","year":2014,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland; University of Toronto","funders":"Pfizer","keywords":"Medicine; Psoriasis; Psoriatic arthritis; Dermatology; Internal medicine; Arthritis; Confidence interval; Epidemiology; Predictive value; Physical therapy","score_opus":0.02088245031708339,"score_gpt":0.2942665033383632,"score_spread":0.27338405302127977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152129288","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99810284,0.0007783423,0.000028702538,0.00007687829,0.000010746918,0.000009681062,0.00010413723,0.00000307378,0.00088575034],"genre_scores_gemma":[0.9997004,0.00010721638,0.000029087552,0.000031163294,0.000007146269,0.0000036175245,0.000080917736,9.0736336e-7,0.000039581373],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958366,0.0022346836,0.0005040129,0.0004491907,0.00062844483,0.00034699944],"domain_scores_gemma":[0.9909106,0.0054658153,0.0014994792,0.00029700235,0.0010951147,0.0007319679],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038840743,0.00031154646,0.0006455013,0.0013306862,0.00051514246,0.0011554715,0.00039369887,0.00072737393,0.0009939455],"category_scores_gemma":[0.015932148,0.00020910268,0.0008478424,0.0016525759,0.00045703875,0.0010379496,0.00078066275,0.00046300262,0.00018050688],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024484158,0.00028376374,0.98703694,0.00006153365,0.0003303841,0.00009185869,0.00067227654,0.00012888199,0.0002454403,0.000052367664,0.00018001015,0.008468103],"study_design_scores_gemma":[0.000091318274,0.00088812766,0.9971596,0.000018554363,0.00021205061,0.0001704323,0.00094005134,0.00024120112,0.00008311381,0.00002950784,0.0001575993,0.000008487575],"about_ca_topic_score_codex":0.0057729264,"about_ca_topic_score_gemma":0.008497934,"teacher_disagreement_score":0.0057729264,"about_ca_system_score_codex":0.0006939046,"about_ca_system_score_gemma":0.00062746607,"threshold_uncertainty_score":0.020541191},"labels":[],"label_agreement":null},{"id":"W2152867766","doi":"10.1016/j.jaad.2004.04.008","title":"Evaluation and treatment of male and female pattern hair loss","year":2004,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":276,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Hair loss; Medicine; Male pseudohermaphroditism; Hair transplantation; Hypotrichosis; Male-pattern baldness; Dermatology; Gynecology; Endocrinology; Genetics; Biology; Gene; Scalp","score_opus":0.023605714673286256,"score_gpt":0.3287460939000232,"score_spread":0.3051403792267369,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152867766","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9217041,0.03591257,0.0045128255,0.0044011995,0.00024695875,0.00016090646,0.00017905225,0.00010874369,0.032773525],"genre_scores_gemma":[0.98906726,0.006327235,0.0014729736,0.00054704753,0.00018226371,0.000033916924,0.00010743514,0.000020510595,0.002241295],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997298,0.000064262334,0.000028303366,0.00002572599,0.00009526413,0.000056731278],"domain_scores_gemma":[0.99979764,0.000058706824,0.000023932062,0.000007547914,0.000047426125,0.00006476284],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040933365,0.00038997357,0.00058376096,0.0013768865,0.0005868893,0.00035949273,0.0003122849,0.0006633754,0.0019261929],"category_scores_gemma":[0.0012070438,0.0001568311,0.0004375106,0.0003420297,0.0003756219,0.00039084023,0.0002487499,0.0005381089,0.0003252457],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046697445,0.00096256734,0.32104382,0.0003895837,0.00011993804,0.094470136,0.0004200043,0.00075054774,0.028538961,0.0006279667,0.005685033,0.54232174],"study_design_scores_gemma":[0.00028144967,0.003228608,0.58352536,0.0002721893,0.00022188236,0.38397792,0.0013539469,0.0023544861,0.012020366,0.0008995556,0.011813634,0.00005057581],"about_ca_topic_score_codex":0.0014512546,"about_ca_topic_score_gemma":0.0025879017,"teacher_disagreement_score":0.0019261929,"about_ca_system_score_codex":0.00037597943,"about_ca_system_score_gemma":0.00043800302,"threshold_uncertainty_score":0.006443739},"labels":[],"label_agreement":null},{"id":"W2152923223","doi":"10.1016/s0190-9622(03)00746-1","title":"Subcutaneous panniculitic T-cell lymphoma in children: response to combination therapy with cyclosporine and chemotherapy","year":2004,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"British Columbia Children's Hospital","funders":"","keywords":"Medicine; Chemotherapy; Lymphoma; Subcutaneous tissue; Biopsy; Subcutaneous injection; T-cell lymphoma; Dermatology; Internal medicine; Pathology","score_opus":0.016298102096956913,"score_gpt":0.34104399638458427,"score_spread":0.32474589428762735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152923223","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009836133,0.99794906,0.00011642695,0.00010410153,0.00007771018,0.0000047096332,0.000018608815,0.000006544068,0.00073916884],"genre_scores_gemma":[0.0068250466,0.9922212,0.00022317734,0.00019670236,0.0001965439,0.000008249396,0.000043824602,0.000001718344,0.00028350705],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99984527,0.000030947773,0.000031580083,0.00002977984,0.000049487895,0.00001290095],"domain_scores_gemma":[0.9997037,0.00015423227,0.00006879057,0.000007375229,0.00004207245,0.000023801493],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032186648,0.00057555287,0.0019544044,0.0009797493,0.00012379493,0.00050013344,0.00068934116,0.00047533907,0.0011223791],"category_scores_gemma":[0.00054869364,0.00016411471,0.00045915463,0.0010953414,0.00020974386,0.00041858197,0.00018600466,0.00082389114,0.00051981024],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004216299,0.00012264478,0.0025592507,0.013911578,0.00040742374,0.0024875002,0.00005474207,0.00039552257,0.0018082673,0.0004370577,0.013829532,0.963565],"study_design_scores_gemma":[0.0009398646,0.0012552604,0.039358187,0.012892722,0.004090014,0.09095247,0.0003331131,0.0007007489,0.002936097,0.0010755889,0.8453824,0.000083574916],"about_ca_topic_score_codex":0.0008237655,"about_ca_topic_score_gemma":0.002054677,"teacher_disagreement_score":0.0019544044,"about_ca_system_score_codex":0.0003266537,"about_ca_system_score_gemma":0.00041420397,"threshold_uncertainty_score":0.003754735},"labels":[],"label_agreement":null},{"id":"W2153216907","doi":"10.1016/j.jaad.2006.06.006","title":"Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: An international consensus","year":2006,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":655,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"","keywords":"Medicine; Skin cancer; Photodynamic therapy; Dermatology; Sunscreening Agents; Consensus conference; Cancer; Internal medicine","score_opus":0.15828948173998456,"score_gpt":0.44599362360045586,"score_spread":0.28770414186047133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153216907","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015808102,0.99392694,0.0005145877,0.003134273,0.0007514024,0.000100899255,0.00025477665,0.000015550966,0.0011434593],"genre_scores_gemma":[0.001247119,0.9919191,0.0029329052,0.002678747,0.00022708368,0.0001588511,0.00032150556,0.000007352173,0.00050746766],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965179,0.00086810003,0.0014088438,0.00027838274,0.0008124568,0.000114317794],"domain_scores_gemma":[0.99361354,0.003097822,0.0012844622,0.00012543045,0.001690323,0.00018843586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00780401,0.0013305779,0.005120519,0.006279928,0.0007433238,0.0017170087,0.0043267007,0.0032210432,0.004177179],"category_scores_gemma":[0.010015963,0.0007093989,0.0045174095,0.005289637,0.00096505083,0.0019866743,0.001604588,0.0028029028,0.0013298652],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032622615,0.00011996052,0.0008033168,0.14806132,0.0016741547,0.00029568444,0.00018705938,0.0003654563,0.00084584753,0.002959965,0.104827546,0.7395335],"study_design_scores_gemma":[0.00050038984,0.0001773433,0.003379755,0.18702883,0.008066708,0.00091442565,0.00025853622,0.0001677017,0.00081243453,0.0032271266,0.79539484,0.00007188513],"about_ca_topic_score_codex":0.00888868,"about_ca_topic_score_gemma":0.016250385,"teacher_disagreement_score":0.00888868,"about_ca_system_score_codex":0.0024001126,"about_ca_system_score_gemma":0.008668332,"threshold_uncertainty_score":0.041272044},"labels":[],"label_agreement":null},{"id":"W2153282585","doi":"10.1016/j.jaad.2014.04.024","title":"Gaps in pain management in dermatology: A needs assessment from Canada","year":2014,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa; Oakville-Trafalgar Memorial Hospital","funders":"","keywords":"Medicine; Dermatology; Pain management; MEDLINE; Family medicine; Physical therapy","score_opus":0.013956393632525693,"score_gpt":0.30010711060712686,"score_spread":0.28615071697460115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153282585","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07755894,0.0031900946,0.000066848595,0.9019543,0.0013437879,0.00010167622,0.0003508989,0.000011334501,0.015422136],"genre_scores_gemma":[0.54845256,0.011910749,0.0011295995,0.42551523,0.0013391231,0.00016808591,0.00029186413,0.000042175005,0.011150658],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99302495,0.00085082254,0.0005664026,0.00022277205,0.0026584216,0.002676613],"domain_scores_gemma":[0.95383185,0.006153724,0.0021214795,0.00021875526,0.018723045,0.018951163],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034562207,0.00024662263,0.00058069715,0.0015842913,0.018483948,0.0045564706,0.0018907278,0.007725955,0.0064879926],"category_scores_gemma":[0.017497553,0.0004811484,0.00052240875,0.0034205853,0.00277669,0.0020157804,0.0030125421,0.008937625,0.00036937758],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023954277,0.0008281014,0.20217709,0.0010806666,0.00013471712,0.017292166,0.061956346,0.00042182716,0.0008714551,0.0056217075,0.62047917,0.0888972],"study_design_scores_gemma":[0.00033077993,0.00029547268,0.2394196,0.0036510269,0.00014290673,0.0075090667,0.4436411,0.00089920074,0.00025410147,0.0032343883,0.3003442,0.00027821888],"about_ca_topic_score_codex":0.9563122,"about_ca_topic_score_gemma":0.98454976,"teacher_disagreement_score":0.06640354,"about_ca_system_score_codex":0.06640354,"about_ca_system_score_gemma":0.25167066,"threshold_uncertainty_score":0.48179364},"labels":[],"label_agreement":null},{"id":"W2153559781","doi":"10.1067/mjd.2003.427","title":"Cutaneous manifestations of antiviral therapy","year":2003,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"HIV-related health complications and treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Lipodystrophy; Stavudine; Medicine; Lipoatrophy; Mitochondrial toxicity; Antiretroviral therapy; Dermatology; Bioinformatics; Virology; Viral load; Virus; Human immunodeficiency virus (HIV); Biology","score_opus":0.0244905855419342,"score_gpt":0.34134346539406313,"score_spread":0.31685287985212895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153559781","genre_codex":"other","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19572543,0.034712605,0.0043228082,0.16407427,0.010483543,0.00026618072,0.00020695607,0.00039006514,0.5898181],"genre_scores_gemma":[0.8921424,0.008671623,0.0010532208,0.05635881,0.009772412,0.00004628708,0.00007776758,0.000031902426,0.031845585],"study_design_codex":"case_report","study_design_gemma":"not_applicable","domain_scores_codex":[0.99939644,0.00022435414,0.00004403254,0.000060962488,0.00012360637,0.00015049402],"domain_scores_gemma":[0.99891996,0.000559047,0.00013213811,0.000095372874,0.00014170782,0.00015177969],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00067034195,0.0005629186,0.0005109254,0.0005275169,0.0010955422,0.0010444352,0.0005157052,0.0040945355,0.0040948703],"category_scores_gemma":[0.0041106143,0.00023065292,0.0006961026,0.00034297138,0.00060463476,0.0007322413,0.00037721446,0.0035491486,0.0010145323],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024000264,0.000120519784,0.012794522,0.00016410302,0.000058369333,0.9149796,0.00024122917,0.00020577006,0.001762597,0.0043512196,0.03761491,0.027467223],"study_design_scores_gemma":[0.00012761552,0.0001674484,0.01517692,0.00030970777,0.000056861743,0.9152554,0.00021031877,0.00079297926,0.0006796999,0.0024868445,0.06471959,0.00001664902],"about_ca_topic_score_codex":0.001545186,"about_ca_topic_score_gemma":0.0023770356,"teacher_disagreement_score":0.0040948703,"about_ca_system_score_codex":0.0010771906,"about_ca_system_score_gemma":0.00038853104,"threshold_uncertainty_score":0.013698697},"labels":[],"label_agreement":null},{"id":"W2153713701","doi":"10.1016/j.jaad.2013.11.005","title":"New insights into pustular dermatoses in pediatric patients","year":2014,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Autoimmune and Inflammatory Disorders","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children; SickKids Foundation","funders":"","keywords":"Medicine; Intensive care medicine; Signs and symptoms; Population; Dermatology; Organ system; Focus (optics); Pathology; Surgery; Disease","score_opus":0.01456677368279131,"score_gpt":0.3194569698201614,"score_spread":0.3048901961373701,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153713701","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016617207,0.99904615,0.000089078516,0.00019336097,0.000103456936,0.000001861495,0.000009904165,0.0000031400405,0.00038682894],"genre_scores_gemma":[0.001534742,0.99752647,0.00020421311,0.00024265966,0.00029656413,0.0000024617607,0.00001970561,8.993138e-7,0.0001722355],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99972886,0.00005057332,0.00006036508,0.000048235772,0.000083661755,0.00002822404],"domain_scores_gemma":[0.99929166,0.00042938453,0.00011682121,0.0000125024235,0.00010713003,0.000042484186],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005538785,0.00074670574,0.0014560561,0.002994709,0.00026232534,0.0013067772,0.00063132285,0.00094373204,0.002342155],"category_scores_gemma":[0.0012464729,0.00030541501,0.00058697263,0.0022756692,0.0005484957,0.0018903977,0.00077610137,0.0017711502,0.0005642801],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008193621,0.00008170665,0.0017763866,0.017700495,0.0001284796,0.0015119307,0.00014374261,0.00026982318,0.0010770287,0.0022911143,0.018924138,0.95601326],"study_design_scores_gemma":[0.0000628189,0.00014501363,0.007670913,0.020956546,0.00065293326,0.028359411,0.0005240431,0.0003533781,0.0007628368,0.0043136817,0.93612766,0.00007074771],"about_ca_topic_score_codex":0.0008283246,"about_ca_topic_score_gemma":0.0019678916,"teacher_disagreement_score":0.002994709,"about_ca_system_score_codex":0.0004040331,"about_ca_system_score_gemma":0.00084839,"threshold_uncertainty_score":0.007835329},"labels":[],"label_agreement":null},{"id":"W2154426869","doi":"10.1016/j.jaad.2004.07.003","title":"Classic Kaposi's sarcoma in the Inuit of northern Quebec","year":2005,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Royal Victoria Hospital; McGill University Health Centre","funders":"","keywords":"Medicine; Sarcoma; Dermatology; Virology; Pathology","score_opus":0.012091282653521855,"score_gpt":0.2931402180853152,"score_spread":0.2810489354317934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2154426869","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944706,0.0004124545,0.0000875984,0.00029610257,0.000018700413,0.000032471864,0.00023500924,0.0000064643164,0.0044406685],"genre_scores_gemma":[0.9975981,0.00030833503,0.00006615115,0.00009941313,0.000009276478,0.0000052346363,0.000072590636,0.0000033201231,0.0018374927],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.99975985,0.000026246664,0.000014388132,0.00003459865,0.00004118247,0.0001236486],"domain_scores_gemma":[0.9996524,0.000040238083,0.00005858544,0.000011393996,0.0001150112,0.0001223289],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017737571,0.00033405365,0.00026207112,0.0014084848,0.004063137,0.0008837146,0.00080660725,0.0006708135,0.004013677],"category_scores_gemma":[0.0006861698,0.00029085882,0.00019160606,0.0017336971,0.00094469194,0.0003880284,0.00046324058,0.0005930592,0.00029290974],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033705984,0.0004003696,0.8489267,0.00015419144,0.00008385594,0.11317704,0.012739682,0.0003586618,0.00344658,0.0014620658,0.0027760207,0.01613788],"study_design_scores_gemma":[0.000048896065,0.00024166913,0.90028983,0.00015519692,0.000113127804,0.061763123,0.028996427,0.0013551415,0.0004910406,0.00043603868,0.0060517634,0.000057839636],"about_ca_topic_score_codex":0.95483106,"about_ca_topic_score_gemma":0.9675,"teacher_disagreement_score":0.045168936,"about_ca_system_score_codex":0.008328119,"about_ca_system_score_gemma":0.005566044,"threshold_uncertainty_score":0.090869844},"labels":[],"label_agreement":null},{"id":"W2155318601","doi":"10.1016/j.jaad.2011.05.033","title":"Prevalence of sunburn, sun protection, and indoor tanning behaviors among Americans: Review from national surveys and case studies of 3 states","year":2011,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Skin Protection and Aging","field":"Medicine","cited_by":316,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Centers for Disease Control and Prevention","keywords":"Sunburn; Medicine; Sun protection; Environmental health; Skin cancer; Behavioral Risk Factor Surveillance System; Incidence (geometry); Demography; Young adult; Sunbathing; Quarter (Canadian coin); Gerontology; Population; Cancer; Geography; Dermatology","score_opus":0.10512477079478579,"score_gpt":0.4124161501165426,"score_spread":0.3072913793217568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155318601","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018112567,0.99765885,0.00004188921,0.000059395075,0.000030229412,0.000014036455,0.00022902172,0.0000027705976,0.00015253488],"genre_scores_gemma":[0.0071388297,0.9923145,0.00020614812,0.00009541137,0.00002201851,0.000016207878,0.00015892534,8.801005e-7,0.000047025977],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99918276,0.00014047316,0.00028650917,0.00015661423,0.00020012363,0.000033520042],"domain_scores_gemma":[0.998216,0.00093571935,0.00048430543,0.000031329597,0.00029279487,0.00003982631],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014684385,0.00062614103,0.0024322302,0.0041182265,0.00024647338,0.00073807186,0.0008865378,0.00056164624,0.0008891002],"category_scores_gemma":[0.002773734,0.0004882854,0.001955491,0.005082865,0.00026733876,0.00077812525,0.0005409306,0.0004457981,0.00012228462],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002847436,0.0001284321,0.038586684,0.26717067,0.005814212,0.0003299987,0.0005558109,0.00019400584,0.00056588405,0.0002949163,0.010737431,0.67533714],"study_design_scores_gemma":[0.00022633941,0.0007707596,0.4253251,0.25947824,0.054885834,0.008189423,0.0024409725,0.00031477146,0.0011437024,0.0006167174,0.24635872,0.00024937224],"about_ca_topic_score_codex":0.01009052,"about_ca_topic_score_gemma":0.023531163,"teacher_disagreement_score":0.01009052,"about_ca_system_score_codex":0.0005057045,"about_ca_system_score_gemma":0.0015808532,"threshold_uncertainty_score":0.02006358},"labels":[],"label_agreement":null},{"id":"W2156148414","doi":"10.1016/j.jaad.2013.12.018","title":"Patient perspectives in the management of psoriasis: Results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis Survey","year":2014,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":511,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Psoriasis; Medicine; Psoriatic arthritis; Dermatology; Multinational corporation; Family medicine","score_opus":0.017635775911214853,"score_gpt":0.2849447469926242,"score_spread":0.26730897108140933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156148414","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99485224,0.0008048751,0.000051007974,0.0011734011,0.000020632193,0.000020493177,0.0015307107,0.0000036897268,0.0015429842],"genre_scores_gemma":[0.998052,0.00046920453,0.000102346065,0.00036159783,0.000027927153,0.000017158425,0.00081002375,0.0000019414038,0.00015783863],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99775153,0.0010843454,0.00029455766,0.0001759676,0.00049067545,0.00020304881],"domain_scores_gemma":[0.99598795,0.0007752135,0.0021581096,0.00009462307,0.00039473214,0.0005894067],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019969018,0.00017414222,0.0003772362,0.00055761455,0.00053624704,0.0008980698,0.00036500182,0.00086796534,0.0011107092],"category_scores_gemma":[0.006630935,0.00023013602,0.000716374,0.0013257811,0.00022577748,0.0007853815,0.00096347067,0.0010331589,0.00018204155],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000072208815,0.00007227068,0.99685824,0.000015507941,0.00006002803,0.000025906522,0.00025552296,0.000027589556,0.000036723734,0.000009578588,0.0003017189,0.0022646468],"study_design_scores_gemma":[0.000006739021,0.000050496456,0.99893135,0.000008711323,0.000021186443,0.00005459672,0.0006147112,0.000051270286,0.000011493609,0.000008709413,0.0002366578,0.000004134851],"about_ca_topic_score_codex":0.014798964,"about_ca_topic_score_gemma":0.02238272,"teacher_disagreement_score":0.014798964,"about_ca_system_score_codex":0.0005618369,"about_ca_system_score_gemma":0.00058231776,"threshold_uncertainty_score":0.02942568},"labels":[],"label_agreement":null},{"id":"W2156756329","doi":"10.1016/j.jaad.2006.03.022","title":"Topical treatments for hypertrophic scars","year":2006,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Dermatologic Treatments and Research","field":"Medicine","cited_by":207,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"","keywords":"Medicine; Cryosurgery; Hypertrophic scars; Dermatology; Muscle contracture; Scars; Topical agents; Cryotherapy; Surgery; Silicone; Electrosurgery; Imiquimod","score_opus":0.08313929373634044,"score_gpt":0.4385796125103727,"score_spread":0.35544031877403226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156756329","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00022591483,0.9982686,0.0001229609,0.00007775634,0.00018513057,0.000008070608,0.000012219888,0.000008774752,0.0010905932],"genre_scores_gemma":[0.0018172263,0.99638546,0.00027899529,0.00020731625,0.00025812443,0.000009078001,0.00003451793,0.0000023606926,0.0010069648],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999795,0.000031454416,0.000034369587,0.000031778003,0.00008807722,0.00001940904],"domain_scores_gemma":[0.9997104,0.00013909907,0.00006585185,0.000010465463,0.000050962415,0.00002308678],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041535104,0.00082209334,0.001506231,0.002855961,0.00032045037,0.00065134675,0.0007736812,0.00080308545,0.0040591233],"category_scores_gemma":[0.0005556809,0.00029381202,0.0006444385,0.0016905174,0.00037296128,0.00085937616,0.00044683728,0.0014580555,0.0017737766],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000097899814,0.0001425816,0.00015835474,0.0102269165,0.00009356858,0.00029683587,0.000026764752,0.00010936699,0.001728805,0.00055965973,0.015295241,0.9712639],"study_design_scores_gemma":[0.00015912336,0.00042032072,0.0037002917,0.007605888,0.0006458149,0.007823778,0.00013642407,0.00024400136,0.0023033048,0.001367426,0.9755501,0.000043572072],"about_ca_topic_score_codex":0.0007681945,"about_ca_topic_score_gemma":0.0019870128,"teacher_disagreement_score":0.0040591233,"about_ca_system_score_codex":0.0002606316,"about_ca_system_score_gemma":0.00039737974,"threshold_uncertainty_score":0.01357919},"labels":[],"label_agreement":null},{"id":"W2158229253","doi":"10.1016/j.jaad.2014.05.041","title":"Acute generalized exanthematous pustulosis associated with 2 common medications: Hydroxyzine and benzocaine","year":2014,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Hydroxyzine; Medicine; Acute generalized exanthematous pustulosis; Benzocaine; Dermatology; Anesthesia","score_opus":0.01828735157051521,"score_gpt":0.30525521128212724,"score_spread":0.28696785971161204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158229253","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.29653233,0.14204626,0.009926893,0.34327972,0.18363495,0.000438946,0.0006090141,0.00086215563,0.022669677],"genre_scores_gemma":[0.5540945,0.028673293,0.0034565818,0.10522801,0.29746515,0.00007457001,0.0002447247,0.00014184153,0.010621355],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99898523,0.00023854864,0.00020104309,0.00020455231,0.00017866876,0.00019197156],"domain_scores_gemma":[0.9964617,0.001699401,0.0006524197,0.00013275229,0.00052583724,0.0005278946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009828915,0.0017451281,0.0018995075,0.0010326175,0.00079172687,0.0013721236,0.0016434932,0.0072823246,0.0031731322],"category_scores_gemma":[0.00505197,0.00085112953,0.00085846166,0.0007400143,0.0010988896,0.0025520422,0.0006291203,0.005075118,0.001462048],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00079458306,0.00025015333,0.01903007,0.0014938938,0.00023544887,0.8184534,0.00043770787,0.00028450022,0.0030995202,0.00091087667,0.13008763,0.024922173],"study_design_scores_gemma":[0.0003120149,0.0004603653,0.02143178,0.0006071655,0.00029660613,0.8513663,0.0008262866,0.0031497935,0.002691244,0.0010243236,0.11772837,0.000105753825],"about_ca_topic_score_codex":0.0006537124,"about_ca_topic_score_gemma":0.0010897071,"teacher_disagreement_score":0.0072823246,"about_ca_system_score_codex":0.00097217853,"about_ca_system_score_gemma":0.00041150374,"threshold_uncertainty_score":0.01061523},"labels":[],"label_agreement":null},{"id":"W2159011171","doi":"10.1016/j.jaad.2005.10.028","title":"Long-term management of plaque psoriasis with continuous efalizumab therapy","year":2006,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Efalizumab; Medicine; Plaque psoriasis; Psoriasis; Dermatology; Term (time)","score_opus":0.026313459963280234,"score_gpt":0.3065750847279561,"score_spread":0.28026162476467587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159011171","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006516768,0.9980494,0.00023545718,0.000218187,0.00020823478,0.000003844937,0.000008666931,0.000009931494,0.00061466946],"genre_scores_gemma":[0.0064640283,0.9909243,0.00049944944,0.00043634188,0.0006336071,0.000011491715,0.00005431261,0.0000030535505,0.0009734828],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99981695,0.00003540487,0.000028768041,0.000029872435,0.0000696858,0.000019388952],"domain_scores_gemma":[0.99977773,0.000107076914,0.000042129974,0.0000074909335,0.000040743955,0.00002488052],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005574708,0.00070238253,0.0018488439,0.0008396963,0.0002073243,0.0006599451,0.001128145,0.00084109895,0.0014057163],"category_scores_gemma":[0.00051751704,0.000174449,0.00047571596,0.0006290741,0.00032901025,0.0006640716,0.00029919043,0.0014388765,0.0010112927],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020387628,0.0001226466,0.0002791467,0.0040235305,0.0001189548,0.0005442534,0.000022487138,0.00015305112,0.0013581619,0.0005232923,0.011347803,0.9813029],"study_design_scores_gemma":[0.00048192422,0.0010232338,0.009690255,0.0047958386,0.00081027095,0.020256089,0.00012595278,0.00059531094,0.0025633692,0.002096931,0.95748955,0.00007127927],"about_ca_topic_score_codex":0.0004502894,"about_ca_topic_score_gemma":0.0011997757,"teacher_disagreement_score":0.0018488439,"about_ca_system_score_codex":0.00036851113,"about_ca_system_score_gemma":0.00040053987,"threshold_uncertainty_score":0.004702568},"labels":[],"label_agreement":null},{"id":"W2159638184","doi":"10.1016/j.jaad.2008.02.004","title":"The classification of inherited epidermolysis bullosa (EB): Report of the Third International Consensus Meeting on Diagnosis and Classification of EB","year":2008,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Skin and Cellular Biology Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":933,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Epidermolysis bullosa; Medicine; Consensus conference; Flexibility (engineering); Disease; Classification scheme; Dermatology; Intensive care medicine; Pathology; Data science; Computer science","score_opus":0.0355538966952952,"score_gpt":0.3213549317653101,"score_spread":0.2858010350700149,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159638184","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19446504,0.33975857,0.1821653,0.16671582,0.05204888,0.0064991335,0.008629834,0.0013621215,0.048355307],"genre_scores_gemma":[0.4438182,0.112864025,0.38545167,0.014226132,0.008850476,0.004248492,0.019944072,0.0006838847,0.009913017],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98922825,0.003130162,0.0030421664,0.00078711094,0.0027885234,0.0010238285],"domain_scores_gemma":[0.9760198,0.0031921018,0.0040747826,0.00070738606,0.0138255395,0.0021802785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.022145364,0.0020765904,0.0038689813,0.009231386,0.002680755,0.0031738095,0.010697708,0.002814083,0.0020782335],"category_scores_gemma":[0.021925388,0.0006770829,0.0043264027,0.004316899,0.0038964676,0.0038548838,0.0035673247,0.0050729467,0.001402706],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017036159,0.00046498756,0.17840077,0.0055953464,0.0011346423,0.0046121674,0.003173021,0.0043795933,0.01422853,0.017328607,0.31385037,0.45512828],"study_design_scores_gemma":[0.0012817505,0.0013643447,0.26951265,0.020981427,0.003629985,0.047531657,0.015948633,0.027187197,0.012080896,0.033632904,0.56603837,0.00081028783],"about_ca_topic_score_codex":0.02493262,"about_ca_topic_score_gemma":0.017230121,"teacher_disagreement_score":0.02493262,"about_ca_system_score_codex":0.007346459,"about_ca_system_score_gemma":0.011034402,"threshold_uncertainty_score":0.117117286},"labels":[],"label_agreement":null},{"id":"W2160168793","doi":"10.1016/j.jaad.2015.08.040","title":"A systematic review of filler agents for aesthetic treatment of HIV facial lipoatrophy (FLA)","year":2015,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Allergan","keywords":"Medicine; Filler (materials); Lipoatrophy; Dermatology; Human immunodeficiency virus (HIV); Cosmetic Techniques; Aesthetics; Antiretroviral therapy; Family medicine; Composite material; Viral load","score_opus":0.09304434876187027,"score_gpt":0.431864107181929,"score_spread":0.33881975842005874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160168793","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005522088,0.9988071,0.00007365133,0.00006782077,0.000064000735,0.00011362338,0.00012474018,0.00000483052,0.00019213987],"genre_scores_gemma":[0.00755113,0.99130553,0.00041072047,0.0003586981,0.00004431143,0.00011411704,0.00007879158,0.0000031113939,0.00013351333],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9982577,0.0004791291,0.0007111241,0.00016236669,0.00031183366,0.00007787386],"domain_scores_gemma":[0.9959636,0.0026735053,0.00094969897,0.000051898154,0.00029164486,0.00006973976],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002471338,0.0012377276,0.007054838,0.0046560513,0.00042437174,0.0018035029,0.0017100379,0.0016040289,0.006985881],"category_scores_gemma":[0.009110709,0.00068702956,0.006753387,0.004247355,0.00057119806,0.0014341964,0.0010006445,0.0011619079,0.00032349632],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004932385,0.000029373514,0.00020421913,0.9409966,0.0095269075,0.00010203962,0.00008873088,0.000075581906,0.00026190342,0.00014499741,0.0013796248,0.046696793],"study_design_scores_gemma":[0.0018330999,0.00081623223,0.0040267017,0.71262103,0.22718905,0.0010123107,0.00032547535,0.00015673392,0.00042145496,0.00048557634,0.051036954,0.0000753449],"about_ca_topic_score_codex":0.005546065,"about_ca_topic_score_gemma":0.01894212,"teacher_disagreement_score":0.007054838,"about_ca_system_score_codex":0.001359037,"about_ca_system_score_gemma":0.0033190534,"threshold_uncertainty_score":0.023370087},"labels":[],"label_agreement":null},{"id":"W2160624893","doi":"10.1067/mjd.2002.107966","title":"Multiple nevoid malignant melanomas in a patient with AIDS: The role of proliferating cell nuclear antigen in the diagnosis","year":2002,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital","funders":"","keywords":"Medicine; Melanoma; Immunohistochemistry; Pathology; Proliferating cell nuclear antigen; Antigen; Human immunodeficiency virus (HIV); Dermatology; Immunology; Cancer research","score_opus":0.010760143725874777,"score_gpt":0.23107541647870725,"score_spread":0.22031527275283247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160624893","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9685685,0.0035001994,0.0019108881,0.0054698335,0.0003754777,0.00020405922,0.00019519695,0.0001427043,0.019633174],"genre_scores_gemma":[0.9956251,0.0009268035,0.001099488,0.0006323826,0.00089658727,0.000019262581,0.000044285116,0.000017414328,0.00073875923],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9991522,0.00011668822,0.00009727283,0.00018321638,0.0001921073,0.0002584899],"domain_scores_gemma":[0.997424,0.0011377785,0.0002722459,0.00014130143,0.00017913351,0.0008454614],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073100446,0.001928809,0.0011774993,0.005148628,0.0034963076,0.0015102718,0.0015667725,0.006908106,0.0027766754],"category_scores_gemma":[0.005609994,0.0013089728,0.0010336029,0.0013495126,0.0017451165,0.0023518563,0.0010513915,0.0041383086,0.00083645043],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000102505845,0.00007390673,0.017622884,0.000021315485,0.000006552917,0.9796862,0.00014997997,0.00009918129,0.00069121836,0.00011223118,0.00018659007,0.001247402],"study_design_scores_gemma":[0.00001610431,0.00015023105,0.011701859,0.00001747001,0.000020164336,0.9865416,0.00017428219,0.00057799957,0.00034818114,0.0001368981,0.00030388832,0.00001138566],"about_ca_topic_score_codex":0.0032207936,"about_ca_topic_score_gemma":0.004017268,"teacher_disagreement_score":0.006908106,"about_ca_system_score_codex":0.0011443992,"about_ca_system_score_gemma":0.0008938897,"threshold_uncertainty_score":0.009288907},"labels":[],"label_agreement":null},{"id":"W2160708937","doi":"10.1016/j.jaad.2015.07.046","title":"Pain management in patients with hidradenitis suppurativa","year":2015,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Hidradenitis suppurativa; Neuropathic pain; Chronic pain; Acetaminophen; Quality of life (healthcare); Disease; Depression (economics); Anesthesia; Physical therapy; Internal medicine","score_opus":0.027095858784423724,"score_gpt":0.34076171882155454,"score_spread":0.3136658600371308,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160708937","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021678943,0.99940753,0.000030501078,0.00006948336,0.00005028121,0.0000038674802,0.000008863294,0.000001732021,0.00021100952],"genre_scores_gemma":[0.004273949,0.99488044,0.00019938663,0.0002910197,0.00015124406,0.000009106868,0.000026195097,7.7573395e-7,0.00016788804],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99977535,0.000056042205,0.000044868026,0.000033063043,0.000067634166,0.000023206361],"domain_scores_gemma":[0.9996215,0.00022465798,0.00008841959,0.0000054593315,0.000043456763,0.000016428485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005110616,0.00056317484,0.0017590274,0.0015468422,0.00024683482,0.00074568356,0.00065894827,0.00074253336,0.0023336967],"category_scores_gemma":[0.0010520557,0.00024152969,0.0008379219,0.001244407,0.00029587586,0.00072081713,0.00047978974,0.0011356403,0.00030525753],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002789885,0.00014929206,0.0011265014,0.05743112,0.00057432556,0.0005697893,0.00009302885,0.00022345551,0.0008455781,0.0006172111,0.010875418,0.9272152],"study_design_scores_gemma":[0.0012744531,0.0016295593,0.040075287,0.1217643,0.0064820563,0.025024708,0.0010342967,0.0010200604,0.0016102488,0.0033133149,0.79655087,0.00022089363],"about_ca_topic_score_codex":0.001169727,"about_ca_topic_score_gemma":0.0032941347,"teacher_disagreement_score":0.0023336967,"about_ca_system_score_codex":0.00030328784,"about_ca_system_score_gemma":0.0005700543,"threshold_uncertainty_score":0.0078070164},"labels":[],"label_agreement":null},{"id":"W2162525192","doi":"10.1067/mjd.2003.453","title":"Effectiveness of dermasanding (manual dermabrasion) on the appearance of surgical scars: A prospective, randomized, blinded study","year":2003,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatologic Treatments and Research","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"","keywords":"Medicine; Scars; Dermabrasion; Surgery; Prospective cohort study; Randomized controlled trial; Confidence interval; Hypertrophic scars; Sandpaper; Acne scars; Internal medicine","score_opus":0.02791826226270421,"score_gpt":0.37441201139868646,"score_spread":0.34649374913598224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162525192","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99479526,0.0016739686,0.00054148625,0.00014380868,0.00032772822,0.0014369874,0.0003069742,0.00004163332,0.0007320316],"genre_scores_gemma":[0.99326974,0.0014559744,0.0012782991,0.0003620335,0.0008922383,0.0014147761,0.00026706822,0.000021108093,0.0010387425],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99508446,0.0029460327,0.00035305152,0.0007295476,0.00045996302,0.00042690278],"domain_scores_gemma":[0.99250937,0.003500878,0.0017792614,0.00090883666,0.00034160496,0.00096008676],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004678428,0.0024705152,0.0041375523,0.00090261817,0.00085958996,0.0016530408,0.0018097914,0.0038191315,0.0042243404],"category_scores_gemma":[0.005725668,0.0014912012,0.0025017408,0.00089674484,0.004105244,0.0016066356,0.00064910774,0.0033895853,0.000903035],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98210424,0.011471245,0.000461425,0.00019454192,0.00033658996,0.000017540211,0.000026768641,0.00007658283,0.001239266,0.000033635715,0.00007692488,0.0039612385],"study_design_scores_gemma":[0.78659046,0.20958924,0.0021797793,0.000022147013,0.0005001169,0.000021686961,0.000022430588,0.0002034107,0.00060972956,0.00009110365,0.00014833146,0.000021564807],"about_ca_topic_score_codex":0.0010089077,"about_ca_topic_score_gemma":0.0010816158,"teacher_disagreement_score":0.004678428,"about_ca_system_score_codex":0.00086415233,"about_ca_system_score_gemma":0.0011970561,"threshold_uncertainty_score":0.024742186},"labels":[],"label_agreement":null},{"id":"W2162668966","doi":"10.1016/j.jaad.2004.06.015","title":"Update on primary cicatricial alopecias","year":2005,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":288,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health Research Institute; University of British Columbia; Vancouver Coastal Health","funders":"","keywords":"Medicine; Dermatology; Primary (astronomy)","score_opus":0.034489683925305034,"score_gpt":0.37268255878256995,"score_spread":0.3381928748572649,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162668966","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00020233932,0.99649125,0.000097752665,0.00053992984,0.0013909761,0.0000066328057,0.00003378006,0.000010917558,0.0012264],"genre_scores_gemma":[0.0012076331,0.99275404,0.00039301976,0.0012821394,0.0025253084,0.000010101724,0.00011403165,0.0000030970332,0.0017106951],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99963677,0.00006611057,0.0000792251,0.000042134845,0.00014005383,0.000035731493],"domain_scores_gemma":[0.99905616,0.00039567333,0.00015870962,0.000022192215,0.00028840516,0.00007881506],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007342156,0.0008664891,0.0020077894,0.0034143198,0.000313185,0.001101513,0.0009945713,0.0012692714,0.0049908413],"category_scores_gemma":[0.0014654575,0.0002998452,0.00063209806,0.0026291558,0.0003578528,0.0015146595,0.0006054799,0.00146148,0.0017214344],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000095271535,0.00008131935,0.00048364128,0.015916081,0.0001336533,0.0010556726,0.00006490563,0.00019518644,0.00075279106,0.00066233485,0.17475581,0.80580336],"study_design_scores_gemma":[0.00004842478,0.00008038645,0.0019436759,0.0056262244,0.0003057302,0.005833628,0.00006828891,0.00008262004,0.00017322323,0.00038410845,0.98543614,0.000017550072],"about_ca_topic_score_codex":0.0017844696,"about_ca_topic_score_gemma":0.006945322,"teacher_disagreement_score":0.0049908413,"about_ca_system_score_codex":0.00065605796,"about_ca_system_score_gemma":0.0009997445,"threshold_uncertainty_score":0.016696036},"labels":[],"label_agreement":null},{"id":"W2163031644","doi":"10.1016/j.jaad.2008.04.027","title":"A new scalp formulation of calcipotriene plus betamethasone compared with its active ingredients and the vehicle in the treatment of scalp psoriasis: A randomized, double-blind, controlled trial","year":2008,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":100,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre de Recherche Dermatologique du Québec Métropolitain","funders":"","keywords":"Betamethasone dipropionate; Medicine; Scalp; Betamethasone; Dermatology; Psoriasis; Randomized controlled trial; Corticosteroid; Surgery; Internal medicine","score_opus":0.03481588415778829,"score_gpt":0.2963953368776418,"score_spread":0.2615794527198535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2163031644","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96767443,0.015093684,0.0016065656,0.00080060714,0.0022869313,0.008751902,0.0010245694,0.00024152012,0.0025198697],"genre_scores_gemma":[0.97015125,0.010429754,0.0031032623,0.00110431,0.0015822523,0.0071900263,0.0008315035,0.000051702027,0.0055558365],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9991856,0.00031121285,0.00006592332,0.00019141915,0.00009976619,0.0001460308],"domain_scores_gemma":[0.99908125,0.00038051818,0.00013571947,0.00007151007,0.000077242476,0.00025361057],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018304661,0.0021692023,0.007039069,0.0010182783,0.0007793995,0.0014517779,0.0016453376,0.003179396,0.008058873],"category_scores_gemma":[0.0019145154,0.0010726685,0.0024211544,0.00095014775,0.002128753,0.0017715194,0.00054241496,0.0042133424,0.0011018205],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9847254,0.0053409054,0.00008538991,0.00077815016,0.0004981287,0.000028764469,0.000028231852,0.00009144033,0.0014403182,0.00009479326,0.0002244714,0.006664014],"study_design_scores_gemma":[0.96411973,0.03475143,0.00022897565,0.000020450712,0.00029980365,0.000010899186,0.000013525219,0.00013772311,0.00017461814,0.000053262884,0.00018109061,0.000008462502],"about_ca_topic_score_codex":0.0019217508,"about_ca_topic_score_gemma":0.0025241266,"teacher_disagreement_score":0.008058873,"about_ca_system_score_codex":0.00070376485,"about_ca_system_score_gemma":0.0011994924,"threshold_uncertainty_score":0.026959598},"labels":[],"label_agreement":null},{"id":"W2164523424","doi":"10.1016/j.jaad.2005.07.029","title":"Multifocal lymphangioendotheliomatosis with thrombocytopenia","year":2006,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Vascular Malformations and Hemangiomas","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Gastrointestinal tract; Lymphatic system; Pathology; Immunohistochemistry; Vascular disease; Vascular malformation; Lymphatic Endothelium; Gastrointestinal bleeding; Lymphatic vessel; Rare disease; Disease; Cancer; Radiology; Gastroenterology; Metastasis; Surgery; Internal medicine","score_opus":0.009649798000336395,"score_gpt":0.2738748639980561,"score_spread":0.2642250659977197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2164523424","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96102417,0.00223071,0.0045410455,0.0015657443,0.00019756578,0.00019728713,0.0005533677,0.00042683998,0.02926327],"genre_scores_gemma":[0.9973068,0.00033139696,0.0007718618,0.00021249695,0.00022184192,0.00001984803,0.00006484364,0.000021318698,0.0010495998],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99955684,0.000049219867,0.000053107116,0.00009386823,0.00008906398,0.0001579422],"domain_scores_gemma":[0.9988218,0.0004101746,0.0002268094,0.00015586494,0.00007842465,0.00030689765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047334642,0.0014745811,0.00068267045,0.0021717355,0.0013662032,0.0006767572,0.00083280366,0.0015875523,0.0025350184],"category_scores_gemma":[0.0025786576,0.00066360907,0.00051099557,0.001352517,0.00096296694,0.0009398767,0.0009028453,0.0013218184,0.00068691507],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016847509,0.000047716076,0.0084269,0.00006498849,0.000023663582,0.98402333,0.00007851431,0.0002093681,0.002940625,0.00066168007,0.00038231426,0.0029724932],"study_design_scores_gemma":[0.000054899712,0.00012113634,0.017761948,0.0000121735375,0.000050581148,0.97811216,0.000043575325,0.0010100073,0.0014899635,0.00055798894,0.0007706874,0.000014870802],"about_ca_topic_score_codex":0.0018742478,"about_ca_topic_score_gemma":0.0027307994,"teacher_disagreement_score":0.0025350184,"about_ca_system_score_codex":0.0011382684,"about_ca_system_score_gemma":0.00047403167,"threshold_uncertainty_score":0.008480489},"labels":[],"label_agreement":null},{"id":"W2165319493","doi":"10.1016/j.jaad.2003.10.519","title":"Quality of life effect of oral tazarotene in patients with moderate to severe psoriasis as measured by the 12-item psoriasis quality of life questionnaire (PQOL-12)","year":2004,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Tazarotene; Medicine; Psoriasis; Placebo; Quality of life (healthcare); Plaque psoriasis; Dermatology; Internal medicine; Physical therapy; Pathology; Nursing","score_opus":0.0192783328908954,"score_gpt":0.2842970265607068,"score_spread":0.2650186936698114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165319493","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938804,0.004784296,0.00007095582,0.00019342001,0.000039474973,0.000020523965,0.00015093679,0.000009480428,0.0008505503],"genre_scores_gemma":[0.99857724,0.00081032247,0.00008337736,0.0001147792,0.00003107015,0.000012181632,0.00014331893,9.357728e-7,0.00022681485],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998381,0.00006137985,0.000021127917,0.000018989691,0.00002978707,0.000030603107],"domain_scores_gemma":[0.99958795,0.0001275983,0.00013004772,0.00001444028,0.000025466876,0.00011455685],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003841624,0.0002785279,0.0008228786,0.00014700726,0.00017122245,0.00027250877,0.00013237644,0.000316978,0.00087801984],"category_scores_gemma":[0.00093426043,0.0001222381,0.0008813088,0.00015784573,0.00011677973,0.00020103484,0.00012669088,0.00061219744,0.000087199376],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.26997098,0.008973765,0.4137946,0.0013943502,0.0076237335,0.00086788216,0.00047534643,0.0029126883,0.037611227,0.00027510244,0.0025630987,0.25353727],"study_design_scores_gemma":[0.011638652,0.039678562,0.9419113,0.00005432866,0.0020928285,0.00066100387,0.00015045151,0.0014101946,0.0010931526,0.00009913294,0.0011773295,0.00003318562],"about_ca_topic_score_codex":0.0012251659,"about_ca_topic_score_gemma":0.0022939523,"teacher_disagreement_score":0.0012251659,"about_ca_system_score_codex":0.00017720075,"about_ca_system_score_gemma":0.00017451754,"threshold_uncertainty_score":0.0029371977},"labels":[],"label_agreement":null},{"id":"W2166655041","doi":"10.1016/j.jaad.2004.12.038","title":"Tacrolimus ointment is more effective than pimecrolimus cream with a similar safety profile in the treatment of atopic dermatitis: Results from 3 randomized, comparative studies","year":2005,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":145,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Pimecrolimus; Tacrolimus; Medicine; Atopic dermatitis; Eczema Area and Severity Index; Dermatology; Incidence (geometry); Adverse effect; Calcineurin; Randomized controlled trial; Body surface area; Atopy; Protein synthesis inhibitor; Allergy; Surgery; Internal medicine; Antibacterial agent; Transplantation; Immunology","score_opus":0.02072795655469779,"score_gpt":0.3398657314214307,"score_spread":0.3191377748667329,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166655041","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9716733,0.02498843,0.00063256896,0.00033753068,0.0004308027,0.000588293,0.0002865523,0.00004294529,0.0010196035],"genre_scores_gemma":[0.988628,0.008106994,0.00080279534,0.00048186808,0.0009539156,0.00027371652,0.0003092508,0.000016332353,0.0004272512],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.996007,0.0023866761,0.0005306947,0.00038473602,0.000488714,0.00020216945],"domain_scores_gemma":[0.9937264,0.0035766503,0.0015554145,0.00045037793,0.00026921852,0.00042194992],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0046962146,0.0012208156,0.0040480006,0.0010397576,0.00053144305,0.0011944183,0.0012206748,0.0022578181,0.0030275788],"category_scores_gemma":[0.005001833,0.00063911924,0.0035496152,0.0011458299,0.0016754989,0.0017149183,0.00028833252,0.002230787,0.00039256853],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9444196,0.007517736,0.0012584744,0.0020150514,0.0059204367,0.00011134902,0.00007243104,0.00017150895,0.006083658,0.000099598576,0.00023682503,0.03209325],"study_design_scores_gemma":[0.7736363,0.20264147,0.011813779,0.00016626052,0.008150427,0.00019855199,0.000050841158,0.00031579135,0.002136358,0.00013900612,0.00070497795,0.000046264347],"about_ca_topic_score_codex":0.000759159,"about_ca_topic_score_gemma":0.0013505374,"teacher_disagreement_score":0.0046962146,"about_ca_system_score_codex":0.0007127645,"about_ca_system_score_gemma":0.0005971589,"threshold_uncertainty_score":0.024836302},"labels":[],"label_agreement":null},{"id":"W2168290076","doi":"10.1016/j.jaad.2010.05.042","title":"Analgesic and nonsteroidal anti-inflammatory use in relation to nonmelanoma skin cancer: A population-based case-control study","year":2011,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences","funders":"National Cancer Institute","keywords":"Medicine; Aspirin; Basal cell carcinoma; Acetaminophen; Analgesic; Skin cancer; Odds ratio; Confidence interval; Population; Case-control study; Internal medicine; Drug; Carcinoma; Cancer; Dermatology; Gastroenterology; Basal cell; Pharmacology","score_opus":0.017407516702756386,"score_gpt":0.2828206584622718,"score_spread":0.2654131417595154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168290076","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99885523,0.00029356134,0.00017297917,0.000024031828,0.000017998647,0.00003765793,0.00023628009,0.000005840464,0.00035634724],"genre_scores_gemma":[0.9988707,0.00017783744,0.00016447918,0.00004581775,0.00003132002,0.000037077076,0.00028502752,0.0000058328505,0.00038189202],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998315,0.00049525005,0.0001758817,0.0005624431,0.00024909637,0.00020237759],"domain_scores_gemma":[0.9979175,0.00058176287,0.00043283065,0.00038710414,0.000292348,0.00038848637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014441691,0.00084897137,0.0011710157,0.0016663348,0.0017250058,0.0015525905,0.000981618,0.0016058963,0.0033023783],"category_scores_gemma":[0.003022313,0.0017435439,0.0015258967,0.0023703305,0.0010641295,0.0011256079,0.0006774831,0.0015701132,0.00059428765],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031569395,0.0015637017,0.99004,0.000057120207,0.0008409273,0.0007111868,0.000438446,0.00006113335,0.0017694831,0.00007300081,0.00017017251,0.0011178496],"study_design_scores_gemma":[0.0003233493,0.0016341193,0.99532664,0.000009680208,0.0004856071,0.0009991997,0.00048778747,0.0003051339,0.00013754131,0.000043135653,0.00022833451,0.00001956534],"about_ca_topic_score_codex":0.011335221,"about_ca_topic_score_gemma":0.009998125,"teacher_disagreement_score":0.011335221,"about_ca_system_score_codex":0.0006913804,"about_ca_system_score_gemma":0.0005683903,"threshold_uncertainty_score":0.022538483},"labels":[],"label_agreement":null},{"id":"W2168765504","doi":"10.1016/j.jaad.2006.03.009","title":"In vivo confocal scanning laser microscopy of benign lentigines: Comparison to conventional histology and in vivo characteristics of lentigo maligna","year":2006,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":112,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Lentigo maligna; Medicine; Lentigo maligna melanoma; Lentigo; Pathology; Dermoepidermal junction; Dermatology; Pagetoid; Histopathology; Melanoma; Nevus; In vivo; Dermis; Biology; Immunohistochemistry","score_opus":0.011523675405889394,"score_gpt":0.2981146646126295,"score_spread":0.2865909892067401,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168765504","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935933,0.0005195317,0.003811455,0.000039308703,0.000008348954,0.000029656208,0.00007936633,0.00004757846,0.001871591],"genre_scores_gemma":[0.9951733,0.0003550381,0.0035079936,0.000018726874,0.000009020884,0.000019418603,0.000069407186,0.000019712648,0.00082745636],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998753,0.00003806639,0.000010446467,0.00001743488,0.000032179225,0.000026508813],"domain_scores_gemma":[0.99927753,0.00028716252,0.00007492353,0.00010954775,0.00018371952,0.00006718351],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043317248,0.00023274917,0.00013780712,0.00070873095,0.00028620963,0.0002618306,0.00022337078,0.00035843684,0.0014639944],"category_scores_gemma":[0.00057594577,0.00026972487,0.00010361325,0.00024723972,0.00033999197,0.00040620507,0.00020136614,0.0003148273,0.00024498565],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000739053,0.000082604456,0.0065621436,0.000083743,0.000012969608,0.0005891964,0.00018573953,0.00023351854,0.9873646,0.0002715409,0.000052760068,0.0038221602],"study_design_scores_gemma":[0.00008674514,0.0011102954,0.18759693,0.000029900311,0.00008637317,0.017324354,0.0007632789,0.0080536185,0.78200185,0.00034670436,0.0025626512,0.000037213526],"about_ca_topic_score_codex":0.0014806843,"about_ca_topic_score_gemma":0.0013162581,"teacher_disagreement_score":0.0014806843,"about_ca_system_score_codex":0.00029124174,"about_ca_system_score_gemma":0.00022623735,"threshold_uncertainty_score":0.0048974752},"labels":[],"label_agreement":null},{"id":"W2170580400","doi":"10.1016/j.jaad.2012.09.020","title":"Commentary: Botulinum A exotoxin in clinical dermatology","year":2013,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Botulinum Toxin and Related Neurological Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Dermatology; Exotoxin; Botulinum toxin; Surgery; Toxin; Microbiology","score_opus":0.024858470039121793,"score_gpt":0.33873414183968137,"score_spread":0.3138756718005596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2170580400","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018900425,0.00316426,0.000074990436,0.7441496,0.25024936,0.000023212438,0.00008291681,0.000027197966,0.0020393508],"genre_scores_gemma":[0.002029444,0.001660942,0.00012588192,0.6591702,0.3325867,0.000034546985,0.000042161704,0.000019424175,0.00433062],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99490815,0.0013520344,0.00076109986,0.0007273115,0.0017504237,0.00050097913],"domain_scores_gemma":[0.9722812,0.014838678,0.0016093137,0.00059671066,0.007383721,0.003290306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005306758,0.0017617013,0.0024092717,0.001844969,0.005019592,0.00421994,0.0044890987,0.07386242,0.008551455],"category_scores_gemma":[0.034534797,0.0014001136,0.0021054538,0.0015108142,0.0036992817,0.004959503,0.0023919812,0.05615921,0.0070656617],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041095587,0.000015087974,0.00009776855,0.00009885518,0.00001421399,0.00033295603,0.00004008676,0.000025917747,0.000066915876,0.0004433613,0.99621505,0.0026086222],"study_design_scores_gemma":[0.0002095917,0.00006296452,0.0010147272,0.0007385547,0.00009713762,0.0009613816,0.00024089853,0.00025959406,0.00019046341,0.0025467565,0.99361575,0.00006212203],"about_ca_topic_score_codex":0.007507617,"about_ca_topic_score_gemma":0.011386191,"teacher_disagreement_score":0.07386242,"about_ca_system_score_codex":0.005630946,"about_ca_system_score_gemma":0.006276754,"threshold_uncertainty_score":0.040855527},"labels":[],"label_agreement":null},{"id":"W2171309002","doi":"10.1016/j.jaad.2010.03.009","title":"Switching to adalimumab for psoriasis patients with a suboptimal response to etanercept, methotrexate, or phototherapy: Efficacy and safety results from an open-label study","year":2011,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":65,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Dalhousie University; Centre de Recherche Dermatologique du Québec Métropolitain","funders":"","keywords":"Medicine; Adalimumab; Etanercept; Psoriasis; Psoriasis Area and Severity Index; Methotrexate; Internal medicine; Dermatology; Clinical endpoint; Infliximab; Clinical trial; Tumor necrosis factor alpha","score_opus":0.05221773961470023,"score_gpt":0.33484986160342134,"score_spread":0.2826321219887211,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171309002","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99789244,0.0010005346,0.00016335702,0.00007232786,0.000066401975,0.00019678853,0.00015543385,0.000020638952,0.00043202925],"genre_scores_gemma":[0.99791116,0.00057904137,0.00033625096,0.00025056966,0.00016862947,0.00019216829,0.00025545666,0.0000082727465,0.0002983363],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9987639,0.0005178433,0.00010765955,0.00024844354,0.00016747661,0.00019462749],"domain_scores_gemma":[0.99756974,0.0010569511,0.00054649194,0.0002907752,0.00012783882,0.00040825314],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021433767,0.0011989629,0.0027890308,0.00044537336,0.00060093746,0.0010820368,0.0006892456,0.001409367,0.0023732143],"category_scores_gemma":[0.0022185144,0.00049637246,0.0023787515,0.0004664133,0.0011689996,0.0010953702,0.00023063422,0.0029672454,0.0004785344],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.86424935,0.030547746,0.01357901,0.00053710816,0.001971853,0.00015655442,0.0001980695,0.0005940739,0.009027089,0.00006842194,0.0005833451,0.07848737],"study_design_scores_gemma":[0.6045424,0.33355352,0.05290817,0.000078790115,0.00263226,0.00036112935,0.00012451145,0.0017298892,0.0027700593,0.0002478869,0.0009788356,0.00007264047],"about_ca_topic_score_codex":0.00069540605,"about_ca_topic_score_gemma":0.0009193456,"teacher_disagreement_score":0.0027890308,"about_ca_system_score_codex":0.0007676321,"about_ca_system_score_gemma":0.0005674241,"threshold_uncertainty_score":0.0113354325},"labels":[],"label_agreement":null},{"id":"W2172047838","doi":"10.1016/j.jaad.2003.10.116","title":"Tazarotene 0.1% cream versus tretinoin 0.05% emollient cream in the treatment of photodamaged facial skin: a multicenter, double-blind, randomized, parallel-group study","year":2004,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Skin Protection and Aging","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec","funders":"","keywords":"Medicine; Moisturizer; Tazarotene; Tolerability; Dermatology; Hyperpigmentation; Tretinoin; Evening; Randomized controlled trial; Multicenter study; Surgery; Internal medicine; Adverse effect; Psoriasis","score_opus":0.0373967434410873,"score_gpt":0.347069905351334,"score_spread":0.3096731619102467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2172047838","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99249166,0.0028028034,0.0006406336,0.00029716178,0.00059218524,0.0020323917,0.0003049198,0.00007964678,0.0007586708],"genre_scores_gemma":[0.9864557,0.0040937075,0.0019344524,0.000517769,0.0010500213,0.0030126264,0.00038392894,0.000037285627,0.0025144757],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9989417,0.0005252981,0.00009204717,0.00018538548,0.00009902228,0.00015652076],"domain_scores_gemma":[0.9987085,0.0004275455,0.00024229656,0.000145773,0.000099193094,0.00037676608],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019834945,0.0021887722,0.005547312,0.0008198696,0.00067812554,0.0011415939,0.0016233373,0.0020209758,0.0040724366],"category_scores_gemma":[0.0020540506,0.0010370095,0.0017580999,0.000834852,0.0019798675,0.0014092696,0.000405007,0.0027277493,0.0010145981],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97386056,0.0112434905,0.00017918424,0.00038090267,0.00034654207,0.00003205973,0.00003713228,0.00015611238,0.006232457,0.000059149803,0.00016923164,0.0073031415],"study_design_scores_gemma":[0.89551824,0.10216663,0.00073395687,0.000013214247,0.00037484398,0.000016977221,0.000017358556,0.00023692405,0.0006930806,0.000049357248,0.00016653481,0.000012844762],"about_ca_topic_score_codex":0.0012123256,"about_ca_topic_score_gemma":0.0018027056,"teacher_disagreement_score":0.005547312,"about_ca_system_score_codex":0.0006608939,"about_ca_system_score_gemma":0.0012737226,"threshold_uncertainty_score":0.013623655},"labels":[],"label_agreement":null},{"id":"W2173496161","doi":"10.1016/j.jaad.2015.07.048","title":"Local wound care and topical management of hidradenitis suppurativa","year":2015,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Hidradenitis suppurativa; Wound care; Dermatology; Keratolytic; Apocrine; Intensive care medicine; Topical agents; Acne; Clindamycin; Disease; Antibiotics; Pathology","score_opus":0.04086980657684747,"score_gpt":0.37790545377099605,"score_spread":0.3370356471941486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2173496161","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000080085134,0.9995647,0.000031939897,0.000046122237,0.000055149732,0.000003307132,0.000005914544,0.0000016605405,0.00021103265],"genre_scores_gemma":[0.0013399232,0.9980326,0.00016240425,0.00015349957,0.00012995151,0.0000054243583,0.00001893827,8.058614e-7,0.00015633597],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996884,0.00006160022,0.00007323284,0.000047925965,0.00010360256,0.000025228152],"domain_scores_gemma":[0.99942374,0.0003413834,0.00011590099,0.0000114598515,0.00008443581,0.000023015014],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006480477,0.0007414215,0.0018620499,0.0025266707,0.00030908713,0.0010141525,0.00085826335,0.0009605103,0.0031465068],"category_scores_gemma":[0.0012097844,0.00031631443,0.0010630692,0.001767861,0.0004476746,0.0010972562,0.00055164413,0.00159091,0.00067687646],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014478863,0.00014709201,0.00035897098,0.056570835,0.00031305497,0.00035773893,0.00006933889,0.00019941102,0.00073557365,0.0010270611,0.013103424,0.9269726],"study_design_scores_gemma":[0.0003012718,0.0006323301,0.0064608143,0.056469966,0.0027726204,0.010692054,0.0003970582,0.00041737768,0.0013433255,0.0024122992,0.91800565,0.00009522134],"about_ca_topic_score_codex":0.0013438291,"about_ca_topic_score_gemma":0.0028123173,"teacher_disagreement_score":0.0031465068,"about_ca_system_score_codex":0.0003699744,"about_ca_system_score_gemma":0.0007687291,"threshold_uncertainty_score":0.010526061},"labels":[],"label_agreement":null},{"id":"W2190836745","doi":"10.1016/j.jaad.2015.09.001","title":"Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with difficult-to-treat nail and scalp psoriasis: Results of 2 phase III randomized, controlled trials (ESTEEM 1 and ESTEEM 2)","year":2015,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":165,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"LEO Pharma; Janssen Pharmaceuticals; Les Laboratories Pierre Fabre; Celgene; Amgen; Pfizer; Kyowa Hakko Kirin; Eli Lilly and Company","keywords":"Apremilast; Medicine; Psoriasis; Placebo; Scalp; Nail (fastener); Randomized controlled trial; Randomization; Internal medicine; Dermatology; Psoriasis Area and Severity Index; Surgery; Psoriatic arthritis; Pathology","score_opus":0.02141852448562145,"score_gpt":0.29201591086730627,"score_spread":0.27059738638168485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2190836745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91697735,0.0717645,0.0012627154,0.0014559486,0.0005079926,0.004284888,0.0008160638,0.00012235431,0.0028082847],"genre_scores_gemma":[0.9658759,0.023524217,0.0028159742,0.001742129,0.0008121928,0.0027657277,0.0013133986,0.000020630841,0.0011298883],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9985158,0.0009671242,0.00013685143,0.00014264566,0.00015829616,0.00007929839],"domain_scores_gemma":[0.99797946,0.00078528817,0.0006271662,0.000103705555,0.00013907756,0.00036527388],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005968366,0.0009265826,0.0021277484,0.00035405118,0.0002740384,0.000817095,0.00061129016,0.0012738949,0.002769734],"category_scores_gemma":[0.0038230303,0.00038772536,0.0020226173,0.00048376882,0.00071134313,0.0006768394,0.00023129751,0.0016683064,0.000280922],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.85883445,0.012373974,0.0048005995,0.0040045627,0.005676083,0.000105014646,0.0001270464,0.00056407286,0.007467191,0.00016828554,0.0020251807,0.10385357],"study_design_scores_gemma":[0.9094689,0.0773579,0.009735714,0.00016218724,0.0013822664,0.00012685284,0.000025679594,0.00026675838,0.00044097408,0.00008358753,0.0009323868,0.000016742986],"about_ca_topic_score_codex":0.00038558766,"about_ca_topic_score_gemma":0.0012058503,"teacher_disagreement_score":0.005968366,"about_ca_system_score_codex":0.00037183412,"about_ca_system_score_gemma":0.00079065666,"threshold_uncertainty_score":0.031564116},"labels":[],"label_agreement":null},{"id":"W2197239904","doi":"10.1016/j.jaad.2015.10.007","title":"Failure to thrive, interstitial lung disease, and progressive digital necrosis with onset in infancy","year":2015,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Parvovirus B19 Infection Studies","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Institutes of Health","keywords":"Medicine; Failure to thrive; Interstitial lung disease; Disease; Erythema; Sting; Dermatology; Lung; Telangiectasia; Necrosis; Pathology; Internal medicine","score_opus":0.0166763448846829,"score_gpt":0.32691639931690164,"score_spread":0.31024005443221875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2197239904","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99638784,0.00074549206,0.0001255908,0.00009750436,0.000010880007,0.00001719302,0.00007755791,0.000008524079,0.0025293846],"genre_scores_gemma":[0.99911135,0.0004384642,0.00009951106,0.000043554544,0.000017701208,0.000009659915,0.000057386824,0.0000015854334,0.00022085138],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.99945337,0.000149468,0.00007529619,0.000064464526,0.000117913376,0.00013941068],"domain_scores_gemma":[0.9990984,0.00032972617,0.00014714237,0.000046267294,0.00011953809,0.0002589776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000754457,0.00056101015,0.00044199466,0.0015777098,0.000585824,0.00036064212,0.00033005927,0.00064821076,0.00092524907],"category_scores_gemma":[0.002870457,0.00029476118,0.0003037022,0.00059009955,0.00073892483,0.00046277005,0.00045323974,0.00058096903,0.00011687921],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005536924,0.00037583362,0.8225416,0.00014406757,0.000053654825,0.15162493,0.002230108,0.00016093555,0.010926786,0.0005006649,0.00055468647,0.0103330165],"study_design_scores_gemma":[0.00002218071,0.0014290111,0.85665977,0.00005591012,0.00007574702,0.13690822,0.0014154869,0.00014622316,0.0020836582,0.00017551132,0.0010139799,0.000014214457],"about_ca_topic_score_codex":0.003576341,"about_ca_topic_score_gemma":0.0036982922,"teacher_disagreement_score":0.003576341,"about_ca_system_score_codex":0.00030478236,"about_ca_system_score_gemma":0.00046754992,"threshold_uncertainty_score":0.0071110725},"labels":[],"label_agreement":null},{"id":"W2204505485","doi":"10.1016/j.jaad.2015.08.030","title":"Effectiveness of sequential use of biologics in the treatment of moderate to severe psoriasis in real world Canadian academic clinical practice: A cohort study","year":2015,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa; Public Health Ontario; McMaster University; University of Toronto","funders":"","keywords":"Medicine; Ustekinumab; Psoriasis; Adalimumab; Infliximab; Etanercept; Psoriasis Area and Severity Index; Dermatology; Internal medicine; Clinical trial; Disease; Tumor necrosis factor alpha","score_opus":0.07845842287127083,"score_gpt":0.377885283379961,"score_spread":0.29942686050869016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2204505485","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943785,0.0014219871,0.000056060504,0.0012730343,0.00004027595,0.00004941871,0.0012590461,0.0000062019985,0.0015154574],"genre_scores_gemma":[0.9981975,0.0004897193,0.0001112036,0.000424107,0.000039110328,0.000013800242,0.00046893294,0.0000032667351,0.00025235646],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963354,0.00063759217,0.0002731535,0.0005858513,0.0011237703,0.0010441369],"domain_scores_gemma":[0.99085367,0.0013977132,0.0026973032,0.0006292379,0.002340882,0.002081181],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021792245,0.0003669413,0.0007676266,0.000762925,0.0016893856,0.0017072188,0.0014827867,0.0014674488,0.002347287],"category_scores_gemma":[0.012824032,0.00038047184,0.001136451,0.00293031,0.0009338849,0.0007401962,0.00063152413,0.0016385021,0.0002280583],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010249756,0.00023846685,0.9922386,0.000042446878,0.00028440647,0.00013610581,0.0003452887,0.000054057382,0.0001267672,0.00007491551,0.0008896535,0.004544406],"study_design_scores_gemma":[0.00017249135,0.0005150433,0.99696016,0.00003584985,0.00024599078,0.00026774008,0.00071436015,0.00030505285,0.0000387419,0.000045817073,0.0006739136,0.000024961842],"about_ca_topic_score_codex":0.7688829,"about_ca_topic_score_gemma":0.76069754,"teacher_disagreement_score":0.23111713,"about_ca_system_score_codex":0.012468684,"about_ca_system_score_gemma":0.015111995,"threshold_uncertainty_score":0.4649564},"labels":[],"label_agreement":null},{"id":"W2204965580","doi":"10.1016/j.jaad.2015.08.061","title":"Hidradenitis suppurativa: Demystifying a chronic and debilitating disease","year":2015,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"","keywords":"Hidradenitis suppurativa; Medicine; Notice; Dermatology; Disease; Pathology","score_opus":0.03757615948370657,"score_gpt":0.34472461687022654,"score_spread":0.30714845738651997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2204965580","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6308004,0.2288351,0.0050559603,0.020098425,0.003164171,0.00018452884,0.00048128408,0.00026760032,0.11111251],"genre_scores_gemma":[0.95564634,0.02691083,0.0019481772,0.0025539468,0.0061603817,0.000020245687,0.00013734662,0.00001922029,0.006603461],"study_design_codex":"case_report","study_design_gemma":"not_applicable","domain_scores_codex":[0.99970645,0.000056133762,0.00005776637,0.0000361462,0.000062836145,0.000080647966],"domain_scores_gemma":[0.99938405,0.00016520654,0.00019166396,0.00003932357,0.00005108327,0.00016859223],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004205636,0.0006176276,0.0005310729,0.0009784647,0.0008628133,0.0010506394,0.0003059962,0.0012230678,0.0027372155],"category_scores_gemma":[0.0013492036,0.00021863071,0.00029867602,0.0007288741,0.00092211994,0.00117972,0.0005660491,0.0011250821,0.00056196033],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005112745,0.00027106883,0.10208897,0.0010551256,0.000054464173,0.7762152,0.00069672597,0.00019221367,0.014650685,0.007961495,0.0090954,0.0872074],"study_design_scores_gemma":[0.00005489152,0.00022891085,0.061124478,0.0002122155,0.000069123875,0.90594095,0.00074063847,0.00039256128,0.0014710544,0.0016677039,0.02807131,0.000026183021],"about_ca_topic_score_codex":0.000811473,"about_ca_topic_score_gemma":0.0019214455,"teacher_disagreement_score":0.0027372155,"about_ca_system_score_codex":0.00038582683,"about_ca_system_score_gemma":0.00051099726,"threshold_uncertainty_score":0.009156942},"labels":[],"label_agreement":null},{"id":"W2218606109","doi":"10.1016/j.jaad.2015.02.001","title":"Skin cancer early detection information in popular US magazines (2000-2012)","year":2015,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Skin Protection and Aging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"Social Sciences and Humanities Research Council of Canada; Canadian Institutes of Health Research","keywords":"Medicine; Skin cancer; Cancer; Dermatology; Internal medicine","score_opus":0.016885783258999185,"score_gpt":0.2987200640977266,"score_spread":0.2818342808387274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2218606109","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01581237,0.0018030647,0.000107860906,0.9191155,0.0153405825,0.00007260808,0.0008613116,0.00008542783,0.04680129],"genre_scores_gemma":[0.09955555,0.004167404,0.00043888693,0.6972284,0.046945173,0.00013383507,0.0006583247,0.00005632929,0.15081613],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99915564,0.00015285611,0.000095289,0.00009449029,0.00030019906,0.00020157122],"domain_scores_gemma":[0.9971584,0.0010938505,0.0005342855,0.000050339575,0.0006139715,0.0005491342],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001028348,0.00043244511,0.00034503883,0.0009382527,0.0025018349,0.0021008432,0.00049432326,0.011884135,0.011981909],"category_scores_gemma":[0.00746995,0.00033010522,0.00045085762,0.00051190914,0.0005512105,0.0014142953,0.00081891427,0.0040750504,0.0040223654],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000112046444,0.00019129743,0.008935947,0.00007066727,0.000008963104,0.0032023676,0.00041353615,0.000040681276,0.00040614355,0.0010180724,0.9646122,0.020988239],"study_design_scores_gemma":[0.00016890802,0.0003640827,0.044589635,0.0010254119,0.00006842286,0.0052182493,0.0018560527,0.001074392,0.00095778547,0.0014142859,0.94320863,0.000054064403],"about_ca_topic_score_codex":0.013095302,"about_ca_topic_score_gemma":0.030778883,"teacher_disagreement_score":0.013095302,"about_ca_system_score_codex":0.003136028,"about_ca_system_score_gemma":0.002040241,"threshold_uncertainty_score":0.040083468},"labels":[],"label_agreement":null},{"id":"W2238151847","doi":"10.1016/j.jaad.2015.09.056","title":"Long-term safety and efficacy of etanercept in children and adolescents with plaque psoriasis","year":2016,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":107,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Novartis Pharmaceuticals Corporation; Pfizer; Amgen; Abbott Laboratories","keywords":"Medicine; Etanercept; Psoriasis; Psoriasis Area and Severity Index; Adverse effect; Internal medicine; Severity of illness; Dermatology","score_opus":0.007268308609013646,"score_gpt":0.2422221157195497,"score_spread":0.23495380711053607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2238151847","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969451,0.0024020474,0.00007360031,0.000056689045,0.000009610717,0.0000222999,0.00009853442,0.0000047899784,0.00038726226],"genre_scores_gemma":[0.9982521,0.0010427083,0.00021357564,0.0000971537,0.000016969365,0.000043764674,0.00016229565,0.0000017590567,0.00016957356],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995295,0.0001805583,0.000053375476,0.00005387471,0.00012381231,0.000058934107],"domain_scores_gemma":[0.99859506,0.00037940973,0.00057872693,0.000051661464,0.00016402673,0.00023098345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012176174,0.00017430584,0.00052976416,0.00013294606,0.00018534677,0.00031901468,0.00014676467,0.00027562527,0.0006600677],"category_scores_gemma":[0.0016752253,0.000109709894,0.0004044759,0.0001513646,0.00016639697,0.0003271611,0.00013264672,0.00078408036,0.00019095988],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025108881,0.0048438828,0.77693725,0.00081967714,0.000655256,0.0014596393,0.0006421114,0.0009781978,0.017073601,0.00013621502,0.0017965259,0.16954872],"study_design_scores_gemma":[0.0049506323,0.06117487,0.9172439,0.0003506164,0.0007604751,0.004306887,0.0004500034,0.00092435634,0.0049370844,0.00008981362,0.0047930735,0.00001844295],"about_ca_topic_score_codex":0.00057924195,"about_ca_topic_score_gemma":0.0010275327,"teacher_disagreement_score":0.0012176174,"about_ca_system_score_codex":0.00027998025,"about_ca_system_score_gemma":0.0004372608,"threshold_uncertainty_score":0.0064394474},"labels":[],"label_agreement":null},{"id":"W2241925357","doi":"10.1016/j.jaad.2015.08.067","title":"Use of Eczema Action Plans (EAPs) to improve parental understanding of treatment regimens in pediatric atopic dermatitis (AD): A randomized controlled trial","year":2016,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Atopic dermatitis; Randomized controlled trial; Dermatology; Action (physics); Atopy; Allergy; Immunology; Surgery","score_opus":0.03985050087718512,"score_gpt":0.317958121695191,"score_spread":0.2781076208180059,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2241925357","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.933273,0.043532472,0.0013603206,0.0067943195,0.004275341,0.004418337,0.001363703,0.00017498365,0.0048073954],"genre_scores_gemma":[0.9756855,0.01168681,0.0021854586,0.0035629878,0.001284769,0.0031668115,0.00043728077,0.000016195258,0.0019742448],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99872535,0.00070527336,0.00014688389,0.00019571178,0.000098211116,0.00012855047],"domain_scores_gemma":[0.99777657,0.0011795688,0.00045749042,0.00010530029,0.000098635224,0.00038248897],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020265954,0.0010544654,0.002896814,0.00035565282,0.0005285172,0.0010844355,0.0010772444,0.0030668743,0.0077418867],"category_scores_gemma":[0.004722404,0.0006664552,0.0032649375,0.00044944565,0.0011146697,0.0012357597,0.00050157594,0.0052103684,0.00061202387],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9615352,0.0071758633,0.001108411,0.0026298014,0.0038993435,0.00006932708,0.00007790001,0.00020001808,0.00038518,0.00023591412,0.0013391953,0.021343866],"study_design_scores_gemma":[0.97299916,0.021713633,0.0013754789,0.0002504366,0.0025712124,0.00002176496,0.000042144136,0.00024567728,0.000092203074,0.00016366866,0.0005130333,0.000011608763],"about_ca_topic_score_codex":0.002097065,"about_ca_topic_score_gemma":0.0031804722,"teacher_disagreement_score":0.0077418867,"about_ca_system_score_codex":0.00090644654,"about_ca_system_score_gemma":0.0010097658,"threshold_uncertainty_score":0.025899231},"labels":[],"label_agreement":null},{"id":"W2257545295","doi":"10.1016/j.jaad.2015.12.017","title":"Comparative effectiveness of biologic agents for the treatment of psoriasis in a real-world setting: Results from a large, prospective, observational study (Psoriasis Longitudinal Assessment and Registry [PSOLAR])","year":2016,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":86,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Innovaderm (Canada); Probity Medical Research","funders":"Medac; Janssen Scientific Affairs; Eli Lilly and Company; Galderma; Incyte; Dermira; University of Connecticut; Celgene; Amgen; Pfizer; GlaxoSmithKline; Abbott Laboratories","keywords":"Ustekinumab; Medicine; Adalimumab; Etanercept; Infliximab; Psoriasis; Internal medicine; Observational study; Psoriasis Area and Severity Index; Body surface area; Odds ratio; Dermatology; Tumor necrosis factor alpha","score_opus":0.09110685648330386,"score_gpt":0.3823672007373807,"score_spread":0.2912603442540768,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2257545295","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968556,0.0018174432,0.0002591682,0.000057981375,0.000018965791,0.000053817206,0.0006547926,0.0000062447475,0.00027589104],"genre_scores_gemma":[0.9981483,0.00037157937,0.00025620178,0.00006084984,0.00003381749,0.00005062369,0.0010298421,0.0000033948959,0.000045449684],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9814849,0.013020963,0.0015461942,0.0016776018,0.0018169396,0.00045348],"domain_scores_gemma":[0.96732885,0.010714319,0.017133258,0.0023327968,0.0010708704,0.001419875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01372401,0.00042104736,0.0007000516,0.0009585991,0.00040102028,0.0010287395,0.0006757784,0.00068305794,0.0010235821],"category_scores_gemma":[0.018218301,0.00028833305,0.0011467361,0.0010757918,0.00058893114,0.00095876714,0.0005995242,0.00085742376,0.0002093289],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006945836,0.0007337675,0.98477465,0.00011406448,0.0024427446,0.000032179258,0.0001154849,0.00014515889,0.00024343019,0.000050015624,0.00022038903,0.0041823466],"study_design_scores_gemma":[0.0014901201,0.0059425705,0.98942274,0.000036258334,0.0009435794,0.0003157808,0.00019390693,0.0006187997,0.00034543776,0.000056397643,0.0006083445,0.000026008449],"about_ca_topic_score_codex":0.0012046088,"about_ca_topic_score_gemma":0.0012764557,"teacher_disagreement_score":0.01372401,"about_ca_system_score_codex":0.00052029977,"about_ca_system_score_gemma":0.0004950051,"threshold_uncertainty_score":0.0725804},"labels":[],"label_agreement":null},{"id":"W2276335262","doi":"10.1016/j.jaad.2015.10.043","title":"Patient burden of moderate to severe atopic dermatitis (AD): Insights from a phase 2b clinical trial of dupilumab in adults","year":2016,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":305,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Galderma; Astellas Pharma; Regeneron Pharmaceuticals; Genentech; Celgene; Valeant Pharmaceuticals International; Sanofi; Chugai Pharmaceutical; Pfizer; Amgen","keywords":"Medicine; Dupilumab; Atopic dermatitis; Quality of life (healthcare); Dermatology Life Quality Index; Anxiety; Eczema Area and Severity Index; Depression (economics); Severity of illness; Clinical trial; Generalizability theory; SCORAD; Disease; Internal medicine; Dermatology; Psychiatry","score_opus":0.02186583079233416,"score_gpt":0.3439859349347897,"score_spread":0.3221201041424555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2276335262","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911423,0.0056155664,0.000112361246,0.0008365326,0.00004430303,0.000088220775,0.0006059131,0.000011107545,0.0015437911],"genre_scores_gemma":[0.99685377,0.0015704335,0.00022297702,0.0005691539,0.00011186931,0.00004910479,0.0004101691,0.0000029697749,0.00020968218],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9993999,0.0003528306,0.00003740386,0.0000651064,0.00006518995,0.00007958553],"domain_scores_gemma":[0.99927765,0.0002953516,0.00019027333,0.000028540962,0.000042643034,0.00016556746],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015402671,0.00034714636,0.0007414497,0.00010318504,0.00022909328,0.0005201019,0.0002141216,0.0003474655,0.0014160859],"category_scores_gemma":[0.001513823,0.00013516253,0.00060458464,0.00022327944,0.0002019058,0.00038677012,0.00022487216,0.0008937351,0.00013649891],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2972898,0.011480093,0.30899352,0.0016559862,0.004575068,0.0008464216,0.00053864846,0.002247665,0.016917119,0.00073124334,0.014468025,0.34025654],"study_design_scores_gemma":[0.1050296,0.12431272,0.7403725,0.00029744554,0.00636243,0.0025996726,0.0005391959,0.0026393516,0.0022637013,0.0009077614,0.014594255,0.0000813745],"about_ca_topic_score_codex":0.0008830291,"about_ca_topic_score_gemma":0.0029808017,"teacher_disagreement_score":0.0015402671,"about_ca_system_score_codex":0.00031930007,"about_ca_system_score_gemma":0.00046574775,"threshold_uncertainty_score":0.008145869},"labels":[],"label_agreement":null},{"id":"W2280552181","doi":"10.1016/j.jaad.2015.08.008","title":"Treatment of toxic epidermal necrolysis in North America","year":2015,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Health Sciences Centre; University of Toronto; SickKids Foundation; Sunnybrook Health Science Centre","funders":"","keywords":"Toxic epidermal necrolysis; Medicine; Scopus; Dermatology; MEDLINE","score_opus":0.03326145937892156,"score_gpt":0.3217150146076165,"score_spread":0.2884535552286949,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2280552181","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02513623,0.03344205,0.0004702481,0.87504953,0.01560337,0.000051399813,0.000052175397,0.00008134815,0.050113685],"genre_scores_gemma":[0.24999158,0.026764575,0.0014463536,0.6408752,0.057843935,0.00008293176,0.000097219825,0.000032236163,0.022866016],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9992823,0.0002464138,0.000111298024,0.000060183524,0.00017987489,0.000120014294],"domain_scores_gemma":[0.998607,0.00043135165,0.00028134367,0.00004359117,0.00022110355,0.00041576943],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007981555,0.00027821818,0.0004482656,0.00048592594,0.002158765,0.0011399932,0.00052112044,0.009127906,0.0027758598],"category_scores_gemma":[0.0026379996,0.00022122501,0.0005331643,0.00043998615,0.00081575295,0.0007818912,0.00072005123,0.005268674,0.0006588688],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034558645,0.0006331913,0.033712395,0.0006413322,0.00012227806,0.14054573,0.00079033885,0.00055083353,0.0033617232,0.0070435484,0.726925,0.085328035],"study_design_scores_gemma":[0.0004953566,0.0005874483,0.0384799,0.0016794889,0.00013962958,0.14175847,0.0010911183,0.0012662241,0.00094905024,0.005493462,0.80800015,0.000059802354],"about_ca_topic_score_codex":0.004330733,"about_ca_topic_score_gemma":0.017693734,"teacher_disagreement_score":0.009127906,"about_ca_system_score_codex":0.0027384001,"about_ca_system_score_gemma":0.0021024963,"threshold_uncertainty_score":0.019868612},"labels":[],"label_agreement":null},{"id":"W2283622962","doi":"10.1016/j.jaad.2016.01.013","title":"Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: Long-term efficacy and safety results from 2 randomized phase-III studies and 1 open-label long-term extension study","year":2016,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":155,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Probity Medical Research","funders":"","keywords":"Tofacitinib; Medicine; Janus kinase inhibitor; Plaque psoriasis; Open label; Term (time); Psoriasis; Dermatology; Randomized controlled trial; Internal medicine","score_opus":0.058195940204066335,"score_gpt":0.36216570395143804,"score_spread":0.3039697637473717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2283622962","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97443604,0.015758803,0.0016090672,0.00068083673,0.00025497263,0.003946727,0.0022599471,0.00008991267,0.00096363405],"genre_scores_gemma":[0.9769158,0.008040814,0.0029848167,0.0012372411,0.0008289726,0.0047411835,0.0039737113,0.000045040375,0.0012323046],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9954164,0.002883669,0.00042742843,0.0004808091,0.0004847763,0.0003069878],"domain_scores_gemma":[0.9925021,0.002300248,0.0025628386,0.0006996876,0.00059208024,0.0013431208],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013747984,0.0017858759,0.0028283643,0.0006740713,0.00062406686,0.0013884063,0.0010433408,0.002082498,0.0029794772],"category_scores_gemma":[0.0073432885,0.0008816532,0.004107873,0.00082283514,0.0013883633,0.0014134578,0.00063430436,0.0029946265,0.0004882351],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.93580455,0.011674686,0.0052237506,0.0009807857,0.0044102073,0.000086028995,0.00012902786,0.0003764712,0.006574942,0.00007535307,0.0009309952,0.03373324],"study_design_scores_gemma":[0.90458006,0.07553663,0.0145416735,0.000091837115,0.0027270436,0.00013923309,0.000028231103,0.00028366948,0.00094188476,0.00012438378,0.00096899335,0.000036319354],"about_ca_topic_score_codex":0.00058832637,"about_ca_topic_score_gemma":0.0014488071,"teacher_disagreement_score":0.013747984,"about_ca_system_score_codex":0.0009851622,"about_ca_system_score_gemma":0.0017232373,"threshold_uncertainty_score":0.072707176},"labels":[],"label_agreement":null},{"id":"W2288240298","doi":"10.1016/j.jaad.2004.10.629","title":"Harlequin ichthyosis: A case report and review of the literature","year":2005,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Skin and Cellular Biology Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Ichthyosis; Dermatology; Congenital ichthyosis; MEDLINE","score_opus":0.010547707243378904,"score_gpt":0.3144824311822334,"score_spread":0.3039347239388545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2288240298","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.61299396,0.27909544,0.010885894,0.011219359,0.0059210844,0.0005181099,0.0011168031,0.0009151674,0.07733417],"genre_scores_gemma":[0.9106405,0.06825788,0.0034550563,0.003026676,0.006908768,0.00011394343,0.0004814127,0.00008108421,0.007034713],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99929416,0.00009008294,0.00013105616,0.00016824542,0.000105564795,0.00021086389],"domain_scores_gemma":[0.9987318,0.00048046696,0.00027961543,0.00014662382,0.00011771986,0.000243678],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045602935,0.002687598,0.0020220128,0.004375281,0.0016958282,0.0022308412,0.0027091766,0.0064179907,0.006143892],"category_scores_gemma":[0.0021232914,0.0010278402,0.0011763049,0.0032590525,0.0021503097,0.0038629689,0.0013407436,0.0020791178,0.00325276],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023738608,0.000045170484,0.0012892163,0.00014155808,0.000018096498,0.99282396,0.000073188785,0.00005945277,0.0004548243,0.000113338625,0.0008231787,0.004134299],"study_design_scores_gemma":[0.0000129027785,0.00003113001,0.0014937305,0.000039580784,0.000026208572,0.99547297,0.00016209652,0.00009921915,0.00019149958,0.00019086344,0.0022639758,0.000015688871],"about_ca_topic_score_codex":0.0012684417,"about_ca_topic_score_gemma":0.0014902118,"teacher_disagreement_score":0.0064179907,"about_ca_system_score_codex":0.0010583905,"about_ca_system_score_gemma":0.0006221226,"threshold_uncertainty_score":0.02055341},"labels":[],"label_agreement":null},{"id":"W2293245600","doi":"10.1016/j.jaad.2014.10.048","title":"What's new: Management of venous leg ulcers","year":2016,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Diagnosis and Treatment of Venous Diseases","field":"Medicine","cited_by":120,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Toronto Public Health; Public Health Ontario; University of Toronto","funders":"","keywords":"Medicine; Venous leg ulcer; Ankle; Intensive care medicine; Population; Leg ulcer; Varicose Ulcer; Surgery","score_opus":0.040376718620148334,"score_gpt":0.3834692535575944,"score_spread":0.34309253493744607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2293245600","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005209349,0.998623,0.00006910619,0.00049347687,0.00042905897,0.000002552272,0.000007258407,0.000003327568,0.00032016114],"genre_scores_gemma":[0.00070244365,0.9969568,0.00020417164,0.00084474473,0.0010802925,0.0000030796907,0.000015540181,0.0000010427141,0.00019181267],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994667,0.000105090985,0.00011070768,0.00009196609,0.00018554306,0.00003999134],"domain_scores_gemma":[0.99893934,0.000538081,0.00020950037,0.000022164197,0.00021592667,0.000075038464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00090965856,0.00078165834,0.0018566853,0.002301623,0.00033303676,0.002003093,0.0011590581,0.0016326031,0.0031464698],"category_scores_gemma":[0.0023569658,0.00033217174,0.0010871994,0.0018228767,0.00072464376,0.0027092977,0.00068540155,0.002800461,0.0010508547],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000067963614,0.00007615158,0.00042664196,0.023058143,0.00018076367,0.00029190825,0.000055425815,0.00021626637,0.00046390673,0.0013060207,0.031101918,0.9427549],"study_design_scores_gemma":[0.00010516094,0.0002680489,0.003915128,0.036050443,0.00079077756,0.007837296,0.0003122229,0.0003703876,0.0002899284,0.0031376418,0.9468491,0.000073893854],"about_ca_topic_score_codex":0.0013847912,"about_ca_topic_score_gemma":0.0034782093,"teacher_disagreement_score":0.0031464698,"about_ca_system_score_codex":0.000523721,"about_ca_system_score_gemma":0.0011016462,"threshold_uncertainty_score":0.010526001},"labels":[],"label_agreement":null},{"id":"W2295144446","doi":"10.1016/j.jaad.2015.09.068","title":"Yellow plaques in a patient with liver cirrhosis","year":2016,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Jaundice; Erythrocyte sedimentation rate; Cirrhosis; Gastroenterology; Pathology","score_opus":0.02950609613394457,"score_gpt":0.25709917737434707,"score_spread":0.2275930812404025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2295144446","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98391587,0.0014011028,0.0006373807,0.0023483597,0.00023723213,0.00007211481,0.00011900681,0.00007970165,0.011189191],"genre_scores_gemma":[0.99787474,0.000505833,0.000204866,0.00031584172,0.0003266729,0.0000063605735,0.000041897514,0.000008601178,0.00071529846],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9996902,0.000046246823,0.000033073276,0.000050779992,0.000048654878,0.00013104534],"domain_scores_gemma":[0.9988721,0.00032894677,0.00018310512,0.00007927654,0.00006130909,0.00047518229],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039333085,0.0013194914,0.00083352375,0.0027215313,0.0023062923,0.0009984947,0.0006301981,0.002970873,0.0029799545],"category_scores_gemma":[0.0026232344,0.0008381096,0.0010705309,0.0013607194,0.0009868836,0.0011654943,0.0010965321,0.0021007874,0.0007266991],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017207305,0.000084599764,0.037141394,0.00002036367,0.000012558454,0.96068937,0.00014816955,0.00008008026,0.0005152724,0.000103165046,0.00016589298,0.000867057],"study_design_scores_gemma":[0.000048337646,0.0003137441,0.05104451,0.000023711607,0.000043952616,0.9466238,0.00031781002,0.00052001973,0.00035662603,0.00027929898,0.0004079129,0.000020285133],"about_ca_topic_score_codex":0.0025927299,"about_ca_topic_score_gemma":0.001779395,"teacher_disagreement_score":0.0029799545,"about_ca_system_score_codex":0.0008858614,"about_ca_system_score_gemma":0.00062651775,"threshold_uncertainty_score":0.009968996},"labels":[],"label_agreement":null},{"id":"W2297405367","doi":"10.1016/j.jaad.2015.03.059","title":"What's new: Management of venous leg ulcers","year":2016,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Diagnosis and Treatment of Venous Diseases","field":"Medicine","cited_by":114,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Toronto Public Health; Public Health Ontario; University of Toronto","funders":"","keywords":"Medicine; Wound care; Venous leg ulcer; Compression stockings; Varicose Ulcer; Compression therapy; Multidisciplinary team; Surgery; Incidence (geometry); Intensive care medicine; Physical therapy; Nursing","score_opus":0.040376718620148334,"score_gpt":0.3834692535575944,"score_spread":0.34309253493744607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2297405367","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005209349,0.998623,0.00006910619,0.00049347687,0.00042905897,0.000002552272,0.000007258407,0.000003327568,0.00032016114],"genre_scores_gemma":[0.00070244365,0.9969568,0.00020417164,0.00084474473,0.0010802925,0.0000030796907,0.000015540181,0.0000010427141,0.00019181267],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9994667,0.000105090985,0.00011070768,0.00009196609,0.00018554306,0.00003999134],"domain_scores_gemma":[0.99893934,0.000538081,0.00020950037,0.000022164197,0.00021592667,0.000075038464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00090965856,0.00078165834,0.0018566853,0.002301623,0.00033303676,0.002003093,0.0011590581,0.0016326031,0.0031464698],"category_scores_gemma":[0.0023569658,0.00033217174,0.0010871994,0.0018228767,0.00072464376,0.0027092977,0.00068540155,0.002800461,0.0010508547],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000067963614,0.00007615158,0.00042664196,0.023058143,0.00018076367,0.00029190825,0.000055425815,0.00021626637,0.00046390673,0.0013060207,0.031101918,0.9427549],"study_design_scores_gemma":[0.00010516094,0.0002680489,0.003915128,0.036050443,0.00079077756,0.007837296,0.0003122229,0.0003703876,0.0002899284,0.0031376418,0.9468491,0.000073893854],"about_ca_topic_score_codex":0.0013847912,"about_ca_topic_score_gemma":0.0034782093,"teacher_disagreement_score":0.0031464698,"about_ca_system_score_codex":0.000523721,"about_ca_system_score_gemma":0.0011016462,"threshold_uncertainty_score":0.010526001},"labels":[],"label_agreement":null},{"id":"W2303282363","doi":"10.1016/j.jaad.2016.01.008","title":"The role of biofilms in onychomycosis","year":2016,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":99,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada); University of Toronto","funders":"","keywords":"Biofilm; Microbiology; Dermatophyte; Extracellular matrix; Antifungal; Medicine; Biology; Bacteria; Cell biology; Genetics","score_opus":0.02023062248523265,"score_gpt":0.3661058770526542,"score_spread":0.3458752545674215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2303282363","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006530974,0.99946266,0.000031978238,0.0001279548,0.00009947953,0.000001471351,0.0000047383996,0.0000011652716,0.0002052646],"genre_scores_gemma":[0.00057115906,0.99895334,0.000082873645,0.000098582655,0.00015330382,0.0000014703754,0.0000075522566,3.0365783e-7,0.00013145801],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996673,0.000057482746,0.00006806522,0.000045457724,0.00013558738,0.00002611573],"domain_scores_gemma":[0.9993861,0.000301309,0.00013906999,0.00001185381,0.00012312506,0.00003869369],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006877814,0.0007797758,0.0013242926,0.0026212016,0.00033789373,0.0013970189,0.00074851396,0.001401838,0.0023193394],"category_scores_gemma":[0.0011149128,0.00032808437,0.0006897299,0.0021114985,0.0005225908,0.0014903189,0.0010179684,0.0016616486,0.000605608],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007473405,0.0000810444,0.0004377189,0.025666874,0.00015446023,0.00035291447,0.00007227146,0.00019981033,0.0009831155,0.0018637538,0.015716607,0.9543967],"study_design_scores_gemma":[0.000052813866,0.00020382143,0.003182198,0.017895067,0.00060958805,0.00482303,0.00025459751,0.00025215847,0.00060339755,0.002917297,0.9691547,0.000051233008],"about_ca_topic_score_codex":0.0012653653,"about_ca_topic_score_gemma":0.0030649141,"teacher_disagreement_score":0.0026212016,"about_ca_system_score_codex":0.0003410046,"about_ca_system_score_gemma":0.0011902297,"threshold_uncertainty_score":0.007758975},"labels":[],"label_agreement":null},{"id":"W2304028829","doi":"10.1016/j.jaad.2016.02.1164","title":"Apremilast, an oral phosphodiesterase-4 inhibitor, in the treatment of palmoplantar psoriasis: Results of a pooled analysis from phase II PSOR-005 and phase III Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis (ESTEEM) clinical trials in patients with moderate to severe psoriasis","year":2016,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Innovaderm (Canada)","funders":"Celgene","keywords":"Apremilast; Medicine; Psoriasis; Dermatology; Phase (matter); Pharmacology; Internal medicine","score_opus":0.042796572009189,"score_gpt":0.3684748574190304,"score_spread":0.3256782854098414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2304028829","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85570246,0.133196,0.0032131572,0.0008764046,0.0004128379,0.0015989887,0.002651042,0.00023459381,0.0021145183],"genre_scores_gemma":[0.98150086,0.013319453,0.0016611975,0.0004901512,0.00041163914,0.00047174972,0.0013984976,0.000035004894,0.00071154075],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99279857,0.004994837,0.00067221693,0.000652929,0.0006763866,0.00020502319],"domain_scores_gemma":[0.99552333,0.0018877635,0.001570185,0.00034873586,0.00032381315,0.00034615764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01630523,0.0017152237,0.0054021506,0.0014151252,0.00033299418,0.001755657,0.00055465486,0.0008508851,0.00230093],"category_scores_gemma":[0.0076955124,0.00077810226,0.008768418,0.0010683674,0.00046522816,0.0008889862,0.00064881274,0.001283759,0.00029721286],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6838072,0.0018518647,0.022007775,0.008040805,0.18644403,0.00018528443,0.00014099567,0.0016832333,0.011374699,0.00008761704,0.0019359675,0.08244051],"study_design_scores_gemma":[0.3917047,0.1020977,0.15375029,0.00084337767,0.33785704,0.0008651692,0.00018578,0.00251385,0.0057226857,0.00037962943,0.0039139357,0.00016583096],"about_ca_topic_score_codex":0.0005677728,"about_ca_topic_score_gemma":0.0015775235,"teacher_disagreement_score":0.01630523,"about_ca_system_score_codex":0.0006337916,"about_ca_system_score_gemma":0.00089942454,"threshold_uncertainty_score":0.08623129},"labels":[],"label_agreement":null},{"id":"W2323903826","doi":"10.1016/j.jaad.2016.02.1221","title":"Systematic review of efficacy of anti–tumor necrosis factor (TNF) therapy in patients with psoriasis previously treated with a different anti–TNF agent","year":2016,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":59,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"","keywords":"Medicine; Psoriasis; Tumor necrosis factor alpha; Tumor necrosis factor α; Necrosis; Tumor necrosis factors; Dermatology; Internal medicine","score_opus":0.020563300929828776,"score_gpt":0.2829021297591856,"score_spread":0.26233882882935683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2323903826","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010921016,0.99808335,0.00007664569,0.000088712026,0.000081350074,0.00009549678,0.0003013398,0.000005816049,0.00017518942],"genre_scores_gemma":[0.016455833,0.9821545,0.00038736008,0.00046354588,0.00007092958,0.00011050032,0.00022911422,0.0000040369446,0.00012412161],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99791974,0.0005037525,0.0009662252,0.0002220477,0.00030746206,0.00008076583],"domain_scores_gemma":[0.9946904,0.0031245993,0.0016044272,0.000081401326,0.0003951753,0.0001039363],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028193023,0.0010371458,0.007367956,0.0037794525,0.00028129667,0.0013544855,0.0016215761,0.0011610615,0.004115656],"category_scores_gemma":[0.009017905,0.00066688244,0.007029221,0.004187102,0.0005069374,0.0010421864,0.00094895804,0.0009509062,0.00022269666],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00089759205,0.00002652189,0.0006370938,0.9322451,0.026770424,0.000115329174,0.00009073059,0.00011864937,0.00035555122,0.00013177903,0.0017827348,0.036828507],"study_design_scores_gemma":[0.0025971013,0.0010625061,0.010334317,0.49450168,0.44094527,0.00084500795,0.00022701517,0.0001611496,0.00044321574,0.00038414123,0.048401006,0.000097595934],"about_ca_topic_score_codex":0.00609803,"about_ca_topic_score_gemma":0.019270772,"teacher_disagreement_score":0.007367956,"about_ca_system_score_codex":0.0014999234,"about_ca_system_score_gemma":0.0040402124,"threshold_uncertainty_score":0.014910042},"labels":[],"label_agreement":null},{"id":"W2335621854","doi":"10.1016/j.jaad.2012.05.039","title":"Short incubation photodynamic therapy with methylaminolevulinate and no occlusion for the treatment of actinic keratoses","year":2012,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"","keywords":"Medicine; Actinic keratoses; Dermatology; Photodynamic therapy; Occlusion; Surgery; Basal cell; Internal medicine","score_opus":0.027620891926402626,"score_gpt":0.3303181755205925,"score_spread":0.3026972835941899,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2335621854","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.58684933,0.07284305,0.002357053,0.26484752,0.020853315,0.0002619372,0.0002461271,0.00020253046,0.051539093],"genre_scores_gemma":[0.9037479,0.015525205,0.00092202745,0.045781218,0.014594412,0.00009139091,0.0000929724,0.000020471804,0.019224381],"study_design_codex":"case_report","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996698,0.00012028546,0.000044040553,0.000030344094,0.00008469227,0.000050788018],"domain_scores_gemma":[0.99943405,0.00037962224,0.00005005447,0.00002479171,0.00003741363,0.00007402765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006043942,0.00032781673,0.00071964064,0.00036352355,0.00077637064,0.00039693015,0.0004379625,0.004637323,0.00097582594],"category_scores_gemma":[0.0017593999,0.0002109629,0.0005040519,0.0003104086,0.0005720276,0.00048633743,0.00014845126,0.0019474197,0.0002930695],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01160426,0.0022547678,0.028560242,0.0012961405,0.00029964474,0.55653965,0.00090526097,0.0005554345,0.03854193,0.0058864197,0.15087932,0.20267689],"study_design_scores_gemma":[0.004238222,0.008624872,0.10134706,0.0004273365,0.0006008331,0.4967432,0.00057947607,0.002184454,0.019189341,0.0033500916,0.36257184,0.00014327985],"about_ca_topic_score_codex":0.001237345,"about_ca_topic_score_gemma":0.00409474,"teacher_disagreement_score":0.004637323,"about_ca_system_score_codex":0.0011968052,"about_ca_system_score_gemma":0.0005053684,"threshold_uncertainty_score":0.008683443},"labels":[],"label_agreement":null},{"id":"W2364278908","doi":"10.1016/j.jaad.2015.09.065","title":"Topical minocycline foam for moderate to severe acne vulgaris: Phase 2 randomized double-blind, vehicle-controlled study results","year":2016,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada); University of Toronto","funders":"","keywords":"Minocycline; Medicine; Acne; Doxycycline; Dermatology; Tolerability; Randomized controlled trial; Adverse effect; Internal medicine; Antibiotics","score_opus":0.03982204969150672,"score_gpt":0.37661478641400786,"score_spread":0.33679273672250115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2364278908","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4054572,0.49973747,0.0049336115,0.014615122,0.020146957,0.041105554,0.0069660023,0.00068053295,0.0063576703],"genre_scores_gemma":[0.7385952,0.16223449,0.011618541,0.020819476,0.0100041805,0.04257844,0.0029560672,0.00017368849,0.01102],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9981679,0.00089495315,0.0003083226,0.00024355481,0.00024200634,0.00014330429],"domain_scores_gemma":[0.99592847,0.0016984058,0.0009917944,0.0002022152,0.000832197,0.0003468138],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0059615797,0.0014118818,0.0077967346,0.00040972017,0.00046282695,0.0013125313,0.0011815734,0.0025646628,0.010455605],"category_scores_gemma":[0.008318941,0.00058495783,0.0046951063,0.0007243144,0.0006993199,0.0014889204,0.0004317523,0.0024731923,0.0008015899],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8265938,0.01349917,0.00085104554,0.05967987,0.017796557,0.00025999272,0.00017317961,0.00024926904,0.0037480178,0.00028472356,0.011122451,0.06574199],"study_design_scores_gemma":[0.88060683,0.08290419,0.0046688407,0.0033724895,0.017428586,0.0001263378,0.00010327472,0.00042300293,0.00087767595,0.0004077709,0.009004457,0.0000764124],"about_ca_topic_score_codex":0.00053209637,"about_ca_topic_score_gemma":0.0012078529,"teacher_disagreement_score":0.010455605,"about_ca_system_score_codex":0.00048601307,"about_ca_system_score_gemma":0.0013833895,"threshold_uncertainty_score":0.034977496},"labels":[],"label_agreement":null},{"id":"W2376792986","doi":"10.1016/j.jaad.2016.01.054","title":"Lenalidomide for refractory chronic and subacute cutaneous lupus erythematosus: 16 patients","year":2016,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Lenalidomide; Subacute cutaneous lupus erythematosus; Dermatology; Refractory (planetary science); Lupus erythematosus; Internal medicine; Immunology; Autoimmune disease; Connective tissue disease; Antibody; Disease; Multiple myeloma","score_opus":0.018475961403810685,"score_gpt":0.3098434531642959,"score_spread":0.2913674917604852,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2376792986","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85263324,0.08659243,0.0016511149,0.038265206,0.0073341182,0.00026864096,0.0019304547,0.00022165323,0.01110317],"genre_scores_gemma":[0.9260648,0.03322777,0.0016988703,0.018092217,0.012376996,0.00013809933,0.0013483983,0.0000925428,0.006960318],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9996774,0.000043220207,0.00007074671,0.000071051785,0.00005680642,0.00008073682],"domain_scores_gemma":[0.99949443,0.00012054086,0.0001405317,0.000017781575,0.000044991568,0.00018165908],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034053827,0.0006952016,0.00086739607,0.00071001344,0.00081068627,0.0010512312,0.0005217325,0.0017422348,0.0025496315],"category_scores_gemma":[0.0011294795,0.0004201038,0.000513955,0.0014791194,0.00043551408,0.0010081447,0.0003914105,0.0009863643,0.0007977099],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022729435,0.0005405636,0.22914986,0.0014744041,0.00043792312,0.52273446,0.0016477676,0.00039383455,0.004101139,0.00059979333,0.083651334,0.15299593],"study_design_scores_gemma":[0.00084738847,0.0008378668,0.11095193,0.0008867902,0.0003913646,0.786201,0.0010924832,0.0008320944,0.0011332532,0.0007420222,0.09595585,0.00012803113],"about_ca_topic_score_codex":0.00079555175,"about_ca_topic_score_gemma":0.0013474796,"teacher_disagreement_score":0.0025496315,"about_ca_system_score_codex":0.0005581327,"about_ca_system_score_gemma":0.0004099884,"threshold_uncertainty_score":0.008529305},"labels":[],"label_agreement":null},{"id":"W2397615067","doi":"10.1016/j.jaad.2016.03.026","title":"Clinical meaningfulness of complete skin clearance in psoriasis","year":2016,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":119,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Medicine; Psoriasis; Psoriasis Area and Severity Index; Dermatology Life Quality Index; Quality of life (healthcare); Severity of illness; Dermatology; Internal medicine","score_opus":0.032898005873031634,"score_gpt":0.3138636616375706,"score_spread":0.28096565576453897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2397615067","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9664884,0.009008858,0.00070916273,0.00093802734,0.00015374576,0.00011105915,0.00044981146,0.000035411333,0.022105599],"genre_scores_gemma":[0.99885297,0.0004524776,0.00015005228,0.000091273796,0.00009153898,0.000010701751,0.00013346663,0.0000032550558,0.00021420635],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971499,0.0013202827,0.0004444179,0.00023319558,0.0006034972,0.0002487316],"domain_scores_gemma":[0.99055535,0.003709785,0.00304632,0.00037037383,0.0012489547,0.0010692488],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023406025,0.00030327943,0.0005680884,0.0014042337,0.0005432972,0.0013696991,0.00037217475,0.0007020159,0.0021126652],"category_scores_gemma":[0.015785176,0.00013514217,0.000361083,0.0010600196,0.00072333426,0.0010772322,0.0006490892,0.00092578435,0.00039094102],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023441084,0.00016121494,0.95229745,0.00025112004,0.00009775467,0.0040126015,0.0005082332,0.00019979184,0.002915635,0.00042109267,0.0011163418,0.03567471],"study_design_scores_gemma":[0.00004426426,0.0009792937,0.9835519,0.00006063515,0.00007053194,0.010747828,0.00068277685,0.00042954486,0.0006559554,0.0004650604,0.0022884025,0.000023789242],"about_ca_topic_score_codex":0.0005068202,"about_ca_topic_score_gemma":0.0008819683,"teacher_disagreement_score":0.0023406025,"about_ca_system_score_codex":0.00046388214,"about_ca_system_score_gemma":0.00044375518,"threshold_uncertainty_score":0.012378395},"labels":[],"label_agreement":null},{"id":"W2441985258","doi":"10.1016/j.jaad.2016.03.002","title":"Objective volumetric grading of postacne scarring","year":2016,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Acne; Acne scars; Dermatology; Scopus; Scars; Grading (engineering); MEDLINE; Surgery","score_opus":0.01455370363782156,"score_gpt":0.30204565727130583,"score_spread":0.2874919536334843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2441985258","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.56745976,0.03591415,0.04604889,0.052439526,0.008727834,0.0007420006,0.001562298,0.0017234617,0.28538215],"genre_scores_gemma":[0.9603115,0.003587817,0.011998295,0.0046425466,0.0029157526,0.000073707604,0.00032218147,0.000066287925,0.01608189],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99947375,0.00017229642,0.000052602794,0.000036630885,0.00018648457,0.00007828785],"domain_scores_gemma":[0.99894994,0.0003509278,0.00021774147,0.000053019827,0.00031469177,0.00011369545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007588443,0.00030349955,0.0003125324,0.0006642817,0.00015236187,0.00055191625,0.00063113007,0.00062944024,0.002928],"category_scores_gemma":[0.002464289,0.00009766836,0.00021658865,0.0003230827,0.00026225232,0.00058842957,0.00030926662,0.00095475354,0.0006543869],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001430722,0.0005599751,0.119760126,0.0013864429,0.00013863025,0.034004033,0.00027436833,0.0014664808,0.06268173,0.0053864224,0.08113354,0.6917775],"study_design_scores_gemma":[0.00033400836,0.004783295,0.36596835,0.0015774015,0.00024356073,0.32116473,0.0010429558,0.022078691,0.045897707,0.008383703,0.22832283,0.00020275736],"about_ca_topic_score_codex":0.0003537983,"about_ca_topic_score_gemma":0.0012817486,"teacher_disagreement_score":0.002928,"about_ca_system_score_codex":0.00032071292,"about_ca_system_score_gemma":0.00018649462,"threshold_uncertainty_score":0.00979507},"labels":[],"label_agreement":null},{"id":"W2489160619","doi":"10.1016/j.jaad.2016.04.028","title":"ATX-101 for reduction of submental fat: A phase III randomized controlled trial","year":2016,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Body Contouring and Surgery","field":"Medicine","cited_by":120,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto; University of British Columbia","funders":"","keywords":"Medicine; Confidence interval; Placebo; Randomized controlled trial; Magnetic resonance imaging; Adverse effect; Internal medicine; Relative risk; Surgery; Urology; Gastroenterology; Pathology; Radiology","score_opus":0.018401366748161174,"score_gpt":0.3293719672734692,"score_spread":0.310970600525308,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2489160619","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93253154,0.041106474,0.0018608148,0.002993325,0.0018267125,0.010001912,0.0030677558,0.00045061382,0.006160883],"genre_scores_gemma":[0.9470561,0.020575838,0.0035068137,0.0037352291,0.0011152829,0.015159796,0.0021111108,0.000050902643,0.0066890107],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99946374,0.00031078924,0.000032294087,0.00007950474,0.000051367766,0.00006236948],"domain_scores_gemma":[0.9993586,0.00020524638,0.0001828365,0.00004082409,0.00004371156,0.00016872385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015422461,0.0012149815,0.0025854143,0.0004311888,0.0003730338,0.0011829997,0.0010224467,0.0016506653,0.011168275],"category_scores_gemma":[0.0013500365,0.00042561186,0.0017987269,0.00059180084,0.00082564534,0.00077358057,0.00029081278,0.0022901043,0.0010440114],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.95463675,0.0056344434,0.0005145688,0.0034033537,0.0022778488,0.00008900983,0.000058252674,0.0004378519,0.0025286754,0.00032845332,0.0025586411,0.02753207],"study_design_scores_gemma":[0.98354167,0.014747581,0.00054476905,0.00007068062,0.00029109124,0.000025171827,0.000010449977,0.00015538595,0.000090690904,0.00006272445,0.00045367816,0.0000060566235],"about_ca_topic_score_codex":0.00076376746,"about_ca_topic_score_gemma":0.0018664508,"teacher_disagreement_score":0.011168275,"about_ca_system_score_codex":0.0006114493,"about_ca_system_score_gemma":0.0011163135,"threshold_uncertainty_score":0.037361562},"labels":[],"label_agreement":null},{"id":"W2499878734","doi":"10.1016/j.jaad.2016.07.007","title":"Imaging mass spectrometry assists in the classification of diagnostically challenging atypical Spitzoid neoplasms","year":2016,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Center for Advancing Translational Sciences; National Institute of General Medical Sciences","keywords":"Medicine; Medical diagnosis; Histopathology; Retrospective cohort study; Melanoma; Pathology; Internal medicine; Dermatology","score_opus":0.015383741864713227,"score_gpt":0.2918709609880321,"score_spread":0.27648721912331886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2499878734","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9171364,0.022099594,0.029354775,0.006079089,0.000745614,0.00019315821,0.00048556217,0.00093032233,0.022975456],"genre_scores_gemma":[0.96030337,0.006428393,0.030234506,0.0007251151,0.00052943436,0.000033526107,0.00028465138,0.00008819131,0.0013728286],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991511,0.00019342004,0.00014332117,0.000091057576,0.00031183727,0.00010933309],"domain_scores_gemma":[0.99761957,0.00091060094,0.0003180233,0.00016946642,0.00075463974,0.00022774533],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002211238,0.0010833172,0.00053986104,0.005246613,0.0007124304,0.0019191826,0.0010190527,0.0016819126,0.002220989],"category_scores_gemma":[0.0077451924,0.00054028933,0.0004461633,0.00095599564,0.00081543357,0.002031709,0.0008954172,0.0010519094,0.0020705124],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015297092,0.0003602181,0.55641127,0.0005228637,0.00014758953,0.054129895,0.0005102214,0.001908705,0.15443833,0.0017131735,0.011260506,0.21706755],"study_design_scores_gemma":[0.00014529827,0.0006638212,0.34034404,0.0010905741,0.0005934643,0.31523696,0.0026162644,0.07022589,0.21579249,0.008804394,0.04436008,0.00012671703],"about_ca_topic_score_codex":0.0009654289,"about_ca_topic_score_gemma":0.0022799617,"teacher_disagreement_score":0.005246613,"about_ca_system_score_codex":0.00041681223,"about_ca_system_score_gemma":0.0004526454,"threshold_uncertainty_score":0.011694312},"labels":[],"label_agreement":null},{"id":"W2503219031","doi":"10.1016/j.jaad.2016.06.012","title":"Effects of tofacitinib on cardiovascular risk factors and cardiovascular outcomes based on phase III and long-term extension data in patients with plaque psoriasis","year":2016,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"Pfizer","keywords":"Medicine; Tofacitinib; Plaque psoriasis; Psoriasis; Internal medicine; Term (time); Cardiology; Dermatology","score_opus":0.013382230975705947,"score_gpt":0.25176488473306263,"score_spread":0.23838265375735668,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2503219031","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9850603,0.01127412,0.00018579444,0.0003687093,0.00008152926,0.000112443326,0.0015139824,0.00002432864,0.0013788656],"genre_scores_gemma":[0.9935607,0.0027243192,0.00025879807,0.0003632959,0.000113673515,0.00008423799,0.0024474836,0.000009711478,0.0004377749],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99895763,0.00047397855,0.00009119949,0.00015837225,0.00011973926,0.00019909069],"domain_scores_gemma":[0.9972561,0.0011225272,0.00067091966,0.00023343982,0.00017841907,0.0005385231],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038655791,0.0010141139,0.0022619974,0.0003571788,0.00043558198,0.0013003368,0.00057305594,0.00081499194,0.0013584723],"category_scores_gemma":[0.0029742296,0.00038932223,0.003685674,0.0005488283,0.00050650316,0.0011750673,0.00041191306,0.0032627257,0.00023685354],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6368046,0.006252611,0.2073982,0.0010582875,0.0145791,0.00041390912,0.0002556541,0.004881558,0.009650973,0.0002860794,0.003981448,0.11443752],"study_design_scores_gemma":[0.12925506,0.09018254,0.75360084,0.00024837194,0.014778127,0.0007811864,0.00029097789,0.003454542,0.0021017918,0.0007054948,0.0044442923,0.00015678984],"about_ca_topic_score_codex":0.0014138771,"about_ca_topic_score_gemma":0.003253637,"teacher_disagreement_score":0.0038655791,"about_ca_system_score_codex":0.00080702745,"about_ca_system_score_gemma":0.00080263335,"threshold_uncertainty_score":0.02044344},"labels":[],"label_agreement":null},{"id":"W2507750354","doi":"10.1016/j.jaad.2016.07.001","title":"The prevalence of anxiety and depression in patients with or without hyperhidrosis (HH)","year":2016,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Sympathectomy and Hyperhidrosis Treatments","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Anxiety; Depression (economics); Medicine; Logistic regression; Hyperhidrosis; Anxiety disorder; Internal medicine; Psychiatry; Dermatology","score_opus":0.010060686094272091,"score_gpt":0.2764134155116371,"score_spread":0.26635272941736504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2507750354","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990426,0.00023479389,0.00001872041,0.000035500132,0.0000061895057,0.0000042110855,0.00015521592,0.000001499281,0.0005012623],"genre_scores_gemma":[0.9997074,0.000079939964,0.000016492218,0.00001850924,0.000008837943,0.0000026068137,0.00009697528,3.4222114e-7,0.000068843525],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997435,0.000053762233,0.000040456507,0.000041013423,0.000053667714,0.000067700355],"domain_scores_gemma":[0.9992347,0.00016064913,0.00036007466,0.00002059201,0.00005329779,0.00017071028],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019520213,0.00015296468,0.00023865979,0.00080567086,0.0003165365,0.0005499898,0.0001822001,0.00040099834,0.001985923],"category_scores_gemma":[0.0014116996,0.00014582237,0.0003619313,0.0006783715,0.00022534735,0.00036449326,0.00033072577,0.0003748078,0.00015772296],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000105159765,0.000026965286,0.9986407,0.000008467947,0.000028386274,0.00007314409,0.00007313774,0.0000057763014,0.00021353045,0.000008639599,0.00003768544,0.00077843474],"study_design_scores_gemma":[0.0000034379714,0.000048468304,0.9993636,0.0000019880913,0.000013493155,0.00028003714,0.00021170329,0.000023112761,0.000012941958,0.0000075288535,0.000032171378,0.000001499923],"about_ca_topic_score_codex":0.0035761932,"about_ca_topic_score_gemma":0.0054434272,"teacher_disagreement_score":0.0035761932,"about_ca_system_score_codex":0.00021495558,"about_ca_system_score_gemma":0.00021041727,"threshold_uncertainty_score":0.0071107745},"labels":[],"label_agreement":null},{"id":"W2521243079","doi":"10.1016/j.jaad.2016.08.008","title":"Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate-to-severe plaque psoriasis up to 1 year: Results from the CLEAR study","year":2016,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":304,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Ustekinumab; Plaque psoriasis; Secukinumab; Dermatology; Psoriasis; Dermatologic agents; Internal medicine; Disease; Adalimumab; Psoriatic arthritis","score_opus":0.01705439731695948,"score_gpt":0.26128476369118464,"score_spread":0.24423036637422516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2521243079","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891473,0.008964085,0.00010108191,0.0001844644,0.000114335846,0.00015487368,0.00034888246,0.000025110936,0.000959796],"genre_scores_gemma":[0.99384356,0.003575295,0.0003054499,0.00031084794,0.0002531892,0.000045430006,0.0006302843,0.000015088908,0.0010209423],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99905163,0.00039630863,0.00009282621,0.00014105809,0.00021096798,0.00010728617],"domain_scores_gemma":[0.9983449,0.0006493962,0.00039340305,0.00017023309,0.00015095947,0.0002910661],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025836786,0.0008732999,0.0025418738,0.00041330332,0.00039768632,0.0008143678,0.00057082553,0.001106253,0.0024546622],"category_scores_gemma":[0.0017002084,0.00052885327,0.0020031913,0.0002915023,0.0005770827,0.0011180467,0.000268013,0.0017566971,0.0004988228],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.77526826,0.020246705,0.03621599,0.001800361,0.0073937876,0.00028395298,0.00037386047,0.0004763492,0.036681492,0.00012955023,0.0018742007,0.11925551],"study_design_scores_gemma":[0.22822371,0.4097721,0.33684814,0.00019105182,0.010323683,0.00089048094,0.00040024664,0.0008867044,0.0075958897,0.00018669447,0.0045595705,0.000121748846],"about_ca_topic_score_codex":0.0012275968,"about_ca_topic_score_gemma":0.0031271977,"teacher_disagreement_score":0.0025836786,"about_ca_system_score_codex":0.00032421015,"about_ca_system_score_gemma":0.00042112687,"threshold_uncertainty_score":0.013664007},"labels":[],"label_agreement":null},{"id":"W2527243486","doi":"10.1016/j.jaad.2016.07.040","title":"Tofacitinib improves pruritus and health-related quality of life up to 52 weeks: Results from 2 randomized phase III trials in patients with moderate to severe plaque psoriasis","year":2016,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":65,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Tofacitinib; Medicine; Dermatology Life Quality Index; Placebo; Psoriasis; Janus kinase inhibitor; Quality of life (healthcare); Randomized controlled trial; Internal medicine; Psoriasis Area and Severity Index; Clinical trial; Dermatology; Rheumatoid arthritis; Alternative medicine; Pathology; Nursing","score_opus":0.03777943338510351,"score_gpt":0.3214798812904353,"score_spread":0.2837004479053318,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2527243486","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9391355,0.048558224,0.00078101835,0.0018486913,0.00070793886,0.001880945,0.0022311101,0.00020489335,0.004651733],"genre_scores_gemma":[0.973357,0.017359477,0.0012698732,0.0018685118,0.0005699617,0.0013568652,0.0020463516,0.000040779523,0.0021311762],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9993711,0.00026246958,0.000050389834,0.00011355643,0.00006704368,0.00013547095],"domain_scores_gemma":[0.9991399,0.0002997641,0.00024782112,0.00005186653,0.000061029376,0.00019953723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002021478,0.0016017578,0.0034349114,0.00049403287,0.00048667454,0.0013011805,0.00077763345,0.0016849483,0.0052696983],"category_scores_gemma":[0.0018219287,0.00060497975,0.004139368,0.00057613925,0.0008860239,0.0012309983,0.00036587784,0.0037932247,0.00060571596],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8777711,0.0065998686,0.0023997964,0.0031563684,0.0062400065,0.00012623229,0.0001358598,0.0008572632,0.0065064826,0.00019110742,0.0034358404,0.09258001],"study_design_scores_gemma":[0.9455365,0.04259939,0.0066430713,0.00015758915,0.0023517583,0.00013676276,0.000044812536,0.00030276732,0.00052116154,0.00019261807,0.0014867722,0.000026747151],"about_ca_topic_score_codex":0.0012432602,"about_ca_topic_score_gemma":0.0039081112,"teacher_disagreement_score":0.0052696983,"about_ca_system_score_codex":0.0010279132,"about_ca_system_score_gemma":0.0007302114,"threshold_uncertainty_score":0.017628908},"labels":[],"label_agreement":null},{"id":"W2529954063","doi":"10.1016/j.jaad.2016.08.047","title":"Autoimmune diseases in adults with atopic dermatitis","year":2016,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":148,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Novo Nordisk Fonden; Region Hovedstaden; Lundbeckfonden; Health Research Foundation; Pfizer; Eli Lilly and Company","keywords":"Medicine; Atopic dermatitis; Dermatology; Immunology","score_opus":0.006835970314813588,"score_gpt":0.2670169014483143,"score_spread":0.2601809311335007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2529954063","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97762626,0.009347102,0.000106038664,0.0006667368,0.00012696044,0.000026268974,0.0004255042,0.000016276852,0.01165886],"genre_scores_gemma":[0.99496233,0.0030526435,0.00011310712,0.00033957532,0.00028493817,0.000013661023,0.0003081304,0.000002300567,0.00092339073],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99964774,0.000060225746,0.00007544001,0.000056453322,0.000073873,0.0000862546],"domain_scores_gemma":[0.9993591,0.0001279125,0.00028426977,0.000017100554,0.00005895121,0.00015264742],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000268115,0.00030278022,0.00045683514,0.0014018713,0.00064634776,0.0007637831,0.00018021418,0.0007880642,0.0042067217],"category_scores_gemma":[0.0012853666,0.00021678349,0.00038805188,0.001225854,0.0002570927,0.0008405305,0.00042571189,0.00066409726,0.0005105985],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008827881,0.00007539086,0.98972684,0.000042324693,0.0000234124,0.0036380717,0.000107544925,0.000016787262,0.00022973306,0.000058871734,0.0005203396,0.0054723932],"study_design_scores_gemma":[0.000011650962,0.00009770313,0.9828022,0.00006360399,0.000046500805,0.0152896615,0.0005051922,0.00006424067,0.00004313733,0.00007325733,0.000998201,0.000004562621],"about_ca_topic_score_codex":0.0020287838,"about_ca_topic_score_gemma":0.0025262968,"teacher_disagreement_score":0.0042067217,"about_ca_system_score_codex":0.0001983812,"about_ca_system_score_gemma":0.00024470527,"threshold_uncertainty_score":0.014072895},"labels":[],"label_agreement":null},{"id":"W2530574096","doi":"10.1016/j.jaad.2016.06.001","title":"Low-dose systemic corticosteroid treatment for recalcitrant hidradenitis suppurativa","year":2016,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre; University of Toronto","funders":"","keywords":"Hidradenitis suppurativa; Medicine; Adalimumab; Dermatology; Apocrine; Disease; Internal medicine; Pathology","score_opus":0.02803303820379454,"score_gpt":0.32673317190108936,"score_spread":0.2987001336972948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2530574096","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.74269557,0.22023515,0.0028896097,0.0065397355,0.0018792793,0.00031814544,0.00018151817,0.0003227953,0.024938285],"genre_scores_gemma":[0.9761703,0.018015236,0.0009872827,0.0013842555,0.00073025323,0.000041467963,0.00010605082,0.0000146564735,0.0025505486],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99990904,0.000023539264,0.000010788093,0.000009569295,0.000021650421,0.000025342728],"domain_scores_gemma":[0.9998585,0.000049611364,0.000017074772,0.000006010528,0.000012538203,0.000056346285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017786857,0.00032089793,0.00063410366,0.00033738356,0.0005661929,0.0002385699,0.00022153655,0.0004602767,0.0020923095],"category_scores_gemma":[0.0004239401,0.00008437633,0.00037607478,0.0002210131,0.00020575104,0.00018139786,0.00013094935,0.0008637099,0.0004762552],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013445731,0.002301221,0.029251985,0.0028427301,0.0004818513,0.11358687,0.0004923175,0.00055261963,0.123328336,0.00076215604,0.020022186,0.69293195],"study_design_scores_gemma":[0.01501253,0.03871084,0.3584152,0.0023744032,0.0023248945,0.35443103,0.0015458856,0.006266031,0.05891299,0.0015448857,0.16024049,0.0002208477],"about_ca_topic_score_codex":0.00099443,"about_ca_topic_score_gemma":0.003698508,"teacher_disagreement_score":0.0020923095,"about_ca_system_score_codex":0.00035006678,"about_ca_system_score_gemma":0.00036097146,"threshold_uncertainty_score":0.006999433},"labels":[],"label_agreement":null},{"id":"W2531891661","doi":"10.1016/j.jaad.2016.05.033","title":"Needling in unresponsive stable vitiligo","year":2016,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"melanin and skin pigmentation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"","keywords":"Vitiligo; Medicine; Dry needling; Dermatology; Therapeutic modalities; Treatment modality; Refractory (planetary science); Modalities; Surgery; Pathology; Internal medicine; Alternative medicine; Acupuncture","score_opus":0.010653556235871064,"score_gpt":0.292928156312205,"score_spread":0.2822746000763339,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2531891661","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99283034,0.0015090499,0.00019606006,0.00032033975,0.00004342875,0.000026499378,0.000053656917,0.000019209481,0.0050013727],"genre_scores_gemma":[0.9990582,0.00019310054,0.00006112141,0.00007570418,0.00002782917,0.0000030726494,0.000031821153,0.0000038143655,0.0005453026],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9998056,0.00004955819,0.000028854485,0.000025139838,0.00003508526,0.000055815664],"domain_scores_gemma":[0.9996076,0.00015705828,0.00008177986,0.000029809526,0.000025491676,0.00009829178],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031140246,0.00032859523,0.00035239643,0.00084720197,0.000531891,0.000388492,0.0003410251,0.0008305423,0.0033905082],"category_scores_gemma":[0.0012254578,0.00014091076,0.00031834017,0.00046264988,0.0005013513,0.00046772065,0.00031443767,0.00059714046,0.00025733278],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017729701,0.0019617185,0.36292294,0.0007430869,0.00028953515,0.41460022,0.0010702171,0.0003994356,0.077298135,0.003132987,0.0027382914,0.11711372],"study_design_scores_gemma":[0.00041335667,0.00312065,0.59995335,0.0000754276,0.00026541628,0.38329172,0.0009460587,0.0011938033,0.0059200814,0.0018857621,0.0028872704,0.000047033955],"about_ca_topic_score_codex":0.0010171047,"about_ca_topic_score_gemma":0.0012267173,"teacher_disagreement_score":0.0033905082,"about_ca_system_score_codex":0.0003636166,"about_ca_system_score_gemma":0.00023029189,"threshold_uncertainty_score":0.011342406},"labels":[],"label_agreement":null},{"id":"W2542144042","doi":"10.1016/j.jaad.2016.08.053","title":"Olumacostat glasaretil, a novel topical sebum inhibitor, in the treatment of acne vulgaris: A phase IIa, multicenter, randomized, vehicle-controlled study","year":2016,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Windsor Clinical Research; Centre de Recherche Dermatologique du Québec Métropolitain; Innovaderm (Canada)","funders":"","keywords":"Medicine; Acne; Adverse effect; Gastroenterology; Randomized controlled trial; Internal medicine; Dosing; Dermatology","score_opus":0.018645785241049023,"score_gpt":0.34351094997309645,"score_spread":0.3248651647320474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2542144042","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98084587,0.0132108675,0.00095311244,0.00040061478,0.0003372405,0.0017397457,0.000620621,0.0001183812,0.0017735736],"genre_scores_gemma":[0.98381305,0.0095864115,0.0012227221,0.0008031703,0.0003824426,0.0013321503,0.00071088265,0.000028724666,0.0021204313],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99959534,0.00017064068,0.00002637321,0.000065192944,0.000043677075,0.00009873382],"domain_scores_gemma":[0.9995882,0.00011411147,0.00008919224,0.00003122914,0.000031192114,0.0001459881],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012215019,0.0014912006,0.0030159873,0.00054646085,0.00040327292,0.0010676947,0.00081992225,0.0012489549,0.003858346],"category_scores_gemma":[0.000764583,0.00065398164,0.0015113235,0.00054107705,0.0010855932,0.0013327708,0.00028189024,0.002309172,0.00057075755],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.93245006,0.015937991,0.0009202951,0.0015148933,0.0016561323,0.00008405621,0.000086337655,0.0005019071,0.011104281,0.00015536141,0.00077038707,0.03481823],"study_design_scores_gemma":[0.8973328,0.09687062,0.0027714765,0.00005117852,0.00097392825,0.000050697265,0.00005068474,0.0003858062,0.00077654445,0.00009036506,0.00062513724,0.00002077132],"about_ca_topic_score_codex":0.0011369538,"about_ca_topic_score_gemma":0.0026789515,"teacher_disagreement_score":0.003858346,"about_ca_system_score_codex":0.0005035712,"about_ca_system_score_gemma":0.00088696403,"threshold_uncertainty_score":0.012907505},"labels":[],"label_agreement":null},{"id":"W2548674252","doi":"10.1016/j.jaad.2016.08.062","title":"Atrophying pityriasis versicolor as an idiosyncratic T cell–mediated response to Malassezia: A case series","year":2016,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Pityriasis; Pathology; Dermatology","score_opus":0.01788443851636737,"score_gpt":0.3320893875415947,"score_spread":0.31420494902522733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2548674252","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96851814,0.0069506685,0.0049882163,0.0026357458,0.0006610475,0.00031222845,0.000433435,0.00037457552,0.015125967],"genre_scores_gemma":[0.9946825,0.0012385392,0.000960686,0.0006280422,0.0010594262,0.000036737918,0.0001041484,0.00004398014,0.0012460261],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9985959,0.00021698223,0.00015689408,0.000363511,0.00016921718,0.0004975358],"domain_scores_gemma":[0.99672747,0.0009406759,0.00062345434,0.00053365243,0.00017460024,0.0010002301],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058565184,0.004123641,0.001980757,0.0033143691,0.0034122649,0.0026563106,0.002176462,0.0062429747,0.003513189],"category_scores_gemma":[0.0040962608,0.0020907223,0.0021825596,0.002260644,0.0032678484,0.003945757,0.0027389666,0.003994053,0.0018701524],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019559651,0.000022383778,0.0020662113,0.00001835811,0.0000071189693,0.9969799,0.00006464521,0.0000323583,0.00025971245,0.000062285355,0.00010600524,0.00036142353],"study_design_scores_gemma":[0.000009710861,0.000026175605,0.0020768242,0.0000065014337,0.000016390728,0.9971482,0.00008082824,0.00015032022,0.00021066927,0.00005584608,0.00021016199,0.000008434842],"about_ca_topic_score_codex":0.0016475102,"about_ca_topic_score_gemma":0.0019465699,"teacher_disagreement_score":0.0062429747,"about_ca_system_score_codex":0.0018792786,"about_ca_system_score_gemma":0.0008394427,"threshold_uncertainty_score":0.013635159},"labels":[],"label_agreement":null},{"id":"W2551958233","doi":"10.1016/j.jaad.2016.09.026","title":"Short- and long-term safety outcomes with ixekizumab from 7 clinical trials in psoriasis: Etanercept comparisons and integrated data","year":2016,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":130,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada); Probity Medical Research","funders":"","keywords":"Ixekizumab; Medicine; Etanercept; Psoriasis; Adverse effect; Clinical trial; Incidence (geometry); Internal medicine; Psoriatic arthritis; Dermatology","score_opus":0.11210315936177297,"score_gpt":0.3928063394197767,"score_spread":0.28070318005800377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2551958233","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93283457,0.05510181,0.0017476364,0.00045688884,0.00015462223,0.0005688177,0.0064813164,0.000052067568,0.0026022492],"genre_scores_gemma":[0.9858606,0.00529519,0.0008446447,0.00033340653,0.0001874095,0.0004138248,0.0065126265,0.00003753405,0.0005147879],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98249507,0.0079928,0.003697824,0.0019160883,0.0029848053,0.0009135176],"domain_scores_gemma":[0.9764024,0.011382893,0.006934315,0.0021347003,0.0021440533,0.0010016968],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.023813749,0.0010859439,0.004445511,0.0013326787,0.00050908903,0.0028016344,0.0008250515,0.0013565382,0.0023004725],"category_scores_gemma":[0.016383333,0.00049208733,0.007913013,0.0017741851,0.00083099474,0.0028212362,0.0014077104,0.00239545,0.0004444774],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5482479,0.0017796606,0.1766841,0.006910204,0.12558286,0.00023189279,0.0006383146,0.0037893476,0.007450682,0.00046368013,0.0027210622,0.12550032],"study_design_scores_gemma":[0.078843534,0.09342911,0.6656814,0.0012728849,0.14099982,0.0010296075,0.0006726247,0.0018525709,0.0056027076,0.0014450895,0.008895623,0.00027503635],"about_ca_topic_score_codex":0.00045673022,"about_ca_topic_score_gemma":0.000987894,"teacher_disagreement_score":0.023813749,"about_ca_system_score_codex":0.0010262869,"about_ca_system_score_gemma":0.0011110943,"threshold_uncertainty_score":0.12594068},"labels":[],"label_agreement":null},{"id":"W2553675566","doi":"10.1016/j.jaad.2014.09.058","title":"Primary cicatricial alopecia","year":2016,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":133,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Université de Montréal","funders":"","keywords":"Medicine; Dermatology; Scarring alopecia; Alopecia areata; Hair loss; Lymphocytic infiltration; Pathology; Scalp","score_opus":0.028175982787709546,"score_gpt":0.36281233213775554,"score_spread":0.334636349350046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553675566","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021218555,0.99816436,0.000056666213,0.000116503164,0.00018107975,0.0000049094306,0.00001635505,0.0000056278427,0.0012424416],"genre_scores_gemma":[0.0022230472,0.99611557,0.00013966848,0.00026910278,0.0003393719,0.000004384103,0.000038386675,0.0000014243772,0.00086900254],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997991,0.000023320837,0.000042158405,0.000037887912,0.00007326511,0.000024255662],"domain_scores_gemma":[0.99967325,0.00013075052,0.00008296184,0.0000102923395,0.000071827075,0.00003091207],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032194934,0.0006942767,0.0011619821,0.0029113048,0.0003496977,0.001002618,0.00055997935,0.00061554345,0.004783428],"category_scores_gemma":[0.0007267586,0.0002446355,0.00041259627,0.0023799266,0.0003832286,0.0010579167,0.00073629024,0.0009928321,0.0010937711],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052483283,0.000073795716,0.0005983151,0.018773481,0.00010327719,0.00080802245,0.000057908343,0.000115101466,0.0008396621,0.0007132211,0.028834734,0.9490301],"study_design_scores_gemma":[0.000055911038,0.00009629399,0.004807574,0.011834838,0.0005266232,0.015210349,0.00020111809,0.00012043466,0.0004915592,0.0011747208,0.9654485,0.000032112584],"about_ca_topic_score_codex":0.0013138902,"about_ca_topic_score_gemma":0.0034054287,"teacher_disagreement_score":0.004783428,"about_ca_system_score_codex":0.00038541603,"about_ca_system_score_gemma":0.0007665853,"threshold_uncertainty_score":0.016002119},"labels":[],"label_agreement":null},{"id":"W2554553446","doi":"10.1016/j.jaad.2016.08.029","title":"Prescribing success: Developing an integrated prescription and eczema action plan for atopic dermatitis","year":2016,"lang":"en","type":"editorial","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Atopic dermatitis; Scopus; Medical prescription; Randomized controlled trial; Dermatology; MEDLINE; Family medicine; Surgery; Pharmacology","score_opus":0.028129830327515554,"score_gpt":0.3401900994102633,"score_spread":0.31206026908274775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2554553446","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012132908,0.01089069,0.00025347804,0.119940035,0.8670248,0.000045854114,0.0000567511,0.00006430571,0.0016027067],"genre_scores_gemma":[0.0008240437,0.008391437,0.00031504777,0.033964515,0.95334613,0.000036646747,0.000032961525,0.000021854492,0.0030674045],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99151003,0.0019534817,0.0015593055,0.0006048927,0.0038983433,0.00047401228],"domain_scores_gemma":[0.95656234,0.024580177,0.0024282956,0.00071508007,0.01075855,0.00495558],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013447403,0.0029683062,0.0031386826,0.00254261,0.002537256,0.007864207,0.0035380458,0.022107948,0.0064382795],"category_scores_gemma":[0.06045709,0.0012351425,0.0032622046,0.0011260037,0.0021922176,0.0038639877,0.0019275362,0.027233206,0.0035572199],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000459543,0.000043867763,0.00012920854,0.00040851015,0.00006071287,0.00016391334,0.000029230563,0.000058195317,0.000029036662,0.0002788643,0.9827663,0.015986241],"study_design_scores_gemma":[0.00047352148,0.0001565979,0.0016809286,0.0033075765,0.0005624266,0.000743306,0.00021282329,0.00072817673,0.0001852661,0.0020478056,0.98983747,0.00006421643],"about_ca_topic_score_codex":0.003994342,"about_ca_topic_score_gemma":0.011423508,"teacher_disagreement_score":0.022107948,"about_ca_system_score_codex":0.0042719506,"about_ca_system_score_gemma":0.006522128,"threshold_uncertainty_score":0.07111752},"labels":[],"label_agreement":null},{"id":"W2555187401","doi":"10.1016/j.jaad.2015.01.056","title":"Primary cicatricial alopecia","year":2016,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":86,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Université de Montréal","funders":"","keywords":"Medicine; Folliculitis; Dermatology; Scarring alopecia; Acne; Cicatricial pemphigoid; Pemphigoid","score_opus":0.028175982787709546,"score_gpt":0.36281233213775554,"score_spread":0.334636349350046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555187401","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021218555,0.99816436,0.000056666213,0.000116503164,0.00018107975,0.0000049094306,0.00001635505,0.0000056278427,0.0012424416],"genre_scores_gemma":[0.0022230472,0.99611557,0.00013966848,0.00026910278,0.0003393719,0.000004384103,0.000038386675,0.0000014243772,0.00086900254],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997991,0.000023320837,0.000042158405,0.000037887912,0.00007326511,0.000024255662],"domain_scores_gemma":[0.99967325,0.00013075052,0.00008296184,0.0000102923395,0.000071827075,0.00003091207],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032194934,0.0006942767,0.0011619821,0.0029113048,0.0003496977,0.001002618,0.00055997935,0.00061554345,0.004783428],"category_scores_gemma":[0.0007267586,0.0002446355,0.00041259627,0.0023799266,0.0003832286,0.0010579167,0.00073629024,0.0009928321,0.0010937711],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052483283,0.000073795716,0.0005983151,0.018773481,0.00010327719,0.00080802245,0.000057908343,0.000115101466,0.0008396621,0.0007132211,0.028834734,0.9490301],"study_design_scores_gemma":[0.000055911038,0.00009629399,0.004807574,0.011834838,0.0005266232,0.015210349,0.00020111809,0.00012043466,0.0004915592,0.0011747208,0.9654485,0.000032112584],"about_ca_topic_score_codex":0.0013138902,"about_ca_topic_score_gemma":0.0034054287,"teacher_disagreement_score":0.004783428,"about_ca_system_score_codex":0.00038541603,"about_ca_system_score_gemma":0.0007665853,"threshold_uncertainty_score":0.016002119},"labels":[],"label_agreement":null},{"id":"W2555680885","doi":"10.1016/j.jaad.2016.09.021","title":"Prescribing practices for systemic agents in the treatment of severe pediatric atopic dermatitis in the US and Canada: The PeDRA TREAT survey","year":2016,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":86,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"University of California, San Diego; National Institutes of Health; National Institute for Health and Care Research","keywords":"Medicine; Atopic dermatitis; Systemic therapy; Methotrexate; Azathioprine; Dermatology; Disease; Surgery; Internal medicine","score_opus":0.042695820484300935,"score_gpt":0.3286090628018338,"score_spread":0.28591324231753285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555680885","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97156197,0.0066976836,0.000106838364,0.0021538099,0.000034070763,0.00005997309,0.009054234,0.0000309767,0.010300536],"genre_scores_gemma":[0.9916005,0.005156758,0.00024143238,0.00070675847,0.000017489336,0.000016261034,0.0014828428,0.000008676993,0.0007692905],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988304,0.00006555788,0.000121361576,0.000093021335,0.000722035,0.00016761622],"domain_scores_gemma":[0.9974485,0.00022629567,0.0009700382,0.00003294378,0.0007758455,0.0005463645],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030951673,0.00016144663,0.00034871977,0.00078959577,0.00081983284,0.0006941338,0.00069564936,0.00045134977,0.0013324338],"category_scores_gemma":[0.0021388747,0.00022065641,0.0005232173,0.002568061,0.00033206693,0.00028441977,0.00034494593,0.0007717002,0.00014392337],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049201517,0.000052481988,0.98949754,0.00008760259,0.000060758895,0.00013712651,0.000332298,0.00015146118,0.00018795903,0.00006995967,0.0025251114,0.006848436],"study_design_scores_gemma":[0.0000045865536,0.000022285041,0.99708766,0.000076517106,0.00003132037,0.00023157125,0.00066970335,0.00019918797,0.00007300554,0.000010447907,0.0015871945,0.0000066130074],"about_ca_topic_score_codex":0.95877653,"about_ca_topic_score_gemma":0.9834359,"teacher_disagreement_score":0.041223466,"about_ca_system_score_codex":0.011276947,"about_ca_system_score_gemma":0.012944071,"threshold_uncertainty_score":0.08293241},"labels":[],"label_agreement":null},{"id":"W2562079198","doi":"10.1016/j.jaad.2016.10.027","title":"Inflammatory bowel disease among patients with psoriasis treated with ixekizumab: A presentation of adjudicated data from an integrated database of 7 randomized controlled and uncontrolled trials","year":2016,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":97,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Ixekizumab; Psoriasis; Inflammatory bowel disease; Incidence (geometry); Internal medicine; Ulcerative colitis; Randomized controlled trial; Crohn's disease; Maintenance therapy; Adverse effect; Clinical trial; Disease; Immunology; Psoriatic arthritis; Chemotherapy","score_opus":0.017057090672657114,"score_gpt":0.27503765125479906,"score_spread":0.25798056058214197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2562079198","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6938698,0.22741938,0.00321619,0.0010268014,0.00019646979,0.0037820647,0.067320995,0.00013625232,0.003032076],"genre_scores_gemma":[0.91193855,0.033159558,0.0055794558,0.0015373208,0.00026114928,0.0021380682,0.0448133,0.00007623702,0.0004963673],"study_design_codex":"observational","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9638546,0.016875133,0.010060519,0.004399896,0.00400274,0.0008069761],"domain_scores_gemma":[0.922253,0.042937055,0.026376827,0.0049114353,0.0028195984,0.00070208986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018970234,0.000926038,0.0049171834,0.003673186,0.0004704545,0.0031097,0.001034514,0.001297782,0.001732688],"category_scores_gemma":[0.036939554,0.0007355595,0.006084329,0.0066892924,0.00084080163,0.0018036024,0.0011099973,0.0011287191,0.00025235317],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15888873,0.0009691473,0.46483687,0.047620956,0.24043287,0.0006526365,0.0005504243,0.00093013246,0.0041081207,0.0010179335,0.008620943,0.07137114],"study_design_scores_gemma":[0.08876591,0.0061414107,0.59323305,0.009765481,0.2706311,0.001581192,0.0006215332,0.0012435123,0.0027481676,0.0011351479,0.023868162,0.00026527882],"about_ca_topic_score_codex":0.0016359533,"about_ca_topic_score_gemma":0.0037546305,"teacher_disagreement_score":0.018970234,"about_ca_system_score_codex":0.0010544815,"about_ca_system_score_gemma":0.0016509199,"threshold_uncertainty_score":0.100325406},"labels":[],"label_agreement":null},{"id":"W2563843741","doi":"10.1016/j.jaad.2016.09.038","title":"Ultraviolet radiation and the skin: Photobiology and sunscreen photoprotection","year":2016,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Skin Protection and Aging","field":"Medicine","cited_by":330,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Québec; Centre hospitalier universitaire de Québec","funders":"","keywords":"Photoprotection; Photoaging; Medicine; Dermatology; Actinic keratoses; Photobiology; Confusion; Ultraviolet radiation; Sun exposure; Basal cell; Sunburn; Pathology","score_opus":0.008122123444131055,"score_gpt":0.27381428720677037,"score_spread":0.2656921637626393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563843741","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011017249,0.9737327,0.00030303936,0.006938701,0.0010929921,0.000005463001,0.000020546193,0.000015404068,0.0068739215],"genre_scores_gemma":[0.1671594,0.80965173,0.0006842017,0.0033473482,0.006057011,0.000016161002,0.000032808483,0.000015355015,0.013036009],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99974746,0.00009419832,0.000016345626,0.00002503187,0.000080258586,0.000036826485],"domain_scores_gemma":[0.9997863,0.000072231785,0.00004918982,0.000011191494,0.000043022206,0.000037998918],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046034998,0.00044929938,0.00050169666,0.0008020847,0.00042946957,0.0017330189,0.0003054523,0.0015176132,0.0059378287],"category_scores_gemma":[0.00041723644,0.00016173815,0.00034521817,0.0004934307,0.0006903803,0.001244816,0.00056236325,0.0012985949,0.0007525868],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018391097,0.001067991,0.016222537,0.0052122176,0.00025853593,0.002225963,0.00065614237,0.00077229115,0.047242228,0.025517963,0.043260023,0.855725],"study_design_scores_gemma":[0.00019593241,0.002995241,0.12243796,0.0029407453,0.00042463667,0.017274283,0.0027561039,0.0009119892,0.023233136,0.03952426,0.78717506,0.00013065673],"about_ca_topic_score_codex":0.00075083616,"about_ca_topic_score_gemma":0.0016096836,"teacher_disagreement_score":0.0059378287,"about_ca_system_score_codex":0.0004079624,"about_ca_system_score_gemma":0.0005054604,"threshold_uncertainty_score":0.019863963},"labels":[],"label_agreement":null},{"id":"W2564912853","doi":"10.1016/j.jaad.2016.09.018","title":"Revisiting vertical growth phase and regression for thin melanoma","year":2016,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Sentinel lymph node; Sentinel node; Melanoma; Biopsy; Breslow Thickness; Retrospective cohort study; Lymph node; Regression; Pathology; Cancer; Internal medicine; Statistics; Breast cancer; Mathematics; Cancer research","score_opus":0.020380554428515968,"score_gpt":0.324271816831797,"score_spread":0.303891262403281,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564912853","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.23465422,0.033517774,0.009238377,0.63366264,0.022342863,0.00033720175,0.00023661161,0.00053587335,0.06547448],"genre_scores_gemma":[0.8569647,0.010386226,0.006891613,0.07746849,0.039519213,0.00007041122,0.0001144379,0.00012973387,0.008455182],"study_design_codex":"case_report","study_design_gemma":"not_applicable","domain_scores_codex":[0.99909425,0.00015760343,0.00014920684,0.00012155465,0.00023558884,0.00024181293],"domain_scores_gemma":[0.9976648,0.0012815405,0.00022875155,0.00016145875,0.0002727298,0.0003908202],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011555667,0.00065586326,0.0007191971,0.0015095724,0.0015691993,0.0014970596,0.0012240025,0.008006663,0.0018646412],"category_scores_gemma":[0.008027429,0.0004618594,0.001097112,0.00048185594,0.0015247283,0.0033057642,0.0008050055,0.009524631,0.0008310866],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001939859,0.00014343936,0.02034134,0.00017671532,0.000023203229,0.90002084,0.00033210585,0.00046657358,0.0021236863,0.0033151396,0.035823386,0.037039496],"study_design_scores_gemma":[0.000086439184,0.00023639217,0.007966185,0.0004124955,0.0000643578,0.93606675,0.0007445893,0.0038995093,0.0015043888,0.0070346575,0.041949194,0.000035046232],"about_ca_topic_score_codex":0.0025403425,"about_ca_topic_score_gemma":0.004423651,"teacher_disagreement_score":0.008006663,"about_ca_system_score_codex":0.001748861,"about_ca_system_score_gemma":0.0010814824,"threshold_uncertainty_score":0.012688935},"labels":[],"label_agreement":null},{"id":"W2566440920","doi":"10.1016/j.jaad.2016.10.002","title":"Hair pull test: Evidence-based update and revision of guidelines","year":2016,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Scalp; Demographics; Vellus hair; Cabello; Significant difference; Hair loss; Test (biology); Mean difference; Dermatology; Surgery; Dentistry; Internal medicine; Demography; Confidence interval","score_opus":0.043375028420662036,"score_gpt":0.3545072949195238,"score_spread":0.3111322664988618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2566440920","genre_codex":"review","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0030046036,0.87154615,0.00620158,0.08911309,0.01768792,0.0006063348,0.0017396478,0.00036394747,0.009736732],"genre_scores_gemma":[0.039706666,0.7989255,0.059520207,0.07471854,0.016800648,0.0010551463,0.0049320357,0.000215103,0.0041260864],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9815398,0.0044315187,0.0071542435,0.0010236338,0.005355662,0.00049506326],"domain_scores_gemma":[0.92345715,0.029751329,0.0074351737,0.0017801101,0.036036182,0.0015400742],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01865717,0.0014964353,0.004213601,0.006074283,0.0011341425,0.0037506765,0.0063692564,0.0065339203,0.0023826123],"category_scores_gemma":[0.06501402,0.00094252214,0.004830622,0.0036171714,0.0016751527,0.002957402,0.0018745307,0.007453944,0.0015697253],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005002057,0.00025242163,0.0053127212,0.03382628,0.0015953165,0.0010184268,0.00040510128,0.00084099954,0.0011467825,0.002449551,0.3506425,0.6020097],"study_design_scores_gemma":[0.0008732744,0.00034360687,0.013089282,0.11885075,0.007565341,0.0051839366,0.0006355891,0.0017235328,0.0018990466,0.0051474473,0.8444463,0.00024185724],"about_ca_topic_score_codex":0.011362897,"about_ca_topic_score_gemma":0.024727473,"teacher_disagreement_score":0.01865717,"about_ca_system_score_codex":0.0034501674,"about_ca_system_score_gemma":0.011834157,"threshold_uncertainty_score":0.09866971},"labels":[],"label_agreement":null},{"id":"W2568858752","doi":"10.1016/j.jaad.2016.11.043","title":"Secukinumab sustains early patient-reported outcome benefits through 1 year: Results from 2 phase III randomized placebo-controlled clinical trials comparing secukinumab with etanercept","year":2017,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Secukinumab; Medicine; Dermatology Life Quality Index; Etanercept; Placebo; Quality of life (healthcare); Psoriasis Area and Severity Index; Randomized controlled trial; Psoriasis; Clinical trial; Internal medicine; Dermatology; Psoriatic arthritis; Tumor necrosis factor alpha; Pathology","score_opus":0.09313924228473613,"score_gpt":0.3864747613679332,"score_spread":0.29333551908319705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2568858752","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97677034,0.018982239,0.00057902385,0.0007240473,0.0003942169,0.0005690779,0.0006245049,0.00010151051,0.001254982],"genre_scores_gemma":[0.99197525,0.004661285,0.00052354485,0.00057307805,0.00030597817,0.00044060667,0.00053601246,0.000020073363,0.00096423517],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9990688,0.00042363198,0.00009012827,0.00014876768,0.0000893563,0.00017936903],"domain_scores_gemma":[0.9983991,0.00055614044,0.0005315932,0.00014785609,0.00009395114,0.0002715356],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028014623,0.0014255288,0.0032845454,0.00036575404,0.00045801175,0.001209388,0.00067113165,0.0016844912,0.0039397534],"category_scores_gemma":[0.0021694626,0.0004655593,0.0029785128,0.00038828497,0.0009548595,0.0013461169,0.00032624288,0.0029951762,0.0005842881],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.91826594,0.008924667,0.00158199,0.0012514661,0.0032735877,0.00009727118,0.000094496834,0.0005161495,0.008123139,0.00013358484,0.0011470865,0.05659066],"study_design_scores_gemma":[0.76538086,0.20750873,0.017478442,0.00017094972,0.0035442219,0.00021909218,0.000090826994,0.00051892194,0.0027036055,0.0003112865,0.0020217146,0.000051252842],"about_ca_topic_score_codex":0.0004997015,"about_ca_topic_score_gemma":0.0013217233,"teacher_disagreement_score":0.0039397534,"about_ca_system_score_codex":0.00059733307,"about_ca_system_score_gemma":0.0006857076,"threshold_uncertainty_score":0.014815748},"labels":[],"label_agreement":null},{"id":"W2570141807","doi":"10.1016/j.jaad.2016.11.041","title":"Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the continuous treatment of patients with moderate to severe psoriasis: Results from the phase III, double-blinded, placebo- and active comparator–controlled VOYAGE 1 trial","year":2017,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":860,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Medicine; Psoriasis; Adalimumab; Psoriasis Area and Severity Index; Dermatology Life Quality Index; Internal medicine; Placebo; Adverse effect; Surgery; Gastroenterology; Dermatology","score_opus":0.03413351889159199,"score_gpt":0.3233729633831536,"score_spread":0.2892394444915616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2570141807","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9819178,0.014079144,0.00041182755,0.00055943226,0.00035778424,0.00078805257,0.0007040794,0.000050231145,0.0011316935],"genre_scores_gemma":[0.9914384,0.004240502,0.00055169297,0.00059432647,0.00045579806,0.0007598206,0.00077178824,0.000017184044,0.0011703816],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99868447,0.0008395176,0.00008691145,0.00016578019,0.00011278026,0.00011059194],"domain_scores_gemma":[0.9985393,0.00046418383,0.00047012695,0.00008309138,0.00007700909,0.00036630023],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033677006,0.0013056465,0.0024123336,0.00036778007,0.00036569807,0.0011240183,0.00080753054,0.0015658314,0.0041822717],"category_scores_gemma":[0.002232046,0.0005459982,0.0021185956,0.00029439357,0.0010106205,0.00078210956,0.00033935258,0.0027976658,0.00066818984],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98021245,0.0024900206,0.00082547736,0.00046025758,0.0012508743,0.000016055576,0.000032264652,0.00014287324,0.0021626735,0.000033162127,0.00036582106,0.012008105],"study_design_scores_gemma":[0.91332006,0.07866468,0.005178634,0.00006155662,0.001159248,0.0000430969,0.000019894735,0.00030988632,0.00064884726,0.00008427331,0.0004961381,0.000013750002],"about_ca_topic_score_codex":0.00055413594,"about_ca_topic_score_gemma":0.0010381142,"teacher_disagreement_score":0.0041822717,"about_ca_system_score_codex":0.0006273599,"about_ca_system_score_gemma":0.00065703504,"threshold_uncertainty_score":0.017810345},"labels":[],"label_agreement":null},{"id":"W2572260648","doi":"10.1016/j.jaad.2009.10.031","title":"Alopecia areata update","year":2010,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":287,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Alopecia areata; Intensive care medicine; Disease; Placebo; Therapeutic approach; Randomized controlled trial; Dermatology; Alternative medicine; Surgery; Internal medicine; Pathology","score_opus":0.030613119683569546,"score_gpt":0.3713504874415956,"score_spread":0.34073736775802604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2572260648","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00025241534,0.99592245,0.00011510691,0.00050753244,0.0010264657,0.000007458583,0.000036906702,0.000013935184,0.0021177712],"genre_scores_gemma":[0.0022419845,0.99081844,0.00036677346,0.0014342078,0.0022816232,0.000010354508,0.00012788923,0.0000034721913,0.002715123],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99980086,0.000030431569,0.000040175146,0.0000306071,0.00007129257,0.000026671458],"domain_scores_gemma":[0.99949527,0.00017002049,0.000116116964,0.00001373295,0.00014679134,0.000057969042],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049695,0.0007939425,0.0012999244,0.003169272,0.0002899778,0.0010033916,0.00068314164,0.0010412551,0.0055365223],"category_scores_gemma":[0.0008377587,0.0002794959,0.0005009398,0.00204627,0.000291539,0.0013976643,0.000617278,0.0014249132,0.0020253034],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007854386,0.000094007744,0.00043195253,0.008755256,0.000079119505,0.00085067976,0.00003314971,0.00016823995,0.0007415517,0.00074093946,0.10309097,0.8849355],"study_design_scores_gemma":[0.00005184037,0.0000813197,0.0024410444,0.0038424192,0.0003147498,0.008360501,0.00006704056,0.00012445076,0.0002216904,0.00062417804,0.98385227,0.00001847144],"about_ca_topic_score_codex":0.0015193297,"about_ca_topic_score_gemma":0.0057356665,"teacher_disagreement_score":0.0055365223,"about_ca_system_score_codex":0.0004633134,"about_ca_system_score_gemma":0.0008751083,"threshold_uncertainty_score":0.018521547},"labels":[],"label_agreement":null},{"id":"W2573184894","doi":"10.1016/j.jaad.2016.09.025","title":"Biomechanics in dermatology: Recent advances and future directions","year":2017,"lang":"en","type":"editorial","venue":"Journal of the American Academy of Dermatology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Biomechanics; Context (archaeology); Disease; Psoriasis; Dermatology; Pathology; Physiology; Biology","score_opus":0.010296819747052686,"score_gpt":0.33680624529331776,"score_spread":0.32650942554626505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2573184894","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000072467745,0.08992455,0.00020260895,0.02815188,0.88052696,0.000011059051,0.000025128826,0.000042855372,0.001042422],"genre_scores_gemma":[0.00039587452,0.04827197,0.00014266837,0.007938961,0.9412599,0.00000684622,0.000014411784,0.000010722938,0.0019586917],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975937,0.00046627733,0.00038318,0.0002548888,0.0011235039,0.00017852559],"domain_scores_gemma":[0.9828919,0.007991585,0.0009129562,0.00026104375,0.0062978063,0.0016447371],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005035347,0.0030604645,0.0035880457,0.0031518526,0.0014755665,0.006284518,0.0025209254,0.008788554,0.007138144],"category_scores_gemma":[0.011678878,0.0008165766,0.0017335139,0.0013575028,0.0021097772,0.0043536797,0.0016054414,0.014190085,0.004518958],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008812617,0.000035157824,0.00010321532,0.001196125,0.000041989097,0.00020111834,0.00002744015,0.000050703562,0.00013806639,0.000670789,0.96183795,0.035609443],"study_design_scores_gemma":[0.0001031092,0.00006378751,0.0006280328,0.0015236498,0.0001245326,0.0008620784,0.00012906226,0.0002308494,0.00012478797,0.0020841241,0.99409807,0.000027924294],"about_ca_topic_score_codex":0.0008284572,"about_ca_topic_score_gemma":0.0030781825,"teacher_disagreement_score":0.008788554,"about_ca_system_score_codex":0.0014353388,"about_ca_system_score_gemma":0.0024519898,"threshold_uncertainty_score":0.026629746},"labels":[],"label_agreement":null},{"id":"W2577936807","doi":"10.1016/j.jaad.2016.09.004","title":"Successful treatment of actinic keratoses using nonthermal atmospheric pressure plasma: A case series","year":2017,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Plasma Applications and Diagnostics","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"","keywords":"Medicine; Dielectric barrier discharge; Cancer research; Materials science; Dielectric","score_opus":0.030238288490061594,"score_gpt":0.34547784344708427,"score_spread":0.31523955495702266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2577936807","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9445875,0.011327197,0.017477622,0.0030856978,0.00113468,0.00040233842,0.00029988593,0.0005923026,0.021092711],"genre_scores_gemma":[0.9887706,0.002372755,0.003209812,0.0008171153,0.0009773781,0.000079293546,0.00011036824,0.00007817925,0.0035845814],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9988576,0.00016630795,0.00016402824,0.00019953681,0.0002398121,0.0003726969],"domain_scores_gemma":[0.99839944,0.0005127298,0.0003015851,0.0003141526,0.00009604057,0.00037603307],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040993874,0.003359887,0.0017084513,0.0024166992,0.0042293016,0.0022619285,0.0018234357,0.008806624,0.0022212025],"category_scores_gemma":[0.0027981594,0.0014119558,0.0026115966,0.0014270771,0.0026011642,0.002269676,0.0019258498,0.0035191004,0.0017028037],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022730746,0.00007855922,0.0016250829,0.000025747977,0.000014652857,0.9958625,0.000121094934,0.000081309605,0.00061514444,0.000111195564,0.00014124284,0.0013007874],"study_design_scores_gemma":[0.000009006213,0.000038949773,0.00098884,0.000007235232,0.000012649807,0.9979115,0.00006381633,0.00015916857,0.00046343677,0.00007226367,0.00026363746,0.000009361122],"about_ca_topic_score_codex":0.000659176,"about_ca_topic_score_gemma":0.0010661975,"teacher_disagreement_score":0.008806624,"about_ca_system_score_codex":0.0010999228,"about_ca_system_score_gemma":0.00074914977,"threshold_uncertainty_score":0.007980585},"labels":[],"label_agreement":null},{"id":"W2587514504","doi":"10.1016/j.jaad.2016.12.012","title":"The relationship between neurofibromatosis type 1, juvenile xanthogranuloma, and malignancy: A retrospective case-control study","year":2017,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Neurofibromatosis and Schwannoma Cases","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; SickKids Foundation; Hospital for Sick Children; London Health Sciences Centre; University of Toronto","funders":"","keywords":"Medicine; Malignancy; Neurofibromatosis; Retrospective cohort study; Odds ratio; Juvenile myelomonocytic leukemia; Juvenile xanthogranuloma; Internal medicine; Pathology; Dermatology; Histiocyte; Genetics; Biology","score_opus":0.038510729863846294,"score_gpt":0.33580805498124405,"score_spread":0.29729732511739776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587514504","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992747,0.000237858,0.00010294425,0.000008559045,0.0000063607004,0.000016834958,0.00007657057,0.0000037546322,0.00027260595],"genre_scores_gemma":[0.9995474,0.000089016525,0.000082819075,0.000012732527,0.00001526102,0.000013911664,0.00011454336,0.000002446707,0.00012186196],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988582,0.00026091843,0.00016969285,0.00038689136,0.00015848111,0.00016577076],"domain_scores_gemma":[0.9976804,0.00069074647,0.0006612713,0.0003730052,0.00027854432,0.00031598387],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010997233,0.0005613947,0.00065680774,0.0019055151,0.0014330278,0.0008160298,0.00055977947,0.00089000835,0.0023372564],"category_scores_gemma":[0.0030421908,0.0008718827,0.00058100995,0.0013935937,0.00093705073,0.00084919465,0.00055547646,0.00057663646,0.0004161278],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060899206,0.00031770515,0.9948495,0.000022502352,0.000096413154,0.0017237817,0.00031707104,0.00003319495,0.000998008,0.00005070311,0.00006684703,0.0009152443],"study_design_scores_gemma":[0.000074901945,0.0013044396,0.98721826,0.000008622234,0.00018123344,0.009151266,0.00089904637,0.0002569014,0.00036136014,0.000057369212,0.00046732137,0.00001923489],"about_ca_topic_score_codex":0.0034612466,"about_ca_topic_score_gemma":0.0030820258,"teacher_disagreement_score":0.0034612466,"about_ca_system_score_codex":0.00047849724,"about_ca_system_score_gemma":0.0003680005,"threshold_uncertainty_score":0.007818878},"labels":[],"label_agreement":null},{"id":"W2593211227","doi":"10.1016/j.jaad.2016.12.014","title":"Clinical similarity of biosimilar ABP 501 to adalimumab in the treatment of patients with moderate to severe plaque psoriasis: A randomized, double-blind, multicenter, phase III study","year":2017,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":137,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health; Probity Medical Research","funders":"","keywords":"Adalimumab; Medicine; Psoriasis Area and Severity Index; Clinical endpoint; Confidence interval; Psoriasis; Internal medicine; Adverse effect; Randomized controlled trial; Biosimilar; Surgery; Dermatology; Disease","score_opus":0.05762649998465511,"score_gpt":0.40559744192652836,"score_spread":0.3479709419418732,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593211227","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935182,0.0014697568,0.0006223039,0.0003059927,0.00023174765,0.0026547634,0.00023830871,0.000051684598,0.0009071704],"genre_scores_gemma":[0.9938882,0.000921042,0.0012462803,0.0006313444,0.00040318124,0.0018528498,0.00038347827,0.000014033019,0.0006596498],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99821967,0.0011611833,0.0001238898,0.00019719917,0.0001824417,0.000115689625],"domain_scores_gemma":[0.99739254,0.00083157455,0.0006688762,0.00024780707,0.00020029329,0.0006587468],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0044755065,0.0010915118,0.0022982487,0.0004939359,0.0004918991,0.0011195041,0.00091965665,0.0015842535,0.004106825],"category_scores_gemma":[0.003168695,0.0007054039,0.0017173993,0.00043190768,0.0013179027,0.0009431541,0.0004039193,0.002461159,0.00084432535],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9418737,0.030489784,0.0015267137,0.0004506525,0.0008014962,0.000054636053,0.00008659007,0.00026939064,0.0074010096,0.00008080725,0.00048554662,0.01647961],"study_design_scores_gemma":[0.8225846,0.17279784,0.0028499707,0.000018537925,0.00030428387,0.00005275572,0.000018474917,0.00036456375,0.00059676793,0.00006647759,0.00033245116,0.00001325867],"about_ca_topic_score_codex":0.00038834807,"about_ca_topic_score_gemma":0.00064776425,"teacher_disagreement_score":0.0044755065,"about_ca_system_score_codex":0.00068595406,"about_ca_system_score_gemma":0.0013446003,"threshold_uncertainty_score":0.023669004},"labels":[],"label_agreement":null},{"id":"W2605226576","doi":"10.1016/j.jaad.2017.02.054","title":"The effectiveness of treatments for androgenetic alopecia: A systematic review and meta-analysis","year":2017,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":407,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Finasteride; Medicine; Minoxidil; Hair loss; Randomized controlled trial; Dermatology; Placebo; Meta-analysis; Male-pattern baldness; Testosterone (patch); Dihydrotestosterone; Internal medicine; Androgen; Scalp; Alternative medicine; Pathology; Hormone","score_opus":0.09822122791610173,"score_gpt":0.43626630755217244,"score_spread":0.3380450796360707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2605226576","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005564317,0.9935546,0.00019977351,0.00008761667,0.00010536545,0.00010695982,0.00021091658,0.000012135038,0.00015842379],"genre_scores_gemma":[0.21961826,0.7762528,0.0016004413,0.001147928,0.00026279452,0.00031750096,0.00046867767,0.000020903717,0.00031069212],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.995574,0.00164075,0.0014980487,0.00056673825,0.00050371373,0.00021678077],"domain_scores_gemma":[0.99030507,0.0069657615,0.0018100975,0.00027941822,0.0004817593,0.00015789013],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006190669,0.0024208815,0.016291043,0.003707207,0.0005655268,0.0024503912,0.002106568,0.0024923626,0.004640154],"category_scores_gemma":[0.016847614,0.0015197397,0.026206119,0.0041237804,0.0008451137,0.001956801,0.0015700766,0.002238349,0.00028231626],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039677415,0.000070507755,0.0037733247,0.36712903,0.6088012,0.0001571947,0.00012148642,0.00030878704,0.0002918161,0.00011568946,0.0005456324,0.01471769],"study_design_scores_gemma":[0.0012242498,0.00025066177,0.0034204945,0.01412854,0.97935337,0.00009190323,0.00006522953,0.0000898645,0.00007353058,0.00013020754,0.00114608,0.00002583619],"about_ca_topic_score_codex":0.0052699656,"about_ca_topic_score_gemma":0.016877592,"teacher_disagreement_score":0.016291043,"about_ca_system_score_codex":0.0017097701,"about_ca_system_score_gemma":0.0018457245,"threshold_uncertainty_score":0.032739818},"labels":[],"label_agreement":null},{"id":"W2606149747","doi":"10.1016/j.jaad.2016.11.067","title":"Conclusions about atopic dermatitis persistence might be premature","year":2017,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"National Institute for Health and Care Research","keywords":"Atopic dermatitis; Medicine; Persistence (discontinuity); Scopus; Terminology; Asymptomatic; Dermatology; Meta-analysis; MEDLINE; Disease; Surgery; Pathology","score_opus":0.023813808293979246,"score_gpt":0.3103662565157061,"score_spread":0.2865524482217269,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2606149747","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012065149,0.0013966266,0.00012695848,0.9748571,0.018097455,0.0000056628974,0.00001792702,0.0000152151015,0.0042765266],"genre_scores_gemma":[0.023483455,0.002270346,0.00031400728,0.8862324,0.08300815,0.000018297802,0.000045819714,0.00002041721,0.004607182],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99586064,0.0016982803,0.0004649988,0.0005153329,0.0010190358,0.000441729],"domain_scores_gemma":[0.97207314,0.019449722,0.0016994005,0.0010928294,0.0038763015,0.0018086747],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005989274,0.00060529524,0.0011454964,0.0007969885,0.0032642952,0.003977212,0.0019860042,0.035351705,0.008570214],"category_scores_gemma":[0.061332628,0.0003931378,0.0010057775,0.0005322655,0.0051805438,0.005514366,0.0016962924,0.045088112,0.0067439904],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024524197,0.00020098605,0.008714203,0.00021805802,0.00010267967,0.023432977,0.0009869195,0.00018677516,0.0004962869,0.031018348,0.8971457,0.037251838],"study_design_scores_gemma":[0.00030666217,0.00018039228,0.0028724617,0.0012961146,0.00015344717,0.019721214,0.0023387794,0.00072713074,0.00066203787,0.099931985,0.8717099,0.00009992181],"about_ca_topic_score_codex":0.001027356,"about_ca_topic_score_gemma":0.0010657939,"teacher_disagreement_score":0.035351705,"about_ca_system_score_codex":0.002382644,"about_ca_system_score_gemma":0.0016438429,"threshold_uncertainty_score":0.031674683},"labels":[],"label_agreement":null},{"id":"W2606731929","doi":"10.1016/j.jaad.2017.01.052","title":"Long-term safety and tolerability of apremilast in patients with psoriasis: Pooled safety analysis for ≥156 weeks from 2 phase 3, randomized, controlled trials (ESTEEM 1 and 2)","year":2017,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":192,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"Cilag; LEO Pharma; Astellas Pharma; Regeneron Pharmaceuticals; Celgene; GlaxoSmithKline; Biogen; Amgen; Pfizer; Eli Lilly and Company","keywords":"Medicine; Apremilast; Tolerability; Psoriasis; Randomized controlled trial; Safety profile; Pooled analysis; Adverse effect; Dermatology; Internal medicine; Meta-analysis; Psoriatic arthritis","score_opus":0.016826691240104122,"score_gpt":0.2979934696584649,"score_spread":0.2811667784183608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2606731929","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.56328255,0.40915018,0.011280936,0.00061818643,0.00072808674,0.0038030345,0.007469304,0.0005218668,0.0031457865],"genre_scores_gemma":[0.95407605,0.031960834,0.0037606307,0.0007597149,0.0005629764,0.0025994792,0.0054689045,0.00008670258,0.00072465825],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9814038,0.01066853,0.003531477,0.0021777928,0.0018064218,0.00041201044],"domain_scores_gemma":[0.97583735,0.012084448,0.008070024,0.0020095888,0.0014316128,0.00056704355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.035213728,0.002311114,0.007833124,0.0022549264,0.00045279707,0.0022940102,0.00079101464,0.001660664,0.0029592784],"category_scores_gemma":[0.024605745,0.0011344007,0.024407633,0.002281074,0.0006375998,0.0017638828,0.0011220141,0.0017837749,0.00035547352],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.39230987,0.0005283846,0.025576644,0.014635676,0.5227986,0.00015112376,0.00010106675,0.002232072,0.0027631442,0.00009443772,0.001048976,0.03776007],"study_design_scores_gemma":[0.20483947,0.04428482,0.16575184,0.0019376444,0.5721716,0.0008272192,0.000120118704,0.0024588136,0.0016634914,0.0007808484,0.004939794,0.00022431926],"about_ca_topic_score_codex":0.00053614296,"about_ca_topic_score_gemma":0.0011978477,"teacher_disagreement_score":0.035213728,"about_ca_system_score_codex":0.00076668937,"about_ca_system_score_gemma":0.0010787458,"threshold_uncertainty_score":0.18623018},"labels":[],"label_agreement":null},{"id":"W2608915546","doi":"10.1016/j.jaad.2005.01.054","title":"Generalized eczematoid graft-versus-host disease: Presentation, natural history, and treatment","year":2005,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Food Allergy and Anaphylaxis Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Natural history; Presentation (obstetrics); Disease; Surgery; Pathology; Internal medicine","score_opus":0.027337274229234345,"score_gpt":0.3352402956739837,"score_spread":0.3079030214447494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2608915546","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9660513,0.025478868,0.00089210976,0.0011790689,0.000080347556,0.0001094316,0.00011970096,0.000039317758,0.0060497737],"genre_scores_gemma":[0.99096537,0.00707905,0.0003691405,0.00038382612,0.00035248365,0.00003457217,0.00014915087,0.0000055292103,0.0006609176],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9997737,0.00006886307,0.000021115879,0.00003261916,0.000039017505,0.00006474073],"domain_scores_gemma":[0.9996536,0.000109505076,0.00007406905,0.000021511993,0.00003224738,0.000108980836],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003385849,0.00049484137,0.0006059937,0.00052653,0.00040680123,0.0004360286,0.0003584529,0.00083897455,0.00094973453],"category_scores_gemma":[0.0010348157,0.00017616653,0.000391434,0.00041780737,0.0003985203,0.00072444184,0.00027761218,0.0007479382,0.00024071171],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019396289,0.0017914872,0.6001507,0.00038718214,0.00015742588,0.25828484,0.0005037883,0.0008136486,0.0076409853,0.0012813485,0.0034232275,0.12362576],"study_design_scores_gemma":[0.00029370308,0.0013883358,0.4641958,0.000115148025,0.00010029128,0.5276701,0.0006617716,0.0012176894,0.0005141742,0.0011143014,0.0026821555,0.00004659514],"about_ca_topic_score_codex":0.00060213916,"about_ca_topic_score_gemma":0.0013140787,"teacher_disagreement_score":0.00094973453,"about_ca_system_score_codex":0.00038325434,"about_ca_system_score_gemma":0.00035560044,"threshold_uncertainty_score":0.0031772256},"labels":[],"label_agreement":null},{"id":"W2621893371","doi":"10.1016/j.jaad.2017.02.030","title":"Development of classification criteria for discoid lupus erythematosus: Results of a Delphi exercise","year":2017,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Discoid lupus erythematosus; Medicine; Delphi method; Observational study; Cutaneous Lupus Erythematosus; Delphi; Expert opinion; Nominal group; Medical diagnosis; Nominal group technique; MEDLINE; Medical physics; Artificial intelligence; Computer science; Pathology; Lupus erythematosus; Intensive care medicine","score_opus":0.08082407946977366,"score_gpt":0.40469511250655366,"score_spread":0.32387103303678,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2621893371","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.74631774,0.0071081338,0.13907816,0.01423137,0.0023844556,0.021283748,0.003148181,0.0002549658,0.06619328],"genre_scores_gemma":[0.67542833,0.0028210813,0.2987897,0.0010237099,0.00039529268,0.010486513,0.003740196,0.00024830736,0.007066846],"study_design_codex":"design_other","study_design_gemma":"qualitative","domain_scores_codex":[0.9799907,0.009994193,0.004016961,0.00076799653,0.0043555256,0.00087452546],"domain_scores_gemma":[0.95096016,0.01702502,0.0017294625,0.0021806015,0.0264872,0.0016175102],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.039788682,0.0007616266,0.00094498944,0.004459099,0.0022565466,0.0017413889,0.0020179688,0.0008783391,0.0046412866],"category_scores_gemma":[0.059149455,0.00035656744,0.0012896912,0.0015490869,0.001119662,0.0017011653,0.0025899038,0.0017329521,0.0010509418],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013431021,0.0017051682,0.1694981,0.0022510784,0.00022280493,0.0015522364,0.025740033,0.004003616,0.013983717,0.011521092,0.052992437,0.7151867],"study_design_scores_gemma":[0.0015203482,0.0029234635,0.39986938,0.010481103,0.0017160026,0.011567238,0.09029393,0.055205327,0.02549145,0.030908594,0.369377,0.00064612855],"about_ca_topic_score_codex":0.0052043465,"about_ca_topic_score_gemma":0.0066642547,"teacher_disagreement_score":0.039788682,"about_ca_system_score_codex":0.0026824677,"about_ca_system_score_gemma":0.005373249,"threshold_uncertainty_score":0.21042514},"labels":[],"label_agreement":null},{"id":"W2734342691","doi":"10.1016/j.jaad.2017.05.036","title":"Early clinical manifestations of Sézary syndrome: A multicenter retrospective cohort study","year":2017,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Retrospective cohort study; Multicenter study; Cohort study; Cohort; Oncology; Internal medicine; Randomized controlled trial","score_opus":0.03775929170950966,"score_gpt":0.4247745084471952,"score_spread":0.3870152167376856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2734342691","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99948514,0.00011815577,0.00006254927,0.000016316671,0.000004008637,0.000009636582,0.00013294077,0.000002367768,0.00016883858],"genre_scores_gemma":[0.99936885,0.00010298744,0.000069185044,0.000025954832,0.000013105289,0.0000123626,0.00028408124,0.00000431809,0.00011921474],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99908984,0.00019690763,0.00008647167,0.00034636268,0.00009774603,0.00018266658],"domain_scores_gemma":[0.998139,0.00025195384,0.00067657453,0.00029751586,0.00019620518,0.00043869216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007691405,0.0008245159,0.0009973105,0.0010952767,0.001082607,0.0011693815,0.0007192475,0.00089298905,0.0026018447],"category_scores_gemma":[0.00216146,0.0009839254,0.00081350957,0.0014144334,0.00061641436,0.0015284459,0.0009749454,0.00096378423,0.0004927466],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024691032,0.000081449165,0.99793255,0.000005516424,0.000071886316,0.00055321906,0.00010828425,0.000015804271,0.00041964927,0.000025077885,0.000075405864,0.00046432402],"study_design_scores_gemma":[0.000049241076,0.000262071,0.9958923,0.00000769561,0.000093707735,0.002567269,0.0006743586,0.00013351455,0.00007524202,0.00004143447,0.00019132975,0.000011828964],"about_ca_topic_score_codex":0.0028855228,"about_ca_topic_score_gemma":0.0026586233,"teacher_disagreement_score":0.0028855228,"about_ca_system_score_codex":0.00042163138,"about_ca_system_score_gemma":0.0006539455,"threshold_uncertainty_score":0.008704007},"labels":[],"label_agreement":null},{"id":"W2735708380","doi":"10.1016/j.jaad.2017.03.026","title":"Rapid onset of action in patients with moderate-to-severe psoriasis treated with brodalumab: A pooled analysis of data from two phase 3 randomized clinical trials (AMAGINE-2 and AMAGINE-3)","year":2017,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":55,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Medicine; Psoriasis; Dermatology; Pooled analysis; Randomized controlled trial; Onset of action; Clinical trial; Internal medicine; Meta-analysis","score_opus":0.07260214420150735,"score_gpt":0.3822649441781529,"score_spread":0.30966279997664553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2735708380","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.62210876,0.2256065,0.0039925748,0.10537995,0.010145281,0.0012838286,0.013791367,0.00034736874,0.017344303],"genre_scores_gemma":[0.91593367,0.016556477,0.0025508439,0.05232874,0.0067938445,0.00041777952,0.0030394155,0.00006350254,0.0023156723],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9893128,0.0072027105,0.0010566153,0.0010020584,0.0010071789,0.000418707],"domain_scores_gemma":[0.9756634,0.017155485,0.00407008,0.0010543828,0.0013686457,0.00068794366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012748506,0.00072197965,0.0040701455,0.0004702122,0.00037985158,0.0020420717,0.0008753513,0.003111483,0.0024620758],"category_scores_gemma":[0.019833934,0.0005050376,0.0052419086,0.0010519656,0.0005787605,0.00097343157,0.00048004754,0.003268159,0.0004467706],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.43743214,0.0008636012,0.13456322,0.008778021,0.09472839,0.0041758493,0.00030333412,0.0019178931,0.0059717647,0.0010865642,0.08858097,0.22159833],"study_design_scores_gemma":[0.32074866,0.032327,0.33075002,0.002696644,0.20607404,0.008159546,0.00061006803,0.006781376,0.005143323,0.00760475,0.078552686,0.0005518443],"about_ca_topic_score_codex":0.0007018426,"about_ca_topic_score_gemma":0.0024430847,"teacher_disagreement_score":0.012748506,"about_ca_system_score_codex":0.00091837475,"about_ca_system_score_gemma":0.0010389849,"threshold_uncertainty_score":0.06742138},"labels":[],"label_agreement":null},{"id":"W2744776760","doi":"10.1016/j.jaad.2017.06.042","title":"When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema Council","year":2017,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":236,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Sanofi Genzyme; Novartis Pharma; LEO Pharma; LEO Fondet; Astellas Pharma; Yonsei University; Dermira; Chugai Pharmaceutical; Wellcome Trust; Regeneron Pharmaceuticals; Genentech; Valeant Pharmaceuticals International; Sanofi; Biotechnology and Biological Sciences Research Council; Amgen; Pfizer; Les Laboratories Pierre Fabre; Medical Research Council; Celgene; Galderma; AstraZeneca; Eli Lilly and Company; GlaxoSmithKline","keywords":"Medicine; Atopic dermatitis; Warrant; Dermatology; Systemic therapy; Intensive care medicine; Internal medicine","score_opus":0.14264748435878807,"score_gpt":0.39459858545002047,"score_spread":0.2519511010912324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2744776760","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000864599,0.89978886,0.002309378,0.08418705,0.004928562,0.0013689308,0.00089032337,0.000069869544,0.0055924566],"genre_scores_gemma":[0.012528371,0.93609995,0.021189006,0.023798246,0.0015815309,0.0017129495,0.0013665084,0.000037392194,0.0016860084],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9812383,0.0064388155,0.007802592,0.00080705096,0.0032538082,0.0004595251],"domain_scores_gemma":[0.95275426,0.019317206,0.00592994,0.0007879766,0.01976926,0.0014412901],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.030626202,0.001597694,0.0041198814,0.008709762,0.0013919976,0.0027569276,0.005206947,0.005123034,0.0045316163],"category_scores_gemma":[0.0722063,0.0010071065,0.004789586,0.0058847917,0.0011595396,0.0051031923,0.0023337486,0.0041877883,0.0021593578],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000220394,0.00007636308,0.0026003346,0.13787787,0.001082997,0.00071505044,0.0013977148,0.00030909362,0.0005450766,0.0019319429,0.2356245,0.6176187],"study_design_scores_gemma":[0.00032424057,0.00011899286,0.0043707406,0.45219532,0.004531156,0.0013831052,0.0019180442,0.00029999163,0.00037244998,0.0044105104,0.52991796,0.0001573841],"about_ca_topic_score_codex":0.009992227,"about_ca_topic_score_gemma":0.020370932,"teacher_disagreement_score":0.030626202,"about_ca_system_score_codex":0.0037825278,"about_ca_system_score_gemma":0.017831618,"threshold_uncertainty_score":0.16196883},"labels":[],"label_agreement":null},{"id":"W2747741688","doi":"10.1016/j.jaad.2017.06.014","title":"Wilms tumor screening in diffuse capillary malformation with overgrowth and macrocephaly–capillary malformation: A retrospective study","year":2017,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Renal and related cancers","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Macrocephaly; Wilms' tumor; Retrospective cohort study; Pathology","score_opus":0.006467025402142431,"score_gpt":0.2594129995376819,"score_spread":0.25294597413553943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2747741688","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992386,0.00016856434,0.000068713794,0.000012068983,0.0000032643159,0.0000070560345,0.00010893424,0.0000024494082,0.00039041648],"genre_scores_gemma":[0.99954826,0.000102319114,0.000034193374,0.000018309745,0.0000075838134,0.000003608323,0.00016638849,0.00000256803,0.00011679783],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992505,0.00010805584,0.00010271543,0.0002714602,0.00010869395,0.00015863],"domain_scores_gemma":[0.99862933,0.00023568097,0.00041632133,0.000186197,0.00018876679,0.00034374447],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038801855,0.00045930833,0.00049981894,0.0014012167,0.00086637883,0.0007555402,0.00043943556,0.000718334,0.0019305081],"category_scores_gemma":[0.001677939,0.00080038665,0.00064004,0.0016130466,0.0007111686,0.0007586881,0.00066096825,0.0005962984,0.0003600998],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011363713,0.000044362674,0.9956116,0.0000058789524,0.00003111585,0.003258088,0.00011115494,0.00002161194,0.00028359462,0.000023204258,0.000038720427,0.0004570571],"study_design_scores_gemma":[0.000017485692,0.00032872226,0.97111964,0.000012994685,0.00014152686,0.02627214,0.0010393073,0.00023555358,0.00027366422,0.000060322047,0.00047948238,0.000019224544],"about_ca_topic_score_codex":0.0068031736,"about_ca_topic_score_gemma":0.0043749423,"teacher_disagreement_score":0.0068031736,"about_ca_system_score_codex":0.00045037526,"about_ca_system_score_gemma":0.0006585867,"threshold_uncertainty_score":0.013527155},"labels":[],"label_agreement":null},{"id":"W2751640077","doi":"10.1016/j.jaad.2017.07.013","title":"Risk of malignancy with systemic psoriasis treatment in the Psoriasis Longitudinal Assessment Registry","year":2017,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":157,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; University of British Columbia","funders":"","keywords":"Medicine; Psoriasis; Malignancy; Ustekinumab; Odds ratio; Internal medicine; Cancer registry; Risk factor; Cancer; Dermatology; Disease; Adalimumab","score_opus":0.022223092664554342,"score_gpt":0.3001702996194061,"score_spread":0.27794720695485176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2751640077","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99265796,0.0012636781,0.0007936526,0.0002445808,0.000016617287,0.00008805177,0.0035066656,0.000031613657,0.001397301],"genre_scores_gemma":[0.99601597,0.00057507347,0.0005394623,0.00009344021,0.000034865283,0.000083180246,0.0023728875,0.00000716141,0.00027793355],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99640745,0.0016395041,0.00034175266,0.0006858537,0.00066359784,0.00026181978],"domain_scores_gemma":[0.9900558,0.001535835,0.006228998,0.0008921538,0.0007341596,0.0005532223],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034133077,0.00019333443,0.00036015545,0.000915742,0.0004579229,0.00059564033,0.00050860597,0.00023295011,0.0017771401],"category_scores_gemma":[0.0057458864,0.0002696511,0.0005346643,0.0015256628,0.00020244576,0.0005271304,0.00077798846,0.0005458606,0.00022280499],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018901129,0.000029536212,0.9973219,0.000018091407,0.000077079545,0.000043780685,0.000031597683,0.00002738419,0.0000860521,0.00003187419,0.0002897152,0.0018539571],"study_design_scores_gemma":[0.00004769551,0.0001746512,0.997375,0.000024310259,0.0001137965,0.00049279036,0.00009213588,0.00028077906,0.00021398549,0.000040371477,0.0011374573,0.0000070288847],"about_ca_topic_score_codex":0.007729549,"about_ca_topic_score_gemma":0.007191919,"teacher_disagreement_score":0.007729549,"about_ca_system_score_codex":0.00041335612,"about_ca_system_score_gemma":0.0006977069,"threshold_uncertainty_score":0.018051505},"labels":[],"label_agreement":null},{"id":"W2755831795","doi":"10.1016/j.jaad.2017.06.153","title":"Efficacy and safety of ixekizumab for the treatment of moderate-to-severe plaque psoriasis: Results through 108 weeks of a randomized, controlled phase 3 clinical trial (UNCOVER-3)","year":2017,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":113,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; SKiN Health","funders":"Eli Lilly and Company","keywords":"Ixekizumab; Medicine; Plaque psoriasis; Psoriasis; Randomized controlled trial; Clinical trial; Dermatology; Internal medicine; Secukinumab; Psoriatic arthritis","score_opus":0.04825524568326119,"score_gpt":0.3700946110253621,"score_spread":0.32183936534210095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2755831795","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99186605,0.0027600299,0.00063905853,0.0003786542,0.00013523908,0.002000224,0.0011298776,0.00009257991,0.0009981957],"genre_scores_gemma":[0.99023527,0.001745317,0.0016088752,0.0005487031,0.0002600615,0.0029312933,0.0014736383,0.00003171429,0.0011651135],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9983394,0.0010516731,0.00009018916,0.000182306,0.000141986,0.00019441012],"domain_scores_gemma":[0.9981129,0.00049988687,0.0006212474,0.0001761378,0.000104745064,0.00048511795],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005443084,0.0014280928,0.0020996402,0.00026234286,0.00044716304,0.0009266157,0.0007378978,0.0011744597,0.0031123722],"category_scores_gemma":[0.0025403982,0.00044219082,0.002413727,0.00032635612,0.0009170321,0.00079750427,0.000391815,0.0024850671,0.0004626514],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9662996,0.008407803,0.0024196303,0.00034080917,0.00092602544,0.00003168384,0.00006320294,0.00037437474,0.0031641447,0.000060004153,0.00082396425,0.01708882],"study_design_scores_gemma":[0.88073176,0.106756166,0.009621579,0.00003520859,0.0007939412,0.00006610317,0.000024805055,0.0005060031,0.0006972408,0.00015318423,0.0005943074,0.00001972049],"about_ca_topic_score_codex":0.00071357464,"about_ca_topic_score_gemma":0.0015915798,"teacher_disagreement_score":0.005443084,"about_ca_system_score_codex":0.0006240984,"about_ca_system_score_gemma":0.0013293712,"threshold_uncertainty_score":0.028786123},"labels":[],"label_agreement":null},{"id":"W2755910317","doi":"10.1016/j.jaad.2017.02.051","title":"Use of capsule endoscopy to identify lesions suggestive of Crohn's disease in patients with moderate to severe psoriasis","year":2017,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lynde Centre for Dermatology; Hôpital du Sacré-Cœur de Montréal; Innovaderm (Canada)","funders":"","keywords":"Medicine; Psoriasis; Ankylosing spondylitis; Psoriatic arthritis; Inflammatory bowel disease; Capsule endoscopy; Disease; Dermatology; Population; Internal medicine; Gastroenterology","score_opus":0.024871127265794175,"score_gpt":0.28964748185703637,"score_spread":0.2647763545912422,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2755910317","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.39973444,0.014991015,0.0024160685,0.49609697,0.009396825,0.00014789023,0.00028353455,0.00026584117,0.07666741],"genre_scores_gemma":[0.9043271,0.0034420919,0.001037165,0.067112066,0.020372951,0.000026918398,0.000118379976,0.000040901,0.0035224336],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.9991366,0.00023883839,0.00014477773,0.00010769706,0.0001816401,0.00019043944],"domain_scores_gemma":[0.99733704,0.0014688122,0.00025572345,0.00014269879,0.00029964952,0.000496134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074169703,0.0005477726,0.0006953202,0.00092246756,0.0011930435,0.001138514,0.0007759066,0.0077745384,0.0019895497],"category_scores_gemma":[0.0093530845,0.0004412609,0.0010430849,0.00050497934,0.0009733764,0.0012315683,0.0003730068,0.004635655,0.00085746666],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00063515094,0.00035839394,0.20020951,0.00017265612,0.00013359387,0.68420756,0.0006154791,0.00034486945,0.0031683429,0.001529693,0.07683942,0.031785276],"study_design_scores_gemma":[0.00022240807,0.00058336,0.08392151,0.00043803203,0.00019395223,0.8745667,0.0011863858,0.003098587,0.0013590225,0.0026126446,0.031739634,0.0000778767],"about_ca_topic_score_codex":0.0021857375,"about_ca_topic_score_gemma":0.0031677252,"teacher_disagreement_score":0.0077745384,"about_ca_system_score_codex":0.0011547914,"about_ca_system_score_gemma":0.00072402734,"threshold_uncertainty_score":0.0083786845},"labels":[],"label_agreement":null},{"id":"W2761027005","doi":"10.1016/j.jaad.2017.09.055","title":"Machine learning and melanoma: The future of screening","year":2017,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McGill University Health Centre","funders":"","keywords":"Medicine; Melanoma; Dermatology; Medical physics; Artificial intelligence; Cancer research","score_opus":0.0368191399328495,"score_gpt":0.35697655699890596,"score_spread":0.32015741706605644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2761027005","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000035813788,0.9983537,0.00006862729,0.0010524984,0.00025835034,0.0000011214615,0.0000055013275,0.000003180416,0.00022127968],"genre_scores_gemma":[0.00079219794,0.99732494,0.00014806085,0.0007883137,0.0007685887,0.0000022830795,0.0000109940065,9.927934e-7,0.00016365634],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994191,0.00017820919,0.00008614568,0.000080710946,0.00019312737,0.000042701286],"domain_scores_gemma":[0.9960951,0.0026591336,0.00035082406,0.00006100945,0.0006698479,0.00016413059],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016663587,0.0006090297,0.0014288069,0.0022631139,0.0003265718,0.0017063543,0.00091237685,0.0021906497,0.0037729805],"category_scores_gemma":[0.003917662,0.0002638821,0.0007216887,0.0020600911,0.0010011819,0.0026064038,0.00088255166,0.0030498395,0.00078840303],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000064996086,0.000059335245,0.0005464455,0.014163726,0.00011409801,0.000112553425,0.00004745629,0.00032742642,0.00030339038,0.005406399,0.0482967,0.9305575],"study_design_scores_gemma":[0.00003897191,0.00012487744,0.0025412645,0.018504985,0.0002974766,0.0014997623,0.00019313267,0.00052749534,0.00019946831,0.009888128,0.9661384,0.000046013327],"about_ca_topic_score_codex":0.0025136026,"about_ca_topic_score_gemma":0.004686133,"teacher_disagreement_score":0.0037729805,"about_ca_system_score_codex":0.0011364844,"about_ca_system_score_gemma":0.0021232408,"threshold_uncertainty_score":0.01262188},"labels":[],"label_agreement":null},{"id":"W2761544020","doi":"10.1016/j.jaad.2017.09.067","title":"Short-term reasons for withdrawal and adverse events associated with apremilast therapy for psoriasis in real-world practice compared with in clinical trials: A multicenter retrospective study","year":2017,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Health Sciences Centre; Sunnybrook Health Science Centre; Western University; Women's College Hospital; University of Toronto","funders":"","keywords":"Apremilast; Medicine; Psoriasis; Adverse effect; Clinical trial; Multicenter study; Intensive care medicine; Retrospective cohort study; Clinical Practice; Term (time); Dermatology; Randomized controlled trial; Internal medicine; Physical therapy; Psoriatic arthritis","score_opus":0.1592838063198003,"score_gpt":0.5008581732316327,"score_spread":0.3415743669118324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2761544020","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99231064,0.0044097137,0.00032574296,0.0012027237,0.000086859036,0.00009389453,0.0006213378,0.0000061155724,0.00094298174],"genre_scores_gemma":[0.9970126,0.00082661543,0.00030647067,0.0010193913,0.00026684362,0.00006301466,0.0003011713,0.0000042981414,0.0001995696],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9882339,0.0054336977,0.0032705495,0.0010972691,0.0015022297,0.00046231505],"domain_scores_gemma":[0.92261153,0.028989369,0.04003741,0.002785131,0.0033172255,0.0022593215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0075516356,0.00022636077,0.00087830436,0.0006614739,0.0004894035,0.0015028507,0.0003350625,0.0011426068,0.0013959523],"category_scores_gemma":[0.033674385,0.000264412,0.0012167646,0.001777223,0.0005737367,0.0009705709,0.00045781708,0.001280134,0.00021875289],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031956697,0.00015215352,0.98902506,0.00016867995,0.00075626525,0.0005335517,0.00017295268,0.000032033542,0.00018317475,0.00005639487,0.00047551602,0.005248525],"study_design_scores_gemma":[0.00072170154,0.0023802062,0.98801816,0.00013321251,0.001141726,0.004263403,0.0006486415,0.00032543816,0.0002381129,0.0001828789,0.0019102271,0.000036366844],"about_ca_topic_score_codex":0.0006692191,"about_ca_topic_score_gemma":0.0010864623,"teacher_disagreement_score":0.0075516356,"about_ca_system_score_codex":0.00071397534,"about_ca_system_score_gemma":0.00074873434,"threshold_uncertainty_score":0.039937377},"labels":[],"label_agreement":null},{"id":"W2761855876","doi":"10.1016/j.jaad.2017.09.052","title":"Risk of infection in patients with atopic dermatitis treated with dupilumab: A meta-analysis of randomized controlled trials","year":2017,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":132,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"","keywords":"Dupilumab; Atopic dermatitis; Medicine; Placebo; Odds ratio; Randomized controlled trial; Meta-analysis; Dermatology; Internal medicine; Eczema Area and Severity Index; Confidence interval; Subgroup analysis; Relative risk; Pathology","score_opus":0.06020756757462335,"score_gpt":0.379972048483526,"score_spread":0.31976448090890264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2761855876","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02458583,0.9738743,0.0005487171,0.0001184604,0.00020562208,0.000097858116,0.0003042966,0.000025343557,0.00023959346],"genre_scores_gemma":[0.5517941,0.44283137,0.002320125,0.0010257887,0.00046647777,0.0002714029,0.00081389624,0.000033986744,0.00044287412],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99528015,0.0022640673,0.0010881602,0.00075205555,0.00039484663,0.00022085062],"domain_scores_gemma":[0.9920907,0.0060631083,0.0011047823,0.00029137117,0.00031785428,0.00013218635],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0060177348,0.0024955927,0.012923648,0.0016628308,0.000452179,0.0023246827,0.0018454846,0.0021298798,0.0027904913],"category_scores_gemma":[0.0121454485,0.0014539099,0.028560763,0.0024261188,0.000602479,0.001414368,0.0010355056,0.0028129953,0.00018571172],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018436901,0.00007332991,0.011942689,0.10566695,0.84895307,0.00015815547,0.0000671189,0.00059170456,0.00033610727,0.0001261054,0.00050397107,0.013143919],"study_design_scores_gemma":[0.0030800342,0.0004562798,0.007634879,0.0033378517,0.9839901,0.00010113365,0.000047265465,0.0002825815,0.00011400709,0.00020012588,0.00072569604,0.000030009824],"about_ca_topic_score_codex":0.0028880346,"about_ca_topic_score_gemma":0.0059043844,"teacher_disagreement_score":0.012923648,"about_ca_system_score_codex":0.0010333606,"about_ca_system_score_gemma":0.0009916362,"threshold_uncertainty_score":0.031825185},"labels":[],"label_agreement":null},{"id":"W2763303699","doi":"10.1016/j.jaad.2017.09.060","title":"A comparison of apremilast monotherapy and combination therapy for plaque psoriasis in clinical practice: A Canadian multicenter retrospective study","year":2017,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Probity Medical Research; Health Sciences Centre; Sunnybrook Health Science Centre; Western University; Women's College Hospital; University of Toronto","funders":"","keywords":"Medicine; Apremilast; Plaque psoriasis; Psoriasis; Multicenter study; Dermatology; Combination therapy; Retrospective cohort study; Internal medicine; Psoriatic arthritis; Randomized controlled trial","score_opus":0.04424193430005016,"score_gpt":0.38726106175395353,"score_spread":0.3430191274539034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2763303699","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99222773,0.00347889,0.00016724743,0.0007324175,0.00005247985,0.00014160293,0.0012281182,0.0000072974085,0.0019640457],"genre_scores_gemma":[0.9969194,0.0010856006,0.00027727318,0.0005741077,0.00006909897,0.000043101336,0.0007057262,0.000009994508,0.0003159356],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9948078,0.0008960247,0.00052479474,0.0010337272,0.0015659889,0.0011717322],"domain_scores_gemma":[0.9894359,0.0014221789,0.0030941595,0.0005854067,0.0038777213,0.0015846227],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031152777,0.0007758097,0.0016508051,0.0016983981,0.0022153186,0.0020251193,0.0016485435,0.0014826447,0.0023142067],"category_scores_gemma":[0.009022871,0.0008756855,0.0014762938,0.006152537,0.0017347835,0.001031875,0.000978632,0.001507979,0.0002940592],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001802747,0.00014999358,0.9909548,0.00014231488,0.0005440259,0.0005739996,0.00060506415,0.000050332867,0.00028436238,0.00015828208,0.00092069164,0.0038133687],"study_design_scores_gemma":[0.00056075293,0.00080695923,0.99221873,0.0001251839,0.00081161695,0.0012474821,0.002010779,0.00028515497,0.000093468094,0.00006945667,0.0017091442,0.000061217484],"about_ca_topic_score_codex":0.76947516,"about_ca_topic_score_gemma":0.7623194,"teacher_disagreement_score":0.23052484,"about_ca_system_score_codex":0.01561023,"about_ca_system_score_gemma":0.019362977,"threshold_uncertainty_score":0.46376485},"labels":[],"label_agreement":null},{"id":"W2763398102","doi":"10.1016/j.jaad.2017.08.029","title":"Adalimumab for nail psoriasis: Efficacy and safety from the first 26 weeks of a phase 3, randomized, placebo-controlled trial","year":2017,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre de Recherche Dermatologique du Québec Métropolitain; Université Laval; Probity Medical Research","funders":"","keywords":"Medicine; Adalimumab; Psoriasis; Placebo; Dermatology; Randomized controlled trial; Nail (fastener); Surgery; Internal medicine; Alternative medicine; Pathology; Tumor necrosis factor alpha","score_opus":0.01864386051948098,"score_gpt":0.2980205265829488,"score_spread":0.27937666606346784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2763398102","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9255624,0.03935311,0.0021927662,0.002034655,0.0013421642,0.019800872,0.003231135,0.00046342108,0.006019625],"genre_scores_gemma":[0.9458513,0.015444272,0.004537426,0.0035162093,0.0012182322,0.022189578,0.002203714,0.00007019831,0.0049690646],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9984427,0.0008598158,0.000116836665,0.0002099567,0.00019919407,0.0001713723],"domain_scores_gemma":[0.99841166,0.0003704827,0.0005141507,0.00010553173,0.00013440079,0.0004638192],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041102474,0.001554946,0.0028566632,0.00051069027,0.0008545886,0.0013692016,0.0008707403,0.0021676198,0.006661203],"category_scores_gemma":[0.0028927661,0.0005729156,0.002277775,0.00048858684,0.0007016707,0.00069406134,0.0003613864,0.002313994,0.0010759296],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9364085,0.009764278,0.0010165736,0.001927402,0.0013366692,0.000093390045,0.000057617202,0.0002538135,0.0032332225,0.000119595185,0.002474283,0.043314684],"study_design_scores_gemma":[0.95642275,0.039210737,0.0021132575,0.000114355644,0.0003420444,0.00006146861,0.000008484767,0.00015477202,0.0003024806,0.00008213407,0.0011763991,0.000011193784],"about_ca_topic_score_codex":0.0004923975,"about_ca_topic_score_gemma":0.0013774728,"teacher_disagreement_score":0.006661203,"about_ca_system_score_codex":0.00078727765,"about_ca_system_score_gemma":0.0020664553,"threshold_uncertainty_score":0.022283971},"labels":[],"label_agreement":null},{"id":"W2763793357","doi":"10.1016/j.jaad.2017.08.024","title":"Psychiatric adverse events during treatment with brodalumab: Analysis of psoriasis clinical trials","year":2017,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":180,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Medicine; Psoriasis; Suicidal ideation; Adverse effect; Psychiatry; Psoriasis Area and Severity Index; Clinical trial; Placebo; Internal medicine; Poison control; Dermatology; Injury prevention; Emergency medicine; Pathology","score_opus":0.1410438715761434,"score_gpt":0.4455467596620446,"score_spread":0.3045028880859012,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2763793357","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005786606,0.99304444,0.00011895513,0.00022929377,0.00010004262,0.00004658257,0.00028259913,0.000008392298,0.0003830519],"genre_scores_gemma":[0.053830497,0.9433727,0.00065023155,0.00092822354,0.00027464904,0.00008805258,0.0005887541,0.000010157784,0.000256735],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99820745,0.00057335966,0.0004368689,0.00027318593,0.00041275186,0.00009634296],"domain_scores_gemma":[0.99424136,0.003490148,0.0016315181,0.00010635446,0.00037953022,0.00015116161],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037081174,0.00061407883,0.0035994758,0.0011996106,0.00017724148,0.0012543029,0.0009813841,0.0006398027,0.0022873713],"category_scores_gemma":[0.0060375556,0.00031397666,0.0034382625,0.002190138,0.00032753995,0.00062197796,0.00051081827,0.0012592443,0.00015978725],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008783381,0.00022491318,0.011411658,0.11041807,0.02691418,0.00028325626,0.00012231153,0.0010000184,0.0011397529,0.00050474633,0.012303212,0.82689446],"study_design_scores_gemma":[0.021621618,0.009750836,0.31172574,0.101835065,0.20753472,0.007890187,0.000798143,0.002330491,0.0023650778,0.0036695218,0.3299666,0.0005119552],"about_ca_topic_score_codex":0.0011058463,"about_ca_topic_score_gemma":0.0046322807,"teacher_disagreement_score":0.0037081174,"about_ca_system_score_codex":0.0008067649,"about_ca_system_score_gemma":0.0012071226,"threshold_uncertainty_score":0.019610643},"labels":[],"label_agreement":null},{"id":"W2764058764","doi":"10.1016/j.jaad.2017.09.074","title":"A systematic review of the safety and efficacy of systemic corticosteroids in atopic dermatitis","year":2017,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":167,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"","keywords":"Medicine; Cochrane Library; Atopic dermatitis; Dermatology; Internal medicine; Meta-analysis","score_opus":0.031563776441147565,"score_gpt":0.36547872370265444,"score_spread":0.3339149472615069,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2764058764","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010653223,0.99835855,0.000058671318,0.00007923133,0.00006122248,0.00009421273,0.00015022379,0.0000029126916,0.00012966573],"genre_scores_gemma":[0.018796854,0.98003983,0.00032110215,0.00045607382,0.00007313445,0.00009962613,0.00012532866,0.0000023694995,0.000085582375],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9957873,0.0012347323,0.0018851747,0.00034458493,0.0006166427,0.00013154096],"domain_scores_gemma":[0.98945683,0.007293166,0.0022841312,0.00014624184,0.0006885212,0.0001311206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0045402264,0.0012330419,0.008220537,0.0038363214,0.00044354599,0.0017886227,0.0017766611,0.0016249223,0.0035559067],"category_scores_gemma":[0.01831826,0.0007438772,0.008281237,0.0043501696,0.000757907,0.0014949875,0.0011963567,0.0012786844,0.00020918643],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006918052,0.000023279777,0.00079176575,0.9396617,0.02686879,0.0001363673,0.000111629284,0.00010902946,0.0002172288,0.000113096896,0.00092739234,0.0303479],"study_design_scores_gemma":[0.0015370925,0.0007560897,0.008928267,0.5526148,0.41034332,0.0008273547,0.00031381196,0.00013425329,0.0002996226,0.00039907583,0.023769533,0.000076835786],"about_ca_topic_score_codex":0.0076853493,"about_ca_topic_score_gemma":0.024900934,"teacher_disagreement_score":0.008220537,"about_ca_system_score_codex":0.001927851,"about_ca_system_score_gemma":0.0049944613,"threshold_uncertainty_score":0.024011254},"labels":[],"label_agreement":null},{"id":"W2765089157","doi":"10.1016/j.jaad.2017.08.051","title":"Depressive symptoms, depression, and the effect of biologic therapy among patients in Psoriasis Longitudinal Assessment and Registry (PSOLAR)","year":2017,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":119,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; SKiN Health; Dalhousie University; Probity Medical Research","funders":"Janssen Scientific Affairs; LEO Pharma; Dermira; Janssen Pharmaceuticals; Novartis Pharmaceuticals Corporation; Celgene; Amgen; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Psoriasis; Depression (economics); Depressive symptoms; Longitudinal study; Psychiatry; Dermatology; Internal medicine; Pathology; Anxiety","score_opus":0.010845533999091824,"score_gpt":0.2901229953823299,"score_spread":0.27927746138323806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765089157","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988649,0.00030298115,0.000029018986,0.00010227881,0.000009653315,0.000007869066,0.0003547142,0.0000029364114,0.00032568554],"genre_scores_gemma":[0.99925786,0.00011835929,0.000050777107,0.000055293665,0.000013706819,0.000008317729,0.00033698487,8.0804284e-7,0.00015801108],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992686,0.0003222769,0.00010068407,0.00008314191,0.000114695795,0.00011056452],"domain_scores_gemma":[0.99807537,0.00030911362,0.0009819963,0.000104272694,0.00014353653,0.00038584118],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013407608,0.00018829928,0.00037775582,0.00045541202,0.00040577873,0.0006508367,0.00033653562,0.00054644205,0.00088958733],"category_scores_gemma":[0.0028707052,0.00024971442,0.00077463663,0.0005725291,0.00014791489,0.00054458866,0.00046652713,0.0009500975,0.00017227628],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046772516,0.00016417028,0.9978052,0.0000066258553,0.000117251155,0.000024998373,0.000031565633,0.000021444466,0.00009076406,0.000010143308,0.00008673868,0.0011735089],"study_design_scores_gemma":[0.000025992944,0.00015398746,0.99945134,0.0000029411074,0.000054454795,0.000054431122,0.00006766353,0.00010083616,0.00002316517,0.000008050841,0.000054438908,0.0000026855555],"about_ca_topic_score_codex":0.0065613207,"about_ca_topic_score_gemma":0.00967551,"teacher_disagreement_score":0.0065613207,"about_ca_system_score_codex":0.00036384928,"about_ca_system_score_gemma":0.00033763563,"threshold_uncertainty_score":0.013046265},"labels":[],"label_agreement":null},{"id":"W2765504547","doi":"10.1016/j.jaad.2017.10.023","title":"Self-healing juvenile cutaneous mucinosis: Clinical and histopathologic findings of 9 patients","year":2017,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Skin Diseases and Diabetes","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Mucinosis; Dermatology; Juvenile; Pathology","score_opus":0.02228172508712865,"score_gpt":0.3397057236922187,"score_spread":0.31742399860509,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765504547","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990752,0.000132993,0.00011965028,0.000018549876,0.000006233188,0.000013055551,0.000047148333,0.0000053446065,0.00058178406],"genre_scores_gemma":[0.99950135,0.000078801546,0.00013384347,0.000022485248,0.00001554089,0.000007625862,0.00008567102,0.0000033473075,0.00015143544],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.99952006,0.000055960234,0.00008263126,0.00011542251,0.00008100984,0.00014495489],"domain_scores_gemma":[0.999241,0.00018765629,0.00017621466,0.00006840509,0.00006559446,0.00026114838],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032329003,0.0007109494,0.00056860107,0.0010556777,0.0011306842,0.00074414205,0.00041133762,0.0005763881,0.0019997566],"category_scores_gemma":[0.0015727587,0.00041770897,0.0005541975,0.0006566613,0.0006640124,0.00060508965,0.00066373846,0.0003606631,0.00039172816],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049588695,0.00040295854,0.88708955,0.000034938832,0.00004380339,0.09909767,0.0007980436,0.00011516666,0.0055521056,0.00008938747,0.00014015,0.0061403015],"study_design_scores_gemma":[0.00006793954,0.00089541194,0.7934451,0.000017760767,0.000061594685,0.20144485,0.0014619596,0.00035659916,0.0013270201,0.000097323435,0.00079136074,0.0000331156],"about_ca_topic_score_codex":0.00089396216,"about_ca_topic_score_gemma":0.0010054815,"teacher_disagreement_score":0.0019997566,"about_ca_system_score_codex":0.00037740398,"about_ca_system_score_gemma":0.00029903048,"threshold_uncertainty_score":0.006689906},"labels":[],"label_agreement":null},{"id":"W2765883502","doi":"10.1016/j.jaad.2017.10.012","title":"Characterization of disease burden, comorbidities, and treatment use in a large, US-based cohort: Results from the Corrona Psoriasis Registry","year":2017,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":100,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"University of Connecticut; AbbVie; Eli Lilly and Company","keywords":"Medicine; Psoriasis; Cohort; Disease; Dermatology; Comorbidity; Intensive care medicine; Internal medicine","score_opus":0.024647535982479415,"score_gpt":0.270676375239329,"score_spread":0.2460288392568496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765883502","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917945,0.00021669267,0.0002423309,0.000110942936,0.000010428024,0.000064489854,0.006512465,0.000015029823,0.0010330876],"genre_scores_gemma":[0.9922765,0.0002065066,0.00030558987,0.000113294926,0.000022793252,0.00009547088,0.0067607765,0.000014374631,0.0002047429],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99783665,0.00071471266,0.00033053147,0.0004972751,0.00044266102,0.00017815811],"domain_scores_gemma":[0.9946837,0.0008922661,0.0023665763,0.00096562656,0.0006890139,0.00040288488],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030759752,0.00020371289,0.00051347783,0.0013296037,0.00049172936,0.0008883702,0.00071457226,0.00036127254,0.0017378251],"category_scores_gemma":[0.0069048163,0.00028948992,0.00062395417,0.0020718144,0.00025080628,0.0007553991,0.001052918,0.0006166097,0.0005373494],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013815207,0.00003749771,0.99782336,0.000014188683,0.00007688492,0.000037546302,0.00008739506,0.00004422673,0.00008405383,0.000028761597,0.000636609,0.0009913562],"study_design_scores_gemma":[0.000027333344,0.00006941631,0.99827087,0.000016343572,0.00006219044,0.00022914364,0.00031921576,0.00020483593,0.000065257744,0.000016545973,0.0007122469,0.000006649076],"about_ca_topic_score_codex":0.0118228495,"about_ca_topic_score_gemma":0.011045454,"teacher_disagreement_score":0.0118228495,"about_ca_system_score_codex":0.00043557162,"about_ca_system_score_gemma":0.0008280851,"threshold_uncertainty_score":0.023508072},"labels":[],"label_agreement":null},{"id":"W2766032132","doi":"10.1016/j.jaad.2017.10.025","title":"Effect of secukinumab on quality of life and psoriasis-related symptoms: A comparative analysis versus ustekinumab from the CLEAR 52-week study","year":2017,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dermatrials Research","funders":"","keywords":"Secukinumab; Medicine; Dermatology Life Quality Index; Ustekinumab; Itching; Psoriasis; Psoriasis Area and Severity Index; Dermatology; Quality of life (healthcare); Post-hoc analysis; Internal medicine; Psoriatic arthritis; Disease; Adalimumab","score_opus":0.03770967794458405,"score_gpt":0.34411604359968195,"score_spread":0.30640636565509793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766032132","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99534637,0.0038031202,0.00007422676,0.000060715436,0.000057104524,0.00008442207,0.00024542288,0.00000706959,0.00032150612],"genre_scores_gemma":[0.99733186,0.0013709526,0.00012627403,0.00009442438,0.00014316244,0.0000795834,0.00037526074,0.0000071494164,0.0004713688],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.997931,0.0012467427,0.00014351441,0.00026285308,0.0001692959,0.0002466875],"domain_scores_gemma":[0.99728906,0.0011174747,0.0005695024,0.0003284051,0.00016105108,0.00053456705],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032654603,0.0017341353,0.005064408,0.0006558948,0.00040237073,0.0010419352,0.0008845613,0.0015922914,0.0035537381],"category_scores_gemma":[0.0023635274,0.0006424381,0.00486325,0.0006697761,0.0011526215,0.0014278269,0.00054021034,0.0021737672,0.00039038088],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97916895,0.002958402,0.003742837,0.00030227442,0.003111197,0.000044609595,0.000038379298,0.00027309882,0.0018962359,0.00002885507,0.00009631041,0.008338844],"study_design_scores_gemma":[0.46936905,0.3891783,0.1220103,0.00010705035,0.014676412,0.00018290123,0.0002642625,0.0011846881,0.0020074537,0.00015634282,0.0007592966,0.00010398509],"about_ca_topic_score_codex":0.0012778839,"about_ca_topic_score_gemma":0.001721236,"teacher_disagreement_score":0.005064408,"about_ca_system_score_codex":0.0007655622,"about_ca_system_score_gemma":0.0005319739,"threshold_uncertainty_score":0.017269611},"labels":[],"label_agreement":null},{"id":"W2766477392","doi":"10.1016/j.jaad.2017.08.037","title":"Standard classification and pathophysiology of rosacea: The 2017 update by the National Rosacea Society Expert Committee","year":2017,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":498,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Windsor; Western University","funders":"National Rosacea Society","keywords":"Rosacea; Medicine; Dermatology; Pathophysiology; Intensive care medicine; Pathology","score_opus":0.08419441421305443,"score_gpt":0.4191881445961421,"score_spread":0.33499373038308766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766477392","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014552154,0.99585587,0.00022598218,0.0017984692,0.0009509542,0.000031117524,0.00017699374,0.000012925763,0.0008022204],"genre_scores_gemma":[0.0011296974,0.99426854,0.00089566543,0.0019922191,0.0006981302,0.000036672616,0.0003817415,0.0000052150363,0.0005922339],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987618,0.00021507451,0.00035283086,0.00013128071,0.00045711355,0.00008203484],"domain_scores_gemma":[0.99764985,0.0007785866,0.0005186255,0.000046496098,0.00091312913,0.00009328037],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003268437,0.0011343667,0.0030654126,0.004657289,0.00044492824,0.0020172324,0.00200212,0.0018300418,0.003276824],"category_scores_gemma":[0.0040434795,0.00045424185,0.0023935735,0.0030270203,0.000771377,0.0026077083,0.001360831,0.0030186279,0.0017487003],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022335665,0.000076958895,0.0010369386,0.042198483,0.00040804307,0.00018199664,0.00011059645,0.000241045,0.000966277,0.0024568634,0.122744255,0.8293553],"study_design_scores_gemma":[0.00013959804,0.00010449259,0.004086625,0.039027296,0.0014963626,0.0015229246,0.00017103991,0.00017475085,0.00039239417,0.0023713736,0.95044935,0.00006383948],"about_ca_topic_score_codex":0.0047769337,"about_ca_topic_score_gemma":0.0092472825,"teacher_disagreement_score":0.0047769337,"about_ca_system_score_codex":0.0015519978,"about_ca_system_score_gemma":0.005134796,"threshold_uncertainty_score":0.017285347},"labels":[],"label_agreement":null},{"id":"W2766689815","doi":"10.1016/j.jaad.2013.06.055","title":"Diabetic foot ulcers","year":2013,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Diabetic Foot Ulcer Assessment and Management","field":"Medicine","cited_by":363,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; University of Toronto; Women's College Hospital","funders":"","keywords":"Medicine; Diabetic foot; Foot (prosody); Amputation; Diabetes mellitus; Foot deformity; Diabetic foot ulcer; Quality of life (healthcare); Mortality rate; Peripheral neuropathy; Disease; Deformity; Intensive care medicine; Surgery; Internal medicine; Nursing","score_opus":0.013003335526729146,"score_gpt":0.29706953880044384,"score_spread":0.2840662032737147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766689815","genre_codex":"other","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19714205,0.056612242,0.002465675,0.010867309,0.0037552868,0.00042862288,0.0019236823,0.00035921898,0.726446],"genre_scores_gemma":[0.76803464,0.02993404,0.0027815676,0.00967644,0.0026810747,0.00016476777,0.0022609737,0.000045081404,0.18442138],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99960357,0.00004675156,0.000034009143,0.000030215548,0.00015605878,0.0001294027],"domain_scores_gemma":[0.9995875,0.000046904788,0.000078117744,0.000024212031,0.0001374363,0.00012590882],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028050365,0.00031308975,0.00036867452,0.001207429,0.0008248142,0.000997579,0.00028162455,0.00054018764,0.03424214],"category_scores_gemma":[0.0011766439,0.00010577366,0.00045619046,0.00096128933,0.00013057579,0.00025629438,0.0003770088,0.00087121583,0.0041693375],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007323127,0.0016982313,0.08894287,0.00083622715,0.00014608107,0.017490042,0.0002431078,0.00007180149,0.0043061613,0.0035983392,0.13128348,0.75065136],"study_design_scores_gemma":[0.00026428627,0.001007909,0.28876153,0.0018918228,0.0003357837,0.09107885,0.0011120428,0.0005300766,0.0036227722,0.0029200825,0.6084223,0.000052622167],"about_ca_topic_score_codex":0.002021294,"about_ca_topic_score_gemma":0.002958886,"teacher_disagreement_score":0.03424214,"about_ca_system_score_codex":0.0003985792,"about_ca_system_score_gemma":0.0005218091,"threshold_uncertainty_score":0.114551306},"labels":[],"label_agreement":null},{"id":"W2766778135","doi":"10.1016/j.jaad.2017.06.150","title":"Rosacea comorbidities and future research: The 2017 update by the National Rosacea Society Expert Committee","year":2017,"lang":"en","type":"editorial","venue":"Journal of the American Academy of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Windsor; Western University","funders":"National Rosacea Society","keywords":"Rosacea; Medicine; Dermatology","score_opus":0.049007864381112654,"score_gpt":0.4027746852715508,"score_spread":0.35376682089043815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766778135","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005350058,0.029089157,0.000111884096,0.09903077,0.8699387,0.00002600402,0.00009853428,0.000041004863,0.0016105333],"genre_scores_gemma":[0.00035069976,0.022875302,0.0001373009,0.053092424,0.91932,0.000031989835,0.000083145394,0.000031503132,0.004077664],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9925235,0.0014059976,0.0012882708,0.0005541151,0.0036930966,0.0005351173],"domain_scores_gemma":[0.96410996,0.012904999,0.003521413,0.00050187676,0.015429251,0.0035326008],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010576899,0.0025981981,0.004123097,0.004618408,0.002342653,0.009416694,0.0030462632,0.014272707,0.008753813],"category_scores_gemma":[0.03795322,0.0010712597,0.0027009835,0.0021466613,0.0017546254,0.0061253207,0.002257234,0.021238677,0.009170918],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003331991,0.000011015501,0.0000568638,0.0002980624,0.000021571048,0.000057932608,0.00001446925,0.000011691481,0.00002732993,0.00014941837,0.98979783,0.0095203705],"study_design_scores_gemma":[0.0001238988,0.00002808145,0.0003534648,0.0020307489,0.00011604214,0.00028059242,0.000082535815,0.000083852035,0.00007335862,0.0007232024,0.99607927,0.000025048004],"about_ca_topic_score_codex":0.0021707295,"about_ca_topic_score_gemma":0.0072859316,"teacher_disagreement_score":0.014272707,"about_ca_system_score_codex":0.0032747828,"about_ca_system_score_gemma":0.007630455,"threshold_uncertainty_score":0.055936694},"labels":[],"label_agreement":null},{"id":"W2767329472","doi":"10.1016/j.jaad.2017.10.044","title":"A novel, noninvasive anesthetic method for neurotoxin injection for palmar hyperhidrosis","year":2017,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Sympathectomy and Hyperhidrosis Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of Alberta","funders":"","keywords":"Hyperhidrosis; Medicine; Neurotoxin; Palmar hyperhidrosis; Anesthesia; Botulinum neurotoxin; Anesthetic; Clostridium botulinum; Surgery; Dermatology; Internal medicine; Toxin","score_opus":0.04263218425518594,"score_gpt":0.37483858574391066,"score_spread":0.3322064014887247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767329472","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6517527,0.031581137,0.29039624,0.0028964875,0.001773961,0.00049715413,0.00017145276,0.0010543069,0.01987653],"genre_scores_gemma":[0.88302475,0.007937239,0.09668778,0.0019222037,0.0009223054,0.00020629304,0.00012338614,0.000093745555,0.009082286],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99981457,0.000018430263,0.000014577064,0.000044041473,0.00008266215,0.00002575456],"domain_scores_gemma":[0.9999093,0.000027757338,0.000024174964,0.000010793498,0.000011318374,0.000016611137],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020865955,0.00038828093,0.00035000587,0.00040499348,0.00043039932,0.00032024208,0.000502017,0.00047713742,0.0018452017],"category_scores_gemma":[0.00023556779,0.00019405766,0.0005014184,0.00014256964,0.00042695674,0.00092084386,0.00038737143,0.0012245768,0.0004097805],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006996154,0.0010567696,0.0024765015,0.0004960945,0.00012182306,0.009754749,0.00018845018,0.0003765045,0.7898971,0.0015099887,0.0031377198,0.19028467],"study_design_scores_gemma":[0.0018881598,0.012418724,0.04912813,0.00034389418,0.0013265834,0.3804578,0.00047035707,0.019789377,0.44892687,0.0035380046,0.08128145,0.0004306794],"about_ca_topic_score_codex":0.00030938548,"about_ca_topic_score_gemma":0.0012669035,"teacher_disagreement_score":0.0018452017,"about_ca_system_score_codex":0.00011082655,"about_ca_system_score_gemma":0.00038190596,"threshold_uncertainty_score":0.006172836},"labels":[],"label_agreement":null},{"id":"W2767747595","doi":"10.1016/j.jaad.2017.09.078","title":"Practical management of acne for clinicians: An international consensus from the Global Alliance to Improve Outcomes in Acne","year":2017,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":415,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Acne; Medicine; Alliance; Clinical Practice; Alternative medicine; MEDLINE; Health care; Family medicine; Interpretation (philosophy); Evidence-based medicine; Dermatology; Pathology","score_opus":0.1400636109102943,"score_gpt":0.5210044508906247,"score_spread":0.38094083998033046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767747595","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008756989,0.9974898,0.00012629428,0.0016053019,0.00028183084,0.000013839919,0.000014334859,0.0000031479267,0.0003778838],"genre_scores_gemma":[0.0014460997,0.9959357,0.0008025775,0.0014337437,0.0001774763,0.00002115002,0.000036000525,0.0000018080557,0.0001455193],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99830997,0.0004569765,0.00042243066,0.0001370864,0.00057627313,0.00009722643],"domain_scores_gemma":[0.9961754,0.0023285518,0.00035588196,0.000064408196,0.0009348018,0.0001408755],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005634303,0.00070097396,0.0023524817,0.0023220598,0.00051626615,0.0021354347,0.0014965308,0.0023368862,0.0022104764],"category_scores_gemma":[0.0067866268,0.0003136272,0.0016578197,0.0020424898,0.0007515681,0.002237196,0.0016562555,0.0037266817,0.00046526585],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000100828125,0.00008597556,0.00034035792,0.0519011,0.00030283176,0.00012883342,0.00023362714,0.0002453382,0.00038825118,0.003017359,0.025107378,0.9181479],"study_design_scores_gemma":[0.00015173445,0.00014640555,0.0026339183,0.11813718,0.0011798027,0.0011887499,0.0005294028,0.00020622289,0.0003646334,0.0037721454,0.8716304,0.000059445454],"about_ca_topic_score_codex":0.0027967668,"about_ca_topic_score_gemma":0.0070829317,"teacher_disagreement_score":0.005634303,"about_ca_system_score_codex":0.0015205771,"about_ca_system_score_gemma":0.0054431744,"threshold_uncertainty_score":0.029797435},"labels":[],"label_agreement":null},{"id":"W2769504915","doi":"10.1016/j.jaad.2017.11.036","title":"Drug survival of secukinumab in real-world plaque psoriasis patients: A 52-week, multicenter, retrospective study","year":2017,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Probity Medical Research; Women's College Hospital; University of Toronto; Sunnybrook Health Science Centre; Western University","funders":"","keywords":"Secukinumab; Medicine; Psoriasis; Psoriasis Area and Severity Index; Adverse effect; Dosing; Clinical endpoint; Retrospective cohort study; Clinical trial; Randomized controlled trial; Dermatology; Discontinuation; Plaque psoriasis; Internal medicine; Surgery; Psoriatic arthritis","score_opus":0.02078974280137467,"score_gpt":0.299219751322203,"score_spread":0.27843000852082833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2769504915","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99918133,0.0004819931,0.00004903359,0.000012041619,0.0000042574497,0.000008414475,0.000104406856,0.0000016192887,0.00015683075],"genre_scores_gemma":[0.99944085,0.00015777934,0.000031435302,0.00002409495,0.000014966033,0.000008333069,0.00024731792,0.0000021100989,0.00007305428],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989856,0.0002861438,0.00013476475,0.00029956634,0.00012828571,0.00016565806],"domain_scores_gemma":[0.9976866,0.00040701492,0.0010848665,0.00030648868,0.0002177444,0.0002972248],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011322707,0.0005167053,0.00089385477,0.0007021942,0.00048117616,0.0011522626,0.00041736092,0.00080596114,0.0010819992],"category_scores_gemma":[0.0020161816,0.0003602882,0.0009403178,0.0010041288,0.00060654525,0.0010478292,0.00046781162,0.00062370417,0.0003279449],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005209667,0.00023250407,0.98942393,0.00005331888,0.0004332722,0.00038521882,0.00015128375,0.000114693314,0.00089961896,0.000030056068,0.00010309712,0.002963285],"study_design_scores_gemma":[0.00020296415,0.0025247592,0.9939476,0.000016132704,0.0005024836,0.0012087588,0.00035316683,0.0003426332,0.00028047088,0.000037131893,0.0005596906,0.000024050913],"about_ca_topic_score_codex":0.00092922646,"about_ca_topic_score_gemma":0.00063681515,"teacher_disagreement_score":0.0011522626,"about_ca_system_score_codex":0.00048014114,"about_ca_system_score_gemma":0.00030815674,"threshold_uncertainty_score":0.0059880614},"labels":[],"label_agreement":null},{"id":"W2769827548","doi":"10.1016/j.jaad.2014.05.008","title":"Evaluation and diagnosis of the hair loss patient","year":2014,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":107,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Hair loss; Dermatology","score_opus":0.03234554808936918,"score_gpt":0.3719685641445745,"score_spread":0.33962301605520534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2769827548","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011467998,0.9703076,0.0018710684,0.0038261125,0.0009082503,0.000049501203,0.000121664816,0.00007435824,0.011373443],"genre_scores_gemma":[0.113666646,0.871739,0.0037776702,0.0043476466,0.0025739323,0.000025934767,0.00044127356,0.000016096814,0.0034117212],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99977475,0.000034425084,0.000037184178,0.00004171625,0.0000791276,0.000032792053],"domain_scores_gemma":[0.99975103,0.000104294064,0.00003638761,0.00001009005,0.000054378273,0.000043886314],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026223934,0.0007104909,0.0008317877,0.0021519638,0.00048241016,0.00078011764,0.00091401825,0.0014100081,0.0017854568],"category_scores_gemma":[0.0011290804,0.00025980445,0.00048175143,0.0008634498,0.00041102857,0.0009899229,0.0005217338,0.001272342,0.00087209826],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015424014,0.00022894629,0.014643924,0.0045741247,0.000120436416,0.20057464,0.00028631676,0.00040374848,0.0067609954,0.0016716612,0.03605439,0.7345266],"study_design_scores_gemma":[0.000028521588,0.000087587396,0.014148082,0.0047438117,0.00020055858,0.8619201,0.00061590504,0.00036500668,0.002094121,0.002184829,0.11355832,0.00005319537],"about_ca_topic_score_codex":0.0011231856,"about_ca_topic_score_gemma":0.0019105596,"teacher_disagreement_score":0.0021519638,"about_ca_system_score_codex":0.0003418263,"about_ca_system_score_gemma":0.00065216667,"threshold_uncertainty_score":0.005972922},"labels":[],"label_agreement":null},{"id":"W2773590722","doi":"10.1016/j.jaad.2017.11.044","title":"A cross-sectional survey of long-term outcomes for patients with diffuse capillary malformation with overgrowth","year":2017,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Vascular Malformations and Hemangiomas","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Cross-sectional study; Term (time); Pediatrics; Pathology","score_opus":0.02853666836526559,"score_gpt":0.3336328831282809,"score_spread":0.3050962147630153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2773590722","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99932873,0.0000765061,0.000024026189,0.000046146146,0.0000045763827,0.000005083946,0.00029787244,0.0000016451286,0.00021549419],"genre_scores_gemma":[0.9993654,0.000067597735,0.000026092732,0.00004581907,0.0000075234047,0.0000062871372,0.000384877,0.0000012894507,0.000095085474],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992211,0.00019692862,0.00012804214,0.0001380068,0.00010721077,0.00020866445],"domain_scores_gemma":[0.9963372,0.00041328106,0.0016657546,0.00019196876,0.00038666496,0.0010051137],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00095710246,0.00039765183,0.00047451674,0.0011441724,0.0009021732,0.0009875115,0.000450709,0.00092192844,0.0015764665],"category_scores_gemma":[0.0029250835,0.00039909797,0.0007726313,0.00159346,0.00057819067,0.0014292091,0.000990648,0.0013485342,0.00035974281],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021271162,0.000037598384,0.99961627,0.0000018383805,0.000019457386,0.000045343135,0.0000447044,0.00000733094,0.000023686196,0.000003567946,0.00002905134,0.00014978106],"study_design_scores_gemma":[0.0000031322327,0.00013580242,0.998979,0.0000030902252,0.00001608791,0.00023749207,0.00050134753,0.000039689665,0.000009508692,0.0000075908943,0.000063191095,0.000004046574],"about_ca_topic_score_codex":0.013270703,"about_ca_topic_score_gemma":0.0127240075,"teacher_disagreement_score":0.013270703,"about_ca_system_score_codex":0.00067168963,"about_ca_system_score_gemma":0.000603013,"threshold_uncertainty_score":0.026386917},"labels":[],"label_agreement":null},{"id":"W2781921947","doi":"10.1016/j.jaad.2018.01.003","title":"Efficacy and safety of switching to ixekizumab in secukinumab nonresponders with plaque psoriasis: A multicenter retrospective study of interleukin 17A antagonist therapies","year":2018,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":54,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Health Sciences Centre; Women's College Hospital; University of Toronto; Sunnybrook Health Science Centre; Western University","funders":"","keywords":"Secukinumab; Ixekizumab; Medicine; Interleukin 17; Psoriasis; Discontinuation; Psoriasis Area and Severity Index; Dermatology; Internal medicine; Dermatology Life Quality Index; Ustekinumab; Plaque psoriasis; Anakinra; Placebo; Adalimumab; Psoriatic arthritis; Alternative medicine; Cytokine; Pathology; Disease","score_opus":0.011777689674929618,"score_gpt":0.2791067948025814,"score_spread":0.2673291051276518,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2781921947","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995728,0.00020820092,0.000027972215,0.000007856843,0.000003998465,0.000009670387,0.000057781017,0.0000012399717,0.00011029074],"genre_scores_gemma":[0.9996847,0.00005087899,0.000023615323,0.000019976116,0.000010449757,0.0000075301946,0.00014360367,0.000002032064,0.00005725975],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978801,0.0007013517,0.00029766737,0.000580563,0.00027441554,0.000265979],"domain_scores_gemma":[0.9960263,0.00094297854,0.0017131622,0.00055402925,0.000369762,0.0003938276],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021997571,0.00038358037,0.0009380056,0.0005450854,0.0005370777,0.0010708781,0.0004722227,0.0006754224,0.001101841],"category_scores_gemma":[0.0036961087,0.00038995148,0.0014857895,0.00083905284,0.00056442316,0.00070544693,0.00030820552,0.00083735725,0.0002525958],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012687585,0.00052963645,0.9792541,0.000034963155,0.00079205126,0.00023831674,0.00018182334,0.00012745571,0.0014847605,0.00003527113,0.00010851413,0.0045254426],"study_design_scores_gemma":[0.0006169057,0.0044447766,0.9919961,0.000013281191,0.00078295206,0.000678787,0.00025893276,0.00038640003,0.0004350374,0.000041842264,0.0003274784,0.000017524502],"about_ca_topic_score_codex":0.0011019439,"about_ca_topic_score_gemma":0.0006805994,"teacher_disagreement_score":0.0021997571,"about_ca_system_score_codex":0.0005295832,"about_ca_system_score_gemma":0.00039010556,"threshold_uncertainty_score":0.011633575},"labels":[],"label_agreement":null},{"id":"W2783829013","doi":"10.1016/j.jaad.2018.01.017","title":"Efficacy and safety of lebrikizumab (an anti-IL-13 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical corticosteroids: A randomized, placebo-controlled phase II trial (TREBLE)","year":2018,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":329,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Sanofi Genzyme; LEO Pharma; Dermira; Vanda Pharmaceuticals; National Institute for Health and Care Research; Regeneron Pharmaceuticals; Roivant Sciences; Celgene; Genentech; Valeant Pharmaceuticals International; Sanofi; GlaxoSmithKline; Pfizer; King's College London; Galderma; Eli Lilly and Company","keywords":"Medicine; Eczema Area and Severity Index; Placebo; Atopic dermatitis; Adverse effect; Randomized controlled trial; Clinical endpoint; Internal medicine; Placebo-controlled study; Gastroenterology; Dermatology; Double blind; Pathology","score_opus":0.009610947437418426,"score_gpt":0.3044593541179478,"score_spread":0.29484840668052936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2783829013","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99066764,0.0053295717,0.00032330988,0.00042370058,0.00023072709,0.0015932154,0.0004955586,0.00006187283,0.000874389],"genre_scores_gemma":[0.9915542,0.0023863807,0.0009976497,0.0009096161,0.00037288317,0.0017096022,0.0007116729,0.000013996059,0.001343932],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9995547,0.0002288804,0.0000351737,0.000086997636,0.00003882913,0.000055395976],"domain_scores_gemma":[0.99929905,0.00021987855,0.00018644877,0.000041056614,0.00005540204,0.00019820093],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019836014,0.0011216326,0.0019554948,0.00025074006,0.00031817815,0.00080918625,0.00063410547,0.0015611454,0.0036791868],"category_scores_gemma":[0.0013535648,0.0004838117,0.0013851798,0.00018781013,0.00070292363,0.00073702325,0.00024246666,0.001802655,0.0006141031],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.955107,0.009296738,0.002182627,0.0008672593,0.00080446235,0.00008753751,0.00007373022,0.00026029532,0.00894435,0.00006207144,0.0008737588,0.021440191],"study_design_scores_gemma":[0.90779287,0.087299705,0.0033325707,0.000030470967,0.0002924299,0.00006939655,0.000015962134,0.00029051275,0.00045529645,0.0000364315,0.000376294,0.000008074933],"about_ca_topic_score_codex":0.00044681193,"about_ca_topic_score_gemma":0.0010544434,"teacher_disagreement_score":0.0036791868,"about_ca_system_score_codex":0.00045491615,"about_ca_system_score_gemma":0.0006839908,"threshold_uncertainty_score":0.012308121},"labels":[],"label_agreement":null},{"id":"W2783970348","doi":"10.1016/j.jaad.2017.06.043","title":"Management of psoriasis in patients with inflammatory bowel disease: From the Medical Board of the National Psoriasis Foundation","year":2018,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"National Psoriasis Foundation","keywords":"Medicine; Psoriasis; Inflammatory bowel disease; Foundation (evidence); Dermatology; Disease; Internal medicine","score_opus":0.018928534677021,"score_gpt":0.3197036396797157,"score_spread":0.3007751050026947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2783970348","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000059898044,0.9990729,0.000012986082,0.0005186963,0.00013677836,0.0000025862078,0.0000072505154,0.0000011068084,0.00018781985],"genre_scores_gemma":[0.0011679229,0.9975848,0.000090091,0.00079707545,0.0002311901,0.0000058427454,0.000022929898,5.606749e-7,0.000099595905],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993548,0.0001587183,0.00014502011,0.000072183466,0.00022525141,0.000044078097],"domain_scores_gemma":[0.9986972,0.0007312169,0.0002902697,0.000017637147,0.00019633626,0.00006736558],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001524054,0.00046760318,0.0013953934,0.0013312408,0.0002711311,0.001002565,0.00077533117,0.0013239874,0.0024188706],"category_scores_gemma":[0.0031558701,0.00022593165,0.0008019957,0.0012956521,0.000334154,0.00086998893,0.0006436654,0.0017956834,0.00036659322],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021916354,0.00006016144,0.00046820368,0.03881679,0.00033515826,0.00009796591,0.0000601374,0.00012300645,0.00029827908,0.0009160756,0.0401819,0.9184232],"study_design_scores_gemma":[0.0005572375,0.00023679111,0.008965414,0.099042594,0.0019937027,0.0017221345,0.00022901564,0.00013355816,0.00028608725,0.0012748872,0.88550776,0.000050758168],"about_ca_topic_score_codex":0.0029632174,"about_ca_topic_score_gemma":0.00784386,"teacher_disagreement_score":0.0029632174,"about_ca_system_score_codex":0.00072753057,"about_ca_system_score_gemma":0.0018871273,"threshold_uncertainty_score":0.008091927},"labels":[],"label_agreement":null},{"id":"W2783973185","doi":"10.1016/j.jaad.2017.10.006","title":"Guidelines of care for the management of basal cell carcinoma","year":2018,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":480,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Astellas Pharma; DUSA Pharmaceuticals; Regeneron Pharmaceuticals; Celgene; Massachusetts General Hospital; Valeant Pharmaceuticals International; Sanofi; Pfizer; Amgen","keywords":"Medicine; Basal cell carcinoma; Basal cell; Internal medicine","score_opus":0.03279352246805929,"score_gpt":0.358450354618178,"score_spread":0.3256568321501187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2783973185","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0039564976,0.16360715,0.04027187,0.4247614,0.024770536,0.0067058466,0.007515467,0.0020883952,0.3263228],"genre_scores_gemma":[0.036285136,0.24984862,0.37437972,0.18773302,0.011419694,0.014085532,0.02342642,0.0008678863,0.101954],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9922799,0.0030349009,0.0017942906,0.00022743724,0.0022210332,0.00044243177],"domain_scores_gemma":[0.97571886,0.0044648107,0.0022128017,0.00056585635,0.015204884,0.0018328753],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0053533646,0.00084763113,0.0011090771,0.0030046585,0.0018468236,0.002054818,0.003728926,0.0065884893,0.01834867],"category_scores_gemma":[0.03301813,0.0003967654,0.0019460716,0.0021364938,0.00085081335,0.0016891042,0.002064456,0.0057926485,0.012766355],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000357121,0.00016597655,0.0012243545,0.0016294271,0.000033345263,0.00051782886,0.00030720897,0.00032599407,0.0002627542,0.0042982902,0.7977562,0.19344305],"study_design_scores_gemma":[0.000081701415,0.00006736444,0.0026614927,0.010442952,0.00006743894,0.0009951902,0.00029505714,0.0002866118,0.0001584441,0.004652277,0.9802517,0.00003976705],"about_ca_topic_score_codex":0.013965314,"about_ca_topic_score_gemma":0.034818895,"teacher_disagreement_score":0.01834867,"about_ca_system_score_codex":0.0031930974,"about_ca_system_score_gemma":0.012530345,"threshold_uncertainty_score":0.061382413},"labels":[],"label_agreement":null},{"id":"W2784072458","doi":"10.1016/j.jaad.2017.10.007","title":"Guidelines of care for the management of cutaneous squamous cell carcinoma","year":2018,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":581,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Astellas Pharma; DUSA Pharmaceuticals; Regeneron Pharmaceuticals; Celgene; Castle Biosciences; Sanofi; Exelixis; Massachusetts General Hospital; Genentech; Valeant Pharmaceuticals International; Pfizer; Amgen","keywords":"Medicine; Basal cell; Dermatology; MEDLINE; Oncology; Internal medicine","score_opus":0.02683494669652586,"score_gpt":0.3427994502889128,"score_spread":0.3159645035923869,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2784072458","genre_codex":"other","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0041651484,0.10239384,0.036567103,0.33112398,0.018222615,0.008376019,0.0065950253,0.002120759,0.4904355],"genre_scores_gemma":[0.041851588,0.17932376,0.37059817,0.19514091,0.009073444,0.020256594,0.023087738,0.0008955368,0.15977223],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9929274,0.002879869,0.0014425438,0.00018131286,0.0021291722,0.00043968446],"domain_scores_gemma":[0.97996485,0.0036740093,0.0019169785,0.00048883504,0.01252496,0.0014303024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0051508117,0.0007455674,0.0010011337,0.0024272315,0.0017613726,0.0022018084,0.0030361805,0.006274117,0.02317518],"category_scores_gemma":[0.029542282,0.0003892716,0.0018066731,0.0017197094,0.0006165748,0.0014798879,0.0019020829,0.00560626,0.014973444],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003784717,0.00016147146,0.0010286318,0.0011162004,0.000024011031,0.00048693336,0.00028126367,0.0003194677,0.00025785406,0.004353054,0.79499793,0.19693536],"study_design_scores_gemma":[0.000098651275,0.000073063835,0.0022667074,0.008230499,0.00004714796,0.00089372834,0.00025148707,0.0002934946,0.00015561625,0.0038086013,0.9838484,0.000032620617],"about_ca_topic_score_codex":0.011163505,"about_ca_topic_score_gemma":0.029198498,"teacher_disagreement_score":0.02317518,"about_ca_system_score_codex":0.0030519685,"about_ca_system_score_gemma":0.012312529,"threshold_uncertainty_score":0.077528715},"labels":[],"label_agreement":null},{"id":"W2785912981","doi":"10.1016/j.jaad.2018.01.031","title":"Horizontal and vertical sections of scalp biopsy specimens from dermatomyositis patients with scalp involvement","year":2018,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Inflammatory Myopathies and Dermatomyositis","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cegep regional de Lanaudiere","funders":"","keywords":"Medicine; Scalp; Dermatomyositis; Pathology; Biopsy; Dermatology; Hyperkeratosis","score_opus":0.006619559511537351,"score_gpt":0.24867214789331885,"score_spread":0.2420525883817815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2785912981","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99307996,0.001023846,0.00081270735,0.00006417763,0.000038901173,0.000044326527,0.00060033763,0.000031155803,0.0043045837],"genre_scores_gemma":[0.99697423,0.00055712427,0.0008809083,0.000056952544,0.00001997425,0.000014308634,0.00048154133,0.000009083003,0.0010057709],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99989057,0.000012325744,0.000015607286,0.000021201933,0.00002168573,0.000038622176],"domain_scores_gemma":[0.9998258,0.000046776848,0.000026279502,0.000017418062,0.000043425785,0.000040460916],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000126539,0.00022712996,0.00011442215,0.0006932678,0.0002895043,0.00017957881,0.000119547956,0.00024256356,0.004307152],"category_scores_gemma":[0.00027177035,0.00014842578,0.0001380462,0.00033214322,0.00021133255,0.00013810216,0.00018498588,0.00019440992,0.00039948203],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028881556,0.00018200967,0.122502744,0.00032082785,0.00008299565,0.034770515,0.0006609923,0.00016014026,0.8161929,0.0001895509,0.0009905113,0.021058684],"study_design_scores_gemma":[0.00007676596,0.0008241745,0.8654084,0.000055533583,0.00012092089,0.056793153,0.0019319606,0.00043637952,0.070039324,0.00015254959,0.004146762,0.000013962012],"about_ca_topic_score_codex":0.002037272,"about_ca_topic_score_gemma":0.0032586434,"teacher_disagreement_score":0.004307152,"about_ca_system_score_codex":0.00011115804,"about_ca_system_score_gemma":0.00013760384,"threshold_uncertainty_score":0.014408827},"labels":[],"label_agreement":null},{"id":"W2789024274","doi":"10.1016/j.jaad.2017.12.022","title":"Dupilumab: A review of its use in the treatment of atopic dermatitis","year":2018,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":330,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health; Probity Medical Research; University of British Columbia; Queen's University","funders":"LEO Pharma; Sanofi","keywords":"Dupilumab; Medicine; Atopic dermatitis; Eczema Area and Severity Index; Dermatology Life Quality Index; Adverse effect; Dermatology; Concomitant; Clinical trial; SCORAD; Quality of life (healthcare); Internal medicine; Placebo; Immune dysregulation; Immunology; Immune system; Pathology; Psoriasis","score_opus":0.06353531610637934,"score_gpt":0.3890980903434734,"score_spread":0.32556277423709407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2789024274","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000072663024,0.99954104,0.000029893685,0.000074170275,0.00007984904,0.000002977349,0.000012272122,0.0000020730647,0.00018512364],"genre_scores_gemma":[0.00067023915,0.99880314,0.00009892286,0.0001801075,0.00011390773,0.0000037171872,0.000017731527,7.072071e-7,0.00011145523],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996774,0.00005721894,0.00008542737,0.000056276207,0.00010031707,0.000023311242],"domain_scores_gemma":[0.9992362,0.00046943678,0.00012579882,0.0000129173995,0.00011434205,0.00004126403],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007844234,0.0009133923,0.002011744,0.003411245,0.00035045264,0.0011266067,0.0012394246,0.0010152803,0.0030778195],"category_scores_gemma":[0.0014631442,0.00036615785,0.0012543543,0.00254089,0.00041067958,0.0011110366,0.0006832506,0.001629294,0.0006588921],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018664922,0.000092538634,0.0003543078,0.06571304,0.0004123961,0.00035916799,0.000076844626,0.00032368817,0.00092107436,0.0011453382,0.024516247,0.90589863],"study_design_scores_gemma":[0.00014635257,0.000375635,0.0026667076,0.0342082,0.0021030873,0.0054745157,0.00016064751,0.0002764154,0.0006655366,0.0013540132,0.9524926,0.00007629632],"about_ca_topic_score_codex":0.0015957496,"about_ca_topic_score_gemma":0.004317739,"teacher_disagreement_score":0.003411245,"about_ca_system_score_codex":0.0004587244,"about_ca_system_score_gemma":0.0010524046,"threshold_uncertainty_score":0.010296285},"labels":[],"label_agreement":null},{"id":"W2789305217","doi":"10.1016/j.jaad.2018.03.020","title":"How data can deliver for dermatology","year":2018,"lang":"en","type":"editorial","venue":"Journal of the American Academy of Dermatology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","keywords":"Medicine; Reimbursement; Teledermatology; Dermatology; MEDLINE; Big data; Data collection; Data science; Computer science; Health care; Data mining; Telemedicine","score_opus":0.027724339667953613,"score_gpt":0.32757443122177243,"score_spread":0.2998500915538188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2789305217","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000113266815,0.005306249,0.00013500148,0.054120023,0.9390639,0.000013749561,0.000040594296,0.0000517018,0.0012574039],"genre_scores_gemma":[0.00015805692,0.004833328,0.00016685908,0.036628477,0.9525716,0.000019802303,0.000026953407,0.00004294104,0.005551943],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98674923,0.0035616385,0.0020880017,0.00095547107,0.005985912,0.0006595977],"domain_scores_gemma":[0.9178023,0.04022599,0.0051051746,0.002596816,0.02489768,0.009372037],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018085383,0.0039440296,0.003922773,0.006237049,0.003987537,0.0158263,0.003859149,0.021480838,0.024385016],"category_scores_gemma":[0.078612655,0.0019887914,0.0035370188,0.0021223743,0.0037439438,0.010437749,0.0040742513,0.040298127,0.017374508],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017047583,0.000010860084,0.00002927872,0.00019044933,0.00001808976,0.000054905617,0.00001407775,0.0000152291705,0.000025298683,0.00048447636,0.9933936,0.0057467436],"study_design_scores_gemma":[0.00005645418,0.000015165512,0.00013711676,0.00069037464,0.00005146323,0.0001472029,0.00005438416,0.000089533074,0.00004736771,0.0019197661,0.99677175,0.0000192878],"about_ca_topic_score_codex":0.0019753154,"about_ca_topic_score_gemma":0.006315349,"teacher_disagreement_score":0.024385016,"about_ca_system_score_codex":0.0043355036,"about_ca_system_score_gemma":0.004842316,"threshold_uncertainty_score":0.095645726},"labels":[],"label_agreement":null},{"id":"W2792012841","doi":"10.1016/j.jaad.2017.10.011","title":"Commentary: The Corrona-National Psoriasis Foundation Psoriasis Registry","year":2017,"lang":"en","type":"editorial","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"University of Connecticut; AbbVie; Eli Lilly and Company","keywords":"Psoriasis; Medicine; Systemic therapy; Cohort; Dermatology; Internal medicine","score_opus":0.019692917563838844,"score_gpt":0.30446377579441486,"score_spread":0.284770858230576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2792012841","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000090014895,0.0024086512,0.00008976269,0.40235218,0.5933688,0.000026598987,0.00011937062,0.000046622525,0.0014979722],"genre_scores_gemma":[0.0010167425,0.0019895236,0.0001109943,0.30197433,0.68882126,0.000055791636,0.000079807774,0.000049846785,0.0059017166],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9907969,0.0024324288,0.0012524672,0.0010840904,0.0036667278,0.0007674647],"domain_scores_gemma":[0.97087806,0.014026395,0.0026181275,0.00093627576,0.008141726,0.0033995064],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012951787,0.002733538,0.0034126653,0.0027693177,0.0039888155,0.00894379,0.0042713606,0.03649747,0.009821728],"category_scores_gemma":[0.053557508,0.0015969656,0.0025259869,0.0014976171,0.003093941,0.0057745357,0.0027573747,0.04110789,0.0085874535],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030134166,0.000008101085,0.000054954515,0.00004999344,0.000012767485,0.00007156779,0.000015115649,0.000011865247,0.000014463688,0.0001906777,0.99819845,0.0013419179],"study_design_scores_gemma":[0.00023033156,0.00004042512,0.00073245063,0.00082141306,0.00012658557,0.00022364924,0.00015280161,0.00023220826,0.00014842673,0.001504046,0.9957416,0.000046086698],"about_ca_topic_score_codex":0.0038352024,"about_ca_topic_score_gemma":0.007460661,"teacher_disagreement_score":0.03649747,"about_ca_system_score_codex":0.0049658557,"about_ca_system_score_gemma":0.007195696,"threshold_uncertainty_score":0.068496466},"labels":[],"label_agreement":null},{"id":"W2792622733","doi":"10.1016/j.jaad.2018.02.073","title":"Dupilumab for hand eczema","year":2018,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Contact Dermatitis and Allergies","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Medicine; Etiology; Dupilumab; Hand eczema; Atopy; Dermatology; Atopic dermatitis; Quality of life (healthcare); Contact dermatitis; Population; Disease; Pediatrics; Allergy; Internal medicine; Immunology; Environmental health","score_opus":0.01969812535663798,"score_gpt":0.32566147793892974,"score_spread":0.3059633525822918,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2792622733","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5641014,0.25930676,0.0038036427,0.012928844,0.0045392136,0.0003078275,0.0008472295,0.00080789794,0.15335721],"genre_scores_gemma":[0.9339411,0.024093121,0.0016771344,0.004587596,0.0009946268,0.00006693181,0.0005556365,0.000035025823,0.034048792],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.99990463,0.00001670272,0.0000068610475,0.000009919344,0.000017911507,0.00004390327],"domain_scores_gemma":[0.99993026,0.000017480726,0.0000070467913,0.000004822513,0.000013225657,0.000027130016],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012814131,0.0002701995,0.0003421145,0.00024337272,0.00033286598,0.00030398407,0.00017760621,0.0004034973,0.0049119876],"category_scores_gemma":[0.00022197464,0.000060008377,0.00030558772,0.00010702964,0.00011169845,0.00017689486,0.000119213044,0.00066901214,0.0013213854],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039245593,0.00074264867,0.008090801,0.0013135327,0.00029947827,0.019789957,0.00009620349,0.0002612659,0.030273758,0.0018663155,0.063326254,0.87001526],"study_design_scores_gemma":[0.0054930076,0.008562137,0.07429283,0.0013292521,0.0012037321,0.22745219,0.0004211874,0.0040524653,0.04396776,0.0025467484,0.6305867,0.00009203198],"about_ca_topic_score_codex":0.00068720937,"about_ca_topic_score_gemma":0.002306592,"teacher_disagreement_score":0.0049119876,"about_ca_system_score_codex":0.00030774425,"about_ca_system_score_gemma":0.00027277754,"threshold_uncertainty_score":0.016432226},"labels":[],"label_agreement":null},{"id":"W2793374690","doi":"10.1016/j.jaad.2018.03.008","title":"Effect of psoriatic arthritis on ixekizumab clinical outcomes in moderate-to-severe psoriasis patients: A post hoc analysis","year":2018,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Medicine; Ixekizumab; Psoriasis; Psoriatic arthritis; Dermatology; Etanercept; Arthritis; Internal medicine; Secukinumab; Tumor necrosis factor alpha","score_opus":0.011637232409715783,"score_gpt":0.3091276638145786,"score_spread":0.29749043140486287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793374690","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99597186,0.0007367637,0.00078100007,0.00012915803,0.0003247658,0.00015738473,0.00076917704,0.000035134228,0.0010947579],"genre_scores_gemma":[0.99558556,0.00018163415,0.00054704526,0.00017985958,0.000222191,0.00033151763,0.0007778044,0.000031223986,0.002143184],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99209714,0.0037394494,0.00042631914,0.0017282449,0.00061743654,0.0013913417],"domain_scores_gemma":[0.99140537,0.0059104874,0.0005732215,0.00086459034,0.0004565355,0.0007898207],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006325624,0.0019231791,0.0062447945,0.0007258208,0.0006380177,0.001822745,0.0018417614,0.0014731978,0.0060434733],"category_scores_gemma":[0.0067610103,0.00071490294,0.008923116,0.0007089981,0.0010548267,0.0019331577,0.0012783762,0.0037815014,0.00058442424],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8453462,0.004551958,0.094746284,0.0006763862,0.028688848,0.0006100578,0.00030429426,0.0025898973,0.005352656,0.00040552855,0.002287586,0.0144401975],"study_design_scores_gemma":[0.060178902,0.2487818,0.6006733,0.0001618332,0.053061333,0.00069146795,0.001286603,0.021650303,0.006351893,0.0015394056,0.005209769,0.00041344948],"about_ca_topic_score_codex":0.0016363045,"about_ca_topic_score_gemma":0.0019451514,"teacher_disagreement_score":0.006325624,"about_ca_system_score_codex":0.0009008693,"about_ca_system_score_gemma":0.001521605,"threshold_uncertainty_score":0.033453465},"labels":[],"label_agreement":null},{"id":"W2794774743","doi":"10.1016/j.jaad.2018.03.032","title":"Wound care for Stevens-Johnson syndrome and toxic epidermal necrolysis","year":2018,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Toxic epidermal necrolysis; Medicine; Dermatology; Erythroderma","score_opus":0.0440278639711152,"score_gpt":0.37817997557008787,"score_spread":0.3341521115989727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2794774743","genre_codex":"editorial","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007493581,0.06652928,0.00035706445,0.33707872,0.5917634,0.000028727198,0.00011865593,0.00006907101,0.003305722],"genre_scores_gemma":[0.007895898,0.06661904,0.00047440373,0.20046467,0.7171962,0.0000344358,0.00011323761,0.00007333446,0.007128854],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961533,0.001006254,0.0008582419,0.00039625913,0.0011908312,0.00039507617],"domain_scores_gemma":[0.98543096,0.0058344575,0.0017419708,0.00024890451,0.0050724493,0.0016712444],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025066289,0.0015244895,0.0017665178,0.0015942642,0.0012647344,0.0029205908,0.0025137318,0.010340555,0.010724463],"category_scores_gemma":[0.02964105,0.00079139764,0.0012598562,0.0012898276,0.0014873482,0.004464237,0.0012628621,0.014081139,0.0049611973],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006804795,0.000033195978,0.00032912506,0.0014108856,0.000051117822,0.0014534038,0.0000738414,0.00007382099,0.000070686445,0.0006390167,0.9612862,0.03451068],"study_design_scores_gemma":[0.000112774615,0.0001172694,0.0016689904,0.007038151,0.0001615294,0.012145431,0.00040857858,0.00037809258,0.0002956729,0.0022056974,0.97539604,0.00007165131],"about_ca_topic_score_codex":0.0025996938,"about_ca_topic_score_gemma":0.0043463856,"teacher_disagreement_score":0.010724463,"about_ca_system_score_codex":0.0023116793,"about_ca_system_score_gemma":0.0032086202,"threshold_uncertainty_score":0.03587687},"labels":[],"label_agreement":null},{"id":"W2794845062","doi":"10.1016/j.jaad.2018.03.037","title":"Dual neutralization of both interleukin 17A and interleukin 17F with bimekizumab in patients with psoriasis: Results from BE ABLE 1, a 12-week randomized, double-blinded, placebo-controlled phase 2b trial","year":2018,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":188,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Medicine; Placebo; Psoriasis; Clinical endpoint; Psoriasis Area and Severity Index; Adverse effect; Internal medicine; Interleukin 17; Randomized controlled trial; Gastroenterology; Clinical trial; Interleukin; Surgery; Immunology; Inflammation; Cytokine; Pathology","score_opus":0.02089051072143032,"score_gpt":0.2762123065281997,"score_spread":0.2553217958067694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2794845062","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9726241,0.01806417,0.00089426927,0.0014385977,0.0008286777,0.0020473865,0.0013097618,0.0001812084,0.002611791],"genre_scores_gemma":[0.9798421,0.008054097,0.0015341258,0.002169794,0.00073104876,0.0019467063,0.0014208885,0.00005003469,0.004251209],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99933785,0.00027424304,0.000048236223,0.00013141132,0.00006846321,0.00013969906],"domain_scores_gemma":[0.9993211,0.00019025078,0.00013693268,0.00005946312,0.00004885648,0.00024353249],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020821404,0.0018268671,0.003818905,0.00055637624,0.00058988476,0.001751758,0.0009413007,0.002460891,0.0054736547],"category_scores_gemma":[0.0014355466,0.0008040533,0.0026366387,0.00041019206,0.0011912447,0.0016331394,0.00041112065,0.004351089,0.0012198995],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.95069546,0.00858717,0.0007535368,0.0012194981,0.0017469036,0.00007380279,0.000092411196,0.00028169755,0.0059921616,0.00012074678,0.0012977491,0.029138818],"study_design_scores_gemma":[0.96518296,0.03174478,0.0013139743,0.000038929873,0.0005115891,0.00004560005,0.00002527231,0.0001335809,0.00035338805,0.00010616575,0.00053140195,0.000012454108],"about_ca_topic_score_codex":0.0007131946,"about_ca_topic_score_gemma":0.0013238827,"teacher_disagreement_score":0.0054736547,"about_ca_system_score_codex":0.0005925676,"about_ca_system_score_gemma":0.0007537431,"threshold_uncertainty_score":0.018311143},"labels":[],"label_agreement":null},{"id":"W2797132528","doi":"10.1016/j.jaad.2018.04.012","title":"Certolizumab pegol for the treatment of chronic plaque psoriasis: Results through 48 weeks from 2 phase 3, multicenter, randomized, double-blinded, placebo-controlled studies (CIMPASI-1 and CIMPASI-2)","year":2018,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":155,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre de Recherche Dermatologique du Québec Métropolitain","funders":"Dermira","keywords":"Certolizumab pegol; Medicine; Placebo; Psoriasis Area and Severity Index; Psoriasis; Clinical endpoint; Adverse effect; Internal medicine; Randomized controlled trial; Clinical trial; Dermatology; Adalimumab; Tumor necrosis factor alpha; Pathology","score_opus":0.04701122508122613,"score_gpt":0.3529104809531127,"score_spread":0.3058992558718866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2797132528","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91510046,0.06598678,0.002659822,0.0017815084,0.00049552054,0.008031189,0.0027791772,0.0003231368,0.0028424638],"genre_scores_gemma":[0.9619821,0.020888783,0.005238699,0.0019383325,0.00065602496,0.0052466057,0.0025694082,0.00008411754,0.0013958802],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9976809,0.0012294975,0.0002771095,0.0003081995,0.00030660475,0.00019760052],"domain_scores_gemma":[0.99573576,0.0012839892,0.0016003828,0.00031083002,0.00049393025,0.0005751354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0115963835,0.0015156369,0.0024741853,0.0006366704,0.00060604943,0.0011573447,0.0007834175,0.0021915764,0.0037224744],"category_scores_gemma":[0.0056545115,0.00057804596,0.0038386271,0.0005997519,0.0007486402,0.0010591631,0.0004719329,0.0022474504,0.0005269779],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.79918903,0.012979393,0.005262691,0.0047709234,0.007998942,0.00014677299,0.0003079219,0.00097214215,0.019295081,0.00016127116,0.0030561658,0.14585963],"study_design_scores_gemma":[0.8145604,0.15204918,0.020588065,0.0004971924,0.0043753744,0.00024489217,0.00004628203,0.0004143493,0.0034626983,0.00016741049,0.0035466026,0.000047521396],"about_ca_topic_score_codex":0.00060348614,"about_ca_topic_score_gemma":0.0012443572,"teacher_disagreement_score":0.0115963835,"about_ca_system_score_codex":0.00083612057,"about_ca_system_score_gemma":0.0016347193,"threshold_uncertainty_score":0.061328232},"labels":[],"label_agreement":null},{"id":"W2797238574","doi":"10.1016/j.jaad.2018.04.013","title":"Certolizumab pegol for the treatment of chronic plaque psoriasis: Results through 48 weeks of a phase 3, multicenter, randomized, double-blind, etanercept- and placebo-controlled study (CIMPACT)","year":2018,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":131,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"","keywords":"Certolizumab pegol; Medicine; Placebo; Etanercept; Psoriasis Area and Severity Index; Clinical endpoint; Psoriasis; Internal medicine; Adverse effect; Randomized controlled trial; Tumor necrosis factor alpha; Dermatology; Pathology","score_opus":0.037537798279241245,"score_gpt":0.345756602853417,"score_spread":0.3082188045741758,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2797238574","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9750209,0.012445951,0.0012676438,0.001134339,0.00030006358,0.0062736757,0.0017280233,0.00021694398,0.0016125368],"genre_scores_gemma":[0.97150403,0.009239775,0.004232753,0.0023239725,0.0006178014,0.0070940526,0.002650343,0.0000809761,0.0022562381],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9989936,0.0005285693,0.000074111544,0.00014362912,0.00013746027,0.00012273059],"domain_scores_gemma":[0.9985145,0.0003199978,0.0004079978,0.0001392493,0.00014009941,0.00047808804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0050838054,0.0012321216,0.0020353275,0.00039448176,0.00049099774,0.0008576146,0.0007434995,0.0021524664,0.003325668],"category_scores_gemma":[0.0023140095,0.0005272208,0.0023583241,0.00044432277,0.00082059775,0.00085880933,0.0002817817,0.002773134,0.00062703656],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8713192,0.025447601,0.003546783,0.001380438,0.0024593023,0.000167909,0.00019208739,0.0006764346,0.0135643035,0.0001252404,0.002523717,0.07859704],"study_design_scores_gemma":[0.92703354,0.06262115,0.007684193,0.00006266301,0.00049864047,0.000115711206,0.0000169467,0.00023441053,0.0007316818,0.000062613435,0.00092434476,0.000014125309],"about_ca_topic_score_codex":0.000789846,"about_ca_topic_score_gemma":0.0011543796,"teacher_disagreement_score":0.0050838054,"about_ca_system_score_codex":0.00056481146,"about_ca_system_score_gemma":0.0014048885,"threshold_uncertainty_score":0.026886046},"labels":[],"label_agreement":null},{"id":"W2797320652","doi":"10.1016/j.jaad.2018.02.071","title":"Epidemiology of pediatric nickel sensitivity: Retrospective review of North American Contact Dermatitis Group (NACDG) data 1994-2014","year":2018,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Contact Dermatitis and Allergies","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; University of Toronto; Royal Victoria Hospital; McGill University; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Nickel allergy; Contact dermatitis; Confidence interval; Nickel; Allergic contact dermatitis; Cohort; Epidemiology; Retrospective cohort study; Allergen; Cohort study; Allergy; Internal medicine; Dermatology; Pediatrics; Immunology; Metallurgy","score_opus":0.03307669191286766,"score_gpt":0.33835303079521023,"score_spread":0.30527633888234257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2797320652","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9797324,0.006817674,0.00015007002,0.0000618243,0.000014131162,0.000037175767,0.011689209,0.000015752594,0.0014817766],"genre_scores_gemma":[0.9885572,0.0039442685,0.000187152,0.00006273543,0.000014885788,0.000047752008,0.0069036107,0.0000069894286,0.00027540643],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984113,0.00021852979,0.00038399617,0.00036504152,0.00043702355,0.0001841487],"domain_scores_gemma":[0.9968166,0.00027087622,0.0018026798,0.00016246662,0.00078951474,0.00015799543],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007576759,0.0002926652,0.00051466806,0.0026406655,0.00039109864,0.0006484934,0.0005175166,0.00034850655,0.0010807646],"category_scores_gemma":[0.0019535127,0.00034158182,0.0007196633,0.0055927006,0.00027482046,0.00059187814,0.00059732964,0.00029666338,0.00023610317],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029007932,0.0000067488086,0.99786854,0.000063323205,0.00005169546,0.0000846058,0.000061281724,0.000026374266,0.00005293436,0.00001056295,0.0003600621,0.0013848613],"study_design_scores_gemma":[0.000001380786,0.000018554008,0.9985261,0.000043491436,0.000039031707,0.0003933876,0.00021657633,0.000028519496,0.000038155296,0.0000033474428,0.00068975374,0.0000016973254],"about_ca_topic_score_codex":0.050680548,"about_ca_topic_score_gemma":0.06518289,"teacher_disagreement_score":0.050680548,"about_ca_system_score_codex":0.0010250479,"about_ca_system_score_gemma":0.0013802764,"threshold_uncertainty_score":0.10077113},"labels":[],"label_agreement":null},{"id":"W2802689151","doi":"10.1016/j.jaad.2018.04.043","title":"Maintenance of therapeutic response after 1 year of apremilast combination therapy compared with monotherapy for the treatment of plaque psoriasis: A multicenter, retrospective study","year":2018,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Health Sciences Centre; Sunnybrook Health Science Centre; Western University; Women's College Hospital; University of Toronto","funders":"","keywords":"Apremilast; Medicine; Psoriasis; Randomized controlled trial; Combination therapy; Dermatology; Internal medicine; Clinical trial; Psoriatic arthritis","score_opus":0.020726983020248026,"score_gpt":0.2901064354930756,"score_spread":0.2693794524728276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2802689151","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983284,0.0011334197,0.00006797425,0.000020969046,0.00000953849,0.000034149558,0.00011719667,0.000003948943,0.00028447507],"genre_scores_gemma":[0.99932885,0.00018248476,0.00006569151,0.000033038443,0.000035460052,0.000023531438,0.00020451713,0.0000029466253,0.0001234908],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99748236,0.0009743723,0.00029079325,0.0005822448,0.00036356962,0.00030661505],"domain_scores_gemma":[0.9967625,0.000828562,0.0013226804,0.00036735044,0.00031237846,0.00040650836],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003150656,0.00045387243,0.001675089,0.0008172682,0.0006081104,0.0008582964,0.00067877764,0.0009872486,0.0010779348],"category_scores_gemma":[0.0030751827,0.0002842422,0.0013224857,0.001051374,0.00054395193,0.00088074006,0.00031531634,0.00086221984,0.0003330936],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11520228,0.0038501408,0.8413589,0.00021597919,0.0013422391,0.0009883302,0.00040546164,0.0003068694,0.010668284,0.00007573806,0.0002806584,0.025305163],"study_design_scores_gemma":[0.002154266,0.048728947,0.9438288,0.000023099183,0.0011748798,0.0013172022,0.0002650812,0.00046614066,0.0012157715,0.00004874866,0.00074084394,0.000036141453],"about_ca_topic_score_codex":0.0009877825,"about_ca_topic_score_gemma":0.0005193551,"teacher_disagreement_score":0.003150656,"about_ca_system_score_codex":0.0005972964,"about_ca_system_score_gemma":0.00046232983,"threshold_uncertainty_score":0.016662478},"labels":[],"label_agreement":null},{"id":"W2803625437","doi":"10.1016/j.jaad.2018.05.032","title":"Maintenance of skin clearance with ixekizumab treatment of psoriasis: Three-year results from the UNCOVER-3 study","year":2018,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":67,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"","keywords":"Ixekizumab; Medicine; Psoriasis; Dermatology; Plaque psoriasis; Secukinumab; Psoriatic arthritis","score_opus":0.017638281568883377,"score_gpt":0.26490242844874773,"score_spread":0.24726414687986437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2803625437","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99388194,0.0041978885,0.00026890935,0.00014459404,0.00004901675,0.00010318554,0.00063198473,0.00002506646,0.0006973771],"genre_scores_gemma":[0.9964091,0.0012475374,0.0001653864,0.00024766618,0.000099012956,0.000086308435,0.0012928899,0.000013780696,0.0004381679],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9982388,0.00057586783,0.00015919346,0.00024915527,0.00029866345,0.00047827797],"domain_scores_gemma":[0.99716645,0.00064006465,0.0009322616,0.0004940129,0.00023862628,0.0005286197],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004321554,0.0011205641,0.003030731,0.00044355955,0.000645428,0.0017826199,0.00084767886,0.0014507828,0.0010524121],"category_scores_gemma":[0.0024743904,0.0003704,0.0040586838,0.00071945146,0.00095997506,0.0015884785,0.0006278441,0.002418689,0.00043463465],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.65306187,0.021229925,0.16556196,0.0009159156,0.010167891,0.0008855416,0.00068575365,0.0020972535,0.01297227,0.00027933982,0.0022953413,0.1298469],"study_design_scores_gemma":[0.09518621,0.21437706,0.66665363,0.00016777881,0.011930972,0.0011705853,0.000586685,0.00151427,0.0036094342,0.00042915426,0.0042246114,0.00014964127],"about_ca_topic_score_codex":0.0020649838,"about_ca_topic_score_gemma":0.0015951958,"teacher_disagreement_score":0.004321554,"about_ca_system_score_codex":0.0009054082,"about_ca_system_score_gemma":0.00094494625,"threshold_uncertainty_score":0.022854865},"labels":[],"label_agreement":null},{"id":"W2806489058","doi":"10.1016/j.jaad.2018.06.002","title":"Minimal clinically important differences for measures of treatment efficacy in Stevens-Johnson syndrome and toxic epidermal necrolysis","year":2018,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institute of Allergy and Infectious Diseases; National Institute of General Medical Sciences","keywords":"Toxic epidermal necrolysis; Medicine; Dermatology","score_opus":0.05820297231923149,"score_gpt":0.363702497997644,"score_spread":0.3054995256784125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2806489058","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9725849,0.005622858,0.0069122803,0.0005311875,0.00040992865,0.0019209627,0.0022116872,0.00008275453,0.009723357],"genre_scores_gemma":[0.99495184,0.00012973226,0.0031820075,0.00013968477,0.000060307513,0.00058566546,0.00055786746,0.000010225127,0.00038265067],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.94651866,0.03654532,0.004917364,0.0016522766,0.009337767,0.0010284832],"domain_scores_gemma":[0.89400744,0.08630918,0.008926221,0.0047245626,0.0038790065,0.0021536248],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.04312644,0.000879869,0.0017884466,0.0015860263,0.00072940666,0.0013828751,0.0013918357,0.0013723379,0.0026937183],"category_scores_gemma":[0.061687734,0.00033817877,0.0023257323,0.0008477778,0.0014275196,0.0016070978,0.0011482533,0.0025064037,0.00036337195],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.36390775,0.007678984,0.422395,0.0023491194,0.014574559,0.00052231713,0.0013530791,0.0067896573,0.024396049,0.0076842266,0.0038053321,0.14454398],"study_design_scores_gemma":[0.010069844,0.07289863,0.87770677,0.00023530616,0.0025925173,0.0007661537,0.0008174894,0.013428617,0.010957687,0.0051928926,0.005130331,0.00020368285],"about_ca_topic_score_codex":0.0004907806,"about_ca_topic_score_gemma":0.0012801053,"teacher_disagreement_score":0.04312644,"about_ca_system_score_codex":0.001327961,"about_ca_system_score_gemma":0.0008512123,"threshold_uncertainty_score":0.22807717},"labels":[],"label_agreement":null},{"id":"W2806696712","doi":"10.1016/j.jaad.2018.05.040","title":"Long-term adalimumab efficacy in patients with moderate-to-severe hidradenitis suppurativa/acne inversa: 3-year results of a phase 3 open-label extension study","year":2018,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":187,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lynde Centre for Dermatology; Probity Medical Research","funders":"AbbVie Deutschland; AbbVie","keywords":"Hidradenitis suppurativa; Medicine; Adalimumab; Acne; Dermatology; Open label; Term (time); Internal medicine; Clinical trial","score_opus":0.03540280525598135,"score_gpt":0.3587357612467559,"score_spread":0.32333295599077455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2806696712","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932734,0.004527913,0.00026908604,0.0002096294,0.00011118563,0.0004599362,0.00043330967,0.000056818455,0.0006587195],"genre_scores_gemma":[0.9950413,0.0014811746,0.0006086493,0.00053747976,0.00018965978,0.00042382086,0.0008714712,0.000017109405,0.00082935713],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99912935,0.0003287147,0.000070839276,0.00012108779,0.00011185778,0.00023817612],"domain_scores_gemma":[0.9984414,0.00036922868,0.000309525,0.00016946586,0.00010824527,0.00060214114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037268766,0.0015881706,0.003741725,0.00044414785,0.0008794713,0.0016311216,0.000865268,0.0016575751,0.0020313389],"category_scores_gemma":[0.0012240806,0.00066662254,0.0037815808,0.0004295734,0.0012996893,0.001750811,0.00039484823,0.004099799,0.00076039124],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8254632,0.047285866,0.014363021,0.0011099919,0.003298986,0.0004128723,0.0005097137,0.0013014296,0.021982213,0.00012774601,0.0016501218,0.08249494],"study_design_scores_gemma":[0.53772354,0.39146623,0.06313622,0.00008478646,0.001914753,0.00041955835,0.00017839971,0.0010859423,0.0021677616,0.00016377827,0.0015758427,0.000083107145],"about_ca_topic_score_codex":0.00073843414,"about_ca_topic_score_gemma":0.0014727062,"teacher_disagreement_score":0.003741725,"about_ca_system_score_codex":0.0006628241,"about_ca_system_score_gemma":0.00093459606,"threshold_uncertainty_score":0.019709826},"labels":[],"label_agreement":null},{"id":"W2809143647","doi":"10.1016/j.jaad.2018.06.027","title":"Prevalence of psoriatic arthritis in patients with psoriasis: A systematic review and meta-analysis of observational and clinical studies","year":2018,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":652,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto Western Hospital","funders":"Janssen Pharmaceuticals; LEO Pharma; Regeneron Pharmaceuticals; Kongelig Hofbuntmager Aage Bangs Fond; H. Lundbeck A/S; Eli Lilly and Company; Galderma; Lundbeckfonden; National Institute for Health and Care Research; Sanofi; Pfizer; Samsung; National Psoriasis Foundation; Amgen","keywords":"Medicine; Psoriatic arthritis; Observational study; Psoriasis; Meta-analysis; Dermatology; Arthritis; MEDLINE; Internal medicine","score_opus":0.1314660718190668,"score_gpt":0.42634875173696746,"score_spread":0.2948826799179006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809143647","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0068534655,0.9921441,0.00029983075,0.00007664574,0.00007985287,0.00008753402,0.00035632143,0.000010749195,0.000091513444],"genre_scores_gemma":[0.17912255,0.8167547,0.0019945994,0.00064104685,0.0001866867,0.0002931196,0.0008262065,0.000018305496,0.00016271166],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99115694,0.0029744687,0.0033433586,0.0012888276,0.00096856744,0.00026793435],"domain_scores_gemma":[0.9836639,0.011833636,0.002787717,0.00059893477,0.00091917795,0.0001966006],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008748866,0.0022652056,0.014088933,0.005220988,0.0006051675,0.0027283928,0.002221843,0.002281001,0.0022967905],"category_scores_gemma":[0.024543645,0.0018634595,0.027384693,0.0067879027,0.0006612647,0.0020110589,0.0018348659,0.0017670424,0.00020496137],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015840577,0.000040278243,0.017206898,0.32330084,0.64386314,0.00018700022,0.0001466269,0.00028990518,0.00025310466,0.00010809631,0.0005441988,0.012475823],"study_design_scores_gemma":[0.00038642538,0.00013305682,0.012580686,0.015009913,0.9700422,0.00022792022,0.000092407005,0.00012207046,0.000075536,0.00014823883,0.0011481948,0.00003331573],"about_ca_topic_score_codex":0.0056157694,"about_ca_topic_score_gemma":0.015584752,"teacher_disagreement_score":0.014088933,"about_ca_system_score_codex":0.0014612491,"about_ca_system_score_gemma":0.0024888678,"threshold_uncertainty_score":0.04626894},"labels":[],"label_agreement":null},{"id":"W2831987875","doi":"10.1016/j.jaad.2018.06.057","title":"Psoriasis: Which therapy for which patient","year":2018,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":361,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Johnson and Johnson; Janssen Biotech; MedImmune; Valeant Pharmaceuticals International; AbbVie; Boehringer Ingelheim; AstraZeneca; Novartis; Pfizer","keywords":"Medicine; Psoriasis; Psoriatic arthritis; Disease; Malignancy; Intensive care medicine; Food and drug administration; Quality of life (healthcare); Dermatology; Internal medicine; Pharmacology","score_opus":0.039947038626975656,"score_gpt":0.32888981877310325,"score_spread":0.2889427801461276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2831987875","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005411869,0.99667954,0.00015988923,0.0015732707,0.00065283495,0.0000055302808,0.000015548028,0.000008138629,0.00085106643],"genre_scores_gemma":[0.00076199527,0.9958455,0.00029493487,0.0014062902,0.0009556077,0.000006637363,0.00002713583,0.0000026082325,0.0006993312],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995628,0.00010739543,0.000077229895,0.000078954356,0.00014123745,0.000032463984],"domain_scores_gemma":[0.99938226,0.00029155784,0.00010667493,0.000018732151,0.00015187947,0.000048947004],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00084536016,0.00067841355,0.0020717226,0.001879649,0.00042177425,0.0017222671,0.0010706078,0.0020221467,0.003470232],"category_scores_gemma":[0.001538503,0.0002849857,0.0006276383,0.0013258726,0.00058363244,0.0020022793,0.00061898085,0.003093463,0.0017253837],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006913469,0.000059825838,0.00023249528,0.008807896,0.00008517583,0.000157046,0.00003711575,0.00015924871,0.00046752396,0.0025707027,0.07292899,0.91442496],"study_design_scores_gemma":[0.000055148867,0.00006683459,0.0009065467,0.012881549,0.0002727994,0.0023575907,0.00012451195,0.0001527171,0.00029266576,0.0035014013,0.9793564,0.000031818334],"about_ca_topic_score_codex":0.0014723438,"about_ca_topic_score_gemma":0.003790703,"teacher_disagreement_score":0.003470232,"about_ca_system_score_codex":0.00065858033,"about_ca_system_score_gemma":0.0011890528,"threshold_uncertainty_score":0.011609137},"labels":[],"label_agreement":null},{"id":"W2852818958","doi":"10.1016/j.jaad.2018.07.004","title":"Efficacy, safety, and comparison of sonic hedgehog inhibitors in basal cell carcinomas: A systematic review and meta-analysis","year":2018,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":90,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Canadian Dermatology Foundation","keywords":"Vismodegib; Medicine; Dysgeusia; Basal cell carcinoma; Discontinuation; Internal medicine; Meta-analysis; Oncology; Systematic review; Adverse effect; MEDLINE; Basal cell","score_opus":0.056827589713356046,"score_gpt":0.36725209778746293,"score_spread":0.3104245080741069,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2852818958","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00830383,0.99032885,0.00030214796,0.0001103652,0.000084815285,0.000100451674,0.00059302535,0.00001081001,0.00016581231],"genre_scores_gemma":[0.22767991,0.7672484,0.001376095,0.001268428,0.00030279896,0.0004299514,0.0012806869,0.000019359375,0.00039439203],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9967719,0.0010358229,0.0011559264,0.00050680136,0.0003768599,0.00015265426],"domain_scores_gemma":[0.99416274,0.003891148,0.0012741546,0.0001933123,0.00037715142,0.00010152645],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0049082716,0.001704526,0.011350553,0.0022687777,0.00033829178,0.0018555227,0.0015504712,0.0015020181,0.0029147104],"category_scores_gemma":[0.010964122,0.00075529545,0.018619802,0.003304457,0.0005263215,0.0011577355,0.00094760867,0.0011916306,0.0002280583],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0066174283,0.000071636154,0.009499104,0.41011018,0.5442007,0.00016157057,0.00011231494,0.0006664287,0.0006364374,0.0001604354,0.0011897372,0.02657405],"study_design_scores_gemma":[0.0016299423,0.0004102785,0.007289804,0.014207455,0.97349393,0.00013122045,0.00006900169,0.00013049242,0.00016148813,0.00023308466,0.00220733,0.000035943198],"about_ca_topic_score_codex":0.0025012956,"about_ca_topic_score_gemma":0.007925923,"teacher_disagreement_score":0.011350553,"about_ca_system_score_codex":0.0010083738,"about_ca_system_score_gemma":0.0016020706,"threshold_uncertainty_score":0.025957763},"labels":[],"label_agreement":null},{"id":"W2853216866","doi":"10.1016/j.jaad.2018.06.052","title":"Skin Confident: A skin health and acne educational intervention to improve the Acne Quality of Life measures in adolescents","year":2018,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Acne; Medicine; Quality of life (healthcare); Intervention (counseling); Psychological intervention; Family medicine; Guideline; Cohort; Dermatology; Gerontology; Psychiatry; Nursing; Pathology","score_opus":0.02437894895677251,"score_gpt":0.3824057738967469,"score_spread":0.3580268249399744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2853216866","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995073,0.00051214854,0.00031005338,0.00046622605,0.00009794644,0.00045033454,0.00014981496,0.000057512567,0.002882882],"genre_scores_gemma":[0.9885535,0.0010054666,0.0058010537,0.00052468415,0.000058914036,0.0007191628,0.00022258535,0.000010025013,0.003104673],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99984324,0.000050939354,0.000012210552,0.000020637257,0.000036737296,0.00003630988],"domain_scores_gemma":[0.9995152,0.00010474827,0.00006229338,0.000016448592,0.000030564555,0.0002707455],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039970074,0.00025770304,0.00046134807,0.00020084402,0.00048578193,0.00024611337,0.00034556485,0.00038358528,0.0061511234],"category_scores_gemma":[0.0009915319,0.0001712045,0.00047819174,0.00012891206,0.00010451009,0.0002540779,0.00044266385,0.0011831422,0.00030074766],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01365279,0.22898054,0.10270061,0.0020161094,0.000794899,0.000751164,0.0016030549,0.001160073,0.010110731,0.0006681351,0.016013054,0.62154883],"study_design_scores_gemma":[0.02078504,0.07237261,0.8759304,0.0010290365,0.0016365733,0.00093490584,0.001937911,0.0034685486,0.0068441844,0.0004536392,0.014531685,0.000075382624],"about_ca_topic_score_codex":0.001302828,"about_ca_topic_score_gemma":0.003912431,"teacher_disagreement_score":0.0061511234,"about_ca_system_score_codex":0.00017583274,"about_ca_system_score_gemma":0.00072055747,"threshold_uncertainty_score":0.02057749},"labels":[],"label_agreement":null},{"id":"W2861704390","doi":"10.1016/j.jaad.2018.06.061","title":"Drug-induced phototoxicity: A systematic review","year":2018,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Skin Protection and Aging","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Phototoxicity; MEDLINE; Drug; Pharmacology; Quality of evidence; Dermatology; Intensive care medicine; Internal medicine; Randomized controlled trial","score_opus":0.051197214490270836,"score_gpt":0.3907958182547362,"score_spread":0.3395986037644654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2861704390","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009095098,0.99828315,0.00007899026,0.00009108482,0.000063884865,0.0001379342,0.0002834356,0.000004908021,0.0001471063],"genre_scores_gemma":[0.01316114,0.9854791,0.00036153928,0.00054739794,0.000050861418,0.0001333358,0.00015091631,0.000003644473,0.00011196659],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9969886,0.00075375685,0.0012840766,0.0003338622,0.0005114806,0.00012820741],"domain_scores_gemma":[0.99089855,0.0057862597,0.0024204133,0.00014467166,0.00061554956,0.00013458107],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034115175,0.0014066242,0.006802372,0.005234006,0.0005201768,0.0020896948,0.0015775437,0.001878496,0.0061295372],"category_scores_gemma":[0.01522531,0.000875874,0.007959159,0.006211945,0.0006129979,0.0019401211,0.0016610863,0.0011924617,0.000311268],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026374304,0.000026736105,0.0012562372,0.9543429,0.020107543,0.00013712855,0.00011518906,0.000078851815,0.00012513054,0.00011531436,0.0016985892,0.021732759],"study_design_scores_gemma":[0.00074098376,0.00033116952,0.011152387,0.64894265,0.3104725,0.0009793359,0.00042710188,0.00012827526,0.00020706575,0.0004159826,0.026112914,0.000089683715],"about_ca_topic_score_codex":0.008895715,"about_ca_topic_score_gemma":0.03549321,"teacher_disagreement_score":0.008895715,"about_ca_system_score_codex":0.0021790639,"about_ca_system_score_gemma":0.0049404367,"threshold_uncertainty_score":0.02050531},"labels":[],"label_agreement":null},{"id":"W2887043192","doi":"10.1016/j.jaad.2018.07.041","title":"Cutaneous malignant melanoma incidence and mortality trends in Canada: A comprehensive population-based study","year":2018,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; University of Ottawa","funders":"","keywords":"Medicine; Incidence (geometry); Epidemiology; Population; Demography; Melanoma; Environmental health; Pathology","score_opus":0.0206548394087277,"score_gpt":0.30799907899779716,"score_spread":0.28734423958906946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887043192","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98544794,0.0011467153,0.00011023784,0.0003110743,0.000015007945,0.000069257054,0.011066159,0.000022593755,0.0018109495],"genre_scores_gemma":[0.99288577,0.00092933304,0.0002103573,0.0001845208,0.000013520025,0.00002699822,0.004815708,0.00000824257,0.0009256075],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991025,0.00004079868,0.00007411016,0.00016186577,0.00032209212,0.00029871296],"domain_scores_gemma":[0.997696,0.00006227971,0.0003184246,0.00006182534,0.0013153418,0.0005462542],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039169285,0.00050172943,0.0006401864,0.0026486823,0.0024945936,0.0014103887,0.0013150064,0.00084981835,0.0017520256],"category_scores_gemma":[0.001435701,0.000552088,0.0011170529,0.0086081335,0.00058589864,0.00071997056,0.00087510917,0.0010153871,0.00032655685],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005268007,0.00004437833,0.99687237,0.00002086477,0.000076272794,0.00007899283,0.00017298682,0.000059587066,0.00007771478,0.000028021057,0.0008194348,0.0016966992],"study_design_scores_gemma":[0.0000070297015,0.000017175622,0.99874556,0.000015290454,0.000044396,0.00008401829,0.00046112027,0.00014888984,0.000023315955,0.000010009494,0.00043562145,0.00000754013],"about_ca_topic_score_codex":0.9896713,"about_ca_topic_score_gemma":0.9929934,"teacher_disagreement_score":0.024123702,"about_ca_system_score_codex":0.024123702,"about_ca_system_score_gemma":0.025724934,"threshold_uncertainty_score":0.17503053},"labels":[],"label_agreement":null},{"id":"W2887426493","doi":"10.1016/j.jaad.2018.07.049","title":"Shingles and pneumonia and risk of cutaneous basal and squamous cell carcinoma","year":2018,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"National Cancer Institute; National Institute on Aging","keywords":"Medicine; Immunosenescence; Shingles; Pneumonia; Public health; Family medicine; Basal cell carcinoma; Health care; Epidemiology; Cohort; Cohort study; Internal medicine; Basal cell; Immunology; Pathology","score_opus":0.009728039450199793,"score_gpt":0.2699160264679108,"score_spread":0.260187987017711,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887426493","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932372,0.004543157,0.000087372355,0.000083682346,0.00003765623,0.000009290495,0.0003787284,0.000006050112,0.001616831],"genre_scores_gemma":[0.9984491,0.00090963877,0.000036364145,0.000023327804,0.000040834962,0.0000028684428,0.00014629225,0.0000015612507,0.00038993618],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99945086,0.00017820329,0.000077471756,0.00008733806,0.0000977434,0.0001084882],"domain_scores_gemma":[0.99736965,0.0006943183,0.0009281937,0.0003055853,0.00018909262,0.0005131392],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006289341,0.000394033,0.0004198424,0.00090997847,0.00038367326,0.0011158846,0.00037441813,0.0007291965,0.003292366],"category_scores_gemma":[0.0027081026,0.00040527715,0.0018065202,0.0009309177,0.0002866026,0.0006002766,0.0005036531,0.0009961909,0.00025805342],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009442253,0.00009746968,0.99531174,0.00007376261,0.0006774156,0.00017315453,0.000052819025,0.000059120153,0.00029098184,0.00005905355,0.0000984047,0.0021618933],"study_design_scores_gemma":[0.000032158638,0.0004133311,0.9977187,0.000030380095,0.0003737288,0.00042742494,0.00030453646,0.00016886309,0.000094917305,0.00009450534,0.00033156644,0.000009959288],"about_ca_topic_score_codex":0.0058877184,"about_ca_topic_score_gemma":0.004752436,"teacher_disagreement_score":0.0058877184,"about_ca_system_score_codex":0.0002378039,"about_ca_system_score_gemma":0.0003241029,"threshold_uncertainty_score":0.011706889},"labels":[],"label_agreement":null},{"id":"W2891257736","doi":"10.1016/j.jaad.2018.03.063","title":"Acquired disorders with depigmentation: A systematic approach to vitiliginoid conditions","year":2018,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"melanin and skin pigmentation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Depigmentation; Dermatology; MEDLINE","score_opus":0.02057259636584438,"score_gpt":0.33791358891435996,"score_spread":0.31734099254851555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2891257736","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014258346,0.998406,0.00025497715,0.00032198487,0.0002406641,0.0000049375553,0.000014892832,0.000009084569,0.0006049294],"genre_scores_gemma":[0.0016933725,0.99621046,0.0005453774,0.00054791145,0.00046865287,0.000007159824,0.000044230597,0.0000038057283,0.00047900932],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9996302,0.00006473489,0.000082657396,0.00007326112,0.00011659017,0.000032494052],"domain_scores_gemma":[0.9992803,0.00041492167,0.00009573019,0.00002135744,0.00013664506,0.000051103692],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006053806,0.00097645586,0.001371191,0.004473654,0.0003412275,0.0012811793,0.0010170189,0.0011419778,0.0030644478],"category_scores_gemma":[0.0017464028,0.00025678528,0.00083033857,0.0021858935,0.0006621763,0.001384997,0.0011817962,0.0018874948,0.00086439814],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008052386,0.000072601426,0.00082468777,0.021397172,0.00015947178,0.0013108107,0.000112896116,0.00029365945,0.0009571803,0.003637517,0.030557653,0.94059575],"study_design_scores_gemma":[0.000055760695,0.00008198708,0.0026916838,0.017072134,0.0006058753,0.018403573,0.00019705339,0.00023768406,0.0006194304,0.0033260137,0.9566614,0.00004747429],"about_ca_topic_score_codex":0.0010479345,"about_ca_topic_score_gemma":0.0020202019,"teacher_disagreement_score":0.004473654,"about_ca_system_score_codex":0.0006009618,"about_ca_system_score_gemma":0.0013021828,"threshold_uncertainty_score":0.010251641},"labels":[],"label_agreement":null},{"id":"W2892171868","doi":"10.1016/j.jaad.2018.07.070","title":"Acquired disorders with hypopigmentation: A clinical approach to diagnosis and treatment","year":2018,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"melanin and skin pigmentation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":64,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Hypopigmentation; Medicine; Asymptomatic; Dermatology; Physical examination; Disease; Quality of life (healthcare); Medical history; Vitiligo; Pediatrics; Pathology; Surgery; Nursing","score_opus":0.0566007420161117,"score_gpt":0.39183388642977063,"score_spread":0.3352331444136589,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2892171868","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013817003,0.9978132,0.00034036668,0.00048804266,0.0002605351,0.000004311816,0.000010587476,0.000009632287,0.0009350921],"genre_scores_gemma":[0.0021265277,0.99509,0.00072484097,0.0005773571,0.00074533647,0.0000079503725,0.00003427067,0.0000028534484,0.0006908003],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99973375,0.00004886402,0.000048730046,0.000042802156,0.00010073334,0.000025139661],"domain_scores_gemma":[0.99968517,0.00014227995,0.000044474997,0.000008816834,0.00008305847,0.0000362985],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050353544,0.0010339179,0.001364759,0.0028937897,0.00034056423,0.0012064294,0.0011137999,0.0013121758,0.002139461],"category_scores_gemma":[0.0008167404,0.0002443197,0.0005143988,0.0015437013,0.00067883515,0.0012287479,0.0008694756,0.0023837301,0.0009156779],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006121975,0.000106421874,0.0007082633,0.008207217,0.00008306858,0.0024410768,0.00007975276,0.00046937063,0.0014297792,0.004149217,0.04212227,0.9401422],"study_design_scores_gemma":[0.000044604443,0.00008960575,0.0024154074,0.00788399,0.00023986217,0.029928977,0.00020348783,0.00034692304,0.0006111759,0.0050066146,0.9531774,0.000052068714],"about_ca_topic_score_codex":0.0008217084,"about_ca_topic_score_gemma":0.0015397319,"teacher_disagreement_score":0.0028937897,"about_ca_system_score_codex":0.0006204856,"about_ca_system_score_gemma":0.0009579267,"threshold_uncertainty_score":0.007157147},"labels":[],"label_agreement":null},{"id":"W2895078012","doi":"10.1016/j.jaad.2018.07.061","title":"Late growth of infantile hemangiomas in children >3 years of age: A retrospective study","year":2018,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Vascular Malformations and Hemangiomas","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Hospital for Sick Children; University of Toronto","funders":"University of California, San Francisco; Department of Surgery; Hospital for Sick Children; Royal College of Physicians and Surgeons of Canada","keywords":"Medicine; Retrospective cohort study; Pediatrics; Surgery","score_opus":0.00863833082666788,"score_gpt":0.287639921846541,"score_spread":0.27900159101987315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2895078012","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991167,0.00028049445,0.00004313731,0.000009377881,0.0000033219758,0.0000052831642,0.00020416525,0.00000326725,0.0003342161],"genre_scores_gemma":[0.9993088,0.00020239483,0.00003860453,0.000015222842,0.000008393963,0.000008082894,0.00030699637,0.000003842303,0.00010770617],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994814,0.00006835671,0.00009004115,0.00010883774,0.00008731725,0.00016410126],"domain_scores_gemma":[0.9979665,0.00039227336,0.0008077212,0.00013879644,0.00027857695,0.00041616327],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049897685,0.0004989706,0.0006304183,0.0019528312,0.000645429,0.00072553556,0.00040938167,0.00070770876,0.0014577653],"category_scores_gemma":[0.0017298006,0.00037839197,0.00089349377,0.0016949495,0.00050785195,0.0006959282,0.00058300974,0.00072099536,0.000359024],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011501756,0.0000371484,0.99653023,0.000010757024,0.000016782798,0.0020670597,0.00014718814,0.000025723946,0.00020048326,0.000011691793,0.00003689448,0.00080095016],"study_design_scores_gemma":[0.0000045687475,0.000335576,0.9891294,0.000016792927,0.000062035935,0.008789632,0.0009989346,0.000070944014,0.00017831786,0.000020711239,0.0003821785,0.000010867059],"about_ca_topic_score_codex":0.0059121507,"about_ca_topic_score_gemma":0.003742941,"teacher_disagreement_score":0.0059121507,"about_ca_system_score_codex":0.00042395305,"about_ca_system_score_gemma":0.0006315341,"threshold_uncertainty_score":0.011755466},"labels":[],"label_agreement":null},{"id":"W2897741492","doi":"10.1016/j.jaad.2018.09.058","title":"Epidemiology of nickel sensitivity: Retrospective cross-sectional analysis of North American Contact Dermatitis Group data 1994-2014","year":2018,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Contact Dermatitis and Allergies","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Sunnybrook Health Science Centre; McGill University; Health Sciences Centre; University of Toronto","funders":"Nickel Producers Environmental Research Association","keywords":"Medicine; Nickel allergy; Contact dermatitis; Patch test; Cross-sectional study; Population; Epidemiology; Nickel; Internal medicine; Retrospective cohort study; Allergy; Dermatology; Surgery; Environmental health; Immunology; Pathology","score_opus":0.037215880735770424,"score_gpt":0.35786547927161333,"score_spread":0.3206495985358429,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2897741492","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99627894,0.00044404544,0.00009157647,0.00002557931,0.0000074786203,0.000017079024,0.0026468376,0.000007076552,0.00048132072],"genre_scores_gemma":[0.9964127,0.0002913198,0.00012185782,0.000031953492,0.000008173157,0.000026958292,0.002816572,0.000003941485,0.00028654197],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99873835,0.00028185605,0.00017510456,0.0003533538,0.00026357349,0.00018773941],"domain_scores_gemma":[0.99803036,0.0001802789,0.00093652727,0.0001966919,0.00045478693,0.0002011939],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000934621,0.00037182632,0.00052700826,0.0014889643,0.00052870985,0.00068772305,0.0006615382,0.0005970149,0.00104004],"category_scores_gemma":[0.0017376307,0.00067693,0.0006929956,0.0031062132,0.0003585559,0.000781196,0.0007770816,0.00051140215,0.00027136668],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004384685,0.000017171998,0.99925214,0.000008117482,0.0000641977,0.000022270568,0.00004404739,0.000022117581,0.000048627993,0.000005580985,0.00013298396,0.00033892394],"study_design_scores_gemma":[0.0000016331286,0.000018609615,0.9996007,0.000004074503,0.000021892589,0.00006233319,0.00011198914,0.000037858652,0.000012975162,0.0000026299094,0.00012395771,0.0000014307382],"about_ca_topic_score_codex":0.09005539,"about_ca_topic_score_gemma":0.10851881,"teacher_disagreement_score":0.09005539,"about_ca_system_score_codex":0.0011182678,"about_ca_system_score_gemma":0.0009845434,"threshold_uncertainty_score":0.17906243},"labels":[],"label_agreement":null},{"id":"W2898213950","doi":"10.1016/j.jaad.2018.10.037","title":"Phase 2, randomized dose-finding study of tapinarof (GSK2894512 cream) for the treatment of plaque psoriasis","year":2018,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":94,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"GlaxoSmithKline","keywords":"Medicine; Plaque psoriasis; Psoriasis; Dermatology; Randomized controlled trial; Internal medicine","score_opus":0.03829803433769064,"score_gpt":0.34196070957018015,"score_spread":0.3036626752324895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2898213950","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.968472,0.0043475507,0.002203975,0.0017750796,0.0012591678,0.011844907,0.0031222177,0.00058232684,0.0063927067],"genre_scores_gemma":[0.95827454,0.004346632,0.004685683,0.0033949194,0.0009784861,0.011478431,0.0029837294,0.00015968643,0.013697786],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9992447,0.0003394204,0.000026187647,0.00016163502,0.00007456546,0.00015349529],"domain_scores_gemma":[0.99900824,0.00027963097,0.00018631472,0.000115266404,0.00007650294,0.0003341272],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020681,0.003668406,0.004161995,0.00080271857,0.00065084815,0.0017230338,0.0017792908,0.0030330312,0.013984269],"category_scores_gemma":[0.0019781648,0.0017439905,0.002009748,0.0005389857,0.0017891063,0.001965462,0.000576262,0.005682363,0.002637923],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.94564515,0.028304465,0.00035816774,0.00053261284,0.0006724506,0.00006136411,0.00007728028,0.00068369025,0.0065130387,0.0002092053,0.0017129633,0.015229629],"study_design_scores_gemma":[0.9494647,0.048378494,0.00062142854,0.000014189264,0.00015140224,0.000028403776,0.000017029568,0.0002912849,0.0002967361,0.00015634716,0.00056735816,0.000012557128],"about_ca_topic_score_codex":0.002106899,"about_ca_topic_score_gemma":0.0047327783,"teacher_disagreement_score":0.013984269,"about_ca_system_score_codex":0.0012775711,"about_ca_system_score_gemma":0.0019217537,"threshold_uncertainty_score":0.046782017},"labels":[],"label_agreement":null},{"id":"W2899164132","doi":"10.1016/j.jaad.2018.10.055","title":"Trends in incidence of cutaneous malignant melanoma in Canada: 1992-2010 versus 2011-2015","year":2018,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; University of Ottawa","funders":"","keywords":"Incidence (geometry); Medicine; Melanoma; Population; Demography; Scopus; Cancer registry; Dermatology; Skin cancer; Cancer; MEDLINE; Internal medicine; Environmental health; Biology","score_opus":0.01860336747893461,"score_gpt":0.2818385335706855,"score_spread":0.2632351660917509,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899164132","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86333716,0.007984308,0.00024564646,0.013127246,0.0004030027,0.00008123801,0.09173886,0.00014366634,0.02293869],"genre_scores_gemma":[0.967953,0.0041634906,0.000256959,0.002115478,0.00013999053,0.000025399864,0.018234266,0.000024372363,0.007087086],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991304,0.000025746069,0.000074451134,0.00008335126,0.00029894186,0.0003870928],"domain_scores_gemma":[0.9972428,0.000081320104,0.00047347386,0.00002928526,0.0016257896,0.00054728583],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026630642,0.00025532243,0.00030869723,0.0015625538,0.0011688799,0.0011899604,0.0009401477,0.0010617995,0.003526147],"category_scores_gemma":[0.0021853268,0.00023350223,0.0006779643,0.004253195,0.0003432167,0.00061089586,0.0005441186,0.0011201693,0.0004693658],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002449744,0.000043364027,0.9638832,0.00010228865,0.00006228694,0.00027442217,0.00028034346,0.00026536314,0.00015963758,0.00020354676,0.024537371,0.009943245],"study_design_scores_gemma":[0.000014075271,0.000021638562,0.99081284,0.00007780301,0.000044929027,0.00034205586,0.0013891258,0.0005077704,0.000096885604,0.000040782637,0.006638186,0.000013931682],"about_ca_topic_score_codex":0.9888053,"about_ca_topic_score_gemma":0.99399203,"teacher_disagreement_score":0.024223344,"about_ca_system_score_codex":0.024223344,"about_ca_system_score_gemma":0.025774313,"threshold_uncertainty_score":0.17575347},"labels":[],"label_agreement":null},{"id":"W2901936821","doi":"10.1016/j.jaad.2018.11.027","title":"A review of smartphone applications for promoting sun protection practices","year":2018,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Mobile Health and mHealth Applications","field":"Health Professions","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; University of Calgary","funders":"","keywords":"Skin cancer; Medicine; Sun protection; Sun exposure; Smartphone application; Randomized controlled trial; Ultraviolet radiation; Cancer; Dermatology; Surgery; Multimedia","score_opus":0.15367398771659302,"score_gpt":0.5413992973755865,"score_spread":0.38772530965899343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2901936821","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016877,0.99924976,0.000042852276,0.00011356961,0.00007600236,0.000015703672,0.000032616714,0.0000029105552,0.0002977319],"genre_scores_gemma":[0.0013656127,0.99786204,0.00021071616,0.00026226274,0.0000882909,0.000019215964,0.000032186854,0.0000012440839,0.00015842154],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999091,0.00021287875,0.00025096166,0.00012732025,0.00026893074,0.000048864007],"domain_scores_gemma":[0.9964833,0.0026591136,0.0003725445,0.00004276724,0.000376363,0.00006595654],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017709496,0.0010889445,0.0021256781,0.0045033875,0.0004314501,0.0015138491,0.0013421285,0.0017563868,0.006125802],"category_scores_gemma":[0.0056490796,0.00048946036,0.0024212028,0.003003846,0.00043942826,0.0017374635,0.0009773695,0.0015258162,0.00073139084],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019678523,0.00014347935,0.0005270235,0.20190823,0.0008270998,0.00013979175,0.00016276338,0.00015428566,0.00058801123,0.00090645853,0.011173837,0.7832722],"study_design_scores_gemma":[0.00032444485,0.0010774812,0.010537187,0.28029037,0.0090633305,0.0024668756,0.00064481364,0.0004068325,0.0010199266,0.0016113401,0.69242144,0.00013591372],"about_ca_topic_score_codex":0.003098729,"about_ca_topic_score_gemma":0.007129572,"teacher_disagreement_score":0.006125802,"about_ca_system_score_codex":0.0006192346,"about_ca_system_score_gemma":0.0019586727,"threshold_uncertainty_score":0.020492852},"labels":[],"label_agreement":null},{"id":"W2902349219","doi":"10.1016/j.jaad.2018.11.047","title":"Vitiligo and major depressive disorder: A bidirectional population-based cohort study","year":2018,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"melanin and skin pigmentation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":55,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Alberta Innovates","keywords":"Medicine; Vitiligo; Hazard ratio; Cohort; Confidence interval; Proportional hazards model; Cohort study; Internal medicine; Major depressive disorder; Depression (economics); Population; Psychiatry; Dermatology; Environmental health","score_opus":0.0065718363961438766,"score_gpt":0.29026467008097484,"score_spread":0.28369283368483095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2902349219","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99810106,0.000351395,0.00016431452,0.00009723669,0.000021300992,0.00002156812,0.0008110627,0.0000056707568,0.0004263948],"genre_scores_gemma":[0.99868435,0.00022696707,0.00016160047,0.0000663245,0.000014132322,0.000028962346,0.00045626392,0.0000053504136,0.0003559735],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990441,0.0002654872,0.00005725865,0.00035363002,0.00008972871,0.00018978494],"domain_scores_gemma":[0.9988142,0.0001383068,0.00029326414,0.00026322625,0.00017326314,0.00031780926],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010224578,0.0006583777,0.000827004,0.0009020998,0.0019939286,0.0015714781,0.0010133939,0.0014458286,0.0026421782],"category_scores_gemma":[0.0017137512,0.0013893805,0.001164991,0.0017516728,0.00050674437,0.0008673568,0.0013407546,0.001882624,0.00054319104],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035305435,0.00018073844,0.9968856,0.0000129633245,0.00043865884,0.00025853468,0.0003034311,0.000027351492,0.00064170116,0.00007644421,0.00023446108,0.0005871209],"study_design_scores_gemma":[0.000055944947,0.00010669692,0.9980508,0.000015496242,0.00025081108,0.00034484634,0.0006789495,0.00015537003,0.00003480615,0.00006607339,0.00022681053,0.000013396947],"about_ca_topic_score_codex":0.039311048,"about_ca_topic_score_gemma":0.042148184,"teacher_disagreement_score":0.039311048,"about_ca_system_score_codex":0.00074021245,"about_ca_system_score_gemma":0.000793345,"threshold_uncertainty_score":0.07816446},"labels":[],"label_agreement":null},{"id":"W2905588867","doi":"10.1016/j.jaad.2018.12.014","title":"Flush technique to minimize adverse reactions from syringe lubricant (silicone oil)","year":2018,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Intravenous Infusion Technology and Safety","field":"Engineering","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Guenther Dermatology Research Centre; McGill University","funders":"","keywords":"Medicine; Syringe; Silicone oil; Lubricant; Silicone; Surgery; Composite material","score_opus":0.007830474288761815,"score_gpt":0.24909096480057083,"score_spread":0.241260490511809,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905588867","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.79909796,0.0068322765,0.17898956,0.0011153831,0.00055798044,0.0006526884,0.00015690221,0.002621027,0.009976356],"genre_scores_gemma":[0.88573086,0.0016831403,0.0977504,0.0015036076,0.00012699526,0.00025110506,0.00015378729,0.0002808829,0.012519134],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.999711,0.000056556644,0.000034169374,0.000052719857,0.00010279658,0.000042727646],"domain_scores_gemma":[0.9994759,0.00018845696,0.00014092703,0.00008369988,0.00007436084,0.00003672359],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007039862,0.00043612067,0.00028248996,0.00051150797,0.00045104846,0.00024054354,0.00026482902,0.0004983651,0.0029798115],"category_scores_gemma":[0.0013338958,0.00016137122,0.00041341461,0.00018044612,0.0002978451,0.0004874634,0.0003636173,0.0007543406,0.0007165994],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012474597,0.00043603656,0.0033488069,0.0004907421,0.00006229835,0.0018044607,0.0006901996,0.0002028323,0.7407665,0.0009560214,0.0034921318,0.24650258],"study_design_scores_gemma":[0.0003389196,0.0075371405,0.027096782,0.00019758707,0.00020341734,0.03403354,0.00048050508,0.0033766173,0.87579966,0.00062729383,0.050234888,0.00007371223],"about_ca_topic_score_codex":0.00047768853,"about_ca_topic_score_gemma":0.00095443113,"teacher_disagreement_score":0.0029798115,"about_ca_system_score_codex":0.00010885332,"about_ca_system_score_gemma":0.0004850691,"threshold_uncertainty_score":0.00996846},"labels":[],"label_agreement":null},{"id":"W2911218486","doi":"10.1016/j.jaad.2018.12.062","title":"Patients with negative patch tests: Retrospective analysis of North American Contact Dermatitis Group (NACDG) data 2001-2016","year":2019,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Contact Dermatitis and Allergies","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Royal Victoria Hospital; University of Toronto; Sunnybrook Health Science Centre; University of Ottawa; McGill University","funders":"","keywords":"Medicine; Contact dermatitis; Dermatology; Retrospective cohort study; Patch testing; Patch test; Surgery; Allergy; Immunology","score_opus":0.010759028752947625,"score_gpt":0.27405040562049765,"score_spread":0.26329137686755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911218486","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99111664,0.0012512646,0.00014525087,0.0000434308,0.000017974677,0.00002983666,0.0047727823,0.000013818368,0.0026090003],"genre_scores_gemma":[0.9952846,0.0003832707,0.00007355822,0.00004877701,0.000014892471,0.000017197472,0.0037707484,0.0000069864873,0.00039999644],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989159,0.00016071093,0.00016859798,0.00027693223,0.00029785506,0.00017997826],"domain_scores_gemma":[0.99769944,0.00029167265,0.0010988585,0.00025291418,0.00043611697,0.00022102734],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056141,0.00028367233,0.00044990002,0.0017570165,0.0004821495,0.0008100665,0.00035537017,0.00042210167,0.0023898478],"category_scores_gemma":[0.0019250499,0.00031792955,0.00048734166,0.002919308,0.00025247375,0.00085626857,0.00046287727,0.00044252333,0.00054299174],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008656485,0.000015484058,0.998271,0.00001412825,0.000033553548,0.00010561211,0.000029818057,0.000016476315,0.00008989832,0.0000127912035,0.00031481998,0.0010097804],"study_design_scores_gemma":[0.000004855444,0.000028652132,0.99825317,0.000013462478,0.00002839093,0.00066522154,0.00018509646,0.000061364546,0.000049036837,0.000011765923,0.0006961028,0.0000029176103],"about_ca_topic_score_codex":0.011695578,"about_ca_topic_score_gemma":0.013707846,"teacher_disagreement_score":0.011695578,"about_ca_system_score_codex":0.00045761964,"about_ca_system_score_gemma":0.00058727677,"threshold_uncertainty_score":0.02325499},"labels":[],"label_agreement":null},{"id":"W2912058252","doi":"10.1016/j.jaad.2018.11.057","title":"Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics","year":2019,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":924,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Medicine; Psoriasis; Dermatology; Joint (building); MEDLINE; Intensive care medicine","score_opus":0.08478409348539527,"score_gpt":0.3482868694989154,"score_spread":0.2635027760135201,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2912058252","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009930868,0.9808828,0.00091199286,0.0058244215,0.0046533905,0.00014342324,0.00046201155,0.000086309024,0.0069362437],"genre_scores_gemma":[0.0008855093,0.98193467,0.0037665814,0.0063383947,0.0020860217,0.0002104796,0.0009807096,0.000022487562,0.0037750988],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99778974,0.00047247834,0.0005171009,0.00013973587,0.00089612073,0.00018485091],"domain_scores_gemma":[0.99596596,0.0011605679,0.00074567896,0.00009663279,0.0017009157,0.00033019795],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037802786,0.0013698465,0.0030594582,0.0057405843,0.00076502975,0.0021937098,0.002719883,0.0035748207,0.00787614],"category_scores_gemma":[0.0056413873,0.0004800672,0.0024435879,0.0035841542,0.0007326039,0.0013898205,0.0014722316,0.0042765536,0.0055090417],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015847322,0.00015959039,0.00024774342,0.015948923,0.00016334349,0.00018322274,0.000060751227,0.00033033369,0.0007519981,0.0041196155,0.36129782,0.61657816],"study_design_scores_gemma":[0.00007715382,0.00006689701,0.00095008436,0.015611746,0.00028170066,0.00055861525,0.000034125507,0.00010209743,0.0001841791,0.0017667144,0.9803421,0.00002449955],"about_ca_topic_score_codex":0.00892522,"about_ca_topic_score_gemma":0.011847314,"teacher_disagreement_score":0.00892522,"about_ca_system_score_codex":0.0022112296,"about_ca_system_score_gemma":0.008246274,"threshold_uncertainty_score":0.026348293},"labels":[],"label_agreement":null},{"id":"W2914164523","doi":"10.1016/j.jaad.2018.11.058","title":"Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities","year":2019,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":486,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"Janssen Pharmaceuticals; Janssen Biotech; Sandoz; Ortho Dermatologics; LEO Pharma Research Foundation; LEO Pharma; Pfizer; Incyte; Prothena; Novartis Pharmaceuticals Corporation; Dermira; Coherus Biosciences; Valeant Pharmaceuticals International; Janssen Research and Development; XBiotech; UCB; Celgene; Eli Lilly and Company; Allergan; AstraZeneca; Boehringer Ingelheim; Amgen; AbbVie; Sanofi; MedImmune; Merck; National Institutes of Health; Regeneron Pharmaceuticals; Abbott Laboratories","keywords":"Medicine; Psoriasis; Guideline; Intensive care medicine; Population; Disease management; Joint disease; Disease; Dermatology; Alternative medicine; Internal medicine; Pathology; Environmental health","score_opus":0.08175444726901368,"score_gpt":0.3534888795521198,"score_spread":0.2717344322831061,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914164523","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011574348,0.97585416,0.0012566994,0.006746193,0.0058923913,0.00013993186,0.00043053227,0.000115310824,0.009449047],"genre_scores_gemma":[0.0010687708,0.9789013,0.0043606036,0.0066823987,0.0030592794,0.00019364191,0.00097624556,0.000024805413,0.0047329795],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983347,0.00033929377,0.00038179083,0.000111535526,0.0006814153,0.00015123344],"domain_scores_gemma":[0.99665976,0.00088468735,0.0005601953,0.0000786984,0.0015120105,0.0003047176],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026593986,0.0012606352,0.0024142163,0.004747265,0.0007289991,0.0017965159,0.0020001545,0.0030747412,0.00876565],"category_scores_gemma":[0.0048281224,0.00039896677,0.001849217,0.0029248567,0.0005897544,0.001262793,0.0013530266,0.003932524,0.006391339],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009416049,0.00015239307,0.0002998383,0.010947685,0.00011319643,0.00020977683,0.00005062786,0.00029651696,0.0006614333,0.0028341715,0.3541279,0.63021225],"study_design_scores_gemma":[0.000054111435,0.00005471066,0.001265333,0.014177771,0.00020201337,0.0008979828,0.00003921724,0.00010818711,0.00017303476,0.0017631493,0.98124,0.000024581133],"about_ca_topic_score_codex":0.007108123,"about_ca_topic_score_gemma":0.0096981255,"teacher_disagreement_score":0.00876565,"about_ca_system_score_codex":0.0016011144,"about_ca_system_score_gemma":0.006392008,"threshold_uncertainty_score":0.029323995},"labels":[],"label_agreement":null},{"id":"W2917028347","doi":"10.1016/j.jaad.2019.02.040","title":"Laboratory monitoring requirements during mycophenolate mofetil therapy for dermatologic conditions: A single-institution retrospective chart review","year":2019,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Medicine; Mycophenolate; Neutropenia; Mycophenolic acid; Common Terminology Criteria for Adverse Events; Pharmacy; Retrospective cohort study; Adverse effect; Intensive care medicine; Surgery; Internal medicine; Transplantation; Chemotherapy","score_opus":0.04230131889956496,"score_gpt":0.34322870088156704,"score_spread":0.3009273819820021,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2917028347","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901315,0.0026542812,0.00073792855,0.0014483207,0.00007869286,0.000103948296,0.0015507798,0.00004344887,0.0032510965],"genre_scores_gemma":[0.9970741,0.00083326286,0.00046453203,0.00068810204,0.00006029114,0.000022618193,0.0006529184,0.000009939641,0.00019417668],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981737,0.00038437406,0.0005081137,0.0002794464,0.00045314443,0.00020123375],"domain_scores_gemma":[0.99025846,0.0032693583,0.004020016,0.00042135874,0.0014442145,0.00058659166],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00089792564,0.00025194278,0.00036084125,0.0013742717,0.0006622769,0.00084329984,0.00039832355,0.0008095033,0.0010756576],"category_scores_gemma":[0.0052004526,0.00033655053,0.00042093062,0.0017573552,0.00041506425,0.00088405947,0.00032734484,0.00072957494,0.0002872183],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008468763,0.000051204883,0.97855556,0.000044692624,0.000034163095,0.014387743,0.0002282738,0.00005635347,0.00043910128,0.00006241516,0.0015536272,0.0045022108],"study_design_scores_gemma":[0.000025735408,0.00019630414,0.91227436,0.00017231064,0.000114740295,0.079267584,0.001415642,0.00074120273,0.0011107788,0.000102448714,0.0045400728,0.000038853046],"about_ca_topic_score_codex":0.00492316,"about_ca_topic_score_gemma":0.0060313204,"teacher_disagreement_score":0.00492316,"about_ca_system_score_codex":0.001100935,"about_ca_system_score_gemma":0.0012113584,"threshold_uncertainty_score":0.00978899},"labels":[],"label_agreement":null},{"id":"W2917427088","doi":"10.1016/j.jaad.2019.02.044","title":"Randomized phase 3 evaluation of trifarotene 50 μg/g cream treatment of moderate facial and truncal acne","year":2019,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":119,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lynde Centre for Dermatology; SKiN Health; University of Windsor; Western University","funders":"","keywords":"Medicine; Acne; Tolerability; Adverse effect; Randomized controlled trial; Trunk; Dermatology; Shoulders; Target lesion; Surgery; Internal medicine","score_opus":0.03216070845553833,"score_gpt":0.3704416015941812,"score_spread":0.3382808931386429,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2917427088","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94017744,0.00451868,0.0031286431,0.00066461257,0.00070229615,0.043245867,0.0032626917,0.00040429327,0.0038955016],"genre_scores_gemma":[0.929076,0.00427884,0.0060360054,0.0018972678,0.00045924415,0.04823116,0.002664074,0.00008951108,0.00726783],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9992483,0.00037776993,0.000045314515,0.0001319629,0.00008484456,0.000111875794],"domain_scores_gemma":[0.99871576,0.00033638236,0.00029248898,0.0001437018,0.00018944846,0.0003221834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021145954,0.0014178575,0.0031167457,0.00048451617,0.00059031526,0.0011064116,0.0014113146,0.0019476216,0.009249289],"category_scores_gemma":[0.0018583869,0.0007583393,0.0015958544,0.0004552187,0.0009528202,0.0008010437,0.00039615386,0.0025484047,0.0012827219],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.94439083,0.024290219,0.00045135766,0.0010249567,0.00067011314,0.000060637525,0.00010033179,0.0004134574,0.010863808,0.00013237799,0.001233562,0.016368393],"study_design_scores_gemma":[0.88893974,0.10771435,0.001187506,0.000045054807,0.0002064571,0.000035607583,0.000019852409,0.00027950804,0.00067938375,0.00010521853,0.0007765138,0.000010892911],"about_ca_topic_score_codex":0.0014072928,"about_ca_topic_score_gemma":0.0030977512,"teacher_disagreement_score":0.009249289,"about_ca_system_score_codex":0.00076076953,"about_ca_system_score_gemma":0.0025741216,"threshold_uncertainty_score":0.030941963},"labels":[],"label_agreement":null},{"id":"W2917979966","doi":"10.1016/j.jaad.2019.02.038","title":"Inflammatory dietary pattern and incident psoriasis, psoriatic arthritis, and atopic dermatitis in women: A cohort study","year":2019,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto; Queen's University","funders":"National Institutes of Health; Brown University; National Cancer Institute; Regeneron Pharmaceuticals; Sanofi","keywords":"Medicine; Psoriasis; Hazard ratio; Psoriatic arthritis; Atopic dermatitis; Proportional hazards model; Cohort; Internal medicine; Cohort study; Confidence interval; Dermatology","score_opus":0.007129921995451364,"score_gpt":0.2375182461267834,"score_spread":0.23038832413133203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2917979966","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99883956,0.00027909278,0.00007582496,0.000041428564,0.000018189348,0.0000128995325,0.00035945908,0.0000040750215,0.00036952176],"genre_scores_gemma":[0.99901474,0.000193674,0.00008340856,0.000045062105,0.000016931148,0.000014002068,0.00021519384,0.0000038073022,0.000413265],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995034,0.00010741783,0.000041435345,0.00017386966,0.000059538772,0.000114333685],"domain_scores_gemma":[0.99915826,0.000092533475,0.00022398923,0.0001760808,0.00008284891,0.00026619248],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057694514,0.0006453564,0.0006898472,0.0007295756,0.0012314697,0.0011432709,0.00061707036,0.0011369847,0.0019744977],"category_scores_gemma":[0.0011334469,0.0013489589,0.0012792776,0.0014623982,0.00045547175,0.0008176647,0.0006098473,0.0013618486,0.00047838435],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044136358,0.00015281334,0.9977564,0.0000071108902,0.00027575323,0.00015587399,0.00010874735,0.000017876931,0.00057236955,0.000017577046,0.00006995378,0.00042423184],"study_design_scores_gemma":[0.00004401132,0.00027105166,0.99832815,0.000006171122,0.00020979893,0.00036323175,0.00040806408,0.000098576405,0.00005721276,0.00002510355,0.00017924939,0.000009447035],"about_ca_topic_score_codex":0.01671953,"about_ca_topic_score_gemma":0.015741697,"teacher_disagreement_score":0.01671953,"about_ca_system_score_codex":0.000443142,"about_ca_system_score_gemma":0.00060312677,"threshold_uncertainty_score":0.03324443},"labels":[],"label_agreement":null},{"id":"W2921704925","doi":"10.1016/j.jaad.2018.09.045","title":"The associations of depression and coping methods on health-related quality of life for those with hidradenitis suppurativa","year":2019,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Windsor","funders":"LEO Pharma; Novartis Stiftung für Medizinisch-Biologische Forschung; AbbVie","keywords":"Hidradenitis suppurativa; Medicine; Coping (psychology); Depression (economics); Quality of life (healthcare); Scopus; Health related quality of life; Psychiatry; Dermatology; MEDLINE; Disease; Internal medicine","score_opus":0.07562327477390916,"score_gpt":0.4287277720711342,"score_spread":0.35310449729722504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2921704925","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7847777,0.006824693,0.00010661935,0.19414812,0.0020682386,0.000023061153,0.00068787247,0.000009077011,0.011354574],"genre_scores_gemma":[0.96741205,0.0019466949,0.00016092262,0.02475808,0.002856369,0.000021236874,0.00018365815,0.0000039161428,0.002657046],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999595,0.0001577074,0.000054629814,0.000036183108,0.0000739128,0.000082735234],"domain_scores_gemma":[0.9974711,0.0014338269,0.00033627517,0.00006865639,0.00031097376,0.00037927247],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051746605,0.0001564292,0.00040443445,0.00032722848,0.0006635449,0.0005860165,0.0002501858,0.0020068705,0.002255703],"category_scores_gemma":[0.0052901763,0.00014151791,0.00049173617,0.0005725561,0.00022387311,0.00046689747,0.00019234979,0.0020299628,0.00021635523],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005047329,0.00026941416,0.9645054,0.000060719183,0.00012184722,0.005757451,0.00027081862,0.000052554886,0.00036617657,0.00016830399,0.011843274,0.016079389],"study_design_scores_gemma":[0.00012463257,0.00023884412,0.9853807,0.00007145881,0.00010086115,0.006979589,0.00089321483,0.00034474008,0.00007350083,0.00048705307,0.0052859997,0.000019437852],"about_ca_topic_score_codex":0.005369287,"about_ca_topic_score_gemma":0.012321108,"teacher_disagreement_score":0.005369287,"about_ca_system_score_codex":0.00051070726,"about_ca_system_score_gemma":0.00045823556,"threshold_uncertainty_score":0.010676026},"labels":[],"label_agreement":null},{"id":"W2921799936","doi":"10.1016/j.jaad.2019.02.067","title":"North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations","year":2019,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":376,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre de Recherche Dermatologique du Québec Métropolitain; University of Toronto","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; AbbVie","keywords":"Hidradenitis suppurativa; Medicine; Guideline; Comorbidity; Dermatology; Grading (engineering); Evidence-based medicine; Quality of life (healthcare); Quality of evidence; Alternative medicine; Surgery; Psychiatry; Disease; Pathology; Nursing; Randomized controlled trial","score_opus":0.15433800099768152,"score_gpt":0.45305944816147825,"score_spread":0.2987214471637967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2921799936","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000067563655,0.99128306,0.00019667257,0.0031341251,0.0026662187,0.00008426848,0.0003068443,0.000024265431,0.002237054],"genre_scores_gemma":[0.00065513485,0.99216264,0.0013040834,0.0033150583,0.00068418874,0.00008320082,0.00041428275,0.000007045063,0.0013744131],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998257,0.00022957771,0.00044177164,0.00011745995,0.0008124897,0.00014173848],"domain_scores_gemma":[0.9940823,0.0014290516,0.0008255778,0.000073823765,0.0031872785,0.0004019231],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031973028,0.0012881217,0.0023895123,0.0076752747,0.00089209224,0.0019804405,0.0018837095,0.0024141197,0.0051085595],"category_scores_gemma":[0.006343741,0.00047903048,0.0020271663,0.007118769,0.0008772313,0.0013645529,0.001284644,0.0034577865,0.001947591],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010077042,0.00009674107,0.00038899822,0.026864892,0.0001461283,0.00013972678,0.00010254276,0.00023217734,0.0003982386,0.0014886376,0.44310454,0.52693665],"study_design_scores_gemma":[0.00009064741,0.00004337468,0.002445463,0.03186544,0.00043268895,0.000423652,0.00009146996,0.00007427532,0.00009847287,0.0005002811,0.96389574,0.00003867438],"about_ca_topic_score_codex":0.07637682,"about_ca_topic_score_gemma":0.14973262,"teacher_disagreement_score":0.9236232,"about_ca_system_score_codex":0.0052385908,"about_ca_system_score_gemma":0.02042027,"threshold_uncertainty_score":0.15186453},"labels":[],"label_agreement":null},{"id":"W2922238701","doi":"10.1016/j.jaad.2019.02.068","title":"North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations","year":2019,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":374,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre de Recherche Dermatologique du Québec Métropolitain; University of Toronto","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; AbbVie","keywords":"Hidradenitis suppurativa; Medicine; Dermatology; Family medicine; Pathology; Disease","score_opus":0.15433800099768152,"score_gpt":0.45305944816147825,"score_spread":0.2987214471637967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2922238701","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000067563655,0.99128306,0.00019667257,0.0031341251,0.0026662187,0.00008426848,0.0003068443,0.000024265431,0.002237054],"genre_scores_gemma":[0.00065513485,0.99216264,0.0013040834,0.0033150583,0.00068418874,0.00008320082,0.00041428275,0.000007045063,0.0013744131],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998257,0.00022957771,0.00044177164,0.00011745995,0.0008124897,0.00014173848],"domain_scores_gemma":[0.9940823,0.0014290516,0.0008255778,0.000073823765,0.0031872785,0.0004019231],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031973028,0.0012881217,0.0023895123,0.0076752747,0.00089209224,0.0019804405,0.0018837095,0.0024141197,0.0051085595],"category_scores_gemma":[0.006343741,0.00047903048,0.0020271663,0.007118769,0.0008772313,0.0013645529,0.001284644,0.0034577865,0.001947591],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010077042,0.00009674107,0.00038899822,0.026864892,0.0001461283,0.00013972678,0.00010254276,0.00023217734,0.0003982386,0.0014886376,0.44310454,0.52693665],"study_design_scores_gemma":[0.00009064741,0.00004337468,0.002445463,0.03186544,0.00043268895,0.000423652,0.00009146996,0.00007427532,0.00009847287,0.0005002811,0.96389574,0.00003867438],"about_ca_topic_score_codex":0.07637682,"about_ca_topic_score_gemma":0.14973262,"teacher_disagreement_score":0.9236232,"about_ca_system_score_codex":0.0052385908,"about_ca_system_score_gemma":0.02042027,"threshold_uncertainty_score":0.15186453},"labels":[],"label_agreement":null},{"id":"W2924419645","doi":"10.1016/j.jaad.2019.01.093","title":"Unraveling incontinentia pigmenti: A comparison of phenotype and genotype variants","year":2019,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Genetic and rare skin diseases.","field":"Biochemistry, Genetics and Molecular Biology","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Incontinentia pigmenti; Medicine; Phenotype; Genotype; Genetics; Genotype-phenotype distinction; Dermatology; Gene; Biology","score_opus":0.007761588554779779,"score_gpt":0.28118862320223514,"score_spread":0.2734270346474554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2924419645","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888164,0.0060960925,0.0024696712,0.00060598395,0.00008154867,0.000007116788,0.00036660823,0.00004493091,0.0015115461],"genre_scores_gemma":[0.9950819,0.0021388733,0.0020016793,0.00014408834,0.00008615083,0.000003902804,0.00023783647,0.000032649372,0.00027290772],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99958676,0.000102122234,0.000053688633,0.00010610154,0.0000973922,0.000053922206],"domain_scores_gemma":[0.9993662,0.00022944802,0.0001467227,0.00008047058,0.00009373181,0.000083364255],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006081513,0.0005033982,0.0005292312,0.0020044958,0.0002773598,0.0010079761,0.00040492785,0.000512996,0.0011493531],"category_scores_gemma":[0.0019083122,0.00013453068,0.00028567505,0.0010972808,0.00043169202,0.00062697113,0.000560069,0.0005016228,0.00023271635],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025543252,0.0002508685,0.57843953,0.00037179954,0.0006403901,0.009917794,0.0015403185,0.0009950252,0.16185895,0.0027582895,0.0025224786,0.23815031],"study_design_scores_gemma":[0.000084992476,0.00054206554,0.9123078,0.00019007704,0.00058944843,0.050055526,0.0015087245,0.0019936305,0.014193724,0.0038557379,0.014622432,0.00005588303],"about_ca_topic_score_codex":0.0005125319,"about_ca_topic_score_gemma":0.00052633055,"teacher_disagreement_score":0.0020044958,"about_ca_system_score_codex":0.00014221716,"about_ca_system_score_gemma":0.00020510955,"threshold_uncertainty_score":0.0038449764},"labels":[],"label_agreement":null},{"id":"W2927738140","doi":"10.1016/j.jaad.2019.03.063","title":"Improving Wikipedia skin disease content","year":2019,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Wikis in Education and Collaboration","field":"Social Sciences","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; MEDLINE; Mentorship; Encyclopedia; Systematic review; Audience measurement; Outreach; Scopus; Medical education; Family medicine; World Wide Web; Library science; Computer science","score_opus":0.02957671965986897,"score_gpt":0.33214666053075764,"score_spread":0.3025699408708887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2927738140","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016070862,0.00050912536,0.00025262972,0.96906406,0.012258044,0.000024040653,0.0001110658,0.00012421672,0.01604978],"genre_scores_gemma":[0.028486218,0.0013444158,0.0017655987,0.86156803,0.02928255,0.00011012656,0.00031152405,0.00016700925,0.07696454],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966648,0.00092896476,0.000297401,0.00027315787,0.0013487926,0.0004868711],"domain_scores_gemma":[0.9641178,0.017022932,0.00138824,0.00111141,0.008906743,0.007452835],"candidate_categories":["scholarly_communication"],"consensus_categories":[],"category_scores_codex":[0.0041106907,0.00035884592,0.00036589877,0.0014544742,0.0046342094,0.0047279946,0.00089170894,0.015149463,0.02548285],"category_scores_gemma":[0.047247533,0.00036629033,0.00049609906,0.00059276476,0.0012440444,0.0044741193,0.003306969,0.010242877,0.010544573],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018722456,0.00007542517,0.0007806498,0.000031485608,0.000005492415,0.0001841874,0.00009147489,0.000027373228,0.0001614778,0.0012332122,0.97325146,0.024138995],"study_design_scores_gemma":[0.000085314765,0.00007601777,0.003020471,0.0002225941,0.000028674514,0.0005093517,0.0008795543,0.0007771317,0.00082573394,0.0064554284,0.9870907,0.000028946579],"about_ca_topic_score_codex":0.010211358,"about_ca_topic_score_gemma":0.025423735,"teacher_disagreement_score":0.995272,"about_ca_system_score_codex":0.0028370586,"about_ca_system_score_gemma":0.0050836173,"threshold_uncertainty_score":0.08524865},"labels":[],"label_agreement":null},{"id":"W2937999970","doi":"10.1016/j.jaad.2019.04.040","title":"Knowledge and opinions among Canadian academic physicians regarding genetic screening to prevent severe cutaneous adverse drug reactions","year":2019,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; Sunnybrook Health Science Centre; Health Sciences Centre; University of Toronto","funders":"Canadian Dermatology Foundation","keywords":"Toxic epidermal necrolysis; Allopurinol; Medicine; Carbamazepine; Incidence (geometry); Pharmacogenomics; Dermatology; Drug; Adverse drug reaction; Internal medicine; Psychiatry; Pharmacology; Epilepsy","score_opus":0.017489981657891354,"score_gpt":0.30064456082993385,"score_spread":0.2831545791720425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2937999970","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0042384514,0.07268341,0.00014718376,0.83680964,0.0680695,0.00005088291,0.0010976646,0.00006935369,0.016833931],"genre_scores_gemma":[0.10104348,0.20517895,0.0009844884,0.54385734,0.12670457,0.00008986585,0.0011386144,0.00012224365,0.020880364],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99620205,0.00053643103,0.00049277936,0.00028501905,0.0017808785,0.00070286845],"domain_scores_gemma":[0.9471163,0.008375066,0.0033512968,0.00034272062,0.031351447,0.009463154],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003010648,0.00051544525,0.0013686741,0.0040901126,0.0033650436,0.0040097735,0.0019989375,0.0073248553,0.029151835],"category_scores_gemma":[0.04302067,0.00043424164,0.0006553181,0.0054853973,0.0014299995,0.0023032671,0.0014108347,0.0040739626,0.0031361086],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032761636,0.000025335961,0.0029942973,0.0009356015,0.000029979732,0.00086330145,0.00043088614,0.000039779086,0.000084596446,0.00027246156,0.9627189,0.03157197],"study_design_scores_gemma":[0.00012130014,0.00005260951,0.016594302,0.007205156,0.00014593378,0.0047946977,0.003500584,0.00026309345,0.00017222378,0.000593177,0.96639585,0.00016100351],"about_ca_topic_score_codex":0.27562562,"about_ca_topic_score_gemma":0.36475518,"teacher_disagreement_score":0.7243744,"about_ca_system_score_codex":0.01258297,"about_ca_system_score_gemma":0.022837326,"threshold_uncertainty_score":0.5480426},"labels":[],"label_agreement":null},{"id":"W2939184371","doi":"10.1016/j.jaad.2019.04.031","title":"Blunt curettage for postoperative hematomas","year":2019,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Hemostasis and retained surgical items","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Surgery; Curettage; Hematoma; Blunt; Dehiscence; Prospective cohort study; General surgery","score_opus":0.017633656443690065,"score_gpt":0.3350251431424706,"score_spread":0.31739148669878053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2939184371","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.946533,0.023009213,0.008805803,0.002097296,0.00088750414,0.00016133298,0.00015543112,0.000425208,0.017925126],"genre_scores_gemma":[0.9895788,0.004325291,0.00299328,0.0005250194,0.00045304763,0.000026419595,0.00012222765,0.00003473529,0.0019413083],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.99988604,0.000010879581,0.000014281585,0.000009004346,0.000030626263,0.000049189523],"domain_scores_gemma":[0.99966323,0.00009378202,0.00006726645,0.00004743712,0.000020012661,0.00010832576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016400771,0.00040703826,0.00029130286,0.00083440624,0.0008455032,0.00033374684,0.00028803552,0.0006168599,0.002324572],"category_scores_gemma":[0.0013049273,0.00016580401,0.0004985461,0.00033919085,0.00044094387,0.0005108146,0.00035208295,0.0008994708,0.0005700138],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025696566,0.0007404716,0.113065146,0.00057493884,0.0001998365,0.3530561,0.00060564827,0.0007166419,0.027272085,0.0010558162,0.014769045,0.48537454],"study_design_scores_gemma":[0.00020835518,0.0019124161,0.12444623,0.00027316797,0.00013427633,0.8434111,0.0004135361,0.0019061387,0.012619678,0.0009104426,0.0137095805,0.00005511904],"about_ca_topic_score_codex":0.00045357426,"about_ca_topic_score_gemma":0.001350473,"teacher_disagreement_score":0.002324572,"about_ca_system_score_codex":0.00025723272,"about_ca_system_score_gemma":0.0005116374,"threshold_uncertainty_score":0.007776499},"labels":[],"label_agreement":null},{"id":"W2941146433","doi":"10.1016/j.jaad.2018.06.056","title":"Psoriasis: Which therapy for which patient","year":2018,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":262,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Johnson and Johnson; Janssen Biotech; MedImmune; Valeant Pharmaceuticals International; AbbVie; Boehringer Ingelheim; AstraZeneca; Novartis; Pfizer","keywords":"Medicine; Psoriasis; Latent tuberculosis; Systemic therapy; Tuberculosis; Concomitant; Intensive care medicine; Adverse effect; Disease; Chronic hepatitis; Hepatitis; Pediatrics; Dermatology; Immunology; Surgery; Internal medicine; Mycobacterium tuberculosis; Virus; Pathology","score_opus":0.05701751079181505,"score_gpt":0.40261252814229775,"score_spread":0.3455950173504827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2941146433","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000053283835,0.99857306,0.00005426734,0.0005840137,0.00021506156,0.0000051047923,0.00001472155,0.0000034736313,0.00049706135],"genre_scores_gemma":[0.00069282117,0.9979809,0.0001681548,0.0005835881,0.00027311794,0.0000047060926,0.000017252418,0.0000012185258,0.0002781692],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99940515,0.00014582848,0.00013503623,0.00009178353,0.00018755077,0.000034769586],"domain_scores_gemma":[0.9989723,0.00059377356,0.00019981814,0.000019965612,0.0001699406,0.00004421533],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00084523455,0.0006981941,0.0024987916,0.0024814717,0.00043188382,0.0018117601,0.0009428419,0.001701248,0.004383167],"category_scores_gemma":[0.0024085876,0.00034792346,0.0008741819,0.002125298,0.000587108,0.0019803133,0.0006762078,0.0022456911,0.0010591333],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000081633414,0.000062741645,0.0002860727,0.03736211,0.0002504874,0.00011737019,0.000070180984,0.00012867698,0.0003276832,0.0015977302,0.033432152,0.92628324],"study_design_scores_gemma":[0.00012769892,0.00009317738,0.0021658784,0.078834474,0.001319843,0.0023080218,0.00032483903,0.00017359022,0.00030354463,0.0032432794,0.9110519,0.000053775486],"about_ca_topic_score_codex":0.0025190075,"about_ca_topic_score_gemma":0.0076839784,"teacher_disagreement_score":0.004383167,"about_ca_system_score_codex":0.0006902029,"about_ca_system_score_gemma":0.0014552231,"threshold_uncertainty_score":0.01466316},"labels":[],"label_agreement":null},{"id":"W2943902212","doi":"10.1016/j.jaad.2018.05.1156","title":"The sun and your health: Targeting teenagers and adolescents in British Columbia","year":2018,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"School Health and Nursing Education","field":"Health Professions","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Adolescent health; Sun protection; Family medicine; Environmental health; Nursing","score_opus":0.03226768736314304,"score_gpt":0.4170877366194401,"score_spread":0.38482004925629704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2943902212","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928308,0.0009124034,0.00009223942,0.0010064732,0.000023652268,0.00008253178,0.0003773893,0.0000058146297,0.0046687303],"genre_scores_gemma":[0.99249,0.0019119825,0.0002829053,0.001018582,0.000011509433,0.00008305669,0.00018092924,0.000007651252,0.004013482],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99952555,0.000040909876,0.000024726918,0.00004890172,0.000113089016,0.00024678427],"domain_scores_gemma":[0.9993248,0.000052684714,0.000084961335,0.0000097846005,0.00022906618,0.00029877602],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003587327,0.00028375562,0.00036534577,0.000875791,0.0029547515,0.0012012132,0.000751088,0.00079514703,0.0018658796],"category_scores_gemma":[0.0008089631,0.00035401422,0.00033337856,0.0015913692,0.00040834624,0.00044072577,0.0013032573,0.0013572301,0.00026676894],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034031134,0.0001987408,0.971722,0.00010842656,0.000020058886,0.0004284368,0.009042012,0.00004693068,0.0005269639,0.00011887745,0.0021473824,0.0156061165],"study_design_scores_gemma":[0.000007420154,0.0000647402,0.96044517,0.0002000472,0.000041886527,0.00021787542,0.034942247,0.0002013322,0.00013572503,0.0000495572,0.0036803754,0.000013520666],"about_ca_topic_score_codex":0.9263434,"about_ca_topic_score_gemma":0.97535026,"teacher_disagreement_score":0.07365662,"about_ca_system_score_codex":0.0052045835,"about_ca_system_score_gemma":0.009859804,"threshold_uncertainty_score":0.14818072},"labels":[],"label_agreement":null},{"id":"W2944144863","doi":"10.1016/j.jaad.2019.04.061","title":"Regarding: Notes & Comments on “Efficacy, safety, and comparison of sonic hedgehog inhibitors in basal cell carcinomas: A systematic review and meta-analysis”","year":2019,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Canadian Dermatology Foundation","keywords":"Medicine; Meta-analysis; Sonic hedgehog; Basal (medicine); Oncology; Hedgehog signaling pathway; Internal medicine; Dermatology; Biology; Genetics","score_opus":0.10320314344790178,"score_gpt":0.39035171524117984,"score_spread":0.2871485717932781,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944144863","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00042399098,0.030019386,0.00043954208,0.8171718,0.13252823,0.0006659728,0.013139998,0.00016623452,0.0054448713],"genre_scores_gemma":[0.0024571668,0.014813002,0.0008409875,0.9199525,0.04834679,0.0010174853,0.0014239901,0.00009481125,0.011053229],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99079925,0.003074658,0.0025761616,0.0006855306,0.0023516503,0.00051271776],"domain_scores_gemma":[0.9171052,0.050379895,0.010076416,0.0013360429,0.019122025,0.0019804887],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017970199,0.0010233675,0.0032049639,0.0028449043,0.0011841378,0.0022170437,0.0029048796,0.010093798,0.036967587],"category_scores_gemma":[0.11869568,0.0007985405,0.00541363,0.003192345,0.0012099359,0.0029185128,0.0025118792,0.0056811105,0.0113395825],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001894123,0.0000075986336,0.00023499836,0.004953599,0.00021138268,0.000080064805,0.000054522287,0.000027469232,0.00010480851,0.00027154502,0.98697853,0.0068861204],"study_design_scores_gemma":[0.0019557758,0.00014221834,0.0041033025,0.024906438,0.0019855197,0.0002505874,0.00023292743,0.00018602588,0.00036507263,0.0024423823,0.96329665,0.00013318412],"about_ca_topic_score_codex":0.011273969,"about_ca_topic_score_gemma":0.03130695,"teacher_disagreement_score":0.036967587,"about_ca_system_score_codex":0.004328143,"about_ca_system_score_gemma":0.008667878,"threshold_uncertainty_score":0.12366885},"labels":[],"label_agreement":null},{"id":"W2944232399","doi":"10.1016/j.jaad.2018.05.543","title":"Epidemiology and geographic trends for chronic myelomonocytic leukemia in Canada","year":2018,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Chronic myelomonocytic leukemia; Epidemiology; Environmental health; Immunology; Pathology; Myelodysplastic syndromes","score_opus":0.02965277291069233,"score_gpt":0.34949860411378364,"score_spread":0.3198458312030913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944232399","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94736934,0.011030277,0.00027778075,0.0037959113,0.00012872391,0.00008291724,0.02875456,0.00006938719,0.008491017],"genre_scores_gemma":[0.98869544,0.0047779367,0.00022051844,0.00030394504,0.000044261444,0.00001952397,0.004367086,0.000013624313,0.0015575363],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99878174,0.00006654861,0.00014052622,0.00016887205,0.00036574906,0.0004766306],"domain_scores_gemma":[0.9954685,0.00014476107,0.0009476038,0.000080069025,0.0023633298,0.0009957916],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004571562,0.00034145793,0.00040468958,0.004106057,0.0022832116,0.0018928185,0.0014071253,0.0007501556,0.0045882454],"category_scores_gemma":[0.002348098,0.0003849229,0.0012102287,0.010403188,0.0008019735,0.00067531556,0.00096570305,0.00110701,0.00034408882],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000072745155,0.000023403249,0.9928324,0.000056635028,0.00008337435,0.00009253967,0.00025759966,0.000121686004,0.00010873267,0.00026816645,0.002195451,0.003887103],"study_design_scores_gemma":[0.0000088888955,0.000017264027,0.99519086,0.00007224516,0.000061825864,0.00019223677,0.0016459192,0.0002693863,0.00005149748,0.00005189455,0.0024229004,0.000015107865],"about_ca_topic_score_codex":0.99399346,"about_ca_topic_score_gemma":0.99507153,"teacher_disagreement_score":0.026949216,"about_ca_system_score_codex":0.026949216,"about_ca_system_score_gemma":0.04664234,"threshold_uncertainty_score":0.19553113},"labels":[],"label_agreement":null},{"id":"W2944551079","doi":"10.1016/j.jaad.2019.05.016","title":"Longitudinal atopic dermatitis control and persistence vary with timing of disease onset in children: A cohort study","year":2019,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; Bausch and Lomb Ireland; National Institutes of Health; Valeant Pharmaceuticals International; Pfizer; Dermatology Foundation","keywords":"Medicine; Age of onset; Cohort; Confidence interval; Odds ratio; Longitudinal study; Cohort study; Pediatrics; Prospective cohort study; Persistence (discontinuity); Atopic dermatitis; Disease; Internal medicine; Immunology; Pathology","score_opus":0.010254618784783707,"score_gpt":0.26967639573908364,"score_spread":0.2594217769542999,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944551079","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991228,0.00023691342,0.00006408859,0.00003535257,0.000009472353,0.0000049225077,0.00035891283,0.000004935816,0.00016243952],"genre_scores_gemma":[0.999166,0.00013969594,0.000076775235,0.000020733713,0.000008694179,0.000008180701,0.00034126086,0.0000056625436,0.00023297705],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984005,0.00034864678,0.00013711453,0.0005305173,0.0001795149,0.00040374717],"domain_scores_gemma":[0.99615353,0.0005228523,0.0015610496,0.0006454997,0.0003846253,0.00073233194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013845111,0.00067884394,0.00074993976,0.0012522098,0.0010456338,0.0014930882,0.0011820922,0.001136968,0.001688387],"category_scores_gemma":[0.003399957,0.0011106938,0.001452004,0.0020477818,0.0006295441,0.0013116179,0.0010803059,0.0018313323,0.00045177096],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014779558,0.00005707713,0.9988551,0.0000034855145,0.00010787319,0.00010227371,0.00012810001,0.000013947658,0.00018666762,0.000012350001,0.000048952646,0.00033632424],"study_design_scores_gemma":[0.000007863373,0.00011362671,0.9990288,0.000005171938,0.00005378562,0.00029196774,0.00027865972,0.00006537902,0.000039774288,0.000012842879,0.00009602086,0.0000060756197],"about_ca_topic_score_codex":0.027537124,"about_ca_topic_score_gemma":0.019870464,"teacher_disagreement_score":0.027537124,"about_ca_system_score_codex":0.00070759916,"about_ca_system_score_gemma":0.00090604374,"threshold_uncertainty_score":0.05475372},"labels":[],"label_agreement":null},{"id":"W2944553568","doi":"10.1016/j.jaad.2018.05.542","title":"Epidemiology and distribution of cutaneous T-cell lymphoma (CTCL) cases in Canada from 1992 to 2010: Implications of cluster proximity of patients to industrial centers and seaports","year":2018,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Epidemiology; Cluster (spacecraft); Lymphoma; Distribution (mathematics); Cutaneous T-cell lymphoma; Dermatology; Mycosis fungoides; Environmental health; Pathology","score_opus":0.03205893253634352,"score_gpt":0.31871408495029036,"score_spread":0.28665515241394685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944553568","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98900163,0.0011208394,0.00010775912,0.0002786008,0.0000160241,0.000032173557,0.0070639,0.000022773707,0.002356345],"genre_scores_gemma":[0.9971041,0.0005595057,0.000083682375,0.00005979449,0.000006697697,0.0000072044973,0.0015917242,0.0000050538692,0.000582339],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991425,0.000046568504,0.000068526184,0.00015162975,0.00021738255,0.0003734496],"domain_scores_gemma":[0.9980211,0.00006711843,0.00043935,0.000051012827,0.00076807046,0.0006532426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025612387,0.00034873307,0.0002588138,0.00268632,0.0017093192,0.0012667461,0.0011547557,0.00053546246,0.0030261136],"category_scores_gemma":[0.0012796273,0.00034122038,0.00052766345,0.0056814067,0.00080878846,0.0004463505,0.000965495,0.00064721657,0.0003084098],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000056670066,0.000013561958,0.9972541,0.000013524555,0.000023764374,0.000111306785,0.00014708687,0.00007949467,0.00015284467,0.000041080155,0.00053337606,0.0015731938],"study_design_scores_gemma":[0.0000031846726,0.000015726071,0.99799806,0.00001890113,0.000018086741,0.00025761506,0.0009282078,0.0001297984,0.000044287615,0.000012789486,0.00056796026,0.0000054035027],"about_ca_topic_score_codex":0.9837774,"about_ca_topic_score_gemma":0.9867639,"teacher_disagreement_score":0.016222596,"about_ca_system_score_codex":0.013448884,"about_ca_system_score_gemma":0.015306304,"threshold_uncertainty_score":0.09757894},"labels":[],"label_agreement":null},{"id":"W2946948895","doi":"10.1016/j.jaad.2019.05.080","title":"Patient-reported outcomes of adalimumab, phototherapy, and placebo in the Vascular Inflammation in Psoriasis Trial: A randomized controlled study","year":2019,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Maruho; Janssen Biotech; Chugai Pharmaceutical; Ortho Dermatologics; LEO Pharma; National Heart, Lung, and Blood Institute; Novartis Pharmaceuticals Corporation; Dermira; Allergan; Regeneron Pharmaceuticals; National Institutes of Health; Vanda Pharmaceuticals; National Psoriasis Foundation; Pfizer; Celgene; Novartis; AbbVie; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Sanofi; MedImmune; Merck; Genentech; Coherus Biosciences; Valeant Pharmaceuticals International; Boehringer Ingelheim; Amgen; Eli Lilly and Company","keywords":"Medicine; Dermatology Life Quality Index; Adalimumab; Interquartile range; Placebo; Psoriasis; Confidence interval; Quality of life (healthcare); Odds ratio; Randomized controlled trial; Psoriasis Area and Severity Index; Internal medicine; Surgery; Dermatology; Pathology","score_opus":0.010844468262028704,"score_gpt":0.2707372972748238,"score_spread":0.2598928290127951,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2946948895","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9708273,0.019777585,0.0008219725,0.0007918746,0.0010613009,0.002527147,0.0016252,0.00010175073,0.00246588],"genre_scores_gemma":[0.9861615,0.0052875397,0.0010067424,0.0010126716,0.001085633,0.0024356386,0.0010176799,0.000020775096,0.0019717931],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99809057,0.0010291964,0.00015690818,0.0003593696,0.00015708321,0.00020687659],"domain_scores_gemma":[0.9976538,0.00091978384,0.0006332736,0.00018470873,0.00016696563,0.00044149774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027343493,0.0021833624,0.006914039,0.00064020255,0.0006913,0.0018481576,0.0013570609,0.0029864034,0.0077305883],"category_scores_gemma":[0.0031842978,0.0010207639,0.0040182127,0.00067981536,0.0015779465,0.0015368208,0.00065968884,0.0039470713,0.00082564924],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9925305,0.0013443396,0.00053023646,0.00052561535,0.0018010588,0.000014879828,0.000012971858,0.000086591914,0.00032821778,0.00003666144,0.00016365104,0.00262525],"study_design_scores_gemma":[0.97774,0.016968817,0.0024873384,0.00004804182,0.0021224485,0.000015089462,0.000019578642,0.00020429296,0.00008789547,0.00008609626,0.00020410425,0.000016320126],"about_ca_topic_score_codex":0.0014268633,"about_ca_topic_score_gemma":0.0018384762,"teacher_disagreement_score":0.0077305883,"about_ca_system_score_codex":0.0009655926,"about_ca_system_score_gemma":0.0008006907,"threshold_uncertainty_score":0.025861323},"labels":[],"label_agreement":null},{"id":"W2947748629","doi":"10.1016/j.jaad.2019.05.063","title":"A randomized phase 3b/4 study to evaluate concomitant use of topical ivermectin 1% cream and doxycycline 40-mg modified-release capsules, versus topical ivermectin 1% cream and placebo in the treatment of severe rosacea","year":2019,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health; University of Toronto","funders":"Sanofi Genzyme; Almirall; LEO Pharma; Galderma; Bayer HealthCare; Allergan; Eli Lilly and Company; Regeneron Pharmaceuticals; Biofrontera; Celgene; Sanofi","keywords":"Ivermectin; Medicine; Doxycycline; Concomitant; Placebo; Dermatology; Randomized controlled trial; Pharmacology; Surgery; Antibiotics; Veterinary medicine; Microbiology; Pathology","score_opus":0.03789430203727268,"score_gpt":0.3605410744082574,"score_spread":0.3226467723709847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947748629","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9457686,0.0037248235,0.0026993346,0.001174883,0.001483757,0.038892314,0.002833598,0.0004242322,0.0029985928],"genre_scores_gemma":[0.9208448,0.0028148864,0.010986028,0.002649161,0.0013810812,0.050265048,0.002676919,0.00011666028,0.008265514],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9980464,0.0011351086,0.00008549671,0.00034419246,0.00014547656,0.0002432506],"domain_scores_gemma":[0.9974427,0.0006630996,0.00054127624,0.00029227723,0.000248733,0.00081191445],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0047053345,0.0030784693,0.0053704283,0.0009866628,0.0008138349,0.0013171597,0.0020478824,0.0030309963,0.013626988],"category_scores_gemma":[0.0036294714,0.0016210875,0.0020004152,0.0007887363,0.0024126158,0.0016404055,0.0006661564,0.003596202,0.0024026085],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9753701,0.015442098,0.00026932702,0.00027291762,0.00029999902,0.000023565535,0.000025555812,0.00012659644,0.0024830338,0.00005204156,0.0003728558,0.005261887],"study_design_scores_gemma":[0.92908084,0.06980124,0.000398746,0.0000086477985,0.000097724966,0.000011448148,0.0000069993944,0.00013126688,0.0001894215,0.000056187062,0.00021142421,0.000006162487],"about_ca_topic_score_codex":0.0009351483,"about_ca_topic_score_gemma":0.0019957619,"teacher_disagreement_score":0.013626988,"about_ca_system_score_codex":0.0010717855,"about_ca_system_score_gemma":0.0024839267,"threshold_uncertainty_score":0.045586824},"labels":[],"label_agreement":null},{"id":"W2947766633","doi":"10.1016/j.jaad.2019.05.065","title":"Exploring changes in placebo treatment arms in hidradenitis suppurativa randomized clinical trials: A systematic review","year":2019,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto; Western University","funders":"National Institute of Neurological Disorders and Stroke; National Institutes of Health","keywords":"Hidradenitis suppurativa; Medicine; Randomized controlled trial; Placebo; MEDLINE; Clinical trial; Dermatology; Physical therapy; Surgery; Alternative medicine; Internal medicine; Pathology; Disease","score_opus":0.42108062371103566,"score_gpt":0.5119326839423455,"score_spread":0.09085206023130982,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947766633","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0037457568,0.99361223,0.0005193056,0.00022028548,0.00034752494,0.00092597783,0.0002989435,0.000030495756,0.00029942743],"genre_scores_gemma":[0.13357472,0.85689884,0.0034978641,0.002081282,0.00037750983,0.002477076,0.00045834316,0.000048334736,0.0005860001],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.98665047,0.0067642126,0.0040098503,0.0011325575,0.0010708543,0.00037197638],"domain_scores_gemma":[0.97268844,0.02070967,0.00468629,0.0005715953,0.0010124613,0.00033150928],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016784443,0.0021111048,0.019892795,0.002969352,0.0005194925,0.0034555297,0.0021854432,0.0032247014,0.0072826105],"category_scores_gemma":[0.04302504,0.0017576747,0.017027853,0.003358067,0.0014056916,0.0025945033,0.0016668101,0.0032452631,0.00045594483],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008244489,0.0000647657,0.00070956774,0.81678903,0.15212055,0.00007107526,0.00013546432,0.00015906742,0.0002675957,0.00020342799,0.00081849965,0.020416541],"study_design_scores_gemma":[0.023246828,0.0013895801,0.0037746453,0.13889079,0.82471246,0.00011953692,0.00019710035,0.0002439681,0.00021108807,0.0006306168,0.00652096,0.00006252052],"about_ca_topic_score_codex":0.0040488234,"about_ca_topic_score_gemma":0.013544643,"teacher_disagreement_score":0.019892795,"about_ca_system_score_codex":0.0029959264,"about_ca_system_score_gemma":0.0040734094,"threshold_uncertainty_score":0.08876568},"labels":[],"label_agreement":null},{"id":"W2947773178","doi":"10.1016/j.jaad.2019.05.056","title":"Management of pediatric plaque psoriasis using biologics","year":2019,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland; Nexus Clinical Research (Canada); University of Calgary; Hospital for Sick Children; Université de Montréal; University of Alberta; Sunnybrook Health Science Centre; University of Toronto; SickKids Foundation; Women's College Hospital; Health Sciences Centre; University of British Columbia","funders":"","keywords":"Medicine; Psoriasis; Plaque psoriasis; Quality of life (healthcare); Population; Disease; Dermatology; Intensive care medicine; MEDLINE; Internal medicine","score_opus":0.06962661869359107,"score_gpt":0.34355088271688067,"score_spread":0.2739242640232896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947773178","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000090340814,0.99919635,0.000092025766,0.00013729975,0.0001332102,0.0000022539791,0.0000050798462,0.0000046628943,0.00033873672],"genre_scores_gemma":[0.001200791,0.99756783,0.00025268528,0.00026101686,0.0003441111,0.00000454072,0.000021820977,0.000001384176,0.00034581425],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997447,0.0000454329,0.00004801692,0.000046946094,0.00009260191,0.000022242886],"domain_scores_gemma":[0.9996476,0.0001804032,0.00006851638,0.000008379089,0.00006704899,0.000027994727],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005690866,0.0008264092,0.0015444704,0.0018102851,0.0002298435,0.0008455238,0.0009445507,0.0009782056,0.0017179691],"category_scores_gemma":[0.0007938512,0.0002585245,0.0006938077,0.00093761657,0.00036008476,0.0007871193,0.00045163964,0.0024352667,0.0008954407],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000831997,0.00007987027,0.00023303379,0.0069618495,0.00010000222,0.00043633312,0.000023009437,0.00022251556,0.0006901581,0.0011009664,0.017929533,0.9721395],"study_design_scores_gemma":[0.00014384642,0.00034355884,0.0030222267,0.008089753,0.000568839,0.010395541,0.00010046869,0.000389396,0.0010592722,0.0021552707,0.97368705,0.00004476634],"about_ca_topic_score_codex":0.0008855045,"about_ca_topic_score_gemma":0.0018384597,"teacher_disagreement_score":0.0018102851,"about_ca_system_score_codex":0.00044940214,"about_ca_system_score_gemma":0.0005751265,"threshold_uncertainty_score":0.0057471395},"labels":[],"label_agreement":null},{"id":"W2948881577","doi":"10.1016/j.jaad.2019.05.094","title":"Immunogenicity and skin clearance recapture in clinical studies of brodalumab","year":2019,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Janssen Biotech; LEO Pharma; MedImmune; Valeant Pharmaceuticals International; Johnson and Johnson; AbbVie; UCB; Ortho Dermatologics; AstraZeneca; Celgene; Novartis; Pfizer; Boehringer Ingelheim","keywords":"Medicine; Psoriasis Area and Severity Index; Psoriasis; Immunogenicity; Pharmacodynamics; Internal medicine; Dermatology; Pharmacokinetics; Immunology; Antibody","score_opus":0.026273331925988894,"score_gpt":0.33084386390404025,"score_spread":0.30457053197805134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2948881577","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9792076,0.011448526,0.004068392,0.00020728476,0.00013912804,0.0009635786,0.00028897394,0.000056235276,0.0036203272],"genre_scores_gemma":[0.9971988,0.00057417445,0.0010941842,0.00018051683,0.000074425705,0.00023540667,0.00024698843,0.00001446477,0.000380996],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99348664,0.004221371,0.0004790738,0.0005294326,0.0010052889,0.000278156],"domain_scores_gemma":[0.99299663,0.0027985976,0.002301597,0.0009594425,0.0006349146,0.00030885515],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014676503,0.00044415484,0.0005293352,0.0004123969,0.0002957966,0.0006364608,0.0004880155,0.00045789106,0.0020713392],"category_scores_gemma":[0.008644133,0.00030008546,0.000693979,0.00026610287,0.00039162138,0.00049000187,0.0003491747,0.0007603521,0.00051044766],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06418007,0.009000813,0.31037483,0.0031971359,0.0022636424,0.0012357512,0.0008925416,0.0030714273,0.38689283,0.0012904379,0.0029912926,0.21460918],"study_design_scores_gemma":[0.006899226,0.16533834,0.5873357,0.00033851343,0.0020313752,0.010890151,0.0002528222,0.00802793,0.1964135,0.0007225436,0.02166949,0.00008044847],"about_ca_topic_score_codex":0.0002035659,"about_ca_topic_score_gemma":0.00020486738,"teacher_disagreement_score":0.014676503,"about_ca_system_score_codex":0.00036457615,"about_ca_system_score_gemma":0.0002870486,"threshold_uncertainty_score":0.077617645},"labels":[],"label_agreement":null},{"id":"W2949450289","doi":"10.1016/j.jaad.2019.06.030","title":"Treatments for primary squamous cell carcinoma and squamous cell carcinoma in situ of the skin: A systematic review and network meta-analysis","year":2019,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"Agency for Healthcare Research and Quality","keywords":"Medicine; Basal cell; Meta-analysis; Oncology; In situ; Primary (astronomy); Dermatology; Pathology","score_opus":0.0535232188995025,"score_gpt":0.33721916202016267,"score_spread":0.28369594312066015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2949450289","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004211387,0.99441373,0.00030906853,0.000100576886,0.00011736089,0.000110157445,0.00051855587,0.000016373504,0.00020279014],"genre_scores_gemma":[0.14768945,0.8484759,0.0012305924,0.00088704354,0.00017916688,0.00039855414,0.0006510392,0.000024865263,0.00046336712],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99642426,0.0014005362,0.001051098,0.00053267233,0.00040577698,0.00018567036],"domain_scores_gemma":[0.9942615,0.0038822654,0.0011662607,0.00020052133,0.00037487442,0.00011458445],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004177693,0.0022792742,0.01261603,0.004247611,0.00051303924,0.0019512251,0.0015970302,0.001536106,0.0046170675],"category_scores_gemma":[0.011539186,0.0012146507,0.025585666,0.0050239,0.00055221544,0.0014833093,0.0015141943,0.0018298145,0.00037478097],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001394142,0.000033180237,0.0043781544,0.38014302,0.60023016,0.00012649113,0.00007931065,0.00041429896,0.00028039474,0.00011666653,0.0008668453,0.011937328],"study_design_scores_gemma":[0.0006090503,0.000141243,0.004085402,0.019363858,0.9735016,0.00010122514,0.0000676338,0.00009197407,0.00009906459,0.00015258092,0.0017607479,0.00002548524],"about_ca_topic_score_codex":0.0095912265,"about_ca_topic_score_gemma":0.030867929,"teacher_disagreement_score":0.01261603,"about_ca_system_score_codex":0.0019878708,"about_ca_system_score_gemma":0.0019576857,"threshold_uncertainty_score":0.022094011},"labels":[],"label_agreement":null},{"id":"W2952538817","doi":"10.1016/j.jaad.2019.04.073","title":"Validation of the electronic Psoriasis Area and Severity Index application: Establishing measurement equivalence","year":2019,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"Janssen UK; Cilag; LEO Pharma; Les Laboratories Pierre Fabre; Janssen Biotech; Novartis; Bausch Health; Celgene; American Academy of Dermatology; Pfizer; Eli Lilly and Company; AbbVie; Sanofi","keywords":"Scopus; Medicine; Psoriasis; Psoriasis Area and Severity Index; Equivalence (formal languages); Patient-reported outcome; MEDLINE; Family medicine; Quality of life (healthcare); Dermatology","score_opus":0.021944010080338364,"score_gpt":0.2521375670072493,"score_spread":0.23019355692691096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2952538817","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.687835,0.0026250873,0.08958386,0.115688615,0.011415704,0.0020174037,0.0023752493,0.0003408987,0.08811815],"genre_scores_gemma":[0.94700456,0.00034042483,0.032067206,0.015014577,0.0016971083,0.00077742495,0.0006797253,0.000074686366,0.002344358],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.86710626,0.090072356,0.011348474,0.0043601003,0.025600689,0.0015120934],"domain_scores_gemma":[0.62550604,0.27052683,0.008689662,0.032206565,0.061414983,0.0016560456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.09613552,0.0003515651,0.0006761576,0.0009064651,0.000915735,0.0026479003,0.0021075928,0.003972217,0.0025331008],"category_scores_gemma":[0.3655251,0.00027461356,0.0007760019,0.0009661402,0.0026323085,0.0019091717,0.0022182844,0.0034864428,0.0017065915],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006207499,0.0023272117,0.5149588,0.0005450822,0.00048237064,0.0013971576,0.0073311,0.001976541,0.009723737,0.024592793,0.043707944,0.38674977],"study_design_scores_gemma":[0.0019088665,0.011895605,0.64151275,0.002140578,0.0006730086,0.007424968,0.0051069763,0.05332255,0.03183564,0.04996477,0.19392107,0.00029336702],"about_ca_topic_score_codex":0.0013747017,"about_ca_topic_score_gemma":0.0009146189,"teacher_disagreement_score":0.09613552,"about_ca_system_score_codex":0.0013593348,"about_ca_system_score_gemma":0.0014686408,"threshold_uncertainty_score":0.5084193},"labels":[],"label_agreement":null},{"id":"W2953907977","doi":"10.1016/j.jaad.2019.06.1301","title":"Evaluating patients' unmet needs in hidradenitis suppurativa: Results from the Global Survey Of Impact and Healthcare Needs (VOICE) Project","year":2019,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":279,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto; University of Windsor; Western University","funders":"Cilag; Janssen Biotech; InflaRx; Marie Curie; AbbVie; Sanofi; UCB; AstraZeneca; Regeneron Pharmaceuticals; Novartis; National Psoriasis Foundation","keywords":"Hidradenitis suppurativa; Medicine; Health care; Survey research; MEDLINE; Family medicine; Pathology; Disease; Applied psychology","score_opus":0.049976433544488795,"score_gpt":0.4012101453159071,"score_spread":0.3512337117714183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953907977","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99528235,0.00023458885,0.000050674502,0.00030827065,0.000008798974,0.000101217694,0.0030550363,0.0000042195074,0.0009549293],"genre_scores_gemma":[0.9965732,0.00029555825,0.0002061097,0.00016844706,0.000011650468,0.00015829843,0.0023374541,0.000004186152,0.0002452506],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99854577,0.0006167077,0.00025456815,0.000080375765,0.00025298295,0.00024966535],"domain_scores_gemma":[0.9970354,0.00060998305,0.0011848467,0.000073432544,0.00039365908,0.0007026853],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021697145,0.00038468518,0.0005344666,0.0014075207,0.000591908,0.00073375256,0.00067902316,0.0008516492,0.0009112274],"category_scores_gemma":[0.0058694156,0.00032758742,0.0011170657,0.0022038333,0.0003192894,0.0010495306,0.0022216898,0.000843438,0.00019381875],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015288938,0.00025309235,0.9926925,0.00009250359,0.000113578855,0.00008735808,0.00079880515,0.000103602564,0.000061412706,0.000025470777,0.0005737195,0.0050450442],"study_design_scores_gemma":[0.000013452136,0.00014036658,0.99786407,0.00001798991,0.00002311246,0.000061677034,0.0014350752,0.00010676846,0.000023364952,0.000016186465,0.00029180647,0.000006103412],"about_ca_topic_score_codex":0.015033356,"about_ca_topic_score_gemma":0.017220104,"teacher_disagreement_score":0.015033356,"about_ca_system_score_codex":0.00079725095,"about_ca_system_score_gemma":0.000861611,"threshold_uncertainty_score":0.02989173},"labels":[],"label_agreement":null},{"id":"W2960606103","doi":"10.1016/j.jaad.2019.07.032","title":"Early ultrasound for diagnosis and treatment of vascular adverse events with hyaluronic acid fillers","year":2019,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Facial Rejuvenation and Surgery Techniques","field":"Medicine","cited_by":105,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Institute of Mining, Metallurgy and Petroleum","funders":"","keywords":"Hyaluronic acid; Medicine; Adverse effect; Hyaluronidase; Ultrasonography; Ultrasound; Duplex ultrasonography; Radiology; Duplex (building); Filler (materials); Surgery; Internal medicine; Anatomy","score_opus":0.014057450413805465,"score_gpt":0.2916027479523579,"score_spread":0.27754529753855245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2960606103","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.25011617,0.34068015,0.2022079,0.029547134,0.005880233,0.0027159324,0.0007743402,0.004258639,0.16381948],"genre_scores_gemma":[0.75816286,0.07041678,0.13772634,0.007185877,0.0035914036,0.00072893547,0.00061455095,0.0002826,0.021290634],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9993488,0.00020620514,0.000056943827,0.00005116518,0.00024015894,0.00009664326],"domain_scores_gemma":[0.99859303,0.0005735809,0.00018510915,0.0000824635,0.00039972158,0.00016604475],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014178198,0.00076346286,0.0006507167,0.0021176513,0.0005509029,0.0007311089,0.00039272103,0.0010967907,0.007820542],"category_scores_gemma":[0.0030479725,0.00029025465,0.00051516475,0.0003989177,0.000565311,0.0011031444,0.00042275104,0.0019107834,0.002413842],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015397234,0.0012171905,0.067037724,0.0018684844,0.00008705334,0.02498986,0.00043008884,0.00064561545,0.054631114,0.0034404183,0.03219394,0.8119188],"study_design_scores_gemma":[0.00086766627,0.0062154294,0.20025854,0.0058365953,0.0004540633,0.30632663,0.0017707433,0.008187732,0.1447497,0.011140002,0.3138468,0.00034604972],"about_ca_topic_score_codex":0.0010617696,"about_ca_topic_score_gemma":0.0018579954,"teacher_disagreement_score":0.007820542,"about_ca_system_score_codex":0.00049716275,"about_ca_system_score_gemma":0.00096470705,"threshold_uncertainty_score":0.026162326},"labels":[],"label_agreement":null},{"id":"W2962311924","doi":"10.1016/j.jaad.2019.03.087","title":"Defining skin cancer local recurrence","year":2019,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Skin cancer; Cancer; Cancer recurrence; Melanoma; Intensive care medicine; Identification (biology); Metastasis; Dermatology; Internal medicine","score_opus":0.05155310935239302,"score_gpt":0.4122512392925033,"score_spread":0.3606981299401103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2962311924","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011571213,0.99961424,0.000015905556,0.000043053627,0.00004102165,0.000003672473,0.000020032932,6.3726543e-7,0.0001455762],"genre_scores_gemma":[0.0024555188,0.997095,0.000087175256,0.00013826098,0.000071297356,0.00000897399,0.000047971247,5.4477647e-7,0.00009525784],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99931204,0.0002103306,0.00017922597,0.00012170134,0.00014062885,0.000036220714],"domain_scores_gemma":[0.9983271,0.0010005219,0.00043478142,0.000035571804,0.0001674797,0.000034617333],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017254346,0.00073838705,0.0021539808,0.004669145,0.00023970811,0.0012504399,0.00091727497,0.0006730446,0.0037643763],"category_scores_gemma":[0.0035659133,0.0003649199,0.0015106105,0.004252977,0.0006189891,0.0013169936,0.0009160654,0.0009062738,0.00041453858],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026785448,0.000049944807,0.0046398174,0.1438487,0.0017733292,0.00010561665,0.00013249912,0.00021279026,0.00027706564,0.0014901084,0.013978196,0.8332241],"study_design_scores_gemma":[0.0003314643,0.0006634839,0.051498767,0.27989525,0.026422948,0.0038126304,0.0011696822,0.0003638207,0.001141798,0.0039049354,0.6306417,0.00015353007],"about_ca_topic_score_codex":0.003819667,"about_ca_topic_score_gemma":0.009016815,"teacher_disagreement_score":0.004669145,"about_ca_system_score_codex":0.00088253274,"about_ca_system_score_gemma":0.0014570575,"threshold_uncertainty_score":0.01259315},"labels":[],"label_agreement":null},{"id":"W2964703987","doi":"10.1016/j.jaad.2019.04.042","title":"Joint American Academy of Dermatology–National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis with phototherapy","year":2019,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":190,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Medicine; Psoriasis; Dermatology; Foundation (evidence)","score_opus":0.0316169742257094,"score_gpt":0.3127807220119973,"score_spread":0.2811637477862879,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2964703987","genre_codex":"review","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006315456,0.5364392,0.045148112,0.1718429,0.033547953,0.005091216,0.005922036,0.0020572217,0.19363596],"genre_scores_gemma":[0.06628796,0.45012456,0.2531612,0.101888806,0.018017381,0.010128144,0.020952217,0.0010172237,0.07842246],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9889416,0.00355819,0.0026246835,0.00030499502,0.0038391529,0.0007313932],"domain_scores_gemma":[0.9822146,0.0031419788,0.002549633,0.0005947671,0.01034637,0.0011526375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008975168,0.0014482097,0.002387776,0.006048081,0.0019049331,0.0029341788,0.0043120133,0.0053865192,0.006138525],"category_scores_gemma":[0.016323121,0.0009309039,0.004504219,0.0030090671,0.0012832481,0.0013640105,0.0018929978,0.008976784,0.004558807],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002574248,0.00078408414,0.0028475544,0.0031086262,0.00031285555,0.0006652329,0.00030939005,0.0009183882,0.002268327,0.0066853845,0.69122607,0.29061672],"study_design_scores_gemma":[0.0003410225,0.00018224737,0.014754445,0.010280562,0.0004363677,0.0035605412,0.0002916621,0.00083535304,0.0009885847,0.005981249,0.96222365,0.00012423604],"about_ca_topic_score_codex":0.024696212,"about_ca_topic_score_gemma":0.039428063,"teacher_disagreement_score":0.024696212,"about_ca_system_score_codex":0.0028579454,"about_ca_system_score_gemma":0.012990799,"threshold_uncertainty_score":0.04910493},"labels":[],"label_agreement":null},{"id":"W2964849557","doi":"10.1016/j.jaad.2019.07.064","title":"Optimizing presentation of expected treatment outcomes","year":2019,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Pharmaceutical industry and healthcare","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Janssen Biotech; LEO Pharma Research Foundation; LEO Pharma; Merz Pharmaceuticals; Sun Pharma; Mylan; Regeneron Pharmaceuticals; Donovan Family Foundation; AbbVie; Novartis; Celgene; Janssen Research and Development; Galderma; Almirall; K&F Baxter Family Foundation; National Psoriasis Foundation; Pfizer; Baxter International; Directorate for Computer and Information Science and Engineering; Sanofi; Astellas Pharma US; Valeant Pharmaceuticals International; Eli Lilly and Company; Merck Company Foundation; Boehringer Ingelheim; Merz Therapeutics","keywords":"Medicine; Scopus; Appeal; Medical prescription; Alternative medicine; Family medicine; Appeal to emotion; Product (mathematics); MEDLINE; Nursing","score_opus":0.3531683761729046,"score_gpt":0.5535478706673636,"score_spread":0.20037949449445897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2964849557","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.020708214,0.0024525786,0.012980007,0.8683638,0.005355285,0.00012747367,0.00020000734,0.0003382466,0.089474276],"genre_scores_gemma":[0.743563,0.0048114136,0.02159647,0.17771901,0.030919323,0.00031059785,0.0005287472,0.00036678728,0.020184599],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99376476,0.0029969567,0.00082473585,0.00038336447,0.0010386746,0.0009914298],"domain_scores_gemma":[0.98413,0.006958031,0.0017553642,0.0005992297,0.0035666574,0.0029906805],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005024107,0.00038599808,0.00054202584,0.00082459336,0.0014667419,0.004437574,0.0008603381,0.0045975563,0.01396695],"category_scores_gemma":[0.05944563,0.0002453325,0.0006645451,0.00038006113,0.000573154,0.0028220639,0.0019397184,0.008473609,0.003268709],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035299797,0.00051228993,0.04524092,0.00023202311,0.00007421642,0.013781107,0.0007750289,0.002994992,0.0011135675,0.028432073,0.6243223,0.28216857],"study_design_scores_gemma":[0.00045778998,0.0013002229,0.06426565,0.003247284,0.00025589566,0.089972116,0.0058995676,0.03872091,0.0048443954,0.21891807,0.57172567,0.00039236282],"about_ca_topic_score_codex":0.001027294,"about_ca_topic_score_gemma":0.0015795414,"teacher_disagreement_score":0.01396695,"about_ca_system_score_codex":0.0036681443,"about_ca_system_score_gemma":0.0046483916,"threshold_uncertainty_score":0},"labels":[],"label_agreement":null},{"id":"W2964946855","doi":"10.1016/j.jaad.2019.07.083","title":"Efficacy and safety of ingenol mebutate gel in field treatment of actinic keratosis on full face, balding scalp, or approximately 250 cm2 on the chest: A phase 3 randomized controlled trial","year":2019,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bellus Health (Canada)","funders":"Cilag; LEO Pharma; Dermira; Astellas Pharma Canada; Genentech; Valeant Pharmaceuticals International; Celgene; Novartis; Galderma; Eli Lilly and Company; Endo International; Australian Wool Innovation; AbbVie; Sanofi; Regeneron Pharmaceuticals; Abbott Laboratories; Merck; GlaxoSmithKline; Amgen","keywords":"Medicine; Actinic keratosis; Scalp; Randomized controlled trial; Clinical endpoint; Dermatology; Randomization; Blinding; Patient satisfaction; Surgery; Internal medicine","score_opus":0.02875779724342187,"score_gpt":0.34793769423088416,"score_spread":0.3191798969874623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2964946855","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9778347,0.012222262,0.000933337,0.0008385642,0.0008899057,0.0038420176,0.00088458473,0.00013738431,0.00241725],"genre_scores_gemma":[0.98447603,0.004936395,0.0012642808,0.0013087195,0.00065166416,0.0031789092,0.0006367578,0.000029905394,0.003517279],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9993389,0.00033006954,0.000038195314,0.00013613226,0.000049088114,0.00010755185],"domain_scores_gemma":[0.99893016,0.00043498786,0.0002184037,0.000081499966,0.00007157416,0.00026333664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015374273,0.0022465342,0.0044369088,0.00047091822,0.0005831117,0.0014994243,0.0013937299,0.0022823242,0.008100987],"category_scores_gemma":[0.0017220639,0.00091249717,0.002894007,0.0004987966,0.001544416,0.0013192527,0.0003708694,0.004273484,0.0010090378],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98578817,0.004648258,0.00023969993,0.00073343667,0.0009863931,0.000027376795,0.000039316332,0.00014875658,0.0012395644,0.00006575944,0.00034844206,0.0057348097],"study_design_scores_gemma":[0.9667163,0.031329464,0.00066844624,0.000038753275,0.00056930556,0.000012016373,0.000021705535,0.00019352039,0.00015352,0.00007702762,0.00020905197,0.000010911231],"about_ca_topic_score_codex":0.0014762986,"about_ca_topic_score_gemma":0.0026266589,"teacher_disagreement_score":0.008100987,"about_ca_system_score_codex":0.000870168,"about_ca_system_score_gemma":0.001048315,"threshold_uncertainty_score":0.027100503},"labels":[],"label_agreement":null},{"id":"W2965009353","doi":"10.1016/j.jaad.2019.07.074","title":"Dupilumab shows long-term safety and efficacy in patients with moderate to severe atopic dermatitis enrolled in a phase 3 open-label extension study","year":2019,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":256,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"Genentech; LEO Pharma; Coherus Biosciences; Kaken Pharmaceutical; Asana Biosciences; Kiniksa Pharmaceuticals; Aimmune Therapeutics; Janssen Biotech; Teva Pharmaceutical Industries; Les Laboratories Pierre Fabre; Valeant Pharmaceuticals International; Galderma; UCB; Regeneron Pharmaceuticals; Sun Pharma; Dermira; Therakos; Taiho Pharmaceutical; F. Hoffmann-La Roche; Glenmark Pharmaceuticals; AbbVie; Novartis; Celgene; Boehringer Ingelheim; Amgen; Sanofi Genzyme; Merck Sharp and Dohme; 3M; Roche; University of Pennsylvania; Kyowa Hakko Kirin; Sanofi; Merck; GlaxoSmithKline; Incyte; Pfizer; Allergan; AstraZeneca; Eli Lilly and Company","keywords":"Dupilumab; Medicine; Atopic dermatitis; Open label; Dermatology; Term (time); Adverse effect; Internal medicine","score_opus":0.016461876736820428,"score_gpt":0.32493151837083456,"score_spread":0.30846964163401414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2965009353","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960432,0.0017613526,0.00019342653,0.0001925694,0.000034550132,0.00037479232,0.0005716958,0.000026695725,0.00080176856],"genre_scores_gemma":[0.99726945,0.00042723003,0.0005271362,0.00035403654,0.00006594886,0.00028630052,0.0007711744,0.0000053297645,0.000293345],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99911886,0.00048488402,0.00007079598,0.00010062463,0.00013112392,0.000093793904],"domain_scores_gemma":[0.9982236,0.00047950764,0.00052108295,0.00014729968,0.00022452275,0.000404003],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034394716,0.00039254644,0.0008090721,0.00014078183,0.0003363485,0.0006770222,0.00030990533,0.00062026683,0.0023545441],"category_scores_gemma":[0.0021059737,0.00017621911,0.0008791911,0.00022400804,0.00026359595,0.00047077212,0.00023407758,0.0011853194,0.000421835],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5576305,0.031891666,0.1292619,0.0014664377,0.0030765012,0.0007598798,0.0006102278,0.0011298618,0.039779313,0.0002217944,0.009661304,0.22451064],"study_design_scores_gemma":[0.24567038,0.36165583,0.36514583,0.00020381497,0.0022880058,0.0022338354,0.00021779443,0.0033821694,0.009041687,0.00026934163,0.009798739,0.00009250967],"about_ca_topic_score_codex":0.00032843486,"about_ca_topic_score_gemma":0.0010068226,"teacher_disagreement_score":0.0034394716,"about_ca_system_score_codex":0.00043537543,"about_ca_system_score_gemma":0.00074109476,"threshold_uncertainty_score":0.018189907},"labels":[],"label_agreement":null},{"id":"W2965055856","doi":"10.1016/j.jaad.2019.07.069","title":"Effect of injection solutions in the dispersion of syringe lubricant (silicone oil)","year":2019,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Advancements in Transdermal Drug Delivery","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Guenther Dermatology Research Centre","funders":"Pfizer","keywords":"Silicone oil; Silicone; Medicine; Syringe; Lubricant; Seal (emblem); Surgery; Chromatography; Materials science; Chemistry; Composite material","score_opus":0.053912333138869124,"score_gpt":0.41183197667773075,"score_spread":0.35791964353886163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2965055856","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9777115,0.008606438,0.0012734145,0.0033792958,0.0014000335,0.00009512349,0.00011739228,0.00007409036,0.007342765],"genre_scores_gemma":[0.9874889,0.0027630029,0.0016044821,0.0009522288,0.00035987512,0.000022225564,0.00006209699,0.000020829742,0.00672637],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997625,0.00008099735,0.000019699783,0.000025784528,0.00007239978,0.00003870077],"domain_scores_gemma":[0.99959403,0.0002691655,0.000044131724,0.000019382907,0.00003916885,0.000034145247],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048715307,0.00023526857,0.0002050722,0.0001564741,0.00023698976,0.00029735343,0.00025763473,0.0008476833,0.0021045262],"category_scores_gemma":[0.00117084,0.00012411702,0.00028413383,0.00010323297,0.0002543935,0.00022756221,0.00014931396,0.00065121916,0.00045109063],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010387154,0.0009238028,0.0011039425,0.00040581072,0.000048341666,0.0027369442,0.00030540346,0.0001463247,0.9251638,0.00047589766,0.0029556544,0.055347025],"study_design_scores_gemma":[0.000600634,0.01178913,0.0039264024,0.000031333275,0.000079207326,0.0015249256,0.00011648165,0.00093508203,0.96639484,0.0001512162,0.014434712,0.000015987729],"about_ca_topic_score_codex":0.0011381892,"about_ca_topic_score_gemma":0.0016650542,"teacher_disagreement_score":0.0021045262,"about_ca_system_score_codex":0.00022042092,"about_ca_system_score_gemma":0.00026408548,"threshold_uncertainty_score":0.007040322},"labels":[],"label_agreement":null},{"id":"W2966010326","doi":"10.1016/j.jaad.2019.04.045","title":"Secukinumab demonstrates sustained efficacy in clearing skin and improving patient-reported outcomes in patients with moderate-to-severe psoriasis through 2 years of treatment: Results from the CLEAR study","year":2019,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dermatrials Research","funders":"Samsung Bioepis; Cilag; Janssen Biotech; Beijing Novartis Pharma; Sanofi Genzyme; Merck Sharp and Dohme; Samsung; LEO Pharma; Medac; Mitsubishi Tanabe Pharma Corporation; Almirall; Galderma; Allergan; Tartu Ülikool; National Taiwan University; Sanofi; Kyowa Hakko Kirin; Eli Lilly and Company; National Taiwan University Hospital; Purdue Pharma; Fresenius Medical Care North America; Sun Pharma; Novartis Pharmaceuticals Corporation; Dermira; UCB Pharma; Valeant Pharmaceuticals International; Regeneron Pharmaceuticals; Pfizer; Biogen; Novartis; Celgene; Purdue University; Baxalta; Genentech; Biogen Idec; Novartis Pharma; AbbVie; Boehringer Ingelheim; Amgen; GlaxoSmithKline","keywords":"Medicine; Secukinumab; Psoriasis; Dermatology; Plaque psoriasis; Intensive care medicine; Psoriatic arthritis","score_opus":0.012299822350368085,"score_gpt":0.24611361904426005,"score_spread":0.23381379669389196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2966010326","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012536727,0.008008788,0.00034066915,0.9311105,0.041688107,0.0000398309,0.00023838786,0.00009649586,0.005940597],"genre_scores_gemma":[0.08533857,0.0074542235,0.0006005455,0.730958,0.16312034,0.00006804049,0.00021288007,0.000074567404,0.012172858],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9988398,0.00049247436,0.00016663074,0.00014843883,0.00023626449,0.00011652587],"domain_scores_gemma":[0.99480283,0.0033729682,0.0003809604,0.00014193468,0.0008811946,0.0004201207],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002608719,0.00054795196,0.0012261576,0.00033759573,0.0011338254,0.0014132021,0.0009251865,0.009349493,0.003146459],"category_scores_gemma":[0.010528645,0.00030663662,0.0005674146,0.00047564253,0.00083695236,0.0012954533,0.00029233782,0.008379685,0.0026466148],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014832453,0.00021666798,0.005435841,0.0003185934,0.00013145788,0.019766163,0.00020662145,0.00012661824,0.001128068,0.0013190942,0.9155981,0.05426947],"study_design_scores_gemma":[0.0028380915,0.0019922426,0.020299805,0.0009469421,0.00059223035,0.05691766,0.00062420237,0.0034886107,0.0034666818,0.0068793,0.90171367,0.00024056932],"about_ca_topic_score_codex":0.001020547,"about_ca_topic_score_gemma":0.0015678924,"teacher_disagreement_score":0.009349493,"about_ca_system_score_codex":0.0012701034,"about_ca_system_score_gemma":0.00089222536,"threshold_uncertainty_score":0.013796389},"labels":[],"label_agreement":null},{"id":"W2967315338","doi":"10.1016/j.jaad.2019.08.019","title":"Pharmacokinetics and safety of apremilast in pediatric patients with moderate to severe plaque psoriasis: Results from a phase 2 open-label study","year":2019,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"LEO Pharma; Galderma; Dermira; Celgene; Amgen; Pfizer; Eli Lilly and Company","keywords":"Medicine; Plaque psoriasis; Apremilast; Pharmacokinetics; Open label; Dermatology; Psoriasis; Adverse effect; Internal medicine","score_opus":0.017765955687691102,"score_gpt":0.29055889634609977,"score_spread":0.27279294065840864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2967315338","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99510384,0.002286913,0.0009071792,0.00014270387,0.000018585673,0.000613222,0.00037519287,0.000039164715,0.0005131982],"genre_scores_gemma":[0.99122393,0.0024694402,0.0036022556,0.00043642515,0.000085130225,0.0007558822,0.0009652872,0.00002476866,0.00043685318],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9994438,0.00030757298,0.0000377759,0.00007116864,0.000095369214,0.000044348053],"domain_scores_gemma":[0.9989869,0.00025709605,0.00037207303,0.00006868037,0.00010357627,0.00021172523],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016912476,0.0006279806,0.001254239,0.00012890986,0.00021049114,0.00045604174,0.00031428123,0.0005182642,0.0016293025],"category_scores_gemma":[0.0011656393,0.00029301422,0.00064077665,0.00021502176,0.0003603909,0.00051157526,0.0001594965,0.001460477,0.0003436263],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.36018854,0.06258947,0.080789976,0.0025451079,0.0026621523,0.0017653094,0.0015585406,0.0048484816,0.2031015,0.00044618663,0.0063632396,0.2731415],"study_design_scores_gemma":[0.14658423,0.67805374,0.1397013,0.00012590794,0.0011494292,0.0042177867,0.00025855162,0.0028919787,0.01851591,0.00020950935,0.008233593,0.000058115813],"about_ca_topic_score_codex":0.00029487163,"about_ca_topic_score_gemma":0.0005629655,"teacher_disagreement_score":0.0016912476,"about_ca_system_score_codex":0.00041530133,"about_ca_system_score_gemma":0.00095771265,"threshold_uncertainty_score":0.008944273},"labels":[],"label_agreement":null},{"id":"W2969158725","doi":"10.1016/j.jaad.2019.08.007","title":"Gluten intake and risk of psoriasis, psoriatic arthritis, and atopic dermatitis among United States women","year":2019,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"Sanofi; AbbVie; National Cancer Institute; National Institutes of Health; Brown University; Regeneron Pharmaceuticals","keywords":"Medicine; Psoriatic arthritis; Psoriasis; Atopic dermatitis; Gluten; Hazard ratio; Dermatology; Arthritis; Internal medicine; Cohort study; Confidence interval; Pathology","score_opus":0.00540153084588657,"score_gpt":0.24818226093783688,"score_spread":0.2427807300919503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2969158725","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99617,0.0010628644,0.00003528804,0.00015400298,0.00002972359,0.0000075319826,0.00067307905,0.0000060297994,0.0018616137],"genre_scores_gemma":[0.9985197,0.0004739755,0.00005237102,0.000100637975,0.000033127435,0.000005872644,0.00027570428,0.0000022951683,0.00053631916],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998516,0.000041702984,0.000014616665,0.000032079155,0.0000310348,0.00002896842],"domain_scores_gemma":[0.99952877,0.00007330051,0.00020732035,0.00003552398,0.000041366435,0.00011379746],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024281577,0.00026593497,0.0002365696,0.0008613286,0.0005095748,0.000547099,0.000208209,0.0006472946,0.0024269915],"category_scores_gemma":[0.00073120295,0.00041654057,0.00052756164,0.0012748574,0.00021143068,0.0003418998,0.00024062497,0.0005841141,0.00026980307],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019641568,0.000103049744,0.9982345,0.000009841325,0.00010680605,0.00007149206,0.000044202992,0.000023119455,0.00025071352,0.000017606848,0.00014807201,0.0007941786],"study_design_scores_gemma":[0.000011058497,0.00008328534,0.999209,0.0000082761,0.000065734006,0.00012204548,0.00016587581,0.000094735,0.000032117478,0.000020262596,0.0001845357,0.0000031532709],"about_ca_topic_score_codex":0.014112646,"about_ca_topic_score_gemma":0.015144157,"teacher_disagreement_score":0.014112646,"about_ca_system_score_codex":0.0002133006,"about_ca_system_score_gemma":0.00023416172,"threshold_uncertainty_score":0.028061032},"labels":[],"label_agreement":null},{"id":"W2969748904","doi":"10.1016/j.jaad.2019.08.037","title":"When you need a third hand, tape and gauze will do","year":2019,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Surgery; Biopsy; Punch Biopsy; General surgery; Radiology","score_opus":0.00840241301626918,"score_gpt":0.25971390745855194,"score_spread":0.25131149444228273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2969748904","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13284087,0.04135267,0.03383311,0.17601213,0.031479657,0.0010265708,0.0013997558,0.008040054,0.57401514],"genre_scores_gemma":[0.36343566,0.017889632,0.038490087,0.062959224,0.010640763,0.00045589783,0.0006375177,0.001187246,0.50430393],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995005,0.00006267157,0.00004122821,0.000048789767,0.00021488842,0.00013185795],"domain_scores_gemma":[0.99842453,0.00027146382,0.0002379119,0.00014682508,0.00035255382,0.0005666912],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054801285,0.000719108,0.0007387703,0.0006227882,0.0012667225,0.0016654332,0.0004298765,0.0023119838,0.057809036],"category_scores_gemma":[0.0043346314,0.00020060477,0.0011349699,0.00017548435,0.00058095984,0.0012492322,0.0006574199,0.002214206,0.035463914],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008703107,0.0011935879,0.01887645,0.00083885196,0.00012683166,0.006317221,0.0007228494,0.00016275897,0.028214343,0.0017775616,0.38660282,0.55429643],"study_design_scores_gemma":[0.00029836138,0.0019268886,0.04263471,0.0012697802,0.0002054787,0.07362786,0.0030636494,0.0004779061,0.023441004,0.0033631136,0.8494838,0.00020750191],"about_ca_topic_score_codex":0.002049562,"about_ca_topic_score_gemma":0.0031508326,"teacher_disagreement_score":0.057809036,"about_ca_system_score_codex":0.00023122829,"about_ca_system_score_gemma":0.00047199184,"threshold_uncertainty_score":0.19339049},"labels":[],"label_agreement":null},{"id":"W2971380562","doi":"10.1016/j.jaad.2019.08.078","title":"The emerging utility of the cutaneous microbiome in the treatment of acne and atopic dermatitis","year":2019,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"National Defence Medical Centre; University of Calgary","funders":"","keywords":"Atopic dermatitis; Microbiome; Acne; Medicine; Dermatology; Disease; Immunology; Psoriasis; Adverse effect; Bioinformatics; Biology; Pathology; Pharmacology","score_opus":0.032369035735192404,"score_gpt":0.356305684095003,"score_spread":0.3239366483598106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2971380562","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006314437,0.99936515,0.00004832258,0.00016598751,0.000116030125,0.0000010689215,0.000005806642,0.0000019241688,0.00023258635],"genre_scores_gemma":[0.0007162432,0.9986473,0.00010984353,0.00018113332,0.0001798808,0.0000015932923,0.000010238528,5.88401e-7,0.00015336782],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998103,0.000045389752,0.000027105838,0.000029184253,0.00007046346,0.00001763185],"domain_scores_gemma":[0.99942696,0.0003496117,0.000067364424,0.000011192381,0.00010691233,0.000038062968],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006286198,0.0005089379,0.001267889,0.0013938461,0.00018056782,0.0010498671,0.0004965388,0.00097230857,0.0027587768],"category_scores_gemma":[0.0011244639,0.00014819638,0.0005101927,0.0011935323,0.00040406836,0.0010088183,0.0006956354,0.0015255924,0.0007330313],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000090100606,0.00005493665,0.0002353702,0.0135415215,0.00011863,0.00013275405,0.00003452106,0.00018244285,0.0010166214,0.0023017148,0.012812011,0.9694793],"study_design_scores_gemma":[0.000051028248,0.00016990966,0.0025288041,0.009294061,0.00035501923,0.0016521079,0.00012394149,0.00020277583,0.00042327857,0.0027359952,0.9824311,0.000031923893],"about_ca_topic_score_codex":0.00091101695,"about_ca_topic_score_gemma":0.0022463717,"teacher_disagreement_score":0.0027587768,"about_ca_system_score_codex":0.0003407003,"about_ca_system_score_gemma":0.0008027687,"threshold_uncertainty_score":0.009229004},"labels":[],"label_agreement":null},{"id":"W2975701376","doi":"10.1016/j.jaad.2019.08.088","title":"Rifampin and clindamycin are safe long-term: Response to “North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations Part II: Topical, intralesional, and systemic medical management”","year":2019,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Hidradenitis suppurativa; Medicine; Scopus; Clindamycin; Dermatology; MEDLINE; Antibiotics; Pathology; Disease","score_opus":0.06364243778473347,"score_gpt":0.3834720060868983,"score_spread":0.3198295683021648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2975701376","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011243813,0.0007233436,0.00008909254,0.98562974,0.0077946517,0.000020165555,0.00006159347,0.000018353,0.004538728],"genre_scores_gemma":[0.010231984,0.0012418233,0.00049242494,0.9563503,0.020199165,0.000040810533,0.00008039387,0.00002244844,0.011340526],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99754155,0.0005480004,0.0004466536,0.00023948631,0.0007012475,0.00052307424],"domain_scores_gemma":[0.99375725,0.002308298,0.00054358516,0.00013366545,0.0021081793,0.001148921],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022638482,0.00046352853,0.0007217911,0.0005259021,0.0038711724,0.0024374109,0.0010569828,0.02967894,0.004752743],"category_scores_gemma":[0.011799113,0.00036195375,0.0009646308,0.0007850219,0.0014340236,0.0014640334,0.00080688746,0.02107179,0.0025917743],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001418317,0.00012136346,0.0026155126,0.00007144653,0.000017896125,0.005455796,0.00022811207,0.000133868,0.0004323144,0.0018506043,0.9755662,0.013365122],"study_design_scores_gemma":[0.00030715365,0.00017167431,0.0056956573,0.000529288,0.000047525024,0.005046205,0.0007068166,0.00092640676,0.00047016406,0.0027595023,0.9832598,0.00007986239],"about_ca_topic_score_codex":0.021016827,"about_ca_topic_score_gemma":0.052150235,"teacher_disagreement_score":0.02967894,"about_ca_system_score_codex":0.006862228,"about_ca_system_score_gemma":0.008214257,"threshold_uncertainty_score":0.04978913},"labels":[],"label_agreement":null},{"id":"W2976695332","doi":"10.1016/j.jaad.2019.09.042","title":"Tildrakizumab efficacy and safety are not altered by metabolic syndrome status in patients with psoriasis: Post hoc analysis of 2 phase 3 randomized controlled studies (reSURFACE 1 and reSURFACE 2)","year":2019,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Janssen Biotech; Merck Sharp and Dohme; Janssen Research and Development; National Institutes of Health; LEO Pharma; Novartis; Valeant Pharmaceuticals International; XBiotech; AbbVie; MedImmune; Merck; School of Public Health, University of California Berkeley; Pfizer; Boehringer Ingelheim; Amgen; UCB; Celgene; Ortho Dermatologics; AstraZeneca; Eli Lilly and Company","keywords":"Medicine; Post-hoc analysis; Post hoc; Psoriasis; Randomized controlled trial; Internal medicine; Dermatology; Physical therapy","score_opus":0.010384056074275607,"score_gpt":0.27071767305180844,"score_spread":0.2603336169775328,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2976695332","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1619131,0.35085818,0.0071357894,0.24139985,0.2012355,0.0079894755,0.02155033,0.0009189661,0.006998857],"genre_scores_gemma":[0.5679508,0.05244704,0.010415946,0.17913403,0.16658977,0.006137606,0.004243734,0.0007009219,0.012380175],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.97627616,0.014975812,0.003768279,0.0018697935,0.0024838585,0.00062607724],"domain_scores_gemma":[0.8834006,0.08389511,0.016035708,0.0033532435,0.011862935,0.0014523768],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.04710203,0.0015256933,0.005644033,0.00085844,0.00057397154,0.0022845655,0.0018093737,0.0036759842,0.007603181],"category_scores_gemma":[0.10018332,0.00091594056,0.0075041964,0.0012668335,0.0012118546,0.0016273484,0.00056690164,0.004807918,0.00088383973],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.37682325,0.0007980211,0.009661432,0.09847116,0.13392459,0.000795772,0.0004748657,0.0005839383,0.004788766,0.0013707086,0.25651485,0.11579264],"study_design_scores_gemma":[0.3502308,0.02039578,0.080704,0.019241001,0.33217987,0.00080799655,0.00034812567,0.004959544,0.009120461,0.005672351,0.17569238,0.0006477079],"about_ca_topic_score_codex":0.0008404996,"about_ca_topic_score_gemma":0.0023755673,"teacher_disagreement_score":0.04710203,"about_ca_system_score_codex":0.0015367095,"about_ca_system_score_gemma":0.002386888,"threshold_uncertainty_score":0.24910235},"labels":[],"label_agreement":null},{"id":"W2977858693","doi":"10.1016/j.jaad.2019.09.064","title":"Efficacy and tolerability of an investigational nitric oxide–releasing topical gel in patients with molluscum contagiosum: A randomized clinical trial","year":2019,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Poxvirus research and outbreaks","field":"Immunology and Microbiology","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Allergan; LEO Pharma; Galderma; Regeneron Pharmaceuticals; Les Laboratories Pierre Fabre; Celgene; Valeant Pharmaceuticals International; Sanofi; Pfizer; Amgen","keywords":"Medicine; Tolerability; Discontinuation; Molluscum contagiosum; Erythema; Randomized controlled trial; Adverse effect; Clinical trial; Dermatology; Internal medicine; Surgery","score_opus":0.019854016651772503,"score_gpt":0.32396438796387717,"score_spread":0.30411037131210467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2977858693","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98510486,0.0067800498,0.0005581035,0.00064563047,0.00045280944,0.004580684,0.00060987636,0.000070718386,0.00119723],"genre_scores_gemma":[0.9863551,0.0033531813,0.0011841644,0.0009890493,0.00058376626,0.0056030285,0.000555524,0.000012698628,0.0013634642],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9992205,0.0004446821,0.000053294694,0.00012209054,0.000060090908,0.00009938687],"domain_scores_gemma":[0.9988506,0.00029571203,0.00031519745,0.000085778935,0.00008812612,0.00036458395],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022145219,0.0014077238,0.002922955,0.00036056613,0.00047391938,0.00090118265,0.0008983034,0.002049209,0.0044393633],"category_scores_gemma":[0.0014833545,0.0006362676,0.0017628722,0.0004467847,0.0010677935,0.0008878565,0.00030435115,0.0018112141,0.00069326477],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9654618,0.011280594,0.0015112028,0.0008309602,0.0007965503,0.00009157908,0.0000558818,0.00019003572,0.0038736186,0.00006770131,0.00053551677,0.015304454],"study_design_scores_gemma":[0.9027308,0.09349578,0.002072,0.000028982067,0.0004077701,0.000045843284,0.00002100132,0.00027158775,0.0003790763,0.00005597767,0.0004784402,0.000012758321],"about_ca_topic_score_codex":0.0004128343,"about_ca_topic_score_gemma":0.0010052923,"teacher_disagreement_score":0.0044393633,"about_ca_system_score_codex":0.00061575265,"about_ca_system_score_gemma":0.0012652719,"threshold_uncertainty_score":0.014851093},"labels":[],"label_agreement":null},{"id":"W2979470964","doi":"10.1016/j.jaad.2019.06.1317","title":"An office-based evaluation of various itraconazole brands","year":2019,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"","keywords":"Itraconazole; Scopus; Solubility; Medicine; Bioavailability; Pharmacology; Chemistry; MEDLINE; Dermatology; Antifungal; Biochemistry; Organic chemistry","score_opus":0.023690725589636565,"score_gpt":0.35368796417149007,"score_spread":0.3299972385818535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979470964","genre_codex":"empirical","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9015455,0.004416237,0.0008387846,0.028278148,0.0010963836,0.0002889257,0.0010500088,0.00010686082,0.062379073],"genre_scores_gemma":[0.97086775,0.0008156985,0.00065868936,0.015321254,0.00083657744,0.00003136359,0.00042832847,0.000040468385,0.010999975],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.9987527,0.00033593876,0.00012718783,0.00013589744,0.00047375815,0.00017450226],"domain_scores_gemma":[0.9976369,0.0011931298,0.00017677134,0.00009949573,0.00062228204,0.00027151365],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049152854,0.0004331227,0.00042440288,0.00090005127,0.0012294948,0.0007982422,0.00041891128,0.0029377202,0.003113534],"category_scores_gemma":[0.0029433698,0.00021884592,0.00055781147,0.000562556,0.00033558343,0.0007168784,0.0002671105,0.0017855384,0.00070066104],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010192288,0.0073113535,0.35807994,0.00045703282,0.00021478013,0.42068782,0.0028996011,0.00093587366,0.022450969,0.0014378604,0.064974315,0.110358134],"study_design_scores_gemma":[0.0007277533,0.019603707,0.56032914,0.00043701212,0.00053811725,0.23733142,0.0068795597,0.006986511,0.022751955,0.0015368802,0.14267415,0.00020388313],"about_ca_topic_score_codex":0.005481312,"about_ca_topic_score_gemma":0.0073327124,"teacher_disagreement_score":0.005481312,"about_ca_system_score_codex":0.0015296435,"about_ca_system_score_gemma":0.00048628205,"threshold_uncertainty_score":0.011098444},"labels":[],"label_agreement":null},{"id":"W2980232689","doi":"10.1016/j.jaad.2019.09.077","title":"Allergic reactions to tattoos: Retrospective analysis of North American Contact Dermatitis Group data, 2001-2016","year":2019,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Tattoo and Body Piercing Complications","field":"Social Sciences","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Health Sciences Centre; University of Ottawa; Montreal General Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Allergic contact dermatitis; Dermatology; Contact dermatitis; Allergy","score_opus":0.035519352836912946,"score_gpt":0.3438622914806044,"score_spread":0.30834293864369144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980232689","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98977715,0.001178821,0.000190976,0.00078693015,0.000053623582,0.000033881566,0.0043268204,0.000018532362,0.0036334507],"genre_scores_gemma":[0.99607724,0.00069447886,0.00010581507,0.00044113334,0.0000641534,0.000020261541,0.0017589302,0.000005731584,0.0008322178],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99863535,0.0003227208,0.0003124116,0.00016016875,0.00039949917,0.00016980132],"domain_scores_gemma":[0.995808,0.00074006035,0.0020456135,0.00040169133,0.0007825191,0.0002220578],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00086607796,0.00021749276,0.00022706653,0.0010892235,0.0005039133,0.0007311915,0.00034734697,0.0007071468,0.0018086504],"category_scores_gemma":[0.0032929936,0.00028497592,0.00050048373,0.002775671,0.0003136021,0.0006271035,0.0003715556,0.00053998764,0.00059955695],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058458238,0.000016299413,0.9958566,0.000014409472,0.000024829,0.00063434767,0.00008141644,0.000016215534,0.00008012843,0.000013924565,0.0013855817,0.0018178162],"study_design_scores_gemma":[0.0000064744468,0.000036181234,0.99454826,0.000029047189,0.000039102033,0.002907305,0.0005031576,0.00011360608,0.00009985539,0.000022229027,0.001689667,0.0000050535596],"about_ca_topic_score_codex":0.019196153,"about_ca_topic_score_gemma":0.026362933,"teacher_disagreement_score":0.019196153,"about_ca_system_score_codex":0.0006203115,"about_ca_system_score_gemma":0.0007496372,"threshold_uncertainty_score":0.038168848},"labels":[],"label_agreement":null},{"id":"W2980553608","doi":"10.1016/j.jaad.2019.09.083","title":"Cutaneous sequelae in neonatal lupus: A retrospective cohort study","year":2019,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Retrospective cohort study; Cutaneous Lupus Erythematosus; Cohort; Cohort study; Dermatology; Pediatrics; Surgery; Lupus erythematosus; Pathology; Immunology","score_opus":0.012325977983364723,"score_gpt":0.31958355279925926,"score_spread":0.30725757481589455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980553608","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99918276,0.00019859694,0.0000800443,0.000019677003,0.0000069412135,0.0000083464165,0.00025344433,0.0000030381227,0.0002471581],"genre_scores_gemma":[0.999241,0.00018911797,0.000068756635,0.00002172706,0.0000101528385,0.0000126072455,0.00028727937,0.0000039639526,0.00016540359],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998787,0.00029365244,0.00016655124,0.00039572312,0.0001458484,0.0002112146],"domain_scores_gemma":[0.9971058,0.00035045572,0.0011847964,0.00054047816,0.0003008745,0.0005175869],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00087999395,0.0006125905,0.0006309418,0.0013482891,0.0009508826,0.001153487,0.0008191546,0.00083006994,0.002216355],"category_scores_gemma":[0.0029424322,0.00088579266,0.00083002215,0.0015761661,0.00057006,0.0010954452,0.0008940447,0.0009797454,0.0005073676],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009196267,0.00004501303,0.99864644,0.0000056973718,0.00006435372,0.00040254885,0.00007897629,0.000014389771,0.0001736901,0.000016201182,0.00005500792,0.00040580012],"study_design_scores_gemma":[0.000010453845,0.00016004911,0.9962112,0.000011584911,0.000077543635,0.002430126,0.00068756647,0.00011759534,0.00007956944,0.000027395881,0.00017777241,0.000009193762],"about_ca_topic_score_codex":0.0064669964,"about_ca_topic_score_gemma":0.005135161,"teacher_disagreement_score":0.0064669964,"about_ca_system_score_codex":0.000597476,"about_ca_system_score_gemma":0.0006424516,"threshold_uncertainty_score":0.012858689},"labels":[],"label_agreement":null},{"id":"W2982537398","doi":"10.1016/j.jaad.2019.10.055","title":"Standardizing serial photography for assessing and monitoring vitiligo: A core set of international recommendations for essential clinical and technical specifications","year":2019,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"melanin and skin pigmentation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health Research Institute; University of British Columbia; Vancouver Coastal Health","funders":"LEO Fondet","keywords":"Vitiligo; Medicine; Standardization; Protocol (science); Medical physics; Clinical Practice; Photography; Set (abstract data type); Clinical trial; Dermatology; Family medicine; Pathology; Alternative medicine; Computer science","score_opus":0.059972895411630554,"score_gpt":0.41594227864627425,"score_spread":0.3559693832346437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2982537398","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0269932,0.03288916,0.8120632,0.046062,0.0055122,0.014617456,0.0045018024,0.008278746,0.049082194],"genre_scores_gemma":[0.04329168,0.011769004,0.9213922,0.004795662,0.0008581539,0.0055692256,0.004701266,0.0012706465,0.0063521992],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9292862,0.025655376,0.017780732,0.002186231,0.023694681,0.0013968133],"domain_scores_gemma":[0.8325129,0.04114308,0.012093609,0.01968625,0.091932185,0.002632011],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.091937095,0.0022152783,0.002750596,0.008875633,0.0023923204,0.0062765284,0.008721067,0.006708075,0.0045463773],"category_scores_gemma":[0.1284809,0.0019091709,0.0036877093,0.0046880613,0.0030990427,0.002982595,0.0036918796,0.0067895073,0.0068914294],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005163223,0.0009782385,0.028285852,0.0049809273,0.00032672947,0.00075369666,0.002129193,0.0032680694,0.034093183,0.0142322285,0.1601092,0.7503264],"study_design_scores_gemma":[0.0004274288,0.0021343068,0.16356921,0.022278653,0.0014727841,0.010515855,0.004112674,0.017516254,0.1078128,0.02203313,0.6472737,0.0008531867],"about_ca_topic_score_codex":0.0059304587,"about_ca_topic_score_gemma":0.007846856,"teacher_disagreement_score":0.091937095,"about_ca_system_score_codex":0.002478262,"about_ca_system_score_gemma":0.011261879,"threshold_uncertainty_score":0.48621565},"labels":[],"label_agreement":null},{"id":"W2983732727","doi":"10.1016/j.jaad.2019.11.002","title":"Assessing perceived adverse effects of biologic medications for patients with psoriasis","year":2019,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Janssen Biotech; LEO Pharma; Mylan; Sun Pharma; Regeneron Pharmaceuticals; AbbVie; Celgene; Novartis; Sanofi; Almirall; Merck; Baxter International; GlaxoSmithKline; Wake Forest School of Medicine; Astellas Pharma US; Pfizer; Valeant Pharmaceuticals International; National Psoriasis Foundation; Galderma; Eli Lilly and Company; Boehringer Ingelheim; Merz Therapeutics","keywords":"Medicine; Adverse effect; Apremilast; Family medicine; Psoriasis; Etanercept; Secukinumab; Tazarotene; Dermatology; Internal medicine; Tumor necrosis factor alpha; Psoriatic arthritis","score_opus":0.033731005960379104,"score_gpt":0.37727998660326406,"score_spread":0.34354898064288497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983732727","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.34816167,0.004283813,0.00051117706,0.59978694,0.004235508,0.00013868009,0.00041297488,0.000045290602,0.04242399],"genre_scores_gemma":[0.83214664,0.0024323745,0.0010947046,0.15013586,0.006582284,0.00006513696,0.00013728283,0.00001267507,0.0073930323],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980294,0.0010061087,0.00036229464,0.000076512355,0.00034576285,0.00017995888],"domain_scores_gemma":[0.9933415,0.003956242,0.0007492919,0.0001520645,0.001115419,0.00068539573],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018159758,0.00018169318,0.0003747626,0.000492744,0.0009630967,0.0009942752,0.0002686124,0.0031447995,0.0026721265],"category_scores_gemma":[0.011262373,0.00014544882,0.0003684962,0.0003860912,0.0003028221,0.0005456221,0.00038533282,0.0026416578,0.0007292333],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000713863,0.00064946816,0.7473445,0.00021004211,0.00011629069,0.024050837,0.0018661938,0.00020166756,0.002303868,0.0007041645,0.122386865,0.09945224],"study_design_scores_gemma":[0.0005708618,0.0025922537,0.73251724,0.00088545994,0.00034324315,0.086963885,0.010640096,0.0034925228,0.0020997839,0.003671185,0.15607466,0.00014876347],"about_ca_topic_score_codex":0.0027269803,"about_ca_topic_score_gemma":0.006150479,"teacher_disagreement_score":0.0031447995,"about_ca_system_score_codex":0.0008911607,"about_ca_system_score_gemma":0.0007535754,"threshold_uncertainty_score":0.009603918},"labels":[],"label_agreement":null},{"id":"W2985756236","doi":"10.1016/j.jaad.2019.11.004","title":"Nagashima-type palmoplantar keratosis in Finland caused by a SERPINB7 founder mutation","year":2019,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Skin and Cellular Biology Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Genetics; Helsingin Yliopisto; Universitetet i Oslo; Kungliga Tekniska Högskolan; King's College London; Karolinska Institutet; Suomen Ihotautilääkäriyhdistys; Science for Life Laboratory; Helsingin ja Uudenmaan Sairaanhoitopiiri; Helsinki Institute of Life Science, Helsingin Yliopisto; Oulun Yliopisto; Medical Research Center Oulu","keywords":"Hyperkeratosis; Medicine; Dermatology; Keratosis; Genetics; Biology","score_opus":0.009682926290496682,"score_gpt":0.28884292451816873,"score_spread":0.27915999822767207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985756236","genre_codex":"editorial","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.030808326,0.07969636,0.0025313848,0.36743253,0.511095,0.00012534318,0.00078927336,0.00033540642,0.0071863993],"genre_scores_gemma":[0.1228592,0.06013559,0.0015617585,0.17621697,0.6192777,0.000086026244,0.00057969085,0.00020161344,0.01908137],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.9988838,0.00015097644,0.00028894836,0.00025543827,0.0002030082,0.00021772622],"domain_scores_gemma":[0.99637955,0.0017440345,0.00043817496,0.000078462275,0.0008680433,0.00049172086],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011173493,0.0012290202,0.0020964295,0.0012906848,0.0010353132,0.001553142,0.0020467697,0.007441611,0.004555482],"category_scores_gemma":[0.007341134,0.00071750034,0.00097211543,0.00091999007,0.001192108,0.0017855911,0.000985974,0.005830265,0.0021441518],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006473261,0.00010561626,0.0039706244,0.0034616801,0.0004255118,0.25217965,0.0004975584,0.00027950303,0.0026859224,0.0011301632,0.69876105,0.035855442],"study_design_scores_gemma":[0.00034229277,0.0002562804,0.009786667,0.002547309,0.0010170867,0.31471607,0.0008058788,0.0016830182,0.0030835553,0.0021893329,0.6633372,0.00023526918],"about_ca_topic_score_codex":0.0017472211,"about_ca_topic_score_gemma":0.0022521785,"teacher_disagreement_score":0.007441611,"about_ca_system_score_codex":0.0013017816,"about_ca_system_score_gemma":0.0008860011,"threshold_uncertainty_score":0.015239656},"labels":[],"label_agreement":null},{"id":"W2990095900","doi":"10.1016/j.jaad.2019.06.1313","title":"DaxibotulinumtoxinA for Injection has a prolonged duration of response in the treatment of glabellar lines: Pooled data from two multicenter, randomized, double-blind, placebo-controlled, phase 3 studies (SAKURA 1 and SAKURA 2)","year":2019,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Botulinum Toxin and Related Neurological Disorders","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Revance","keywords":"Medicine; Placebo; Adverse effect; Wrinkle; Multicenter study; Placebo response; Randomized controlled trial; Internal medicine; Surgery; Pathology","score_opus":0.07944808609675488,"score_gpt":0.39549531009595135,"score_spread":0.3160472239991965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2990095900","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.59467,0.38344187,0.0048774,0.0011748482,0.0011950315,0.004219693,0.005988021,0.00031680387,0.0041162795],"genre_scores_gemma":[0.95372623,0.0373113,0.002117344,0.001112363,0.0007786673,0.0016828134,0.002576274,0.000072884024,0.00062207563],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9885958,0.0064519425,0.0019988846,0.0012300081,0.0013308243,0.00039257892],"domain_scores_gemma":[0.9767319,0.011237809,0.008460284,0.0013754625,0.0014921864,0.0007023225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.023847768,0.0017260688,0.0048343926,0.0012326109,0.0005264221,0.0017133036,0.0006816257,0.0014472441,0.004920829],"category_scores_gemma":[0.015534428,0.00073752936,0.01156429,0.0015756043,0.00080101384,0.0011735114,0.00083556026,0.0013574763,0.00037237987],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6568859,0.0022015774,0.019869545,0.026395459,0.19387841,0.000116328185,0.00020428325,0.00083948165,0.0097612785,0.0001548349,0.0027270229,0.08696586],"study_design_scores_gemma":[0.33208326,0.14598931,0.19076724,0.0033844232,0.30841503,0.0007607585,0.00022818336,0.0009834577,0.006243449,0.0004653047,0.010469835,0.0002098262],"about_ca_topic_score_codex":0.00059982704,"about_ca_topic_score_gemma":0.001482642,"teacher_disagreement_score":0.023847768,"about_ca_system_score_codex":0.0007925402,"about_ca_system_score_gemma":0.0010746231,"threshold_uncertainty_score":0.12612057},"labels":[],"label_agreement":null},{"id":"W2991659810","doi":"10.1016/j.jaad.2019.11.040","title":"Maintenance of clinical response and consistent safety profile with up to 3 years of continuous treatment with guselkumab: Results from the VOYAGE 1 and VOYAGE 2 trials","year":2019,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":91,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"Janssen Research and Development; LEO Pharma; Janssen Scientific Affairs; Janssen Pharmaceuticals; Celgene; Amgen; Pfizer; Bristol-Myers Squibb; Eli Lilly and Company; Biogen","keywords":"Medicine; Psoriasis; Adverse effect; Psoriasis Area and Severity Index; Clinical trial; Internal medicine; Placebo; Dermatology; Skin cancer; Surgery; Cancer","score_opus":0.03350037897020353,"score_gpt":0.3140369355287464,"score_spread":0.28053655655854287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2991659810","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96358335,0.031682715,0.00073842553,0.00046550512,0.00011649809,0.00059072685,0.00093630585,0.00006098916,0.0018255026],"genre_scores_gemma":[0.9910307,0.005489483,0.00064386684,0.00051181146,0.00012565815,0.00040711803,0.0010759438,0.000017630495,0.00069780485],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99792457,0.0012311204,0.00021167484,0.0001985346,0.00022431467,0.00020981615],"domain_scores_gemma":[0.9958683,0.0015622533,0.0013839136,0.00047004997,0.00026747107,0.0004480281],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007026053,0.00064743956,0.001869373,0.000327838,0.0003265824,0.0011421181,0.0005858199,0.00117482,0.002084206],"category_scores_gemma":[0.004564764,0.00023846643,0.0023819313,0.00043543315,0.00058217265,0.0010022164,0.00036824544,0.0019605546,0.00029692907],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6345817,0.008708115,0.025751416,0.0035989883,0.008981006,0.00019495423,0.00060687104,0.0011974698,0.01693222,0.00029300473,0.0033717726,0.29578245],"study_design_scores_gemma":[0.43592492,0.34822205,0.18365704,0.00094330305,0.008453633,0.0012332253,0.0003706248,0.0012102933,0.0066940114,0.00072114804,0.0124494,0.000120485136],"about_ca_topic_score_codex":0.0003807563,"about_ca_topic_score_gemma":0.0007983798,"teacher_disagreement_score":0.007026053,"about_ca_system_score_codex":0.00042526168,"about_ca_system_score_gemma":0.0005683936,"threshold_uncertainty_score":0.037157714},"labels":[],"label_agreement":null},{"id":"W2998319702","doi":"10.1016/j.jaad.2019.12.038","title":"Comparison of cumulative clinical benefits of biologics for the treatment of psoriasis over 16 weeks: Results from a network meta-analysis","year":2019,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":61,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"Eli Lilly and Company","keywords":"Medicine; Ixekizumab; Psoriasis Area and Severity Index; Ustekinumab; Secukinumab; Etanercept; Psoriasis; Adalimumab; Infliximab; Cumulative dose; Anakinra; Internal medicine; Dermatology; Psoriatic arthritis; Tumor necrosis factor alpha; Disease","score_opus":0.29854250948539174,"score_gpt":0.4549858454893279,"score_spread":0.15644333600393617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2998319702","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02524208,0.97244734,0.00079076405,0.0001925271,0.00025540162,0.00008836264,0.0006363439,0.00003055829,0.00031666883],"genre_scores_gemma":[0.46526375,0.52832866,0.0024352032,0.0010167123,0.00045177643,0.00027092878,0.0014551305,0.000057962654,0.0007198687],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9965939,0.0018261626,0.0005845019,0.00054452894,0.0003015238,0.00014936764],"domain_scores_gemma":[0.9939593,0.004638013,0.0007748484,0.000240196,0.00026353062,0.00012414859],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005809945,0.002123242,0.01125466,0.0014300606,0.0002456169,0.0017164145,0.001462543,0.0013903507,0.0031418488],"category_scores_gemma":[0.009231656,0.00080915657,0.023855606,0.0020140852,0.0003988194,0.0009249213,0.0009432124,0.002359701,0.00024447043],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.033023175,0.00007925207,0.003777011,0.062990986,0.87535787,0.00008060728,0.00004412519,0.0011015655,0.0004651697,0.00013128787,0.0006479828,0.022300908],"study_design_scores_gemma":[0.005551584,0.0008079186,0.0068634846,0.0026224738,0.98161525,0.00006604793,0.000030493873,0.00036434853,0.00014179703,0.00033650774,0.0015680495,0.000032108615],"about_ca_topic_score_codex":0.0033827834,"about_ca_topic_score_gemma":0.0061520617,"teacher_disagreement_score":0.01125466,"about_ca_system_score_codex":0.0011262376,"about_ca_system_score_gemma":0.00079578074,"threshold_uncertainty_score":0.030726314},"labels":[],"label_agreement":null},{"id":"W2998879831","doi":"10.1016/j.jaad.2019.12.064","title":"Deep cutaneous fungal infections in solid-organ transplant recipients","year":2020,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Fungal Infections and Studies","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Janet D. Cottrelle Foundation; Société Française de Dermatologie et de Pathologie Sexuellement Transmissible; Novartis; Bristol-Myers Squibb; Roche; GlaxoSmithKline; Amgen","keywords":"Medicine; Immunosuppression; Retrospective cohort study; Organ transplantation; Observational study; Histopathology; Dermatology; Antifungal; Phaeohyphomycosis; Transplantation; Surgery; Internal medicine; Pathology","score_opus":0.020026814078341306,"score_gpt":0.3091037124186717,"score_spread":0.2890768983403304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2998879831","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99792635,0.00056932477,0.000037777907,0.00005708451,0.000009391646,0.0000033479218,0.00005096893,0.0000027764088,0.0013429993],"genre_scores_gemma":[0.99943537,0.00023286502,0.000024592575,0.000033014592,0.000020200498,0.000001593601,0.00003605606,8.1755076e-7,0.00021536268],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997168,0.000066044224,0.000025923022,0.000027088732,0.00005064404,0.00011343787],"domain_scores_gemma":[0.99938774,0.00014430707,0.00019788176,0.000020988735,0.00003397162,0.00021507472],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033165468,0.00025958088,0.00019455141,0.0007299759,0.00033726505,0.00094416115,0.0001383171,0.00041892147,0.0025309501],"category_scores_gemma":[0.0014231707,0.00016647157,0.000162346,0.000517301,0.00022839276,0.00045082884,0.00041291758,0.00053667347,0.00025020368],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045582623,0.00018719332,0.9886312,0.000024274068,0.000021532354,0.0022477084,0.0001279242,0.000038360176,0.0010078512,0.00006552368,0.00023062663,0.006962073],"study_design_scores_gemma":[0.00001903233,0.00024981465,0.99137807,0.00002170209,0.000030773284,0.006567729,0.00076039886,0.0001788919,0.00024501764,0.00010609795,0.00043663767,0.000005766215],"about_ca_topic_score_codex":0.0010441262,"about_ca_topic_score_gemma":0.001151975,"teacher_disagreement_score":0.0025309501,"about_ca_system_score_codex":0.00021121831,"about_ca_system_score_gemma":0.00025387763,"threshold_uncertainty_score":0.008466899},"labels":[],"label_agreement":null},{"id":"W2999135678","doi":"10.1016/j.jaad.2020.01.019","title":"Health care regulation, the Food and Drug Administration (FDA), and access to medicine","year":2020,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Food and drug administration; Administration (probate law); Drug; Drug administration; Drug approval; Drug labeling; MEDLINE; Intensive care medicine; Pharmacology; Family medicine","score_opus":0.0698036604122799,"score_gpt":0.4332728433730878,"score_spread":0.3634691829608079,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2999135678","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07874966,0.0436517,0.0010520164,0.6221121,0.0016679515,0.000062932515,0.0005404727,0.000045946705,0.25211716],"genre_scores_gemma":[0.8546374,0.013482993,0.0006490128,0.11290894,0.0037004012,0.000047351376,0.00013528187,0.000031887314,0.014406739],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9896427,0.004115655,0.00070668606,0.00060368754,0.0030361614,0.0018950808],"domain_scores_gemma":[0.93545806,0.04430838,0.007786373,0.0012132295,0.004723219,0.0065107364],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008620685,0.00013061789,0.0003879237,0.0027830694,0.0031973135,0.008302863,0.0008285527,0.009585235,0.030441953],"category_scores_gemma":[0.04762375,0.00023379094,0.0006836984,0.0022193454,0.006171656,0.0046130563,0.0031522377,0.0054865447,0.0008187727],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044840472,0.0012267089,0.121210024,0.00034798603,0.00018159836,0.0008042974,0.0027246983,0.00038560294,0.00072013255,0.6663052,0.1049729,0.10067248],"study_design_scores_gemma":[0.0003031491,0.00044770585,0.21483897,0.0031931715,0.0002637105,0.0017176401,0.008698137,0.0009578789,0.00068107183,0.29330716,0.47539094,0.00020040065],"about_ca_topic_score_codex":0.026879614,"about_ca_topic_score_gemma":0.037614875,"teacher_disagreement_score":0.030441953,"about_ca_system_score_codex":0.005342536,"about_ca_system_score_gemma":0.01061966,"threshold_uncertainty_score":0.10183841},"labels":[],"label_agreement":null},{"id":"W2999366663","doi":"10.1016/j.jaad.2020.01.009","title":"Efficacies and merits of the cotton swab technique for diagnosing tinea capitis in the pediatric population","year":2020,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; University of Ottawa; McGill University","funders":"","keywords":"Medicine; Tinea capitis; Dermatology; Cotton swab; Pathology","score_opus":0.01784585029938778,"score_gpt":0.30758327775953315,"score_spread":0.28973742746014536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2999366663","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7355917,0.027125351,0.0022299297,0.16545561,0.0017795394,0.00016380295,0.0003345877,0.00006990453,0.06724958],"genre_scores_gemma":[0.96539325,0.007933121,0.002951864,0.019280013,0.0024229877,0.00003541154,0.000079269346,0.000022850327,0.0018813313],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972543,0.001481773,0.00030513326,0.00015186977,0.00062411296,0.00018270747],"domain_scores_gemma":[0.9833329,0.013521206,0.00059362897,0.00032675228,0.0018601591,0.0003653531],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035136417,0.00030866748,0.0003817813,0.00063167734,0.00051982736,0.00079430337,0.00045851737,0.0028453844,0.0014641267],"category_scores_gemma":[0.026108585,0.0002677548,0.00043981802,0.00048337723,0.0007184634,0.00077360787,0.00023360313,0.002078916,0.0005316019],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020700374,0.0007496739,0.6916162,0.0004071728,0.00012669819,0.05123798,0.001872094,0.00076176133,0.005862291,0.001541464,0.029124506,0.21463005],"study_design_scores_gemma":[0.00042438033,0.005162121,0.7008714,0.0013595241,0.0005049378,0.20939952,0.005301495,0.0070807296,0.008925786,0.0024685685,0.058364097,0.0001373525],"about_ca_topic_score_codex":0.004998242,"about_ca_topic_score_gemma":0.0062992824,"teacher_disagreement_score":0.004998242,"about_ca_system_score_codex":0.0011896833,"about_ca_system_score_gemma":0.0007860572,"threshold_uncertainty_score":0.018582165},"labels":[],"label_agreement":null},{"id":"W3003274437","doi":"10.1016/j.jaad.2020.01.056","title":"Serlopitant for psoriatic pruritus: A phase 2 randomized, double-blind, placebo-controlled clinical trial","year":2020,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":46,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"LEO Pharma; MedImmune; Galderma; Ortho Dermatologics; Dermira; DUSA Pharmaceuticals; Vanda Pharmaceuticals; Celgene; Valeant Pharmaceuticals International; Kiniksa Pharmaceuticals; AbbVie; Sun Pharma; Regeneron Pharmaceuticals; Abbott Laboratories; Sanofi; Novartis; Pfizer; Amgen","keywords":"Medicine; Double blind; Placebo; Dermatology; Randomized controlled trial; Clinical trial; Internal medicine; Alternative medicine; Pathology","score_opus":0.06953297999972495,"score_gpt":0.37603478330456547,"score_spread":0.3065018033048405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3003274437","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95610577,0.018446246,0.0022293336,0.0022729877,0.002409928,0.010446648,0.0022956668,0.00066443795,0.0051290537],"genre_scores_gemma":[0.96465945,0.009811862,0.0031895628,0.0031066986,0.001155469,0.008704576,0.0017563446,0.00007920282,0.007536915],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.999383,0.00026186465,0.00003256319,0.00014809919,0.00005421903,0.0001203277],"domain_scores_gemma":[0.99934965,0.00019827373,0.000121644654,0.000051364303,0.00004868861,0.00023030666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018718791,0.0025393434,0.004345655,0.00065690605,0.0006006125,0.0013662832,0.0012605721,0.0031332208,0.012644031],"category_scores_gemma":[0.0017749952,0.0009640933,0.0020987,0.00053929526,0.0015533223,0.0017822024,0.00043745598,0.0037048652,0.0019340282],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9790693,0.005010891,0.0001604757,0.0012204623,0.00072136836,0.00004862271,0.00004216944,0.00018669358,0.0024743427,0.00014114873,0.0010486743,0.009875879],"study_design_scores_gemma":[0.9841814,0.014866051,0.00029422852,0.000020309455,0.00014771732,0.000014778262,0.000008211147,0.000101513,0.00008229363,0.00005987914,0.00021747233,0.000006251551],"about_ca_topic_score_codex":0.0008660409,"about_ca_topic_score_gemma":0.0019446884,"teacher_disagreement_score":0.012644031,"about_ca_system_score_codex":0.00062541704,"about_ca_system_score_gemma":0.0010292768,"threshold_uncertainty_score":0.042298496},"labels":[],"label_agreement":null},{"id":"W3004301873","doi":"10.1016/j.jaad.2020.01.044","title":"Placebo tailoring improves patient satisfaction of treatment plans in atopic dermatitis","year":2020,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Behavioral Health and Interventions","field":"Psychology","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Advancing Translational Sciences; Janssen Biotech; LEO Pharma; Mylan; Celgene; Sun Pharma; Regeneron Pharmaceuticals; Novartis; Samsung; National Psoriasis Foundation; Valeant Pharmaceuticals International; AbbVie; Sanofi; Almirall; Merck; GlaxoSmithKline; Galderma; Eli Lilly and Company; Pfizer","keywords":"Scopus; Medicine; Psychological intervention; Atopic dermatitis; Placebo; Patient satisfaction; Alternative medicine; Personalization; MEDLINE; Family medicine; Psychiatry; Nursing; World Wide Web","score_opus":0.04656593320795228,"score_gpt":0.3631188519642183,"score_spread":0.316552918756266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3004301873","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976393,0.0005604652,0.00045001844,0.00024422715,0.000048124162,0.00008190452,0.000061457664,0.000050009203,0.00086454564],"genre_scores_gemma":[0.99884975,0.00016194215,0.0005276751,0.000074737494,0.000035146946,0.000027233973,0.000051972365,0.000004404677,0.00026715512],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99919087,0.000528472,0.000078152465,0.000055582368,0.00010536109,0.00004157238],"domain_scores_gemma":[0.9975012,0.001756848,0.00036891474,0.00012261869,0.000068895766,0.00018157781],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012217194,0.00018748791,0.00062296155,0.00018685061,0.00018857545,0.000353521,0.0002539154,0.00035275373,0.0046223537],"category_scores_gemma":[0.0059632505,0.00011554953,0.00045804365,0.00016795099,0.00015676397,0.00036539786,0.00018282415,0.00070109486,0.00021064734],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19128811,0.04522949,0.04791262,0.00094118173,0.0010619594,0.00015761016,0.00047651326,0.0025963848,0.011477297,0.00035111,0.0028710065,0.69563663],"study_design_scores_gemma":[0.057549108,0.28351134,0.6024654,0.00038618222,0.0025612027,0.000584717,0.00084751745,0.036317613,0.0093604615,0.0024839942,0.003831011,0.0001013642],"about_ca_topic_score_codex":0.00041210416,"about_ca_topic_score_gemma":0.0005244521,"teacher_disagreement_score":0.0046223537,"about_ca_system_score_codex":0.00019991584,"about_ca_system_score_gemma":0.00019066605,"threshold_uncertainty_score":0.015463293},"labels":[],"label_agreement":null},{"id":"W3004669767","doi":"10.1016/j.jaad.2020.01.077","title":"Standard management options for rosacea: The 2019 update by the National Rosacea Society Expert Committee","year":2020,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":231,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Windsor; Western University","funders":"Allergan; National Rosacea Society","keywords":"Rosacea; Medicine; Dermatology","score_opus":0.0352926052350798,"score_gpt":0.38413518569833527,"score_spread":0.34884258046325545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3004669767","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000072875475,0.9966562,0.00010413932,0.0014831533,0.0006706376,0.000025106194,0.00014545498,0.000011244633,0.00083126343],"genre_scores_gemma":[0.0005407549,0.9955928,0.00043625303,0.0023309928,0.0003070785,0.000028426604,0.00020227049,0.000003882602,0.0005575171],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991829,0.00015489967,0.00018299797,0.000078759236,0.00033645672,0.000064021704],"domain_scores_gemma":[0.9976821,0.0010413214,0.0004628826,0.000031120228,0.000669705,0.000112880116],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028139183,0.00093928224,0.0026316552,0.0032881612,0.0003521318,0.0016336839,0.001664158,0.0021002295,0.0059502255],"category_scores_gemma":[0.0039617904,0.00045438824,0.0023496847,0.0022485007,0.00043581377,0.0019057764,0.0010926839,0.003419108,0.002130571],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026637668,0.00008087396,0.00022474909,0.050100707,0.00034660424,0.000085526866,0.00005211019,0.00021648979,0.00061394076,0.00159266,0.1099828,0.83643717],"study_design_scores_gemma":[0.000250155,0.00016031766,0.0018639088,0.06269954,0.001559399,0.0005123476,0.00007032453,0.00013534701,0.0002022647,0.0012969141,0.93121004,0.00003932716],"about_ca_topic_score_codex":0.0051019457,"about_ca_topic_score_gemma":0.012987283,"teacher_disagreement_score":0.0059502255,"about_ca_system_score_codex":0.0016535572,"about_ca_system_score_gemma":0.0040928796,"threshold_uncertainty_score":0.019905448},"labels":[],"label_agreement":null},{"id":"W3004878629","doi":"10.1016/j.jaad.2020.01.066","title":"Retrospective review of delayed adverse events secondary to treatment with a smooth, cohesive 20-mg/mL hyaluronic acid filler in 4500 patients","year":2020,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Facial Rejuvenation and Surgery Techniques","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Hyaluronic acid; Adverse effect; Retrospective cohort study; Incidence (geometry); Surgery; Internal medicine","score_opus":0.013397966689655108,"score_gpt":0.2949270466327506,"score_spread":0.2815290799430955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3004878629","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947155,0.0038522708,0.00017752108,0.000019720295,0.000011773144,0.00004912415,0.00029189698,0.0000062888025,0.00087596494],"genre_scores_gemma":[0.99807405,0.0010173849,0.00015827818,0.00007934862,0.000022943812,0.000029846397,0.00042283683,0.000003998658,0.00019136674],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994923,0.00010231651,0.00015741982,0.00009718278,0.00009749135,0.000053293435],"domain_scores_gemma":[0.997959,0.0006034687,0.00092434185,0.00013157487,0.00021835935,0.00016329503],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043106778,0.00017345778,0.00046391287,0.0007436603,0.0003905499,0.00040462826,0.00024980324,0.00031240666,0.0015169458],"category_scores_gemma":[0.0018555508,0.00016697455,0.0006595354,0.0008575329,0.00022965731,0.00023115949,0.000198725,0.00028698266,0.00026771906],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015705646,0.00021982387,0.97082514,0.00036349648,0.00021884806,0.009744407,0.00021716443,0.00007399705,0.0016645542,0.00006489502,0.00032383276,0.014713243],"study_design_scores_gemma":[0.00012452061,0.0025325075,0.94340825,0.00008613741,0.00050241617,0.04782274,0.00055463775,0.00016980567,0.001388022,0.00003569961,0.0033521554,0.000022952205],"about_ca_topic_score_codex":0.0009405665,"about_ca_topic_score_gemma":0.0008066826,"teacher_disagreement_score":0.0015169458,"about_ca_system_score_codex":0.0004024841,"about_ca_system_score_gemma":0.00042747718,"threshold_uncertainty_score":0.00507468},"labels":[],"label_agreement":null},{"id":"W3005184972","doi":"10.1016/j.jaad.2020.01.072","title":"Efficacy and safety of apremilast in patients with moderate to severe plaque psoriasis of the scalp: Results of a phase 3b, multicenter, randomized, placebo-controlled, double-blind study","year":2020,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":70,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lynde Centre for Dermatology","funders":"Janssen Biotech; Ortho Dermatologics; LEO Pharma; Sanofi Genzyme; GlaxoSmithKline; Australian Renewable Energy Agency; MedImmune; Kyowa Hakko Kirin; Sun Pharma; Dermira; UCB Pharma; Valeant Pharmaceuticals International; Medac; AbbVie; Novartis; Celgene; Regeneron Pharmaceuticals; University of Connecticut; Amgen; Meiji Seika Pharma; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb; Almirall","keywords":"Medicine; Apremilast; Scalp; Placebo; Dermatology; Multicenter study; Double blind; Psoriasis; Randomized controlled trial; Adverse effect; Multicenter trial; Surgery; Internal medicine; Pathology; Alternative medicine","score_opus":0.017344251703946573,"score_gpt":0.27603364919306417,"score_spread":0.25868939748911757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3005184972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889024,0.0066358587,0.00063015794,0.00038207305,0.00022771499,0.0013368067,0.00055327144,0.000113568,0.0012180932],"genre_scores_gemma":[0.9918759,0.002888679,0.0011093924,0.0008011298,0.00043152267,0.0010072009,0.0006140917,0.0000276846,0.0012444083],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9992901,0.00041682055,0.000052858322,0.000089372166,0.000071843926,0.000078934776],"domain_scores_gemma":[0.9988594,0.00041872356,0.00024043059,0.000086378794,0.000075356875,0.00031968128],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021469921,0.0013892011,0.003233305,0.0004082472,0.00047398306,0.00080438517,0.00072332943,0.0017159595,0.0032001368],"category_scores_gemma":[0.0017430518,0.0006678416,0.0014796371,0.00039569795,0.0011008222,0.0011009244,0.00024152348,0.0022569227,0.0005892925],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.95748854,0.009677477,0.0011003552,0.00073045667,0.0007542809,0.00007972087,0.00006737967,0.00027504397,0.008341014,0.000063325235,0.0005527402,0.020869657],"study_design_scores_gemma":[0.8774296,0.11537151,0.0051620933,0.000023221002,0.00036324645,0.00008758368,0.000025493215,0.0003065773,0.00070658926,0.00008707772,0.00041690614,0.00002010678],"about_ca_topic_score_codex":0.00040225068,"about_ca_topic_score_gemma":0.000628317,"teacher_disagreement_score":0.003233305,"about_ca_system_score_codex":0.00031828284,"about_ca_system_score_gemma":0.0007031323,"threshold_uncertainty_score":0.011354506},"labels":[],"label_agreement":null},{"id":"W3005301847","doi":"10.1016/j.jaad.2020.01.068","title":"The bandwagon effect increases acne treatment willingness in teenagers","year":2020,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psychology of Moral and Emotional Judgment","field":"Neuroscience","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Janssen Biotech; LEO Pharma; Mylan; Sun Pharma; Regeneron Pharmaceuticals; Celgene; Novartis; AbbVie; Sanofi; Almirall; Merck; Baxter International; GlaxoSmithKline; Galderma; Eli Lilly and Company; Pfizer; Valeant Pharmaceuticals International; National Psoriasis Foundation; Merz Therapeutics","keywords":"Bandwagon effect; Scopus; Popularity; Medicine; Family medicine; Psychiatry; Psychology; MEDLINE; Social psychology","score_opus":0.05655489366713509,"score_gpt":0.3121525459458436,"score_spread":0.25559765227870845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3005301847","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99875915,0.000120374556,0.000028703504,0.00009610284,0.000015693775,0.000011690619,0.0000058061937,0.0000039499687,0.0009584703],"genre_scores_gemma":[0.9987594,0.0002494167,0.00017818091,0.000125029,0.000018078974,0.000015150403,0.000015308304,0.0000033008453,0.0006361303],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99983585,0.000077415454,0.0000065431864,0.000019843537,0.000035038138,0.000025294226],"domain_scores_gemma":[0.9988777,0.0006749278,0.00017893496,0.000029972754,0.000037516824,0.00020085167],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031720925,0.000106413645,0.00022614718,0.00016177286,0.00025855037,0.00046527915,0.00010911895,0.00039924125,0.0064207823],"category_scores_gemma":[0.0029121672,0.00016482153,0.00025858957,0.000072861905,0.00019240097,0.0002673923,0.00023840256,0.00080673373,0.00024578132],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020029088,0.061298344,0.56935513,0.00065025425,0.0006886546,0.0009310932,0.0028879636,0.00023594563,0.080042884,0.001206886,0.0029234162,0.2597504],"study_design_scores_gemma":[0.0015319934,0.03136704,0.9497186,0.00015346991,0.00042737921,0.0009950548,0.0031127776,0.0011548783,0.0076400163,0.00059820013,0.0032739828,0.000026613256],"about_ca_topic_score_codex":0.00064841437,"about_ca_topic_score_gemma":0.0009434714,"teacher_disagreement_score":0.0064207823,"about_ca_system_score_codex":0.000118943026,"about_ca_system_score_gemma":0.00022113304,"threshold_uncertainty_score":0.021479666},"labels":[],"label_agreement":null},{"id":"W3005791127","doi":"10.1016/j.jaad.2020.02.029","title":"Evaluation of long-term efficacy, safety, and reasons for discontinuation of dupilumab for moderate to severe atopic dermatitis in clinical practice: A retrospective cohort study","year":2020,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Health Sciences Centre; Sunnybrook Health Science Centre; Women's College Hospital; University of Toronto; University of Ottawa","funders":"National Alliance for Accessible Golf; Merck Sharp and Dohme; LEO Pharma; Almirall; Galderma; Celgene; Cardiff University; Spirit AeroSystems; AbbVie; Sanofi; L'Oreal USA; Biotest; Cilag; UCB; Regeneron Pharmaceuticals; Novartis; Pfizer","keywords":"Medicine; Dupilumab; Atopic dermatitis; Eczema Area and Severity Index; Discontinuation; Retrospective cohort study; Dermatology; Randomized controlled trial; Clinical endpoint; Internal medicine","score_opus":0.03993167540193422,"score_gpt":0.40562318392535535,"score_spread":0.36569150852342114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3005791127","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983613,0.00050330296,0.00008265676,0.00026997426,0.000025299687,0.000018332705,0.0004033532,0.000002533843,0.00033311473],"genre_scores_gemma":[0.998858,0.00017212165,0.00010556763,0.0003459601,0.000052831536,0.000021395108,0.00028791107,0.0000024232543,0.00015377223],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979067,0.0006686252,0.00032158176,0.00047454832,0.00034460673,0.00028400857],"domain_scores_gemma":[0.9905391,0.0024625715,0.0042184144,0.0009886452,0.00092389283,0.00086742634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021336472,0.0002851303,0.00054676173,0.0006008515,0.0007436398,0.0011859218,0.00051247934,0.0011240762,0.0014357277],"category_scores_gemma":[0.008250101,0.00044778705,0.0010522953,0.0012160966,0.00043068576,0.0008629851,0.00041318455,0.0012705759,0.00029662377],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003184175,0.0000689025,0.9979297,0.000010805023,0.000116035735,0.00022835057,0.00006633572,0.000009171495,0.000061291976,0.000013833008,0.00018230401,0.000994874],"study_design_scores_gemma":[0.00012228912,0.0006381986,0.9951296,0.00002617351,0.00022843304,0.0024187723,0.00041511247,0.00030625667,0.000056610963,0.00005009435,0.0005929308,0.00001554797],"about_ca_topic_score_codex":0.0048344177,"about_ca_topic_score_gemma":0.0048046447,"teacher_disagreement_score":0.0048344177,"about_ca_system_score_codex":0.00092946336,"about_ca_system_score_gemma":0.0009159353,"threshold_uncertainty_score":0.011283994},"labels":[],"label_agreement":null},{"id":"W3005910897","doi":"10.1016/j.jaad.2020.02.009","title":"Effects of ruxolitinib cream on pruritus and quality of life in atopic dermatitis: Results from a phase 2, randomized, dose-ranging, vehicle- and active-controlled study","year":2020,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":106,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"Janssen Biotech; Genentech; Bausch Health; MedImmune; Sanofi; Kyowa Hakko Kirin; InflaRx; Pfizer; Incyte; Dermira; Astellas Pharma Canada; Coherus Biosciences; Valeant Pharmaceuticals International; Galderma; UCB; Regeneron Pharmaceuticals; Novartis; Celgene; LEO Pharma; Gilead Sciences; GlaxoSmithKline; Merck; Roche; Baxalta; AbbVie; Genzyme; Amgen; Meiji Seika Pharma; Bristol-Myers Squibb","keywords":"Medicine; Atopic dermatitis; Dose-ranging study; Ruxolitinib; Randomized controlled trial; Dermatology; Quality of life (healthcare); Internal medicine; Alternative medicine; Double blind","score_opus":0.020691982840766593,"score_gpt":0.331547145434567,"score_spread":0.3108551625938004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3005910897","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98863375,0.007835443,0.00036472923,0.0002230384,0.00014699456,0.0014476284,0.0005369377,0.000071510214,0.00073987985],"genre_scores_gemma":[0.99079156,0.004515503,0.00081300025,0.0005156003,0.0003087803,0.0015460291,0.0007018731,0.000016089945,0.000791594],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99917835,0.00045008774,0.00006288308,0.00010137579,0.000094696596,0.00011256486],"domain_scores_gemma":[0.99901175,0.00035517412,0.00024197013,0.00008238125,0.00007875971,0.00023000254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002581858,0.0012009019,0.0029203075,0.00046193643,0.00035273205,0.00075520587,0.0007816077,0.0012615463,0.002864221],"category_scores_gemma":[0.001363561,0.0005140469,0.0016929399,0.0003970613,0.0007749407,0.0007155986,0.00023180396,0.0019391766,0.00050632935],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.88917595,0.031639222,0.002405926,0.0016752471,0.0020491572,0.00011447247,0.00009639465,0.0005637324,0.014900099,0.000063328735,0.0010276254,0.056288812],"study_design_scores_gemma":[0.8535478,0.13501494,0.008212893,0.000043247026,0.00088187424,0.00008827661,0.000023074716,0.000421841,0.001179109,0.000040753017,0.0005303054,0.000015910844],"about_ca_topic_score_codex":0.00050002406,"about_ca_topic_score_gemma":0.0010691707,"teacher_disagreement_score":0.0029203075,"about_ca_system_score_codex":0.00051849225,"about_ca_system_score_gemma":0.00063279364,"threshold_uncertainty_score":0.013654351},"labels":[],"label_agreement":null},{"id":"W3007263672","doi":"10.1016/j.jaad.2019.09.072","title":"Melanoma incidence, stage, and survival after solid organ transplant: A population-based cohort study in Ontario, Canada","year":2020,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute for Clinical Evaluative Sciences; Women's College Hospital; University of Toronto","funders":"Ontario Ministry of Health and Long-Term Care; Heart and Stroke Foundation of Canada; Institute for Clinical Evaluative Sciences; Cancer Care Ontario; University of Toronto; Canadian Dermatology Foundation","keywords":"Medicine; Incidence (geometry); Melanoma; Stage (stratigraphy); Cohort; Population; Organ transplantation; Cohort study; Solid organ; Demography; Surgery; Internal medicine; Transplantation; Environmental health","score_opus":0.013485615650329151,"score_gpt":0.27881092861549234,"score_spread":0.2653253129651632,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3007263672","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901412,0.00095931895,0.00011988604,0.0004674689,0.000024835173,0.00006137,0.0058881445,0.000012250564,0.0023254708],"genre_scores_gemma":[0.99582064,0.0006725113,0.00012992791,0.00012387324,0.000009825892,0.00002825778,0.0017005078,0.0000075715516,0.0015068962],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989717,0.00007930268,0.00007966516,0.0001829771,0.00028634106,0.0004000797],"domain_scores_gemma":[0.99775934,0.000106400286,0.00041855252,0.00010955189,0.0010276408,0.0005784229],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006072437,0.000470966,0.00066392537,0.0015223112,0.0039000874,0.0015446969,0.001478585,0.00068505865,0.0023328208],"category_scores_gemma":[0.001729239,0.00077160314,0.0011745492,0.0053460468,0.00085615757,0.00063821475,0.0009844074,0.0009756274,0.00030838922],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009062225,0.00003478091,0.9964477,0.000024497414,0.000089699475,0.00010563326,0.0006837559,0.000060144466,0.00014027204,0.00008181464,0.0011111703,0.0011299804],"study_design_scores_gemma":[0.000018398005,0.000018485869,0.9978522,0.000027206359,0.000049959046,0.00005853758,0.0010002182,0.00014155042,0.000025947595,0.000023149974,0.00077450357,0.000009852879],"about_ca_topic_score_codex":0.9958546,"about_ca_topic_score_gemma":0.997957,"teacher_disagreement_score":0.030052846,"about_ca_system_score_codex":0.030052846,"about_ca_system_score_gemma":0.033478715,"threshold_uncertainty_score":0.2180497},"labels":[],"label_agreement":null},{"id":"W3007972273","doi":"10.1016/j.jaad.2020.02.041","title":"Chronic urticaria in children can be controlled effectively with updosing second-generation antihistamines","year":2020,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Urticaria and Related Conditions","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Children's Hospital","funders":"Canadian Allergy, Asthma and Immunology Foundation","keywords":"Medicine; Angioedema; Chronic urticaria; Cohort; Patient registry; Dermatology; Pediatrics; Internal medicine","score_opus":0.011056838064916247,"score_gpt":0.26460844393406374,"score_spread":0.2535516058691475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3007972273","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.943919,0.023940185,0.0020214089,0.001237012,0.00025071861,0.00008671994,0.00027771748,0.00029616937,0.02797118],"genre_scores_gemma":[0.99209034,0.004360822,0.0010143054,0.0001978771,0.00011326427,0.000029816882,0.00014301024,0.000017604061,0.0020328318],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998672,0.000027508118,0.000012924977,0.000014966263,0.000027747885,0.00004968372],"domain_scores_gemma":[0.99974054,0.00007525845,0.00007211498,0.000014962627,0.000019508358,0.00007760395],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018931391,0.00034028463,0.0005725605,0.00023979384,0.00038051192,0.0002337379,0.00015441976,0.00033656994,0.0020696209],"category_scores_gemma":[0.00095374667,0.00010056813,0.0004708879,0.00017867598,0.0002596039,0.0002910394,0.00023963819,0.00071470166,0.00039503383],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032209165,0.0015283216,0.4477651,0.001911903,0.00025673423,0.06515511,0.0011230872,0.0005703208,0.03534842,0.0014718183,0.015952922,0.4256954],"study_design_scores_gemma":[0.001013504,0.0055172243,0.7827456,0.00057564065,0.0003854688,0.15558712,0.00084375095,0.0009679531,0.009372673,0.0004374468,0.042522874,0.000030730844],"about_ca_topic_score_codex":0.0020123436,"about_ca_topic_score_gemma":0.005603374,"teacher_disagreement_score":0.0020696209,"about_ca_system_score_codex":0.00023613739,"about_ca_system_score_gemma":0.00048331387,"threshold_uncertainty_score":0},"labels":[],"label_agreement":null},{"id":"W3010563098","doi":"10.1016/j.jaad.2019.06.1292","title":"A novel and efficient way to deal with small dog ears","year":2020,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Reconstructive Facial Surgery Techniques","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"","keywords":"Medicine; Mohs surgery; Wound closure; Surgery; Wound healing","score_opus":0.02475544659065353,"score_gpt":0.2917036778143049,"score_spread":0.26694823122365136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010563098","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08501804,0.0025898356,0.899066,0.0005533765,0.00096193276,0.00029599466,0.00018665016,0.0030475962,0.0082806125],"genre_scores_gemma":[0.20713168,0.0011528649,0.7728921,0.0005047671,0.0002993317,0.00020779313,0.00043795496,0.00028485,0.017088654],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99957436,0.000032404972,0.00002756439,0.00010823487,0.00020667913,0.000050797502],"domain_scores_gemma":[0.99965537,0.00007287156,0.000057416262,0.00008530362,0.00008898497,0.000039951232],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000347722,0.00089920044,0.0006630683,0.0011663357,0.0005008407,0.0007837838,0.0010214623,0.0009236804,0.007393661],"category_scores_gemma":[0.00052462186,0.0005855224,0.0007591745,0.00050930795,0.0003303618,0.0018320298,0.0012160792,0.0011068665,0.0029269962],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021128084,0.0003161001,0.0011848357,0.0003481763,0.000054823013,0.00090825796,0.00014443514,0.0012063468,0.7238938,0.0013832978,0.0068445434,0.26350418],"study_design_scores_gemma":[0.00020815793,0.0018777625,0.004093466,0.000085736676,0.0003148967,0.017699903,0.0005016041,0.079112425,0.74161434,0.003312397,0.15093176,0.00024751117],"about_ca_topic_score_codex":0.00021191263,"about_ca_topic_score_gemma":0.00075239217,"teacher_disagreement_score":0.007393661,"about_ca_system_score_codex":0.00013020504,"about_ca_system_score_gemma":0.0003589713,"threshold_uncertainty_score":0.024734259},"labels":[],"label_agreement":null},{"id":"W3014198344","doi":"10.1016/j.jaad.2020.03.074","title":"Framing atopic dermatitis topical medication application site discomfort as a signal of efficacy improves willingness to continue use","year":2020,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Janssen Biotech; LEO Pharma; Mylan; Celgene; Sun Pharma; Regeneron Pharmaceuticals; Novartis; AbbVie; Sanofi; Almirall; Merck; GlaxoSmithKline; Galderma; Eli Lilly and Company; Wake Forest University; Pfizer; Samsung; Valeant Pharmaceuticals International; National Psoriasis Foundation","keywords":"Medicine; Atopic dermatitis; Framing (construction); Dermatology","score_opus":0.013907585514508738,"score_gpt":0.3040367535178532,"score_spread":0.2901291680033445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3014198344","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954602,0.00028415953,0.00023027568,0.00033572863,0.000048694696,0.000026613976,0.00012975126,0.00001467192,0.0034698793],"genre_scores_gemma":[0.9987382,0.000108273634,0.00036984863,0.000120905526,0.00004857384,0.000018660705,0.00007984571,0.0000036441115,0.00051206705],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985843,0.00067000696,0.000086068794,0.00016943419,0.0003360734,0.00015421803],"domain_scores_gemma":[0.98951924,0.0062944316,0.002288502,0.0004091379,0.0007097377,0.0007788383],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020684523,0.00030777595,0.00044927665,0.00044881523,0.0003553988,0.0010794603,0.0002218627,0.00078299694,0.006930137],"category_scores_gemma":[0.01135743,0.00016562923,0.0006235725,0.00027483568,0.000240633,0.00073027506,0.00038220224,0.0011314125,0.0005283059],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040042023,0.003017761,0.9269396,0.00020230026,0.00037012043,0.00010881634,0.000616506,0.0002859905,0.003449487,0.0002908105,0.0010501591,0.059664167],"study_design_scores_gemma":[0.00008793907,0.002531566,0.9926334,0.000053772692,0.00038960608,0.00010612253,0.00047091924,0.001355754,0.0011842628,0.00034979227,0.00081507186,0.000021769436],"about_ca_topic_score_codex":0.00082866644,"about_ca_topic_score_gemma":0.0014223699,"teacher_disagreement_score":0.006930137,"about_ca_system_score_codex":0.00023621036,"about_ca_system_score_gemma":0.00027397962,"threshold_uncertainty_score":0.023183644},"labels":[],"label_agreement":null},{"id":"W3014913078","doi":"10.1016/j.jaad.2020.03.058","title":"Systematic retrospective study of 64 patients with anti-Mi2 dermatomyositis: A classic skin rash with a necrotizing myositis and high risk of malignancy","year":2020,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Inflammatory Myopathies and Dermatomyositis","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Dermatomyositis; Medicine; Rash; Dermatology; Autoantibody; Malignancy; Juvenile dermatomyositis; Myositis; Pathology; Inflammatory myopathy; Antibody; Immunology","score_opus":0.004821080533157802,"score_gpt":0.2222714637287857,"score_spread":0.2174503831956279,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3014913078","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981377,0.0008971209,0.00009285387,0.000025204565,0.000010477658,0.0000313235,0.00035025526,0.0000030720792,0.00045193438],"genre_scores_gemma":[0.9986045,0.0003821964,0.00009826771,0.00012757856,0.000029121189,0.00004554271,0.0004901961,0.0000030297754,0.0002196256],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990305,0.00026255558,0.00021271748,0.0002556837,0.00012806656,0.00011060831],"domain_scores_gemma":[0.99772257,0.0007288137,0.00070672133,0.0002713182,0.00031730963,0.00025325915],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052855496,0.00037169413,0.0008056985,0.0009593625,0.0009185646,0.00050931453,0.00033267532,0.0008243596,0.002318727],"category_scores_gemma":[0.0026986664,0.0007487771,0.00057733845,0.0015267513,0.00046064498,0.0005436474,0.0005686585,0.0003773338,0.00065876835],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038282212,0.00006962075,0.99586856,0.000056943714,0.0000935703,0.0020620876,0.0001311152,0.000011496853,0.0002959044,0.00001029865,0.00014390193,0.00087386544],"study_design_scores_gemma":[0.00014255446,0.00070500263,0.98443353,0.000046812806,0.0003035436,0.012375377,0.00067112,0.00007627371,0.00017220805,0.000033359705,0.0010249875,0.000015210798],"about_ca_topic_score_codex":0.0028832667,"about_ca_topic_score_gemma":0.0028427572,"teacher_disagreement_score":0.0028832667,"about_ca_system_score_codex":0.00040947105,"about_ca_system_score_gemma":0.00062115066,"threshold_uncertainty_score":0.0077569485},"labels":[],"label_agreement":null},{"id":"W3015351665","doi":"10.1016/j.jaad.2020.04.019","title":"The use of noninvasive imaging techniques in the diagnosis of melanoma: a prospective diagnostic accuracy study","year":2020,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Dalhousie Medical Research Foundation","keywords":"Medicine; Melanoma; Diagnostic accuracy; Radiology; Prospective cohort study; Medical imaging; Dermatology; Medical physics; Pathology","score_opus":0.03161479433333561,"score_gpt":0.31510564016083104,"score_spread":0.2834908458274954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3015351665","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99841666,0.0006551654,0.0002564976,0.00003495195,0.000009447189,0.000015896047,0.000108090746,0.0000031528325,0.0005002143],"genre_scores_gemma":[0.9994023,0.0001942505,0.00017268614,0.000018144901,0.000015414864,0.000007854469,0.0001145889,0.0000024580331,0.000072420924],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99725914,0.00091377535,0.0004090372,0.00037494936,0.00080831494,0.00023476803],"domain_scores_gemma":[0.983606,0.007600112,0.0052083707,0.0010993409,0.0018242537,0.00066199887],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034009863,0.00050883944,0.00041470415,0.0017683828,0.00046489143,0.0012094582,0.00063692225,0.0011940736,0.00084874325],"category_scores_gemma":[0.016360935,0.0006738385,0.0008090074,0.0010841122,0.00074155466,0.001462885,0.00069535105,0.00083010324,0.0003935454],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020749055,0.00006822114,0.99874973,0.0000064975957,0.00004084944,0.000046638226,0.000034814613,0.000025817113,0.00013402308,0.000010326661,0.000013373,0.0006622446],"study_design_scores_gemma":[0.000021697177,0.0005526546,0.9966455,0.00001455105,0.00014631447,0.0010482098,0.0001903453,0.00086357485,0.00030042257,0.00003817605,0.00016780556,0.000010767003],"about_ca_topic_score_codex":0.0013108834,"about_ca_topic_score_gemma":0.001402041,"teacher_disagreement_score":0.0034009863,"about_ca_system_score_codex":0.00034601585,"about_ca_system_score_gemma":0.00039435847,"threshold_uncertainty_score":0.017986298},"labels":[],"label_agreement":null},{"id":"W3015461905","doi":"10.1016/j.jaad.2020.04.025","title":"Guselkumab dosing interval optimization in adult patients with psoriasis: A retrospective, multicenter case series","year":2020,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Toronto","funders":"","keywords":"Medicine; Dosing; Psoriasis; Dermatology; Ustekinumab; Placebo; Adalimumab; Internal medicine; Surgery; Pathology; Disease","score_opus":0.008962762758613624,"score_gpt":0.26352306138155557,"score_spread":0.25456029862294194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3015461905","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919802,0.002283574,0.0005250189,0.0014115238,0.000072486895,0.000023567072,0.0001291642,0.000013831397,0.0035605775],"genre_scores_gemma":[0.9983139,0.00051479926,0.00020478285,0.0005318077,0.00013607515,0.000006079574,0.00008636192,0.000004816077,0.00020143522],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99926883,0.00019239156,0.00013108584,0.00015289136,0.00011814462,0.00013672405],"domain_scores_gemma":[0.99805546,0.0007062523,0.00069795165,0.00016574895,0.00014654647,0.00022810748],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048114336,0.00031099303,0.00047740585,0.0005320307,0.0006568995,0.0010038796,0.00032855824,0.0013112712,0.0016633841],"category_scores_gemma":[0.0027813665,0.00034011662,0.000495453,0.0008452732,0.0006064068,0.00095587346,0.00030849216,0.0009409676,0.00039413068],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003911639,0.00019092279,0.7869876,0.00005307198,0.00009999847,0.200492,0.00025556577,0.00012641172,0.0011025037,0.00023964832,0.002005322,0.008055797],"study_design_scores_gemma":[0.00009623716,0.0004499244,0.19117863,0.000061115206,0.0001856533,0.8013565,0.0014553735,0.0010179023,0.0006096029,0.00039123264,0.0031712507,0.000026637708],"about_ca_topic_score_codex":0.00081764295,"about_ca_topic_score_gemma":0.0009712106,"teacher_disagreement_score":0.0016633841,"about_ca_system_score_codex":0.00045446385,"about_ca_system_score_gemma":0.0004474101,"threshold_uncertainty_score":0.0055645704},"labels":[],"label_agreement":null},{"id":"W3015567270","doi":"10.1016/j.jaad.2020.04.013","title":"Limited utility of repeated vital sign monitoring during initiation of oral propranolol for complicated infantile hemangioma","year":2020,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Vascular Malformations and Hemangiomas","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","keywords":"Medicine; Propranolol; Adverse effect; Discontinuation; Bradycardia; Asymptomatic; Infantile hemangioma; Vital signs; Heart rate; Anesthesia; Hemangioma; Pediatrics; Surgery; Internal medicine; Blood pressure","score_opus":0.04520064669932528,"score_gpt":0.3211954607519851,"score_spread":0.2759948140526598,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3015567270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9720353,0.013608496,0.0033669127,0.0022986555,0.0002611599,0.00006800611,0.00017278975,0.00022902213,0.007959692],"genre_scores_gemma":[0.99742067,0.0012754744,0.0008402283,0.00019914015,0.00011868701,0.00000879302,0.000051329633,0.000012495782,0.00007321563],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993868,0.00019759682,0.000104996434,0.00006067647,0.00016633022,0.00008366568],"domain_scores_gemma":[0.99360234,0.004016695,0.0007970197,0.00031545668,0.0005879999,0.000680465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008566477,0.000620054,0.0007366011,0.00095331913,0.0002838736,0.00086138106,0.00054987316,0.0007098524,0.0006492646],"category_scores_gemma":[0.010720355,0.0002057522,0.00037546275,0.00054716575,0.00042448746,0.00083552045,0.00023576866,0.0012928593,0.00026479343],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045264587,0.0004877927,0.6171977,0.0005464072,0.0002095237,0.16854206,0.00064552587,0.0016963662,0.025806768,0.00042920397,0.002913349,0.17699881],"study_design_scores_gemma":[0.00043430604,0.003714039,0.62530154,0.0015410269,0.0010843511,0.30738685,0.0017074196,0.019589584,0.02825391,0.0010248891,0.009816314,0.00014577623],"about_ca_topic_score_codex":0.0011477984,"about_ca_topic_score_gemma":0.0020800657,"teacher_disagreement_score":0.0011477984,"about_ca_system_score_codex":0.000541472,"about_ca_system_score_gemma":0.0010819306,"threshold_uncertainty_score":0.0045304894},"labels":[],"label_agreement":null},{"id":"W3015912305","doi":"10.1016/j.jaad.2020.04.029","title":"Reply to: “Comment on ‘Efficacies and merits of the cotton swab technique for diagnosing tinea capitis in the pediatric population’”","year":2020,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; University of Ottawa; McGill University","funders":"","keywords":"Medicine; Tinea capitis; Dermatology; Cotton swab; Pathology","score_opus":0.02038155435629196,"score_gpt":0.31632222510149505,"score_spread":0.2959406707452031,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3015912305","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00042606454,0.00046894728,0.000052777657,0.98665816,0.011217745,0.000009751783,0.00007030203,0.00002157291,0.001074783],"genre_scores_gemma":[0.0018974099,0.00020349452,0.00008129644,0.98630816,0.0096041635,0.00001711359,0.000020445947,0.000011957733,0.0018559363],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961606,0.0008540995,0.0005974933,0.0006452704,0.0009314597,0.000811051],"domain_scores_gemma":[0.9886285,0.005735788,0.0011892975,0.0002733619,0.0026408604,0.0015321575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003614069,0.000879776,0.0013334963,0.0009091981,0.003886734,0.0029887382,0.0024873093,0.06481409,0.0058946665],"category_scores_gemma":[0.029565096,0.0012353673,0.0013727203,0.00085975876,0.002760295,0.0031105531,0.0016608941,0.040949166,0.006350962],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006878996,0.000025745017,0.0011726277,0.000047538888,0.000015542388,0.0015646194,0.00021099995,0.000043545868,0.00016835799,0.0007681202,0.9934592,0.0024547873],"study_design_scores_gemma":[0.0001844488,0.00012306453,0.0063621067,0.00052375474,0.00008601348,0.003591842,0.0013440024,0.0005468899,0.00077896984,0.0046424274,0.9816429,0.00017358872],"about_ca_topic_score_codex":0.01677549,"about_ca_topic_score_gemma":0.021078942,"teacher_disagreement_score":0.06481409,"about_ca_system_score_codex":0.0051740427,"about_ca_system_score_gemma":0.0054136585,"threshold_uncertainty_score":0.037540495},"labels":[],"label_agreement":null},{"id":"W3016897715","doi":"10.1016/j.jaad.2020.04.046","title":"COVID-19 and racial disparities","year":2020,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"COVID-19 and Mental Health","field":"Psychology","cited_by":146,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre; University of Toronto","funders":"","keywords":"Medicine; Coronavirus disease 2019 (COVID-19); 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Betacoronavirus; Coronavirus Infections; MEDLINE; Pandemic; Virology; Internal medicine; Outbreak; Infectious disease (medical specialty); Disease","score_opus":0.06503730290139309,"score_gpt":0.41995675541416666,"score_spread":0.35491945251277357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3016897715","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002831062,0.0025922325,0.00002602217,0.95633465,0.011016763,0.00001984015,0.00008609108,0.000012131302,0.027081262],"genre_scores_gemma":[0.032864977,0.00278642,0.00014721019,0.91240484,0.02843119,0.00007281979,0.00010409659,0.00002518359,0.023163227],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99617577,0.001082922,0.00035686753,0.0002993931,0.0008477665,0.001237302],"domain_scores_gemma":[0.9877752,0.004249763,0.0008933127,0.00040433166,0.0015934563,0.0050839367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0051211943,0.00042113688,0.000856333,0.0011093398,0.011818309,0.0043601706,0.001269237,0.032606993,0.02313531],"category_scores_gemma":[0.01857299,0.00044740157,0.0010085169,0.00075384043,0.0031634083,0.002531747,0.0039986977,0.02052591,0.003977072],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006239454,0.00019929688,0.0100301495,0.00005623539,0.000017739165,0.0010477284,0.0004347497,0.000030498264,0.000119609205,0.009444959,0.9612228,0.017333876],"study_design_scores_gemma":[0.0002493213,0.00012203975,0.029967828,0.0011580035,0.00008341315,0.0017890622,0.0035632332,0.0003759666,0.00026535784,0.01718518,0.94515896,0.00008159091],"about_ca_topic_score_codex":0.042087633,"about_ca_topic_score_gemma":0.111978374,"teacher_disagreement_score":0.042087633,"about_ca_system_score_codex":0.005546594,"about_ca_system_score_gemma":0.01252441,"threshold_uncertainty_score":0.08368534},"labels":[],"label_agreement":null},{"id":"W3017839166","doi":"10.1016/j.jaad.2020.04.104","title":"The Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD): The development and reliability testing of a novel clinical outcome measurement instrument for the severity of atopic dermatitis","year":2020,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":178,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"Samsung Bioepis; Cilag; Maruho; Merck Sharp and Dohme; LEO Pharma; Medac; AbbVie; Glenmark Pharmaceuticals; Fresenius Medical Care North America; Janssen Biotech; Les Laboratories Pierre Fabre; Galápagos; Valeant Pharmaceuticals International; Sun Pharma; School of Public Health, University of California Berkeley; Miltenyi Biotec; Regeneron Pharmaceuticals; Kiniksa Pharmaceuticals; Pfizer; Biogen; Novartis; Celgene; Procter and Gamble; Sanofi; GlaxoSmithKline; Boehringer Ingelheim; Amgen; Almirall; Galderma; Asana Biosciences; Bristol-Myers Squibb; Eli Lilly and Company","keywords":"Atopic dermatitis; Medicine; Reliability (semiconductor); Dermatology","score_opus":0.12205902178998883,"score_gpt":0.38606146932039453,"score_spread":0.2640024475304057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3017839166","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9619854,0.0027768952,0.023386477,0.0003488244,0.00030808107,0.0025851068,0.003033617,0.00022066878,0.0053550024],"genre_scores_gemma":[0.9613553,0.00090024906,0.031118382,0.00027055756,0.00013106063,0.0018955444,0.0031048113,0.00007277696,0.001151289],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99032813,0.004074852,0.0009960968,0.00090139045,0.0034474996,0.0002521132],"domain_scores_gemma":[0.99088144,0.0035517374,0.0022687914,0.0005841518,0.0024471642,0.00026672398],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012747114,0.00065320206,0.0009240347,0.0013837899,0.0004388535,0.0008235717,0.0008212974,0.00070942193,0.00082974613],"category_scores_gemma":[0.015190447,0.0002450202,0.0012636436,0.0008716036,0.00049980415,0.0009058102,0.0014282587,0.0012027136,0.00035282993],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028525123,0.0013726071,0.8073249,0.00047232085,0.001112569,0.00011430841,0.0008632632,0.0019322777,0.008724189,0.00091905595,0.003349552,0.17096242],"study_design_scores_gemma":[0.00060888147,0.0041009886,0.978323,0.00013096312,0.0003866579,0.0006716291,0.00026041054,0.006028479,0.0035573712,0.00072796474,0.0051376023,0.00006603547],"about_ca_topic_score_codex":0.001210137,"about_ca_topic_score_gemma":0.0027179306,"teacher_disagreement_score":0.012747114,"about_ca_system_score_codex":0.00055176136,"about_ca_system_score_gemma":0.0010142032,"threshold_uncertainty_score":0.067413986},"labels":[],"label_agreement":null},{"id":"W3018008580","doi":"10.1016/j.jaad.2020.04.069","title":"Machine learning for prediction of cutaneous adverse events in patients receiving anti–PD-1 immunotherapy","year":2020,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Adverse effect; Scopus; Immunotherapy; Dermatology; MEDLINE; Internal medicine; Oncology; Cancer","score_opus":0.014631323788627252,"score_gpt":0.28029141604083807,"score_spread":0.2656600922522108,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3018008580","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98834026,0.0017587346,0.006610526,0.0005321449,0.00010510355,0.00005161366,0.0013319821,0.000091824404,0.0011778625],"genre_scores_gemma":[0.9964862,0.00024693058,0.0018645736,0.000054002514,0.00007987161,0.000021474589,0.0009382745,0.0000038688468,0.00030480843],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992085,0.00034213046,0.00009427998,0.00014862952,0.000111838584,0.00009453117],"domain_scores_gemma":[0.9957616,0.0030293842,0.0006315649,0.00012629412,0.00026417014,0.00018697485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018040068,0.00045373035,0.0007785892,0.0008958776,0.00021955506,0.0009204505,0.0004475387,0.00056099624,0.0013968952],"category_scores_gemma":[0.0058874898,0.0001676676,0.000770397,0.00043275708,0.0001402015,0.0004195387,0.00034133263,0.0011250424,0.00028848872],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002612351,0.00071360613,0.8572676,0.00011960591,0.000555124,0.00018928852,0.00003507284,0.03370768,0.0010346149,0.00023101168,0.0027269078,0.10080707],"study_design_scores_gemma":[0.0001686932,0.0010104462,0.22881469,0.00006517691,0.00036194117,0.00050918636,0.00007706827,0.76468384,0.0014510953,0.001389463,0.0014370065,0.000031344985],"about_ca_topic_score_codex":0.0012250843,"about_ca_topic_score_gemma":0.0014532718,"teacher_disagreement_score":0.0018040068,"about_ca_system_score_codex":0.00034015556,"about_ca_system_score_gemma":0.00036050892,"threshold_uncertainty_score":0.0095406175},"labels":[],"label_agreement":null},{"id":"W3020100058","doi":"10.1016/j.jaad.2020.04.111","title":"Risks of hydroxychloroquine use for COVID-19 prophylaxis","year":2020,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"COVID-19 Clinical Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Hydroxychloroquine; Medicine; Coronavirus disease 2019 (COVID-19); 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Betacoronavirus; Pandemic; Virology; Pre-exposure prophylaxis; MEDLINE; Coronavirus Infections; Intensive care medicine; Internal medicine; Outbreak; Human immunodeficiency virus (HIV)","score_opus":0.18268066281291132,"score_gpt":0.48652279664244974,"score_spread":0.3038421338295384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3020100058","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.034417074,0.008603965,0.00032672996,0.87896186,0.0058938256,0.00007818527,0.0003457716,0.000026646088,0.07134598],"genre_scores_gemma":[0.33127028,0.007029855,0.0010656391,0.6128004,0.02299322,0.00011316811,0.00027024045,0.000026355608,0.024430739],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.993361,0.0042532403,0.0005545258,0.00020418919,0.0012209723,0.00040602952],"domain_scores_gemma":[0.9783684,0.015333208,0.002051771,0.0005380661,0.0015983718,0.002110149],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004510045,0.00022243397,0.00046452935,0.0005706566,0.0017531901,0.0015047889,0.00059995486,0.0116834305,0.0061683687],"category_scores_gemma":[0.027064996,0.00020248763,0.0004501643,0.0004917404,0.0008163568,0.00079875166,0.00063367415,0.0040941043,0.001328722],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017492248,0.0007336618,0.15278244,0.00044077553,0.00013986173,0.030919133,0.0010098506,0.00023241053,0.0019030948,0.015126338,0.6794861,0.11547721],"study_design_scores_gemma":[0.00088022236,0.0016867126,0.06468327,0.0019898084,0.00021924346,0.066569015,0.0019147109,0.0010370249,0.001744016,0.016116288,0.8430677,0.00009192356],"about_ca_topic_score_codex":0.0034177857,"about_ca_topic_score_gemma":0.00793069,"teacher_disagreement_score":0.0116834305,"about_ca_system_score_codex":0.0015165891,"about_ca_system_score_gemma":0.0026191615,"threshold_uncertainty_score":0.023851693},"labels":[],"label_agreement":null},{"id":"W3022235427","doi":"10.1016/j.jaad.2010.11.020","title":"Guidelines for the Diagnosis and Management of Food Allergy in the United States: Summary of the NIAID-Sponsored Expert Panel Report","year":2010,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Food Allergy and Anaphylaxis Research","field":"Medicine","cited_by":130,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Food allergy; Medicine; Natural history; Guideline; Eosinophilic esophagitis; Allergy; Asthma; Epidemiology; Environmental health; Oral food challenge; Pediatrics; Family medicine; Immunology; Disease; Pathology; Internal medicine","score_opus":0.0944075752458631,"score_gpt":0.39123091687927575,"score_spread":0.2968233416334126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3022235427","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008425826,0.5284699,0.045737084,0.314792,0.024329912,0.005753687,0.014295955,0.0018383549,0.056357145],"genre_scores_gemma":[0.046202734,0.44579014,0.31098244,0.102154486,0.016625043,0.007638605,0.041486163,0.0004971753,0.028623281],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99171185,0.002448423,0.0020033175,0.00035349914,0.0030297432,0.0004531653],"domain_scores_gemma":[0.9695367,0.0048948983,0.003437345,0.0003257824,0.020184146,0.0016210804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013841743,0.0020166375,0.0035865256,0.005610909,0.0015024601,0.0027244398,0.0072101736,0.0075515066,0.0040405025],"category_scores_gemma":[0.021568783,0.0011284874,0.005139343,0.0040705996,0.0011638852,0.002059408,0.0015211804,0.009838005,0.0030604838],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027120064,0.00063561805,0.006960948,0.0039686165,0.00034087658,0.0006708923,0.00029178776,0.0017452454,0.0009431914,0.0017962976,0.7394365,0.24293879],"study_design_scores_gemma":[0.0009797837,0.00047062524,0.03720356,0.03489465,0.0020539851,0.003162541,0.0009400838,0.0038430388,0.0015905765,0.0041405605,0.91046536,0.0002553307],"about_ca_topic_score_codex":0.043419342,"about_ca_topic_score_gemma":0.061066356,"teacher_disagreement_score":0.043419342,"about_ca_system_score_codex":0.0036826932,"about_ca_system_score_gemma":0.014038208,"threshold_uncertainty_score":0.086333215},"labels":[],"label_agreement":null},{"id":"W3023416951","doi":"10.1016/j.jaad.2020.04.142","title":"Hidradenitis suppurativa: The importance of virtual outpatient care during COVID-19 pandemic","year":2020,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre; University of Toronto","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; Hidradenitis Suppurativa Foundation; AbbVie","keywords":"Medicine; Hidradenitis suppurativa; Coronavirus disease 2019 (COVID-19); Pandemic; 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Betacoronavirus; MEDLINE; Coronavirus Infections; Dermatology; Virology; Intensive care medicine; Internal medicine; Disease; Infectious disease (medical specialty)","score_opus":0.03183722240489702,"score_gpt":0.3230729319795025,"score_spread":0.2912357095746055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3023416951","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004577875,0.0010516219,0.00009237311,0.9762299,0.0080211265,0.000015936343,0.000020179788,0.0000148225945,0.009976264],"genre_scores_gemma":[0.06221693,0.0018399203,0.00045913988,0.8886967,0.037192658,0.000038922364,0.000021713222,0.000032066353,0.009501934],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99826753,0.0006811602,0.0001782777,0.00014893274,0.00027496807,0.00044909932],"domain_scores_gemma":[0.99587315,0.0015798679,0.00035286546,0.000107703876,0.00050601637,0.0015804195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019065149,0.00032911505,0.00046198885,0.0003093613,0.004980199,0.0027880087,0.00084828807,0.029042816,0.0051562195],"category_scores_gemma":[0.010307025,0.00037487372,0.00056063087,0.00025030534,0.0020271384,0.002913228,0.0016854071,0.022030646,0.0011420626],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012888381,0.00017399291,0.012285004,0.00011826571,0.000021687112,0.09561287,0.0021401036,0.00020277992,0.0010612811,0.0079778135,0.85880125,0.021476058],"study_design_scores_gemma":[0.00015566636,0.00020722751,0.011763231,0.001142994,0.00003550279,0.0691402,0.009428636,0.0017551256,0.0003371519,0.010580382,0.8953383,0.000115531686],"about_ca_topic_score_codex":0.00921552,"about_ca_topic_score_gemma":0.021692779,"teacher_disagreement_score":0.029042816,"about_ca_system_score_codex":0.0035447127,"about_ca_system_score_gemma":0.0046859686,"threshold_uncertainty_score":0.025718868},"labels":[],"label_agreement":null},{"id":"W3024836372","doi":"10.1016/j.jaad.2020.05.027","title":"Optimizing care for atopic dermatitis patients during the COVID-19 pandemic","year":2020,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"School of Public Health, University of California Berkeley; Sun Pharma; Dermira; AbbVie; Sanofi; Regeneron Pharmaceuticals; Novartis; Pfizer; Eli Lilly and Company","keywords":"Medicine; Atopic dermatitis; Dupilumab; Coronavirus disease 2019 (COVID-19); Placebo; Dermatology; Pandemic; Randomized controlled trial; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Coronavirus; Quality of life (healthcare); Disease; Internal medicine; Alternative medicine; Infectious disease (medical specialty); Pathology","score_opus":0.025685747450466305,"score_gpt":0.314672878353456,"score_spread":0.28898713090298966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3024836372","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00798057,0.001273664,0.00007795206,0.9758414,0.0041730916,0.000027700746,0.000035911587,0.000016215728,0.010573551],"genre_scores_gemma":[0.09205717,0.0037055728,0.0008385812,0.8755544,0.019481251,0.000094860676,0.000059811453,0.000039789244,0.008168565],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983693,0.0005945299,0.0001371505,0.00010155564,0.0001578671,0.00063978945],"domain_scores_gemma":[0.995611,0.00080002024,0.00036708426,0.00006636374,0.00049087394,0.0026646242],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012071352,0.00028954624,0.00042361068,0.0003517619,0.004932272,0.0023908198,0.0008274608,0.011891507,0.00708098],"category_scores_gemma":[0.009872003,0.00029226815,0.0005270959,0.0002593565,0.0011218163,0.0020895556,0.0024496207,0.012193047,0.0013896141],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000112128495,0.0003467732,0.03482797,0.00013590249,0.000029818078,0.018806597,0.0023584017,0.00023782648,0.0007890109,0.00365131,0.89532816,0.043376114],"study_design_scores_gemma":[0.00026276012,0.0005660219,0.061159488,0.0030539804,0.00012167895,0.029327493,0.029075252,0.0017298531,0.0006361571,0.019921664,0.8539919,0.0001537477],"about_ca_topic_score_codex":0.018812818,"about_ca_topic_score_gemma":0.041967228,"teacher_disagreement_score":0.018812818,"about_ca_system_score_codex":0.0034212489,"about_ca_system_score_gemma":0.008950285,"threshold_uncertainty_score":0.037406623},"labels":[],"label_agreement":null},{"id":"W3025029990","doi":"10.1016/j.jaad.2020.05.074","title":"Hydroxychloroquine effects on psoriasis: A systematic review and a cautionary note for COVID-19 treatment","year":2020,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Psoriasis; Hydroxychloroquine; Medicine; Exacerbation; Adverse effect; Dermatology; Internal medicine; Coronavirus disease 2019 (COVID-19); Disease","score_opus":0.033956187007473985,"score_gpt":0.34790483479555245,"score_spread":0.31394864778807846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3025029990","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018710915,0.998623,0.00005217941,0.0005241389,0.0002510978,0.000057107365,0.00014712624,0.000006442095,0.00015178797],"genre_scores_gemma":[0.0058424002,0.99038106,0.000568634,0.0026062632,0.00018426625,0.00008643389,0.00012269124,0.000006587177,0.00020165308],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99456465,0.0017687073,0.0021189982,0.0003970058,0.00093634904,0.00021420278],"domain_scores_gemma":[0.9842465,0.010128917,0.0035348623,0.00030049338,0.0015104519,0.00027880128],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009952305,0.0009695861,0.0081490725,0.0038029782,0.00040951572,0.0028526832,0.0020147928,0.002629711,0.006815674],"category_scores_gemma":[0.019538285,0.0008462782,0.007662691,0.0039276187,0.0007211373,0.001760319,0.001502174,0.0021093113,0.0005212419],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061566435,0.000024570845,0.0005329925,0.8705916,0.019940883,0.00015245091,0.0001517849,0.000118329306,0.00042217193,0.000448915,0.014062572,0.09293811],"study_design_scores_gemma":[0.0015754206,0.00035429627,0.0050855395,0.7070145,0.16005653,0.000442796,0.0002697698,0.0001600378,0.0002477074,0.0009145284,0.12380154,0.0000773569],"about_ca_topic_score_codex":0.008551104,"about_ca_topic_score_gemma":0.04501336,"teacher_disagreement_score":0.009952305,"about_ca_system_score_codex":0.0026914275,"about_ca_system_score_gemma":0.008486732,"threshold_uncertainty_score":0.052633464},"labels":[],"label_agreement":null},{"id":"W3025991462","doi":"10.1016/j.jaad.2020.05.037","title":"Reply to: “Skin damage among health care workers managing coronavirus disease 2019”","year":2020,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Infection Control and Ventilation","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Personal protective equipment; Medicine; Coronavirus disease 2019 (COVID-19); Health care; Pandemic; Clothing; Disease; Dermatology; Family medicine; Medical emergency; Infectious disease (medical specialty); Pathology","score_opus":0.022651616839038307,"score_gpt":0.33403337803908845,"score_spread":0.3113817612000501,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3025991462","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010657889,0.0004086093,0.000045907585,0.9827161,0.013226311,0.000017409506,0.00009466129,0.000019402862,0.0024056712],"genre_scores_gemma":[0.0047021196,0.000271218,0.0000817218,0.9779348,0.012076629,0.000033937755,0.000039608145,0.000011061574,0.004848883],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99758255,0.00066859863,0.00030748863,0.00027960338,0.00048726276,0.0006745154],"domain_scores_gemma":[0.9931651,0.002904404,0.0006437068,0.00017750658,0.0014494901,0.0016597783],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025353779,0.00071758346,0.00080067886,0.0007703842,0.005187483,0.0030548237,0.0016413297,0.056664787,0.007787942],"category_scores_gemma":[0.017379493,0.000887571,0.00090340164,0.00052710925,0.0015449529,0.0022818497,0.001678435,0.025365103,0.004859038],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009529172,0.000056829154,0.0027191935,0.00005478759,0.000019458976,0.0024570012,0.00036744084,0.000041842613,0.00024674187,0.00071801216,0.98968923,0.0035342472],"study_design_scores_gemma":[0.00023640382,0.00024913606,0.012842069,0.00089830026,0.00011959004,0.0034635598,0.003586518,0.00075002486,0.0006230485,0.004062509,0.97298765,0.00018123204],"about_ca_topic_score_codex":0.013796838,"about_ca_topic_score_gemma":0.019243836,"teacher_disagreement_score":0.056664787,"about_ca_system_score_codex":0.0035905032,"about_ca_system_score_gemma":0.0056443247,"threshold_uncertainty_score":0.027433038},"labels":[],"label_agreement":null},{"id":"W3027636528","doi":"10.1016/j.jaad.2020.05.091","title":"Association between psoriasis and risk of dementia: A systematic review and meta-analysis","year":2020,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto; McMaster University; Hamilton Health Sciences","funders":"Regeneron Pharmaceuticals; Sanofi","keywords":"Medicine; Psoriasis; Dementia; Meta-analysis; Etiology; Systematic review; Association (psychology); MEDLINE; Neuroinflammation; Psychiatry; Dermatology; Disease; Pathology; Psychotherapist; Psychology","score_opus":0.04289654479483503,"score_gpt":0.31919215038933024,"score_spread":0.27629560559449523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3027636528","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006602087,0.99200284,0.00038975207,0.00012546692,0.00012282678,0.000115510935,0.00045011245,0.000025188016,0.00016615707],"genre_scores_gemma":[0.18941584,0.80610734,0.0019328888,0.000930195,0.00023672977,0.0002924395,0.0006205299,0.0000311536,0.00043283383],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9972355,0.0009991154,0.00085168367,0.0004412596,0.00028366898,0.00018887599],"domain_scores_gemma":[0.99364567,0.0041967663,0.0012559652,0.00028171937,0.0004830499,0.000136917],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004897721,0.0024504762,0.013747008,0.0032930814,0.0005565592,0.002446279,0.0021310546,0.0025388037,0.004913946],"category_scores_gemma":[0.0123109585,0.001667256,0.025250668,0.005111459,0.0006275525,0.0015266619,0.0016740494,0.0019667046,0.000429269],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028622746,0.000050790262,0.0062267235,0.2973475,0.6790335,0.00024227283,0.000112067755,0.00037745092,0.000336148,0.000106567975,0.0008652715,0.012439493],"study_design_scores_gemma":[0.00060709694,0.00013417956,0.0047729383,0.009597313,0.9832651,0.00011622255,0.000045552533,0.00011089589,0.000063945175,0.000118416996,0.0011392424,0.000029094263],"about_ca_topic_score_codex":0.007932274,"about_ca_topic_score_gemma":0.023709672,"teacher_disagreement_score":0.013747008,"about_ca_system_score_codex":0.0014468845,"about_ca_system_score_gemma":0.002386511,"threshold_uncertainty_score":0.025901973},"labels":[],"label_agreement":null},{"id":"W3031554237","doi":"10.1016/j.jaad.2020.05.105","title":"Bimekizumab for patients with moderate to severe plaque psoriasis: 60-week results from BE ABLE 2, a randomized, double-blinded, placebo-controlled, phase 2b extension study","year":2020,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":61,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; University of Toronto","funders":"UCB","keywords":"Medicine; Double blinded; Placebo; Plaque psoriasis; Randomized controlled trial; Blinded study; Dermatology; Psoriasis; Physical therapy; Surgery; Pathology; Alternative medicine","score_opus":0.03360327941764896,"score_gpt":0.2916476084855545,"score_spread":0.25804432906790553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3031554237","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98187476,0.00936859,0.00070287444,0.0008625841,0.00051399623,0.001867183,0.0017806839,0.00020730082,0.0028220888],"genre_scores_gemma":[0.98088765,0.0054380936,0.001606918,0.0021375683,0.00065628125,0.0021471137,0.0019925763,0.00006174515,0.0050720135],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99949074,0.00021281894,0.000031172898,0.000085398555,0.000059600457,0.000120176555],"domain_scores_gemma":[0.9993956,0.0001428551,0.00012637013,0.000064060434,0.000044050314,0.00022701525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018711399,0.0016061286,0.0032370845,0.00041611292,0.00048456655,0.0011709643,0.00075926457,0.0018277055,0.005452625],"category_scores_gemma":[0.001321792,0.00069896237,0.0021755542,0.00030409216,0.00071983953,0.0010580699,0.00039080053,0.003019162,0.0011155556],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.94642234,0.010858128,0.0008968081,0.0009566738,0.0010801736,0.0000650557,0.00008011983,0.000331844,0.007891603,0.00008322655,0.0019701228,0.029363977],"study_design_scores_gemma":[0.9545789,0.03945963,0.004030524,0.000034481112,0.00043777234,0.000042435913,0.000019220457,0.00017756406,0.0004049752,0.00008734322,0.0007123194,0.00001482413],"about_ca_topic_score_codex":0.00083433546,"about_ca_topic_score_gemma":0.0015020359,"teacher_disagreement_score":0.005452625,"about_ca_system_score_codex":0.00043746157,"about_ca_system_score_gemma":0.00080902816,"threshold_uncertainty_score":0.018240869},"labels":[],"label_agreement":null},{"id":"W3032361563","doi":"10.1016/j.jaad.2020.05.106","title":"Modifications to dermatology residency education during the COVID-19 pandemic","year":2020,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Pandemic; Coronavirus disease 2019 (COVID-19); Social distance; Asymptomatic; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); 2019-20 coronavirus outbreak; Residency training; Dermatology; Transmission (telecommunications); Patient care; Family medicine; Disease; Medical education; Infectious disease (medical specialty); Continuing education; Nursing; Surgery; Virology; Pathology","score_opus":0.10874367794123736,"score_gpt":0.44116191673137933,"score_spread":0.332418238790142,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3032361563","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.17570767,0.0033210097,0.0030130162,0.7112415,0.02380575,0.0010525032,0.0008890479,0.00043902887,0.08053053],"genre_scores_gemma":[0.7029189,0.0043205493,0.009072754,0.24653146,0.010838009,0.0011400997,0.0008842077,0.0001625055,0.024131529],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9909768,0.0025022442,0.000614165,0.0005073205,0.0013522593,0.0040471274],"domain_scores_gemma":[0.97118336,0.0042543975,0.0023641018,0.0007440087,0.0044631823,0.016990874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010606862,0.00033313138,0.0002956094,0.001003718,0.0038916015,0.0027728637,0.0019803848,0.004567152,0.022923075],"category_scores_gemma":[0.038386412,0.0003833223,0.0007833455,0.0005299498,0.0011094555,0.0020084288,0.005146352,0.0069926586,0.0017989666],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007325519,0.0048103984,0.082288675,0.0011694364,0.00012981561,0.0031465064,0.0077270367,0.0034890054,0.0032488185,0.010933862,0.4457037,0.43662012],"study_design_scores_gemma":[0.00029644847,0.0015542763,0.34033844,0.0025465067,0.00005582855,0.0015567818,0.025096316,0.001541725,0.0011373324,0.004533024,0.6211695,0.00017381727],"about_ca_topic_score_codex":0.029412765,"about_ca_topic_score_gemma":0.08413652,"teacher_disagreement_score":0.029412765,"about_ca_system_score_codex":0.0075919353,"about_ca_system_score_gemma":0.027284145,"threshold_uncertainty_score":0.07668537},"labels":[],"label_agreement":null},{"id":"W3032928530","doi":"10.1016/j.jaad.2020.05.114","title":"Proceeding report of the Fourth Symposium on Hidradenitis Suppurativa Advances 2019","year":2020,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; Sanofi Genzyme; LEO Pharma; Sun Pharma; Novartis; Regeneron Pharmaceuticals; Hidradenitis Suppurativa Foundation; AbbVie; Pfizer","keywords":"Hidradenitis suppurativa; Medicine; Dermatology; Observational study; Pathology; Disease","score_opus":0.018894682240673318,"score_gpt":0.3083428847526744,"score_spread":0.2894482025120011,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3032928530","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0036366656,0.07455415,0.0017110213,0.07403888,0.6913119,0.0005025682,0.0013046205,0.00023055353,0.15270968],"genre_scores_gemma":[0.016383173,0.072248906,0.0026402522,0.02232983,0.21895343,0.00047706996,0.0033313509,0.0002918577,0.663344],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983864,0.00026869113,0.00011075204,0.00018732957,0.0007491704,0.000297593],"domain_scores_gemma":[0.99677163,0.0003053284,0.00016258172,0.00010287262,0.0015094404,0.0011481136],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028539884,0.0011037698,0.0006111169,0.0014768771,0.0012248807,0.0041971905,0.0011387417,0.0031968271,0.08010983],"category_scores_gemma":[0.0031930762,0.00033686272,0.0010501401,0.00090486184,0.0004132188,0.00151042,0.0021153027,0.0034765105,0.035862636],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012615148,0.00009074227,0.00040280487,0.00033939828,0.0000119003325,0.00026429314,0.000057862984,0.000043582408,0.0008310791,0.0006884187,0.9341603,0.062983386],"study_design_scores_gemma":[0.000011096421,0.00005492737,0.000516532,0.00018800849,0.000007533913,0.0001570013,0.00006473691,0.00002328432,0.00020901539,0.00020793184,0.9985543,0.0000057383136],"about_ca_topic_score_codex":0.0016790696,"about_ca_topic_score_gemma":0.004994366,"teacher_disagreement_score":0.08010983,"about_ca_system_score_codex":0.0013823727,"about_ca_system_score_gemma":0.0031593328,"threshold_uncertainty_score":0.2679941},"labels":[],"label_agreement":null},{"id":"W3032983471","doi":"10.1016/j.jaad.2020.05.142","title":"Dupilumab reduces absenteeism in patients with moderate to severe atopic dermatitis: Pooled results from the LIBERTY AD SOLO clinical trials","year":2020,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Sanofi Genzyme; Astellas Pharma; LEO Pharma; Galderma; Dermira; Regeneron Pharmaceuticals; Sanofi; Valeant Pharmaceuticals International; Pfizer; Kyowa Hakko Kirin; Eli Lilly and Company","keywords":"Medicine; Atopic dermatitis; Dupilumab; Placebo; Quality of life (healthcare); Dermatology; Clinical trial; Work productivity; Internal medicine; Alternative medicine; Productivity","score_opus":0.04931393344143473,"score_gpt":0.35539411008337396,"score_spread":0.3060801766419392,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3032983471","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011135328,0.9424205,0.00036258373,0.024778906,0.015690738,0.0003692498,0.002684725,0.000077432196,0.0024804417],"genre_scores_gemma":[0.25155857,0.6045207,0.0019442562,0.06350893,0.06842464,0.0013435314,0.0032496692,0.00019001968,0.0052598095],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99485403,0.0027706607,0.0011691625,0.0003224169,0.0006685897,0.00021519214],"domain_scores_gemma":[0.96622854,0.022867337,0.0066188793,0.00057541695,0.0029699847,0.00073971786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0135190105,0.0009756451,0.006565419,0.0012610927,0.00031488793,0.0024229956,0.0012592701,0.0022184397,0.0053549367],"category_scores_gemma":[0.03497531,0.000447318,0.0044189743,0.0020349652,0.0004520581,0.0011330432,0.0006302855,0.0022300803,0.0005877995],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0850765,0.0002394593,0.0062522986,0.30880794,0.10464983,0.00063660473,0.00028715993,0.000630577,0.0010712908,0.0006690947,0.2526422,0.23903704],"study_design_scores_gemma":[0.09982972,0.008540745,0.051570147,0.13751675,0.43455923,0.0018867174,0.00039884026,0.002230072,0.0019150176,0.004427486,0.2566504,0.00047482012],"about_ca_topic_score_codex":0.0007792509,"about_ca_topic_score_gemma":0.0021259796,"teacher_disagreement_score":0.0135190105,"about_ca_system_score_codex":0.0008298105,"about_ca_system_score_gemma":0.0013202324,"threshold_uncertainty_score":0.07149619},"labels":[],"label_agreement":null},{"id":"W3033232785","doi":"10.1016/j.jaad.2020.05.135","title":"Efficacy and patient-reported outcomes from a phase 2b, randomized clinical trial of tapinarof cream for the treatment of adolescents and adults with atopic dermatitis","year":2020,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":137,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Queen's University","funders":"Janssen Biotech; Imclone; Allergan; Kyowa Hakko Kirin; Galderma; Ortho Dermatologics; Actavis; LEO Pharma; Dermira; UCB; AbbVie; Pfizer","keywords":"Medicine; Atopic dermatitis; Randomized controlled trial; Dermatology; Clinical trial; Surgery; Internal medicine","score_opus":0.034993505803194165,"score_gpt":0.364369946351149,"score_spread":0.32937644054795484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3033232785","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.986667,0.0040517794,0.00042910874,0.0003683838,0.00024217977,0.005284852,0.0014233016,0.00005789759,0.0014755664],"genre_scores_gemma":[0.98424226,0.0022279506,0.0012540688,0.000907456,0.00048291843,0.007847736,0.0015800584,0.000019974324,0.001437561],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99864036,0.0007725313,0.000089784786,0.0001978645,0.00011867993,0.00018076622],"domain_scores_gemma":[0.99818146,0.0005240973,0.0005113583,0.00011406635,0.00016755238,0.0005015436],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034289407,0.0017469293,0.0025614349,0.00047529873,0.0005033855,0.0009956791,0.0007822072,0.0019648438,0.0063043316],"category_scores_gemma":[0.002768928,0.00067305745,0.0016583509,0.00038155954,0.0009734237,0.0010090306,0.00040140835,0.0025792182,0.00075706525],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9700429,0.012831256,0.0015728718,0.00042244847,0.00070193637,0.000035739413,0.000038581144,0.00020006769,0.0021123935,0.000045448163,0.000538871,0.011457562],"study_design_scores_gemma":[0.8926141,0.102486424,0.0035652926,0.000021582004,0.0003832745,0.00003134356,0.000015024984,0.00019813782,0.00028746275,0.0000499371,0.0003384619,0.000008845546],"about_ca_topic_score_codex":0.0005691314,"about_ca_topic_score_gemma":0.0010564759,"teacher_disagreement_score":0.0063043316,"about_ca_system_score_codex":0.000556065,"about_ca_system_score_gemma":0.00095625286,"threshold_uncertainty_score":0.02109009},"labels":[],"label_agreement":null},{"id":"W3033996533","doi":"10.1016/j.jaad.2020.05.143","title":"Effect of onychomycosis and treatment on patient-reported quality-of-life outcomes: A systematic review","year":2020,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Quality of life (healthcare); Nail disease; MEDLINE; Intensive care medicine; Dermatology","score_opus":0.059688544098390174,"score_gpt":0.4277624592229455,"score_spread":0.3680739151245553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3033996533","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0026091577,0.99662673,0.00008569608,0.00008680338,0.00008073891,0.00009258369,0.00028358935,0.0000061069345,0.00012866028],"genre_scores_gemma":[0.052542575,0.94587994,0.00047177763,0.00048077165,0.00008212242,0.00016942178,0.00024289919,0.000006006219,0.00012448992],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99708647,0.00094778085,0.0009887958,0.00037506968,0.0004609794,0.00014089949],"domain_scores_gemma":[0.98972076,0.0073875263,0.0020351612,0.00013099205,0.0005397837,0.00018587602],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00367279,0.001307647,0.009025553,0.0032663187,0.0004110035,0.002027284,0.0014935831,0.0017989367,0.004165809],"category_scores_gemma":[0.016412683,0.00093637826,0.011255015,0.004707003,0.0007111029,0.0014201069,0.0012823371,0.0017330033,0.0002472713],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010083147,0.000053084095,0.0032066198,0.8629806,0.106101476,0.00011131314,0.00012129224,0.00017699745,0.00014843032,0.00012632475,0.0011811377,0.024784422],"study_design_scores_gemma":[0.0014863239,0.0005069362,0.018059755,0.30052027,0.6698107,0.000354443,0.00030382327,0.00021282151,0.0001701702,0.0003196254,0.008170764,0.000084379695],"about_ca_topic_score_codex":0.011873383,"about_ca_topic_score_gemma":0.03657333,"teacher_disagreement_score":0.011873383,"about_ca_system_score_codex":0.0020753795,"about_ca_system_score_gemma":0.004037972,"threshold_uncertainty_score":0.023608565},"labels":[],"label_agreement":null},{"id":"W3034250972","doi":"10.1016/j.jaad.2020.06.016","title":"Photographic assessment of postsurgical facial scars epidermally sutured with rapidly absorbable polyglactin 910 or nylon: A randomized clinical trial","year":2020,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Surgical Sutures and Adhesives","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; University of British Columbia","funders":"","keywords":"Medicine; Surgery; Vicryl; Scars; Fibrous joint; Visual analogue scale; Absorbable suture; Randomized controlled trial","score_opus":0.04650625351687914,"score_gpt":0.388336003847226,"score_spread":0.34182975033034685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3034250972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99046856,0.0038922478,0.0006548579,0.00037105652,0.00062385626,0.0023459774,0.00027055663,0.00004762405,0.0013250973],"genre_scores_gemma":[0.99082047,0.0026472681,0.001034842,0.0007004689,0.00060297933,0.0021657392,0.0003143063,0.000012565442,0.0017014174],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9990357,0.000495475,0.00006885398,0.00019460324,0.000083066276,0.00012232701],"domain_scores_gemma":[0.9985757,0.000548547,0.00038466384,0.00013052528,0.00008585229,0.00027483504],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019102206,0.0018144386,0.0032357876,0.00045080046,0.00057871884,0.0010569128,0.00097922,0.0023567236,0.00715093],"category_scores_gemma":[0.0021537582,0.00075358833,0.0019916499,0.0005637092,0.0017357632,0.0011295597,0.00035689137,0.0030523443,0.00088061887],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9762006,0.010216521,0.0006743614,0.0004792291,0.00055951625,0.000034593846,0.00003149223,0.00010439964,0.0019561246,0.000060608567,0.00021511101,0.009467494],"study_design_scores_gemma":[0.8490707,0.1464186,0.0025922963,0.000042620883,0.0007047741,0.00003207503,0.000044581615,0.0002649642,0.00041565616,0.00010138425,0.00029221937,0.00002004612],"about_ca_topic_score_codex":0.00095684524,"about_ca_topic_score_gemma":0.0014765158,"teacher_disagreement_score":0.00715093,"about_ca_system_score_codex":0.0006116918,"about_ca_system_score_gemma":0.00075976,"threshold_uncertainty_score":0.023922205},"labels":[],"label_agreement":null},{"id":"W3036639957","doi":"10.1016/j.jaad.2020.06.054","title":"Efficacy and safety of dupilumab with concomitant topical corticosteroids in children 6 to 11 years old with severe atopic dermatitis: A randomized, double-blinded, placebo-controlled phase 3 trial","year":2020,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":389,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; SKiN Health; Queen's University","funders":"Sanofi Genzyme; Regeneron Pharmaceuticals","keywords":"Medicine; Dupilumab; Atopic dermatitis; Eczema Area and Severity Index; Placebo; Concomitant; Dermatology Life Quality Index; Regimen; Clinical endpoint; Randomized controlled trial; Internal medicine; Dermatology; Quality of life (healthcare); Adverse effect; Pathology; Disease","score_opus":0.014268213486860968,"score_gpt":0.29614001373963983,"score_spread":0.28187180025277886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3036639957","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9876223,0.005414802,0.00039455522,0.00045465032,0.0003079541,0.0038617384,0.00079760293,0.00007162452,0.0010747203],"genre_scores_gemma":[0.9864399,0.0028659997,0.0014895982,0.0011471774,0.00037302138,0.005575349,0.0008149863,0.000016902826,0.0012770995],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99899846,0.0005172205,0.00007424293,0.00016709791,0.00010071504,0.00014222994],"domain_scores_gemma":[0.9987954,0.0002785436,0.00037608785,0.000074655065,0.00007822814,0.00039704802],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024560776,0.0013231616,0.0025362002,0.00031778254,0.0006518184,0.0011038512,0.00089292816,0.00223905,0.003943127],"category_scores_gemma":[0.001507323,0.0006570228,0.0019763957,0.000355503,0.0010591848,0.00077608513,0.0003897194,0.0026341947,0.0005992176],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.96831983,0.00940297,0.0019373202,0.0007065789,0.00079590373,0.00008631572,0.00007816142,0.00017543772,0.0036686768,0.000072636336,0.00069760316,0.014058541],"study_design_scores_gemma":[0.9380585,0.058361553,0.0023237977,0.000029569834,0.00028344957,0.000054277654,0.00001657528,0.00015323117,0.00031119806,0.000042763197,0.0003567015,0.000008298598],"about_ca_topic_score_codex":0.0010777757,"about_ca_topic_score_gemma":0.002988066,"teacher_disagreement_score":0.003943127,"about_ca_system_score_codex":0.0008501759,"about_ca_system_score_gemma":0.0017431936,"threshold_uncertainty_score":0.013191044},"labels":[],"label_agreement":null},{"id":"W3036674396","doi":"10.1016/j.jaad.2020.06.055","title":"Efficacy and safety of topical terbinafine 10% solution (MOB-015) in the treatment of mild to moderate distal subungual onychomycosis: A randomized, multicenter, double-blind, vehicle-controlled phase 3 study","year":2020,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada); University of Toronto","funders":"","keywords":"Medicine; Double blind; Terbinafine; Multicenter study; Dermatology; Nail disease; Randomized controlled trial; Surgery; Antifungal; Placebo; Pathology","score_opus":0.03977989631949598,"score_gpt":0.3652875502802331,"score_spread":0.3255076539607371,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3036674396","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959902,0.00168183,0.00041852082,0.00011192376,0.000104961015,0.00080245954,0.00020599837,0.00005601771,0.0006281462],"genre_scores_gemma":[0.9952859,0.0013968884,0.0006650633,0.00030802228,0.000139558,0.0006752376,0.00032139005,0.000014631405,0.0011934042],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9995585,0.00021233929,0.000027983075,0.000068669746,0.00004437925,0.00008809243],"domain_scores_gemma":[0.9995016,0.00013563252,0.00010912024,0.00004178256,0.00003189353,0.00017991866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011860535,0.0011155694,0.002181833,0.00042590426,0.0004175776,0.00077259674,0.0009530522,0.0012938831,0.0033650405],"category_scores_gemma":[0.0007980738,0.000575047,0.0010166367,0.00031021424,0.0011140242,0.0007691903,0.00022844328,0.0017477609,0.00064606965],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9097937,0.028551405,0.0007691299,0.0006549829,0.0006155299,0.00007933982,0.0000915332,0.00038620652,0.025917346,0.00013312846,0.0005297351,0.032478005],"study_design_scores_gemma":[0.695554,0.29618892,0.00406307,0.000027782979,0.00044820813,0.000071470306,0.00004177283,0.0005263682,0.0024825656,0.00009804187,0.0004721226,0.000025549321],"about_ca_topic_score_codex":0.0009790373,"about_ca_topic_score_gemma":0.0016940702,"teacher_disagreement_score":0.0033650405,"about_ca_system_score_codex":0.00043789466,"about_ca_system_score_gemma":0.0009500436,"threshold_uncertainty_score":0.011257172},"labels":[],"label_agreement":null},{"id":"W3036722623","doi":"10.1016/j.jaad.2020.06.433","title":"17850 Predicting the long-term outcomes of biologics in psoriasis patients using machine learning","year":2020,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Computational Drug Discovery Methods","field":"Computer Science","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Psoriasis; Predictive value; Drug; Term (time); Internal medicine; Intensive care medicine; Dermatology; Pharmacology","score_opus":0.05018088638839765,"score_gpt":0.34599231533253083,"score_spread":0.2958114289441332,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3036722623","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98819214,0.0027670728,0.0020896604,0.00052811264,0.000098675955,0.000026592563,0.0023778412,0.000052072664,0.003867779],"genre_scores_gemma":[0.996527,0.00041955765,0.0006983997,0.000065145614,0.00006813516,0.000014586526,0.0014783015,0.00000394679,0.0007248961],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9996151,0.000108600645,0.00004867661,0.000073401694,0.00010444251,0.000049863982],"domain_scores_gemma":[0.99868375,0.00065339764,0.00031092897,0.0000677789,0.00016464897,0.00011950032],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078343274,0.00022080944,0.00040100538,0.00058932364,0.00023376665,0.00071268814,0.0002079065,0.0003293903,0.002869731],"category_scores_gemma":[0.0026341833,0.00009082899,0.0007509109,0.0006272616,0.0001318564,0.0003008024,0.00023664745,0.00066020235,0.0006500872],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013743365,0.00043715598,0.89454365,0.00010290665,0.0004302757,0.00018187182,0.000034439407,0.004029959,0.0018147809,0.00026476706,0.002686719,0.09409917],"study_design_scores_gemma":[0.00023499053,0.0011107097,0.9166487,0.000099063625,0.0009793692,0.0010299598,0.00017959399,0.0681977,0.0029859375,0.0019545285,0.0065428345,0.000036493482],"about_ca_topic_score_codex":0.00209477,"about_ca_topic_score_gemma":0.0033311222,"teacher_disagreement_score":0.002869731,"about_ca_system_score_codex":0.00043104147,"about_ca_system_score_gemma":0.00041815505,"threshold_uncertainty_score":0.0096001625},"labels":[],"label_agreement":null},{"id":"W3036809488","doi":"10.1016/j.jaad.2020.06.050","title":"International collaboration and rapid harmonization across dermatologic COVID-19 registries","year":2020,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Dermatological and COVID-19 studies","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre; Hospital for Sick Children","funders":"Department of Medicine, University of Toronto; Janssen Biotech; Medical Research Council; King's University College; Wake Forest School of Medicine; Hospital for Sick Children; University of North Carolina at Chapel Hill; Manchester Biomedical Research Centre; Société Française de Dermatologie et de Pathologie Sexuellement Transmissible; Trinity College Dublin; Children's Hospital of Philadelphia; King's College London; Amsterdam University Medical Centers; Psoriasis Association; Cardiff University; Henry Ford Health System; Guy's and St Thomas' NHS Foundation Trust; Noda Institute for Scientific Research; University of Toronto; European Society for Dermatological Research; Saint Louis University; AbbVie; University of California, San Francisco; National Institute for Health and Care Research; Massachusetts General Hospital; National Institute of Arthritis and Musculoskeletal and Skin Diseases; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research; Sunnybrook Research Institute; American Academy of Dermatology","keywords":"Medicine; Coronavirus disease 2019 (COVID-19); 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Harmonization; Betacoronavirus; MEDLINE; Coronavirus Infections; Pandemic; Virology; Internal medicine; Outbreak; Infectious disease (medical specialty)","score_opus":0.04373499990119655,"score_gpt":0.359161128333656,"score_spread":0.31542612843245943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3036809488","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00106614,0.000482192,0.0012970666,0.9804262,0.0076849023,0.00012109116,0.0001372941,0.000038720707,0.0087464],"genre_scores_gemma":[0.013445658,0.00059428904,0.004234353,0.95840067,0.011923996,0.00033086218,0.00036658047,0.00007912677,0.010624327],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9473848,0.024461722,0.0064718067,0.0030755259,0.011052472,0.0075536193],"domain_scores_gemma":[0.79707533,0.096895844,0.010647538,0.016108138,0.041076485,0.038196687],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0647115,0.0005239814,0.0012660144,0.0014788897,0.0052700182,0.009760966,0.0033914496,0.0353559,0.010844269],"category_scores_gemma":[0.13089201,0.0010852179,0.0018449655,0.0014312433,0.003759896,0.007815024,0.0133183235,0.031093044,0.0037441042],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006849842,0.0001345705,0.0059453915,0.00009634423,0.000042417363,0.0009540195,0.00050307554,0.0001579594,0.00035440188,0.02304072,0.947382,0.021320688],"study_design_scores_gemma":[0.00021429689,0.000091023816,0.007528604,0.0005744056,0.000043916614,0.0008754397,0.0017698768,0.00059193536,0.00036468395,0.017060261,0.9708213,0.00006421351],"about_ca_topic_score_codex":0.008120253,"about_ca_topic_score_gemma":0.016537007,"teacher_disagreement_score":0.0647115,"about_ca_system_score_codex":0.005976142,"about_ca_system_score_gemma":0.04578157,"threshold_uncertainty_score":0.3422312},"labels":[],"label_agreement":null},{"id":"W3036825125","doi":"10.1016/j.jaad.2020.06.067","title":"Gender and racial underrepresentation in academic dermatology positions in the United States: A retrospective, cross-sectional study from 2007 to 2018","year":2020,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Diversity and Career in Medicine","field":"Social Sciences","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia; McMaster University","funders":"","keywords":"Census; Medicine; Ethnic group; Diversification (marketing strategy); Demography; Health care; Population; Ethnic composition; Cross-sectional study; Racial composition; Gerontology; Family medicine; Race (biology); Environmental health; Gender studies; Political science; Sociology; Law","score_opus":0.08543913308606639,"score_gpt":0.4114880071086424,"score_spread":0.32604887402257604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3036825125","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"incentives","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"incentives","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986921,0.00019055979,0.000030422123,0.00012016541,0.000014695403,0.0000039197103,0.0004675303,0.0000018756624,0.00047873412],"genre_scores_gemma":[0.99937975,0.00010100737,0.000021443104,0.00009551128,0.000010908547,0.000005034566,0.00023589474,0.0000017670529,0.00014861005],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99937373,0.00014579318,0.00006188083,0.00012463372,0.0001053871,0.00018862254],"domain_scores_gemma":[0.9981116,0.00018363085,0.00094875076,0.000081181795,0.00023461985,0.0004401254],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0005960024,0.00018687964,0.00023345281,0.0008952833,0.0008119525,0.000771007,0.0004796549,0.0005768698,0.0014406493],"category_scores_gemma":[0.0021081583,0.00029170333,0.00033042196,0.0014608804,0.00039095257,0.0008457409,0.00077352126,0.0007417554,0.00024441732],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002000071,0.000029203533,0.99915683,0.000002841659,0.000013140024,0.000025332527,0.00019216555,0.000005133072,0.000033609984,0.000012767914,0.00015006671,0.0003590007],"study_design_scores_gemma":[0.00000107866,0.000019450028,0.99800974,0.000006988187,0.0000077189325,0.00008496128,0.0016038051,0.000033088072,0.000020235015,0.000009536001,0.00020127592,0.0000021217936],"about_ca_topic_score_codex":0.028971387,"about_ca_topic_score_gemma":0.047566872,"teacher_disagreement_score":0.999404,"about_ca_system_score_codex":0.00063152745,"about_ca_system_score_gemma":0.0007903433,"threshold_uncertainty_score":0.057605505},"labels":[],"label_agreement":null},{"id":"W3037710438","doi":"10.1016/j.jaad.2020.06.985","title":"Characterization of vascular stains associated with high flow","year":2020,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Vascular Malformations and Hemangiomas","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Port-wine stain; Pathology; Dermatology; Laser","score_opus":0.012972442763907492,"score_gpt":0.2503015808055606,"score_spread":0.2373291380416531,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3037710438","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911584,0.00076815597,0.0037154509,0.000056382574,0.000021462956,0.000036439313,0.00010305884,0.00007266151,0.0040677926],"genre_scores_gemma":[0.9947982,0.00035695825,0.0036695637,0.00004530863,0.000024687424,0.000019901785,0.00017903751,0.000020206633,0.00088618],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998215,0.000029381043,0.000017394217,0.000029667675,0.000044229164,0.000057846788],"domain_scores_gemma":[0.9993787,0.00014211932,0.00018099857,0.000044600274,0.00015124468,0.00010230137],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003834484,0.00031619234,0.00012547323,0.0024504308,0.00025201295,0.0004670673,0.00019514388,0.00036361523,0.0024573407],"category_scores_gemma":[0.0006642387,0.00018614074,0.00019623914,0.0006563353,0.0003684386,0.00041905747,0.0003076058,0.00030901728,0.00043599054],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001306892,0.00024606797,0.06897042,0.00012231628,0.000058833255,0.008819844,0.00031536975,0.00013381316,0.9066367,0.0006515341,0.0002238405,0.0125144655],"study_design_scores_gemma":[0.00007528752,0.00085638085,0.36352757,0.000089555135,0.00022704485,0.04276549,0.0010354152,0.0048372694,0.57944363,0.00083638757,0.0062742955,0.000031716383],"about_ca_topic_score_codex":0.00043631796,"about_ca_topic_score_gemma":0.00035985137,"teacher_disagreement_score":0.0024573407,"about_ca_system_score_codex":0.00012110077,"about_ca_system_score_gemma":0.00012357226,"threshold_uncertainty_score":0.008220673},"labels":[],"label_agreement":null},{"id":"W3039795767","doi":"10.1016/j.jaad.2020.06.997","title":"Reply to “Comment on: ‘Children with chronic urticaria can be effectively controlled with updosing second-generation antihistamines’”","year":2020,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Urticaria and Related Conditions","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Children's Hospital","funders":"Canadian Allergy, Asthma and Immunology Foundation","keywords":"Medicine; Antihistamine; Chronic urticaria; Scopus; Dermatology; Adverse effect; Natural history; Population; Pediatrics; MEDLINE; Immunology; Internal medicine","score_opus":0.011745944893235105,"score_gpt":0.2625978393473026,"score_spread":0.25085189445406747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3039795767","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00054266443,0.0005716786,0.00005653771,0.9815778,0.015199681,0.000012187718,0.000072988485,0.000023409111,0.0019430836],"genre_scores_gemma":[0.0026639223,0.0002823968,0.00008453462,0.98053116,0.0128716035,0.000025035572,0.000028525119,0.000012434184,0.003500451],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969773,0.000649317,0.00042995953,0.00045947407,0.0006929216,0.000790998],"domain_scores_gemma":[0.9937412,0.0028938327,0.0007430205,0.00015023284,0.0012931139,0.0011785834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002945325,0.00091612904,0.001360678,0.0008663228,0.0043492587,0.0030345025,0.002008443,0.06578935,0.007358459],"category_scores_gemma":[0.020946357,0.0010643207,0.0014037838,0.00066547876,0.002531793,0.003075716,0.0016892013,0.034727648,0.00612447],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006330737,0.00003299403,0.0013499367,0.000048427642,0.000019370014,0.002657007,0.00023459176,0.00004717427,0.00014872347,0.0010208887,0.99180967,0.0025679278],"study_design_scores_gemma":[0.0002334053,0.000114490234,0.0051809484,0.00053318765,0.00009706389,0.004426136,0.0010297952,0.0004963189,0.00039789855,0.0041179312,0.98323894,0.00013389619],"about_ca_topic_score_codex":0.013909715,"about_ca_topic_score_gemma":0.020262167,"teacher_disagreement_score":0.06578935,"about_ca_system_score_codex":0.0045740074,"about_ca_system_score_gemma":0.0051335488,"threshold_uncertainty_score":0.033186853},"labels":[],"label_agreement":null},{"id":"W3040296223","doi":"10.1016/j.jaad.2020.06.1004","title":"Efinaconazole 10% topical solution for the treatment of onychomycosis in pediatric patients: Open-label phase 4 study","year":2020,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada); University of Toronto","funders":"","keywords":"Medicine; Dermatology; Food and drug administration; Nail (fastener); Azole; Nail disease; Antifungal; Open label; Adverse effect; Internal medicine; Pharmacology","score_opus":0.06306246655753374,"score_gpt":0.39453889534881587,"score_spread":0.33147642879128214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3040296223","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896966,0.004261853,0.0007702359,0.00037336024,0.0001900535,0.0021912348,0.0011465552,0.00010702293,0.0012629392],"genre_scores_gemma":[0.9761282,0.009070128,0.0034904703,0.0013397917,0.00038197645,0.003919495,0.0022513873,0.00005431888,0.003364231],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9995542,0.00019063192,0.000024212839,0.00007676691,0.00004532199,0.000108847446],"domain_scores_gemma":[0.9992465,0.00020949385,0.00013942488,0.000070527494,0.00007175076,0.0002624456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012628182,0.0018760525,0.0032773258,0.0004976008,0.00042392113,0.0010469027,0.0011484923,0.0016208785,0.004522606],"category_scores_gemma":[0.001013012,0.0007143105,0.001619026,0.00048646057,0.0011351516,0.0012240951,0.000274529,0.0030066718,0.0007367501],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7535492,0.09133567,0.0034531113,0.0020983736,0.0020866217,0.0006732653,0.00034169198,0.0022994687,0.0288313,0.00054142415,0.003879138,0.11091068],"study_design_scores_gemma":[0.61782247,0.36579674,0.008945331,0.000117415744,0.00062438415,0.0004484971,0.00011577543,0.0010459364,0.0021788368,0.00017581331,0.002681747,0.00004698419],"about_ca_topic_score_codex":0.0015353697,"about_ca_topic_score_gemma":0.004262908,"teacher_disagreement_score":0.004522606,"about_ca_system_score_codex":0.00092974363,"about_ca_system_score_gemma":0.0017474332,"threshold_uncertainty_score":0.015129566},"labels":[],"label_agreement":null},{"id":"W3040356231","doi":"10.1016/j.jaad.2020.06.1010","title":"A retrospective multicenter study of fatal pediatric melanoma","year":2020,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children","funders":"Harvard Medical School; Dermatology Foundation","keywords":"Medicine; Multicenter study; Retrospective cohort study; Melanoma; MEDLINE; Surgery; Randomized controlled trial","score_opus":0.01724371558275429,"score_gpt":0.2893468762126468,"score_spread":0.27210316062989254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3040356231","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99931645,0.00015677809,0.00007251602,0.000015891874,0.0000044687813,0.000010376642,0.00018272927,0.0000036413007,0.00023709632],"genre_scores_gemma":[0.9993717,0.00010913177,0.00008583997,0.000026605756,0.000012781662,0.000014244106,0.00031751356,0.0000047179847,0.000057388752],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987374,0.00036852836,0.00012945861,0.00039658142,0.00015115082,0.0002168456],"domain_scores_gemma":[0.9971494,0.0004631082,0.0012828944,0.000367079,0.00030744984,0.00043014795],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009247661,0.0005341822,0.00065764895,0.0010906804,0.00092512567,0.0008792823,0.0005282117,0.0005091179,0.0019796763],"category_scores_gemma":[0.002675692,0.00057994464,0.0005241955,0.0012216788,0.000529147,0.0008299454,0.00064164266,0.0006361885,0.00034251035],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014316372,0.000051416355,0.9982115,0.000006847862,0.00004450877,0.00051566644,0.00007757762,0.000019221867,0.000115882685,0.00002779567,0.00010155199,0.0006848888],"study_design_scores_gemma":[0.00005758218,0.0005536613,0.9906591,0.00002032701,0.00012528693,0.0063339737,0.0011794562,0.00025728668,0.00019078267,0.000042279036,0.00056955364,0.000010744371],"about_ca_topic_score_codex":0.004064837,"about_ca_topic_score_gemma":0.0031973151,"teacher_disagreement_score":0.004064837,"about_ca_system_score_codex":0.00087562745,"about_ca_system_score_gemma":0.0010304208,"threshold_uncertainty_score":0.00808233},"labels":[],"label_agreement":null},{"id":"W3042065713","doi":"10.1016/j.jaad.2020.07.021","title":"Treatment discontinuation and rate of disease transmission in psoriasis patients receiving biologic therapy during the COVID-19 pandemic: A Canadian multicenter retrospective study","year":2020,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Probity Medical Research; Health Sciences Centre; Sunnybrook Health Science Centre; Dermatrials Research; Women's College Hospital; McMaster University; University of Toronto","funders":"","keywords":"Medicine; Discontinuation; Psoriasis; Retrospective cohort study; Scopus; Pandemic; Coronavirus disease 2019 (COVID-19); Disease; Internal medicine; Pediatrics; MEDLINE; Dermatology; Infectious disease (medical specialty)","score_opus":0.028700329493420856,"score_gpt":0.2849309258967448,"score_spread":0.2562305964033239,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3042065713","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942325,0.0010461098,0.000089003915,0.00045484988,0.0000264184,0.00005723084,0.0022443328,0.000008058432,0.0018415046],"genre_scores_gemma":[0.9974535,0.00053835445,0.0001159191,0.00049672264,0.000039758335,0.000025735848,0.00092562014,0.000009380332,0.00039516916],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99751055,0.00030656817,0.00021140487,0.00040252187,0.0006795754,0.0008893261],"domain_scores_gemma":[0.9935156,0.00053814886,0.0024016148,0.00047553674,0.0018145982,0.0012545355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013332627,0.00051820395,0.00077760976,0.001531897,0.0024119813,0.0018208355,0.0017867737,0.0016140913,0.0023438325],"category_scores_gemma":[0.0057814005,0.0007343979,0.0011602616,0.005076414,0.0009891439,0.00062487426,0.0006807736,0.0018985475,0.00028292442],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017509161,0.000036679507,0.99797815,0.000014464704,0.00007049316,0.00014405968,0.00021317317,0.00002431056,0.00006282115,0.00003059279,0.00041207287,0.00083811267],"study_design_scores_gemma":[0.000027044855,0.00008074101,0.9978834,0.000024163057,0.000074602845,0.0004453921,0.00064813846,0.00014560102,0.000030977375,0.0000142019235,0.00060760754,0.000018047034],"about_ca_topic_score_codex":0.8838994,"about_ca_topic_score_gemma":0.82730484,"teacher_disagreement_score":0.11610061,"about_ca_system_score_codex":0.013466768,"about_ca_system_score_gemma":0.011975262,"threshold_uncertainty_score":0.23356867},"labels":[],"label_agreement":null},{"id":"W3042336585","doi":"10.1016/j.jaad.2020.06.1023","title":"Multidisciplinary care of epidermolysis bullosa during the COVID-19 pandemic—Consensus: Recommendations by an international panel of experts","year":2020,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Skin and Cellular Biology Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"University of California, San Diego; University of the Philippines; Shahid Beheshti University of Medical Sciences; Uniwersytet Warszawski; Albert-Ludwigs-Universität Freiburg; Tel Aviv University; University of Melbourne; Hokkaido University; Thomas Jefferson University; University of Colorado School of Medicine, Anschutz Medical Campus; Monash University; University of New South Wales; Akdeniz Üniversitesi; Children's Hospital Colorado; Hospital for Sick Children; Northwestern University","keywords":"Medicine; Epidermolysis bullosa; Pandemic; Population; Coronavirus disease 2019 (COVID-19); Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Dermatology; Pathology; Internal medicine; Disease","score_opus":0.05077250293758847,"score_gpt":0.3649305564443982,"score_spread":0.31415805350680975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3042336585","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004969824,0.046621732,0.00090086996,0.8732677,0.07690263,0.00009416339,0.000110354835,0.000042899963,0.0015625999],"genre_scores_gemma":[0.014884022,0.122572266,0.009232317,0.6740291,0.17494619,0.0005729831,0.0007491929,0.0000811115,0.0029328493],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98798835,0.0054714307,0.0029669707,0.00072452915,0.0019405389,0.00090827316],"domain_scores_gemma":[0.93967223,0.018845685,0.0040353844,0.0006945753,0.03060424,0.0061478913],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020025702,0.0011724567,0.002452608,0.0028290192,0.0025560996,0.0038753855,0.0065802922,0.020506822,0.0040220446],"category_scores_gemma":[0.060916428,0.00087290385,0.0028967478,0.0015997033,0.0020549665,0.0054984656,0.0036408824,0.022727774,0.0025318037],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006374636,0.00007760769,0.0010337923,0.0021830308,0.00011184954,0.0004435972,0.00029505717,0.00022949903,0.00013401019,0.0012033179,0.9272301,0.06699446],"study_design_scores_gemma":[0.00035649785,0.00015021615,0.0037329793,0.038603757,0.00045774248,0.00257399,0.0022638717,0.0011968288,0.00033593274,0.010628352,0.9394677,0.00023214422],"about_ca_topic_score_codex":0.0036566902,"about_ca_topic_score_gemma":0.0062794816,"teacher_disagreement_score":0.020506822,"about_ca_system_score_codex":0.003933279,"about_ca_system_score_gemma":0.012880088,"threshold_uncertainty_score":0.10590732},"labels":[],"label_agreement":null},{"id":"W3042463797","doi":"10.1016/j.jaad.2020.06.1027","title":"Development of morphea in patients receiving biologic therapies: A systematic review","year":2020,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Autoimmune Bullous Skin Diseases","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Morphea; Medicine; Adalimumab; Etanercept; Dermatology; Psoriasis; Localized Scleroderma; Tazarotene; Ustekinumab; Surgery; Internal medicine; Tumor necrosis factor alpha","score_opus":0.03608247388230301,"score_gpt":0.34822468713073185,"score_spread":0.31214221324842883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3042463797","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010615543,0.9984053,0.000047480687,0.000071974035,0.00006235621,0.00004614243,0.000207687,0.000003310824,0.00009415102],"genre_scores_gemma":[0.021443838,0.977427,0.00027482503,0.00046032103,0.00007068113,0.00007968507,0.00016370504,0.0000033216015,0.00007664634],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9974661,0.00064119673,0.0010285141,0.000339938,0.00040213598,0.00012214192],"domain_scores_gemma":[0.9910614,0.0060126437,0.0021893901,0.00011239345,0.0004781938,0.00014587815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002814281,0.0009998716,0.0071782647,0.0042870943,0.00035507607,0.0017791985,0.0013955568,0.0018492955,0.0044881073],"category_scores_gemma":[0.011854003,0.0008592014,0.008321029,0.0058088214,0.0006244179,0.0015413455,0.0012010438,0.0013841762,0.00024674094],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008411054,0.000034525496,0.0036119048,0.9102316,0.0501861,0.00014550284,0.00013042205,0.000116697476,0.0001865356,0.00013491997,0.0019677074,0.032413036],"study_design_scores_gemma":[0.0017378161,0.00053813145,0.024544185,0.45854622,0.4927268,0.0008510506,0.0003789296,0.00017681354,0.00020076799,0.0003568203,0.019837331,0.00010507774],"about_ca_topic_score_codex":0.0074491976,"about_ca_topic_score_gemma":0.02503551,"teacher_disagreement_score":0.0074491976,"about_ca_system_score_codex":0.0014125038,"about_ca_system_score_gemma":0.0033193112,"threshold_uncertainty_score":0.015014231},"labels":[],"label_agreement":null},{"id":"W3043280112","doi":"10.1016/j.jaad.2020.07.044","title":"Cutaneous reactions in children treated with MEK inhibitors, BRAF inhibitors, or combination therapy: A multicenter study","year":2020,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institutes of Health","keywords":"Medicine; Multicenter study; Oncology; Dermatology; Internal medicine; Randomized controlled trial","score_opus":0.012379842251330356,"score_gpt":0.2599215950624793,"score_spread":0.24754175281114896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3043280112","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99922764,0.00033021127,0.000047557292,0.000014074999,0.0000039576407,0.00004525131,0.00008441376,0.0000019787155,0.0002448545],"genre_scores_gemma":[0.9990569,0.0003276068,0.00014072857,0.000069758295,0.000024928753,0.000058928665,0.00018873939,0.0000031353673,0.00012928272],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992124,0.00030978085,0.000062157145,0.00018321713,0.000102511876,0.00012983778],"domain_scores_gemma":[0.9986687,0.00027551068,0.00057230314,0.000068709196,0.00010372968,0.00031109512],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079221296,0.0006229411,0.0009741417,0.00041606688,0.0005798275,0.0005059844,0.00032256226,0.00058652746,0.0014697124],"category_scores_gemma":[0.0012360975,0.0003207435,0.00089170894,0.0006570685,0.00055278995,0.0005293228,0.00034643637,0.0008306005,0.00020965328],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00951467,0.0028716105,0.9721953,0.00011980178,0.00045042872,0.0012766643,0.0003161297,0.0001875847,0.003320314,0.000068566274,0.00028899073,0.009389859],"study_design_scores_gemma":[0.0023347577,0.026691657,0.96064776,0.000047009755,0.0006779377,0.0055353255,0.0010529164,0.00030863538,0.0010609255,0.000044138294,0.0015742813,0.000024596902],"about_ca_topic_score_codex":0.0013883685,"about_ca_topic_score_gemma":0.0012836575,"teacher_disagreement_score":0.0014697124,"about_ca_system_score_codex":0.000660371,"about_ca_system_score_gemma":0.00053786585,"threshold_uncertainty_score":0.004916668},"labels":[],"label_agreement":null},{"id":"W3043299604","doi":"10.1016/j.jaad.2020.07.052","title":"Drugs associated with development of pityriasis rubra pilaris: A systematic review","year":2020,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Psoriasis Association","keywords":"Pityriasis rubra pilaris; Medicine; Dermatology; Palmoplantar keratoderma; Hyperkeratosis; Psoriasis","score_opus":0.02841740291168345,"score_gpt":0.29726308212343866,"score_spread":0.26884567921175523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3043299604","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008024202,0.9987087,0.000038849175,0.000068800335,0.000046970134,0.000035202767,0.00018833691,0.0000032633254,0.00010745697],"genre_scores_gemma":[0.009963178,0.98926103,0.00015784541,0.00033324602,0.000049293398,0.000035984183,0.00012777458,0.0000019440904,0.00006973487],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9987978,0.00023047952,0.00052182295,0.00015754644,0.0002226988,0.000069658585],"domain_scores_gemma":[0.9960205,0.0023532838,0.0012298769,0.00005373224,0.00026287278,0.000079791425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013793376,0.00086650014,0.0048447954,0.004045654,0.00027080817,0.0012509563,0.0011996655,0.0013250117,0.004280029],"category_scores_gemma":[0.005426344,0.0005996293,0.005439879,0.0046711047,0.0004249446,0.001051414,0.00096245314,0.0008120768,0.00024573],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006447417,0.00004100849,0.0028810622,0.9007122,0.024827389,0.0003719344,0.00013405962,0.00013545733,0.00036417312,0.00020249675,0.003807306,0.0658781],"study_design_scores_gemma":[0.0012988346,0.00064579037,0.0319512,0.5367065,0.35741857,0.0028215065,0.0005183369,0.00019165194,0.00045170155,0.00049367966,0.06735276,0.00014960027],"about_ca_topic_score_codex":0.0059345425,"about_ca_topic_score_gemma":0.018035373,"teacher_disagreement_score":0.0059345425,"about_ca_system_score_codex":0.00090777024,"about_ca_system_score_gemma":0.0025409637,"threshold_uncertainty_score":0.014318109},"labels":[],"label_agreement":null},{"id":"W3043469535","doi":"10.1016/j.jaad.2020.07.046","title":"Characteristics of nonmelanoma skin cancer in children without identifiable risk factors","year":2020,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Skin cancer; Dermatology; Medical record; Retrospective cohort study; Young adult; Pediatrics; Cancer; Surgery; Internal medicine","score_opus":0.013064496622745846,"score_gpt":0.2939779029071443,"score_spread":0.2809134062843985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3043469535","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885848,0.001302021,0.000052643118,0.00291879,0.00012066378,0.000016567988,0.0016644624,0.0000060326192,0.0053341077],"genre_scores_gemma":[0.99640816,0.0008091023,0.00007088645,0.000974221,0.00013818446,0.000031480944,0.00074272964,0.0000050959798,0.00082014984],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993693,0.0001921168,0.00008234882,0.00007488177,0.00011661245,0.00016473669],"domain_scores_gemma":[0.99683845,0.0012302052,0.0009463607,0.00013574892,0.00030876236,0.00054052885],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047029267,0.00016145973,0.00033045723,0.0009711934,0.00050824514,0.00043423483,0.00033872292,0.0010835603,0.0027151161],"category_scores_gemma":[0.0047756573,0.00017339693,0.0004163847,0.0017547306,0.00025386116,0.0005011186,0.00022044026,0.0006780897,0.0003024043],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000536499,0.000033069362,0.9969689,0.000010154534,0.000008801554,0.0008634758,0.00006334037,0.000015985946,0.000092502574,0.00004373469,0.0010265516,0.00081969943],"study_design_scores_gemma":[0.00000777619,0.00009602465,0.9950972,0.000021340467,0.000013016473,0.0031352874,0.000335369,0.000038839928,0.000058918653,0.000038006256,0.0011547841,0.0000034203053],"about_ca_topic_score_codex":0.010514669,"about_ca_topic_score_gemma":0.013356964,"teacher_disagreement_score":0.010514669,"about_ca_system_score_codex":0.0006469656,"about_ca_system_score_gemma":0.000729487,"threshold_uncertainty_score":0.020906925},"labels":[],"label_agreement":null},{"id":"W3043484918","doi":"10.1016/j.jaad.2020.07.020","title":"Eyelid dermatitis in patients referred for patch testing: Retrospective analysis of North American Contact Dermatitis Group data, 1994-2016","year":2020,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Contact Dermatitis and Allergies","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; University of Toronto; Royal Victoria Hospital; McGill University; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Pfizer","keywords":"Medicine; Eyelid; Dermatology; Atopic dermatitis; Contact dermatitis; Surgery; Allergy","score_opus":0.03325854950795958,"score_gpt":0.30384230532115236,"score_spread":0.2705837558131928,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3043484918","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99619627,0.00086496683,0.000059245365,0.00002694344,0.0000083778705,0.000012327962,0.0018501699,0.0000069863413,0.00097479485],"genre_scores_gemma":[0.997523,0.0003781803,0.000050016108,0.000040985953,0.000010718992,0.000010328664,0.0016892798,0.0000040448554,0.00029332138],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990325,0.0001422899,0.00016187372,0.00023941827,0.00024994573,0.00017394112],"domain_scores_gemma":[0.9980736,0.00022861209,0.0010500964,0.00013377062,0.00030048916,0.00021334406],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005305186,0.0003076935,0.00036766037,0.0020307791,0.00054892356,0.0008576015,0.00042385023,0.0005783913,0.0022640356],"category_scores_gemma":[0.0016884048,0.00039441092,0.00064736005,0.002851387,0.0003830925,0.00094240176,0.0006447745,0.00050062686,0.00045020098],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005430625,0.000013657336,0.9989298,0.000009853488,0.000030006979,0.00009110593,0.000038575683,0.0000114923405,0.000055190125,0.0000054988404,0.000118432974,0.00064205227],"study_design_scores_gemma":[0.0000031302034,0.000027981696,0.9990299,0.0000092786095,0.000021345513,0.00043456233,0.00019535872,0.00003192719,0.000026926446,0.000004622648,0.00021278311,0.0000021274982],"about_ca_topic_score_codex":0.024289347,"about_ca_topic_score_gemma":0.034498986,"teacher_disagreement_score":0.024289347,"about_ca_system_score_codex":0.00076424214,"about_ca_system_score_gemma":0.0006419282,"threshold_uncertainty_score":0.048295915},"labels":[],"label_agreement":null},{"id":"W3044282243","doi":"10.1016/j.jaad.2020.07.082","title":"Sex differences in the risk of diabetes mellitus among individuals with psoriasis: A retrospective cohort study in Québec, Canada","year":2020,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre; Université de Montréal; Centre Hospitalier de l’Université de Montréal; McGill University","funders":"Fonds de Recherche du Québec - Santé; Bristol-Myers Squibb","keywords":"Medicine; Psoriasis; Diabetes mellitus; Comorbidity; Cohort study; Internal medicine; Cohort; Population; Concomitant; Scopus; Odds ratio; Retrospective cohort study; MEDLINE; Dermatology; Endocrinology; Environmental health","score_opus":0.01061704103209296,"score_gpt":0.2265440255837226,"score_spread":0.21592698455162965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3044282243","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98968667,0.0018710128,0.00024345113,0.00043794734,0.00004690466,0.00005091992,0.005016587,0.000022204867,0.0026242158],"genre_scores_gemma":[0.99752766,0.00048577512,0.00012818379,0.00013547922,0.0000093550225,0.000016074868,0.0007469329,0.000008712342,0.0009418348],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998946,0.00012343572,0.000080138205,0.00025403977,0.00023371232,0.00036257223],"domain_scores_gemma":[0.99790454,0.00014135252,0.00038562913,0.00012355232,0.00090848224,0.00053638115],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073158916,0.0005958274,0.0007258778,0.0015851604,0.0030093088,0.0016660857,0.0016147776,0.0009826757,0.0031630339],"category_scores_gemma":[0.0016084488,0.00070451177,0.0010556449,0.004597934,0.0007986169,0.0005607979,0.0006718103,0.0011065776,0.00036800277],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000089116926,0.000028299608,0.9974421,0.000011314571,0.00011312128,0.00011747415,0.0002691137,0.000049335584,0.00018458221,0.000060293092,0.000578436,0.0010567931],"study_design_scores_gemma":[0.000012039661,0.000020684762,0.99863017,0.000020189133,0.000048425576,0.00007194673,0.00052709214,0.0001751676,0.000025167965,0.00001712209,0.00044167132,0.000010366411],"about_ca_topic_score_codex":0.9884496,"about_ca_topic_score_gemma":0.98908305,"teacher_disagreement_score":0.014807442,"about_ca_system_score_codex":0.014807442,"about_ca_system_score_gemma":0.010981535,"threshold_uncertainty_score":0.107436},"labels":[],"label_agreement":null},{"id":"W3044965707","doi":"10.1016/j.jaad.2020.07.077","title":"Smoking and risk of adult-onset atopic dermatitis in US women","year":2020,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; University of Toronto; Women's College Hospital","funders":"National Cancer Institute; University of Utah","keywords":"Medicine; Atopic dermatitis; Scopus; Cohort; Young adult; Cohort study; Gerontology; Dermatology; MEDLINE; Internal medicine","score_opus":0.009951193272207925,"score_gpt":0.2713197457122477,"score_spread":0.26136855244003976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3044965707","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.977246,0.002530293,0.000101706966,0.009502281,0.00038325888,0.000016350803,0.00090471265,0.000022536105,0.0092928875],"genre_scores_gemma":[0.99282336,0.0010325194,0.0000902002,0.0027148502,0.0005711745,0.000008480457,0.00021637056,0.0000046649434,0.0025383583],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99983954,0.000048137204,0.000019196601,0.000022141308,0.00003266349,0.000038272294],"domain_scores_gemma":[0.99936885,0.00017977951,0.0001586892,0.000041888477,0.0000931109,0.00015764238],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002723067,0.00015772927,0.00024221274,0.0005619089,0.0004685359,0.0004614224,0.00022768417,0.0016296834,0.0022374857],"category_scores_gemma":[0.0013601338,0.00021067624,0.00033299328,0.0010016785,0.00015300742,0.00030060345,0.00016035595,0.00074722717,0.00031069788],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019950024,0.00008869248,0.99322927,0.000012880071,0.000035222714,0.001446856,0.0001288278,0.000028123564,0.00031115304,0.00005789875,0.0020105077,0.0024510953],"study_design_scores_gemma":[0.000023733788,0.00015240301,0.99363106,0.000027242055,0.000055727753,0.0029275864,0.00042888004,0.00032345112,0.00008659382,0.00011376226,0.0022218337,0.0000075767657],"about_ca_topic_score_codex":0.015659135,"about_ca_topic_score_gemma":0.023452885,"teacher_disagreement_score":0.015659135,"about_ca_system_score_codex":0.0003399756,"about_ca_system_score_gemma":0.0003613297,"threshold_uncertainty_score":0.031135976},"labels":[],"label_agreement":null},{"id":"W3047192465","doi":"10.1016/j.jaad.2020.07.110","title":"Response to: Comment on “Systematic retrospective study on 64 patients anti-Mi2 dermatomyositis: A classic skin rash with a necrotizing myositis and high risk of malignancy”","year":2020,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Inflammatory Myopathies and Dermatomyositis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Dermatomyositis; Myositis; Dermatology; Rash; Polymyositis; Malignancy; Retrospective cohort study; Juvenile dermatomyositis; Autoantibody; Internal medicine; Pathology; Antibody; Immunology","score_opus":0.00828734922388759,"score_gpt":0.25494417686361853,"score_spread":0.24665682763973093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047192465","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012613784,0.0004670731,0.00009336065,0.9776895,0.018725704,0.000027981898,0.00042446615,0.000056821653,0.0012536612],"genre_scores_gemma":[0.0037294468,0.00026546698,0.00012245085,0.97692937,0.016107908,0.00005967897,0.00011855774,0.000020691485,0.0026463564],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99566877,0.0011373224,0.0008588739,0.00067803316,0.0008737876,0.000783176],"domain_scores_gemma":[0.98540074,0.0072804126,0.0019373917,0.000609254,0.0031739168,0.0015982728],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005107527,0.0009035492,0.0017732735,0.0012921601,0.0030220365,0.002868862,0.0022086105,0.040341027,0.0066526425],"category_scores_gemma":[0.02931516,0.0009998193,0.0013874955,0.001355716,0.0020143604,0.0020068763,0.0017901966,0.0230772,0.00865444],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011522533,0.000026666772,0.0028363564,0.00007135384,0.000036084784,0.0013072265,0.00013805288,0.000033595767,0.00012437462,0.0003684636,0.9925368,0.0024057822],"study_design_scores_gemma":[0.00064487505,0.00028212325,0.017790759,0.0012997101,0.00034385693,0.0048982,0.0017621431,0.00081394037,0.0009838019,0.0039611505,0.96697104,0.00024844919],"about_ca_topic_score_codex":0.008423601,"about_ca_topic_score_gemma":0.010009118,"teacher_disagreement_score":0.040341027,"about_ca_system_score_codex":0.0044609387,"about_ca_system_score_gemma":0.0047212653,"threshold_uncertainty_score":0.032366574},"labels":[],"label_agreement":null},{"id":"W3047275686","doi":"10.1016/j.jaad.2020.07.115","title":"Impact of hidradenitis suppurativa on work productivity and associated risk factors","year":2020,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Feinstein Institutes for Medical Research; Universitair Medisch Centrum Groningen; Amgen; National Psoriasis Foundation; National Institutes of Health; Northwell Health; Incyte","keywords":"Hidradenitis suppurativa; Medicine; Work productivity; Dermatology; Productivity; Internal medicine; Disease","score_opus":0.0252759960668082,"score_gpt":0.31836389197420006,"score_spread":0.29308789590739187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047275686","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.038849805,0.21517156,0.0009679738,0.4634092,0.2750822,0.00011849025,0.0023047263,0.00018932522,0.0039067124],"genre_scores_gemma":[0.18908733,0.08628959,0.0008339548,0.123057604,0.5951002,0.00012409742,0.0008011793,0.00007667867,0.0046293745],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99811506,0.0005709784,0.0003605566,0.0003352669,0.00042204824,0.00019614585],"domain_scores_gemma":[0.9858964,0.007508706,0.0024314788,0.00023329453,0.0031425487,0.0007874877],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002788954,0.0009805453,0.0019963908,0.0014956817,0.0005584025,0.0022730972,0.0017001623,0.004386433,0.0034676164],"category_scores_gemma":[0.019644495,0.00050685834,0.00055225595,0.0012771107,0.00094171916,0.0014806872,0.00075272704,0.003662798,0.0013718983],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010733831,0.00022854692,0.03520519,0.0061476184,0.0006473857,0.008443851,0.00024311297,0.00021746669,0.00039508956,0.00048509127,0.8876924,0.059220772],"study_design_scores_gemma":[0.0010914521,0.0010037071,0.20928368,0.016881935,0.0028334586,0.06338472,0.0017412702,0.0071370634,0.0023860727,0.0026624503,0.6910807,0.00051359856],"about_ca_topic_score_codex":0.0018868956,"about_ca_topic_score_gemma":0.0016615506,"teacher_disagreement_score":0.004386433,"about_ca_system_score_codex":0.0008594696,"about_ca_system_score_gemma":0.0010223653,"threshold_uncertainty_score":0.014749587},"labels":[],"label_agreement":null},{"id":"W3047658321","doi":"10.1016/j.jaad.2020.07.120","title":"Comment on “Patient preference for cellulitis treatment: At-home care is preferred to hospital-based treatment”","year":2020,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"York University","keywords":"Medicine; Pandemic; Coronavirus disease 2019 (COVID-19); Cellulitis; Scopus; Emergency department; Anxiety; Medical emergency; Family medicine; MEDLINE; Psychiatry; Internal medicine; Disease; Surgery","score_opus":0.07818857096071281,"score_gpt":0.3630438387715171,"score_spread":0.2848552678108043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047658321","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00052385504,0.00020555212,0.00004819004,0.98821497,0.008206739,0.0000122438505,0.000069801186,0.000018211993,0.002700372],"genre_scores_gemma":[0.002270162,0.0001475521,0.00007104266,0.986534,0.007896494,0.000022242177,0.000024038613,0.000013059002,0.003021358],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9936215,0.0012379463,0.00092436257,0.0009041009,0.0015272142,0.0017849401],"domain_scores_gemma":[0.9829941,0.00841352,0.001456392,0.00036714305,0.0037124646,0.0030564356],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005506226,0.0008663887,0.0018054862,0.0010828669,0.008356134,0.005514143,0.003236177,0.09878403,0.015005182],"category_scores_gemma":[0.035237767,0.0013178135,0.0018371799,0.0013578273,0.003676353,0.0036318968,0.002491093,0.062875845,0.010062909],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007321024,0.000035582572,0.0009954029,0.000037476384,0.00001958112,0.0015705097,0.00026703376,0.00005487834,0.00014326612,0.0022832756,0.99160844,0.002911325],"study_design_scores_gemma":[0.0003034014,0.00013426108,0.0048035416,0.0007785036,0.00010962209,0.002965289,0.0023594587,0.0008273712,0.0005935266,0.009804726,0.9771309,0.00018940258],"about_ca_topic_score_codex":0.033326168,"about_ca_topic_score_gemma":0.048971392,"teacher_disagreement_score":0.09878403,"about_ca_system_score_codex":0.009025571,"about_ca_system_score_gemma":0.013315654,"threshold_uncertainty_score":0.06626439},"labels":[],"label_agreement":null},{"id":"W3048255287","doi":"10.1016/j.jaad.2020.08.022","title":"Association of clinical severity scores with psychosocial impact in patients with hidradenitis suppurativa","year":2020,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal General Hospital; Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Hidradenitis suppurativa; Psychosocial; Psychiatry; Population; Depression (economics); Family medicine; Disease; Internal medicine","score_opus":0.019664390083713977,"score_gpt":0.351131676630686,"score_spread":0.33146728654697205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3048255287","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985726,0.00028353182,0.00003875046,0.00007643874,0.000015746491,0.0000062778313,0.00009403381,0.0000022058855,0.00091058196],"genre_scores_gemma":[0.99971336,0.000058017424,0.000028553786,0.000016003756,0.000017848868,0.0000022610266,0.000088239096,5.7699657e-7,0.000075122894],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995127,0.00014317191,0.0000817526,0.000046982124,0.00010818238,0.00010727601],"domain_scores_gemma":[0.9970847,0.00081415294,0.001150364,0.00006632178,0.00024015062,0.000644393],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044382157,0.00030174368,0.00035650673,0.0009332884,0.00036954402,0.00071939384,0.00020294166,0.00039692485,0.0019446635],"category_scores_gemma":[0.003873087,0.00016549537,0.00050377403,0.00086683995,0.00030861245,0.0004358173,0.000518474,0.0007624272,0.00018050756],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000111890055,0.000035354125,0.9988049,0.0000053033696,0.000033643035,0.000097963275,0.00002530649,0.000018087077,0.000104013685,0.0000062191057,0.000027915272,0.0007293362],"study_design_scores_gemma":[0.000004889096,0.000083126084,0.9993032,0.0000025188374,0.000015791016,0.00026711155,0.00013205853,0.00010700139,0.000026802136,0.000012480756,0.00004203218,0.0000028422053],"about_ca_topic_score_codex":0.0010663058,"about_ca_topic_score_gemma":0.00149759,"teacher_disagreement_score":0.0019446635,"about_ca_system_score_codex":0.0002061139,"about_ca_system_score_gemma":0.00022919379,"threshold_uncertainty_score":0.006505549},"labels":[],"label_agreement":null},{"id":"W3048687053","doi":"10.1016/j.jaad.2020.08.032","title":"Reduced risk of mortality associated with systemic psoriasis treatment in the Psoriasis Longitudinal Assessment and Registry (PSOLAR): A nested case-control analysis","year":2020,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre de Recherche Dermatologique du Québec Métropolitain; Hôtel-Dieu de Québec; Université Laval; Dalhousie University","funders":"Janssen Research and Development","keywords":"Medicine; Nested case-control study; Psoriasis; Systemic therapy; Risk assessment; Case-control study; Dermatology; Internal medicine; Intensive care medicine; Cancer","score_opus":0.02685730341905348,"score_gpt":0.29734917634228203,"score_spread":0.27049187292322857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3048687053","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967638,0.0006874636,0.0015898006,0.0000620602,0.00001839454,0.00006946981,0.0004919309,0.0000179512,0.00029900245],"genre_scores_gemma":[0.9983557,0.00011926163,0.00084610435,0.000032352254,0.000017290908,0.00006768779,0.00042366242,0.0000068698173,0.00013119256],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9935143,0.0036250667,0.00041206653,0.0015544317,0.0006161241,0.00027807726],"domain_scores_gemma":[0.9934994,0.0017696325,0.0022782634,0.001488088,0.0005478564,0.0004167339],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007658214,0.00048441504,0.0007327662,0.00087070593,0.0007585208,0.0009507209,0.0009891216,0.00051704893,0.0013370897],"category_scores_gemma":[0.009009987,0.0005953551,0.0019033698,0.00074213854,0.0006426702,0.0004072399,0.0007530119,0.00074261473,0.00017472301],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027988974,0.0002650964,0.98992157,0.00007716651,0.0024777895,0.0002476025,0.0002495259,0.00017960787,0.0009799815,0.00017847138,0.00033396564,0.0022904512],"study_design_scores_gemma":[0.0007169492,0.0014749297,0.98708665,0.00006500518,0.003208102,0.0012369826,0.00030251054,0.0036909482,0.0006695006,0.0002697874,0.0012416115,0.000036899924],"about_ca_topic_score_codex":0.0057881163,"about_ca_topic_score_gemma":0.0060365913,"teacher_disagreement_score":0.007658214,"about_ca_system_score_codex":0.00060178316,"about_ca_system_score_gemma":0.00057571003,"threshold_uncertainty_score":0.040501},"labels":[],"label_agreement":null},{"id":"W3055133919","doi":"10.1016/j.jaad.2020.08.046","title":"Scalp involvement in patients referred for patch testing: Retrospective cross-sectional analysis of North American Contact Dermatitis Group data, 1996 to 2016","year":2020,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Contact Dermatitis and Allergies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Ottawa; Montreal General Hospital; University of Toronto; McGill University; Health Sciences Centre","funders":"","keywords":"Medicine; Scalp; Seborrheic dermatitis; Dermatology; Allergic contact dermatitis; Contact dermatitis; Irritant contact dermatitis; Retrospective cohort study; Patch test; Cross-sectional study; Allergy; Surgery; Pathology; Immunology","score_opus":0.04728106911865136,"score_gpt":0.33138448860687847,"score_spread":0.2841034194882271,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3055133919","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99756783,0.0003374406,0.00004617113,0.000020493788,0.000006768932,0.000008276545,0.0013523573,0.0000049803607,0.0006557096],"genre_scores_gemma":[0.99855334,0.00020502134,0.000034930974,0.000026515605,0.000008167417,0.000007271147,0.0009236005,0.000002762979,0.00023837342],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99935,0.00011809182,0.00008833406,0.00017106588,0.00013880765,0.00013372395],"domain_scores_gemma":[0.9981907,0.00022160147,0.0009834077,0.00011920078,0.00022103098,0.0002640011],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044583745,0.00033224552,0.0003039426,0.0015146681,0.00048185198,0.00072613143,0.00035868856,0.0005532219,0.002244889],"category_scores_gemma":[0.0015412758,0.00048089918,0.00046265475,0.00240984,0.0003421657,0.0009447307,0.00050398585,0.0005810939,0.0003845094],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049021208,0.000017460954,0.99925107,0.0000058794685,0.000022794457,0.00006843005,0.000040871815,0.000012778291,0.00007535867,0.00000355059,0.00008356485,0.0003691477],"study_design_scores_gemma":[0.0000022569184,0.00002684108,0.999358,0.000004223115,0.0000131851275,0.00025312524,0.00017607435,0.00003228704,0.00001942707,0.0000030092979,0.000110122004,0.000001493849],"about_ca_topic_score_codex":0.024166863,"about_ca_topic_score_gemma":0.030575927,"teacher_disagreement_score":0.024166863,"about_ca_system_score_codex":0.0005031284,"about_ca_system_score_gemma":0.00043980038,"threshold_uncertainty_score":0.04805237},"labels":[],"label_agreement":null},{"id":"W3082286918","doi":"10.1016/j.jaad.2020.09.001","title":"National Psoriasis Foundation COVID-19 Task Force Guidance for Management of Psoriatic Disease During the Pandemic: Version 1","year":2020,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":49,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto; University Health Network","funders":"Janssen Biotech; Ortho Dermatologics; Gilead Sciences; LEO Pharma; National Heart, Lung, and Blood Institute; Sun Pharma; Dermira; Regeneron Pharmaceuticals; Mylan; Janssen Research and Development; Galderma; Almirall; UCB; University of Pennsylvania; Celgene; Novartis; AbbVie; Agency for Healthcare Research and Quality; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Sanofi; Merck; Allergan; AstraZeneca; Eli Lilly and Company; National Psoriasis Foundation; Pfizer; Samsung; Amgen","keywords":"Medicine; Task force; Psoriasis; Pandemic; Coronavirus disease 2019 (COVID-19); 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Foundation (evidence); Disease; Dermatology; Virology; Pathology; Infectious disease (medical specialty); Outbreak","score_opus":0.028539436760893468,"score_gpt":0.30323649867281544,"score_spread":0.27469706191192195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3082286918","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0026242707,0.058182422,0.01667452,0.47229925,0.08365977,0.010165066,0.07925582,0.0037292598,0.27340966],"genre_scores_gemma":[0.02073256,0.116372794,0.10210987,0.32234287,0.042402707,0.018389167,0.09964942,0.0025917022,0.27540898],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98658574,0.0041273544,0.0024582942,0.0003743653,0.0051894695,0.0012648773],"domain_scores_gemma":[0.9437648,0.01574906,0.0063754716,0.0016796745,0.027662309,0.0047687725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017992789,0.0012916372,0.0020300846,0.0030267527,0.0013815358,0.0050436696,0.0053601987,0.012834958,0.040509507],"category_scores_gemma":[0.079918265,0.0016210017,0.003469332,0.0022177156,0.0013136851,0.0024291512,0.0031720237,0.010752556,0.03314834],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000775398,0.00011226218,0.00044949993,0.0005583862,0.000021328246,0.00005594461,0.000062324834,0.0001845453,0.00013823756,0.0009762008,0.9563847,0.04097889],"study_design_scores_gemma":[0.0003484889,0.000113558,0.0040282276,0.00616746,0.00006726902,0.00017603394,0.00011151601,0.00017211871,0.00021790403,0.0018735223,0.9866648,0.000059197755],"about_ca_topic_score_codex":0.049511086,"about_ca_topic_score_gemma":0.069051065,"teacher_disagreement_score":0.049511086,"about_ca_system_score_codex":0.0039900867,"about_ca_system_score_gemma":0.028080624,"threshold_uncertainty_score":0.13551778},"labels":[],"label_agreement":null},{"id":"W3082587154","doi":"10.1016/j.jaad.2020.08.099","title":"Cutaneous signs and risk factors for ocular melanoma","year":2020,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Ocular Oncology and Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Women's College Hospital; University of Toronto","funders":"","keywords":"Medicine; Melanoma; Ocular Melanoma; Choroid; Ciliary body; Eyelid; Dermatology; IRIS (biosensor); Ophthalmology; Cancer research; Retina","score_opus":0.03490515049596458,"score_gpt":0.3603702933922608,"score_spread":0.3254651428962962,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3082587154","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000088584755,0.9994041,0.000025897938,0.000099178724,0.000075045886,0.0000018072392,0.000011741916,0.0000019063617,0.00029179174],"genre_scores_gemma":[0.0010177661,0.9983211,0.00008686476,0.00014466618,0.00019756578,0.000003523647,0.000025274989,5.2642594e-7,0.00020258622],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99982506,0.00003109234,0.000036453454,0.000034554603,0.00005834252,0.000014518918],"domain_scores_gemma":[0.99952984,0.00025002268,0.000119699136,0.000009296311,0.00006579426,0.00002536077],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043571118,0.00071862567,0.0013648629,0.0017729856,0.00020856428,0.0007056335,0.000605507,0.0008256996,0.004377724],"category_scores_gemma":[0.0010735583,0.00030707777,0.00083072635,0.0015237993,0.00026648625,0.00076349964,0.0004493107,0.0012964495,0.0008650676],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011410521,0.00008002887,0.0017069554,0.023789972,0.00039009933,0.00016352285,0.00003193634,0.0001270951,0.00030206094,0.00078446214,0.021340795,0.951169],"study_design_scores_gemma":[0.0001786963,0.00038398232,0.03295722,0.06023537,0.00505319,0.0061627245,0.00025910305,0.00039356272,0.00063757494,0.0033212432,0.8903052,0.00011215146],"about_ca_topic_score_codex":0.0022882137,"about_ca_topic_score_gemma":0.0045391447,"teacher_disagreement_score":0.004377724,"about_ca_system_score_codex":0.00030926132,"about_ca_system_score_gemma":0.00079417246,"threshold_uncertainty_score":0.014644921},"labels":[],"label_agreement":null},{"id":"W3083095563","doi":"10.1016/j.jaad.2020.08.115","title":"Availability and quality of patient decision aids for dermatologic conditions","year":2020,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Patient-Provider Communication in Healthcare","field":"Health Professions","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Decision aids; Medicine; Scopus; Regret; MEDLINE; Family medicine; Alternative medicine; Pathology; Computer science","score_opus":0.20469445896757074,"score_gpt":0.4662639824507547,"score_spread":0.26156952348318396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083095563","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.028655639,0.0010093261,0.00031195668,0.90329546,0.00218074,0.000037809034,0.00022679858,0.000027935748,0.064254425],"genre_scores_gemma":[0.57460177,0.001846015,0.0022579264,0.36859152,0.0097168945,0.00013772809,0.00026612726,0.000085324646,0.0424967],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9886225,0.005974538,0.0013344887,0.00032170347,0.0028283948,0.0009185094],"domain_scores_gemma":[0.814372,0.15565273,0.00895698,0.0022303215,0.013341694,0.005446259],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010775405,0.00012345212,0.00028462728,0.0007528221,0.0023363403,0.0029756764,0.000686313,0.008758199,0.020455837],"category_scores_gemma":[0.1087467,0.0002741845,0.00044603762,0.0005525134,0.0010052726,0.0021177821,0.00094225275,0.0048876153,0.001712926],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009344899,0.0010994476,0.15619504,0.00022047546,0.00005401745,0.0041953307,0.0021429001,0.0008657034,0.00045739056,0.009025904,0.6534829,0.17132631],"study_design_scores_gemma":[0.0006092288,0.0011520216,0.19880073,0.0017792443,0.00018732095,0.010509724,0.010267181,0.008461386,0.0016040681,0.020606922,0.7457996,0.00022252319],"about_ca_topic_score_codex":0.0131272,"about_ca_topic_score_gemma":0.03009797,"teacher_disagreement_score":0.020455837,"about_ca_system_score_codex":0.0035582427,"about_ca_system_score_gemma":0.0052428218,"threshold_uncertainty_score":0.068431616},"labels":[],"label_agreement":null},{"id":"W3085117737","doi":"10.1016/j.jaad.2020.09.037","title":"Twice-weekly topical calcipotriene/betamethasone dipropionate foam as proactive management of plaque psoriasis increases time in remission and is well tolerated over 52 weeks (PSO-LONG trial)","year":2020,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; University of Toronto","funders":"Daiichi Sankyo Europe; Samsung; Sandoz; Janssen Pharmaceuticals; Sanofi Genzyme; Novartis; Merck Sharp and Dohme; Bausch Health; Allergan; Beiersdorf; Janssen Research and Development; Language Literacy and Culture, University of Maryland, Baltimore County; EMD Serono; Almirall; MorphoSys; Galderma; Bayer; Astellas Pharma; Daiichi-Sankyo; National Institute for Health and Care Research; LEO Pharma; UCB Pharma; Dermira; Galápagos; MedImmune; Janssen UK; Sanofi; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research; Ortho Dermatologics; Celgene; Johnson and Johnson; Les Laboratories Pierre Fabre; Regeneron Pharmaceuticals; Takeda Pharmaceutical Company; Amgen; Boehringer Ingelheim; Schering-Plough; AbbVie; Roche; Merck; GlaxoSmithKline; Incyte; Pfizer; Biogen; Asana Biosciences; Santen; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca","keywords":"Medicine; Betamethasone dipropionate; Randomized controlled trial; Psoriasis; Clinical endpoint; Internal medicine; Dermatology","score_opus":0.01794440259014538,"score_gpt":0.2784574218106345,"score_spread":0.2605130192204891,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3085117737","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97566015,0.015844086,0.0006816849,0.0007461994,0.00042775422,0.0017002145,0.0005624863,0.0001827413,0.004194627],"genre_scores_gemma":[0.98937196,0.0037892892,0.0012814368,0.0008737685,0.0002660605,0.0010087319,0.0005465354,0.000012116598,0.0028500455],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9997943,0.00008941966,0.000013821726,0.000036498805,0.000033346514,0.000032541193],"domain_scores_gemma":[0.9997248,0.00007836638,0.000070201364,0.000018783016,0.000021114405,0.000086797954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008205758,0.000510016,0.0008395939,0.00021501459,0.00019235603,0.00046448637,0.0003841055,0.0007258056,0.004003106],"category_scores_gemma":[0.0004668483,0.0002014858,0.0008415715,0.00016938863,0.00031136212,0.00031763234,0.00015213048,0.0011174227,0.00040385424],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7121901,0.014334847,0.002823545,0.001970682,0.0013228327,0.000121189194,0.00010026453,0.00056933943,0.025260312,0.00031498348,0.003656926,0.23733503],"study_design_scores_gemma":[0.8371011,0.14788666,0.008877173,0.00013616701,0.0005677504,0.00014919294,0.000030063266,0.00064281625,0.0023026569,0.0001152944,0.0021763921,0.000014806263],"about_ca_topic_score_codex":0.00042130047,"about_ca_topic_score_gemma":0.0013630143,"teacher_disagreement_score":0.004003106,"about_ca_system_score_codex":0.0002515554,"about_ca_system_score_gemma":0.00045232644,"threshold_uncertainty_score":0.013391733},"labels":[],"label_agreement":null},{"id":"W3085796913","doi":"10.1016/j.jaad.2020.09.027","title":"Stevens-Johnson syndrome and toxic epidermal necrolysis reactions to BRAF and MEK inhibitors in patients with melanoma: A systematic review","year":2020,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Psoriasis Association","keywords":"Vemurafenib; Medicine; Toxic epidermal necrolysis; Adverse effect; Melanoma; MEK inhibitor; Dermatology; Internal medicine; MEDLINE; Oncology; Pediatrics; Metastatic melanoma; Cancer research","score_opus":0.010522160189657064,"score_gpt":0.2689324435796214,"score_spread":0.25841028338996436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3085796913","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00042321178,0.9991654,0.000032609296,0.0000757022,0.00004293886,0.000021921762,0.00011079924,0.000002636932,0.00012470975],"genre_scores_gemma":[0.0041885995,0.9951997,0.00013499429,0.00025917063,0.000041422514,0.000023451288,0.00008115211,0.000001197203,0.00007017826],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9991572,0.00015327224,0.00036658908,0.000116377734,0.00016772449,0.000038900773],"domain_scores_gemma":[0.99706596,0.0017043743,0.00089451997,0.00003909327,0.00023571675,0.000060398612],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012313918,0.00075095275,0.0035092062,0.003781879,0.0002242164,0.0011276095,0.0009844205,0.001038776,0.0038197485],"category_scores_gemma":[0.0046687084,0.00048547596,0.0034353605,0.0036573224,0.0003623057,0.0011096357,0.0008208972,0.0007332814,0.00023392205],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046234715,0.000044331915,0.0021548774,0.7478384,0.009070063,0.00027442686,0.00014762908,0.00018909168,0.00058675575,0.00032786635,0.008239364,0.23066488],"study_design_scores_gemma":[0.0009187124,0.00059535797,0.021986777,0.66865396,0.13227822,0.003164212,0.00047036432,0.00018028707,0.0005627368,0.00079682784,0.17024575,0.00014684713],"about_ca_topic_score_codex":0.0033375414,"about_ca_topic_score_gemma":0.012148292,"teacher_disagreement_score":0.0038197485,"about_ca_system_score_codex":0.0006993768,"about_ca_system_score_gemma":0.0019425211,"threshold_uncertainty_score":0.012778282},"labels":[],"label_agreement":null},{"id":"W3089987941","doi":"10.1016/j.jaad.2020.08.135","title":"Characteristics and treatment outcomes in chromhidrosis: A systematic review","year":2020,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Sympathectomy and Hyperhidrosis Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Brock University; University of Toronto; Memorial University of Newfoundland","funders":"","keywords":"Medicine; Dermatology; Apocrine; Pathology","score_opus":0.04369861053098266,"score_gpt":0.3714788084074826,"score_spread":0.3277801978764999,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3089987941","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0029409907,0.99617106,0.00007903654,0.00010321106,0.00006614497,0.00010179064,0.0004191033,0.0000057411457,0.00011300179],"genre_scores_gemma":[0.06846288,0.92960227,0.00051012833,0.0005952833,0.000078593315,0.00025678813,0.00036438563,0.000006767021,0.0001229292],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99580705,0.0012160027,0.001665826,0.000514403,0.0005718094,0.00022483483],"domain_scores_gemma":[0.9868195,0.009033525,0.003095328,0.00018884863,0.00063058425,0.00023237067],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004066536,0.0011916006,0.008765638,0.0044160066,0.00050385954,0.002234626,0.0014855646,0.0019704285,0.0052596023],"category_scores_gemma":[0.019031126,0.0011034901,0.012138911,0.006962206,0.000835632,0.0017536466,0.0015796368,0.0017334702,0.00028476137],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008759625,0.00004794605,0.00756781,0.8680503,0.103092745,0.00013218472,0.00017390838,0.0001300674,0.00014057483,0.00013860082,0.0013515992,0.018298341],"study_design_scores_gemma":[0.001715332,0.00034846456,0.025046341,0.3140689,0.6502374,0.00044463566,0.00040496257,0.00014984173,0.00013074913,0.00037157803,0.007002119,0.000079692516],"about_ca_topic_score_codex":0.011481405,"about_ca_topic_score_gemma":0.040444132,"teacher_disagreement_score":0.011481405,"about_ca_system_score_codex":0.0021356712,"about_ca_system_score_gemma":0.004996634,"threshold_uncertainty_score":0.022829175},"labels":[],"label_agreement":null},{"id":"W3091276467","doi":"10.1016/j.jaad.2020.09.087","title":"Development of chronic cutaneous lupus erythematosus during biologic therapy: A systematic review","year":2020,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Probity Medical Research; Sunnybrook Health Science Centre; Women's College Hospital; McMaster University; University of Toronto","funders":"","keywords":"Medicine; Cutaneous Lupus Erythematosus; Dermatology; Lupus erythematosus; Immunology","score_opus":0.04236667957580036,"score_gpt":0.33545471120061304,"score_spread":0.2930880316248127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3091276467","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014068688,0.99797267,0.00006424931,0.0000726352,0.0000620095,0.00007462161,0.00024136993,0.0000039040056,0.000101767706],"genre_scores_gemma":[0.022067973,0.9767535,0.0003331988,0.00040338424,0.000060748716,0.00012229635,0.0001796586,0.0000037579755,0.00007550298],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9969566,0.00084052887,0.0012182426,0.0003804631,0.00046354884,0.00014060049],"domain_scores_gemma":[0.9881711,0.0082877325,0.0025672046,0.0001431268,0.00064458343,0.00018628078],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033638363,0.0011298491,0.0081063425,0.004859709,0.00042451516,0.002087105,0.0015513307,0.0019430157,0.0047254013],"category_scores_gemma":[0.014013757,0.0009589329,0.008438023,0.0066486513,0.000667167,0.0019175959,0.0014464752,0.0014035145,0.00026446543],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005394902,0.000027322514,0.0028699364,0.92937374,0.040273532,0.00013516762,0.00016624854,0.00008898516,0.00013278413,0.000118048294,0.0015099436,0.02476492],"study_design_scores_gemma":[0.0011606201,0.00039004095,0.020385826,0.5272644,0.43304858,0.0008299578,0.00045195216,0.000137312,0.00014045586,0.00029754842,0.015795304,0.00009804529],"about_ca_topic_score_codex":0.008691436,"about_ca_topic_score_gemma":0.029781787,"teacher_disagreement_score":0.008691436,"about_ca_system_score_codex":0.0016668172,"about_ca_system_score_gemma":0.004054921,"threshold_uncertainty_score":0.01778984},"labels":[],"label_agreement":null},{"id":"W3091954147","doi":"10.1016/j.jaad.2020.09.084","title":"Dupilumab and the risk of conjunctivitis and serious infection in patients with atopic dermatitis: A propensity score–matched cohort study","year":2020,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institutes of Health; Vertex Pharmaceuticals; AbbVie; Patient-Centered Outcomes Research Institute; Roche; Bayer; Pfizer; Bristol-Myers Squibb Canada; Boehringer Ingelheim","keywords":"Dupilumab; Medicine; Atopic dermatitis; Relative risk; Dermatology; Cohort; Internal medicine; Cohort study; Retrospective cohort study; Confidence interval","score_opus":0.009657395789270539,"score_gpt":0.24272930717703764,"score_spread":0.2330719113877671,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3091954147","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998971,0.00036695358,0.00012339703,0.000028933082,0.000024928177,0.00001060422,0.00022292485,0.000004936779,0.0002464153],"genre_scores_gemma":[0.99939,0.00011483143,0.00006955181,0.000028660645,0.00002685584,0.000007789987,0.00019519743,0.000002701316,0.00016455309],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991597,0.00017576582,0.00009318743,0.0002919837,0.00011195606,0.00016751549],"domain_scores_gemma":[0.99848455,0.00019241535,0.00058325985,0.0003644677,0.00011550885,0.000259855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079677545,0.0006319158,0.0007252966,0.0007854156,0.0008661799,0.0012824594,0.00064244855,0.0009932474,0.0019212334],"category_scores_gemma":[0.0015744136,0.0009685207,0.0017856208,0.0014596962,0.00047346784,0.00080713513,0.000601113,0.0013884809,0.00034057949],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019181035,0.00017174176,0.99491936,0.000018806093,0.00087355886,0.00019965494,0.000046095698,0.000083922685,0.00055423274,0.000055429326,0.0001685662,0.000990437],"study_design_scores_gemma":[0.00018992893,0.0004373822,0.9965313,0.00000819254,0.00054665655,0.00057177607,0.00016918908,0.0010489882,0.00011722449,0.00007731723,0.00028063785,0.000021562679],"about_ca_topic_score_codex":0.005360491,"about_ca_topic_score_gemma":0.0045123515,"teacher_disagreement_score":0.005360491,"about_ca_system_score_codex":0.00052650063,"about_ca_system_score_gemma":0.0005094077,"threshold_uncertainty_score":0.010658562},"labels":[],"label_agreement":null},{"id":"W3092227026","doi":"10.1016/j.jaad.2020.10.003","title":"Contact dermatitis to personal care products is increasing (but different!) in males and females: North American Contact Dermatitis Group data, 1996-2016","year":2020,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Contact Dermatitis and Allergies","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Ottawa; Montreal General Hospital; University of Toronto; McGill University; Health Sciences Centre","funders":"","keywords":"Contact dermatitis; Allergic contact dermatitis; Medicine; Irritant contact dermatitis; Dermatology; Patch test; Population; Allergy; Immunology; Environmental health","score_opus":0.029826041078624275,"score_gpt":0.28967462547178774,"score_spread":0.25984858439316344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092227026","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90949714,0.011043684,0.0002815579,0.0012300543,0.00024286025,0.00006661247,0.05819296,0.00008880168,0.01935632],"genre_scores_gemma":[0.9647172,0.005130957,0.00026279557,0.0004903673,0.00012644447,0.000043928434,0.024927715,0.000019050087,0.0042815693],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991872,0.00007506094,0.00013544447,0.00013468208,0.00034045998,0.00012717377],"domain_scores_gemma":[0.9978935,0.00012666703,0.0010565099,0.00009089536,0.00057859067,0.00025387958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045752368,0.00024714167,0.0002853843,0.001717567,0.00032751934,0.0006791729,0.00028468345,0.0004158871,0.004988694],"category_scores_gemma":[0.0011387325,0.00020970427,0.00080122956,0.003170462,0.00019701458,0.00076560705,0.00053081656,0.00052018766,0.0008819616],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000080917074,0.000021389424,0.9906476,0.00006938427,0.00008303607,0.000043114716,0.00007780191,0.000016397244,0.00016047776,0.000018992027,0.0031169744,0.00566387],"study_design_scores_gemma":[0.0000014081792,0.000010656275,0.99852496,0.000016096896,0.000012974789,0.00009038986,0.00014167017,0.000006083905,0.000021874952,0.0000029543412,0.001169559,0.0000014728429],"about_ca_topic_score_codex":0.05859646,"about_ca_topic_score_gemma":0.109291054,"teacher_disagreement_score":0.05859646,"about_ca_system_score_codex":0.0004635599,"about_ca_system_score_gemma":0.0004925599,"threshold_uncertainty_score":0.11651081},"labels":[],"label_agreement":null},{"id":"W3092534047","doi":"10.1016/j.jaad.2020.10.005","title":"Hidradenitis suppurativa and major adverse cardiac events: A systematic review and meta-analysis","year":2020,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Bristol-Myers Squibb","keywords":"Medicine; Hidradenitis suppurativa; Meta-analysis; Myocardial infarction; Internal medicine; Population; Odds ratio; Cohort study; MEDLINE; Relative risk; Cohort; Confidence interval; Disease","score_opus":0.047336489089576536,"score_gpt":0.3668701768913367,"score_spread":0.31953368780176017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092534047","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0039639077,0.9950654,0.00020526646,0.00009283151,0.00009376102,0.00012920966,0.00028560378,0.000013808862,0.00015027815],"genre_scores_gemma":[0.115756035,0.8805303,0.0014414241,0.0009026509,0.00021959857,0.00038629674,0.00037439467,0.000016383732,0.00037296276],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9969694,0.001148732,0.00097205257,0.00039368542,0.00033654898,0.00017962414],"domain_scores_gemma":[0.9923889,0.0050786077,0.0016883685,0.00022403765,0.00046552107,0.0001544789],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005686096,0.0021897564,0.01259164,0.0037596764,0.0005125368,0.0021461535,0.001580827,0.0021347753,0.0061834943],"category_scores_gemma":[0.01319366,0.0015328111,0.022562811,0.004528926,0.000623189,0.0015990508,0.0015970073,0.0018797704,0.00038225876],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022127484,0.000058049693,0.0039136023,0.47434327,0.5033144,0.00018802182,0.00010820976,0.00026937545,0.00026537763,0.000096616015,0.0009274532,0.014302862],"study_design_scores_gemma":[0.0011585645,0.00021351724,0.005342339,0.025102634,0.9655916,0.00014759839,0.000068385714,0.00010624859,0.000070926224,0.00012083472,0.002045603,0.00003178618],"about_ca_topic_score_codex":0.005540477,"about_ca_topic_score_gemma":0.02281734,"teacher_disagreement_score":0.01259164,"about_ca_system_score_codex":0.0014866932,"about_ca_system_score_gemma":0.002205349,"threshold_uncertainty_score":0.030071259},"labels":[],"label_agreement":null},{"id":"W3092813108","doi":"10.1016/j.jaad.2020.10.012","title":"Diagnosis of gamma/delta mycosis fungoides requires longitudinal clinical observation","year":2020,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Mycosis fungoides; Medicine; Lymphoma; Peripheral T-cell lymphoma; Phenotype; Cutaneous T-cell lymphoma; Pathology; CD8; T cell; Immunology; Antigen; Biology; Immune system; Gene","score_opus":0.11743088506398577,"score_gpt":0.41140490255054446,"score_spread":0.2939740174865587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092813108","genre_codex":"empirical","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6497103,0.021194281,0.00904924,0.21690404,0.005036617,0.0004161892,0.0003646402,0.00039498252,0.09692975],"genre_scores_gemma":[0.95762354,0.004576406,0.0028897694,0.023585133,0.007774747,0.00006290737,0.00013728839,0.000031520965,0.0033187896],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99917537,0.00019523257,0.00013105207,0.00010283806,0.00019763567,0.00019793991],"domain_scores_gemma":[0.99668103,0.0017586407,0.00025654424,0.00015737998,0.00045209067,0.0006943662],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012863225,0.00067494786,0.0008433492,0.00080782565,0.0019438714,0.0010590133,0.0008299569,0.005960868,0.0013826144],"category_scores_gemma":[0.007526949,0.0004727201,0.00067179365,0.00044035813,0.0014106956,0.0023284801,0.00053141825,0.004153253,0.0007747219],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021302668,0.0001649537,0.12102239,0.00011136349,0.000023074557,0.8378308,0.0005381252,0.00029999434,0.0031852457,0.0014740096,0.017014064,0.018122967],"study_design_scores_gemma":[0.000047984027,0.0002645121,0.049028162,0.00032980874,0.000052762098,0.92547417,0.0012304552,0.0019469158,0.0006614023,0.0031331738,0.01779034,0.00004027656],"about_ca_topic_score_codex":0.0025410808,"about_ca_topic_score_gemma":0.00375386,"teacher_disagreement_score":0.005960868,"about_ca_system_score_codex":0.0009674809,"about_ca_system_score_gemma":0.0010935132,"threshold_uncertainty_score":0.007019639},"labels":[],"label_agreement":null},{"id":"W3093351725","doi":"10.1016/j.jaad.2020.03.114","title":"Skin permeation and penetration of crisaborole when coapplied with emollients","year":2020,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Pfizer","keywords":"Medicine; Atopic dermatitis; Moisturizer; Dermatology; Antipruritic; Penetration (warfare); Food science","score_opus":0.013772016143768554,"score_gpt":0.2797321736162812,"score_spread":0.26596015747251267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3093351725","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.043720447,0.48297605,0.0017477949,0.17204805,0.2938875,0.000090882946,0.00049887615,0.00018349024,0.004846865],"genre_scores_gemma":[0.22597285,0.26723632,0.0025440713,0.15865442,0.3113832,0.00010155013,0.0005536043,0.00016121632,0.033392854],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992341,0.00017183623,0.0001068388,0.00011878197,0.00028353385,0.0000849307],"domain_scores_gemma":[0.99745566,0.0011801474,0.00031412605,0.000048364054,0.00087976834,0.00012192919],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013811581,0.0006648195,0.001255121,0.000453547,0.00043693103,0.0013085017,0.0010424515,0.0031610301,0.0034546922],"category_scores_gemma":[0.0030194088,0.00025179103,0.00044146937,0.00058772473,0.0007003853,0.0011739692,0.000369096,0.0022009914,0.0016623426],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003395175,0.0003310072,0.002669077,0.016022403,0.0002890089,0.01033723,0.00029986454,0.00021827596,0.038442537,0.0009737456,0.7813824,0.14563932],"study_design_scores_gemma":[0.00016220556,0.0012886879,0.0059836498,0.0013131478,0.0005556555,0.01202895,0.0005199763,0.00090307643,0.045084547,0.0007256062,0.9313493,0.00008522797],"about_ca_topic_score_codex":0.00058372394,"about_ca_topic_score_gemma":0.0009236218,"teacher_disagreement_score":0.0034546922,"about_ca_system_score_codex":0.0006184572,"about_ca_system_score_gemma":0.00050793326,"threshold_uncertainty_score":0.011557102},"labels":[],"label_agreement":null},{"id":"W3093567390","doi":"10.1016/j.jaad.2020.10.032","title":"Low-dose oral minoxidil for treating alopecia: A 3-year North American retrospective case series","year":2020,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"","keywords":"Minoxidil; Medicine; Dermatology; Dosing; Food and drug administration; Hair loss; Drug; Pharmacology","score_opus":0.01672180378980583,"score_gpt":0.2945849876192159,"score_spread":0.2778631838294101,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3093567390","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9385989,0.041764073,0.0017575388,0.007909528,0.0009988692,0.000192247,0.0005900403,0.00015210338,0.008036844],"genre_scores_gemma":[0.9882423,0.006527386,0.0006108646,0.0018145405,0.0014774681,0.000028445822,0.00026454977,0.000039546034,0.0009948956],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.9991301,0.0001126594,0.00018825832,0.00019984438,0.00016225058,0.00020696865],"domain_scores_gemma":[0.99615437,0.001284766,0.0012560671,0.00020440771,0.00041564254,0.00068479305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075671944,0.0007482365,0.001161499,0.0025426513,0.0017744672,0.0016141613,0.0010327091,0.0028503323,0.003560617],"category_scores_gemma":[0.003940369,0.00088232174,0.0009959328,0.0021190734,0.0010038228,0.0024702062,0.0010103919,0.0020045196,0.00089292275],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008556778,0.00011764223,0.09679511,0.00023529827,0.00010052987,0.8914766,0.0008075727,0.00007739684,0.00062229176,0.00023297472,0.0041831797,0.0052659875],"study_design_scores_gemma":[0.000014096245,0.0000524803,0.021780146,0.00010575219,0.00006334402,0.9746514,0.0007014842,0.00017071064,0.0001037684,0.00009741819,0.0022369996,0.000022511947],"about_ca_topic_score_codex":0.002343771,"about_ca_topic_score_gemma":0.003576482,"teacher_disagreement_score":0.003560617,"about_ca_system_score_codex":0.00089825125,"about_ca_system_score_gemma":0.0008661795,"threshold_uncertainty_score":0.011911392},"labels":[],"label_agreement":null},{"id":"W3094618645","doi":"10.1016/j.jaad.2020.10.031","title":"Trends in mortality and cause-specific mortality among patients with psoriasis and psoriatic arthritis in Ontario, Canada","year":2020,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Institute for Clinical Evaluative Sciences; North York General Hospital; Sunnybrook Health Science Centre; Women's College Hospital; University Health Network; University of Toronto; Health Sciences Centre","funders":"Canadian Rheumatology Association","keywords":"Medicine; Psoriatic arthritis; Psoriasis; Dermatology","score_opus":0.024147865576726,"score_gpt":0.24328618507093408,"score_spread":0.2191383194942081,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3094618645","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9461589,0.00548194,0.00026526896,0.0037044762,0.00012778254,0.000097591,0.032769173,0.000086117674,0.011308745],"genre_scores_gemma":[0.98925483,0.0016926719,0.00022586808,0.00036415784,0.000031287265,0.000029102512,0.0052643013,0.000015150873,0.003122631],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99829537,0.00009989161,0.0001727708,0.0001861926,0.00054624677,0.0006994776],"domain_scores_gemma":[0.9953968,0.00017340633,0.00085127103,0.00008630261,0.002323675,0.001168548],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054681697,0.00045346704,0.0007700928,0.002084472,0.0030593942,0.0015642957,0.0020182368,0.00087109173,0.0037752828],"category_scores_gemma":[0.0028366123,0.0006022081,0.0014932937,0.00556612,0.0008975539,0.0006248233,0.0011081182,0.0012545406,0.00043774757],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013510215,0.000030425666,0.9912918,0.0000879763,0.0001246244,0.000145109,0.00047483924,0.00021674484,0.00015820761,0.00019706856,0.0041942797,0.0029437938],"study_design_scores_gemma":[0.000014015623,0.000012518433,0.9977537,0.00004301113,0.00003782508,0.000072921706,0.0006746713,0.00023508053,0.00002384745,0.000023886098,0.0010960232,0.00001262113],"about_ca_topic_score_codex":0.997969,"about_ca_topic_score_gemma":0.99870884,"teacher_disagreement_score":0.050161503,"about_ca_system_score_codex":0.050161503,"about_ca_system_score_gemma":0.051654134,"threshold_uncertainty_score":0.36394888},"labels":[],"label_agreement":null},{"id":"W3094901197","doi":"10.1016/j.jaad.2020.10.027","title":"Fairness and transparency in medical journals","year":2020,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Academic Publishing and Open Access","field":"Decision Sciences","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Vetting; Medicine; Transparency (behavior); Focus (optics); Internet privacy; Family medicine; Political science; Law","score_opus":0.08878137889595014,"score_gpt":0.4246582247916334,"score_spread":0.33587684589568323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3094901197","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009992284,0.021649351,0.041650034,0.6808768,0.018530868,0.0006086491,0.00034646774,0.0006541227,0.22569145],"genre_scores_gemma":[0.631361,0.01034996,0.04152834,0.21832156,0.04906873,0.0017205391,0.00032886956,0.001146722,0.046174273],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.46171898,0.36130098,0.034810152,0.022009244,0.1076914,0.012469372],"domain_scores_gemma":[0.23116617,0.5077673,0.0648393,0.09137237,0.0806058,0.024249075],"candidate_categories":["metaresearch","scholarly_communication"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.2934156,0.00080434536,0.0025435078,0.009181644,0.015697092,0.04356365,0.005076582,0.020206034,0.013772586],"category_scores_gemma":[0.6193136,0.0017203791,0.001466321,0.008319837,0.048680972,0.02678903,0.023882192,0.01629338,0.0060835886],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002083103,0.0000663869,0.0016742265,0.00086120435,0.00011022436,0.00036673906,0.023042215,0.00046409445,0.000348733,0.79540867,0.09578966,0.08165958],"study_design_scores_gemma":[0.00013560093,0.00009980294,0.0013610304,0.0017820533,0.00004960102,0.00034295965,0.0031599822,0.00051287195,0.0006176342,0.6013092,0.39049146,0.00013791102],"about_ca_topic_score_codex":0.0019371463,"about_ca_topic_score_gemma":0.0014941293,"teacher_disagreement_score":0.95643634,"about_ca_system_score_codex":0.014449061,"about_ca_system_score_gemma":0.040437628,"threshold_uncertainty_score":0.8713443},"labels":[],"label_agreement":null},{"id":"W3097601648","doi":"10.1016/j.jaad.2020.10.085","title":"Tapinarof in the treatment of psoriasis: A review of the unique mechanism of action of a novel therapeutic aryl hydrocarbon receptor–modulating agent","year":2020,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":174,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"","keywords":"Medicine; Mechanism of action; Aryl hydrocarbon receptor; Psoriasis; Mechanism (biology); Action (physics); Receptor; Hydrocarbon; Pharmacology; Dermatology; Biochemistry; Internal medicine; Organic chemistry; Epistemology; Chemistry","score_opus":0.0718099664436638,"score_gpt":0.3435358538899207,"score_spread":0.2717258874462569,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097601648","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008986077,0.9991966,0.00010095429,0.00014241997,0.00018339079,0.0000045033844,0.00001297823,0.000004963976,0.00026438208],"genre_scores_gemma":[0.00057200907,0.998434,0.00023468488,0.0002532001,0.00019884824,0.000005937791,0.000024589592,0.000001415569,0.0002753548],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998319,0.000027704917,0.000029916588,0.000031325686,0.00006159279,0.000017504026],"domain_scores_gemma":[0.999699,0.00014151544,0.000049165454,0.0000072311586,0.00006891323,0.00003420724],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071288785,0.00086432154,0.0016112246,0.0018044363,0.0002285995,0.00089159474,0.0009592249,0.0010065751,0.0023259802],"category_scores_gemma":[0.000720575,0.00027696,0.0006200617,0.0017679537,0.0004183169,0.0011451233,0.00052264135,0.0027412,0.001186852],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022126205,0.00013890465,0.00013345545,0.015509671,0.00015244233,0.00020557342,0.00004980863,0.00030102316,0.0025866823,0.0020440954,0.03188448,0.94677263],"study_design_scores_gemma":[0.00013942341,0.000441817,0.0010983028,0.004279006,0.0003970167,0.0017490841,0.00005598478,0.00018263317,0.00085414277,0.001413358,0.9893506,0.00003854811],"about_ca_topic_score_codex":0.0010066935,"about_ca_topic_score_gemma":0.0027346613,"teacher_disagreement_score":0.0023259802,"about_ca_system_score_codex":0.0004165483,"about_ca_system_score_gemma":0.0007496425,"threshold_uncertainty_score":0.0077812076},"labels":[],"label_agreement":null},{"id":"W3097815721","doi":"10.1016/j.jaad.2020.10.086","title":"Currently relevant p-phenylenediamine patch test reactions associated with hair dye and nonscalp anatomic areas: Retrospective cross-sectional analysis of North American Contact Dermatitis Group data, 2001 to 2016","year":2020,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Contact Dermatitis and Allergies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; McGill University; Health Sciences Centre; University of Ottawa; Montreal General Hospital; University of Toronto","funders":"","keywords":"Medicine; Dermatology; Scalp; Patch test; Contact dermatitis; Retrospective cohort study; Allergic contact dermatitis; Irritant contact dermatitis; Contact allergy; Allergy; Atopic dermatitis; Surgery; Immunology","score_opus":0.021197630109241743,"score_gpt":0.3047331929438285,"score_spread":0.28353556283458675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097815721","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99675214,0.00034624035,0.00006963375,0.000010866892,0.000005723927,0.0000116271185,0.0020205248,0.000005681312,0.00077754335],"genre_scores_gemma":[0.99785405,0.00019030368,0.000058166395,0.000019427474,0.0000073113893,0.000009945681,0.001602967,0.0000035022604,0.00025430086],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991973,0.00013443947,0.0001320511,0.00022446457,0.00017799182,0.00013376118],"domain_scores_gemma":[0.9974698,0.0002754979,0.0014982598,0.00017552577,0.00030512412,0.00027585492],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005358773,0.0003396638,0.0003324179,0.0016524404,0.00047232804,0.00069835386,0.00044957313,0.00047514855,0.0018268932],"category_scores_gemma":[0.0013881366,0.00045653174,0.0005736541,0.0022656657,0.0003941824,0.0008763103,0.0004927569,0.0005388539,0.00039788595],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000055204124,0.000018859311,0.99921644,0.0000079895335,0.00003055539,0.000052999392,0.00003711751,0.000012553165,0.00011421707,0.0000043669907,0.000069286725,0.00038030828],"study_design_scores_gemma":[0.0000010667603,0.000027220229,0.9995165,0.0000025061709,0.000012503137,0.00018384092,0.000103280916,0.000019165527,0.000027717291,0.0000022262495,0.000102602055,0.0000012697362],"about_ca_topic_score_codex":0.015524259,"about_ca_topic_score_gemma":0.023365319,"teacher_disagreement_score":0.015524259,"about_ca_system_score_codex":0.00047978837,"about_ca_system_score_gemma":0.00040465908,"threshold_uncertainty_score":0.030867815},"labels":[],"label_agreement":null},{"id":"W3100764894","doi":"10.1016/j.jaad.2020.11.013","title":"Brodalumab success in patients with moderate-to-severe psoriasis who failed previous interleukin-17A inhibitors","year":2020,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; University of British Columbia; Dermatrials Research; Health Sciences Centre; Bausch Health (Canada); McMaster University; Women's College Hospital; Dalhousie University; Hospital for Sick Children; University of New Brunswick; University of Toronto; Sunnybrook Health Science Centre","funders":"Janssen Biotech; Takeda Canada; LEO Pharma; Eli Lilly and Company; Galderma; Dermira; UCB; Celgene; Regeneron Pharmaceuticals; Bausch Health; Novartis; Amgen; Pfizer; AbbVie; Merck","keywords":"Medicine; Psoriasis; Interleukin 17; Dermatology; Interleukin; Internal medicine; Cytokine","score_opus":0.009972853653798554,"score_gpt":0.23722944270815155,"score_spread":0.227256589054353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3100764894","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.961132,0.02137709,0.0004051242,0.0025132315,0.00042481764,0.00010876228,0.00025303572,0.000055455643,0.013730575],"genre_scores_gemma":[0.995317,0.0024004744,0.00018107242,0.0007712097,0.00017941862,0.000018996368,0.00023904843,0.000007016682,0.00088589324],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997185,0.00005074275,0.00003552517,0.000035101144,0.000051567986,0.00010856145],"domain_scores_gemma":[0.9995552,0.00012907501,0.00007633757,0.00001966597,0.00003626693,0.00018347813],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042403975,0.000330193,0.0010151858,0.0003249804,0.00051719754,0.0008241593,0.00023395394,0.00040153728,0.001446956],"category_scores_gemma":[0.00086982816,0.0001483621,0.0007222538,0.00030877817,0.00022082165,0.0003193086,0.00016947571,0.0009930667,0.00032675616],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04029516,0.0029018666,0.5005639,0.0011145887,0.0025476841,0.0141742285,0.00051805296,0.0011192516,0.019799232,0.0011299098,0.01433736,0.40149876],"study_design_scores_gemma":[0.007847282,0.023560215,0.8724768,0.0006456186,0.0035372344,0.038884632,0.00083284825,0.003440895,0.0061138943,0.0012304222,0.041307062,0.00012313107],"about_ca_topic_score_codex":0.00076015573,"about_ca_topic_score_gemma":0.0033763798,"teacher_disagreement_score":0.001446956,"about_ca_system_score_codex":0.0004300905,"about_ca_system_score_gemma":0.00047288617,"threshold_uncertainty_score":0.004840553},"labels":[],"label_agreement":null},{"id":"W3106097577","doi":"10.1016/j.jaad.2020.08.133","title":"Treatment outcomes in confluent and reticulated papillomatosis: A systematic review","year":2020,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Cancer and Skin Lesions","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; McMaster University; Women's College Hospital; Trillium Health Centre; University of Toronto","funders":"Psoriasis Association","keywords":"Medicine; Papillomatosis; MEDLINE; Dermatology; Systematic review","score_opus":0.03640097537734587,"score_gpt":0.38940285118913603,"score_spread":0.35300187581179016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3106097577","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002212932,0.9969699,0.000078935795,0.00009712038,0.000067225796,0.00010912812,0.00032858033,0.000006688504,0.00012957629],"genre_scores_gemma":[0.0632542,0.93482697,0.0005055672,0.0006941801,0.00007484972,0.00023833489,0.00027657088,0.000008319785,0.00012102151],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99566853,0.001452282,0.0016042002,0.00050445576,0.0005393024,0.0002310836],"domain_scores_gemma":[0.9880463,0.008240415,0.0027327999,0.00017170886,0.0006124548,0.00019627843],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041624852,0.0012993168,0.0106156925,0.0042478633,0.0004783734,0.0023401135,0.0016636051,0.002026012,0.0054403613],"category_scores_gemma":[0.01968214,0.0011293272,0.011601648,0.0055093947,0.0008737576,0.0020068828,0.0017826775,0.0020009521,0.0002909276],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007611513,0.000030011139,0.0023783215,0.9148158,0.062088165,0.00009068027,0.00016165043,0.0001165542,0.00012168697,0.000118974014,0.0011191881,0.01819779],"study_design_scores_gemma":[0.0020312672,0.00038331051,0.0124975825,0.41334066,0.5612846,0.00041249377,0.00046287736,0.00015392555,0.00014614004,0.00037296247,0.008829888,0.00008437554],"about_ca_topic_score_codex":0.010855512,"about_ca_topic_score_gemma":0.037643425,"teacher_disagreement_score":0.010855512,"about_ca_system_score_codex":0.0025012956,"about_ca_system_score_gemma":0.0045369,"threshold_uncertainty_score":0.022013605},"labels":[],"label_agreement":null},{"id":"W3106710293","doi":"10.1016/j.jaad.2020.06.655","title":"15112 Epidemiology of atopic dermatitis in children aged 6-11 years: A cross-sectional Study in the United States, Canada, Europe, and Japan","year":2020,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cross-sectional study; Atopic dermatitis; Epidemiology; Environmental health; Dermatology; Pathology","score_opus":0.026186022790403354,"score_gpt":0.31900862131925345,"score_spread":0.2928225985288501,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3106710293","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99696535,0.000496466,0.000032500062,0.000045006735,0.000012342728,0.000015364347,0.0016905766,0.0000040183713,0.0007383613],"genre_scores_gemma":[0.99776673,0.0005077883,0.00008115483,0.000060161976,0.000010319647,0.00001736423,0.0011480697,0.0000036562797,0.00040467083],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992674,0.000088879715,0.00008436883,0.00014140958,0.00020562926,0.00021236695],"domain_scores_gemma":[0.9985891,0.00008262597,0.00037942428,0.000050897394,0.00043067412,0.00046722224],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004677833,0.0005116077,0.00058338995,0.0016364005,0.0012803412,0.00095357816,0.0007123296,0.0006537959,0.001460703],"category_scores_gemma":[0.00085790147,0.0006473326,0.0008561417,0.0039307633,0.0004807743,0.0005542593,0.0005643481,0.00091519946,0.00023615496],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013714861,0.000013889593,0.9995609,0.000005080028,0.000024971816,0.00003413588,0.000059123424,0.000008205457,0.000046114626,0.000004844448,0.000063289204,0.0001657122],"study_design_scores_gemma":[9.0845623e-7,0.000011762404,0.99952424,0.0000045968895,0.000011687686,0.000042119253,0.000307209,0.000014834442,0.000008308229,0.0000011336498,0.00007188715,0.0000014443526],"about_ca_topic_score_codex":0.76035553,"about_ca_topic_score_gemma":0.81225884,"teacher_disagreement_score":0.23964447,"about_ca_system_score_codex":0.0030780667,"about_ca_system_score_gemma":0.0032459004,"threshold_uncertainty_score":0.4821115},"labels":[],"label_agreement":null},{"id":"W3107147526","doi":"10.1016/j.jaad.2020.11.054","title":"Hand dermatitis in adults referred for patch testing: Analysis of North American Contact Dermatitis Group Data, 2000 to 2016","year":2020,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Contact Dermatitis and Allergies","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre; University of Ottawa; Montreal General Hospital; Health Sciences Centre; McGill University","funders":"","keywords":"Medicine; Dermatology; Patch test; Irritant contact dermatitis; Contact dermatitis; Allergic contact dermatitis; Allergen; Atopic dermatitis; Etiology; Odds ratio; Patch testing; Clinical significance; Retrospective cohort study; Allergy; Internal medicine; Immunology","score_opus":0.03719737997568045,"score_gpt":0.3108306398913488,"score_spread":0.27363325991566834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3107147526","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97299033,0.0039847177,0.00018833093,0.000087391534,0.000030028123,0.000054591615,0.019839687,0.000029892492,0.002795056],"genre_scores_gemma":[0.9852958,0.0016394437,0.00016157111,0.00011347271,0.0000342337,0.000044396773,0.011892694,0.000010386691,0.0008081338],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99875414,0.00014872679,0.00031619516,0.00025049405,0.0003913912,0.00013900432],"domain_scores_gemma":[0.99716777,0.00028778755,0.0017314068,0.0001210503,0.0004401015,0.00025199758],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007959127,0.0004026923,0.000499526,0.0037805012,0.00037156465,0.00085706764,0.00047549998,0.00052342186,0.0019952366],"category_scores_gemma":[0.0023198558,0.00030978362,0.0009716956,0.0049125217,0.00029364147,0.0010047781,0.0007546519,0.0004884392,0.00045655022],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000105881365,0.000019260577,0.9972813,0.000059610717,0.00011248666,0.000056808953,0.000048754337,0.000033664994,0.000069540816,0.000010027299,0.00051083096,0.0016917922],"study_design_scores_gemma":[0.0000044204203,0.000017993147,0.9992387,0.000019251342,0.000031471325,0.00014995212,0.00011274894,0.000036949266,0.000017643562,0.0000048350416,0.00036427646,0.0000017650151],"about_ca_topic_score_codex":0.02942036,"about_ca_topic_score_gemma":0.046978686,"teacher_disagreement_score":0.02942036,"about_ca_system_score_codex":0.0007408734,"about_ca_system_score_gemma":0.00064806617,"threshold_uncertainty_score":0.058498263},"labels":[],"label_agreement":null},{"id":"W3107214515","doi":"10.1016/j.jaad.2020.06.501","title":"18630 The influence of biologics on psoriasis comorbidities: A systematic review","year":2020,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Psoriasis; Dermatology; Comorbidity; Internal medicine","score_opus":0.03897750591068198,"score_gpt":0.3234318766053687,"score_spread":0.2844543706946867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3107214515","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00069986755,0.99857295,0.00005401449,0.00008932132,0.000067296525,0.000042716718,0.0003179489,0.0000043164364,0.00015147582],"genre_scores_gemma":[0.012588309,0.98627347,0.00024270616,0.00045148746,0.00007565539,0.000061599916,0.00020496426,0.0000037882246,0.00009801186],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99800926,0.0005008611,0.00075771287,0.0002726024,0.00034478496,0.000114779905],"domain_scores_gemma":[0.99253005,0.005004249,0.0017850559,0.00011326391,0.00043931135,0.00012800659],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027919873,0.001142684,0.0072549633,0.00432005,0.00033350158,0.0017990068,0.0013980583,0.0016383163,0.0077926638],"category_scores_gemma":[0.010769459,0.00080852496,0.007950613,0.006624785,0.00053313,0.0014621301,0.0011967364,0.0011939331,0.00051130174],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009186056,0.000032222128,0.0019740544,0.89588505,0.04935014,0.00013624769,0.00008980413,0.00014077174,0.00029121607,0.00017604054,0.0031132447,0.04789263],"study_design_scores_gemma":[0.0018659957,0.00045360843,0.017218774,0.4028169,0.54364467,0.00047584024,0.00022729674,0.00015057721,0.00024118894,0.0004084916,0.032398317,0.000098363606],"about_ca_topic_score_codex":0.007256664,"about_ca_topic_score_gemma":0.02411998,"teacher_disagreement_score":0.0077926638,"about_ca_system_score_codex":0.0012332939,"about_ca_system_score_gemma":0.003762694,"threshold_uncertainty_score":0.026069045},"labels":[],"label_agreement":null},{"id":"W3107299701","doi":"10.1016/j.jaad.2020.06.365","title":"16742 Depression as a risk factor for the development of psoriasis","year":2020,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Psoriasis; Medicine; Depression (economics); Psoriatic arthritis; Risk factor; Tumor necrosis factor alpha; Disease; Dermatology; Immunology; Internal medicine","score_opus":0.02880965044664332,"score_gpt":0.2897154125729932,"score_spread":0.2609057621263499,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3107299701","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9884089,0.004682475,0.0002559189,0.0005025764,0.00010064866,0.000020707583,0.0005509301,0.0000160788,0.005461673],"genre_scores_gemma":[0.99792886,0.0008232677,0.00015625892,0.000060130445,0.00008856517,0.000005586196,0.00019112478,0.0000025419429,0.0007437702],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997254,0.00009036916,0.000023090695,0.000030194744,0.00008020907,0.000050663803],"domain_scores_gemma":[0.9991763,0.00015861733,0.00026747808,0.000040018742,0.00011941603,0.00023805696],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024715392,0.00022080375,0.00028289747,0.00068898185,0.00032778768,0.00059850275,0.00021942616,0.00046866972,0.0042382916],"category_scores_gemma":[0.0014356655,0.0001745688,0.00036967316,0.0009172785,0.000118352895,0.00017969769,0.0001966666,0.0008407179,0.00043095968],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046029786,0.00012487892,0.98946065,0.000025200376,0.0001389968,0.0007551264,0.000035046865,0.000020681002,0.0009533302,0.00007739245,0.00047506375,0.007473232],"study_design_scores_gemma":[0.000013425174,0.00011005541,0.9981013,0.000012274505,0.00008963215,0.0010095149,0.000050922576,0.00011900621,0.000075838536,0.00004680183,0.00036752384,0.0000036281015],"about_ca_topic_score_codex":0.003268836,"about_ca_topic_score_gemma":0.00306728,"teacher_disagreement_score":0.0042382916,"about_ca_system_score_codex":0.00013896846,"about_ca_system_score_gemma":0.00038984927,"threshold_uncertainty_score":0.014178455},"labels":[],"label_agreement":null},{"id":"W3107307654","doi":"10.1016/j.jaad.2020.06.225","title":"15302 Psoriasis area and severity index component improvements at week 48 in patients treated with guselkumab compared with secukinumab: Findings from the ECLIPSE study","year":2020,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health; Dalhousie University","funders":"","keywords":"Secukinumab; Medicine; Psoriasis Area and Severity Index; Psoriasis; Dermatology; Plaque psoriasis; Interleukin 17; Internal medicine; Cytokine; Psoriatic arthritis","score_opus":0.017716807709537933,"score_gpt":0.232999873465712,"score_spread":0.21528306575617406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3107307654","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957658,0.0024359399,0.000061798375,0.000096757125,0.000080844766,0.000038590457,0.00034899867,0.0000137544985,0.0011575216],"genre_scores_gemma":[0.9977435,0.00080868363,0.00012242538,0.00014093371,0.00008587446,0.00003524321,0.00046969356,0.000008047346,0.00058572076],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9993461,0.00028298292,0.000059034046,0.000096855576,0.00010981121,0.000105146566],"domain_scores_gemma":[0.99923754,0.00026447614,0.00019999627,0.00007813629,0.00008208011,0.00013777826],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014928877,0.0004345541,0.0018462877,0.00021502403,0.00019424815,0.0007435367,0.00028526163,0.0005328584,0.0020151513],"category_scores_gemma":[0.0014351924,0.00025342128,0.0015880618,0.00035858122,0.00028615783,0.0005176754,0.00022133955,0.0011950942,0.00040155643],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8138035,0.0070426017,0.053430073,0.0009292353,0.00547075,0.00017396588,0.00015723494,0.00045235298,0.016587526,0.00012404475,0.002098001,0.09973069],"study_design_scores_gemma":[0.1715793,0.19466949,0.6157109,0.00014665692,0.008262404,0.00044284845,0.00025342556,0.00116727,0.003289798,0.00013638714,0.004261243,0.000080260565],"about_ca_topic_score_codex":0.00090988184,"about_ca_topic_score_gemma":0.0019869013,"teacher_disagreement_score":0.0020151513,"about_ca_system_score_codex":0.00034111386,"about_ca_system_score_gemma":0.0004205953,"threshold_uncertainty_score":0.007895231},"labels":[],"label_agreement":null},{"id":"W3107456787","doi":"10.1016/j.jaad.2020.06.194","title":"15021 The family impact of atopic dermatitis in children aged 6-11 years: A cross-sectional study in the United States, Canada, Europe, and Japan","year":2020,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Atopic dermatitis; Cross-sectional study; Multinational corporation; Environmental health; Gerontology; Family medicine; Pediatrics; Dermatology; Pathology","score_opus":0.01746635249846736,"score_gpt":0.3084063144276166,"score_spread":0.2909399619291493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3107456787","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99824286,0.00035510035,0.00001745785,0.000051051706,0.000009699833,0.0000068337763,0.00075298763,0.0000021130277,0.0005618887],"genre_scores_gemma":[0.99886596,0.00030421806,0.000036453723,0.00005068014,0.000008450969,0.000007555162,0.0004533761,0.0000021803296,0.0002711304],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99942744,0.00010099967,0.000058589692,0.00011312667,0.00013344282,0.0001663952],"domain_scores_gemma":[0.9984347,0.00013870127,0.0004968702,0.000061724844,0.0002972395,0.0005707562],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047404363,0.00042923322,0.00044018184,0.0013522382,0.0013391491,0.0009049062,0.00062558847,0.00067332626,0.002033156],"category_scores_gemma":[0.001135004,0.00048988184,0.00078330294,0.002757801,0.00051676953,0.00061786687,0.0005466275,0.00097565254,0.00025219345],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012470525,0.000015744254,0.99961793,0.0000026790372,0.000021417045,0.000044341905,0.00006842763,0.000006554737,0.000032345837,0.0000038537646,0.00004201287,0.00013213906],"study_design_scores_gemma":[7.300349e-7,0.000013254842,0.9994511,0.0000037539417,0.000011826442,0.00005864306,0.0003796555,0.000013448484,0.0000075641524,0.0000014966578,0.000056953457,0.0000014932176],"about_ca_topic_score_codex":0.5222868,"about_ca_topic_score_gemma":0.6153785,"teacher_disagreement_score":0.47771323,"about_ca_system_score_codex":0.0018968135,"about_ca_system_score_gemma":0.0018259499,"threshold_uncertainty_score":0.96105313},"labels":[],"label_agreement":null},{"id":"W3107960804","doi":"10.1016/j.jaad.2020.06.922","title":"18277 Development of a patient decision aid for hidradenitis suppurativa: Facilitating informed shared decision making","year":2020,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph; Windsor Clinical Research; Western University","funders":"","keywords":"Hidradenitis suppurativa; Medicine; Clinical decision making; Patient participation; Decision aids; MEDLINE; Health care; Family medicine; Alternative medicine; Pathology","score_opus":0.03276920751384137,"score_gpt":0.34508459723779206,"score_spread":0.3123153897239507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3107960804","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.27215764,0.0012751896,0.57184416,0.022943806,0.0016038894,0.0056203916,0.002051757,0.008398124,0.11410503],"genre_scores_gemma":[0.28051057,0.0006211105,0.7024644,0.0023214917,0.00016259926,0.0015968721,0.0007684334,0.00019930131,0.011355253],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9938731,0.004819184,0.00026332663,0.0002092349,0.0006466721,0.00018848527],"domain_scores_gemma":[0.9898107,0.0074088397,0.00040418556,0.00049703324,0.0010314857,0.0008478317],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007560507,0.00042520105,0.00028025266,0.00046572133,0.0006626371,0.002242311,0.00081587536,0.0008156523,0.02148988],"category_scores_gemma":[0.020316284,0.00021865177,0.00046659293,0.00029497175,0.00041624522,0.0014515808,0.0023578517,0.0010053364,0.0031575537],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002008608,0.0023946327,0.015412691,0.00080476486,0.00016090677,0.001988335,0.004944117,0.004401433,0.006861363,0.012862339,0.07238408,0.8757767],"study_design_scores_gemma":[0.0026760017,0.004117471,0.014521827,0.0023441934,0.0007250644,0.0065090656,0.008339064,0.16378993,0.038000192,0.057510193,0.70106345,0.00040350718],"about_ca_topic_score_codex":0.00057848886,"about_ca_topic_score_gemma":0.001601539,"teacher_disagreement_score":0.02148988,"about_ca_system_score_codex":0.0005022831,"about_ca_system_score_gemma":0.0035820873,"threshold_uncertainty_score":0.07189083},"labels":[],"label_agreement":null},{"id":"W3108023592","doi":"10.1016/j.jaad.2020.06.765","title":"16050 Global mixed infections in onychomycosis","year":2020,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada)","funders":"","keywords":"Trichophyton rubrum; Medicine; Trichophyton; Dermatology; Fungal growth; Identification (biology); Microbiology; Antifungal; Biology; Ecology","score_opus":0.02087051967920645,"score_gpt":0.3305156385152889,"score_spread":0.3096451188360825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3108023592","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8868446,0.03614063,0.00071152044,0.0020578878,0.00027947145,0.00006904709,0.001097981,0.00006686169,0.07273199],"genre_scores_gemma":[0.99435943,0.0035883526,0.00020437824,0.00022023405,0.00008355723,0.0000089961595,0.00020627174,0.000009228628,0.0013195104],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995672,0.00016307052,0.000043718435,0.00003105297,0.00007149867,0.00012337486],"domain_scores_gemma":[0.99970514,0.000044173983,0.00011262635,0.000018395305,0.00004895946,0.00007065967],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045477742,0.00044269764,0.00031374028,0.0013563766,0.0003431992,0.0010848241,0.00013143211,0.000511536,0.008159691],"category_scores_gemma":[0.0008207772,0.0001392287,0.00022752097,0.0011793037,0.00040732784,0.00078772637,0.0008319708,0.00046278266,0.00086406054],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014035037,0.00017136162,0.79935354,0.0006809787,0.00020351168,0.014821494,0.0009780059,0.00022462376,0.0049901684,0.0024348835,0.008383365,0.16635464],"study_design_scores_gemma":[0.00004440503,0.00041116477,0.91563135,0.0005531993,0.00018085704,0.057321418,0.0040551377,0.0003642192,0.000694107,0.0012108021,0.019515302,0.000018000432],"about_ca_topic_score_codex":0.0019659896,"about_ca_topic_score_gemma":0.0032412137,"teacher_disagreement_score":0.008159691,"about_ca_system_score_codex":0.00033031328,"about_ca_system_score_gemma":0.00036569283,"threshold_uncertainty_score":0.0272969},"labels":[],"label_agreement":null},{"id":"W3108079365","doi":"10.1016/j.jaad.2020.06.270","title":"15716 The high rate of placebo response in hidradenitis suppurativa clinical trials: Recommendations for future clinical trials","year":2020,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Calgary","funders":"","keywords":"Medicine; Placebo; Clinical endpoint; Hidradenitis suppurativa; Internal medicine; Randomization; Clinical trial; Randomized controlled trial; Surgery; Disease; Pathology; Alternative medicine","score_opus":0.2811879149168895,"score_gpt":0.5314721361226058,"score_spread":0.2502842212057163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3108079365","genre_codex":"review","genre_gemma":"empirical","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008972853,0.464601,0.037212975,0.3772247,0.047063544,0.029102918,0.004165975,0.0012027753,0.030453267],"genre_scores_gemma":[0.1004942,0.16810556,0.21822532,0.38684654,0.04766789,0.057804815,0.0034276554,0.0008796741,0.01654836],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.4489503,0.45071065,0.06400608,0.0077098333,0.025924634,0.0026984978],"domain_scores_gemma":[0.25078583,0.5942253,0.058789574,0.02171188,0.06503425,0.009453251],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.43416145,0.00319875,0.016968207,0.0036093725,0.0026999959,0.011450928,0.005450862,0.02555709,0.012970326],"category_scores_gemma":[0.5400403,0.0030782088,0.013809001,0.0055956794,0.006041351,0.009710521,0.002799421,0.017708259,0.006816691],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06901079,0.0013731053,0.010546905,0.116736025,0.021140916,0.0007095473,0.0012104769,0.0014567082,0.0035438323,0.01609997,0.1839684,0.5742034],"study_design_scores_gemma":[0.115729615,0.024391701,0.036662046,0.17868952,0.038510002,0.0013161881,0.001052018,0.0056856424,0.0037857355,0.037371773,0.55590016,0.00090559124],"about_ca_topic_score_codex":0.002959909,"about_ca_topic_score_gemma":0.008650436,"teacher_disagreement_score":0.5658386,"about_ca_system_score_codex":0.0061200163,"about_ca_system_score_gemma":0.015385692,"threshold_uncertainty_score":0.69777966},"labels":[],"label_agreement":null},{"id":"W3108138683","doi":"10.1016/j.jaad.2020.06.256","title":"15578 Cutaneous immune-related adverse events to immune checkpoint inhibitors: A dermatology perspective","year":2020,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Atezolizumab; Toxic epidermal necrolysis; Durvalumab; Nivolumab; Avelumab; Pembrolizumab; Ipilimumab; Adverse effect; Immunology; Dermatology; Erythema multiforme; Immune system; Immunotherapy; Internal medicine","score_opus":0.012328381913671659,"score_gpt":0.29464151945984407,"score_spread":0.28231313754617243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3108138683","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004016327,0.84537554,0.0009537981,0.10544664,0.011192912,0.000026983253,0.00016961229,0.00004674023,0.032771427],"genre_scores_gemma":[0.033752244,0.7907797,0.001378085,0.084676765,0.079926975,0.000027587039,0.00012645227,0.000018845532,0.009313276],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9993507,0.00018136932,0.0000906771,0.00007702398,0.00022790069,0.00007237072],"domain_scores_gemma":[0.9970023,0.0013978435,0.0004474765,0.000061356535,0.00082600757,0.00026502172],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015409301,0.0004816766,0.0010045536,0.0009996773,0.00046643082,0.0022583038,0.0005109347,0.0031320981,0.0065647345],"category_scores_gemma":[0.0026538644,0.0002486356,0.00088265934,0.00052212103,0.00058107724,0.0018173403,0.00058588246,0.004539707,0.0020810498],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055994495,0.00049381406,0.00581073,0.0038832335,0.00035001867,0.007999925,0.00014604941,0.00048876845,0.005546673,0.019652732,0.2865868,0.66848135],"study_design_scores_gemma":[0.00018880307,0.000831757,0.008275788,0.00501556,0.0003308545,0.02084392,0.0003149812,0.0002631307,0.0008521261,0.005913619,0.95712703,0.000042295283],"about_ca_topic_score_codex":0.00070199743,"about_ca_topic_score_gemma":0.0032935243,"teacher_disagreement_score":0.0065647345,"about_ca_system_score_codex":0.00087585155,"about_ca_system_score_gemma":0.000990901,"threshold_uncertainty_score":0.021961212},"labels":[],"label_agreement":null},{"id":"W3108229751","doi":"10.1016/j.jaad.2020.06.335","title":"16392 Efficacy of tapinarof cream by body region in subjects with plaque psoriasis in a phase 2b randomized controlled study","year":2020,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"","keywords":"Medicine; Psoriasis Area and Severity Index; Trunk; Psoriasis; Randomized controlled trial; Gastroenterology; Internal medicine; Atopic dermatitis; Post-hoc analysis; Plaque psoriasis; Dermatology","score_opus":0.01450576798681795,"score_gpt":0.2806347988607247,"score_spread":0.2661290308739067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3108229751","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97652787,0.008284392,0.0013514545,0.0008588229,0.0010667226,0.0071399817,0.0016687708,0.00028136134,0.0028205854],"genre_scores_gemma":[0.9756174,0.005475254,0.0024670595,0.0019677933,0.0011600009,0.0062555606,0.001316129,0.00006403412,0.0056767645],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9992156,0.0003857493,0.00004606903,0.00014369586,0.00006018553,0.00014867296],"domain_scores_gemma":[0.99918,0.00025831402,0.00014508575,0.00007543183,0.00007865227,0.00026257234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019731347,0.0021088978,0.0051915324,0.0007666054,0.0006329839,0.0013748365,0.0010727901,0.0026640806,0.012076895],"category_scores_gemma":[0.0014976641,0.001182486,0.002342848,0.00070031796,0.001407083,0.00134569,0.000453614,0.003772061,0.0016341646],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9810501,0.007406737,0.00025562663,0.0005345981,0.000602968,0.000027706348,0.000028041524,0.00011810529,0.002377968,0.000056612385,0.00044278058,0.007098733],"study_design_scores_gemma":[0.9553872,0.042897828,0.00085384306,0.000019254629,0.0003013008,0.000008166797,0.000012093987,0.00011068645,0.000119793396,0.000038394057,0.00024220753,0.000009203858],"about_ca_topic_score_codex":0.0012128858,"about_ca_topic_score_gemma":0.0023124667,"teacher_disagreement_score":0.012076895,"about_ca_system_score_codex":0.0005797634,"about_ca_system_score_gemma":0.0010786097,"threshold_uncertainty_score":0.04040122},"labels":[],"label_agreement":null},{"id":"W3108618187","doi":"10.1016/j.jaad.2020.06.667","title":"15277 Malignancy rates and comparisons to the general US population through 3 years of follow-up in guselkumab-treated patients with moderate to severe psoriasis from the VOYAGE 1 and 2 trials","year":2020,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Medicine; Skin cancer; Dermatology; Malignancy; Psoriasis; Incidence (geometry); Population; Cancer; Internal medicine","score_opus":0.03297475188691685,"score_gpt":0.2877946203099817,"score_spread":0.25481986842306487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3108618187","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99119544,0.004895921,0.00014407386,0.000045953355,0.00003536515,0.0000638721,0.0020854636,0.000007571526,0.001526329],"genre_scores_gemma":[0.9934011,0.001563155,0.000086348016,0.000074512354,0.00003561767,0.00007884121,0.003714885,0.000008072761,0.0010374245],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99885905,0.0005845134,0.0001159038,0.00019762492,0.000101347454,0.00014163514],"domain_scores_gemma":[0.99900657,0.000377275,0.00032823233,0.00010356902,0.00008253762,0.0001018813],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016957403,0.00038123011,0.00094962097,0.00094038906,0.00028050045,0.000783494,0.00041275582,0.0006351698,0.0028788217],"category_scores_gemma":[0.0019956583,0.00039065004,0.0023116749,0.0014026947,0.00026500053,0.0007641048,0.00043445302,0.00076513697,0.00039537932],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1869006,0.0008151399,0.76902413,0.0009382543,0.010022311,0.00039694892,0.0002458226,0.0010312523,0.0021496227,0.0003151609,0.0021229796,0.026037818],"study_design_scores_gemma":[0.0110598765,0.009473971,0.96572745,0.0001157651,0.007484493,0.0004873214,0.00029551506,0.0006633148,0.0007361334,0.00017774897,0.0037411456,0.00003732183],"about_ca_topic_score_codex":0.0028918888,"about_ca_topic_score_gemma":0.0033693174,"teacher_disagreement_score":0.0028918888,"about_ca_system_score_codex":0.00043914915,"about_ca_system_score_gemma":0.00032561523,"threshold_uncertainty_score":0.0096306205},"labels":[],"label_agreement":null},{"id":"W3108686266","doi":"10.1016/j.jaad.2020.06.302","title":"16110 In silico analyses of the tumor microenvironment in basal cell carcinoma highlight the importance of TH2 cytokine profile, tumor-associated macrophages, and acquisition of mesenchymal stem cell-like phenotype in advanced and treatment-resistant tumors","year":2020,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Stroma; Basal cell carcinoma; Mesenchymal stem cell; Medicine; Tumor microenvironment; Phenotype; Pathology; Cytokine; Cancer research; Carcinoma; In silico; Cell; Cancer; Basal cell; Immunology; Biology; Tumor cells; Immunohistochemistry; Internal medicine; Gene; Genetics","score_opus":0.01477880456124932,"score_gpt":0.2686106675622197,"score_spread":0.2538318630009704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3108686266","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9856858,0.000198931,0.00854349,0.00008475427,0.00003015877,0.000031490978,0.0025576202,0.00035990882,0.002507826],"genre_scores_gemma":[0.9925804,0.00007299156,0.0036734648,0.000036752346,0.000010113489,0.000021243784,0.0026972932,0.0000748222,0.00083294825],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99985397,0.000055905894,0.00000845228,0.000035918576,0.000022369042,0.000023360539],"domain_scores_gemma":[0.9994155,0.0004742582,0.00003238061,0.00002188749,0.000032595755,0.000023342325],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052473636,0.0005526662,0.00051139947,0.00039745038,0.00030296735,0.0006077981,0.0004528411,0.00051815354,0.0042289784],"category_scores_gemma":[0.0008111541,0.0002658222,0.00091968506,0.00025845945,0.00014951742,0.00020349643,0.00018612584,0.00027365668,0.00078791514],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010246566,0.0005046996,0.14487168,0.0003540914,0.00053414685,0.00054755685,0.000070069356,0.8179871,0.018886141,0.0009565672,0.0016881782,0.012575116],"study_design_scores_gemma":[0.00009826361,0.0004042147,0.025624525,0.000017871938,0.00019430218,0.00024290322,0.00008403153,0.9654223,0.00533349,0.0007523531,0.001805954,0.000019904453],"about_ca_topic_score_codex":0.005842434,"about_ca_topic_score_gemma":0.008472435,"teacher_disagreement_score":0.005842434,"about_ca_system_score_codex":0.00023665828,"about_ca_system_score_gemma":0.0004512162,"threshold_uncertainty_score":0.014147341},"labels":[],"label_agreement":null},{"id":"W3108746558","doi":"10.1016/j.jaad.2020.06.675","title":"15313 Gender differences in moderate to severe psoriasis: Analysis of the PSOLAR registry","year":2020,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"","keywords":"Medicine; Psoriasis; Disease; Longitudinal data; Dermatology; Demography; Internal medicine","score_opus":0.032568229207752826,"score_gpt":0.27092265866402504,"score_spread":0.23835442945627222,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3108746558","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945697,0.00021869525,0.00012897533,0.00003570061,0.0000066584744,0.000009568627,0.0035250601,0.0000073124916,0.001498299],"genre_scores_gemma":[0.9969933,0.00014394484,0.00006481942,0.000041319112,0.00001167761,0.000013855685,0.0021554632,0.000011812975,0.0005638131],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99913424,0.00021597397,0.00009813849,0.00024178781,0.00012985436,0.000179997],"domain_scores_gemma":[0.9982578,0.00028103456,0.0007124527,0.00022224094,0.00022166605,0.00030469437],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072352524,0.00016458891,0.0003803192,0.0011066541,0.0003894932,0.00062527874,0.00032248476,0.00032627926,0.0036445027],"category_scores_gemma":[0.0019212352,0.0002464884,0.0005476003,0.0024862175,0.00019793832,0.00048535567,0.0004922379,0.00039698958,0.0009675988],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013182004,0.000017431978,0.9984902,0.000005478764,0.00004280542,0.000048716658,0.00003792527,0.000014587412,0.00012229859,0.000027089265,0.00019832079,0.00086322],"study_design_scores_gemma":[0.000004368295,0.000035673103,0.999308,0.0000032893686,0.000019660129,0.000111488385,0.00012087625,0.00004199596,0.00003203937,0.000012467146,0.00030803136,0.000002064765],"about_ca_topic_score_codex":0.006329306,"about_ca_topic_score_gemma":0.007349822,"teacher_disagreement_score":0.006329306,"about_ca_system_score_codex":0.00025189956,"about_ca_system_score_gemma":0.00046173303,"threshold_uncertainty_score":0.012584925},"labels":[],"label_agreement":null},{"id":"W3108752263","doi":"10.1016/j.jaad.2020.06.668","title":"15280 Characterization of super responders to guselkumab treatment in moderate to severe psoriasis: Results from the VOYAGE 1 and 2 clinical trials","year":2020,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Psoriasis; Psoriasis Area and Severity Index; Dermatology; Clinical trial; Plaque psoriasis; Internal medicine","score_opus":0.07814616633827731,"score_gpt":0.3506989008348348,"score_spread":0.2725527344965575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3108752263","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927817,0.004359217,0.00022158024,0.00023740665,0.00006427692,0.000722666,0.0004735433,0.000020033163,0.0011196339],"genre_scores_gemma":[0.99202806,0.002184921,0.0008083241,0.00081788155,0.00016292554,0.0008985512,0.0014311122,0.000020164382,0.0016480902],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99943346,0.00026923828,0.000050959723,0.0000663266,0.0000810104,0.00009890611],"domain_scores_gemma":[0.99943787,0.00015845276,0.0001513734,0.000050408387,0.00005306106,0.00014875992],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001868438,0.00047205327,0.0013645873,0.0002928,0.00028696432,0.0008531445,0.00035258834,0.0008315381,0.0021400943],"category_scores_gemma":[0.0008661329,0.00023369024,0.00084535615,0.00037516578,0.00036932863,0.00067109073,0.00025978388,0.0010881755,0.0006245661],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4897744,0.020804742,0.10006504,0.0017242638,0.001750077,0.0003011586,0.0005332183,0.0010993485,0.09287295,0.0005572519,0.004295832,0.28622174],"study_design_scores_gemma":[0.15716134,0.4107772,0.3954749,0.0002572689,0.0019397329,0.00091916486,0.0004213514,0.001705973,0.013177255,0.0007702046,0.017283967,0.00011162631],"about_ca_topic_score_codex":0.0003030618,"about_ca_topic_score_gemma":0.00065500644,"teacher_disagreement_score":0.0021400943,"about_ca_system_score_codex":0.0003427676,"about_ca_system_score_gemma":0.0004755342,"threshold_uncertainty_score":0.009881377},"labels":[],"label_agreement":null},{"id":"W3108835797","doi":"10.1016/j.jaad.2020.06.196","title":"15036 Pregnancy outcomes in women exposed to guselkumab: Experience from the clinical development program","year":2020,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Pregnancy; Clinical trial; Obstetrics; Gynecology; Internal medicine","score_opus":0.08132243635984256,"score_gpt":0.4153656565485484,"score_spread":0.33404322018870586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3108835797","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972863,0.00039266617,0.0000352893,0.0002627579,0.0000065959,0.000038137114,0.00008179242,0.0000036318556,0.0018928505],"genre_scores_gemma":[0.99654007,0.0010543633,0.0001640006,0.00027100596,0.000009803787,0.000032346124,0.00015094504,0.000005094409,0.0017722914],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99927646,0.00034111016,0.000039013055,0.000040871255,0.0001379397,0.00016460518],"domain_scores_gemma":[0.9987993,0.00030605576,0.00021290753,0.000039831917,0.00013845782,0.0005034398],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012831385,0.00013389693,0.00018334646,0.00032088358,0.00094331626,0.0005465684,0.00022918724,0.00028675946,0.002222304],"category_scores_gemma":[0.002965116,0.00013222278,0.0001664684,0.0004805381,0.00030249314,0.00022242549,0.0008207005,0.000538259,0.00032040058],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017693705,0.0052379817,0.8054826,0.00008785907,0.00003758064,0.0035830915,0.0062932796,0.0000971981,0.0024575118,0.00033177788,0.002562687,0.17205894],"study_design_scores_gemma":[0.00039910065,0.009882094,0.96253055,0.00012747357,0.00009615202,0.003758067,0.010028042,0.00027186013,0.0021918602,0.00015354194,0.010536232,0.000024971436],"about_ca_topic_score_codex":0.009183527,"about_ca_topic_score_gemma":0.009922051,"teacher_disagreement_score":0.009183527,"about_ca_system_score_codex":0.0010802525,"about_ca_system_score_gemma":0.0020998858,"threshold_uncertainty_score":0.018260121},"labels":[],"label_agreement":null},{"id":"W3108854688","doi":"10.1016/j.jaad.2020.06.152","title":"14020 Durability of responses with bimekizumab, a selective dual inhibitor of interleukin-17A and -17F, in moderate to severe chronic plaque psoriasis in a 60-week randomized, double-blinded, phase 2b study (BE ABLE 2)","year":2020,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health; Probity Medical Research","funders":"","keywords":"Medicine; Post-hoc analysis; Plaque psoriasis; Psoriasis; Internal medicine; Post hoc; Gastroenterology; Randomized controlled trial; Surgery; Dermatology","score_opus":0.03296586563614887,"score_gpt":0.30592894606983007,"score_spread":0.2729630804336812,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3108854688","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929004,0.002667279,0.00048647288,0.00026794503,0.00022864237,0.000905022,0.0009412876,0.00010844816,0.0014944524],"genre_scores_gemma":[0.98889905,0.0016748591,0.000998562,0.00091893546,0.00034412788,0.0013742981,0.0013146665,0.000037536374,0.0044378904],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9995247,0.00018727097,0.000024247804,0.00008281072,0.00005127487,0.00012971458],"domain_scores_gemma":[0.9995172,0.00011685515,0.00007660099,0.00004470807,0.000029961784,0.00021469679],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017662309,0.0010439259,0.0022602847,0.0003496437,0.00032101115,0.0009126746,0.0005757051,0.0013299729,0.005943545],"category_scores_gemma":[0.00081215374,0.0005582809,0.0013136475,0.0002479687,0.0007278863,0.0008497273,0.00030202168,0.0022089554,0.0010976875],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8944585,0.022791216,0.0012710452,0.00069646863,0.0008642336,0.00005478529,0.00008036045,0.00056765456,0.025051434,0.00016907499,0.0019982974,0.051996995],"study_design_scores_gemma":[0.7734698,0.2169565,0.005338086,0.000025329415,0.0003243509,0.0000771001,0.000023825438,0.00043481909,0.0021717828,0.00014708968,0.001009423,0.000021821686],"about_ca_topic_score_codex":0.0004577861,"about_ca_topic_score_gemma":0.0008018811,"teacher_disagreement_score":0.005943545,"about_ca_system_score_codex":0.0003853137,"about_ca_system_score_gemma":0.0006214645,"threshold_uncertainty_score":0.019883096},"labels":[],"label_agreement":null},{"id":"W3108934295","doi":"10.1016/j.jaad.2020.11.058","title":"Ultra-hypofractionated low-dose total skin electron beam followed by maintenance therapy: Preliminary findings from a prospective open-label study","year":2020,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Toronto","keywords":"Medicine; Prospective cohort study; Open label; Beam (structure); Surgery; Internal medicine; Clinical trial; Optics","score_opus":0.022299513335369336,"score_gpt":0.33918118811864717,"score_spread":0.31688167478327783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3108934295","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923435,0.0028759213,0.00074144074,0.001078685,0.00031029707,0.0006276655,0.00064846425,0.000039788123,0.0013342141],"genre_scores_gemma":[0.9920076,0.0015849686,0.0013870723,0.001835423,0.00064811186,0.00073460804,0.0006447219,0.00002184934,0.0011355793],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9984585,0.0010150279,0.00010391169,0.00017280364,0.000109663895,0.00014008461],"domain_scores_gemma":[0.9959032,0.0022917413,0.00060699054,0.00051228085,0.0001409066,0.00054484373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038353244,0.0008618076,0.0024572788,0.00023946026,0.0005253557,0.0011727911,0.0010346328,0.0022681379,0.0029498462],"category_scores_gemma":[0.0030467757,0.00036417894,0.0014492971,0.00054705364,0.0012163167,0.0013025891,0.00020181247,0.0024849016,0.0005925422],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.91627276,0.023087755,0.0068040024,0.00038260836,0.001130151,0.00042154186,0.0001525474,0.00036036756,0.008495284,0.00014250299,0.0010743972,0.04167606],"study_design_scores_gemma":[0.40954733,0.54680026,0.033809192,0.00010662065,0.0016720697,0.00064819446,0.00013393277,0.0012885411,0.002432885,0.00047949678,0.003028203,0.00005332474],"about_ca_topic_score_codex":0.0006931604,"about_ca_topic_score_gemma":0.000948487,"teacher_disagreement_score":0.0038353244,"about_ca_system_score_codex":0.00067662104,"about_ca_system_score_gemma":0.00088512315,"threshold_uncertainty_score":0.020283341},"labels":[],"label_agreement":null},{"id":"W3108993003","doi":"10.1016/j.jaad.2020.06.573","title":"13711 Isotretinoin use in acne is associated with a higher odds of the adverse effect of insomnia: Results from the US FDA Adverse Events Reporting System","year":2020,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Western University","funders":"","keywords":"Isotretinoin; Medicine; Adverse effect; Acne; Odds; Insomnia; Odds ratio; Dermatology; Psychiatry; Internal medicine; Logistic regression","score_opus":0.013562855056520422,"score_gpt":0.25490979454813967,"score_spread":0.24134693949161926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3108993003","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98888737,0.0007639852,0.00034180062,0.00023889651,0.000026516882,0.00005277501,0.0058818185,0.00002842717,0.0037784807],"genre_scores_gemma":[0.99604994,0.00026004197,0.00028067274,0.00013112907,0.00002553122,0.000017875262,0.0025137258,0.000009161696,0.0007119299],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997717,0.0006564084,0.0005053194,0.00022836006,0.0007488802,0.00014405647],"domain_scores_gemma":[0.9828688,0.0032963667,0.010849587,0.00060025457,0.0018780429,0.0005069659],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014682359,0.00024517867,0.0003125717,0.0012211355,0.00030752164,0.0006663463,0.00024333445,0.00043781725,0.0028817167],"category_scores_gemma":[0.0066057453,0.00017212145,0.0010062477,0.0021647525,0.00015789796,0.0003455247,0.00033304468,0.00060874625,0.00042141744],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005715623,0.000048344926,0.9949449,0.000035409492,0.0001953756,0.00005782798,0.000028001601,0.000029394161,0.00056099606,0.000018221685,0.00034564687,0.0031643605],"study_design_scores_gemma":[0.000013103823,0.0000770979,0.9988569,0.000007203801,0.00008231806,0.00016596164,0.000036441434,0.000115505434,0.00022216956,0.000011422297,0.00040699905,0.000004895868],"about_ca_topic_score_codex":0.0117627345,"about_ca_topic_score_gemma":0.0135048125,"teacher_disagreement_score":0.0117627345,"about_ca_system_score_codex":0.00034272234,"about_ca_system_score_gemma":0.0004818536,"threshold_uncertainty_score":0.023388565},"labels":[],"label_agreement":null},{"id":"W3109095351","doi":"10.1016/j.jaad.2020.06.747","title":"15953 Clearance of head involvement in plaque psoriasis with tildrakizumab treatment in the phase 3 reSURFACE 1 study","year":2020,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Plaque psoriasis; Dermatology; Psoriasis","score_opus":0.03844495734310572,"score_gpt":0.3170295103483425,"score_spread":0.27858455300523677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3109095351","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933026,0.0026261387,0.00032666494,0.00020466944,0.00010988439,0.00074086536,0.00040175684,0.00005779858,0.0022295562],"genre_scores_gemma":[0.9947606,0.0012434452,0.00047980793,0.00037911508,0.00014073473,0.00046753115,0.00061041914,0.000024429433,0.0018939013],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9993019,0.0003042063,0.000027494245,0.00008238097,0.00008475562,0.00019923909],"domain_scores_gemma":[0.9996126,0.00007359049,0.00008422616,0.00006391738,0.00003510603,0.00013044506],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016585152,0.0008415262,0.0020269195,0.00041374876,0.00056992937,0.0011743221,0.00061510655,0.0011448899,0.0037257562],"category_scores_gemma":[0.0005719093,0.0004546658,0.0016170748,0.00031225837,0.00070588343,0.0007938997,0.00025573027,0.0019535683,0.0008722388],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.68002945,0.054911554,0.009119232,0.0010490472,0.0018637904,0.00044500607,0.00038630955,0.0012339891,0.093076736,0.0005317367,0.0036557585,0.15369749],"study_design_scores_gemma":[0.2081801,0.73095953,0.040274184,0.00008128167,0.0010275951,0.00049751997,0.00013310014,0.0006832704,0.012196904,0.00032467523,0.0055929837,0.000048793452],"about_ca_topic_score_codex":0.0009378787,"about_ca_topic_score_gemma":0.0019297466,"teacher_disagreement_score":0.0037257562,"about_ca_system_score_codex":0.00065529,"about_ca_system_score_gemma":0.00091526186,"threshold_uncertainty_score":0.012463927},"labels":[],"label_agreement":null},{"id":"W3109328263","doi":"10.1016/j.jaad.2020.11.053","title":"Development of granuloma annulare in patients on biologic therapies: A systematic review","year":2020,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Skin Diseases and Diabetes","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Psoriasis Association","keywords":"Medicine; Granuloma annulare; Dermatology; Dermatologic agents; Antibiotics","score_opus":0.03320441535056751,"score_gpt":0.35136527319542504,"score_spread":0.31816085784485754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3109328263","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019396987,0.99753594,0.000047475285,0.00006580513,0.000051827337,0.000043923377,0.00021777402,0.0000029524565,0.00009461823],"genre_scores_gemma":[0.040585443,0.95822155,0.00029566765,0.00046323412,0.00007598089,0.00007989863,0.00019796932,0.0000037797972,0.000076588425],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99733883,0.0006491258,0.0011344396,0.0003645456,0.0003909409,0.00012208629],"domain_scores_gemma":[0.9887926,0.0075055216,0.0028619026,0.00014567668,0.000533006,0.00016136598],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025875915,0.000988862,0.0068264343,0.004040443,0.00036309875,0.0017246382,0.001383995,0.0017807548,0.0041362303],"category_scores_gemma":[0.01337785,0.0009350583,0.008368008,0.004868348,0.00069841737,0.001607319,0.0013073132,0.0012923342,0.00022274423],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009965494,0.00003904773,0.007787665,0.8993471,0.05334008,0.00024938106,0.00021069362,0.00010424749,0.00020264911,0.00014323893,0.001870995,0.035708442],"study_design_scores_gemma":[0.0015048354,0.00056457595,0.039245866,0.4641632,0.4753888,0.001521439,0.00059729407,0.0001463263,0.00020447628,0.0003802404,0.016163882,0.00011901397],"about_ca_topic_score_codex":0.006663863,"about_ca_topic_score_gemma":0.022722125,"teacher_disagreement_score":0.0068264343,"about_ca_system_score_codex":0.0012953405,"about_ca_system_score_gemma":0.0026423251,"threshold_uncertainty_score":0.013837099},"labels":[],"label_agreement":null},{"id":"W3109638692","doi":"10.1016/j.jaad.2020.06.769","title":"16079 Alternate data presentation models in psoriasis: Exploring individualized approaches","year":2020,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Psoriasis; Frequentist inference; Clinical trial; Presentation (obstetrics); MEDLINE; External validity; Cohort; Medical physics; Intensive care medicine; Internal medicine; Bayesian probability; Dermatology; Statistics; Surgery; Bayesian inference","score_opus":0.7458863654206493,"score_gpt":0.46379094761113726,"score_spread":0.2820954178095121,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3109638692","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16358797,0.0015894178,0.8056503,0.011956754,0.00029849212,0.00052039186,0.0011417248,0.0005281031,0.014726841],"genre_scores_gemma":[0.8828265,0.00092613726,0.098718755,0.00084272784,0.00031799468,0.00049385417,0.00081374816,0.00019074013,0.014869399],"study_design_codex":"simulation_or_modeling","study_design_gemma":"not_applicable","domain_scores_codex":[0.9800933,0.01606061,0.0005238834,0.0014201126,0.0010620527,0.00083996623],"domain_scores_gemma":[0.8580088,0.12908858,0.004131275,0.003850989,0.0034065214,0.0015137526],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.032367684,0.0010505134,0.0024422237,0.0015781681,0.00093038345,0.0058176233,0.0037181706,0.003684664,0.015769027],"category_scores_gemma":[0.10569237,0.00090147124,0.0022848274,0.0018260472,0.0015103517,0.0073998407,0.002978085,0.0057479595,0.001403137],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013441897,0.00089491974,0.006552786,0.00031093587,0.0002374636,0.0002532881,0.00056706066,0.60059685,0.00030174092,0.28806487,0.007218228,0.09365767],"study_design_scores_gemma":[0.00009882885,0.00010388484,0.00041483718,0.00004749867,0.000057215322,0.000040802766,0.000100166384,0.9171174,0.000087059765,0.080975756,0.00093069306,0.0000258248],"about_ca_topic_score_codex":0.0056266277,"about_ca_topic_score_gemma":0.0058107935,"teacher_disagreement_score":0.032367684,"about_ca_system_score_codex":0.0033646037,"about_ca_system_score_gemma":0.0032916274,"threshold_uncertainty_score":0.17117876},"labels":[],"label_agreement":null},{"id":"W3109656022","doi":"10.1016/j.jaad.2020.06.307","title":"16177 Assessment of conjunctivitis occurring in patients with long-term use of dupilumab for the treatment of atopic dermatitis in clinical practice","year":2020,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Ottawa","funders":"","keywords":"Medicine; Dupilumab; Atopic dermatitis; Dermatology; Adverse effect; Allergic conjunctivitis; Retrospective cohort study; Incidence (geometry); Young adult; Pediatrics; Surgery; Internal medicine; Asthma","score_opus":0.04305699511383452,"score_gpt":0.38396531445560383,"score_spread":0.3409083193417693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3109656022","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886565,0.004071244,0.00013635105,0.0001442033,0.00003629413,0.00003707928,0.00023618762,0.000014754914,0.006667422],"genre_scores_gemma":[0.9984452,0.0007219487,0.00020643325,0.00011003569,0.00003392337,0.000014086207,0.00012189858,0.000001878641,0.00034454055],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99891627,0.00034217903,0.0001972333,0.00009375691,0.00030258927,0.00014799068],"domain_scores_gemma":[0.9981718,0.00050582684,0.0007188021,0.000043328564,0.00027619864,0.0002839651],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009019477,0.0003053201,0.0004375592,0.001482632,0.00060932327,0.0009806298,0.00023631666,0.0005601571,0.0026239692],"category_scores_gemma":[0.0028236168,0.000174197,0.0005486055,0.0011462611,0.00029637216,0.0005561575,0.00041059073,0.00042078353,0.0004546302],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024052613,0.0000751028,0.9871438,0.00009958418,0.000061963205,0.00172606,0.00012896345,0.00003082871,0.00096636114,0.000029608633,0.00027222035,0.009224939],"study_design_scores_gemma":[0.0000115382545,0.00057482556,0.986919,0.00006741944,0.00008832882,0.010227735,0.0004976487,0.00019103807,0.00041268117,0.000024663206,0.00097590144,0.000009214262],"about_ca_topic_score_codex":0.0018404181,"about_ca_topic_score_gemma":0.0038068914,"teacher_disagreement_score":0.0026239692,"about_ca_system_score_codex":0.00051653193,"about_ca_system_score_gemma":0.00048614788,"threshold_uncertainty_score":0.008778095},"labels":[],"label_agreement":null},{"id":"W3109737605","doi":"10.1016/j.jaad.2020.06.203","title":"15115 The patient-reported disease burden in pediatric patients with atopic dermatitis: A cross-sectional study in the United States, Canada, Europe, and Japan","year":2020,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Atopic dermatitis; Cross-sectional study; Burden of disease; Disease burden; Pediatrics; Disease; Environmental health; Family medicine; Dermatology; Internal medicine; Pathology","score_opus":0.012874592406776944,"score_gpt":0.27000565925853487,"score_spread":0.2571310668517579,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3109737605","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979151,0.00030738115,0.000023096412,0.00003990885,0.000005589625,0.000004874823,0.0012985582,0.000003498188,0.00040194692],"genre_scores_gemma":[0.99869436,0.00029516092,0.000041254716,0.000031805957,0.0000064070305,0.000006115089,0.0008135111,0.0000025631798,0.00010882072],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994747,0.00008099134,0.00006270761,0.00009803625,0.00014504469,0.0001386416],"domain_scores_gemma":[0.9987055,0.00010590786,0.0005038137,0.00005145809,0.00028777815,0.000345511],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042343506,0.00037823655,0.00041890866,0.0011350752,0.0006186144,0.0008285361,0.00051781733,0.00041741706,0.0013971932],"category_scores_gemma":[0.0011239112,0.0003393453,0.000579867,0.0029688382,0.0003538835,0.0004612672,0.0004314186,0.00058902573,0.0001796499],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000007653763,0.0000053618646,0.99967897,0.000002207041,0.000019113077,0.00002294221,0.000027478636,0.000007838456,0.000026342635,0.0000035050066,0.000051180275,0.000147442],"study_design_scores_gemma":[7.236951e-7,0.0000071593095,0.99969816,0.0000023692733,0.000009608652,0.000063051666,0.00013252386,0.000023131657,0.000009362217,0.0000011616489,0.00005172149,0.0000011098082],"about_ca_topic_score_codex":0.40113056,"about_ca_topic_score_gemma":0.46196336,"teacher_disagreement_score":0.59886944,"about_ca_system_score_codex":0.0019168523,"about_ca_system_score_gemma":0.002117082,"threshold_uncertainty_score":0.79759145},"labels":[],"label_agreement":null},{"id":"W3109999669","doi":"10.1016/j.jaad.2020.06.565","title":"13508 Trichodysplasia spinulosa in a renal transplant patient: A case report of successful treatment","year":2020,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Polyomavirus and related diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Renal transplant; Dermatology; Solid organ; Organ transplantation; Kidney; Transplantation; Internal medicine","score_opus":0.018381089543623177,"score_gpt":0.30134602011654027,"score_spread":0.2829649305729171,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3109999669","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9526184,0.006563372,0.004714885,0.006761746,0.001062644,0.0002897484,0.00030822415,0.00028761424,0.027393397],"genre_scores_gemma":[0.990378,0.0015586158,0.0015639567,0.0015696316,0.0014226815,0.00003497327,0.00017408215,0.000046251924,0.0032518206],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9993463,0.00007577109,0.00008340633,0.0001498133,0.00013267218,0.00021197356],"domain_scores_gemma":[0.99890244,0.00029385253,0.00016141857,0.00010503576,0.00007981643,0.00045739862],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034144556,0.0016920923,0.0011001886,0.0025497454,0.0032745805,0.0020444277,0.0015103114,0.006160458,0.0023694558],"category_scores_gemma":[0.0022471414,0.00095495005,0.0018444493,0.0011813563,0.0013589833,0.0021019701,0.0014539582,0.0034035374,0.001008395],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012287806,0.000032091164,0.0017590589,0.000008661694,0.000004575239,0.9969765,0.0000470174,0.000027820755,0.00031679127,0.000074706404,0.00010970944,0.0006307658],"study_design_scores_gemma":[0.000008653276,0.000042007945,0.0022073232,0.00000934984,0.000011730884,0.9968135,0.0000659697,0.00021135084,0.00023157071,0.0000766226,0.00031382774,0.000008188398],"about_ca_topic_score_codex":0.0026935171,"about_ca_topic_score_gemma":0.0035610772,"teacher_disagreement_score":0.006160458,"about_ca_system_score_codex":0.0015050052,"about_ca_system_score_gemma":0.0014136604,"threshold_uncertainty_score":0.0109196305},"labels":[],"label_agreement":null},{"id":"W3110108782","doi":"10.1016/j.jaad.2020.06.677","title":"15328 Efficacy and safety of mirikizumab in patients with moderate to severe plaque psoriasis: 104-week results from a randomized phase 2 study","year":2020,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Innovaderm (Canada)","funders":"","keywords":"Medicine; Psoriasis Area and Severity Index; Plaque psoriasis; Psoriasis; Placebo; Internal medicine; Dermatology; Randomized controlled trial; Gastroenterology; Pathology; Alternative medicine","score_opus":0.01574543642778634,"score_gpt":0.2625358340282847,"score_spread":0.24679039760049834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110108782","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99295795,0.0029111141,0.0005311938,0.00036143258,0.00016542613,0.0012253472,0.00047144582,0.00013765096,0.001238339],"genre_scores_gemma":[0.99007446,0.0017814735,0.001652204,0.0009186153,0.0003248047,0.001919655,0.000913617,0.00005555932,0.0023597],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9992341,0.00039691324,0.000046583966,0.00011567882,0.00007897011,0.00012783697],"domain_scores_gemma":[0.99929535,0.00021251026,0.00015115867,0.0000694688,0.00004716138,0.00022426536],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015696671,0.0015203079,0.0036886623,0.00043301046,0.0004719075,0.0008793866,0.0008630645,0.0018166285,0.005159623],"category_scores_gemma":[0.0013329345,0.0009205539,0.0018510892,0.0003883261,0.0010054456,0.0009985218,0.00032843236,0.002887672,0.0011334465],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.92395073,0.0176531,0.0014081995,0.0005940094,0.0011243303,0.00009259008,0.00007574003,0.000515918,0.017769273,0.00010279504,0.0012249191,0.03548843],"study_design_scores_gemma":[0.8708608,0.121086285,0.0055802865,0.000018663215,0.0004437494,0.00006423645,0.000019806957,0.00038653146,0.0008270071,0.000080270525,0.0006073998,0.000025021225],"about_ca_topic_score_codex":0.00052124466,"about_ca_topic_score_gemma":0.0010446337,"teacher_disagreement_score":0.005159623,"about_ca_system_score_codex":0.00055552996,"about_ca_system_score_gemma":0.00077156076,"threshold_uncertainty_score":0.017260611},"labels":[],"label_agreement":null},{"id":"W3110187030","doi":"10.1016/j.jaad.2020.06.764","title":"16046 Long-term efficacy and safety of daily efinaconazole 10% nail solution for mild to moderate onychomycosis","year":2020,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada)","funders":"","keywords":"Medicine; Dermatology; Nail (fastener); Cure rate; Surgery","score_opus":0.03188136386150577,"score_gpt":0.3286131244206811,"score_spread":0.29673176055917533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110187030","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99599105,0.0028024283,0.00012936676,0.00007354559,0.00008463286,0.00007623974,0.00012860495,0.000017277183,0.000696865],"genre_scores_gemma":[0.9980659,0.000667952,0.00011166234,0.000093133094,0.00008032021,0.00003366758,0.00019738403,0.000003180518,0.00074680086],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997981,0.00006938646,0.000023645836,0.000025439555,0.000036632642,0.000046849575],"domain_scores_gemma":[0.99978894,0.000048544083,0.000032816453,0.000023822506,0.000033851702,0.00007202986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036058988,0.0003127446,0.0009885286,0.00025295635,0.00025001648,0.00025056512,0.00028284866,0.00050084095,0.0017746962],"category_scores_gemma":[0.00050213013,0.000102728416,0.0005357946,0.0001574726,0.00023388148,0.0003314426,0.000120617784,0.0007431807,0.00043518815],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.37581715,0.043257315,0.015915351,0.00087767484,0.0009732334,0.0012473513,0.0002162182,0.0008520677,0.2247328,0.0002334659,0.0022266405,0.3336507],"study_design_scores_gemma":[0.04670199,0.73566717,0.1633937,0.0001225092,0.0009912618,0.0020002585,0.00021792293,0.0029700033,0.04259532,0.00018209289,0.0050744712,0.00008342578],"about_ca_topic_score_codex":0.00082653324,"about_ca_topic_score_gemma":0.001212444,"teacher_disagreement_score":0.0017746962,"about_ca_system_score_codex":0.00019745613,"about_ca_system_score_gemma":0.0003106475,"threshold_uncertainty_score":0.0059369802},"labels":[],"label_agreement":null},{"id":"W3110190739","doi":"10.1016/j.jaad.2020.06.269","title":"15706 Effect of a one-hour interactive sun safety presentation on sun protection knowledge and intentions in high school students","year":2020,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Skin Protection and Aging","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Sun protection; Skin cancer; Sun exposure; Sunlight; Presentation (obstetrics); Sun protection factor; Cancer; Family medicine; Dermatology; Surgery; Internal medicine; Astronomy","score_opus":0.022325146934916322,"score_gpt":0.35694027670834355,"score_spread":0.3346151297734272,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110190739","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992561,0.00003101676,0.000008616559,0.00004687422,0.000025932111,0.000019924408,0.000044293232,0.0000050146814,0.0005622396],"genre_scores_gemma":[0.99666566,0.000078339806,0.00011643813,0.000075710384,0.00003238014,0.00008649226,0.000089244706,0.0000031844845,0.0028524965],"study_design_codex":"nonrandomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99946207,0.00015754813,0.000041781946,0.00008991782,0.00008999674,0.00015867177],"domain_scores_gemma":[0.9956664,0.0017207984,0.00043672533,0.00014895236,0.0002279644,0.0017991939],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008550297,0.0004581301,0.0009276019,0.00033862123,0.0011560742,0.0010552483,0.00053064176,0.0015427675,0.014991141],"category_scores_gemma":[0.003772796,0.0004980749,0.0008707257,0.0003082543,0.00031394942,0.0005349778,0.00078509306,0.0017730894,0.0015040317],"study_design_candidate":"nonrandomized_trial","study_design_consensus":"nonrandomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10897781,0.40920645,0.36694652,0.00073126156,0.0009494931,0.0004404576,0.006094503,0.0006791865,0.009236367,0.00030307623,0.0026094818,0.09382527],"study_design_scores_gemma":[0.0036383676,0.10245033,0.8829481,0.00012837093,0.00074766105,0.000038286285,0.004634879,0.001281397,0.0023508705,0.00017920401,0.0015236903,0.00007887929],"about_ca_topic_score_codex":0.007753211,"about_ca_topic_score_gemma":0.009933596,"teacher_disagreement_score":0.014991141,"about_ca_system_score_codex":0.00046425776,"about_ca_system_score_gemma":0.0011826707,"threshold_uncertainty_score":0.050150335},"labels":[],"label_agreement":null},{"id":"W3110512790","doi":"10.1016/j.jaad.2020.06.154","title":"14027 Long-term efficacy and safety of continuous q12w risankizumab: Results from the open-label extension LIMMitless trial","year":2020,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Medicine; Ustekinumab; Open label; Monoclonal; Monoclonal antibody; Internal medicine; Clinical trial; Adalimumab; Immunology; Antibody; Disease","score_opus":0.07985569615250328,"score_gpt":0.38304809912941945,"score_spread":0.3031924029769162,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110512790","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9757652,0.011889967,0.000959624,0.0012356519,0.0004489358,0.0006900054,0.00359353,0.00021193126,0.0052052294],"genre_scores_gemma":[0.98716366,0.002609606,0.00077147566,0.0013578981,0.0004581659,0.000613354,0.0035192994,0.000043849497,0.0034626932],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99890554,0.0004934385,0.000057377027,0.0002036339,0.00013939395,0.00020057379],"domain_scores_gemma":[0.99862826,0.0005032163,0.00028619674,0.00019257983,0.00010413701,0.00028558765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002032098,0.00094627205,0.0022405686,0.00021168686,0.00031336778,0.0013418512,0.0007728633,0.0012932904,0.005486071],"category_scores_gemma":[0.0020180054,0.0003390782,0.0025907685,0.00033502548,0.0012593187,0.0011740794,0.00037344478,0.0036090498,0.0018821894],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8871086,0.004434111,0.0025210527,0.0011826748,0.0023415645,0.000090581016,0.00008596321,0.0007510064,0.0074235676,0.0004081187,0.0057404647,0.08791232],"study_design_scores_gemma":[0.8207318,0.14580892,0.020079173,0.00019601044,0.0026298,0.00019685588,0.00008732803,0.0012680811,0.002314648,0.0007383444,0.005881169,0.000067844914],"about_ca_topic_score_codex":0.0006042223,"about_ca_topic_score_gemma":0.00090798084,"teacher_disagreement_score":0.005486071,"about_ca_system_score_codex":0.00094036263,"about_ca_system_score_gemma":0.0010007976,"threshold_uncertainty_score":0.018352747},"labels":[],"label_agreement":null},{"id":"W3112157931","doi":"10.1016/j.jaad.2020.11.057","title":"Hair pull test: A clinical update for patients with Asian- and Afro-textured hair","year":2020,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa; Probity Medical Research; Women's College Hospital; University of Toronto","funders":"","keywords":"Medicine; Hair shaft; Ethnic group; Test (biology); Hair growth; Dermatology; Internal medicine; Physiology; Biology; Hair follicle; Botany","score_opus":0.014266414283493444,"score_gpt":0.30249945028690883,"score_spread":0.2882330360034154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112157931","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.18310453,0.21411224,0.019578276,0.36913782,0.016057499,0.0010117394,0.0032089266,0.0024919556,0.19129705],"genre_scores_gemma":[0.70159674,0.08899835,0.022504935,0.13541824,0.030103885,0.00044803458,0.0025762604,0.00039611754,0.017957365],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99888295,0.00022939766,0.00022375118,0.00012583063,0.00037119756,0.00016697744],"domain_scores_gemma":[0.9976555,0.00092529657,0.00023817863,0.00006768756,0.00066624145,0.00044703152],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009424471,0.0013876793,0.0012032778,0.0022322405,0.001289367,0.0016820905,0.0014046766,0.005030165,0.0034768425],"category_scores_gemma":[0.006683427,0.00042812948,0.0010117438,0.0010483678,0.0008046466,0.002768907,0.0006817488,0.0034427599,0.0019343254],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046509717,0.0004848758,0.19567794,0.0007945383,0.00018160186,0.26494414,0.0007547235,0.00088102004,0.0047464054,0.0014033793,0.33819753,0.19146882],"study_design_scores_gemma":[0.00016758549,0.00037374182,0.08970531,0.0031720886,0.0002940474,0.77043885,0.002135175,0.0026641095,0.0011791204,0.0033094832,0.12641765,0.00014293272],"about_ca_topic_score_codex":0.005322404,"about_ca_topic_score_gemma":0.008333812,"teacher_disagreement_score":0.005322404,"about_ca_system_score_codex":0.00092788,"about_ca_system_score_gemma":0.0011152724,"threshold_uncertainty_score":0.011631131},"labels":[],"label_agreement":null},{"id":"W3114081019","doi":"10.1016/j.jaad.2020.11.071","title":"A systematic review of eczematous eruptions in patients receiving biologic therapy","year":2020,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Women's College Hospital; McMaster University; University of Toronto","funders":"Psoriasis Association","keywords":"Medicine; Secukinumab; Infliximab; Dermatology; Natalizumab; Ixekizumab; MEDLINE; Systematic review; Adalimumab; Psoriasis; Internal medicine; Disease","score_opus":0.034489927062003885,"score_gpt":0.36775937262600117,"score_spread":0.3332694455639973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3114081019","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011645715,0.998027,0.000052284013,0.00010905522,0.00007422068,0.00011126894,0.0002786911,0.000004452948,0.0001784676],"genre_scores_gemma":[0.026294328,0.97208023,0.00044710713,0.00062150176,0.00007837461,0.00015416407,0.00019850318,0.0000045121906,0.00012137485],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9949108,0.0016174039,0.0022231257,0.00044917947,0.0006382408,0.00016138169],"domain_scores_gemma":[0.98879707,0.0070130173,0.0031003337,0.00016773067,0.0007591842,0.00016261853],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003948348,0.0012157989,0.008039567,0.007029927,0.00040645723,0.0019492046,0.001446584,0.001472775,0.004905955],"category_scores_gemma":[0.01640624,0.0009010337,0.007606806,0.0068443026,0.0006659958,0.0015741745,0.0014650193,0.0011375292,0.00024749184],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043542558,0.000020298483,0.0014387481,0.94062126,0.030625695,0.000121811805,0.00014427649,0.00006849569,0.00021198213,0.000104199105,0.0013926976,0.024815146],"study_design_scores_gemma":[0.0012391101,0.00045074726,0.013554557,0.62226003,0.33250305,0.0008154451,0.00031379765,0.00008892728,0.00018558002,0.00023669192,0.028287414,0.00006470886],"about_ca_topic_score_codex":0.0070882956,"about_ca_topic_score_gemma":0.031138277,"teacher_disagreement_score":0.008039567,"about_ca_system_score_codex":0.0019633865,"about_ca_system_score_gemma":0.0043486906,"threshold_uncertainty_score":0.020881116},"labels":[],"label_agreement":null},{"id":"W3114683587","doi":"10.1016/j.jaad.2020.12.038","title":"Side effects of low-dose oral minoxidil for treating alopecia","year":2021,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Sympathectomy and Hyperhidrosis Treatments","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; University Health Network; Women's College Hospital; University of Toronto","funders":"","keywords":"Medicine; Minoxidil; Adverse effect; Dermatology; Medical prescription; Internal medicine; Pharmacology","score_opus":0.01995335376503299,"score_gpt":0.3122769284587072,"score_spread":0.2923235746936742,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3114683587","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3842633,0.028711742,0.0021348747,0.4244692,0.01435419,0.00025739978,0.0002989444,0.0004019274,0.14510848],"genre_scores_gemma":[0.8418494,0.0062749083,0.0010576262,0.10779511,0.020388259,0.000072945244,0.000090406254,0.00004805641,0.022423305],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99966943,0.00010314533,0.000037930644,0.000028100405,0.00009631685,0.000065096516],"domain_scores_gemma":[0.9991392,0.00046785068,0.00012472218,0.000025744037,0.00007987572,0.00016251097],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038307844,0.0003866391,0.00053114933,0.00033759928,0.0011850349,0.00067494233,0.0004784489,0.006200628,0.0016081111],"category_scores_gemma":[0.0027242168,0.0001887935,0.0006683172,0.00021659814,0.00038322416,0.0003973006,0.00018491887,0.0041854805,0.0005218952],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015390366,0.00054844806,0.020328784,0.00032136764,0.00013256732,0.7816187,0.00044349875,0.0004925581,0.00709548,0.002501295,0.12307039,0.061907806],"study_design_scores_gemma":[0.0011077059,0.002344252,0.058744323,0.00040753547,0.00024546788,0.77342445,0.0005254141,0.0042629447,0.0031598262,0.0025632284,0.15313317,0.00008169417],"about_ca_topic_score_codex":0.0023212258,"about_ca_topic_score_gemma":0.006119889,"teacher_disagreement_score":0.006200628,"about_ca_system_score_codex":0.0014581617,"about_ca_system_score_gemma":0.0005227704,"threshold_uncertainty_score":0.010579824},"labels":[],"label_agreement":null},{"id":"W3118463777","doi":"10.1016/j.jaad.2021.01.012","title":"Facial and neck erythema associated with dupilumab treatment: A systematic review","year":2021,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":151,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre; Women's College Hospital; University of Toronto; Probity Medical Research; University of Ottawa","funders":"Sanofi","keywords":"Medicine; Dupilumab; Dermatology; Erythema; MEDLINE; Atopic dermatitis","score_opus":0.03053850633021762,"score_gpt":0.34724221627890567,"score_spread":0.3167037099486881,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3118463777","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016744449,0.99770373,0.0000441551,0.00007411496,0.000051538424,0.000064569605,0.00023871592,0.0000042398133,0.00014442678],"genre_scores_gemma":[0.035154223,0.96343464,0.00032151805,0.0006102105,0.0000667943,0.00010610097,0.0001838625,0.000004179548,0.00011852582],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9982297,0.0004860574,0.0006650432,0.00025062673,0.00027185978,0.00009665967],"domain_scores_gemma":[0.9937709,0.003870013,0.0018544926,0.00008606866,0.00032153647,0.00009706852],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002087717,0.0009410169,0.005221091,0.0030596007,0.00034970287,0.001515562,0.0011928856,0.0013848646,0.005435835],"category_scores_gemma":[0.009352183,0.0007269879,0.0074524977,0.0037914265,0.00057809614,0.0012191224,0.0010795764,0.0011380786,0.0002664733],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010371801,0.000047496185,0.0029136774,0.9029231,0.04226469,0.00017916807,0.00013380987,0.00012165635,0.00028904527,0.000120533834,0.0026798877,0.047289673],"study_design_scores_gemma":[0.00206163,0.00069704367,0.024512,0.41769436,0.52527964,0.0011505281,0.00043557942,0.0001753012,0.00031643748,0.00031317107,0.027255518,0.00010874416],"about_ca_topic_score_codex":0.0056348266,"about_ca_topic_score_gemma":0.025929362,"teacher_disagreement_score":0.0056348266,"about_ca_system_score_codex":0.0014994679,"about_ca_system_score_gemma":0.0025870146,"threshold_uncertainty_score":0.018184662},"labels":[],"label_agreement":null},{"id":"W3119727280","doi":"10.1016/j.jaad.2020.12.058","title":"National Psoriasis Foundation COVID-19 Task Force guidance for management of psoriatic disease during the pandemic: Version 2—Advances in psoriatic disease management, COVID-19 vaccines, and COVID-19 treatments","year":2021,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":98,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto; University Health Network","funders":"National Institute of Allergy and Infectious Diseases; Sanofi Genzyme; Genentech; Agency for Healthcare Research and Quality; Bausch Health; Inozyme Pharma; National Psoriasis Foundation; Pfizer; Incyte; Mylan; Regeneron Pharmaceuticals; Castle Biosciences; National Heart, Lung, and Blood Institute; Sun Pharma; Dermira; UCB Pharma; Valeant Pharmaceuticals International; Boston Scientific Corporation; University of Pennsylvania; LEO Pharma; Ortho Dermatologics; Gilead Sciences; Sanofi; GlaxoSmithKline; Health Canada; Centers for Disease Control and Prevention; Celgene; Janssen Research and Development; EMD Serono; Galderma; Allergan; AstraZeneca; Samsung; Bristol-Myers Squibb; Eli Lilly and Company; Meiji Seika Pharma; Coherus Biosciences; Amgen","keywords":"Medicine; Coronavirus disease 2019 (COVID-19); Psoriasis; Pandemic; Disease; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); 2019-20 coronavirus outbreak; Task force; Virology; Dermatology; Pathology; Infectious disease (medical specialty); Outbreak","score_opus":0.021404988142710114,"score_gpt":0.3234124267463879,"score_spread":0.3020074386036778,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3119727280","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0050988677,0.13426189,0.02620071,0.6008331,0.043460853,0.0052745035,0.019096417,0.0029960095,0.16277765],"genre_scores_gemma":[0.0401226,0.22298938,0.15396175,0.3686925,0.03877899,0.009019343,0.042204034,0.0015309374,0.122700505],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9895893,0.0036771148,0.0014320795,0.00029195801,0.0038894247,0.0011200854],"domain_scores_gemma":[0.97331536,0.007114949,0.003637724,0.0007454422,0.011442008,0.0037445568],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016900796,0.0011969934,0.0018314203,0.0019619025,0.001103273,0.0041596536,0.0034663244,0.009206125,0.010410421],"category_scores_gemma":[0.03024572,0.0010024522,0.0028173698,0.0014054492,0.0011285304,0.0021067495,0.0026280333,0.010942168,0.007877843],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019825506,0.00026081243,0.0011369933,0.0007799851,0.00005199144,0.000116133844,0.000109339184,0.0005703038,0.00087596354,0.0025119612,0.85645056,0.13693765],"study_design_scores_gemma":[0.00033518864,0.00024241988,0.0034326885,0.0037108003,0.000078951794,0.00021326705,0.000100615114,0.0003811064,0.0004908226,0.002003367,0.9889572,0.000053640924],"about_ca_topic_score_codex":0.030822927,"about_ca_topic_score_gemma":0.044059534,"teacher_disagreement_score":0.030822927,"about_ca_system_score_codex":0.0030332503,"about_ca_system_score_gemma":0.02252512,"threshold_uncertainty_score":0.08938098},"labels":[],"label_agreement":null},{"id":"W3120633077","doi":"10.1016/j.jaad.2020.12.056","title":"Biologic treatment outcomes in mucous membrane pemphigoid: A systematic review","year":2021,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Autoimmune Bullous Skin Diseases","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre; Brock University; Women's College Hospital; University of Toronto","funders":"Psoriasis Association","keywords":"Medicine; Dermatology; Pemphigoid; Mucous membrane; Cicatricial pemphigoid; Bullous pemphigoid; Pathology; Immunology; Antibody","score_opus":0.044898845365762594,"score_gpt":0.39371028475918746,"score_spread":0.34881143939342485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3120633077","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018414981,0.9975293,0.000061807295,0.000084654355,0.000062418,0.00006035325,0.00024948255,0.0000043218224,0.0001061273],"genre_scores_gemma":[0.044903416,0.9536562,0.00033616312,0.00053673657,0.00007920606,0.00014343583,0.00023866641,0.000004821028,0.00010127141],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99683076,0.000936471,0.0012248994,0.0003922582,0.00043457674,0.0001810573],"domain_scores_gemma":[0.9890525,0.007541699,0.0024831996,0.00015741681,0.0005888006,0.00017646549],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036353616,0.001197862,0.008763293,0.0042710584,0.00042020134,0.0020083543,0.001523066,0.0018564952,0.004895412],"category_scores_gemma":[0.014456953,0.0010141496,0.009977101,0.005443329,0.0006909993,0.0017315008,0.001504971,0.0015844875,0.0002837013],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00092205673,0.00003904403,0.003770599,0.88720506,0.08317077,0.00013702485,0.00015159517,0.00012931279,0.00018049957,0.00012477921,0.00145739,0.022711812],"study_design_scores_gemma":[0.0018985082,0.00039895915,0.018015001,0.3176824,0.65060455,0.00044991763,0.00034981253,0.00013906986,0.00014645387,0.000312617,0.009925236,0.00007752527],"about_ca_topic_score_codex":0.0073629045,"about_ca_topic_score_gemma":0.024881124,"teacher_disagreement_score":0.008763293,"about_ca_system_score_codex":0.0017393527,"about_ca_system_score_gemma":0.003371025,"threshold_uncertainty_score":0.019225836},"labels":[],"label_agreement":null},{"id":"W3120866829","doi":"10.1016/j.jaad.2020.12.080","title":"Biologic treatment in pediatric Stevens-Johnson syndrome/toxic epidermal necrolysis: A systematic review","year":2021,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; Women's College Hospital; McMaster University; University of Toronto","funders":"","keywords":"Toxic epidermal necrolysis; Medicine; Etanercept; Dermatology; Infliximab; Erythroderma; MEDLINE; Pediatrics; Internal medicine; Tumor necrosis factor alpha","score_opus":0.05199170982957337,"score_gpt":0.3794512913210057,"score_spread":0.32745958149143234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3120866829","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007359942,0.99878246,0.000051260642,0.000063711544,0.000052945816,0.00005961351,0.00013787784,0.0000042144047,0.00011192052],"genre_scores_gemma":[0.010216746,0.9890344,0.00023380708,0.00027628272,0.000034347937,0.00006138102,0.000076468416,0.0000021904357,0.000064341606],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99814534,0.00047622222,0.0007451504,0.0002093093,0.00032829138,0.00009569846],"domain_scores_gemma":[0.9942193,0.0035685685,0.0016442967,0.000069115,0.00038732123,0.000111330475],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024302804,0.0011091046,0.0068452265,0.0040675155,0.00033870063,0.0016603003,0.0013802949,0.0016019508,0.0049321735],"category_scores_gemma":[0.008502687,0.0007576138,0.006994364,0.0048067565,0.000514089,0.0014381901,0.0010664017,0.0012398065,0.0002632112],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048399574,0.00003601635,0.0010987836,0.9287151,0.021451304,0.00015052264,0.000120094344,0.0001479642,0.00022634257,0.00015276419,0.0020274846,0.04538968],"study_design_scores_gemma":[0.0015216633,0.00052260904,0.009858638,0.6457834,0.31053224,0.00080160546,0.0003477562,0.00018011553,0.0002656032,0.00031039707,0.029799625,0.000076290446],"about_ca_topic_score_codex":0.00687617,"about_ca_topic_score_gemma":0.025460705,"teacher_disagreement_score":0.00687617,"about_ca_system_score_codex":0.0015576963,"about_ca_system_score_gemma":0.0037025094,"threshold_uncertainty_score":0.016499758},"labels":[],"label_agreement":null},{"id":"W3121004557","doi":"10.1016/j.jaad.2020.12.015","title":"February 2021: Public outreach, risk perceptions, and behavioral change: Skin-lightening agent use in Ghana","year":2021,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Skin Protection and Aging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Outreach; Scopus; Popularity; Beauty; Family medicine; Quarter (Canadian coin); MEDLINE; Psychology; Social psychology; Geography; Economic growth; Political science","score_opus":0.05736281431644923,"score_gpt":0.34167413912795475,"score_spread":0.2843113248115055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3121004557","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.69292295,0.0031602492,0.00021408533,0.27284458,0.005243026,0.00053318654,0.009334278,0.00012704585,0.015620508],"genre_scores_gemma":[0.90940744,0.0036410354,0.0011864323,0.04053708,0.0022975553,0.0007037703,0.004545493,0.000041172687,0.03764003],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997671,0.00008764727,0.000012495877,0.000018486424,0.000031273663,0.00008296956],"domain_scores_gemma":[0.9987129,0.00018424122,0.00015569685,0.000023886316,0.00018627118,0.0007369726],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001114659,0.0002424669,0.00022136996,0.00028038627,0.0012440337,0.0008963741,0.00056694326,0.0018809815,0.014036427],"category_scores_gemma":[0.0030413521,0.00023706003,0.0002069747,0.0003384881,0.00024885428,0.0007432303,0.0006497019,0.0017425349,0.00080496253],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012714299,0.0030495613,0.46281576,0.00038187578,0.0000664344,0.002040458,0.0022671947,0.00027416358,0.00086315616,0.00045761722,0.4405577,0.085954584],"study_design_scores_gemma":[0.00047693038,0.00057876494,0.9106746,0.00045529357,0.000085000844,0.00031147778,0.008924623,0.0010442034,0.00046542514,0.00046933524,0.076481596,0.000032901575],"about_ca_topic_score_codex":0.15122461,"about_ca_topic_score_gemma":0.30419427,"teacher_disagreement_score":0.15122461,"about_ca_system_score_codex":0.0019980283,"about_ca_system_score_gemma":0.0043649073,"threshold_uncertainty_score":0.3006888},"labels":[],"label_agreement":null},{"id":"W3121564094","doi":"10.1016/j.jaad.2021.01.047","title":"An evidence-based guide to SARS-CoV-2 vaccination of patients on immunotherapies in dermatology","year":2021,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Ottawa Hospital; University of Ottawa","funders":"University of British Columbia","keywords":"Medicine; Vaccination; Pandemic; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Immune system; Coronavirus disease 2019 (COVID-19); Immunology; Immunotherapy; Intensive care medicine; Disease; Infectious disease (medical specialty); Internal medicine","score_opus":0.08509074923121908,"score_gpt":0.45681951249891756,"score_spread":0.3717287632676985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3121564094","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008260641,0.99448895,0.0005264808,0.0023653032,0.0007482033,0.00020308088,0.00031615066,0.000032137978,0.0012370251],"genre_scores_gemma":[0.0010905961,0.9905826,0.0029347956,0.003262071,0.00039896645,0.00026592438,0.00030206348,0.000006456181,0.0011565905],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99814653,0.00058776484,0.00067779055,0.00013187814,0.00039053525,0.0000655413],"domain_scores_gemma":[0.99574405,0.0024654206,0.00079853536,0.000054573084,0.0007938364,0.00014351188],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029974254,0.0014823251,0.004271959,0.0051487037,0.00042478056,0.0021065301,0.002051624,0.0033579264,0.011145469],"category_scores_gemma":[0.007903163,0.0007264588,0.0032235093,0.0025789863,0.0004717613,0.0018958551,0.0009927219,0.003116294,0.0027157874],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004828629,0.00014341515,0.00022765993,0.19761617,0.0010867162,0.00018759239,0.000106531756,0.0003740198,0.00073310046,0.002520037,0.10177225,0.69474965],"study_design_scores_gemma":[0.00071387884,0.0002775655,0.0016973657,0.35428405,0.0039003924,0.00047893226,0.00012312185,0.00027077625,0.00021814453,0.0034058474,0.6345645,0.00006545153],"about_ca_topic_score_codex":0.0058866804,"about_ca_topic_score_gemma":0.013813957,"teacher_disagreement_score":0.011145469,"about_ca_system_score_codex":0.0017960311,"about_ca_system_score_gemma":0.004777876,"threshold_uncertainty_score":0.037285328},"labels":[],"label_agreement":null},{"id":"W3121795825","doi":"10.1016/j.jaad.2020.11.073","title":"Next-generation sequencing analysis suggests varied multistep mutational pathogenesis for endocrine mucin-producing sweat gland carcinoma with comments on INSM1 and MUC2 suggesting a conjunctival origin","year":2021,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Salivary Gland Tumors Diagnosis and Treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"National Cancer Institute; National Institutes of Health","keywords":"Mucin; Medicine; SWEAT; Carcinoma; Eccrine sweat; Pathogenesis; Sweat gland; Endocrine system; Pathology; Endocrinology; Internal medicine; Hormone","score_opus":0.06830211915137081,"score_gpt":0.32590015310735093,"score_spread":0.25759803395598013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3121795825","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9578447,0.004590046,0.011309574,0.009523439,0.0008558451,0.00008441476,0.00051774463,0.00026877507,0.0150056165],"genre_scores_gemma":[0.9872684,0.0009476053,0.0057048234,0.002087074,0.0002797018,0.00001352945,0.00022880231,0.000055006058,0.0034150425],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99977344,0.000025792115,0.000038896305,0.000050791343,0.0000590196,0.000052103736],"domain_scores_gemma":[0.9994673,0.0003161157,0.000047409372,0.000040484923,0.00007511443,0.00005357216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047764732,0.0004762793,0.00022714859,0.00095476856,0.00046677643,0.0007357218,0.00047623937,0.0017262766,0.0023151217],"category_scores_gemma":[0.0014324657,0.0001604794,0.00062037975,0.00036295736,0.0006796288,0.00042792645,0.00023716717,0.00089078635,0.00064570893],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010949483,0.00016014889,0.1673962,0.0002873762,0.00014400779,0.43501553,0.0016068259,0.0012496512,0.32985017,0.0052406145,0.00707789,0.05087673],"study_design_scores_gemma":[0.00009170808,0.0006450536,0.17439745,0.0002824676,0.00046935043,0.5429848,0.0014910315,0.014627831,0.20763153,0.007969303,0.04931191,0.000097629636],"about_ca_topic_score_codex":0.0008353446,"about_ca_topic_score_gemma":0.0014042886,"teacher_disagreement_score":0.0023151217,"about_ca_system_score_codex":0.0003502995,"about_ca_system_score_gemma":0.00022525156,"threshold_uncertainty_score":0.0077449083},"labels":[],"label_agreement":null},{"id":"W3122447475","doi":"10.1016/j.jaad.2021.01.064","title":"Validation of artificial intelligence application in clinical dermatology","year":2021,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Toronto Metropolitan University; Public Health Ontario; University of Toronto","funders":"","keywords":"Medicine; Dermatology; Psoriasis; Artificial intelligence; Teledermatology; Scopus; MEDLINE; Medical physics; Health care; Telemedicine; Computer science","score_opus":0.04399282564674125,"score_gpt":0.36013474384711885,"score_spread":0.3161419182003776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3122447475","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7723557,0.0020931466,0.055657588,0.07019089,0.0038702558,0.0021032447,0.0017216605,0.0010767236,0.09093088],"genre_scores_gemma":[0.94065267,0.0004963939,0.045394257,0.007504418,0.00036412998,0.00037209239,0.000690494,0.00004568592,0.004479926],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9893594,0.0073886407,0.0007092797,0.00030514193,0.00198664,0.00025093992],"domain_scores_gemma":[0.9084603,0.066822134,0.0012345971,0.0050283265,0.01757752,0.0008770983],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015891038,0.00024756405,0.00025584587,0.000688888,0.00050262193,0.0019206647,0.0009795934,0.0014583027,0.0038724374],"category_scores_gemma":[0.07527436,0.00013735844,0.00033117694,0.00047272714,0.000763774,0.00072161405,0.00077523215,0.0010776339,0.0013037731],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034801825,0.004144818,0.24351732,0.000853893,0.00033667497,0.004519477,0.002888468,0.023369787,0.015922844,0.009902631,0.06715294,0.62391096],"study_design_scores_gemma":[0.0014272028,0.007939563,0.22067331,0.0022273744,0.00048253222,0.0073599983,0.0046822517,0.39903697,0.05777944,0.025246115,0.272972,0.0001731983],"about_ca_topic_score_codex":0.002286999,"about_ca_topic_score_gemma":0.0023287493,"teacher_disagreement_score":0.015891038,"about_ca_system_score_codex":0.00093106495,"about_ca_system_score_gemma":0.0016905247,"threshold_uncertainty_score":0.08404082},"labels":[],"label_agreement":null},{"id":"W3123328370","doi":"10.1016/j.jaad.2021.01.059","title":"Comorbidity screening in hidradenitis suppurativa: Evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations","year":2021,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":222,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; University of Windsor; University of Ottawa; Ottawa Hospital; Memorial University of Newfoundland; Sunnybrook Health Science Centre; University of Toronto; Women's College Hospital","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Northwell Health","keywords":"Medicine; Hidradenitis suppurativa; Comorbidity; Metabolic syndrome; Disease; Pyoderma gangrenosum; Dyslipidemia; Irritable bowel syndrome; Intensive care medicine; Dermatology; Psychiatry; Internal medicine; Obesity","score_opus":0.12279370833605667,"score_gpt":0.40287422238934634,"score_spread":0.28008051405328965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3123328370","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0023368034,0.94912887,0.0014141363,0.031680647,0.002603998,0.0023831313,0.003987653,0.00010223513,0.006362436],"genre_scores_gemma":[0.050336305,0.90101606,0.024048068,0.01622056,0.0008793078,0.0028542904,0.003445063,0.000046115907,0.0011543215],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9720362,0.006791337,0.011385384,0.0010599645,0.007646038,0.0010810684],"domain_scores_gemma":[0.90568066,0.037280675,0.01706664,0.0011481725,0.035464305,0.0033595779],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.028432915,0.0016877161,0.0043728286,0.015009312,0.0017062122,0.0035897032,0.004710489,0.004248083,0.0047033364],"category_scores_gemma":[0.13433944,0.0011563054,0.009708632,0.009652874,0.0011954056,0.002369502,0.003039583,0.003592942,0.0007009546],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047724615,0.000073035444,0.0059477175,0.62491214,0.009064119,0.00028045193,0.0009085824,0.000824366,0.00046634662,0.002156907,0.06282325,0.2920658],"study_design_scores_gemma":[0.00077730836,0.00011026869,0.012054892,0.864656,0.025090504,0.00023840852,0.00040266238,0.00045723194,0.00021862726,0.001543141,0.09432562,0.00012531763],"about_ca_topic_score_codex":0.24071822,"about_ca_topic_score_gemma":0.3237182,"teacher_disagreement_score":0.75928175,"about_ca_system_score_codex":0.01789018,"about_ca_system_score_gemma":0.068009146,"threshold_uncertainty_score":0.47863418},"labels":[],"label_agreement":null},{"id":"W3126603515","doi":"10.1016/j.jaad.2021.01.087","title":"Development of dermatomyositis in patients on biologic therapy: A systematic review","year":2021,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Inflammatory Myopathies and Dermatomyositis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland; University of Toronto","funders":"","keywords":"Medicine; Dermatomyositis; Dermatology; MEDLINE; Intensive care medicine","score_opus":0.03612757452647844,"score_gpt":0.35275145327105395,"score_spread":0.31662387874457554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3126603515","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015746751,0.99776614,0.000053069944,0.000082449136,0.000053910455,0.000056308065,0.00030951694,0.000003344203,0.0001007057],"genre_scores_gemma":[0.02271396,0.97623366,0.00030120104,0.00034838117,0.0000519978,0.000089007684,0.00019416239,0.0000029223963,0.00006460403],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9972042,0.000677317,0.001206109,0.00036779774,0.00042629836,0.000118269665],"domain_scores_gemma":[0.9894024,0.0070432546,0.0026581523,0.00012337312,0.0006040978,0.00016870955],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027468996,0.0009920477,0.0066332184,0.005127897,0.00039652095,0.0016902954,0.0012915591,0.0016556398,0.0038901689],"category_scores_gemma":[0.013051958,0.00089048716,0.0076125665,0.0070266286,0.0006357945,0.0016346268,0.0014077225,0.00126043,0.00020948003],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005326097,0.000030807052,0.0055210725,0.9192869,0.040144835,0.00017282699,0.0002035652,0.000102974176,0.0001852217,0.00013112633,0.001976974,0.031711012],"study_design_scores_gemma":[0.000989168,0.00037292895,0.033584643,0.5810743,0.36433822,0.001070806,0.00052166596,0.00013296354,0.00017403248,0.000314537,0.017322531,0.000104206345],"about_ca_topic_score_codex":0.008410853,"about_ca_topic_score_gemma":0.030689199,"teacher_disagreement_score":0.008410853,"about_ca_system_score_codex":0.0014545594,"about_ca_system_score_gemma":0.003525495,"threshold_uncertainty_score":0.016723752},"labels":[],"label_agreement":null},{"id":"W3126856229","doi":"10.1016/j.jaad.2020.07.059","title":"Contact dermatitis associated with preservatives: Retrospective analysis of North American Contact Dermatitis Group data, 1994 through 2016","year":2021,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Contact Dermatitis and Allergies","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Sunnybrook Health Science Centre; McGill University Health Centre; University of Ottawa; Montreal General Hospital; University of Toronto; Health Sciences Centre","funders":"National Institute of General Medical Sciences; National Cancer Institute","keywords":"Medicine; Preservative; Dermatology; Allergic contact dermatitis; Contact dermatitis; Patch test; Retrospective cohort study; Allergy; Surgery; Food science; Immunology","score_opus":0.022233031293330086,"score_gpt":0.3009874325686751,"score_spread":0.278754401275345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3126856229","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990484,0.0017857628,0.000114492104,0.000028535102,0.000011564262,0.00003641084,0.005968818,0.000010460682,0.0015598764],"genre_scores_gemma":[0.99312544,0.0011789415,0.0001185916,0.000053123193,0.000013882617,0.000036493006,0.004888641,0.000005285544,0.00057964487],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99897987,0.0001331332,0.0001799826,0.0002369516,0.0003031435,0.00016687281],"domain_scores_gemma":[0.99786925,0.00016025557,0.001227314,0.00014912682,0.00042534774,0.00016865984],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005511895,0.00035051594,0.00040652326,0.002237377,0.00058986456,0.00078190456,0.00038353392,0.00039546113,0.0016080546],"category_scores_gemma":[0.001402642,0.0003737199,0.00069058326,0.0042938334,0.0003367662,0.0007718006,0.0006729625,0.00039956963,0.00033601164],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007271213,0.000017705432,0.9981164,0.000027886397,0.000057629906,0.00006713367,0.000056848876,0.000021610576,0.00007875669,0.000008199728,0.00023343005,0.0012417606],"study_design_scores_gemma":[0.0000027989602,0.000026593405,0.9989267,0.000015850974,0.000031900185,0.00022551918,0.0002011343,0.00002597157,0.000039121845,0.0000044411486,0.0004979259,0.0000020465955],"about_ca_topic_score_codex":0.05100537,"about_ca_topic_score_gemma":0.072927006,"teacher_disagreement_score":0.05100537,"about_ca_system_score_codex":0.001031087,"about_ca_system_score_gemma":0.0011094011,"threshold_uncertainty_score":0.101416945},"labels":[],"label_agreement":null},{"id":"W3127489043","doi":"10.1016/j.jaad.2021.03.017","title":"Body site distribution of pediatric-onset morphea and association with extracutaneous manifestations","year":2021,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Dermatology Foundation","keywords":"Morphea; Medicine; Trunk; Odds ratio; Confidence interval; Retrospective cohort study; Dermatology; Radiology; Surgery; Pathology; Internal medicine; Biopsy","score_opus":0.00937871432107767,"score_gpt":0.26992872339312807,"score_spread":0.2605500090720504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3127489043","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99579525,0.00058795407,0.00027857855,0.000051016556,0.000010099434,0.0000066910357,0.0003056487,0.000026634107,0.0029381854],"genre_scores_gemma":[0.9993079,0.00020834035,0.0001249019,0.000010439683,0.000012222557,0.000001970145,0.000119761375,0.000006056193,0.00020839181],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99974686,0.00003472463,0.000022462626,0.00006616687,0.000045220968,0.00008471367],"domain_scores_gemma":[0.9991819,0.00012029375,0.0004551157,0.000041599014,0.00006590422,0.00013517728],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001698711,0.00037909969,0.00033188084,0.0013192778,0.00024395168,0.0004905634,0.00020317594,0.0003291141,0.005690287],"category_scores_gemma":[0.0007886599,0.00017785399,0.00030492072,0.0009376607,0.0003405764,0.00036296376,0.00027073614,0.00035379914,0.00047477733],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017661537,0.000042246233,0.96880585,0.000028727782,0.000043076798,0.016821299,0.000076029806,0.00015828392,0.0070124757,0.00014490029,0.00028635806,0.006404239],"study_design_scores_gemma":[0.0000050645463,0.00007724681,0.94194204,0.00001243996,0.00003716164,0.05625819,0.00022858483,0.0002640512,0.0006260854,0.000072962765,0.00046931018,0.0000067816895],"about_ca_topic_score_codex":0.0012383637,"about_ca_topic_score_gemma":0.0016724406,"teacher_disagreement_score":0.005690287,"about_ca_system_score_codex":0.0001882842,"about_ca_system_score_gemma":0.00023891339,"threshold_uncertainty_score":0.019035876},"labels":[],"label_agreement":null},{"id":"W3129325639","doi":"10.1016/j.jaad.2021.02.028","title":"Baricitinib in patients with moderate-to-severe atopic dermatitis: Results from a randomized monotherapy phase 3 trial in the United States and Canada (BREEZE-AD5)","year":2021,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":135,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Probity Medical Research; Innovaderm (Canada)","funders":"Eli Lilly and Company; Intel Corporation","keywords":"Medicine; Atopic dermatitis; Randomized controlled trial; Dermatology; Surgery","score_opus":0.010397117862195118,"score_gpt":0.27656975701541103,"score_spread":0.26617263915321593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3129325639","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95983803,0.028943708,0.00033025042,0.0020176354,0.0005276187,0.0013665758,0.0024971145,0.00011809112,0.004361067],"genre_scores_gemma":[0.9819542,0.010045288,0.0006620555,0.0018636532,0.0002047665,0.00046176254,0.0026296729,0.00001839127,0.0021603536],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9996382,0.00011553097,0.000020007159,0.00006287657,0.000058821304,0.000104473416],"domain_scores_gemma":[0.999474,0.00009633466,0.00009252079,0.000018844286,0.00007070372,0.0002476072],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011848498,0.00082426885,0.0018930717,0.00025758956,0.00047942172,0.0010172355,0.00071508624,0.000876036,0.0040328726],"category_scores_gemma":[0.0010065631,0.00029700212,0.0018273453,0.0004995646,0.00057882693,0.00055784633,0.00023115663,0.002217207,0.00043080281],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.86957395,0.0051406976,0.006135117,0.0019360866,0.0061120517,0.00015024573,0.00014088982,0.0008797158,0.0049411776,0.00027875285,0.01089217,0.09381906],"study_design_scores_gemma":[0.93098825,0.033031758,0.026172101,0.00019869053,0.0039542136,0.0001840918,0.00017556029,0.0008487222,0.0005256826,0.00020781286,0.003671778,0.000041386087],"about_ca_topic_score_codex":0.03743357,"about_ca_topic_score_gemma":0.14471254,"teacher_disagreement_score":0.96256644,"about_ca_system_score_codex":0.0029031483,"about_ca_system_score_gemma":0.002976511,"threshold_uncertainty_score":0.07443136},"labels":[],"label_agreement":null},{"id":"W3129416935","doi":"10.1016/j.jaad.2021.02.057","title":"Comparative safety and benefit-risk profile of biologics and oral treatment for moderate-to-severe plaque psoriasis: A network meta-analysis of clinical trial data","year":2021,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":67,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; Health Sciences Centre","funders":"AbbVie","keywords":"Medicine; Discontinuation; Etanercept; Adverse effect; Psoriasis; Internal medicine; Randomized controlled trial; Certolizumab pegol; Dermatology","score_opus":0.32446007850646374,"score_gpt":0.45548821782294396,"score_spread":0.13102813931648022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3129416935","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.023492198,0.97318345,0.0013901063,0.00028218812,0.00026952446,0.00015060183,0.0006601824,0.000046809007,0.0005248661],"genre_scores_gemma":[0.5235812,0.46809617,0.0033812015,0.001357627,0.0005250865,0.00036211158,0.0017711938,0.00008181642,0.000843538],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99532855,0.0029167759,0.0007244272,0.0005762557,0.0003120921,0.00014199696],"domain_scores_gemma":[0.9903584,0.007484865,0.0011879352,0.00045194148,0.0003601584,0.0001566975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008696651,0.0018557999,0.010843189,0.0011811436,0.00023549458,0.001871481,0.0014739211,0.0013674528,0.0032741043],"category_scores_gemma":[0.013697071,0.00077402004,0.018751105,0.0017973396,0.00046669185,0.0009539551,0.00090062513,0.0021700468,0.00028233998],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024990376,0.00005844244,0.004073028,0.062286355,0.8837466,0.00007954503,0.00004636313,0.0009198939,0.00051642256,0.00020525766,0.00082061964,0.022257011],"study_design_scores_gemma":[0.0047631287,0.0006827641,0.005676799,0.0027098188,0.982866,0.00007525286,0.00003300695,0.000411344,0.00016570058,0.000598094,0.001986993,0.00003106114],"about_ca_topic_score_codex":0.0017751559,"about_ca_topic_score_gemma":0.0034946383,"teacher_disagreement_score":0.010843189,"about_ca_system_score_codex":0.0009731784,"about_ca_system_score_gemma":0.00079632766,"threshold_uncertainty_score":0.04599279},"labels":[],"label_agreement":null},{"id":"W3130293843","doi":"10.1016/j.jaad.2021.02.044","title":"Effect of dupilumab on allergic contact dermatitis and patch testing","year":2021,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Contact Dermatitis and Allergies","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto; Probity Medical Research; University of Ottawa","funders":"","keywords":"Medicine; Dupilumab; Atopic dermatitis; Dermatology; Allergic contact dermatitis; Allergy; MEDLINE; Immunology","score_opus":0.03026718249507266,"score_gpt":0.3531005852500744,"score_spread":0.3228334027550017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3130293843","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00032277883,0.9989741,0.00004582407,0.000047191334,0.0000898417,0.0000051740226,0.000016455153,0.0000040275963,0.00049469067],"genre_scores_gemma":[0.005513269,0.99310666,0.00017520454,0.00028390973,0.00017867157,0.000010461336,0.000054665335,0.0000017332773,0.000675436],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99977404,0.000048084134,0.000029208728,0.000038312657,0.00008746477,0.000022902963],"domain_scores_gemma":[0.9997292,0.00013720957,0.000051794028,0.000006918923,0.000054197797,0.000020538524],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000661236,0.00088046485,0.0020121126,0.0017283568,0.00017447046,0.00068086316,0.0010023161,0.00079739455,0.0035080346],"category_scores_gemma":[0.0007296845,0.0002214259,0.0011650244,0.0009739255,0.00023089783,0.0005769328,0.00031883284,0.0012405183,0.00081920694],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048078742,0.0001827277,0.0002991102,0.02578066,0.00046907392,0.00027206258,0.000034098997,0.00022147933,0.0013694373,0.0005921377,0.013068379,0.9572299],"study_design_scores_gemma":[0.0014070333,0.00221057,0.010961363,0.01922618,0.00495892,0.0084706005,0.0001566461,0.00070160476,0.0031338516,0.0012902147,0.9473798,0.00010318761],"about_ca_topic_score_codex":0.0012340753,"about_ca_topic_score_gemma":0.002906685,"teacher_disagreement_score":0.0035080346,"about_ca_system_score_codex":0.00034361074,"about_ca_system_score_gemma":0.00041832266,"threshold_uncertainty_score":0.0117355585},"labels":[],"label_agreement":null},{"id":"W3133390125","doi":"10.1016/j.jaad.2021.02.038","title":"Long-term dupilumab treatment for chronic refractory generalized prurigo nodularis: A retrospective cohort study","year":2021,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Sunnybrook Hospital; Health Sciences Centre; Sunnybrook Health Science Centre; Women's College Hospital; University of Toronto","funders":"","keywords":"Dupilumab; Prurigo nodularis; Medicine; Atopic dermatitis; Dermatology; Prurigo; Retrospective cohort study; Cohort; Internal medicine","score_opus":0.02214786881763944,"score_gpt":0.3312890580440169,"score_spread":0.3091411892263775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3133390125","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99737215,0.0010246707,0.00015254792,0.00028546026,0.000050509996,0.00001709462,0.00059806573,0.000004961854,0.000494441],"genre_scores_gemma":[0.9983707,0.00034167885,0.00010222831,0.0003227922,0.000072347895,0.000016901638,0.0005038768,0.000004669414,0.00026484844],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991405,0.00019939717,0.00010247644,0.00027640027,0.00011281002,0.00016849009],"domain_scores_gemma":[0.9973787,0.0005389155,0.0008840806,0.0005363846,0.00027372187,0.00038814743],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008321964,0.00035442354,0.00064863404,0.0005622344,0.0008258373,0.0011417038,0.0005418179,0.000934033,0.0019913493],"category_scores_gemma":[0.0024649103,0.00057311304,0.0010737793,0.0010640798,0.00041017056,0.00096039404,0.000491315,0.0013218662,0.0004196673],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005895416,0.00008060873,0.99455583,0.000025535384,0.0003684184,0.0016469196,0.000097413205,0.000020387375,0.00027633898,0.000051286665,0.0005928608,0.0016946932],"study_design_scores_gemma":[0.00014777678,0.00050319365,0.987181,0.000036884347,0.00060809107,0.008817644,0.00062941987,0.0003350752,0.000091034555,0.00012096599,0.0014977981,0.00003094959],"about_ca_topic_score_codex":0.003772124,"about_ca_topic_score_gemma":0.0045358236,"teacher_disagreement_score":0.003772124,"about_ca_system_score_codex":0.0006159598,"about_ca_system_score_gemma":0.0005398857,"threshold_uncertainty_score":0.007500291},"labels":[],"label_agreement":null},{"id":"W3133945238","doi":"10.1016/j.jaad.2021.03.006","title":"Tapinarof-associated folliculitis is generally mild, self-limiting, and rarely interferes with therapy","year":2021,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Dermatological and Skeletal Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"","keywords":"Medicine; Limiting; Folliculitis; Dermatology","score_opus":0.01436453522254192,"score_gpt":0.25399880205937336,"score_spread":0.23963426683683145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3133945238","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.060694735,0.009910945,0.002483364,0.7648783,0.02628238,0.00012987845,0.00023867874,0.00030271962,0.13507912],"genre_scores_gemma":[0.5198953,0.010078117,0.0019896282,0.35191742,0.07141592,0.00009697797,0.00017686814,0.00013365997,0.044296138],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99942774,0.00013999423,0.00005962518,0.0000731187,0.0001418545,0.0001576783],"domain_scores_gemma":[0.998466,0.00076002826,0.0001746716,0.00009728449,0.00022530042,0.00027667847],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051671243,0.00054153136,0.0006056028,0.00043863914,0.0009902399,0.00078715273,0.0005453333,0.008279495,0.0039646756],"category_scores_gemma":[0.0065821786,0.0001846551,0.00057513634,0.0002470347,0.0009662124,0.00095203397,0.00040391218,0.0046342113,0.0026556763],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001845438,0.00016971165,0.01559712,0.00017295875,0.000037331825,0.687469,0.00026054645,0.00023150245,0.0019917667,0.0056383195,0.25594783,0.032299317],"study_design_scores_gemma":[0.00018687212,0.0002342027,0.008890612,0.0004560116,0.00003953931,0.76664686,0.00038455747,0.0015091116,0.0011354019,0.011494854,0.20897578,0.000046098157],"about_ca_topic_score_codex":0.0012006784,"about_ca_topic_score_gemma":0.0017640154,"teacher_disagreement_score":0.008279495,"about_ca_system_score_codex":0.0010146841,"about_ca_system_score_gemma":0.0005216671,"threshold_uncertainty_score":0.013263106},"labels":[],"label_agreement":null},{"id":"W3134102290","doi":"10.1016/j.jaad.2021.02.081","title":"Lasers as an adjuvant for vulvar lichen sclerosus: A systematic review and meta-analysis","year":2021,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Genital Health and Disease","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Lichen sclerosus; Psychosocial; Dermatology; MEDLINE; Meta-analysis; Internal medicine; Psychiatry","score_opus":0.11390683561080532,"score_gpt":0.4469525873325263,"score_spread":0.33304575172172096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3134102290","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0063194563,0.99276054,0.0001821746,0.00009925786,0.00010761533,0.0001430831,0.00017753008,0.000012349854,0.00019798339],"genre_scores_gemma":[0.17450763,0.82175463,0.0012189284,0.0011815414,0.00021256063,0.0003376002,0.0003093934,0.000019998784,0.0004576002],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9977793,0.00088960264,0.000623791,0.00029602658,0.00026981483,0.00014152603],"domain_scores_gemma":[0.9951391,0.0032713928,0.0010616829,0.00013963487,0.000277058,0.00011110505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003926272,0.0017330799,0.011575645,0.0020296373,0.00045453644,0.0019774644,0.0016105106,0.0023492542,0.0059146173],"category_scores_gemma":[0.00914672,0.0010633584,0.017486151,0.0026213299,0.0006357405,0.001556076,0.0011368688,0.0021419444,0.00040153883],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008576082,0.00016565163,0.0035684651,0.5670432,0.38674718,0.0001817319,0.0001510378,0.0004505829,0.0005993757,0.00014551244,0.0010514762,0.03131977],"study_design_scores_gemma":[0.0035809863,0.0008405585,0.0048946626,0.031603824,0.9558642,0.00012778059,0.0001018477,0.00015412988,0.00014151644,0.00016761544,0.0024825558,0.000040363124],"about_ca_topic_score_codex":0.0048400597,"about_ca_topic_score_gemma":0.01974767,"teacher_disagreement_score":0.011575645,"about_ca_system_score_codex":0.0013830259,"about_ca_system_score_gemma":0.0019141828,"threshold_uncertainty_score":0.02076441},"labels":[],"label_agreement":null},{"id":"W3134284151","doi":"10.1016/j.jaad.2021.03.005","title":"The preponderance of evidence supports an aryl hydrocarbon receptor-dependent mechanism of action of tapinarof","year":2021,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"","keywords":"Aryl hydrocarbon receptor; Psoriasis; Mechanism of action; Medicine; Mechanism (biology); Scopus; Receptor; Dermatology; MEDLINE; Internal medicine; Biochemistry; Biology; Transcription factor; In vitro","score_opus":0.05483533039360631,"score_gpt":0.30972760476677896,"score_spread":0.25489227437317263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3134284151","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010614731,0.0048651714,0.0008640364,0.9235949,0.036187753,0.000024092993,0.00009641233,0.00009681755,0.023656074],"genre_scores_gemma":[0.19057888,0.0072256997,0.0010940655,0.59668624,0.17413446,0.00004421923,0.00013848649,0.00007738264,0.030020574],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.999185,0.00019814618,0.00011062098,0.00013993315,0.00019858546,0.0001676607],"domain_scores_gemma":[0.9965744,0.0022591816,0.00021462355,0.00024115798,0.00043476006,0.00027576849],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012227776,0.00048520043,0.0010794896,0.0003782526,0.0010058724,0.0014894188,0.0007891727,0.015092739,0.00603261],"category_scores_gemma":[0.0073048766,0.00022488482,0.0006168322,0.00032691882,0.0014225825,0.0014561948,0.00036938814,0.013216839,0.0048559722],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011336308,0.0003650527,0.009571882,0.0005536062,0.00011651657,0.10005431,0.0005948899,0.00017027205,0.005433323,0.017814873,0.7913058,0.07288595],"study_design_scores_gemma":[0.00044133532,0.0004971462,0.00805234,0.00043305926,0.00012013203,0.06860602,0.0006818481,0.0012546165,0.0039357143,0.020013524,0.8958893,0.00007506121],"about_ca_topic_score_codex":0.0005231677,"about_ca_topic_score_gemma":0.000709759,"teacher_disagreement_score":0.015092739,"about_ca_system_score_codex":0.0011113617,"about_ca_system_score_gemma":0.0005571462,"threshold_uncertainty_score":0.02018112},"labels":[],"label_agreement":null},{"id":"W3134902852","doi":"10.1016/j.jaad.2021.02.066","title":"Clinical and psychosocial factors affecting work productivity among patients with hidradenitis suppurativa: A cluster analytical investigation","year":2021,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Montreal General Hospital","funders":"","keywords":"Hidradenitis suppurativa; Medicine; Presenteeism; Psychosocial; Absenteeism; Dermatology Life Quality Index; Quality of life (healthcare); Comorbidity; Depression (economics); Sick leave; Physical therapy; Gerontology; Psychiatry; Disease; Internal medicine","score_opus":0.02670381687739254,"score_gpt":0.31752322362368246,"score_spread":0.2908194067462899,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3134902852","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992099,0.0000650806,0.000039122373,0.00024106217,0.000015203158,0.000018068371,0.00011539945,0.0000011886441,0.00029496034],"genre_scores_gemma":[0.99939907,0.00005247561,0.000100285215,0.00013934422,0.000039432955,0.000024232044,0.0000992951,9.4224964e-7,0.00014502971],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99869734,0.00051799644,0.00020494514,0.00012703678,0.00019993162,0.00025287736],"domain_scores_gemma":[0.9971565,0.001264992,0.0005144057,0.00013634685,0.00044964373,0.00047817262],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011528246,0.00032580463,0.0006222009,0.0012336487,0.0013843258,0.0007143952,0.00045058568,0.00069783686,0.0012762947],"category_scores_gemma":[0.0038038148,0.00028864993,0.00066229934,0.0019499599,0.00044413877,0.00045681858,0.0005626614,0.00075140444,0.00019793115],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014438246,0.00016098966,0.997332,0.00000874958,0.000046812966,0.0006683033,0.00035865905,0.0000236787,0.0001474121,0.0000132504865,0.00017582919,0.0009199727],"study_design_scores_gemma":[0.000018894127,0.00029029988,0.9956038,0.000006170437,0.000030004203,0.0013555635,0.0022153629,0.00022306641,0.00003655429,0.000023434759,0.00019025571,0.0000065654026],"about_ca_topic_score_codex":0.006091805,"about_ca_topic_score_gemma":0.005448823,"teacher_disagreement_score":0.006091805,"about_ca_system_score_codex":0.0005832429,"about_ca_system_score_gemma":0.0007991959,"threshold_uncertainty_score":0.012112677},"labels":[],"label_agreement":null},{"id":"W3137539669","doi":"10.1016/j.jaad.2021.03.032","title":"Tralokinumab does not impact vaccine-induced immune responses: Results from a 30-week, randomized, placebo-controlled trial in adults with moderate-to-severe atopic dermatitis","year":2021,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"LEO Pharma Research Foundation","keywords":"Medicine; Atopic dermatitis; Placebo; Randomized controlled trial; Dermatology; Internal medicine; Alternative medicine","score_opus":0.011604803143348453,"score_gpt":0.29429853536370304,"score_spread":0.2826937322203546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3137539669","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9868486,0.010000201,0.00027461516,0.0004189812,0.00044137894,0.000616366,0.00040390322,0.00005623209,0.0009395722],"genre_scores_gemma":[0.9936991,0.0034732055,0.00041013327,0.00051653176,0.00027722123,0.0004136852,0.00032702697,0.000013566465,0.000869653],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9993025,0.00030060622,0.000065547785,0.00015434515,0.000058434944,0.00011847469],"domain_scores_gemma":[0.9990477,0.0003816622,0.00022534073,0.00006503629,0.000060432434,0.00021990106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001798791,0.0011898413,0.0031255973,0.00026633005,0.0004370835,0.0010330781,0.0008130218,0.0014912055,0.0040053786],"category_scores_gemma":[0.0017090344,0.0005428559,0.0025701527,0.00027846018,0.0009831242,0.0010717594,0.00025601985,0.0027789422,0.00059997715],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9721586,0.0037011576,0.0007945559,0.0013842058,0.0022643534,0.000058037716,0.000053619275,0.00022709795,0.0037913786,0.000052024676,0.00047531325,0.015039648],"study_design_scores_gemma":[0.9235851,0.06670028,0.0059130066,0.00008288157,0.0022384631,0.000064954926,0.00004415888,0.00030911522,0.00050420995,0.00008079894,0.0004551119,0.00002182124],"about_ca_topic_score_codex":0.00104346,"about_ca_topic_score_gemma":0.0024320185,"teacher_disagreement_score":0.0040053786,"about_ca_system_score_codex":0.0005997719,"about_ca_system_score_gemma":0.0006116955,"threshold_uncertainty_score":0.013399303},"labels":[],"label_agreement":null},{"id":"W3138079474","doi":"10.1016/j.jaad.2021.03.042","title":"Occupational contact dermatitis: Retrospective analysis of North American Contact Dermatitis Group Data, 2001 to 2016","year":2021,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Contact Dermatitis and Allergies","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; University of Ottawa; Montreal General Hospital; Sunnybrook Hospital; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Allergic contact dermatitis; Contact dermatitis; Irritant contact dermatitis; Dermatology; Population; Hand eczema; Cohort; Patch testing; Allergy; Environmental health; Internal medicine; Immunology","score_opus":0.021720899301420928,"score_gpt":0.3204714732389638,"score_spread":0.2987505739375429,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3138079474","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9787279,0.0021800683,0.00021655932,0.000049586164,0.000025110361,0.00005181171,0.01654261,0.0000238001,0.0021826373],"genre_scores_gemma":[0.98516893,0.001170144,0.0001376468,0.00006822438,0.000023982973,0.000059950256,0.012431796,0.00001146997,0.00092792755],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986986,0.00015666724,0.0002609086,0.00035706113,0.00035143422,0.00017518712],"domain_scores_gemma":[0.9972838,0.00023118824,0.0012864171,0.000329121,0.00062693254,0.00024248015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072072435,0.0004370025,0.0005318109,0.002675916,0.0007031002,0.0010377177,0.00048287617,0.00055662525,0.0020193723],"category_scores_gemma":[0.0020476242,0.0005501424,0.0007081618,0.0052985013,0.0003157718,0.0010095835,0.00083436526,0.00045647728,0.0006197444],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012357968,0.000023974682,0.99721485,0.000053108957,0.00010083096,0.00010696664,0.00007081217,0.00004085331,0.00010882056,0.000013588301,0.0006890447,0.001453573],"study_design_scores_gemma":[0.0000059913473,0.000023183216,0.9984773,0.00002157954,0.000047872883,0.00027299306,0.00022308918,0.000051033563,0.00004523078,0.000008162598,0.00082035066,0.0000032243254],"about_ca_topic_score_codex":0.044743307,"about_ca_topic_score_gemma":0.06574356,"teacher_disagreement_score":0.044743307,"about_ca_system_score_codex":0.0011132822,"about_ca_system_score_gemma":0.0014648429,"threshold_uncertainty_score":0.088965714},"labels":[],"label_agreement":null},{"id":"W3139030104","doi":"10.1016/j.jaad.2021.03.055","title":"Geographic distribution and environmental triggers of systemic sclerosis cases from 2 large academic tertiary centers in Massachusetts","year":2021,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Scopus; Epidemiology; Incidence (geometry); Scleroderma (fungus); Connective tissue disease; Disease; Pathology; MEDLINE; Environmental health; Gerontology; Autoimmune disease; Biology","score_opus":0.016928391330280117,"score_gpt":0.25154759230186136,"score_spread":0.23461920097158123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3139030104","genre_codex":"empirical","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994396,0.00031803915,0.00007729494,0.002264897,0.00002938083,0.000014209186,0.0003340814,0.000011939665,0.002554191],"genre_scores_gemma":[0.9988501,0.00013555588,0.00004346557,0.00050126686,0.00009054718,0.000006062246,0.00013251479,0.0000040751265,0.0002364971],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99895966,0.00028614624,0.00015215907,0.0001795596,0.00016268894,0.0002597779],"domain_scores_gemma":[0.9968176,0.0008547378,0.0009215542,0.00019974305,0.0005484253,0.0006580319],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005117057,0.00032502966,0.00042431147,0.0015135248,0.0018524148,0.0010340642,0.0007624926,0.0011299159,0.0040769703],"category_scores_gemma":[0.003258371,0.00042447087,0.00027081487,0.002390615,0.00050770916,0.000559891,0.0010025583,0.00052776304,0.0004027099],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008772525,0.00004283027,0.9829506,0.000019226916,0.000036970483,0.010774924,0.0016529557,0.000062989515,0.0007713107,0.00008569065,0.0017130678,0.001801538],"study_design_scores_gemma":[0.000023330747,0.000054672946,0.9801185,0.000026404367,0.0000313452,0.012985839,0.0053334637,0.00025078587,0.00014381108,0.00006906102,0.0009519848,0.000010703171],"about_ca_topic_score_codex":0.043374505,"about_ca_topic_score_gemma":0.07199585,"teacher_disagreement_score":0.043374505,"about_ca_system_score_codex":0.0014619756,"about_ca_system_score_gemma":0.0009173419,"threshold_uncertainty_score":0.08624411},"labels":[],"label_agreement":null},{"id":"W31399223","doi":"10.1016/j.jaad.2019.04.045","title":"Восточное языкознание: Учебно-методический комплекс.","year":2013,"lang":"ru","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Military Technology and Strategies","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Samsung Bioepis; Cilag; Janssen Biotech; Novartis Pharma; LEO Pharma; Almirall; Biogen Idec; Medac; Fresenius Medical Care North America; Celgene; Valeant Pharmaceuticals International; Pfizer; Amgen","keywords":"Environmental science","score_opus":0.009112035912385373,"score_gpt":0.24637595338840657,"score_spread":0.23726391747602119,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W31399223","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.067656614,0.0671285,0.041328587,0.020508772,0.003796,0.00011482308,0.000304779,0.00017166151,0.79899037],"genre_scores_gemma":[0.85665876,0.020597978,0.02697787,0.0009370779,0.0008123705,0.00014609586,0.0001017022,0.00009858482,0.09366955],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99908674,0.00016877402,0.00003148548,0.00014249941,0.00041291534,0.00015764164],"domain_scores_gemma":[0.99929404,0.00023252121,0.00008589472,0.0001097943,0.00019101136,0.00008674748],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009602724,0.00026041924,0.0002743482,0.001192141,0.0018127961,0.0036838131,0.00046626193,0.0009226793,0.010520317],"category_scores_gemma":[0.002137729,0.00032730988,0.00027451775,0.0009757134,0.0040974496,0.0018218793,0.001197405,0.0015896994,0.0020300082],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004155783,0.000023418565,0.00038672375,0.00013374511,0.000008730089,0.00037386944,0.0018240223,0.0002577503,0.0024553365,0.93168133,0.005983009,0.056830563],"study_design_scores_gemma":[0.00002647374,0.00004790352,0.0017022563,0.00028334747,0.000024833493,0.0011168862,0.0022645628,0.0006186814,0.0044239596,0.42221272,0.56723624,0.00004209616],"about_ca_topic_score_codex":0.0030532354,"about_ca_topic_score_gemma":0.0045175212,"teacher_disagreement_score":0.98947966,"about_ca_system_score_codex":0.00191312,"about_ca_system_score_gemma":0.0024100945,"threshold_uncertainty_score":0.03519392},"labels":[],"label_agreement":null},{"id":"W3147203604","doi":"10.1016/j.jaad.2021.03.089","title":"Biologic treatment outcomes in refractory eosinophilic fasciitis: A systematic review of published reports","year":2021,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Eosinophilic Disorders and Syndromes","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Western University; Memorial University of Newfoundland; University of Toronto","funders":"","keywords":"Medicine; Eosinophilic fasciitis; Dermatology; Refractory (planetary science); Fasciitis; MEDLINE; Intensive care medicine; Surgery","score_opus":0.03474692725819928,"score_gpt":0.37227554648955946,"score_spread":0.3375286192313602,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3147203604","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016679574,0.99781847,0.00003982723,0.000057899782,0.000033807966,0.000036287845,0.00026222155,0.0000028067627,0.00008079584],"genre_scores_gemma":[0.02229781,0.97671,0.00025123067,0.00028264732,0.00005762643,0.0000763689,0.0002644531,0.0000032498858,0.000056570123],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99674416,0.0006840686,0.0015167037,0.00041557304,0.00051024894,0.00012917907],"domain_scores_gemma":[0.98909646,0.007151265,0.0029351867,0.00012843877,0.00054144714,0.00014719905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003242927,0.0011169593,0.007485213,0.00564566,0.00040083248,0.0020778845,0.001452268,0.0014001282,0.0035804627],"category_scores_gemma":[0.012178445,0.0007573406,0.007869135,0.0068507334,0.0006108746,0.0017375248,0.0013967481,0.001087085,0.00022022368],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008161091,0.000040579635,0.0048877317,0.9032391,0.041629117,0.00018093287,0.00020744748,0.000120988625,0.0002817739,0.00011795566,0.0018012833,0.046676945],"study_design_scores_gemma":[0.0012769795,0.00045799455,0.034299526,0.5178099,0.4220266,0.0012020901,0.0006558808,0.00014708043,0.00025531402,0.00038677838,0.021358175,0.00012363866],"about_ca_topic_score_codex":0.0032779905,"about_ca_topic_score_gemma":0.0133041935,"teacher_disagreement_score":0.007485213,"about_ca_system_score_codex":0.0011115978,"about_ca_system_score_gemma":0.0026603597,"threshold_uncertainty_score":0.017150402},"labels":[],"label_agreement":null},{"id":"W3155003812","doi":"10.1016/j.jaad.2021.04.026","title":"Response to comment on “An evidence-based guide to SARS-Cov-2 vaccination of patients on immunotherapies in dermatology.”","year":2021,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Autoimmune Bullous Skin Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Rituximab; Vaccination; Ocrelizumab; Influenza vaccine; Immunology; Dermatology; Pemphigus; Antibody","score_opus":0.034548959733360175,"score_gpt":0.3577393007701165,"score_spread":0.3231903410367563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3155003812","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015417735,0.00052489655,0.0000713737,0.97982603,0.017372856,0.000021274616,0.00014466091,0.000048434864,0.0018363056],"genre_scores_gemma":[0.000615882,0.00020542162,0.000078963065,0.9872645,0.008893853,0.00003053113,0.000031457752,0.000015033158,0.0028643375],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959978,0.00091467676,0.00060483953,0.0005215336,0.0012739325,0.0006873006],"domain_scores_gemma":[0.9912032,0.0042393473,0.0007460959,0.00019285927,0.0023295474,0.0012889628],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004842819,0.0012293156,0.0019258098,0.0010262199,0.004260223,0.0034294396,0.0029589494,0.07038558,0.0114027085],"category_scores_gemma":[0.02624282,0.0010293914,0.0020891023,0.0008858214,0.0027712265,0.00371065,0.0016511634,0.04372878,0.015695183],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000043036376,0.000016702847,0.0002106184,0.000032941418,0.000008677522,0.00038868116,0.00004684211,0.00002512498,0.00006662071,0.00051387766,0.996761,0.0018858522],"study_design_scores_gemma":[0.00019248917,0.00008831878,0.0020234135,0.00046157566,0.000048667396,0.0011763503,0.00034945516,0.00036541303,0.0003210854,0.0038647773,0.9910102,0.00009823802],"about_ca_topic_score_codex":0.017195089,"about_ca_topic_score_gemma":0.02279638,"teacher_disagreement_score":0.07038558,"about_ca_system_score_codex":0.005756662,"about_ca_system_score_gemma":0.0067537585,"threshold_uncertainty_score":0.041767716},"labels":[],"label_agreement":null},{"id":"W3155055769","doi":"10.1016/j.jaad.2021.03.116","title":"Microneedling as an adjuvant to topical therapies for melasma: A systematic review and meta-analysis","year":2021,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Dermatologic Treatments and Research","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Melasma; Medicine; Dermatology; Adjuvant therapy; Adjuvant; Adverse effect; Tolerability; Surgery; Internal medicine; Chemotherapy","score_opus":0.12937375660217587,"score_gpt":0.46929229732351047,"score_spread":0.3399185407213346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3155055769","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00791918,0.9907657,0.00030481888,0.00010671462,0.00015016588,0.0002571353,0.00024581223,0.000018859133,0.00023170875],"genre_scores_gemma":[0.19518352,0.80005646,0.0018403349,0.001159972,0.00020763798,0.0005157233,0.00042447718,0.000030006173,0.00058192183],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99697125,0.0012483543,0.00086647464,0.00038423046,0.00036602264,0.00016358831],"domain_scores_gemma":[0.9943276,0.0038138046,0.0012235027,0.00017850625,0.00033577342,0.00012082046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005340558,0.002286491,0.014115843,0.0024526604,0.00049641577,0.0023133524,0.0018217865,0.0023545418,0.005558448],"category_scores_gemma":[0.011177778,0.0011907972,0.024506764,0.0029401458,0.00065292575,0.001625747,0.0013618647,0.00233021,0.00041501617],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006774517,0.000110080546,0.00235025,0.45386133,0.5174594,0.00013157626,0.000108378656,0.00035535367,0.00041681074,0.000106613676,0.0006150924,0.017710553],"study_design_scores_gemma":[0.0024301666,0.0005246437,0.0028131958,0.018564438,0.9737341,0.00008455308,0.000063898995,0.00013550346,0.000109314584,0.00011322624,0.0013987244,0.000028229082],"about_ca_topic_score_codex":0.0058831545,"about_ca_topic_score_gemma":0.022018546,"teacher_disagreement_score":0.014115843,"about_ca_system_score_codex":0.0017571478,"about_ca_system_score_gemma":0.0021350384,"threshold_uncertainty_score":0.0282439},"labels":[],"label_agreement":null},{"id":"W3159816148","doi":"10.1016/j.jaad.2021.04.068","title":"A response to “Cannabinoids in Dermatologic Surgery”: The added considerations of factors affecting tissue perfusion, wound healing, and modes of administration in safety and efficacy of cannabinoids","year":2021,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Cannabinoid receptor; Cannabinoid; Synthetic cannabinoids; Agonist; Wound healing; Pharmacology; Anesthesia; Surgery; Receptor; Internal medicine","score_opus":0.029663781533294194,"score_gpt":0.33997065059611103,"score_spread":0.31030686906281685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3159816148","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001164805,0.00060477224,0.00010750567,0.9835714,0.012460095,0.000018699136,0.000026807995,0.000016111147,0.0020299114],"genre_scores_gemma":[0.0068813944,0.000855904,0.0003903389,0.9587359,0.027449751,0.000032516593,0.000020438625,0.00001761001,0.0056162504],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969885,0.0009281886,0.0004562084,0.00037960958,0.00079961726,0.0004478718],"domain_scores_gemma":[0.9928973,0.0039903224,0.00049805944,0.00017349112,0.0013637118,0.0010771374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030303304,0.0008147854,0.0013441521,0.0006178758,0.0045509785,0.0026803545,0.0019267934,0.053168867,0.004001861],"category_scores_gemma":[0.02066532,0.0008142808,0.0014312855,0.00064868416,0.0022599257,0.002994578,0.0012547899,0.04110501,0.002132567],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022688435,0.0002103904,0.002456226,0.00013518936,0.000046202,0.019847997,0.00056245615,0.00023252808,0.0007553914,0.004150089,0.9580815,0.013295098],"study_design_scores_gemma":[0.0003359474,0.00041983376,0.004478532,0.0007059239,0.000114147944,0.020234613,0.0018485895,0.0018965135,0.00076911633,0.008794808,0.9602273,0.00017467624],"about_ca_topic_score_codex":0.0071286606,"about_ca_topic_score_gemma":0.01321585,"teacher_disagreement_score":0.053168867,"about_ca_system_score_codex":0.004761265,"about_ca_system_score_gemma":0.0051132804,"threshold_uncertainty_score":0.03454554},"labels":[],"label_agreement":null},{"id":"W3159897478","doi":"10.1016/j.jaad.2021.04.085","title":"Efficacy and safety of ruxolitinib cream for the treatment of atopic dermatitis: Results from 2 phase 3, randomized, double-blind studies","year":2021,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":297,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"Incyte; Intel Corporation","keywords":"Medicine; Atopic dermatitis; Ruxolitinib; Eczema Area and Severity Index; Clinical endpoint; Randomized controlled trial; Dermatology; Internal medicine","score_opus":0.0536459511798173,"score_gpt":0.38895864852939155,"score_spread":0.33531269734957425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3159897478","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97273266,0.019249931,0.001434788,0.000426039,0.00038084632,0.003203922,0.00094655517,0.00016356425,0.0014617249],"genre_scores_gemma":[0.9830194,0.00794448,0.002474278,0.0009155143,0.0005380692,0.002840098,0.0009613266,0.00005027848,0.0012564873],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99825925,0.00090444577,0.0001835169,0.00028829632,0.00018624037,0.00017823033],"domain_scores_gemma":[0.99783295,0.0009752215,0.00057318393,0.00018953858,0.00015048156,0.00027864115],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004365258,0.0017739419,0.004554222,0.00053804973,0.00067646406,0.001414273,0.0012129003,0.0025403872,0.0036119611],"category_scores_gemma":[0.0030921001,0.0008822591,0.0031968046,0.0005249665,0.0014962353,0.0017406457,0.00037009484,0.0030160917,0.00074450806],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9491947,0.009380887,0.00066421047,0.0014861664,0.0020966711,0.00004552409,0.0000990512,0.00036107606,0.008471377,0.00007196315,0.0004844173,0.027643893],"study_design_scores_gemma":[0.92371917,0.06985999,0.0028240797,0.000064250504,0.0012913689,0.000062338375,0.000023580376,0.0003527848,0.0011797084,0.00010418229,0.000487765,0.000030829346],"about_ca_topic_score_codex":0.0005864229,"about_ca_topic_score_gemma":0.0013413612,"teacher_disagreement_score":0.004554222,"about_ca_system_score_codex":0.00069945917,"about_ca_system_score_gemma":0.0009823649,"threshold_uncertainty_score":0.023085952},"labels":[],"label_agreement":null},{"id":"W3173090002","doi":"10.1016/j.jaad.2021.05.054","title":"Use of silicone gel sheet to reduce pain during laser hair reduction of the upper lip","year":2021,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatologic Treatments and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"","keywords":"Medicine; Silicone; Reduction (mathematics); Upper lip; Dentistry; Dermatology; Surgery; Anatomy; Composite material","score_opus":0.0362080406540249,"score_gpt":0.33529680875068435,"score_spread":0.29908876809665946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3173090002","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98885334,0.0034009211,0.0022465417,0.00075457076,0.00030421463,0.00010135627,0.000056911595,0.00013090434,0.004151181],"genre_scores_gemma":[0.99383587,0.0014100368,0.0023590634,0.00034513662,0.00014874575,0.00004098079,0.000052186886,0.000015345257,0.0017926289],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99991715,0.000014268743,0.000009165219,0.000010408359,0.000029471303,0.00001954544],"domain_scores_gemma":[0.99988985,0.000052972075,0.000016315606,0.000009424916,0.000008865871,0.000022561318],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000167765,0.00029603782,0.0003141015,0.00034629586,0.0003852529,0.00015549973,0.0002541319,0.0003713293,0.0022798749],"category_scores_gemma":[0.0005366254,0.00012799172,0.0006890423,0.00012148477,0.00014076076,0.00019516973,0.00016543904,0.00062673364,0.00031814966],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018271463,0.0061816066,0.012277064,0.0013846471,0.00035939188,0.027340773,0.0010292473,0.0008156052,0.47349495,0.0005583991,0.0049011414,0.4533857],"study_design_scores_gemma":[0.004816011,0.10795542,0.31523064,0.0009938765,0.0011621034,0.15518089,0.0024642716,0.009504198,0.35594705,0.0010418812,0.045467444,0.00023621916],"about_ca_topic_score_codex":0.00035563842,"about_ca_topic_score_gemma":0.00074199156,"teacher_disagreement_score":0.0022798749,"about_ca_system_score_codex":0.00010455824,"about_ca_system_score_gemma":0.00023731965,"threshold_uncertainty_score":0.0076269507},"labels":[],"label_agreement":null},{"id":"W3180310091","doi":"10.1016/j.jaad.2021.06.865","title":"Reproductive and hormonal factors and risk of incident rosacea among US White women","year":2021,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"National Cancer Institute; National Institutes of Health","keywords":"Rosacea; Medicine; Scopus; Immune system; Dermatology; Internal medicine; Immunology; MEDLINE; Biology; Acne","score_opus":0.007944356398057694,"score_gpt":0.2666841515854126,"score_spread":0.2587397951873549,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3180310091","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957872,0.0008904551,0.00007856759,0.00014150517,0.000030152132,0.000011379702,0.00072762865,0.0000063416273,0.00232677],"genre_scores_gemma":[0.9983323,0.00041135825,0.000051930136,0.000085097985,0.00003386756,0.000008272829,0.00026133773,0.0000029135401,0.000812882],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99983644,0.000035715326,0.00001256335,0.00003769298,0.000029469822,0.00004817407],"domain_scores_gemma":[0.99952805,0.00008641798,0.00019760495,0.000036228197,0.000031762764,0.00011997205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023661833,0.00022162801,0.00021944393,0.0007492086,0.0005750478,0.00052253605,0.00021607382,0.00047502224,0.0031966146],"category_scores_gemma":[0.0008918738,0.00040572693,0.0004694573,0.0010954253,0.00021755252,0.00042813682,0.00023708286,0.00059272524,0.0003019267],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000095869036,0.00006946814,0.99825233,0.000006133749,0.00005785584,0.00007873918,0.00006735748,0.000018554387,0.0002281342,0.000026822354,0.000110527,0.0009881961],"study_design_scores_gemma":[0.0000068652967,0.00006807523,0.9989183,0.0000064639794,0.000039039223,0.00018350116,0.0002878502,0.000082301296,0.000037417867,0.000025245188,0.00034145796,0.0000035708651],"about_ca_topic_score_codex":0.0117808245,"about_ca_topic_score_gemma":0.01425366,"teacher_disagreement_score":0.0117808245,"about_ca_system_score_codex":0.00019061078,"about_ca_system_score_gemma":0.00030289803,"threshold_uncertainty_score":0.023424506},"labels":[],"label_agreement":null},{"id":"W3186008730","doi":"10.1016/j.jaad.2021.07.030","title":"Age-related differences in patch testing results among children: Analysis of North American Contact Dermatitis Group Data, 2001-2018","year":2021,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Contact Dermatitis and Allergies","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec; McGill University; Health Sciences Centre; University of Ottawa; Montreal General Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Contact dermatitis; Allergen; Patch testing; Dermatology; Patch test; Cobalt chloride; Allergic contact dermatitis; Allergy; Linalool; Immunology; Cobalt; Food science; Organic chemistry","score_opus":0.030110893921684482,"score_gpt":0.2904492891694288,"score_spread":0.2603383952477443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3186008730","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99317706,0.00041109973,0.00008829143,0.000033633474,0.000008426864,0.000011564594,0.0049724053,0.000012251348,0.0012852896],"genre_scores_gemma":[0.9959549,0.00019646787,0.00006885742,0.000015872649,0.000007022492,0.000010563647,0.0034411282,0.0000064921546,0.0002988062],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99879515,0.0002219083,0.0002219868,0.0002603149,0.0003212805,0.00017946497],"domain_scores_gemma":[0.99607277,0.00069399807,0.001985805,0.00024579576,0.00071655354,0.00028497068],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010643121,0.0002792908,0.0003328879,0.0025397432,0.00035569066,0.00057570596,0.00047007194,0.0004055871,0.0018827843],"category_scores_gemma":[0.0028768224,0.0002697606,0.0006362891,0.003187522,0.00025750065,0.0007041036,0.00048360374,0.00047265028,0.00041540765],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053343523,0.000013253102,0.9987606,0.000009855718,0.000039986415,0.000025279049,0.000062091196,0.0000272796,0.000076147226,0.0000071207082,0.00016462173,0.00076045445],"study_design_scores_gemma":[6.813786e-7,0.000013181858,0.99967444,0.0000022795405,0.0000098867185,0.000051770254,0.00008964261,0.000027289881,0.00002022864,0.0000019543927,0.00010779315,8.4504757e-7],"about_ca_topic_score_codex":0.039059352,"about_ca_topic_score_gemma":0.051170725,"teacher_disagreement_score":0.039059352,"about_ca_system_score_codex":0.00065600104,"about_ca_system_score_gemma":0.00044327695,"threshold_uncertainty_score":0.07766396},"labels":[],"label_agreement":null},{"id":"W3187090426","doi":"10.1016/j.jaad.2021.06.032","title":"25445 North American study of pediatric SJS and TEN: Setting diagnostic criteria, systematic review and retrospective cohort study comparing outcomes of common treatments","year":2021,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Vascular Tumors and Angiosarcomas","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Retrospective cohort study; Intervention (counseling); Cohort; MEDLINE; Cohort study; Pediatrics; Intensive care medicine; Surgery; Pathology; Psychiatry","score_opus":0.013909380452701297,"score_gpt":0.3204164384590491,"score_spread":0.3065070580063478,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3187090426","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5669719,0.3958142,0.0008653474,0.00039734712,0.00027002883,0.001526144,0.03171102,0.000030760322,0.00241326],"genre_scores_gemma":[0.94849914,0.040071514,0.0013082084,0.0008653441,0.000109530505,0.0020834634,0.006667808,0.00001863396,0.00037632664],"study_design_codex":"observational","study_design_gemma":"systematic_review","domain_scores_codex":[0.98905843,0.0029860735,0.0042722346,0.0021023743,0.0012010717,0.00037974023],"domain_scores_gemma":[0.98157996,0.0073599042,0.0074728513,0.0010750766,0.0020886487,0.00042354592],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0046721157,0.00067863014,0.0030167042,0.0037647448,0.00080593844,0.0012493065,0.00088795467,0.0011253646,0.0022393963],"category_scores_gemma":[0.019327717,0.0009354103,0.0051879724,0.0059514698,0.00059333874,0.0008663607,0.0011002241,0.0007003366,0.0002566472],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034851574,0.00011024937,0.8011174,0.087104596,0.09141209,0.0005628445,0.0007023208,0.00015116889,0.00095637946,0.00025766858,0.0036322027,0.010507911],"study_design_scores_gemma":[0.0022063174,0.00059923844,0.8508279,0.016891355,0.119659565,0.001093957,0.00081924454,0.00011921955,0.0003108295,0.0001632193,0.0072352844,0.0000738739],"about_ca_topic_score_codex":0.016268332,"about_ca_topic_score_gemma":0.044409554,"teacher_disagreement_score":0.016268332,"about_ca_system_score_codex":0.0014642425,"about_ca_system_score_gemma":0.004493049,"threshold_uncertainty_score":0.03234732},"labels":[],"label_agreement":null},{"id":"W3187360239","doi":"10.1016/j.jaad.2021.06.734","title":"28251 Quantification of erythema associated with continuous nylon, polyglactin-910, and fast absorbing gut sutures in facial surgery repair: A randomized prospective study","year":2021,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Surgical Sutures and Adhesives","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health; University of British Columbia","funders":"","keywords":"Medicine; Erythema; Scars; Surgery; Fibrous joint; Prospective cohort study; Dermatology","score_opus":0.015662642577303938,"score_gpt":0.29222449751988305,"score_spread":0.2765618549425791,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3187360239","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99740845,0.0007209312,0.00038371768,0.000029817049,0.00010644943,0.0009012388,0.00014909235,0.000014246184,0.00028608576],"genre_scores_gemma":[0.9958103,0.0005335454,0.0009013351,0.00018038996,0.0003401673,0.001030973,0.0003423468,0.000011104928,0.00084982475],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9960444,0.002060346,0.0002631354,0.0008526254,0.0004730481,0.00030649087],"domain_scores_gemma":[0.9949694,0.0018441803,0.001160919,0.00064596144,0.00035910436,0.0010203512],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004519157,0.0026064992,0.0030950103,0.0009096365,0.0010932981,0.0017381675,0.0012737984,0.0024375396,0.0044028354],"category_scores_gemma":[0.0035445457,0.0017631063,0.0030112208,0.0010613231,0.0029475947,0.0014679903,0.00065297645,0.002870817,0.0010045402],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.95284075,0.025684237,0.012177757,0.00023886793,0.0013035889,0.000046778438,0.000072098956,0.00016306351,0.003194506,0.000049871476,0.00009445846,0.004133913],"study_design_scores_gemma":[0.3697954,0.58442384,0.039974295,0.000041728104,0.0021130575,0.000079693906,0.00012542038,0.00073932594,0.002041294,0.00013245994,0.00044735795,0.00008611422],"about_ca_topic_score_codex":0.0011192732,"about_ca_topic_score_gemma":0.0011385075,"teacher_disagreement_score":0.004519157,"about_ca_system_score_codex":0.00094245566,"about_ca_system_score_gemma":0.0010717185,"threshold_uncertainty_score":0.023899853},"labels":[],"label_agreement":null},{"id":"W3187630027","doi":"10.1016/j.jaad.2021.06.479","title":"26750 Cumulative clinical benefits of biologic treatments for psoriasis over 1 year","year":2021,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"","keywords":"Medicine; Psoriasis; Psoriasis Area and Severity Index; Cumulative dose; Clinical trial; Dermatology; Internal medicine","score_opus":0.4025609658336517,"score_gpt":0.509463432227694,"score_spread":0.10690246639404227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3187630027","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9447556,0.020646842,0.00091568055,0.0011927478,0.00042914235,0.00020991822,0.01814024,0.00011823619,0.013591666],"genre_scores_gemma":[0.9832218,0.0049437014,0.0002809598,0.00026486974,0.00022472237,0.000075150485,0.008818738,0.0000071796576,0.002162899],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9986979,0.000671841,0.00013571708,0.000109696986,0.00021850581,0.0001663897],"domain_scores_gemma":[0.99669015,0.0022426755,0.00055524195,0.0001311243,0.00015432147,0.00022640197],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022154576,0.0003754488,0.00067828293,0.0009700255,0.00016006922,0.0004978831,0.00027246593,0.00050703256,0.0061289966],"category_scores_gemma":[0.0065358523,0.00023684655,0.002038496,0.0011832882,0.000247994,0.00034417643,0.00038771756,0.0009900164,0.0009122208],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14155571,0.0034143215,0.38569713,0.003222357,0.009321563,0.0014373485,0.00015738353,0.019832425,0.00291897,0.002550221,0.031454068,0.3984385],"study_design_scores_gemma":[0.012284521,0.029906305,0.9199652,0.00071106816,0.00773222,0.0011253909,0.00022759866,0.007932939,0.0013081321,0.0012493609,0.01746434,0.000092870425],"about_ca_topic_score_codex":0.004217418,"about_ca_topic_score_gemma":0.0053315177,"teacher_disagreement_score":0.0061289966,"about_ca_system_score_codex":0.00083003956,"about_ca_system_score_gemma":0.0008781261,"threshold_uncertainty_score":0.020503521},"labels":[],"label_agreement":null},{"id":"W3188094560","doi":"10.1016/j.jaad.2021.06.181","title":"27764 Muffin technique micrographic surgery for nonmelanoma skin cancer","year":2021,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Skin cancer; Dermatology; Mohs surgery; Melanoma; Margin (machine learning); Surgery; Cancer; Internal medicine","score_opus":0.022676815386717453,"score_gpt":0.3343272466708293,"score_spread":0.31165043128411185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3188094560","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87073535,0.018040698,0.00021520097,0.00085958565,0.00048731617,0.00016847429,0.0004406185,0.000018528735,0.109034106],"genre_scores_gemma":[0.95924115,0.007862438,0.0003982611,0.0004016194,0.00021040373,0.000051645853,0.00019356255,0.0000049117607,0.031635985],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.99985135,0.000039662547,0.0000109183575,0.0000132459445,0.000050383907,0.000034305143],"domain_scores_gemma":[0.999749,0.0001192137,0.000025324227,0.000019928953,0.00004056962,0.00004608905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003338216,0.000118783886,0.00010076011,0.0009903918,0.0005642933,0.00021616861,0.00016790583,0.00018376615,0.028625032],"category_scores_gemma":[0.00054782303,0.00006175663,0.00013555167,0.0005760528,0.00017670807,0.0002839448,0.00025568056,0.00015079167,0.0013090151],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047763423,0.0019701812,0.39150566,0.0013870704,0.00018501247,0.0066193147,0.001494279,0.00021129732,0.029193703,0.004142463,0.027530728,0.530984],"study_design_scores_gemma":[0.00034205458,0.009722355,0.79892963,0.000431933,0.00013430482,0.016195957,0.0013959607,0.00012278644,0.008740695,0.0004780424,0.16348346,0.000022875789],"about_ca_topic_score_codex":0.0032277526,"about_ca_topic_score_gemma":0.011528383,"teacher_disagreement_score":0.028625032,"about_ca_system_score_codex":0.00025677696,"about_ca_system_score_gemma":0.0004670176,"threshold_uncertainty_score":0.095760286},"labels":[],"label_agreement":null},{"id":"W3190862714","doi":"10.1016/j.jaad.2021.06.038","title":"24972 Exploring the effect of dupilumab on allergic contact dermatitis and patch testing","year":2021,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Contact Dermatitis and Allergies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Health Sciences Centre; Sunnybrook Health Science Centre; Women's College Hospital; University of Toronto; University of Ottawa","funders":"","keywords":"Dupilumab; Medicine; Atopic dermatitis; Dermatology; Allergic contact dermatitis; Allergy; Immunology","score_opus":0.02758362290371148,"score_gpt":0.2879331008661107,"score_spread":0.2603494779623992,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3190862714","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9741563,0.014400672,0.00031043202,0.00081167486,0.00028923113,0.00016131147,0.0002641284,0.000049756825,0.009556487],"genre_scores_gemma":[0.99325126,0.0029887694,0.0005558204,0.00034347764,0.00015367202,0.0000326785,0.00013741378,0.0000072314424,0.002529594],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99965787,0.0001273717,0.000017493672,0.00003720693,0.000093106384,0.00006691961],"domain_scores_gemma":[0.9996891,0.0001444613,0.00003523739,0.000013302453,0.00004917636,0.00006869405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059005484,0.00033442743,0.00050364155,0.00025437676,0.00023134537,0.00031965948,0.00025247206,0.00043684503,0.003993357],"category_scores_gemma":[0.0008513222,0.000101136495,0.0006350402,0.00017926592,0.00013627601,0.0002538566,0.000098241035,0.00062934455,0.00042305462],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.079227686,0.011581511,0.027692523,0.0018878774,0.0007401744,0.002074953,0.0002196746,0.0005104216,0.11387721,0.00032436618,0.0062536225,0.75561],"study_design_scores_gemma":[0.016351506,0.41817203,0.39662504,0.00070823997,0.0038937528,0.009402456,0.00083174964,0.005058856,0.08269424,0.00048775927,0.065653674,0.000120662924],"about_ca_topic_score_codex":0.0013693685,"about_ca_topic_score_gemma":0.00405731,"teacher_disagreement_score":0.003993357,"about_ca_system_score_codex":0.0003010885,"about_ca_system_score_gemma":0.0003073877,"threshold_uncertainty_score":0.013359129},"labels":[],"label_agreement":null},{"id":"W3190914580","doi":"10.1016/j.jaad.2021.08.005","title":"Patch testing with ammonium persulfate: The North American Contact Dermatitis Group Experience, 2015-2018","year":2021,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Contact Dermatitis and Allergies","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec; Montreal General Hospital; University of Ottawa; University of Toronto; Sunnybrook Health Science Centre; McGill University; Health Sciences Centre","funders":"","keywords":"Ammonium persulfate; Medicine; Contact dermatitis; Patch test; Dermatology; Trunk; Oxidizing agent; Persulfate; Hand dermatitis; Allergic contact dermatitis; Patch testing; Allergy; Immunology; Organic chemistry; Chemistry","score_opus":0.01856974944073936,"score_gpt":0.2859253396927305,"score_spread":0.2673555902519911,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3190914580","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9683571,0.0057046763,0.00083801546,0.001688106,0.00010233789,0.00008102507,0.00011567453,0.000040935764,0.023072058],"genre_scores_gemma":[0.99004424,0.0034535737,0.0006485061,0.00093527697,0.000057478537,0.00001935991,0.00018371253,0.00001916515,0.0046387785],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984579,0.00050383,0.00010604936,0.00018496059,0.00056105247,0.00018610645],"domain_scores_gemma":[0.99848866,0.0004448364,0.0001854637,0.00009278188,0.00040770645,0.00038058384],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027580552,0.00026862673,0.00020899405,0.0004462698,0.00093331427,0.00069962715,0.00041225227,0.0005285222,0.0024358702],"category_scores_gemma":[0.002977285,0.00015745757,0.00030038258,0.00048956746,0.0005985618,0.0009604156,0.0009098241,0.0005143539,0.0005189637],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007720558,0.0036026808,0.7205043,0.00023240376,0.00008880051,0.008511461,0.011100282,0.00021269413,0.0060193287,0.0006461111,0.016207099,0.23210283],"study_design_scores_gemma":[0.00011651779,0.0041578677,0.84142536,0.00044978908,0.00018114461,0.04547355,0.017598119,0.0006727047,0.0041182055,0.00067029044,0.08509227,0.000044174034],"about_ca_topic_score_codex":0.009716332,"about_ca_topic_score_gemma":0.040081058,"teacher_disagreement_score":0.009716332,"about_ca_system_score_codex":0.0009554342,"about_ca_system_score_gemma":0.0012633788,"threshold_uncertainty_score":0.019319534},"labels":[],"label_agreement":null},{"id":"W3191669539","doi":"10.1016/j.jaad.2021.06.447","title":"26574 Acne consultations: Recommendations for optimizing patient-centred care","year":2021,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Windsor Clinical Research; Western University","funders":"","keywords":"Acne; Medicine; Tolerability; Adapalene; Patient satisfaction; Family medicine; Acne treatment; Delphi method; Dermatology; Alternative medicine; Nursing; Pathology","score_opus":0.0262863915816935,"score_gpt":0.3314344754530376,"score_spread":0.3051480838713441,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3191669539","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015069828,0.021215418,0.028363038,0.7660439,0.007329944,0.0058324854,0.00175057,0.0026849946,0.1517098],"genre_scores_gemma":[0.19460714,0.054918367,0.4576672,0.20341319,0.009259839,0.015789513,0.0048272484,0.0011622385,0.058355287],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.97911537,0.011818287,0.0026976226,0.0007028979,0.0038032853,0.0018625518],"domain_scores_gemma":[0.9398136,0.016358431,0.0038450179,0.0014975792,0.02437636,0.014109012],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016482918,0.0011958674,0.0010875972,0.0029718745,0.0041841487,0.005648185,0.0031311545,0.0073680296,0.04330525],"category_scores_gemma":[0.061779425,0.0007549162,0.0025270586,0.0019150814,0.00077805674,0.0033852584,0.004007087,0.0061749206,0.0106579],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021424096,0.0018239769,0.0130552305,0.0013423278,0.000086226006,0.0005276732,0.0005275829,0.0011283469,0.0004468765,0.0027878343,0.47715268,0.50090706],"study_design_scores_gemma":[0.0023862354,0.0016331299,0.13410987,0.03366405,0.00083838904,0.0021604602,0.009255794,0.0063918624,0.0014549275,0.014352027,0.7933294,0.0004239084],"about_ca_topic_score_codex":0.02356885,"about_ca_topic_score_gemma":0.08312103,"teacher_disagreement_score":0.04330525,"about_ca_system_score_codex":0.007258365,"about_ca_system_score_gemma":0.043977052,"threshold_uncertainty_score":0.14487046},"labels":[],"label_agreement":null},{"id":"W3191957004","doi":"10.1016/j.jaad.2021.08.006","title":"Attrition of topical calcineurin inhibitor use over time in patients with atopic dermatitis","year":2021,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Perelman School of Medicine, University of Pennsylvania; Bausch and Lomb Ireland; Bausch Health; University of Pennsylvania; Valeant Pharmaceuticals International; Brigham and Women's Hospital","keywords":"Medicine; Atopic dermatitis; Calcineurin; Dermatology; Pharmacology; Internal medicine","score_opus":0.010602701663557925,"score_gpt":0.27113002674122827,"score_spread":0.26052732507767035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3191957004","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973126,0.001218458,0.000043373344,0.00015786916,0.000017422795,0.0000044611224,0.00042834863,0.0000046918944,0.0008125537],"genre_scores_gemma":[0.9989699,0.00025049824,0.000027745176,0.00006836657,0.000019413155,0.0000044093385,0.00036136236,0.0000021475837,0.00029621454],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99902916,0.00017809549,0.00011385779,0.00018977468,0.0002136192,0.00027549185],"domain_scores_gemma":[0.99661285,0.00083770195,0.001557119,0.00019712467,0.00039837637,0.0003968749],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008127015,0.00019295615,0.0005556433,0.000941263,0.0006924684,0.0013140016,0.00052923226,0.000799587,0.0022250377],"category_scores_gemma":[0.0049521313,0.00021424882,0.00087388005,0.0017515662,0.00023675307,0.0010891291,0.0005365504,0.0011740979,0.00036832478],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021670535,0.00005031384,0.9965487,0.000011703791,0.000054144988,0.00006407637,0.00006674947,0.000021207485,0.000099129444,0.0000112274865,0.000085476604,0.0027706032],"study_design_scores_gemma":[0.0000039281103,0.00007092538,0.99916637,0.0000069341127,0.000031669493,0.00019949058,0.00021004457,0.00011064762,0.000030327425,0.000015384983,0.00015118891,0.0000032355388],"about_ca_topic_score_codex":0.009240435,"about_ca_topic_score_gemma":0.007985535,"teacher_disagreement_score":0.009240435,"about_ca_system_score_codex":0.0006489964,"about_ca_system_score_gemma":0.00060158473,"threshold_uncertainty_score":0.01837331},"labels":[],"label_agreement":null},{"id":"W3192197705","doi":"10.1016/j.jaad.2021.06.607","title":"27489 Depth of response to abrocitinib in adults with moderate-to-severe atopic dermatitis (AD): Pooled analysis of monotherapy studies","year":2021,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"","keywords":"Medicine; Atopic dermatitis; Quality of life (healthcare); Dermatology; Pooled analysis; Internal medicine; Meta-analysis","score_opus":0.0158397596892936,"score_gpt":0.3286483080765466,"score_spread":0.312808548387253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3192197705","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.34881043,0.63868994,0.0020748435,0.00034934175,0.0005901116,0.00033480083,0.0057097916,0.00011470516,0.0033260004],"genre_scores_gemma":[0.9590564,0.036360223,0.0006939447,0.00045104066,0.0003817477,0.00017921494,0.0023144155,0.000028532131,0.0005346355],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99217695,0.0039808564,0.0015730775,0.0011780913,0.00081956247,0.00027147468],"domain_scores_gemma":[0.9921754,0.004626526,0.0018128972,0.0005501804,0.0006371188,0.000197729],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008103298,0.0017014424,0.008758555,0.0022451892,0.00028429777,0.0018990139,0.00078142376,0.001125534,0.0024679408],"category_scores_gemma":[0.009139307,0.0008390317,0.02035136,0.0024388442,0.0003431333,0.0012637308,0.0009525515,0.00128079,0.0003220018],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07583329,0.00007612599,0.065941095,0.018643139,0.80721855,0.00018889814,0.00007027563,0.00092013064,0.001853023,0.00010292392,0.0012323087,0.02792017],"study_design_scores_gemma":[0.013043432,0.0035043436,0.17581534,0.0015207592,0.7995518,0.00054092554,0.00015736457,0.0011835074,0.00066829665,0.00038423706,0.003540666,0.000089455054],"about_ca_topic_score_codex":0.001734388,"about_ca_topic_score_gemma":0.0043673306,"teacher_disagreement_score":0.008758555,"about_ca_system_score_codex":0.00065999915,"about_ca_system_score_gemma":0.0004490059,"threshold_uncertainty_score":0.042854846},"labels":[],"label_agreement":null},{"id":"W3192809805","doi":"10.1016/j.jaad.2021.07.040","title":"Efficacy and safety of apremilast in patients with mild-to-moderate plaque psoriasis: Results of a phase 3, multicenter, randomized, double-blind, placebo-controlled trial","year":2021,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":55,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health; Bellus Health (Canada); Queen's University; University of British Columbia; Probity Medical Research","funders":"UCB; Celgene; Boehringer Ingelheim; Eli Lilly and Company; Amgen","keywords":"Apremilast; Medicine; Psoriasis; Psoriasis Area and Severity Index; Placebo; Clinical endpoint; Adverse effect; Body surface area; Internal medicine; Dermatology Life Quality Index; Nausea; Randomized controlled trial; Dermatology; Psoriatic arthritis; Pathology","score_opus":0.016988566822548692,"score_gpt":0.2859902605222075,"score_spread":0.2690016936996588,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3192809805","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9756776,0.016357116,0.00088869955,0.0009940797,0.0005788026,0.0023437303,0.00087547617,0.00019424787,0.0020901735],"genre_scores_gemma":[0.98737377,0.00495807,0.0014145018,0.0014022632,0.00064305443,0.0016614328,0.0008121034,0.000035923138,0.0016989821],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99928707,0.00038704308,0.000056393037,0.0001188583,0.00006791467,0.00008281196],"domain_scores_gemma":[0.998899,0.00040457642,0.00026073554,0.00007343618,0.00006774232,0.0002944785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021886723,0.001591823,0.004209621,0.00038483413,0.00060856383,0.0011348131,0.0008157355,0.0023093412,0.004147321],"category_scores_gemma":[0.001935952,0.0007184312,0.0023297444,0.00039426636,0.0011616844,0.0013138052,0.000295109,0.0030369398,0.0007050682],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97819155,0.0038090323,0.0005823913,0.0007497329,0.0009504312,0.000049938117,0.00004444279,0.00017719701,0.0030696888,0.000063073356,0.0005414513,0.011770901],"study_design_scores_gemma":[0.9520052,0.044293996,0.0022311865,0.000028644983,0.0004567326,0.000047891415,0.00001672698,0.00021629535,0.00026542007,0.000097089825,0.00032515408,0.000015506012],"about_ca_topic_score_codex":0.0004021236,"about_ca_topic_score_gemma":0.0007792892,"teacher_disagreement_score":0.004209621,"about_ca_system_score_codex":0.00040816763,"about_ca_system_score_gemma":0.0007548432,"threshold_uncertainty_score":0.013874173},"labels":[],"label_agreement":null},{"id":"W3193391496","doi":"10.1016/j.jaad.2021.06.257","title":"25423 Improvements in work productivity following baricitinib treatment in patients with moderate-to-severe atopic dermatitis: Results from BREEZE-AD5","year":2021,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Windsor Clinical Research","funders":"","keywords":"Medicine; Atopic dermatitis; Work productivity; Dermatology; Janus kinase inhibitor; Janus kinase; Productivity; Internal medicine; Cytokine","score_opus":0.0115657680305984,"score_gpt":0.2699404762782591,"score_spread":0.25837470824766073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3193391496","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891488,0.0073972577,0.00007583906,0.00019142422,0.00009098569,0.000086101805,0.0006546739,0.000017941382,0.0023369477],"genre_scores_gemma":[0.9967038,0.0014224667,0.00010790202,0.00012678972,0.000046256613,0.000029755716,0.0007888715,0.0000028432596,0.00077137817],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997311,0.00006101321,0.000023170795,0.000037447604,0.000072048446,0.00007519368],"domain_scores_gemma":[0.9997285,0.00005228731,0.000054757347,0.000019771196,0.000055732853,0.00008891988],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000491559,0.00038172945,0.00094786106,0.00024840602,0.00031870004,0.00060576614,0.00026397244,0.00031154114,0.0024729923],"category_scores_gemma":[0.00066258345,0.000079630096,0.0011356928,0.00033104027,0.0001238196,0.00023019551,0.00019258725,0.0006145393,0.00035580204],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14964592,0.009938565,0.28786734,0.0018502988,0.0056649954,0.0009719906,0.00022263677,0.00089712517,0.023236455,0.00009878957,0.005140312,0.5144656],"study_design_scores_gemma":[0.00511843,0.04004143,0.94292897,0.00017874799,0.002497867,0.0008025426,0.0002933778,0.00061309617,0.0028717143,0.000090716814,0.0045235143,0.0000396125],"about_ca_topic_score_codex":0.002324947,"about_ca_topic_score_gemma":0.0042286953,"teacher_disagreement_score":0.0024729923,"about_ca_system_score_codex":0.00040466274,"about_ca_system_score_gemma":0.0002986652,"threshold_uncertainty_score":0.0082730055},"labels":[],"label_agreement":null},{"id":"W3193399673","doi":"10.1016/j.jaad.2021.06.150","title":"27328 The impact of a dedicated wound clinic on wound healing","year":2021,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Diagnosis and Treatment of Venous Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Wound care; Wound healing; Multidisciplinary approach; Surgery","score_opus":0.03695067373231313,"score_gpt":0.38934257323424154,"score_spread":0.3523918995019284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3193399673","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.23902026,0.023187062,0.0024181132,0.42586344,0.027362132,0.00033234837,0.000715797,0.0005596307,0.28054115],"genre_scores_gemma":[0.8456884,0.010923556,0.0066876295,0.081176184,0.02005254,0.00018499047,0.0004325505,0.00036710018,0.03448713],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99152654,0.0047293175,0.00034207283,0.00049299933,0.0015310128,0.0013780213],"domain_scores_gemma":[0.95602775,0.0092064915,0.0021911433,0.0011741141,0.007538477,0.023862036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0045766113,0.00052085106,0.00038124612,0.0008693898,0.0027714414,0.0043193465,0.0014870627,0.002878147,0.077434],"category_scores_gemma":[0.018238032,0.00039151649,0.0008536197,0.0004955794,0.0011156901,0.001570034,0.0030127685,0.004183094,0.0058893682],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019521433,0.007639328,0.07613148,0.0011924577,0.00028403365,0.005980821,0.0009168736,0.0009340172,0.0032939576,0.0054334137,0.33894944,0.55729204],"study_design_scores_gemma":[0.0017442479,0.0051897895,0.44932914,0.00433128,0.0005630249,0.013318874,0.013466682,0.0028098512,0.0018107668,0.007445993,0.4996459,0.0003444828],"about_ca_topic_score_codex":0.0067323446,"about_ca_topic_score_gemma":0.023639558,"teacher_disagreement_score":0.077434,"about_ca_system_score_codex":0.0032869985,"about_ca_system_score_gemma":0.0125869345,"threshold_uncertainty_score":0.25904256},"labels":[],"label_agreement":null},{"id":"W3193412904","doi":"10.1016/j.jaad.2021.06.570","title":"27375 Dupilumab provides early and sustained improvement of sleep disturbance in children ≥ 6 years with severe atopic dermatitis (AD) and adolescents with moderate-to-severe AD","year":2021,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine; University of British Columbia","funders":"","keywords":"Dupilumab; Medicine; Atopic dermatitis; Dermatology; Sleep disorder; Psychiatry; Cognition","score_opus":0.004032580307002184,"score_gpt":0.23190881854950793,"score_spread":0.22787623824250575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3193412904","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99375147,0.0041516786,0.00009471505,0.00014784218,0.00005206559,0.000035665387,0.00020305999,0.000023878774,0.001539577],"genre_scores_gemma":[0.99776566,0.0011433128,0.00022677904,0.00010902853,0.000027637065,0.000020504618,0.00022189085,0.0000033182494,0.00048190015],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99991214,0.000021774002,0.000007563407,0.000011787747,0.000014388896,0.000032317206],"domain_scores_gemma":[0.9998323,0.000040136583,0.00003334851,0.000004525919,0.000015255617,0.000074442214],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015719341,0.0002360012,0.00057525834,0.00010349456,0.00015437824,0.00019872027,0.00012623264,0.0001690464,0.001722636],"category_scores_gemma":[0.00038126393,0.00008973657,0.00040779405,0.00009324955,0.00007837853,0.0001465447,0.00011710368,0.00047818373,0.00018379929],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.056184247,0.00670751,0.39530727,0.0012579868,0.0013034893,0.0038837255,0.00047354627,0.00059831777,0.028038459,0.00019094082,0.009555612,0.49649882],"study_design_scores_gemma":[0.002817652,0.02234264,0.96049005,0.00014262222,0.0005191116,0.0042089587,0.0003640654,0.00075787096,0.0026188758,0.00005223966,0.005665729,0.000020018679],"about_ca_topic_score_codex":0.0026466802,"about_ca_topic_score_gemma":0.009452756,"teacher_disagreement_score":0.0026466802,"about_ca_system_score_codex":0.00022380738,"about_ca_system_score_gemma":0.00027766195,"threshold_uncertainty_score":0.005762756},"labels":[],"label_agreement":null},{"id":"W3193469733","doi":"10.1016/j.jaad.2021.06.557","title":"27291 Cryoglobulinemic vasculitis associated with Epstein–Barr virus infection: A case report","year":2021,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Eosinophilic Disorders and Syndromes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Vasculitis; Cryoglobulinemia; Purpura (gastropod); Immunology; Palpable purpura; Cryoglobulins; Livedo reticularis; Skin biopsy; Dermatology; Pathology; Henoch-Schonlein purpura; Biopsy; Virus; Antibody; Hepatitis C virus","score_opus":0.01512039833798093,"score_gpt":0.29435595218620453,"score_spread":0.27923555384822357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3193469733","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9560592,0.009554015,0.004660722,0.003981204,0.00090936845,0.00027626994,0.000372583,0.00029366853,0.023892919],"genre_scores_gemma":[0.99035966,0.0024382228,0.0015029334,0.0008122473,0.0024706481,0.000056651348,0.00016951821,0.000028644254,0.002161486],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9988887,0.00015722786,0.00014402799,0.0002626022,0.00014304636,0.00040447307],"domain_scores_gemma":[0.9977362,0.0007941536,0.00035347487,0.00028867365,0.00013693787,0.000690515],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006774579,0.0039857402,0.0017975818,0.003833667,0.0050211353,0.0030745745,0.002402203,0.007775267,0.0039985497],"category_scores_gemma":[0.002989996,0.0026752558,0.0021967639,0.0024206145,0.0029574346,0.004665632,0.0027518887,0.004670965,0.0023630913],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001966544,0.000031160755,0.0014658845,0.000017516111,0.0000067407595,0.9975267,0.00006583716,0.000028069791,0.0003202705,0.0000973671,0.00011004031,0.00031066115],"study_design_scores_gemma":[0.000019496236,0.000044506152,0.0024041117,0.000010923919,0.000025530351,0.9962012,0.00012982494,0.00026385312,0.00033684404,0.000119265926,0.00043195608,0.00001248248],"about_ca_topic_score_codex":0.0023050033,"about_ca_topic_score_gemma":0.0019921958,"teacher_disagreement_score":0.007775267,"about_ca_system_score_codex":0.0020398865,"about_ca_system_score_gemma":0.0011965767,"threshold_uncertainty_score":0.014800429},"labels":[],"label_agreement":null},{"id":"W3193639533","doi":"10.1016/j.jaad.2021.05.074","title":"Comment on “Cannabinoids in dermatologic surgery”","year":2021,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"ITS Electronics (Canada); Toronto and Region Conservation Authority; University of Toronto; University of Ottawa","funders":"","keywords":"Cannabidiol; Medicine; Cannabis; Cannabinoid; Scopus; Cannabinoid receptor; Pharmacology; Traditional medicine; MEDLINE; Psychiatry; Biology; Internal medicine","score_opus":0.03513767561559356,"score_gpt":0.3313100958404014,"score_spread":0.29617242022480783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3193639533","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005035629,0.00080223236,0.000044976718,0.97809315,0.0154289575,0.000013161447,0.00003388875,0.0000152295615,0.0050647794],"genre_scores_gemma":[0.0028050942,0.0004369934,0.00006752713,0.97046196,0.019843074,0.000022281656,0.000013544636,0.0000085889915,0.00634098],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964747,0.0007429889,0.0003964144,0.00047283157,0.0010420221,0.00087108766],"domain_scores_gemma":[0.99335384,0.0036650675,0.0005186453,0.00017014134,0.0010209678,0.0012712635],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031920264,0.0008651006,0.0013854166,0.0009877966,0.008388644,0.0044642477,0.0025260025,0.092872925,0.00763897],"category_scores_gemma":[0.019088041,0.0010671467,0.0016082021,0.00082130014,0.003592884,0.0035994279,0.0020805884,0.047132302,0.004457389],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007181402,0.000044347296,0.0008445712,0.000048272632,0.000018218658,0.0032154655,0.00022655082,0.00006448937,0.00017952503,0.0038462142,0.98753345,0.003907096],"study_design_scores_gemma":[0.00017039113,0.00009515412,0.002902744,0.0004759217,0.00007514729,0.0025643867,0.0010762804,0.00054075517,0.00035642274,0.009662088,0.9819863,0.000094426585],"about_ca_topic_score_codex":0.018903717,"about_ca_topic_score_gemma":0.03303107,"teacher_disagreement_score":0.092872925,"about_ca_system_score_codex":0.0057576583,"about_ca_system_score_gemma":0.008962863,"threshold_uncertainty_score":0.04177493},"labels":[],"label_agreement":null},{"id":"W3193688282","doi":"10.1016/j.jaad.2021.06.367","title":"26155 A lesser-known presentation of acute systemic lupus erythematosus","year":2021,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Autoimmune Bullous Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Dermatology; Presentation (obstetrics); Malar rash; Erythema; Rash; Lupus erythematosus; Systemic disease; Photosensitivity; Discoid lupus erythematosus; Immunopathology; Pathology; Immunology; Surgery; Autoantibody","score_opus":0.013677077130870114,"score_gpt":0.31141166467258147,"score_spread":0.29773458754171134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3193688282","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.60677004,0.013620486,0.0031823851,0.0037003057,0.0011870007,0.00019799708,0.0019460906,0.0005188862,0.3688769],"genre_scores_gemma":[0.95201707,0.003423992,0.0011647048,0.0014445353,0.001194316,0.000030259172,0.0009962866,0.00008920108,0.039639633],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9996308,0.0000464586,0.00004797657,0.000075230455,0.000070350914,0.0001291275],"domain_scores_gemma":[0.99949086,0.00010253752,0.0001328945,0.00007259905,0.000054877157,0.00014622258],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000189826,0.0009678289,0.00056925375,0.0014766839,0.0010064902,0.0013154317,0.0006107465,0.0014058514,0.028217902],"category_scores_gemma":[0.0013238809,0.00024828524,0.0004414454,0.0011593528,0.00041422134,0.000989841,0.00058772636,0.0010707143,0.0069144815],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00066439813,0.00027165943,0.06025087,0.00037608496,0.000059796148,0.86175144,0.0002998505,0.00013012243,0.015695745,0.0039545577,0.010495862,0.046049558],"study_design_scores_gemma":[0.00004404406,0.00015708251,0.042825542,0.00010682755,0.000042449567,0.9360123,0.0002619779,0.00014321224,0.0014038448,0.0007096234,0.018270735,0.000022364144],"about_ca_topic_score_codex":0.0008070897,"about_ca_topic_score_gemma":0.0010082951,"teacher_disagreement_score":0.028217902,"about_ca_system_score_codex":0.00039229376,"about_ca_system_score_gemma":0.0003318843,"threshold_uncertainty_score":0.09439832},"labels":[],"label_agreement":null},{"id":"W3193688776","doi":"10.1016/j.jaad.2021.06.097","title":"26423 Psychometric properties of patient-reported outcome measures for nail conditions: A systematic review","year":2021,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McMaster University","funders":"","keywords":"Prom; Patient-reported outcome; Medicine; Psychometric testing; Quality of life (healthcare); Critical appraisal; Nail (fastener); Outcome (game theory); Psychometrics; Physical therapy; Clinical psychology; Alternative medicine; Nursing; Pathology; Internal consistency","score_opus":0.12390839915664122,"score_gpt":0.4164520708182257,"score_spread":0.2925436716615845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3193688776","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008460215,0.9883909,0.000595898,0.00025399897,0.00020902134,0.00064052455,0.0011077725,0.000019540978,0.00032210205],"genre_scores_gemma":[0.1637497,0.8280145,0.0033652303,0.0012527577,0.0001871989,0.0016419673,0.0014986633,0.000023017392,0.00026700782],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.98324907,0.0072697964,0.005312925,0.0014776969,0.0023995126,0.00029112343],"domain_scores_gemma":[0.9254836,0.062457506,0.008208534,0.0012073141,0.0023036788,0.0003394069],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018537896,0.0016234841,0.009987789,0.0038071284,0.0006690663,0.003054632,0.0017464128,0.002422705,0.004310253],"category_scores_gemma":[0.087587655,0.001033619,0.015657313,0.006125271,0.0013452843,0.0023622024,0.0017534955,0.0020304807,0.00038456745],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013679005,0.0000764855,0.01320906,0.7664587,0.16879795,0.00010758221,0.00024441283,0.00025048657,0.00019455557,0.0002981277,0.0020129331,0.04698195],"study_design_scores_gemma":[0.0024246247,0.0006651156,0.04537843,0.33769318,0.6041059,0.00029766705,0.00051589456,0.0005389175,0.00033574319,0.0007118143,0.0071851425,0.00014756699],"about_ca_topic_score_codex":0.0062506883,"about_ca_topic_score_gemma":0.02218925,"teacher_disagreement_score":0.018537896,"about_ca_system_score_codex":0.0028347622,"about_ca_system_score_gemma":0.0056006145,"threshold_uncertainty_score":0.09803891},"labels":[],"label_agreement":null},{"id":"W3193746428","doi":"10.1016/j.jaad.2021.06.238","title":"25133 A single-center, open-label clinical trial evaluated the efficacy and tolerability of a comprehensive, hydrating topical antioxidant developed specifically for men","year":2021,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Skin Protection and Aging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"","keywords":"Tolerability; Medicine; Clinical trial; Single Center; Clinical efficacy; Open label; Pharmacology; Antioxidant; Internal medicine; Adverse effect","score_opus":0.23215027132225036,"score_gpt":0.45544628871107085,"score_spread":0.2232960173888205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3193746428","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98864615,0.0038082763,0.0008937568,0.00032277632,0.0002763007,0.002722579,0.0008892495,0.00010538654,0.0023355053],"genre_scores_gemma":[0.98980427,0.0020874937,0.0018981822,0.0008028274,0.00024994218,0.0011683116,0.0008597422,0.00001868348,0.0031107292],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997168,0.00011210964,0.000016040882,0.000078315396,0.00002363262,0.000053021886],"domain_scores_gemma":[0.999468,0.00018156941,0.00009020678,0.000034460332,0.000037874284,0.00018788931],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013256642,0.0012003473,0.0021134445,0.00031465327,0.0004363159,0.0006226858,0.00058482296,0.0013645452,0.007022281],"category_scores_gemma":[0.00074062316,0.00039095554,0.0010803445,0.0002971559,0.0009475577,0.0006608832,0.0002075007,0.0022193748,0.0008930554],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8706357,0.039376248,0.0015105532,0.0012865509,0.0012657149,0.00013114285,0.000104464605,0.0008867668,0.029416569,0.0003761194,0.002084779,0.052925386],"study_design_scores_gemma":[0.4886963,0.5013295,0.0042847395,0.00005792988,0.000514609,0.00008591343,0.00005268739,0.0006096415,0.0030418318,0.00009742985,0.0011998721,0.000029614903],"about_ca_topic_score_codex":0.0007650677,"about_ca_topic_score_gemma":0.00248892,"teacher_disagreement_score":0.007022281,"about_ca_system_score_codex":0.0004370502,"about_ca_system_score_gemma":0.00091792195,"threshold_uncertainty_score":0.023491919},"labels":[],"label_agreement":null},{"id":"W3193808171","doi":"10.1016/j.jaad.2021.06.376","title":"26198 Evaluating patient outcomes in the BOLT 42-month trial using modified Response Evaluation Criteria in Solid Tumors methodology: Results from a preplanned analysis","year":2021,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Medicine; Response Evaluation Criteria in Solid Tumors; Vismodegib; Basal cell carcinoma; Solid tumor; Oncology; Clinical trial; Complete response; Radiology; Medical physics; Basal cell; Surgery; Internal medicine; Cancer; Chemotherapy","score_opus":0.15688400153559634,"score_gpt":0.5071435909954048,"score_spread":0.3502595894598085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3193808171","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9604083,0.009547617,0.011610361,0.0008879125,0.0002568477,0.0027555635,0.008753623,0.0002857509,0.00549413],"genre_scores_gemma":[0.98297656,0.00084139185,0.0055813366,0.0008582225,0.00014962521,0.0013946716,0.004970918,0.00014781195,0.0030794288],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9657873,0.02967754,0.0010398271,0.0011281642,0.0016741126,0.0006930442],"domain_scores_gemma":[0.9808765,0.012151167,0.0034290273,0.0020771362,0.00080434495,0.0006617806],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.026174307,0.0010474893,0.0031331645,0.0007411481,0.00033811625,0.001727878,0.000980159,0.00074991403,0.005114137],"category_scores_gemma":[0.017748939,0.00042979003,0.00769993,0.0011479022,0.0005604919,0.00085997424,0.0009363925,0.0019085121,0.0008124189],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.80960804,0.0014271388,0.06348183,0.0015796912,0.04353022,0.00014371781,0.00012033708,0.0048370156,0.0032058118,0.00042425175,0.004764328,0.0668776],"study_design_scores_gemma":[0.34377018,0.1123973,0.4578551,0.00047626626,0.050186414,0.00043833544,0.00027386678,0.0146226585,0.006931371,0.0015331185,0.011277912,0.00023739356],"about_ca_topic_score_codex":0.00090286677,"about_ca_topic_score_gemma":0.0019462651,"teacher_disagreement_score":0.026174307,"about_ca_system_score_codex":0.00089032477,"about_ca_system_score_gemma":0.0012105348,"threshold_uncertainty_score":0.13842463},"labels":[],"label_agreement":null},{"id":"W3193937532","doi":"10.1016/j.jaad.2021.06.374","title":"26191 Time to onset of creatine kinase elevation in patients with advanced basal cell carcinoma receiving sonidegib 200 mg daily: Results from the 42-month BOLT study","year":2021,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Medicine; Basal cell carcinoma; Creatine kinase; Internal medicine; Adverse effect; Basal (medicine); Hedgehog signaling pathway; Oncology; Vismodegib; Basal cell; Signal transduction","score_opus":0.007011138040111309,"score_gpt":0.24273273317551522,"score_spread":0.23572159513540392,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3193937532","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981008,0.0007069943,0.00006245793,0.000041754378,0.000012782463,0.0000144182195,0.00045597428,0.0000052176674,0.0005996805],"genre_scores_gemma":[0.9982521,0.0002952472,0.00006103169,0.000048488193,0.000028235183,0.000011545779,0.0009438874,0.0000030763133,0.00035637856],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997893,0.000046252026,0.000018958257,0.00005766267,0.00004687003,0.000041036466],"domain_scores_gemma":[0.9996088,0.000063985804,0.0001420584,0.00002389484,0.000036511596,0.00012481103],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039051098,0.00035208667,0.00071056234,0.00035922328,0.00023277092,0.00060358254,0.00019800967,0.00033827536,0.0010055883],"category_scores_gemma":[0.00065232266,0.00019754314,0.00061465293,0.0005042535,0.00014988528,0.0004012153,0.00020057496,0.0004849695,0.0003324778],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.032229204,0.00080916553,0.93653077,0.00007961234,0.0009770867,0.00058099953,0.0000829145,0.0003754722,0.007457522,0.000046216082,0.0006648138,0.020166215],"study_design_scores_gemma":[0.0008835574,0.0028889508,0.9934574,0.000009049149,0.00041284648,0.00046238708,0.00006956752,0.00042927728,0.00052033283,0.000043639284,0.00080828025,0.00001478319],"about_ca_topic_score_codex":0.001133652,"about_ca_topic_score_gemma":0.0015483533,"teacher_disagreement_score":0.001133652,"about_ca_system_score_codex":0.00037324085,"about_ca_system_score_gemma":0.00023562642,"threshold_uncertainty_score":0.0033640265},"labels":[],"label_agreement":null},{"id":"W3194042231","doi":"10.1016/j.jaad.2021.06.117","title":"26670 The contribution of itch and skin severity improvements to the Dermatology Life Quality Index in patients with atopic dermatitis in a baricitinib phase 3 study, BREEZE-AD5","year":2021,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Dermatology Life Quality Index; Eczema Area and Severity Index; Atopic dermatitis; Medicine; Post-hoc analysis; Dermatology; Placebo; Quality of life (healthcare); Body surface area; Randomized controlled trial; Internal medicine; Psoriasis; Pathology","score_opus":0.011562039176450292,"score_gpt":0.32172824507503406,"score_spread":0.3101662058985838,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3194042231","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921726,0.00582263,0.00009901137,0.00022524301,0.00010922747,0.00015104488,0.0004311981,0.00001751133,0.0009715012],"genre_scores_gemma":[0.9973648,0.0011017674,0.00015016344,0.0002249249,0.000082731356,0.00006163824,0.00051121664,0.000003552313,0.00049908814],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9996809,0.00013547845,0.000019564912,0.000051378538,0.000051060055,0.00006171801],"domain_scores_gemma":[0.9996567,0.00010323553,0.00008120114,0.000023325969,0.000044453758,0.00009116675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011677075,0.0005332624,0.0011838058,0.000177119,0.00024740453,0.0008992245,0.00031963846,0.0004492287,0.0019557024],"category_scores_gemma":[0.00085591286,0.00019054227,0.0017009549,0.0002288839,0.00025359145,0.0003915245,0.0001997474,0.0014054098,0.00022745135],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7230258,0.012011252,0.06781709,0.001438968,0.011408952,0.00015715678,0.00012284357,0.0017566576,0.015212111,0.00022367733,0.0040062047,0.16281933],"study_design_scores_gemma":[0.22749373,0.2578578,0.49195948,0.0002159652,0.010694578,0.00034322083,0.0002308543,0.0035008444,0.0031326483,0.00029042648,0.004184914,0.00009548075],"about_ca_topic_score_codex":0.001271152,"about_ca_topic_score_gemma":0.0031348926,"teacher_disagreement_score":0.0019557024,"about_ca_system_score_codex":0.00047612406,"about_ca_system_score_gemma":0.00044455915,"threshold_uncertainty_score":0.006542444},"labels":[],"label_agreement":null},{"id":"W3194130459","doi":"10.1016/j.jaad.2021.06.526","title":"27038 Efficacy of guselkumab using composite endpoints in patients with active psoriatic arthritis: Domain-specific efficacy from DISCOVER-1 and DISCOVER-2 phase 3 trials","year":2021,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Medicine; Psoriatic arthritis; Dermatology; Psoriasis; Internal medicine","score_opus":0.15834053126406347,"score_gpt":0.41836450346408705,"score_spread":0.2600239722000236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3194130459","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94544166,0.039258253,0.0014667233,0.0019135114,0.0004986678,0.00094221596,0.004384702,0.00016292231,0.0059311977],"genre_scores_gemma":[0.9786468,0.011666869,0.0013443406,0.0011386595,0.0003409331,0.0007288623,0.0043161656,0.00003828797,0.0017790673],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99912304,0.00050438306,0.00006643176,0.00008056356,0.00011664165,0.000109003944],"domain_scores_gemma":[0.9986085,0.0006207106,0.00033186813,0.000093155926,0.000119042954,0.000226735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035184163,0.0008525488,0.002098863,0.00041353938,0.00026183884,0.0009953983,0.00034604387,0.0007943613,0.003414156],"category_scores_gemma":[0.0024640171,0.000280409,0.003006299,0.00049574714,0.0005760921,0.00091873,0.0004204127,0.0024872322,0.00067801017],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7441281,0.0049701394,0.009011801,0.0030572158,0.0072784685,0.00012491412,0.000111659545,0.0027811613,0.0060490714,0.00079231244,0.007836364,0.21385878],"study_design_scores_gemma":[0.7730808,0.14187743,0.054002557,0.0007005128,0.008353107,0.00033539534,0.00013521692,0.0036491652,0.0032955818,0.0018510221,0.01259162,0.000127556],"about_ca_topic_score_codex":0.00048639864,"about_ca_topic_score_gemma":0.0012233573,"teacher_disagreement_score":0.0035184163,"about_ca_system_score_codex":0.0006334692,"about_ca_system_score_gemma":0.0008769355,"threshold_uncertainty_score":0.018607378},"labels":[],"label_agreement":null},{"id":"W3194137308","doi":"10.1016/j.jaad.2021.06.356","title":"26085 Key efficacy and safety of apremilast in patients with mild to moderate plaque psoriasis in the phase 3 ADVANCE trial","year":2021,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Apremilast; Medicine; Psoriasis; Placebo; Dermatology; Plaque psoriasis; Clinical trial; Internal medicine; Alternative medicine; Psoriatic arthritis; Pathology","score_opus":0.01308272054913317,"score_gpt":0.27586255638548524,"score_spread":0.26277983583635206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3194137308","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9448815,0.020544372,0.0015517857,0.0029722145,0.0009502519,0.0039295238,0.004768916,0.00048071233,0.019920679],"genre_scores_gemma":[0.97491086,0.004465968,0.0020322322,0.0026994445,0.00059653516,0.0019165686,0.0031256285,0.000050097882,0.010202537],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99960107,0.00022628003,0.0000203871,0.00004404374,0.00004216799,0.000066085966],"domain_scores_gemma":[0.9995846,0.00012554886,0.00007922157,0.000032793167,0.000033288972,0.00014455037],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001531154,0.0008686971,0.0015498608,0.00024135955,0.0003607097,0.00081046805,0.00035068626,0.0010885539,0.010236367],"category_scores_gemma":[0.0010244357,0.00036583477,0.0011568938,0.00019769839,0.0004825318,0.00070521474,0.0002304118,0.002603413,0.00166815],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8734191,0.0070133414,0.0018841388,0.0015182928,0.0014736584,0.0001763295,0.0000993748,0.0010410047,0.0123166,0.0007012338,0.011811145,0.088545665],"study_design_scores_gemma":[0.8297184,0.15105823,0.008268975,0.00011352559,0.00055660546,0.00025981135,0.00004059837,0.0007523822,0.0012298119,0.0005757069,0.007391317,0.000034700366],"about_ca_topic_score_codex":0.00031733932,"about_ca_topic_score_gemma":0.0009876936,"teacher_disagreement_score":0.010236367,"about_ca_system_score_codex":0.00030973667,"about_ca_system_score_gemma":0.0005496054,"threshold_uncertainty_score":0.034244},"labels":[],"label_agreement":null},{"id":"W3194232218","doi":"10.1016/j.jaad.2021.06.345","title":"25995 5-year efficacy of tildrakizumab 100 and 200 mg by PASI 50/75/90/100 and PGA in reSURFACE 1","year":2021,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Guenther Dermatology Research Centre","funders":"","keywords":"Medicine; Dermatology; Monoclonal; Interleukin 23; Psoriasis; Monoclonal antibody; Plaque psoriasis; Internal medicine; Pharmacology; Immunology; Interleukin 17; Antibody; Cytokine","score_opus":0.012845542329437395,"score_gpt":0.270598440928868,"score_spread":0.25775289859943057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3194232218","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99149877,0.00454805,0.00020004006,0.00012585867,0.00026251524,0.00013557775,0.000539897,0.000037371243,0.0026519157],"genre_scores_gemma":[0.99444157,0.0012744203,0.00013325765,0.00021308527,0.00022032789,0.000050677347,0.0012395974,0.000007426286,0.0024195816],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9997358,0.00006357337,0.000026483964,0.00004259928,0.000029650255,0.00010188627],"domain_scores_gemma":[0.99976665,0.000052473588,0.00003152007,0.000026442156,0.000018121145,0.00010485539],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006455828,0.0005227308,0.0014754814,0.00043493556,0.00041751075,0.00055379566,0.0003918236,0.0007852423,0.0025286903],"category_scores_gemma":[0.00036927953,0.00016620195,0.0012346321,0.00023891497,0.00036265125,0.0005548394,0.0001602349,0.001252477,0.0007773842],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.69955033,0.0653517,0.02070904,0.0005651729,0.0013397833,0.0019820968,0.00021575361,0.0019369627,0.038824312,0.00064420054,0.0040128175,0.16486782],"study_design_scores_gemma":[0.075386025,0.7459386,0.1493422,0.00015436937,0.002115535,0.0014425965,0.00020308913,0.002989878,0.013251697,0.00036486244,0.008712301,0.00009884632],"about_ca_topic_score_codex":0.0014467342,"about_ca_topic_score_gemma":0.0018481964,"teacher_disagreement_score":0.0025286903,"about_ca_system_score_codex":0.00030647675,"about_ca_system_score_gemma":0.00041066587,"threshold_uncertainty_score":0.00845933},"labels":[],"label_agreement":null},{"id":"W3194241125","doi":"10.1016/j.jaad.2021.06.083","title":"26130 Sentinel lymph node biopsy in high-risk cutaneous squamous cell carcinoma: Analysis of a large size retrospective series","year":2021,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Sentinel lymph node; Biopsy; Basal cell; Series (stratigraphy); Retrospective cohort study; Carcinoma; Lymph node; Dermatology; Radiology; Oncology; Pathology; Internal medicine; Cancer","score_opus":0.006857790741779397,"score_gpt":0.26944773633746594,"score_spread":0.26258994559568655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3194241125","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986119,0.0007636047,0.00013908344,0.000007983946,0.000004422693,0.000008670766,0.00014026307,0.0000023360362,0.00032167713],"genre_scores_gemma":[0.9993594,0.00026407992,0.000060114224,0.000011060468,0.000008893092,0.0000054106054,0.00021140117,0.0000021702742,0.00007738875],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999241,0.00026269985,0.00008792707,0.0001809959,0.00016007647,0.00006737469],"domain_scores_gemma":[0.9982595,0.0006090153,0.00046973166,0.0002615705,0.00022315604,0.00017708285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010309711,0.0002515957,0.00037772127,0.001133582,0.00038925637,0.00062813296,0.0002624722,0.00020759371,0.0013645302],"category_scores_gemma":[0.0021472587,0.00039005352,0.0003890238,0.0010801496,0.0004004278,0.0003993507,0.00032951316,0.00019504639,0.0002868899],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002562179,0.00002514927,0.996747,0.000021911705,0.000117819385,0.00022136583,0.000053020038,0.000023920735,0.0011711185,0.000017418264,0.000058284506,0.0012866963],"study_design_scores_gemma":[0.00002166609,0.00016269788,0.9974752,0.000009209132,0.0001773737,0.00097196246,0.00019252466,0.00011856305,0.00042412925,0.000015751943,0.000426176,0.0000047391354],"about_ca_topic_score_codex":0.0021142322,"about_ca_topic_score_gemma":0.003584958,"teacher_disagreement_score":0.0021142322,"about_ca_system_score_codex":0.00026281926,"about_ca_system_score_gemma":0.00036406697,"threshold_uncertainty_score":0.005452335},"labels":[],"label_agreement":null},{"id":"W3194332414","doi":"10.1016/j.jaad.2021.06.656","title":"27737 The clinical spectrum of primary cutaneous CD4 + small/medium-sized pleomorphic T-cell lymphoproliferative disorder: An updated systematic literature review and case series","year":2021,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of Alberta","funders":"","keywords":"Medicine; Lymphoproliferative disorders; Dermatology; Pathology; Treatment modality; Lymphoma; Surgery","score_opus":0.022487750189555074,"score_gpt":0.3319351994328782,"score_spread":0.3094474492433231,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3194332414","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015903627,0.9804125,0.0001669644,0.00031039343,0.00010679924,0.000096924894,0.0020956602,0.000010656874,0.00089650654],"genre_scores_gemma":[0.11835755,0.87576777,0.0011335133,0.00118802,0.00020089102,0.00019926646,0.0028369352,0.000011219696,0.00030485238],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99857986,0.00019902224,0.0007507468,0.00019830663,0.00020476808,0.00006726941],"domain_scores_gemma":[0.9945527,0.003018084,0.0017105181,0.00013883243,0.0005007715,0.00007915679],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014528165,0.0005237742,0.0017180264,0.007992976,0.0003079359,0.0012019435,0.0007472753,0.0007987695,0.0031223658],"category_scores_gemma":[0.0058548017,0.00040277097,0.0017986652,0.008844817,0.0005529836,0.0016566095,0.0008497253,0.00041333403,0.00040319547],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011114416,0.00012458107,0.13470311,0.5266666,0.012363177,0.008282569,0.0011939639,0.0002905619,0.004935093,0.0010098832,0.018781537,0.29053748],"study_design_scores_gemma":[0.00061589846,0.0004168419,0.2912682,0.37952968,0.0945882,0.053802058,0.00247139,0.00036541064,0.00162776,0.00092011085,0.17414638,0.000248029],"about_ca_topic_score_codex":0.002091354,"about_ca_topic_score_gemma":0.0068239323,"teacher_disagreement_score":0.007992976,"about_ca_system_score_codex":0.00058292085,"about_ca_system_score_gemma":0.0023100115,"threshold_uncertainty_score":0.010445356},"labels":[],"label_agreement":null},{"id":"W3194367373","doi":"10.1016/j.jaad.2021.06.329","title":"25934 Bimekizumab efficacy for moderate to severe plaque psoriasis across patient subgroups: Pooled results from 3 multicenter, randomized, double-blinded phase 3 trials","year":2021,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Queen's University","funders":"","keywords":"Medicine; Plaque psoriasis; Psoriasis; Randomized controlled trial; Multicenter study; Internal medicine; Double blinded; Severity of illness; Dermatology; Surgery; Pathology; Placebo; Alternative medicine","score_opus":0.05329753619340438,"score_gpt":0.3557059412527911,"score_spread":0.3024084050593867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3194367373","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8363695,0.14317723,0.004440721,0.0013638057,0.0017413365,0.0050773183,0.0030581788,0.0003444414,0.0044275383],"genre_scores_gemma":[0.9765646,0.014723656,0.0021782662,0.0013672486,0.0006224947,0.0021480587,0.0013491712,0.00005258412,0.0009940056],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99692255,0.0018434651,0.00033873448,0.00044054873,0.00022294284,0.00023178651],"domain_scores_gemma":[0.99752456,0.0011807226,0.00067739724,0.00022201396,0.00017781946,0.00021749362],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0071139713,0.0021835526,0.0068769488,0.00065999036,0.0006103843,0.0020290513,0.00077925954,0.001967623,0.00352009],"category_scores_gemma":[0.006485467,0.00097604067,0.008679583,0.0008492113,0.00086686155,0.001385181,0.0006397811,0.002593894,0.00048211848],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9147677,0.0011763363,0.0023436411,0.0048450767,0.041935544,0.000051915853,0.000074828014,0.00069383136,0.0026164611,0.0001300948,0.0014321111,0.029932441],"study_design_scores_gemma":[0.9207477,0.030168947,0.009498235,0.0003999951,0.035901785,0.00009937953,0.00006594408,0.0005308338,0.0005659234,0.00049915846,0.0014574629,0.000064603206],"about_ca_topic_score_codex":0.00070967857,"about_ca_topic_score_gemma":0.0018691116,"teacher_disagreement_score":0.0071139713,"about_ca_system_score_codex":0.00067102804,"about_ca_system_score_gemma":0.00094935595,"threshold_uncertainty_score":0.03762275},"labels":[],"label_agreement":null},{"id":"W3194489379","doi":"10.1016/j.jaad.2021.06.309","title":"25842 Basal cell carcinoma–like cutaneous metastases of a breast adenocarcinoma: A case report","year":2021,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Malignancy; Basal cell carcinoma; Adenocarcinoma; Dermatology; Oncology; Carcinoma; Pathology; Breast carcinoma; Basal cell; Internal medicine; Breast cancer; Cancer","score_opus":0.01570695898278141,"score_gpt":0.29384091096830417,"score_spread":0.27813395198552276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3194489379","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9537412,0.008284945,0.0071900277,0.0045734555,0.0011348233,0.0004447992,0.00066397176,0.0005196794,0.023447052],"genre_scores_gemma":[0.9862766,0.0020538338,0.0035817907,0.0012589326,0.002925192,0.000092923045,0.00026656242,0.000066069,0.0034780276],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9986909,0.0001599217,0.00018419816,0.00039529675,0.00024193116,0.00032778614],"domain_scores_gemma":[0.99721587,0.00075091096,0.00039854556,0.00048050302,0.00021602458,0.0009381345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005952053,0.0037766527,0.0020563165,0.0044005495,0.0040091393,0.0031282417,0.0024174454,0.009800011,0.005005599],"category_scores_gemma":[0.0039985743,0.002644905,0.0026543858,0.0023472903,0.0025676214,0.0045155697,0.0033089535,0.004362612,0.003411871],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015564696,0.00001828461,0.0009228441,0.000019157558,0.0000052332307,0.9977736,0.000052893847,0.000027099604,0.0006172584,0.000070301016,0.00009926795,0.00037848606],"study_design_scores_gemma":[0.000011580131,0.00003364485,0.0019550468,0.000010253559,0.000024397215,0.9964604,0.00011164754,0.00030016774,0.0004999965,0.00013334161,0.00044820656,0.000011405198],"about_ca_topic_score_codex":0.0017791417,"about_ca_topic_score_gemma":0.0025441176,"teacher_disagreement_score":0.009800011,"about_ca_system_score_codex":0.0017661226,"about_ca_system_score_gemma":0.00085528434,"threshold_uncertainty_score":0.016745389},"labels":[],"label_agreement":null},{"id":"W3194541493","doi":"10.1016/j.jaad.2021.06.705","title":"28081 Strategies to improve quality of atopic dermatitis care in North America: Results from the Atopic Dermatitis Quality of Care (ADQoC) initiative","year":2021,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"","keywords":"Atopic dermatitis; Medicine; Psychosocial; Quality of life (healthcare); Quality (philosophy); Dermatology; Affect (linguistics); Disease control; Family medicine; Environmental health; Nursing; Psychiatry","score_opus":0.029764007354707318,"score_gpt":0.3470591069430339,"score_spread":0.3172950995883266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3194541493","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7597247,0.014341196,0.001561015,0.15125532,0.002291468,0.0030387605,0.013023865,0.00040621226,0.0543575],"genre_scores_gemma":[0.9108792,0.010905408,0.010233317,0.040864002,0.0012618222,0.0024307845,0.013614163,0.000088149965,0.009723102],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.995572,0.0018531961,0.00021621832,0.00025703365,0.0012408486,0.0008607595],"domain_scores_gemma":[0.9876671,0.0016406215,0.0014056311,0.00040304128,0.0027718868,0.0061116326],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007899215,0.000433863,0.00045830678,0.0007060936,0.0014352116,0.0025687425,0.0012020762,0.0015045167,0.0050065154],"category_scores_gemma":[0.009390066,0.00023282954,0.0010900617,0.0015152791,0.0005904304,0.00095055834,0.0030198896,0.0015923065,0.00042088606],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015763933,0.011344366,0.38355073,0.0011498687,0.00065601827,0.0001594662,0.0018444305,0.0011025447,0.0008535232,0.001871991,0.16350283,0.43238786],"study_design_scores_gemma":[0.0018670807,0.0009861344,0.96549225,0.00061450026,0.0003060787,0.000038917773,0.0030369288,0.00067317317,0.00026980665,0.00044792437,0.026237663,0.000029452809],"about_ca_topic_score_codex":0.16160345,"about_ca_topic_score_gemma":0.21481839,"teacher_disagreement_score":0.16160345,"about_ca_system_score_codex":0.0061573354,"about_ca_system_score_gemma":0.03190102,"threshold_uncertainty_score":0.3213256},"labels":[],"label_agreement":null},{"id":"W3194670242","doi":"10.1016/j.jaad.2021.06.398","title":"26285 A rare case of congenital erythropoietic porphyria presenting with pulse oximeter–induced blisters","year":2021,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Porphyrin Metabolism and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Porphyria; Porphyria cutanea tarda; Photosensitivity; Hemolytic anemia; Internal medicine; Dermatology; Pathology; Endocrinology","score_opus":0.011850439802019528,"score_gpt":0.27903234032096574,"score_spread":0.2671819005189462,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3194670242","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9634283,0.0023507148,0.0044496623,0.0020453518,0.0005569283,0.00016472956,0.0004059723,0.00033924702,0.026259106],"genre_scores_gemma":[0.9956268,0.00034159597,0.0009473239,0.00029062017,0.00058393826,0.000020047511,0.00008963499,0.000039482875,0.0020605815],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99918264,0.00008425932,0.00009236618,0.00018856273,0.00013298106,0.00031927277],"domain_scores_gemma":[0.99777323,0.00087572634,0.00040684204,0.00022179754,0.00009333489,0.00062907307],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036372582,0.0026068203,0.0012096502,0.0029216006,0.0021540227,0.0017841256,0.0017154106,0.0046496717,0.004850949],"category_scores_gemma":[0.0038285803,0.0015246645,0.0013909738,0.0014867965,0.0018699076,0.001804662,0.0019582533,0.003201097,0.0015743086],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001551847,0.000013710867,0.000590345,0.0000077764325,0.0000030241852,0.998425,0.00002792214,0.000023482056,0.00046048456,0.00015161338,0.00005208048,0.00022909185],"study_design_scores_gemma":[0.00001946805,0.000045163248,0.002247027,0.0000039856823,0.000011151854,0.9964379,0.000032898315,0.00024272218,0.00058382546,0.00014370833,0.00022519472,0.0000069940224],"about_ca_topic_score_codex":0.0015763695,"about_ca_topic_score_gemma":0.0011141007,"teacher_disagreement_score":0.004850949,"about_ca_system_score_codex":0.0011236233,"about_ca_system_score_gemma":0.0006592149,"threshold_uncertainty_score":0.01622808},"labels":[],"label_agreement":null},{"id":"W3194690028","doi":"10.1016/j.jaad.2021.06.722","title":"28170 Neutralizing interleukin-13 increases skin microbial diversity: Results from a phase 3, randomized, double-blind, placebo-controlled trial with tralokinumab in adult patients with atopic dermatitis","year":2021,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Atopic dermatitis; Medicine; Placebo; Immunology; Immune system; Eczema Area and Severity Index; Dermatology; Pathology","score_opus":0.013210809913418933,"score_gpt":0.279208592042047,"score_spread":0.26599778212862807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3194690028","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888915,0.007444496,0.0003724584,0.00037067,0.00039616847,0.0011648376,0.00042363585,0.000095573894,0.00084060326],"genre_scores_gemma":[0.99134386,0.0041305847,0.00073478144,0.00071462325,0.00032635705,0.0010692853,0.0004382067,0.000019826984,0.001222441],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9995802,0.00017627061,0.00003384489,0.00008405644,0.000042464082,0.00008323449],"domain_scores_gemma":[0.999438,0.00020219025,0.00011561518,0.00003141495,0.000045539928,0.00016730108],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013303447,0.0013680317,0.0025159626,0.0003081118,0.0004442023,0.0009030905,0.0007336487,0.0011791403,0.0049221534],"category_scores_gemma":[0.0010899957,0.0005676643,0.0019864475,0.00028997695,0.0008335324,0.00082786655,0.0002581026,0.0026225608,0.00071834354],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.94910604,0.009721421,0.0010000239,0.001538103,0.0017635564,0.0000682543,0.0000689512,0.00030137965,0.0062689637,0.000060170652,0.0008340853,0.029269077],"study_design_scores_gemma":[0.92679685,0.06773054,0.0034941335,0.000044666507,0.0006826963,0.000053767988,0.000033555978,0.00027723552,0.00048090523,0.0000560708,0.0003324432,0.00001712101],"about_ca_topic_score_codex":0.00097013585,"about_ca_topic_score_gemma":0.0023529676,"teacher_disagreement_score":0.0049221534,"about_ca_system_score_codex":0.00052940653,"about_ca_system_score_gemma":0.00071217417,"threshold_uncertainty_score":0.01646626},"labels":[],"label_agreement":null},{"id":"W3194711549","doi":"10.1016/j.jaad.2021.06.336","title":"25983 Rates of individual and composite cardiovascular events through 5 years of tildrakizumab exposure in 2 phase 3 clinical trials","year":2021,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Monoclonal; Clinical trial; Plaque psoriasis; Psoriasis; Internal medicine; Dermatology; Monoclonal antibody; Interleukin 23; Immunology; Antibody; Interleukin; Cytokine","score_opus":0.07598746161508962,"score_gpt":0.38961181960893976,"score_spread":0.31362435799385013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3194711549","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9756158,0.01334107,0.0012689375,0.00044070877,0.00021204313,0.0010536498,0.003618712,0.000096965865,0.0043521477],"genre_scores_gemma":[0.99001545,0.0027962292,0.0008318399,0.00051472697,0.00015809147,0.000850751,0.0025275163,0.0000349423,0.002270283],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.996626,0.0020303584,0.00030289651,0.000491038,0.00030083873,0.00024893545],"domain_scores_gemma":[0.99686486,0.0012585997,0.001066799,0.0003127259,0.00023987843,0.0002570662],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0063313358,0.0007447305,0.0018867286,0.00039965537,0.00038700123,0.0011947829,0.00047820585,0.0011666685,0.003839032],"category_scores_gemma":[0.004251594,0.00061989506,0.0032724908,0.0007921793,0.00047039194,0.0008593341,0.00042107428,0.0017614261,0.0006448569],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8452283,0.0041410415,0.043523964,0.0015738598,0.014137283,0.00019307964,0.00017942967,0.0018571732,0.008420964,0.00038611895,0.0053501,0.075008705],"study_design_scores_gemma":[0.5010738,0.20112808,0.25672853,0.0003790832,0.019436289,0.0006134587,0.00016457078,0.0023503234,0.004042933,0.0007659839,0.013185938,0.00013108546],"about_ca_topic_score_codex":0.0006319715,"about_ca_topic_score_gemma":0.0015926849,"teacher_disagreement_score":0.0063313358,"about_ca_system_score_codex":0.00056091737,"about_ca_system_score_gemma":0.00083460304,"threshold_uncertainty_score":0.033483744},"labels":[],"label_agreement":null},{"id":"W3194740112","doi":"10.1016/j.jaad.2021.06.080","title":"26053 Improvement in sleep is associated with improved quality of life in adult patients with moderate-to-severe atopic dermatitis: Results from a phase 3 trial of baricitinib therapy","year":2021,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"","keywords":"Medicine; Atopic dermatitis; Work productivity; Quality of life (healthcare); Dermatology; Productivity","score_opus":0.01858993508776908,"score_gpt":0.3095720448224219,"score_spread":0.2909821097346528,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3194740112","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99110794,0.006080641,0.00013270306,0.00047510286,0.00016667249,0.00031451893,0.00039602083,0.000051542647,0.0012748725],"genre_scores_gemma":[0.9949043,0.0025163835,0.00024586168,0.0006884566,0.00015256555,0.00020529411,0.0006331125,0.000007761185,0.0006463807],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9997633,0.000086482854,0.00002050695,0.000037125534,0.000034371184,0.00005825191],"domain_scores_gemma":[0.9996817,0.00007492954,0.00008645007,0.000017874037,0.000030330624,0.000108746564],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008328735,0.0006835718,0.0016058144,0.00021280091,0.0003129698,0.000709962,0.0004242894,0.00070236315,0.0026354038],"category_scores_gemma":[0.00066997175,0.00024806306,0.0017015954,0.00030239826,0.00043160355,0.0003964994,0.00019620603,0.0017758447,0.00039594262],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.73612213,0.022432156,0.026385682,0.0019914217,0.007350175,0.0003288067,0.0001390428,0.0010988277,0.027186109,0.00019082321,0.006367195,0.1704076],"study_design_scores_gemma":[0.5464437,0.27460232,0.16447167,0.00021833993,0.0043459344,0.00073386135,0.00017064388,0.001723827,0.0028456303,0.00023168448,0.00414098,0.00007141037],"about_ca_topic_score_codex":0.001206415,"about_ca_topic_score_gemma":0.004031371,"teacher_disagreement_score":0.0026354038,"about_ca_system_score_codex":0.00051461335,"about_ca_system_score_gemma":0.0004570351,"threshold_uncertainty_score":0.008816242},"labels":[],"label_agreement":null},{"id":"W3194797567","doi":"10.1016/j.jaad.2021.06.530","title":"27062 Necrobiotic xanthogranulomas: 2 cases highlighting the refractoriness of this condition to treatment","year":2021,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Histiocytic Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Histiocytosis; Dermatology; Langerhans cell histiocytosis; Pathology; Disease","score_opus":0.021042331911147023,"score_gpt":0.3353445345558021,"score_spread":0.3143022026446551,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3194797567","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9397764,0.008705313,0.0074747745,0.004610606,0.0013038614,0.0006136544,0.0003973895,0.0003932802,0.03672475],"genre_scores_gemma":[0.98763674,0.0021913138,0.0026235133,0.0011760222,0.0024823109,0.000096135605,0.00017429056,0.00006396541,0.0035557426],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9989768,0.00014939261,0.00015054276,0.00018747378,0.00017538288,0.00036037853],"domain_scores_gemma":[0.9973658,0.0011194278,0.0005235002,0.00031946605,0.00016073922,0.00051115814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00086800614,0.0031163322,0.001143882,0.0049613034,0.0020094765,0.0017500994,0.0016976681,0.008698111,0.003326817],"category_scores_gemma":[0.005967373,0.0015059571,0.0015382268,0.0016317788,0.0020768375,0.002289159,0.0022347218,0.003609307,0.0023217117],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044995122,0.000047148278,0.0022603425,0.000018652761,0.0000037641344,0.9955273,0.00012667895,0.000049645812,0.0005271936,0.00015421525,0.00009183207,0.0011480779],"study_design_scores_gemma":[0.000032849443,0.000096622,0.0033421877,0.000012543547,0.000011682987,0.9948808,0.00008328822,0.00024124574,0.00048749454,0.00015630801,0.00064321735,0.000011788596],"about_ca_topic_score_codex":0.0018780482,"about_ca_topic_score_gemma":0.0014017172,"teacher_disagreement_score":0.008698111,"about_ca_system_score_codex":0.001048248,"about_ca_system_score_gemma":0.00058156013,"threshold_uncertainty_score":0.01112926},"labels":[],"label_agreement":null},{"id":"W3194908373","doi":"10.1016/j.jaad.2021.06.338","title":"25985 Efficacy of tildrakizumab 100 mg for PASI improvement in patients with moderate to severe plaque psoriasis: Pooled analysis using nonresponder imputation from reSURFACE 1 and 2 through week 52","year":2021,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Plaque psoriasis; Psoriasis; Imputation (statistics); Internal medicine; Psoriasis Area and Severity Index; Dermatology; Monoclonal; Monoclonal antibody; Gastroenterology; Antibody; Immunology; Missing data; Statistics","score_opus":0.01708652485733887,"score_gpt":0.28061181591653966,"score_spread":0.2635252910592008,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3194908373","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93820035,0.029868811,0.012184821,0.00037767016,0.0006510928,0.0011506086,0.012853827,0.00071485783,0.0039978563],"genre_scores_gemma":[0.98762894,0.0015496301,0.0025204609,0.0003271583,0.0001990291,0.0005743795,0.0049066753,0.00009189748,0.002201912],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98300123,0.011936722,0.0012738028,0.002198292,0.000992741,0.00059726834],"domain_scores_gemma":[0.9915575,0.004358513,0.0015049105,0.0019767587,0.00040577076,0.0001965166],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020761365,0.001990886,0.008183113,0.0009843094,0.00041494516,0.0013933483,0.0016733316,0.0019690823,0.0045283567],"category_scores_gemma":[0.012983188,0.0018947138,0.01795795,0.001340337,0.00052115595,0.0013103918,0.00102013,0.0025292293,0.0009137091],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5765337,0.0011656116,0.058361977,0.0037445321,0.29747865,0.00018189671,0.00021268924,0.004494319,0.0030122285,0.00028241848,0.00433902,0.050192956],"study_design_scores_gemma":[0.1356003,0.037645366,0.45958272,0.00070419215,0.3401651,0.0003811973,0.0001778174,0.015509125,0.0022509696,0.0012120745,0.00650995,0.0002612655],"about_ca_topic_score_codex":0.0019539255,"about_ca_topic_score_gemma":0.0023544366,"teacher_disagreement_score":0.020761365,"about_ca_system_score_codex":0.00054251065,"about_ca_system_score_gemma":0.00060771493,"threshold_uncertainty_score":0.109797955},"labels":[],"label_agreement":null},{"id":"W3194923171","doi":"10.1016/j.jaad.2021.06.650","title":"27697 Long-term efficacy, safety, and adherence to tralokinumab treatment in moderate-to-severe atopic dermatitis for up to 3 years: Interim readout of ECZTEND, a phase 3, long-term extension trial","year":2021,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital; Probity Medical Research","funders":"","keywords":"Medicine; Discontinuation; Atopic dermatitis; Eczema Area and Severity Index; Adverse effect; Interim; Interim analysis; Dermatology Life Quality Index; Clinical endpoint; Dupilumab; Quality of life (healthcare); Randomized controlled trial; Clinical trial; Internal medicine; Physical therapy; Pediatrics; Dermatology; Disease","score_opus":0.043150837695636345,"score_gpt":0.38078268589539543,"score_spread":0.3376318481997591,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3194923171","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945365,0.0021918814,0.00018336125,0.00030207646,0.00014481752,0.00038923748,0.00082480593,0.00006093433,0.0013663312],"genre_scores_gemma":[0.9930369,0.0012509628,0.00044795033,0.000685415,0.00021239887,0.00060110475,0.0013646296,0.00001921828,0.0023812875],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9993543,0.0002617967,0.00004908269,0.0000925955,0.00009835678,0.00014379765],"domain_scores_gemma":[0.9987929,0.00035650653,0.00025760592,0.00012900573,0.00010479583,0.0003591868],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021603175,0.0010266193,0.0018551411,0.00027922078,0.0005697018,0.0011913582,0.00074426585,0.0014773703,0.0049115825],"category_scores_gemma":[0.0015518906,0.00037410256,0.0020616297,0.00033465165,0.00077735825,0.0011326385,0.00032039417,0.0037107735,0.0012798108],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8714766,0.020258501,0.00891977,0.00083132164,0.003140674,0.00014525639,0.00018059683,0.0011421465,0.0076471493,0.00023422755,0.0034313446,0.082592495],"study_design_scores_gemma":[0.68365824,0.25175798,0.054525994,0.0001197016,0.0022802886,0.00029098324,0.00015076359,0.0018337833,0.0022890433,0.00030538466,0.002709585,0.00007817082],"about_ca_topic_score_codex":0.00062896835,"about_ca_topic_score_gemma":0.0015696641,"teacher_disagreement_score":0.0049115825,"about_ca_system_score_codex":0.0005162263,"about_ca_system_score_gemma":0.00070713845,"threshold_uncertainty_score":0.016430855},"labels":[],"label_agreement":null},{"id":"W3195059386","doi":"10.1016/j.jaad.2021.06.619","title":"27550 Durability of response to abrocitinib in patients with moderate-to-severe atopic dermatitis (AD) after treatment discontinuation in a phase 2b trial","year":2021,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada); SKiN Health","funders":"","keywords":"Medicine; Discontinuation; Atopic dermatitis; Dermatology; Surgery","score_opus":0.012144941334292605,"score_gpt":0.3146190388702931,"score_spread":0.30247409753600046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3195059386","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.976858,0.014578791,0.0003799994,0.00085042114,0.0004281695,0.0006003586,0.0010064052,0.00014290752,0.0051547852],"genre_scores_gemma":[0.9902863,0.0033170828,0.00034810184,0.0012894579,0.00022601215,0.0003990069,0.0012862909,0.000021806332,0.0028259377],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996593,0.000114369854,0.000018782592,0.00005560641,0.00003724504,0.00011462843],"domain_scores_gemma":[0.99953604,0.00013394759,0.00007476859,0.000033704444,0.00003617953,0.00018534723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014488568,0.00096627086,0.0016920536,0.00025263723,0.00031080394,0.0010304193,0.000514353,0.0008965646,0.0046755117],"category_scores_gemma":[0.0009658111,0.0002604987,0.001554626,0.0002560821,0.00046693799,0.0007309215,0.00020113627,0.0028426799,0.0010659457],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.689364,0.0116388975,0.01066396,0.0024171548,0.0044469773,0.00061780686,0.0003457628,0.0025731607,0.0241577,0.0008780228,0.013933047,0.23896345],"study_design_scores_gemma":[0.7289725,0.20552786,0.04337824,0.00030082345,0.0019822232,0.0010667645,0.00018410939,0.0021809794,0.0027680786,0.00083307084,0.012735165,0.00007017195],"about_ca_topic_score_codex":0.00047987755,"about_ca_topic_score_gemma":0.0016009527,"teacher_disagreement_score":0.0046755117,"about_ca_system_score_codex":0.0006025143,"about_ca_system_score_gemma":0.0005094133,"threshold_uncertainty_score":0.015641153},"labels":[],"label_agreement":null},{"id":"W3195112423","doi":"10.1016/j.jaad.2021.06.242","title":"25200 Public versus private drug insurance and psoriasis degree of severity in patients with prescribed biologics in Canada: A retrospective cohort study","year":2021,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Psoriasis; Retrospective cohort study; Drug; Cohort; Private insurance; Public health insurance; Health insurance; Family medicine; Cohort study; Internal medicine; Dermatology; Pharmacology; Health care","score_opus":0.03783819804355346,"score_gpt":0.2634106845124622,"score_spread":0.22557248646890873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3195112423","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99018735,0.0007702923,0.000077962985,0.00029054962,0.000025499905,0.00004433098,0.007231063,0.000011505859,0.0013614775],"genre_scores_gemma":[0.99479634,0.0004728802,0.00010927553,0.00023674754,0.000021777956,0.000022234233,0.0030777126,0.000010311105,0.0012528041],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99828595,0.00011596518,0.00012619128,0.00037540952,0.000499886,0.0005965373],"domain_scores_gemma":[0.9952721,0.00024973287,0.0013661394,0.00030465864,0.0014933984,0.0013140516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007252849,0.00053283,0.0008204069,0.0018788349,0.0027389391,0.0020667256,0.0019208218,0.0014067891,0.0040089223],"category_scores_gemma":[0.002702204,0.0010266658,0.0014785138,0.0062437793,0.0010617378,0.0007674277,0.0009208487,0.0021063616,0.0005781689],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000110450994,0.000039901657,0.99838054,0.000009930697,0.000096763666,0.00008222303,0.00012310775,0.000032410626,0.00007390978,0.000054533375,0.0004500381,0.0005462316],"study_design_scores_gemma":[0.00001724731,0.000033612763,0.9985555,0.000015905945,0.000058120862,0.00011814386,0.00042472832,0.0001476956,0.000028678254,0.000022593655,0.00056242786,0.000015346233],"about_ca_topic_score_codex":0.97592384,"about_ca_topic_score_gemma":0.9779482,"teacher_disagreement_score":0.024076164,"about_ca_system_score_codex":0.018438974,"about_ca_system_score_gemma":0.022763548,"threshold_uncertainty_score":0.13378471},"labels":[],"label_agreement":null},{"id":"W3195123012","doi":"10.1016/j.jaad.2021.06.575","title":"27383 Bimekizumab response maintenance up to 1 year in patients with moderate to severe plaque psoriasis: Pooled results from three phase 3 trials","year":2021,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Plaque psoriasis; Medicine; Psoriasis; Dermatology; Maintenance therapy; Complete response; Internal medicine; Clinical trial; Surgery; Chemotherapy","score_opus":0.023730521157013258,"score_gpt":0.2901031741811524,"score_spread":0.26637265302413915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3195123012","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7685711,0.21240611,0.0035418484,0.0015030076,0.001289989,0.002104132,0.0031413352,0.0004275521,0.0070149805],"genre_scores_gemma":[0.9695584,0.022560164,0.001303337,0.0014756543,0.00054854463,0.0009515999,0.0019982548,0.000055505378,0.0015485572],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99829525,0.0008722689,0.00015572885,0.00028110057,0.00016333105,0.00023229301],"domain_scores_gemma":[0.9984687,0.0006534797,0.00042520932,0.00015198569,0.00012053757,0.00018010093],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005289175,0.0016762456,0.0066031427,0.0005839251,0.00037125024,0.0017470457,0.000902884,0.0012289772,0.003033408],"category_scores_gemma":[0.0029772413,0.00070101063,0.008575835,0.0008761579,0.0006211631,0.0012550475,0.00053154817,0.0030085538,0.0005667725],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7965117,0.0015903895,0.004729583,0.008035583,0.06418723,0.00011799484,0.00012187073,0.0025001972,0.0051979637,0.00023323153,0.004477305,0.112296976],"study_design_scores_gemma":[0.8032196,0.08328816,0.03467133,0.0008799336,0.06762942,0.00035419196,0.00012908375,0.0014704044,0.0012562088,0.0007960144,0.006198107,0.00010754784],"about_ca_topic_score_codex":0.0010580891,"about_ca_topic_score_gemma":0.00310248,"teacher_disagreement_score":0.0066031427,"about_ca_system_score_codex":0.0008714366,"about_ca_system_score_gemma":0.00094312447,"threshold_uncertainty_score":0.027972221},"labels":[],"label_agreement":null},{"id":"W3195227536","doi":"10.1016/j.jaad.2021.06.709","title":"28096 Sustained improvement in general health-related quality of life and work productivity in patients with moderate to severe psoriasis treated with guselkumab: 5-year data from clinical trial VOYAGE 2","year":2021,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Medicine; Work productivity; Psoriasis; Depression (economics); Quality of life (healthcare); Productivity; Placebo; Physical therapy; Anxiety; Adalimumab; Clinical trial; Alternative medicine; Internal medicine; Psychiatry; Dermatology; Nursing; Disease","score_opus":0.0458343997511304,"score_gpt":0.3228891366153647,"score_spread":0.2770547368642343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3195227536","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9839171,0.009349217,0.0003540279,0.0005262233,0.0002146434,0.0005734798,0.0029226695,0.000063847016,0.0020787332],"genre_scores_gemma":[0.98624706,0.0041975137,0.00051518716,0.0007549416,0.00025829236,0.00050851493,0.0052444604,0.00002158775,0.0022525513],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9988732,0.00055919087,0.00010992109,0.000119777564,0.0001269063,0.00021099809],"domain_scores_gemma":[0.9987563,0.0003555399,0.0003142026,0.00017656879,0.000101216676,0.00029615595],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035548308,0.00087535894,0.0029117297,0.0005214434,0.0004527151,0.001288377,0.00068747695,0.0013497402,0.003920506],"category_scores_gemma":[0.0018300741,0.00037276276,0.003058596,0.00080795045,0.0007614459,0.0009114332,0.00046474233,0.0026210658,0.0010148687],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8953336,0.008880795,0.015489528,0.00092291826,0.003953919,0.00013157648,0.00009945526,0.00074503507,0.0057388265,0.00012292755,0.0026902661,0.06589109],"study_design_scores_gemma":[0.56851834,0.2696941,0.15022524,0.00021653814,0.0030198528,0.0003452609,0.00012684602,0.00093356206,0.0019643053,0.00024838108,0.004627988,0.000079617705],"about_ca_topic_score_codex":0.0012753761,"about_ca_topic_score_gemma":0.0017925927,"teacher_disagreement_score":0.003920506,"about_ca_system_score_codex":0.0006111224,"about_ca_system_score_gemma":0.00080573955,"threshold_uncertainty_score":0.01880002},"labels":[],"label_agreement":null},{"id":"W3195268188","doi":"10.1016/j.jaad.2021.06.609","title":"27496 Efficacy of ruxolitinib cream for the treatment of atopic dermatitis by baseline patient demographics: Pooled subgroup analysis from two randomized phase 3 studies","year":2021,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Medicine; Ruxolitinib; Atopic dermatitis; Internal medicine; Demographics; Randomized controlled trial; Eczema Area and Severity Index; Janus kinase inhibitor; Subgroup analysis; Adverse effect; Gastroenterology; Janus kinase; Dermatology; Demography; Confidence interval; Myelofibrosis","score_opus":0.01977835687656888,"score_gpt":0.3529004577024576,"score_spread":0.3331221008258887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3195268188","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83002126,0.15297993,0.0035808627,0.00084060605,0.0016668563,0.0027105778,0.0037793105,0.00024997842,0.0041705486],"genre_scores_gemma":[0.98133737,0.0121869175,0.0010140986,0.0009173735,0.0005575078,0.0011360138,0.0014765203,0.00004359278,0.0013305548],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9970772,0.0016380891,0.00041709328,0.0003992698,0.00023613835,0.00023216984],"domain_scores_gemma":[0.99762076,0.0013747896,0.0005279441,0.00022745931,0.00012455341,0.0001245609],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0047842884,0.0020223141,0.007602063,0.000853608,0.00036004558,0.0017486305,0.00084103964,0.001754181,0.0042500603],"category_scores_gemma":[0.0048866183,0.00085251837,0.016176289,0.00079003756,0.00064785714,0.0011170108,0.0005851199,0.002345075,0.00046999037],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.85375714,0.0005083022,0.003217938,0.0063693877,0.109759085,0.00011528065,0.000046298857,0.000939229,0.0024389967,0.000106368265,0.0008844672,0.021857595],"study_design_scores_gemma":[0.7265283,0.026673699,0.022360884,0.0007238299,0.21775018,0.00019726023,0.000103267565,0.0015884611,0.0013007987,0.0007183875,0.0019323939,0.00012268402],"about_ca_topic_score_codex":0.001057821,"about_ca_topic_score_gemma":0.0030420462,"teacher_disagreement_score":0.007602063,"about_ca_system_score_codex":0.00077280693,"about_ca_system_score_gemma":0.0007197566,"threshold_uncertainty_score":0.025302052},"labels":[],"label_agreement":null},{"id":"W3195269693","doi":"10.1016/j.jaad.2021.06.105","title":"26562 Dermatologic disparities amongst persons experiencing homelessness","year":2021,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatological and COVID-19 studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Variety (cybernetics); Gerontology","score_opus":0.026626766184782096,"score_gpt":0.31817896078613433,"score_spread":0.29155219460135223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3195269693","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908255,0.0010290976,0.00003078586,0.00069825276,0.000037815716,0.00001687386,0.00096295914,0.0000015334512,0.0063972673],"genre_scores_gemma":[0.99868673,0.0003092431,0.000014828133,0.00023688974,0.000024827526,0.000006753505,0.00021636652,6.874943e-7,0.00050359074],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99947923,0.00011527886,0.000042296917,0.00006060124,0.00006790849,0.00023473529],"domain_scores_gemma":[0.9989579,0.00020344209,0.0004147908,0.000051244126,0.00011796748,0.00025459236],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003757148,0.000091564085,0.0001681245,0.00068620185,0.00094142364,0.00068187487,0.00020891416,0.00039535557,0.008350533],"category_scores_gemma":[0.0021021003,0.000119381744,0.0002571545,0.0014350619,0.00021007127,0.00056590966,0.00049339846,0.0005480539,0.00035451137],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006475293,0.00012489111,0.99506205,0.000027082566,0.00003336388,0.000059440754,0.00034162382,0.000010123867,0.0000684992,0.00023882225,0.00067817507,0.0032910812],"study_design_scores_gemma":[0.000009033333,0.000045579865,0.99672544,0.000049196897,0.000021168747,0.00008382453,0.0018310191,0.000020573863,0.000019408,0.00007125326,0.0011210304,0.000002367781],"about_ca_topic_score_codex":0.03392055,"about_ca_topic_score_gemma":0.049267076,"teacher_disagreement_score":0.03392055,"about_ca_system_score_codex":0.00037854697,"about_ca_system_score_gemma":0.00070357975,"threshold_uncertainty_score":0.06744623},"labels":[],"label_agreement":null},{"id":"W3195315889","doi":"10.1016/j.jaad.2021.06.794","title":"28527 A Canada wide survey of access to patch testing","year":2021,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Contact Dermatitis and Allergies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Patch testing; Family medicine; Immunology","score_opus":0.05238294316974799,"score_gpt":0.33012136895610705,"score_spread":0.27773842578635904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3195315889","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.804161,0.0051129493,0.00043434958,0.0061387615,0.0001403588,0.00048927445,0.101990014,0.00014085587,0.081392534],"genre_scores_gemma":[0.9524994,0.0028700733,0.00059346977,0.004321347,0.00003743168,0.00011713739,0.012638527,0.00005316615,0.026869506],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99788696,0.00012826495,0.000121467296,0.00021882284,0.0010603073,0.0005842057],"domain_scores_gemma":[0.99132127,0.00049918855,0.0011897606,0.00016336299,0.004960067,0.0018663694],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007145331,0.00034581305,0.00034895437,0.0020814608,0.0023813795,0.0013487006,0.00092082896,0.00071287935,0.01412602],"category_scores_gemma":[0.0035825232,0.00047118898,0.00052584667,0.0059309597,0.00052423467,0.0003810443,0.000797992,0.00090591813,0.0019214409],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000111975765,0.00009416221,0.9525956,0.00014107155,0.000073914336,0.00023816599,0.00041247695,0.00007955726,0.00037375267,0.00028776343,0.03408194,0.011509709],"study_design_scores_gemma":[0.000012614077,0.000030363317,0.9872378,0.00006253297,0.000020853142,0.0001235381,0.00076222763,0.00010880555,0.000077846475,0.000014876131,0.011534924,0.000013509499],"about_ca_topic_score_codex":0.9926351,"about_ca_topic_score_gemma":0.9964265,"teacher_disagreement_score":0.018137055,"about_ca_system_score_codex":0.018137055,"about_ca_system_score_gemma":0.04397461,"threshold_uncertainty_score":0.13159412},"labels":[],"label_agreement":null},{"id":"W3195322805","doi":"10.1016/j.jaad.2021.06.723","title":"28171 Assessing long-term maintenance of efficacy with tralokinumab monotherapy in patients with moderate-to-severe atopic dermatitis: Combined results from two phase 3, randomized, double-blind, placebo-controlled trials (ECZTRA 1 and 2)","year":2021,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; University of Toronto; St. Thomas Hospital","funders":"","keywords":"Placebo; Medicine; Eczema Area and Severity Index; Adverse effect; Atopic dermatitis; Discontinuation; Post-hoc analysis; Double blind; Placebo-controlled study; Internal medicine; Randomized controlled trial; Dermatology","score_opus":0.02515657840128567,"score_gpt":0.34087913610565684,"score_spread":0.3157225577043712,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3195322805","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95808256,0.033015393,0.0008507642,0.0008354252,0.0007436331,0.0026481962,0.001633856,0.00016209859,0.0020280797],"genre_scores_gemma":[0.9786798,0.01142231,0.0017978585,0.001081635,0.0007370836,0.002017043,0.0019762528,0.000038416394,0.002249568],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9987425,0.0006897897,0.00012203177,0.00017470213,0.000114871465,0.00015608087],"domain_scores_gemma":[0.9982167,0.0006767653,0.00046464452,0.00014175451,0.00016958274,0.0003304837],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003820676,0.002009118,0.005569724,0.00062271074,0.0005796855,0.0013762855,0.0010373574,0.001995211,0.00490192],"category_scores_gemma":[0.002236381,0.0008152673,0.00522604,0.0005732212,0.0009474665,0.0014264353,0.00045145626,0.003234638,0.0009781306],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9552811,0.0038854044,0.0011308024,0.0017694142,0.0049472996,0.000047168625,0.00006972739,0.00031775897,0.0049927784,0.000049893555,0.00078536186,0.026723217],"study_design_scores_gemma":[0.9245156,0.067590155,0.0043169423,0.000067116016,0.0020781064,0.00005412936,0.00002604703,0.000200902,0.00051012036,0.000058201895,0.00056032836,0.000022338734],"about_ca_topic_score_codex":0.0009626261,"about_ca_topic_score_gemma":0.0025766178,"teacher_disagreement_score":0.005569724,"about_ca_system_score_codex":0.00065003673,"about_ca_system_score_gemma":0.001041782,"threshold_uncertainty_score":0.020205915},"labels":[],"label_agreement":null},{"id":"W3195365745","doi":"10.1016/j.jaad.2021.06.785","title":"28496 Comprehensive national analysis of geographic distribution of cutaneous melanoma and nonmelanoma skin cancer in Russia","year":2021,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Skin cancer; Dermatology; Melanoma; Cancer; Internal medicine; Cancer research","score_opus":0.011834603188476319,"score_gpt":0.29705637651386174,"score_spread":0.2852217733253854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3195365745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99298954,0.00020537831,0.00016480971,0.00002143678,0.000005029521,0.0000074585078,0.0058511943,0.0000071943773,0.0007479842],"genre_scores_gemma":[0.9929219,0.00011666073,0.000108030894,0.0000114846325,0.000004205881,0.000016287577,0.0064924485,0.0000045071592,0.00032444723],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99933344,0.00016964671,0.00011160175,0.00015918726,0.000109387875,0.00011671851],"domain_scores_gemma":[0.9989035,0.00017080022,0.0003732232,0.00019417077,0.00024587027,0.000112463626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005818041,0.00016895004,0.00043587084,0.0014910756,0.00051089743,0.0003972146,0.00044458758,0.000248214,0.0015136149],"category_scores_gemma":[0.0010474959,0.00029426586,0.00078267505,0.0023745233,0.00016758704,0.0002385458,0.00065479055,0.0002383296,0.0004656616],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004411241,0.000011714044,0.99830306,0.000014284278,0.00011565848,0.00004240946,0.00007124105,0.00007634031,0.0002865131,0.00002249501,0.00019229362,0.00081977],"study_design_scores_gemma":[0.0000014571369,0.00001129943,0.99930346,0.000003717684,0.000037523867,0.000054446427,0.00011353477,0.00006763146,0.000044105767,0.000005032099,0.00035601875,0.0000017760714],"about_ca_topic_score_codex":0.038250864,"about_ca_topic_score_gemma":0.03247936,"teacher_disagreement_score":0.038250864,"about_ca_system_score_codex":0.0005239647,"about_ca_system_score_gemma":0.0010089687,"threshold_uncertainty_score":0.07605642},"labels":[],"label_agreement":null},{"id":"W3195417065","doi":"10.1016/j.jaad.2021.06.569","title":"27374 Bimekizumab efficacy in patients with moderate to severe plaque psoriasis receiving continuous bimekizumab or switching from adalimumab: Results from the phase 3 BE SURE trial","year":2021,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Queen's University","funders":"","keywords":"Medicine; Adalimumab; Plaque psoriasis; Psoriasis; Monoclonal antibody; Dermatology; Interleukin 17; Monoclonal; Internal medicine; Immunology; Antibody; Tumor necrosis factor alpha; Inflammation","score_opus":0.02062054342886212,"score_gpt":0.2772263132695126,"score_spread":0.2566057698406505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3195417065","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98665434,0.0077622156,0.00030909976,0.0008090139,0.0003027093,0.00048168574,0.00060848607,0.00011977608,0.0029527433],"genre_scores_gemma":[0.9915109,0.0027046553,0.00054480013,0.0014727586,0.00033969883,0.00043256578,0.0010327607,0.000033403463,0.0019284263],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9995932,0.00016023601,0.000017539598,0.000067866255,0.000047893256,0.00011330891],"domain_scores_gemma":[0.9995394,0.00013679158,0.00009042718,0.000036016816,0.000026625756,0.00017082797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012918414,0.0010206049,0.0023951728,0.00022723632,0.0003992093,0.0013298145,0.0005937874,0.0010286415,0.003614222],"category_scores_gemma":[0.0009076098,0.00037761938,0.0020676414,0.00034327628,0.00075851317,0.00082365057,0.00027046754,0.003409642,0.0008044971],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.84289235,0.010280714,0.005134703,0.0009870313,0.0028467928,0.00015853954,0.00012916182,0.0010326441,0.011921822,0.0003132014,0.0059169317,0.11838605],"study_design_scores_gemma":[0.84659094,0.12536564,0.020193808,0.00008732753,0.0015893293,0.0002482812,0.000070367605,0.0009713193,0.001114499,0.00044783237,0.0032797914,0.00004090926],"about_ca_topic_score_codex":0.00064537855,"about_ca_topic_score_gemma":0.0013727203,"teacher_disagreement_score":0.003614222,"about_ca_system_score_codex":0.0006334314,"about_ca_system_score_gemma":0.0007076356,"threshold_uncertainty_score":0.012090743},"labels":[],"label_agreement":null},{"id":"W3195838575","doi":"10.1016/j.jaad.2021.06.275","title":"25597 Improvements in scalp and nail psoriasis with apremilast treatment in patients with moderate to severe plaque psoriasis with and without a history of psoriatic arthritis","year":2021,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"","keywords":"Medicine; Apremilast; Psoriasis; Psoriatic arthritis; Dermatology; Scalp; Nail (fastener); Plaque psoriasis; Nail disease; Arthritis; Internal medicine","score_opus":0.008278212771125748,"score_gpt":0.21812394385396022,"score_spread":0.20984573108283447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3195838575","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99197644,0.0040350244,0.00010572581,0.0001058064,0.00006708937,0.000046912235,0.00017932741,0.000019410074,0.003464248],"genre_scores_gemma":[0.9986426,0.000546344,0.00009868507,0.000062849416,0.000038839047,0.00001168649,0.00013748696,0.0000018815426,0.0004595955],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9997085,0.00012832787,0.000030158373,0.000023627937,0.00006139829,0.00004800048],"domain_scores_gemma":[0.9996197,0.00016105025,0.00008014448,0.000016987948,0.000045122517,0.000076813325],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051306636,0.0002407294,0.00093711587,0.00030388407,0.00019980436,0.00028688824,0.00013144739,0.00025758194,0.002718908],"category_scores_gemma":[0.0011259387,0.00009913052,0.00056022755,0.0003164034,0.00012515468,0.00025231828,0.00011978096,0.0005341483,0.0002227948],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.26548022,0.008140587,0.21114236,0.0017261024,0.0028032055,0.0018304306,0.0004668139,0.0010557558,0.044655852,0.00019453323,0.0025897217,0.4599145],"study_design_scores_gemma":[0.00677689,0.044312276,0.94266677,0.000052482657,0.0008061433,0.0010305918,0.00017485363,0.0006497195,0.0017033849,0.00007448527,0.0017293754,0.000022993645],"about_ca_topic_score_codex":0.00066788454,"about_ca_topic_score_gemma":0.0012724991,"teacher_disagreement_score":0.002718908,"about_ca_system_score_codex":0.00015692908,"about_ca_system_score_gemma":0.00015911902,"threshold_uncertainty_score":0.009095609},"labels":[],"label_agreement":null},{"id":"W3195857661","doi":"10.1016/j.jaad.2021.06.348","title":"26003 An objective, quantitative assessment of flexible hyaluronic acid fillers in lip and perioral enhancement","year":2021,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Facial Rejuvenation and Surgery Techniques","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Victoria Park; University of Toronto","funders":"","keywords":"Medicine; Filler (materials); Hyaluronic acid; Cosmetic Techniques; Dentistry; Wrinkle; Orthodontics; Surgery; Composite material; Anatomy","score_opus":0.03158874348665254,"score_gpt":0.3987057153142831,"score_spread":0.3671169718276306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3195857661","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97654676,0.0019839606,0.014448371,0.000060888495,0.000041796957,0.00023815881,0.00012537313,0.000068173744,0.006486451],"genre_scores_gemma":[0.98206353,0.0005201793,0.013230844,0.00006490145,0.000019846919,0.00006490671,0.00006225039,0.000018591012,0.0039548744],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99970263,0.000102391336,0.000025936775,0.000029925674,0.00011410254,0.000025011683],"domain_scores_gemma":[0.99960417,0.00020523377,0.000029421924,0.000022725573,0.00009729559,0.000041199077],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001013222,0.00030452994,0.00014299511,0.0007029434,0.00018052306,0.00020649018,0.00014751783,0.00036471855,0.0031613247],"category_scores_gemma":[0.00071613,0.0001707088,0.00013523293,0.00021111521,0.00027034176,0.00050235656,0.00024482686,0.00022141618,0.00029878484],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032115951,0.0005260878,0.015389086,0.00031497955,0.000035008306,0.0021521961,0.00020518366,0.0003631628,0.89019644,0.0005014766,0.0003822592,0.086722486],"study_design_scores_gemma":[0.0004430867,0.0145763,0.32497308,0.00015950065,0.00026016566,0.02650447,0.0010283291,0.013674048,0.6093222,0.00068348984,0.00825016,0.00012516603],"about_ca_topic_score_codex":0.0008433532,"about_ca_topic_score_gemma":0.0020604148,"teacher_disagreement_score":0.0031613247,"about_ca_system_score_codex":0.00012066276,"about_ca_system_score_gemma":0.00022692521,"threshold_uncertainty_score":0.010575652},"labels":[],"label_agreement":null},{"id":"W3195918713","doi":"10.1016/j.jaad.2021.06.592","title":"27454 Efficacy and safety of long-term risankizumab re-treatment following drug withdrawal: IMMhance trial","year":2021,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Psoriasis; Drug; Plaque psoriasis; Monoclonal; Dermatology; Internal medicine; Monoclonal antibody; Pharmacology; Antibody; Immunology","score_opus":0.01513750163859811,"score_gpt":0.2884609842801245,"score_spread":0.2733234826415264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3195918713","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98500293,0.0074261203,0.00032959037,0.0009371181,0.00043773119,0.00043257742,0.0010389277,0.00011196757,0.0042829434],"genre_scores_gemma":[0.98939824,0.0019357366,0.0002833885,0.0013478178,0.00030003925,0.00033548177,0.0015621472,0.000025998308,0.004811204],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9993587,0.00026019168,0.00002947783,0.00010030326,0.00007560551,0.00017570225],"domain_scores_gemma":[0.99937797,0.0001558628,0.00011374331,0.00006754136,0.000054861328,0.0002300072],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012869457,0.0011114706,0.0025036836,0.00029889593,0.00040722455,0.001578295,0.0007470688,0.001508899,0.0045748283],"category_scores_gemma":[0.0011381155,0.00036551806,0.002499589,0.00023822738,0.00093158224,0.00087290385,0.00037890836,0.0036364512,0.0015867673],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8833878,0.005926555,0.005157327,0.00071944774,0.002611732,0.00027057866,0.000101963946,0.0009956006,0.0079678325,0.00046352154,0.0039891577,0.08840847],"study_design_scores_gemma":[0.76105386,0.19607012,0.028835079,0.00018007863,0.0018616181,0.00046083375,0.00013604279,0.0019850093,0.0030417468,0.0007148691,0.0055602645,0.00010056606],"about_ca_topic_score_codex":0.0006791299,"about_ca_topic_score_gemma":0.0013208236,"teacher_disagreement_score":0.0045748283,"about_ca_system_score_codex":0.00093020976,"about_ca_system_score_gemma":0.0009374789,"threshold_uncertainty_score":0.015304327},"labels":[],"label_agreement":null},{"id":"W3196029592","doi":"10.1016/j.jaad.2021.06.366","title":"26147 Beyond skin deep: Electronic case-based learning modules to teach multidisciplinary care in dermatology among clerkship students","year":2021,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Medicine and Dermatology Studies History","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; SKiN Health; University of British Columbia","funders":"","keywords":"Medicine; Multidisciplinary approach; Dermatology; Curriculum; Medical education; Relevance (law); Psychology","score_opus":0.01027371186769676,"score_gpt":0.319929437417155,"score_spread":0.30965572554945825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3196029592","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.65017045,0.0019583057,0.09456117,0.013845702,0.0031114104,0.0039850594,0.0023526577,0.008823885,0.22119138],"genre_scores_gemma":[0.6766917,0.002739544,0.19865684,0.008104741,0.0010143,0.002904021,0.0025143533,0.00077778235,0.10659664],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994469,0.00022247364,0.00002833635,0.00006800773,0.00013900075,0.00009514866],"domain_scores_gemma":[0.9972391,0.0010582121,0.0001372436,0.00014368829,0.00023670659,0.0011850442],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001376313,0.0005608717,0.00028212552,0.00053547753,0.00041960928,0.0012401844,0.0010075613,0.0008475226,0.055636335],"category_scores_gemma":[0.004947866,0.0003097913,0.00046444434,0.000210562,0.00022954436,0.001272267,0.00271626,0.0012356573,0.009360885],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008104469,0.01446281,0.010315697,0.00037936695,0.00006369505,0.00040147817,0.0006518197,0.0022292042,0.006705561,0.0013764707,0.0925172,0.8700862],"study_design_scores_gemma":[0.0053877993,0.021310845,0.18435921,0.004118629,0.0006842718,0.0051173866,0.005475492,0.06564399,0.048158217,0.050978348,0.60829735,0.00046857444],"about_ca_topic_score_codex":0.0003480452,"about_ca_topic_score_gemma":0.0016942314,"teacher_disagreement_score":0.055636335,"about_ca_system_score_codex":0.00049461104,"about_ca_system_score_gemma":0.0012585069,"threshold_uncertainty_score":0.18612206},"labels":[],"label_agreement":null},{"id":"W3196094841","doi":"10.1016/j.jaad.2021.06.439","title":"26549 Risk of malignancy associated with medication use in elderly patients with psoriasis","year":2021,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences; Western University; University of Ottawa","funders":"","keywords":"Medicine; Malignancy; Internal medicine; Psoriasis; Etanercept; Relative risk; Retrospective cohort study; Psoriatic arthritis; Cancer; Dermatology; Rheumatoid arthritis; Confidence interval","score_opus":0.010843493977580242,"score_gpt":0.23392598948120422,"score_spread":0.22308249550362397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3196094841","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965952,0.0008399962,0.000091098074,0.000077430064,0.00002302986,0.0000065799927,0.0005654161,0.0000071842824,0.0017940644],"genre_scores_gemma":[0.99902785,0.00023026543,0.00005082166,0.000046804777,0.00005314212,0.0000038739236,0.00020539183,0.0000019689035,0.00037988598],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997842,0.000045706183,0.000030298344,0.000038542017,0.000047661808,0.000053619406],"domain_scores_gemma":[0.9989004,0.00023475935,0.0004794227,0.00006084182,0.000108226894,0.00021629212],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020231762,0.00021100596,0.00036818965,0.0010040518,0.00040452814,0.0005907698,0.00015971412,0.00044438758,0.004814386],"category_scores_gemma":[0.0014587792,0.00020167953,0.00051590876,0.0012101734,0.00014642222,0.0003407037,0.00024149768,0.0005521717,0.00055155845],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014259965,0.00002440458,0.99822897,0.000007456731,0.00004158904,0.00019241657,0.000019514151,0.000014554168,0.00017872805,0.000009158073,0.00008753871,0.0010530208],"study_design_scores_gemma":[0.0000060034336,0.00008168022,0.99878114,0.0000052051155,0.000047046928,0.0006611276,0.000089634705,0.00009236113,0.000032123724,0.000015498385,0.00018528127,0.0000029541693],"about_ca_topic_score_codex":0.0032394703,"about_ca_topic_score_gemma":0.0025075376,"teacher_disagreement_score":0.004814386,"about_ca_system_score_codex":0.00013988021,"about_ca_system_score_gemma":0.00021740841,"threshold_uncertainty_score":0.016105711},"labels":[],"label_agreement":null},{"id":"W3196193197","doi":"10.1016/j.jaad.2021.06.312","title":"25851 Efficacy of secukinumab in managing axial manifestations and nail psoriasis in patients with psoriatic arthritis: Results from the MAXIMISE trial","year":2021,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"","keywords":"Secukinumab; Medicine; Psoriatic arthritis; Psoriasis; Dermatology; Nail (fastener); Nail disease; Arthritis; Randomized controlled trial; Clinical trial; Surgery; Internal medicine","score_opus":0.011418717243678102,"score_gpt":0.24256455179875466,"score_spread":0.23114583455507656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3196193197","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96780115,0.020995764,0.00038802964,0.0013859784,0.00047405227,0.00046516952,0.00092971954,0.00011670847,0.007443433],"genre_scores_gemma":[0.9848658,0.006581453,0.00058337225,0.0013050654,0.0005238946,0.00040678802,0.001356982,0.000024792183,0.004351805],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9996934,0.00014815864,0.000020107254,0.00004014211,0.000038742855,0.000059402963],"domain_scores_gemma":[0.999607,0.0001537756,0.00007944094,0.000031624688,0.000028609815,0.00009952179],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011229583,0.0008944537,0.0021689578,0.00021373792,0.00024623427,0.00087891374,0.0003880896,0.0011121506,0.0042815963],"category_scores_gemma":[0.0010657746,0.00030178338,0.0016180804,0.00022238796,0.0004985998,0.00067924644,0.0003120203,0.0023177091,0.0007861741],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8476005,0.004030525,0.0048503373,0.002208017,0.0038031435,0.00021525416,0.00012631099,0.0014878567,0.009237762,0.00057639513,0.006201609,0.11966235],"study_design_scores_gemma":[0.8189457,0.13446532,0.03249688,0.0003388432,0.0030811199,0.00036672677,0.00009870863,0.0012711801,0.0013262958,0.00057674636,0.006967688,0.000064927044],"about_ca_topic_score_codex":0.00029362412,"about_ca_topic_score_gemma":0.00088688213,"teacher_disagreement_score":0.0042815963,"about_ca_system_score_codex":0.00029524352,"about_ca_system_score_gemma":0.00025707873,"threshold_uncertainty_score":0.014323413},"labels":[],"label_agreement":null},{"id":"W3196240023","doi":"10.1016/j.jaad.2021.06.377","title":"26200 Tumor burden in patients with locally advanced basal cell carcinoma and metastatic basal cell carcinoma following treatment with sonidegib: Results of the 42-month BOLT study","year":2021,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Medicine; Basal cell carcinoma; Vismodegib; Basal cell; Oncology; Radiation therapy; Internal medicine; Carcinoma; Surgery","score_opus":0.007883646856624483,"score_gpt":0.24003785777410067,"score_spread":0.23215421091747618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3196240023","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99930096,0.00013825827,0.00002114742,0.00002402433,0.000003187474,0.000006743984,0.00023970928,0.000002160751,0.0002637994],"genre_scores_gemma":[0.9986224,0.00012799825,0.000038877915,0.00003350987,0.000019480241,0.000009911225,0.0007975199,0.000002708111,0.00034750957],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998479,0.00003954683,0.000010691723,0.000036100875,0.000036664806,0.000029016532],"domain_scores_gemma":[0.99965847,0.00005132782,0.000106637075,0.000025516201,0.000030898907,0.00012718681],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038747332,0.00026025416,0.0005577421,0.00042044275,0.0003457255,0.0005578833,0.00021931238,0.00038434006,0.0008423955],"category_scores_gemma":[0.00057994574,0.00023140605,0.00046575995,0.00054629025,0.00020915274,0.0005835871,0.00030325228,0.00044710314,0.0003281804],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017894268,0.00096205436,0.9653369,0.000024662952,0.00024654448,0.000548374,0.00011661854,0.00022800639,0.0047906023,0.000028437471,0.00046217314,0.009361385],"study_design_scores_gemma":[0.0002465689,0.0012782076,0.9971373,0.0000023424177,0.00010165256,0.00038403503,0.000064524946,0.00021096291,0.00022408321,0.000020824984,0.0003224565,0.000006905712],"about_ca_topic_score_codex":0.0030123864,"about_ca_topic_score_gemma":0.003361372,"teacher_disagreement_score":0.0030123864,"about_ca_system_score_codex":0.00047869387,"about_ca_system_score_gemma":0.00027352446,"threshold_uncertainty_score":0.0059897304},"labels":[],"label_agreement":null},{"id":"W3196275328","doi":"10.1016/j.jaad.2021.05.075","title":"Abrocitinib induction, randomized withdrawal, and retreatment in patients with moderate-to-severe atopic dermatitis: Results from the JAK1 Atopic Dermatitis Efficacy and Safety (JADE) REGIMEN phase 3 trial","year":2021,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":152,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Mitsubishi Tanabe Pharma Corporation; Castle Biosciences; Ortho Dermatologics; Amgen; Pfizer; Allergan; Meiji Seika Pharma; Inozyme Pharma; Eli Lilly and Company; Bristol-Myers Squibb; Incyte","keywords":"Medicine; Atopic dermatitis; Eczema Area and Severity Index; Regimen; Placebo; Adverse effect; Randomized controlled trial; Internal medicine; Maintenance therapy; Tolerability; Dermatology Life Quality Index; Dermatology; Chemotherapy; Psoriasis","score_opus":0.010477653574416296,"score_gpt":0.2823512698242048,"score_spread":0.27187361624978845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3196275328","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97874475,0.0135211935,0.00050737924,0.00085037644,0.00028127676,0.0016167524,0.0012228622,0.00008461778,0.0031706893],"genre_scores_gemma":[0.98833233,0.004224243,0.0009298504,0.0013585661,0.00030024038,0.0015986852,0.0015690868,0.00001871318,0.0016683388],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9991972,0.00047189632,0.000062387226,0.000089920824,0.00008462802,0.00009398607],"domain_scores_gemma":[0.99910104,0.00025289896,0.00023720306,0.00008186393,0.00005789266,0.00026908738],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024500252,0.00076182117,0.0016584125,0.00021565313,0.00030282006,0.0008693214,0.000539825,0.0007827511,0.0035927661],"category_scores_gemma":[0.0016657321,0.00029296504,0.0017803506,0.00030029725,0.00047480903,0.0006455606,0.00026896145,0.0019523955,0.0004937177],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.92435217,0.0056684827,0.0037385563,0.00081125245,0.0017325461,0.000081214304,0.0000828263,0.00037441184,0.004142085,0.00015789905,0.0028642437,0.055994254],"study_design_scores_gemma":[0.92995596,0.05443595,0.011716848,0.00008132472,0.0008864578,0.0001502238,0.000028589837,0.00053007226,0.00041497327,0.00022271746,0.0015594367,0.000017518634],"about_ca_topic_score_codex":0.00049936055,"about_ca_topic_score_gemma":0.0019322122,"teacher_disagreement_score":0.0035927661,"about_ca_system_score_codex":0.0005474746,"about_ca_system_score_gemma":0.00077306473,"threshold_uncertainty_score":0.012957096},"labels":[],"label_agreement":null},{"id":"W3196287952","doi":"10.1016/j.jaad.2021.06.532","title":"27078 Mediation analysis of independent treatment effect of guselkumab on health-related quality of life in patients with moderate to severe plaque-type psoriasis: Results from 2 phase 3 studies VOYAGE-1&2","year":2021,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Medicine; Dermatology Life Quality Index; Psoriasis; Psoriasis Area and Severity Index; Plaque psoriasis; Quality of life (healthcare); Dermatology; Adalimumab; Randomized controlled trial; Clinical trial; Internal medicine; Disease; Nursing","score_opus":0.03653642598415063,"score_gpt":0.33865943086376954,"score_spread":0.3021230048796189,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3196287952","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936707,0.0022699437,0.0006542639,0.00050132634,0.00012924778,0.000266688,0.0010754848,0.000026980295,0.0014053223],"genre_scores_gemma":[0.9970816,0.00045981363,0.00059888413,0.00014834736,0.00008080365,0.0002213219,0.0004190266,0.0000160572,0.00097409415],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99429095,0.0044506444,0.00013636562,0.0003741294,0.00032630964,0.00042161974],"domain_scores_gemma":[0.9915764,0.006352454,0.0008232628,0.0005697296,0.0003443781,0.0003338712],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005990892,0.001089015,0.0015526318,0.00037358436,0.00046946673,0.00095770997,0.001313478,0.00078571535,0.010009028],"category_scores_gemma":[0.009014744,0.00056367775,0.0052220304,0.00039738428,0.00066847104,0.0007793683,0.0008451918,0.0020596029,0.00073585537],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6846661,0.010871328,0.16728108,0.0015367501,0.030775487,0.0003947081,0.000882659,0.0020305852,0.007902109,0.0011725213,0.0029041583,0.08958245],"study_design_scores_gemma":[0.19027855,0.089095734,0.6292174,0.00025599648,0.06572381,0.000432734,0.0007602748,0.008309194,0.008188615,0.0018120005,0.005789343,0.00013643311],"about_ca_topic_score_codex":0.003488576,"about_ca_topic_score_gemma":0.0037329968,"teacher_disagreement_score":0.010009028,"about_ca_system_score_codex":0.0007022527,"about_ca_system_score_gemma":0.0017846598,"threshold_uncertainty_score":0.033483505},"labels":[],"label_agreement":null},{"id":"W3201603123","doi":"10.1016/j.jaad.2021.09.016","title":"Biologic therapy is not associated with increased COVID-19 severity in patients with hidradenitis suppurativa: Initial findings from the Global Hidradenitis Suppurativa COVID-19 Registry","year":2021,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"National Institutes of Health; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico; University of California, San Francisco; University of Toronto; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Cardiff University; University of New South Wales; Sunnybrook Research Institute","keywords":"Hidradenitis suppurativa; Medicine; Coronavirus disease 2019 (COVID-19); Logistic regression; Dermatology; Comorbidity; Internal medicine; Disease","score_opus":0.029333621109456823,"score_gpt":0.3273567077531507,"score_spread":0.29802308664369387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3201603123","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.67046267,0.120352484,0.001674375,0.14682892,0.018948007,0.00025726124,0.031198151,0.00024955918,0.010028541],"genre_scores_gemma":[0.9217241,0.026052892,0.0012109127,0.019218994,0.022788411,0.00012518707,0.0077963867,0.00010341263,0.0009797978],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99768114,0.00066151645,0.0006371775,0.00033630125,0.0004907635,0.00019315352],"domain_scores_gemma":[0.9576942,0.023495706,0.01003425,0.0012375794,0.0061514354,0.0013868907],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033594908,0.000251743,0.00097199646,0.0021269945,0.00034745428,0.0012081366,0.00074832496,0.0012740211,0.0028185651],"category_scores_gemma":[0.04051923,0.00029176506,0.0007637831,0.0032035643,0.00043203885,0.0011618038,0.00055205595,0.0017143217,0.00060297473],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017940801,0.00012481699,0.832146,0.0033652526,0.0011836197,0.002491628,0.00037013032,0.00018540284,0.00025249724,0.0003342806,0.1210326,0.036719766],"study_design_scores_gemma":[0.0003667203,0.0005155001,0.9157332,0.006131543,0.0029863326,0.0117215235,0.0013296204,0.0021730415,0.00058396603,0.0012896226,0.056978066,0.00019086024],"about_ca_topic_score_codex":0.0022234186,"about_ca_topic_score_gemma":0.002591417,"teacher_disagreement_score":0.0033594908,"about_ca_system_score_codex":0.000389074,"about_ca_system_score_gemma":0.0007180387,"threshold_uncertainty_score":0.017766953},"labels":[],"label_agreement":null},{"id":"W3202378136","doi":"10.1016/j.jaad.2021.09.050","title":"Adverse events associated with dupilumab in the World Health Organization pharmacovigilance database","year":2021,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"","keywords":"Dupilumab; Pharmacovigilance; Medicine; Atopic dermatitis; Adverse effect; Dermatology; Internal medicine","score_opus":0.02065191318415805,"score_gpt":0.32768113314573816,"score_spread":0.3070292199615801,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3202378136","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.20540795,0.008458767,0.0018104953,0.68898624,0.006633942,0.00018149908,0.02200897,0.00046167182,0.06605048],"genre_scores_gemma":[0.6666491,0.0039449143,0.002079822,0.2896749,0.015196377,0.00013728776,0.009702952,0.000105550476,0.012509066],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9964155,0.0010557452,0.001006603,0.00031495723,0.000895444,0.00031166812],"domain_scores_gemma":[0.9860117,0.007307046,0.0034602722,0.00045798204,0.00167773,0.0010853157],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002213322,0.0002776654,0.0006382418,0.0012035548,0.0009805803,0.0018576947,0.000604082,0.005127199,0.0034507085],"category_scores_gemma":[0.015209841,0.00023934797,0.0008196122,0.001947756,0.00026985505,0.00087382086,0.00050205644,0.002717923,0.00097487704],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016432604,0.00038434734,0.31991464,0.00030202544,0.0004837915,0.038590588,0.0004137295,0.0010998476,0.0013049379,0.0032046135,0.5828802,0.049777955],"study_design_scores_gemma":[0.0017888137,0.0006990069,0.44877014,0.001703789,0.0016661709,0.08126935,0.0011908301,0.01721825,0.0040818877,0.009598719,0.4316771,0.00033586923],"about_ca_topic_score_codex":0.01001497,"about_ca_topic_score_gemma":0.01609449,"teacher_disagreement_score":0.01001497,"about_ca_system_score_codex":0.0021393164,"about_ca_system_score_gemma":0.0019523983,"threshold_uncertainty_score":0.019913375},"labels":[],"label_agreement":null},{"id":"W3203103293","doi":"10.1016/j.jaad.2021.09.039","title":"Allergens in patients with a diagnosis of seborrheic dermatitis, North American Contact Dermatitis Group data, 2001-2016","year":2021,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Contact Dermatitis and Allergies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec; Sunnybrook Health Science Centre; McGill University; Health Sciences Centre; University of Ottawa; Montreal General Hospital; University of Toronto","funders":"Merck; AstraZeneca; Johnson and Johnson; Pfizer","keywords":"Medicine; Seborrheic dermatitis; Dermatology; Contact dermatitis; Allergic contact dermatitis; Allergy; Immunology","score_opus":0.016237571035914528,"score_gpt":0.26343974731573944,"score_spread":0.2472021762798249,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3203103293","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6367605,0.020221686,0.0007264314,0.18001367,0.006115722,0.00021654104,0.017286887,0.00022950464,0.1384291],"genre_scores_gemma":[0.9437904,0.004635481,0.0004063248,0.031047823,0.0042565013,0.00007426292,0.004542343,0.00002799022,0.011218796],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99932885,0.000116928546,0.00014493754,0.00007344964,0.00019621289,0.00013964305],"domain_scores_gemma":[0.9986255,0.00047354697,0.00034398123,0.000058156933,0.0002866166,0.0002121842],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050130277,0.00027182605,0.00042328896,0.00071628223,0.0008287205,0.00072287465,0.00039782532,0.0031343796,0.0028676987],"category_scores_gemma":[0.0031625528,0.0001980176,0.0004415353,0.0014958661,0.00027875954,0.0006266401,0.00023329463,0.0010511006,0.0009779525],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010233637,0.00023500892,0.7646816,0.00027055567,0.00005589649,0.030960513,0.0003322477,0.00023487584,0.0009247622,0.0003119204,0.18082282,0.0201465],"study_design_scores_gemma":[0.00036745428,0.00030333415,0.8974644,0.0004913704,0.00010313715,0.037700586,0.0011378014,0.00084777037,0.00043008293,0.00087214226,0.060248803,0.00003310692],"about_ca_topic_score_codex":0.016179243,"about_ca_topic_score_gemma":0.027493121,"teacher_disagreement_score":0.016179243,"about_ca_system_score_codex":0.00075982587,"about_ca_system_score_gemma":0.0010400568,"threshold_uncertainty_score":0.032170117},"labels":[],"label_agreement":null},{"id":"W3204912623","doi":"10.1016/j.jaad.2021.09.065","title":"A retrospective analysis of diagnostic testing in a large North American cohort of patients with epidermolysis bullosa","year":2021,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Skin and Cellular Biology Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine; Hospital for Sick Children","funders":"Colorado Clinical and Translational Sciences Institute; Epidermolysis Bullosa Medical Research Foundation","keywords":"Medicine; Concordance; Epidermolysis bullosa; Retrospective cohort study; Genetic testing; Epidermolysis bullosa simplex; Dermatology; Cohort; Pathology; Genetic counseling; Internal medicine; Genetics","score_opus":0.00763527461984294,"score_gpt":0.2709606567190209,"score_spread":0.263325382099178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3204912623","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993056,0.00011912037,0.00007419751,0.000021277618,0.000004862816,0.000005775574,0.00017233515,0.000003133735,0.0002936038],"genre_scores_gemma":[0.9995079,0.000056353343,0.000053592015,0.000029674806,0.0000075447197,0.000006195549,0.00025349515,0.0000027664328,0.00008262631],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99873453,0.0002994976,0.00012484619,0.000450774,0.00019863946,0.00019167937],"domain_scores_gemma":[0.9970784,0.00069299777,0.0010270629,0.00038605966,0.00036137257,0.00045412182],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069179724,0.00044042003,0.00048283063,0.00144336,0.0012021947,0.001200981,0.00061101816,0.00061785715,0.0016329499],"category_scores_gemma":[0.002723401,0.0006439062,0.00044007317,0.001609387,0.00073462503,0.0007431779,0.0007434382,0.00064034597,0.00032877448],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044584154,0.000024591765,0.9990689,0.0000023216087,0.000024751547,0.0002594285,0.0000680714,0.00000931202,0.00019475397,0.000010064355,0.0000460548,0.00024715922],"study_design_scores_gemma":[0.0000065060817,0.000051809384,0.99766695,0.0000040125224,0.00003186412,0.0014227608,0.000468234,0.00012992014,0.000056560948,0.000014723812,0.00014227438,0.000004493721],"about_ca_topic_score_codex":0.0085912915,"about_ca_topic_score_gemma":0.0076196305,"teacher_disagreement_score":0.0085912915,"about_ca_system_score_codex":0.00048604133,"about_ca_system_score_gemma":0.0006480338,"threshold_uncertainty_score":0.017082572},"labels":[],"label_agreement":null},{"id":"W3205723104","doi":"10.1016/j.jaad.2021.10.028","title":"Management of pediatric generalized pustular psoriasis using biologics: An evidence-based review","year":2021,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health; Probity Medical Research; Alberta Children's Hospital; Dermatrials Research; University of Calgary; McMaster University; University of Toronto","funders":"","keywords":"Medicine; Generalized pustular psoriasis; Dermatology; Pustular psoriasis; Psoriasis; Intensive care medicine","score_opus":0.11480744055827849,"score_gpt":0.3780322666719299,"score_spread":0.2632248261136514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3205723104","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006649997,0.9996902,0.00003377857,0.000050206243,0.00004974157,0.0000061593014,0.000015423157,0.0000018989805,0.00008617858],"genre_scores_gemma":[0.0006153189,0.9990662,0.00011347491,0.00009697502,0.00004081607,0.000005491206,0.000019862367,4.694981e-7,0.000041453335],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99954456,0.00008999782,0.0001337204,0.00006939784,0.00013427116,0.000028018041],"domain_scores_gemma":[0.99898773,0.00061864994,0.00022102462,0.000012594547,0.00012841991,0.0000315859],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010812634,0.001016595,0.0034694492,0.0023320087,0.00023171093,0.0012370781,0.0015933682,0.0012291888,0.0029236167],"category_scores_gemma":[0.0021200387,0.00038203213,0.0022028615,0.0019530971,0.00030399274,0.001046025,0.0005767225,0.0013142275,0.00047809488],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037863269,0.000093855015,0.0003875282,0.23815678,0.0017316812,0.0002968073,0.000062862484,0.00048720188,0.00075777475,0.0009144758,0.016772494,0.7399599],"study_design_scores_gemma":[0.0008878243,0.00083204283,0.0060971156,0.2842838,0.02456093,0.005571979,0.00036989836,0.00063658494,0.0009970478,0.002452582,0.6731785,0.00013177878],"about_ca_topic_score_codex":0.00184809,"about_ca_topic_score_gemma":0.0039352207,"teacher_disagreement_score":0.0034694492,"about_ca_system_score_codex":0.0006135043,"about_ca_system_score_gemma":0.0014886481,"threshold_uncertainty_score":0.009780467},"labels":[],"label_agreement":null},{"id":"W3207934489","doi":"10.1016/j.jaad.2021.10.013","title":"Disparities in pediatric clinical trials for acne vulgaris: A cross-sectional study","year":2021,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of Toronto; Hospital for Sick Children; University of British Columbia","funders":"","keywords":"Medicine; Cross-sectional study; Acne; Dermatology; Environmental health; Pathology","score_opus":0.14631739393855955,"score_gpt":0.5014587405506927,"score_spread":0.35514134661213315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3207934489","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99373865,0.0037489263,0.00027564124,0.00044940267,0.0000301019,0.000085485415,0.0008524944,0.0000037232492,0.00081562775],"genre_scores_gemma":[0.9984499,0.0005165822,0.00019850768,0.00032829546,0.000029307595,0.00007803227,0.00032317702,0.0000043510663,0.00007178633],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98490083,0.009176564,0.0019469482,0.0016914152,0.0012571934,0.0010269607],"domain_scores_gemma":[0.9644149,0.011315983,0.01928686,0.0017474965,0.001589406,0.0016452698],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.008125846,0.0002763051,0.0010111906,0.0005957522,0.0007109932,0.0012208127,0.0005467873,0.00102414,0.0018914082],"category_scores_gemma":[0.032004233,0.00044387847,0.0009151197,0.0023703047,0.00068712654,0.0012398165,0.0007700004,0.0012889795,0.00014423979],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007031828,0.00018865577,0.9955647,0.00009780717,0.0006512285,0.000049473463,0.00019545817,0.000033073746,0.00007204075,0.00021785479,0.00036771395,0.0018589185],"study_design_scores_gemma":[0.00032288826,0.0009129282,0.995786,0.00015890805,0.0007311667,0.00024024028,0.00050106156,0.00017332645,0.00008641856,0.00015649156,0.000920453,0.000010107771],"about_ca_topic_score_codex":0.0048180223,"about_ca_topic_score_gemma":0.0062604053,"teacher_disagreement_score":0.99187416,"about_ca_system_score_codex":0.0009169963,"about_ca_system_score_gemma":0.0016875315,"threshold_uncertainty_score":0.042974055},"labels":[],"label_agreement":null},{"id":"W3207973275","doi":"10.1016/j.jaad.2021.09.067","title":"Cumulative incidence and disease-specific survival of metastatic cutaneous squamous cell carcinoma: A nationwide cancer registry study","year":2021,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Erasmus Medisch Centrum; Nuclear Waste Management Organization; Sanofi Genzyme; Ministerio de Economía y Competitividad; Sanofi","keywords":"Medicine; Cancer registry; Cumulative incidence; Internal medicine; Proportional hazards model; Interquartile range; Hazard ratio; Oncology; Population; Incidence (geometry); Skin cancer; Cancer; Survival analysis; Transplantation; Confidence interval","score_opus":0.0343340666535896,"score_gpt":0.33304232778653414,"score_spread":0.2987082611329445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3207973275","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956209,0.0001799219,0.0002739703,0.00004096335,0.000003270934,0.000016037899,0.0034787003,0.0000070265805,0.00037922573],"genre_scores_gemma":[0.99444973,0.00020378099,0.00019975072,0.000014266196,0.0000058342066,0.000031508727,0.004989981,0.0000033357935,0.00010184343],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991073,0.00026329167,0.00011264384,0.00024595583,0.00017203364,0.00009872422],"domain_scores_gemma":[0.9976519,0.00040557949,0.0011169264,0.00026580662,0.000366104,0.00019365027],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001395331,0.0001605994,0.00040848154,0.0008852329,0.0002029916,0.0003813459,0.0003849159,0.00023839278,0.0008788933],"category_scores_gemma":[0.0033006694,0.00021423268,0.00050897815,0.0019437058,0.00013331242,0.0005215003,0.00041781474,0.00027444473,0.0001944494],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005714264,0.000014968359,0.9980883,0.0000128246475,0.00007236386,0.00008093995,0.000041519375,0.00014959133,0.00008089796,0.000022049491,0.0002589372,0.0011204627],"study_design_scores_gemma":[0.000013458335,0.00005114386,0.99835336,0.000008273714,0.00006576253,0.0003567827,0.00010084466,0.0005756141,0.000045870074,0.000020351288,0.00040326998,0.0000053414274],"about_ca_topic_score_codex":0.020253055,"about_ca_topic_score_gemma":0.020964578,"teacher_disagreement_score":0.020253055,"about_ca_system_score_codex":0.0006734963,"about_ca_system_score_gemma":0.00083765533,"threshold_uncertainty_score":0.04027033},"labels":[],"label_agreement":null},{"id":"W3209534611","doi":"10.1016/j.jaad.2021.10.038","title":"Prevalence of type 2 inflammatory diseases in pediatric patients with atopic dermatitis: Real-world evidence","year":2021,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Statistics Canada","funders":"Regeneron Pharmaceuticals; Sanofi","keywords":"Medicine; Eosinophilic esophagitis; Atopic dermatitis; Incidence (geometry); Asthma; Internal medicine; Sinusitis; Dermatology; Pediatrics; Disease; Immunology","score_opus":0.012592983056919436,"score_gpt":0.29351221860466326,"score_spread":0.28091923554774384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3209534611","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93550825,0.05843117,0.0002470626,0.00087850133,0.000078621044,0.00002320125,0.0023478703,0.0000067470046,0.0024785777],"genre_scores_gemma":[0.9888626,0.009927445,0.00023370449,0.00020878947,0.0000619074,0.000014428046,0.0006388653,0.0000020820469,0.000050179675],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99779475,0.0007143444,0.0004290749,0.0004153887,0.00045267484,0.00019383764],"domain_scores_gemma":[0.9882527,0.00496597,0.005398329,0.0003703306,0.0006652303,0.00034735602],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018734176,0.0003527142,0.00062174175,0.0012394978,0.00026988977,0.0013253652,0.0005764238,0.0009761848,0.0022723598],"category_scores_gemma":[0.010810052,0.0004107395,0.0010722,0.0022671,0.00063462846,0.001204716,0.00048791684,0.0009431123,0.00016292132],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000082880804,0.000030487501,0.9959889,0.00025108547,0.00034953607,0.00008947384,0.000051373256,0.000026269137,0.000030094574,0.00005736536,0.000177488,0.0028650833],"study_design_scores_gemma":[0.000019821582,0.00009833534,0.99663925,0.00039648951,0.0004667542,0.0009455316,0.00040629553,0.00008664616,0.000047178393,0.00006901904,0.0008172642,0.000007272923],"about_ca_topic_score_codex":0.0035291072,"about_ca_topic_score_gemma":0.0049140113,"teacher_disagreement_score":0.0035291072,"about_ca_system_score_codex":0.00046143975,"about_ca_system_score_gemma":0.0005690327,"threshold_uncertainty_score":0.0099077225},"labels":[],"label_agreement":null},{"id":"W3213232762","doi":"10.1016/j.jaad.2021.11.004","title":"Consistent safety profile with up to 5 years of continuous treatment with guselkumab: Pooled analyses from the phase 3 VOYAGE 1 and VOYAGE 2 trials of patients with moderate-to-severe psoriasis","year":2021,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":59,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Dalhousie University","funders":"Janssen Research and Development","keywords":"Medicine; Adverse effect; Psoriasis; Placebo; Dermatology; Randomized controlled trial; Crossover study; Internal medicine","score_opus":0.03140226911436131,"score_gpt":0.3067322821856013,"score_spread":0.27533001307123994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213232762","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.76171595,0.21520537,0.0057748132,0.0019859008,0.001123534,0.00076753815,0.007372136,0.00029013364,0.0057646227],"genre_scores_gemma":[0.98595667,0.0077869794,0.0007735729,0.0012356415,0.0004601296,0.00023861798,0.0026277846,0.000058953985,0.0008616589],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9926273,0.0046644565,0.0006431288,0.0009955717,0.00058048376,0.0004889597],"domain_scores_gemma":[0.9875496,0.0066871685,0.0026914242,0.0016902603,0.0007824324,0.000599093],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013565294,0.0013930711,0.0057133,0.00052280404,0.00042578697,0.0024271877,0.0009564374,0.0017887105,0.0038804966],"category_scores_gemma":[0.011863788,0.0007351832,0.013738193,0.00092074374,0.000789965,0.002038141,0.0008161628,0.0042463774,0.0005821219],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.72449875,0.0006646915,0.025036797,0.006700907,0.15964083,0.0001841273,0.00018748028,0.002494711,0.0061264858,0.0003869568,0.004391292,0.06968695],"study_design_scores_gemma":[0.28067997,0.08832706,0.24880174,0.0015604702,0.35416484,0.0009160064,0.0003943399,0.0029486052,0.0034392707,0.0027326553,0.0157229,0.00031214673],"about_ca_topic_score_codex":0.00072249724,"about_ca_topic_score_gemma":0.0015663474,"teacher_disagreement_score":0.013565294,"about_ca_system_score_codex":0.0007811733,"about_ca_system_score_gemma":0.000831241,"threshold_uncertainty_score":0.071740925},"labels":[],"label_agreement":null},{"id":"W3217495936","doi":"10.1016/j.jaad.2021.11.048","title":"Incidence of skin cancers in patients with eczema treated with ultraviolet phototherapy","year":2021,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health; BC Children's Hospital; University of British Columbia; Vancouver Coastal Health Research Institute","funders":"British Association of Dermatologists; Michael Smith Health Research BC; Eczema Society of Canada; Vancouver Coastal Health Research Institute; Canadian Dermatology Foundation","keywords":"Medicine; Dermatology; Incidence (geometry); Ultraviolet a; Skin cancer; Cancer; Internal medicine","score_opus":0.00597077826523512,"score_gpt":0.2699334393648636,"score_spread":0.26396266109962846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217495936","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972293,0.0005517639,0.000048202342,0.000046074238,0.000012309009,0.000005620099,0.00045742528,0.000008091638,0.0016412359],"genre_scores_gemma":[0.9992824,0.00017571515,0.000020153922,0.000021500684,0.000017362869,0.0000028640443,0.00019677961,0.000001774666,0.0002815353],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99973387,0.000049899212,0.000032201104,0.000054186163,0.000058300822,0.00007155971],"domain_scores_gemma":[0.9991844,0.00019035015,0.00037140131,0.00004502877,0.00007476325,0.00013393788],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019166053,0.00017166499,0.00032876286,0.0011179578,0.00032385488,0.00056972593,0.00021273902,0.00045510675,0.0036898262],"category_scores_gemma":[0.0011588632,0.0002071352,0.00063332875,0.0010333699,0.00016178629,0.00036448755,0.0002261416,0.000513969,0.0003277633],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019898401,0.000042299165,0.99808913,0.000007731216,0.00004245188,0.0001296195,0.000027410144,0.00002980742,0.00029505297,0.000011367968,0.0000805662,0.0010456641],"study_design_scores_gemma":[0.0000053395775,0.000060990445,0.9990513,0.000002415112,0.000023391658,0.0005333488,0.000088193025,0.00005864197,0.00005318352,0.000008533378,0.000112348935,0.0000023490522],"about_ca_topic_score_codex":0.0035038514,"about_ca_topic_score_gemma":0.0033786204,"teacher_disagreement_score":0.0036898262,"about_ca_system_score_codex":0.00024036357,"about_ca_system_score_gemma":0.00017951326,"threshold_uncertainty_score":0.012343705},"labels":[],"label_agreement":null},{"id":"W38387852","doi":"10.1016/j.jaad.2024.01.078","title":"Kvinnans roller i Elsa Graves diktsamling Mödrar som vargar","year":2007,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Social and Educational Sciences","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Alberta Innovates; Canadian Dermatology Foundation","keywords":"Character (mathematics); Art; Art history; Visual arts; Mathematics","score_opus":0.02906600425429083,"score_gpt":0.3793955170145691,"score_spread":0.35032951276027824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W38387852","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.895497,0.047648292,0.0034858065,0.010668627,0.0006563699,0.00015983076,0.0023706094,0.00044754823,0.039065793],"genre_scores_gemma":[0.96527326,0.008676844,0.001663194,0.001004819,0.00073759735,0.00004414292,0.0011415789,0.000060326198,0.021398224],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992999,0.00015864437,0.000068546724,0.00011653675,0.00020053417,0.00015597271],"domain_scores_gemma":[0.99897975,0.00032353884,0.00029567129,0.000060098097,0.00014900247,0.00019196226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010732546,0.000363016,0.0005010931,0.00064866093,0.00057707465,0.0012669264,0.00032378233,0.00047401016,0.018868849],"category_scores_gemma":[0.0029276572,0.00014980968,0.00068883155,0.00031610523,0.0004026347,0.0006948589,0.0007450517,0.0015846874,0.003129241],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028662463,0.0014343872,0.29113048,0.0013884221,0.0007429831,0.004845653,0.0012645982,0.00091496616,0.009107283,0.0021900025,0.018312007,0.66580296],"study_design_scores_gemma":[0.00045728832,0.0034018985,0.8280901,0.002019229,0.0017096354,0.028705224,0.0028409453,0.001733888,0.007908663,0.0057000318,0.11728709,0.00014606908],"about_ca_topic_score_codex":0.002382932,"about_ca_topic_score_gemma":0.003913342,"teacher_disagreement_score":0.018868849,"about_ca_system_score_codex":0.00060570065,"about_ca_system_score_gemma":0.0006228562,"threshold_uncertainty_score":0.06312251},"labels":[],"label_agreement":null},{"id":"W4200053170","doi":"10.1016/j.jaad.2021.12.022","title":"Reporting of primary outcome measures and sample size calculations in randomized controlled trials in dermatology journals","year":2021,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Delphi Technique in Research","field":"Social Sciences","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; McMaster University; University of Toronto","funders":"","keywords":"Medicine; Dermatology; Randomized controlled trial; Sample size determination; Outcome (game theory); Medical physics; Statistics; Surgery","score_opus":0.2252172517830521,"score_gpt":0.5109549589214111,"score_spread":0.285737707138359,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200053170","genre_codex":"protocol","genre_gemma":"empirical","domain_codex":"methods","domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.029389035,0.019769084,0.44627067,0.008072366,0.008807763,0.46824232,0.0056177764,0.0012329454,0.012597937],"genre_scores_gemma":[0.07222126,0.0015201091,0.3044325,0.0023764507,0.00080181425,0.61679584,0.0007324819,0.0001655256,0.0009539627],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.063774854,0.70497626,0.19547114,0.00870839,0.025751567,0.0013178346],"domain_scores_gemma":[0.04458445,0.8693373,0.028587112,0.037411645,0.019219765,0.00085968856],"candidate_categories":["metaresearch","metaepi_broad"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.7475498,0.0043828753,0.015135795,0.016354742,0.003664636,0.009468896,0.0058881454,0.011216271,0.013038923],"category_scores_gemma":[0.9156067,0.0055847587,0.019199075,0.011205867,0.008575706,0.009615639,0.0059091947,0.0124710575,0.0019658203],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07377588,0.0029562474,0.027498594,0.28535596,0.06398237,0.0011222138,0.017491259,0.009279178,0.005398578,0.08127074,0.040199924,0.39166912],"study_design_scores_gemma":[0.14816543,0.029908614,0.06917586,0.12655443,0.05665955,0.0036709122,0.0046616057,0.09187904,0.039550714,0.2903031,0.13777931,0.001691486],"about_ca_topic_score_codex":0.0009158528,"about_ca_topic_score_gemma":0.0011064486,"teacher_disagreement_score":0.98486423,"about_ca_system_score_codex":0.005726366,"about_ca_system_score_gemma":0.009987869,"threshold_uncertainty_score":0.31131613},"labels":[],"label_agreement":null},{"id":"W4200143540","doi":"10.1016/j.jaad.2021.12.028","title":"Clinical manifestations and treatment outcomes of pyoderma gangrenosum following rituximab exposure: A systematic review","year":2021,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Autoimmune and Inflammatory Disorders","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre; Hospital for Sick Children; Women's College Hospital; University of Toronto","funders":"","keywords":"Medicine; Pyoderma gangrenosum; Rituximab; Pharmacovigilance; Adverse effect; Dermatology; MEDLINE; Internal medicine; Lymphoma","score_opus":0.05377195063860344,"score_gpt":0.41996043167569513,"score_spread":0.3661884810370917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200143540","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002491124,0.9970391,0.00004144762,0.00005495129,0.000034849876,0.000046389257,0.00019689702,0.0000025628049,0.000092782284],"genre_scores_gemma":[0.049730513,0.9490202,0.0002622936,0.00044713824,0.00007385549,0.0001060325,0.00026836904,0.000003707033,0.00008787939],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.997682,0.00058498216,0.00094300334,0.00034213727,0.0003351213,0.00011275025],"domain_scores_gemma":[0.99269485,0.004764746,0.0019208236,0.00010000398,0.00041290783,0.000106619074],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023329197,0.00094698806,0.006886425,0.0028019634,0.00034216602,0.001705565,0.001288334,0.001438834,0.003448322],"category_scores_gemma":[0.01127701,0.00075667904,0.008118528,0.0042043976,0.0005680851,0.0013391842,0.0011027677,0.0011497544,0.00020817944],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014164156,0.000052981086,0.008364861,0.8694548,0.07128642,0.00018565707,0.00019001614,0.0001505866,0.00023029829,0.00012845198,0.0018735256,0.046665967],"study_design_scores_gemma":[0.0016639808,0.0005669476,0.04322578,0.37204093,0.5667458,0.0011703274,0.0004970904,0.00016594476,0.00023423287,0.00034734572,0.013223569,0.00011797888],"about_ca_topic_score_codex":0.0060066925,"about_ca_topic_score_gemma":0.018995058,"teacher_disagreement_score":0.006886425,"about_ca_system_score_codex":0.0012837822,"about_ca_system_score_gemma":0.0025414955,"threshold_uncertainty_score":0.012337863},"labels":[],"label_agreement":null},{"id":"W4200252938","doi":"10.1016/j.jaad.2021.11.055","title":"Medical adhesive allergens: Retrospective analysis of cross-sectional data from the North American Contact Dermatitis Group, 2001-2018","year":2021,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Contact Dermatitis and Allergies","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Montreal General Hospital; Université Laval; Ottawa Hospital; Centre hospitalier universitaire de Québec; Health Sciences Centre; University of Toronto; McGill University Health Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Patch test; Contact dermatitis; Dermatology; Allergy; Population; Odds ratio; Allergen; Allergic contact dermatitis; Retrospective cohort study; Surgery; Internal medicine; Immunology","score_opus":0.03477044434537499,"score_gpt":0.3414574857008702,"score_spread":0.3066870413554952,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200252938","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99661297,0.00043123402,0.00008276515,0.000020669024,0.000008143962,0.000017195856,0.0023161191,0.0000056376994,0.0005051662],"genre_scores_gemma":[0.995849,0.00026352773,0.00008844854,0.00004357305,0.000011425419,0.000029615336,0.0034295274,0.0000049687937,0.00027991345],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988299,0.00020832234,0.00018070986,0.00036352684,0.00024011759,0.00017728882],"domain_scores_gemma":[0.99810374,0.00025838072,0.00089082425,0.00020804764,0.00032870125,0.00021028052],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081315427,0.0005088661,0.00053503446,0.0017090198,0.0007034202,0.0009290331,0.00052003004,0.00061631505,0.0015872795],"category_scores_gemma":[0.0018832542,0.00061243406,0.00057349174,0.0032891692,0.00031651082,0.001000006,0.0007753226,0.00047799942,0.00047935935],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057665715,0.00002451204,0.9990872,0.000010442434,0.000041909036,0.00006811193,0.000058219175,0.000011177527,0.00007305769,0.0000057978846,0.00014833607,0.00041359756],"study_design_scores_gemma":[0.000004252575,0.00003426224,0.99921346,0.000006337756,0.000026520109,0.0001988699,0.0002414491,0.000042084033,0.0000234289,0.0000041036365,0.00020333333,0.0000018872937],"about_ca_topic_score_codex":0.019820724,"about_ca_topic_score_gemma":0.02849359,"teacher_disagreement_score":0.019820724,"about_ca_system_score_codex":0.0006464257,"about_ca_system_score_gemma":0.00072900957,"threshold_uncertainty_score":0.03941071},"labels":[],"label_agreement":null},{"id":"W4200361564","doi":"10.1016/j.jaad.2021.12.029","title":"From the Cochrane library: Topical and device-based treatments for fungal infections of the toenails","year":2021,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada); University of Toronto","funders":"","keywords":"Medicine; Cochrane Library; Dermatology; Terbinafine; Adverse effect; Nail (fastener); Itraconazole; Surgery; Internal medicine; Antifungal; Randomized controlled trial","score_opus":0.021349907691556157,"score_gpt":0.3176126386385294,"score_spread":0.29626273094697325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200361564","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019645225,0.610509,0.00068125664,0.23714502,0.044385888,0.0024455232,0.018346969,0.000701688,0.083820075],"genre_scores_gemma":[0.018749557,0.5345999,0.001956243,0.33415,0.045824874,0.0045215003,0.007283386,0.00022840805,0.052686114],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967415,0.000876825,0.000911952,0.00024317986,0.0010358378,0.00019066232],"domain_scores_gemma":[0.98491514,0.008748812,0.0029128946,0.0001828804,0.0021255254,0.0011148629],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023219227,0.0016847966,0.0049200845,0.0077033197,0.0013381712,0.0035589628,0.0016980619,0.0107894465,0.06665623],"category_scores_gemma":[0.034837347,0.0007870837,0.0020266685,0.006799589,0.0007798225,0.002570055,0.0012975866,0.0051558847,0.015158821],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006118736,0.00004167069,0.00027270993,0.05155211,0.00040834732,0.0005274365,0.000055249573,0.00011180099,0.00015205164,0.00063206785,0.90591294,0.039721753],"study_design_scores_gemma":[0.0057456563,0.00048989727,0.0047122426,0.13489425,0.0050490894,0.001926076,0.00027419018,0.0005888716,0.00046807108,0.0046440284,0.84099,0.00021767564],"about_ca_topic_score_codex":0.012398173,"about_ca_topic_score_gemma":0.03615183,"teacher_disagreement_score":0.06665623,"about_ca_system_score_codex":0.006593081,"about_ca_system_score_gemma":0.007454064,"threshold_uncertainty_score":0.2229873},"labels":[],"label_agreement":null},{"id":"W4205611115","doi":"10.1016/j.jaad.2021.12.055","title":"Geographical distribution of systemic sclerosis in Canada: An ecologic study based on the Canadian Scleroderma Research Group","year":2022,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Jewish General Hospital; Moncton Hospital; McGill University; Group for Research in Decision Analysis; McGill University Health Centre","funders":"","keywords":"Scopus; Medicine; Scleroderma (fungus); Epidemiology; Demography; MEDLINE; Pathology","score_opus":0.0649282068900565,"score_gpt":0.3154385505451889,"score_spread":0.25051034365513236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205611115","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935823,0.00081781956,0.00011818224,0.0004475038,0.00001478856,0.00005193177,0.003082633,0.000010334176,0.0018743934],"genre_scores_gemma":[0.99758625,0.00057075836,0.0001666195,0.00012385286,0.000010032316,0.000016937005,0.000977839,0.0000067967426,0.0005409457],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986815,0.000112546346,0.000085821106,0.000199832,0.00036376895,0.0005564463],"domain_scores_gemma":[0.99794585,0.00009745438,0.00039119285,0.000059057456,0.00090762874,0.000598941],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006623852,0.0006272879,0.0006242998,0.0036637504,0.0052815443,0.0019004886,0.001663903,0.00089453557,0.003454597],"category_scores_gemma":[0.0016871787,0.0005950545,0.0011667068,0.010244294,0.0013426604,0.0007775205,0.001846278,0.0010718728,0.0003842569],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000675872,0.000057752753,0.9956929,0.000030169871,0.00008681216,0.00014109818,0.0010439687,0.00007393562,0.0001865363,0.00014684907,0.0006964366,0.0017760784],"study_design_scores_gemma":[0.000007163424,0.000018427634,0.9970983,0.00002455035,0.00003306999,0.000094920084,0.0020672635,0.00012583722,0.000024766134,0.000024457997,0.00046794504,0.0000132543455],"about_ca_topic_score_codex":0.99399054,"about_ca_topic_score_gemma":0.9956369,"teacher_disagreement_score":0.02414482,"about_ca_system_score_codex":0.02414482,"about_ca_system_score_gemma":0.029399976,"threshold_uncertainty_score":0.17518377},"labels":[],"label_agreement":null},{"id":"W4206952539","doi":"10.1016/j.jaad.2022.01.018","title":"Disease characteristics, comorbidities, treatment patterns and quality of life impact in children <12 years old with atopic dermatitis: Interim results from the PEDISTAD Real-World Registry","year":2022,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Université de Montréal","funders":"Sanofi Genzyme; Regeneron Pharmaceuticals","keywords":"Medicine; Atopic dermatitis; Interim; Quality of life (healthcare); Disease; Interim analysis; Pediatrics; Dermatology; Clinical trial; Internal medicine","score_opus":0.026191955499229605,"score_gpt":0.3202079790504868,"score_spread":0.2940160235512572,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206952539","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.31161293,0.15318894,0.0016738989,0.08381984,0.009139954,0.001059917,0.43042126,0.00027864106,0.008804671],"genre_scores_gemma":[0.680478,0.06766545,0.0057623712,0.022234287,0.013764796,0.0030265013,0.20307721,0.00023766757,0.0037537415],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9953375,0.0017755181,0.0012389163,0.0003502151,0.00101955,0.00027833448],"domain_scores_gemma":[0.9599939,0.020679621,0.008693677,0.0018761309,0.0074179033,0.0013388381],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008313403,0.00035629558,0.0012879008,0.0025682137,0.0003363645,0.0016006799,0.0010763602,0.0013021667,0.005212307],"category_scores_gemma":[0.05692705,0.0003315238,0.0014988926,0.004700951,0.0003168218,0.001538566,0.0011108033,0.0016317088,0.0012595257],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043395306,0.00021962967,0.51987493,0.018217226,0.0053244904,0.0008191941,0.001093144,0.00048481306,0.00013530941,0.0009813679,0.36112133,0.08738908],"study_design_scores_gemma":[0.0014991806,0.0006294453,0.83484685,0.030754311,0.008745144,0.001667693,0.0014606212,0.0007640856,0.0003027745,0.0011428181,0.11793034,0.00025676467],"about_ca_topic_score_codex":0.0058566616,"about_ca_topic_score_gemma":0.0069683343,"teacher_disagreement_score":0.008313403,"about_ca_system_score_codex":0.0006157359,"about_ca_system_score_gemma":0.0019221341,"threshold_uncertainty_score":0.043965995},"labels":[],"label_agreement":null},{"id":"W4206994975","doi":"10.1016/j.jaad.2022.01.009","title":"American Academy of Dermatology Guidelines: Awareness of comorbidities associated with atopic dermatitis in adults","year":2022,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":152,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"American Academy of Dermatology","keywords":"Medicine; Atopic dermatitis; Dermatology; MEDLINE; Family medicine","score_opus":0.06291945743269978,"score_gpt":0.38663780204234655,"score_spread":0.32371834460964677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206994975","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00037676704,0.993636,0.00015937998,0.0023574186,0.0008504868,0.00003792617,0.0003282864,0.000021229214,0.0022325488],"genre_scores_gemma":[0.003972701,0.99057263,0.0011280981,0.002665496,0.00060982164,0.000063092826,0.00044994126,0.000003830492,0.0005343997],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99925,0.00014993893,0.0002137123,0.00006283879,0.00027047916,0.0000529758],"domain_scores_gemma":[0.99763656,0.0010245217,0.00054343865,0.00002854269,0.00063899014,0.00012799035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011699415,0.00065767026,0.0014460785,0.0025527354,0.0002907787,0.0008006518,0.0008308985,0.0013272194,0.0031347494],"category_scores_gemma":[0.004214089,0.00023080054,0.0013191968,0.0019756209,0.00021231025,0.00081826095,0.0006661672,0.0015756291,0.0007148736],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010856034,0.00012196843,0.0046479753,0.034703895,0.0004233263,0.00021366884,0.00007236501,0.0001627078,0.0003827342,0.000788432,0.14766468,0.81070954],"study_design_scores_gemma":[0.0001913026,0.00017535003,0.045370214,0.12384469,0.0028472992,0.0038778405,0.00024034665,0.00031578494,0.00042600202,0.0016591771,0.8209703,0.00008171092],"about_ca_topic_score_codex":0.0059961593,"about_ca_topic_score_gemma":0.0114297345,"teacher_disagreement_score":0.0059961593,"about_ca_system_score_codex":0.0005804999,"about_ca_system_score_gemma":0.002519814,"threshold_uncertainty_score":0.011922538},"labels":[],"label_agreement":null},{"id":"W4210418974","doi":"10.1016/j.jaad.2004.10.602","title":"Pigmented Bowen's disease","year":2005,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Mediprobe Research (Canada); Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Bowen's disease; Dermatology; Pathology; Basal cell","score_opus":0.014200562619031007,"score_gpt":0.3215437282430779,"score_spread":0.3073431656240469,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210418974","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9759093,0.011604243,0.00012486745,0.00024977268,0.00007595605,0.0000849223,0.00026376193,0.000007119386,0.011679963],"genre_scores_gemma":[0.99437153,0.0029410822,0.00007752373,0.00017484678,0.00007453729,0.000020827736,0.00015122957,0.000002212702,0.0021861373],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9989642,0.00035307556,0.00014080638,0.00014917618,0.00022085782,0.00017187273],"domain_scores_gemma":[0.99843913,0.00065628736,0.00028375688,0.00014754408,0.00019868452,0.0002746329],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014049822,0.00035451306,0.00046358927,0.0022451526,0.0016524161,0.0010907535,0.00031249426,0.00038149735,0.0072684553],"category_scores_gemma":[0.0034959868,0.00021393078,0.00028120092,0.0021208166,0.0006490289,0.0010088413,0.00072894775,0.00040674425,0.00034073862],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006328586,0.001878928,0.89233935,0.0012790675,0.00069474865,0.015691157,0.004849358,0.00012806694,0.0081479065,0.0066853613,0.0032311776,0.05874645],"study_design_scores_gemma":[0.0007178057,0.0041813133,0.9225841,0.00033428054,0.0006140991,0.03706316,0.0047187353,0.00011689011,0.0030793091,0.00201952,0.024528624,0.000042140393],"about_ca_topic_score_codex":0.0037639313,"about_ca_topic_score_gemma":0.0031798314,"teacher_disagreement_score":0.0072684553,"about_ca_system_score_codex":0.00050223904,"about_ca_system_score_gemma":0.0005586689,"threshold_uncertainty_score":0.024315417},"labels":[],"label_agreement":null},{"id":"W4210430537","doi":"10.1016/j.jaad.2022.01.048","title":"Association of psoriasis with risk of COVID-19: A 2-sample Mendelian randomization study","year":2022,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"Project 211; National Key Research and Development Program of China","keywords":"Mendelian randomization; Medicine; Coronavirus disease 2019 (COVID-19); Psoriasis; 2019-20 coronavirus outbreak; Genome-wide association study; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Dermatology; Internal medicine; Single-nucleotide polymorphism; Genetics; Virology; Genotype; Disease; Genetic variants; Outbreak; Gene","score_opus":0.013703356770142191,"score_gpt":0.2737573127698547,"score_spread":0.26005395599971254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210430537","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921714,0.00024595144,0.0062856087,0.0000984974,0.00006550632,0.00019760718,0.00038958952,0.00008566357,0.00046022775],"genre_scores_gemma":[0.99406564,0.00006694136,0.004417637,0.00010214134,0.000047206777,0.00022665803,0.00029229498,0.00005242675,0.00072905887],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9829297,0.012044385,0.000682768,0.0029934049,0.0007005282,0.0006491838],"domain_scores_gemma":[0.99029267,0.004429141,0.0014378685,0.0030633628,0.00036367768,0.00041323423],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007902632,0.0022436054,0.0024121339,0.0011679683,0.0013001369,0.0011571441,0.0017861198,0.002255145,0.006411487],"category_scores_gemma":[0.012961623,0.0016485073,0.0026929202,0.0012651044,0.0012836887,0.0008653562,0.00087636034,0.0013480193,0.00062104914],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.28494477,0.0073811873,0.61137867,0.00052350835,0.027013866,0.005545428,0.0014533458,0.0024186154,0.03043145,0.004039877,0.0021573573,0.022711884],"study_design_scores_gemma":[0.058359627,0.050114676,0.80807483,0.00011651599,0.024397684,0.0077804183,0.0006433621,0.037719138,0.004658793,0.0043369895,0.003324541,0.00047338693],"about_ca_topic_score_codex":0.002024702,"about_ca_topic_score_gemma":0.0011845665,"teacher_disagreement_score":0.007902632,"about_ca_system_score_codex":0.00046381386,"about_ca_system_score_gemma":0.0005333234,"threshold_uncertainty_score":0.041793644},"labels":[],"label_agreement":null},{"id":"W4210965611","doi":"10.1016/j.jaad.2004.09.019","title":"Dermatoepidemiology","year":2005,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Dermatology; Epidemiology; Reading (process); MEDLINE; Pathology","score_opus":0.06717909004039282,"score_gpt":0.44080667749804636,"score_spread":0.37362758745765356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210965611","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016928434,0.99125004,0.00019451792,0.00039858473,0.0016101124,0.000018667319,0.000054810553,0.000022398668,0.006281587],"genre_scores_gemma":[0.0021309564,0.9843141,0.0004373719,0.0009167498,0.0020935168,0.000020400641,0.00018859135,0.0000050995914,0.009893248],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99963284,0.000065229724,0.00006469161,0.000060172035,0.0001287176,0.00004837809],"domain_scores_gemma":[0.9995511,0.00012760321,0.000090857946,0.000029313436,0.00014324898,0.000057827063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006318716,0.001094398,0.0017647435,0.0036190744,0.00041644226,0.0015209283,0.0008700026,0.0010808756,0.022752305],"category_scores_gemma":[0.001171043,0.00040080285,0.00043743924,0.0027725603,0.000560777,0.0013571732,0.001139865,0.0017067385,0.012970845],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000082123224,0.00008910584,0.0002547037,0.006305118,0.000046155168,0.0003190735,0.000024375939,0.00008879249,0.00073634693,0.0007278217,0.06122891,0.9300974],"study_design_scores_gemma":[0.00003899486,0.00005493495,0.0015207678,0.0031250378,0.00011167607,0.0037243273,0.000037424208,0.00005486307,0.00028064038,0.0005815461,0.99045837,0.000011368265],"about_ca_topic_score_codex":0.0010041288,"about_ca_topic_score_gemma":0.0023254303,"teacher_disagreement_score":0.022752305,"about_ca_system_score_codex":0.00060603704,"about_ca_system_score_gemma":0.0010126367,"threshold_uncertainty_score":0.07611406},"labels":[],"label_agreement":null},{"id":"W4212893275","doi":"10.1016/j.jaad.2022.02.022","title":"Real-world experience with ustekinumab for the treatment of plaque psoriasis in pediatric patients: A retrospective, single-center chart review","year":2022,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; Probity Medical Research; Heritage Medical Research Clinic; Alberta Children's Hospital; University of Calgary; University of Toronto","funders":"","keywords":"Medicine; Ustekinumab; Plaque psoriasis; Psoriasis; Retrospective cohort study; Chart; Dermatology; Single Center; Clinical trial; Pediatrics; Surgery; Disease; Internal medicine","score_opus":0.021068995867963486,"score_gpt":0.2779999749853104,"score_spread":0.25693097911734697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4212893275","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98899406,0.007305724,0.0008781282,0.00018171237,0.000018185376,0.000062736464,0.00087102706,0.0000190664,0.0016694033],"genre_scores_gemma":[0.99454826,0.00373715,0.0007630917,0.00013497169,0.000020789741,0.000024532888,0.0006396461,0.000015197933,0.00011628576],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99869424,0.0003554644,0.00027917544,0.00023035676,0.00032479438,0.00011595421],"domain_scores_gemma":[0.9954094,0.0014859941,0.002039158,0.00021715749,0.0005712465,0.00027696756],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00086036685,0.00017661104,0.00037170475,0.00092584867,0.00044601085,0.0008882462,0.00029788204,0.00033588381,0.0009074174],"category_scores_gemma":[0.0044311727,0.00022198944,0.0003683641,0.0014986378,0.00040310863,0.00057559425,0.0003032329,0.00047876986,0.00018742589],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016816637,0.000112556896,0.97087145,0.00023675644,0.00010038054,0.005736273,0.0014260211,0.00019406326,0.0010065566,0.00020221536,0.0009053974,0.019040188],"study_design_scores_gemma":[0.000034711436,0.00077696494,0.9234052,0.0003153834,0.00032335785,0.056395598,0.0047494685,0.0005967767,0.002835122,0.00009354113,0.010427732,0.000046207406],"about_ca_topic_score_codex":0.0024120295,"about_ca_topic_score_gemma":0.0031041158,"teacher_disagreement_score":0.0024120295,"about_ca_system_score_codex":0.0007583903,"about_ca_system_score_gemma":0.0009281969,"threshold_uncertainty_score":0.0055025816},"labels":[],"label_agreement":null},{"id":"W4221077223","doi":"10.1016/j.jaad.2022.03.037","title":"Disproportional signal of sexual dysfunction reports associated with finasteride use in young men with androgenetic alopecia: A pharmacovigilance analysis of VigiBase","year":2022,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Sexual function and dysfunction studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Centre Hospitalier de l’Université de Montréal; McGill University Health Centre","funders":"Sexual Medicine Society of North America","keywords":"Finasteride; Medicine; Sexual dysfunction; Erectile dysfunction; Sexual function; Gynecology; Decreased Libido; Depression (economics); Population; Internal medicine; Prostate","score_opus":0.02658459495233378,"score_gpt":0.2971169742570758,"score_spread":0.270532379304742,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4221077223","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9768002,0.0019829527,0.00020302749,0.014157583,0.0004916015,0.000030963653,0.0012218858,0.00004341507,0.005068362],"genre_scores_gemma":[0.9924442,0.00032925513,0.00015972547,0.0057567186,0.00061000534,0.000007862368,0.00021354541,0.000007326101,0.00047130793],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99913126,0.00026746574,0.00016641158,0.00013017624,0.00020109628,0.00010362681],"domain_scores_gemma":[0.99633384,0.0017670839,0.0007939219,0.00016278085,0.000458289,0.00048400855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055302057,0.00024352339,0.00044028132,0.0009422789,0.00050399353,0.0008246967,0.00033848212,0.0017084123,0.0016429003],"category_scores_gemma":[0.0057118945,0.00020315521,0.0005114492,0.0009958612,0.00026728984,0.00033328225,0.000259939,0.000929053,0.0002712963],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032656002,0.00006665107,0.9716375,0.000052925636,0.00016245595,0.019160494,0.00016280773,0.000042650743,0.0011709955,0.00006455442,0.0036596034,0.003492751],"study_design_scores_gemma":[0.00009565342,0.00030850605,0.9404886,0.00008924003,0.00027030805,0.053840663,0.00052822137,0.00052881974,0.00045665604,0.00019629447,0.0031704772,0.000026616082],"about_ca_topic_score_codex":0.0062732343,"about_ca_topic_score_gemma":0.006399587,"teacher_disagreement_score":0.0062732343,"about_ca_system_score_codex":0.00043452758,"about_ca_system_score_gemma":0.00044126454,"threshold_uncertainty_score":0.012473464},"labels":[],"label_agreement":null},{"id":"W4223550633","doi":"10.1016/j.jaad.2022.04.006","title":"Associations of combined lifestyle and genetic risks with incident psoriasis: A prospective cohort study among UK Biobank participants of European ancestry","year":2022,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":52,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"National Key Research and Development Program of China; Medical Research Council; National Natural Science Foundation of China","keywords":"Medicine; Biobank; Hazard ratio; Psoriasis; Cohort study; Confidence interval; Population; Risk assessment; Prospective cohort study; Body mass index; Relative risk; Cohort; Lower risk; Demography; Internal medicine; Environmental health; Bioinformatics; Immunology","score_opus":0.0315458950562501,"score_gpt":0.2973487181065467,"score_spread":0.2658028230502966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4223550633","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99835473,0.00032647085,0.0001505538,0.000059814873,0.000016033331,0.000012047927,0.00069878175,0.000006402995,0.00037511077],"genre_scores_gemma":[0.99856645,0.00015281144,0.00014946445,0.00006500559,0.000013573463,0.000021001428,0.00047191881,0.000007823539,0.00055200263],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986356,0.00039126354,0.00013832269,0.00045056007,0.00014730962,0.00023699037],"domain_scores_gemma":[0.9980714,0.00026379363,0.000592681,0.0004327156,0.0002357367,0.00040384202],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00090602733,0.0007027318,0.0008204201,0.0009883976,0.0013448085,0.0017604488,0.00071568927,0.001607025,0.0034576748],"category_scores_gemma":[0.0024960581,0.0011315995,0.001175027,0.002195512,0.00065255095,0.0010795164,0.0012384292,0.0016358723,0.0006299462],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072653097,0.00014250705,0.9956286,0.000018973888,0.00036331674,0.0002938642,0.00051624916,0.00003167492,0.0013125617,0.00004446394,0.00019756956,0.0007236968],"study_design_scores_gemma":[0.000023667844,0.000105484214,0.99884087,0.000009219245,0.000100461555,0.00030704142,0.00030760447,0.00005885269,0.00005102197,0.00002093554,0.00016701451,0.000007812564],"about_ca_topic_score_codex":0.023817798,"about_ca_topic_score_gemma":0.02019268,"teacher_disagreement_score":0.023817798,"about_ca_system_score_codex":0.00041622858,"about_ca_system_score_gemma":0.00039895877,"threshold_uncertainty_score":0.047358334},"labels":[],"label_agreement":null},{"id":"W4224280270","doi":"10.1016/j.jaad.2022.04.024","title":"European tattoo ingredient ban: Implications for North America","year":2022,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Tattoo and Body Piercing Complications","field":"Social Sciences","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Parliament; European union; Authorization; Medicine; European commission; Commission; Law; Political science; International trade; Business; Computer security","score_opus":0.03768694489879188,"score_gpt":0.3488203026396334,"score_spread":0.3111333577408415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224280270","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.040142644,0.037256546,0.0011694396,0.81891817,0.0065416177,0.0000628995,0.0010039973,0.00009494371,0.094809644],"genre_scores_gemma":[0.3437243,0.034324277,0.0042201094,0.58381766,0.0059093377,0.00020141734,0.00058434706,0.00007529295,0.027143205],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968651,0.000708881,0.00024879436,0.0005211861,0.0009691861,0.00068679],"domain_scores_gemma":[0.9910527,0.0032745244,0.0011272926,0.00027414822,0.0023880561,0.0018833498],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0057312762,0.00038346357,0.0007330358,0.0010446507,0.0026655255,0.004499247,0.0021493623,0.008760055,0.020443171],"category_scores_gemma":[0.011261023,0.00024193416,0.0009637296,0.0015901104,0.0032002556,0.003509989,0.0018566878,0.0071498193,0.0009805154],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012147791,0.0022360366,0.06357084,0.0015884909,0.00031083723,0.0022957022,0.0037945344,0.000789332,0.0042355214,0.18540244,0.42454016,0.31002137],"study_design_scores_gemma":[0.00038971726,0.00048272283,0.14393313,0.006558494,0.00054047984,0.001425175,0.015263325,0.0006970693,0.0014434027,0.06478266,0.7642985,0.00018522578],"about_ca_topic_score_codex":0.11861357,"about_ca_topic_score_gemma":0.24918424,"teacher_disagreement_score":0.8813864,"about_ca_system_score_codex":0.006597615,"about_ca_system_score_gemma":0.02075804,"threshold_uncertainty_score":0.23584634},"labels":[],"label_agreement":null},{"id":"W4224879671","doi":"10.1016/j.jaad.2022.04.028","title":"Cross-sectional characteristics of pediatric-onset discoid lupus erythematosus: Results of a multicenter, retrospective cohort study","year":2022,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"EMD Serono; National Institutes of Health; Principia Biopharma; Georgia Clinical and Translational Science Alliance; National Center for Advancing Translational Sciences; Pediatric Dermatology Research Alliance; Biogen","keywords":"Medicine; Discoid lupus erythematosus; Systemic lupus erythematosus; Rheumatology; Retrospective cohort study; Internal medicine; Anti-nuclear antibody; Lupus erythematosus; Cohort; Dermatology; Connective tissue disease; Autoimmune disease; Immunology; Disease; Antibody; Autoantibody","score_opus":0.02268654362423272,"score_gpt":0.3460607837391337,"score_spread":0.32337424011490096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224879671","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993057,0.00012016313,0.000054905617,0.000014587233,0.000003813212,0.0000050043386,0.00037913592,0.0000025504655,0.00011401396],"genre_scores_gemma":[0.9993425,0.00009941161,0.00006274381,0.0000141646615,0.0000061636156,0.000007558918,0.00041978754,0.0000027299493,0.000044967146],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989127,0.00029089852,0.00012453405,0.0003413776,0.00014465833,0.00018580948],"domain_scores_gemma":[0.9978662,0.0002967831,0.0009494225,0.00026992534,0.00026582036,0.0003518372],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011603837,0.0006217278,0.00068015786,0.0008856362,0.0006283305,0.0008612251,0.00055019197,0.0006539714,0.0010335398],"category_scores_gemma":[0.0023287935,0.0006876824,0.000729301,0.0016686281,0.0004167562,0.0009840553,0.0005869511,0.0006692372,0.00023329261],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000073817624,0.00002983924,0.9992842,0.0000026237815,0.000049088892,0.000076217526,0.00004798949,0.00001521672,0.00013027179,0.000007700126,0.000038930924,0.00024415576],"study_design_scores_gemma":[0.000007253296,0.000086585576,0.99915683,0.0000023054192,0.000034993678,0.00033202596,0.00021250875,0.000063918465,0.000031292086,0.0000056040203,0.000064232365,0.0000025285713],"about_ca_topic_score_codex":0.0070974636,"about_ca_topic_score_gemma":0.005447205,"teacher_disagreement_score":0.0070974636,"about_ca_system_score_codex":0.0005153168,"about_ca_system_score_gemma":0.00054778566,"threshold_uncertainty_score":0.014112294},"labels":[],"label_agreement":null},{"id":"W4229442988","doi":"10.1016/j.jaad.2022.04.058","title":"Patch testing with glucosides: The North American Contact Dermatitis Group experience, 2009-2018","year":2022,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Contact Dermatitis and Allergies","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Montreal General Hospital; University of Ottawa; Sunnybrook Health Science Centre; McGill University; Health Sciences Centre; University of Toronto","funders":"","keywords":"Medicine; Glucoside; Dermatology; Allergic contact dermatitis; Odds ratio; Atopic dermatitis; Allergy; Internal medicine; Immunology; Pathology","score_opus":0.017921733769118476,"score_gpt":0.2733843149431667,"score_spread":0.2554625811740482,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4229442988","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9625718,0.0064096577,0.0004426413,0.0017835628,0.0001089781,0.00007045757,0.00016938943,0.000031613243,0.028411815],"genre_scores_gemma":[0.9885378,0.004754704,0.0004006142,0.0010909974,0.00006137841,0.000016146207,0.0001810986,0.000019231158,0.004938078],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99909484,0.00023017898,0.000066503795,0.00011230466,0.00035829114,0.0001379249],"domain_scores_gemma":[0.998966,0.00030565172,0.00013980418,0.000057022036,0.00026079733,0.0002707893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012564211,0.00025731634,0.00020125885,0.0004051848,0.0009723605,0.0006488508,0.00033302658,0.00052175764,0.0024920034],"category_scores_gemma":[0.002166703,0.00015438398,0.00025623938,0.00052590785,0.0004491285,0.0008430294,0.00066273095,0.00055881566,0.0005166543],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005169385,0.0030984534,0.7577264,0.00022881459,0.00007271022,0.0164972,0.009408165,0.00016653872,0.004876255,0.0004626592,0.020193588,0.18675224],"study_design_scores_gemma":[0.00007044629,0.0018485201,0.837094,0.00042437855,0.00015069917,0.06909018,0.015887905,0.00041230916,0.0027428216,0.00039756778,0.07184615,0.00003500409],"about_ca_topic_score_codex":0.01277547,"about_ca_topic_score_gemma":0.05691594,"teacher_disagreement_score":0.01277547,"about_ca_system_score_codex":0.00090457086,"about_ca_system_score_gemma":0.0010962094,"threshold_uncertainty_score":0.025402248},"labels":[],"label_agreement":null},{"id":"W4229445175","doi":"10.1016/j.jaad.2022.04.059","title":"Development of a core outcome set for basal cell carcinoma","year":2022,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Delphi Technique in Research","field":"Social Sciences","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Toronto; Women's College Hospital","funders":"University of Illinois at Chicago; Feinberg School of Medicine; Northeast Ohio Medical University; Dartmouth College; University of Oklahoma; School of Medicine, Stanford University; Pennsylvania State University; Northwestern University; University of Pennsylvania; Cleveland Clinic; University of Illinois at Urbana-Champaign; Memorial Sloan-Kettering Cancer Center; Medical Center, University of Pittsburgh; University of Pittsburgh","keywords":"Medicine; Basal cell carcinoma; Outcome (game theory); Core (optical fiber); Set (abstract data type); Basal cell; Internal medicine; Optics","score_opus":0.4274609666802424,"score_gpt":0.5450723558346213,"score_spread":0.11761138915437891,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4229445175","genre_codex":"review","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005593992,0.9709612,0.012429877,0.0032721236,0.00087643805,0.0009974664,0.0012789964,0.00008090547,0.004508996],"genre_scores_gemma":[0.09200887,0.85188854,0.042277377,0.003278111,0.0006960649,0.0035654926,0.0050144643,0.000051368068,0.0012196727],"study_design_codex":"design_other","study_design_gemma":"qualitative","domain_scores_codex":[0.99437606,0.0021383082,0.0013630604,0.00033460985,0.0015241972,0.00026375125],"domain_scores_gemma":[0.9888925,0.006967537,0.0014731564,0.00023388212,0.0021372007,0.00029566485],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.016895434,0.0012599336,0.0060066665,0.0054102987,0.00071382086,0.0020860813,0.0022351886,0.0010458869,0.0020007382],"category_scores_gemma":[0.02345712,0.00039613916,0.0028253775,0.0039032027,0.0011327454,0.001784247,0.0025751658,0.0028520771,0.00034365087],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033621432,0.00014844087,0.004704294,0.033996485,0.00082859077,0.00006124407,0.00014988316,0.000986814,0.00021357553,0.012165931,0.010470265,0.9359382],"study_design_scores_gemma":[0.0013879534,0.0022317471,0.1057634,0.28092054,0.0150615955,0.0035654958,0.0025464043,0.007992645,0.0036443847,0.08250993,0.49387994,0.000495968],"about_ca_topic_score_codex":0.004277642,"about_ca_topic_score_gemma":0.0058889273,"teacher_disagreement_score":0.9831046,"about_ca_system_score_codex":0.0041805203,"about_ca_system_score_gemma":0.007718026,"threshold_uncertainty_score":0.08935261},"labels":[],"label_agreement":null},{"id":"W4230616299","doi":"10.1016/j.jaad.2006.04.013","title":"Digitocutaneous dysplasia","year":2006,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Urologic and reproductive health conditions","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Dysplasia; Dermatology; Girl; Genetic disorder; Genetic syndromes; Genetic Condition; Pathology; Pediatrics; Genetics","score_opus":0.012144042233466738,"score_gpt":0.30614646378455584,"score_spread":0.29400242155108913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230616299","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7035436,0.007132644,0.0051051476,0.0018236969,0.00050366874,0.00012868042,0.0012619025,0.00067243795,0.27982822],"genre_scores_gemma":[0.97998446,0.001033977,0.00095948885,0.0003772309,0.00007382143,0.000009983825,0.00016261228,0.00003160438,0.017366877],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9996352,0.000028950219,0.00003091437,0.00008241458,0.0001239873,0.00009855215],"domain_scores_gemma":[0.99938464,0.0001541913,0.00013319783,0.00010221216,0.00009662987,0.0001290946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015587219,0.00058061635,0.00032143286,0.0026937732,0.0014632605,0.0009225488,0.00047323725,0.00064310734,0.017189657],"category_scores_gemma":[0.0015645906,0.00020709926,0.00027124875,0.0009862953,0.00066554407,0.0004802134,0.0008144955,0.0004903159,0.0020978705],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017135276,0.0001460498,0.098165944,0.0003573136,0.000088500594,0.7451745,0.0004928556,0.00037372028,0.035405,0.007100319,0.0052563744,0.107267976],"study_design_scores_gemma":[0.0000093751405,0.000026037065,0.023964126,0.000051098516,0.000023658211,0.9590445,0.0001254167,0.00014109265,0.0038768724,0.00058064057,0.012147812,0.000009288016],"about_ca_topic_score_codex":0.001268533,"about_ca_topic_score_gemma":0.0027151275,"teacher_disagreement_score":0.017189657,"about_ca_system_score_codex":0.00048756774,"about_ca_system_score_gemma":0.000515803,"threshold_uncertainty_score":0.05750513},"labels":[],"label_agreement":null},{"id":"W4230836530","doi":"10.1016/j.jaad.2018.05.1108","title":"Teledermatology in rural and remote British Columbia: A survey of primary care providers","year":2018,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Infectious Diseases and Mycology","field":"Veterinary","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Teledermatology; Medicine; Primary care; Telemedicine; Family medicine; MEDLINE; Medical emergency; Nursing; Health care; Economic growth","score_opus":0.017151923986100465,"score_gpt":0.29938459475835155,"score_spread":0.2822326707722511,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230836530","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975591,0.00023179587,0.000021156935,0.00038811026,0.000004908026,0.000025956057,0.00039495365,0.0000022797121,0.0013718365],"genre_scores_gemma":[0.99834025,0.0003712079,0.000046194902,0.00035793686,0.0000046996233,0.000016934891,0.00015956502,0.0000025566208,0.0007007546],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990344,0.00013394844,0.00008430895,0.00010354949,0.00030309006,0.0003407382],"domain_scores_gemma":[0.99694234,0.0004226876,0.0007630336,0.00005622022,0.0007475162,0.0010682238],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035802665,0.0001942876,0.00032678078,0.0009972223,0.0021003515,0.001152538,0.0009258355,0.0007447153,0.0042629503],"category_scores_gemma":[0.0024617116,0.00046131533,0.00020520088,0.0030717975,0.0006670865,0.000513164,0.0009691603,0.0010078844,0.00043084202],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034272434,0.00014674306,0.99132204,0.000038214122,0.000020116315,0.00042460684,0.0038753015,0.000025724692,0.00024534186,0.000035930083,0.0008532158,0.0029785424],"study_design_scores_gemma":[0.0000049928826,0.00003573113,0.98475325,0.000046028865,0.000009655915,0.0001774575,0.014443418,0.000087100714,0.000024761635,0.000008898993,0.00040327944,0.000005423223],"about_ca_topic_score_codex":0.89410895,"about_ca_topic_score_gemma":0.94961476,"teacher_disagreement_score":0.10589105,"about_ca_system_score_codex":0.005589069,"about_ca_system_score_gemma":0.006426349,"threshold_uncertainty_score":0.21302927},"labels":[],"label_agreement":null},{"id":"W4231561986","doi":"10.1016/j.jaad.2021.06.697","title":"28032 Rapid itch improvement with upadacitinib with or without concomitant topical corticosteroids (TCS) in moderate-to-severe atopic dermatitis (AD): Results from 3 phase 3 studies (Measure Up 1, Measure Up 2, and AD Up)","year":2021,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; University of British Columbia","funders":"","keywords":"Medicine; Placebo; Concomitant; Atopic dermatitis; Randomized controlled trial; Anesthesia; Gastroenterology; Internal medicine; Dermatology; Pathology","score_opus":0.035873297965879694,"score_gpt":0.33060061962795056,"score_spread":0.2947273216620709,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4231561986","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95065075,0.03584956,0.00088255876,0.0009574938,0.0005306142,0.0016043438,0.0015325606,0.0004852895,0.0075068623],"genre_scores_gemma":[0.9806296,0.010598185,0.001268277,0.0012955084,0.00019929526,0.00073940057,0.0018498744,0.000034906046,0.003384798],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9997898,0.000066027496,0.000014698835,0.00003251201,0.000035383862,0.00006164156],"domain_scores_gemma":[0.99975985,0.00006345593,0.000042575248,0.000021816806,0.00003245314,0.00007989523],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008419854,0.0007121399,0.0017578423,0.00039929018,0.00029482666,0.0007548447,0.0004806407,0.0007711554,0.0067034317],"category_scores_gemma":[0.0005301423,0.00025235437,0.0015530895,0.00030504283,0.0003636818,0.0006566243,0.00026039092,0.0023799879,0.001154743],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3147502,0.02811048,0.004990032,0.0063437447,0.0044932067,0.00051333243,0.00027354868,0.0018166269,0.054392498,0.0005158212,0.019262664,0.56453794],"study_design_scores_gemma":[0.6001045,0.32658896,0.037225395,0.0007765435,0.0033411945,0.0014880055,0.00022157971,0.0024693215,0.011451128,0.00044692683,0.015771316,0.00011510335],"about_ca_topic_score_codex":0.0007307324,"about_ca_topic_score_gemma":0.0026941164,"teacher_disagreement_score":0.0067034317,"about_ca_system_score_codex":0.000344214,"about_ca_system_score_gemma":0.00040299568,"threshold_uncertainty_score":0.022425234},"labels":[],"label_agreement":null},{"id":"W4231986655","doi":"10.1016/j.jaad.2004.10.766","title":"Infliximab therapy improves health-related quality of life in patients with psoriatic arthritis","year":2005,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"","keywords":"Medicine; Psoriatic arthritis; Infliximab; Dermatology; Psoriasis; Quality of life (healthcare); Antirheumatic Agents; Arthritis; Internal medicine; Tumor necrosis factor alpha","score_opus":0.01642938443715207,"score_gpt":0.30458838380311803,"score_spread":0.28815899936596595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4231986655","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9840936,0.012741907,0.000072088704,0.00056580186,0.00008450173,0.00001939074,0.00017716772,0.000018451532,0.002227115],"genre_scores_gemma":[0.99728096,0.0018041906,0.000113434944,0.00029462657,0.00007858713,0.000009853101,0.00019253876,0.0000013753486,0.00022433019],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99963534,0.00015966812,0.00005314174,0.000033841658,0.00006308048,0.000054929125],"domain_scores_gemma":[0.9993007,0.00026577784,0.00022902375,0.00003251607,0.00005383927,0.000118008305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005213808,0.00025484845,0.0009649708,0.0002558483,0.00027444446,0.00046191594,0.00018982816,0.00045065826,0.00164439],"category_scores_gemma":[0.002085586,0.00014905861,0.00066431466,0.0004260358,0.0001351834,0.00033678964,0.00015287151,0.00055150694,0.0001791036],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05644227,0.0053644343,0.60061693,0.0013708487,0.0066908123,0.0010793919,0.0005088752,0.0010642437,0.008575465,0.0001076536,0.004758893,0.31342024],"study_design_scores_gemma":[0.003110047,0.0066907844,0.9857875,0.000054314172,0.0014401051,0.00064721843,0.00013906974,0.0004144294,0.00034213733,0.00009208865,0.0012644652,0.000017889966],"about_ca_topic_score_codex":0.0010272738,"about_ca_topic_score_gemma":0.0025267992,"teacher_disagreement_score":0.00164439,"about_ca_system_score_codex":0.00023280976,"about_ca_system_score_gemma":0.00016730589,"threshold_uncertainty_score":0.0055010915},"labels":[],"label_agreement":null},{"id":"W4232027599","doi":"10.1016/s0190-9622(03)00455-9","title":"Cutaneous lymphadenoma","year":2003,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Cancer and Skin Lesions","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Histogenesis; Medicine; Head and neck; Basal cell carcinoma; Pathology; Lesion; Basal cell; Neoplasm; Benign tumor; Dermatology; Immunohistochemistry; Surgery","score_opus":0.015260157659055518,"score_gpt":0.31510524352485075,"score_spread":0.2998450858657952,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4232027599","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.40286955,0.0116716055,0.006772177,0.0031589987,0.000953537,0.00031294883,0.0016541214,0.0012274546,0.57137966],"genre_scores_gemma":[0.9522678,0.002682175,0.00091643026,0.0012361754,0.00032293852,0.00002890332,0.00043387344,0.00006606931,0.04204562],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9998934,0.000005965612,0.0000070075093,0.000037083904,0.000020510206,0.000035972716],"domain_scores_gemma":[0.99978536,0.000038506794,0.00002754703,0.000058849153,0.000033613844,0.000056136854],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010822971,0.00057128875,0.00026052378,0.0010733313,0.0006071719,0.00047516602,0.00047596317,0.0005832784,0.021375975],"category_scores_gemma":[0.0008584048,0.00020662253,0.00036283318,0.000520005,0.00035104516,0.00071011385,0.00037650362,0.0007972064,0.005550167],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027005264,0.0001907376,0.03062195,0.00028589912,0.00005529266,0.8577106,0.00024534957,0.0002938789,0.025932608,0.0030001216,0.008507318,0.072886184],"study_design_scores_gemma":[0.000045460823,0.00015328563,0.027578741,0.00008350671,0.000065819026,0.9288596,0.00013190968,0.00041670972,0.0056868885,0.0007289349,0.03623335,0.00001589752],"about_ca_topic_score_codex":0.0017640019,"about_ca_topic_score_gemma":0.0021393388,"teacher_disagreement_score":0.021375975,"about_ca_system_score_codex":0.00052825455,"about_ca_system_score_gemma":0.0002976646,"threshold_uncertainty_score":0.07150978},"labels":[],"label_agreement":null},{"id":"W4232133412","doi":"10.1067/mjd.2000.110042","title":"Reply","year":2000,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Glutathione Transferases and Polymorphisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"CYP2D6; Pharmacology; Pharmacogenetics; Medicine; Fluconazole; Population; Terbinafine; Drug metabolism; Drug; Itraconazole; Cytochrome P450; Genetics; Biology; Internal medicine; Metabolism; Dermatology; Antifungal; Genotype","score_opus":0.007713922858211596,"score_gpt":0.2641639529015511,"score_spread":0.2564500300433395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4232133412","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00029728038,0.0024159276,0.00007646144,0.92258096,0.07266227,0.000010987626,0.00008239361,0.000024609275,0.0018490107],"genre_scores_gemma":[0.0024709085,0.0011307736,0.00009618149,0.94559866,0.04183388,0.00003850837,0.000045245866,0.000016062751,0.008769864],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99790716,0.00042400227,0.0002863334,0.0004080813,0.00059600396,0.00037846688],"domain_scores_gemma":[0.98963916,0.003926565,0.0008200277,0.00042921474,0.0032143798,0.001970646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029480488,0.00064505753,0.0010089908,0.0010867236,0.0027573917,0.0037781743,0.0015533698,0.025435686,0.012064789],"category_scores_gemma":[0.024395898,0.00071058504,0.0010031383,0.0006229465,0.0019361391,0.0033047523,0.002451001,0.027656425,0.0088343145],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029027804,0.000009935388,0.00054360274,0.00003539919,0.000011565815,0.0002135331,0.00008105607,0.000009924261,0.00007305026,0.0007581417,0.99476826,0.0034665132],"study_design_scores_gemma":[0.00004732306,0.000018751374,0.0018725428,0.00013025246,0.000027796163,0.0007043554,0.00039745052,0.000042383035,0.00012769736,0.0013213052,0.995271,0.0000391611],"about_ca_topic_score_codex":0.0036144177,"about_ca_topic_score_gemma":0.0040853643,"teacher_disagreement_score":0.025435686,"about_ca_system_score_codex":0.0018699426,"about_ca_system_score_gemma":0.0029705311,"threshold_uncertainty_score":0},"labels":[],"label_agreement":null},{"id":"W4233620320","doi":"10.1016/j.jaad.2006.10.653","title":"Mycosis fungoides in Manitoba 1982-2002","year":2007,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Mycosis fungoides; Medicine; Dermatology; Internal medicine; Lymphoma","score_opus":0.026756741602102414,"score_gpt":0.35009524839626355,"score_spread":0.32333850679416115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4233620320","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9779351,0.0044555143,0.00016464789,0.00073602766,0.00010556395,0.00009088941,0.0069366973,0.000026035508,0.009549523],"genre_scores_gemma":[0.97656584,0.0061294083,0.00023901764,0.0005545846,0.00007651625,0.000042794447,0.004406729,0.000012694731,0.011972295],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997826,0.000019365554,0.000023544819,0.000028646678,0.00005666268,0.000089192494],"domain_scores_gemma":[0.9994623,0.00003565541,0.00011517965,0.000013204147,0.00022630881,0.00014737954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024509287,0.00049401756,0.0002691079,0.0022094336,0.0015545572,0.0006089996,0.000752665,0.0005136188,0.0020563223],"category_scores_gemma":[0.00065163116,0.00032760273,0.00023902548,0.0034422872,0.00034825117,0.00037211017,0.0006431634,0.00044603017,0.00053961616],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022507571,0.00012976897,0.9639439,0.00019166527,0.000068499234,0.010508311,0.003482816,0.00014779138,0.0019651148,0.00020502566,0.003442719,0.01568925],"study_design_scores_gemma":[0.000012801305,0.0000442148,0.98633575,0.00009638979,0.000059399037,0.0034960979,0.0026012242,0.000079105455,0.00028117758,0.000022687858,0.0069612805,0.000009939286],"about_ca_topic_score_codex":0.7955073,"about_ca_topic_score_gemma":0.9332069,"teacher_disagreement_score":0.20449269,"about_ca_system_score_codex":0.0043490236,"about_ca_system_score_gemma":0.0059286742,"threshold_uncertainty_score":0.41139394},"labels":[],"label_agreement":null},{"id":"W4233727148","doi":"10.1016/j.jaad.2004.10.526","title":"The use of terbinafine to treat superficial fungal infections in children","year":2005,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Mediprobe Research (Canada); Sunnybrook Health Science Centre","funders":"","keywords":"Terbinafine; Medicine; Dermatology; Mycosis; Antifungal; Itraconazole; Surgery","score_opus":0.019516367381883126,"score_gpt":0.3132969773488485,"score_spread":0.29378060996696537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4233727148","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9205161,0.066812396,0.00071808806,0.00343236,0.00026592254,0.000050245904,0.00014999183,0.000034179157,0.008020628],"genre_scores_gemma":[0.9791422,0.01866524,0.0007301811,0.0005270831,0.00012282761,0.000018393219,0.000051348376,0.000008006151,0.00073464896],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9996505,0.00010499709,0.00005338713,0.000021560561,0.00009741179,0.00007223651],"domain_scores_gemma":[0.9994099,0.00018705064,0.00021667853,0.000020585157,0.000045588265,0.00012008699],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035588568,0.00019835433,0.00049233536,0.00032776644,0.0005634634,0.00031783676,0.00024655633,0.0005936872,0.0006786589],"category_scores_gemma":[0.0017748686,0.00010729266,0.00056802126,0.00032063865,0.00038287017,0.00025816957,0.00020332653,0.001156555,0.00014166682],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005697293,0.0018046692,0.32174885,0.0022041213,0.00052746927,0.071198665,0.002231686,0.0012231638,0.030763257,0.0025734627,0.008890063,0.5511374],"study_design_scores_gemma":[0.0010389355,0.011218439,0.61459845,0.0013921558,0.0011118494,0.2649184,0.002490523,0.0010827272,0.03089588,0.00082226424,0.070355445,0.00007505216],"about_ca_topic_score_codex":0.0034865327,"about_ca_topic_score_gemma":0.0067344657,"teacher_disagreement_score":0.0034865327,"about_ca_system_score_codex":0.0006240827,"about_ca_system_score_gemma":0.0010222669,"threshold_uncertainty_score":0.006932497},"labels":[],"label_agreement":null},{"id":"W4234786816","doi":"10.1016/j.jaad.2004.10.643","title":"Ciprofloxacin-induced phototoxicity in patients with cystic fibrosis","year":2005,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Selkirk College","funders":"","keywords":"Medicine; Phototoxicity; Cystic fibrosis; Ciprofloxacin; Dermatology; Internal medicine; Antibiotics; Microbiology","score_opus":0.011066859736046757,"score_gpt":0.2923576795108802,"score_spread":0.28129081977483344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4234786816","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955445,0.0021327238,0.00015722285,0.00019879227,0.000017245144,0.000031813135,0.000072699426,0.00001671044,0.0018283745],"genre_scores_gemma":[0.9993135,0.00032905478,0.00007132928,0.000073683055,0.000020971649,0.000006323285,0.00003901301,0.000002623726,0.00014358458],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996012,0.000115075534,0.00005551205,0.00004930648,0.00010657159,0.00007240647],"domain_scores_gemma":[0.99848783,0.0005830721,0.00045571954,0.00005067681,0.00015942796,0.0002632007],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038794885,0.00031239892,0.00057186675,0.0005401794,0.0005403166,0.0004503158,0.00017660044,0.0006243694,0.0015748236],"category_scores_gemma":[0.0038633195,0.00020907576,0.00043924316,0.0004047704,0.00022192343,0.0003664814,0.00020690898,0.00069096807,0.00020905325],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003394496,0.00030315394,0.9477367,0.00016862922,0.00011886711,0.019997774,0.00024014476,0.00020545724,0.0051874802,0.00006746722,0.0005841503,0.021995721],"study_design_scores_gemma":[0.00013521028,0.0013726654,0.96577203,0.000031339194,0.00010491465,0.030601792,0.00020884817,0.00044966198,0.00070849515,0.000042921267,0.0005579912,0.000014074314],"about_ca_topic_score_codex":0.0025637567,"about_ca_topic_score_gemma":0.0027783094,"teacher_disagreement_score":0.0025637567,"about_ca_system_score_codex":0.00068248826,"about_ca_system_score_gemma":0.00043425485,"threshold_uncertainty_score":0.0052682757},"labels":[],"label_agreement":null},{"id":"W4235288901","doi":"10.1016/j.jaad.2018.05.546","title":"Epidemiology of diffuse large B-cell lymphoma in Canada","year":2018,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Epidemiology; Lymphoma; Dermatology; Diffuse large B-cell lymphoma; Pathology","score_opus":0.018282922450906507,"score_gpt":0.30332098257356827,"score_spread":0.28503806012266175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4235288901","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9673969,0.0066155987,0.00024626305,0.00250626,0.00010579739,0.00011293006,0.012690652,0.000060080663,0.010265576],"genre_scores_gemma":[0.99348044,0.0029481684,0.00015197226,0.00031830865,0.000029711351,0.000018737608,0.0016927726,0.00001311771,0.001346806],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985989,0.0000895372,0.00012977167,0.00019573589,0.00043685685,0.00054924993],"domain_scores_gemma":[0.9960736,0.00014927427,0.00077042816,0.000070818605,0.0015894674,0.0013464489],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035227736,0.000431404,0.0004661246,0.003988109,0.0027536403,0.0019352186,0.0015122197,0.0008814961,0.0048089423],"category_scores_gemma":[0.0020914804,0.0005604236,0.00087339716,0.00936017,0.00091000536,0.0006174807,0.001122198,0.0010972228,0.0003932214],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000736007,0.00003238815,0.99403,0.0000447075,0.00006394612,0.00026291597,0.00023495554,0.00015708042,0.00018875266,0.00027730796,0.0018592479,0.002775047],"study_design_scores_gemma":[0.000016591828,0.00003118055,0.9941267,0.00009861982,0.00004719163,0.0005331573,0.0019879562,0.0003859436,0.00006404255,0.000067191715,0.0026174341,0.000024004461],"about_ca_topic_score_codex":0.99373627,"about_ca_topic_score_gemma":0.99497026,"teacher_disagreement_score":0.03942732,"about_ca_system_score_codex":0.03942732,"about_ca_system_score_gemma":0.050099917,"threshold_uncertainty_score":0.2860666},"labels":[],"label_agreement":null},{"id":"W4235339542","doi":"10.1016/j.jaad.2018.05.735","title":"Long-term incidence and geographic trends of follicular lymphoma in Canada: A population-based study","year":2018,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Follicular lymphoma; Incidence (geometry); Term (time); Population; Follicular phase; Demography; Lymphoma; Environmental health; Internal medicine","score_opus":0.011264561706176745,"score_gpt":0.29121312827931845,"score_spread":0.2799485665731417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4235339542","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99379,0.0008146725,0.000070393,0.00020043425,0.000009436613,0.000028749966,0.0039738095,0.00001187567,0.0011007218],"genre_scores_gemma":[0.9972378,0.00044079038,0.00009093705,0.00008242301,0.000008769336,0.000011036156,0.0017481073,0.000004888837,0.0003751824],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989236,0.00006141389,0.000090668604,0.0002103144,0.0003047284,0.00040925128],"domain_scores_gemma":[0.9971553,0.00009957733,0.00047687095,0.00010294363,0.001418285,0.0007469903],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004993032,0.00048328534,0.00057871745,0.002169827,0.0025289527,0.0016055959,0.0015652172,0.0009442933,0.0016387088],"category_scores_gemma":[0.0016432444,0.0005029818,0.0010133919,0.0072541498,0.00100087,0.0008238197,0.000896765,0.0010684228,0.0003006989],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058382167,0.000028889503,0.9983114,0.000011198071,0.000058083664,0.000064101434,0.00017772874,0.00003702205,0.000085000334,0.000024444704,0.0002585903,0.0008851711],"study_design_scores_gemma":[0.0000056610957,0.000021177375,0.9987305,0.000009515661,0.000037549235,0.00007760833,0.00066870125,0.00010862796,0.000019713541,0.000011530917,0.00030098186,0.000008309916],"about_ca_topic_score_codex":0.9829543,"about_ca_topic_score_gemma":0.9832696,"teacher_disagreement_score":0.022796633,"about_ca_system_score_codex":0.022796633,"about_ca_system_score_gemma":0.019106682,"threshold_uncertainty_score":0.16540194},"labels":[],"label_agreement":null},{"id":"W4235468158","doi":"10.1016/j.jaad.2015.02.206","title":"Hidradenitis suppurativa: Canadian dermatologists perspective","year":2015,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Hidradenitis suppurativa; Medicine; Dermatology; Perspective (graphical); Pathology; Artificial intelligence; Disease","score_opus":0.03694195619633782,"score_gpt":0.34347280000988384,"score_spread":0.306530843813546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4235468158","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014099057,0.3279475,0.00009020501,0.6074902,0.014671058,0.0000185144,0.00025569677,0.000022118424,0.04809482],"genre_scores_gemma":[0.038644657,0.7038832,0.00063577347,0.20732902,0.034565326,0.000023126484,0.00022693729,0.000018377214,0.014673621],"study_design_codex":"not_applicable","study_design_gemma":"qualitative","domain_scores_codex":[0.9973404,0.00025986286,0.00016267109,0.00021058272,0.0012359342,0.0007906441],"domain_scores_gemma":[0.9861187,0.001240837,0.0005897197,0.00010158845,0.0075537483,0.0043953774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029832374,0.0007197624,0.0008494937,0.0034308073,0.0055886316,0.005466578,0.0013229734,0.008896466,0.018749649],"category_scores_gemma":[0.0058811298,0.00038803022,0.0007572226,0.0038078085,0.004235435,0.0024860306,0.0015583207,0.009992675,0.0016880134],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009031785,0.00014159658,0.0038079997,0.0012328993,0.000050442384,0.0023385095,0.00078924285,0.00017750236,0.00033933518,0.019511113,0.8836974,0.087823674],"study_design_scores_gemma":[0.00007297418,0.000035568064,0.0073239435,0.002338848,0.00005793945,0.0016373383,0.0019394493,0.000056672467,0.00004400724,0.0018579644,0.9845867,0.000048624872],"about_ca_topic_score_codex":0.8388985,"about_ca_topic_score_gemma":0.95025265,"teacher_disagreement_score":0.16110152,"about_ca_system_score_codex":0.035800874,"about_ca_system_score_gemma":0.081745565,"threshold_uncertainty_score":0.3241005},"labels":[],"label_agreement":null},{"id":"W4235949135","doi":"10.1016/j.jaad.2003.10.329","title":"Prevalence and epidemiology of onychomycosis in patients visiting physicians’ offices: a multicenter Canadian survey of 35,000 patients","year":2004,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Epidemiology; Multicenter study; Family medicine; Environmental health; Dermatology; Surgery; Internal medicine; Randomized controlled trial","score_opus":0.019461271737805576,"score_gpt":0.30990839705534284,"score_spread":0.29044712531753725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4235949135","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99519867,0.0005686885,0.000049800063,0.00018446887,0.000010478537,0.000043043816,0.0024961208,0.000009014904,0.0014398127],"genre_scores_gemma":[0.9978666,0.0005029941,0.00013082488,0.00011891526,0.0000081470625,0.000015697377,0.0010426923,0.000004608304,0.00030963635],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99852055,0.0001146095,0.000104062245,0.00023069128,0.0005181592,0.00051200716],"domain_scores_gemma":[0.9977215,0.00010333021,0.0004970072,0.00006194307,0.0010014084,0.00061475154],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070554845,0.0006997131,0.00064339273,0.0024077718,0.0027610785,0.0014044658,0.0019538084,0.0011394091,0.0016143711],"category_scores_gemma":[0.0018330992,0.00077672774,0.0010008052,0.005655576,0.0010243654,0.0008452011,0.00097544526,0.0010126054,0.00023762169],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046885554,0.000045623117,0.9981509,0.000017244614,0.000039501025,0.000071584924,0.0003773592,0.000030588024,0.0001449601,0.000021137108,0.00033011948,0.0007242512],"study_design_scores_gemma":[0.0000044627127,0.00002711662,0.998782,0.000010391715,0.000018345643,0.00011740421,0.00076254335,0.00006576811,0.0000177068,0.000004958671,0.00018200403,0.0000074043264],"about_ca_topic_score_codex":0.97754514,"about_ca_topic_score_gemma":0.98218185,"teacher_disagreement_score":0.022454858,"about_ca_system_score_codex":0.014145463,"about_ca_system_score_gemma":0.013738515,"threshold_uncertainty_score":0.102633},"labels":[],"label_agreement":null},{"id":"W4237011638","doi":"10.1016/j.jaad.2006.10.831","title":"Association of stat3 variants and psoriasis in the Newfoundland and Labrador (NL) founder population","year":2007,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Founder effect; Psoriasis; Population; Genetics; Dermatology; Demography; Haplotype; Gene; Genotype; Environmental health; Biology","score_opus":0.01644531077510608,"score_gpt":0.3206746282119794,"score_spread":0.3042293174368733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4237011638","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980324,0.000150319,0.00009471328,0.00012418082,0.00000882157,0.000005015318,0.0006983423,0.00000792986,0.00087824493],"genre_scores_gemma":[0.99820006,0.00008565287,0.00015976018,0.000072965326,0.000010818634,0.000007488684,0.0005291489,0.000009503308,0.00092453195],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993381,0.0001226263,0.000059500097,0.00019162847,0.000113543254,0.00017470798],"domain_scores_gemma":[0.99897975,0.00021217487,0.00031279874,0.00007010985,0.00017306492,0.00025208792],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005118813,0.00050890713,0.0006086836,0.0018886854,0.0012269948,0.0005833752,0.00078712613,0.0005342308,0.0052966117],"category_scores_gemma":[0.0013287422,0.00034346647,0.0006186863,0.0014464065,0.00065886916,0.00041233207,0.00042889168,0.0006168681,0.00040969535],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006667083,0.000080179096,0.99181694,0.000008915988,0.00016953872,0.0009204198,0.00023538792,0.00013755469,0.0032083755,0.00008984147,0.0006024597,0.0020636676],"study_design_scores_gemma":[0.000028722827,0.00006233119,0.99801517,0.000008363754,0.000094154086,0.0007796903,0.00029499058,0.00022002036,0.0001562368,0.000020620751,0.00031082128,0.000008889299],"about_ca_topic_score_codex":0.47239068,"about_ca_topic_score_gemma":0.52184594,"teacher_disagreement_score":0.52760935,"about_ca_system_score_codex":0.0017108561,"about_ca_system_score_gemma":0.0017027744,"threshold_uncertainty_score":0.9392821},"labels":[],"label_agreement":null},{"id":"W4238976693","doi":"10.1016/j.jaad.2004.10.520","title":"Sertaconazole nitrate has a broad spectrum of activity in vitro","year":2005,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mediprobe Research (Canada); Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Broad spectrum; Nitrate; In vitro; Spectrum (functional analysis); Genetics; Ecology; Combinatorial chemistry; Biology","score_opus":0.018222490939380245,"score_gpt":0.31724835321064987,"score_spread":0.29902586227126965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4238976693","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92936754,0.041573815,0.0048775775,0.0010137784,0.0004661173,0.00017658457,0.0022224872,0.00042150627,0.019880636],"genre_scores_gemma":[0.9729604,0.011835951,0.0019991559,0.0002658694,0.00015073441,0.00006526162,0.00332445,0.00006012704,0.009337854],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997255,0.000088196175,0.000026291107,0.000029879704,0.00007320846,0.00005692516],"domain_scores_gemma":[0.9996501,0.0001284732,0.000028882758,0.0000415807,0.00008132422,0.00006972574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002997515,0.0005481604,0.000825298,0.00035548996,0.00036311915,0.00031003627,0.00039657086,0.00043986473,0.0034797664],"category_scores_gemma":[0.00037204102,0.00020037347,0.00050216174,0.00025942104,0.000258685,0.00021332786,0.00023140448,0.0008451069,0.0011821908],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013789188,0.00023556042,0.00032209486,0.00024375517,0.000026412541,0.00020198822,0.000058441015,0.0002162459,0.98336315,0.00014148223,0.0009722518,0.012839741],"study_design_scores_gemma":[0.00035345065,0.0062365797,0.005772505,0.000041357554,0.00008078249,0.0011238318,0.00007311772,0.00049367745,0.9732529,0.000091430455,0.01245663,0.000023777022],"about_ca_topic_score_codex":0.0026846384,"about_ca_topic_score_gemma":0.006075621,"teacher_disagreement_score":0.0034797664,"about_ca_system_score_codex":0.00029168246,"about_ca_system_score_gemma":0.0005283769,"threshold_uncertainty_score":0.011641026},"labels":[],"label_agreement":null},{"id":"W4238989400","doi":"10.1016/j.jaad.2004.10.528","title":"Tinea corporis with subepidermal vesiculation: A report of three cases","year":2005,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Mediprobe Research (Canada)","funders":"","keywords":"Medicine; Dermatology","score_opus":0.024251373851316593,"score_gpt":0.31712325413410464,"score_spread":0.29287188028278804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4238989400","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9697369,0.008096784,0.004129809,0.00081163313,0.00046406986,0.0002997109,0.0002493126,0.00027870454,0.015933186],"genre_scores_gemma":[0.996003,0.0010528046,0.0009449816,0.00027000005,0.00047832896,0.000048307986,0.000093182534,0.00004178137,0.0010675141],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9971589,0.00030418657,0.00033586516,0.0007191322,0.00035356358,0.0011284449],"domain_scores_gemma":[0.9946137,0.0017406364,0.0008749457,0.00093095034,0.0003294067,0.0015104311],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001034759,0.0052205687,0.0019797168,0.0043286076,0.0045609386,0.0033361602,0.0037784097,0.008105437,0.002932469],"category_scores_gemma":[0.008389278,0.0029036326,0.0022743142,0.0034340252,0.0056666723,0.002702352,0.003065956,0.0037180043,0.0017443274],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047536192,0.00011321615,0.008432243,0.000036066678,0.000018463337,0.9891243,0.000355266,0.00005033129,0.0005005237,0.00010815427,0.00012491699,0.0010890706],"study_design_scores_gemma":[0.000021587053,0.00009937879,0.0066259988,0.000013259555,0.00002785336,0.99190485,0.00030187357,0.0001321277,0.00044095793,0.00009412971,0.00031802003,0.00001989827],"about_ca_topic_score_codex":0.0032585275,"about_ca_topic_score_gemma":0.0031534755,"teacher_disagreement_score":0.008105437,"about_ca_system_score_codex":0.0016946113,"about_ca_system_score_gemma":0.0010536003,"threshold_uncertainty_score":0.012295246},"labels":[],"label_agreement":null},{"id":"W4239616806","doi":"10.1016/j.jaad.2018.05.207","title":"Analysis of availability and usage of current treatments for cutaneous T-cell lymphoma in Canada","year":2018,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Lymphoma; Current (fluid); Dermatology; Cutaneous T-cell lymphoma; Internal medicine; Mycosis fungoides","score_opus":0.02444176298645398,"score_gpt":0.34575471439621397,"score_spread":0.32131295140976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4239616806","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9490049,0.0064322334,0.00023939113,0.002973191,0.00005961963,0.00009498748,0.022137824,0.000038119608,0.019019723],"genre_scores_gemma":[0.99244237,0.0025003124,0.0001991818,0.00037948752,0.000017324079,0.00001640339,0.0022645404,0.00001878301,0.002161593],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979577,0.00015515566,0.00019546907,0.00020148704,0.00082557346,0.00066460966],"domain_scores_gemma":[0.9913884,0.00071449246,0.0017383756,0.00011324589,0.0038885148,0.0021569908],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060586777,0.00023579024,0.00040314283,0.0036994764,0.002053426,0.0019634904,0.0017631416,0.00059645326,0.0069702812],"category_scores_gemma":[0.0046911975,0.00031521384,0.00084979326,0.009983254,0.00077981735,0.00047223395,0.00087234844,0.0010887375,0.00048211985],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021325883,0.00005147435,0.98180836,0.00011639585,0.00013900262,0.00025404818,0.0008214407,0.00026643634,0.00020659213,0.0006536601,0.003613309,0.011856021],"study_design_scores_gemma":[0.000011453944,0.000030361702,0.9908676,0.00012485689,0.00007014746,0.00026860513,0.0028730084,0.00041511815,0.00011650445,0.00005171688,0.005149829,0.000020762302],"about_ca_topic_score_codex":0.99286014,"about_ca_topic_score_gemma":0.99514127,"teacher_disagreement_score":0.040384468,"about_ca_system_score_codex":0.040384468,"about_ca_system_score_gemma":0.04789194,"threshold_uncertainty_score":0.29301125},"labels":[],"label_agreement":null},{"id":"W4240889591","doi":"10.1016/s0190-9622(00)90164-6","title":"Alopecia areata update","year":2000,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Alopecia areata; Medicine; Dermatology; Etiology; Hair loss; Histopathology; Alopecia universalis; Pathogenesis; Disease; Immunology; Pathology","score_opus":0.010327212171099194,"score_gpt":0.29292460574759066,"score_spread":0.28259739357649144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4240889591","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.023269849,0.82284516,0.002456921,0.040842213,0.021347607,0.00009797635,0.0007817004,0.000551586,0.08780695],"genre_scores_gemma":[0.14844762,0.66844505,0.005056815,0.043615937,0.06496171,0.00012129847,0.002543928,0.00008018387,0.06672744],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997197,0.000036204056,0.000055989032,0.000034229684,0.00009045556,0.00006344951],"domain_scores_gemma":[0.9991799,0.00023290474,0.000111929505,0.000037939124,0.00030526097,0.00013193325],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005309909,0.00048298918,0.0007690661,0.0019665866,0.00044082472,0.0010024074,0.00054888113,0.0018529526,0.0062857782],"category_scores_gemma":[0.0013730198,0.0001474769,0.0005123182,0.00088382076,0.00024156054,0.0012109956,0.00046192147,0.0013856872,0.0022464318],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022502568,0.0001999512,0.007978124,0.001312403,0.00007203057,0.015687367,0.00009297362,0.00017621114,0.0012525228,0.0012304994,0.20941244,0.7623605],"study_design_scores_gemma":[0.00008899556,0.00015992002,0.015007738,0.0011321036,0.0002660639,0.07915507,0.00019206438,0.0002834946,0.00044330576,0.00078081596,0.90247095,0.000019557581],"about_ca_topic_score_codex":0.0017633706,"about_ca_topic_score_gemma":0.0065678232,"teacher_disagreement_score":0.0062857782,"about_ca_system_score_codex":0.0004215494,"about_ca_system_score_gemma":0.00054076564,"threshold_uncertainty_score":0.021028042},"labels":[],"label_agreement":null},{"id":"W4241204972","doi":"10.1016/j.jaad.2004.10.598","title":"Guidelines of care for actinic keratosis","year":2005,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada); Sunnybrook Health Science Centre; Health Sciences Centre","funders":"","keywords":"Medicine; Actinic keratosis; Dermatology; Keratosis; Pathology","score_opus":0.03848552100372998,"score_gpt":0.3938181691628929,"score_spread":0.35533264815916293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4241204972","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.020283535,0.26610407,0.026450766,0.4248515,0.021489646,0.005488341,0.007671087,0.0011381151,0.22652295],"genre_scores_gemma":[0.1568546,0.2182433,0.33448943,0.17766073,0.0094272215,0.014531021,0.02561742,0.00048359876,0.062692665],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9908902,0.0033804995,0.002873733,0.00018929303,0.002185097,0.00048129706],"domain_scores_gemma":[0.97561705,0.0051237806,0.003281558,0.00056143967,0.013764315,0.00165181],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008335396,0.00059214165,0.0010621303,0.003490224,0.0018432699,0.0020530762,0.0027992972,0.004617611,0.00553612],"category_scores_gemma":[0.026441645,0.0004323268,0.0017997974,0.0026402988,0.0007288449,0.0010841516,0.0013905605,0.004482104,0.002059746],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014010075,0.00041913425,0.012576737,0.0024872653,0.00014560728,0.0006661322,0.0005757215,0.0006091668,0.0006811143,0.009408055,0.6912815,0.28100947],"study_design_scores_gemma":[0.0004369917,0.0002703079,0.036508173,0.018018767,0.00035009213,0.0019831003,0.00082943216,0.00087577174,0.00063688116,0.0074114297,0.93259186,0.00008721658],"about_ca_topic_score_codex":0.024089506,"about_ca_topic_score_gemma":0.05153728,"teacher_disagreement_score":0.024089506,"about_ca_system_score_codex":0.003306886,"about_ca_system_score_gemma":0.015158365,"threshold_uncertainty_score":0.04789859},"labels":[],"label_agreement":null},{"id":"W4241294363","doi":"10.1016/j.jaad.2005.08.067","title":"Infectious occupational exposures in dermatology–A review of risks and prevention measures","year":2005,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Parvovirus B19 Infection Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"","keywords":"Medicine; Physician assistants; Family medicine; Occupational medicine; Occupational exposure; Health care; Dermatology; Nurse practitioners; Environmental health","score_opus":0.0725395768800677,"score_gpt":0.4158172995376334,"score_spread":0.34327772265756573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4241294363","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00031422707,0.998979,0.00007766274,0.00031014121,0.00007056566,0.0000068980953,0.000011626242,0.0000014686445,0.00022847146],"genre_scores_gemma":[0.0018015287,0.9974806,0.00027965507,0.00015373543,0.00019334578,0.000008029106,0.000013308162,6.141929e-7,0.000069121124],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9979545,0.0005957163,0.00056563306,0.00020833258,0.0006203904,0.00005538615],"domain_scores_gemma":[0.9932105,0.005350645,0.0006770658,0.00008860017,0.00058782357,0.000085381405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035224978,0.0009783813,0.003255108,0.0045106597,0.0005625627,0.0018884265,0.0012953324,0.0018854566,0.0015492478],"category_scores_gemma":[0.004729233,0.0006307975,0.0015008786,0.0037251934,0.00073239335,0.0020522664,0.0006167752,0.001245387,0.00044120412],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037397238,0.00044151282,0.0063276133,0.057108324,0.0009343672,0.0006385597,0.00024183866,0.00035864525,0.0006514386,0.0016826205,0.009332443,0.92190874],"study_design_scores_gemma":[0.0004115384,0.002684077,0.096762784,0.15946425,0.00740867,0.01747765,0.0030512016,0.0008234062,0.002562911,0.008583322,0.70044756,0.00032269873],"about_ca_topic_score_codex":0.00308394,"about_ca_topic_score_gemma":0.0069469195,"teacher_disagreement_score":0.0045106597,"about_ca_system_score_codex":0.0009831327,"about_ca_system_score_gemma":0.0021350007,"threshold_uncertainty_score":0.018629014},"labels":[],"label_agreement":null},{"id":"W4242507114","doi":"10.1016/j.jaad.2016.02.446","title":"Ten-year review of inpatient consultations at St. Paul‘s Hospital in Vancouver, BC","year":2016,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Primary Care and Health Outcomes","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Gerontology; Family medicine","score_opus":0.022938903025469738,"score_gpt":0.39214015898080584,"score_spread":0.3692012559553361,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4242507114","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.54839635,0.41404542,0.00024650793,0.0058813714,0.00091450213,0.00050656317,0.014254128,0.000045833287,0.015709274],"genre_scores_gemma":[0.80370754,0.17813018,0.0007424166,0.00339379,0.00035231776,0.00023577441,0.00994912,0.000039589355,0.0034493294],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9923636,0.0012475826,0.001961912,0.0004792618,0.003085174,0.000862573],"domain_scores_gemma":[0.9760808,0.0032946852,0.0052422136,0.00031171253,0.013100387,0.001970317],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019228259,0.0002705986,0.0009913193,0.004289373,0.0021039334,0.0022157866,0.001182316,0.00075188826,0.001828096],"category_scores_gemma":[0.015149356,0.00048443608,0.0005947194,0.010268825,0.00046626793,0.00059215206,0.0010909624,0.0009098658,0.00035882246],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005203693,0.0002705677,0.70938724,0.016353087,0.00115912,0.004688875,0.0092554,0.00017240302,0.00061590696,0.00030690196,0.05936254,0.19790764],"study_design_scores_gemma":[0.000026167801,0.000083827814,0.94881004,0.007496351,0.00039181823,0.0022016426,0.0092199,0.00008611908,0.000101546255,0.000025621273,0.031523224,0.000033689066],"about_ca_topic_score_codex":0.6963412,"about_ca_topic_score_gemma":0.910634,"teacher_disagreement_score":0.30365878,"about_ca_system_score_codex":0.014938312,"about_ca_system_score_gemma":0.030952215,"threshold_uncertainty_score":0.6108942},"labels":[],"label_agreement":null},{"id":"W4242757905","doi":"10.1016/j.jaad.2004.10.245","title":"Recalcitrant necrobiotic xanthogranuloma responding to infliximab","year":2005,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Infectious Disease Case Reports and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Infliximab; Dermatology; Immunology; Tumor necrosis factor alpha","score_opus":0.013553684042769987,"score_gpt":0.32882269802027747,"score_spread":0.3152690139775075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4242757905","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94492996,0.0069677215,0.0031775625,0.0046351776,0.00049858,0.0002958886,0.0001784104,0.00039976728,0.038916923],"genre_scores_gemma":[0.9939237,0.00085999235,0.0007198791,0.0011270215,0.00080591807,0.000024860057,0.00008005326,0.000035172026,0.002423372],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9993067,0.0001468755,0.00009339778,0.00010507115,0.00011433092,0.00023356226],"domain_scores_gemma":[0.99789894,0.0010275999,0.0003893151,0.00022691794,0.00008543086,0.00037178447],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008851009,0.0018131989,0.0014071802,0.0015935807,0.0019648026,0.00094444177,0.0011353348,0.0030747717,0.003077315],"category_scores_gemma":[0.0038572925,0.0006089851,0.0011369078,0.0010410537,0.0011930452,0.000979894,0.0005694689,0.0026987174,0.0011974644],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030680146,0.00005453949,0.0025756392,0.000055797835,0.000018494311,0.9928381,0.00008253954,0.000065350774,0.0014814623,0.00019207387,0.00024179526,0.0020873337],"study_design_scores_gemma":[0.00034647717,0.00046301843,0.015349304,0.000033023913,0.000100053665,0.97879124,0.00014013557,0.0007472079,0.0017034975,0.0004723139,0.0018382927,0.000015442096],"about_ca_topic_score_codex":0.0012561142,"about_ca_topic_score_gemma":0.0012582246,"teacher_disagreement_score":0.003077315,"about_ca_system_score_codex":0.00092479785,"about_ca_system_score_gemma":0.00042313564,"threshold_uncertainty_score":0.010294676},"labels":[],"label_agreement":null},{"id":"W4242976790","doi":"10.1016/j.jaad.2007.05.038","title":"Reply","year":2007,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Vascular Malformations and Hemangiomas","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Imiquimod; Medicine; Randomized controlled trial; Infantile hemangioma; Pediatrics; Surgery; Dermatology; Hemangioma","score_opus":0.015785247698903646,"score_gpt":0.32098143930667516,"score_spread":0.3051961916077715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4242976790","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000390266,0.0014236189,0.000077053744,0.9275844,0.06785986,0.000013782575,0.00009174921,0.00003215247,0.0025270854],"genre_scores_gemma":[0.0023724497,0.0005872421,0.00009254933,0.9621123,0.025129804,0.000034107605,0.000037903756,0.000017491479,0.009616027],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977102,0.0004471008,0.00028398732,0.00046038578,0.00064982806,0.00044837582],"domain_scores_gemma":[0.9901204,0.003611078,0.00067829184,0.0003667159,0.0035036404,0.0017197869],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029846488,0.0006792772,0.0011326586,0.0010961153,0.0033926282,0.0042865938,0.0018596179,0.03184495,0.015556436],"category_scores_gemma":[0.025976209,0.0007524976,0.0011933515,0.0006853039,0.0021207884,0.0036210679,0.0026948303,0.030727413,0.010746668],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003234962,0.000013191397,0.00052346697,0.000033838056,0.000012980097,0.00032621025,0.00009966285,0.000014452284,0.000077939876,0.0010430339,0.99517184,0.002651045],"study_design_scores_gemma":[0.00005429439,0.000029190047,0.0018957608,0.00014543517,0.000033184744,0.0008787638,0.00063552527,0.0000734753,0.00017571531,0.0020762295,0.99394554,0.000056811918],"about_ca_topic_score_codex":0.004517199,"about_ca_topic_score_gemma":0.0055172686,"teacher_disagreement_score":0.03184495,"about_ca_system_score_codex":0.0024039596,"about_ca_system_score_gemma":0.0038290806,"threshold_uncertainty_score":0},"labels":[],"label_agreement":null},{"id":"W4243334477","doi":"10.1016/j.jaad.2019.06.1270","title":"Vaginal and vulvular incidence and mortality trends in Canada: A comprehensive population-based study","year":2019,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Health disparities and outcomes","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Incidence (geometry); Demography; Population; Environmental health","score_opus":0.02604011842693908,"score_gpt":0.3644171639323241,"score_spread":0.338377045505385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4243334477","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9805031,0.0012919805,0.00011745182,0.0004534513,0.000022456426,0.000077503384,0.015687373,0.000020864845,0.0018258035],"genre_scores_gemma":[0.9918637,0.00092698564,0.00020886985,0.0002578291,0.000017887345,0.00003201404,0.005866031,0.000010224809,0.0008164716],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99842536,0.00008129704,0.00012769637,0.00030249855,0.0004728506,0.00059029716],"domain_scores_gemma":[0.9968034,0.00010622497,0.0005167805,0.00010994678,0.0016204328,0.00084323843],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005746739,0.0006708679,0.0009211382,0.0030808481,0.0033709642,0.002108958,0.002114716,0.0013812042,0.0020175849],"category_scores_gemma":[0.0021073963,0.0007965197,0.0017308069,0.01151738,0.0008312988,0.0009947105,0.0014172839,0.001638587,0.00036915863],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005916668,0.00006508303,0.9969741,0.000025316607,0.0001315061,0.00006272348,0.00023521046,0.000056689183,0.00006368091,0.000053909956,0.0009706944,0.0013020475],"study_design_scores_gemma":[0.000011000005,0.000018766465,0.99840206,0.00002568004,0.000066766675,0.0000661818,0.00078818423,0.00015632599,0.000021761549,0.000019136236,0.00041226656,0.00001189974],"about_ca_topic_score_codex":0.99078685,"about_ca_topic_score_gemma":0.9941907,"teacher_disagreement_score":0.02736913,"about_ca_system_score_codex":0.02736913,"about_ca_system_score_gemma":0.03778448,"threshold_uncertainty_score":0.19857782},"labels":[],"label_agreement":null},{"id":"W4244308554","doi":"10.1016/j.jaad.2004.10.640","title":"A placebo-controlled european study comparing MAL–PDT with cryotherapy and 5-fluorouracil in patients with Bowen's disease","year":2005,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Selkirk College","funders":"","keywords":"Medicine; Cryotherapy; Fluorouracil; Bowen's disease; Placebo; Internal medicine; Oncology; Dermatology; Surgery; Chemotherapy; Pathology; Basal cell","score_opus":0.009405296631452375,"score_gpt":0.2678255837360194,"score_spread":0.258420287104567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4244308554","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9822614,0.013042087,0.0005171991,0.0004664486,0.0004331165,0.0009497536,0.00042572373,0.000035688437,0.0018684795],"genre_scores_gemma":[0.9930074,0.0031271684,0.0007414173,0.0007156091,0.00036747562,0.00062315486,0.00040206747,0.000009703719,0.0010059264],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99855167,0.0008981112,0.00012388894,0.00020263321,0.000057224916,0.00016643738],"domain_scores_gemma":[0.9986927,0.0005032766,0.00027506155,0.00014850647,0.000105212086,0.00027523606],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023302187,0.0011028139,0.0029614724,0.0004430115,0.00070697773,0.00072638824,0.0007319448,0.0020426589,0.0052665],"category_scores_gemma":[0.0021380628,0.00062960316,0.002850964,0.0005800112,0.0012260992,0.0010350671,0.00048416975,0.0022053323,0.00049383397],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98269975,0.0045806724,0.0006373863,0.00047169242,0.001545055,0.000027647136,0.00003229449,0.00006725553,0.0023985582,0.00005304118,0.00017882972,0.007307809],"study_design_scores_gemma":[0.7996348,0.18533619,0.009568129,0.00009248718,0.0029682193,0.00006919371,0.00007142072,0.000146243,0.0007923238,0.000082506886,0.0012136648,0.00002492304],"about_ca_topic_score_codex":0.0015185463,"about_ca_topic_score_gemma":0.002556513,"teacher_disagreement_score":0.0052665,"about_ca_system_score_codex":0.0007443527,"about_ca_system_score_gemma":0.000876056,"threshold_uncertainty_score":0.01761818},"labels":[],"label_agreement":null},{"id":"W4244401231","doi":"10.1016/j.jaad.2005.04.080","title":"False firstedness","year":2005,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Sympathectomy and Hyperhidrosis Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Paragraph; Scopus; Medical journal; Notice; MEDLINE; Library science; Family medicine; World Wide Web; Computer science; Law","score_opus":0.024224962515939672,"score_gpt":0.3175039747703653,"score_spread":0.2932790122544256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4244401231","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006243795,0.0056217257,0.00026698827,0.87221557,0.035862297,0.000018187295,0.000048136393,0.000036193287,0.07968723],"genre_scores_gemma":[0.08908015,0.0032769034,0.0005162426,0.8022105,0.040230025,0.000029149995,0.000037260736,0.00003127544,0.06458846],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.9991435,0.0002453605,0.000060199618,0.00016067261,0.00019024237,0.0002000959],"domain_scores_gemma":[0.9980521,0.000763663,0.00013031186,0.000118989796,0.00044701778,0.00048794513],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00094022823,0.000373703,0.00048452427,0.00048710758,0.003714511,0.0018955328,0.0006774492,0.011865744,0.0075108795],"category_scores_gemma":[0.01143597,0.00029044927,0.0004510511,0.0002639045,0.0015245336,0.0017411313,0.00072493317,0.015653469,0.0018629807],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008678285,0.00007804072,0.0038981216,0.000052679698,0.000032005984,0.06140843,0.00072778936,0.00008375118,0.0003336726,0.01512921,0.9023715,0.015797935],"study_design_scores_gemma":[0.0000779635,0.000083597966,0.004203193,0.0004597397,0.0000472767,0.11847031,0.0014045286,0.0005571728,0.000291111,0.015908642,0.85845625,0.00004021124],"about_ca_topic_score_codex":0.0038687624,"about_ca_topic_score_gemma":0.009318724,"teacher_disagreement_score":0.011865744,"about_ca_system_score_codex":0.0024923899,"about_ca_system_score_gemma":0.001849159,"threshold_uncertainty_score":0.025126338},"labels":[],"label_agreement":null},{"id":"W4244735314","doi":"10.1016/j.jaad.2021.06.703","title":"28076 Patient perceptions of aesthetic benefit: Comparing benign lesion clearance to other common aesthetic procedures","year":2021,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Body Image and Dysmorphia Studies","field":"Psychology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"","keywords":"Medicine; Lesion; Contouring; Surgery; Aesthetic value; Dermatology; Aesthetics","score_opus":0.027745071710301127,"score_gpt":0.34115256592598586,"score_spread":0.31340749421568476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4244735314","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973768,0.00013597282,0.000040523646,0.00003363616,0.000017705665,0.000023600674,0.000052147796,0.000002123291,0.002317522],"genre_scores_gemma":[0.99923885,0.00006496579,0.00010105546,0.000046462177,0.000017356117,0.000013174003,0.000039715742,0.0000016052237,0.0004766903],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990632,0.00042047928,0.000094952346,0.00005445348,0.00028421055,0.00008276072],"domain_scores_gemma":[0.9950346,0.0032118035,0.0007025809,0.00012511082,0.00036439495,0.0005615777],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019595379,0.00019962137,0.00031310678,0.0005983191,0.00035824534,0.00040189843,0.00018549581,0.00027611342,0.007956287],"category_scores_gemma":[0.0078011267,0.00010636201,0.0005096734,0.00042788405,0.00040212914,0.00058311893,0.0003672995,0.00039636524,0.0006113257],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09481796,0.012168802,0.7053696,0.00056110125,0.000727726,0.00076935044,0.0031060108,0.0013858534,0.011180173,0.0008093138,0.00286221,0.16624193],"study_design_scores_gemma":[0.0023804253,0.07254816,0.9133976,0.000056529992,0.00038887863,0.0010975392,0.0027616022,0.0013279377,0.0027121152,0.0003000847,0.0029704738,0.00005869216],"about_ca_topic_score_codex":0.00088000443,"about_ca_topic_score_gemma":0.0017463556,"teacher_disagreement_score":0.007956287,"about_ca_system_score_codex":0.00051764236,"about_ca_system_score_gemma":0.00030950553,"threshold_uncertainty_score":0.026616454},"labels":[],"label_agreement":null},{"id":"W4244956376","doi":"10.1016/j.jaad.2004.10.832","title":"Superior periorbital wrinkles rejuvenation using ablative plasma skin resurfacing","year":2005,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Facial Rejuvenation and Surgery Techniques","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Rejuvenation; Ablative case; Medicine; Dermatology; Cosmetic Techniques; Intense pulsed light; Surgery; Skin Aging; Photoaging; Radiation therapy","score_opus":0.02600724864050696,"score_gpt":0.33924042223594586,"score_spread":0.3132331735954389,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4244956376","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97358084,0.0013395157,0.009968686,0.00055922725,0.00021809303,0.00016067312,0.000052977048,0.0006145267,0.01350551],"genre_scores_gemma":[0.99398214,0.00034118394,0.0017292545,0.00016238252,0.000068269524,0.000025054263,0.000024766625,0.000030338104,0.0036366116],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99983144,0.000018139126,0.000009067517,0.000030473071,0.00006084106,0.00005009171],"domain_scores_gemma":[0.9999175,0.000023797958,0.000012769022,0.000028127113,0.000005901704,0.000011825982],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022989984,0.0005972252,0.0003961771,0.00050524605,0.0007025807,0.0003186335,0.00038425068,0.00047105242,0.0043941825],"category_scores_gemma":[0.00031940482,0.00024817922,0.0006682128,0.00018973062,0.0006459967,0.0007104543,0.00039318352,0.0011340431,0.00069679687],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0063513042,0.0037590992,0.005475109,0.00057743007,0.00024527896,0.11636784,0.00052656897,0.0015360301,0.599432,0.0030233134,0.0030160064,0.25969008],"study_design_scores_gemma":[0.003474883,0.023320345,0.06358916,0.00012479829,0.00055839954,0.4831189,0.0006229587,0.02010421,0.3749379,0.0025272355,0.027487243,0.00013393091],"about_ca_topic_score_codex":0.0006847457,"about_ca_topic_score_gemma":0.0013812963,"teacher_disagreement_score":0.0043941825,"about_ca_system_score_codex":0.0002258957,"about_ca_system_score_gemma":0.00028899635,"threshold_uncertainty_score":0.0146999955},"labels":[],"label_agreement":null},{"id":"W4246138268","doi":"10.1016/j.jaad.2019.06.665","title":"Case report: Invasive melanoma in a 5-year-old Canadian patient","year":2019,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Melanoma; Dermatology; Cancer research","score_opus":0.011064330133025033,"score_gpt":0.2582599486038765,"score_spread":0.24719561847085147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4246138268","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9411291,0.0039542904,0.0014814235,0.011372343,0.0011246793,0.00029731955,0.0010705774,0.00023182556,0.039338384],"genre_scores_gemma":[0.98944014,0.0013021816,0.0010756543,0.0017606876,0.000916759,0.000025915713,0.00025763092,0.000040069357,0.0051809438],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9993801,0.000021971056,0.000043989596,0.000121822275,0.00011765807,0.0003144015],"domain_scores_gemma":[0.9989097,0.00015651427,0.00016512923,0.000038947892,0.0001421487,0.0005875179],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026512638,0.0022679458,0.001098427,0.0027434991,0.007894934,0.0020950413,0.002015512,0.005798924,0.0038943233],"category_scores_gemma":[0.0020874755,0.00083251245,0.0015252024,0.002091161,0.0018016385,0.0013934313,0.00169299,0.0034600713,0.0012745715],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018815672,0.000041011575,0.005298124,0.000013523977,0.0000038819776,0.9930888,0.00014130649,0.000044516753,0.0002841433,0.00011196325,0.0004363914,0.00051760796],"study_design_scores_gemma":[0.000006692567,0.00004547071,0.008556729,0.000021116946,0.000014754087,0.9895886,0.0005254289,0.00020270556,0.00016902541,0.000106204,0.00074796536,0.000015338881],"about_ca_topic_score_codex":0.1428089,"about_ca_topic_score_gemma":0.22552304,"teacher_disagreement_score":0.8571911,"about_ca_system_score_codex":0.0072060004,"about_ca_system_score_gemma":0.0055734916,"threshold_uncertainty_score":0.28395534},"labels":[],"label_agreement":null},{"id":"W4247176307","doi":"10.1016/j.jaad.2018.05.209","title":"Analysis of incidence and geographic distribution of myeloproliferative neoplasms in Canada","year":2018,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Incidence (geometry); Distribution (mathematics); Dermatology","score_opus":0.009336622356722732,"score_gpt":0.2829380887523283,"score_spread":0.27360146639560556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4247176307","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98104835,0.0022772974,0.00016570817,0.00045459674,0.000019730976,0.000047916175,0.01059716,0.000024496585,0.0053646285],"genre_scores_gemma":[0.9951658,0.0013254306,0.00014753419,0.000076082266,0.000009523701,0.000011404989,0.002440195,0.000008451448,0.0008155779],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988802,0.00008222614,0.000102851416,0.00013830065,0.00038669852,0.00040974078],"domain_scores_gemma":[0.9964217,0.00020595732,0.0005665482,0.00007443944,0.001964585,0.00076675403],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004046429,0.00031942734,0.00037308875,0.004306023,0.0018563016,0.0012054616,0.0013025189,0.0004353908,0.003302096],"category_scores_gemma":[0.0023108008,0.00038719492,0.0008850519,0.0096574705,0.00062151783,0.00030274762,0.0007120669,0.0005933444,0.00030841833],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007178757,0.000016081078,0.9950924,0.00002656487,0.00006890949,0.000108076616,0.00016918873,0.00013408766,0.00011258185,0.00014435944,0.0008671964,0.0031888974],"study_design_scores_gemma":[0.0000055164764,0.000014292272,0.99760604,0.000022254204,0.000035276553,0.00016467844,0.00085612515,0.00026698766,0.000059726026,0.000020458778,0.000941085,0.0000075890694],"about_ca_topic_score_codex":0.99099356,"about_ca_topic_score_gemma":0.9923735,"teacher_disagreement_score":0.021086369,"about_ca_system_score_codex":0.021086369,"about_ca_system_score_gemma":0.028571082,"threshold_uncertainty_score":0.15299302},"labels":[],"label_agreement":null},{"id":"W4247576793","doi":"10.1016/j.jaad.2018.05.959","title":"Real-world safety of secukinumab in patients with moderate to severe chronic plaque psoriasis in Latin America and Canada: Results from the PURE registry","year":2018,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Secukinumab; Medicine; Plaque psoriasis; Latin Americans; Dermatology; Psoriasis; Family medicine; Environmental health; Psoriatic arthritis","score_opus":0.008009628017007464,"score_gpt":0.22717380278816046,"score_spread":0.219164174771153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4247576793","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9733074,0.0033093533,0.00025504187,0.0010907538,0.00003479006,0.00018486178,0.01684521,0.000032718384,0.0049399375],"genre_scores_gemma":[0.98623985,0.00206809,0.0002858982,0.00057305826,0.00003563723,0.00007678659,0.009814685,0.000021537171,0.00088441663],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970259,0.0005084026,0.0002508335,0.00034299295,0.0012782173,0.0005937175],"domain_scores_gemma":[0.99042505,0.0009557872,0.0023734225,0.00047329493,0.0048271525,0.00094527286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030554526,0.0003846522,0.00092639984,0.0009709061,0.0011602173,0.0021439355,0.001142874,0.0005082447,0.0014916224],"category_scores_gemma":[0.0073271506,0.00028315003,0.00087172684,0.0042079864,0.00092829065,0.00057359773,0.00080626993,0.0007340907,0.00022860736],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018291393,0.000111457135,0.9870415,0.00014086923,0.0004534974,0.00007445706,0.00026977892,0.00020191444,0.00013155461,0.00017938067,0.0022676634,0.007298755],"study_design_scores_gemma":[0.00064648,0.000310026,0.99218786,0.00014650304,0.00057856715,0.0001579574,0.0011341373,0.0003925378,0.0001718873,0.00007773612,0.004159677,0.000036526413],"about_ca_topic_score_codex":0.91541314,"about_ca_topic_score_gemma":0.94022536,"teacher_disagreement_score":0.08458686,"about_ca_system_score_codex":0.018812804,"about_ca_system_score_gemma":0.03469262,"threshold_uncertainty_score":0.17016995},"labels":[],"label_agreement":null},{"id":"W4249889268","doi":"10.1016/j.jaad.2004.10.749","title":"Etanercept improves symptoms of depression in patients with moderate to severe psoriasis","year":2005,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada)","funders":"","keywords":"Medicine; Etanercept; Psoriasis; Depression (economics); Dermatology; Internal medicine; Tumor necrosis factor alpha","score_opus":0.006723590018332699,"score_gpt":0.23842215804445557,"score_spread":0.23169856802612288,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249889268","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98710793,0.008369042,0.00018607735,0.0006576251,0.00017831205,0.00006966583,0.00018253051,0.000052930176,0.003195944],"genre_scores_gemma":[0.9967512,0.001750463,0.00015066144,0.0003785176,0.000092270595,0.000017345168,0.00012833688,0.0000024755113,0.0007287773],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9998797,0.00004384774,0.000018105004,0.0000102553295,0.000022241835,0.000025699412],"domain_scores_gemma":[0.99982053,0.000053481628,0.000038931426,0.000008731402,0.00002054759,0.00005781932],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022800526,0.00028865846,0.0008215522,0.00012371597,0.00015879588,0.00022643546,0.0001535391,0.00023410613,0.001575716],"category_scores_gemma":[0.0007370204,0.00010977352,0.0004031578,0.00015374142,0.00007039745,0.0001874618,0.00009015969,0.0006217515,0.00015970759],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.114292845,0.010196985,0.115790024,0.0018311284,0.004014369,0.0025021587,0.00046285836,0.0009270857,0.058956813,0.00018522925,0.012683477,0.678157],"study_design_scores_gemma":[0.034517545,0.036887053,0.9062605,0.00018034245,0.0020708737,0.0048831576,0.00041168276,0.0015053533,0.004113553,0.00030359233,0.008812136,0.0000541884],"about_ca_topic_score_codex":0.00087300746,"about_ca_topic_score_gemma":0.0026542458,"teacher_disagreement_score":0.001575716,"about_ca_system_score_codex":0.00015061795,"about_ca_system_score_gemma":0.0001369555,"threshold_uncertainty_score":0.005271256},"labels":[],"label_agreement":null},{"id":"W4250334105","doi":"10.1016/j.jaad.2004.10.246","title":"Recurrent pancreatic panniculitis","year":2005,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatological and COVID-19 studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Panniculitis; Dermatology","score_opus":0.024952672479337013,"score_gpt":0.33301486057831114,"score_spread":0.3080621880989741,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4250334105","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.960172,0.0098732915,0.0006244719,0.0015498339,0.00024477913,0.000057190853,0.00037669583,0.00018963977,0.026912075],"genre_scores_gemma":[0.99608743,0.0013228848,0.0001402819,0.00039986958,0.00026646737,0.000005358,0.000234857,0.000014334268,0.0015285241],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99897504,0.00013724604,0.00013791889,0.00019883364,0.00020661313,0.00034432684],"domain_scores_gemma":[0.9975049,0.00060824276,0.000557954,0.00046207051,0.0002793039,0.000587563],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072661595,0.0005752638,0.0009253783,0.0027567768,0.0014318369,0.0012946732,0.00075124303,0.001207494,0.005301762],"category_scores_gemma":[0.0037694154,0.00029054008,0.0009908953,0.0015643053,0.00078521087,0.0017528163,0.0006639634,0.0018898185,0.0012875563],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011964192,0.00054081366,0.4000888,0.00029810623,0.00021266873,0.53646314,0.0007851896,0.00010785012,0.006111131,0.00070358405,0.0018412231,0.05165104],"study_design_scores_gemma":[0.00007961649,0.00056394096,0.13448775,0.000068821224,0.00020532825,0.8546844,0.00036991545,0.0001902527,0.0019297323,0.00025741017,0.0071356473,0.000027269796],"about_ca_topic_score_codex":0.0013726366,"about_ca_topic_score_gemma":0.0010683851,"teacher_disagreement_score":0.005301762,"about_ca_system_score_codex":0.0007719436,"about_ca_system_score_gemma":0.0005034068,"threshold_uncertainty_score":0.017736197},"labels":[],"label_agreement":null},{"id":"W4250702373","doi":"10.1016/j.jaad.2019.06.1273","title":"Validation of medical service insurance claims as a surrogate for ascertaining vitiligo cases","year":2019,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"melanin and skin pigmentation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Vitiligo; Actuarial science; Medical insurance; Intensive care medicine; Dermatology; Family medicine","score_opus":0.016297035195244718,"score_gpt":0.33444631521235,"score_spread":0.3181492800171053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4250702373","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98012197,0.0006022264,0.004854176,0.00090660324,0.00020391989,0.00047691033,0.0039283447,0.00004581304,0.008860066],"genre_scores_gemma":[0.9940428,0.000092624476,0.002507731,0.00026388373,0.000047047764,0.00022932803,0.0021386796,0.000012790708,0.0006650699],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.95447505,0.028089298,0.0049652583,0.0030581362,0.0070803864,0.0023319651],"domain_scores_gemma":[0.87275887,0.06456739,0.027341552,0.019315438,0.013466142,0.0025506672],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.038840286,0.0006218129,0.0005975723,0.0028570313,0.0013464034,0.0027263279,0.0022579483,0.002466076,0.0026806365],"category_scores_gemma":[0.11381448,0.00053845474,0.001005242,0.0015667015,0.001911279,0.0012860695,0.0023481527,0.0014330606,0.001125669],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007789736,0.00023683537,0.98835653,0.00012620239,0.000123901,0.0003009435,0.0008757818,0.00032392776,0.0015766688,0.0016261019,0.0010974031,0.004576726],"study_design_scores_gemma":[0.00020024677,0.001236498,0.95837694,0.0005124797,0.00024857454,0.0028016209,0.0014239749,0.010013276,0.010047166,0.0018014632,0.0132882055,0.000049535633],"about_ca_topic_score_codex":0.0026618633,"about_ca_topic_score_gemma":0.0022715903,"teacher_disagreement_score":0.038840286,"about_ca_system_score_codex":0.0007898539,"about_ca_system_score_gemma":0.0017508708,"threshold_uncertainty_score":0.20540947},"labels":[],"label_agreement":null},{"id":"W4251587185","doi":"10.1016/j.jaad.2004.10.529","title":"Two is better than one: Rationale for the use of combination therapy for onychomycosis","year":2005,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Mediprobe Research (Canada); Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Dermatology; Intensive care medicine","score_opus":0.062177010160160445,"score_gpt":0.3564006597604629,"score_spread":0.29422364960030245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4251587185","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09239952,0.08809688,0.037594598,0.7000215,0.014963589,0.0009998858,0.00043934368,0.00025565407,0.06522909],"genre_scores_gemma":[0.7994244,0.019412242,0.047555506,0.113936596,0.009033374,0.0007338165,0.0001723124,0.00011148511,0.0096201915],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99640733,0.0015883466,0.00043032249,0.00055636215,0.00077953225,0.00023805858],"domain_scores_gemma":[0.99378926,0.004207035,0.00042917524,0.0002450609,0.0007492009,0.00058026303],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0054266118,0.0007117738,0.0016900653,0.00070544187,0.0020219465,0.0017464203,0.0021804858,0.006764319,0.0052654557],"category_scores_gemma":[0.009240077,0.00039825353,0.001656989,0.00042306428,0.004561651,0.0022140509,0.0013449859,0.012825379,0.0011871131],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007900145,0.004339686,0.021457398,0.0038269535,0.0010986465,0.02207142,0.0021015792,0.0024406845,0.027922038,0.4148393,0.14394574,0.34805635],"study_design_scores_gemma":[0.00587148,0.008264982,0.010942824,0.0034815944,0.0014214464,0.06266633,0.0024456745,0.009649198,0.018981546,0.26925278,0.60651803,0.00050403207],"about_ca_topic_score_codex":0.0005419786,"about_ca_topic_score_gemma":0.002616262,"teacher_disagreement_score":0.006764319,"about_ca_system_score_codex":0.0018549027,"about_ca_system_score_gemma":0.0026723642,"threshold_uncertainty_score":0.02869904},"labels":[],"label_agreement":null},{"id":"W4252313440","doi":"10.1016/j.jaad.2021.06.266","title":"25511 Effects of upadacitinib on the patient-reported impact of atopic dermatitis: Atopic Dermatitis Impact Scale (ADerm-IS) results from two pivotal phase 3 studies (MEASURE UP 1 and MEASURE UP 2)","year":2021,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health; University of Calgary","funders":"","keywords":"Atopic dermatitis; Medicine; Dermatology; Measure (data warehouse)","score_opus":0.026930699627742607,"score_gpt":0.3512136527599825,"score_spread":0.3242829531322399,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4252313440","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9754616,0.0135032525,0.00032301474,0.0010219399,0.00049168314,0.0010300941,0.002834748,0.00015073846,0.005182885],"genre_scores_gemma":[0.9875985,0.003992009,0.00061774714,0.0010821079,0.0002059329,0.00057818636,0.0031744936,0.000016987844,0.002734049],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9996049,0.00015894164,0.000034560275,0.000046968722,0.00006075538,0.00009392262],"domain_scores_gemma":[0.9994373,0.00019764129,0.00013301162,0.000033172266,0.0000665219,0.00013249888],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014698284,0.0009846616,0.001826874,0.00028280335,0.0003060913,0.0007908631,0.0005521715,0.0010505305,0.0048267157],"category_scores_gemma":[0.0011127256,0.00032629172,0.0021661061,0.00028386468,0.00040485818,0.00058550364,0.00027757726,0.0028732042,0.0007754837],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7047474,0.021346066,0.01104429,0.0027433115,0.0065806545,0.00026416016,0.00015112548,0.0025460182,0.018530924,0.00040739612,0.016709402,0.21492924],"study_design_scores_gemma":[0.59188366,0.3127912,0.07482233,0.00027677405,0.004087615,0.00040851958,0.00013648596,0.0021885955,0.0045437585,0.00028065417,0.008476966,0.000103420534],"about_ca_topic_score_codex":0.0009973344,"about_ca_topic_score_gemma":0.0033783363,"teacher_disagreement_score":0.0048267157,"about_ca_system_score_codex":0.00048431952,"about_ca_system_score_gemma":0.00052920124,"threshold_uncertainty_score":0.016147017},"labels":[],"label_agreement":null},{"id":"W4252332467","doi":"10.1016/j.jaad.2004.10.252","title":"Systemic exposure to lidocaine and tetracaine is low after application of a lidocaine 7% and tetracaine 7% peel in adults","year":2005,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dental Anxiety and Anesthesia Techniques","field":"Dentistry","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Manitoba Health","funders":"","keywords":"Tetracaine; Lidocaine; Medicine; Anesthesia","score_opus":0.00405725781750304,"score_gpt":0.25795844357022757,"score_spread":0.2539011857527245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4252332467","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998351,0.0002921399,0.000097762466,0.000062004794,0.0000067916208,0.000006216979,0.00005103976,0.0000073210467,0.0011258455],"genre_scores_gemma":[0.99953866,0.00010145142,0.000053972195,0.000032105778,0.000012170822,0.0000029397434,0.000054636475,0.0000026181349,0.00020148413],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99969435,0.000054101405,0.00004120232,0.00004279573,0.00009488557,0.000072673276],"domain_scores_gemma":[0.9978604,0.0006549287,0.0009024201,0.00006748332,0.00020090351,0.00031397582],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022853784,0.00012914029,0.00031592537,0.000382745,0.00026435655,0.00042840053,0.000099096775,0.0004583933,0.0021396768],"category_scores_gemma":[0.002884203,0.00014755708,0.0003027075,0.0002772863,0.0002424447,0.00037084063,0.00016325613,0.0005443969,0.00044699322],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009707426,0.00014974797,0.9871569,0.000028394019,0.00001904865,0.0012881503,0.00030484816,0.000019290439,0.0027791576,0.000022633585,0.00026543546,0.0069954116],"study_design_scores_gemma":[0.0000063130806,0.00070654583,0.99558026,0.000009427334,0.000020028729,0.0027531309,0.00029352616,0.000071807895,0.0003643579,0.00001660666,0.00017358488,0.0000043832015],"about_ca_topic_score_codex":0.0010801243,"about_ca_topic_score_gemma":0.0016992053,"teacher_disagreement_score":0.0021396768,"about_ca_system_score_codex":0.00016147895,"about_ca_system_score_gemma":0.00018559559,"threshold_uncertainty_score":0.0071579814},"labels":[],"label_agreement":null},{"id":"W4253191276","doi":"10.1016/j.jaad.2004.10.768","title":"Integrated analysis of 50 mg twice-weekly etanercept in patients with psoriasis from three phase 3 studies","year":2005,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"","keywords":"Medicine; Etanercept; Psoriasis; Dermatology; Internal medicine; Tumor necrosis factor alpha","score_opus":0.021549939789075098,"score_gpt":0.2945817627103043,"score_spread":0.2730318229212292,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4253191276","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9861923,0.008063021,0.0010421823,0.00026319633,0.00006858243,0.0006183147,0.0016160443,0.00009828139,0.0020380288],"genre_scores_gemma":[0.9946302,0.001106991,0.00094105175,0.000353569,0.0000620495,0.0002687756,0.0019621013,0.000023735392,0.00065153703],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9979849,0.0008292269,0.0001661701,0.0003082499,0.00038267282,0.00032872605],"domain_scores_gemma":[0.9981415,0.000633347,0.00038126382,0.00023089397,0.0002651376,0.00034786164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0044257846,0.00074561033,0.0023866815,0.00076154567,0.00044069134,0.0012552848,0.0005007591,0.0008506484,0.001935519],"category_scores_gemma":[0.002772277,0.00046439562,0.0023855949,0.0007665502,0.0003627028,0.0008675213,0.00037102768,0.0012972868,0.00036228704],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.50057936,0.006389158,0.110541366,0.0009722606,0.013438095,0.00041381666,0.0004073729,0.0031725157,0.07605589,0.00021412042,0.0028045014,0.2850115],"study_design_scores_gemma":[0.1211208,0.21125229,0.62146384,0.00014850132,0.017302364,0.0014140377,0.00024180303,0.002623665,0.015173371,0.00054437475,0.00855676,0.00015819057],"about_ca_topic_score_codex":0.0008227167,"about_ca_topic_score_gemma":0.0020385243,"teacher_disagreement_score":0.0044257846,"about_ca_system_score_codex":0.000915862,"about_ca_system_score_gemma":0.0010537539,"threshold_uncertainty_score":0.023406029},"labels":[],"label_agreement":null},{"id":"W4253291110","doi":"10.1016/j.jaad.2004.10.250","title":"Survey of antibiotic prescription use for inflamed epidermal inclusion cysts","year":2005,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Teratomas and Epidermoid Cysts","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Manitoba Health","funders":"","keywords":"Medicine; Antibiotics; Dermatology; Medical prescription; Dermatologic agents; Microbiology; Pharmacology","score_opus":0.0356767012855019,"score_gpt":0.33493436577838587,"score_spread":0.299257664492884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4253291110","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981059,0.0004809562,0.000041914212,0.000049343795,0.0000049035284,0.000011733364,0.00063818664,0.0000043557225,0.000662735],"genre_scores_gemma":[0.9986671,0.00043277224,0.00009996245,0.000063893836,0.00000964614,0.000011806024,0.00041547578,0.000002787592,0.00029653366],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99922705,0.00017828235,0.00020558624,0.00008189511,0.0001974012,0.00010975343],"domain_scores_gemma":[0.99666864,0.0006586879,0.0015610692,0.00009839931,0.0005618105,0.00045129244],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005560017,0.0001595496,0.00033007376,0.0017296185,0.00046687832,0.0004721363,0.00022972366,0.00059366995,0.0020350611],"category_scores_gemma":[0.002554737,0.00024344583,0.00051407237,0.0019788172,0.00017948005,0.000546528,0.0002758692,0.0004675655,0.0005030629],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044396886,0.00006022518,0.998216,0.000019424551,0.000019810197,0.000107944696,0.00007774512,0.000012643559,0.00020358009,0.0000049467103,0.000069204616,0.0011641596],"study_design_scores_gemma":[0.0000015049968,0.00012963879,0.99874145,0.000009498231,0.000012675405,0.0005151465,0.00025264334,0.000042358548,0.000056071185,0.0000026263558,0.0002340695,0.0000023635366],"about_ca_topic_score_codex":0.004798222,"about_ca_topic_score_gemma":0.0057869856,"teacher_disagreement_score":0.004798222,"about_ca_system_score_codex":0.00034587717,"about_ca_system_score_gemma":0.00043598327,"threshold_uncertainty_score":0.0095406175},"labels":[],"label_agreement":null},{"id":"W4253899569","doi":"10.1016/j.jaad.2019.10.087","title":"Short term efficacy and safety of dupilumab for treatment of moderate-to-severe atopic dermatitis in real-world practice: A Canadian retrospective study","year":2019,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dupilumab; Medicine; Atopic dermatitis; Retrospective cohort study; Dermatology; Term (time); Intensive care medicine; Internal medicine","score_opus":0.01656496481815275,"score_gpt":0.33758465097884927,"score_spread":0.32101968616069654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4253899569","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99367565,0.0029847715,0.00012424913,0.00020734084,0.0000206558,0.00008779146,0.0012199755,0.0000050918866,0.0016745207],"genre_scores_gemma":[0.9976273,0.00093949045,0.00015383505,0.00016885101,0.000025933088,0.000026963935,0.00077463116,0.0000062667045,0.00027670033],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99670756,0.000459316,0.00035283525,0.00056599436,0.0012253474,0.0006888016],"domain_scores_gemma":[0.99189395,0.001260562,0.0022771973,0.00044482684,0.0030369074,0.0010864424],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002322398,0.00059327,0.0010966873,0.0013229576,0.002090929,0.00199801,0.0012210592,0.0009795883,0.0016724905],"category_scores_gemma":[0.0064439373,0.0005760501,0.0013971392,0.003585113,0.0016406603,0.0006147824,0.0006008871,0.0012348484,0.00023484544],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015030999,0.0001854001,0.99033713,0.00018863285,0.00043728232,0.0005166195,0.0007109672,0.00010971872,0.00044213908,0.00014182174,0.00052136125,0.004905893],"study_design_scores_gemma":[0.0002100243,0.0008347871,0.99410206,0.00007934966,0.00054371933,0.0011610652,0.0009874626,0.00023678433,0.00015325066,0.000038462542,0.0015924943,0.000060389415],"about_ca_topic_score_codex":0.7121475,"about_ca_topic_score_gemma":0.7055959,"teacher_disagreement_score":0.28785253,"about_ca_system_score_codex":0.014500016,"about_ca_system_score_gemma":0.0159732,"threshold_uncertainty_score":0.5790955},"labels":[],"label_agreement":null},{"id":"W4255728492","doi":"10.1016/j.jaad.2017.04.427","title":"Early real-world effectiveness of secukinumab in the treatment of psoriasis in Canada: Retrospective analysis of patient support program data","year":2017,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Secukinumab; Medicine; Psoriasis; Dermatology; Retrospective cohort study; Family medicine; Surgery; Psoriatic arthritis","score_opus":0.022819028533895065,"score_gpt":0.3102219016915647,"score_spread":0.28740287315766966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4255728492","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9893969,0.0016131994,0.00008342584,0.0004228959,0.000012824073,0.00005883185,0.0071851616,0.000009280488,0.0012173438],"genre_scores_gemma":[0.9971226,0.00046107592,0.000099501165,0.00011086076,0.000008714254,0.000013671479,0.002032268,0.000005384982,0.00014597423],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99462837,0.00092106534,0.0005930794,0.00051772833,0.0021242495,0.0012155182],"domain_scores_gemma":[0.98333967,0.0025097167,0.0056345654,0.0007560547,0.0057854867,0.0019745573],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025972726,0.00033089228,0.0007144201,0.0015920004,0.0011976982,0.001823809,0.0012990674,0.00059481576,0.0014028958],"category_scores_gemma":[0.012525702,0.00035271625,0.0008586326,0.0056925397,0.0009229013,0.0006451584,0.0007569437,0.0011179342,0.0001328495],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005559684,0.00005754338,0.9948544,0.00005668708,0.00020542012,0.00005595516,0.00015341726,0.00025079178,0.00008641547,0.00009599132,0.00055916695,0.003068133],"study_design_scores_gemma":[0.000035221365,0.000095203584,0.99813545,0.000037693935,0.00014037489,0.000060803348,0.00031788147,0.00039565944,0.00009430204,0.000014562133,0.0006605374,0.000012365985],"about_ca_topic_score_codex":0.9553728,"about_ca_topic_score_gemma":0.9653064,"teacher_disagreement_score":0.04462719,"about_ca_system_score_codex":0.031175105,"about_ca_system_score_gemma":0.039599232,"threshold_uncertainty_score":0.2261923},"labels":[],"label_agreement":null},{"id":"W4255850102","doi":"10.1016/j.jaad.2016.02.756","title":"A 13-year retrospective study of basal cell carcinoma in a Canadian population: A comparison between anatomical location and histopathologic subtypes","year":2016,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Basal cell carcinoma; Retrospective cohort study; Basal (medicine); Pathology; Basal cell; Population; Internal medicine; Environmental health","score_opus":0.018101237438870762,"score_gpt":0.3043330638873993,"score_spread":0.2862318264485285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4255850102","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982855,0.00023883164,0.00003918516,0.000060255283,0.000004665833,0.000015286703,0.00060484454,0.0000033882561,0.0007481109],"genre_scores_gemma":[0.99863535,0.0002677103,0.00007726752,0.000054202294,0.0000056710655,0.000007488178,0.00059378106,0.0000040162677,0.00035440704],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990381,0.000070399365,0.000060295362,0.00017970751,0.0002567253,0.0003947987],"domain_scores_gemma":[0.9985305,0.000076737604,0.00027658555,0.000063260755,0.0006715234,0.00038138602],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006967202,0.0006295602,0.00056789344,0.0021809007,0.003954727,0.0014209916,0.0013521339,0.0007895165,0.002249786],"category_scores_gemma":[0.0016289351,0.0007898863,0.00090219895,0.0048616533,0.0011105012,0.00088864745,0.001055008,0.00089868833,0.00040630306],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007097585,0.0000324804,0.99823195,0.000008299116,0.000031789623,0.00022559069,0.00034203965,0.000018321487,0.00023550048,0.000021848104,0.000115713,0.00066554686],"study_design_scores_gemma":[0.000004358358,0.000045806573,0.9977597,0.0000054900484,0.00002663727,0.00027199468,0.0015584992,0.00004829845,0.000031632513,0.000008647204,0.00023127253,0.000007690161],"about_ca_topic_score_codex":0.9520459,"about_ca_topic_score_gemma":0.9535126,"teacher_disagreement_score":0.047954082,"about_ca_system_score_codex":0.0115975095,"about_ca_system_score_gemma":0.012979785,"threshold_uncertainty_score":0.09647292},"labels":[],"label_agreement":null},{"id":"W4280535347","doi":"10.1016/j.jaad.2022.05.010","title":"Management of juvenile-onset systemic sclerosis with systemic immunosuppressive therapies: An evidence-based review","year":2022,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; University of Calgary; SKiN Health; Alberta Children's Hospital; Western University","funders":"","keywords":"Medicine; Systemic therapy; Scleroderma (fungus); Methotrexate; Systemic scleroderma; Juvenile dermatomyositis; MEDLINE; Connective tissue disease; Dermatology; Internal medicine; Pathology; Autoimmune disease; Disease; Dermatomyositis","score_opus":0.08097309065495614,"score_gpt":0.35303138940445833,"score_spread":0.27205829874950216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280535347","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000062487656,0.99971074,0.000027708773,0.00004468467,0.000048051337,0.000008011099,0.000017442802,0.0000015221015,0.0000793161],"genre_scores_gemma":[0.0006310543,0.99905497,0.00011089673,0.00009921038,0.00003911351,0.0000074327427,0.000021004891,4.1560656e-7,0.000035850975],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99936706,0.00013548785,0.00020226443,0.000081514,0.00017935483,0.00003433057],"domain_scores_gemma":[0.9984864,0.0009663845,0.00032728395,0.000015068476,0.00016760868,0.0000372433],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013045309,0.0011201943,0.0039190785,0.0029335315,0.00028594563,0.0014451046,0.001593982,0.0013526079,0.0034195501],"category_scores_gemma":[0.0030829578,0.0004006254,0.0025335527,0.0025845205,0.00036471902,0.0011903719,0.00073056744,0.0012182153,0.0004607253],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037740608,0.00008920146,0.00037170007,0.42608148,0.002523893,0.0002554708,0.00008493183,0.000425518,0.00063958287,0.0007420412,0.0136200925,0.55478865],"study_design_scores_gemma":[0.00088079023,0.00071276753,0.0060490035,0.47196224,0.035456922,0.003900842,0.00040217862,0.0005079897,0.0006573741,0.0019831904,0.47735292,0.00013371627],"about_ca_topic_score_codex":0.0025925103,"about_ca_topic_score_gemma":0.0060090297,"teacher_disagreement_score":0.0039190785,"about_ca_system_score_codex":0.0007285765,"about_ca_system_score_gemma":0.0019164453,"threshold_uncertainty_score":0.011439502},"labels":[],"label_agreement":null},{"id":"W4282927176","doi":"10.1016/j.jaad.2022.06.009","title":"Cutaneous polyarteritis nodosa diagnosis and treatment: A retrospective case series","year":2022,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Vasculitis and related conditions","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of British Columbia","funders":"","keywords":"Polyarteritis nodosa; Medicine; Dermatology; Livedo reticularis; Vasculitis; Purpura (gastropod); Pathology","score_opus":0.010988635871552887,"score_gpt":0.2732825887711671,"score_spread":0.2622939528996142,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282927176","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948644,0.0019605458,0.0005156818,0.000111319874,0.000040892817,0.00005916018,0.00012887988,0.000014561912,0.0023045586],"genre_scores_gemma":[0.9983487,0.00070627953,0.00027355,0.00009619831,0.00009532006,0.00002511791,0.00019103897,0.000007905088,0.00025586132],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990435,0.0001410988,0.00019240945,0.00023938119,0.00014038461,0.00024307298],"domain_scores_gemma":[0.9981152,0.00052304217,0.000532012,0.00025602747,0.0001799002,0.00039387727],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047211736,0.0007626252,0.0006952725,0.0019729477,0.0018526776,0.0013906705,0.00071267487,0.001611375,0.0026067484],"category_scores_gemma":[0.002679283,0.0008987414,0.0007521951,0.0013135212,0.0012412807,0.0013822601,0.0012380306,0.00093281904,0.0009416689],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002763755,0.00043878696,0.5737029,0.0000847151,0.00006294838,0.41741788,0.00073328696,0.00013581805,0.0014780842,0.00020276102,0.00042445387,0.005042046],"study_design_scores_gemma":[0.000027047969,0.00026406354,0.11833961,0.00003858896,0.00008706206,0.87758887,0.0015958662,0.00022752196,0.0005025206,0.00012628987,0.0011674108,0.000035187524],"about_ca_topic_score_codex":0.0011430265,"about_ca_topic_score_gemma":0.0012295312,"teacher_disagreement_score":0.0026067484,"about_ca_system_score_codex":0.000636806,"about_ca_system_score_gemma":0.00084166776,"threshold_uncertainty_score":0.008720458},"labels":[],"label_agreement":null},{"id":"W4282942340","doi":"10.1016/j.jaad.2022.06.012","title":"Characterization of acne associated with upadacitinib treatment in patients with moderate-to-severe atopic dermatitis: A post hoc integrated analysis of 3 phase 3 randomized, double-blind, placebo-controlled trials","year":2022,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health; University of Calgary; Probity Medical Research","funders":"AbbVie; Sanofi","keywords":"Medicine; Acne; Placebo; Post-hoc analysis; Adverse effect; Dermatology; Atopic dermatitis; Randomized controlled trial; Internal medicine; Pathology","score_opus":0.019050978064798444,"score_gpt":0.30912155001450314,"score_spread":0.2900705719497047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282942340","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9034631,0.06187034,0.0070491764,0.0005591433,0.00038729727,0.019223196,0.004344678,0.00021378494,0.0028892707],"genre_scores_gemma":[0.98267233,0.0040071616,0.005034564,0.00042049977,0.00025173323,0.00471262,0.0024286532,0.00003688431,0.00043554092],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.97659147,0.016284037,0.002405601,0.0018902562,0.0020867144,0.0007419941],"domain_scores_gemma":[0.98520166,0.0072370516,0.004713526,0.0010638303,0.0012019674,0.00058200525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02663193,0.0017303927,0.0052031097,0.0013196943,0.00051468005,0.0019606703,0.000948268,0.0010686723,0.0029458841],"category_scores_gemma":[0.012991819,0.0006657991,0.013968938,0.0013788642,0.0008972594,0.0011647047,0.0009891414,0.0012546172,0.00022259222],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.73819965,0.0021952803,0.041808255,0.008324096,0.15076837,0.00009351825,0.00016633805,0.0011945451,0.0065085148,0.0001476625,0.0011132893,0.04948042],"study_design_scores_gemma":[0.41971162,0.12252711,0.2582037,0.00093497126,0.1824171,0.00043879307,0.00019181272,0.0036712657,0.0048792535,0.00054372835,0.006317668,0.00016298865],"about_ca_topic_score_codex":0.00045693357,"about_ca_topic_score_gemma":0.0020943356,"teacher_disagreement_score":0.02663193,"about_ca_system_score_codex":0.0012472466,"about_ca_system_score_gemma":0.0019391506,"threshold_uncertainty_score":0.14084482},"labels":[],"label_agreement":null},{"id":"W4282958432","doi":"10.1016/j.jaad.2022.06.016","title":"Management of morphea with systemic immunosuppressive therapies: An evidence-based review","year":2022,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health; Vanguard College; University of Alberta; University of Calgary; Probity Medical Research; Heritage Medical Research Clinic; Alberta Children's Hospital; Western University","funders":"","keywords":"Medicine; Morphea; Dermatology; Systemic scleroderma; Scleroderma (fungus); Intensive care medicine; MEDLINE; Systemic disease; Immunopathology; Immunology; Dermatomyositis","score_opus":0.07544871176519874,"score_gpt":0.37229013325519283,"score_spread":0.2968414214899941,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282958432","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000067856934,0.9996772,0.00002966786,0.000049257684,0.000050948238,0.000008884779,0.000020173366,0.0000015147161,0.00009450194],"genre_scores_gemma":[0.00067191035,0.9989911,0.00011157246,0.00010926127,0.00004456763,0.000007792463,0.000022754604,4.4909422e-7,0.000040670955],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99941885,0.000115440875,0.00018397415,0.00008499389,0.00016437042,0.000032332948],"domain_scores_gemma":[0.9984847,0.0009986702,0.000310072,0.00001543135,0.00015690338,0.00003426299],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012325622,0.0011683712,0.0038016886,0.0030654622,0.00030228152,0.0014394554,0.0016183055,0.0013127633,0.003988075],"category_scores_gemma":[0.0029676782,0.00040724495,0.002604078,0.002704217,0.0003857996,0.0012101429,0.0007502221,0.0012160132,0.00046468302],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040233624,0.00009221102,0.00039368647,0.38556322,0.002431197,0.0002407294,0.00007332504,0.00042063824,0.00060209073,0.0007480495,0.013086994,0.5959455],"study_design_scores_gemma":[0.00088390656,0.00074739393,0.0065245084,0.4534147,0.036726464,0.004088865,0.00037078123,0.0005557445,0.0007317766,0.0021209794,0.49369472,0.00014020553],"about_ca_topic_score_codex":0.0024611542,"about_ca_topic_score_gemma":0.0057002376,"teacher_disagreement_score":0.003988075,"about_ca_system_score_codex":0.0006967016,"about_ca_system_score_gemma":0.0018242188,"threshold_uncertainty_score":0.013341486},"labels":[],"label_agreement":null},{"id":"W4282973374","doi":"10.1016/j.jaad.2022.06.019","title":"Predictors of severity in paradoxical psoriasis from biologic therapies: A systematic review","year":2022,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Women's College Hospital; University of Toronto","funders":"Canadian Dermatology Foundation","keywords":"Medicine; Psoriasis; Dermatology; MEDLINE; Dermatologic agents; Intensive care medicine","score_opus":0.03896320573970135,"score_gpt":0.3143981676912017,"score_spread":0.27543496195150036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282973374","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015748593,0.9977373,0.000070479095,0.00010020931,0.000048222017,0.00003685465,0.00033535901,0.0000038667176,0.00009284911],"genre_scores_gemma":[0.035325278,0.9632802,0.0003581647,0.00045105786,0.000089907015,0.00008487364,0.0003344228,0.000004784349,0.000071278955],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.998041,0.0005391741,0.0007279695,0.00031062486,0.0002887073,0.00009243873],"domain_scores_gemma":[0.9897351,0.00752657,0.001958702,0.00016069335,0.00047457375,0.0001443474],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030733019,0.0010077836,0.0072193816,0.0032297168,0.00028633518,0.0016867988,0.0014543815,0.0014603621,0.0040871226],"category_scores_gemma":[0.012513134,0.0008114239,0.009326925,0.005246882,0.00054431625,0.0014126047,0.0011924754,0.0013757698,0.0002764055],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012242829,0.000051159626,0.009722925,0.8173899,0.10249818,0.00018126475,0.00019308104,0.0002528667,0.00023929661,0.00022550525,0.0034441203,0.06457737],"study_design_scores_gemma":[0.0014814802,0.00035792738,0.044083696,0.29086822,0.64450604,0.00057055615,0.00035839074,0.00023415689,0.00019863353,0.0006444589,0.016567277,0.0001292421],"about_ca_topic_score_codex":0.0060825017,"about_ca_topic_score_gemma":0.021781838,"teacher_disagreement_score":0.0072193816,"about_ca_system_score_codex":0.00090910704,"about_ca_system_score_gemma":0.0027973293,"threshold_uncertainty_score":0.016253412},"labels":[],"label_agreement":null},{"id":"W4283591596","doi":"10.1016/j.jaad.2022.06.1171","title":"One-year safety and efficacy of tapinarof cream for the treatment of plaque psoriasis: Results from the PSOARING 3 trial","year":2022,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":88,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"","keywords":"Medicine; Tolerability; Adverse effect; Psoriasis; Clinical trial; Internal medicine; Open label; Surgery; Randomized controlled trial; Dermatology","score_opus":0.030047973570930392,"score_gpt":0.28341841874877,"score_spread":0.2533704451778396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283591596","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9726221,0.018626748,0.0005821807,0.0006216771,0.00022587171,0.0010822412,0.0023195334,0.00007420291,0.0038453748],"genre_scores_gemma":[0.98851204,0.0050173756,0.00036580468,0.0008426601,0.00031845376,0.0008041325,0.00261515,0.000021248065,0.0015031375],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99907863,0.00043956935,0.00006540779,0.00011822694,0.00012891581,0.00016931948],"domain_scores_gemma":[0.99859244,0.00042053088,0.0003891219,0.0001271119,0.000106676045,0.00036407594],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003813568,0.0008076213,0.0015693622,0.00022505643,0.00035222046,0.001049648,0.00051052356,0.0012105389,0.0040438618],"category_scores_gemma":[0.0018935483,0.00024626454,0.0020110388,0.000264948,0.00055890996,0.0008958823,0.00030879994,0.0028202678,0.00063479604],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.868878,0.011055754,0.0076796575,0.0015708435,0.0031750572,0.00018008376,0.00020520542,0.00084379537,0.007355006,0.00022211559,0.004304413,0.09453003],"study_design_scores_gemma":[0.7154798,0.20181957,0.069455996,0.0002541094,0.0033572942,0.00044890103,0.0001036361,0.0009590981,0.002427207,0.00062861806,0.0050056586,0.00006011868],"about_ca_topic_score_codex":0.0005619836,"about_ca_topic_score_gemma":0.000954774,"teacher_disagreement_score":0.0040438618,"about_ca_system_score_codex":0.00049561815,"about_ca_system_score_gemma":0.0005858109,"threshold_uncertainty_score":0.020168304},"labels":[],"label_agreement":null},{"id":"W4284989117","doi":"10.1016/j.jaad.2022.07.002","title":"Deucravacitinib versus placebo and apremilast in moderate to severe plaque psoriasis: Efficacy and safety results from the 52-week, randomized, double-blinded, placebo-controlled phase 3 POETYK PSO-1 trial","year":2022,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":347,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Queen's University","funders":"Manchester Biomedical Research Centre; Bristol-Myers Squibb Canada; Bristol-Myers Squibb","keywords":"Medicine; Apremilast; Placebo; Psoriasis; Double blinded; Randomized controlled trial; Plaque psoriasis; Internal medicine; Dermatology; Alternative medicine; Psoriatic arthritis; Pathology","score_opus":0.03301569140574727,"score_gpt":0.30046359644093135,"score_spread":0.26744790503518406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4284989117","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9838725,0.010042836,0.00055594114,0.0006293759,0.00032814263,0.0017682151,0.00078900333,0.00013329627,0.0018807184],"genre_scores_gemma":[0.9915542,0.0030078813,0.0008499166,0.00065132935,0.00030449734,0.001486719,0.00069721404,0.000023006121,0.0014251313],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9989293,0.0006102998,0.00008736545,0.00016836404,0.00010834352,0.000096182404],"domain_scores_gemma":[0.99881196,0.00034132134,0.00038670193,0.000081520324,0.00007138921,0.00030702841],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028409124,0.0012539524,0.002628157,0.00034655115,0.0004283681,0.00100086,0.0007438138,0.0016116473,0.004920269],"category_scores_gemma":[0.0021416915,0.0005221708,0.0018382618,0.00027493262,0.00087782834,0.0010438741,0.00030622265,0.0027305174,0.00075707503],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9595837,0.006283061,0.0005182102,0.00085909566,0.000994302,0.000031420277,0.00006166947,0.00034391368,0.0054648286,0.000064945445,0.0009454181,0.02484938],"study_design_scores_gemma":[0.8981613,0.09610194,0.0030264312,0.00005059659,0.0004909256,0.00008697584,0.000021096443,0.00042236145,0.00082244957,0.00011921577,0.0006782877,0.000018515699],"about_ca_topic_score_codex":0.000367649,"about_ca_topic_score_gemma":0.0010455492,"teacher_disagreement_score":0.004920269,"about_ca_system_score_codex":0.0006205409,"about_ca_system_score_gemma":0.00086047547,"threshold_uncertainty_score":0.016459942},"labels":[],"label_agreement":null},{"id":"W4285810037","doi":"10.1016/j.jaad.2022.07.024","title":"Pityrosporum folliculitis in immunocompromised populations: A systematic review","year":2022,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Malassezia; Folliculitis; Medicine; Dermatology; Acne; Pathology","score_opus":0.060850153968042754,"score_gpt":0.3964960876754135,"score_spread":0.3356459337073707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285810037","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00088243093,0.99851507,0.00004875752,0.00008842927,0.000053596457,0.000106372674,0.00019634014,0.000004152443,0.00010472342],"genre_scores_gemma":[0.015118854,0.9837769,0.0002960818,0.00045643316,0.000041909632,0.00013443646,0.00009823628,0.0000027527542,0.000074483345],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9971927,0.0007368606,0.0011947745,0.00031333242,0.000401363,0.00016096779],"domain_scores_gemma":[0.9911573,0.0055608368,0.002438866,0.000114789975,0.0005596447,0.0001685478],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003138235,0.0014326766,0.008105437,0.007334271,0.0004896671,0.002321332,0.0013463912,0.0021081083,0.0060815844],"category_scores_gemma":[0.01343192,0.0011693136,0.0076788384,0.0069987364,0.000759058,0.002108319,0.0018131834,0.0012830762,0.00028771357],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024146233,0.000021305856,0.0010912203,0.96104914,0.0155804455,0.00013058192,0.0001327137,0.00005849187,0.00015103685,0.00008718231,0.0010999923,0.020356301],"study_design_scores_gemma":[0.000777921,0.00027563484,0.008679532,0.72876924,0.24356458,0.00078279484,0.00042197332,0.000081010454,0.00014699093,0.00020443338,0.016231054,0.000064902495],"about_ca_topic_score_codex":0.009053407,"about_ca_topic_score_gemma":0.03741778,"teacher_disagreement_score":0.009053407,"about_ca_system_score_codex":0.0020858857,"about_ca_system_score_gemma":0.0054973243,"threshold_uncertainty_score":0.020344913},"labels":[],"label_agreement":null},{"id":"W4286255965","doi":"10.1016/j.jaad.2022.07.019","title":"Long-term 2-year safety and efficacy of tralokinumab in adults with moderate-to-severe atopic dermatitis: Interim analysis of the ECZTEND open-label extension trial","year":2022,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Dalhousie University","funders":"LEO Pharma Research Foundation","keywords":"Medicine; Adverse effect; Atopic dermatitis; Eczema Area and Severity Index; Placebo; Incidence (geometry); Interim analysis; Pediatrics; Clinical endpoint; Confidence interval; Randomized controlled trial; Post-hoc analysis; Physical therapy; Internal medicine; Dermatology; Alternative medicine","score_opus":0.020988536391963828,"score_gpt":0.3210321999785117,"score_spread":0.3000436635865478,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4286255965","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98735714,0.003228519,0.0011442028,0.00032051562,0.00016970022,0.0013383945,0.0043762377,0.000076588345,0.0019887146],"genre_scores_gemma":[0.9870979,0.0006155263,0.0011173822,0.000455085,0.00019547407,0.0018835407,0.007112467,0.000020885473,0.0015016838],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99745184,0.0011763589,0.00020755397,0.0004126216,0.00034465632,0.00040681573],"domain_scores_gemma":[0.9956678,0.00109311,0.0014653312,0.0007746846,0.00042397855,0.00057507143],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010111184,0.0012270894,0.0019447142,0.00032883216,0.00055752817,0.0015414555,0.00067757996,0.0012539721,0.0037585762],"category_scores_gemma":[0.0060345745,0.0004500763,0.0036508318,0.00035576578,0.0005621087,0.0014553124,0.0007222728,0.0025209312,0.0007656392],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.90968853,0.0056630275,0.040685385,0.0007049025,0.0060847355,0.0001659174,0.00015036348,0.0013048331,0.0028139339,0.00022997968,0.0033369097,0.02917156],"study_design_scores_gemma":[0.4486814,0.25755918,0.25704032,0.00031943127,0.01793262,0.0007737019,0.00020005298,0.0037302373,0.0050283,0.0011905709,0.0074157817,0.00012836052],"about_ca_topic_score_codex":0.00036984147,"about_ca_topic_score_gemma":0.0007276228,"teacher_disagreement_score":0.010111184,"about_ca_system_score_codex":0.0004960102,"about_ca_system_score_gemma":0.0010189974,"threshold_uncertainty_score":0.05347371},"labels":[],"label_agreement":null},{"id":"W4291398513","doi":"10.1016/j.jaad.2022.07.055","title":"Association of atypical skin manifestations at the onset of systemic juvenile idiopathic arthritis with difficult-to-treat disease: A retrospective multicenter study","year":2022,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Université de Montréal","funders":"","keywords":"Medicine; Rash; Arthritis; Incidence (geometry); Disease; Dermatology; Juvenile; Systemic disease; Juvenile rheumatoid arthritis; Retrospective cohort study; Pediatrics; Immunology; Internal medicine","score_opus":0.008656993472760067,"score_gpt":0.2870527195360699,"score_spread":0.27839572606330987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4291398513","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993436,0.00024170797,0.000055837132,0.000011816591,0.000004621882,0.0000072331736,0.00006806941,0.0000011812382,0.00026594318],"genre_scores_gemma":[0.9997627,0.00005203669,0.00003779804,0.000015106166,0.000013339692,0.000004226409,0.00008241307,0.0000014031173,0.000030867373],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986694,0.00039330186,0.00017793833,0.00039019503,0.00017666325,0.00019247722],"domain_scores_gemma":[0.9967068,0.00047929416,0.0015774837,0.00032493507,0.00027136866,0.0006400549],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009023976,0.00035629762,0.0006509949,0.00082015357,0.0006837448,0.00082915457,0.00042017587,0.000747417,0.001850951],"category_scores_gemma":[0.0026802756,0.0004393627,0.00067767105,0.0009632458,0.0005341587,0.00086283515,0.0006007977,0.0005967672,0.00019993947],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016215516,0.00003615998,0.99888545,0.0000065090726,0.0000505535,0.0002798615,0.00004407261,0.000011563201,0.0002121251,0.000012107641,0.00002519001,0.0002741312],"study_design_scores_gemma":[0.000023232647,0.00021977577,0.99702746,0.0000065221448,0.000060955543,0.002084398,0.00028725763,0.00009809634,0.000049050483,0.000019842071,0.00011658764,0.000006866719],"about_ca_topic_score_codex":0.0017918762,"about_ca_topic_score_gemma":0.0016209532,"teacher_disagreement_score":0.001850951,"about_ca_system_score_codex":0.0003301115,"about_ca_system_score_gemma":0.0003507103,"threshold_uncertainty_score":0.006192088},"labels":[],"label_agreement":null},{"id":"W4292362240","doi":"10.1016/j.jaad.2022.07.035","title":"Hand and foot dermatitis in patients referred for patch testing: Analysis of North American Contact Dermatitis Group Data, 2001-2018","year":2022,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Contact Dermatitis and Allergies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; University of Ottawa; Montreal General Hospital; Université Laval; Centre hospitalier universitaire de Québec; Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Contact dermatitis; Etiology; Patch test; Dermatology; Allergen; Allergic contact dermatitis; Atopic dermatitis; Patch testing; Irritant contact dermatitis; Demographics; Retrospective cohort study; Allergy; Internal medicine; Immunology","score_opus":0.03582064768750639,"score_gpt":0.30285689302994173,"score_spread":0.26703624534243536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4292362240","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9868443,0.0013566113,0.000104118844,0.00006608963,0.000015465142,0.000033698798,0.008927412,0.000015978323,0.002636303],"genre_scores_gemma":[0.99302155,0.0004902477,0.000090144764,0.000060605693,0.0000153799,0.000024365921,0.0057119424,0.0000072484168,0.0005786282],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99883395,0.00019216264,0.00023030506,0.0002278593,0.00035879383,0.00015698043],"domain_scores_gemma":[0.99741155,0.0004186527,0.0013133282,0.00013477457,0.00047144154,0.00025026491],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071731815,0.00032302696,0.00041843433,0.0032513523,0.00046612773,0.00085190195,0.0005072395,0.0006180268,0.0025901957],"category_scores_gemma":[0.0022743023,0.00028435225,0.0007288366,0.004094283,0.00026746854,0.00083299616,0.00058941945,0.0005207798,0.0005372418],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010326613,0.000024387442,0.99812084,0.000023975555,0.000057886682,0.00007949012,0.00004730335,0.000024776,0.00007573138,0.000007874033,0.00030242157,0.0011318945],"study_design_scores_gemma":[0.0000035301885,0.000020573458,0.9993364,0.000008688617,0.00001953755,0.00019511773,0.00011817515,0.000031150077,0.00001847851,0.000003965549,0.00024262053,0.0000015938597],"about_ca_topic_score_codex":0.02505358,"about_ca_topic_score_gemma":0.036377,"teacher_disagreement_score":0.02505358,"about_ca_system_score_codex":0.0006476272,"about_ca_system_score_gemma":0.0005358699,"threshold_uncertainty_score":0.049815536},"labels":[],"label_agreement":null},{"id":"W4295249189","doi":"10.1016/j.jaad.2022.06.910","title":"33348 When tanning is trending: A content quality study of skin cancer on TikTok","year":2022,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Social Media in Health Education","field":"Social Sciences","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Medical Association; SKiN Health; University of British Columbia","funders":"","keywords":"Medicine; Dermatology; Quality (philosophy); Skin cancer; Cancer; Internal medicine","score_opus":0.27605421599220253,"score_gpt":0.5037159187386563,"score_spread":0.22766170274645375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295249189","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99833703,0.00012574652,0.00004061511,0.0000810114,0.000010590781,0.00008227758,0.00045246023,0.0000026658033,0.0008676013],"genre_scores_gemma":[0.9971744,0.00032431123,0.00024721143,0.00024915035,0.00001842484,0.00013719294,0.0006418821,0.00001568508,0.0011918137],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983479,0.0005825107,0.00025036876,0.00015854674,0.00045774496,0.00020292774],"domain_scores_gemma":[0.9910815,0.0032661983,0.0029002836,0.0004023915,0.0015266521,0.00082291703],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017961108,0.0001836917,0.00039453743,0.001851654,0.0014122818,0.0012209592,0.00045355907,0.0005303836,0.003345453],"category_scores_gemma":[0.01093886,0.00030004914,0.00060153974,0.0024368207,0.00048153565,0.0011047417,0.0011589073,0.00087445433,0.00049514405],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004913906,0.0008907452,0.9499961,0.00048906566,0.00018191237,0.00019094968,0.026939213,0.000037040838,0.0005906599,0.00007739574,0.0008946205,0.019220913],"study_design_scores_gemma":[0.00002560343,0.0003057366,0.9760903,0.00014540067,0.00019149795,0.00008714681,0.020929432,0.000080777376,0.00015151019,0.000023017928,0.0019478472,0.000021799004],"about_ca_topic_score_codex":0.027829224,"about_ca_topic_score_gemma":0.04613021,"teacher_disagreement_score":0.027829224,"about_ca_system_score_codex":0.001684734,"about_ca_system_score_gemma":0.0015829877,"threshold_uncertainty_score":0.05533451},"labels":[],"label_agreement":null},{"id":"W4295254378","doi":"10.1016/j.jaad.2022.06.177","title":"33724 Cosmetic outcome and viability of right angle paramedian forehead flaps: A retrospective chart review","year":2022,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Nasal Surgery and Airway Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Forehead; Surgery; Chart; Retrospective cohort study; Outcome (game theory)","score_opus":0.021381530630832125,"score_gpt":0.32644551519076387,"score_spread":0.3050639845599317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295254378","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99581486,0.0011002877,0.00026966448,0.000025357032,0.000011379845,0.000053563526,0.0010177487,0.000008727244,0.0016983311],"genre_scores_gemma":[0.99786985,0.0005638552,0.00020798104,0.00002916094,0.0000137806965,0.00002777842,0.00093718653,0.000005653818,0.00034477233],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99956435,0.000056759978,0.00009759233,0.000090349095,0.00010156827,0.00008947005],"domain_scores_gemma":[0.99833256,0.00046285585,0.0006735065,0.00014875605,0.00022653295,0.0001558999],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040086245,0.00023155459,0.00031402454,0.0019983572,0.00048045383,0.0005453673,0.0003074809,0.00031040475,0.0032232807],"category_scores_gemma":[0.001390593,0.00024420835,0.00055219204,0.0017372081,0.00044748903,0.0005418995,0.00034053987,0.00032550906,0.00059732515],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016657365,0.0000883403,0.97018975,0.000096621174,0.00004874011,0.020173348,0.00027708805,0.00007193964,0.0014664005,0.00011387157,0.00033987,0.006967348],"study_design_scores_gemma":[0.000010803569,0.0005149238,0.92155313,0.00007055287,0.00010440043,0.07157839,0.0014641358,0.0002273586,0.0018530886,0.000074308904,0.0025188285,0.000029971672],"about_ca_topic_score_codex":0.0016091197,"about_ca_topic_score_gemma":0.0015026717,"teacher_disagreement_score":0.0032232807,"about_ca_system_score_codex":0.00042715867,"about_ca_system_score_gemma":0.0004909086,"threshold_uncertainty_score":0.0107828975},"labels":[],"label_agreement":null},{"id":"W4295254586","doi":"10.1016/j.jaad.2022.06.348","title":"34039 Maintenance of skin clearance in a long-term open-label study of fixed-combination halobetasol propionate and tazarotene lotion for psoriasis in participants with prior use of topical treatments","year":2022,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Bausch Health; Ortho Dermatologics","keywords":"Tazarotene; Medicine; Lotion; Psoriasis; Dermatology; Post-hoc analysis; Open label; Adverse effect; Pharmacology; Internal medicine","score_opus":0.04740504003006497,"score_gpt":0.3188376131538056,"score_spread":0.27143257312374064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295254586","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976683,0.0010723426,0.00011282669,0.0001002999,0.000111279456,0.00026899044,0.00022506183,0.000016737771,0.00042409083],"genre_scores_gemma":[0.9971443,0.00042803667,0.0002596983,0.00020645725,0.00018279921,0.0003455908,0.00037876656,0.000005792048,0.0010485379],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9991504,0.00030989372,0.000054757787,0.00018459899,0.00012976472,0.00017060425],"domain_scores_gemma":[0.99900717,0.00018021525,0.00023677826,0.00010256592,0.00011811177,0.00035523294],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016690603,0.0009036039,0.0019037611,0.00033988518,0.00088966795,0.00083609385,0.0007038289,0.0017366309,0.0034667659],"category_scores_gemma":[0.0016440253,0.0005470672,0.0018287514,0.00030899135,0.0005827436,0.0011731476,0.00036336607,0.0027054586,0.0008033579],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.88412696,0.034147702,0.026733313,0.0003716625,0.0016517875,0.0001598018,0.0002105011,0.0001579018,0.01746534,0.000051878764,0.000740133,0.03418303],"study_design_scores_gemma":[0.18428887,0.5819006,0.22524697,0.00008897284,0.0021659965,0.00023461774,0.00020881138,0.00093049125,0.002632351,0.00011145845,0.0021177246,0.000073128664],"about_ca_topic_score_codex":0.0015880573,"about_ca_topic_score_gemma":0.0027049773,"teacher_disagreement_score":0.0034667659,"about_ca_system_score_codex":0.000569095,"about_ca_system_score_gemma":0.00073349493,"threshold_uncertainty_score":0.011597455},"labels":[],"label_agreement":null},{"id":"W4295254913","doi":"10.1016/j.jaad.2022.06.881","title":"33184 The variable burden and impact of atopic dermatitis: A multi-method analysis of the More Than Skin Deep survey","year":2022,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Sex and Gender in Healthcare","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Women's College Hospital","funders":"","keywords":"Medicine; Atopic dermatitis; Dermatology","score_opus":0.037825466990468286,"score_gpt":0.3912878208946398,"score_spread":0.3534623539041715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295254913","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968315,0.00039139116,0.0009455309,0.00006351746,0.000021879985,0.00005716263,0.0013630651,0.0000071268073,0.00031889262],"genre_scores_gemma":[0.9982955,0.0000929568,0.0006218056,0.000040145045,0.00001551338,0.00006961021,0.00053698366,0.000008393859,0.00031919562],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9863985,0.010505174,0.00073059363,0.0008714873,0.0008122683,0.0006820007],"domain_scores_gemma":[0.9881606,0.0057326634,0.0033150024,0.0016769554,0.00058904244,0.0005258393],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00956555,0.00072792935,0.0008574966,0.0015204817,0.0007988536,0.0012906435,0.0009467693,0.0007264789,0.003548447],"category_scores_gemma":[0.014089133,0.00058142043,0.0036365185,0.0028470736,0.0004553797,0.00078646967,0.0020240701,0.0007965265,0.0002919234],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031453554,0.00005131274,0.99685186,0.000025379373,0.001077161,0.000027920398,0.00012539934,0.00008230817,0.00007516111,0.000034062425,0.000093173236,0.0012417389],"study_design_scores_gemma":[0.000026273308,0.00023697132,0.99779,0.000020346184,0.00037655566,0.00008997119,0.00046286732,0.00065454125,0.00004182202,0.000044709668,0.00024502183,0.0000110267965],"about_ca_topic_score_codex":0.016591107,"about_ca_topic_score_gemma":0.017443473,"teacher_disagreement_score":0.016591107,"about_ca_system_score_codex":0.00061302184,"about_ca_system_score_gemma":0.0007568273,"threshold_uncertainty_score":0.05058807},"labels":[],"label_agreement":null},{"id":"W4295255034","doi":"10.1016/j.jaad.2022.06.515","title":"33968 Time to improvement in daily signs and symptoms associated with atopic dermatitis (AD) in patients with moderate-to-severe AD in pooled monotherapy studies of abrocitinib","year":2022,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"","keywords":"Medicine; Atopic dermatitis; Dermatology; Signs and symptoms; Pediatrics; Internal medicine","score_opus":0.008575375448643705,"score_gpt":0.2680555042894727,"score_spread":0.259480128840829,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295255034","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.80351543,0.18695049,0.0011583333,0.00035382077,0.0007529666,0.00036074166,0.003177512,0.00008235999,0.0036483458],"genre_scores_gemma":[0.9874385,0.009355879,0.0003078257,0.00028216687,0.00027739778,0.00013825472,0.0015687931,0.000010897467,0.00062033423],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.996503,0.0016258855,0.0007155062,0.00055715715,0.00034627467,0.0002521752],"domain_scores_gemma":[0.9971756,0.001227461,0.00082094315,0.00025122956,0.00035203624,0.00017283543],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0060336995,0.0011324978,0.0050059003,0.0009855373,0.0003391857,0.0014442689,0.0004743781,0.00095460576,0.0027426302],"category_scores_gemma":[0.0058254222,0.0007727436,0.0077111856,0.0012738487,0.0002766813,0.0011400372,0.00055798586,0.0016398303,0.00034652092],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.54595214,0.00084715174,0.10995496,0.01015832,0.23342322,0.0003566113,0.00021091136,0.0012280928,0.008815834,0.00018619945,0.0030172688,0.085849345],"study_design_scores_gemma":[0.07640132,0.04845547,0.5875344,0.0011703691,0.2724333,0.0011958714,0.00034115987,0.0015709767,0.002334062,0.00037389502,0.00800902,0.00018007925],"about_ca_topic_score_codex":0.0012840256,"about_ca_topic_score_gemma":0.0036821999,"teacher_disagreement_score":0.0060336995,"about_ca_system_score_codex":0.0005669403,"about_ca_system_score_gemma":0.0006175734,"threshold_uncertainty_score":0.031909645},"labels":[],"label_agreement":null},{"id":"W4295255159","doi":"10.1016/j.jaad.2022.06.558","title":"32923 A multicenter, double-blind, randomized, placebo-controlled, phase IIb dose-finding study to evaluate efficacy and safety of spesolimab in patients with moderate-to-severe palmoplantar pustulosis","year":2022,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Autoimmune Bullous Skin Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada); Institute of Infection and Immunity","funders":"","keywords":"Palmoplantar pustulosis; Medicine; Placebo; Double blind; Multicenter study; Randomized controlled trial; Dermatology; Internal medicine; Psoriasis; Pathology","score_opus":0.020556458271793965,"score_gpt":0.3321643663996288,"score_spread":0.31160790812783484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295255159","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9779855,0.005491903,0.0013134533,0.000980959,0.0005766926,0.007826184,0.0020307708,0.00022774974,0.0035667291],"genre_scores_gemma":[0.9790055,0.0024393343,0.0032222236,0.0023439194,0.0005373185,0.005961774,0.002412485,0.000048801176,0.004028567],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9992193,0.00045434255,0.000052334693,0.00010790058,0.00005331095,0.00011283323],"domain_scores_gemma":[0.9991659,0.00020395307,0.00013005827,0.000060425173,0.00007118257,0.0003684573],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002266084,0.0019734043,0.003448068,0.00051812513,0.0006145287,0.00093421194,0.0007236945,0.0019703985,0.009103114],"category_scores_gemma":[0.0014364244,0.00074283587,0.0016718506,0.0004499989,0.0010058613,0.00080842903,0.00033238207,0.0029459568,0.0015980751],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.94932693,0.015228817,0.0009935288,0.0007261761,0.0011855313,0.00010220654,0.000074436735,0.0003848288,0.010857431,0.00016823488,0.0018792888,0.019072609],"study_design_scores_gemma":[0.93775755,0.059826374,0.0012296379,0.000013550153,0.00018539834,0.000031272546,0.000009836215,0.00017443857,0.00029860242,0.00005964268,0.00040274556,0.000011032386],"about_ca_topic_score_codex":0.0007237366,"about_ca_topic_score_gemma":0.0015216788,"teacher_disagreement_score":0.009103114,"about_ca_system_score_codex":0.00048971147,"about_ca_system_score_gemma":0.0013401054,"threshold_uncertainty_score":0.030452967},"labels":[],"label_agreement":null},{"id":"W4295255179","doi":"10.1016/j.jaad.2022.06.820","title":"33532 Randomized split-face study to assess the efficacy and tolerability of M89PF as an adjunct to topical retinoids for antiaging benefits","year":2022,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Skin Protection and Aging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Windsor Clinical Research","funders":"","keywords":"Medicine; Tolerability; Moisturizer; Sensitive skin; Dermatology; Randomized controlled trial; Skin Aging; Surgery; Internal medicine; Adverse effect; Food science","score_opus":0.04068281794518583,"score_gpt":0.3730045007582565,"score_spread":0.3323216828130706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295255179","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905562,0.0013937342,0.00062591216,0.00040207317,0.00034136054,0.0033587937,0.0010083624,0.00010291591,0.0022106476],"genre_scores_gemma":[0.9860787,0.00089474604,0.0017911575,0.001246718,0.00055634906,0.0037942263,0.0009507551,0.000030223606,0.00465709],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99943346,0.0002826066,0.000025985984,0.000089007146,0.00004558565,0.00012328601],"domain_scores_gemma":[0.9993587,0.00015584391,0.00011593933,0.00008376049,0.00004349591,0.00024230477],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015890722,0.0015918822,0.0031274774,0.00051881257,0.00051955937,0.00096431834,0.00083980634,0.0019125403,0.015443572],"category_scores_gemma":[0.0011041799,0.0008428981,0.0013626951,0.0004452152,0.0012989976,0.0010717635,0.00044755876,0.0034645183,0.0022087756],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97746766,0.011223956,0.00031179158,0.00013950073,0.00020553442,0.000030344447,0.000018102948,0.00011172625,0.0031484084,0.0000936285,0.00039816333,0.0068511316],"study_design_scores_gemma":[0.8655377,0.13091126,0.0018198867,0.000016111282,0.0002555582,0.000027425354,0.000019209154,0.000330933,0.00049002684,0.00008591787,0.00049065205,0.000015300127],"about_ca_topic_score_codex":0.0012094283,"about_ca_topic_score_gemma":0.0022569967,"teacher_disagreement_score":0.015443572,"about_ca_system_score_codex":0.0006987849,"about_ca_system_score_gemma":0.0011472168,"threshold_uncertainty_score":0.051663876},"labels":[],"label_agreement":null},{"id":"W4295255208","doi":"10.1016/j.jaad.2022.06.740","title":"32741 Investigating sun safety behaviors, beliefs, and skin cancer-related knowledge and risk factors in the Canadian population","year":2022,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Skin Protection and Aging","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University","funders":"","keywords":"Seriousness; Medicine; Skin cancer; Incidence (geometry); Malignancy; Environmental health; Public health; Cancer incidence; Population; Demography; Cancer; Population health; Dermatology; Family medicine; Gerontology; Pathology; Internal medicine","score_opus":0.01719827952732187,"score_gpt":0.31106036189275604,"score_spread":0.29386208236543415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295255208","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902019,0.00058668794,0.00006933526,0.0004223106,0.000024560783,0.00013705163,0.0028165737,0.000006665684,0.0057350663],"genre_scores_gemma":[0.9928022,0.0011690656,0.0003474129,0.00056945666,0.000018228538,0.00009331262,0.0016578283,0.0000067227834,0.0033357807],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99890685,0.000077057426,0.000054552027,0.00010013006,0.0004478322,0.00041359212],"domain_scores_gemma":[0.9981517,0.00014088252,0.00023129566,0.0000458875,0.0009819383,0.00044830053],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010360014,0.00051697745,0.00047047937,0.0021305366,0.0059035807,0.0013074963,0.0011464461,0.0006693671,0.0065968833],"category_scores_gemma":[0.0033514872,0.00058993034,0.0011951962,0.004489695,0.0006475908,0.000519069,0.00079748343,0.0011490164,0.0006293047],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000056199,0.00020597244,0.9926098,0.000058019676,0.00005156938,0.00007214717,0.0011746028,0.000027698637,0.0001390652,0.00007970534,0.0011394204,0.0043858225],"study_design_scores_gemma":[0.000015656426,0.00008596339,0.9952956,0.00006721031,0.000059451304,0.000060016177,0.0030034087,0.00009636821,0.000060386545,0.000023649087,0.0012196713,0.000012491463],"about_ca_topic_score_codex":0.993024,"about_ca_topic_score_gemma":0.9950787,"teacher_disagreement_score":0.01780494,"about_ca_system_score_codex":0.01780494,"about_ca_system_score_gemma":0.037881214,"threshold_uncertainty_score":0.12918442},"labels":[],"label_agreement":null},{"id":"W4295255311","doi":"10.1016/j.jaad.2022.06.680","title":"33354 Efficacy of apremilast in patients with mild to moderate psoriasis assessed by the physician global assessment and body surface area composite tool: Post hoc analysis from ADVANCE","year":2022,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Medicine; Apremilast; Post-hoc analysis; Post hoc; Body surface area; Psoriasis; Internal medicine; Gastroenterology; Randomized controlled trial; Immunology","score_opus":0.007718523954101549,"score_gpt":0.2608112989600135,"score_spread":0.25309277500591193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295255311","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967957,0.00084907026,0.0002365788,0.00008581416,0.00010492185,0.000113563285,0.00057715026,0.00002122786,0.0012159777],"genre_scores_gemma":[0.9969309,0.00023387748,0.00025141693,0.00009314748,0.0001258215,0.00010966092,0.0007278498,0.000007368421,0.0015199683],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9984609,0.0008805823,0.000092038405,0.00017208868,0.00014374776,0.00025067327],"domain_scores_gemma":[0.9983802,0.00093022955,0.00018800027,0.0001839041,0.00012627496,0.00019137413],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026922838,0.00050936645,0.0020864794,0.0003050853,0.00024426007,0.0006096009,0.00037134968,0.00047855673,0.004673994],"category_scores_gemma":[0.0024599908,0.0002302787,0.0021203686,0.0002897155,0.00037085457,0.0007954634,0.00034843897,0.0011729621,0.0004557777],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9364591,0.0030240293,0.026584117,0.00018051079,0.0023439745,0.00011452669,0.00007025756,0.0008239295,0.0041818577,0.000080488266,0.0009570938,0.025180103],"study_design_scores_gemma":[0.10002965,0.4098783,0.4710818,0.00006533327,0.0059548947,0.00027204456,0.00023565961,0.0039674337,0.0045345156,0.00031256958,0.0035824254,0.00008537838],"about_ca_topic_score_codex":0.0007191577,"about_ca_topic_score_gemma":0.0012132805,"teacher_disagreement_score":0.004673994,"about_ca_system_score_codex":0.00037730523,"about_ca_system_score_gemma":0.0006043299,"threshold_uncertainty_score":0.015636027},"labels":[],"label_agreement":null},{"id":"W4295255312","doi":"10.1016/j.jaad.2022.06.593","title":"32805 Analysis of time to second relapse confirms the superiority of long-term proactive management with Cal/BD foam vs reactive management of psoriasis","year":2022,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Medicine; Hazard ratio; Confidence interval; Randomization; Post-hoc analysis; Betamethasone dipropionate; Internal medicine; Psoriasis; Randomized controlled trial; Gastroenterology; Surgery; Dermatology","score_opus":0.010540934019017125,"score_gpt":0.25395623991958066,"score_spread":0.24341530590056354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295255312","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896716,0.0013932281,0.0013093617,0.0002200453,0.00008207238,0.00004440061,0.001827169,0.00004972405,0.005402346],"genre_scores_gemma":[0.99582654,0.0001672534,0.00037201305,0.00010422942,0.000049575,0.000019706093,0.0013201837,0.0000149991265,0.0021254134],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987772,0.00048337074,0.00007455282,0.00021964012,0.00020426355,0.00024089069],"domain_scores_gemma":[0.9963257,0.002269346,0.00039916008,0.00044832873,0.00017693898,0.00038048238],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022184977,0.00024874113,0.00085131166,0.00031562313,0.00026228308,0.0007879666,0.00034877728,0.0005393161,0.012642288],"category_scores_gemma":[0.0026852065,0.00009911359,0.0014386305,0.00036500063,0.00021316156,0.00042758413,0.00021655191,0.0009874306,0.00094566547],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19307546,0.0034745312,0.56986797,0.00035098114,0.0044948854,0.000558681,0.00012689408,0.0016016212,0.023730913,0.00078248186,0.004354515,0.19758104],"study_design_scores_gemma":[0.0020614904,0.027960045,0.9528547,0.000055596312,0.0020126696,0.00089418585,0.00015828147,0.004553536,0.0032756454,0.0005184388,0.005623523,0.00003187234],"about_ca_topic_score_codex":0.0015841699,"about_ca_topic_score_gemma":0.0017972464,"teacher_disagreement_score":0.012642288,"about_ca_system_score_codex":0.00029768728,"about_ca_system_score_gemma":0.00036699537,"threshold_uncertainty_score":0.042292714},"labels":[],"label_agreement":null},{"id":"W4295255316","doi":"10.1016/j.jaad.2022.06.543","title":"33168 Visual vulnerability: Daily burden and psycosocial impact of acne and video calling during COVID-19","year":2022,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Body Image and Dysmorphia Studies","field":"Psychology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Windsor Clinical Research","funders":"","keywords":"Acne; Medicine; Psychosocial; Vulnerability (computing); Coronavirus disease 2019 (COVID-19); Pandemic; Disease; Dermatology; Psychiatry; Internal medicine; Infectious disease (medical specialty)","score_opus":0.027344732702120025,"score_gpt":0.394246929876155,"score_spread":0.366902197174035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295255316","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99652773,0.000117776275,0.000015523201,0.00004603954,0.000008899189,0.00001360834,0.000108654975,0.0000024756741,0.00315938],"genre_scores_gemma":[0.99889684,0.000049745442,0.000023232784,0.000017756323,0.000009154733,0.0000038501844,0.00008230942,0.0000014001637,0.0009157051],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.9996119,0.000072792755,0.000028450053,0.000042121017,0.00013721388,0.00010759816],"domain_scores_gemma":[0.99824774,0.00025786925,0.00067668053,0.00006763892,0.00023118868,0.0005189576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032498472,0.00018115017,0.0001887206,0.00092180417,0.00068611815,0.0008180502,0.00020924967,0.00033910875,0.008656617],"category_scores_gemma":[0.003462933,0.00011894733,0.0002675012,0.0004269264,0.00020925367,0.0005997636,0.0007329482,0.0005179938,0.00054348883],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005041497,0.0005550679,0.97709674,0.000030793126,0.000037303344,0.00059908326,0.00086532935,0.000050447845,0.0013326731,0.00006693816,0.0004414794,0.018419988],"study_design_scores_gemma":[0.0000031313252,0.00016559364,0.99825245,0.0000052884047,0.000006774301,0.00037083347,0.00083673635,0.00003977804,0.000056485816,0.0000141603205,0.0002451176,0.0000036804759],"about_ca_topic_score_codex":0.009049314,"about_ca_topic_score_gemma":0.017607523,"teacher_disagreement_score":0.009049314,"about_ca_system_score_codex":0.00051270734,"about_ca_system_score_gemma":0.0003779592,"threshold_uncertainty_score":0.028959274},"labels":[],"label_agreement":null},{"id":"W4295255326","doi":"10.1016/j.jaad.2022.06.857","title":"34385 Sustained long-term dupilumab efficacy in adult patients with moderate-to-severe atopic dermatitis transitioning from weekly dosing to every other week: Results from an open-label extension trial","year":2022,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Medicine; Dupilumab; Dosing; Atopic dermatitis; Open label; Dermatology; Clinical trial; Internal medicine","score_opus":0.021808538391881713,"score_gpt":0.3098094815173046,"score_spread":0.28800094312542285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295255326","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932567,0.003734867,0.00023268486,0.00032223336,0.00020558723,0.00043116653,0.0006441076,0.00007964419,0.0010930476],"genre_scores_gemma":[0.9951747,0.0013863759,0.000488166,0.00059029623,0.00018675829,0.00038191583,0.0007554571,0.000011641999,0.0010247692],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99960417,0.00014856178,0.000028029011,0.00007794775,0.00003757305,0.00010376033],"domain_scores_gemma":[0.99948704,0.00015502633,0.00008937598,0.000036788355,0.00003680815,0.0001949905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011814788,0.0010304428,0.0019330105,0.0002508429,0.00037398617,0.0010143052,0.0004716381,0.0010305435,0.004089994],"category_scores_gemma":[0.0009841603,0.000358765,0.0017507193,0.00027551412,0.00066015363,0.00095122476,0.0002540711,0.0027720819,0.00092394924],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8920693,0.011400575,0.0038772612,0.0010398135,0.0018480462,0.00017476677,0.00020494679,0.00072447455,0.008946942,0.00018146944,0.002370481,0.07716201],"study_design_scores_gemma":[0.81233865,0.16329432,0.019097531,0.00008696953,0.001220812,0.00016877164,0.00009701523,0.0009930931,0.00086614495,0.00018195962,0.0016119628,0.000042784333],"about_ca_topic_score_codex":0.00077720935,"about_ca_topic_score_gemma":0.0018247328,"teacher_disagreement_score":0.004089994,"about_ca_system_score_codex":0.0005692247,"about_ca_system_score_gemma":0.00050488935,"threshold_uncertainty_score":0.013682365},"labels":[],"label_agreement":null},{"id":"W4295255365","doi":"10.1016/j.jaad.2022.06.334","title":"33514 Learning practical dermatology skills through animated vignettes: An effective medical school educational intervention to support the dissemination of national guidelines","year":2022,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Empathy and Medical Education","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health; University of British Columbia","funders":"","keywords":"Medicine; Intervention (counseling); Continuing medical education; Medical education; Dermatology; Continuing education; Nursing","score_opus":0.024370978879481434,"score_gpt":0.4547244757257271,"score_spread":0.4303534968462457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295255365","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90691155,0.00039276454,0.014776372,0.014436397,0.001259189,0.0056275227,0.00029094156,0.001590607,0.05471465],"genre_scores_gemma":[0.8493984,0.001079325,0.115995646,0.004423365,0.0004378543,0.0050043887,0.00046807743,0.000107842774,0.02308517],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99725753,0.0019296706,0.000110811176,0.00013732378,0.00035342257,0.00021130206],"domain_scores_gemma":[0.9907506,0.004558232,0.000696208,0.0004132381,0.00072982395,0.0028519519],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041201888,0.00043174552,0.00042541916,0.0006383997,0.0016872743,0.0010377226,0.0010378724,0.0012686943,0.026614582],"category_scores_gemma":[0.020028943,0.00042894486,0.00035004926,0.00031723588,0.00036113724,0.0009820444,0.00238433,0.00203882,0.003387051],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019260255,0.08841665,0.01549109,0.0012845577,0.00008154967,0.0015503941,0.01739267,0.0009552999,0.0061587575,0.0026801734,0.10498439,0.75907844],"study_design_scores_gemma":[0.012188372,0.056901425,0.27852648,0.0051895655,0.0009181291,0.0045860554,0.05184547,0.022832813,0.0212421,0.011812649,0.5331209,0.00083616626],"about_ca_topic_score_codex":0.00069306395,"about_ca_topic_score_gemma":0.0028544432,"teacher_disagreement_score":0.026614582,"about_ca_system_score_codex":0.000756873,"about_ca_system_score_gemma":0.0030588736,"threshold_uncertainty_score":0.08903462},"labels":[],"label_agreement":null},{"id":"W4295255613","doi":"10.1016/j.jaad.2022.06.148","title":"35226 Characterization of pain in prurigo nodularis: An online survey-based study","year":2022,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pregabalin; Neuropathic pain; Gabapentin; McGill Pain Questionnaire; Prurigo nodularis; Physical therapy; Neuralgia; Internal medicine; Dermatology; Anesthesia; Alternative medicine; Visual analogue scale","score_opus":0.034831330166181576,"score_gpt":0.33017118213401986,"score_spread":0.2953398519678383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295255613","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99876225,0.00015024855,0.00004976607,0.000041030882,0.000006215419,0.000036900914,0.00035000578,0.0000012930057,0.0006023493],"genre_scores_gemma":[0.99907327,0.00013390652,0.00007439095,0.000088317174,0.000011724,0.000031564665,0.00034911872,0.0000012844131,0.00023640807],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998623,0.00062163785,0.0001753109,0.00017792261,0.00022172325,0.00018030201],"domain_scores_gemma":[0.99751043,0.00054194994,0.0012104693,0.00010646528,0.00023063026,0.00040009996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001021134,0.00026362008,0.000439245,0.001113278,0.00048041352,0.00089489017,0.0004084243,0.00079204876,0.0028216655],"category_scores_gemma":[0.0038699755,0.00034197298,0.00074925856,0.001371571,0.00030036425,0.0009016155,0.00076279603,0.0008115256,0.00067668234],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000051164618,0.00026875694,0.9983272,0.000027240656,0.000055205455,0.000056272605,0.00014868051,0.000010855546,0.00010641689,0.00000999482,0.00006341378,0.00087486114],"study_design_scores_gemma":[0.000005911512,0.00015549759,0.99911505,0.000008854246,0.00001809573,0.00010073083,0.00043943824,0.00004462586,0.000011941354,0.0000057211378,0.00009124692,0.0000028502252],"about_ca_topic_score_codex":0.003594028,"about_ca_topic_score_gemma":0.0042961393,"teacher_disagreement_score":0.003594028,"about_ca_system_score_codex":0.00032193214,"about_ca_system_score_gemma":0.00026396665,"threshold_uncertainty_score":0.009439349},"labels":[],"label_agreement":null},{"id":"W4295255957","doi":"10.1016/j.jaad.2022.06.052","title":"34222 Prospective study of surgical deroofing in the management of hidradenitis suppurativa","year":2022,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Hidradenitis suppurativa; Dermatology Life Quality Index; Adalimumab; Prospective cohort study; Quality of life (healthcare); Erythema; Stage (stratigraphy); Surgery; Dermatology; Internal medicine; Disease; Psoriasis","score_opus":0.018251033697106487,"score_gpt":0.3246946517371602,"score_spread":0.3064436180400537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295255957","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99847084,0.0006573778,0.000048911697,0.0000269661,0.000020316293,0.000036279103,0.00021707095,0.0000018483249,0.0005202526],"genre_scores_gemma":[0.9987686,0.00026575543,0.00004866838,0.0000620898,0.00004868351,0.000032995304,0.00038482386,0.0000021701997,0.00038615064],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989718,0.00047409895,0.000088447945,0.00016816774,0.00011828738,0.0001791528],"domain_scores_gemma":[0.99793303,0.0006366908,0.0005817802,0.00014194554,0.00015790666,0.00054877927],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011734052,0.00054512825,0.0006780864,0.0006461919,0.00086400413,0.00087532843,0.00047318675,0.0010212098,0.0033430243],"category_scores_gemma":[0.0023628182,0.00064522325,0.00090794236,0.0012665379,0.0006315524,0.00070561975,0.00039248285,0.0012355372,0.0006374503],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018741243,0.0020750044,0.9752528,0.00005087942,0.00032236156,0.0004264901,0.000095571384,0.000055835364,0.00063241675,0.000040313742,0.00011644272,0.002190578],"study_design_scores_gemma":[0.0012545137,0.011598179,0.98546326,0.000018344263,0.00018589298,0.0003872233,0.0002470475,0.00012881514,0.00015442463,0.000032691085,0.00050945015,0.00002009067],"about_ca_topic_score_codex":0.0030230237,"about_ca_topic_score_gemma":0.0031143334,"teacher_disagreement_score":0.0033430243,"about_ca_system_score_codex":0.00041129978,"about_ca_system_score_gemma":0.00066013786,"threshold_uncertainty_score":0.0111835},"labels":[],"label_agreement":null},{"id":"W4295256640","doi":"10.1016/j.jaad.2022.06.723","title":"31924 Hydroxyurea-induced ulcers: Anagrelide as a treatment option after hydroxyurea discontinuation","year":2022,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Discontinuation; Medicine; Anagrelide; Hydroxycarbamide; Dermatology; Surgery; Chemotherapy; Internal medicine; Essential thrombocythemia; Polycythemia vera","score_opus":0.01721270540044,"score_gpt":0.3159962406476453,"score_spread":0.2987835352472053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295256640","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6106782,0.15277778,0.007758413,0.057492282,0.008538667,0.0005831448,0.0014252041,0.00062484783,0.16012143],"genre_scores_gemma":[0.9357747,0.019846754,0.004089557,0.010310836,0.003924542,0.000085429914,0.00072283717,0.000042850355,0.025202459],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.9998789,0.000029207893,0.00001842326,0.000015669744,0.000026611162,0.000031145413],"domain_scores_gemma":[0.9998155,0.000042469786,0.00003587447,0.000011396485,0.000019736708,0.00007493157],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020640713,0.0003065679,0.00039127562,0.00040643182,0.00041620573,0.00046355173,0.00029465667,0.0013702334,0.0056773517],"category_scores_gemma":[0.0005641518,0.0000740393,0.0005672897,0.00020776459,0.00015294149,0.00024735948,0.00018425711,0.0013757206,0.001440405],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009897451,0.0023990413,0.022090726,0.00093038625,0.00032516915,0.25266582,0.00020938192,0.0005368695,0.029751213,0.0038033877,0.0504577,0.6269328],"study_design_scores_gemma":[0.004153248,0.01490017,0.08602362,0.0020327242,0.00069602876,0.4283112,0.00050385384,0.0031295305,0.016912721,0.0060639014,0.43712112,0.00015180898],"about_ca_topic_score_codex":0.00043627137,"about_ca_topic_score_gemma":0.0013579872,"teacher_disagreement_score":0.0056773517,"about_ca_system_score_codex":0.00031257735,"about_ca_system_score_gemma":0.0003151075,"threshold_uncertainty_score":0.018992603},"labels":[],"label_agreement":null},{"id":"W4295257029","doi":"10.1016/j.jaad.2022.06.763","title":"34783 Metagenomic microbial profiling of keratinocyte carcinomas in solid organ transplant recipients","year":2022,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Dysbiosis; Medicine; Microbiome; Immunosuppression; Immunology; Metagenomics; Transplantation; Skin cancer; Malignancy; Gut flora; Organ transplantation; Immune system; Atopic dermatitis; Cancer; Biology; Pathology; Bioinformatics; Internal medicine","score_opus":0.02013920482009409,"score_gpt":0.3040010651684963,"score_spread":0.2838618603484022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295257029","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99796474,0.00059870107,0.00027029408,0.00003698802,0.000011325294,0.000013550208,0.000639568,0.0000054850634,0.00045945696],"genre_scores_gemma":[0.99772114,0.0003241615,0.00038278115,0.00007546881,0.00001460686,0.000018931927,0.0007993937,0.000004599739,0.00065893214],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997192,0.000065561675,0.00002145718,0.000056096484,0.00007355847,0.000064087544],"domain_scores_gemma":[0.99987185,0.000021458982,0.000035592275,0.00001491454,0.000033915032,0.000022173594],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003398933,0.00022453324,0.00024646867,0.0007242796,0.0003064598,0.0007740725,0.00012107272,0.00019186712,0.0012972171],"category_scores_gemma":[0.00036952464,0.000112254755,0.00033202293,0.00058899826,0.0001134553,0.00016554366,0.00033085662,0.00024315287,0.00025649872],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034421075,0.0003009943,0.66650593,0.00013837256,0.0004272418,0.00032017153,0.0003794665,0.00018689694,0.303867,0.0001435467,0.00044304284,0.023845207],"study_design_scores_gemma":[0.000028174558,0.0008643317,0.9499951,0.000033615568,0.00043398244,0.0007368996,0.00094578683,0.00062694703,0.043046653,0.00012920854,0.0031454095,0.000013893135],"about_ca_topic_score_codex":0.000956972,"about_ca_topic_score_gemma":0.0013299906,"teacher_disagreement_score":0.0012972171,"about_ca_system_score_codex":0.00016239462,"about_ca_system_score_gemma":0.00022181681,"threshold_uncertainty_score":0.004339576},"labels":[],"label_agreement":null},{"id":"W4295257226","doi":"10.1016/j.jaad.2022.06.863","title":"34615 Tapinarof cream 1% once daily for plaque psoriasis: Dermatology Life Quality Index and local tolerability scores from a long-term extension trial","year":2022,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"","keywords":"Medicine; Dermatology Life Quality Index; Tolerability; Psoriasis; Plaque psoriasis; Dermatology; Quality of life (healthcare); Psoriasis Area and Severity Index; Term (time); Index (typography); Internal medicine; Adverse effect","score_opus":0.0342122122168233,"score_gpt":0.31389656540569266,"score_spread":0.27968435318886936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295257226","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9882117,0.006566415,0.00034209504,0.0003687762,0.00027567614,0.00086895464,0.0015232321,0.00007792045,0.0017653488],"genre_scores_gemma":[0.991109,0.002778956,0.0004666689,0.000595009,0.00030421928,0.0006567459,0.0022377933,0.000015205786,0.0018364374],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99940777,0.00025039542,0.000032290744,0.00010650393,0.00007652266,0.00012661511],"domain_scores_gemma":[0.9992623,0.00019982505,0.00015698366,0.000062155035,0.00007735614,0.00024136949],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001726137,0.0014190774,0.0026630217,0.00040462648,0.00038939907,0.000982378,0.0007779629,0.0012974149,0.005909814],"category_scores_gemma":[0.0011379052,0.0005061426,0.0025417407,0.00049907033,0.00067585224,0.00091448997,0.00035637422,0.0030999663,0.00088807195],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.944967,0.008135603,0.0035738482,0.0006753763,0.0026119067,0.00007354666,0.000054756132,0.00061955303,0.00519591,0.0000911738,0.0013157154,0.032685727],"study_design_scores_gemma":[0.7982283,0.16212583,0.033716112,0.00008155523,0.0028176536,0.00011008061,0.0000549123,0.00085475546,0.0006440604,0.00014893593,0.0011707162,0.000047065067],"about_ca_topic_score_codex":0.0010804598,"about_ca_topic_score_gemma":0.001829326,"teacher_disagreement_score":0.005909814,"about_ca_system_score_codex":0.0005763403,"about_ca_system_score_gemma":0.00060561724,"threshold_uncertainty_score":0.019770265},"labels":[],"label_agreement":null},{"id":"W4295257253","doi":"10.1016/j.jaad.2022.06.465","title":"35098 Secukinumab versus guselkumab in the treatment of ustekinumab-resistant psoriatic plaques: 16-week randomized, open-label, multicenter ARROW study","year":2022,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Dalhousie University","funders":"","keywords":"Medicine; Secukinumab; Ustekinumab; Psoriasis; Psoriasis Area and Severity Index; Clinical endpoint; Internal medicine; Dermatology; Gastroenterology; Randomized controlled trial; Disease; Psoriatic arthritis","score_opus":0.042380024080505466,"score_gpt":0.3190129473043446,"score_spread":0.27663292322383914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295257253","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99396825,0.0021984228,0.0004726236,0.00032945615,0.0003742713,0.0010731886,0.00047786967,0.00008448877,0.0010214341],"genre_scores_gemma":[0.9870112,0.0027632478,0.0016958372,0.0008844426,0.0006237548,0.0018876712,0.00083516986,0.00004149996,0.0042572566],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9991793,0.00042197196,0.00004793236,0.0001257733,0.000068656525,0.00015649202],"domain_scores_gemma":[0.9991641,0.00021856008,0.0001644878,0.00010735362,0.00006480352,0.0002807197],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021761481,0.0023321528,0.004200638,0.00060559844,0.00054819416,0.0015155785,0.0010833044,0.002204169,0.0063238502],"category_scores_gemma":[0.0014222438,0.0010829633,0.002169541,0.0005681924,0.0015919972,0.0021393104,0.00057408947,0.0029688242,0.001605605],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9799002,0.007925375,0.00029751455,0.00027938615,0.00039726618,0.000027775377,0.000034540786,0.00023921333,0.0026646012,0.00006805633,0.0002688722,0.007897166],"study_design_scores_gemma":[0.91533536,0.08112446,0.0018702635,0.000024944098,0.00036762105,0.000023567618,0.00003196371,0.00039986905,0.00038248312,0.000093508315,0.0003260945,0.00002003468],"about_ca_topic_score_codex":0.0009430485,"about_ca_topic_score_gemma":0.0014560547,"teacher_disagreement_score":0.0063238502,"about_ca_system_score_codex":0.0006309442,"about_ca_system_score_gemma":0.0008876091,"threshold_uncertainty_score":0.021155357},"labels":[],"label_agreement":null},{"id":"W4295257805","doi":"10.1016/j.jaad.2022.06.314","title":"34223 Incidence and prognosis of COVID-19 in patients with psoriasis on apremilast: A multicenter retrospective cohort study","year":2022,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Apremilast; Medicine; Psoriasis; Discontinuation; Incidence (geometry); Population; Retrospective cohort study; Internal medicine; Dermatology; Psoriatic arthritis; Environmental health","score_opus":0.010656211458400924,"score_gpt":0.2650077681667486,"score_spread":0.2543515567083477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295257805","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99884737,0.00022032649,0.00006375234,0.000021260175,0.000008090511,0.000007686989,0.00037732135,0.0000041144112,0.00045011548],"genre_scores_gemma":[0.9991387,0.00010294477,0.000040382703,0.000022723354,0.000018111352,0.000007861298,0.00044073947,0.0000035775747,0.00022503633],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993962,0.00012440151,0.0000591293,0.00019722177,0.00008812088,0.00013494412],"domain_scores_gemma":[0.9990507,0.00008423574,0.00043179048,0.00014771165,0.00009564933,0.00018993283],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041161184,0.00046901382,0.0006026579,0.00094642484,0.00066502567,0.0011534222,0.0004427392,0.0006638615,0.0029459652],"category_scores_gemma":[0.001059585,0.0006401361,0.0009851964,0.0015600764,0.00033112234,0.00066588,0.00045941517,0.0008214633,0.0006518252],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044498357,0.00006627037,0.997797,0.0000069628254,0.00012874663,0.00025675382,0.00004129039,0.000020014448,0.00038107097,0.000017911669,0.00010830837,0.000730632],"study_design_scores_gemma":[0.000028284549,0.00020014857,0.99816614,0.0000043439177,0.00008551733,0.0008975846,0.00018625763,0.00008952998,0.00006988393,0.000019989264,0.00024402568,0.000008305775],"about_ca_topic_score_codex":0.0027635822,"about_ca_topic_score_gemma":0.0020352672,"teacher_disagreement_score":0.0029459652,"about_ca_system_score_codex":0.00033540383,"about_ca_system_score_gemma":0.00030779236,"threshold_uncertainty_score":0.009855211},"labels":[],"label_agreement":null},{"id":"W4295259359","doi":"10.1016/j.jaad.2022.06.754","title":"33298 Long-term safety and efficacy of tralokinumab in more than 1400 moderate-to-severe atopic dermatitis patients treated for up to 42 months: An interim analysis of ECZTEND","year":2022,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Dalhousie University","funders":"","keywords":"Medicine; Atopic dermatitis; Interim; Interim analysis; Dermatology; Term (time); Surgery; Randomized controlled trial","score_opus":0.016401408763777405,"score_gpt":0.32126475575845975,"score_spread":0.30486334699468237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295259359","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944159,0.0012718722,0.00037490902,0.00006722068,0.00004648073,0.00015648383,0.0025380936,0.000036006764,0.0010930523],"genre_scores_gemma":[0.9901848,0.00042992752,0.00043920765,0.00019860498,0.000060584553,0.00020338749,0.0066710426,0.000019544414,0.0017930261],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99869424,0.00034594862,0.00010275472,0.00027520763,0.00030678153,0.00027504886],"domain_scores_gemma":[0.998909,0.0002205966,0.00031777422,0.0002616688,0.00012045337,0.000170457],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002677944,0.00077822653,0.0018486063,0.0003785545,0.00055443286,0.0013860586,0.0005631466,0.0006879158,0.0023136816],"category_scores_gemma":[0.0012290278,0.00037961864,0.0034992094,0.00058319845,0.0004761597,0.0010853508,0.00042451094,0.0020388898,0.0007839444],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.53394043,0.007859137,0.3193997,0.00079996133,0.014703417,0.000768972,0.00023929088,0.00475131,0.019320367,0.0002907426,0.0034880247,0.09443859],"study_design_scores_gemma":[0.04217098,0.09193388,0.83267385,0.00012107904,0.0121673895,0.0011895823,0.00019001505,0.0033374322,0.0074860626,0.00036443627,0.008222114,0.00014315594],"about_ca_topic_score_codex":0.00063594355,"about_ca_topic_score_gemma":0.0012693275,"teacher_disagreement_score":0.002677944,"about_ca_system_score_codex":0.0005846588,"about_ca_system_score_gemma":0.0006881459,"threshold_uncertainty_score":0.014162481},"labels":[],"label_agreement":null},{"id":"W4295259494","doi":"10.1016/j.jaad.2022.06.303","title":"33950 Impact of psoriasis in special areas on patient quality-of-life outcomes and depression screening: Findings from the multinational UPLIFT survey","year":2022,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Multinational corporation; Psoriasis; Depression (economics); Quality of life (healthcare); Psychiatry; Dermatology; Nursing","score_opus":0.03977499198604127,"score_gpt":0.32593808936542107,"score_spread":0.2861630973793798,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295259494","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954751,0.00016794323,0.000032868033,0.00019861983,0.000011064914,0.000011637342,0.003107946,0.0000035269532,0.0009913009],"genre_scores_gemma":[0.99768853,0.00011079322,0.000038448245,0.00013516795,0.000015448748,0.000013965328,0.001688055,0.0000020995244,0.00030743305],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990821,0.00032533848,0.00009606189,0.00012507569,0.00018466843,0.00018667977],"domain_scores_gemma":[0.9975737,0.00033364233,0.0012364838,0.00013001346,0.00021029117,0.0005159393],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011307945,0.00021769838,0.00033759492,0.00061697594,0.000331369,0.0006087376,0.0003580241,0.0005611336,0.0019202268],"category_scores_gemma":[0.0027104963,0.00022902928,0.0007114924,0.0013723968,0.00022747152,0.0004838733,0.0008124432,0.0008205868,0.00035005595],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000040664123,0.000045633435,0.9990024,0.000004342833,0.00004598897,0.00001339888,0.000019782517,0.000017794395,0.000037404927,0.0000039904676,0.00019315863,0.0005754683],"study_design_scores_gemma":[0.0000017718161,0.0000138995,0.9998704,0.0000014070487,0.000007700956,0.000008958501,0.000034504963,0.00001528741,0.000003739737,0.0000015249049,0.000040163693,6.8000793e-7],"about_ca_topic_score_codex":0.026168436,"about_ca_topic_score_gemma":0.037721287,"teacher_disagreement_score":0.026168436,"about_ca_system_score_codex":0.00039479873,"about_ca_system_score_gemma":0.00043155334,"threshold_uncertainty_score":0.052032232},"labels":[],"label_agreement":null},{"id":"W4295259504","doi":"10.1016/j.jaad.2022.06.760","title":"32761 Mechanism for improvement in the appearance of skin laxity resulting from a single treatment with acoustic subcision: Induction of new collagen (type III) and elastin","year":2022,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatologic Treatments and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"","keywords":"Elastin; Medicine; Mechanism (biology); Surgery; Pathology","score_opus":0.041572759859710665,"score_gpt":0.32837481370064886,"score_spread":0.2868020538409382,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295259504","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9480436,0.010408596,0.02033593,0.0019080517,0.0007668157,0.00068477483,0.00033521742,0.0004785101,0.017038519],"genre_scores_gemma":[0.9903238,0.001304447,0.0026444795,0.0002898427,0.00016846984,0.00013075014,0.00007097083,0.000020542606,0.0050467523],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998,0.000039980645,0.000015746822,0.00002853228,0.000044048767,0.00007165705],"domain_scores_gemma":[0.9997968,0.00007485568,0.00004502566,0.000029237905,0.000016605089,0.00003750439],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003595729,0.000458989,0.00037814895,0.00051411573,0.0004578173,0.00035402874,0.00058223755,0.0013104571,0.010358454],"category_scores_gemma":[0.00035164706,0.00022950629,0.00090610806,0.00014136039,0.00049270643,0.0003553793,0.0002824528,0.0010283568,0.0010216356],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0069925655,0.0016874396,0.0034967295,0.00067029917,0.00010551337,0.012559897,0.000116474424,0.0003563322,0.9325272,0.003326096,0.0014880197,0.036673468],"study_design_scores_gemma":[0.0023731056,0.015550033,0.051827993,0.00012703185,0.00037313026,0.05343599,0.00026390908,0.0062359776,0.8531575,0.0021176278,0.014456992,0.00008074227],"about_ca_topic_score_codex":0.0003506545,"about_ca_topic_score_gemma":0.0002487416,"teacher_disagreement_score":0.010358454,"about_ca_system_score_codex":0.0002724059,"about_ca_system_score_gemma":0.00035936234,"threshold_uncertainty_score":0.03465247},"labels":[],"label_agreement":null},{"id":"W4295259512","doi":"10.1016/j.jaad.2022.06.237","title":"33180 Efficacy and safety of the oral JAK3/TEC inhibitor ritlecitinib in adolescents with alopecia areata: Results from the ALLEGRO Phase 2b/3 randomized, double-blind, placebo-controlled trial","year":2022,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Medicine; Alopecia areata; Double blind; Placebo; Dermatology; TEC; Randomized controlled trial; Internal medicine; Alternative medicine; Pathology","score_opus":0.030115548726574116,"score_gpt":0.3270124437933456,"score_spread":0.29689689506677147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295259512","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9666758,0.026311535,0.00053166354,0.00082907645,0.000357226,0.0010979656,0.001109738,0.00018188318,0.0029050594],"genre_scores_gemma":[0.98912174,0.0057407296,0.0007434205,0.00094550615,0.00024450148,0.0007778404,0.0008594727,0.000018452374,0.0015482819],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9997209,0.00011702618,0.000021459098,0.000054804943,0.000030359422,0.00005542897],"domain_scores_gemma":[0.9996455,0.00012767185,0.000087954606,0.00001811145,0.000026231326,0.00009461365],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007426894,0.00082293514,0.0020838988,0.00021168505,0.0003087034,0.00067869475,0.00043041183,0.0014295746,0.004558303],"category_scores_gemma":[0.00067894324,0.00036407204,0.0016530723,0.00021931632,0.0005523607,0.0006730539,0.00017200857,0.0025544334,0.00094803894],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8699069,0.005943019,0.0028780717,0.0031692986,0.0027900285,0.00018087255,0.000093252456,0.00080120115,0.011365574,0.00028551227,0.0034839504,0.099102356],"study_design_scores_gemma":[0.9205962,0.06507791,0.008424862,0.0001609477,0.0013710844,0.00019132035,0.00003773509,0.00060632365,0.0012410677,0.00016894785,0.0020925999,0.00003084234],"about_ca_topic_score_codex":0.00049594184,"about_ca_topic_score_gemma":0.0013442975,"teacher_disagreement_score":0.004558303,"about_ca_system_score_codex":0.00042917943,"about_ca_system_score_gemma":0.00053269544,"threshold_uncertainty_score":0.015249014},"labels":[],"label_agreement":null},{"id":"W4295259533","doi":"10.1016/j.jaad.2022.06.343","title":"33270 Long-term efficacy and safety of risankizumab (RZB) for the treatment of moderate to-severe plaque psoriasis: Interim analysis of results from the LIMMitless open-label extension trial beyond 4 years of follow-up","year":2022,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Medicine; Plaque psoriasis; Open label; Interim analysis; Interim; Term (time); Psoriasis; Dermatology; Adverse effect; Surgery; Randomized controlled trial; Internal medicine","score_opus":0.06921087710824349,"score_gpt":0.3868242283742427,"score_spread":0.3176133512659992,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295259533","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883471,0.0046628206,0.0007051978,0.00035757647,0.0001682277,0.00040616255,0.0024686605,0.00010361699,0.0027807055],"genre_scores_gemma":[0.99259573,0.0009358546,0.00045842273,0.00042548234,0.00015936245,0.00042365748,0.0028125404,0.00002490258,0.0021639317],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9985403,0.00072755263,0.000067059336,0.00017070507,0.00019422443,0.00030021538],"domain_scores_gemma":[0.9985587,0.0005733949,0.00034809764,0.00018985434,0.00011933027,0.00021066991],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041351975,0.0009957122,0.0024630693,0.00033448165,0.00037698686,0.0014776918,0.00065072783,0.0010083104,0.00382935],"category_scores_gemma":[0.0023668513,0.00044262505,0.003116291,0.0003428163,0.0007131423,0.00097376085,0.0004172205,0.0029884384,0.0011468241],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9235583,0.0047383634,0.006317113,0.000513417,0.0028622341,0.00011175565,0.00007115528,0.0021010987,0.009072457,0.00020836235,0.002723129,0.047722775],"study_design_scores_gemma":[0.56424046,0.3150606,0.09580338,0.00016299175,0.00848463,0.0003418132,0.0000963604,0.004232705,0.005777085,0.0008914783,0.0047964337,0.00011206629],"about_ca_topic_score_codex":0.00069530634,"about_ca_topic_score_gemma":0.0010975855,"teacher_disagreement_score":0.0041351975,"about_ca_system_score_codex":0.0006127128,"about_ca_system_score_gemma":0.0010084761,"threshold_uncertainty_score":0.021869242},"labels":[],"label_agreement":null},{"id":"W4295260246","doi":"10.1016/j.jaad.2022.06.248","title":"33007 Efficacy of spesolimab for the treatment of GPP flares across prespecified patient subgroups in the Effisayil 1 study","year":2022,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Medicine; Internal medicine","score_opus":0.03116722314343098,"score_gpt":0.314117501322825,"score_spread":0.28295027817939405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295260246","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99287134,0.003218612,0.00012692309,0.00040895032,0.000097817,0.00022351962,0.000920305,0.000020377161,0.002112287],"genre_scores_gemma":[0.9941222,0.0014025907,0.00035699765,0.00071573263,0.00020748784,0.00022515269,0.0018761373,0.000010889649,0.0010826909],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9993598,0.000293063,0.000040279934,0.00008817266,0.000069495676,0.00014922486],"domain_scores_gemma":[0.9994771,0.00013173973,0.0001099347,0.000044461627,0.000041681284,0.00019501422],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016333067,0.0009138084,0.0019574799,0.00033926216,0.00045662833,0.0009519632,0.00040874234,0.00094890466,0.0028392083],"category_scores_gemma":[0.00094229134,0.0003354478,0.0017986242,0.0004167729,0.0004168365,0.0007311016,0.00032898673,0.0017576002,0.00043807313],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8214147,0.0069137327,0.04769291,0.00093407783,0.005924278,0.0003260602,0.00018032153,0.0010373908,0.01830603,0.00044767035,0.004317868,0.09250499],"study_design_scores_gemma":[0.35882485,0.25024688,0.3719121,0.00024898569,0.006479594,0.0005635888,0.0002621775,0.001182186,0.0026421426,0.0007585865,0.0067789955,0.00009985767],"about_ca_topic_score_codex":0.0007511299,"about_ca_topic_score_gemma":0.0019881157,"teacher_disagreement_score":0.0028392083,"about_ca_system_score_codex":0.0004501795,"about_ca_system_score_gemma":0.0006851517,"threshold_uncertainty_score":0.009498119},"labels":[],"label_agreement":null},{"id":"W4295260797","doi":"10.1016/j.jaad.2022.06.293","title":"32793 How can we teach clerkship medical students the multidisciplinary aspects of dermatology? A medical education initiative","year":2022,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Medicine and Dermatology Studies History","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Multidisciplinary approach; Medicine; Medical education; Dermatology; Educational resources; Multidisciplinary team; Nursing; Pedagogy; Psychology","score_opus":0.02600806984386292,"score_gpt":0.3567415978107425,"score_spread":0.3307335279668796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295260797","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0039245556,0.0017131065,0.00041754686,0.9573823,0.013244068,0.00009531332,0.00003476421,0.00009792692,0.02309041],"genre_scores_gemma":[0.08012899,0.010392738,0.008136181,0.7181207,0.03408325,0.00054790324,0.00029862823,0.0001812165,0.1481104],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99226975,0.0020458566,0.00041359235,0.00059588376,0.0021036747,0.0025712945],"domain_scores_gemma":[0.86651003,0.006724718,0.0025248616,0.0016247703,0.012829161,0.10978644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020837085,0.00089392846,0.00069327233,0.0021772068,0.0107186055,0.012939832,0.0025331683,0.022336671,0.079008654],"category_scores_gemma":[0.024411071,0.00091850106,0.0010230839,0.0009760053,0.0044065136,0.007999028,0.012615091,0.01782655,0.017947719],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015785887,0.003973267,0.010135141,0.00047650066,0.000030322546,0.00071040355,0.0013979507,0.00024042843,0.0016644137,0.018058015,0.7690274,0.1941283],"study_design_scores_gemma":[0.00033235876,0.0007624051,0.024534963,0.0013669712,0.00003712235,0.00038315868,0.005100361,0.0005287885,0.000777059,0.0073970426,0.95869523,0.00008460244],"about_ca_topic_score_codex":0.0048920866,"about_ca_topic_score_gemma":0.021827355,"teacher_disagreement_score":0.079008654,"about_ca_system_score_codex":0.0047046174,"about_ca_system_score_gemma":0.049709797,"threshold_uncertainty_score":0.2643103},"labels":[],"label_agreement":null},{"id":"W4295261491","doi":"10.1016/j.jaad.2022.06.851","title":"33542 Stability of response prior to baricitinib downtitration or treatment withdrawal: Outcome from a substudy of BREEZE AD3","year":2022,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"Eli Lilly and Company","keywords":"Medicine; Atopic dermatitis; Internal medicine; Dermatology","score_opus":0.03760513049871761,"score_gpt":0.3501574947420966,"score_spread":0.312552364243379,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295261491","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97705734,0.010491285,0.0003497048,0.00071093306,0.00026750093,0.0005864798,0.006353126,0.000055196517,0.0041283416],"genre_scores_gemma":[0.9903274,0.0019253063,0.00021833678,0.0007523188,0.00019649981,0.0003752209,0.0053469357,0.000014256352,0.00084380555],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9984321,0.00062534487,0.00018898796,0.00027854746,0.00020078909,0.00027413826],"domain_scores_gemma":[0.9969638,0.0011098539,0.00079766405,0.00033793057,0.00038336447,0.00040733506],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034648934,0.00092670356,0.0022819594,0.00055747636,0.00079497235,0.0014623752,0.0006558391,0.001187415,0.0028171288],"category_scores_gemma":[0.0043393853,0.00047145222,0.0038536298,0.0010535964,0.0005572219,0.0012253912,0.00049722363,0.0025960836,0.0008301147],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.46883932,0.0038545073,0.36342606,0.0036227223,0.047380593,0.0010121539,0.0005496618,0.0012989346,0.012080587,0.00042878228,0.012196145,0.08531065],"study_design_scores_gemma":[0.0648813,0.0528273,0.819118,0.0007174009,0.04281533,0.0017257166,0.00033712204,0.0010471732,0.002553565,0.0007104407,0.01307075,0.00019590525],"about_ca_topic_score_codex":0.0040860744,"about_ca_topic_score_gemma":0.01085393,"teacher_disagreement_score":0.0040860744,"about_ca_system_score_codex":0.001042982,"about_ca_system_score_gemma":0.0008014632,"threshold_uncertainty_score":0.018324316},"labels":[],"label_agreement":null},{"id":"W4295807681","doi":"10.1016/j.jaad.2022.08.061","title":"Deucravacitinib versus placebo and apremilast in moderate to severe plaque psoriasis: Efficacy and safety results from the 52-week, randomized, double-blinded, phase 3 Program fOr Evaluation of TYK2 inhibitor psoriasis second trial","year":2022,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":279,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"Cilag; LEO Pharma; Eli Lilly and Company; Bristol-Myers Squibb; Galderma; Dermira; Sun Pharma; Regeneron Pharmaceuticals; Biogen; Celgene; Amgen; Pfizer","keywords":"Apremilast; Medicine; Psoriasis; Placebo; Adverse effect; Psoriasis Area and Severity Index; Internal medicine; Randomized controlled trial; Gastroenterology; Dermatology Life Quality Index; Clinical trial; Dermatology; Psoriatic arthritis; Pathology","score_opus":0.051617200701128164,"score_gpt":0.3402775865708558,"score_spread":0.2886603858697276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295807681","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9871132,0.0063363547,0.00064426503,0.00065013074,0.0004249802,0.0012607926,0.001158728,0.00028249386,0.0021290502],"genre_scores_gemma":[0.98948866,0.0027751713,0.0008599355,0.0007020523,0.00036003639,0.0012400614,0.0010705418,0.000052786912,0.0034507932],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9993679,0.00029786312,0.000037949016,0.00012513572,0.000053019252,0.00011816343],"domain_scores_gemma":[0.99917114,0.00021447474,0.00019910475,0.000076056065,0.00004971788,0.00028954793],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017827675,0.0020567207,0.0044592917,0.0004802034,0.0005119274,0.0013560711,0.0010275812,0.0016928916,0.006258347],"category_scores_gemma":[0.0014075782,0.00080760324,0.0022631385,0.0003633153,0.0009640051,0.0015439006,0.00035861132,0.0035244697,0.0012631087],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.970781,0.0044505987,0.00026691295,0.00047143293,0.000877436,0.000028403536,0.000037447142,0.00040465328,0.004032112,0.00007612744,0.00092921,0.017644646],"study_design_scores_gemma":[0.94537985,0.050486818,0.0019085432,0.000023222294,0.00038912546,0.000054490254,0.00002447109,0.00051113125,0.0005957703,0.00012754383,0.00047620686,0.000022811631],"about_ca_topic_score_codex":0.00078710215,"about_ca_topic_score_gemma":0.0021843424,"teacher_disagreement_score":0.006258347,"about_ca_system_score_codex":0.0007755351,"about_ca_system_score_gemma":0.0008891844,"threshold_uncertainty_score":0.02093625},"labels":[],"label_agreement":null},{"id":"W4296164016","doi":"10.1016/j.jaad.2022.09.010","title":"Itch-free state in patients with atopic dermatitis treated with ruxolitinib cream: A pooled analysis from two randomized phase 3 studies","year":2022,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"Cilag; Bausch Health; Galderma; Astellas Pharma; Sanofi; Kyowa Hakko Kirin; Glenmark Pharmaceuticals; InflaRx; Pfizer; Incyte; Sun Pharma; Dermira; Les Laboratories Pierre Fabre; Celldex Therapeutics; Coherus Biosciences; UCB Pharma; Valeant Pharmaceuticals International; Sanofi Genzyme; Daewoong Pharmaceutical Company; Regeneron Pharmaceuticals; Meiji Seika Pharma; Kiniksa Pharmaceuticals; Baxalta; LEO Pharma; Ortho Dermatologics; Gilead Sciences; GlaxoSmithKline; Amgen; Celgene; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Ruxolitinib; Atopic dermatitis; Dermatology; Randomized controlled trial; Dupilumab; Internal medicine; Myelofibrosis","score_opus":0.010982937097256507,"score_gpt":0.30665430993118786,"score_spread":0.29567137283393136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296164016","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3161882,0.66283244,0.0042006406,0.0033280326,0.0031656781,0.001973073,0.0060866605,0.00019585206,0.002029445],"genre_scores_gemma":[0.9414471,0.045132857,0.002767366,0.003447335,0.0026600175,0.0012976741,0.0026147,0.000057522004,0.00057534483],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98805505,0.0074179526,0.0024787032,0.00095332507,0.00080604973,0.00028905267],"domain_scores_gemma":[0.96542245,0.023303173,0.007701063,0.0014702006,0.0015151022,0.0005880093],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.021501439,0.0016302778,0.00861144,0.0012452713,0.00032616046,0.0024636548,0.00091820274,0.0017699064,0.0029488602],"category_scores_gemma":[0.032096423,0.00071397837,0.017858086,0.0017585803,0.00057000294,0.0013259074,0.0007096558,0.0019650261,0.00023389306],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.28516927,0.0003040581,0.020191189,0.041091993,0.6140525,0.00028656318,0.000089512956,0.0009245544,0.0013705046,0.00020696221,0.0028987725,0.033414196],"study_design_scores_gemma":[0.10131317,0.008634775,0.03857618,0.0027936916,0.8417567,0.0003232482,0.00008309634,0.0012540587,0.0007121016,0.0006259435,0.0038085333,0.000118475975],"about_ca_topic_score_codex":0.0004457896,"about_ca_topic_score_gemma":0.0011340987,"teacher_disagreement_score":0.021501439,"about_ca_system_score_codex":0.00062115747,"about_ca_system_score_gemma":0.0008147346,"threshold_uncertainty_score":0.113711834},"labels":[],"label_agreement":null},{"id":"W4296164535","doi":"10.1016/j.jaad.2022.09.006","title":"Disparities in psoriasis clinical trials: A cross-sectional analysis","year":2022,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of Toronto; University of British Columbia","funders":"","keywords":"Medicine; Cross-sectional study; Psoriasis; Dermatology; Clinical trial; MEDLINE; Internal medicine; Pathology","score_opus":0.08554311277228233,"score_gpt":0.4083347676896008,"score_spread":0.3227916549173185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296164535","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.984263,0.010717316,0.0007755394,0.00059184065,0.000077477605,0.00017029581,0.0021341892,0.000010345847,0.0012600925],"genre_scores_gemma":[0.99757725,0.0007257299,0.00032060395,0.00038794227,0.000062669315,0.00008728539,0.00070886296,0.0000072581465,0.00012233916],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9607912,0.02589941,0.005320337,0.0039437907,0.002503941,0.0015412834],"domain_scores_gemma":[0.9397798,0.02683763,0.024634635,0.004541748,0.0020936828,0.0021124515],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.01673891,0.00034959655,0.0018131281,0.0009761945,0.0006151722,0.001671199,0.0008203869,0.0014293077,0.0025834327],"category_scores_gemma":[0.043216523,0.0006274102,0.0021314917,0.0034544033,0.0007137073,0.0013211004,0.0011451751,0.00132023,0.00020843289],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048085237,0.00025141155,0.9827297,0.00031200206,0.006729396,0.000056409353,0.00011372627,0.00012672148,0.00018592617,0.0003436651,0.00072754733,0.0036150117],"study_design_scores_gemma":[0.001416106,0.001239881,0.9876516,0.00015901176,0.006694799,0.0001902715,0.00028161125,0.0005666342,0.00013785003,0.0003854632,0.0012551214,0.000021656999],"about_ca_topic_score_codex":0.002589112,"about_ca_topic_score_gemma":0.0038174503,"teacher_disagreement_score":0.9832611,"about_ca_system_score_codex":0.00074645743,"about_ca_system_score_gemma":0.0013039607,"threshold_uncertainty_score":0.08852488},"labels":[],"label_agreement":null},{"id":"W4304127900","doi":"10.1016/j.jaad.2022.09.051","title":"Skin disorders and interstitial lung disease: Part II—The spectrum of cutaneous diseases with lung disease association","year":2022,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; University of Alberta; McGill University Health Centre","funders":"","keywords":"Medicine; Interstitial lung disease; Connective tissue disease; Lung; Disease; Context (archaeology); Sarcoidosis; Dermatology; Dermatomyositis; Mixed connective tissue disease; Vasculitis; Pathology; Autoimmune disease; Internal medicine","score_opus":0.0124559410233054,"score_gpt":0.29622386700601044,"score_spread":0.28376792598270506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4304127900","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004025348,0.9993494,0.000033737382,0.0001011817,0.00011759198,0.0000044626768,0.0000152473185,0.0000025654167,0.00033562712],"genre_scores_gemma":[0.00026658553,0.99911076,0.00008039479,0.00012169064,0.00016401928,0.0000041896656,0.000030565974,6.16604e-7,0.00022118683],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996654,0.000047013513,0.00007122569,0.000053366854,0.0001327005,0.000030253574],"domain_scores_gemma":[0.99937457,0.00027422802,0.00014059058,0.000011213963,0.00013892178,0.00006051508],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005751161,0.001100645,0.0025496352,0.0048381863,0.00031050036,0.0014483635,0.0010286459,0.0010928545,0.0051969457],"category_scores_gemma":[0.00092011323,0.00036510554,0.00086374,0.0045686373,0.00053544005,0.0016434666,0.0010211067,0.0018057147,0.0019676257],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000083169296,0.00010364544,0.00045317982,0.027329408,0.00018992234,0.00021554953,0.000047464335,0.00024128547,0.00081170665,0.0014429382,0.03824949,0.9308323],"study_design_scores_gemma":[0.000080089696,0.00013699399,0.0052288854,0.020353455,0.0006286118,0.00429416,0.00013148275,0.00018541263,0.00026291847,0.0016478419,0.9670019,0.000048136215],"about_ca_topic_score_codex":0.0021395811,"about_ca_topic_score_gemma":0.0039952314,"teacher_disagreement_score":0.0051969457,"about_ca_system_score_codex":0.000636634,"about_ca_system_score_gemma":0.0014073718,"threshold_uncertainty_score":0.017385542},"labels":[],"label_agreement":null},{"id":"W4304127942","doi":"10.1016/j.jaad.2022.10.001","title":"Skin disorders and interstitial lung disease: Part I—Screening, diagnosis, and therapeutic principles","year":2022,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; University of Alberta","funders":"","keywords":"Medicine; Interstitial lung disease; Intensive care medicine; Disease; Referral; Pulmonary function testing; Lung; Dermatology; Internal medicine","score_opus":0.040154853797835115,"score_gpt":0.3469022010909791,"score_spread":0.30674734729314396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4304127942","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000020902135,0.9994874,0.00003960926,0.0001079493,0.00013338224,0.0000042006086,0.0000071641034,0.0000022141858,0.00019711265],"genre_scores_gemma":[0.0002058734,0.9990256,0.000105497485,0.0001973915,0.00029371725,0.0000056441404,0.00001609675,6.054069e-7,0.00014952634],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99944824,0.00011351538,0.00010862281,0.00008997147,0.00020069329,0.000038921575],"domain_scores_gemma":[0.99898,0.00058715255,0.00016077474,0.00001975415,0.0001879407,0.000064401494],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010675077,0.001573653,0.0030009814,0.004542945,0.0003468956,0.0015948093,0.0013425881,0.0016316809,0.003143997],"category_scores_gemma":[0.0014475418,0.00055267825,0.001010751,0.0032907028,0.0010097601,0.0022166332,0.001011816,0.0030477522,0.0016673846],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010795506,0.00017304937,0.00038419157,0.037358973,0.00020911533,0.0002129181,0.00006907714,0.00047234748,0.0009808487,0.0033134692,0.043901633,0.91281635],"study_design_scores_gemma":[0.000091878035,0.00028361514,0.003908406,0.0247488,0.0005340945,0.00372849,0.00014105221,0.00032447773,0.00034126156,0.003536169,0.9622945,0.00006715149],"about_ca_topic_score_codex":0.002366753,"about_ca_topic_score_gemma":0.0038962362,"teacher_disagreement_score":0.004542945,"about_ca_system_score_codex":0.0010218517,"about_ca_system_score_gemma":0.0018177304,"threshold_uncertainty_score":0.010517716},"labels":[],"label_agreement":null},{"id":"W4304127970","doi":"10.1016/j.jaad.2022.10.005","title":"Prognostic factors for the development of acneiform eruptions in patients on epidermal growth factor receptor inhibitors","year":2022,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"","keywords":"Medicine; Dermatology; Epidermal growth factor receptor; Receptor; Internal medicine","score_opus":0.0506189236224899,"score_gpt":0.3628806373907033,"score_spread":0.31226171376821343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4304127970","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970396,0.00094151584,0.00009136461,0.0001247436,0.0000340899,0.000007939375,0.00026640407,0.00000959928,0.0014846709],"genre_scores_gemma":[0.99937785,0.00015112171,0.00003652705,0.00002249467,0.000051276576,0.0000034648197,0.00017488579,0.00000216438,0.00018018947],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996451,0.00007903182,0.000035655066,0.000060941613,0.00007211868,0.00010721393],"domain_scores_gemma":[0.9972691,0.0007162138,0.0010900592,0.00012124955,0.00017463331,0.00062872935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045096746,0.0003609572,0.00050789356,0.00085276004,0.00058346614,0.00093079795,0.0003645296,0.00085887156,0.0031251544],"category_scores_gemma":[0.002803304,0.0002877185,0.0007048294,0.001316166,0.00038715027,0.00071072794,0.00035279008,0.0012644822,0.00038215765],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003321293,0.000034622033,0.9979267,0.0000048484058,0.000037379905,0.00015831235,0.000012010406,0.000057655783,0.00021333527,0.0000162408,0.000100495374,0.0011062396],"study_design_scores_gemma":[0.000019785477,0.0001346252,0.9980311,0.0000054914162,0.00006687662,0.0008919077,0.00008581504,0.0003933505,0.00008246119,0.000044636956,0.00023782538,0.000006067879],"about_ca_topic_score_codex":0.0014206655,"about_ca_topic_score_gemma":0.0016630184,"teacher_disagreement_score":0.0031251544,"about_ca_system_score_codex":0.00026620235,"about_ca_system_score_gemma":0.00041128095,"threshold_uncertainty_score":0.010454714},"labels":[],"label_agreement":null},{"id":"W4307723138","doi":"10.1016/j.jaad.2022.10.041","title":"Efficacy and safety of apremilast in patients with mild-to-moderate psoriasis up to 32 weeks: Results from the extension phase of the randomized, phase 3 ADVANCE trial","year":2022,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health; Bellus Health (Canada); Queen's University; University of British Columbia; Probity Medical Research","funders":"Manitoba Beekeepers' Association; Amgen","keywords":"Apremilast; Medicine; Psoriasis; Randomized controlled trial; Phase (matter); Extension (predicate logic); Internal medicine; Dermatology; Psoriatic arthritis","score_opus":0.01600549215371726,"score_gpt":0.2848892945368695,"score_spread":0.26888380238315224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307723138","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14236423,0.46386927,0.0016229467,0.2827623,0.08926404,0.0026739982,0.006379972,0.00044500045,0.010618148],"genre_scores_gemma":[0.5015473,0.1239175,0.0042341803,0.22348791,0.12393262,0.0031875903,0.0029678517,0.0002500623,0.016475031],"study_design_codex":"not_applicable","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99729365,0.0015977016,0.00036027053,0.00021409745,0.0003697283,0.00016451858],"domain_scores_gemma":[0.984097,0.010731696,0.0023850463,0.00027371894,0.0017962955,0.00071620144],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010121469,0.0007657989,0.0029464625,0.000293728,0.00039423388,0.0015008507,0.0011487659,0.0032510418,0.004633187],"category_scores_gemma":[0.01730175,0.0003829519,0.0023511918,0.00044281202,0.00063485414,0.0013741893,0.0002935474,0.0050309263,0.0007949357],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.32728204,0.001550691,0.004328072,0.04271147,0.009845192,0.00090904144,0.0003861065,0.000639837,0.002550176,0.0010985994,0.39630628,0.21239254],"study_design_scores_gemma":[0.6227806,0.052171253,0.028655479,0.01600322,0.030436918,0.0015278342,0.00037899462,0.0033185354,0.0043677064,0.004144706,0.23588215,0.00033269374],"about_ca_topic_score_codex":0.00041406185,"about_ca_topic_score_gemma":0.0011551199,"teacher_disagreement_score":0.010121469,"about_ca_system_score_codex":0.0006746729,"about_ca_system_score_gemma":0.0012687722,"threshold_uncertainty_score":0.05352807},"labels":[],"label_agreement":null},{"id":"W4307955601","doi":"10.1016/j.jaad.2022.10.047","title":"Incidence and clinical factors associated with ulceration in infantile hemangiomas","year":2022,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Vascular Malformations and Hemangiomas","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Pediatric Dermatology Research Alliance","keywords":"Medicine; Incidence (geometry); Dermatology; Pediatrics; Surgery","score_opus":0.024802148766975778,"score_gpt":0.32963907953153665,"score_spread":0.30483693076456087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307955601","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99839586,0.00053355406,0.00005441483,0.00003638312,0.000006382901,0.0000041513977,0.000107532265,0.0000063116495,0.00085531676],"genre_scores_gemma":[0.99957925,0.00017667873,0.00004628996,0.00000818905,0.000023285977,0.0000027232545,0.00008403272,0.0000023431835,0.0000772291],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99950516,0.00012351022,0.000073866904,0.00005978799,0.00010282767,0.0001348109],"domain_scores_gemma":[0.9959849,0.00096238026,0.0019086812,0.00015693087,0.00028880412,0.00069836935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004195463,0.00031120185,0.000401367,0.0018957214,0.00042185027,0.00085379626,0.00037846866,0.00065387384,0.0023930809],"category_scores_gemma":[0.003872502,0.00026947298,0.00044995235,0.0018328627,0.00044431872,0.0006219246,0.00038936568,0.0008387028,0.00033982735],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012848504,0.00004063886,0.99766123,0.000006614067,0.000016333575,0.0007672171,0.00003113276,0.000023402099,0.00024085755,0.000017474256,0.00004349871,0.0010229913],"study_design_scores_gemma":[0.000002203543,0.000081535625,0.9965006,0.0000041156063,0.000012644325,0.002942887,0.00017350115,0.00012079984,0.00006418024,0.000019690679,0.0000737031,0.0000041932826],"about_ca_topic_score_codex":0.0012371006,"about_ca_topic_score_gemma":0.0010526207,"teacher_disagreement_score":0.0023930809,"about_ca_system_score_codex":0.00023565786,"about_ca_system_score_gemma":0.00021986658,"threshold_uncertainty_score":0.008005619},"labels":[],"label_agreement":null},{"id":"W4308388739","doi":"10.1016/j.jaad.2022.10.055","title":"JAK inhibitors for the treatment of adult dermatomyositis: A pilot study","year":2022,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Inflammatory Myopathies and Dermatomyositis","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Dermatomyositis; Medicine; Interferon; Scopus; MEDLINE; Dermatology; Immunology","score_opus":0.019750075560708964,"score_gpt":0.30615655051894747,"score_spread":0.2864064749582385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308388739","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99298555,0.0035123117,0.0003032849,0.0002373318,0.000078066776,0.001143539,0.00044882167,0.000026292002,0.0012647952],"genre_scores_gemma":[0.99175185,0.0041165617,0.00078768027,0.00045923432,0.00027179217,0.0010005672,0.0007570919,0.000008747601,0.00084649527],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996147,0.00017944667,0.00003065141,0.000041859006,0.000031012063,0.00010228416],"domain_scores_gemma":[0.9992574,0.00022544779,0.00008539246,0.000056226283,0.00004344984,0.00033207552],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011911477,0.00095841225,0.0022783363,0.0002694951,0.0004087538,0.0006628614,0.00050759787,0.00078304845,0.0026714467],"category_scores_gemma":[0.00076832075,0.00029041545,0.0014123982,0.00035837907,0.0007018619,0.00061522966,0.00026486136,0.0016987263,0.00037495838],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.73976487,0.10222931,0.0069696703,0.0011755858,0.0023284324,0.0016148057,0.0003440209,0.0015276687,0.040991124,0.00029442777,0.0018103698,0.10094975],"study_design_scores_gemma":[0.27264056,0.6968877,0.023866557,0.000058565733,0.0011215741,0.0006508157,0.00009629373,0.0004630475,0.0018167015,0.000091487665,0.002276391,0.000030453037],"about_ca_topic_score_codex":0.0009340855,"about_ca_topic_score_gemma":0.0019438306,"teacher_disagreement_score":0.0026714467,"about_ca_system_score_codex":0.00037280683,"about_ca_system_score_gemma":0.0009303963,"threshold_uncertainty_score":0.008936882},"labels":[],"label_agreement":null},{"id":"W4310015221","doi":"10.1016/j.jaad.2022.09.060","title":"Long-term safety and disease control with ruxolitinib cream in atopic dermatitis: Results from two phase 3 studies","year":2022,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":92,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"Incyte","keywords":"Medicine; Ruxolitinib; Atopic dermatitis; Dermatology; Term (time); Disease; Internal medicine; Myelofibrosis","score_opus":0.017498852421558707,"score_gpt":0.3363663046836683,"score_spread":0.3188674522621096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310015221","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95335025,0.03440777,0.0023405042,0.00075524225,0.00020079403,0.0046022804,0.00154288,0.00014797352,0.002652303],"genre_scores_gemma":[0.9764807,0.013194764,0.0024349748,0.0012197403,0.0003970283,0.0026870891,0.0022476665,0.0000502329,0.0012877483],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.995777,0.0023043081,0.00045893577,0.00035646025,0.00069060124,0.00041262506],"domain_scores_gemma":[0.9937874,0.002023506,0.0019254626,0.0006812216,0.00077902776,0.000803359],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012121854,0.0013919545,0.003004893,0.00051094586,0.0007335711,0.0015632801,0.0010812846,0.001903087,0.0030504384],"category_scores_gemma":[0.005166383,0.00048752635,0.0044624237,0.00056492747,0.0009347315,0.0012244835,0.0004929984,0.0025910619,0.00065934495],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5485428,0.06648108,0.014776289,0.0052033192,0.012340438,0.0005457217,0.0008020931,0.0014990332,0.05970712,0.00024731323,0.0043747984,0.28547996],"study_design_scores_gemma":[0.38972807,0.501989,0.07444859,0.0005335588,0.007957232,0.001163924,0.00018155857,0.001032995,0.0143508045,0.0003786081,0.008088126,0.00014750785],"about_ca_topic_score_codex":0.00063688523,"about_ca_topic_score_gemma":0.0017817188,"teacher_disagreement_score":0.012121854,"about_ca_system_score_codex":0.0011155263,"about_ca_system_score_gemma":0.0015198396,"threshold_uncertainty_score":0.0641073},"labels":[],"label_agreement":null},{"id":"W4311423249","doi":"10.1016/j.jaad.2022.08.065","title":"Real-world evidence on atopic dermatitis: Baseline characteristics and predictors of treatment choice in the TARGET cohort","year":2022,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"","keywords":"Medicine; Atopic dermatitis; Cohort; Baseline (sea); Dermatology; Cohort study; Real world evidence; Internal medicine","score_opus":0.023138704809194492,"score_gpt":0.31595220927574197,"score_spread":0.29281350446654747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311423249","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1648442,0.013796229,0.00027444155,0.8014705,0.0061748507,0.000014969318,0.0030722886,0.000022688324,0.010329894],"genre_scores_gemma":[0.67672735,0.009568581,0.00057286303,0.2866951,0.022182724,0.00004577738,0.0011700232,0.00002342937,0.0030140972],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977889,0.001240585,0.00029316967,0.00020436503,0.00032717045,0.00014576229],"domain_scores_gemma":[0.9639572,0.02923169,0.002806451,0.0007733762,0.0019441108,0.0012872859],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030550472,0.00015009264,0.0006658933,0.00046082176,0.0004856662,0.0012108537,0.00046037743,0.0035416265,0.0040972177],"category_scores_gemma":[0.028451273,0.00015837068,0.0005244456,0.00094242924,0.00042238264,0.00097114255,0.00033180078,0.003412711,0.00081862713],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033334848,0.00030988205,0.60774153,0.00050645386,0.0008869777,0.0059254547,0.00032546517,0.0005130059,0.0005120852,0.002284098,0.32747272,0.050188925],"study_design_scores_gemma":[0.002714547,0.00096024835,0.7256612,0.0022587099,0.0022744527,0.017924193,0.002665128,0.0046188864,0.0007607906,0.019587185,0.22038217,0.00019248624],"about_ca_topic_score_codex":0.0051751346,"about_ca_topic_score_gemma":0.009497795,"teacher_disagreement_score":0.0051751346,"about_ca_system_score_codex":0.0008974924,"about_ca_system_score_gemma":0.0010981079,"threshold_uncertainty_score":0.016156852},"labels":[],"label_agreement":null},{"id":"W4313627938","doi":"10.1016/j.jaad.2022.08.068","title":"Executive summary: American Academy of Dermatology guidelines of care for the management of atopic dermatitis in adults with topical therapies","year":2023,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"American Academy of Dermatology","keywords":"Medicine; Atopic dermatitis; Dermatology; Skin care; Executive summary; MEDLINE; Nursing","score_opus":0.04281556773733994,"score_gpt":0.38575872259012944,"score_spread":0.3429431548527895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313627938","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013589712,0.95886517,0.0004471891,0.013530775,0.014054036,0.00055454613,0.001756174,0.00007629712,0.010579945],"genre_scores_gemma":[0.0009264283,0.96914357,0.0015019178,0.013664676,0.005851389,0.0004449172,0.0024628632,0.00002275225,0.005981599],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99839216,0.00039962764,0.00040217701,0.00009041801,0.00060597906,0.00010962242],"domain_scores_gemma":[0.9944882,0.0014060749,0.0013602317,0.000063393585,0.0023702995,0.00031173707],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027941866,0.0013349513,0.0031147418,0.0045507145,0.00053991587,0.0020287258,0.0019446061,0.0026419056,0.017437214],"category_scores_gemma":[0.009047018,0.000442881,0.001982833,0.0034818475,0.00046731488,0.0017394173,0.0013553287,0.0031726584,0.009005973],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012024422,0.00005906294,0.00017611509,0.026823917,0.0001356201,0.00005369747,0.000027008664,0.000087305845,0.00018760122,0.00065613317,0.6472299,0.32444343],"study_design_scores_gemma":[0.00019475984,0.00007225403,0.0016706261,0.049403872,0.0004935864,0.00023905568,0.000039974224,0.00006315526,0.00008109226,0.00054504926,0.94717276,0.00002374333],"about_ca_topic_score_codex":0.0063628317,"about_ca_topic_score_gemma":0.011873087,"teacher_disagreement_score":0.017437214,"about_ca_system_score_codex":0.0015860391,"about_ca_system_score_gemma":0.0065950467,"threshold_uncertainty_score":0.058333337},"labels":[],"label_agreement":null},{"id":"W4315607647","doi":"10.1016/j.jaad.2022.12.029","title":"Guidelines of care for the management of atopic dermatitis in adults with topical therapies","year":2023,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":182,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"LEO Pharma; Glenmark Pharmaceuticals; Sanofi Genzyme; American Academy of Dermatology; Incyte; Dermira; Kiniksa Pharmaceuticals; Les Laboratories Pierre Fabre; Celgene; GlaxoSmithKline; Pfizer; Galderma; Ortho Dermatologics; Eli Lilly and Company; Sanofi; Regeneron Pharmaceuticals","keywords":"Medicine; Atopic dermatitis; Dermatology; MEDLINE; Intensive care medicine","score_opus":0.0469550005692714,"score_gpt":0.3893356656790567,"score_spread":0.3423806651097853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4315607647","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000119638236,0.9944729,0.0006023921,0.0015109031,0.0007341525,0.00009362542,0.00019739539,0.000033353448,0.0022356133],"genre_scores_gemma":[0.0012252259,0.9918315,0.0032320467,0.0019089554,0.00040680828,0.00012763124,0.0004313552,0.000005768423,0.00083079864],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988053,0.00029759377,0.00034507495,0.00008475827,0.0004009616,0.00006630825],"domain_scores_gemma":[0.9980101,0.0008921935,0.00043325225,0.000030638475,0.0005492689,0.00008449765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015358266,0.0013225223,0.0022876433,0.0035639973,0.00047746478,0.0013650671,0.002142984,0.0021587054,0.0045622448],"category_scores_gemma":[0.0043546306,0.00034248145,0.0019688648,0.0021524264,0.0004069684,0.0009443576,0.0007749079,0.0024016097,0.0018814057],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001228155,0.00012823123,0.00041586795,0.048632115,0.0003231161,0.00025221406,0.000083439976,0.00037234233,0.00054599764,0.0024875987,0.11607243,0.8305638],"study_design_scores_gemma":[0.00021371042,0.00013085514,0.0028863307,0.11166413,0.0014879955,0.0014782902,0.0001092974,0.00031762992,0.00029111718,0.0026860912,0.8786793,0.000055349774],"about_ca_topic_score_codex":0.005889868,"about_ca_topic_score_gemma":0.0123428935,"teacher_disagreement_score":0.005889868,"about_ca_system_score_codex":0.0011801921,"about_ca_system_score_gemma":0.003636144,"threshold_uncertainty_score":0.015262246},"labels":[],"label_agreement":null},{"id":"W4315607744","doi":"10.1016/j.jaad.2022.12.040","title":"Differential gene expression in lesional skin may signify immune-mediated lung parenchymal damage in patients with dermatomyositis","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Inflammatory Myopathies and Dermatomyositis","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"NYU Grossman School of Medicine; York University; Brigham and Women's Hospital","keywords":"Medicine; Dermatomyositis; Autoantibody; Interstitial lung disease; Polymyositis; Pathology; Immune dysregulation; Disease; Connective tissue disease; Lung; Autoimmune disease; Immunology; Internal medicine; Antibody","score_opus":0.006522287888469613,"score_gpt":0.25955738712061155,"score_spread":0.25303509923214196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4315607744","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99763286,0.00060430093,0.0002649613,0.00004949569,0.0000091039765,0.00001066651,0.0001243866,0.000011514058,0.0012926675],"genre_scores_gemma":[0.9992581,0.00015695457,0.00021748693,0.000040684772,0.000013348989,0.000007481723,0.00008015683,0.0000030802476,0.00022267271],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997831,0.0000522608,0.000026432606,0.00003848864,0.000042591262,0.00005716466],"domain_scores_gemma":[0.99970347,0.000104961815,0.00009039338,0.000013568923,0.00004012441,0.000047444686],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018214174,0.00020781215,0.00031054948,0.00075851136,0.00025426352,0.0004390627,0.00011308396,0.00031391348,0.0017936878],"category_scores_gemma":[0.00062832964,0.00009145972,0.00018515794,0.00059574906,0.0002606798,0.00018637587,0.00016668424,0.00027812083,0.00026780792],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016820207,0.0001510739,0.7047829,0.00020313011,0.000077585646,0.008079384,0.0003970338,0.0001846433,0.2657154,0.00014167791,0.0002653229,0.018319853],"study_design_scores_gemma":[0.0000160748,0.0003012714,0.9740666,0.00001718236,0.00005649358,0.008498933,0.00044695748,0.00026348874,0.0156305,0.000118736156,0.0005781484,0.000005639171],"about_ca_topic_score_codex":0.000291194,"about_ca_topic_score_gemma":0.00048075963,"teacher_disagreement_score":0.0017936878,"about_ca_system_score_codex":0.00014772404,"about_ca_system_score_gemma":0.00008343706,"threshold_uncertainty_score":0.006000459},"labels":[],"label_agreement":null},{"id":"W4318754522","doi":"10.1016/j.jaad.2022.12.046","title":"Machine learning model for predicting outcomes of biologic therapy in psoriasis","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Bispebjerg Hospital; Alberta Innovates; Aalborg Universitetshospital; Gentofte Hospital; Aalborg Universitet; Odense Universitetshospital; University of Alberta","keywords":"Medicine; Secukinumab; Ustekinumab; Discontinuation; Scopus; Psoriasis; Adalimumab; Dermatology; Biosimilar; Internal medicine; MEDLINE; Psoriatic arthritis; Tumor necrosis factor alpha","score_opus":0.03867615573282402,"score_gpt":0.3070818252715341,"score_spread":0.2684056695387101,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4318754522","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83175564,0.00401981,0.15007763,0.0035888564,0.00048821248,0.00014176812,0.005379295,0.0010092312,0.0035395385],"genre_scores_gemma":[0.987452,0.00035845136,0.008290075,0.00013222238,0.000121946345,0.00008124246,0.0017753481,0.000013482655,0.0017751891],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99950325,0.00020191268,0.000044064174,0.000105594736,0.00006237943,0.000082720544],"domain_scores_gemma":[0.996421,0.002878349,0.00020316556,0.00009795349,0.0003008801,0.00009874848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021582074,0.0006122047,0.0010211257,0.0011001115,0.00029845713,0.00084572035,0.0008340437,0.0009636029,0.0020790612],"category_scores_gemma":[0.004971525,0.00018161368,0.00085558876,0.00058181374,0.00021982339,0.00043120215,0.00035028145,0.0015470425,0.00053581194],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013526898,0.0011616683,0.10729765,0.00012614102,0.00051027274,0.00027922454,0.00006743895,0.7239168,0.00085046067,0.0017114023,0.0077264886,0.1549998],"study_design_scores_gemma":[0.000016974014,0.00006697091,0.004240516,0.000010012357,0.00003492694,0.000027687589,0.000008666577,0.9943756,0.0001322141,0.0008962617,0.00018488351,0.000005416003],"about_ca_topic_score_codex":0.007798595,"about_ca_topic_score_gemma":0.004996065,"teacher_disagreement_score":0.007798595,"about_ca_system_score_codex":0.00070978876,"about_ca_system_score_gemma":0.00074006076,"threshold_uncertainty_score":0.015506387},"labels":[],"label_agreement":null},{"id":"W4319066240","doi":"10.1016/j.jaad.2023.01.029","title":"Trajectories and prognosis after discontinuation of biologics due to remission in psoriasis: A nationwide cohort study","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Janssen Pharmaceuticals; Sanofi Genzyme; LEO Pharma; Bausch Health; Simon Spies Fonden; LEO Fondet; Coloplast; Mylan; Horizon Therapeutics; UCB Pharma; Kongelig Hofbuntmager Aage Bangs Fond; Regeneron Pharmaceuticals; Sanofi; Galderma; AstraZeneca; Bristol-Myers Squibb; Eli Lilly and Company; Pfizer; Samsung; National Psoriasis Foundation; Amgen","keywords":"Medicine; Discontinuation; Psoriasis; Cohort study; Cohort; Dermatology; MEDLINE; Internal medicine; Pediatrics","score_opus":0.016527922586928024,"score_gpt":0.2864238922055715,"score_spread":0.2698959696186435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319066240","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9710333,0.012396492,0.00040052732,0.0016024146,0.0001371632,0.00005503872,0.0135141825,0.000015590285,0.00084524474],"genre_scores_gemma":[0.98978233,0.0024733208,0.0003813591,0.0003128015,0.00010771068,0.000054320994,0.0066959364,0.000011176295,0.00018096434],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972862,0.00092982146,0.0005246867,0.0006292791,0.00035998755,0.00027003355],"domain_scores_gemma":[0.99004924,0.0028785127,0.004302981,0.0011061345,0.0011058023,0.0005572976],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031385424,0.00025354695,0.0006800288,0.0012692811,0.0004639958,0.0010870378,0.00075010303,0.00092718226,0.0020078325],"category_scores_gemma":[0.0128926365,0.00044130866,0.0012939879,0.0037549338,0.00025431346,0.00081297377,0.0009589393,0.0010542675,0.00030033677],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004679449,0.00006651411,0.98906916,0.00031564748,0.0014034264,0.00015260703,0.00025949057,0.00009984428,0.00008047687,0.00013000272,0.0033216455,0.004633211],"study_design_scores_gemma":[0.000045325844,0.00008845295,0.99620456,0.0002494358,0.0006872476,0.00024469598,0.00022573902,0.00036671176,0.000024420815,0.000101253034,0.0017425255,0.000019675595],"about_ca_topic_score_codex":0.016680902,"about_ca_topic_score_gemma":0.015526212,"teacher_disagreement_score":0.016680902,"about_ca_system_score_codex":0.0005827511,"about_ca_system_score_gemma":0.00074276474,"threshold_uncertainty_score":0.0331676},"labels":[],"label_agreement":null},{"id":"W4320921261","doi":"10.1016/j.jaad.2023.01.043","title":"Practical management of ocular surface disease in patients with atopic dermatitis, with a focus on conjunctivitis: A review","year":2023,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Allergan; LEO Pharma; Sanofi Genzyme; Incyte; Sanofi; Kowa Company; Castle Biosciences; National Eczema Association; Dermira; Sun Pharma; Regeneron Pharmaceuticals; Pfizer; Galderma; Ortho Dermatologics; Eli Lilly and Company; Kiniksa Pharmaceuticals; Les Laboratories Pierre Fabre; Celgene; Valeant Pharmaceuticals International","keywords":"Medicine; Atopic dermatitis; Dermatology; Allergic conjunctivitis; Disease management; Focus (optics); Disease; Allergy; Immunology; Pathology","score_opus":0.029747887491088223,"score_gpt":0.35684524771890225,"score_spread":0.32709736022781405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4320921261","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014816305,0.998632,0.00007967218,0.00024672947,0.00016536002,0.000010256696,0.00001754231,0.000005019834,0.0006952273],"genre_scores_gemma":[0.00083939976,0.998338,0.00023539123,0.00021239254,0.0001455618,0.000009381517,0.000028611368,9.997813e-7,0.0001902789],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99975187,0.000052287884,0.00006622111,0.000031864394,0.00008221921,0.000015516718],"domain_scores_gemma":[0.99949145,0.00029280715,0.00008666612,0.0000084313215,0.00009704906,0.000023549863],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039526436,0.000707962,0.0010254986,0.002340766,0.00029940502,0.0006914183,0.00063003233,0.0008740425,0.0032774704],"category_scores_gemma":[0.0014061708,0.000207848,0.00074318744,0.001451681,0.0002221169,0.00093957584,0.0004511726,0.0010050022,0.00084424607],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047511676,0.00006691484,0.00043280196,0.040041294,0.00012543975,0.0003925044,0.00007870935,0.00019639815,0.0004465436,0.00066604506,0.031923253,0.9255825],"study_design_scores_gemma":[0.00006515996,0.0001969598,0.005876546,0.06512943,0.0006275098,0.012251967,0.0002938103,0.00023259518,0.00036105115,0.0017511804,0.9131634,0.000050346047],"about_ca_topic_score_codex":0.001461153,"about_ca_topic_score_gemma":0.0033418634,"teacher_disagreement_score":0.0032774704,"about_ca_system_score_codex":0.00037412823,"about_ca_system_score_gemma":0.0008303018,"threshold_uncertainty_score":0.010964274},"labels":[],"label_agreement":null},{"id":"W4322765827","doi":"10.1016/j.jaad.2023.02.040","title":"Rapid and sustained improvements in Generalized Pustular Psoriasis Physician Global Assessment scores with spesolimab for treatment of generalized pustular psoriasis flares in the randomized, placebo-controlled Effisayil 1 study","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Cilag; Medac; Bausch Health; Eisai; Celltrion; XBiotech; InflaRx; Pfizer; Biogen; Incyte; Les Laboratories Pierre Fabre; Regeneron Pharmaceuticals; Mylan; AstraZeneca; Novocure; Valeant Pharmaceuticals International; Springworks Therapeutics; Castle Biosciences; Therakos; Celgene; Sanofi; LEO Pharma; Ortho Dermatologics; Eli Lilly and Company; Samsung; Bristol-Myers Squibb; Boehringer Ingelheim; Amgen; Meiji Seika Pharma","keywords":"Medicine; Generalized pustular psoriasis; Psoriasis; Dermatology; Randomized controlled trial; Placebo; Pustular psoriasis; Internal medicine; Alternative medicine; Pathology","score_opus":0.01630509240174297,"score_gpt":0.3020979104907079,"score_spread":0.2857928180889649,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322765827","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9866563,0.006522637,0.0006864575,0.00069667905,0.00036544423,0.0027760107,0.0007007561,0.00015014093,0.001445617],"genre_scores_gemma":[0.98840255,0.00322479,0.0014808427,0.0011155874,0.00044915854,0.002904389,0.0008456463,0.00002607852,0.0015509127],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9988432,0.0006659115,0.0000825405,0.00012848107,0.00011159957,0.00016833251],"domain_scores_gemma":[0.9989453,0.00023702928,0.00034043856,0.000090725065,0.00008767751,0.0002988289],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037583243,0.0014703156,0.0026877567,0.0004593915,0.00035383002,0.0008440052,0.000812475,0.001726981,0.004594701],"category_scores_gemma":[0.0018153258,0.0006112937,0.002190442,0.0002680222,0.0009037176,0.0009700449,0.00040829994,0.0028849111,0.00058949355],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.94272345,0.011605989,0.0013190504,0.0011707651,0.0012547798,0.000085288,0.000081335515,0.00035342312,0.008169011,0.00013683357,0.0012707869,0.03182934],"study_design_scores_gemma":[0.9075096,0.087286405,0.0036390345,0.00004433549,0.00035787895,0.00005041729,0.000014994963,0.0001587226,0.000472512,0.0000680232,0.0003872197,0.000010899853],"about_ca_topic_score_codex":0.00035018512,"about_ca_topic_score_gemma":0.000933634,"teacher_disagreement_score":0.004594701,"about_ca_system_score_codex":0.000441437,"about_ca_system_score_gemma":0.0009373445,"threshold_uncertainty_score":0.019876182},"labels":[],"label_agreement":null},{"id":"W4323308836","doi":"10.1016/j.jaad.2023.02.045","title":"Concurrent onset of skin and joint symptoms correlates with higher psoriatic arthritis disease activity: A single-center retrospective study","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"Swedish Orphan Biovitrum; National Natural Science Foundation of China; ViiV Healthcare; AstraZeneca; Celgene; Gilead Sciences; Eli Lilly and Company; Amgen","keywords":"Medicine; Psoriatic arthritis; Single Center; Retrospective cohort study; Dermatology; Joint disease; Arthritis; Disease; Psoriasis; Internal medicine; Pathology; Osteoarthritis; Alternative medicine","score_opus":0.018660250806910854,"score_gpt":0.2859321967272103,"score_spread":0.26727194592029946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323308836","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994099,0.00020560407,0.00007144394,0.000009685183,0.000005528697,0.0000060383213,0.00011097072,0.0000019645947,0.00017894684],"genre_scores_gemma":[0.99962103,0.000071439135,0.00005007128,0.000015351392,0.000011143385,0.000004156218,0.00016126163,0.0000019444649,0.000063522195],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99893826,0.00027444205,0.00013094828,0.00037061234,0.00012953406,0.00015611803],"domain_scores_gemma":[0.9976139,0.00036551518,0.0009177722,0.000343245,0.00024776612,0.0005119317],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062675605,0.00051599136,0.0007366033,0.00096395874,0.0009802114,0.0011889158,0.00054215064,0.0007154557,0.0023869765],"category_scores_gemma":[0.0019222558,0.0008679384,0.0009791679,0.0016458592,0.0006082434,0.00083173584,0.0006193774,0.00078812806,0.0004482325],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017347532,0.000064750515,0.998865,0.000006251329,0.00010031156,0.00016431816,0.00004991817,0.000009725828,0.00029353457,0.0000075735716,0.000025124573,0.00024011298],"study_design_scores_gemma":[0.00001481637,0.00021851626,0.99824286,0.000003935619,0.000090583824,0.00092321204,0.0002735695,0.00006832529,0.000060678332,0.0000125830675,0.0000844434,0.000006387738],"about_ca_topic_score_codex":0.0037368273,"about_ca_topic_score_gemma":0.0039673713,"teacher_disagreement_score":0.0037368273,"about_ca_system_score_codex":0.0003215101,"about_ca_system_score_gemma":0.00055950985,"threshold_uncertainty_score":0.007985294},"labels":[],"label_agreement":null},{"id":"W4323922836","doi":"10.1016/j.jaad.2023.01.036","title":"A comparison of family physician and dermatologist topical corticosteroid prescriptions: A population-based cross-sectional study","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; University Health Network; Sunnybrook Health Science Centre; North York General Hospital; Institute for Clinical Evaluative Sciences; Women's College Hospital","funders":"","keywords":"Medicine; Medical prescription; Potency; Confidence interval; Cross-sectional study; Family medicine; Family history; Pediatrics; Dermatology; Internal medicine; Pharmacology; Pathology","score_opus":0.057725653738949036,"score_gpt":0.4057806815617437,"score_spread":0.3480550278227946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323922836","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99802244,0.00020360254,0.00009469671,0.0000722837,0.000005445019,0.000026964812,0.0012105057,0.000003270473,0.00036071005],"genre_scores_gemma":[0.9991579,0.00009036715,0.0000625109,0.000046268375,0.0000055304977,0.000018975215,0.0005008977,0.0000017392778,0.00011587514],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99799216,0.00040136237,0.00019320195,0.0004707915,0.0005328792,0.00040966942],"domain_scores_gemma":[0.9954743,0.0006357654,0.0023734816,0.0002737913,0.0006073303,0.00063527504],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017924366,0.00033776154,0.00043237934,0.0010456633,0.0010118773,0.00093330676,0.00088072923,0.0007577889,0.0024134873],"category_scores_gemma":[0.004475989,0.00059761526,0.0008821608,0.002394626,0.0006358945,0.0006733949,0.0006292615,0.0005930462,0.00027664754],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000045432145,0.000027106687,0.99929154,0.000010581685,0.000080049955,0.000023699331,0.00014347152,0.000014496426,0.000043030494,0.000009203582,0.000089595036,0.00022177077],"study_design_scores_gemma":[0.000007756535,0.000038674567,0.9995134,0.0000052273094,0.000026678465,0.00003237791,0.00019879267,0.00006591105,0.000008205623,0.0000044097346,0.00009577946,0.0000027932685],"about_ca_topic_score_codex":0.43988293,"about_ca_topic_score_gemma":0.4711795,"teacher_disagreement_score":0.43988293,"about_ca_system_score_codex":0.0039228476,"about_ca_system_score_gemma":0.0026589746,"threshold_uncertainty_score":0.87464505},"labels":[],"label_agreement":null},{"id":"W4327694400","doi":"10.1016/j.jaad.2022.12.037","title":"Management of cutaneous lupus erythematosus with Janus kinase inhibitor therapy: An evidence-based review","year":2023,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Health Sciences Centre; Women's College Hospital; University of Toronto; Sunnybrook Health Science Centre; Western University","funders":"","keywords":"Medicine; Dermatology; Systemic lupus erythematosus; Lupus erythematosus; MEDLINE; Scopus; Internal medicine; Immunology; Antibody","score_opus":0.10088955847557574,"score_gpt":0.40573868189056833,"score_spread":0.3048491234149926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4327694400","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007563077,0.99963737,0.000033596465,0.00006370475,0.000064381464,0.000009934534,0.000018057392,0.0000020947487,0.000095317846],"genre_scores_gemma":[0.00078740413,0.9988146,0.00011269582,0.00014777886,0.00005544372,0.000009425904,0.000023649645,5.376511e-7,0.000048475136],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99947315,0.00011293468,0.00016120242,0.000071898634,0.00015145847,0.000029414618],"domain_scores_gemma":[0.9986829,0.0008129856,0.0002971249,0.000013873027,0.00015588934,0.000037170394],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012317067,0.001036491,0.0041349516,0.002374651,0.00027049874,0.0013032461,0.0017026812,0.0012666936,0.003721125],"category_scores_gemma":[0.002833633,0.0003973233,0.0026640806,0.0021220774,0.00034058891,0.0010944491,0.00063314533,0.001266839,0.00049609883],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005021465,0.00009150752,0.0003739655,0.3691691,0.003072701,0.00025558085,0.00006372513,0.00044130735,0.00066420017,0.00066099485,0.017557174,0.60714763],"study_design_scores_gemma":[0.0014446053,0.0010124104,0.0067091207,0.42053822,0.04866332,0.0039271144,0.00036267965,0.0006703322,0.0008122853,0.002240675,0.5134639,0.00015535712],"about_ca_topic_score_codex":0.0019597737,"about_ca_topic_score_gemma":0.0049237674,"teacher_disagreement_score":0.0041349516,"about_ca_system_score_codex":0.00066227093,"about_ca_system_score_gemma":0.0016155605,"threshold_uncertainty_score":0.01244837},"labels":[],"label_agreement":null},{"id":"W4361207033","doi":"10.1016/j.jaad.2023.03.024","title":"Use of Janus kinase inhibitors for granulomatous dermatoses: A systematic review","year":2023,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Autoimmune Bullous Skin Diseases","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; SKiN Health; University of Calgary; Health Sciences Centre; Sunnybrook Health Science Centre; Women's College Hospital; McMaster University; University of Toronto","funders":"","keywords":"Medicine; Janus kinase; Tofacitinib; Janus; Dermatology; Sarcoidosis; Immunology; Cytokine","score_opus":0.08283276170250911,"score_gpt":0.3899620720675869,"score_spread":0.30712931036507773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361207033","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00088585465,0.998516,0.000060993993,0.000084778665,0.00007386041,0.00006316694,0.00018381742,0.0000048631505,0.00012663392],"genre_scores_gemma":[0.014234049,0.9846569,0.00023006012,0.0004907177,0.000064309614,0.00008496881,0.00013478623,0.0000032465125,0.0001010554],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.998338,0.00042447384,0.00063828967,0.00021344924,0.0002894536,0.00009642708],"domain_scores_gemma":[0.99510163,0.003151476,0.0012888007,0.000061836115,0.00029274137,0.00010356806],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022175817,0.0010785671,0.007971179,0.0031931521,0.00035719038,0.0015999014,0.0015607361,0.0016509381,0.0050590094],"category_scores_gemma":[0.008033077,0.000742401,0.007951004,0.0040210094,0.000560574,0.0013502982,0.0009975552,0.00129282,0.0003036599],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012384503,0.00004176909,0.0011727163,0.90913,0.04179787,0.00014054072,0.000093747716,0.00017275102,0.00031962342,0.0001409649,0.0026848554,0.04306672],"study_design_scores_gemma":[0.0033724825,0.00080569985,0.011405613,0.44182602,0.51323617,0.0006889752,0.00030738005,0.00019562671,0.00029945033,0.00041927694,0.027343376,0.00009999204],"about_ca_topic_score_codex":0.0053337915,"about_ca_topic_score_gemma":0.018463012,"teacher_disagreement_score":0.007971179,"about_ca_system_score_codex":0.0013795629,"about_ca_system_score_gemma":0.0026600247,"threshold_uncertainty_score":0.016924083},"labels":[],"label_agreement":null},{"id":"W4362578693","doi":"10.1016/j.jaad.2023.03.035","title":"Malignancy rates through 5 years of follow-up in patients with moderate-to-severe psoriasis treated with guselkumab: Pooled results from the VOYAGE 1 and VOYAGE 2 trials","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Dalhousie University","funders":"Janssen Research and Development; LEO Pharma; Sun Pharma; Argenx; Janssen Scientific Affairs; Amgen; Pfizer; Celgene; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Malignancy; Psoriasis; Skin cancer; Population; Dermatology; Incidence (geometry); Epidemiology; Cancer registry; Basal cell carcinoma; Cancer; Surgery; Internal medicine; Basal cell","score_opus":0.024262026976789353,"score_gpt":0.27236752075920756,"score_spread":0.2481054937824182,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362578693","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7608013,0.23247398,0.0010067032,0.0002559736,0.0002312222,0.0002876386,0.003223191,0.000055963625,0.0016640207],"genre_scores_gemma":[0.9827308,0.014410318,0.0003315663,0.00020625761,0.00020111776,0.00017086494,0.0016901472,0.0000130164635,0.0002459552],"study_design_codex":"observational","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99502784,0.0027643624,0.0006962187,0.0008376121,0.00047228485,0.00020174451],"domain_scores_gemma":[0.9926559,0.003284211,0.0028288364,0.00062367914,0.0003291407,0.00027830637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007992084,0.0008199528,0.0027392923,0.0014977905,0.00025464952,0.0013685289,0.0006046705,0.0008185492,0.0011857146],"category_scores_gemma":[0.0083044255,0.0005171928,0.00935126,0.0012939177,0.00037210414,0.000751441,0.0007771845,0.000851276,0.000107518186],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19362357,0.00026980127,0.46645352,0.009403569,0.2558817,0.00017516135,0.00025240873,0.002088349,0.0017792915,0.00017200848,0.0022055293,0.06769505],"study_design_scores_gemma":[0.02173709,0.00898181,0.7625829,0.0013785695,0.19802111,0.0006261565,0.00019375407,0.0011067789,0.0008653775,0.00038537534,0.0040187743,0.00010224787],"about_ca_topic_score_codex":0.0014325879,"about_ca_topic_score_gemma":0.0030486737,"teacher_disagreement_score":0.007992084,"about_ca_system_score_codex":0.00040183865,"about_ca_system_score_gemma":0.00036031686,"threshold_uncertainty_score":0.042266726},"labels":[],"label_agreement":null},{"id":"W4364375344","doi":"10.1016/j.jaad.2023.02.064","title":"Crisaborole reverses dysregulation of the mild to moderate atopic dermatitis proteome toward nonlesional and normal skin","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"Pfizer","keywords":"Atopic dermatitis; Medicine; Dermatology; Proteome; Bioinformatics","score_opus":0.01947097879040258,"score_gpt":0.3048157477206949,"score_spread":0.2853447689302923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4364375344","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941397,0.0020982414,0.00068125647,0.0002756841,0.0002113812,0.00003052975,0.00038672975,0.00017202567,0.002004549],"genre_scores_gemma":[0.99523747,0.0010781054,0.00073353725,0.00017355723,0.000029393526,0.000024715317,0.00050550466,0.000026854177,0.002190717],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999056,0.000017885513,0.000005959748,0.000022821181,0.00001920798,0.000028575569],"domain_scores_gemma":[0.99992394,0.000008844258,0.000013709717,0.000009249833,0.000012835522,0.000031359898],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011638509,0.00021251703,0.00019777984,0.00016747875,0.00018876127,0.00029166104,0.0001796225,0.00021909585,0.0022447233],"category_scores_gemma":[0.00016590348,0.000095825504,0.00020901479,0.00008259555,0.00019068693,0.00017927497,0.0002039107,0.0009167573,0.00042241666],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012953898,0.00018454637,0.0004624,0.00009297336,0.000021653132,0.00008486199,0.000025867801,0.00003745703,0.98930955,0.000115794974,0.0005773451,0.007792062],"study_design_scores_gemma":[0.000378163,0.004159522,0.047404833,0.000065313514,0.00012988463,0.0015377541,0.00040817718,0.0007824687,0.9269513,0.00028750833,0.017867528,0.000027668435],"about_ca_topic_score_codex":0.0003817238,"about_ca_topic_score_gemma":0.00090877275,"teacher_disagreement_score":0.0022447233,"about_ca_system_score_codex":0.00015537048,"about_ca_system_score_gemma":0.00023375999,"threshold_uncertainty_score":0.007509291},"labels":[],"label_agreement":null},{"id":"W4365520309","doi":"10.1016/j.jaad.2022.08.017","title":"Investigating the risk of malignancy in elderly patients with psoriasis: A population-based retrospective matched cohort study","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences; University of Ottawa; University of Toronto","funders":"","keywords":"Medicine; Psoriasis; Retrospective cohort study; Malignancy; Cohort; Cohort study; Population; Dermatology; Internal medicine; Environmental health","score_opus":0.010555768877568528,"score_gpt":0.25381484978135854,"score_spread":0.24325908090379,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4365520309","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993298,0.00016812551,0.00008730659,0.000015966156,0.0000056003846,0.000007690775,0.00017875955,0.000002657582,0.00020413383],"genre_scores_gemma":[0.9995493,0.00009627377,0.000056980785,0.000024589772,0.0000088631805,0.000005854586,0.00013672057,0.0000015449417,0.00011981418],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99952865,0.000104271865,0.000053908174,0.00016410401,0.00006226517,0.00008683582],"domain_scores_gemma":[0.99926656,0.00009661899,0.00023330246,0.00013906583,0.00009066549,0.00017367768],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056965294,0.00038600972,0.0005076148,0.00080057164,0.00072826206,0.0008350557,0.00035052648,0.0006707979,0.0014345188],"category_scores_gemma":[0.0012172086,0.00065714994,0.0007689232,0.001211663,0.00032563633,0.00061100215,0.00042376982,0.00074709754,0.00030607323],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003073898,0.00006593465,0.9982743,0.0000049602977,0.00011749314,0.00015509923,0.000063721964,0.000015456846,0.00046669715,0.000011059496,0.000045949277,0.00047193575],"study_design_scores_gemma":[0.000021222677,0.00022494582,0.99866164,0.0000024699739,0.0001064368,0.00044331627,0.0002220573,0.000099747725,0.000062548235,0.000017535203,0.00013385416,0.000004274041],"about_ca_topic_score_codex":0.006783076,"about_ca_topic_score_gemma":0.004917377,"teacher_disagreement_score":0.006783076,"about_ca_system_score_codex":0.00028255998,"about_ca_system_score_gemma":0.0003551231,"threshold_uncertainty_score":0.01348716},"labels":[],"label_agreement":null},{"id":"W4366245896","doi":"10.1016/j.jaad.2023.03.054","title":"Gender and leadership: Continued progress in academic dermatology","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Diversity and Career in Medicine","field":"Social Sciences","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dermatopathology; Medicine; Academic medicine; Dermatology; Quarter (Canadian coin); Family medicine; Representation (politics); Medical education; Political science","score_opus":0.11017870813809919,"score_gpt":0.37152094170750805,"score_spread":0.2613422335694089,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366245896","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"incentives","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"incentives","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16083623,0.09066258,0.00046030906,0.6838349,0.011745741,0.0000367161,0.0003127583,0.000081838836,0.052028917],"genre_scores_gemma":[0.91308016,0.040160168,0.0010929967,0.027641028,0.0059771817,0.000041843097,0.00016937584,0.000041803567,0.011795417],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9940959,0.0020696982,0.00029362572,0.00035194345,0.0013074328,0.00188128],"domain_scores_gemma":[0.96915597,0.006084911,0.0016318843,0.0005678832,0.0049441275,0.017615242],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.011321608,0.00026328902,0.00042602365,0.0015514548,0.005413879,0.008727463,0.0010526557,0.00263542,0.012507249],"category_scores_gemma":[0.017980635,0.00014796764,0.00039912766,0.0027371985,0.0027679303,0.004568817,0.003792776,0.003818069,0.00093367795],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037891,0.0010676681,0.11875994,0.0013187802,0.000058819267,0.0005841624,0.02136682,0.00017767065,0.0008086874,0.04208119,0.17199071,0.64140666],"study_design_scores_gemma":[0.00015096214,0.00074332807,0.24354914,0.0028268956,0.000058937087,0.0012928081,0.13109447,0.00041383252,0.0006292525,0.017964648,0.601169,0.00010679061],"about_ca_topic_score_codex":0.01141263,"about_ca_topic_score_gemma":0.030294541,"teacher_disagreement_score":0.9886784,"about_ca_system_score_codex":0.0049396046,"about_ca_system_score_gemma":0.02302228,"threshold_uncertainty_score":0.05987507},"labels":[],"label_agreement":null},{"id":"W4366352757","doi":"10.1016/j.jaad.2023.01.053","title":"Treat-to-target in the management of moderate-to-severe atopic dermatitis in adults: A Canadian perspective","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; Alberta Children's Hospital; McGill University; McGill University Health Centre; University of Manitoba; Dalhousie University; Innovaderm (Canada); University of Calgary; Lynde Centre for Dermatology; Hospital for Sick Children; Probity Medical Research; University of British Columbia; SKiN Health; Health Sciences Centre; Sunnybrook Health Science Centre; Queen's University; Women's College Hospital; University of Toronto","funders":"LEO Pharma; Bausch Health; Bristol-Myers Squibb; Eli Lilly and Company; Galderma; Incyte; Dermira; Sun Pharma; Regeneron Pharmaceuticals; Celgene; Sanofi; Amgen; Pfizer; GlaxoSmithKline","keywords":"Medicine; Atopic dermatitis; Perspective (graphical); Dermatology","score_opus":0.011604366678986391,"score_gpt":0.2969701399534107,"score_spread":0.2853657732744243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366352757","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00039031586,0.07442867,0.00043918868,0.8395981,0.07939624,0.000046542355,0.00027462805,0.000046952726,0.00537939],"genre_scores_gemma":[0.017978817,0.16902047,0.0037031015,0.63870895,0.16136193,0.00007680911,0.00037807002,0.00017685218,0.008595005],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99105036,0.0012752884,0.001075381,0.000727629,0.004660356,0.0012109799],"domain_scores_gemma":[0.9328476,0.011688088,0.0025678468,0.00058537436,0.03971195,0.012599117],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009440806,0.0008958934,0.0019526716,0.0026492758,0.0044200905,0.005436134,0.004295862,0.0123097,0.007762718],"category_scores_gemma":[0.05246122,0.0005741368,0.0012417507,0.0032649436,0.0038565923,0.0034510824,0.0016243607,0.020331575,0.0019173922],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003940881,0.00002465355,0.00043685647,0.00083019276,0.000030685675,0.00024357463,0.00025940183,0.00009516876,0.00006838868,0.0018682991,0.95654315,0.039560292],"study_design_scores_gemma":[0.000065340086,0.000040616105,0.0015983549,0.0047534974,0.000097297685,0.0008256859,0.00051709736,0.00022103506,0.00008664703,0.0014423706,0.9902569,0.00009509348],"about_ca_topic_score_codex":0.58784986,"about_ca_topic_score_gemma":0.77906424,"teacher_disagreement_score":0.41215014,"about_ca_system_score_codex":0.029890342,"about_ca_system_score_gemma":0.08751109,"threshold_uncertainty_score":0.82915473},"labels":[],"label_agreement":null},{"id":"W4366747967","doi":"10.1016/j.jaad.2023.04.027","title":"Oral spleen tyrosine kinase/Janus Kinase inhibitor gusacitinib for the treatment of chronic hand eczema: Results of a randomized phase 2 study","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"Asana Biosciences","keywords":"Medicine; Janus kinase; Janus kinase inhibitor; Tyrosine-kinase inhibitor; Randomized controlled trial; Tyrosine kinase; Internal medicine; Dermatology; Receptor; Cancer","score_opus":0.03176045916983997,"score_gpt":0.36530483240718525,"score_spread":0.33354437323734526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366747967","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97655815,0.012486293,0.0010687617,0.0010902574,0.00045702982,0.0048729856,0.0014754392,0.00014807208,0.0018429776],"genre_scores_gemma":[0.97398674,0.010140543,0.0028301275,0.002234246,0.0009773581,0.005077869,0.0021791041,0.000052398816,0.002521497],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9990202,0.00052934664,0.00006255476,0.00014208365,0.00010465507,0.00014117382],"domain_scores_gemma":[0.99866986,0.00039577766,0.0003421509,0.00010992262,0.00012281505,0.00035949622],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004430887,0.0017035445,0.0031871249,0.00050581177,0.0004604942,0.001215646,0.00085823797,0.0018296952,0.005368944],"category_scores_gemma":[0.0020760363,0.0009257341,0.0022116285,0.00049436826,0.0010075374,0.0010378645,0.00031973203,0.002218146,0.00075865013],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.942349,0.0154799735,0.001485082,0.0011043951,0.0018307839,0.00010598558,0.00007488353,0.00034707782,0.008211865,0.000083291445,0.0012343598,0.027693285],"study_design_scores_gemma":[0.9463409,0.049468923,0.0023632068,0.00003164221,0.00060314406,0.00005599995,0.000013387372,0.00019758432,0.000359224,0.000060158236,0.00049458543,0.000011349013],"about_ca_topic_score_codex":0.00069807365,"about_ca_topic_score_gemma":0.0018710294,"teacher_disagreement_score":0.005368944,"about_ca_system_score_codex":0.0007979164,"about_ca_system_score_gemma":0.0013808471,"threshold_uncertainty_score":0.02343309},"labels":[],"label_agreement":null},{"id":"W4366817818","doi":"10.1016/j.jaad.2023.04.031","title":"Management of adult generalized pustular psoriasis using biologics: A systematic review","year":2023,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; SKiN Health; Probity Medical Research; Health Sciences Centre; Sunnybrook Health Science Centre; Dermatrials Research; Women's College Hospital; McMaster University; University of Toronto; University of Calgary; Western University","funders":"","keywords":"Medicine; Dermatology; Generalized pustular psoriasis; Psoriasis; Pustular psoriasis","score_opus":0.06246607280875774,"score_gpt":0.35067533315529137,"score_spread":0.2882092603465336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366817818","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00061819406,0.99895155,0.000053634463,0.00007263112,0.000043649445,0.000043570628,0.00011803955,0.0000033510416,0.000095317424],"genre_scores_gemma":[0.0100134825,0.9891446,0.00026536974,0.00032241349,0.0000431419,0.000051272797,0.00010246695,0.000001943272,0.000055211178],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99847347,0.00039384022,0.00059911597,0.00018299452,0.00027735368,0.000073291245],"domain_scores_gemma":[0.9960173,0.0025827265,0.0009816077,0.000051757317,0.0002882978,0.000078400764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002157076,0.0009997479,0.0058698137,0.0031253623,0.00030434536,0.0014168331,0.0015612578,0.001253353,0.0036354735],"category_scores_gemma":[0.007457145,0.00063957897,0.0063009304,0.0035520077,0.00045788125,0.0013366592,0.00086848275,0.000992008,0.00023270037],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006809291,0.00004143716,0.0013237522,0.886951,0.024125632,0.00014562641,0.000118856355,0.00018505435,0.0002353264,0.00017180893,0.0029962012,0.08302439],"study_design_scores_gemma":[0.0017562088,0.00062814145,0.011984313,0.6224049,0.3215519,0.000987648,0.00039538371,0.0002415858,0.0002938797,0.00051050715,0.039149486,0.00009605836],"about_ca_topic_score_codex":0.0054349997,"about_ca_topic_score_gemma":0.019278444,"teacher_disagreement_score":0.0058698137,"about_ca_system_score_codex":0.0011996004,"about_ca_system_score_gemma":0.0027689096,"threshold_uncertainty_score":0.012161851},"labels":[],"label_agreement":null},{"id":"W4366978110","doi":"10.1016/j.jaad.2023.04.035","title":"Hydrochlorothiazide use and risk of keratinocyte carcinoma and melanoma: A multisite population-based cohort study","year":2023,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University; Dalhousie University; University of British Columbia; University of Toronto; Saskatchewan Health Quality Council; Women's College Hospital; University of Manitoba; McGill University; Institute for Clinical Evaluative Sciences; McGill University Health Centre; Jewish General Hospital; Manitoba Health; University of Calgary","funders":"Fonds de Recherche du Québec - Santé; Canadian Institutes of Health Research; McGill University","keywords":"Medicine; Hydrochlorothiazide; Keratinocyte; Dermatology; Cohort; Oncology; Internal medicine; Carcinoma; Cohort study; Melanoma; Cancer research","score_opus":0.04333348859150553,"score_gpt":0.3572729861322468,"score_spread":0.31393949754074124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366978110","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006403707,0.99292445,0.000073628304,0.000061760875,0.000053579264,0.000011179702,0.00028815676,0.000003492311,0.00018009188],"genre_scores_gemma":[0.03280538,0.9662791,0.00020097462,0.00012423759,0.00007111751,0.000015575151,0.00031799122,0.0000016821293,0.00018396988],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99972826,0.00006173736,0.000067232344,0.00006531632,0.000059206002,0.000018237437],"domain_scores_gemma":[0.9991611,0.00050934445,0.00018328601,0.000024886385,0.000092825234,0.00002852101],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077036663,0.0005031607,0.0018728292,0.0010778086,0.00012716824,0.00048626677,0.0005153084,0.00051082583,0.002026007],"category_scores_gemma":[0.0013931566,0.0003010563,0.0024410659,0.0021701315,0.00014130649,0.00030474982,0.00037550536,0.0004909388,0.000208322],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047970023,0.00024067349,0.08809619,0.24777551,0.11050333,0.000744877,0.0002342148,0.0005793732,0.0015350172,0.00062268274,0.0102961995,0.53457487],"study_design_scores_gemma":[0.001788937,0.0016074711,0.4471644,0.056815278,0.3893903,0.0024934127,0.0005614549,0.0005669693,0.00091142126,0.0009947708,0.09751182,0.00019372485],"about_ca_topic_score_codex":0.0055648903,"about_ca_topic_score_gemma":0.011307376,"teacher_disagreement_score":0.0055648903,"about_ca_system_score_codex":0.000300881,"about_ca_system_score_gemma":0.0006160391,"threshold_uncertainty_score":0.011065006},"labels":[],"label_agreement":null},{"id":"W4376272535","doi":"10.1016/j.jaad.2023.04.062","title":"Organic solvent exposure and systemic sclerosis: A retrospective cohort study based on the Canadian Scleroderma Research Group registry","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Montreal General Hospital; Jewish General Hospital; McGill University Health Centre; McGill University","funders":"Canadian Dermatology Foundation","keywords":"Medicine; Scleroderma (fungus); Retrospective cohort study; Cohort; Organic solvent; Cohort study; Multiple sclerosis; Systemic scleroderma; Dermatology; Internal medicine; Pathology; Immunology","score_opus":0.04874572594168767,"score_gpt":0.3183370297877973,"score_spread":0.26959130384610963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376272535","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992086,0.00055376446,0.0001396141,0.00014111116,0.000019510306,0.0000663555,0.005666633,0.000016703778,0.0013102897],"genre_scores_gemma":[0.99554247,0.00048855745,0.00021836933,0.00008363996,0.0000146437205,0.00003539817,0.0030572983,0.0000081375965,0.0005516491],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985574,0.00011310387,0.00007727651,0.0003584943,0.00041816046,0.0004755611],"domain_scores_gemma":[0.998321,0.00008203055,0.00038795988,0.00016026315,0.00069076486,0.00035797645],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008643331,0.000870506,0.00089378835,0.0028419015,0.0028499598,0.00145633,0.0015681059,0.0008690101,0.0020376425],"category_scores_gemma":[0.0015934319,0.0010268966,0.0010763941,0.006461564,0.000744169,0.0008716522,0.0009993669,0.0011117232,0.00034644658],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000115613424,0.000039441828,0.9975441,0.000013524902,0.00014606769,0.00014688908,0.00019503079,0.00004011609,0.00019943238,0.000051575902,0.00072819885,0.00077988365],"study_design_scores_gemma":[0.00001490431,0.000027108294,0.99860865,0.00001153062,0.00008015867,0.00016024499,0.00041198474,0.00013006598,0.00003375114,0.00001801945,0.00048915134,0.000014398865],"about_ca_topic_score_codex":0.9140584,"about_ca_topic_score_gemma":0.93128085,"teacher_disagreement_score":0.08594161,"about_ca_system_score_codex":0.0076262425,"about_ca_system_score_gemma":0.013714094,"threshold_uncertainty_score":0.17289543},"labels":[],"label_agreement":null},{"id":"W4377690919","doi":"10.1016/j.jaad.2023.05.033","title":"Efficacy and safety of switching from dupilumab to upadacitinib versus continuous upadacitinib in moderate-to-severe atopic dermatitis: Results from an open-label extension of the phase 3, randomized, controlled trial (Heads Up)","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Calgary Laboratory Services; SKiN Health; University of Calgary","funders":"AbbVie","keywords":"Medicine; Dupilumab; Atopic dermatitis; Randomized controlled trial; Open label; Dermatology; Internal medicine","score_opus":0.036451070026738204,"score_gpt":0.3680601446707623,"score_spread":0.3316090746440241,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4377690919","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99519426,0.0023235579,0.0002138353,0.0001335378,0.000102557235,0.0008686307,0.00044563808,0.000023197274,0.0006948986],"genre_scores_gemma":[0.9969477,0.00083398557,0.00042672904,0.00021140228,0.0001567339,0.0005301717,0.0005054711,0.0000058174146,0.00038198684],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99832183,0.00089851435,0.00016989151,0.00021368956,0.00018703578,0.00020891552],"domain_scores_gemma":[0.9973902,0.00087275024,0.00077070564,0.00021481358,0.00018817637,0.00056337274],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032205964,0.000730558,0.0015489904,0.00027815797,0.0004143811,0.0010548306,0.0006600482,0.00090841134,0.0034138837],"category_scores_gemma":[0.0028691292,0.00032583135,0.0021882702,0.00032749656,0.0009567286,0.000887684,0.00032569095,0.0022652852,0.0003197762],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.94527876,0.00999453,0.0039753523,0.0005482016,0.0013850223,0.000039769464,0.00008092045,0.00029337607,0.0037000398,0.00005317461,0.00045799508,0.034192752],"study_design_scores_gemma":[0.71441877,0.25320998,0.023806063,0.0000996058,0.0025508425,0.00016487265,0.00009372496,0.00094194105,0.0034796225,0.00021828232,0.0009755195,0.000040767958],"about_ca_topic_score_codex":0.0006533786,"about_ca_topic_score_gemma":0.0017031034,"teacher_disagreement_score":0.0034138837,"about_ca_system_score_codex":0.0007502939,"about_ca_system_score_gemma":0.0010250317,"threshold_uncertainty_score":0.017032385},"labels":[],"label_agreement":null},{"id":"W4378417578","doi":"10.1016/j.jaad.2023.05.041","title":"A case-control pharmacovigilance study of TNF-alpha inhibitors and interleukin inhibitors on tuberculosis, Candida, lymphoma and suicidality using the FAERS database (2014-2020)","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"McGill University","keywords":"Medicine; Pharmacovigilance; Adverse Event Reporting System; Tuberculosis; Tumor necrosis factor alpha; Pharmacology; Immunology; Database; Adverse effect; Pathology","score_opus":0.06389973989305911,"score_gpt":0.42089964981552613,"score_spread":0.356999909922467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378417578","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939235,0.001051459,0.00032160085,0.000074948315,0.00003301088,0.0001387675,0.0038937484,0.000012099091,0.0005508174],"genre_scores_gemma":[0.99497616,0.00034490626,0.0004990414,0.00013931248,0.00002809388,0.000075018106,0.0035835316,0.000005666199,0.0003482671],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974841,0.00054601784,0.00047405387,0.0008647661,0.00039388318,0.00023718487],"domain_scores_gemma":[0.9975006,0.0005787897,0.00091044937,0.00035462232,0.00040528466,0.00025018395],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015027283,0.0005486405,0.0010783204,0.0022848763,0.0009944466,0.0015532159,0.0007895837,0.001286964,0.0023624676],"category_scores_gemma":[0.0050581647,0.0008700162,0.0020696318,0.00252383,0.000376908,0.00082248123,0.0008780299,0.0011368088,0.00040550827],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024731532,0.00046160095,0.98911756,0.000148099,0.002201568,0.0013532828,0.0001657024,0.000097713426,0.0006339274,0.00010780846,0.00095111557,0.0022886219],"study_design_scores_gemma":[0.00052965747,0.0005646588,0.9941281,0.00005568012,0.0013585268,0.0017596971,0.00024432217,0.00047878822,0.00016366156,0.000055522527,0.0006293222,0.000032027416],"about_ca_topic_score_codex":0.035021327,"about_ca_topic_score_gemma":0.027269166,"teacher_disagreement_score":0.035021327,"about_ca_system_score_codex":0.0015713786,"about_ca_system_score_gemma":0.0010975975,"threshold_uncertainty_score":0.069634974},"labels":[],"label_agreement":null},{"id":"W4380870035","doi":"10.1016/j.jaad.2023.04.075","title":"Patient-reported outcomes with sarecycline treatment for acne vulgaris: Pooled analysis of phase 3 clinical studies","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Bausch Health; Castle Biosciences; University of Nebraska Medical Center; Amgen","keywords":"Acne; Medicine; Tetracycline; Dermatology; Epidemiology; Clinical trial; Antibiotics; Internal medicine; Microbiology","score_opus":0.07780741286486034,"score_gpt":0.46356403903504995,"score_spread":0.3857566261701896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380870035","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.045591652,0.9054685,0.0021070396,0.019549763,0.008651682,0.00055766065,0.015590168,0.00012513075,0.002358392],"genre_scores_gemma":[0.66644114,0.26471224,0.0032212602,0.023581516,0.027527273,0.001930598,0.010547878,0.00027752807,0.0017605658],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.96921074,0.01873212,0.006279946,0.0021387418,0.0030718653,0.0005665464],"domain_scores_gemma":[0.81898147,0.132267,0.03340183,0.0045015654,0.00944849,0.0013996081],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.038350433,0.0012551927,0.008557634,0.0020825833,0.00028817393,0.0029672072,0.0016036113,0.0025701066,0.0060509797],"category_scores_gemma":[0.10157683,0.0006698384,0.010827275,0.00419786,0.0007036387,0.0014762059,0.0011560087,0.0026700941,0.0005334648],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06075469,0.00026367712,0.053421505,0.19125551,0.49225247,0.000507814,0.00026888566,0.0021390514,0.0008767154,0.00073101575,0.076936565,0.12059208],"study_design_scores_gemma":[0.028962214,0.0059170597,0.16510524,0.04404949,0.68439937,0.0012049287,0.00027400206,0.00314113,0.0010858049,0.004096482,0.061192133,0.0005722104],"about_ca_topic_score_codex":0.0006118483,"about_ca_topic_score_gemma":0.0009714668,"teacher_disagreement_score":0.038350433,"about_ca_system_score_codex":0.0008535994,"about_ca_system_score_gemma":0.0013055439,"threshold_uncertainty_score":0.20281887},"labels":[],"label_agreement":null},{"id":"W4381194784","doi":"10.1016/j.jaad.2023.06.021","title":"Novel suturing technique for reduced electrocautery in excisional procedures for non-melanoma skin cancer","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Medicine; Melanoma; Skin cancer; Cancer; Surgery; Dermatology; Internal medicine; Cancer research","score_opus":0.019603524735890557,"score_gpt":0.33277614684531753,"score_spread":0.313172622109427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381194784","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.76720446,0.009766712,0.2037789,0.0018792546,0.0018065138,0.00028653353,0.00020557882,0.0015510913,0.013521063],"genre_scores_gemma":[0.8666891,0.0030949244,0.1221136,0.00079219777,0.0009262512,0.00010974891,0.00017266834,0.00014627224,0.0059553683],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996613,0.00004427972,0.000044177734,0.00008340088,0.00012148663,0.000045390392],"domain_scores_gemma":[0.99963653,0.00012586049,0.00007380014,0.00007747159,0.000040392657,0.00004592084],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029678302,0.0004359365,0.0003153578,0.000632105,0.00047382832,0.00043082377,0.00071875344,0.00058725773,0.0019195525],"category_scores_gemma":[0.00071036466,0.00023385427,0.00072399183,0.00027091507,0.00036309907,0.0007724517,0.0004873419,0.0010083824,0.0004291117],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011821361,0.0006562661,0.013997895,0.00064685865,0.00019107471,0.019849434,0.00061206735,0.0007783601,0.47050986,0.0010084165,0.0062704757,0.48429722],"study_design_scores_gemma":[0.0008086602,0.006774652,0.15468402,0.00026959568,0.0011526363,0.5285271,0.0005737349,0.026853373,0.21419416,0.0018517849,0.06396946,0.00034094517],"about_ca_topic_score_codex":0.00036751368,"about_ca_topic_score_gemma":0.0010258182,"teacher_disagreement_score":0.0019195525,"about_ca_system_score_codex":0.0001111022,"about_ca_system_score_gemma":0.00036424072,"threshold_uncertainty_score":0.0064215064},"labels":[],"label_agreement":null},{"id":"W4384023471","doi":"10.1016/j.jaad.2023.06.049","title":"Characteristics and complications of anogenital infantile hemangiomas: A multicenter retrospective analysis","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Vascular Malformations and Hemangiomas","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; University of Ottawa; Hospital for Sick Children","funders":"","keywords":"Medicine; Odds ratio; Buttocks; Retrospective cohort study; Anogenital distance; Sex organ; Logistic regression; Surgery; Internal medicine; Pregnancy","score_opus":0.013652484306144847,"score_gpt":0.30477644607837945,"score_spread":0.2911239617722346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384023471","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993772,0.00016285258,0.000053688538,0.000008804129,0.000002396937,0.0000067586766,0.00021253598,0.0000019697177,0.00017380495],"genre_scores_gemma":[0.99940145,0.00009890945,0.000059273694,0.00001588789,0.000009632395,0.00001194243,0.0003340121,0.0000027570072,0.000066132336],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990446,0.00019973371,0.00014994085,0.0002981879,0.00013286887,0.00017456958],"domain_scores_gemma":[0.9975401,0.00038103975,0.0012635384,0.0002505174,0.0002166875,0.00034822745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070387416,0.00045283377,0.0006988845,0.0013166562,0.0005661878,0.0008311627,0.00046871885,0.00066556974,0.0015533438],"category_scores_gemma":[0.001857798,0.0005844591,0.0007920838,0.0020030262,0.0004311822,0.0009784246,0.00059020845,0.0005966022,0.00027583633],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012300338,0.000042773485,0.998804,0.0000058201144,0.000060030532,0.0002606615,0.000047002304,0.00002392123,0.00014141409,0.000014032851,0.000039192055,0.00043815208],"study_design_scores_gemma":[0.0000125050265,0.00018352411,0.99699783,0.000006739384,0.00006965875,0.0018335382,0.00043828087,0.00018410682,0.00007625185,0.000017484266,0.00017068717,0.000009385109],"about_ca_topic_score_codex":0.001880311,"about_ca_topic_score_gemma":0.0015968241,"teacher_disagreement_score":0.001880311,"about_ca_system_score_codex":0.000501629,"about_ca_system_score_gemma":0.00044600022,"threshold_uncertainty_score":0.0051965117},"labels":[],"label_agreement":null},{"id":"W4384343629","doi":"10.1016/j.jaad.2023.07.010","title":"Isotretinoin for the management of moderate-to-severe seborrheic dermatitis: A systematic review","year":2023,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Seborrheic dermatitis; Isotretinoin; Dermatology; Dermatologic agents; Acne","score_opus":0.045054390262647126,"score_gpt":0.38269129448220696,"score_spread":0.33763690421955983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384343629","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000746225,0.9987463,0.000059127604,0.00007484287,0.000062786574,0.00007815122,0.00010083587,0.0000045410625,0.00012722182],"genre_scores_gemma":[0.011169238,0.9878775,0.00028023683,0.00035369757,0.000048587266,0.00008034756,0.000081719554,0.0000023939563,0.00010633],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9984848,0.00046458142,0.00055390457,0.0001625037,0.00025615696,0.0000780411],"domain_scores_gemma":[0.9963935,0.0023499618,0.000834862,0.000047687623,0.0002809855,0.000092889655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021383956,0.0010720151,0.0067313467,0.0031248338,0.00038698147,0.0015558004,0.001535981,0.0015044342,0.004781059],"category_scores_gemma":[0.008237562,0.0006057543,0.0068239192,0.0033659057,0.0005576698,0.0012747919,0.0009691853,0.0012000878,0.00028640535],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009498114,0.000047151225,0.00060268503,0.9113844,0.02677395,0.00013042185,0.000113301976,0.0001356703,0.00027699867,0.00013486392,0.002000331,0.057450328],"study_design_scores_gemma":[0.0024038423,0.0007793691,0.007513111,0.55810404,0.40001222,0.0006623873,0.00034441447,0.00018700391,0.00033893305,0.00042205647,0.029141255,0.000091436596],"about_ca_topic_score_codex":0.0085871015,"about_ca_topic_score_gemma":0.02803786,"teacher_disagreement_score":0.0085871015,"about_ca_system_score_codex":0.0013244515,"about_ca_system_score_gemma":0.003191761,"threshold_uncertainty_score":0.017074227},"labels":[],"label_agreement":null},{"id":"W4385248844","doi":"10.1016/j.jaad.2023.07.1012","title":"Response to Magnaterra et al’s unveiling hydrochlorothiazide: Skin cancer risk and hidden interactions","year":2023,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Skin Protection and Aging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital; McGill University Health Centre","funders":"","keywords":"Medicine; Thiazide; Drug; Hydrochlorothiazide; Diabetes mellitus; Cancer; Pharmacology; Heart failure; Metformin; Internal medicine; Diuretic; Endocrinology","score_opus":0.024326896293827373,"score_gpt":0.3597296720254986,"score_spread":0.3354027757316712,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385248844","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00032427022,0.00078195654,0.000040497594,0.98266023,0.015055109,0.0000072629377,0.000030033698,0.000014193086,0.0010864355],"genre_scores_gemma":[0.0040680384,0.00092677644,0.00014125719,0.9431339,0.047940347,0.000025510171,0.000022839076,0.000018140332,0.0037232675],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977368,0.0007159198,0.00026515397,0.00030970416,0.0005656823,0.00040680388],"domain_scores_gemma":[0.9928099,0.0033503016,0.00056744384,0.00020043355,0.0013803024,0.0016915076],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024569049,0.00093662186,0.0017313318,0.0009002356,0.004231519,0.0032601121,0.0013903612,0.05120524,0.0055576437],"category_scores_gemma":[0.023071852,0.00084768696,0.0012046586,0.00067429617,0.002115803,0.003070663,0.0016102062,0.040250946,0.0039769043],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000068074456,0.000054649096,0.0011093081,0.000051480405,0.000021463316,0.0040003876,0.00016610963,0.000053858414,0.00012143468,0.0009201958,0.9878477,0.0055852043],"study_design_scores_gemma":[0.0002615544,0.00018158669,0.0032765002,0.0006711235,0.00008897617,0.009724614,0.0013555024,0.0008805105,0.00029144378,0.007864673,0.9752841,0.00011930036],"about_ca_topic_score_codex":0.006030792,"about_ca_topic_score_gemma":0.009809127,"teacher_disagreement_score":0.05120524,"about_ca_system_score_codex":0.0035874746,"about_ca_system_score_gemma":0.00366624,"threshold_uncertainty_score":0.02602905},"labels":[],"label_agreement":null},{"id":"W4385612755","doi":"10.1016/j.jaad.2023.07.1024","title":"Long-term safety and efficacy of risankizumab for the treatment of moderate-to-severe plaque psoriasis: Interim analysis of the LIMMitless open-label extension trial up to 5 years of follow-up","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Probity Medical Research","funders":"Sanofi Genzyme; Celltrion; Eisai; Bristol-Myers Squibb; Samsung; AbbVie Canada; Coherus Biosciences; Mitsubishi Tanabe Pharma Corporation; Pfizer; Incyte; Regeneron Pharmaceuticals; Mylan; Castle Biosciences; Dermira; Sun Pharma; Helsinn; Celgene; AbbVie; Sanofi; Amgen; Meiji Seika Pharma; EMD Serono; Galderma; Ortho Dermatologics; Eli Lilly and Company; GlaxoSmithKline","keywords":"Medicine; Psoriasis Area and Severity Index; Psoriasis; Discontinuation; Adverse effect; Dermatology Life Quality Index; Internal medicine; Placebo; Randomized controlled trial; Severity of illness; Interim analysis; Surgery; Dermatology","score_opus":0.051637281120511344,"score_gpt":0.3408411507546446,"score_spread":0.28920386963413325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385612755","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9855517,0.0046921954,0.0013313323,0.00040743058,0.00017008142,0.0011544279,0.0035777006,0.00013277915,0.0029822818],"genre_scores_gemma":[0.9913607,0.0005778445,0.0010092431,0.00048470372,0.00015748788,0.0011599622,0.0041146474,0.000020752796,0.0011145066],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9968989,0.0016384741,0.00021360979,0.00033960913,0.0004455644,0.00046391605],"domain_scores_gemma":[0.9945155,0.0016960471,0.0016601959,0.0008379632,0.0005173473,0.000772823],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012517678,0.0010771474,0.0029667967,0.00043624724,0.0005866208,0.001618042,0.00086748076,0.0014180966,0.0031737443],"category_scores_gemma":[0.0062240344,0.00042826805,0.004154823,0.00041935855,0.0006387669,0.0012832884,0.0006512862,0.0026180658,0.0006503211],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.93228084,0.0047315867,0.021001503,0.0005596266,0.0049111554,0.00014212952,0.00012144247,0.0014481127,0.0037356436,0.00015724893,0.0025606297,0.02835015],"study_design_scores_gemma":[0.45311564,0.32227468,0.19283457,0.00027760715,0.015742844,0.0005073347,0.00012748715,0.004191997,0.0049882233,0.0008915987,0.0049316743,0.00011624342],"about_ca_topic_score_codex":0.00032699583,"about_ca_topic_score_gemma":0.00053331675,"teacher_disagreement_score":0.012517678,"about_ca_system_score_codex":0.00052265235,"about_ca_system_score_gemma":0.001177962,"threshold_uncertainty_score":0.066200614},"labels":[],"label_agreement":null},{"id":"W4386010289","doi":"10.1016/j.jaad.2023.07.1037","title":"Wound care for patients with hidradenitis suppurativa: Recommendations of an international panel of experts","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Hidradenitis suppurativa; Medicine; Wound care; Psychological intervention; Quality of life (healthcare); Dermatology; Disease; Intensive care medicine; Surgery; Internal medicine; Nursing","score_opus":0.028165005061442778,"score_gpt":0.34200142043986437,"score_spread":0.3138364153784216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386010289","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007345463,0.115003504,0.009337048,0.8083383,0.027457986,0.0018945634,0.0009001785,0.00028418572,0.029438809],"genre_scores_gemma":[0.12030803,0.29712307,0.17104518,0.35070822,0.030562818,0.005656492,0.005164477,0.00032433795,0.019107448],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9889404,0.0031577153,0.003151147,0.00045893382,0.0031293137,0.0011624809],"domain_scores_gemma":[0.95758265,0.008252115,0.004815693,0.0007860684,0.02234477,0.006218805],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.022420498,0.0014562793,0.001845,0.0029802222,0.0033077286,0.003926468,0.0037339828,0.011214668,0.003101874],"category_scores_gemma":[0.030118056,0.0008256838,0.0034664087,0.002264472,0.0017394834,0.0027682,0.0033373304,0.012817509,0.0012714379],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023202058,0.0007329368,0.019982914,0.004352194,0.0003827263,0.0012097171,0.0012135325,0.0009202507,0.0010825886,0.001941727,0.70993066,0.2580188],"study_design_scores_gemma":[0.00071582757,0.00038020886,0.046789266,0.02943734,0.00090919423,0.0031815649,0.005598649,0.0021449355,0.0009615835,0.005401714,0.9042306,0.00024909998],"about_ca_topic_score_codex":0.010727847,"about_ca_topic_score_gemma":0.018344985,"teacher_disagreement_score":0.022420498,"about_ca_system_score_codex":0.0031855348,"about_ca_system_score_gemma":0.022716455,"threshold_uncertainty_score":0.118572354},"labels":[],"label_agreement":null},{"id":"W4386034975","doi":"10.1016/j.jaad.2023.08.037","title":"Reply to letter to the editor","year":2023,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences; University of Ottawa; University of Toronto","funders":"Canadian Institutes of Health Research; Bausch Health; Eli Lilly and Company","keywords":"Medicine","score_opus":0.019030809670791432,"score_gpt":0.30983926760145586,"score_spread":0.29080845793066445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386034975","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004749533,0.0012347752,0.00004760536,0.94763565,0.046565775,0.000012826968,0.000043888664,0.000025835901,0.003958713],"genre_scores_gemma":[0.0051992335,0.0010572423,0.000112383525,0.93393326,0.048453882,0.000034184257,0.000026561327,0.000025720221,0.011157544],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973537,0.00083950313,0.00027831932,0.00034583732,0.00071273866,0.00046987284],"domain_scores_gemma":[0.99498934,0.002161293,0.0004063384,0.00016424697,0.0011649027,0.001113816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027483394,0.0009178258,0.0016328605,0.0010572729,0.003641972,0.0034543064,0.0017459865,0.040833518,0.008573691],"category_scores_gemma":[0.020912804,0.0008060164,0.0011116697,0.0007272685,0.0019681435,0.0026558456,0.0013975225,0.023678698,0.007231541],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046382745,0.000023057983,0.00043308642,0.00003257249,0.000012975288,0.002574924,0.000092245034,0.000034279485,0.000059061433,0.00070114416,0.9941354,0.0018550276],"study_design_scores_gemma":[0.00014013604,0.00007038021,0.001963864,0.0003643982,0.000052138774,0.0053678155,0.0007535537,0.00043924205,0.00023275302,0.0043731015,0.9861647,0.000077915225],"about_ca_topic_score_codex":0.0048101614,"about_ca_topic_score_gemma":0.006432629,"teacher_disagreement_score":0.040833518,"about_ca_system_score_codex":0.0036373292,"about_ca_system_score_gemma":0.0046636793,"threshold_uncertainty_score":0.028681815},"labels":[],"label_agreement":null},{"id":"W4386193192","doi":"10.1016/j.jaad.2023.08.057","title":"Biologic treatment options for pityriasis rubra pilaris: An evidence-based systematic review","year":2023,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Health Sciences Centre; Sunnybrook Health Science Centre; Women's College Hospital; University of Toronto","funders":"","keywords":"Pityriasis rubra pilaris; Medicine; Dermatology; Secukinumab; Scopus; MEDLINE; Psoriasis","score_opus":0.15731246814195635,"score_gpt":0.39652969027962864,"score_spread":0.2392172221376723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386193192","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00047408647,0.9990784,0.000052912834,0.000072228286,0.000051478582,0.000045780496,0.000108607994,0.0000034657082,0.00011300824],"genre_scores_gemma":[0.0075646914,0.99167436,0.00022872056,0.00028464975,0.000042938445,0.00004299438,0.00009544498,0.0000016663656,0.00006453857],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9985933,0.00037029453,0.00050913333,0.00016552336,0.00028639394,0.00007528451],"domain_scores_gemma":[0.9956382,0.003014502,0.0009472046,0.0000485889,0.0002811259,0.00007032719],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002215386,0.001173617,0.006677728,0.0035537332,0.0003452124,0.0016052534,0.0017658385,0.0016182569,0.0047664763],"category_scores_gemma":[0.007543627,0.00069036614,0.007685131,0.0035501348,0.0005402876,0.0013765102,0.00088108133,0.0012432614,0.00031701213],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007547305,0.00005000617,0.0007239241,0.89274377,0.022780279,0.00014151663,0.0000920551,0.00020419908,0.0002799313,0.00021889072,0.0027606473,0.07925007],"study_design_scores_gemma":[0.001807883,0.0006286933,0.007942106,0.5831771,0.3673575,0.00088787655,0.00033325277,0.00026244402,0.00034163118,0.0006473814,0.03652322,0.00009098395],"about_ca_topic_score_codex":0.005585267,"about_ca_topic_score_gemma":0.01761796,"teacher_disagreement_score":0.006677728,"about_ca_system_score_codex":0.0011807824,"about_ca_system_score_gemma":0.002757722,"threshold_uncertainty_score":0.015945435},"labels":[],"label_agreement":null},{"id":"W4386226896","doi":"10.1016/j.jaad.2023.08.059","title":"Real-world effectiveness and safety of upadacitinib for the treatment of atopic dermatitis in adult patients switched from dupilumab: A multicenter retrospective study","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Women's College Hospital; Probity Medical Research; Sunnybrook Health Science Centre; SKiN Health; University of Calgary; University of Toronto","funders":"","keywords":"Dupilumab; Medicine; Atopic dermatitis; Eczema Area and Severity Index; Dermatology; Clinical trial; Adverse effect; Randomized controlled trial; Internal medicine","score_opus":0.013421152187691457,"score_gpt":0.3189399198756029,"score_spread":0.3055187676879114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386226896","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99824417,0.0011027603,0.000058846537,0.000027735701,0.000009405762,0.000023198856,0.00030528673,0.000001591225,0.000226996],"genre_scores_gemma":[0.99915564,0.00020397063,0.000058732894,0.0000588773,0.000023819408,0.000016703489,0.0004436392,0.0000018351832,0.000036766374],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977835,0.00073059456,0.00034144628,0.00055973476,0.00035118236,0.00023363456],"domain_scores_gemma":[0.9959227,0.0010808837,0.001965152,0.00033218093,0.00036470036,0.00033442027],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019717098,0.00034810213,0.0009604087,0.00044259574,0.00042369205,0.0013325448,0.0004115455,0.00059743813,0.0008895357],"category_scores_gemma":[0.0034466067,0.00027991857,0.0013821438,0.0010054332,0.0005438404,0.0007588092,0.00036691836,0.0008009608,0.00014510224],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009578454,0.00044082847,0.97994745,0.0001874107,0.0019388215,0.00032587527,0.00017375307,0.00021608868,0.00065179775,0.000061053935,0.00028109783,0.0061974484],"study_design_scores_gemma":[0.0010057401,0.0051788036,0.986537,0.000076878256,0.0027049726,0.0015811994,0.0004733408,0.00065341685,0.0005047926,0.000060831888,0.0011838148,0.00003922638],"about_ca_topic_score_codex":0.001283377,"about_ca_topic_score_gemma":0.0012470881,"teacher_disagreement_score":0.0019717098,"about_ca_system_score_codex":0.00086864375,"about_ca_system_score_gemma":0.000508517,"threshold_uncertainty_score":0.010427535},"labels":[],"label_agreement":null},{"id":"W4386347985","doi":"10.1016/j.jaad.2022.08.069","title":"Clindamycin phosphate 1.2%/adapalene 0.15%/benzoyl peroxide 3.1% gel for moderate-to-severe acne: Efficacy and safety results from two randomized phase 3 trials","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"Ortho Dermatologics","keywords":"Adapalene; Acne; Medicine; Benzoyl peroxide; Clindamycin; Dermatology; Randomized controlled trial; Internal medicine; Antibiotics; Microbiology; Organic chemistry","score_opus":0.045123971546133276,"score_gpt":0.3914773489370845,"score_spread":0.34635337739095123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386347985","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9411961,0.044966266,0.00151355,0.0008285257,0.00045002816,0.0069489107,0.001311457,0.0001591978,0.002626014],"genre_scores_gemma":[0.97653514,0.014756429,0.0020567281,0.0007612224,0.00028738688,0.0037354564,0.0006857055,0.00002700369,0.0011548339],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99880743,0.0005809782,0.00014387116,0.00020036579,0.0001684675,0.00009896631],"domain_scores_gemma":[0.9976706,0.0009220758,0.0007167881,0.00014769015,0.00021631816,0.0003264432],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004430521,0.0010291885,0.002193835,0.00043773316,0.00038893477,0.0010288943,0.00060721097,0.0011850687,0.0035474487],"category_scores_gemma":[0.0027119364,0.0004876746,0.0021520813,0.00049878354,0.00087414193,0.00072854076,0.00028632893,0.0015215817,0.0005148123],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.87084925,0.012997888,0.0024261018,0.005507272,0.0049132686,0.000062675754,0.00016901326,0.00040705147,0.01563293,0.00016302311,0.0014821498,0.08538932],"study_design_scores_gemma":[0.86530876,0.12154817,0.00549002,0.00030137412,0.003087749,0.00009507816,0.00005091376,0.000340143,0.0021407844,0.00016473011,0.0014475128,0.000024722542],"about_ca_topic_score_codex":0.00054808153,"about_ca_topic_score_gemma":0.0019194494,"teacher_disagreement_score":0.004430521,"about_ca_system_score_codex":0.0005375166,"about_ca_system_score_gemma":0.0009887782,"threshold_uncertainty_score":0.023431122},"labels":[],"label_agreement":null},{"id":"W4386886950","doi":"10.1016/j.jaad.2023.08.096","title":"Development of the Generalized Pustular Psoriasis Clinical Assessment Tool","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Janssen Pharmaceuticals; Feinstein Institutes for Medical Research; Sanofi Genzyme; Bausch Health; Galderma; Northwell Health; Celltrion; National Psoriasis Foundation; Pfizer; Biogen; Incyte; AstraZeneca; Novocure; Springworks Therapeutics; National Institutes of Health; Regeneron Pharmaceuticals; Helsinn; Castle Biosciences; Therakos; Celgene; Massachusetts General Hospital; Melanoma Research Alliance; Eli Lilly and Company; U.S. Department of Defense; Sanofi; LEO Pharma; Ortho Dermatologics; Bristol-Myers Squibb; Meiji Seika Pharma; Amgen","keywords":"Medicine; Generalized pustular psoriasis; Dermatology; Pustular psoriasis; Psoriasis; Intensive care medicine","score_opus":0.061474653781619655,"score_gpt":0.4182101662546722,"score_spread":0.3567355124730526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386886950","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.51771003,0.009616566,0.2989858,0.010312338,0.0022611723,0.03886421,0.050927475,0.011011726,0.06031071],"genre_scores_gemma":[0.4949804,0.003033668,0.43785176,0.002707015,0.00039172434,0.020034218,0.029651742,0.00066158036,0.010687872],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99320686,0.0019345031,0.0017274058,0.00049221085,0.0023550435,0.000283917],"domain_scores_gemma":[0.9842063,0.0066700233,0.0020881942,0.00053545175,0.0057623084,0.00073770917],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0099801915,0.0006020467,0.0010928655,0.0027620934,0.00041957668,0.0021604719,0.0010075936,0.00051268237,0.003997792],"category_scores_gemma":[0.024198454,0.00044923235,0.0016778174,0.0011017937,0.00022804634,0.0013169107,0.0022241815,0.0019146403,0.0015743213],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015498835,0.0011325702,0.17222373,0.0010703894,0.000682314,0.00036570468,0.0006873681,0.002164043,0.004302304,0.0035523165,0.04723687,0.7650324],"study_design_scores_gemma":[0.0019867464,0.0027308816,0.6398333,0.002397197,0.001475053,0.0046849293,0.0010605499,0.034806103,0.017164398,0.009181897,0.28426817,0.00041089347],"about_ca_topic_score_codex":0.001758206,"about_ca_topic_score_gemma":0.0036593059,"teacher_disagreement_score":0.0099801915,"about_ca_system_score_codex":0.0009667694,"about_ca_system_score_gemma":0.0029772285,"threshold_uncertainty_score":0.052780926},"labels":[],"label_agreement":null},{"id":"W4386886964","doi":"10.1016/j.jaad.2023.08.097","title":"Real-world effectiveness of risankizumab in patients with moderate-to-severe psoriasis using the CorEvitas Psoriasis Registry","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"AbbVie","keywords":"Medicine; Psoriasis; Dermatology","score_opus":0.018688156576502652,"score_gpt":0.2841982089956106,"score_spread":0.26551005241910797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386886964","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.969146,0.0027952995,0.0009027081,0.0003398414,0.000042589683,0.00036461905,0.022468265,0.00005334948,0.0038872934],"genre_scores_gemma":[0.982463,0.0008188686,0.00084688456,0.00017588341,0.000051541792,0.00031324994,0.015072721,0.000015626569,0.0002422134],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9912378,0.003504642,0.0015608498,0.0013624489,0.0019590228,0.00037511892],"domain_scores_gemma":[0.9785684,0.0042429483,0.012006803,0.0018219393,0.0024002078,0.0009598135],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006496497,0.00020406143,0.0007671941,0.0010365779,0.0003895296,0.0011141474,0.0006748812,0.00037794802,0.0014682142],"category_scores_gemma":[0.012880155,0.00027683645,0.0010547462,0.0023509904,0.00020404278,0.0006590155,0.0006179431,0.0007449775,0.00035341247],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002318099,0.00023701071,0.9803883,0.00025291595,0.00064096146,0.000057206697,0.00010223826,0.00030486748,0.00019759672,0.00012957535,0.0035169853,0.01185417],"study_design_scores_gemma":[0.0005635594,0.0007269693,0.99127275,0.00012666362,0.0005593487,0.00051480083,0.0001962351,0.0010280121,0.00036254435,0.00008750186,0.004529491,0.000031936856],"about_ca_topic_score_codex":0.009590356,"about_ca_topic_score_gemma":0.012834577,"teacher_disagreement_score":0.009590356,"about_ca_system_score_codex":0.0009275135,"about_ca_system_score_gemma":0.0015690648,"threshold_uncertainty_score":0.03435719},"labels":[],"label_agreement":null},{"id":"W4387014050","doi":"10.1016/j.jaad.2023.07.472","title":"42810 Adverse Cutaneous Events of Low-Dose Methotrexate: A Systematic Review","year":2023,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Queen's University","funders":"","keywords":"Medicine; Toxic epidermal necrolysis; Methotrexate; Adverse effect; Dermatology; Erythema; Systematic review; Prospective cohort study; Surgery; MEDLINE; Internal medicine","score_opus":0.05882692156984736,"score_gpt":0.41106469082740416,"score_spread":0.3522377692575568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387014050","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014832031,0.99761355,0.000088876666,0.00009694666,0.00007499806,0.0001234447,0.0002737268,0.0000068075287,0.00023849387],"genre_scores_gemma":[0.023015942,0.97557425,0.00034188357,0.0005586599,0.000071934315,0.00012311329,0.00015692432,0.000003655576,0.0001535376],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99735653,0.0008228285,0.0010369138,0.00027609416,0.00041106538,0.000096728596],"domain_scores_gemma":[0.99017906,0.0063092816,0.0027423697,0.000115009745,0.00052134413,0.00013284067],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028736645,0.0010708965,0.005112684,0.0034863984,0.00036028097,0.0013718074,0.00100764,0.0013819488,0.0072776345],"category_scores_gemma":[0.013654511,0.00064373313,0.0065556513,0.004255508,0.00048077566,0.0011419425,0.0011364293,0.0010902128,0.00033664794],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007139655,0.000034082674,0.0016508393,0.92800105,0.02636832,0.00015801807,0.000095674135,0.00012343437,0.00024961028,0.00010223462,0.0020468885,0.04045578],"study_design_scores_gemma":[0.0022208905,0.0007880287,0.019950839,0.53950715,0.4029208,0.00096313376,0.00031441826,0.00020010794,0.00032742097,0.00030047956,0.03241046,0.0000962906],"about_ca_topic_score_codex":0.0059484746,"about_ca_topic_score_gemma":0.021892082,"teacher_disagreement_score":0.0072776345,"about_ca_system_score_codex":0.0014349642,"about_ca_system_score_gemma":0.002581626,"threshold_uncertainty_score":0.024346113},"labels":[],"label_agreement":null},{"id":"W4387014083","doi":"10.1016/j.jaad.2023.07.466","title":"44042 Abrocitinib Long-Term Efficacy for up to 96 Weeks in Patients With Moderate-to-Severe Atopic Dermatitis: Interim Analysis of JADE EXTEND, a Long-Term Extension Study","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Medicine; JADE (particle detector); Atopic dermatitis; Placebo; Dermatology; Internal medicine; Pediatrics","score_opus":0.052575795830133165,"score_gpt":0.40483284480895293,"score_spread":0.35225704897881976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387014083","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97992295,0.012046303,0.00095261075,0.00031165945,0.0002312404,0.00059851655,0.0026051726,0.00013190591,0.003199578],"genre_scores_gemma":[0.98917645,0.0022193613,0.0007700907,0.000625351,0.00023568187,0.0005774804,0.0036846744,0.000027845068,0.0026829941],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9988625,0.00045059645,0.00009290482,0.00015766127,0.00017171171,0.00026468918],"domain_scores_gemma":[0.9983359,0.00039086366,0.00041853046,0.00034765442,0.00017193033,0.00033512738],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004706612,0.0012936946,0.003488705,0.00044239237,0.00063530414,0.0018313018,0.0006389127,0.001077883,0.0032532413],"category_scores_gemma":[0.0021699436,0.00045002013,0.004476522,0.0005022991,0.0005543412,0.0013071719,0.0004366627,0.0031764458,0.0009853729],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8281112,0.0072134305,0.032866307,0.0012810723,0.012942766,0.00039944655,0.00022872424,0.0024887237,0.011354463,0.00027820424,0.00374182,0.099093795],"study_design_scores_gemma":[0.3986974,0.3151521,0.24585098,0.0003694851,0.020753304,0.0011344288,0.0002989098,0.0030916226,0.0049153334,0.0007748762,0.008761381,0.00020011154],"about_ca_topic_score_codex":0.0004805633,"about_ca_topic_score_gemma":0.0011797335,"teacher_disagreement_score":0.004706612,"about_ca_system_score_codex":0.00053976564,"about_ca_system_score_gemma":0.0008179924,"threshold_uncertainty_score":0.024891198},"labels":[],"label_agreement":null},{"id":"W4387014163","doi":"10.1016/j.jaad.2023.07.429","title":"43322 A 10-year population-based prevalence study of the burden of palmoplantar pustulosis in Canadian patients hospitalized or seen in emergency departments and hospital- or community-based outpatient clinics","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Impact; McMaster University; University of Toronto; University of Calgary","funders":"","keywords":"Medicine; Palmoplantar pustulosis; Epidemiology; Psoriasis; Emergency department; Outpatient visits; Emergency medicine; Population; Outpatient clinic; Family medicine; Dermatology; Internal medicine; Health care; Environmental health; Psychiatry","score_opus":0.02239707966958353,"score_gpt":0.299034380869453,"score_spread":0.27663730119986946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387014163","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993454,0.00024415815,0.00008321082,0.00011682282,0.000009957754,0.000052596944,0.0047461223,0.000010688857,0.0012826384],"genre_scores_gemma":[0.99549353,0.00022440164,0.00018369005,0.00014820817,0.000013040509,0.000028877768,0.0030247024,0.000005569901,0.00087796577],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992681,0.00005526076,0.0000471712,0.00012795588,0.00021968753,0.00028179827],"domain_scores_gemma":[0.9989675,0.000038529968,0.00018897196,0.00003216016,0.0004933031,0.000279574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005309537,0.0006211246,0.0005431445,0.001770031,0.0030318047,0.0011476125,0.0010273198,0.00080783415,0.0025342721],"category_scores_gemma":[0.001242579,0.00063901633,0.00093627744,0.0045420392,0.0005069064,0.0005266043,0.0007165481,0.0010161095,0.0004999295],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013837122,0.00007274141,0.99717075,0.000025426114,0.00007508211,0.000088023575,0.00032718733,0.000030673928,0.00027058588,0.000030843035,0.0007225078,0.0010479065],"study_design_scores_gemma":[0.000009929527,0.000039666935,0.9991345,0.0000069411817,0.000020131327,0.00008547051,0.00034684653,0.00006927259,0.00001755303,0.000004179891,0.00025967078,0.000005861858],"about_ca_topic_score_codex":0.97542065,"about_ca_topic_score_gemma":0.9722493,"teacher_disagreement_score":0.024579346,"about_ca_system_score_codex":0.01130575,"about_ca_system_score_gemma":0.010370932,"threshold_uncertainty_score":0.08202934},"labels":[],"label_agreement":null},{"id":"W4387014167","doi":"10.1016/j.jaad.2023.07.383","title":"40212 The Global Prevalence of Primary Psychodermatologic Disorders: A Systematic Reviews","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Body Image and Dysmorphia Studies","field":"Psychology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Primary care; Psychological intervention; Systematic review; Primary health care; MEDLINE; Family medicine; Environmental health; Nursing; Population","score_opus":0.05276256913149477,"score_gpt":0.37376766681042156,"score_spread":0.3210050976789268,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387014167","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01328556,0.98167944,0.00019940248,0.00054773723,0.00024633372,0.0006147763,0.0027955454,0.000018563936,0.00061265443],"genre_scores_gemma":[0.20872249,0.78295016,0.0020104677,0.0026380338,0.00018446104,0.0016329032,0.001453889,0.00002293833,0.00038463352],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9829653,0.005261677,0.008031654,0.0013309161,0.0018882724,0.00052224007],"domain_scores_gemma":[0.95887107,0.028054904,0.008667581,0.00092872407,0.0030281318,0.0004495552],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010497364,0.0011534452,0.0050976244,0.010562387,0.0006363252,0.0022033541,0.001038396,0.0019061321,0.0048412015],"category_scores_gemma":[0.05641498,0.0015764905,0.011161925,0.009507956,0.0008925369,0.0017284538,0.001893424,0.0010202992,0.00038850788],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005942049,0.00004226861,0.027561212,0.8644321,0.08452691,0.00021870786,0.00045204526,0.000066148714,0.00031092777,0.00015878606,0.0024477444,0.019189073],"study_design_scores_gemma":[0.0013472444,0.00041822984,0.081078835,0.50812876,0.3959623,0.00064030156,0.00087697676,0.00008479046,0.00026788132,0.00019491886,0.010927463,0.000072291856],"about_ca_topic_score_codex":0.018510154,"about_ca_topic_score_gemma":0.06474281,"teacher_disagreement_score":0.018510154,"about_ca_system_score_codex":0.0026575122,"about_ca_system_score_gemma":0.008467142,"threshold_uncertainty_score":0.055516005},"labels":[],"label_agreement":null},{"id":"W4387014235","doi":"10.1016/j.jaad.2023.07.428","title":"43266 A 10-year population-based prevalence study of the burden of generalized pustular psoriasis in Canadian patients hospitalized or seen in emergency departments and hospital- or community-based outpatient clinics","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; McMaster University; University of Toronto","funders":"","keywords":"Medicine; Psoriasis; Epidemiology; Outpatient visits; Emergency department; Outpatient clinic; Emergency medicine; Population; Generalized pustular psoriasis; Family medicine; Pediatrics; Dermatology; Internal medicine; Environmental health; Health care; Psychiatry","score_opus":0.023984480276759933,"score_gpt":0.30333473389030036,"score_spread":0.27935025361354043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387014235","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940568,0.00024211954,0.00006589797,0.00010620865,0.000009549411,0.00003916315,0.004306296,0.000009444802,0.0011643821],"genre_scores_gemma":[0.9959382,0.00024073663,0.00017560257,0.0001210074,0.000011928179,0.000019827748,0.0028531477,0.0000042092374,0.0006354114],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99928147,0.00005874768,0.00004217477,0.0001310095,0.00022354412,0.00026308428],"domain_scores_gemma":[0.99902105,0.000039052957,0.00019629225,0.000030634666,0.0004332391,0.00027974765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051098387,0.0005626563,0.00051096996,0.0016548376,0.0027301772,0.0010991471,0.0009539606,0.0007843748,0.002328489],"category_scores_gemma":[0.0010836482,0.00056959456,0.00090964814,0.004390523,0.000532485,0.0004832653,0.00067989284,0.0010160117,0.0004091544],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014484584,0.00006816684,0.99748874,0.000022637721,0.00007059633,0.00006557686,0.00025210757,0.000031431162,0.00025950576,0.000028609284,0.00058872765,0.0009790615],"study_design_scores_gemma":[0.000008445044,0.00003245545,0.9993543,0.0000051835495,0.00001573557,0.000054902,0.00026299182,0.000058270576,0.000013950158,0.0000035512176,0.0001852607,0.000004945069],"about_ca_topic_score_codex":0.97280407,"about_ca_topic_score_gemma":0.9715286,"teacher_disagreement_score":0.02719593,"about_ca_system_score_codex":0.010419912,"about_ca_system_score_gemma":0.00996537,"threshold_uncertainty_score":0.075602055},"labels":[],"label_agreement":null},{"id":"W4387014242","doi":"10.1016/j.jaad.2023.07.386","title":"43565 The Medicolegal Risks of Skin Cancer: An Analysis of Canadian Closed Medicolegal Data between 2016 and 2020","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa; University of Toronto; Canadian Medical Protective Association; University of British Columbia","funders":"","keywords":"Medicine; Skin cancer; Intensive care medicine; Cancer; Dermatology; Internal medicine","score_opus":0.1000699964190697,"score_gpt":0.41455481333381355,"score_spread":0.31448481691474384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387014242","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.76870567,0.011043326,0.000309639,0.0016032595,0.00013324415,0.0002193768,0.20574214,0.00004475779,0.01219863],"genre_scores_gemma":[0.9385431,0.005221467,0.00057823356,0.0007625466,0.000051052906,0.00012220425,0.050768312,0.000026354199,0.003926794],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996876,0.0002907299,0.00031784447,0.00030900407,0.0013796057,0.00082673866],"domain_scores_gemma":[0.9923201,0.00071138184,0.0018524193,0.00030389585,0.0036932996,0.0011189735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020790335,0.00055753323,0.0006253312,0.006399657,0.0019077192,0.0013932554,0.0014819447,0.0006761015,0.0031138225],"category_scores_gemma":[0.008044777,0.00061916054,0.0016719135,0.018702745,0.0006635838,0.00050572306,0.0012393161,0.00108837,0.0003132029],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005290471,0.000053482865,0.97804135,0.00045149785,0.0007387763,0.00013081523,0.00054730923,0.00030210835,0.00016155957,0.0006253309,0.010604192,0.007814474],"study_design_scores_gemma":[0.000025334934,0.00002825311,0.99186134,0.00012695743,0.00019145811,0.000048031518,0.00048070768,0.00014759308,0.0000701494,0.000037071415,0.006964985,0.00001802182],"about_ca_topic_score_codex":0.9964148,"about_ca_topic_score_gemma":0.9975419,"teacher_disagreement_score":0.034276515,"about_ca_system_score_codex":0.034276515,"about_ca_system_score_gemma":0.06378595,"threshold_uncertainty_score":0.24869472},"labels":[],"label_agreement":null},{"id":"W4387014246","doi":"10.1016/j.jaad.2023.07.392","title":"43169 The use of ultrasound to examine subcutaneous nodules: a scoping review","year":2023,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Tumors and Oncological Cases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health; University of British Columbia","funders":"","keywords":"Medicine; Ultrasound; Modalities; Medical diagnosis; Radiology; Visualization; Ultrasound imaging; Subcutaneous fat; Medical physics; Artificial intelligence; Internal medicine","score_opus":0.21136993203902865,"score_gpt":0.4450719570096216,"score_spread":0.23370202497059295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387014246","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015476659,0.9993599,0.00004072988,0.000091209935,0.00006843418,0.000023434302,0.000034035635,0.0000020026832,0.00022547826],"genre_scores_gemma":[0.0014008525,0.99809223,0.00014985309,0.00019645906,0.000038477454,0.00001728636,0.000038385828,0.0000016311322,0.000064871994],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99692935,0.0006882236,0.0013085685,0.00033921006,0.00062239304,0.00011222937],"domain_scores_gemma":[0.9851865,0.011650632,0.001742987,0.00015840007,0.0011353293,0.00012611978],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004538339,0.0011051601,0.0035687098,0.010321803,0.00050163595,0.0028362237,0.0013437651,0.0022246249,0.0043379683],"category_scores_gemma":[0.017166039,0.00088842894,0.002645052,0.009632056,0.001061762,0.0026720173,0.0013828019,0.0011234991,0.0006880154],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017297638,0.000046392903,0.0014224707,0.5747415,0.0021826304,0.0005424765,0.00037895524,0.00016048645,0.0008078548,0.00066764315,0.0088683795,0.4100083],"study_design_scores_gemma":[0.000101171,0.00012780495,0.0049917293,0.84420294,0.014823852,0.002542494,0.00061567273,0.00009989243,0.0004086339,0.0003163776,0.13171452,0.00005483262],"about_ca_topic_score_codex":0.0074159834,"about_ca_topic_score_gemma":0.015705463,"teacher_disagreement_score":0.010321803,"about_ca_system_score_codex":0.0018713457,"about_ca_system_score_gemma":0.0061444426,"threshold_uncertainty_score":0.02400136},"labels":[],"label_agreement":null},{"id":"W4387014301","doi":"10.1016/j.jaad.2023.07.365","title":"42262 Sustained Improvement Over 52 Weeks in Patient-Reported Itch, Symptoms, and Quality of Life With Upadacitinib in Patients With Atopic Dermatitis: Results From Phase 3 Studies (Measure Up 1, Measure Up 2, and AD Up)","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Queen's University","funders":"","keywords":"Medicine; Atopic dermatitis; Measure (data warehouse); Quality of life (healthcare); Dermatology","score_opus":0.026163151452358136,"score_gpt":0.3228975051290781,"score_spread":0.29673435367671996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387014301","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895517,0.006540365,0.00023693505,0.0002126227,0.00007770487,0.00031006007,0.00080936897,0.00012263728,0.002138517],"genre_scores_gemma":[0.9941088,0.0022090639,0.0005019075,0.00031717084,0.00005952318,0.00022050824,0.0012695177,0.000012953946,0.0013006569],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99973494,0.00008721488,0.000019703111,0.000038882124,0.000053732656,0.00006552582],"domain_scores_gemma":[0.9997986,0.000040705538,0.000054672113,0.000018413068,0.000031470434,0.000056134282],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007828865,0.000531906,0.0014122005,0.00023911396,0.00023012354,0.00057704194,0.00031563785,0.00043382312,0.0024666158],"category_scores_gemma":[0.00041739672,0.00017407213,0.0012333514,0.00030603964,0.00018087178,0.0003626286,0.00020639494,0.0012801009,0.0004995222],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.283829,0.028751431,0.026150342,0.0028051115,0.0047760806,0.0005976809,0.00023012256,0.0022580968,0.09024573,0.00016078494,0.00976853,0.5504271],"study_design_scores_gemma":[0.25534165,0.3754665,0.32405424,0.00038557258,0.0037546412,0.0019816083,0.00024974716,0.0035267568,0.025321929,0.00022776132,0.009548047,0.00014151142],"about_ca_topic_score_codex":0.00069959316,"about_ca_topic_score_gemma":0.002147456,"teacher_disagreement_score":0.0024666158,"about_ca_system_score_codex":0.00029808944,"about_ca_system_score_gemma":0.00030824696,"threshold_uncertainty_score":0.008251667},"labels":[],"label_agreement":null},{"id":"W4387014319","doi":"10.1016/j.jaad.2023.07.430","title":"44100 A 3-year population-based incidence study of the burden of generalized pustular psoriasis in Canadian patients hospitalized or seen in emergency departments and hospital- or community-based outpatient clinics","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Impact; McMaster University; University of Toronto; University of Calgary","funders":"","keywords":"Medicine; Incidence (geometry); Psoriasis; Outpatient visits; Emergency department; Generalized pustular psoriasis; Emergency medicine; Population; Outpatient clinic; Pediatrics; Family medicine; Dermatology; Health care; Internal medicine; Environmental health; Psychiatry","score_opus":0.023270365545776335,"score_gpt":0.30472914957633035,"score_spread":0.281458784030554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387014319","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989748,0.00026348987,0.0000886815,0.00011418728,0.000009890056,0.000057359615,0.008185906,0.000018881274,0.0015136073],"genre_scores_gemma":[0.9914546,0.00029445297,0.00019761099,0.0001383848,0.00001555268,0.000027873393,0.006975321,0.000006948686,0.00088913075],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99924064,0.000057880596,0.000044505658,0.00012127232,0.00026573223,0.0002699519],"domain_scores_gemma":[0.99885404,0.00004805276,0.00022345342,0.00004493175,0.0005110531,0.00031843808],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043842616,0.00063798943,0.0005926586,0.0019498216,0.0025453025,0.001184249,0.0011682555,0.0008273941,0.0024003957],"category_scores_gemma":[0.0012145455,0.00059603614,0.0010433581,0.006145019,0.0005022805,0.00048483012,0.00071925257,0.0011838496,0.000427681],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021771094,0.00008587349,0.9964599,0.000025428859,0.00010624965,0.0000781685,0.00020034813,0.000059432816,0.00022786816,0.000037744307,0.0010329334,0.0014682147],"study_design_scores_gemma":[0.000010900728,0.000032869793,0.9993943,0.0000043814857,0.00002101439,0.00005354,0.00015711972,0.000077817305,0.000014402416,0.0000046571067,0.00022354764,0.000005406585],"about_ca_topic_score_codex":0.97280395,"about_ca_topic_score_gemma":0.9704615,"teacher_disagreement_score":0.02719605,"about_ca_system_score_codex":0.011442052,"about_ca_system_score_gemma":0.010854642,"threshold_uncertainty_score":0.0830183},"labels":[],"label_agreement":null},{"id":"W4387014374","doi":"10.1016/j.jaad.2023.07.419","title":"44156 Vitiligo and Lichen Planus Following COVID-19 Vaccination/Infection: A Possible Type 1 Interferon Response?","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"melanin and skin pigmentation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Vitiligo; Medicine; Vaccination; Exacerbation; Dermatology; Immunology; Internal medicine","score_opus":0.02325174147935872,"score_gpt":0.3520429912831367,"score_spread":0.328791249803778,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387014374","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98455924,0.003061041,0.0006677147,0.0015868185,0.0001810781,0.00006646876,0.00011967778,0.000032641947,0.00972532],"genre_scores_gemma":[0.9977927,0.00033802012,0.00015374848,0.00025475465,0.00009320205,0.0000129043865,0.000055895445,0.000003556431,0.0012950927],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99980026,0.000060591916,0.000014289924,0.000017189006,0.000024891073,0.00008274094],"domain_scores_gemma":[0.99985945,0.000041777996,0.000042126223,0.000014858676,0.000016726384,0.000025080844],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035619337,0.0001899375,0.00027093393,0.0002408157,0.00020959733,0.00037271585,0.00020041472,0.0012415763,0.0053100237],"category_scores_gemma":[0.0006062655,0.00010236279,0.0002937655,0.00012928259,0.00031908494,0.0003248859,0.00020552811,0.00062275765,0.0004567021],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014453638,0.001499803,0.27309138,0.000729566,0.00022295101,0.07485118,0.0006741706,0.00056069816,0.5345174,0.005027147,0.0035230652,0.09084892],"study_design_scores_gemma":[0.0006250158,0.004261362,0.8065711,0.0003105153,0.00023681966,0.0909086,0.0012351932,0.0034413368,0.06545294,0.0036362682,0.023274459,0.00004644774],"about_ca_topic_score_codex":0.00043242783,"about_ca_topic_score_gemma":0.00037040265,"teacher_disagreement_score":0.0053100237,"about_ca_system_score_codex":0.00030537977,"about_ca_system_score_gemma":0.00014796172,"threshold_uncertainty_score":0.017763793},"labels":[],"label_agreement":null},{"id":"W4387014384","doi":"10.1016/j.jaad.2023.07.366","title":"42005 Sustained scalp, eyebrow, and eyelash hair regrowth with ritlecitinib through Week 48 in patients with alopecia areata: post hoc analysis of the ALLEGRO phase 2b/3 study","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Pfizer","keywords":"Alopecia areata; Medicine; Post-hoc analysis; Scalp; Dermatology; Post hoc; Eyelash; Hair loss; Eyebrow; Cabello; Surgery; Internal medicine","score_opus":0.010048385467983654,"score_gpt":0.2971184392843504,"score_spread":0.28707005381636674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387014384","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99606967,0.0017652058,0.00025375633,0.00010735152,0.00006634936,0.00032390436,0.00050082296,0.000056359186,0.0008565101],"genre_scores_gemma":[0.99708766,0.00062022766,0.00031774223,0.00016957341,0.00006380264,0.00028913654,0.00046052298,0.0000170858,0.00097419246],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9991677,0.0004393424,0.00004183861,0.000120088,0.00006830803,0.00016285975],"domain_scores_gemma":[0.99939895,0.0002142235,0.00013783904,0.000078192745,0.00003765077,0.00013313166],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018761606,0.00080153503,0.0024590467,0.0002800307,0.00029590717,0.0008733015,0.00053251244,0.0005952632,0.003172025],"category_scores_gemma":[0.0009183169,0.00033261697,0.0025780175,0.00031704328,0.00049581024,0.000847674,0.00027614183,0.002055384,0.00054815575],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9026235,0.0075728176,0.008484777,0.0007197676,0.004878558,0.000094050796,0.00011785356,0.0018836466,0.010474963,0.000125773,0.0016163063,0.061408024],"study_design_scores_gemma":[0.45298606,0.4465679,0.084520064,0.00008538626,0.0054227887,0.00025872528,0.00019754193,0.002722618,0.0034617637,0.00032793987,0.0033771826,0.000072030925],"about_ca_topic_score_codex":0.00077968475,"about_ca_topic_score_gemma":0.00306019,"teacher_disagreement_score":0.003172025,"about_ca_system_score_codex":0.000513482,"about_ca_system_score_gemma":0.0008386341,"threshold_uncertainty_score":0.010611415},"labels":[],"label_agreement":null},{"id":"W4387014395","doi":"10.1016/j.jaad.2023.07.333","title":"44102 Risankizumab Efficacy for Moderate-to-Severe Plaque Psoriasis over 256 Weeks in Patients with Prior Biologic Treatments","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Queen's University; University of British Columbia","funders":"","keywords":"Medicine; Plaque psoriasis; Psoriasis; Biologic Agents; Dermatology; Internal medicine; Disease","score_opus":0.016472015054450798,"score_gpt":0.2740454491434924,"score_spread":0.2575734340890416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387014395","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902625,0.0055987565,0.000112482165,0.00025109597,0.00010687284,0.00008382426,0.00028137778,0.000039548304,0.0032635261],"genre_scores_gemma":[0.9969399,0.0011626448,0.00015618924,0.00019627284,0.000092927476,0.000030077837,0.00034314918,0.000004806894,0.0010740325],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9997639,0.0000648214,0.000024827297,0.00003574231,0.0000528095,0.000057907924],"domain_scores_gemma":[0.9997478,0.0000719704,0.00005857952,0.000015150377,0.000024625777,0.00008170447],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050647487,0.00031875412,0.0009955562,0.00017765485,0.00020528877,0.00047366758,0.00015831647,0.00034736085,0.0021835682],"category_scores_gemma":[0.00068389135,0.00017307846,0.00089163246,0.0001673536,0.00012357108,0.00027302263,0.00012709768,0.00087160646,0.0003904179],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.31171426,0.01161126,0.13206178,0.0013670434,0.0031192612,0.0011164113,0.0002496576,0.0016577072,0.07025666,0.00039384043,0.0074318796,0.4590202],"study_design_scores_gemma":[0.059912995,0.15217267,0.759955,0.00027507104,0.0027277325,0.0024889982,0.0002061072,0.002698715,0.006843385,0.0003698777,0.012264447,0.00008502345],"about_ca_topic_score_codex":0.0007649803,"about_ca_topic_score_gemma":0.0017791274,"teacher_disagreement_score":0.0021835682,"about_ca_system_score_codex":0.00036099626,"about_ca_system_score_gemma":0.000341539,"threshold_uncertainty_score":0.007304728},"labels":[],"label_agreement":null},{"id":"W4387014407","doi":"10.1016/j.jaad.2023.07.431","title":"44118 A 3-year population-based incidence study of the burden of palmoplantar pustolosis in Canadian patients hospitalized or seen in emergency departments and hospital- or community-based outpatient clinics","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Impact; University of Calgary; McMaster University; University of Toronto","funders":"","keywords":"Medicine; Incidence (geometry); Outpatient visits; Emergency department; Emergency medicine; Outpatient clinic; Community hospital; Population; Medical emergency; Family medicine; Pediatrics; Environmental health; Health care; Nursing; Internal medicine","score_opus":0.022064892522852757,"score_gpt":0.3003822051454872,"score_spread":0.2783173126226344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387014407","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921765,0.0002063104,0.00007654393,0.000113922935,0.000009783485,0.00005298383,0.0059398813,0.000013976224,0.0014100545],"genre_scores_gemma":[0.9937364,0.00020912853,0.00016969843,0.00011044456,0.000015427107,0.000025458148,0.004906602,0.0000059085346,0.00082108745],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992378,0.00005367163,0.00004581794,0.000111051966,0.00023696554,0.00031471817],"domain_scores_gemma":[0.9989203,0.000044833327,0.00022725116,0.00003783,0.000471473,0.00029844439],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004123924,0.0006126483,0.000573239,0.0020536985,0.0029133803,0.0011862738,0.0010964067,0.0007538922,0.0030492248],"category_scores_gemma":[0.0011803394,0.000656927,0.0010292699,0.0053083566,0.00052660157,0.00049378333,0.0007551778,0.0011523354,0.00049293897],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020863848,0.00008570512,0.9967327,0.000022334758,0.00008079064,0.000098211465,0.00023063207,0.000049724276,0.00022896694,0.000035267458,0.00090217,0.001324785],"study_design_scores_gemma":[0.000014206579,0.000042065418,0.9992029,0.00000613661,0.000023001285,0.000080215636,0.00026958206,0.00008743105,0.000018002887,0.0000049348796,0.00024496386,0.000006470139],"about_ca_topic_score_codex":0.97404873,"about_ca_topic_score_gemma":0.970667,"teacher_disagreement_score":0.025951266,"about_ca_system_score_codex":0.011986946,"about_ca_system_score_gemma":0.011892106,"threshold_uncertainty_score":0.08697176},"labels":[],"label_agreement":null},{"id":"W4387014424","doi":"10.1016/j.jaad.2023.07.378","title":"44596 The Acne Education Project: An Educational Initiative to Improve Acne Health Literacy and Increase Help-seeking Behaviour in Pre-pubescent Youth","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; BC Children's Hospital; University of British Columbia","funders":"","keywords":"Medicine; Psychosocial; Acne; Intervention (counseling); Misinformation; Quality of life (healthcare); Health literacy; Family medicine; Literacy; Clinical psychology; Health care; Psychiatry; Dermatology; Psychology; Nursing","score_opus":0.022497649409952542,"score_gpt":0.3859874909944776,"score_spread":0.3634898415845251,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387014424","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91241616,0.0006149632,0.0016288199,0.007967689,0.00086465804,0.00918966,0.008996982,0.0005707382,0.05775026],"genre_scores_gemma":[0.83513767,0.0015747042,0.026425008,0.008851704,0.0005234429,0.015932282,0.012156523,0.00022343238,0.09917523],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99862814,0.0005798206,0.00004517816,0.00010364893,0.00024949052,0.00039361094],"domain_scores_gemma":[0.99515486,0.0003697321,0.00018223192,0.00013148825,0.00049849355,0.0036632675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027138484,0.00041478875,0.0004308936,0.0007314246,0.0024680453,0.0012127969,0.0013574343,0.001452147,0.025693867],"category_scores_gemma":[0.0026963083,0.00047932006,0.00046874434,0.0005630935,0.0005346439,0.00062187243,0.0025697201,0.0020964784,0.0029994908],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054310067,0.0835533,0.16900414,0.001042813,0.00017049366,0.000546075,0.0028279629,0.00044041022,0.005413715,0.0012385481,0.1023337,0.62799776],"study_design_scores_gemma":[0.008534771,0.015165701,0.87973607,0.0006179656,0.000209369,0.00027233653,0.003558061,0.0006660237,0.00334394,0.0003568487,0.08748347,0.00005551659],"about_ca_topic_score_codex":0.032208018,"about_ca_topic_score_gemma":0.054020878,"teacher_disagreement_score":0.032208018,"about_ca_system_score_codex":0.0013491142,"about_ca_system_score_gemma":0.014735943,"threshold_uncertainty_score":0.08595455},"labels":[],"label_agreement":null},{"id":"W4387014710","doi":"10.1016/j.jaad.2023.07.162","title":"42275 Dupilumab Improves Itch, Skin Pain, and Sleep in Adult Patients With Prurigo Nodularis (LIBERTY PN-PRIME and PRIME2)","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of South Florida; McGill University; Johns Hopkins University; McGill University Health Centre; Regeneron Pharmaceuticals; Sanofi","keywords":"Prurigo nodularis; Medicine; Dupilumab; Placebo; Dermatology; Trunk; Clinical trial; Randomized controlled trial; Atopic dermatitis; Surgery; Internal medicine; Pathology","score_opus":0.00450513374679407,"score_gpt":0.24629017125319802,"score_spread":0.24178503750640395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387014710","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96017385,0.023756132,0.0005443085,0.0013740807,0.00031651798,0.00023706713,0.0005876862,0.0002848647,0.012725526],"genre_scores_gemma":[0.98941106,0.0039819963,0.00089740165,0.001100432,0.00016517937,0.00008671473,0.0005589748,0.000013372073,0.003784953],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99990773,0.000022577262,0.0000052366627,0.0000140457605,0.000013658482,0.00003667655],"domain_scores_gemma":[0.9999157,0.000016591168,0.000017546477,0.0000046017126,0.000008742858,0.000036845504],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028642014,0.0003135184,0.00050430396,0.000108379776,0.00016342963,0.0002786817,0.00020093634,0.00024880446,0.0043155486],"category_scores_gemma":[0.00027355444,0.00009446838,0.00044346464,0.00010047265,0.00010970404,0.00019103526,0.00015081368,0.0006831354,0.00062750373],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.051286235,0.0046270643,0.019069243,0.0018931084,0.00077151204,0.0021600027,0.00012348266,0.0007471607,0.05003665,0.00060016726,0.025446095,0.84323925],"study_design_scores_gemma":[0.13184641,0.19626299,0.4606893,0.0010066491,0.0025766334,0.03691053,0.00048740098,0.0075617,0.03368356,0.001218545,0.12760039,0.00015586178],"about_ca_topic_score_codex":0.00070668804,"about_ca_topic_score_gemma":0.0024081785,"teacher_disagreement_score":0.0043155486,"about_ca_system_score_codex":0.00025489728,"about_ca_system_score_gemma":0.00021248906,"threshold_uncertainty_score":0.01443696},"labels":[],"label_agreement":null},{"id":"W4387014712","doi":"10.1016/j.jaad.2023.07.164","title":"41817 Dupilumab Treatment Improves Sleep Quality in Children Aged 6 Months to 5 Years with Moderate-to-Severe Atopic Dermatitis and Their Caregivers","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of South Florida; McGill University; Johns Hopkins University; McGill University Health Centre; Regeneron Pharmaceuticals; Sanofi","keywords":"Dupilumab; Medicine; Atopic dermatitis; Sleep quality; Dermatology; Quality of life (healthcare); Pediatrics; Psychiatry; Cognition; Nursing","score_opus":0.011534803325828666,"score_gpt":0.2852206160316022,"score_spread":0.2736858127057735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387014712","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972161,0.0015747754,0.000021883125,0.00011611377,0.000022796878,0.0000073273986,0.00015510764,0.000004039479,0.0008818332],"genre_scores_gemma":[0.99890316,0.0005994487,0.000054854092,0.000056366855,0.000008682688,0.0000055605933,0.00011884517,8.096115e-7,0.00025226027],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9998902,0.000029455166,0.000009595781,0.000014871056,0.000020288035,0.000035584715],"domain_scores_gemma":[0.9997683,0.000043508102,0.000077500204,0.000005672288,0.000030372563,0.00007467443],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014866119,0.00020736484,0.0003402559,0.00015481295,0.00038961446,0.00023891043,0.00013261054,0.00014557522,0.0015481403],"category_scores_gemma":[0.00085834635,0.00009977949,0.00033155666,0.00017254852,0.0000824344,0.00018859324,0.00017280951,0.00033954077,0.00012511517],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024187576,0.0005809516,0.93947953,0.00022960934,0.0002465109,0.0022234474,0.0006182068,0.00009470283,0.001541994,0.000047113474,0.002445103,0.05007412],"study_design_scores_gemma":[0.000077270706,0.0009421664,0.9944095,0.00007951648,0.00014100234,0.001790514,0.0010983835,0.00017538488,0.00020354317,0.0000286796,0.0010478594,0.0000062519866],"about_ca_topic_score_codex":0.009813384,"about_ca_topic_score_gemma":0.027526729,"teacher_disagreement_score":0.009813384,"about_ca_system_score_codex":0.00035204706,"about_ca_system_score_gemma":0.00028938122,"threshold_uncertainty_score":0.019512534},"labels":[],"label_agreement":null},{"id":"W4387014720","doi":"10.1016/j.jaad.2023.07.246","title":"41679 Lebrikizumab monotherapy improves quality of life through improvement in itch and sleep: Results from two Phase 3 trials in patients with moderate-to-severe atopic dermatitis","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Atopic dermatitis; Quality of life (healthcare); Dermatology; Sleep quality; Pharmacology; Insomnia","score_opus":0.037003118332078026,"score_gpt":0.3642989925118372,"score_spread":0.3272958741797592,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387014720","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9679565,0.025104614,0.00038222852,0.0011726924,0.000459111,0.00086930994,0.0010330058,0.00012544695,0.0028970905],"genre_scores_gemma":[0.98453426,0.009062458,0.00087645225,0.0017384209,0.00032713247,0.00056693616,0.001232212,0.000023654022,0.0016384562],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996426,0.00014019162,0.000034148143,0.000054900458,0.000042402673,0.00008561549],"domain_scores_gemma":[0.9995041,0.00016654942,0.00010343075,0.000027915981,0.000051635758,0.00014646917],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012109943,0.00096668146,0.0022545767,0.00029342793,0.00039403848,0.0009646069,0.00058594864,0.0010285699,0.0041201827],"category_scores_gemma":[0.0007754789,0.00036183937,0.002949243,0.00031671487,0.00060410134,0.0005914535,0.0002204436,0.0026109447,0.0007101927],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.69897014,0.017074704,0.007711597,0.0052462365,0.008026397,0.00036164405,0.00025466186,0.0011466207,0.02574752,0.0003267312,0.0068342434,0.22829948],"study_design_scores_gemma":[0.8185935,0.1486409,0.022767348,0.00029522623,0.0029619946,0.00038644794,0.0001267635,0.00071021763,0.0017947734,0.00024130226,0.0034284291,0.00005310675],"about_ca_topic_score_codex":0.0011517423,"about_ca_topic_score_gemma":0.0042680884,"teacher_disagreement_score":0.0041201827,"about_ca_system_score_codex":0.0007007649,"about_ca_system_score_gemma":0.0006580048,"threshold_uncertainty_score":0.013783336},"labels":[],"label_agreement":null},{"id":"W4387014730","doi":"10.1016/j.jaad.2023.07.221","title":"44094 Impact of Risankizumab on Nail Psoriasis and Enthesitis Among Psoriatic Arthritis Patients with High Nail Symptom Burden","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Medicine; Psoriatic arthritis; Psoriasis; Dermatology; Enthesitis; Dactylitis; Arthritis; Internal medicine","score_opus":0.007079896877637167,"score_gpt":0.2400602803463201,"score_spread":0.23298038346868294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387014730","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99517137,0.0021893359,0.000036062516,0.00028372777,0.000063921696,0.000012883539,0.0002193018,0.00000772849,0.0020155415],"genre_scores_gemma":[0.99899834,0.0002713337,0.000044492277,0.00012553326,0.000056626006,0.0000051498882,0.00017159215,0.0000018194451,0.00032525568],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994288,0.00018073754,0.000052508913,0.0000694286,0.00010458201,0.00016383773],"domain_scores_gemma":[0.9992238,0.00021667767,0.00021104077,0.000035425193,0.000105026775,0.00020797385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056161394,0.00021252452,0.00053949736,0.00019822085,0.00038843753,0.0007107449,0.00017108586,0.0003255612,0.0024764014],"category_scores_gemma":[0.001705488,0.00015570686,0.00093933824,0.00032129255,0.00018090542,0.00042771135,0.0003003714,0.00075349683,0.0003332743],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016884845,0.0010960638,0.8887962,0.00020737678,0.001022821,0.0003836978,0.00015035676,0.00031968046,0.0020132118,0.00010332213,0.0018621021,0.087160215],"study_design_scores_gemma":[0.0005678365,0.0032323385,0.9927932,0.000040226507,0.00064354774,0.0003457396,0.00023229986,0.00047433976,0.0001817653,0.00009269411,0.0013819137,0.000014152542],"about_ca_topic_score_codex":0.003024395,"about_ca_topic_score_gemma":0.006149406,"teacher_disagreement_score":0.003024395,"about_ca_system_score_codex":0.00037654903,"about_ca_system_score_gemma":0.00054175465,"threshold_uncertainty_score":0.00828439},"labels":[],"label_agreement":null},{"id":"W4387014775","doi":"10.1016/j.jaad.2023.07.165","title":"43251 Duration of acceptable delay until subsequent full body skin examination, given prior history of skin cancer or lesions suspicious for skin cancer","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of South Florida; McGill University; Johns Hopkins University; McGill University Health Centre; Regeneron Pharmaceuticals; Sanofi","keywords":"Medicine; Skin cancer; Physical examination; Skin lesion; Dermatology; Surgery; Cancer; Internal medicine","score_opus":0.029966447177925373,"score_gpt":0.3271185035299746,"score_spread":0.2971520563520493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387014775","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86319387,0.025710724,0.0033226316,0.00430619,0.0012450911,0.00026026746,0.0021551521,0.00018769313,0.0996183],"genre_scores_gemma":[0.98033285,0.0027993312,0.001131817,0.0007504467,0.00022007897,0.00008540279,0.0009914308,0.000026266693,0.013662382],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997911,0.000033230088,0.00001950486,0.000043909422,0.00004491685,0.00006735877],"domain_scores_gemma":[0.99946266,0.000110331704,0.00012994438,0.000017294255,0.00010120291,0.0001786243],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028189455,0.00017058058,0.00025577415,0.00027846682,0.0005177186,0.00043102546,0.00020757552,0.00032740322,0.015633937],"category_scores_gemma":[0.0015820151,0.00005796565,0.00028257587,0.00022737548,0.00006754418,0.0002312406,0.00022239854,0.0005956375,0.0017750122],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005999782,0.0023987803,0.5318178,0.0009870883,0.00025587843,0.00871068,0.0004452549,0.0011315144,0.03166964,0.0012017756,0.022538098,0.39284378],"study_design_scores_gemma":[0.00024308712,0.007649321,0.8072397,0.00091195974,0.000485702,0.028309898,0.0011725032,0.0014199343,0.007682786,0.000987754,0.14383145,0.00006590131],"about_ca_topic_score_codex":0.00281875,"about_ca_topic_score_gemma":0.0075399084,"teacher_disagreement_score":0.015633937,"about_ca_system_score_codex":0.00059672736,"about_ca_system_score_gemma":0.000942537,"threshold_uncertainty_score":0.05230075},"labels":[],"label_agreement":null},{"id":"W4387014783","doi":"10.1016/j.jaad.2023.07.240","title":"43113 Ixekizumab improves fatigue, an important patient-reported outcome in psoriasis","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Ixekizumab; Medicine; Psoriasis; Outcome (game theory); Dermatology; Psoriatic arthritis; Secukinumab","score_opus":0.03769193699997926,"score_gpt":0.31077275355054135,"score_spread":0.2730808165505621,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387014783","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9411528,0.040363062,0.00074454176,0.0013586263,0.0005974556,0.00013798353,0.0008112728,0.0002655034,0.014568776],"genre_scores_gemma":[0.99097997,0.0044389092,0.00044173546,0.0007364276,0.0003002233,0.000039515897,0.00054395106,0.000017450295,0.0025018824],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9997756,0.00006988662,0.000021320782,0.000021628795,0.00005302571,0.00005851337],"domain_scores_gemma":[0.9997943,0.000057640966,0.000056555426,0.000013311036,0.000033781125,0.00004441614],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044962266,0.00023132178,0.0007324685,0.0001680189,0.00017278742,0.00039165607,0.00015728216,0.00027896426,0.0039133364],"category_scores_gemma":[0.0006288308,0.00009969303,0.0005568468,0.000161282,0.00007968683,0.00014969474,0.00013794463,0.0007361727,0.00048656395],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.040386576,0.0056060646,0.03358962,0.0012958476,0.001628249,0.00042030268,0.000078983605,0.00073901034,0.041596007,0.00018911602,0.014347222,0.86012316],"study_design_scores_gemma":[0.029861052,0.0907629,0.7999043,0.0006916463,0.0033775338,0.0045951456,0.00026766118,0.0024583542,0.020587714,0.0007228355,0.04668723,0.000083650106],"about_ca_topic_score_codex":0.00063004135,"about_ca_topic_score_gemma":0.0012804649,"teacher_disagreement_score":0.0039133364,"about_ca_system_score_codex":0.00018700602,"about_ca_system_score_gemma":0.00018144543,"threshold_uncertainty_score":0.013091445},"labels":[],"label_agreement":null},{"id":"W4387014784","doi":"10.1016/j.jaad.2023.07.241","title":"43335 Ixekizumab reduces IL-17 and IL-23 pathway genes more rapidly than guselkumab: 4-week results from IXORA-R","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Ixekizumab; Medicine; Psoriasis; Interleukin 17; Plaque psoriasis; Interleukin 23; Blockade; Dermatology; Immunology; Internal medicine; Secukinumab; Cytokine; Psoriatic arthritis","score_opus":0.024997677638711146,"score_gpt":0.2703099281402654,"score_spread":0.24531225050155425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387014784","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99409395,0.0019376145,0.00073331094,0.0004208142,0.00029133898,0.00016281003,0.0006698027,0.0001919672,0.0014985524],"genre_scores_gemma":[0.9895335,0.0012755169,0.0012225335,0.00028005175,0.00013751679,0.00015596728,0.0015880886,0.00006498881,0.005741775],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99963915,0.000075518474,0.000023969333,0.00005346091,0.000049138274,0.00015886479],"domain_scores_gemma":[0.9998362,0.000025426287,0.000025667605,0.000030772673,0.000014070818,0.00006792769],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005038862,0.0007056369,0.0010631406,0.00023886602,0.00026160676,0.0007310281,0.00039885307,0.0007076501,0.0043847715],"category_scores_gemma":[0.0002687479,0.0002474798,0.0012314785,0.00013270896,0.00042053752,0.00045335593,0.00016936344,0.0026765931,0.0011597263],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.109562166,0.023708468,0.0016154319,0.0004530463,0.0004479226,0.00025968975,0.00014578547,0.0011445348,0.76356095,0.0003531661,0.005900549,0.09284837],"study_design_scores_gemma":[0.038386732,0.36755964,0.042599607,0.000073875024,0.0011727427,0.0012281367,0.0003340124,0.0038439222,0.525432,0.0005059691,0.018751305,0.00011219223],"about_ca_topic_score_codex":0.0011393407,"about_ca_topic_score_gemma":0.0014524057,"teacher_disagreement_score":0.0043847715,"about_ca_system_score_codex":0.00038383403,"about_ca_system_score_gemma":0.00077117124,"threshold_uncertainty_score":0.014668584},"labels":[],"label_agreement":null},{"id":"W4387014809","doi":"10.1016/j.jaad.2023.07.226","title":"41942 Improving Acne Care Recommendations From Personalising Acne: Consensus Of Experts (PACE)","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Windsor Clinical Research","funders":"Galderma","keywords":"Acne; Medicine; Pace; Skin care; Acne treatment; Dermatology; Nursing","score_opus":0.024726980004997155,"score_gpt":0.3399349232470824,"score_spread":0.31520794324208523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387014809","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.055161517,0.042232767,0.053273898,0.7062532,0.04855548,0.0047753877,0.002243882,0.00066539407,0.08683857],"genre_scores_gemma":[0.48741674,0.049920466,0.26598945,0.13821128,0.01985586,0.0051700724,0.00609381,0.00051350315,0.026828801],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.94892436,0.02427194,0.010647619,0.0028820466,0.010833769,0.0024403322],"domain_scores_gemma":[0.8358018,0.036135126,0.008307792,0.0051677492,0.09524902,0.019338619],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.07487831,0.00070488977,0.001319981,0.004111216,0.0028385809,0.004125561,0.0036614777,0.0076661212,0.009321266],"category_scores_gemma":[0.13288781,0.00070829206,0.0031065487,0.0017902282,0.0009010329,0.0033305266,0.0065494613,0.008027224,0.0029412084],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028888843,0.0006641345,0.021056289,0.004454863,0.00075514504,0.0010236843,0.0061407615,0.00083715416,0.0016815194,0.0023509804,0.43697986,0.52376664],"study_design_scores_gemma":[0.0011513479,0.00061611016,0.036227938,0.030165743,0.0017090865,0.003012282,0.01486871,0.0042285514,0.0021826706,0.011548353,0.8938016,0.00048755735],"about_ca_topic_score_codex":0.004539586,"about_ca_topic_score_gemma":0.010422768,"teacher_disagreement_score":0.07487831,"about_ca_system_score_codex":0.0031382365,"about_ca_system_score_gemma":0.021972856,"threshold_uncertainty_score":0.39599907},"labels":[],"label_agreement":null},{"id":"W4387014811","doi":"10.1016/j.jaad.2023.07.172","title":"43799 Efficacy and Safety of Upadacitinib in Moderate-to-Severe Hidradenitis Suppurativa: A Phase 2, Randomized, Placebo-Controlled Study","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; University of Calgary","funders":"","keywords":"Hidradenitis suppurativa; Medicine; Placebo; Dermatology; Randomized controlled trial; Surgery; Internal medicine; Alternative medicine; Pathology","score_opus":0.019446866892096414,"score_gpt":0.34607315814798434,"score_spread":0.32662629125588793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387014811","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97702026,0.014306279,0.00066340994,0.000500558,0.0005514567,0.00331101,0.0009820955,0.00015205785,0.0025128555],"genre_scores_gemma":[0.9881805,0.0051915315,0.0008788995,0.0009702578,0.00040099278,0.0016130616,0.00089922384,0.000019391271,0.0018461446],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9996288,0.00014999979,0.00002804569,0.0000602823,0.000042316802,0.000090608606],"domain_scores_gemma":[0.99958926,0.00011827677,0.00007408859,0.0000326986,0.00003963408,0.00014597029],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011972665,0.0012827623,0.0033502022,0.000398916,0.0004285323,0.0009544447,0.0007365054,0.0017711393,0.006096701],"category_scores_gemma":[0.00087080913,0.00061785243,0.0018450929,0.0004040774,0.00085934886,0.0009127281,0.0002833342,0.002535057,0.000895082],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9284715,0.01480817,0.00093302986,0.0019067571,0.0015624637,0.00011423268,0.000051957897,0.00042632036,0.009220713,0.00013515145,0.0016688379,0.040700857],"study_design_scores_gemma":[0.89766943,0.09618319,0.0030156462,0.00006329253,0.00067968713,0.0000940082,0.000029439125,0.00042392846,0.00079112995,0.00008935985,0.00093711657,0.000023744118],"about_ca_topic_score_codex":0.00045739897,"about_ca_topic_score_gemma":0.0012175872,"teacher_disagreement_score":0.006096701,"about_ca_system_score_codex":0.00042175315,"about_ca_system_score_gemma":0.00070753274,"threshold_uncertainty_score":0.020395458},"labels":[],"label_agreement":null},{"id":"W4387014874","doi":"10.1016/j.jaad.2023.07.231","title":"42788 Inhibition of the IL-15 receptor reduces tissue resident memory T-cells and prevents contact hypersensitivity","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health; University of British Columbia","funders":"","keywords":"Medicine; Immunology; Immune system; Inflammation; Delayed hypersensitivity; Disease; Hypersensitivity reaction; Pathology","score_opus":0.015656460090517806,"score_gpt":0.3010696403259768,"score_spread":0.285413180235459,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387014874","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959254,0.0008802368,0.00040848317,0.00015376254,0.00013707679,0.000028904353,0.00014496957,0.00008495308,0.0022361493],"genre_scores_gemma":[0.9945095,0.00043436105,0.00045600507,0.00009675937,0.000050195613,0.000048273287,0.00027439385,0.000017952601,0.0041125044],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996799,0.000053055945,0.000019817655,0.00002984397,0.00007510469,0.00014234231],"domain_scores_gemma":[0.99987674,0.000021395945,0.00001682667,0.000017122977,0.000010915896,0.000056920577],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000135535,0.00039344933,0.00065967056,0.00019877616,0.00022360602,0.00035763741,0.00042134186,0.0005271766,0.004050035],"category_scores_gemma":[0.00020342329,0.00021011055,0.0002640019,0.000110391265,0.00028255134,0.00023136611,0.00016856658,0.0015822372,0.0011044435],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023491052,0.001306143,0.00043286936,0.00008964152,0.000029207162,0.00014242479,0.000029225133,0.00031259898,0.98684156,0.0002396974,0.00062439626,0.0076031717],"study_design_scores_gemma":[0.00094998546,0.014172776,0.013385054,0.000032001815,0.0000702144,0.00080957956,0.00012845153,0.0036781842,0.96071184,0.0003073465,0.005727106,0.000027570088],"about_ca_topic_score_codex":0.0005787566,"about_ca_topic_score_gemma":0.001165863,"teacher_disagreement_score":0.004050035,"about_ca_system_score_codex":0.00020188231,"about_ca_system_score_gemma":0.00036849864,"threshold_uncertainty_score":0.013548732},"labels":[],"label_agreement":null},{"id":"W4387014992","doi":"10.1016/j.jaad.2023.07.111","title":"40660 Clinically Meaningful Improvement on the Acne Quality of Life Following Treatment with IDP- 126 Gel for Moderate-to-Severe Acne: A Post Hoc Exploratory Pooled Analysis of Phase III Trial Data","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bausch Health (Canada)","funders":"","keywords":"Acne; Medicine; Post-hoc analysis; Quality of life (healthcare); Post hoc; Confidence interval; Odds ratio; Acne treatment; Randomized controlled trial; Internal medicine; Exploratory analysis; Physical therapy; Dermatology","score_opus":0.09828262484437489,"score_gpt":0.42010651000315663,"score_spread":0.32182388515878174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387014992","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.954625,0.027496867,0.0024350712,0.0006624495,0.00095115026,0.0036683015,0.004427934,0.00034029255,0.005392895],"genre_scores_gemma":[0.9846676,0.005381049,0.0018192789,0.00063450343,0.00037049776,0.0020683415,0.0019876068,0.000042738626,0.003028275],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99792176,0.001414296,0.00013164201,0.0002093271,0.00013552254,0.0001874829],"domain_scores_gemma":[0.9985838,0.000742188,0.0003003032,0.00010470966,0.00009490887,0.00017405662],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0044406806,0.0018341036,0.005283967,0.0005600501,0.0002994427,0.0013536008,0.0006066013,0.0009872975,0.005868765],"category_scores_gemma":[0.0030034592,0.00068754604,0.0065547903,0.000668444,0.0008362198,0.0010207648,0.0005555064,0.0029909671,0.0006468216],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9584112,0.0012832052,0.0008571058,0.0030341677,0.0150108915,0.00003604208,0.0000414139,0.00082579936,0.002420262,0.000103347564,0.0009868752,0.016989578],"study_design_scores_gemma":[0.89923084,0.07402888,0.009339771,0.00021015928,0.013950589,0.000058809608,0.00005323702,0.0009848723,0.0006049258,0.00026613765,0.0012261044,0.000045691333],"about_ca_topic_score_codex":0.0008811225,"about_ca_topic_score_gemma":0.0025352838,"teacher_disagreement_score":0.005868765,"about_ca_system_score_codex":0.0006197028,"about_ca_system_score_gemma":0.00085824897,"threshold_uncertainty_score":0.023484826},"labels":[],"label_agreement":null},{"id":"W4387015031","doi":"10.1016/j.jaad.2023.07.093","title":"43758 Bimekizumab safety and tolerability in patients with moderate to severe plaque psoriasis: Analysis of pooled data from up to three years of treatment in five phase 3/3b clinical trials","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Queen's University","funders":"UCB Pharma","keywords":"Medicine; Plaque psoriasis; Tolerability; Psoriasis; Clinical trial; Pooled analysis; Safety profile; Dermatology; Adverse effect; Internal medicine; Meta-analysis","score_opus":0.07382226389681977,"score_gpt":0.3803119089144869,"score_spread":0.3064896450176671,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387015031","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8922014,0.10027427,0.0019028317,0.00035338904,0.00027825465,0.000592141,0.002310607,0.00015097312,0.0019361323],"genre_scores_gemma":[0.988974,0.0074288184,0.0005820517,0.00039385565,0.00020387046,0.00029216328,0.001707251,0.000032034848,0.0003859565],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9953027,0.0026491291,0.00046181143,0.000686987,0.00053300086,0.00036647657],"domain_scores_gemma":[0.99527174,0.0022181224,0.0014154344,0.00046258303,0.0003197895,0.00031238966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012768939,0.0016044291,0.006681499,0.0008831199,0.000420802,0.0019543078,0.0007313779,0.0013864666,0.0014916153],"category_scores_gemma":[0.0060723047,0.0007465008,0.010589826,0.0013988034,0.0006723397,0.0014055931,0.0007409913,0.0021542974,0.0002536536],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6892977,0.0013000839,0.04290993,0.006286351,0.16720629,0.00024779403,0.00024193562,0.005311469,0.00656552,0.00019268916,0.0024540399,0.077986255],"study_design_scores_gemma":[0.3049696,0.12119651,0.31766346,0.000869185,0.23770437,0.0011127568,0.00035041236,0.004648237,0.002793867,0.0010722926,0.007294196,0.00032507858],"about_ca_topic_score_codex":0.00071380043,"about_ca_topic_score_gemma":0.001509967,"teacher_disagreement_score":0.012768939,"about_ca_system_score_codex":0.00073642883,"about_ca_system_score_gemma":0.00085182127,"threshold_uncertainty_score":0.06752944},"labels":[],"label_agreement":null},{"id":"W4387015063","doi":"10.1016/j.jaad.2023.07.135","title":"42977 Demographics, Disease Characteristics and Patient Perspectives of Hidradenitis Suppuritiva","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Hidradenitis suppurativa; Medicine; Demographics; Disease; Quality of life (healthcare); Perspective (graphical); Dermatology; MEDLINE; Disease burden; Comorbidity; Psychiatry; Pathology; Demography","score_opus":0.0117551267539896,"score_gpt":0.29053576285660054,"score_spread":0.27878063610261095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387015063","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992603,0.00034764936,0.000058500325,0.00021797365,0.00002290543,0.00001329341,0.0017808961,0.000003608549,0.0049520787],"genre_scores_gemma":[0.9965988,0.00031488936,0.00009245774,0.0003171796,0.0000535355,0.000027966707,0.0010304515,0.000004557531,0.0015601338],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995382,0.0001009114,0.00006237948,0.00006255163,0.000098731936,0.00013713731],"domain_scores_gemma":[0.99862504,0.0003602834,0.0004241135,0.000041580628,0.00015067027,0.00039826543],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041188716,0.00012895817,0.00031148177,0.000735344,0.00077924796,0.00069823535,0.0001312435,0.00027797717,0.014666355],"category_scores_gemma":[0.0020502966,0.0001562068,0.000268964,0.0015395749,0.0002272071,0.0007445985,0.00043558967,0.00045713657,0.0018508354],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010816138,0.0001153206,0.994972,0.000015521715,0.00001955404,0.00037276288,0.00021882023,0.00001697495,0.00017364486,0.000057213194,0.0008024449,0.003127632],"study_design_scores_gemma":[0.000011320045,0.0001582441,0.99431485,0.000021048045,0.000017231536,0.0017058122,0.0012150608,0.00008356296,0.000055359258,0.00004293977,0.0023666467,0.000007958784],"about_ca_topic_score_codex":0.0032686032,"about_ca_topic_score_gemma":0.0038928103,"teacher_disagreement_score":0.014666355,"about_ca_system_score_codex":0.0003103426,"about_ca_system_score_gemma":0.0005344376,"threshold_uncertainty_score":0.0490638},"labels":[],"label_agreement":null},{"id":"W4387015081","doi":"10.1016/j.jaad.2023.07.149","title":"40541 Diagnostic Reliability in Teledermatology: A Systematic Review and a Meta-Analysis","year":2023,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; University of Toronto; McGill University Health Centre; McGill University; Queen's University","funders":"","keywords":"Teledermatology; Medicine; Standardization; Coronavirus disease 2019 (COVID-19); Meta-analysis; Reliability (semiconductor); Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); 2019-20 coronavirus outbreak; MEDLINE; Diagnostic accuracy; Medical physics; Telemedicine; Dermatology; Pathology; Radiology; Health care","score_opus":0.06772118965656707,"score_gpt":0.38581407421900893,"score_spread":0.3180928845624419,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387015081","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0065921764,0.9918451,0.00039773542,0.00017096895,0.0001765686,0.00014018423,0.00046974537,0.00001739261,0.00019012581],"genre_scores_gemma":[0.2873666,0.7058253,0.002321311,0.0020996253,0.00043426012,0.0005767245,0.0008212208,0.000044887922,0.0005100294],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9896857,0.004199832,0.003482954,0.0013148774,0.0009864483,0.00033010036],"domain_scores_gemma":[0.968233,0.02466302,0.004504524,0.0009290723,0.0014037868,0.00026665244],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010992976,0.002347468,0.011836456,0.0043601026,0.00070008537,0.002961284,0.0017736185,0.0027617037,0.0055084904],"category_scores_gemma":[0.044594448,0.001812707,0.025835944,0.0052965786,0.0009739079,0.002339003,0.0019260041,0.002081857,0.00061566517],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00210079,0.000041647858,0.0149076395,0.35983238,0.606532,0.00018945672,0.00017151183,0.00023936536,0.0002785006,0.00009009709,0.0008533578,0.01476321],"study_design_scores_gemma":[0.0007528375,0.00013957605,0.0076072267,0.02304001,0.9669407,0.00011953361,0.00007225879,0.000097175594,0.00007380619,0.000098683005,0.0010288729,0.000029285735],"about_ca_topic_score_codex":0.006679727,"about_ca_topic_score_gemma":0.021365,"teacher_disagreement_score":0.011836456,"about_ca_system_score_codex":0.0016581165,"about_ca_system_score_gemma":0.0028126491,"threshold_uncertainty_score":0.05813712},"labels":[],"label_agreement":null},{"id":"W4387015085","doi":"10.1016/j.jaad.2023.07.152","title":"42086 Disease Course and Risk of Relapse in Juvenile Localized Scleroderma","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; University of Alberta; University of Calgary","funders":"","keywords":"Medicine; Juvenile; Disease; Scleroderma (fungus); Pathology","score_opus":0.017032118035387137,"score_gpt":0.30138111260598355,"score_spread":0.2843489945705964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387015085","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991621,0.00019820816,0.000029233279,0.000036611327,0.0000046926225,0.000001597675,0.000049327515,0.00000436592,0.0005137805],"genre_scores_gemma":[0.999653,0.0000499819,0.000011961886,0.000011383011,0.000012616258,8.7784224e-7,0.000058986374,0.0000025262684,0.00019866483],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996891,0.00009846388,0.000022804492,0.000047279547,0.00004599053,0.00009636706],"domain_scores_gemma":[0.99841213,0.00026538153,0.00059255044,0.00007696331,0.0000829667,0.00056992134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003399218,0.00024186636,0.00035252582,0.0005455803,0.0004696988,0.0005465121,0.0002489041,0.00051563885,0.0028973154],"category_scores_gemma":[0.0014677717,0.0001949499,0.00042501566,0.00057486346,0.00022065536,0.00045252888,0.0002745405,0.000803193,0.00042670057],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00073197944,0.00010651512,0.9949706,0.000007542454,0.000043602424,0.0004627693,0.000045109216,0.00006931309,0.0007490856,0.000023929944,0.00011721638,0.0026724592],"study_design_scores_gemma":[0.00001450917,0.00018128673,0.9983985,0.0000043722634,0.000025548039,0.0009266637,0.000079745594,0.00019924242,0.00004792812,0.00002709644,0.00009102708,0.0000040524615],"about_ca_topic_score_codex":0.0022003362,"about_ca_topic_score_gemma":0.002647938,"teacher_disagreement_score":0.0028973154,"about_ca_system_score_codex":0.00023003074,"about_ca_system_score_gemma":0.0002448675,"threshold_uncertainty_score":0.00969249},"labels":[],"label_agreement":null},{"id":"W4387015096","doi":"10.1016/j.jaad.2023.07.145","title":"43887 Deucravacitinib, an Oral, Selective, Allosteric Tyrosine Kinase 2 Inhibitor, in Moderate to Severe Plaque Psoriasis: Efficacy by Baseline Demographic and Disease Characteristics in the Phase 3 POETYK PSO-1 and PSO-2 Trials","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Queen's University","funders":"","keywords":"Medicine; Plaque psoriasis; Placebo; Psoriasis; Apremilast; Internal medicine; Pharmacology; Clinical trial; Dermatology; Pathology","score_opus":0.030909819029725366,"score_gpt":0.31949963247556634,"score_spread":0.288589813445841,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387015096","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97367257,0.016954733,0.00049189274,0.0005719349,0.00016260786,0.00042667583,0.0012242936,0.0003250909,0.006170044],"genre_scores_gemma":[0.9885837,0.004665676,0.0006544787,0.00046799766,0.00009681616,0.00025004806,0.001815079,0.000027144311,0.0034390562],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99980956,0.00006556547,0.000011498009,0.000028611299,0.000033159282,0.000051762196],"domain_scores_gemma":[0.9998307,0.00003607345,0.000030474444,0.000009352829,0.000016445734,0.000076860466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006858122,0.00059672596,0.0014185342,0.00022496459,0.00022416361,0.00063281594,0.00032983467,0.00048132706,0.0031741927],"category_scores_gemma":[0.00036655844,0.00020948704,0.00076434517,0.00024328154,0.0002321968,0.00040720243,0.00016474217,0.0012652376,0.00061757106],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.34696665,0.01032137,0.014163519,0.0019299729,0.0022878486,0.00023422128,0.00016288854,0.0032674505,0.043553706,0.00072081067,0.020201866,0.55618966],"study_design_scores_gemma":[0.52888376,0.27212712,0.13617446,0.000312115,0.002150431,0.002087896,0.00020153045,0.008900234,0.01294825,0.0011570945,0.03488257,0.00017455366],"about_ca_topic_score_codex":0.00077978655,"about_ca_topic_score_gemma":0.0036688522,"teacher_disagreement_score":0.0031741927,"about_ca_system_score_codex":0.00046923364,"about_ca_system_score_gemma":0.0004896748,"threshold_uncertainty_score":0.010618687},"labels":[],"label_agreement":null},{"id":"W4387015293","doi":"10.1016/j.jaad.2023.07.015","title":"43608 Association of Biomarkers with Treatment and Disease Resolution of Chronic Spontaneous Urticaria in Children","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Urticaria and Related Conditions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Disease; Chronic urticaria; Association (psychology); Chronic disease; Dermatology; Internal medicine","score_opus":0.006274465963475309,"score_gpt":0.26147329303710354,"score_spread":0.25519882707362823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387015293","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976427,0.0012818457,0.000076354445,0.00007506151,0.000013979958,0.000005389744,0.00040240458,0.0000064873116,0.0004956763],"genre_scores_gemma":[0.9991424,0.000286168,0.00010629497,0.000020514824,0.000012427252,0.000005091236,0.00028526637,0.0000028096426,0.00013917206],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99940896,0.00016651388,0.0000664689,0.00008098153,0.00014484013,0.00013221643],"domain_scores_gemma":[0.99771345,0.00053990347,0.0012736113,0.000077040415,0.00021754953,0.00017847637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053040107,0.00029886002,0.00048551548,0.00068374735,0.00026288893,0.0006629081,0.00024894587,0.00043906877,0.0011883418],"category_scores_gemma":[0.003245837,0.00021946632,0.0005092375,0.0008443016,0.0002880924,0.0004278592,0.00023582937,0.00066102267,0.0001640609],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014233583,0.000029650893,0.9979227,0.000018904806,0.000053907195,0.00008939656,0.000028730574,0.000029900952,0.00024673465,0.000015774618,0.000086830754,0.00133503],"study_design_scores_gemma":[0.000006149149,0.000114945826,0.998946,0.000010711315,0.000028795523,0.00039481916,0.00006634567,0.000089643014,0.00013601023,0.000010174439,0.0001940911,0.0000022829117],"about_ca_topic_score_codex":0.0035916718,"about_ca_topic_score_gemma":0.0037412734,"teacher_disagreement_score":0.0035916718,"about_ca_system_score_codex":0.0004288083,"about_ca_system_score_gemma":0.00049362826,"threshold_uncertainty_score":0.00714159},"labels":[],"label_agreement":null},{"id":"W4387015554","doi":"10.1016/j.jaad.2023.07.968","title":"42174 Treatment patterns and inadequate symptom control among commercially insured patients with moderate-to-severe acne vulgaris in the US: A retrospective cohort study","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Retrospective cohort study; Acne; Cohort; Cohort study; Surgery; Dermatology; Internal medicine","score_opus":0.008347412633566451,"score_gpt":0.27443471150707277,"score_spread":0.2660872988735063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387015554","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999175,0.0001109183,0.00003072843,0.000025315045,0.0000041023477,0.0000070003916,0.00033332806,0.0000015852714,0.00031210892],"genre_scores_gemma":[0.99953616,0.000047952817,0.000019302302,0.00002963704,0.0000058788078,0.0000061330447,0.0002444445,0.0000014015837,0.00010922241],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99954396,0.00009062892,0.000052681495,0.00011404245,0.00008116644,0.0001175662],"domain_scores_gemma":[0.9990897,0.000118201424,0.0004600934,0.00008573248,0.00008404909,0.00016219422],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028759483,0.00027179808,0.00037286564,0.0008958495,0.0007345449,0.00089334225,0.00037196334,0.00058053003,0.003029253],"category_scores_gemma":[0.001210694,0.0005061253,0.00069889845,0.0018292823,0.00031564117,0.0007411149,0.00042673454,0.00071522733,0.00039823056],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000060184433,0.00004409196,0.9994031,0.0000026788982,0.000031510892,0.00007243294,0.000044893044,0.000007911777,0.00009928613,0.000007191447,0.00003965354,0.00018699655],"study_design_scores_gemma":[0.000006237244,0.000057045418,0.9992536,0.000002564537,0.000021439273,0.00021947807,0.00028176568,0.000053237785,0.00001893047,0.000007753972,0.00007499588,0.0000030194583],"about_ca_topic_score_codex":0.017738318,"about_ca_topic_score_gemma":0.01400358,"teacher_disagreement_score":0.017738318,"about_ca_system_score_codex":0.00043252695,"about_ca_system_score_gemma":0.0004433856,"threshold_uncertainty_score":0.035270154},"labels":[],"label_agreement":null},{"id":"W4387015569","doi":"10.1016/j.jaad.2023.07.941","title":"43927 The Impact of Treatment with Guselkumab on Skin-related Quality of Life in Male and Female Patients with Moderate to Severe Psoriasis: Results from the VOYAGE 1 and 2 Trials","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Medicine; Psoriasis; Quality of life (healthcare); Health related quality of life; Clinical trial; Dermatology; Internal medicine; Disease; Nursing","score_opus":0.04126863102983205,"score_gpt":0.31267627200400705,"score_spread":0.271407640974175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387015569","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9464436,0.045194168,0.00018567186,0.0017850109,0.0005924903,0.0005644936,0.0016189074,0.000049882245,0.0035656819],"genre_scores_gemma":[0.97570884,0.017564857,0.00033237538,0.001605875,0.00057406316,0.0005483373,0.001419945,0.000015731783,0.0022301013],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9993926,0.00031602517,0.000036436017,0.00007768318,0.00006223564,0.00011502014],"domain_scores_gemma":[0.9993543,0.00021522859,0.00018568292,0.00003154772,0.00003439512,0.00017881507],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013481278,0.0007782124,0.0026365332,0.00034752616,0.00038328592,0.0011599659,0.00053026003,0.0014174052,0.0045454795],"category_scores_gemma":[0.0013180765,0.00038277,0.0032308595,0.00049583055,0.0006545918,0.000746462,0.00038438843,0.0024991052,0.00052101986],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8557759,0.005372483,0.012351797,0.0031086993,0.010100957,0.00012803418,0.00010813253,0.0005301345,0.0034836074,0.00028528986,0.00389176,0.10486317],"study_design_scores_gemma":[0.79414487,0.1189023,0.07252154,0.00049647584,0.0072137266,0.00022221907,0.00015694357,0.00048623097,0.0006068672,0.00033875086,0.00484513,0.000064999054],"about_ca_topic_score_codex":0.0011982927,"about_ca_topic_score_gemma":0.0030644727,"teacher_disagreement_score":0.0045454795,"about_ca_system_score_codex":0.0005169851,"about_ca_system_score_gemma":0.0005028155,"threshold_uncertainty_score":0.015206158},"labels":[],"label_agreement":null},{"id":"W4387015585","doi":"10.1016/j.jaad.2023.07.976","title":"42077 Trifarotene in Context: Exploring the Acne Burden in Latin America","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Windsor Clinical Research","funders":"Galderma","keywords":"Medicine; Acne; Dermatology; Context (archaeology); Latin Americans; Hyperpigmentation; Population; MEDLINE; Environmental health","score_opus":0.041886389544496944,"score_gpt":0.3232070280635154,"score_spread":0.28132063851901845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387015585","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9427365,0.014737528,0.00034295738,0.0062891725,0.00007416875,0.000048083446,0.0020057298,0.000013049107,0.033752784],"genre_scores_gemma":[0.9830403,0.012800301,0.00042635514,0.0011940447,0.00008088735,0.000033528682,0.000665984,0.000011935812,0.0017468244],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998312,0.00006231985,0.000009533682,0.000016888329,0.00002908359,0.00005093189],"domain_scores_gemma":[0.99966455,0.00006404218,0.00011553787,0.000011000204,0.000110175126,0.000034616303],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046461212,0.00016467557,0.00020343628,0.0008996809,0.00034502186,0.00096982863,0.0001767357,0.00022873512,0.0032405006],"category_scores_gemma":[0.0009957321,0.00007190358,0.00024698596,0.0017640188,0.00029161267,0.000498668,0.00057279656,0.0003518875,0.00020725375],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004170657,0.00020560539,0.8746093,0.00085485616,0.00014552643,0.0009109204,0.0062188194,0.00021882408,0.0034034569,0.003718624,0.0041608065,0.105136335],"study_design_scores_gemma":[0.000022512362,0.00013206754,0.9130238,0.0011041546,0.00018875021,0.00070688204,0.028732538,0.00022003858,0.00033647462,0.00071553385,0.05480379,0.000013427523],"about_ca_topic_score_codex":0.081052646,"about_ca_topic_score_gemma":0.12176781,"teacher_disagreement_score":0.081052646,"about_ca_system_score_codex":0.0011673482,"about_ca_system_score_gemma":0.0015329571,"threshold_uncertainty_score":0.16116178},"labels":[],"label_agreement":null},{"id":"W4387015592","doi":"10.1016/j.jaad.2023.07.949","title":"44382 The Rise of Traditional Chinese Medicine Promoted by Social Media in Western Dermatology","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Mycobacterium research and diagnosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Calgary","funders":"Eli Lilly and Company","keywords":"Medicine; Modalities; Social media; Western medicine; Alternative medicine; Traditional medicine; Traditional Chinese medicine; Treatment modality; Dermatology; Social science; Surgery; Sociology","score_opus":0.03977827700634947,"score_gpt":0.3510361569435134,"score_spread":0.311257879937164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387015592","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5230875,0.13356598,0.0013818401,0.09623517,0.007360847,0.00011839636,0.0012377737,0.00014787384,0.23686461],"genre_scores_gemma":[0.9259357,0.038573477,0.00092507,0.010716362,0.0059127808,0.000031050557,0.00019298484,0.00003511905,0.017677449],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999653,0.00010286946,0.000027413429,0.000049906786,0.00011868567,0.00004808734],"domain_scores_gemma":[0.99817073,0.0007694063,0.00033727442,0.000071591465,0.00036159324,0.0002893596],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00083203503,0.00015420288,0.00019109319,0.0016023315,0.0009686633,0.002009133,0.00019292103,0.000743276,0.013279516],"category_scores_gemma":[0.0017575268,0.000105611594,0.00020346869,0.002032154,0.0010913366,0.0011294817,0.00073015224,0.00096835644,0.0006936091],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00093171943,0.00055442785,0.14936206,0.0043887454,0.00019589096,0.003164766,0.017813018,0.0001391991,0.018732369,0.058391053,0.06084219,0.68548465],"study_design_scores_gemma":[0.0000843181,0.00037538793,0.5313315,0.0012456591,0.0001615235,0.0015543438,0.009992318,0.00058958057,0.0025285182,0.0052960175,0.44678527,0.00005554282],"about_ca_topic_score_codex":0.0069661834,"about_ca_topic_score_gemma":0.011181952,"teacher_disagreement_score":0.013279516,"about_ca_system_score_codex":0.0011766567,"about_ca_system_score_gemma":0.0011244045,"threshold_uncertainty_score":0.044424474},"labels":[],"label_agreement":null},{"id":"W4387015621","doi":"10.1016/j.jaad.2023.07.947","title":"43054 The Psoriasis Study of Health Outcomes (PSoHO) in biologic-naïve and -experienced patients: A post-hoc analysis of patients receiving treatment according to US labels","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lynde Centre for Dermatology; SKiN Health","funders":"Eli Lilly and Company","keywords":"Medicine; Post-hoc analysis; Psoriasis; Post hoc; Dermatology; Physical therapy; Internal medicine","score_opus":0.1970756864090838,"score_gpt":0.4536069567703367,"score_spread":0.2565312703612529,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387015621","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963198,0.00040109083,0.00017832975,0.000061815175,0.000055656237,0.00011687602,0.0022469694,0.0000060178368,0.00061343046],"genre_scores_gemma":[0.993153,0.00022680397,0.00022110826,0.00014018822,0.00010871986,0.0002331501,0.004797732,0.000014677434,0.0011046714],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99608636,0.0028159972,0.0001939649,0.0003224827,0.00020408754,0.00037708774],"domain_scores_gemma":[0.9950295,0.002951521,0.0006677359,0.00050497166,0.00024195071,0.0006043397],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033834085,0.0006273985,0.0019774279,0.0006760812,0.0004381715,0.0008765086,0.0006847529,0.0006685204,0.006595474],"category_scores_gemma":[0.0058840243,0.00034542193,0.0037110164,0.001025977,0.00038428293,0.00081095705,0.000860105,0.0017797042,0.00042133607],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.36355072,0.0022805845,0.5991421,0.00042238625,0.01695692,0.00039940872,0.0002397856,0.0010618971,0.0014444857,0.00032469406,0.0042134747,0.009963631],"study_design_scores_gemma":[0.023790393,0.017379565,0.9457428,0.000076782955,0.0065043657,0.00025316142,0.00050574203,0.0021563084,0.00045481487,0.00027409825,0.0028044258,0.000057609548],"about_ca_topic_score_codex":0.0036606323,"about_ca_topic_score_gemma":0.0055533494,"teacher_disagreement_score":0.006595474,"about_ca_system_score_codex":0.00040107,"about_ca_system_score_gemma":0.000878789,"threshold_uncertainty_score":0.02206403},"labels":[],"label_agreement":null},{"id":"W4387015632","doi":"10.1016/j.jaad.2023.07.932","title":"43740 The Effect of Systemic Treatment on Different Anatomical Regions in Pediatric Patients with Atopic Dermatitis: Real-World Data from PEDISTAD","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Université de Montréal; Alberta Children's Hospital; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Atopic dermatitis; Dupilumab; Dermatology; Clinical trial; Disease; Severity of illness; Internal medicine","score_opus":0.021092474431362904,"score_gpt":0.31634478364737506,"score_spread":0.29525230921601214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387015632","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995771,0.00041348403,0.000076735785,0.00003067285,0.0000028376203,0.000010840263,0.002973849,0.0000045349025,0.00071597204],"genre_scores_gemma":[0.99626523,0.0003162222,0.00017475076,0.000033075466,0.0000062539425,0.000017930724,0.0030564105,0.0000040263394,0.00012597286],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99934226,0.00025504932,0.00009546798,0.00011985176,0.000107216816,0.00008022988],"domain_scores_gemma":[0.9974366,0.00097453897,0.0010494251,0.00014204456,0.00021394892,0.00018351541],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005396638,0.00021212993,0.00035682623,0.00062387245,0.000276464,0.0005655468,0.00020467897,0.00035923062,0.0024669536],"category_scores_gemma":[0.0022021416,0.00013291552,0.0007508658,0.0011606612,0.0002671311,0.0003668717,0.00032979788,0.00032487413,0.0004032981],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010328718,0.00013779235,0.9903937,0.00008711931,0.00018339361,0.0002936592,0.00013912734,0.0002564188,0.00022757608,0.000023878545,0.0004922915,0.0067322254],"study_design_scores_gemma":[0.000055229244,0.00038471122,0.9969682,0.00002865944,0.000113839946,0.00075715495,0.00041032067,0.0002694274,0.00017554645,0.00001692751,0.0008117093,0.0000082776305],"about_ca_topic_score_codex":0.007188981,"about_ca_topic_score_gemma":0.008736501,"teacher_disagreement_score":0.007188981,"about_ca_system_score_codex":0.00050234364,"about_ca_system_score_gemma":0.00031662674,"threshold_uncertainty_score":0.014294267},"labels":[],"label_agreement":null},{"id":"W4387015641","doi":"10.1016/j.jaad.2023.07.862","title":"43755 Rapid Reduction and Strict Complete Response in Itch With Oral Difelikefalin in Subjects With Notalgia Paresthetica and Moderate-to-Severe Pruritus","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"","keywords":"Medicine; Dermatology; Agonist; Neuropathic pain; Reduction (mathematics); Anesthesia; Receptor; Internal medicine","score_opus":0.018828266251238467,"score_gpt":0.29194341870911394,"score_spread":0.2731151524578755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387015641","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940843,0.0016553011,0.00041652456,0.00012687664,0.000058006033,0.00015470533,0.00017791962,0.000059570775,0.0032668815],"genre_scores_gemma":[0.9989749,0.00020633153,0.00019364245,0.000062517574,0.00002260547,0.000018624376,0.00011016403,0.0000032949586,0.00040784507],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99971956,0.000087814275,0.000028538447,0.000031900458,0.00006726216,0.000065056454],"domain_scores_gemma":[0.99972314,0.00009518775,0.000061594845,0.000016211196,0.000024498842,0.000079321995],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045798466,0.00042913383,0.00069133326,0.00029751193,0.00022165889,0.00019660905,0.00016360193,0.0003530712,0.0017254609],"category_scores_gemma":[0.0009461399,0.00013124425,0.0003142929,0.00023643747,0.00013202775,0.00020751951,0.00015486154,0.00047436182,0.00029292985],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11693582,0.004450274,0.388578,0.0009790332,0.00055632374,0.012806134,0.00042347226,0.0007202269,0.14136937,0.00020715095,0.003717813,0.32925642],"study_design_scores_gemma":[0.002205931,0.024799703,0.95674914,0.000035840123,0.00010969442,0.0070778774,0.00013223107,0.00093685644,0.0059703733,0.00004319295,0.0019187232,0.000020519714],"about_ca_topic_score_codex":0.0011036688,"about_ca_topic_score_gemma":0.0023753615,"teacher_disagreement_score":0.0017254609,"about_ca_system_score_codex":0.00025741107,"about_ca_system_score_gemma":0.000141422,"threshold_uncertainty_score":0.005772233},"labels":[],"label_agreement":null},{"id":"W4387015668","doi":"10.1016/j.jaad.2023.07.837","title":"43359 Post hoc Analysis of Long-term Efficacy of Brodalumab in Early vs Late Responders With Psoriasis","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bausch Health (Canada)","funders":"","keywords":"Medicine; Post-hoc analysis; Psoriasis; Post hoc; Ixekizumab; Dermatology; Internal medicine; Pharmacology; Secukinumab","score_opus":0.015075996549449753,"score_gpt":0.27917989123261255,"score_spread":0.2641038946831628,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387015668","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931444,0.0015551947,0.0009130524,0.00021631466,0.0009848819,0.00024606538,0.0010488469,0.00005795998,0.0018332957],"genre_scores_gemma":[0.99080175,0.00038585457,0.00083735574,0.00032766265,0.00035202937,0.00056324626,0.0008495778,0.000052916574,0.0058297236],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99430865,0.002891556,0.00032046877,0.00097299746,0.00038375997,0.001122473],"domain_scores_gemma":[0.9931056,0.004963084,0.00040692065,0.0006317744,0.00037939326,0.0005132192],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006790842,0.0014475826,0.0074984203,0.000473083,0.00045809714,0.001829845,0.0012416756,0.0016377354,0.009053544],"category_scores_gemma":[0.006806155,0.0005865937,0.0062971488,0.00050241046,0.00069058524,0.0016244334,0.0007749744,0.003947448,0.0008920468],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.96343815,0.0018434917,0.009182706,0.0004496508,0.006985887,0.00018790698,0.00011035721,0.0008947548,0.005332952,0.0001650953,0.0013083358,0.010100597],"study_design_scores_gemma":[0.14705211,0.47636285,0.2784107,0.00035865125,0.043875765,0.0005466891,0.0008884021,0.027255988,0.011460955,0.0014679795,0.0119616985,0.00035817083],"about_ca_topic_score_codex":0.0012534771,"about_ca_topic_score_gemma":0.0016161304,"teacher_disagreement_score":0.009053544,"about_ca_system_score_codex":0.00080141093,"about_ca_system_score_gemma":0.0014141451,"threshold_uncertainty_score":0.035913885},"labels":[],"label_agreement":null},{"id":"W4387015676","doi":"10.1016/j.jaad.2023.07.918","title":"41141 Teledermatology: Lessons learned and future directions - experience from Canada (Quebec) and Australia","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatological diseases and infestations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre; McGill University","funders":"","keywords":"Teledermatology; Indigenous; Medicine; Healthcare delivery; Health care; Healthcare system; Telemedicine; MEDLINE; Economic growth","score_opus":0.04550449860686955,"score_gpt":0.36123971617156025,"score_spread":0.3157352175646907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387015676","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86203676,0.01653041,0.0010023793,0.02759605,0.00071946834,0.00036555633,0.0007653761,0.00007394459,0.09091018],"genre_scores_gemma":[0.9052803,0.013395496,0.0023891854,0.004912314,0.00014987978,0.00007510814,0.0005636144,0.000052524316,0.07318146],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986345,0.0002927191,0.000038229555,0.000064776585,0.00042149058,0.00054825563],"domain_scores_gemma":[0.9952825,0.00027821402,0.00012719307,0.000043601412,0.0015153313,0.0027531094],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017580631,0.00036629732,0.00024034362,0.0004566788,0.0038828128,0.0023017337,0.00082894677,0.0010256501,0.016260153],"category_scores_gemma":[0.0018879798,0.00020037843,0.00025872595,0.0011675885,0.0011569445,0.0006990207,0.0013725184,0.0010471427,0.0009882799],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009285848,0.0025484832,0.42620304,0.0010520031,0.000095562515,0.011313248,0.031417776,0.0012232842,0.0062483265,0.0034132733,0.0695087,0.44604772],"study_design_scores_gemma":[0.00017255741,0.0014790857,0.72046816,0.0010814078,0.00007828516,0.0031247793,0.08520151,0.0009555904,0.000883801,0.00027896202,0.1861597,0.00011621761],"about_ca_topic_score_codex":0.9501223,"about_ca_topic_score_gemma":0.9883492,"teacher_disagreement_score":0.049877703,"about_ca_system_score_codex":0.021970324,"about_ca_system_score_gemma":0.064863384,"threshold_uncertainty_score":0.1594066},"labels":[],"label_agreement":null},{"id":"W4387015733","doi":"10.1016/j.jaad.2023.07.768","title":"41437 M89PF mitigates topical retinoid skin irritation and is an adjunct in anti-aging treatment","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Skin Protection and Aging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Windsor Clinical Research; Western University","funders":"","keywords":"Medicine; Adjunct; Retinoid; Irritation; Dermatology; Skin irritation; Immunology; Retinoic acid","score_opus":0.028978677588847472,"score_gpt":0.3426793222418117,"score_spread":0.3137006446529642,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387015733","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88319975,0.033476442,0.0035348898,0.003967521,0.0018551255,0.0006604591,0.0013716271,0.0011997815,0.07073442],"genre_scores_gemma":[0.9507525,0.015755177,0.004355837,0.0013044756,0.0004673264,0.00017950477,0.0009941565,0.000077575496,0.026113415],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99986243,0.000029749184,0.0000070673514,0.000014464868,0.00004543422,0.000040885086],"domain_scores_gemma":[0.9999243,0.000009811267,0.000016483375,0.000006713323,0.000015347587,0.000027287826],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018309211,0.00032893184,0.00045970757,0.00043416713,0.00024111413,0.00029701513,0.00031771077,0.00062650815,0.014040057],"category_scores_gemma":[0.00019851346,0.0001384673,0.00041243643,0.0001919383,0.00014755539,0.0002731596,0.00019914136,0.0012313864,0.0024176869],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01789844,0.009634295,0.0011081601,0.0011283739,0.00020143378,0.0007188349,0.000075197495,0.0004183565,0.45278805,0.0014737162,0.023709638,0.49084547],"study_design_scores_gemma":[0.016293801,0.12878495,0.084171124,0.001175649,0.0010308002,0.0075313826,0.0005274474,0.0050454815,0.4223489,0.0019475638,0.3309954,0.00014753419],"about_ca_topic_score_codex":0.0010443343,"about_ca_topic_score_gemma":0.0019358257,"teacher_disagreement_score":0.014040057,"about_ca_system_score_codex":0.0001390704,"about_ca_system_score_gemma":0.00042631858,"threshold_uncertainty_score":0.04696864},"labels":[],"label_agreement":null},{"id":"W4387015750","doi":"10.1016/j.jaad.2023.07.739","title":"42664 Itching in patients with moderate to severe plaque psoriasis: The relationship between improvements in Psoriasis Area and Severity Index and patient-reported symptoms in the BE RADIANT phase 3b trial","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Itching; Psoriasis; Dermatology; Dermatology Life Quality Index; Psoriasis Area and Severity Index; Severity of illness; Clinical trial; Internal medicine","score_opus":0.028238009921756554,"score_gpt":0.28616639389567144,"score_spread":0.2579283839739149,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387015750","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97213566,0.017569715,0.0003642771,0.0015030052,0.00053676666,0.00053964095,0.0010995256,0.00018384696,0.0060676713],"genre_scores_gemma":[0.9840268,0.007162159,0.00044186178,0.0017975013,0.0004414448,0.00039113982,0.0011476997,0.000029412073,0.004561948],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9995807,0.00023190153,0.000016601007,0.000042943026,0.000048315862,0.000079668884],"domain_scores_gemma":[0.9995652,0.00012718233,0.00010714812,0.000026977074,0.000033084285,0.00014043285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00112185,0.0010246197,0.002253651,0.00027480474,0.0003209922,0.00088105944,0.0003970747,0.0011887646,0.0054186266],"category_scores_gemma":[0.000954136,0.00043491417,0.0015360357,0.00047499847,0.0003930516,0.00056404964,0.00026704324,0.0027480246,0.0008207619],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.889715,0.005663125,0.006783544,0.0014996659,0.0039992635,0.00014029253,0.00008640748,0.0011846235,0.007971478,0.00041605972,0.0061409264,0.07639962],"study_design_scores_gemma":[0.803037,0.12515856,0.060088843,0.00020562054,0.0023006601,0.00028376325,0.00010171183,0.0012859977,0.00075237843,0.0007661681,0.005957621,0.0000616309],"about_ca_topic_score_codex":0.00080383354,"about_ca_topic_score_gemma":0.001985099,"teacher_disagreement_score":0.0054186266,"about_ca_system_score_codex":0.00029913313,"about_ca_system_score_gemma":0.00042611893,"threshold_uncertainty_score":0.018127143},"labels":[],"label_agreement":null},{"id":"W4387015801","doi":"10.1016/j.jaad.2023.07.521","title":"44505 Bowel-associated dermatosis-arthritis syndrome masquerading as viral rash: Recognizing a rare cutaneous manifestation of inflammatory bowel disease","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Autoimmune Bullous Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; University of Ottawa","funders":"","keywords":"Medicine; Inflammatory bowel disease; Rash; Dermatology; Infliximab; Context (archaeology); Malaise; Diarrhea; Immunosuppression; Pyoderma gangrenosum; Ulcerative colitis; Arthritis; Abdominal pain; Disease; Immunology; Gastroenterology; Pathology","score_opus":0.010999698754226836,"score_gpt":0.2765089331350487,"score_spread":0.26550923438082186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387015801","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9625902,0.0037029665,0.0030648122,0.001822743,0.00048626534,0.0001251958,0.0001260381,0.00009368545,0.027988028],"genre_scores_gemma":[0.9960586,0.0005779987,0.0012200152,0.0004891378,0.00040306294,0.000012312747,0.00005665576,0.000009484856,0.0011726742],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9994174,0.00009419831,0.00007937256,0.00008989082,0.00008819725,0.00023095925],"domain_scores_gemma":[0.99941695,0.00015289072,0.000113023685,0.00003823416,0.00006363903,0.00021527495],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032158612,0.0009463144,0.0005536289,0.0015410542,0.0008542064,0.0011721004,0.00058671087,0.0024460661,0.003954789],"category_scores_gemma":[0.0015816732,0.00035869697,0.00046867595,0.0005643457,0.0006888303,0.0011791089,0.00077006314,0.0013235076,0.0011923693],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009152553,0.00007660587,0.044869922,0.000058830108,0.000014126431,0.9438154,0.00009799544,0.00008239934,0.005167158,0.0005654974,0.0009718737,0.004188706],"study_design_scores_gemma":[0.000023580096,0.00014208864,0.025162887,0.000042987067,0.00003169054,0.97049946,0.0002099191,0.00093640434,0.0010800388,0.0002448709,0.0016153182,0.000010723404],"about_ca_topic_score_codex":0.001192727,"about_ca_topic_score_gemma":0.0016976198,"teacher_disagreement_score":0.003954789,"about_ca_system_score_codex":0.00037427273,"about_ca_system_score_gemma":0.00042300398,"threshold_uncertainty_score":0.013230145},"labels":[],"label_agreement":null},{"id":"W4387015828","doi":"10.1016/j.jaad.2023.07.748","title":"44409 Laser Applications for Wound Healing and Scar Revision Post-Mohs Micrographic Surgery: A Systematic Review","year":2023,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Dermatologic Treatments and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; University of British Columbia; McGill University","funders":"","keywords":"Medicine; Mohs surgery; Surgery; Wound healing","score_opus":0.07715975661214569,"score_gpt":0.43402848394342564,"score_spread":0.35686872733127994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387015828","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011103158,0.9981072,0.00006539743,0.00008210306,0.00008149894,0.00014766844,0.00021813367,0.00000666805,0.00018105833],"genre_scores_gemma":[0.012901513,0.98582155,0.00026896462,0.0005189427,0.000061914034,0.00013722795,0.000111730566,0.0000047101776,0.00017337066],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99756396,0.00064232585,0.0009895826,0.00025664663,0.00041160712,0.0001359602],"domain_scores_gemma":[0.99373627,0.0037217191,0.0018576176,0.000091194175,0.00047449794,0.0001187739],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028134647,0.0013465906,0.007365495,0.005202708,0.0005603026,0.0021940188,0.0014578382,0.001978016,0.010151942],"category_scores_gemma":[0.01051661,0.00091536384,0.009212525,0.005353608,0.0007772012,0.001652122,0.0014479148,0.0014436336,0.00061309984],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006077538,0.000038121318,0.0007259256,0.949453,0.019323556,0.00009762817,0.00011718477,0.00005646412,0.0002421527,0.00007999785,0.0014968704,0.027761338],"study_design_scores_gemma":[0.0020831113,0.00069155387,0.008502863,0.6338571,0.33232468,0.00056450407,0.0003886748,0.00011462396,0.00025629037,0.00022399325,0.020911956,0.00008068441],"about_ca_topic_score_codex":0.008211324,"about_ca_topic_score_gemma":0.035541914,"teacher_disagreement_score":0.010151942,"about_ca_system_score_codex":0.0019074596,"about_ca_system_score_gemma":0.004392272,"threshold_uncertainty_score":0.033961654},"labels":[],"label_agreement":null},{"id":"W4387015843","doi":"10.1016/j.jaad.2023.07.608","title":"44441 Dupilumab-Induced Sweet Syndrome","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Autoimmune and Inflammatory Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Griffith University; University of Leeds; University of Oxford; Janssen Scientific Affairs; Ottawa Hospital Research Institute; McGill University; University of Ottawa; Leeds Biomedical Research Centre; University of Washington","keywords":"Medicine; Rash; Dermatology; Dupilumab; Prednisone; Adverse effect; Erythema; Angioedema; Dysgeusia; Edema; Surgery; Atopic dermatitis; Internal medicine","score_opus":0.02184445532877338,"score_gpt":0.31358753512971316,"score_spread":0.2917430798009398,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387015843","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94352317,0.0048055835,0.0013948103,0.0030859122,0.00042134267,0.0001395099,0.00035083707,0.000181775,0.046097003],"genre_scores_gemma":[0.99459547,0.0007302444,0.000417285,0.00115522,0.00010672952,0.000011769143,0.00015333506,0.000010912949,0.0028189716],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9997899,0.000040770956,0.000020977044,0.000028871482,0.00003843139,0.00008107453],"domain_scores_gemma":[0.99975914,0.00008141038,0.000037199312,0.000019196777,0.00002827549,0.0000748677],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025010112,0.0006878528,0.00038976953,0.0007555698,0.000645068,0.0005455124,0.00035154732,0.0009260817,0.0037742534],"category_scores_gemma":[0.00073824805,0.00016624284,0.00056432444,0.00045425983,0.0003680093,0.00051116385,0.00037155027,0.00095214363,0.00074502826],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001203557,0.00028520593,0.029785227,0.00022470472,0.00016808146,0.89220256,0.00017943578,0.00030546507,0.02044822,0.0033182723,0.005168783,0.04671053],"study_design_scores_gemma":[0.00018437847,0.0005629946,0.04574577,0.000088838184,0.00017098665,0.9387265,0.00016406282,0.001484613,0.003777263,0.0010962927,0.007968524,0.000029824852],"about_ca_topic_score_codex":0.0009728539,"about_ca_topic_score_gemma":0.0011832026,"teacher_disagreement_score":0.0037742534,"about_ca_system_score_codex":0.0006360733,"about_ca_system_score_gemma":0.00040927122,"threshold_uncertainty_score":0.012626171},"labels":[],"label_agreement":null},{"id":"W4387015860","doi":"10.1016/j.jaad.2023.07.727","title":"44180 Influence of Baseline Disease Severity Defined by Investigator’s Global Assessment on Abrocitinib Efficacy for up to 96 Weeks in Patients With Moderate-to-Severe Atopic Dermatitis: Interim Analysis of JADE EXTEND, a Long-Term Extension Study","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"","keywords":"Medicine; JADE (particle detector); Atopic dermatitis; Internal medicine; Eczema Area and Severity Index; Placebo; Severity of illness; Gastroenterology; Clinical endpoint; Clinical trial; Dermatology","score_opus":0.036844753595638616,"score_gpt":0.4020369379760233,"score_spread":0.3651921843803847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387015860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926483,0.0038004762,0.00044448258,0.000120455355,0.000118563905,0.00019872178,0.001132674,0.000047580925,0.001488777],"genre_scores_gemma":[0.99639064,0.00047533948,0.00037296396,0.0001485538,0.0001066408,0.00017220023,0.0013511686,0.000012043379,0.0009704697],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.997821,0.001107372,0.00018078074,0.00026830626,0.0002878163,0.0003346582],"domain_scores_gemma":[0.9978771,0.0008090052,0.00047950877,0.00040305668,0.00017364007,0.0002576961],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005616251,0.00097100093,0.0026982364,0.00037634664,0.00040982326,0.0013544474,0.00056885177,0.00077519333,0.0026786458],"category_scores_gemma":[0.003101119,0.00037957844,0.004978737,0.00041721572,0.00046228443,0.001086672,0.00046587564,0.0022920705,0.00054040446],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7990137,0.0052257013,0.089446686,0.00068666606,0.014798537,0.0001704853,0.00017585751,0.0027468423,0.010199293,0.00018499758,0.0018822019,0.07546921],"study_design_scores_gemma":[0.1378374,0.24260934,0.5839658,0.00014702891,0.020260805,0.00039881127,0.0002061767,0.00349992,0.0057811914,0.00051796646,0.0046325917,0.00014289918],"about_ca_topic_score_codex":0.00042797686,"about_ca_topic_score_gemma":0.0010469601,"teacher_disagreement_score":0.005616251,"about_ca_system_score_codex":0.00043417915,"about_ca_system_score_gemma":0.0006532796,"threshold_uncertainty_score":0.029701889},"labels":[],"label_agreement":null},{"id":"W4387015862","doi":"10.1016/j.jaad.2023.07.764","title":"42276 Long-Term Safety of Ixekizumab Treatment in Adult Patients with Psoriasis, Psoriatic Arthritis, or Axial Spondyloarthritis: A Post-hoc Analysis of End-Of-Study Program Data Relating to Major Adverse Cardiovascular Events","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Memorial University of Newfoundland","funders":"","keywords":"Ixekizumab; Medicine; Psoriatic arthritis; Psoriasis; Mace; Adverse effect; Dermatology; Arthritis; Axial spondyloarthritis; Secukinumab; Enthesitis; Post-hoc analysis; Internal medicine; Sacroiliitis","score_opus":0.01717214329732582,"score_gpt":0.2868384428223365,"score_spread":0.2696662995250107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387015862","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980014,0.0007101958,0.00020325564,0.00005407225,0.00003688321,0.0000578818,0.00044523456,0.000012597119,0.00047853214],"genre_scores_gemma":[0.9982809,0.00016884951,0.00013346567,0.000068293426,0.00006632476,0.000051729206,0.0006862549,0.000005614732,0.00053860317],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99758244,0.0014172426,0.00014278508,0.00032830093,0.0002519632,0.00027718412],"domain_scores_gemma":[0.9975084,0.001203096,0.00043046824,0.0002877508,0.00023203822,0.0003382506],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041531385,0.0006342222,0.0021096908,0.00028734404,0.00030553268,0.0010309279,0.00048093908,0.0006143024,0.0022729977],"category_scores_gemma":[0.0027058867,0.00034410294,0.0029967015,0.0003382223,0.0004189602,0.0007152655,0.00042251614,0.0015191966,0.00036970736],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8532236,0.0025755526,0.10321635,0.00026207598,0.0084726615,0.00016097879,0.000085265405,0.0013899908,0.005627155,0.000085509615,0.00071843516,0.024182469],"study_design_scores_gemma":[0.107208945,0.22232655,0.6443379,0.000082466926,0.010632832,0.00044378522,0.00024798213,0.007097815,0.00468812,0.000308696,0.0025297445,0.00009525438],"about_ca_topic_score_codex":0.0006004657,"about_ca_topic_score_gemma":0.0009502473,"teacher_disagreement_score":0.0041531385,"about_ca_system_score_codex":0.00036997016,"about_ca_system_score_gemma":0.0008129641,"threshold_uncertainty_score":0.021964133},"labels":[],"label_agreement":null},{"id":"W4387015875","doi":"10.1016/j.jaad.2023.07.491","title":"42163 Apremilast in Pediatric Patients With Moderate to Severe Plaque Psoriasis: 16-Week Efficacy and Safety Results From the Phase 3, Randomized, Double-Blind, Placebo-Controlled SPROUT Study","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Stollery Children's Hospital; University of Alberta","funders":"","keywords":"Medicine; Apremilast; Psoriasis; Plaque psoriasis; Dermatology; Placebo; Randomized controlled trial; Internal medicine; Psoriatic arthritis; Alternative medicine; Pathology","score_opus":0.02033938590694062,"score_gpt":0.27960522576656005,"score_spread":0.25926583985961943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387015875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99073267,0.0058328486,0.0005241027,0.0002954592,0.00015270342,0.0008244919,0.00054573163,0.00017005204,0.00092195114],"genre_scores_gemma":[0.98594683,0.0065440903,0.0018924047,0.0008714181,0.00034466718,0.0012759463,0.0009106797,0.00005660735,0.0021575086],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9995958,0.00020589957,0.000027291639,0.00006222519,0.000052812862,0.000056025514],"domain_scores_gemma":[0.9994259,0.00015379672,0.00015428134,0.000043203156,0.00003905619,0.00018378271],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012774566,0.0012424464,0.0030381023,0.00028097205,0.00029895065,0.0006420332,0.0006235847,0.0012798626,0.0029014398],"category_scores_gemma":[0.00079728966,0.0005705549,0.0013398419,0.00027576246,0.0006805721,0.00071642315,0.00025939234,0.0024305799,0.00065642444],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8476206,0.023497252,0.0026777533,0.0018359332,0.0016742328,0.00036016223,0.00017394994,0.0009916102,0.029765928,0.00019497082,0.0023474153,0.08886026],"study_design_scores_gemma":[0.79975075,0.18797153,0.008070415,0.00005914061,0.0004435341,0.00028382326,0.000043180764,0.0004860881,0.0018428054,0.000091186426,0.00093613454,0.000021441936],"about_ca_topic_score_codex":0.00050284644,"about_ca_topic_score_gemma":0.0011794447,"teacher_disagreement_score":0.0030381023,"about_ca_system_score_codex":0.00029775428,"about_ca_system_score_gemma":0.0008220878,"threshold_uncertainty_score":0.009706259},"labels":[],"label_agreement":null},{"id":"W4387015888","doi":"10.1016/j.jaad.2023.07.509","title":"42592 Baseline Characteristics and Interim Month 12 mNAPSI Results in Patients with Moderate-to- Severe Plaque Psoriasis and Concomitant Nail Psoriasis Treated with Biologics in the Psoriasis Study of Health Outcomes (PSoHO)","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dermatrials Research","funders":"","keywords":"Medicine; Psoriasis; Plaque psoriasis; Concomitant; Interim; Nail (fastener); Dermatology; Prospective cohort study; Interim analysis; Cohort; Cohort study; Surgery; Internal medicine; Clinical trial","score_opus":0.025710493637592674,"score_gpt":0.3108639992056764,"score_spread":0.2851535055680837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387015888","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932473,0.00047133496,0.00007137081,0.00004008139,0.000019547679,0.000021595788,0.004746099,0.0000065134786,0.001376089],"genre_scores_gemma":[0.9927779,0.00017248245,0.00009052404,0.00010249817,0.000036799713,0.000052898373,0.0055627306,0.000004750477,0.0011993431],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99970275,0.000061856896,0.000035904035,0.00008759433,0.000045563807,0.00006633808],"domain_scores_gemma":[0.9995745,0.0000746935,0.0001913131,0.000031941243,0.000034424786,0.00009311949],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035990728,0.0002523462,0.00056849816,0.0004768394,0.00031955072,0.0005052545,0.00025628117,0.0004070656,0.004077559],"category_scores_gemma":[0.0007187137,0.00028172342,0.0005110538,0.0011175158,0.00013766145,0.00052305,0.00025509443,0.00064360036,0.00077044405],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037114248,0.00024229207,0.9901434,0.00004783232,0.0003963658,0.00008959857,0.000044009554,0.000079420985,0.00049356214,0.00004158523,0.0010016242,0.0037087887],"study_design_scores_gemma":[0.00023604558,0.00040911115,0.9982303,0.000009824592,0.00012655229,0.00012635067,0.00006428428,0.00012030038,0.000037819154,0.000026629434,0.0006060724,0.0000067717415],"about_ca_topic_score_codex":0.0030499436,"about_ca_topic_score_gemma":0.004474703,"teacher_disagreement_score":0.004077559,"about_ca_system_score_codex":0.00022555223,"about_ca_system_score_gemma":0.00020585778,"threshold_uncertainty_score":0.013640761},"labels":[],"label_agreement":null},{"id":"W4387015914","doi":"10.1016/j.jaad.2023.07.786","title":"42686 Mycobacterium haemophilum infection with cutaneous involvement: an updated review of literature","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Mycobacterium research and diagnosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Dermatology; Mycobacterium Infections; Mycobacterium; Pathology; Tuberculosis","score_opus":0.019638887214808252,"score_gpt":0.3290467635067071,"score_spread":0.3094078762918988,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387015914","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019962362,0.9962419,0.00007163216,0.00045818576,0.00041220302,0.000008150198,0.000074773125,0.0000063734205,0.00073049153],"genre_scores_gemma":[0.010355279,0.98697335,0.00024567364,0.0010009609,0.0010449388,0.000008303869,0.00013739339,0.0000031105913,0.00023096429],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99931407,0.000104656705,0.00027627934,0.00010955948,0.00015012125,0.000045347762],"domain_scores_gemma":[0.99817026,0.00084854156,0.0005954588,0.000037723046,0.00026359168,0.00008444442],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006685746,0.00068630127,0.0014948373,0.006689593,0.00038539272,0.001533122,0.00069974386,0.0012015713,0.0027418283],"category_scores_gemma":[0.0021292707,0.00042060128,0.0007187223,0.005049976,0.0006253145,0.0024616004,0.0007281139,0.00078916515,0.0007183443],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000523767,0.00020681277,0.031612795,0.118413106,0.0012687886,0.0555202,0.0007272142,0.00032831548,0.005173279,0.0014110544,0.07719989,0.70761484],"study_design_scores_gemma":[0.0001320389,0.00029919643,0.06825745,0.064853214,0.0052601555,0.29471752,0.0018097586,0.00033576222,0.0009872009,0.0011991117,0.5619714,0.00017720835],"about_ca_topic_score_codex":0.0012940334,"about_ca_topic_score_gemma":0.0029750129,"teacher_disagreement_score":0.006689593,"about_ca_system_score_codex":0.00044840065,"about_ca_system_score_gemma":0.0013851475,"threshold_uncertainty_score":0.009172261},"labels":[],"label_agreement":null},{"id":"W4387015936","doi":"10.1016/j.jaad.2023.07.631","title":"43049 Efficacy and Safety of Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: Subgroup Analysis of the Measure Up 1, Measure Up 2, and AD Up Phase 3 Clinical Trials at 52 Weeks","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Atopic dermatitis; Measure (data warehouse); Subgroup analysis; Dermatology; Pediatrics; Internal medicine; Meta-analysis","score_opus":0.045210549882137095,"score_gpt":0.37525129593626655,"score_spread":0.3300407460541295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387015936","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95544803,0.038114134,0.00055282656,0.00052138575,0.00035698732,0.0009136409,0.0018129036,0.00006845719,0.0022116965],"genre_scores_gemma":[0.9914819,0.0048167864,0.0003133123,0.00044415172,0.0002013888,0.00052900787,0.0012148386,0.000013379731,0.0009852179],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9992287,0.00035103274,0.00009993104,0.00010481977,0.00007719731,0.00013829191],"domain_scores_gemma":[0.99932635,0.00026051272,0.00016317744,0.00007313332,0.00006707028,0.00010974916],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002235684,0.0011455187,0.004171215,0.0004975077,0.0002832418,0.001355474,0.00051409955,0.0010090417,0.0022590668],"category_scores_gemma":[0.0019030212,0.00043689256,0.005791973,0.0005641338,0.00037608176,0.0009625885,0.0003563418,0.0022577432,0.00032723375],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.87514,0.0015657605,0.013880505,0.0038657414,0.037213996,0.00022636191,0.00015733631,0.0017838923,0.0055561163,0.00027520838,0.0030743543,0.057260692],"study_design_scores_gemma":[0.7325804,0.08471539,0.08972095,0.000788528,0.07700799,0.0006595927,0.00036053068,0.0036232446,0.0025100831,0.000951616,0.0069284807,0.00015311124],"about_ca_topic_score_codex":0.00087666477,"about_ca_topic_score_gemma":0.0037274752,"teacher_disagreement_score":0.004171215,"about_ca_system_score_codex":0.0006206151,"about_ca_system_score_gemma":0.00070423016,"threshold_uncertainty_score":0.011823535},"labels":[],"label_agreement":null},{"id":"W4387015941","doi":"10.1016/j.jaad.2023.07.604","title":"42314 Dupilumab Inhibits Vascular Leakage of Blood Proteins into the Skin and Improves Clinical Outcomes of Patients With Moderate to Severe Atopic Dermatitis","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"","keywords":"Dupilumab; Atopic dermatitis; Medicine; Vascular permeability; Dermatology; Immunology; Internal medicine","score_opus":0.010610212347921831,"score_gpt":0.2936510648505111,"score_spread":0.2830408525025893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387015941","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908828,0.006016324,0.00015802655,0.00019659013,0.00010471117,0.000036330995,0.0001200429,0.000049417922,0.0024358144],"genre_scores_gemma":[0.99764603,0.0010453648,0.00016248322,0.0001796076,0.000048920163,0.000016458196,0.00014790245,0.0000034066338,0.0007498792],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9999074,0.000026376687,0.000007596261,0.000010829235,0.000019184397,0.000028639244],"domain_scores_gemma":[0.99991417,0.000018604216,0.000020675994,0.0000045436545,0.000014348748,0.000027712429],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017601004,0.00021291699,0.0004844934,0.00011482832,0.000149352,0.00033810365,0.00013162386,0.0001633751,0.0015016828],"category_scores_gemma":[0.0002552302,0.000067238405,0.0002586448,0.00010565612,0.000083112194,0.0001329169,0.00009479441,0.00045698514,0.00027947646],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.053739693,0.008357663,0.0849305,0.0014168528,0.0010560808,0.0012905896,0.00015569002,0.00083853817,0.16082056,0.00027879167,0.010628646,0.67648643],"study_design_scores_gemma":[0.015094462,0.08791693,0.77804905,0.00028611426,0.0019258704,0.008813296,0.0005527866,0.0057565826,0.070464626,0.00046367996,0.030587526,0.00008916249],"about_ca_topic_score_codex":0.00038432635,"about_ca_topic_score_gemma":0.0010274593,"teacher_disagreement_score":0.0015016828,"about_ca_system_score_codex":0.00016783971,"about_ca_system_score_gemma":0.00016927884,"threshold_uncertainty_score":0.0050235987},"labels":[],"label_agreement":null},{"id":"W4387015984","doi":"10.1016/j.jaad.2023.07.760","title":"44134 Long-Term Improvement in Difficult-To-Treat Areas and Quality of Life in Patients with Psoriasis Up to 204 Weeks Post Switch From Ustekinumab To Risankizumab","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"","keywords":"Medicine; Ustekinumab; Quality of life (healthcare); Psoriasis; Dermatology; Scalp; Internal medicine; Disease; Nursing","score_opus":0.016258537470750428,"score_gpt":0.27352683714822457,"score_spread":0.2572682996774741,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387015984","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968675,0.0010759782,0.00004909793,0.00009418224,0.000032436154,0.000026405889,0.0003297966,0.000012246898,0.001512459],"genre_scores_gemma":[0.9985322,0.00020570874,0.00006353923,0.00006200055,0.000023715495,0.000013831675,0.00044022544,0.0000014497784,0.00065741537],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999752,0.000058540507,0.00001887831,0.000036324855,0.000049907256,0.00008440636],"domain_scores_gemma":[0.9995296,0.000093663315,0.00015146213,0.000025074674,0.00007133198,0.00012885351],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041363697,0.00022418241,0.0006830436,0.000274679,0.00031264205,0.0004953185,0.00016908058,0.0003567813,0.0021672412],"category_scores_gemma":[0.0010221672,0.00010122265,0.0008046968,0.0003861247,0.00012835398,0.00037403783,0.00022206461,0.000683434,0.00038425144],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0513457,0.0037879928,0.80920607,0.00027371245,0.0014175309,0.0006776432,0.0002622342,0.00059002,0.007690114,0.00006318772,0.0018380347,0.12284775],"study_design_scores_gemma":[0.0004165159,0.0064072334,0.99151057,0.000018006067,0.000256672,0.00017078877,0.0000698251,0.00021037248,0.00036635,0.000031570486,0.00052797026,0.000013997072],"about_ca_topic_score_codex":0.0017384065,"about_ca_topic_score_gemma":0.002701229,"teacher_disagreement_score":0.0021672412,"about_ca_system_score_codex":0.00037369513,"about_ca_system_score_gemma":0.00024402264,"threshold_uncertainty_score":0.00725019},"labels":[],"label_agreement":null},{"id":"W4387015988","doi":"10.1016/j.jaad.2023.07.713","title":"43299 Improvement in Itch, Dryness, and Stinging/Burning With and Without Study-Defined Treatment Success","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bausch Health (Canada)","funders":"Ortho Dermatologics","keywords":"Medicine; Lotion; Dryness; Tazarotene; Psoriasis; Dermatology; Post-hoc analysis; Clinical endpoint; Randomized controlled trial; Erythema; Sensitive skin; Open label; Psoriasis Area and Severity Index; Rosacea; Internal medicine; Surgery; Pharmacology; Acne","score_opus":0.016983107241140726,"score_gpt":0.32184485040685046,"score_spread":0.30486174316570974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387015988","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96506715,0.004147053,0.0011824683,0.000361107,0.00030117427,0.0011270769,0.0009949364,0.00014170948,0.02667719],"genre_scores_gemma":[0.9943996,0.00070451194,0.0009239622,0.00015981827,0.00013853295,0.00024337045,0.0004963611,0.000015260228,0.0029185286],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99895525,0.00043004384,0.00014163837,0.00012518883,0.0001881814,0.00015977374],"domain_scores_gemma":[0.99888843,0.0003736777,0.00018733299,0.00017061125,0.0001342916,0.0002456357],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018442351,0.0003544617,0.0013839139,0.00039653608,0.00033411896,0.00046403077,0.0003049992,0.00044482623,0.0086071165],"category_scores_gemma":[0.0018246147,0.0000799958,0.0009972237,0.00040121246,0.0003801682,0.0004609481,0.000336436,0.0008562901,0.0007315208],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3003169,0.023431228,0.045057103,0.0017558007,0.0017259455,0.00065775245,0.00023635488,0.00074686384,0.053480305,0.001200557,0.0044349204,0.5669563],"study_design_scores_gemma":[0.047074065,0.35707593,0.5395081,0.00049024133,0.0018987296,0.0020506552,0.00049872097,0.002488549,0.019064719,0.00092672865,0.02881539,0.00010812013],"about_ca_topic_score_codex":0.00043290397,"about_ca_topic_score_gemma":0.0011296753,"teacher_disagreement_score":0.0086071165,"about_ca_system_score_codex":0.00032170294,"about_ca_system_score_gemma":0.00054888375,"threshold_uncertainty_score":0.028793693},"labels":[],"label_agreement":null},{"id":"W4387015996","doi":"10.1016/j.jaad.2023.07.635","title":"43250 Efficacy of Apremilast in Patients With Moderate-to-Severe Plaque Psoriasis Across Weight and BMI Subgroups: Analysis From ESTEEM 1 and ESTEEM 2","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Amgen","keywords":"Apremilast; Medicine; Psoriasis; Plaque psoriasis; Obesity; Internal medicine; Dermatology","score_opus":0.009579686812385016,"score_gpt":0.25252133280181693,"score_spread":0.2429416459894319,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387015996","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997519,0.0015968255,0.00007699852,0.000041268064,0.000016720334,0.00003222913,0.00021661556,0.0000060539714,0.00049432996],"genre_scores_gemma":[0.998911,0.00029121505,0.000075700686,0.00006283706,0.00004562835,0.00001838995,0.00043283973,0.0000028274885,0.000159557],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99913883,0.0004248014,0.000087200955,0.00012122921,0.0001305207,0.000097432705],"domain_scores_gemma":[0.9985241,0.0007475212,0.0003075465,0.00009722819,0.00007470579,0.0002488016],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016483143,0.000472013,0.0015345373,0.0005682817,0.00025555867,0.0005853491,0.00028629863,0.00051020464,0.0011995621],"category_scores_gemma":[0.0017885758,0.00024659935,0.0021313336,0.00048722464,0.00034799095,0.00058098475,0.0002972477,0.00075173465,0.00018535682],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4366963,0.0026925085,0.49112433,0.000407073,0.0079838075,0.00036099632,0.00022906158,0.0011446009,0.00878874,0.00015457293,0.0006918343,0.04972617],"study_design_scores_gemma":[0.010989482,0.039541136,0.94482416,0.000027205895,0.0017789502,0.00034857486,0.00015146672,0.0008949241,0.00044705297,0.0001400527,0.00080692285,0.000050105486],"about_ca_topic_score_codex":0.00046582165,"about_ca_topic_score_gemma":0.0007865109,"teacher_disagreement_score":0.0016483143,"about_ca_system_score_codex":0.00025479426,"about_ca_system_score_gemma":0.00024425468,"threshold_uncertainty_score":0.008717239},"labels":[],"label_agreement":null},{"id":"W4387016013","doi":"10.1016/j.jaad.2023.07.815","title":"42175 PASI improvement in the first 12 weeks from the Phase 3 VOYAGE 1, VOYAGE 2, ORION and ECLIPSE guselkumab clinical trials","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; McMaster University; Dalhousie University; Probity Medical Research","funders":"","keywords":"Medicine; Placebo; Eclipse; Clinical trial; Internal medicine; Astronomy; Pathology; Alternative medicine","score_opus":0.07612226255220515,"score_gpt":0.381308500926952,"score_spread":0.30518623837474684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387016013","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8531696,0.07222252,0.002459116,0.0030790237,0.003087966,0.004070801,0.010610542,0.001005859,0.05029455],"genre_scores_gemma":[0.95553267,0.011006401,0.0022337714,0.0028963734,0.00073266675,0.0026089943,0.0069262655,0.000103205326,0.017959552],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9994598,0.00018866253,0.00003897454,0.00006993254,0.00009466394,0.0001479841],"domain_scores_gemma":[0.9995328,0.00012668602,0.00008055004,0.00004202813,0.00006877317,0.00014923161],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013772453,0.0007597223,0.0023210314,0.00036783828,0.00044681874,0.0009699206,0.00035223018,0.0009875176,0.012649081],"category_scores_gemma":[0.00115883,0.0002164198,0.0018574321,0.00037877454,0.00028563774,0.00047869844,0.0002535378,0.0025828162,0.0025220478],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.42074406,0.0075729075,0.005899454,0.0027656618,0.0024301829,0.00020877755,0.00012603229,0.0010260561,0.018390866,0.0009020502,0.026660975,0.51327306],"study_design_scores_gemma":[0.3538799,0.42978373,0.10039816,0.0011674372,0.003077002,0.0008561402,0.00016523172,0.001421391,0.010733374,0.0016819484,0.09671434,0.00012137336],"about_ca_topic_score_codex":0.0007311831,"about_ca_topic_score_gemma":0.0024179467,"teacher_disagreement_score":0.012649081,"about_ca_system_score_codex":0.0006081072,"about_ca_system_score_gemma":0.0010351377,"threshold_uncertainty_score":0.042315423},"labels":[],"label_agreement":null},{"id":"W4387016034","doi":"10.1016/j.jaad.2023.07.762","title":"43997 Long-term safety and efficacy of tralokinumab in adolescents with moderate-to-severe atopic dermatitis: an interim analysis of ECZTEND","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Atopic dermatitis; Interim; Interim analysis; Dermatology; Term (time); Pediatrics; Clinical trial; Internal medicine","score_opus":0.016796449870806786,"score_gpt":0.31926475811696686,"score_spread":0.30246830824616006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387016034","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99202454,0.0021053755,0.00065964094,0.00018723437,0.00008776486,0.00029428527,0.0026917637,0.000058543224,0.001890872],"genre_scores_gemma":[0.99238986,0.00054104225,0.00057691394,0.00034458074,0.0000763592,0.00033049542,0.0037333965,0.000022105563,0.0019852223],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9981699,0.0006122055,0.00012458228,0.00028071358,0.00036945264,0.00044309886],"domain_scores_gemma":[0.9981129,0.0005511127,0.0004863875,0.00037334382,0.00019694712,0.00027933],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0042292913,0.00082854397,0.0022245583,0.0004019446,0.0005697952,0.001907533,0.0006671587,0.00095344905,0.002758879],"category_scores_gemma":[0.0022947916,0.000401486,0.004494668,0.00042557533,0.00057217234,0.0011140539,0.00035170524,0.0032198022,0.00087219465],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.64593846,0.01443146,0.15431675,0.0010123423,0.01747988,0.0008485458,0.00035197602,0.0062769284,0.015829423,0.00057778065,0.0056510274,0.13728544],"study_design_scores_gemma":[0.10654399,0.27756998,0.55157197,0.00034644493,0.023571635,0.0017988958,0.000405713,0.0072897603,0.015944792,0.0009688852,0.013767847,0.00022014543],"about_ca_topic_score_codex":0.00057438284,"about_ca_topic_score_gemma":0.0012030636,"teacher_disagreement_score":0.0042292913,"about_ca_system_score_codex":0.0007863255,"about_ca_system_score_gemma":0.001095714,"threshold_uncertainty_score":0.022366881},"labels":[],"label_agreement":null},{"id":"W4387016059","doi":"10.1016/j.jaad.2023.07.877","title":"44007 Risankizumab Long-Term Safety in Patients With Psoriatic Disease: Integrated Interval Analyses From Psoriasis and Psoriatic Arthritis Clinical Trials","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Medicine; Psoriatic arthritis; Psoriasis; Dermatology; Clinical trial; Internal medicine","score_opus":0.058643317489252667,"score_gpt":0.37469207841959,"score_spread":0.31604876093033735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387016059","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.935491,0.052111678,0.0015721326,0.00059480546,0.00025539714,0.0005716698,0.006115813,0.000110790534,0.0031767278],"genre_scores_gemma":[0.98578554,0.0064413436,0.00084865774,0.000605232,0.00026071197,0.00034630732,0.0049272445,0.000032032895,0.0007528916],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9946096,0.0032218369,0.0005130601,0.0006571036,0.00063471776,0.00036372035],"domain_scores_gemma":[0.9926944,0.003473566,0.002062541,0.00067561,0.0005666581,0.00052734185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010985653,0.00084208086,0.0028914048,0.0005799347,0.00036653713,0.0017509592,0.00064919004,0.0009556605,0.0029305667],"category_scores_gemma":[0.0089132665,0.00047456103,0.005582699,0.0011424196,0.00052020926,0.001313041,0.00072492694,0.002402422,0.00043308534],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6979919,0.001496172,0.09016989,0.0038334564,0.087069646,0.00018131726,0.00017458606,0.002262272,0.0040870644,0.0004630747,0.0042837565,0.107986815],"study_design_scores_gemma":[0.32166317,0.10201647,0.43907234,0.00078751135,0.113576755,0.0009304383,0.00031109076,0.0032715201,0.0019570533,0.001467827,0.014733206,0.00021263119],"about_ca_topic_score_codex":0.0006422728,"about_ca_topic_score_gemma":0.0018874004,"teacher_disagreement_score":0.010985653,"about_ca_system_score_codex":0.000530957,"about_ca_system_score_gemma":0.0010897632,"threshold_uncertainty_score":0.058098376},"labels":[],"label_agreement":null},{"id":"W4387016064","doi":"10.1016/j.jaad.2023.07.628","title":"43516 Efficacy and Safety of Sonic Hedgehog Inhibitors in Basal Cell Carcinomas: An Updated Systematic Review and Meta-Analysis","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Bispebjerg Hospital; Feinberg School of Medicine; University of California, San Diego; School of Medicine, University of California, San Diego; Northwestern University; AbbVie","keywords":"Medicine; Basal cell carcinoma; Meta-analysis; Skin cancer; Systematic review; Basal cell; Dermatology; Oncology; Clinical trial; Vismodegib; Internal medicine; MEDLINE; Cancer; Biology","score_opus":0.026511597877587986,"score_gpt":0.3057151947225278,"score_spread":0.2792035968449398,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387016064","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.021110442,0.9749211,0.0006254495,0.00029354022,0.00025662265,0.00017407314,0.0020319892,0.00003342644,0.000553398],"genre_scores_gemma":[0.52131194,0.4695322,0.0016371243,0.0028871137,0.0005140224,0.00048946403,0.0026266808,0.00006279603,0.00093865755],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9956735,0.0014119382,0.0014952514,0.0007426762,0.0004658554,0.0002106966],"domain_scores_gemma":[0.99322045,0.0039491756,0.0018153103,0.0003599005,0.0005255235,0.0001295186],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0054193484,0.00135491,0.010618828,0.0023228507,0.00031042667,0.0020325398,0.0013906169,0.0015485502,0.0039162072],"category_scores_gemma":[0.012054063,0.0009650854,0.020984828,0.0037567143,0.0006094464,0.0014941358,0.0011026127,0.0013884287,0.0004152762],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0065293214,0.000037864294,0.01362843,0.22465295,0.7349033,0.00015357109,0.000110072644,0.00050033187,0.0008321764,0.00012504819,0.0014202564,0.017106697],"study_design_scores_gemma":[0.0018119073,0.0002734658,0.010005988,0.0065773684,0.97886366,0.00008706374,0.000044801447,0.00009070844,0.0001221312,0.00012360017,0.0019698224,0.00002947485],"about_ca_topic_score_codex":0.003382214,"about_ca_topic_score_gemma":0.010091472,"teacher_disagreement_score":0.010618828,"about_ca_system_score_codex":0.0010430028,"about_ca_system_score_gemma":0.0014589444,"threshold_uncertainty_score":0.028660595},"labels":[],"label_agreement":null},{"id":"W4387016067","doi":"10.1016/j.jaad.2023.07.813","title":"41824 Palmoplantar psoriasis complete clearance is achieved rapidly and sustained with ixekizumab treatment in adult and pediatric patients with moderate-to-severe plaque psoriasis","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Ixekizumab; Plaque psoriasis; Psoriasis; Psoriasis Area and Severity Index; Post-hoc analysis; Population; Internal medicine; Dermatology; Gastroenterology; Psoriatic arthritis; Secukinumab","score_opus":0.010124645004568441,"score_gpt":0.23311386049575591,"score_spread":0.22298921549118747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387016067","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953538,0.0019895437,0.00030968038,0.00015752019,0.000016008784,0.000019257866,0.00010241699,0.000031361615,0.0020203697],"genre_scores_gemma":[0.99901533,0.00045174995,0.00017545221,0.000046286706,0.000019499412,0.000006415082,0.00009979182,0.0000035471567,0.00018188395],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99981064,0.00005446035,0.000019244548,0.000024186233,0.00003788983,0.00005362318],"domain_scores_gemma":[0.9996948,0.000076161195,0.00011415162,0.00001239003,0.000023256332,0.00007920629],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002806088,0.00020354765,0.0005646535,0.0001190288,0.00018716014,0.00035716844,0.00011181003,0.00026289295,0.001187549],"category_scores_gemma":[0.0008535007,0.00010625668,0.0002654823,0.00015285447,0.0001505707,0.00023463373,0.00010524957,0.00049462373,0.00022760342],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008983689,0.0012047822,0.78144795,0.00030443323,0.00020127634,0.019567158,0.00056178804,0.00055888714,0.03292395,0.00051626435,0.004145776,0.1495839],"study_design_scores_gemma":[0.00046414975,0.0081116,0.9285923,0.00006328669,0.00016527601,0.050104365,0.00038784088,0.0009428758,0.0052042995,0.00012728228,0.005822564,0.000014069952],"about_ca_topic_score_codex":0.00049054914,"about_ca_topic_score_gemma":0.00071953575,"teacher_disagreement_score":0.001187549,"about_ca_system_score_codex":0.0002315486,"about_ca_system_score_gemma":0.00024928624,"threshold_uncertainty_score":0.003972769},"labels":[],"label_agreement":null},{"id":"W4387016071","doi":"10.1016/j.jaad.2023.07.832","title":"44066 Photography and Image Acquisition in Dermatology: A Scoping Review","year":2023,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Digital Imaging in Medicine","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Memorial University of Newfoundland","funders":"","keywords":"Medicine; Photography; Dermatology; Visual arts","score_opus":0.04667278806881263,"score_gpt":0.42414214738172806,"score_spread":0.3774693593129154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387016071","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004351406,0.9995974,0.000026217684,0.00006650109,0.00006608421,0.000013659401,0.000017828133,0.000001977476,0.00016676237],"genre_scores_gemma":[0.00036228946,0.99916506,0.00012934963,0.00016482855,0.00005329799,0.000015403564,0.00002537447,0.0000012240623,0.00008324937],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977982,0.00050185045,0.0007645412,0.00028284278,0.00053872436,0.00011387878],"domain_scores_gemma":[0.99003345,0.007188681,0.0013217513,0.00014510403,0.0011631843,0.00014780363],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004493277,0.0014345065,0.0045959027,0.010514168,0.0006750517,0.0037085707,0.0017591772,0.003217709,0.008341124],"category_scores_gemma":[0.0113853915,0.001091879,0.002896376,0.009575227,0.001230605,0.0033530868,0.0019155061,0.0017720921,0.0015803056],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015530523,0.0000826081,0.00045267123,0.40384436,0.0010586852,0.00023301829,0.0002007909,0.00014878751,0.00055265706,0.0009716228,0.015701978,0.5765975],"study_design_scores_gemma":[0.00013911234,0.00019330067,0.0029601222,0.67381746,0.008161238,0.0016249013,0.00037010774,0.00012314403,0.00037807442,0.00077249226,0.3113855,0.00007451745],"about_ca_topic_score_codex":0.006549304,"about_ca_topic_score_gemma":0.013342927,"teacher_disagreement_score":0.010514168,"about_ca_system_score_codex":0.0020203344,"about_ca_system_score_gemma":0.006391672,"threshold_uncertainty_score":0.027903855},"labels":[],"label_agreement":null},{"id":"W4387016096","doi":"10.1016/j.jaad.2023.07.773","title":"42307 Matching-adjusted indirect comparison of efficacy of ixekizumab versus secukinumab through 1 year in pediatric patients with severe plaque psoriasis","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Probity Medical Research; Calgary Laboratory Services; Sunnybrook Health Science Centre; SKiN Health; University of Calgary","funders":"","keywords":"Ixekizumab; Secukinumab; Medicine; Etanercept; Psoriasis; Dermatology; Plaque psoriasis; Placebo; Clinical trial; Internal medicine; Tumor necrosis factor alpha; Psoriatic arthritis; Pathology; Alternative medicine","score_opus":0.025012510889219176,"score_gpt":0.28816546072793786,"score_spread":0.2631529498387187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387016096","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964192,0.0015027474,0.00028224668,0.00007095961,0.000086154694,0.000043431137,0.0009945194,0.000013642057,0.0005871098],"genre_scores_gemma":[0.9982346,0.00030388692,0.00021987615,0.00005899578,0.000030912535,0.00004755391,0.00066296844,0.0000054251923,0.00043569246],"study_design_codex":"randomized_trial","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.996292,0.0021457265,0.00027623484,0.00064736133,0.0002420898,0.00039665273],"domain_scores_gemma":[0.9969946,0.0015069529,0.0007621525,0.00038501265,0.00015797695,0.0001932597],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031088754,0.00080083415,0.0018634746,0.00038828258,0.00026648803,0.0007572251,0.0009292769,0.00114045,0.0038809152],"category_scores_gemma":[0.006111223,0.00073431,0.0057607736,0.00077293476,0.00033967348,0.00080420275,0.00070293836,0.001671978,0.00028679884],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.53528476,0.001819599,0.3539608,0.0012956935,0.063678086,0.00032776495,0.0002468493,0.005415131,0.0019025783,0.00056742236,0.0022730296,0.033228282],"study_design_scores_gemma":[0.058963038,0.07242728,0.7934285,0.00027225388,0.059023842,0.00045608298,0.00041663856,0.009640844,0.0016371813,0.00064995285,0.002984664,0.00009975025],"about_ca_topic_score_codex":0.010792104,"about_ca_topic_score_gemma":0.008151602,"teacher_disagreement_score":0.010792104,"about_ca_system_score_codex":0.00092581875,"about_ca_system_score_gemma":0.0009559819,"threshold_uncertainty_score":0.021458566},"labels":[],"label_agreement":null},{"id":"W4387026085","doi":"10.1016/j.jaad.2023.07.064","title":"44568 An Analysis of the Average Age of Skin Cancer Reported by Subjects with Fitzpatrick Phototypes I through VI","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Semtech (Canada)","funders":"","keywords":"Medicine; Dermatology; Skin cancer; Population; Cancer; Internal medicine; Environmental health","score_opus":0.022259156743400246,"score_gpt":0.3349132714085689,"score_spread":0.3126541146651687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387026085","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99703157,0.00012573955,0.0000888466,0.0000125593515,0.000007865823,0.000012853413,0.0011450732,0.0000029006399,0.0015725197],"genre_scores_gemma":[0.9967012,0.000084162915,0.00010922509,0.00002330905,0.000010459925,0.000021423479,0.0010342669,0.0000035905416,0.0020123806],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99959785,0.00012939813,0.000043097123,0.00009514588,0.00006332409,0.000071251256],"domain_scores_gemma":[0.9992405,0.00018453256,0.00021961966,0.00006299864,0.00016340526,0.00012884894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041512598,0.00022083301,0.00024550522,0.0020049927,0.0008020259,0.00036642095,0.00024733003,0.0001976232,0.00707669],"category_scores_gemma":[0.0010739721,0.00019723372,0.0004521046,0.0019595695,0.00012998794,0.00032245927,0.00032327647,0.000228087,0.00080323697],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004882722,0.00006718188,0.99546957,0.000018779097,0.00011522983,0.00007936763,0.00013960132,0.00001567766,0.0007751921,0.00003436181,0.00033997386,0.0024567961],"study_design_scores_gemma":[0.000007687729,0.00017918446,0.99875677,0.0000034348354,0.000043495344,0.000082856306,0.00028673327,0.000028566428,0.00009542097,0.0000072334783,0.00050661946,0.0000020510865],"about_ca_topic_score_codex":0.022179684,"about_ca_topic_score_gemma":0.027087927,"teacher_disagreement_score":0.022179684,"about_ca_system_score_codex":0.00028977878,"about_ca_system_score_gemma":0.00021078657,"threshold_uncertainty_score":0.04410118},"labels":[],"label_agreement":null},{"id":"W4387026137","doi":"10.1016/j.jaad.2023.07.937","title":"41290 The Gold Standard for Skin Decontamination?: Evaluating the Efficacy of Soap and Water across Human and Animal Models","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Climate Change and Health Impacts","field":"Environmental Science","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Medicine; Gold standard (test); SOAP; Human decontamination; Animal model; Dermatology; Pathology; Internal medicine; World Wide Web","score_opus":0.09053196739404082,"score_gpt":0.4278632010295315,"score_spread":0.33733123363549067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387026137","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9173554,0.05529347,0.014089797,0.0029658023,0.0021206278,0.0012315068,0.00095394906,0.00010503497,0.0058844397],"genre_scores_gemma":[0.94833195,0.0308488,0.012929276,0.0015123661,0.00029703064,0.0005526764,0.0008247704,0.000085546366,0.004617593],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99758184,0.0011216331,0.00013805949,0.00026333734,0.00074128713,0.00015384593],"domain_scores_gemma":[0.99844545,0.00024285914,0.00039548107,0.00029791726,0.00046776803,0.00015046672],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004421866,0.00081552914,0.0011301134,0.00066946115,0.00053441746,0.00114337,0.000761974,0.0016213136,0.0023436628],"category_scores_gemma":[0.0025957427,0.00036313196,0.0010665216,0.0004336772,0.0013297119,0.0012024203,0.0005165307,0.0016710247,0.00051254267],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023222588,0.009946262,0.0052460125,0.002478764,0.0006713737,0.0002124708,0.00037837177,0.0011660135,0.86076015,0.001284987,0.0033914195,0.091241576],"study_design_scores_gemma":[0.0014140769,0.2881563,0.021215044,0.0008810819,0.001762284,0.0010275356,0.0011311179,0.0049910625,0.643572,0.0018525529,0.03384053,0.00015643517],"about_ca_topic_score_codex":0.0023963924,"about_ca_topic_score_gemma":0.005185217,"teacher_disagreement_score":0.004421866,"about_ca_system_score_codex":0.0006138041,"about_ca_system_score_gemma":0.0009891278,"threshold_uncertainty_score":0.023385286},"labels":[],"label_agreement":null},{"id":"W4387026142","doi":"10.1016/j.jaad.2023.07.676","title":"43341 Fixed-Combination Halobetasol Propionate and Tazarotene Topical Lotion Decreases Interleukin-17A Levels in Psoriasis","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bausch Health (Canada)","funders":"Bausch Health; Ortho Dermatologics","keywords":"Tazarotene; Psoriasis; Medicine; Lotion; Dermatology; Interleukin 17; Tolerability; Proinflammatory cytokine; Interleukin; Pharmacology; Adverse effect; Immunology; Inflammation; Cytokine","score_opus":0.02367842836896941,"score_gpt":0.28439644556160626,"score_spread":0.2607180171926369,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387026142","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99368626,0.0033068976,0.00031655683,0.00020710118,0.00022191691,0.000057044523,0.00014533014,0.00010879919,0.0019501663],"genre_scores_gemma":[0.99363023,0.0013407816,0.00081441336,0.00012153769,0.00014576805,0.000055453194,0.0002709413,0.00001479115,0.0036061308],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99976367,0.000057005018,0.000017290524,0.000023609891,0.000067934496,0.00007056366],"domain_scores_gemma":[0.99988854,0.00002041912,0.000016687069,0.000012349134,0.000012238025,0.00004974528],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021630738,0.00040290307,0.0007405318,0.00039263946,0.0002877912,0.0003457061,0.00036192287,0.0005228434,0.00497727],"category_scores_gemma":[0.00023018279,0.00024129514,0.00041228923,0.00020955077,0.00021659052,0.00019162451,0.00015317617,0.0009929839,0.00081058114],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.050627954,0.006911226,0.0024906846,0.00020745386,0.0001627096,0.00042068103,0.000042316005,0.00027649742,0.8567747,0.00010312364,0.0016711559,0.08031149],"study_design_scores_gemma":[0.016150462,0.17221715,0.122519545,0.00010221461,0.00095347175,0.004086706,0.00031679732,0.003323514,0.6659599,0.00019516125,0.014106668,0.00006844195],"about_ca_topic_score_codex":0.0011070574,"about_ca_topic_score_gemma":0.0024637182,"teacher_disagreement_score":0.00497727,"about_ca_system_score_codex":0.0001559364,"about_ca_system_score_gemma":0.00041265826,"threshold_uncertainty_score":0.016650558},"labels":[],"label_agreement":null},{"id":"W4387026144","doi":"10.1016/j.jaad.2023.07.874","title":"44095 Response to Abrocitinib up to Week 96 According to Short-Term Response: A Post Hoc Analysis of the JADE-EXTEND Phase 3 Trial","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Medicine; JADE (particle detector); Post-hoc analysis; Internal medicine; Clinical endpoint; Atopic dermatitis; Post hoc; Gastroenterology; Clinical trial; Dermatology","score_opus":0.09088699570514046,"score_gpt":0.47077334084542033,"score_spread":0.37988634514027986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387026144","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9872398,0.0032038114,0.001349903,0.00037718756,0.0005026317,0.0012033781,0.0028833393,0.00014685787,0.003093059],"genre_scores_gemma":[0.99060506,0.00051995047,0.00094321975,0.00064678956,0.0002803652,0.0016369605,0.0019053417,0.00009857251,0.0033637278],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9926246,0.0048516416,0.0003685561,0.00087990175,0.0004547542,0.0008205549],"domain_scores_gemma":[0.99333596,0.003923272,0.00086399727,0.0009960673,0.00030581083,0.0005749165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010620611,0.0016972035,0.0059306617,0.00047895173,0.00060498144,0.0022353192,0.0011199868,0.0014302221,0.008206378],"category_scores_gemma":[0.0075625395,0.0006501049,0.00747564,0.0005462814,0.0010374853,0.0022674743,0.00089819776,0.0054086237,0.0011305608],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9791764,0.0007309329,0.0025427332,0.00027674154,0.006856423,0.000045058667,0.00005361658,0.0006128402,0.0018237703,0.00010885252,0.0010061257,0.00676663],"study_design_scores_gemma":[0.656386,0.21063145,0.09092731,0.00019377664,0.024473839,0.00026187603,0.0002456485,0.005291843,0.0037337358,0.0013301832,0.006317699,0.00020661556],"about_ca_topic_score_codex":0.00045662507,"about_ca_topic_score_gemma":0.0011646354,"teacher_disagreement_score":0.010620611,"about_ca_system_score_codex":0.00086535997,"about_ca_system_score_gemma":0.0012179948,"threshold_uncertainty_score":0.05616784},"labels":[],"label_agreement":null},{"id":"W4387026147","doi":"10.1016/j.jaad.2023.07.605","title":"42317 Dupilumab Normalizes Epidermal Hyperplasia Protein Expression and Improves Clinical Outcome in Patients with Moderate-to-Severe Atopic Dermatitis","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"","keywords":"Dupilumab; Atopic dermatitis; Medicine; Dermatology; Interleukin 13; Immunology; Interleukin; Cytokine","score_opus":0.018621435628694914,"score_gpt":0.32234163844614866,"score_spread":0.30372020281745377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387026147","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99052316,0.005795008,0.00019695557,0.00020455192,0.000120684614,0.000038707545,0.00013500408,0.00010418477,0.0028817535],"genre_scores_gemma":[0.997355,0.0011882478,0.00022675488,0.00016997561,0.000042144802,0.000014909963,0.00018475277,0.000006636643,0.000811718],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9999341,0.000015193529,0.0000052915566,0.0000081058815,0.000016464037,0.000020895548],"domain_scores_gemma":[0.9999448,0.000009459609,0.000010054828,0.0000036887134,0.000007977452,0.000024058592],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013874087,0.00028063927,0.0005578631,0.00013108866,0.00015510315,0.0002735122,0.00016260937,0.00015025948,0.0012315249],"category_scores_gemma":[0.00015028943,0.00006531691,0.00024175661,0.000115556904,0.00008708545,0.0001127506,0.00007440495,0.0004475507,0.00026305567],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04440296,0.007941051,0.044389848,0.0012116876,0.0008958835,0.0036837547,0.00015114629,0.00070801575,0.296441,0.00033723292,0.009799121,0.5900383],"study_design_scores_gemma":[0.017467063,0.08675932,0.7139831,0.00032000997,0.0020976532,0.026887162,0.00074744364,0.006011485,0.10821389,0.00072982523,0.036671504,0.00011148241],"about_ca_topic_score_codex":0.00040739926,"about_ca_topic_score_gemma":0.0012457774,"teacher_disagreement_score":0.0012315249,"about_ca_system_score_codex":0.0001757134,"about_ca_system_score_gemma":0.00016349713,"threshold_uncertainty_score":0.004119873},"labels":[],"label_agreement":null},{"id":"W4387026171","doi":"10.1016/j.jaad.2023.07.678","title":"41296 Fluorescence visualization of doxycycline distribution following ablative fractional laser treatment","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Bausch Health; Ortho Dermatologics","keywords":"Biomedical engineering; Fluorescence; Autofluorescence; Microscopy; Fluorescence microscope; Laser; Doxycycline; Penetration (warfare); Fluorescence-lifetime imaging microscopy; Penetration depth; Dermis; Drug delivery; Materials science; Medicine; Optics; Pathology; Nanotechnology; Chemistry","score_opus":0.02112292179992212,"score_gpt":0.356877137606893,"score_spread":0.33575421580697085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387026171","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.979003,0.0022756385,0.009654218,0.0002147443,0.00007003167,0.00004972922,0.00022412204,0.00016665347,0.008341765],"genre_scores_gemma":[0.98856026,0.00071570295,0.005146522,0.00006560845,0.000021031025,0.00004173884,0.00014293296,0.000033097014,0.005273095],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999151,0.000013973876,0.0000043272953,0.000015346144,0.000019212906,0.000032082877],"domain_scores_gemma":[0.9998361,0.000072853945,0.000022175442,0.000017475546,0.000028558708,0.000022767988],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015451461,0.00016164641,0.00015098247,0.00038358386,0.00030499834,0.00024359814,0.00016848158,0.00036551664,0.0023975426],"category_scores_gemma":[0.00017076741,0.0001257534,0.00015143187,0.0002525303,0.000253139,0.00024460288,0.00014898545,0.000491675,0.00029868854],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004200775,0.00004304006,0.00026853467,0.000029953479,0.0000041534263,0.00024965743,0.000039006987,0.00006719215,0.9953473,0.00012798318,0.00007400997,0.0033290295],"study_design_scores_gemma":[0.000028137054,0.00030981196,0.008513741,0.0000061540345,0.00001685401,0.0004949704,0.00005839754,0.0020614497,0.9871373,0.00006498304,0.0013004172,0.0000078598105],"about_ca_topic_score_codex":0.0031154081,"about_ca_topic_score_gemma":0.0023923123,"teacher_disagreement_score":0.0031154081,"about_ca_system_score_codex":0.00027538493,"about_ca_system_score_gemma":0.0002893942,"threshold_uncertainty_score":0.00802058},"labels":[],"label_agreement":null},{"id":"W4387026197","doi":"10.1016/j.jaad.2023.07.610","title":"43696 Early real-world experience with baricitinib in the treatment of severe alopecia areata","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Autoimmune Bullous Skin Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Griffith University; University of Leeds; University of Oxford; Janssen Scientific Affairs; Ottawa Hospital Research Institute; McGill University; University of Ottawa; Leeds Biomedical Research Centre; University of Washington","keywords":"Alopecia areata; Medicine; Dermatology; Psychosocial; Hair loss; Psychiatry","score_opus":0.02759886662790074,"score_gpt":0.3360635303121031,"score_spread":0.3084646636842024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387026197","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9578779,0.020430924,0.0014555652,0.0038811571,0.00038868038,0.00012064585,0.00031343207,0.00004638567,0.0154853035],"genre_scores_gemma":[0.9934875,0.0031178694,0.00043525558,0.0011156552,0.00024431266,0.000019202225,0.00027945402,0.000013464995,0.0012873065],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9997758,0.00009298665,0.000021239428,0.000022372627,0.00003644881,0.000051164057],"domain_scores_gemma":[0.99955684,0.00017772216,0.000049794075,0.000022784609,0.00003239674,0.0001604458],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006107803,0.00026619373,0.0003791461,0.00009635154,0.00048359708,0.0006057465,0.00017245953,0.0004992009,0.0018374475],"category_scores_gemma":[0.0011372431,0.00006815223,0.0005206076,0.0001416224,0.00019471305,0.00033320763,0.00027134805,0.0009999631,0.00042420832],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028622445,0.011130099,0.09654868,0.0013610515,0.0016314168,0.08068189,0.0020993366,0.005227651,0.031072358,0.0022541785,0.025817875,0.713553],"study_design_scores_gemma":[0.013204296,0.09276956,0.348801,0.0010774222,0.0017320343,0.26499817,0.0016304756,0.009636098,0.018853717,0.00211506,0.244898,0.00028412754],"about_ca_topic_score_codex":0.00044705434,"about_ca_topic_score_gemma":0.0012564056,"teacher_disagreement_score":0.0018374475,"about_ca_system_score_codex":0.0003335671,"about_ca_system_score_gemma":0.00020846307,"threshold_uncertainty_score":0.006146908},"labels":[],"label_agreement":null},{"id":"W4387026237","doi":"10.1016/j.jaad.2023.07.747","title":"44491 Laser and Energy-Based Devices for the Treatment of Cutaneous Verrucae: A Systematic Review","year":2023,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Cancer and Skin Lesions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health; University of British Columbia; McGill University","funders":"","keywords":"Medicine; Dermatology; Laser; High energy; Intense pulsed light; Laser treatment; Surgery; Optics; Engineering physics","score_opus":0.05931301548073724,"score_gpt":0.39931275636972474,"score_spread":0.3399997408889875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387026237","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006071078,0.9986291,0.00007679592,0.000076485936,0.000083666535,0.00012563201,0.00019428524,0.00000549105,0.0002014504],"genre_scores_gemma":[0.006521362,0.99254066,0.00022539383,0.00031701528,0.00004750703,0.00010520062,0.000103506936,0.000003020694,0.00013635542],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99796367,0.00062039465,0.00070023147,0.00022454199,0.0003864715,0.00010469804],"domain_scores_gemma":[0.9946656,0.0037442248,0.0010448244,0.00007028885,0.0003935239,0.000081402555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002561554,0.0013351764,0.007727322,0.004371452,0.00056878163,0.0022174825,0.0014773126,0.0018115866,0.009046711],"category_scores_gemma":[0.011253211,0.0007428285,0.008743553,0.0052209897,0.00065063016,0.0016186706,0.0011156794,0.0013666846,0.0006090362],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054439326,0.000034030145,0.00045339984,0.9443702,0.019224834,0.00008991206,0.00007732535,0.00008553187,0.00022876357,0.0001426499,0.0017994121,0.03294958],"study_design_scores_gemma":[0.0017574219,0.00056399085,0.005477031,0.6750606,0.29292658,0.00047654237,0.00026156905,0.00013252825,0.00025999377,0.0003444478,0.022663038,0.000076376426],"about_ca_topic_score_codex":0.0103285955,"about_ca_topic_score_gemma":0.030748414,"teacher_disagreement_score":0.0103285955,"about_ca_system_score_codex":0.0018113315,"about_ca_system_score_gemma":0.0044001294,"threshold_uncertainty_score":0.030264258},"labels":[],"label_agreement":null},{"id":"W4387026253","doi":"10.1016/j.jaad.2023.07.636","title":"43072 Efficacy of lebrikizumab in adolescent patients with moderate-to-severe atopic dermatitis: 16-week results from three randomized Phase 3 clinical trials","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; University of British Columbia","funders":"","keywords":"Medicine; Atopic dermatitis; Eczema Area and Severity Index; Placebo; Randomized controlled trial; Internal medicine; Clinical endpoint; Population; Clinical trial; Gastroenterology; Dermatology; Pathology","score_opus":0.06824432351958573,"score_gpt":0.39534801938748404,"score_spread":0.32710369586789834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387026253","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9775184,0.017735984,0.000567243,0.0006813977,0.00028259272,0.0011724676,0.0005557368,0.000109233224,0.0013770362],"genre_scores_gemma":[0.9872914,0.0071735852,0.0010321956,0.0009779087,0.00020774963,0.0010191734,0.00057670294,0.000025158366,0.0016961682],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99948585,0.0002586924,0.00003503389,0.00007800767,0.000054001364,0.00008847237],"domain_scores_gemma":[0.9990846,0.00034357698,0.00020557281,0.000055191733,0.00006467248,0.00024634274],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021526692,0.0009427251,0.002427429,0.0002738595,0.00041564633,0.0009663068,0.00065048854,0.0014916642,0.0031538547],"category_scores_gemma":[0.0014853857,0.00046500686,0.0025887955,0.0002894491,0.0008495876,0.000860116,0.0002404053,0.0028848122,0.0005245186],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8562744,0.012558505,0.0043659136,0.0026560223,0.0037780446,0.00018707993,0.00025827374,0.0012328085,0.008850319,0.00020424763,0.0029485705,0.106685765],"study_design_scores_gemma":[0.8871249,0.10028108,0.008190889,0.00015543279,0.001188753,0.00013721305,0.00008444201,0.00059237296,0.00076258084,0.00014816783,0.0013063557,0.000027797832],"about_ca_topic_score_codex":0.0011187871,"about_ca_topic_score_gemma":0.0029583347,"teacher_disagreement_score":0.0031538547,"about_ca_system_score_codex":0.0006704125,"about_ca_system_score_gemma":0.0009628885,"threshold_uncertainty_score":0.011384547},"labels":[],"label_agreement":null},{"id":"W4387026273","doi":"10.1016/j.jaad.2023.07.611","title":"44145 Early Skin and Early Enthesitis Responses in Psoriatic Arthritis Patients Treated with Guselkumab Associate with Long-term Response: Pooled Post Hoc Analyses Through 1 Year of Two Phase 3 Studies","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GDI Integrated Facility Services (Canada); McGill University; Ottawa Hospital; University of Ottawa","funders":"Griffith University; University of Leeds; University of Oxford; Janssen Scientific Affairs; Ottawa Hospital Research Institute; McGill University; University of Ottawa; Leeds Biomedical Research Centre; University of Washington","keywords":"Medicine; Psoriatic arthritis; Enthesitis; Dermatology; Psoriasis; Internal medicine","score_opus":0.03133662812782889,"score_gpt":0.3807560441380218,"score_spread":0.3494194160101929,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387026273","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98493874,0.01177041,0.001069571,0.00006645204,0.00016726318,0.00031690733,0.0008190181,0.00004767496,0.0008038988],"genre_scores_gemma":[0.997259,0.0007588037,0.000400836,0.00007843064,0.00008684809,0.00018689012,0.00064880215,0.000013927456,0.00056631805],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9927192,0.00439815,0.0006262406,0.000971746,0.00068967196,0.000594932],"domain_scores_gemma":[0.9941407,0.003309969,0.0011258745,0.00072617613,0.00038533576,0.0003119769],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009176314,0.001424766,0.005002496,0.00069045793,0.0005548164,0.0018333861,0.0007706647,0.0014051922,0.0028530946],"category_scores_gemma":[0.0052362033,0.00086271757,0.009951769,0.0009981167,0.0006054672,0.0014543945,0.0009170321,0.0017577042,0.00029609373],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7654788,0.0013758611,0.107608736,0.0015249995,0.08496985,0.00018068966,0.00018377909,0.0011335937,0.007421959,0.000086555156,0.0005935648,0.029441638],"study_design_scores_gemma":[0.05575664,0.077070825,0.764531,0.0001896427,0.093918726,0.00028756371,0.00024909573,0.0024286848,0.0029880642,0.0003373809,0.0020850047,0.00015738883],"about_ca_topic_score_codex":0.0008571829,"about_ca_topic_score_gemma":0.0016109385,"teacher_disagreement_score":0.009176314,"about_ca_system_score_codex":0.00043769204,"about_ca_system_score_gemma":0.0006778642,"threshold_uncertainty_score":0.048529565},"labels":[],"label_agreement":null},{"id":"W4387026281","doi":"10.1016/j.jaad.2023.07.759","title":"42134 Long-term Efficacy of Guselkumab (GUS) on Fatigue and Identification of Early Treatment Targets: Post Hoc Analysis Through 2 Years of a Phase 3, Randomized, Double-blind, Placebo-controlled Study in Biologic-naïve Patients With Psoriatic Arthritis (PsA)","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; GDI Integrated Facility Services (Canada); Montreal General Hospital; Krembil Foundation; Toronto Western Hospital","funders":"","keywords":"Medicine; Post-hoc analysis; Placebo; Double blind; Post hoc; Term (time); Internal medicine; Oncology; Alternative medicine; Pathology","score_opus":0.02617833358952999,"score_gpt":0.3171300572902101,"score_spread":0.2909517237006801,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387026281","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954561,0.0022181692,0.0003428437,0.00013621616,0.00012617171,0.0006058501,0.00050966,0.00006888447,0.0005361764],"genre_scores_gemma":[0.99506134,0.001026613,0.0006274503,0.00026498825,0.00020321501,0.00077929033,0.00073567673,0.000022636019,0.0012788102],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99894816,0.00054774235,0.000062066676,0.0001605692,0.00007531981,0.00020629255],"domain_scores_gemma":[0.99900407,0.00029972903,0.00017606352,0.00012289317,0.00007882027,0.0003184996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023226507,0.0013470234,0.0038518931,0.00045636855,0.00056227966,0.00085482927,0.00073844404,0.0015480894,0.003917699],"category_scores_gemma":[0.0013513486,0.00074610114,0.002902015,0.00049588346,0.0012691377,0.0010437533,0.00044542408,0.002778699,0.0006500246],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9715125,0.0075257244,0.000998926,0.00022670864,0.0010760032,0.000023165312,0.000035149522,0.00032877625,0.0065365667,0.00002958467,0.00021793274,0.011488838],"study_design_scores_gemma":[0.5998934,0.38068265,0.014656041,0.000024833425,0.00153251,0.000036809,0.000039140476,0.00057303446,0.001906178,0.00008301921,0.00054080907,0.0000316361],"about_ca_topic_score_codex":0.0009956349,"about_ca_topic_score_gemma":0.0021424182,"teacher_disagreement_score":0.003917699,"about_ca_system_score_codex":0.0005161579,"about_ca_system_score_gemma":0.0010117886,"threshold_uncertainty_score":0.0131059885},"labels":[],"label_agreement":null},{"id":"W4387026325","doi":"10.1016/j.jaad.2023.07.730","title":"43117 Integrated safety analysis of ritlecitinib in adolescent patients with alopecia areata from the randomized, placebo-controlled ALLEGRO phase 2b/3 and ongoing open-label phase 3 ALLEGRO-LT studies","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Alopecia areata; Medicine; Placebo; Hair loss; Open label; Dermatology; Randomized controlled trial; Internal medicine; Pathology; Alternative medicine","score_opus":0.05473817354729585,"score_gpt":0.3909709963074463,"score_spread":0.33623282276015043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387026325","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9708896,0.01637833,0.0014346497,0.00087572844,0.00022112741,0.0015946947,0.0034936923,0.00021036953,0.004901745],"genre_scores_gemma":[0.98712677,0.0042086197,0.001488503,0.0010876276,0.00021277326,0.0008690799,0.003172814,0.00003556751,0.0017982596],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99918324,0.0004325217,0.000051037267,0.00009804647,0.00012591649,0.00010926405],"domain_scores_gemma":[0.9990627,0.00030553588,0.0002694576,0.00007786943,0.000113949165,0.00017053251],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021212234,0.00050237647,0.0014929227,0.0003250132,0.000283565,0.0008562673,0.0004291287,0.00078054523,0.0047026174],"category_scores_gemma":[0.0014512851,0.00024203151,0.0020516464,0.0003079808,0.00037317007,0.0005762557,0.00020723617,0.0020570662,0.0006561574],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.58318025,0.0076592253,0.015511364,0.0026034662,0.00664279,0.00021791425,0.00016720976,0.0025351464,0.022353807,0.0006237057,0.008266727,0.3502383],"study_design_scores_gemma":[0.63346815,0.25284302,0.074546345,0.00040816364,0.0063215964,0.0009015734,0.000114511466,0.0027233288,0.0075993626,0.00066069537,0.02031799,0.00009529391],"about_ca_topic_score_codex":0.00048179296,"about_ca_topic_score_gemma":0.0017206102,"teacher_disagreement_score":0.0047026174,"about_ca_system_score_codex":0.0006712468,"about_ca_system_score_gemma":0.0009976047,"threshold_uncertainty_score":0.015731871},"labels":[],"label_agreement":null},{"id":"W4387026331","doi":"10.1016/j.jaad.2023.07.514","title":"43744 Bimekizumab in bDMARD-naïve patients with psoriatic arthritis and skin involvement: Analysis of radiographic progression at Week 16 of BE OPTIMAL, a phase 3, multicenter, randomized, placebo- controlled, active reference study","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"UCB Pharma","keywords":"Medicine; Psoriatic arthritis; Tolerability; Placebo; Internal medicine; Psoriasis; Multicenter trial; Randomized controlled trial; Multicenter study; Gastroenterology; Arthritis; Surgery; Dermatology; Adverse effect; Pathology; Alternative medicine","score_opus":0.015716327021604214,"score_gpt":0.2906388282815742,"score_spread":0.27492250125997003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387026331","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99216425,0.0048849722,0.00034401286,0.00026441916,0.00015181521,0.00055950804,0.0005304716,0.00005837484,0.0010421566],"genre_scores_gemma":[0.9945931,0.001702081,0.0008152831,0.0004700049,0.0002790948,0.00049091014,0.00065668614,0.000016523561,0.0009762142],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99890745,0.00065989146,0.00005436893,0.00012496383,0.00012288481,0.00013037752],"domain_scores_gemma":[0.9988833,0.00034814872,0.00025492418,0.00008912577,0.00008393129,0.00034047134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002717132,0.0012578454,0.0033172418,0.00061445765,0.0004986186,0.0010547121,0.0008990428,0.0014377403,0.0028865163],"category_scores_gemma":[0.0017714327,0.00080867676,0.001667171,0.0004706499,0.000841918,0.0009357365,0.00033460956,0.0023807508,0.000576384],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.94097537,0.011725545,0.0056273243,0.00058537244,0.001957447,0.00007812222,0.00007339821,0.00056892453,0.007327679,0.00012176125,0.0010755578,0.02988357],"study_design_scores_gemma":[0.7925343,0.18367434,0.018913947,0.000039621205,0.0014057935,0.00013722025,0.000047225818,0.0009629424,0.001147448,0.0001453253,0.0009617653,0.000029989656],"about_ca_topic_score_codex":0.0007739235,"about_ca_topic_score_gemma":0.0015463599,"teacher_disagreement_score":0.0033172418,"about_ca_system_score_codex":0.00057109573,"about_ca_system_score_gemma":0.0010648511,"threshold_uncertainty_score":0.014369786},"labels":[],"label_agreement":null},{"id":"W4387026333","doi":"10.1016/j.jaad.2023.07.626","title":"42835 Efficacy and safety of roflumilast foam 0.3% in patients with seborrheic dermatitis in a phase 3 trial: Assessment of Pruritus","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Queen's University","funders":"","keywords":"Medicine; Tolerability; Roflumilast; Scalp; Clinical endpoint; Randomized controlled trial; Internal medicine; Adverse effect; Randomization; Gastroenterology; Dermatology","score_opus":0.012251089590632168,"score_gpt":0.3440580405928691,"score_spread":0.33180695100223695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387026333","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9855177,0.006743006,0.0004448899,0.0006494269,0.00023729655,0.0014212425,0.00079336675,0.00020657422,0.00398649],"genre_scores_gemma":[0.9910856,0.0028146866,0.00078048964,0.0008297323,0.00019645457,0.0010100512,0.00078247214,0.000030545823,0.0024699564],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99960953,0.00020197015,0.000022420056,0.000047358095,0.000039003546,0.00007977291],"domain_scores_gemma":[0.9996215,0.00012253271,0.00006267031,0.000027766953,0.00003551349,0.00012994942],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011794391,0.0010261944,0.0017058734,0.00035046317,0.00034589894,0.0008573515,0.0005834486,0.0013165722,0.0058230613],"category_scores_gemma":[0.00073628925,0.00045853207,0.0013882489,0.00031010364,0.00061314076,0.00069690385,0.00020361636,0.0023787064,0.0011988076],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.80352247,0.026454808,0.0021867135,0.001701413,0.0016889815,0.00029741516,0.00021802293,0.0012681468,0.03772601,0.00032577539,0.004250661,0.12035954],"study_design_scores_gemma":[0.738293,0.24709818,0.008475519,0.00008846714,0.0004713842,0.0002473517,0.00007834369,0.0011267138,0.0018452589,0.00016392104,0.0020743895,0.00003750367],"about_ca_topic_score_codex":0.0007992621,"about_ca_topic_score_gemma":0.0017463905,"teacher_disagreement_score":0.0058230613,"about_ca_system_score_codex":0.00039360035,"about_ca_system_score_gemma":0.00063144113,"threshold_uncertainty_score":0.01948011},"labels":[],"label_agreement":null},{"id":"W4387026341","doi":"10.1016/j.jaad.2023.07.891","title":"44063 Short Term Efficacy and Racial and Ethnic Diversity in Risankizumab Phase 3 Clinical Trials for Treatment of Moderate-to-Severe Plaque Psoriasis","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Medicine; Ethnic group; Clinical trial; Diversity (politics); Psoriasis; Plaque psoriasis; Dermatology; Internal medicine","score_opus":0.6591517899572624,"score_gpt":0.579525738351541,"score_spread":0.07962605160572145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387026341","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9845977,0.008522745,0.0005679064,0.00089822,0.00031299575,0.00037124334,0.001223297,0.000045099398,0.0034607563],"genre_scores_gemma":[0.99442154,0.0012278792,0.00042185248,0.0008018381,0.00016426318,0.00030989118,0.0011281022,0.000018174673,0.0015064224],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9969717,0.002211607,0.00019861704,0.00018084735,0.00021856795,0.00021864152],"domain_scores_gemma":[0.997053,0.0016476691,0.0005091625,0.00021069277,0.00023172113,0.00034763443],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0065255556,0.00046037417,0.0016444277,0.00033164205,0.0005092895,0.000988749,0.00037342714,0.0010371731,0.006172229],"category_scores_gemma":[0.005965631,0.00032785456,0.0027803262,0.00050816935,0.0004889272,0.00080892566,0.0004031901,0.0020999848,0.00078195153],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8682199,0.003357412,0.017706042,0.00059774367,0.008366346,0.000087743254,0.00017249987,0.0016471194,0.0041879173,0.00041754748,0.0043255994,0.09091419],"study_design_scores_gemma":[0.59925705,0.17681581,0.19573423,0.00028178244,0.009651297,0.00032514636,0.0002955125,0.004552316,0.0020414705,0.0014980482,0.009427456,0.00011995104],"about_ca_topic_score_codex":0.00083868275,"about_ca_topic_score_gemma":0.0017874782,"teacher_disagreement_score":0.0065255556,"about_ca_system_score_codex":0.000418731,"about_ca_system_score_gemma":0.0006986361,"threshold_uncertainty_score":0.03451085},"labels":[],"label_agreement":null},{"id":"W4387026349","doi":"10.1016/j.jaad.2023.07.729","title":"43759 Insights Into Baseline Demographics and Disease Characteristics in Subjects With Notalgia Paresthetica","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Musculoskeletal pain and rehabilitation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"","keywords":"Medicine; Demographics; Baseline (sea); Disease; Dermatology; Physical therapy; Internal medicine; Demography","score_opus":0.008448779242076765,"score_gpt":0.28305214146592905,"score_spread":0.2746033622238523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387026349","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99187076,0.0009101716,0.00023511531,0.00030205157,0.000031143274,0.000037969505,0.0019874983,0.000010211385,0.0046151704],"genre_scores_gemma":[0.9961488,0.0004462568,0.00023733295,0.0002783497,0.00005309191,0.00002646927,0.0016675551,0.000004827939,0.0011374421],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996524,0.00006823918,0.00004783775,0.000067571505,0.000070616596,0.00009338813],"domain_scores_gemma":[0.99963534,0.00007525749,0.00012066943,0.00001867353,0.00007572293,0.00007430174],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042069313,0.00018201586,0.00034910595,0.00067742856,0.00039846846,0.00062789384,0.00017199414,0.00028204187,0.0028588956],"category_scores_gemma":[0.0010651337,0.00011155582,0.00027828952,0.00085413194,0.0001057674,0.00040422054,0.00027915742,0.00038978478,0.0007730526],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022370955,0.0001813515,0.98615485,0.000030778916,0.00003298196,0.00030059027,0.00013325861,0.000034813245,0.0013606267,0.000054650587,0.00061417685,0.010878144],"study_design_scores_gemma":[0.0000070277933,0.00010152247,0.9983126,0.000014533361,0.000013253969,0.00038641295,0.000220092,0.000082026265,0.00008515159,0.000040130537,0.00073401054,0.0000032341898],"about_ca_topic_score_codex":0.006302262,"about_ca_topic_score_gemma":0.009285025,"teacher_disagreement_score":0.006302262,"about_ca_system_score_codex":0.0003147745,"about_ca_system_score_gemma":0.00045780966,"threshold_uncertainty_score":0.012531161},"labels":[],"label_agreement":null},{"id":"W4387026350","doi":"10.1016/j.jaad.2023.07.679","title":"44309 Food Insecurity in People with Hidradenitis Suppurativa – Preliminary Results from A Cross Sectional Study","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Bausch Health; Ortho Dermatologics","keywords":"Hidradenitis suppurativa; Medicine; Cross-sectional study; Food insecurity; Environmental health; Dermatology; Food security; Pathology; Disease","score_opus":0.025064771395655747,"score_gpt":0.3266143918422493,"score_spread":0.3015496204465935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387026350","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99885166,0.00017940071,0.00004474589,0.000040982304,0.000011267716,0.000028221119,0.0004365026,0.0000013122557,0.0004058303],"genre_scores_gemma":[0.9988551,0.00016257638,0.00008363935,0.00009568216,0.00001604634,0.00003508304,0.00044578227,0.0000014197958,0.00030474816],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99949515,0.00018403698,0.000063980355,0.00007350875,0.00007806608,0.0001052898],"domain_scores_gemma":[0.9986534,0.00028847373,0.00044972473,0.00008885365,0.00017969243,0.0003398257],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00096277415,0.00040091004,0.00045350916,0.00092655385,0.000984091,0.000991325,0.00038677713,0.0008383979,0.0025315362],"category_scores_gemma":[0.0020385038,0.0007022052,0.0008894861,0.0017130573,0.0003754173,0.00090248365,0.00067296764,0.0009286543,0.0005978081],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012740107,0.00018563142,0.9987495,0.0000108866125,0.00005113045,0.00009028948,0.00021671137,0.000007540792,0.00010606708,0.000005136893,0.000040343268,0.00040936653],"study_design_scores_gemma":[0.00001082143,0.00028176268,0.9987846,0.0000063406574,0.0000313635,0.000120812474,0.00062042027,0.000024429879,0.000017814878,0.0000059408844,0.00009198758,0.0000035834694],"about_ca_topic_score_codex":0.007244644,"about_ca_topic_score_gemma":0.010141957,"teacher_disagreement_score":0.007244644,"about_ca_system_score_codex":0.00027769717,"about_ca_system_score_gemma":0.00037853522,"threshold_uncertainty_score":0.0144049525},"labels":[],"label_agreement":null},{"id":"W4387026351","doi":"10.1016/j.jaad.2023.07.741","title":"42766 JAK of All Trades: Novel Off-Label Use of the Systemic JAK Inhibitor Upadacitinib As An Adjunct to Systemic Biologic Therapy for Various Immune-Mediated Inflammatory Diseases of the Skin","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Autoimmune Bullous Skin Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of Alberta; SKiN Health; Western University","funders":"Eli Lilly and Company","keywords":"Medicine; Adalimumab; Secukinumab; Infliximab; Etanercept; Dermatology; Psoriasis; Ustekinumab; Adverse effect; Janus kinase; Atopic dermatitis; Systemic therapy; Internal medicine; Immunology; Psoriatic arthritis; Disease; Tumor necrosis factor alpha; Cytokine; Cancer","score_opus":0.035045833619410695,"score_gpt":0.31507777161785827,"score_spread":0.28003193799844756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387026351","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8127309,0.07165783,0.005994856,0.008354111,0.0028875591,0.00057051936,0.001704062,0.0009679157,0.095132194],"genre_scores_gemma":[0.97266495,0.009103006,0.0023524777,0.0022411211,0.00054529944,0.000094456766,0.0007635258,0.000046255907,0.012188821],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.99989164,0.000017536186,0.000007445284,0.000021667684,0.000027758091,0.000034009052],"domain_scores_gemma":[0.9999318,0.000013592567,0.000011643115,0.0000060548446,0.00000794611,0.00002886633],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021362037,0.0002888096,0.0005555395,0.00031054713,0.00033697078,0.00069095264,0.00028983073,0.0005894554,0.006956314],"category_scores_gemma":[0.00020414416,0.000096874086,0.00045634893,0.00019701305,0.0002611435,0.00035539086,0.0002731648,0.0012314756,0.0013495235],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013221382,0.00235971,0.004465352,0.00090003945,0.00030771972,0.0063053397,0.00011609378,0.00079350837,0.11117196,0.003352022,0.03375036,0.8232566],"study_design_scores_gemma":[0.021766242,0.041864824,0.048749056,0.00088592677,0.0018881467,0.08830861,0.00029519983,0.012136812,0.16436847,0.0036209452,0.61583084,0.00028493488],"about_ca_topic_score_codex":0.0003639407,"about_ca_topic_score_gemma":0.0017812508,"teacher_disagreement_score":0.006956314,"about_ca_system_score_codex":0.0003498261,"about_ca_system_score_gemma":0.0003152971,"threshold_uncertainty_score":0.023271143},"labels":[],"label_agreement":null},{"id":"W4387026365","doi":"10.1016/j.jaad.2023.07.903","title":"42148 Stringent Disease Activity Control at 2 Years Across Psoriatic Arthritis Domains Irrespective of Baseline Characteristics in Patients Treated with Guselkumab: Post-Hoc Analysis of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; GDI Integrated Facility Services (Canada)","funders":"","keywords":"Medicine; Post-hoc analysis; Post hoc; Placebo; Psoriatic arthritis; Double blind; Physical therapy; Internal medicine; Arthritis; Alternative medicine; Pathology","score_opus":0.07958087571950129,"score_gpt":0.4075303536650777,"score_spread":0.32794947794557644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387026365","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951245,0.0017718013,0.0004291132,0.00015541953,0.00024368288,0.0011000058,0.0004305941,0.00004321813,0.0007017233],"genre_scores_gemma":[0.99593085,0.00070587953,0.00063697726,0.000263132,0.00025591973,0.0010496483,0.000493361,0.000016115931,0.0006479785],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99781847,0.0013730127,0.00014576466,0.00026338847,0.00011459774,0.0002848756],"domain_scores_gemma":[0.9982755,0.0007584599,0.00028457155,0.00023485448,0.00012901922,0.00031757937],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003276419,0.0016088722,0.005523599,0.00046563963,0.0005515263,0.001167792,0.0007807264,0.0016078914,0.005271878],"category_scores_gemma":[0.0024685632,0.000766533,0.0041335854,0.0005336051,0.0012269503,0.0011278415,0.00053403043,0.0028703394,0.00069452287],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98966694,0.0027600997,0.00057174073,0.00015436228,0.0009749258,0.000013188384,0.000015509406,0.00013481845,0.0014739292,0.000024192695,0.00012790639,0.0040823603],"study_design_scores_gemma":[0.8477323,0.14070049,0.008403998,0.00002268572,0.0017298667,0.000018771945,0.000024578989,0.00041221574,0.00059069536,0.000082224906,0.0002603267,0.00002178768],"about_ca_topic_score_codex":0.0008373756,"about_ca_topic_score_gemma":0.0014976847,"teacher_disagreement_score":0.005523599,"about_ca_system_score_codex":0.00061551295,"about_ca_system_score_gemma":0.0013083696,"threshold_uncertainty_score":0.01763618},"labels":[],"label_agreement":null},{"id":"W4387026372","doi":"10.1016/j.jaad.2023.07.634","title":"40665 Efficacy of Apremilast in Patients With Moderate-to-Severe Genital Psoriasis: Body Surface Area Subgroup Results From the Phase 3 DISCREET Trial","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lynde Centre for Dermatology; Probity Medical Research; Guenther Dermatology Research Centre","funders":"","keywords":"Apremilast; Medicine; Psoriasis; Dermatology; Body surface area; Clinical trial; Randomized controlled trial; Internal medicine; Psoriatic arthritis","score_opus":0.01914038285220168,"score_gpt":0.270290612974961,"score_spread":0.2511502301227593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387026372","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9664338,0.02124044,0.0008052842,0.001734863,0.00070277636,0.0009866167,0.0021059376,0.0002463294,0.005743946],"genre_scores_gemma":[0.9851046,0.00522886,0.0007689474,0.001991081,0.0005235801,0.0005394487,0.0018882283,0.00004223133,0.0039129704],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9996389,0.00019169693,0.000018811623,0.000049026392,0.000035983045,0.00006558205],"domain_scores_gemma":[0.9996075,0.00012172525,0.00009675987,0.00003475799,0.000024679566,0.000114606526],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012693711,0.0011640342,0.0023951968,0.0002561837,0.0002929396,0.0010790804,0.0005006954,0.001018304,0.0060053715],"category_scores_gemma":[0.00096455816,0.00037413643,0.0024233507,0.00030854213,0.000423767,0.0006895186,0.00029719868,0.002595943,0.0008177353],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.92590016,0.0025896803,0.0027457236,0.0013272009,0.004375891,0.000120510005,0.00007364718,0.0010999971,0.0069297226,0.00029497614,0.0036061837,0.05093634],"study_design_scores_gemma":[0.9194102,0.057195317,0.015109741,0.00013495983,0.002653557,0.00017054306,0.000078623314,0.0008907358,0.0005628313,0.00084387476,0.00290111,0.00004841791],"about_ca_topic_score_codex":0.00056625064,"about_ca_topic_score_gemma":0.0018272566,"teacher_disagreement_score":0.0060053715,"about_ca_system_score_codex":0.00039009424,"about_ca_system_score_gemma":0.00054080895,"threshold_uncertainty_score":0.020089984},"labels":[],"label_agreement":null},{"id":"W4387026377","doi":"10.1016/j.jaad.2023.07.714","title":"42065 Improvement in Itch, Symptoms, and Quality of Life With Upadacitinib Through Week 16 in Adults and Adolescents With Atopic Dermatitis: Results From Phase 3 Studies (Measure Up 1, Measure Up 2, and AD Up)","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"Ortho Dermatologics","keywords":"Medicine; Placebo; Atopic dermatitis; Post-hoc analysis; Quality of life (healthcare); Internal medicine; Anesthesia; Dermatology","score_opus":0.03957076075616715,"score_gpt":0.33871127887490216,"score_spread":0.299140518118735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387026377","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944878,0.0038602601,0.00009695632,0.00010002851,0.00004167002,0.00029232708,0.00047421304,0.00003159937,0.00061516056],"genre_scores_gemma":[0.9956124,0.002093327,0.00037568778,0.00023101372,0.000042473694,0.00030445136,0.00069989666,0.0000063083667,0.00063451356],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99957424,0.00018148482,0.00003611462,0.000050979976,0.00007215677,0.00008491474],"domain_scores_gemma":[0.9995629,0.00008947556,0.00014140147,0.000030594278,0.0000603542,0.00011514654],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014839033,0.00047645884,0.001549275,0.00032447177,0.00026866773,0.0005451989,0.00033679223,0.00054059684,0.0017364565],"category_scores_gemma":[0.0008571159,0.0002491501,0.0017859787,0.00040961607,0.0002818615,0.0005835813,0.0002693556,0.0014299728,0.00026308803],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.54750663,0.038346943,0.067650124,0.0028506,0.009091047,0.00019987441,0.0004521743,0.0013048995,0.019501446,0.00014467764,0.00417814,0.30877343],"study_design_scores_gemma":[0.2102457,0.39061502,0.38653097,0.0003509458,0.004277787,0.0003079782,0.000244537,0.00092862657,0.0033939157,0.000100774894,0.0029406901,0.00006309206],"about_ca_topic_score_codex":0.0014411543,"about_ca_topic_score_gemma":0.004399432,"teacher_disagreement_score":0.0017364565,"about_ca_system_score_codex":0.00038474222,"about_ca_system_score_gemma":0.00048535934,"threshold_uncertainty_score":0.007847726},"labels":[],"label_agreement":null},{"id":"W4387026410","doi":"10.1016/j.jaad.2023.07.539","title":"44373 Characterizing the Cutaneous Late Effects of Haematopoietic Stem Cell Transplantation: A Systematic Review.","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto; Queen's University","funders":"","keywords":"Medicine; Stem cell; Hematopoietic stem cell transplantation; Haematopoiesis; Transplantation; Oncology; Dermatology; Surgery","score_opus":0.012600707138613549,"score_gpt":0.28236471660098633,"score_spread":0.2697640094623728,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387026410","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0033680387,0.9948265,0.00011329182,0.00023696004,0.00007764876,0.00012382088,0.0009294692,0.0000036370532,0.00032064578],"genre_scores_gemma":[0.073338985,0.9233155,0.0005267926,0.0011483906,0.00018339076,0.00037487198,0.0008909893,0.00000554933,0.0002154213],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9958592,0.0015666853,0.0014167847,0.00038322122,0.0006250899,0.00014908866],"domain_scores_gemma":[0.9750048,0.019007485,0.0038749215,0.0003543703,0.0015641069,0.00019421965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004722458,0.0006406298,0.003736318,0.0028763616,0.00035495253,0.0012353907,0.0008168377,0.000995312,0.0044440147],"category_scores_gemma":[0.025226485,0.00037648674,0.005891393,0.0035098554,0.0003804655,0.0009595265,0.00073989615,0.00072265865,0.00030731826],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013644778,0.00003766208,0.009539537,0.8788473,0.039567184,0.00017673316,0.00016525328,0.000119838776,0.00042560181,0.00021278721,0.0036581843,0.065885514],"study_design_scores_gemma":[0.0012666032,0.0006588774,0.045897614,0.5738089,0.3467971,0.0009725911,0.00042045777,0.00016798096,0.00053914037,0.00049404235,0.02889924,0.000077407436],"about_ca_topic_score_codex":0.0038580569,"about_ca_topic_score_gemma":0.015505556,"teacher_disagreement_score":0.004722458,"about_ca_system_score_codex":0.0010051429,"about_ca_system_score_gemma":0.0032604125,"threshold_uncertainty_score":0.024975061},"labels":[],"label_agreement":null},{"id":"W4387026417","doi":"10.1016/j.jaad.2023.07.625","title":"42828 Efficacy and safety of roflumilast cream 0.3% in patients with chronic plaque psoriasis: pooled PASI and PASI-HD results from the DERMIS-1 and DERMIS-2 Phase 3 Trials","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Phosphodiesterase function and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Probity Medical Research","funders":"","keywords":"Medicine; Roflumilast; Psoriasis Area and Severity Index; Psoriasis; Plaque psoriasis; Clinical endpoint; Dermatology; Clinical trial; Adverse effect; Randomized controlled trial; Internal medicine; Dermis; Surgery; Pathology","score_opus":0.013652893191447956,"score_gpt":0.28742618076971826,"score_spread":0.2737732875782703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387026417","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9232219,0.061604567,0.000991354,0.0009603709,0.00044707482,0.0008858758,0.0019732707,0.00033340536,0.009582325],"genre_scores_gemma":[0.9805685,0.012341981,0.0007405058,0.00095271756,0.00043436192,0.00042540807,0.0016316791,0.000032048814,0.002872688],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9995128,0.00025362865,0.00003709546,0.00006692406,0.00006537901,0.00006415465],"domain_scores_gemma":[0.9995597,0.00017685801,0.00009985258,0.000030532385,0.00004530288,0.00008781011],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015115385,0.0009479712,0.002877445,0.00039310855,0.00022671476,0.00081927684,0.0003928218,0.0008671188,0.003061175],"category_scores_gemma":[0.00084962446,0.0003891944,0.0016511824,0.0004013448,0.00030682495,0.0005926871,0.00018447824,0.001408081,0.0009686619],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.62492114,0.0067550708,0.008354094,0.0038455224,0.011793119,0.00028109888,0.00012107514,0.0019728686,0.040402845,0.00028244115,0.0068526757,0.2944181],"study_design_scores_gemma":[0.7070873,0.20504794,0.06353101,0.00039582804,0.0079927,0.0007944223,0.00013699022,0.0019230549,0.0038190938,0.00047303177,0.008700232,0.00009838996],"about_ca_topic_score_codex":0.0005100316,"about_ca_topic_score_gemma":0.0017662226,"teacher_disagreement_score":0.003061175,"about_ca_system_score_codex":0.00028624758,"about_ca_system_score_gemma":0.00041367876,"threshold_uncertainty_score":0.010240674},"labels":[],"label_agreement":null},{"id":"W4387026420","doi":"10.1016/j.jaad.2023.07.609","title":"42551 Earlier Detection of Invasive Melanoma After the COVID-19 Pandemic","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Griffith University; University of Leeds; University of Oxford; Janssen Scientific Affairs; Ottawa Hospital Research Institute; McGill University; University of Ottawa; Leeds Biomedical Research Centre; University of Washington","keywords":"Medicine; Pandemic; Melanoma; Coronavirus disease 2019 (COVID-19); Retrospective cohort study; Stage (stratigraphy); Dermatology; Internal medicine; Disease; Infectious disease (medical specialty)","score_opus":0.0716172363060159,"score_gpt":0.4016441213643209,"score_spread":0.330026885058305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387026420","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92023295,0.0044888877,0.00074119424,0.0076576006,0.0014385969,0.00012226032,0.008520572,0.00012561116,0.056672227],"genre_scores_gemma":[0.9904214,0.0009811438,0.00035478428,0.001719242,0.0003558249,0.000029480314,0.0021406722,0.000021839487,0.0039755525],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987388,0.0002340171,0.000081087455,0.00023385536,0.00029145207,0.0004208044],"domain_scores_gemma":[0.99602795,0.00065511244,0.0012732848,0.0002587294,0.0010752024,0.0007098024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008941806,0.0002839026,0.00026482574,0.0009856307,0.0006774298,0.0015693785,0.0004141998,0.0012076469,0.013430068],"category_scores_gemma":[0.006637493,0.0002466372,0.00049039343,0.0008731892,0.00023756256,0.0009381925,0.00079176994,0.0017305607,0.0019366236],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020333202,0.00011377037,0.9707245,0.00009162873,0.000035751913,0.00037996442,0.0002010791,0.00008913467,0.00088514516,0.00020795666,0.009107526,0.01796014],"study_design_scores_gemma":[0.00000800156,0.00012359144,0.9900233,0.00014234026,0.000024701741,0.00071121246,0.0007249881,0.0002099668,0.0003435365,0.00011449289,0.0075611626,0.000012653891],"about_ca_topic_score_codex":0.026183441,"about_ca_topic_score_gemma":0.024660094,"teacher_disagreement_score":0.026183441,"about_ca_system_score_codex":0.0009532688,"about_ca_system_score_gemma":0.00075991714,"threshold_uncertainty_score":0.052062035},"labels":[],"label_agreement":null},{"id":"W4387026423","doi":"10.1016/j.jaad.2023.07.512","title":"41032 Beyond Acne Vulgaris: Role of Cutibacterium Acnes in Atopic Dermatitis and Psoriasis","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Medicine; Acne; Psoriasis; Dermatology; Atopic dermatitis","score_opus":0.009081781180555179,"score_gpt":0.28640313302205533,"score_spread":0.27732135184150014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387026423","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.078367606,0.85368663,0.0006103271,0.016615985,0.0034057845,0.000044339173,0.00031602144,0.00005362401,0.04689974],"genre_scores_gemma":[0.51312834,0.42660472,0.0019365138,0.00694047,0.009690088,0.000055330584,0.0004903362,0.000029984101,0.04112426],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99983346,0.000055889395,0.000015910166,0.000017588927,0.00005214087,0.000025141593],"domain_scores_gemma":[0.9997453,0.00007710607,0.000046068886,0.000009824547,0.000058678455,0.0000629385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037828434,0.0003311602,0.0004753044,0.00066208886,0.0002691302,0.0010387785,0.00024829898,0.0009786647,0.010518043],"category_scores_gemma":[0.0003579741,0.00010672105,0.00023522193,0.00061175384,0.00037073207,0.0009797753,0.00041072263,0.00095910794,0.0015531715],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004102359,0.0009727286,0.019495996,0.0043410445,0.00012851821,0.0036705825,0.00037141083,0.000303303,0.04551254,0.009259848,0.04083946,0.8710022],"study_design_scores_gemma":[0.0005971097,0.0034811187,0.17847149,0.0025548541,0.00037054918,0.0143037215,0.0009596541,0.00086738536,0.0051880097,0.010472723,0.782659,0.000074410826],"about_ca_topic_score_codex":0.0008432785,"about_ca_topic_score_gemma":0.002215038,"teacher_disagreement_score":0.010518043,"about_ca_system_score_codex":0.00023001735,"about_ca_system_score_gemma":0.00046181402,"threshold_uncertainty_score":0.03518635},"labels":[],"label_agreement":null},{"id":"W4387341321","doi":"10.1016/j.jaad.2023.09.070","title":"Onset of psoriasis with immune checkpoint inhibitor therapy: A systematic review","year":2023,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Toronto; Western University","funders":"","keywords":"Psoriasis; Medicine; Adverse effect; Dermatology; Immune system; Immune checkpoint; Intensive care medicine; Oncology; Internal medicine; Immunology; Immunotherapy","score_opus":0.0448462268079264,"score_gpt":0.36322248899155074,"score_spread":0.31837626218362436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387341321","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00089637376,0.9984799,0.00005830616,0.000082948995,0.000058034882,0.00006186554,0.00024467852,0.000003967114,0.00011389823],"genre_scores_gemma":[0.022440745,0.97619706,0.00029921063,0.00062013493,0.00007527611,0.0000998876,0.00016978188,0.0000045305655,0.00009335746],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9973788,0.00069121923,0.0010021895,0.00039286647,0.00040485832,0.00013014449],"domain_scores_gemma":[0.99095285,0.0058938568,0.0023646106,0.00011556763,0.00051133754,0.00016171497],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028435613,0.0011926555,0.007972702,0.0039806454,0.0003840209,0.0020103871,0.0014995356,0.0017235997,0.0060648555],"category_scores_gemma":[0.011953296,0.0009857359,0.009666989,0.005248313,0.0005719376,0.0016613085,0.0014500024,0.0015229058,0.0003151354],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070080796,0.000027979004,0.0022506325,0.9187623,0.047520597,0.00012369853,0.0001267367,0.000098688244,0.00015620951,0.00011784118,0.0019348728,0.028179565],"study_design_scores_gemma":[0.001552461,0.00041256106,0.017333172,0.4959918,0.46434754,0.00076025445,0.00033802076,0.00012735915,0.00015910728,0.0003744647,0.018507432,0.00009590452],"about_ca_topic_score_codex":0.0079987105,"about_ca_topic_score_gemma":0.031391934,"teacher_disagreement_score":0.0079987105,"about_ca_system_score_codex":0.0016962917,"about_ca_system_score_gemma":0.0036404426,"threshold_uncertainty_score":0.020289004},"labels":[],"label_agreement":null},{"id":"W4387666949","doi":"10.1016/j.jaad.2023.10.020","title":"Efficacy and safety of apremilast in patients with moderate-to-severe genital psoriasis: Results from DISCREET, a phase 3 randomized, double-blind, placebo-controlled trial","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Lynde Centre for Dermatology; Probity Medical Research; Guenther Dermatology Research Centre","funders":"Amgen","keywords":"Apremilast; Medicine; Psoriasis; Placebo; Adverse effect; Randomized controlled trial; Clinical endpoint; Internal medicine; Dermatology; Psoriatic arthritis; Pathology; Alternative medicine","score_opus":0.01753623319444852,"score_gpt":0.2776379369077473,"score_spread":0.26010170371329877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387666949","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95058256,0.03022699,0.0014421139,0.0015711829,0.0007757455,0.0065281847,0.0027660993,0.00026740844,0.0058396035],"genre_scores_gemma":[0.9789493,0.0074115368,0.0027581446,0.0021226138,0.0007044589,0.003907712,0.0018732172,0.000035434903,0.0022374543],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9989197,0.00057589856,0.00011526719,0.00015921792,0.00015472718,0.00007524501],"domain_scores_gemma":[0.998292,0.00057414314,0.0005524999,0.000118954056,0.00012823824,0.000334045],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003252836,0.0009753095,0.0026619683,0.00033924423,0.00042688628,0.0012622674,0.000782863,0.0014527473,0.008488389],"category_scores_gemma":[0.0032402987,0.00044380402,0.002679669,0.00040387138,0.00079057686,0.0010006846,0.00031572423,0.0023948094,0.00077745965],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9431368,0.0052873218,0.0014877707,0.0027766922,0.0022073674,0.00008294411,0.00007859134,0.0002818308,0.0048899897,0.0001164143,0.001755325,0.037899017],"study_design_scores_gemma":[0.9582295,0.036019932,0.0035588737,0.00011215577,0.0005790527,0.00011766599,0.000018801617,0.00021976298,0.000331319,0.0001281619,0.00067104027,0.000013944992],"about_ca_topic_score_codex":0.00024522917,"about_ca_topic_score_gemma":0.0007763085,"teacher_disagreement_score":0.008488389,"about_ca_system_score_codex":0.00043992008,"about_ca_system_score_gemma":0.0009566725,"threshold_uncertainty_score":0.028396487},"labels":[],"label_agreement":null},{"id":"W4387844428","doi":"10.1016/j.jaad.2023.10.031","title":"Association between alopecia areata and atopic dermatitis: A nested case-control study of the All of Us database","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"Glenmark Pharmaceuticals; Castle Biosciences; National Institutes of Health; Incyte; Regeneron Pharmaceuticals; Celgene; Sanofi; Pfizer; Eli Lilly and Company","keywords":"Medicine; Alopecia areata; Atopic dermatitis; Dermatology; Nested case-control study; Association (psychology); Case-control study; Internal medicine","score_opus":0.023933729920376002,"score_gpt":0.319187006240313,"score_spread":0.295253276319937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387844428","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99869907,0.00021957458,0.000112294656,0.0000224958,0.00000734887,0.000013861601,0.00071130187,0.0000037581922,0.00021030144],"genre_scores_gemma":[0.99898404,0.000076212935,0.0001231824,0.000036379915,0.000008380525,0.000016390772,0.0006192724,0.0000035942417,0.00013265724],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982414,0.0005232715,0.00017661163,0.00062852463,0.00022650191,0.00020378806],"domain_scores_gemma":[0.9977914,0.00039402224,0.00082209206,0.00045440346,0.00023911355,0.0002990639],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009466706,0.0004239674,0.00075323763,0.0010738464,0.00095270126,0.0010763223,0.0008757826,0.0005826948,0.0012215432],"category_scores_gemma":[0.0024931014,0.0007107456,0.0010749492,0.0018447391,0.0005193138,0.0006083237,0.00077859516,0.00080322055,0.00020673033],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044321697,0.00015135693,0.99731064,0.000018063636,0.00044412538,0.00017577899,0.00016235736,0.000028822007,0.0006426136,0.000035809993,0.00019641401,0.0003908093],"study_design_scores_gemma":[0.000057583595,0.00011424954,0.99834204,0.000007936156,0.000249043,0.00038385057,0.00024923187,0.00024207165,0.000078906,0.000026247113,0.00024151085,0.000007456523],"about_ca_topic_score_codex":0.026169105,"about_ca_topic_score_gemma":0.031778343,"teacher_disagreement_score":0.026169105,"about_ca_system_score_codex":0.0006214414,"about_ca_system_score_gemma":0.00058554026,"threshold_uncertainty_score":0.052033544},"labels":[],"label_agreement":null},{"id":"W4387881600","doi":"10.1016/j.jaad.2023.10.032","title":"More than just methylisothiazolinone: Retrospective analysis of patients with isothiazolinone allergy in North America, 2017-2020","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Contact Dermatitis and Allergies","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Université Laval; Sunnybrook Health Science Centre; University of Toronto; Health Sciences Centre","funders":"","keywords":"Medicine; Allergy; Dermatology; Sensitization; Allergic contact dermatitis; Patch test; Contact dermatitis; Retrospective cohort study; Internal medicine; Gastroenterology; Immunology","score_opus":0.012677202170367219,"score_gpt":0.28945925682126816,"score_spread":0.27678205465090094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387881600","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980478,0.0009200314,0.000040997384,0.00004187222,0.000011219076,0.000005763828,0.00035354565,0.0000030003239,0.0005758406],"genre_scores_gemma":[0.99905294,0.00039885237,0.00003615294,0.00007428054,0.000020242282,0.0000043202417,0.00030401425,0.0000030957694,0.00010610942],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99933124,0.00009933828,0.00010970754,0.00018626568,0.00013969066,0.0001337296],"domain_scores_gemma":[0.99834,0.00026692252,0.0008321685,0.00012948587,0.00016424686,0.00026717418],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029727237,0.00025036716,0.00040371856,0.00087638624,0.000540208,0.0007582057,0.00030416434,0.00045072893,0.0021485619],"category_scores_gemma":[0.0011458282,0.00037805934,0.00056867074,0.001948928,0.00037779094,0.00068919006,0.0003985562,0.00051929126,0.00032751873],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010287019,0.00001954114,0.9984301,0.000010593101,0.000043003238,0.00042681186,0.000045372548,0.0000066983575,0.00020327566,0.000009169017,0.00009126317,0.0006113279],"study_design_scores_gemma":[0.000008062016,0.00007268981,0.9967865,0.000014124376,0.000075156175,0.0020489586,0.00053042494,0.000043067204,0.00006429233,0.000013578916,0.00033827778,0.000004886289],"about_ca_topic_score_codex":0.008188948,"about_ca_topic_score_gemma":0.013304469,"teacher_disagreement_score":0.008188948,"about_ca_system_score_codex":0.00042409875,"about_ca_system_score_gemma":0.00075749063,"threshold_uncertainty_score":0.016282618},"labels":[],"label_agreement":null},{"id":"W4388312772","doi":"10.1016/j.jaad.2023.08.112","title":"Preliminary summary and reclassification of cases from the Pediatric Research of Management in Stevens-Johnson syndrome and Epidermonecrolysis (PROMISE) study: A North American, multisite retrospective cohort","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; University of Calgary; Children's Hospital of Eastern Ontario; Hospital for Sick Children; Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine; Alberta Children's Hospital","funders":"Pediatric Dermatology Research Alliance","keywords":"Medicine; Retrospective cohort study; Cohort study; Family medicine; Pediatrics; Surgery; Internal medicine","score_opus":0.05112478543127793,"score_gpt":0.3660042951600795,"score_spread":0.3148795097288016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388312772","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98149914,0.00032874517,0.0012507681,0.00013752225,0.00002950532,0.0002123603,0.012798914,0.000032309777,0.003710789],"genre_scores_gemma":[0.98630583,0.00027154916,0.0008526062,0.00011674485,0.000033192224,0.00022867497,0.011147588,0.00003352467,0.0010101733],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972339,0.00071017264,0.0005665328,0.00071379344,0.00042787555,0.0003476478],"domain_scores_gemma":[0.9947076,0.00081997336,0.0017369775,0.0011826899,0.0011305648,0.0004222673],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022947765,0.0003810412,0.00046389297,0.0021036542,0.0010515292,0.0010126434,0.00059852813,0.0005119009,0.0046164338],"category_scores_gemma":[0.0068193353,0.00038281744,0.00080615934,0.002172327,0.0002540539,0.0007940211,0.00061559596,0.00051679,0.0009530708],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013403727,0.000030459792,0.99694073,0.000012154178,0.00004103992,0.00029479412,0.00013616716,0.000027285525,0.00036709968,0.000038808037,0.00051576056,0.0014616107],"study_design_scores_gemma":[0.000017062266,0.00012033362,0.9963887,0.000013859016,0.000060441333,0.001344843,0.0005752461,0.00011018396,0.00021041466,0.000034439552,0.0011168513,0.0000076029687],"about_ca_topic_score_codex":0.008130817,"about_ca_topic_score_gemma":0.009426716,"teacher_disagreement_score":0.008130817,"about_ca_system_score_codex":0.00040729734,"about_ca_system_score_gemma":0.0006398637,"threshold_uncertainty_score":0.016166985},"labels":[],"label_agreement":null},{"id":"W4388454963","doi":"10.1016/j.jaad.2023.08.102","title":"Guidelines of care for the management of atopic dermatitis in adults with phototherapy and systemic therapies","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":215,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"American Academy of Dermatology","keywords":"Medicine; Atopic dermatitis; Dermatology; Intensive care medicine","score_opus":0.01649695844230801,"score_gpt":0.3198586223176512,"score_spread":0.3033616638753432,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388454963","genre_codex":"review","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015561933,0.3557067,0.054121193,0.32368508,0.018911194,0.006708484,0.0049372874,0.0017894942,0.21857873],"genre_scores_gemma":[0.10412602,0.29859233,0.40302807,0.11234638,0.012760634,0.010730909,0.014990292,0.00046968964,0.042955615],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99485517,0.0017993009,0.0016022006,0.00015689373,0.0012381873,0.00034819252],"domain_scores_gemma":[0.9884192,0.002849243,0.0017368672,0.00018803713,0.005807674,0.0009989497],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037841557,0.0010647735,0.0015391441,0.0030238016,0.0015742524,0.00218947,0.0029886472,0.004951706,0.0048634927],"category_scores_gemma":[0.0149623705,0.00046706418,0.0027347135,0.0015572573,0.00076642237,0.0011701193,0.0015027771,0.0057990565,0.0026124588],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021839204,0.00081393594,0.009162214,0.0032779637,0.00024311681,0.0018387885,0.000639575,0.0019082086,0.0011973169,0.0084425425,0.6025012,0.36975673],"study_design_scores_gemma":[0.00063341775,0.00035917247,0.027746422,0.03180763,0.0004948688,0.0060255365,0.0007981462,0.0024760244,0.00085346296,0.009325821,0.91932076,0.00015872714],"about_ca_topic_score_codex":0.01563832,"about_ca_topic_score_gemma":0.03823901,"teacher_disagreement_score":0.01563832,"about_ca_system_score_codex":0.0027795818,"about_ca_system_score_gemma":0.00948015,"threshold_uncertainty_score":0.03109461},"labels":[],"label_agreement":null},{"id":"W4388456111","doi":"10.1016/j.jaad.2023.08.103","title":"Executive summary: Guidelines of care for the management of atopic dermatitis in adults with phototherapy and systemic therapies","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"American Academy of Dermatology","keywords":"Medicine; Atopic dermatitis; Dermatology; Executive summary; MEDLINE; Intensive care medicine","score_opus":0.015995978812012614,"score_gpt":0.28062449977625,"score_spread":0.2646285209642374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388456111","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017123558,0.17315775,0.007702376,0.55987936,0.084546454,0.0062663574,0.030162241,0.0010898033,0.13548332],"genre_scores_gemma":[0.0148164565,0.24581198,0.07039658,0.41170982,0.07579911,0.012443791,0.06877625,0.00096383883,0.099282175],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9910796,0.0030804405,0.0022125912,0.00035011783,0.002610102,0.00066714786],"domain_scores_gemma":[0.93949986,0.012848354,0.009821166,0.0009031811,0.03160868,0.005318769],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010201738,0.0014512691,0.0029318405,0.0035557551,0.0012437612,0.0037909853,0.004076252,0.010117247,0.022533653],"category_scores_gemma":[0.04251372,0.00077436643,0.0023569637,0.004206486,0.0008245289,0.0022551785,0.001847936,0.008379289,0.018560192],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057341313,0.000064520515,0.000375883,0.0012146789,0.000021570278,0.000039359555,0.000024734078,0.00013541071,0.000060386286,0.00063131115,0.94122803,0.056146912],"study_design_scores_gemma":[0.00022969134,0.00007070414,0.004275467,0.010850804,0.00011540325,0.00017702498,0.00008241421,0.00021710187,0.00010066572,0.0011348462,0.982711,0.00003488389],"about_ca_topic_score_codex":0.013978262,"about_ca_topic_score_gemma":0.021187762,"teacher_disagreement_score":0.022533653,"about_ca_system_score_codex":0.0036751342,"about_ca_system_score_gemma":0.018385338,"threshold_uncertainty_score":0.07538259},"labels":[],"label_agreement":null},{"id":"W4388570445","doi":"10.1016/j.jaad.2023.11.005","title":"Orismilast in moderate-to-severe psoriasis: Efficacy and safety from a 16-week, randomized, double-blinded, placebo-controlled, dose-finding, and phase 2b trial (IASOS)","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Phosphodiesterase function and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health; Queen's University; Dalhousie University","funders":"Manchester Biomedical Research Centre; LEO Pharma; Simon Spies Fonden; Novo Nordisk Fonden; National Institute for Health and Care Research; Sanofi Genzyme; Incyte; Mylan; Horizon Therapeutics; Sun Pharma; Regeneron Pharmaceuticals; Sanofi; Galderma; Bristol-Myers Squibb; Eli Lilly and Company; Samsung; National Psoriasis Foundation; Galápagos; Meiji Seika Pharma; Pfizer; Amgen","keywords":"Medicine; Placebo; Double blinded; Psoriasis; Randomized controlled trial; Physical therapy; Surgery; Dermatology; Alternative medicine; Pathology","score_opus":0.025052605329066766,"score_gpt":0.3189194022564432,"score_spread":0.29386679692737644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388570445","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9817472,0.0062589627,0.0008994693,0.00096856063,0.00028414946,0.0055947467,0.0021235617,0.00021472813,0.0019084553],"genre_scores_gemma":[0.97321284,0.004985313,0.0038906145,0.0020454973,0.00069996837,0.007677125,0.0035717133,0.00006444117,0.0038523732],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99891424,0.000582089,0.00007966239,0.00018985657,0.00011810923,0.00011599657],"domain_scores_gemma":[0.9986487,0.00022663972,0.00040039115,0.00013588938,0.000121922145,0.00046649232],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0042433958,0.0015256657,0.00298016,0.000450707,0.00046072426,0.0010002342,0.0008713756,0.0016715229,0.0056635486],"category_scores_gemma":[0.0025418797,0.000652847,0.0022508213,0.0004994624,0.0009372074,0.0007845534,0.0005222293,0.0024108295,0.0008036351],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9534162,0.0092442725,0.0015197583,0.0010365517,0.0013978103,0.000052324063,0.00009238525,0.00026542845,0.008191369,0.00008020387,0.0016999858,0.02300349],"study_design_scores_gemma":[0.9407705,0.053867836,0.0036797752,0.000041459578,0.00045708317,0.000055431236,0.000011439055,0.00018170575,0.00032338643,0.0000600925,0.0005388376,0.000012414752],"about_ca_topic_score_codex":0.00038886786,"about_ca_topic_score_gemma":0.0011461355,"teacher_disagreement_score":0.0056635486,"about_ca_system_score_codex":0.00047185554,"about_ca_system_score_gemma":0.001355614,"threshold_uncertainty_score":0.022441447},"labels":[],"label_agreement":null},{"id":"W4388979729","doi":"10.1016/j.jaad.2023.10.066","title":"Risk of infections among patients with psoriasis on Janus kinase inhibitor treatment: A systematic review and meta-analysis","year":2023,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Health Sciences Centre; Women's College Hospital; McMaster University; University of Toronto; Sunnybrook Health Science Centre; Western University","funders":"","keywords":"Medicine; Meta-analysis; Psoriasis; Janus kinase; Janus kinase inhibitor; Tofacitinib; Randomized controlled trial; Dermatology; Incidence (geometry); Clinical trial; Systematic review; Internal medicine; MEDLINE","score_opus":0.03849742366906728,"score_gpt":0.3089216441822099,"score_spread":0.27042422051314263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388979729","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012635086,0.98590356,0.0003765772,0.000114874856,0.0001309501,0.00007987881,0.000555158,0.000020739497,0.00018308662],"genre_scores_gemma":[0.31557572,0.6801619,0.0015479516,0.0009266361,0.00025812545,0.0002595833,0.00080766703,0.000030481382,0.0004319841],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99719584,0.00096978317,0.0008621318,0.000499354,0.00029567664,0.00017731321],"domain_scores_gemma":[0.9950458,0.0032784843,0.0010162046,0.0001971662,0.00035853047,0.00010379045],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035910236,0.0019282682,0.011178939,0.0024752945,0.00042404153,0.0019227793,0.0014506909,0.00188758,0.0031731594],"category_scores_gemma":[0.008536159,0.0014466475,0.026657097,0.0039369105,0.00047303858,0.0011763559,0.0011924038,0.0018497778,0.00027287353],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036291638,0.00004423523,0.012172435,0.21847038,0.751131,0.00021000093,0.00010124511,0.000421297,0.00038105357,0.000091892514,0.0008493734,0.01249786],"study_design_scores_gemma":[0.0006327212,0.00015586278,0.008945601,0.008325924,0.98039585,0.000117326694,0.000052766405,0.00014332007,0.00007913852,0.000104850595,0.0010159808,0.00003063675],"about_ca_topic_score_codex":0.0058866837,"about_ca_topic_score_gemma":0.014469862,"teacher_disagreement_score":0.011178939,"about_ca_system_score_codex":0.000982929,"about_ca_system_score_gemma":0.0014860483,"threshold_uncertainty_score":0.01899141},"labels":[],"label_agreement":null},{"id":"W4389118705","doi":"10.1016/j.jaad.2023.10.067","title":"Risk factors and outcomes of melanoma in children and adolescents: A retrospective multicenter study","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Retrospective cohort study; Melanoma; Sentinel lymph node; Pediatrics; Referral; Mucosal melanoma; Cohort study; Surgery; Internal medicine; Cancer; Family medicine; Breast cancer","score_opus":0.008519171030876611,"score_gpt":0.2849518312130803,"score_spread":0.2764326601822037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389118705","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993893,0.00017554282,0.000032828433,0.000016119773,0.0000034639872,0.0000074021546,0.00022348277,0.0000014230078,0.00015051891],"genre_scores_gemma":[0.9994186,0.000140975,0.000052751304,0.000020307727,0.000011061376,0.000012968679,0.00029057966,0.000002220665,0.000050506394],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99929655,0.00016027634,0.000083308696,0.00020659826,0.00009652233,0.00015683236],"domain_scores_gemma":[0.9980028,0.0002556912,0.0010029187,0.00014252927,0.00018316033,0.00041280306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006422997,0.0004634596,0.00069449574,0.0011095406,0.0007153381,0.00088736304,0.00050545775,0.000640057,0.0012406791],"category_scores_gemma":[0.0018218862,0.0005384722,0.0007415254,0.0018611202,0.0005035186,0.00091959443,0.0006242944,0.0008879115,0.00021855088],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000064936685,0.000034145658,0.9994154,0.0000039871443,0.000029358776,0.0000972479,0.000041825642,0.000009676881,0.000055807133,0.0000092904875,0.000033238583,0.00020507762],"study_design_scores_gemma":[0.00001490793,0.00017654196,0.9979723,0.000008764788,0.000055204102,0.0008778655,0.00060222024,0.00007243015,0.000044864737,0.0000141364735,0.00015609755,0.000004723832],"about_ca_topic_score_codex":0.0058776406,"about_ca_topic_score_gemma":0.004677609,"teacher_disagreement_score":0.0058776406,"about_ca_system_score_codex":0.00072290114,"about_ca_system_score_gemma":0.0007838043,"threshold_uncertainty_score":0.0116868615},"labels":[],"label_agreement":null},{"id":"W4389430532","doi":"10.1016/j.jaad.2023.11.053","title":"Incidence and profile of skin cancers in patients following ultraviolet phototherapy without psoralens: A retrospective cohort study","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Skin Protection and Aging","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; Vancouver Coastal Health Research Institute; University of British Columbia; Vancouver Coastal Health","funders":"Institute of Musculoskeletal Health and Arthritis; Canadian Dermatology Foundation; British Association of Dermatologists; Michael Smith Health Research BC; Eczema Society of Canada; University of British Columbia","keywords":"Medicine; Retrospective cohort study; Incidence (geometry); Dermatology; Cohort; Ultraviolet a; Cohort study; Surgery; Internal medicine","score_opus":0.010439927673429083,"score_gpt":0.3172565657808687,"score_spread":0.3068166381074396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389430532","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99897194,0.00019740839,0.00006723814,0.000015295347,0.0000055733367,0.0000074725926,0.00044996644,0.000003403259,0.00028172092],"genre_scores_gemma":[0.9992155,0.00011581454,0.000045710294,0.00001680246,0.0000064286173,0.000005823645,0.00041851628,0.0000026280034,0.00017286671],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995627,0.00006445197,0.000052886964,0.0001628533,0.00006212529,0.00009495978],"domain_scores_gemma":[0.9991321,0.00007999803,0.0003366014,0.00012292604,0.000113235474,0.00021511139],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035733395,0.00035269928,0.0005151903,0.0009804183,0.0007122267,0.0008560564,0.00042730584,0.0006244289,0.0019786025],"category_scores_gemma":[0.00083047897,0.00059802237,0.0010805854,0.0015332928,0.00030538475,0.0007519016,0.00044398298,0.0007660519,0.00040760168],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016725279,0.000052130097,0.9988475,0.0000042219526,0.00007479501,0.00011524149,0.00003876593,0.000017635442,0.0003359346,0.000008698083,0.00004126474,0.00029644356],"study_design_scores_gemma":[0.0000057151915,0.000117378826,0.99901557,0.0000022240984,0.000037622794,0.0004060378,0.000204709,0.00006217479,0.000045847955,0.0000088472025,0.00008939143,0.000004414458],"about_ca_topic_score_codex":0.0074791047,"about_ca_topic_score_gemma":0.0061717844,"teacher_disagreement_score":0.0074791047,"about_ca_system_score_codex":0.000353365,"about_ca_system_score_gemma":0.00037827296,"threshold_uncertainty_score":0.01487112},"labels":[],"label_agreement":null},{"id":"W4390191795","doi":"10.1016/j.jaad.2023.12.030","title":"Population-based mortality in hidradenitis suppurativa: A systematic review","year":2023,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; Women's College Hospital; McMaster University; University of Toronto","funders":"","keywords":"Hidradenitis suppurativa; Medicine; Dermatology; Population; MEDLINE; Internal medicine; Environmental health; Disease","score_opus":0.07452699560815772,"score_gpt":0.4245023246279104,"score_spread":0.34997532901975265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390191795","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018199176,0.99726886,0.00009590575,0.00009677878,0.00009882705,0.00007974673,0.0004409038,0.0000071740437,0.00009192519],"genre_scores_gemma":[0.049134213,0.94900024,0.00048017502,0.0005468487,0.00012461006,0.00021214984,0.00039867937,0.000007287774,0.00009586823],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9955557,0.0012537754,0.0018198736,0.00058209186,0.00057903706,0.00020963293],"domain_scores_gemma":[0.98777485,0.008564888,0.00245241,0.00023069908,0.0007632927,0.00021385984],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0046560317,0.0014452863,0.010379656,0.006156956,0.0004320615,0.0021395853,0.0015167269,0.0020356898,0.0045659076],"category_scores_gemma":[0.019380795,0.0013644269,0.013964645,0.0076381643,0.00069569645,0.00200365,0.0017502578,0.0018844625,0.0003201554],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053951243,0.000031919495,0.00704803,0.8598218,0.11037605,0.00013652268,0.00013876679,0.0001580382,0.00009957207,0.00013768164,0.0016318555,0.019880114],"study_design_scores_gemma":[0.0010051166,0.00029328663,0.027198464,0.30033225,0.66077197,0.00044507664,0.00035402935,0.00021410335,0.00012194984,0.0003975592,0.008772483,0.000093681236],"about_ca_topic_score_codex":0.0099778315,"about_ca_topic_score_gemma":0.029622067,"teacher_disagreement_score":0.010379656,"about_ca_system_score_codex":0.0018382724,"about_ca_system_score_gemma":0.004298467,"threshold_uncertainty_score":0.024623752},"labels":[],"label_agreement":null},{"id":"W4390238645","doi":"10.1016/j.jaad.2023.11.035","title":"Implementation of Mohs micrographic surgery at the VA New York Manhattan Harbor Healthcare System eliminated need for re-excision and decreased time to treatment: A retrospective and prospective cohort study","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"NYU Grossman School of Medicine; York University","keywords":"Medicine; Retrospective cohort study; Prospective cohort study; Cohort; Cohort study; Mohs surgery; Health care; Surgery; General surgery; Internal medicine","score_opus":0.022977403141800835,"score_gpt":0.3392365393797457,"score_spread":0.3162591362379448,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390238645","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99896944,0.00015338072,0.000030192808,0.000051424297,0.000013050323,0.000012205258,0.0003062565,0.0000013909754,0.000462651],"genre_scores_gemma":[0.9991702,0.00010920554,0.00003622493,0.000047246176,0.000015091254,0.0000110184865,0.00023714257,0.0000022529034,0.00037161855],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99946076,0.000140889,0.000052929852,0.00012575235,0.00007755605,0.00014217776],"domain_scores_gemma":[0.9980988,0.0003363905,0.0008134502,0.00019211517,0.00024313419,0.00031619027],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051804935,0.00022934134,0.00023576731,0.0005334833,0.0006270437,0.0008679649,0.0005203622,0.0005720267,0.0045674727],"category_scores_gemma":[0.0022113665,0.0003931408,0.00063484145,0.0009429052,0.0002944904,0.00069233385,0.00039885647,0.0008721835,0.00032289515],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019837885,0.00014442019,0.99840254,0.000007410285,0.00008736494,0.000053685308,0.000078011086,0.000015404923,0.00009550182,0.000020330057,0.00018236291,0.0007147307],"study_design_scores_gemma":[0.000018392217,0.00022459426,0.9989254,0.000007310617,0.000051593168,0.00009232858,0.0003758759,0.000060723523,0.000034988876,0.000009769075,0.00019563602,0.0000033412593],"about_ca_topic_score_codex":0.023543641,"about_ca_topic_score_gemma":0.03150797,"teacher_disagreement_score":0.023543641,"about_ca_system_score_codex":0.0006299711,"about_ca_system_score_gemma":0.0010514435,"threshold_uncertainty_score":0.04681325},"labels":[],"label_agreement":null},{"id":"W4391067179","doi":"10.1016/j.jaad.2023.12.065","title":"Roflumilast foam 0.3% for adolescent and adult patients with seborrheic dermatitis: A randomized, double-blinded, vehicle-controlled, phase 3 trial","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Probity Medical Research; Queen's University","funders":"Genentech; Galderma; Incyte; Regeneron Pharmaceuticals; Sanofi; Pfizer; Eli Lilly and Company","keywords":"Roflumilast; Medicine; Adverse effect; Randomization; Clinical endpoint; Randomized controlled trial; Internal medicine; Surgery","score_opus":0.014422094298199692,"score_gpt":0.3252466073632807,"score_spread":0.310824513065081,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391067179","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9766456,0.010992476,0.0008368594,0.0009580399,0.00046329593,0.006657292,0.0010539058,0.00016007492,0.0022326224],"genre_scores_gemma":[0.97811365,0.0058215307,0.0023638494,0.0018046012,0.00037274088,0.0088520255,0.0006869318,0.000025256231,0.0019594654],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9995203,0.00024595263,0.00004109763,0.00008441377,0.00004345891,0.00006478014],"domain_scores_gemma":[0.999241,0.0002105629,0.0002228788,0.000044482418,0.00007150683,0.00020964681],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016926941,0.0009049092,0.001982714,0.00030006314,0.00040364792,0.00076051767,0.0006283581,0.0016263523,0.006051883],"category_scores_gemma":[0.0015000713,0.00045010014,0.0015772487,0.00027758704,0.0005986562,0.00076579564,0.00023855625,0.0019479962,0.00076275534],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.92452854,0.015108236,0.0018978361,0.0020462847,0.001359338,0.00012952686,0.00015848591,0.00028265486,0.0064075766,0.00018364817,0.0022274326,0.045670535],"study_design_scores_gemma":[0.94709545,0.04895699,0.0022038221,0.00007689776,0.00028042885,0.000067696106,0.000023195405,0.00024121969,0.000237719,0.00007792205,0.00072956516,0.000009042983],"about_ca_topic_score_codex":0.0006955532,"about_ca_topic_score_gemma":0.0018673545,"teacher_disagreement_score":0.006051883,"about_ca_system_score_codex":0.000458595,"about_ca_system_score_gemma":0.0012283155,"threshold_uncertainty_score":0.020245492},"labels":[],"label_agreement":null},{"id":"W4391115649","doi":"10.1016/j.jaad.2023.11.068","title":"Efficacy and safety of apremilast in pediatric patients with moderate-to-severe plaque psoriasis: 16-week results from SPROUT, a randomized controlled trial","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Stollery Children's Hospital; University of Alberta","funders":"LEO Pharma; European Academy of Dermatology and Venereology; Bristol-Myers Squibb; Eli Lilly and Company; Galderma; Incyte; Regeneron Pharmaceuticals; Les Laboratories Pierre Fabre; Celgene; Sanofi; Amgen; Pfizer","keywords":"Medicine; Apremilast; Plaque psoriasis; Randomized controlled trial; Psoriasis; Dermatology; Internal medicine; Psoriatic arthritis","score_opus":0.009041776613370692,"score_gpt":0.23924886932093425,"score_spread":0.23020709270756357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391115649","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97324216,0.016596522,0.0009713542,0.00057029596,0.00028716336,0.0048307152,0.001961093,0.00014883878,0.0013919361],"genre_scores_gemma":[0.9768565,0.008654261,0.003056877,0.0009566837,0.00047903776,0.007027171,0.0017530229,0.00004003577,0.0011764318],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99807703,0.0011454576,0.00020299344,0.0002692963,0.00019211812,0.00011309487],"domain_scores_gemma":[0.9973688,0.00068327895,0.0011203898,0.00019264169,0.00019778563,0.0004369854],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004078173,0.0013639065,0.0033276062,0.00036695146,0.00046139842,0.0009676541,0.00081029197,0.0016018769,0.004203641],"category_scores_gemma":[0.0035068498,0.00062644127,0.0029966033,0.00051215314,0.0009062302,0.0009870849,0.00039591602,0.002093414,0.0005188702],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97177505,0.0035355184,0.0019167782,0.0015240985,0.0021533188,0.00006883527,0.00007389172,0.00022083044,0.0021476964,0.00005762492,0.0006747877,0.015851622],"study_design_scores_gemma":[0.9279395,0.06328371,0.0059464765,0.000119942575,0.0012376177,0.00010978485,0.000024768173,0.00021404804,0.00045273342,0.000058414214,0.00059821486,0.000014797399],"about_ca_topic_score_codex":0.0004883871,"about_ca_topic_score_gemma":0.0012716613,"teacher_disagreement_score":0.004203641,"about_ca_system_score_codex":0.00066965964,"about_ca_system_score_gemma":0.0014711673,"threshold_uncertainty_score":0.021567762},"labels":[],"label_agreement":null},{"id":"W4391290415","doi":"10.1016/j.jaad.2024.01.025","title":"Efficacy of brodalumab in moderate-to-severe plaque psoriasis after failure of previous biologic therapy: A phase 4, multicenter, open-label study","year":2024,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Dermatrials Research; Bausch Health (Canada); Université de Montréal; SKiN Health; University of Calgary; Innovaderm (Canada); Probity Medical Research; Calgary Laboratory Services; University of Toronto","funders":"","keywords":"Medicine; Plaque psoriasis; Multicenter study; Open label; Psoriasis; Dermatology; Internal medicine; Clinical trial; Randomized controlled trial","score_opus":0.035794806361481725,"score_gpt":0.3299326365636837,"score_spread":0.29413783020220197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391290415","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98347497,0.007626917,0.000506004,0.0028989841,0.00082638144,0.0006509109,0.0005547705,0.00007623455,0.003384742],"genre_scores_gemma":[0.98796344,0.0023256585,0.00076467975,0.004694773,0.00071417075,0.00038574782,0.0005905683,0.000018239964,0.0025427667],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.999508,0.00023264799,0.000031065472,0.00006546112,0.00006708318,0.000095740405],"domain_scores_gemma":[0.9990025,0.00038633903,0.00013941039,0.00006840664,0.00007499455,0.00032827325],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021075637,0.00090894557,0.0023650783,0.00024198653,0.0005295716,0.0010628444,0.0007386897,0.0023742884,0.0017976202],"category_scores_gemma":[0.00132221,0.00029364793,0.0013440704,0.00023967499,0.0006295687,0.00067441445,0.00015486286,0.002784426,0.0006063091],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.69886416,0.03258584,0.017898355,0.0013468349,0.0029217736,0.0024250348,0.00031868985,0.0013116053,0.031527065,0.00046033558,0.013068224,0.19727206],"study_design_scores_gemma":[0.63253313,0.29460794,0.05141509,0.00017450562,0.0012701978,0.0020848503,0.00013618237,0.0025109465,0.0036330211,0.0005705418,0.010964675,0.00009896062],"about_ca_topic_score_codex":0.0004891297,"about_ca_topic_score_gemma":0.0012985874,"teacher_disagreement_score":0.0023742884,"about_ca_system_score_codex":0.0006980081,"about_ca_system_score_gemma":0.00060921645,"threshold_uncertainty_score":0.011146009},"labels":[],"label_agreement":null},{"id":"W4391339756","doi":"10.1016/j.jaad.2023.12.017","title":"Guidelines of care for the management of acne vulgaris","year":2024,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":412,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Windsor Clinical Research; Western University","funders":"National Institutes of Health; LEO Pharma; Bausch Health; Ortho Dermatologics; Galderma; Sanofi Genzyme; American Academy of Dermatology; Incyte; Dermira; Pfizer; National Psoriasis Foundation; Valeant Pharmaceuticals International; Sanofi; Regeneron Pharmaceuticals; U.S. Department of Veterans Affairs","keywords":"Medicine; Acne; Dermatology; Isotretinoin; Benzoyl peroxide; Minocycline; Antibiotics; Doxycycline; Limiting","score_opus":0.0659309625539375,"score_gpt":0.44632877700141027,"score_spread":0.3803978144474728,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391339756","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000096152056,0.99361634,0.000621721,0.0018973663,0.00080053194,0.00012522738,0.00025881876,0.00003376249,0.0025500404],"genre_scores_gemma":[0.0012677761,0.98963505,0.004107779,0.002585108,0.00039672092,0.00021112552,0.0005333171,0.0000075461794,0.0012554522],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99860007,0.00036380868,0.00038446896,0.00010038418,0.00047207827,0.00007910967],"domain_scores_gemma":[0.997815,0.0009655726,0.00042060763,0.0000370786,0.0006700561,0.00009162474],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001972149,0.0011941594,0.0025685765,0.0039199237,0.00060606556,0.0013640221,0.002491046,0.0027566508,0.0068207853],"category_scores_gemma":[0.0051164734,0.0004250959,0.0024337533,0.0023647838,0.00051241444,0.0010176596,0.00081018306,0.002859306,0.0025627704],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015755535,0.00012432254,0.00027048055,0.055143643,0.0003484448,0.00021602894,0.00008966341,0.00034879555,0.0005712127,0.003049975,0.12046946,0.8192103],"study_design_scores_gemma":[0.0002449633,0.0001318292,0.0019691964,0.0968613,0.0014342065,0.0010305956,0.000098993754,0.0002003243,0.00028480025,0.0029578018,0.89473695,0.00004905793],"about_ca_topic_score_codex":0.00801467,"about_ca_topic_score_gemma":0.0143410945,"teacher_disagreement_score":0.00801467,"about_ca_system_score_codex":0.0013876944,"about_ca_system_score_gemma":0.0046082377,"threshold_uncertainty_score":0.02281785},"labels":[],"label_agreement":null},{"id":"W4391678945","doi":"10.1016/j.jaad.2023.12.074","title":"Executive summary: Consensus treatment guidelines for the use of methotrexate for inflammatory skin disease in pediatric patients","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Sanofi Genzyme; Ortho Dermatologics; LEO Pharma; Ipsen; Sanofi; Kyowa Hakko Kirin; Pfizer; National Psoriasis Foundation; Incyte; McGovern Medical School; Les Laboratories Pierre Fabre; Dermira; Sun Pharma; National Institutes of Health; Regeneron Pharmaceuticals; University of Texas Health Science Center at Houston; Celgene; National Institute for Health and Care Research; Massachusetts General Hospital; Valeant Pharmaceuticals International; European Commission; Pediatric Dermatology Research Alliance; Eli Lilly and Company; National Eczema Association; Amgen","keywords":"Medicine; Methotrexate; Consensus conference; Disease; Intensive care medicine; MEDLINE; Executive summary; Disease management; Dermatology; Surgery; Internal medicine","score_opus":0.08962334245408322,"score_gpt":0.39602621651681486,"score_spread":0.30640287406273164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391678945","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015789863,0.14479989,0.006568063,0.6341385,0.10700843,0.0054013426,0.031203685,0.0008449887,0.06845611],"genre_scores_gemma":[0.019134399,0.20764932,0.061064336,0.47866097,0.101907484,0.014746901,0.062883504,0.0008639284,0.05308919],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.97727,0.009411209,0.00530832,0.0008806785,0.005930308,0.001199563],"domain_scores_gemma":[0.8459653,0.03583518,0.025442746,0.002037332,0.08140756,0.009311832],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.024426293,0.0017130483,0.0038918029,0.004575363,0.0014216385,0.004594917,0.005961281,0.012201418,0.018339984],"category_scores_gemma":[0.08617731,0.0011665056,0.003599787,0.0053119455,0.0010607389,0.0023673659,0.0021987201,0.011768406,0.01523888],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014934536,0.00006494054,0.00048743462,0.0027734267,0.0000821881,0.000038018818,0.000028195984,0.0001718984,0.00007814387,0.00060795655,0.9365907,0.058927685],"study_design_scores_gemma":[0.0008338365,0.00013205936,0.0059120734,0.024047097,0.0004855152,0.00019623154,0.00013529295,0.00037075803,0.00027642935,0.0017759205,0.96578026,0.000054517524],"about_ca_topic_score_codex":0.010840633,"about_ca_topic_score_gemma":0.013652295,"teacher_disagreement_score":0.024426293,"about_ca_system_score_codex":0.0049218168,"about_ca_system_score_gemma":0.024491603,"threshold_uncertainty_score":0.12918013},"labels":[],"label_agreement":null},{"id":"W4391837689","doi":"10.1016/j.jaad.2024.02.008","title":"Reticulated livedoid skin patterns after soft-tissue filler–related vascular adverse events","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Facial Rejuvenation and Surgery Techniques","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"Erasmus Medisch Centrum","keywords":"Medicine; Duplex (building); Ultrasound; Soft tissue; Vascular disease; Adverse effect; Radiology; Anatomy; Surgery; Internal medicine","score_opus":0.007871749006861224,"score_gpt":0.29712750461235155,"score_spread":0.28925575560549033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391837689","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99637514,0.0005461229,0.0017013736,0.000014748452,0.0000068083823,0.000021219388,0.000026708442,0.000023619621,0.0012842164],"genre_scores_gemma":[0.9992581,0.000105207124,0.00036097277,0.0000146120865,0.000004644772,0.0000043457267,0.000022955175,0.000003182253,0.00022598158],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9998336,0.000044048444,0.000012580411,0.000034443627,0.000042868076,0.000032346208],"domain_scores_gemma":[0.99916506,0.00029112108,0.00030551563,0.00012696131,0.000057954203,0.000053392363],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036610637,0.00020467331,0.00014760465,0.0003899665,0.00016679172,0.00026695113,0.00012781608,0.00020699028,0.0022799908],"category_scores_gemma":[0.0013231252,0.00010000133,0.00016199653,0.00016678902,0.0003655494,0.00024313015,0.00018366949,0.00022624512,0.0002672027],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030926312,0.00036614956,0.4490677,0.00058186235,0.000278202,0.17552026,0.0011889682,0.0018966402,0.23390403,0.0012658347,0.00067946303,0.13215832],"study_design_scores_gemma":[0.00009499335,0.0028346598,0.46838936,0.000079307116,0.00014986542,0.4540295,0.0005577406,0.0017380224,0.06817704,0.00085396355,0.003058673,0.000036946607],"about_ca_topic_score_codex":0.0001760619,"about_ca_topic_score_gemma":0.00018636858,"teacher_disagreement_score":0.0022799908,"about_ca_system_score_codex":0.00015447912,"about_ca_system_score_gemma":0.00008797505,"threshold_uncertainty_score":0.007627368},"labels":[],"label_agreement":null},{"id":"W4391888429","doi":"10.1016/j.jaad.2024.02.015","title":"Association between dermatology follow-up and melanoma survival: A population-based cohort study","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; Women's College Hospital; University of Toronto; Queen's University","funders":"University of Toronto; Canadian Dermatology Foundation","keywords":"Medicine; Dermatology; Cohort; Cohort study; Melanoma; Association (psychology); Internal medicine; Cancer research","score_opus":0.015477001939527373,"score_gpt":0.3042125485706422,"score_spread":0.28873554663111484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391888429","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991136,0.00017069887,0.00007247302,0.000040522424,0.000010599637,0.0000055400346,0.00037199142,0.0000046619034,0.00020981848],"genre_scores_gemma":[0.99934286,0.000088023546,0.000051308045,0.000025454054,0.000012381818,0.0000064974997,0.0002692393,0.0000029627902,0.00020118222],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993024,0.00013456598,0.00006045337,0.00026376508,0.0000869115,0.00015193339],"domain_scores_gemma":[0.9982679,0.00021091568,0.00057327084,0.00035949584,0.0002193699,0.0003691682],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069549226,0.00041563084,0.0005175479,0.0009225818,0.0008851004,0.0010434968,0.0006506633,0.0009165141,0.002097536],"category_scores_gemma":[0.0017407888,0.0008119831,0.00118553,0.0013907341,0.00032762834,0.00082598836,0.00061944744,0.0012903553,0.00034361435],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025751613,0.0001092185,0.9983267,0.000004544305,0.00022414434,0.00011441559,0.00004805456,0.000022501548,0.00035469912,0.000012721854,0.000099593584,0.00042574975],"study_design_scores_gemma":[0.000018163117,0.000099798584,0.99914694,0.0000027987442,0.00010824638,0.00023537962,0.0001246776,0.00012179408,0.000033056094,0.000016462503,0.00008743116,0.000005252212],"about_ca_topic_score_codex":0.010906324,"about_ca_topic_score_gemma":0.011759359,"teacher_disagreement_score":0.010906324,"about_ca_system_score_codex":0.0004412138,"about_ca_system_score_gemma":0.00048973784,"threshold_uncertainty_score":0.02168572},"labels":[],"label_agreement":null},{"id":"W4391953210","doi":"10.1016/j.jaad.2024.01.078","title":"Negative impact of comorbidities on all-cause mortality of patients with psoriasis is partially alleviated by biologic treatment: A real-world case-control study","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Health Services; University of Alberta","funders":"Alberta Innovates; Canadian Dermatology Foundation; Scottish Rock Garden Club; TD Bank","keywords":"Medicine; Psoriasis; Comorbidity; Intensive care medicine; Dermatology; Internal medicine","score_opus":0.03545970573030689,"score_gpt":0.3308789436656919,"score_spread":0.29541923793538505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391953210","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99863356,0.0003907668,0.00010106921,0.000041446136,0.0000062999084,0.00002864884,0.0004745006,0.0000048118295,0.00031876034],"genre_scores_gemma":[0.99923694,0.00013027819,0.00008538933,0.000025244115,0.0000133273625,0.000012663034,0.00041474012,0.0000018395381,0.000079622114],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988387,0.00027698296,0.0000841258,0.00032684318,0.0002775965,0.00019570393],"domain_scores_gemma":[0.99767774,0.0003959722,0.00090921007,0.00035092738,0.00034812273,0.00031796694],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010896495,0.0004210385,0.00046811695,0.0009533655,0.0010686874,0.0010721714,0.0007381095,0.00062043086,0.0017903552],"category_scores_gemma":[0.00278306,0.0004620029,0.0006031524,0.0014488678,0.00069630635,0.00033837438,0.00044245084,0.0006155223,0.00017830683],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003168108,0.00008676767,0.9979169,0.000017461656,0.00013847224,0.00012716588,0.000098501034,0.000027020727,0.00012504963,0.000021744401,0.00024242404,0.0008817635],"study_design_scores_gemma":[0.00004878994,0.0000996694,0.99890757,0.00000824777,0.000105902625,0.00028541588,0.00014732993,0.00017459458,0.000025302936,0.000016054393,0.00017557002,0.0000055834307],"about_ca_topic_score_codex":0.1650466,"about_ca_topic_score_gemma":0.1494874,"teacher_disagreement_score":0.1650466,"about_ca_system_score_codex":0.0019365684,"about_ca_system_score_gemma":0.0013903189,"threshold_uncertainty_score":0.32817185},"labels":[],"label_agreement":null},{"id":"W4392219630","doi":"10.1016/j.jaad.2023.12.070","title":"Vaccination recommendations for adults receiving biologics and oral therapies for psoriasis and psoriatic arthritis: Delphi consensus from the medical board of the National Psoriasis Foundation","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Toronto Western Hospital","funders":"","keywords":"Medicine; Psoriatic arthritis; Psoriasis; Dermatology; Vaccination; Delphi; Family medicine; Immunology","score_opus":0.030577084136270468,"score_gpt":0.3157510814859053,"score_spread":0.28517399734963483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392219630","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13506828,0.037721425,0.036223765,0.72611076,0.011476955,0.009845347,0.0025848553,0.00029588153,0.040672738],"genre_scores_gemma":[0.6326326,0.032204334,0.1665037,0.14442424,0.0038956387,0.009860667,0.0032489814,0.00019797,0.007031794],"study_design_codex":"design_other","study_design_gemma":"qualitative","domain_scores_codex":[0.9692658,0.018378202,0.0070908526,0.0009733577,0.002550062,0.0017417781],"domain_scores_gemma":[0.94447577,0.029109478,0.004674265,0.0011358357,0.016706835,0.0038977754],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.07981736,0.00048134013,0.001077884,0.0017521441,0.002011769,0.0018521557,0.0013847762,0.0037435298,0.0029652975],"category_scores_gemma":[0.07615312,0.000613987,0.002174455,0.0009182676,0.0012127443,0.0018653985,0.0033504283,0.0057563754,0.0008109918],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013024998,0.0006491457,0.06447295,0.009368886,0.0007955631,0.0010694497,0.029241152,0.002139646,0.006089509,0.00799591,0.341674,0.5352012],"study_design_scores_gemma":[0.0015388527,0.0009823929,0.117557526,0.05396475,0.0010866148,0.0026727524,0.050764,0.0063227406,0.0030445382,0.015864514,0.7455504,0.00065104035],"about_ca_topic_score_codex":0.0053403876,"about_ca_topic_score_gemma":0.0067533744,"teacher_disagreement_score":0.07981736,"about_ca_system_score_codex":0.0032311743,"about_ca_system_score_gemma":0.016538573,"threshold_uncertainty_score":0.42211962},"labels":[],"label_agreement":null},{"id":"W4392453816","doi":"10.1016/j.jaad.2024.02.040","title":"Psoriasis and non-Hodgkin’s lymphoma in a diverse sample of U.S. adults: a propensity matched case-control study","year":2024,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Medicine; Lymphoma; Hodgkin lymphoma; Scopus; Psoriasis; Internal medicine; Oncology; Dermatology; MEDLINE","score_opus":0.016808118772618064,"score_gpt":0.25925037272467427,"score_spread":0.2424422539520562,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392453816","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983236,0.00037732138,0.00017381572,0.00023360703,0.000034352997,0.000027551123,0.0002808505,0.000004955668,0.0005439065],"genre_scores_gemma":[0.99913174,0.0001450995,0.0000917592,0.00022920656,0.00006636851,0.000015350595,0.00014298747,0.0000017346438,0.00017584069],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989133,0.0004416921,0.00013194533,0.00026966023,0.00014521742,0.00009832819],"domain_scores_gemma":[0.9979777,0.0005135989,0.000572624,0.00041872895,0.00028569516,0.00023180536],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010788805,0.00034706513,0.00045046714,0.0007782113,0.00081887096,0.0007637485,0.00047257866,0.0010479899,0.0019458659],"category_scores_gemma":[0.0039930744,0.00058864075,0.0004736084,0.001435118,0.00044405094,0.0005680367,0.0003258941,0.0006955035,0.00036371697],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006993294,0.0001793766,0.994859,0.000018745326,0.00029533278,0.0009968113,0.00013116303,0.000023871009,0.0004558111,0.00008564302,0.00068961224,0.0015653721],"study_design_scores_gemma":[0.00029144614,0.0005272784,0.99277097,0.00001693181,0.00029675686,0.004064198,0.00045045733,0.00043320988,0.00011144025,0.00010900771,0.00091442413,0.000013823531],"about_ca_topic_score_codex":0.00551559,"about_ca_topic_score_gemma":0.0048939134,"teacher_disagreement_score":0.00551559,"about_ca_system_score_codex":0.00037845096,"about_ca_system_score_gemma":0.00028616135,"threshold_uncertainty_score":0.010966957},"labels":[],"label_agreement":null},{"id":"W4392455278","doi":"10.1016/j.jaad.2024.02.042","title":"Use of biologic treatment in psoriasis patients with HIV: A systematic review","year":2024,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Health Sciences Centre; Sunnybrook Health Science Centre; Women's College Hospital; McMaster University; University of Toronto","funders":"","keywords":"Medicine; Psoriasis; Human immunodeficiency virus (HIV); Dermatology; Biologic Agents; Intensive care medicine; MEDLINE; Immunology; Internal medicine; Disease","score_opus":0.04516504020753033,"score_gpt":0.31305596098121624,"score_spread":0.2678909207736859,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392455278","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00076140027,0.9987804,0.000034713674,0.00006971519,0.000048584927,0.000028768847,0.00017726957,0.0000027029732,0.000096409385],"genre_scores_gemma":[0.01336885,0.9857869,0.00019248304,0.0003767791,0.00004921449,0.000043067146,0.00012412194,0.000002018962,0.000056605404],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9982674,0.00045463972,0.00066710997,0.00022715397,0.00029714438,0.0000865042],"domain_scores_gemma":[0.9946407,0.0036159968,0.0012914881,0.000064315835,0.00029260523,0.00009486944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001929145,0.0008091716,0.00526374,0.0034470705,0.0002798564,0.0013620413,0.001292053,0.0015550613,0.003825497],"category_scores_gemma":[0.008308483,0.0007299609,0.0064419038,0.004748971,0.0004246783,0.0011844938,0.0008950104,0.0011631337,0.00021893965],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000886463,0.000047296944,0.002778953,0.8911502,0.039822128,0.0001466405,0.00013006332,0.00016706673,0.00024848964,0.00014620942,0.0031036101,0.061372817],"study_design_scores_gemma":[0.00176416,0.00062397454,0.023810484,0.540965,0.39547905,0.0008653326,0.00039025603,0.00021045316,0.0002661519,0.00039579047,0.035112973,0.00011646126],"about_ca_topic_score_codex":0.008144134,"about_ca_topic_score_gemma":0.027198564,"teacher_disagreement_score":0.008144134,"about_ca_system_score_codex":0.0012565844,"about_ca_system_score_gemma":0.0028839854,"threshold_uncertainty_score":0.01619345},"labels":[],"label_agreement":null},{"id":"W4392946850","doi":"10.1016/j.jaad.2024.02.058","title":"Dermatoscopic features and potential pitfalls of artificial intelligence–based analysis of benign acral pigmented lesions in Black patients: A multicenter observational study","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Melanoma Research Alliance; Canadian Institutes of Health Research; Weill Cornell Medical College; National Cancer Institute; National Institutes of Health; Massachusetts General Hospital","keywords":"Medicine; Observational study; Dermatology; Dermatoscopy; Multicenter study; Surgery; Pathology; Melanoma; Randomized controlled trial","score_opus":0.03431675346665605,"score_gpt":0.3370786621031892,"score_spread":0.3027619086365332,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392946850","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9997032,0.00007256622,0.000042086438,0.000012283119,0.0000018332879,0.0000056848617,0.000040998202,8.1320087e-7,0.000120466735],"genre_scores_gemma":[0.9998022,0.0000313454,0.00004680234,0.000012813951,0.0000066601515,0.0000048124916,0.000064223546,0.0000010280576,0.000030019557],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999015,0.00040913455,0.000093023795,0.00022736896,0.00014817603,0.00010736145],"domain_scores_gemma":[0.9969606,0.0007353877,0.0014825901,0.00025318374,0.00027796483,0.00029026944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010542414,0.0003459479,0.0004186879,0.0008119603,0.00062409695,0.00073536404,0.00044862062,0.0004977645,0.0012312317],"category_scores_gemma":[0.0037920193,0.000292269,0.000501989,0.0008223628,0.00045051242,0.0007036753,0.00046059978,0.00053447555,0.00019341354],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025845898,0.000113457805,0.9981566,0.000007914035,0.00006227941,0.000094299634,0.00008476908,0.000024457608,0.00030068963,0.000017406719,0.000037064634,0.0008426376],"study_design_scores_gemma":[0.000022371398,0.00029438175,0.9979348,0.0000057357106,0.000076474396,0.00060579623,0.0003648887,0.0004014783,0.00012216099,0.00003812801,0.00012725261,0.000006467279],"about_ca_topic_score_codex":0.0019923921,"about_ca_topic_score_gemma":0.0018992743,"teacher_disagreement_score":0.0019923921,"about_ca_system_score_codex":0.00036809698,"about_ca_system_score_gemma":0.00032741882,"threshold_uncertainty_score":0.0055754185},"labels":[],"label_agreement":null},{"id":"W4392948578","doi":"10.1016/j.jaad.2024.02.057","title":"Evaluation of the measurement properties and validation of the Skindex-16 among patients with acne","year":2024,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Windsor Clinical Research; Western University","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; Canadian Institutes of Health Research; Penn State College of Medicine; National Institutes of Health; Galderma; Pennsylvania State University; Massachusetts General Hospital; Brigham and Women's Hospital","keywords":"Medicine; Acne; Dermatology","score_opus":0.05421297734379511,"score_gpt":0.28101113792800686,"score_spread":0.22679816058421176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392948578","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.957747,0.0010888267,0.0006329242,0.03197857,0.0006597603,0.00005123272,0.00024085377,0.000025187574,0.0075756824],"genre_scores_gemma":[0.9924999,0.00014686125,0.00036085973,0.00577342,0.00036855956,0.000024320765,0.00007974814,0.000006273024,0.0007400658],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975158,0.0010817458,0.0004154159,0.00020960983,0.00052620476,0.0002513378],"domain_scores_gemma":[0.9909588,0.005868417,0.0005430238,0.0003995428,0.0018272247,0.00040294114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027612508,0.00031800015,0.00046985867,0.0005148236,0.00061638706,0.0009632384,0.00042752078,0.001722682,0.00078635244],"category_scores_gemma":[0.019560125,0.00020944768,0.00046075895,0.0004920655,0.0004519189,0.0007573247,0.00031454707,0.0016682453,0.0004927287],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005262827,0.00023505549,0.9666146,0.000031652093,0.000037000143,0.004477259,0.00061814836,0.0001409547,0.0015025105,0.00017795723,0.005623893,0.020014644],"study_design_scores_gemma":[0.00016605684,0.0017508073,0.95046294,0.00014167445,0.00012806412,0.022482788,0.002487872,0.0045213634,0.00270314,0.00079588784,0.01431324,0.00004629081],"about_ca_topic_score_codex":0.0028461749,"about_ca_topic_score_gemma":0.0027279377,"teacher_disagreement_score":0.0028461749,"about_ca_system_score_codex":0.00080187153,"about_ca_system_score_gemma":0.0006066467,"threshold_uncertainty_score":0.014603019},"labels":[],"label_agreement":null},{"id":"W4393062280","doi":"10.1016/j.jaad.2024.03.015","title":"Characteristics and management of sclerosing skin diseases during immune checkpoint inhibitor therapy: An evidence-based review","year":2024,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Inflammatory Myopathies and Dermatomyositis","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Health Sciences Centre; Sunnybrook Health Science Centre; University of Ottawa; Women's College Hospital; McMaster University; University of Toronto","funders":"","keywords":"Medicine; Dermatology","score_opus":0.045494841873222336,"score_gpt":0.35428733929938344,"score_spread":0.3087924974261611,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393062280","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000083670406,0.99969685,0.000026125019,0.00004812606,0.00003964088,0.000008582962,0.000026893644,0.0000012939022,0.00006879016],"genre_scores_gemma":[0.00078163185,0.99888676,0.00011295888,0.00010433338,0.000040083487,0.000009885657,0.000031256644,4.8962596e-7,0.000032691736],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9991295,0.00016995096,0.00032716384,0.00011869118,0.00021587368,0.000038895578],"domain_scores_gemma":[0.99765116,0.001462807,0.0005965294,0.000021055583,0.00022097366,0.000047452748],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016445639,0.0011030897,0.004578821,0.0037003097,0.0002859178,0.0016960955,0.0016499385,0.0013725837,0.0032171768],"category_scores_gemma":[0.0041397335,0.00050194736,0.0034346094,0.0037444886,0.0004344491,0.0015165716,0.00079850614,0.0013650599,0.00040618182],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005281757,0.000086525186,0.00076766324,0.47985873,0.0038300273,0.00018517164,0.00009487032,0.00041890476,0.00056796655,0.0006271308,0.010685087,0.50234985],"study_design_scores_gemma":[0.0010209988,0.0007906408,0.011143224,0.5654453,0.056402933,0.0035760128,0.00040820503,0.000521925,0.000701658,0.0018956197,0.35792574,0.00016773844],"about_ca_topic_score_codex":0.0026368257,"about_ca_topic_score_gemma":0.006747587,"teacher_disagreement_score":0.004578821,"about_ca_system_score_codex":0.00078623625,"about_ca_system_score_gemma":0.0019262239,"threshold_uncertainty_score":0.010762572},"labels":[],"label_agreement":null},{"id":"W4393064608","doi":"10.1016/j.jaad.2024.03.008","title":"Full Guidelines—From the Medical Board of the National Psoriasis Foundation: Perioperative management of systemic immunomodulatory agents in patients with psoriasis and psoriatic arthritis","year":2024,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Psoriasis; Psoriatic arthritis; Perioperative; Dermatology; Complication; Plaque psoriasis; Arthritis; Intensive care medicine; Surgery; Immunology","score_opus":0.03593636161910609,"score_gpt":0.3250930398090816,"score_spread":0.28915667818997554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393064608","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00031163674,0.87137747,0.0019953493,0.06591423,0.032000776,0.00053171034,0.0016835616,0.00031908267,0.025866153],"genre_scores_gemma":[0.002325975,0.8355472,0.008116106,0.095338106,0.021899197,0.000754883,0.0042099273,0.00010197852,0.031706654],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99848276,0.0004243484,0.00034237007,0.00009873281,0.00054003356,0.0001117757],"domain_scores_gemma":[0.9964599,0.000774498,0.00076170085,0.000098094744,0.0015213764,0.00038443974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021556756,0.0009954628,0.0020282557,0.0023707005,0.00062439026,0.0017052907,0.0019405576,0.004864081,0.01386657],"category_scores_gemma":[0.004786912,0.00049301976,0.0015942021,0.0015674103,0.0004937149,0.0015568215,0.0012596978,0.0059009907,0.011090077],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007120299,0.00008381421,0.00010553934,0.0024327463,0.000040427567,0.00007802857,0.000018686858,0.00006780268,0.00040140873,0.0008607739,0.79071033,0.20512924],"study_design_scores_gemma":[0.00011568025,0.00004366174,0.0009640375,0.004936799,0.00006688104,0.00032031396,0.00001552644,0.00004514715,0.00012404419,0.00067252934,0.99267936,0.000015991536],"about_ca_topic_score_codex":0.004663648,"about_ca_topic_score_gemma":0.01136675,"teacher_disagreement_score":0.01386657,"about_ca_system_score_codex":0.0012271315,"about_ca_system_score_gemma":0.0050202566,"threshold_uncertainty_score":0.046388328},"labels":[],"label_agreement":null},{"id":"W4393282163","doi":"10.1016/j.jaad.2024.03.027","title":"Elevation of creatine phosphokinase in moderate-to-severe atopic dermatitis is associated with the use of JAK inhibitors but not dupilumab: A systematic review and meta-analysis","year":2024,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McMaster University","funders":"","keywords":"Medicine; Dupilumab; Atopic dermatitis; Meta-analysis; Dermatology; Creatine kinase; Internal medicine","score_opus":0.06269774951808084,"score_gpt":0.3423722867218614,"score_spread":0.27967453720378055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393282163","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009751923,0.9891382,0.00028009716,0.000102372804,0.00014107412,0.00007942249,0.0003212123,0.000014713276,0.00017088327],"genre_scores_gemma":[0.25596768,0.7401229,0.0013014638,0.00096042297,0.00031817518,0.00026241495,0.0006350536,0.00002148255,0.0004104406],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9965364,0.0012105958,0.0010966755,0.0005633746,0.0004176129,0.00017541906],"domain_scores_gemma":[0.9922355,0.0052189934,0.0016751128,0.00024981762,0.00048352542,0.00013704748],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004257986,0.002173796,0.012601474,0.0028537565,0.00047580237,0.002252324,0.001621103,0.0021741313,0.0028317538],"category_scores_gemma":[0.011935462,0.0012417051,0.026705602,0.004152046,0.0005956815,0.0012360775,0.0012220651,0.0017787878,0.00028311656],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038835532,0.000060769526,0.011381776,0.24565421,0.7228512,0.00017659314,0.0000864685,0.00036630302,0.00044509128,0.000080054146,0.00063979183,0.014374275],"study_design_scores_gemma":[0.000536005,0.00017552817,0.006839401,0.007516428,0.98364985,0.0000966864,0.000039028866,0.00010548764,0.000089824316,0.00008206678,0.0008420846,0.000027598939],"about_ca_topic_score_codex":0.0057763234,"about_ca_topic_score_gemma":0.016494084,"teacher_disagreement_score":0.012601474,"about_ca_system_score_codex":0.0011842591,"about_ca_system_score_gemma":0.0016360078,"threshold_uncertainty_score":0.022518694},"labels":[],"label_agreement":null},{"id":"W4393282627","doi":"10.1016/j.jaad.2024.03.025","title":"Efficacy and safety of tildrakizumab for the treatment of moderate-to-severe plaque psoriasis of the scalp: A multicenter, randomized, double-blind, placebo-controlled, Phase 3b study","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"Sun Pharma; Amgen","keywords":"Medicine; Scalp; Placebo; Dermatology; Multicenter study; Psoriasis; Plaque psoriasis; Adverse effect; Double blind; Randomized controlled trial; Surgery; Internal medicine; Pathology","score_opus":0.025329845663090534,"score_gpt":0.3236869785360868,"score_spread":0.29835713287299626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393282627","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9814091,0.0076732743,0.0011993098,0.00074651436,0.0002716927,0.004976561,0.0015540826,0.00017205202,0.0019974578],"genre_scores_gemma":[0.98688614,0.0032211188,0.002129067,0.001200281,0.00031252307,0.0034365512,0.0012965316,0.000045675966,0.001472254],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99916863,0.00043880474,0.000058695747,0.000120130724,0.00012251784,0.000091147005],"domain_scores_gemma":[0.99895453,0.00019727735,0.00034393577,0.00008758255,0.00010364603,0.00031306423],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030569737,0.0011903346,0.0022413584,0.0003194514,0.00047114788,0.0009174323,0.0008350202,0.0012652864,0.0052342787],"category_scores_gemma":[0.0013438776,0.000529923,0.0018153647,0.00038108643,0.0007833615,0.0007321377,0.00025648234,0.0023194058,0.0010340997],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8944658,0.026613737,0.0023326145,0.0015448688,0.0019104102,0.000088607725,0.000110488,0.00040900472,0.029163187,0.000116316805,0.0023564154,0.04088862],"study_design_scores_gemma":[0.91352206,0.0774101,0.0057755173,0.000046062156,0.0005900737,0.00010203861,0.000015604688,0.00031570173,0.0012530428,0.00008547048,0.00086876284,0.000015673682],"about_ca_topic_score_codex":0.00059060514,"about_ca_topic_score_gemma":0.0012630388,"teacher_disagreement_score":0.0052342787,"about_ca_system_score_codex":0.0005320685,"about_ca_system_score_gemma":0.0013792298,"threshold_uncertainty_score":0.017510355},"labels":[],"label_agreement":null},{"id":"W4393321344","doi":"10.1016/j.jaad.2024.03.030","title":"Long-term safety and effectiveness of roflumilast cream 0.3% in adults with chronic plaque psoriasis: A 52-week, phase 2, open-label trial","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"XLV Diagnostics (Canada); SKiN Health; Surrey Memorial Hospital; Trent University; Western University; Probity Medical Research","funders":"","keywords":"Medicine; Open label; Psoriasis; Plaque psoriasis; Dermatology; Adverse effect; Term (time); Safety profile; Roflumilast; Clinical trial; Internal medicine; Pulmonary disease","score_opus":0.01780337476514756,"score_gpt":0.3083348050804826,"score_spread":0.29053143031533507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393321344","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98697764,0.007371739,0.00044444663,0.0006077652,0.00026346394,0.0014165594,0.00084223354,0.00013684985,0.0019393857],"genre_scores_gemma":[0.9865362,0.004242464,0.0011020587,0.001294203,0.0005130477,0.002079901,0.0011302502,0.000031774434,0.0030700422],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99948967,0.00021108561,0.000032993157,0.0001111357,0.000047451686,0.000107709224],"domain_scores_gemma":[0.9993325,0.00018511448,0.0001424441,0.000059815295,0.00005465814,0.0002254183],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014838885,0.0016674179,0.002917963,0.00034941945,0.00045957987,0.0010316889,0.0007804095,0.0023228189,0.005045785],"category_scores_gemma":[0.0011974096,0.0007244825,0.0016453288,0.00029383413,0.0009774179,0.0014265602,0.00031405536,0.003219669,0.0015906268],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9168744,0.017414099,0.001414899,0.0009935586,0.0010032812,0.00014461784,0.00014145934,0.00046480304,0.012425945,0.000115355804,0.0015678914,0.047439683],"study_design_scores_gemma":[0.8282689,0.16395734,0.0050048893,0.000055560788,0.00043573914,0.000117521944,0.00005007259,0.00039072553,0.0006504036,0.000107216816,0.00093391887,0.00002774654],"about_ca_topic_score_codex":0.00070632476,"about_ca_topic_score_gemma":0.0014131443,"teacher_disagreement_score":0.005045785,"about_ca_system_score_codex":0.0005398011,"about_ca_system_score_gemma":0.0006610627,"threshold_uncertainty_score":0.016879797},"labels":[],"label_agreement":null},{"id":"W4394008818","doi":"10.1016/j.jaad.2024.01.091","title":"Cognitive bias in the patient encounter: Part I. Background and significance","year":2024,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Clinical Reasoning and Diagnostic Skills","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Cognitive bias; Cognition; Heuristics; Medicine; Affect (linguistics); Clinical judgment; Confirmation bias; Cognitive psychology; Dual process theory (moral psychology); Process (computing); Clinical psychology; Psychology; Psychiatry; Social psychology; Medical physics; Computer science","score_opus":0.12304003657404039,"score_gpt":0.43827730684533717,"score_spread":0.3152372702712968,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394008818","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019985953,0.9987972,0.00006301569,0.0006015035,0.00010001514,0.000008086772,0.000013821102,9.286162e-7,0.0002155569],"genre_scores_gemma":[0.005920197,0.99223256,0.00022793643,0.00084478164,0.0006171369,0.00004471352,0.000029615057,0.0000010134604,0.00008193693],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99822253,0.00078202627,0.00031724255,0.0002648114,0.00032695287,0.00008633656],"domain_scores_gemma":[0.98283005,0.013767018,0.0018557846,0.00013882358,0.0012223568,0.00018600564],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037327167,0.00086285605,0.0019932087,0.0020252727,0.00041406896,0.0023186798,0.0012218311,0.0016593743,0.0038073035],"category_scores_gemma":[0.015444587,0.0003227096,0.0009707989,0.0026420082,0.0014921665,0.0020757597,0.001106634,0.0022209182,0.0003915301],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030461885,0.00010494738,0.0032313818,0.1518595,0.00075533154,0.00018858397,0.0004803932,0.00041703242,0.00028054457,0.0036062903,0.011097219,0.82767415],"study_design_scores_gemma":[0.000274716,0.0007096714,0.065607294,0.49255237,0.006796713,0.00893644,0.0022361716,0.00086811394,0.00090370694,0.019015113,0.40186566,0.00023414032],"about_ca_topic_score_codex":0.00458136,"about_ca_topic_score_gemma":0.006275883,"teacher_disagreement_score":0.00458136,"about_ca_system_score_codex":0.0019976888,"about_ca_system_score_gemma":0.004003053,"threshold_uncertainty_score":0.0197407},"labels":[],"label_agreement":null},{"id":"W4394015458","doi":"10.1016/j.jaad.2024.02.061","title":"Cognitive bias in the patient encounter: Part II. Debiasing using an adaptive toolbox","year":2024,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Clinical Reasoning and Diagnostic Skills","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Debiasing; Cognitive bias; Cognition; Toolbox; Confirmation bias; Cognitive psychology; Heuristics; Metacognition; Psychology; Situational ethics; Computer science; Social psychology","score_opus":0.1764372603810211,"score_gpt":0.45214755548332863,"score_spread":0.27571029510230755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394015458","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006128593,0.9986725,0.00012136669,0.00017692547,0.000042732707,0.000020719795,0.00002247333,0.0000031470067,0.00032725753],"genre_scores_gemma":[0.0075714304,0.99117064,0.00052797806,0.0003310484,0.00011244347,0.000047727623,0.00007133654,0.0000021052208,0.00016520303],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99879164,0.00045582472,0.00025771293,0.00016099389,0.00028431625,0.00004961929],"domain_scores_gemma":[0.9953376,0.0034794356,0.0006414646,0.00006589999,0.00040106592,0.0000745715],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025099553,0.00091275724,0.0025795898,0.0017721385,0.00021729796,0.0016200731,0.001546089,0.0011709934,0.0025698105],"category_scores_gemma":[0.008574429,0.00032425093,0.0014900983,0.0015330323,0.00069512543,0.0012950104,0.00091307214,0.0016888357,0.0005161475],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023260125,0.000098337805,0.0015404965,0.040112153,0.0005770472,0.00007031171,0.00007040377,0.00017645505,0.00017041118,0.0005602863,0.003710287,0.95268124],"study_design_scores_gemma":[0.0021356712,0.0020597426,0.14463004,0.37549266,0.016702093,0.01585535,0.0015557223,0.0029199882,0.0027253556,0.0073609306,0.4280586,0.000503857],"about_ca_topic_score_codex":0.003955355,"about_ca_topic_score_gemma":0.007496622,"teacher_disagreement_score":0.003955355,"about_ca_system_score_codex":0.0011056567,"about_ca_system_score_gemma":0.0019347463,"threshold_uncertainty_score":0.013274074},"labels":[],"label_agreement":null},{"id":"W4394603583","doi":"10.1016/j.jaad.2024.04.014","title":"Inpatient management of epidermolysis bullosa: Consensus-based hands-on instructions for neonates and postneonates","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Skin and Cellular Biology Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto; Université de Montréal; SickKids Foundation; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Delphi method; Epidermolysis bullosa; Context (archaeology); Likert scale; Delphi; Transitional care; MEDLINE; Health care; Family medicine; Nursing","score_opus":0.013571471485987294,"score_gpt":0.308480725329229,"score_spread":0.2949092538432417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394603583","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.64450234,0.015291688,0.024592308,0.13953412,0.0047907787,0.00418014,0.00097146496,0.0013758779,0.1647612],"genre_scores_gemma":[0.9035474,0.01289071,0.04909036,0.0148149375,0.0028668074,0.0022496982,0.001689369,0.00023657152,0.012614218],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99913126,0.0002892491,0.00015237894,0.000048110305,0.00017362519,0.00020536981],"domain_scores_gemma":[0.99840754,0.00021584897,0.00022399091,0.000030493991,0.00031079524,0.00081140804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010200338,0.00045838542,0.000519621,0.0007919729,0.0015961895,0.0006920208,0.0008656518,0.0017542394,0.00978821],"category_scores_gemma":[0.00465147,0.00023160336,0.0005109276,0.00028159423,0.0002913795,0.0007472941,0.0015782056,0.0018748583,0.0013645159],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00062914257,0.0054060295,0.16011095,0.00078575726,0.00008514097,0.054671146,0.0018038822,0.0022394755,0.0045802733,0.0024104533,0.26120833,0.5060694],"study_design_scores_gemma":[0.0011162439,0.004743998,0.7017464,0.009062744,0.00022069353,0.080956824,0.020016383,0.011583442,0.0056189783,0.013989304,0.15047477,0.0004701878],"about_ca_topic_score_codex":0.003093482,"about_ca_topic_score_gemma":0.0061460794,"teacher_disagreement_score":0.00978821,"about_ca_system_score_codex":0.0011007452,"about_ca_system_score_gemma":0.0034240463,"threshold_uncertainty_score":0.032744825},"labels":[],"label_agreement":null},{"id":"W4394990011","doi":"10.1016/j.jaad.2024.04.027","title":"Real-world experience of bimekizumab for adult patients with plaque psoriasis: A 16-week multicenter retrospective study","year":2024,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; Probity Medical Research; Health Sciences Centre; Sunnybrook Health Science Centre; Dermatrials Research; SKiN Health; University of Calgary; Women's College Hospital; McMaster University; University of Toronto","funders":"Women's College Hospital","keywords":"Medicine; Multicenter study; Plaque psoriasis; Retrospective cohort study; Psoriasis; Dermatology; Surgery","score_opus":0.014456860253421104,"score_gpt":0.2766678771711971,"score_spread":0.26221101691777604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394990011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988747,0.00040613586,0.00012059199,0.00012468429,0.000009362734,0.000013598619,0.00012080897,0.0000020501338,0.00032807258],"genre_scores_gemma":[0.99927455,0.00015949455,0.00010454533,0.00016586915,0.000036209338,0.000010925752,0.00016620339,0.000002639482,0.00007958048],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99830246,0.00075541413,0.00021740308,0.00031421828,0.0002134561,0.00019694713],"domain_scores_gemma":[0.9954986,0.00137566,0.0016270186,0.00045639806,0.00041153032,0.00063076854],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019812116,0.0003194118,0.00066286576,0.00030756768,0.000535649,0.0011262258,0.00039806755,0.0008972474,0.0010112388],"category_scores_gemma":[0.005039419,0.00032583383,0.00066436053,0.0006079798,0.0006293194,0.0010074174,0.0005438622,0.0007211895,0.0003301307],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014969727,0.00031367262,0.9896408,0.000034626726,0.00014586074,0.0027485325,0.00047676888,0.0001008085,0.00056156213,0.00004296501,0.00034039278,0.0040971884],"study_design_scores_gemma":[0.00055206806,0.0054648793,0.9656133,0.000054245233,0.00038607768,0.02105804,0.0028493768,0.00091774017,0.0004589248,0.00012651933,0.0024622642,0.000056603832],"about_ca_topic_score_codex":0.001231159,"about_ca_topic_score_gemma":0.00092952355,"teacher_disagreement_score":0.0019812116,"about_ca_system_score_codex":0.00070268824,"about_ca_system_score_gemma":0.0004719671,"threshold_uncertainty_score":0.010477781},"labels":[],"label_agreement":null},{"id":"W4395450174","doi":"10.1016/j.jaad.2024.03.048","title":"Real-world effectiveness and safety of risankizumab in adult patients with plaque psoriasis: A 1-year international multicenter retrospective cohort study","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; Calgary Laboratory Services; Dermatrials Research; Sunnybrook Health Science Centre; University of British Columbia; University of Calgary; University of Toronto","funders":"Department of Medicine, University of Toronto; Temerty Faculty of Medicine, University of Toronto; National Institutes of Health; UCB; University of Toronto; GlaxoSmithKline; Women's College Hospital; Universidade do Porto; Faculty of Medicine, University of British Columbia; Eli Lilly and Company","keywords":"Medicine; Plaque psoriasis; Retrospective cohort study; Psoriasis; Cohort study; Multicenter study; Cohort; Internal medicine; Dermatology; Pediatrics; Randomized controlled trial","score_opus":0.005299296752437013,"score_gpt":0.2599715143050303,"score_spread":0.2546722175525933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395450174","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998667,0.0004846132,0.000087250344,0.00003754463,0.000008564738,0.000015215562,0.00047215878,0.0000031474367,0.00022451604],"genre_scores_gemma":[0.99885535,0.0001605823,0.00008191385,0.00005347608,0.000023843766,0.000015889811,0.00074027665,0.000003616825,0.00006498379],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99797815,0.0005914073,0.00025060825,0.00067616365,0.00024926654,0.0002544089],"domain_scores_gemma":[0.99580234,0.0007346118,0.0020083506,0.00064009544,0.0003752599,0.00043940495],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023208084,0.00059319707,0.0008762831,0.0006446513,0.00053197774,0.0015411518,0.0005810396,0.00089591986,0.0011516936],"category_scores_gemma":[0.0035720686,0.0005437399,0.0015783296,0.0011226364,0.00066557544,0.0011760656,0.0006453315,0.0011275939,0.00035026175],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002701372,0.00018700572,0.9935041,0.00003622531,0.0008457727,0.00017646315,0.00012419403,0.000093623006,0.00041581088,0.00003722784,0.00019716604,0.00168102],"study_design_scores_gemma":[0.00032147102,0.001396826,0.995663,0.000017595372,0.000678894,0.00066732644,0.00033978207,0.00029809139,0.00013543556,0.000037490387,0.0004200048,0.000024044586],"about_ca_topic_score_codex":0.0022361258,"about_ca_topic_score_gemma":0.0019516095,"teacher_disagreement_score":0.0023208084,"about_ca_system_score_codex":0.0007003937,"about_ca_system_score_gemma":0.0005275903,"threshold_uncertainty_score":0.012273788},"labels":[],"label_agreement":null},{"id":"W4396811198","doi":"10.1016/j.jaad.2024.04.070","title":"Zinc supplementation for epidermal growth factor receptor inhibitors induced skin toxicity","year":2024,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal; University of Ottawa","funders":"","keywords":"Medicine; Toxicity; Epidermal growth factor receptor; Pharmacology; Receptor; Internal medicine","score_opus":0.02829127672661358,"score_gpt":0.3305900035680535,"score_spread":0.30229872684143994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396811198","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06260799,0.019920178,0.0010508499,0.8404448,0.020434877,0.00012169112,0.00014956506,0.00020864184,0.055061482],"genre_scores_gemma":[0.4920441,0.014396552,0.0021620977,0.38019338,0.025039041,0.00013677707,0.0001093404,0.000051084375,0.0858676],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998217,0.000064660475,0.000021437167,0.000014099521,0.000048007478,0.00003010311],"domain_scores_gemma":[0.99965334,0.00017676852,0.00004064121,0.0000129172595,0.000053657506,0.00006275567],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031708105,0.00024787465,0.000357125,0.0002195536,0.0009470482,0.00052091334,0.00028839876,0.0046409825,0.0024746659],"category_scores_gemma":[0.0018362219,0.00009041945,0.000398085,0.00011545933,0.0003683174,0.00027879223,0.00021912385,0.0025115043,0.0009129582],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001551884,0.00065683277,0.0065170946,0.0003482054,0.000088142006,0.15257198,0.0002301282,0.00028274526,0.010021341,0.0061494242,0.6929553,0.12862697],"study_design_scores_gemma":[0.0013706466,0.0012447579,0.011073455,0.00046428535,0.00015608026,0.15657964,0.00032585344,0.0015674833,0.0068929386,0.0077599157,0.81252337,0.000041646952],"about_ca_topic_score_codex":0.0013271569,"about_ca_topic_score_gemma":0.0036328614,"teacher_disagreement_score":0.0046409825,"about_ca_system_score_codex":0.0012573783,"about_ca_system_score_gemma":0.00056489866,"threshold_uncertainty_score":0.009122908},"labels":[],"label_agreement":null},{"id":"W4396831059","doi":"10.1016/j.jaad.2024.01.096","title":"Part 1: Management of antithrombotic medications in dermatologic surgery","year":2024,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"","keywords":"Medicine; Antithrombotic; Apixaban; Dabigatran; Edoxaban; Rivaroxaban; Clopidogrel; Warfarin; Prasugrel; Ticagrelor; Fondaparinux; Perioperative; Anesthesia; Aspirin; Thrombosis; Low molecular weight heparin; Stroke (engine); Surgery; Atrial fibrillation; Internal medicine; Venous thromboembolism","score_opus":0.06515057529501224,"score_gpt":0.3939136621385493,"score_spread":0.32876308684353706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396831059","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000054107,0.99879044,0.00007112421,0.00016604163,0.0003346682,0.000008878542,0.00001813644,0.000005785504,0.00055075355],"genre_scores_gemma":[0.0004452068,0.99780446,0.00022356225,0.0003885361,0.0007109857,0.000009453153,0.00004254412,0.0000017725026,0.00037352613],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993794,0.00010897796,0.00017104416,0.0000828185,0.00022385447,0.000033807253],"domain_scores_gemma":[0.9983348,0.0008280097,0.00044040315,0.000023660254,0.00029120865,0.00008182908],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00085577264,0.0011273678,0.001953418,0.0043150242,0.00031519067,0.0015086477,0.001037818,0.0012510284,0.005771427],"category_scores_gemma":[0.0027861188,0.00039394214,0.0009998664,0.003193667,0.0005639123,0.0014095299,0.0006569902,0.002141492,0.0019112327],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010019351,0.00011886774,0.0003407294,0.041347984,0.00025354413,0.00015360229,0.000044083736,0.0003077654,0.00086136704,0.0009339272,0.054529864,0.9010081],"study_design_scores_gemma":[0.00014595623,0.00026628113,0.004638975,0.037349008,0.0011245726,0.0026685952,0.00006119468,0.00032146423,0.00044652302,0.0010565092,0.9518665,0.000054469998],"about_ca_topic_score_codex":0.0021511018,"about_ca_topic_score_gemma":0.004525256,"teacher_disagreement_score":0.005771427,"about_ca_system_score_codex":0.0008255288,"about_ca_system_score_gemma":0.0013001207,"threshold_uncertainty_score":0.019307375},"labels":[],"label_agreement":null},{"id":"W4396831710","doi":"10.1016/j.jaad.2024.05.007","title":"Medical Assistance in Dying in Dermatology","year":2024,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Dermatology; MEDLINE; Family medicine","score_opus":0.0681750110400912,"score_gpt":0.42094379739053406,"score_spread":0.35276878635044284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396831710","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015725767,0.002096928,0.000064405576,0.96031064,0.013577763,0.00002344972,0.000010892951,0.0000099487615,0.022333436],"genre_scores_gemma":[0.017856356,0.002542656,0.00023554776,0.9164376,0.03704491,0.00006407736,0.000012425446,0.000021697659,0.02578469],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960704,0.0016442394,0.00035481615,0.0002781577,0.0006074619,0.0010449807],"domain_scores_gemma":[0.990319,0.004258646,0.0006387887,0.0002086874,0.0011176408,0.0034572743],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038193658,0.0007227637,0.000858251,0.00086793804,0.018120648,0.0073060207,0.0016727096,0.06505383,0.011735316],"category_scores_gemma":[0.019315189,0.0009741028,0.0008663793,0.00077453395,0.004354333,0.0057703895,0.004311917,0.049997535,0.0027372881],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005297424,0.00017847001,0.002888486,0.00013256191,0.000018103801,0.019967385,0.0017296454,0.00012877879,0.000316815,0.0142874895,0.9459455,0.014353851],"study_design_scores_gemma":[0.00013691184,0.00011165491,0.0041923956,0.0011105082,0.000034124863,0.013140917,0.0049345405,0.0006201321,0.00017440309,0.014249102,0.9612378,0.00005744472],"about_ca_topic_score_codex":0.012342562,"about_ca_topic_score_gemma":0.04020281,"teacher_disagreement_score":0.06505383,"about_ca_system_score_codex":0.0056387554,"about_ca_system_score_gemma":0.010507761,"threshold_uncertainty_score":0.04091215},"labels":[],"label_agreement":null},{"id":"W4396855201","doi":"10.1016/j.jaad.2024.01.097","title":"Part 2: Management of intraoperative and perioperative bleeding","year":2024,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Hemostasis and retained surgical items","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"","keywords":"Medicine; Perioperative; MEDLINE; Surgery; General surgery; Anesthesia","score_opus":0.055478211565321886,"score_gpt":0.4013566173709026,"score_spread":0.3458784058055807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396855201","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008254726,0.9988403,0.00011758027,0.00014069014,0.00025563015,0.0000072461107,0.00001303381,0.0000052080104,0.0005377809],"genre_scores_gemma":[0.0006224822,0.9978694,0.00021988271,0.000246506,0.00059506303,0.0000080601285,0.000038574515,0.0000019663107,0.00039802006],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99960476,0.000072449555,0.00009953676,0.00006372108,0.00012942383,0.000030174693],"domain_scores_gemma":[0.9992118,0.00038051524,0.00018513945,0.000016208343,0.00015261504,0.00005379722],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007457458,0.0009701914,0.0015638794,0.0033889783,0.00027186077,0.0013340642,0.0010558938,0.0011785339,0.004428321],"category_scores_gemma":[0.0018482272,0.00034567429,0.0009638407,0.002228259,0.00067395606,0.0013969649,0.00060549146,0.0021429127,0.0016855114],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000080959864,0.00010056226,0.0004476372,0.02175903,0.00017399745,0.00028798508,0.00004540562,0.00035666788,0.0008396921,0.0010143246,0.03882047,0.9360733],"study_design_scores_gemma":[0.0000858925,0.00024501188,0.005129957,0.028266259,0.00070330524,0.006179777,0.00010936166,0.0003240319,0.000667675,0.0016059867,0.9566262,0.000056683835],"about_ca_topic_score_codex":0.0016420739,"about_ca_topic_score_gemma":0.002595786,"teacher_disagreement_score":0.004428321,"about_ca_system_score_codex":0.00062082836,"about_ca_system_score_gemma":0.0011602687,"threshold_uncertainty_score":0.014814258},"labels":[],"label_agreement":null},{"id":"W4398134337","doi":"10.1016/j.jaad.2024.05.023","title":"Tapinarof cream 1% once daily: Significant efficacy in the treatment of moderate to severe atopic dermatitis in adults and children down to 2 years of age in the pivotal phase 3 ADORING trials","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":86,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; University of Toronto; Innovaderm (Canada)","funders":"Allergan; Genentech; Galderma; Astellas Pharma; Meiji Seika Pharma; Pfizer; Biogen; Incyte; Boston Pharmaceuticals; Castle Biosciences; Sun Pharma; Dermira; Les Laboratories Pierre Fabre; Coherus Biosciences; UCB Pharma; Valeant Pharmaceuticals International; Baxalta; Celgene; Ablynx; LEO Pharma; Ortho Dermatologics; Gilead Sciences; GlaxoSmithKline; Astellas Pharma US; Amgen; Eli Lilly and Company; Bristol-Myers Squibb; Bausch Health; Bayer HealthCare; Sanofi; Regeneron Pharmaceuticals; Abbott Laboratories","keywords":"Medicine; Atopic dermatitis; Dermatology; Pediatrics","score_opus":0.024242074217119155,"score_gpt":0.34879682933780554,"score_spread":0.3245547551206864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4398134337","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8755626,0.11464692,0.0008626875,0.0011176608,0.00034946844,0.0014339483,0.0012715969,0.00014146294,0.0046137185],"genre_scores_gemma":[0.96453756,0.029611012,0.0014487073,0.0010569007,0.00027409274,0.00075239735,0.00096921,0.000019574303,0.0013305914],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9996921,0.00012160907,0.000027164322,0.000047068603,0.00005891155,0.000053214084],"domain_scores_gemma":[0.9994005,0.0001757842,0.00021748494,0.000017263897,0.000060039063,0.00012903362],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015540044,0.0005423581,0.0012108479,0.00022959754,0.00020749595,0.00070565805,0.00035046466,0.00074263767,0.0034701878],"category_scores_gemma":[0.0008868103,0.00020305412,0.0011997484,0.00022568493,0.0002728967,0.00046390516,0.00016373972,0.0011571534,0.00029609486],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.45071605,0.008895968,0.011157879,0.012408451,0.0039652945,0.0005610963,0.000418933,0.0010333037,0.05250027,0.0007356508,0.013320318,0.44428685],"study_design_scores_gemma":[0.62158185,0.2846199,0.056798566,0.0016826466,0.0033014857,0.0016311882,0.00015898945,0.0010648776,0.0065541486,0.00054610457,0.02198612,0.00007418572],"about_ca_topic_score_codex":0.00035921214,"about_ca_topic_score_gemma":0.0018749089,"teacher_disagreement_score":0.0034701878,"about_ca_system_score_codex":0.0003651205,"about_ca_system_score_gemma":0.00043439583,"threshold_uncertainty_score":0.011608899},"labels":[],"label_agreement":null},{"id":"W4399269368","doi":"10.1016/j.jaad.2024.05.065","title":"Efficacy of moxifloxacin as a mono-antibiotic therapy for hidradenitis suppurativa: A retrospective cohort study","year":2024,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Moxifloxacin; Hidradenitis suppurativa; Retrospective cohort study; Antibiotics; Dermatology; Antibiotic therapy; Cohort; Internal medicine; Microbiology","score_opus":0.019807160721658387,"score_gpt":0.33786795023658583,"score_spread":0.31806078951492744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399269368","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983858,0.00067561626,0.0000810591,0.000108754735,0.000031031803,0.0000104502205,0.00037752595,0.00000261525,0.00032714423],"genre_scores_gemma":[0.99900347,0.0002525234,0.00007219216,0.00013494297,0.000049984497,0.00001110335,0.00032061225,0.0000036255087,0.00015154706],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99881965,0.0003448113,0.00016634335,0.0003336668,0.000166728,0.00016880664],"domain_scores_gemma":[0.9963863,0.0008058303,0.0013481058,0.00063252274,0.00039645616,0.00043080328],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011004086,0.0003455344,0.00061234273,0.00062960706,0.00061600766,0.0010275964,0.0005209474,0.00094447954,0.0018295045],"category_scores_gemma":[0.003981884,0.00058117445,0.0012949783,0.0011651897,0.00039809637,0.00093087024,0.000389545,0.0010735737,0.0004172213],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007764267,0.00008890153,0.99708587,0.000014445791,0.00029197655,0.00039977295,0.00004829654,0.000015051732,0.0002454507,0.000017438364,0.00014529417,0.0008711283],"study_design_scores_gemma":[0.00011922388,0.000901721,0.9949909,0.00001853915,0.00043256485,0.0022238507,0.00034451607,0.00026785702,0.00011882467,0.000043572098,0.0005214079,0.000016956485],"about_ca_topic_score_codex":0.0031283142,"about_ca_topic_score_gemma":0.0021638996,"teacher_disagreement_score":0.0031283142,"about_ca_system_score_codex":0.0005328288,"about_ca_system_score_gemma":0.0004375488,"threshold_uncertainty_score":0.0062202215},"labels":[],"label_agreement":null},{"id":"W4399531993","doi":"10.1016/j.jaad.2024.05.082","title":"Evoked piloerection sign/pseudo-Darier sign: A clinical clue to the diagnosis of cutaneous leiomyomas","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Genetic and rare skin diseases.","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Medicine; Sign (mathematics); Dermatology","score_opus":0.016747274882912742,"score_gpt":0.3282766307131597,"score_spread":0.311529355830247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399531993","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.26841462,0.07457989,0.008803497,0.53175014,0.09499202,0.00033221356,0.0006392573,0.0007819794,0.019706357],"genre_scores_gemma":[0.7004364,0.015040124,0.003989647,0.09238162,0.18199503,0.00007206945,0.00014199257,0.00010553772,0.0058374396],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9991047,0.00027625967,0.00017397858,0.0001547058,0.00013678415,0.00015359327],"domain_scores_gemma":[0.9948138,0.0031361664,0.000500202,0.00015289774,0.0006419423,0.0007549606],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010469077,0.0010721183,0.0012295013,0.0012153665,0.00066489424,0.0014180966,0.0017524025,0.0074840374,0.002137971],"category_scores_gemma":[0.009380317,0.0006618847,0.00054707035,0.00045559683,0.0016071567,0.002041628,0.0005648785,0.006424991,0.0009846006],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006842647,0.00015009104,0.017261088,0.00071588525,0.000140651,0.8439025,0.0003879299,0.00031954612,0.003700956,0.0013064223,0.111650795,0.01977984],"study_design_scores_gemma":[0.00019128606,0.00020083404,0.010631029,0.000469408,0.00013102601,0.9471796,0.0004906534,0.003290692,0.002001065,0.0017707264,0.033553235,0.00009044585],"about_ca_topic_score_codex":0.0007188836,"about_ca_topic_score_gemma":0.0009874838,"teacher_disagreement_score":0.0074840374,"about_ca_system_score_codex":0.0008530534,"about_ca_system_score_gemma":0.0003738651,"threshold_uncertainty_score":0.0071521997},"labels":[],"label_agreement":null},{"id":"W4399553284","doi":"10.1016/j.jaad.2024.05.081","title":"Effectiveness of abrocitinib for the treatment of moderate-to-severe atopic dermatitis in patients switched from dupilumab and/or tralokinumab: A real-world retrospective study","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Dupilumab; Medicine; Atopic dermatitis; Dermatology; Retrospective cohort study; Internal medicine","score_opus":0.015499314328197724,"score_gpt":0.32487113738176887,"score_spread":0.30937182305357114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399553284","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9705977,0.021106318,0.00029818315,0.0037481193,0.00063309504,0.0000804303,0.0022631758,0.000015050373,0.0012579747],"genre_scores_gemma":[0.9919624,0.002590708,0.00022186384,0.0021147344,0.001903349,0.000026080208,0.0008893049,0.000009462648,0.00028206114],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983652,0.00045088437,0.00041350862,0.0003759212,0.00027352737,0.0001209788],"domain_scores_gemma":[0.9889094,0.005063246,0.0038614813,0.0006098079,0.0008870978,0.00066891604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029918714,0.0002659426,0.0008088713,0.0005339592,0.00036867132,0.0010216794,0.0006639817,0.0012566366,0.0023716232],"category_scores_gemma":[0.008546706,0.00027938615,0.0011748329,0.00088192546,0.00044785257,0.0007479809,0.00027987084,0.0013177785,0.000299215],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008159645,0.00039007177,0.95226175,0.0013949651,0.0029528874,0.004332112,0.00016189172,0.00019571028,0.00069747225,0.00020913593,0.008627747,0.02061669],"study_design_scores_gemma":[0.0021485952,0.004481144,0.94360673,0.0008038122,0.006583645,0.02322255,0.00052243244,0.0026503045,0.0006983368,0.00037141517,0.014769573,0.00014155732],"about_ca_topic_score_codex":0.00064946234,"about_ca_topic_score_gemma":0.0007180897,"teacher_disagreement_score":0.0029918714,"about_ca_system_score_codex":0.00056457357,"about_ca_system_score_gemma":0.00034688436,"threshold_uncertainty_score":0.015822709},"labels":[],"label_agreement":null},{"id":"W4399662252","doi":"10.1016/j.jaad.2024.06.013","title":"Historic and continued underrepresentation of the Hispanic/Latino ethnicity among dermatologic clinical trial participants","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Ethics in Clinical Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Allergy and Infectious Diseases; National Institutes of Health; McGill University Health Centre; McGill University","keywords":"Medicine; Ethnic group; Representation (politics); Clinical trial; MEDLINE; Family medicine; Dermatology; Pathology; Anthropology","score_opus":0.5162803261903761,"score_gpt":0.6039827714137848,"score_spread":0.08770244522340864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399662252","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.80190086,0.005993205,0.018381502,0.08166178,0.0020595263,0.0006061923,0.0009550642,0.00007833777,0.08836345],"genre_scores_gemma":[0.95842695,0.0017524568,0.0041120476,0.030511102,0.00090558786,0.00044772643,0.00021505002,0.000070284426,0.0035587382],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9702542,0.020057106,0.0018684104,0.0022564589,0.0045168125,0.0010470506],"domain_scores_gemma":[0.95236856,0.023670359,0.009951766,0.0050944383,0.005870209,0.0030445808],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.03845071,0.00012377782,0.0002588318,0.0014652371,0.0023365805,0.002805623,0.00067824154,0.0009208074,0.0052055465],"category_scores_gemma":[0.058726482,0.00022140435,0.00016816202,0.001432019,0.0024917226,0.0012777628,0.0015610816,0.0020028432,0.000588597],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015842299,0.00046977488,0.6261188,0.0008059905,0.0003031432,0.0011606922,0.046282597,0.0001812595,0.0069204,0.06728989,0.03531844,0.21356475],"study_design_scores_gemma":[0.000402215,0.0009826223,0.54607713,0.0032137348,0.00041141923,0.00953392,0.06314051,0.0020837924,0.011089221,0.033398733,0.32951134,0.00015532359],"about_ca_topic_score_codex":0.003231629,"about_ca_topic_score_gemma":0.0051099313,"teacher_disagreement_score":0.99907917,"about_ca_system_score_codex":0.00098082,"about_ca_system_score_gemma":0.0020222939,"threshold_uncertainty_score":0.20334917},"labels":[],"label_agreement":null},{"id":"W4399696611","doi":"10.1016/j.jaad.2024.05.085","title":"Real-world experience of bimekizumab for adult patients with plaque psoriasis: A 52-week multicenter retrospective study","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; Health Sciences Centre; Sunnybrook Health Science Centre; Women's College Hospital; McMaster University; Dermatrials Research; Probity Medical Research; SKiN Health; University of Calgary; University of Toronto","funders":"LEO Pharma; Bausch Health; Women's College Hospital; Sanofi Genzyme; Incyte; Astellas Pharma; Mylan; Dermira; Sun Pharma; Regeneron Pharmaceuticals; Baxalta; Celgene; Coherus Biosciences; Valeant Pharmaceuticals International; Sanofi; Amgen; Pfizer; Galderma; Eli Lilly and Company; Bristol-Myers Squibb; GlaxoSmithKline","keywords":"Medicine; Multicenter study; Plaque psoriasis; Psoriasis; Retrospective cohort study; Dermatology; Internal medicine; Randomized controlled trial","score_opus":0.013227376201327848,"score_gpt":0.2844077789418028,"score_spread":0.27118040274047495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399696611","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991634,0.00038276755,0.000093100636,0.000031832853,0.0000047234926,0.000014539007,0.00009615202,0.0000015520983,0.00021188261],"genre_scores_gemma":[0.9994369,0.0001543712,0.00008272483,0.00006159095,0.000018263132,0.000012756801,0.00018076865,0.000002329469,0.00005024046],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985226,0.00052323326,0.0002008933,0.00036932738,0.00018540403,0.00019850697],"domain_scores_gemma":[0.9970331,0.00072177936,0.0012357526,0.0002782792,0.00028199534,0.00044901966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016909683,0.0003511387,0.00076341815,0.00033446445,0.00051733904,0.0010827509,0.00037038836,0.0007746432,0.00096528215],"category_scores_gemma":[0.0037439314,0.00032137556,0.0006645895,0.0005769817,0.00058806315,0.00085057056,0.000587881,0.000638518,0.00029929858],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001973717,0.00044430533,0.9902512,0.000054089745,0.00019862776,0.0010966072,0.00055582996,0.00013273764,0.000718719,0.0000421437,0.00021054776,0.004321297],"study_design_scores_gemma":[0.00037311006,0.0055186446,0.9835352,0.000045168606,0.0003819494,0.0056759664,0.0020149702,0.0005837394,0.00038535128,0.000057199515,0.0013850167,0.000043599674],"about_ca_topic_score_codex":0.0011768552,"about_ca_topic_score_gemma":0.0009779787,"teacher_disagreement_score":0.0016909683,"about_ca_system_score_codex":0.0005998865,"about_ca_system_score_gemma":0.0004730093,"threshold_uncertainty_score":0.008942783},"labels":[],"label_agreement":null},{"id":"W4399701149","doi":"10.1016/j.jaad.2024.06.018","title":"Investigating corrected QT prolongation with hydroxychloroquine use among patients with cutaneous sarcoidosis: A multicenter retrospective study","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Sarcoidosis and Beryllium Toxicity Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"NYU Grossman School of Medicine; York University","keywords":"Medicine; Hydroxychloroquine; Prolongation; Retrospective cohort study; Sarcoidosis; Multicenter study; Dermatology; Internal medicine; Coronavirus disease 2019 (COVID-19); Randomized controlled trial","score_opus":0.015959142725179738,"score_gpt":0.29837105547850723,"score_spread":0.2824119127533275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399701149","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994192,0.00026431365,0.000059001046,0.000013055028,0.0000038826697,0.00000964171,0.00007341231,0.0000013903626,0.00015609266],"genre_scores_gemma":[0.9996656,0.00008405384,0.000044048098,0.000027648897,0.000012386431,0.000006977807,0.00011785038,0.0000018610405,0.000039486942],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990477,0.00023706624,0.00016973911,0.00031723725,0.0001235093,0.000104789586],"domain_scores_gemma":[0.99691236,0.0006829106,0.0013842379,0.00036492685,0.00029721286,0.00035830427],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007581746,0.0003831957,0.0007125044,0.0008146581,0.0006108554,0.0008819464,0.00042492533,0.0007745266,0.0013304866],"category_scores_gemma":[0.0029307269,0.00043267434,0.00081073225,0.0011950526,0.0005849294,0.00078639504,0.0004216338,0.0006219086,0.00022393077],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002998995,0.00004575937,0.9982461,0.000010326083,0.00007671604,0.00039556276,0.00009461808,0.000012336481,0.00033061195,0.0000073104056,0.000018892095,0.00046194048],"study_design_scores_gemma":[0.00006390786,0.0007794842,0.9950053,0.000009802307,0.00017200215,0.0030331665,0.00041814503,0.000120163,0.00016509231,0.000017685412,0.00020565299,0.000009581631],"about_ca_topic_score_codex":0.0016813227,"about_ca_topic_score_gemma":0.0011801341,"teacher_disagreement_score":0.0016813227,"about_ca_system_score_codex":0.00035621185,"about_ca_system_score_gemma":0.0004097711,"threshold_uncertainty_score":0.004450977},"labels":[],"label_agreement":null},{"id":"W4399796251","doi":"10.1016/j.jaad.2024.05.086","title":"Investigating historic cases of pyoderma gangrenosum in myelodysplastic syndrome and chronic myelomonocytic leukemia for possible VEXAS syndrome: A systematic review","year":2024,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Otitis Media and Relapsing Polychondritis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; McMaster University; University of Toronto; Women's College Hospital","funders":"Bausch Health; LEO Pharma; Galderma; University of Toronto; Cardiff University; Regeneron Pharmaceuticals; Celgene; Sanofi; Amgen; Pfizer; Eli Lilly and Company","keywords":"Pyoderma gangrenosum; Medicine; Chronic myelomonocytic leukemia; Dermatology; Myelodysplastic syndromes; Leukemia; Immunology; Pathology; Disease; Bone marrow","score_opus":0.03287953684833826,"score_gpt":0.34956109370240335,"score_spread":0.31668155685406507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399796251","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00152459,0.99774086,0.000076960576,0.000079159814,0.000054042874,0.00012082523,0.00023231462,0.0000032975295,0.00016801337],"genre_scores_gemma":[0.017308587,0.98134965,0.0004846129,0.00039180226,0.00005089125,0.000105123705,0.00021950569,0.0000030792996,0.00008681896],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9976096,0.00046714826,0.001227018,0.0002677074,0.0003506455,0.000077906996],"domain_scores_gemma":[0.9910874,0.0057701375,0.0021894623,0.00013024663,0.0006830068,0.00013981076],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002763431,0.0009032833,0.005641558,0.0075482232,0.0004227369,0.0016374883,0.0015626276,0.0015617373,0.0032756827],"category_scores_gemma":[0.011756948,0.00078364374,0.004729415,0.0057896096,0.00068051607,0.0019483819,0.0011436141,0.0008568758,0.00021334171],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003092017,0.000040197854,0.0040195673,0.91120064,0.012386336,0.0005007265,0.0003530969,0.00011991402,0.00039508427,0.00024814604,0.0022448464,0.068182305],"study_design_scores_gemma":[0.0005877449,0.0004511948,0.022636425,0.75972205,0.16000178,0.0043884832,0.0011318512,0.000121321274,0.00036593655,0.00037961293,0.050083246,0.0001302111],"about_ca_topic_score_codex":0.0052129203,"about_ca_topic_score_gemma":0.01997861,"teacher_disagreement_score":0.0075482232,"about_ca_system_score_codex":0.0011120717,"about_ca_system_score_gemma":0.0035782347,"threshold_uncertainty_score":0.014614642},"labels":[],"label_agreement":null},{"id":"W4400871351","doi":"10.1016/j.jaad.2024.07.1464","title":"Efficacy of botulinum toxin in male androgenetic alopecia: A triple-blind, randomized clinical trial","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Botulinum Toxin and Related Neurological Disorders","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Grand River Hospital","funders":"AbbVie","keywords":"Medicine; Randomized controlled trial; Dermatology; Botulinum toxin; Double blind; Internal medicine; Surgery; Alternative medicine; Pathology; Placebo","score_opus":0.041545917146566864,"score_gpt":0.3820733394272533,"score_spread":0.34052742228068644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400871351","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98144215,0.007969174,0.0010988521,0.0008802142,0.0011099373,0.0042048534,0.0007044407,0.00017707262,0.002413341],"genre_scores_gemma":[0.9841697,0.0036988142,0.001376586,0.0015546147,0.00086952315,0.004148283,0.0005786878,0.000034389028,0.0035694095],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9989567,0.00048376294,0.00007930647,0.00022354201,0.00009300754,0.0001636342],"domain_scores_gemma":[0.9986212,0.0004686135,0.00029618965,0.00011052778,0.00008507173,0.00041828273],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002263582,0.0021904882,0.005743234,0.0006366904,0.0008521582,0.0015216091,0.0012239103,0.0034088856,0.008889683],"category_scores_gemma":[0.0021011243,0.00093719136,0.0026146886,0.0005839171,0.0018601656,0.0014717802,0.00050771324,0.0032530213,0.0012058923],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9885133,0.003585214,0.00018398998,0.0004884522,0.0006229396,0.000026080324,0.000028886738,0.00009635316,0.0011995027,0.000066945104,0.00024233093,0.004946024],"study_design_scores_gemma":[0.97604877,0.022644488,0.00053870224,0.000020436351,0.00029907786,0.0000121885405,0.000010985426,0.00015095063,0.0000942886,0.000062060244,0.00010926806,0.000008926567],"about_ca_topic_score_codex":0.0013704122,"about_ca_topic_score_gemma":0.0019045006,"teacher_disagreement_score":0.008889683,"about_ca_system_score_codex":0.00085463584,"about_ca_system_score_gemma":0.0011458761,"threshold_uncertainty_score":0.029738903},"labels":[],"label_agreement":null},{"id":"W4400914165","doi":"10.1016/j.jaad.2024.06.097","title":"Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: Results from the Phase 3 randomized, controlled trial (THRIVE-AA1)","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; University of Calgary; Lynde Centre for Dermatology; Université de Montréal; Heritage Medical Research Clinic; Probity Medical Research; Institute of Cosmetic and Laser Surgery; University of Toronto","funders":"LEO Pharma; Bausch Health; Coherus Biosciences; Glenmark Pharmaceuticals; Incyte; Dermira; Sun Pharma; Regeneron Pharmaceuticals; Sanofi; Amgen; Concert Pharmaceuticals; Pfizer; Celgene; Galderma; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Alopecia areata; Medicine; Janus kinase; Janus kinase inhibitor; Hair loss; Dermatology; Randomized controlled trial; Hair growth; Safety profile; Janus; Pharmacology; Adverse effect; Internal medicine; Physiology; Nanotechnology","score_opus":0.010828802369416628,"score_gpt":0.3073237314717573,"score_spread":0.29649492910234065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400914165","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9636998,0.026717655,0.00051254407,0.0013909598,0.00042060806,0.0020679997,0.0022058948,0.00010913713,0.0028753243],"genre_scores_gemma":[0.98544747,0.006832686,0.000918965,0.0017561878,0.0005233075,0.0015894797,0.0017990608,0.000018284134,0.0011144595],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9991003,0.0004676741,0.00009894908,0.00012989131,0.00010348475,0.00009963474],"domain_scores_gemma":[0.9984079,0.00043505305,0.0005849334,0.000075329845,0.00014374108,0.00035293918],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025792462,0.00082898274,0.0018017602,0.00026455472,0.00038199738,0.0009407059,0.00045227166,0.001559319,0.0034067368],"category_scores_gemma":[0.002308045,0.00031997357,0.00248118,0.00030424062,0.00057435135,0.0006688767,0.00022937392,0.0023073668,0.00048176752],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.91569203,0.0076436796,0.004753572,0.0019247874,0.0032657785,0.00012652646,0.0001326082,0.00040075803,0.0079211155,0.00012898333,0.0026475824,0.05536262],"study_design_scores_gemma":[0.8663166,0.1084723,0.019741496,0.00015183461,0.0020159774,0.00022109087,0.000046630445,0.00038314203,0.00086217927,0.00013137408,0.0016344268,0.000022910266],"about_ca_topic_score_codex":0.00063185254,"about_ca_topic_score_gemma":0.0015604486,"teacher_disagreement_score":0.0034067368,"about_ca_system_score_codex":0.00056804426,"about_ca_system_score_gemma":0.0008314018,"threshold_uncertainty_score":0.013640523},"labels":[],"label_agreement":null},{"id":"W4401630658","doi":"10.1016/j.jaad.2024.08.013","title":"Response to Chawla et al, “Response to Vu et al’s “Efficacy of moxifloxacin as a mono-antibiotic therapy for hidradenitis suppurativa: A retrospective cohort study””","year":2024,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Hidradenitis suppurativa; Moxifloxacin; Dermatology; Retrospective cohort study; Antibiotics; Surgery; Internal medicine; Microbiology","score_opus":0.022454594639060552,"score_gpt":0.36795814364349516,"score_spread":0.3455035490044346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401630658","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009692271,0.00075741747,0.00007965805,0.9761781,0.019611225,0.000022538956,0.00025543064,0.000031469168,0.0020950106],"genre_scores_gemma":[0.0031069985,0.00047716277,0.00013708981,0.9694527,0.023155909,0.000030752468,0.00010612672,0.000017375556,0.003515931],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99651957,0.00085571525,0.0005541678,0.0007002552,0.00081059,0.00055970484],"domain_scores_gemma":[0.99201596,0.003369436,0.0008786318,0.0003069078,0.0020875584,0.0013414595],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033068531,0.00085081207,0.001231793,0.00090900145,0.0028518927,0.0032844327,0.0016257849,0.0303753,0.005996551],"category_scores_gemma":[0.021749197,0.00060569635,0.0013307984,0.0009284308,0.0012949987,0.0019382889,0.00097512745,0.022319026,0.004974156],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019501623,0.000095885356,0.0032561403,0.000057875397,0.000049271624,0.0025970924,0.000099795085,0.000056169167,0.0002185843,0.0005055452,0.98662937,0.0062393798],"study_design_scores_gemma":[0.0008817007,0.00035842025,0.0110084815,0.0008664342,0.00022802576,0.006163293,0.0012030532,0.0010358562,0.0007036393,0.0046113613,0.9727755,0.00016436364],"about_ca_topic_score_codex":0.009468418,"about_ca_topic_score_gemma":0.018255554,"teacher_disagreement_score":0.0303753,"about_ca_system_score_codex":0.0040406403,"about_ca_system_score_gemma":0.004704352,"threshold_uncertainty_score":0.029317081},"labels":[],"label_agreement":null},{"id":"W4401799514","doi":"10.1016/j.jaad.2024.07.1501","title":"Approach to Mycosis Fungoides in children: Consensus-based recommendations","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto; McMaster University; Impact","funders":"Pediatric Dermatology Research Alliance","keywords":"Mycosis fungoides; Medicine; Dermatology; Lymphoma; Pathology","score_opus":0.025697372341745572,"score_gpt":0.36239959255197957,"score_spread":0.336702220210234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401799514","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0039194007,0.35967568,0.013045695,0.5885382,0.015205173,0.0010812611,0.0007340646,0.00034258305,0.017457942],"genre_scores_gemma":[0.115094684,0.47355038,0.15141721,0.22231086,0.022818988,0.0031661754,0.004572988,0.00020564624,0.00686313],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98318326,0.005863676,0.004531957,0.0013063207,0.0041796635,0.0009351554],"domain_scores_gemma":[0.9558656,0.013588282,0.006106484,0.00079466944,0.018346397,0.005298491],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.021583578,0.0014794533,0.003751386,0.0055060666,0.0028896607,0.0057154293,0.0064477175,0.012171616,0.0046041035],"category_scores_gemma":[0.05218163,0.0010216511,0.0047054864,0.002455657,0.0018537659,0.005074319,0.0041981633,0.014151249,0.0018926781],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005432356,0.0010268276,0.019772502,0.022161692,0.002280175,0.0019717196,0.0012555072,0.0034174963,0.0007990485,0.009593284,0.45748356,0.4796949],"study_design_scores_gemma":[0.0027779473,0.0005948226,0.030014252,0.18314467,0.005165767,0.004871169,0.005734128,0.005699809,0.00085534854,0.03730744,0.72339946,0.00043523792],"about_ca_topic_score_codex":0.01270251,"about_ca_topic_score_gemma":0.020617926,"teacher_disagreement_score":0.021583578,"about_ca_system_score_codex":0.0058417525,"about_ca_system_score_gemma":0.021651676,"threshold_uncertainty_score":0.11414623},"labels":[],"label_agreement":null},{"id":"W4401832225","doi":"10.1016/j.jaad.2024.07.1503","title":"Prevalence and clinical impact of topical corticosteroid phobia among patients with chronic hand eczema—Findings from the Danish Skin Cohort","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"LEO Pharma; Janssen Pharmaceuticals; Simon Spies Fonden; Kongelig Hofbuntmager Aage Bangs Fond; Regeneron Pharmaceuticals; Sanofi; Bristol-Myers Squibb; Eli Lilly and Company; Pfizer; National Psoriasis Foundation; Amgen","keywords":"Medicine; Danish; Cohort; Corticosteroid; Dermatology; Cohort study; Internal medicine","score_opus":0.009804997984277718,"score_gpt":0.3185027504148149,"score_spread":0.3086977524305372,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401832225","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99881846,0.00019954136,0.00002879514,0.000019277151,0.0000035036196,0.000012129989,0.00046192575,8.1668e-7,0.0004556544],"genre_scores_gemma":[0.99947196,0.00008701135,0.000028327844,0.000013028938,0.0000020224936,0.000007001056,0.00031029427,6.4374007e-7,0.00007972581],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99916697,0.0001848642,0.00013579715,0.00019447962,0.00019978352,0.000118165255],"domain_scores_gemma":[0.99895966,0.00015698941,0.0004686561,0.00008889744,0.00015466254,0.0001711761],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007302542,0.00016206822,0.000309479,0.0006880331,0.00069232786,0.0007435268,0.00030238615,0.00033384006,0.0015143191],"category_scores_gemma":[0.0017570098,0.00025173533,0.0004352501,0.00066277356,0.00028475214,0.00024896534,0.0006565039,0.00032923682,0.00015644888],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000064676555,0.000024715613,0.9987903,0.0000165266,0.000042374762,0.00007300367,0.0001747145,0.000014624368,0.00016679181,0.000010840404,0.00008295579,0.00053845166],"study_design_scores_gemma":[0.0000041014214,0.000025893416,0.9992562,0.0000066021307,0.000018549963,0.00019854317,0.00031954848,0.00003048009,0.000022598319,0.0000039059446,0.000110996945,0.000002480157],"about_ca_topic_score_codex":0.03986918,"about_ca_topic_score_gemma":0.031042146,"teacher_disagreement_score":0.03986918,"about_ca_system_score_codex":0.00053629454,"about_ca_system_score_gemma":0.00044268285,"threshold_uncertainty_score":0.07927424},"labels":[],"label_agreement":null},{"id":"W4401840934","doi":"10.1016/j.jaad.2024.07.1515","title":"Real-world experience of bimekizumab for plaque psoriasis in adult patients with prior exposure to interleukin-17 inhibitors: A 16-week multicenter retrospective review","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; Women's College Hospital; Dermatrials Research; Probity Medical Research; SKiN Health; University of Calgary; University of Toronto","funders":"","keywords":"Medicine; Plaque psoriasis; Psoriasis; Multicenter study; Retrospective cohort study; Dermatology; Interleukin; Internal medicine; Cytokine; Randomized controlled trial","score_opus":0.011097755775325135,"score_gpt":0.28089732347365287,"score_spread":0.26979956769832775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401840934","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.56909394,0.41429392,0.0014106535,0.007062031,0.0010923663,0.00024436665,0.004633759,0.000028310109,0.0021406307],"genre_scores_gemma":[0.93213457,0.05853878,0.0009738709,0.0035171087,0.002640501,0.000118887765,0.0017090745,0.000025299827,0.00034194058],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99519664,0.0013091951,0.0019548908,0.0006210592,0.00079617725,0.00012208457],"domain_scores_gemma":[0.95534575,0.0191289,0.018930916,0.0014560232,0.0043334486,0.00080497476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006679515,0.00023001364,0.0009179604,0.0015582443,0.00029429953,0.001139133,0.0006294109,0.00089921465,0.0016845391],"category_scores_gemma":[0.020901484,0.00032139118,0.00080294424,0.002156536,0.0005544622,0.0011646387,0.000488888,0.00068957114,0.0003233064],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017269877,0.00018364309,0.8684421,0.017959252,0.0046764454,0.015341708,0.0011978025,0.00024797104,0.0012523544,0.0006036368,0.020138303,0.06822985],"study_design_scores_gemma":[0.000490656,0.0017084844,0.7310158,0.014245033,0.009936391,0.14703916,0.00359718,0.0012663903,0.0019169825,0.00064410566,0.087910086,0.00022973544],"about_ca_topic_score_codex":0.00051057176,"about_ca_topic_score_gemma":0.0006343255,"teacher_disagreement_score":0.006679515,"about_ca_system_score_codex":0.00049381464,"about_ca_system_score_gemma":0.0006647459,"threshold_uncertainty_score":0.03532511},"labels":[],"label_agreement":null},{"id":"W4401853223","doi":"10.1016/j.jaad.2024.07.1520","title":"Keratinocyte carcinomas in survivors of childhood cancer: A report from the childhood cancer survivor study","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Cancer Institute; Springworks Therapeutics; American Lebanese Syrian Associated Charities","keywords":"Medicine; Childhood cancer; Incidence (geometry); Keratinocyte; Cancer; Oncology; Skin cancer; Dermatology; Internal medicine","score_opus":0.018327562355874603,"score_gpt":0.3330590958023101,"score_spread":0.31473153344643545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401853223","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984024,0.0002786428,0.000029115017,0.00005356308,0.0000054678635,0.000007987038,0.00074117054,0.0000020276063,0.00047969486],"genre_scores_gemma":[0.9985833,0.00045852014,0.000023130357,0.000027843598,0.000009131807,0.000008277309,0.00056303066,0.0000017514049,0.00032492404],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997009,0.00007304869,0.000025394615,0.00006017527,0.000055775607,0.000084739026],"domain_scores_gemma":[0.99906963,0.00013937987,0.0003181034,0.000096003365,0.00015467856,0.00022217321],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039727445,0.00025480252,0.00031798956,0.0011101379,0.0008713013,0.0007860617,0.00027064528,0.00036156247,0.0010327947],"category_scores_gemma":[0.0010680361,0.00026421619,0.00036611754,0.0019176678,0.00033082196,0.0004826574,0.00054308336,0.0004630717,0.00015596615],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008628278,0.000033980155,0.99794227,0.000009306185,0.000045059514,0.00015236055,0.000396464,0.0000126943805,0.00026977735,0.000020560454,0.00015469125,0.00087651476],"study_design_scores_gemma":[0.0000063685825,0.00006791697,0.9977725,0.0000043647406,0.00005269004,0.00030090057,0.0012870363,0.000014222816,0.00009758606,0.000007001601,0.0003855877,0.0000037505756],"about_ca_topic_score_codex":0.051658455,"about_ca_topic_score_gemma":0.05317085,"teacher_disagreement_score":0.051658455,"about_ca_system_score_codex":0.00044784488,"about_ca_system_score_gemma":0.0006930332,"threshold_uncertainty_score":0.10271555},"labels":[],"label_agreement":null},{"id":"W4401930402","doi":"10.1016/j.jaad.2024.07.1523","title":"Examining blood pressure changes with spironolactone for alopecia: A retrospective analysis","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Hormonal Regulation and Hypertension","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"York University","keywords":"Medicine; Spironolactone; Blood pressure; Dermatology; Retrospective cohort study; Internal medicine; Aldosterone","score_opus":0.02690965042589891,"score_gpt":0.3076455634640818,"score_spread":0.28073591303818285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401930402","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9877921,0.009442527,0.0006972273,0.00054203835,0.00007523473,0.00003415339,0.00087204506,0.000010847214,0.000533773],"genre_scores_gemma":[0.9974523,0.0013652628,0.00027878943,0.00023392816,0.0001811291,0.000012902666,0.00039584894,0.0000048598467,0.00007492204],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970987,0.00095107016,0.00081249943,0.0004633875,0.00052472565,0.00014950588],"domain_scores_gemma":[0.9851987,0.0062387805,0.0058266465,0.0010186686,0.0012424816,0.0004748231],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029865748,0.00020822768,0.00047858182,0.0011754216,0.00029461845,0.00069651334,0.0004607824,0.00048037534,0.0010363943],"category_scores_gemma":[0.009708691,0.00024751943,0.00055880257,0.0018387205,0.00033568454,0.0004878857,0.00032059767,0.00053032953,0.00016641887],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000120149874,0.000021051164,0.99569774,0.000071734365,0.00022117539,0.000605561,0.00004460205,0.000017922837,0.00011257505,0.000023959356,0.00033907074,0.0027244424],"study_design_scores_gemma":[0.00003212087,0.00028128162,0.9868955,0.00011833983,0.00059939397,0.009101586,0.0002920159,0.0005092624,0.00028645026,0.00009534579,0.0017679738,0.000020708121],"about_ca_topic_score_codex":0.0008247485,"about_ca_topic_score_gemma":0.0008778685,"teacher_disagreement_score":0.0029865748,"about_ca_system_score_codex":0.00019003551,"about_ca_system_score_gemma":0.00027577823,"threshold_uncertainty_score":0.015794754},"labels":[],"label_agreement":null},{"id":"W4402034013","doi":"10.1016/j.jaad.2024.07.1521","title":"A randomized phase 3b study evaluating the safety and efficacy of risankizumab in adult patients with moderate-to-severe plaque psoriasis with non-pustular palmoplantar involvement","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"AbbVie; Amgen","keywords":"Medicine; Plaque psoriasis; Dermatology; Psoriasis; Randomized controlled trial; Pustular psoriasis; Palmoplantar pustulosis; Surgery","score_opus":0.014854132486827355,"score_gpt":0.29709449608560323,"score_spread":0.28224036359877586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402034013","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97302306,0.005287455,0.0015829495,0.0010980917,0.0005178675,0.012357692,0.0027864615,0.0002856564,0.0030607292],"genre_scores_gemma":[0.97465897,0.0026359279,0.0036292693,0.002152654,0.00033420653,0.011181926,0.0022977076,0.00004306895,0.0030663079],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9992781,0.00041959478,0.00004026573,0.00009929246,0.000076222146,0.00008650851],"domain_scores_gemma":[0.9989711,0.00023692602,0.00025692067,0.0000852963,0.00009536448,0.00035447362],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021841137,0.0011204525,0.0024120582,0.0002809118,0.00039371802,0.0008701153,0.0006733111,0.0013365416,0.0064796684],"category_scores_gemma":[0.0018894902,0.0006132079,0.0013300951,0.00034933168,0.000797273,0.0007178492,0.00035410438,0.0027590652,0.001092178],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.966599,0.00952328,0.0012013168,0.00049891375,0.00076568575,0.000060230897,0.0000589441,0.00029795268,0.0040963576,0.000098948985,0.0013897382,0.015409694],"study_design_scores_gemma":[0.9502672,0.04631413,0.0021137786,0.00001872054,0.00017376701,0.00005201693,0.000010495364,0.00025419696,0.00018740773,0.00007344824,0.00052799535,0.0000069500443],"about_ca_topic_score_codex":0.00078455376,"about_ca_topic_score_gemma":0.0021323378,"teacher_disagreement_score":0.0064796684,"about_ca_system_score_codex":0.0005863466,"about_ca_system_score_gemma":0.0017790934,"threshold_uncertainty_score":0.02167672},"labels":[],"label_agreement":null},{"id":"W4402103592","doi":"10.1016/j.jaad.2024.07.391","title":"50532 VISIBLE: Guselkumab Demonstrated Significant Scalp Psoriasis Clearance and Scalp Itch Improvements at Week 16 in Skin of Color Participants With Moderate-to-Severe Plaque Psoriasis","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Scalp; Dermatology; Psoriasis; Plaque psoriasis","score_opus":0.01816836815974643,"score_gpt":0.27052522720317956,"score_spread":0.25235685904343313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402103592","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9849492,0.004027541,0.0007474629,0.0008606549,0.0005064335,0.00020476872,0.001263444,0.00039191102,0.007048632],"genre_scores_gemma":[0.9903116,0.001006874,0.00082067645,0.00041865555,0.00008234152,0.00008408544,0.00056092656,0.000027973912,0.0066869585],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998498,0.00003589562,0.000009703021,0.000025039686,0.000040601037,0.000038945902],"domain_scores_gemma":[0.99983966,0.000032171203,0.000031084965,0.000013605098,0.00002886089,0.00005452637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004056076,0.0003096003,0.00040909473,0.00016313305,0.00018836196,0.000363365,0.00021931487,0.00047714676,0.018908277],"category_scores_gemma":[0.00044631178,0.0001440221,0.00035622547,0.00011486611,0.00013273896,0.00036636612,0.00018092801,0.0010835706,0.0014748472],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12985045,0.010561738,0.008786298,0.0021447132,0.00087832945,0.00031537857,0.00017944528,0.00021663075,0.4861867,0.00021955796,0.014359121,0.34630165],"study_design_scores_gemma":[0.0572431,0.2032506,0.41093215,0.0008372336,0.0030319944,0.0033540467,0.00059972407,0.0020853067,0.25610372,0.00063842797,0.061768923,0.00015472273],"about_ca_topic_score_codex":0.000619216,"about_ca_topic_score_gemma":0.001497406,"teacher_disagreement_score":0.018908277,"about_ca_system_score_codex":0.00016303989,"about_ca_system_score_gemma":0.00028359957,"threshold_uncertainty_score":0.063254535},"labels":[],"label_agreement":null},{"id":"W4402103595","doi":"10.1016/j.jaad.2024.07.426","title":"54025 A Maximum-Use Trial of Ruxolitinib Cream in Children ≥2 to <12 Years Old with Atopic Dermatitis (AD): Patient-Reported Outcomes (PROs) at Week 8","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Transgenic Plants and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"","keywords":"Medicine; Atopic dermatitis; Ruxolitinib; Dermatology; Pediatrics; Internal medicine; Myelofibrosis","score_opus":0.01078352826150884,"score_gpt":0.26768928178907775,"score_spread":0.2569057535275689,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402103595","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9856873,0.007917239,0.00019973503,0.00044292602,0.00021159391,0.00041562904,0.0010450042,0.00007114577,0.0040094885],"genre_scores_gemma":[0.9935905,0.0017744624,0.0003082701,0.0005227105,0.00010739882,0.0003979804,0.0009829126,0.000007716713,0.0023080008],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9997874,0.00007287041,0.000012462688,0.000042514992,0.000022122169,0.00006259635],"domain_scores_gemma":[0.99974376,0.00006419213,0.000059984755,0.0000133455715,0.00001745864,0.00010137165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060902827,0.0005861947,0.0013478743,0.00015925686,0.00023932218,0.0005551068,0.0004162242,0.0008239402,0.0058502266],"category_scores_gemma":[0.00059372454,0.00022711328,0.0013087958,0.00015047555,0.00026368292,0.00055722747,0.00023246242,0.0017791933,0.00086812075],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.78929937,0.012549134,0.013222563,0.001836248,0.003287834,0.00037614675,0.00015216302,0.001262521,0.01134292,0.00040009944,0.008427225,0.15784374],"study_design_scores_gemma":[0.6035555,0.28817698,0.091468915,0.00058623496,0.0026694532,0.0007129497,0.00019388033,0.0017346634,0.0026602,0.00040904141,0.0077561666,0.00007602802],"about_ca_topic_score_codex":0.0008297659,"about_ca_topic_score_gemma":0.0024594679,"teacher_disagreement_score":0.0058502266,"about_ca_system_score_codex":0.00039506078,"about_ca_system_score_gemma":0.00028170377,"threshold_uncertainty_score":0.019570947},"labels":[],"label_agreement":null},{"id":"W4402103596","doi":"10.1016/j.jaad.2024.07.359","title":"53928 Tapinarof Cream 1% Once Daily: Interim Analysis of ADORING 3 Phase 3 Long-term Extension Trial in Adults and Children Down to 2 Years of Age with Atopic Dermatitis","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Probity Medical Research; University of British Columbia; Innovaderm (Canada)","funders":"","keywords":"Medicine; Atopic dermatitis; Interim; Interim analysis; Term (time); Extension (predicate logic); Dermatology; Pediatrics; Clinical trial; Internal medicine","score_opus":0.013636146350007827,"score_gpt":0.33438005809947213,"score_spread":0.3207439117494643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402103596","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.972179,0.013055841,0.0013070094,0.00095219444,0.00069337134,0.0020761178,0.0039450033,0.00032029272,0.005471161],"genre_scores_gemma":[0.9806675,0.00403072,0.0016116352,0.0014715923,0.00036368304,0.002174467,0.0033254137,0.00006980696,0.006285309],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.999199,0.00035413323,0.000036751175,0.00010678931,0.000060643437,0.00024273504],"domain_scores_gemma":[0.9990356,0.0003115034,0.0001658388,0.00011860083,0.00006930485,0.00029924608],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025946826,0.0015058345,0.003226044,0.00035633295,0.00044804876,0.0015790528,0.00084291655,0.0012565707,0.008038824],"category_scores_gemma":[0.001361881,0.00047137268,0.003161959,0.00035515748,0.00078131317,0.0012592779,0.0004002238,0.003979349,0.0015430887],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.93196476,0.0062527778,0.0023649158,0.0008455858,0.0022481615,0.00014605033,0.00012667914,0.0011305474,0.0052113566,0.0002861922,0.0032994098,0.046123575],"study_design_scores_gemma":[0.8660301,0.11618657,0.010865122,0.0001248916,0.001728209,0.00015093188,0.00007259126,0.0011070418,0.0008991089,0.0003948343,0.0024030947,0.000037547135],"about_ca_topic_score_codex":0.0011440488,"about_ca_topic_score_gemma":0.0032473987,"teacher_disagreement_score":0.008038824,"about_ca_system_score_codex":0.00060944207,"about_ca_system_score_gemma":0.0010066058,"threshold_uncertainty_score":0.026892543},"labels":[],"label_agreement":null},{"id":"W4402103609","doi":"10.1016/j.jaad.2024.07.379","title":"53959 Treatment With Upadacitinib Increases the Achievement of Minimal Disease Activity Among Patients With Moderate-to-Severe Atopic Dermatitis: Results From Phase 3 Studies (Measure Up 1 and Measure Up 2)","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; SKiN Health; Queen's University","funders":"","keywords":"Medicine; Atopic dermatitis; Measure (data warehouse); Dermatology","score_opus":0.02376680708519913,"score_gpt":0.3076311942316339,"score_spread":0.28386438714643475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402103609","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98277414,0.011256292,0.00036980858,0.0006455283,0.00022509246,0.0006578561,0.00113856,0.00018253471,0.0027501886],"genre_scores_gemma":[0.9926945,0.0033700932,0.00078928465,0.00072524394,0.0001295052,0.00031181853,0.0010570108,0.000017105247,0.00090540404],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99948335,0.0002155148,0.00003491912,0.00006933128,0.00009539664,0.00010145219],"domain_scores_gemma":[0.999432,0.00016368896,0.00017272915,0.00004191454,0.000057917583,0.00013166683],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013381055,0.0007056655,0.0016366233,0.00032657804,0.00027030514,0.0010113453,0.0005906367,0.00071083364,0.0033958459],"category_scores_gemma":[0.00089531357,0.0003145501,0.0020776321,0.00035980987,0.00034464104,0.00068850996,0.00030883614,0.0026995237,0.00053392793],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.49133962,0.02759258,0.0242963,0.0026838267,0.007305047,0.0001839306,0.00020866292,0.0016020155,0.031187711,0.00027220667,0.011532411,0.40179563],"study_design_scores_gemma":[0.46931937,0.3458508,0.1581037,0.00036242482,0.0053771916,0.0007183414,0.00017737127,0.0021184594,0.009070152,0.00034165056,0.008433818,0.00012670207],"about_ca_topic_score_codex":0.00085484394,"about_ca_topic_score_gemma":0.0028622048,"teacher_disagreement_score":0.0033958459,"about_ca_system_score_codex":0.0005061262,"about_ca_system_score_gemma":0.00052000646,"threshold_uncertainty_score":0.011360288},"labels":[],"label_agreement":null},{"id":"W4402103614","doi":"10.1016/j.jaad.2024.07.355","title":"54341 Study Design and Recruitment into the North American Post-authorization Safety Study (PASS) to Monitor Pregnancy and Infant Outcomes Following Dupilumab Exposure During Pregnancy","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Metropolitan University","funders":"","keywords":"Medicine; Dupilumab; Pregnancy; Authorization; Obstetrics; Internal medicine; Computer security","score_opus":0.030169125305920173,"score_gpt":0.35185882131014007,"score_spread":0.32168969600421987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402103614","genre_codex":"empirical","genre_gemma":"protocol","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"protocol","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9570963,0.0007698361,0.0028862343,0.00049064506,0.00013942542,0.020298077,0.0069227885,0.000056659792,0.01133998],"genre_scores_gemma":[0.94116485,0.00057650084,0.0039021466,0.0014399434,0.0002217946,0.041873906,0.0025978545,0.000033046526,0.00818978],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973207,0.0015155195,0.00016580631,0.0003642429,0.00029368815,0.0003400843],"domain_scores_gemma":[0.99881566,0.0003006128,0.0003198301,0.00020571024,0.00012740272,0.00023086245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031991561,0.00074192963,0.00067845936,0.00046546035,0.00073087343,0.00044215145,0.0005588226,0.00068687805,0.010562213],"category_scores_gemma":[0.003956657,0.00047832212,0.0004380314,0.0005706079,0.00048035884,0.000422665,0.00034340884,0.0007604217,0.0015779389],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.30714643,0.019990148,0.47800645,0.0011558823,0.001611427,0.0011641049,0.0016855367,0.00091830804,0.012312755,0.0033621879,0.02649646,0.14615032],"study_design_scores_gemma":[0.05253175,0.1402192,0.7632425,0.00044068517,0.0014434753,0.00075223244,0.0006746664,0.0017829818,0.00304433,0.0015080173,0.03427322,0.00008702746],"about_ca_topic_score_codex":0.0014166138,"about_ca_topic_score_gemma":0.0032592227,"teacher_disagreement_score":0.010562213,"about_ca_system_score_codex":0.0005341595,"about_ca_system_score_gemma":0.0016984175,"threshold_uncertainty_score":0.03533411},"labels":[],"label_agreement":null},{"id":"W4402103617","doi":"10.1016/j.jaad.2024.07.388","title":"53429 Use of Systemic Janus Kinase Inhibitors for Vitiligo: An Evidence-Based Review","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"melanin and skin pigmentation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Women's College Hospital; University of Calgary; Health Sciences Centre; SKiN Health; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Medicine; Vitiligo; Janus kinase; Dermatology; Internal medicine","score_opus":0.045824865031744655,"score_gpt":0.35149986264548294,"score_spread":0.3056749976137383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402103617","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000103286555,0.99928504,0.0000467561,0.00021977884,0.000113830174,0.000005566535,0.00001749562,0.0000025657698,0.0002057714],"genre_scores_gemma":[0.001434121,0.99762434,0.00013577395,0.00048227163,0.00017117566,0.000008088901,0.000027413558,0.0000011095885,0.00011571892],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.999595,0.00008134309,0.00013453506,0.00006650727,0.00009890653,0.000023763343],"domain_scores_gemma":[0.99844724,0.00097398605,0.00034883275,0.0000179926,0.000165914,0.00004604713],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012197543,0.0006005132,0.0026114178,0.0016783488,0.00020781017,0.0010895868,0.0011845721,0.0011439284,0.0037920228],"category_scores_gemma":[0.0020415657,0.0003477729,0.0016370432,0.0012755989,0.00036625942,0.0010173314,0.0005057568,0.0017611309,0.00079808134],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007898008,0.000109348526,0.00040254838,0.10464618,0.0017142121,0.00033203434,0.000042384407,0.00031270814,0.0014030288,0.0011914256,0.020094268,0.8689621],"study_design_scores_gemma":[0.0014101916,0.0012200269,0.0065918155,0.105018,0.018078476,0.0048171734,0.00018871609,0.0004918357,0.001510044,0.002264838,0.8582952,0.000113784154],"about_ca_topic_score_codex":0.00075233233,"about_ca_topic_score_gemma":0.0021567487,"teacher_disagreement_score":0.0037920228,"about_ca_system_score_codex":0.0004910469,"about_ca_system_score_gemma":0.0009894444,"threshold_uncertainty_score":0.012685537},"labels":[],"label_agreement":null},{"id":"W4402103631","doi":"10.1016/j.jaad.2024.07.363","title":"52137 The Effects of Botulinum Toxin Injections on Mood and Mood Disorders: A Systematic Review of Randomized Controlled Trials","year":2024,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Botulinum Toxin and Related Neurological Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Vancouver General Hospital; University of Toronto; University of Ottawa; University of Calgary","funders":"","keywords":"Medicine; Randomized controlled trial; Mood; Mood disorders; Botulinum toxin; Psychiatry; Anesthesia; Surgery; Anxiety","score_opus":0.02174594848925407,"score_gpt":0.360603572815462,"score_spread":0.3388576243262079,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402103631","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013941855,0.99720854,0.00016400953,0.00012740509,0.000121125006,0.00035121958,0.00038738767,0.000012895035,0.00023325822],"genre_scores_gemma":[0.022407852,0.97507906,0.00078268425,0.0006999776,0.0000996302,0.000387842,0.0002914231,0.000009652728,0.00024180062],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9959971,0.0013816163,0.0014820226,0.0004262386,0.0005581739,0.00015492439],"domain_scores_gemma":[0.9884821,0.008054214,0.00258233,0.00016619697,0.000564259,0.00015083679],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0063262773,0.0018639828,0.011801208,0.003876547,0.0004943716,0.0022227513,0.0017251093,0.0020272676,0.008242964],"category_scores_gemma":[0.020850312,0.0010677924,0.01180997,0.004489429,0.00088093855,0.0015652052,0.0012761779,0.0016722995,0.00045999384],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022351684,0.00003239198,0.00054116896,0.91782504,0.05240921,0.00007283006,0.000058714686,0.0001249529,0.00028143165,0.00011081253,0.0011040331,0.025204279],"study_design_scores_gemma":[0.007962214,0.0009159186,0.006282545,0.3615409,0.6085897,0.00027566773,0.00015501535,0.00014392799,0.00033552235,0.00038026695,0.013345181,0.00007315769],"about_ca_topic_score_codex":0.0063810186,"about_ca_topic_score_gemma":0.02086367,"teacher_disagreement_score":0.011801208,"about_ca_system_score_codex":0.0024576564,"about_ca_system_score_gemma":0.004208372,"threshold_uncertainty_score":0.03345692},"labels":[],"label_agreement":null},{"id":"W4402103638","doi":"10.1016/j.jaad.2024.07.368","title":"53250 The Presentation of Anxiety and Depression among Children and Youth Diagnosed with Hidradenitis Suppurativa: A Review","year":2024,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Hidradenitis suppurativa; Medicine; Presentation (obstetrics); Depression (economics); Anxiety; Dermatology; Psychiatry; Surgery; Internal medicine; Disease","score_opus":0.02044490330952451,"score_gpt":0.3386641289080639,"score_spread":0.3182192255985394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402103638","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000954387,0.9995733,0.000016347316,0.00005806077,0.00007466933,0.0000040297355,0.000018565815,0.0000014553982,0.00015823275],"genre_scores_gemma":[0.0007975195,0.9988238,0.00006011909,0.00012702573,0.00009142211,0.0000043094296,0.000022307904,4.6104708e-7,0.00007303669],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997093,0.00004564805,0.00009422294,0.000051323186,0.00007887411,0.00002058885],"domain_scores_gemma":[0.9991485,0.00046798287,0.0002267328,0.000010248582,0.0001119485,0.000034503766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005772353,0.0006566175,0.0019041989,0.0028623722,0.00019184298,0.00094744883,0.0007746369,0.0007734092,0.0034832854],"category_scores_gemma":[0.001627253,0.00033432222,0.0010267856,0.0025530013,0.00028187572,0.0009526645,0.0006075771,0.0008438842,0.0005366154],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017789054,0.00007853013,0.0015967516,0.14436246,0.00084022613,0.00044814261,0.00015030142,0.0001836265,0.0007184204,0.0006240182,0.025321653,0.825498],"study_design_scores_gemma":[0.00028274886,0.00048162104,0.018527737,0.17854828,0.008430634,0.010318515,0.0006398655,0.00026194495,0.0005344044,0.0009556471,0.7808932,0.00012531191],"about_ca_topic_score_codex":0.0027701526,"about_ca_topic_score_gemma":0.0059573883,"teacher_disagreement_score":0.0034832854,"about_ca_system_score_codex":0.0004072164,"about_ca_system_score_gemma":0.0011634246,"threshold_uncertainty_score":0.011652768},"labels":[],"label_agreement":null},{"id":"W4402103643","doi":"10.1016/j.jaad.2024.07.390","title":"54203 VISIBLE: Clearance and Symptom Improvement With Guselkumab at Week 16 in Skin of Color Participants With Moderate-to-Severe Plaque Psoriasis","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Health Sciences Centre; Women's College Hospital; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Plaque psoriasis; Dermatology; Psoriasis","score_opus":0.01351958969289073,"score_gpt":0.2601794413498324,"score_spread":0.24665985165694165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402103643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980027,0.00063234405,0.000069187394,0.00008051905,0.000042550142,0.000048634858,0.0002506701,0.000016704958,0.0008565934],"genre_scores_gemma":[0.99834895,0.00019916872,0.00012712138,0.00008421615,0.00002440507,0.00003321043,0.00020061503,0.000004349431,0.0009778969],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9997023,0.00007809945,0.000020973846,0.000047344693,0.000060315942,0.00009091911],"domain_scores_gemma":[0.9996431,0.00007494759,0.00008630159,0.000023140863,0.000048947735,0.00012351327],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007711429,0.00028303478,0.00072854734,0.00018533527,0.00027807418,0.00041373592,0.00020713225,0.0005199361,0.004897726],"category_scores_gemma":[0.001007152,0.00016504152,0.0005627697,0.00013841725,0.00012827945,0.00050793885,0.00018659547,0.0010046785,0.0005552788],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4411183,0.02222448,0.16014127,0.0012059007,0.001846481,0.00062578754,0.0006670988,0.0004566701,0.13090815,0.00015254077,0.0047599147,0.23589341],"study_design_scores_gemma":[0.009056833,0.08095171,0.89784724,0.00009317649,0.0009245359,0.00051445584,0.00041990905,0.0005926571,0.0067390767,0.00012110103,0.0026885879,0.000050814306],"about_ca_topic_score_codex":0.0010585962,"about_ca_topic_score_gemma":0.0020056101,"teacher_disagreement_score":0.004897726,"about_ca_system_score_codex":0.00019558014,"about_ca_system_score_gemma":0.00028196172,"threshold_uncertainty_score":0.016384482},"labels":[],"label_agreement":null},{"id":"W4402103647","doi":"10.1016/j.jaad.2024.07.360","title":"50607 Ten-year Data on Canadian Medicolegal Trends for Laser Therapy from 2013 to 2022","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Clinical practice guidelines implementation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa; University of Toronto; Canadian Medical Protective Association; Vancouver Coastal Health Research Institute; University of British Columbia","funders":"","keywords":"Medicine; Laser therapy; MEDLINE; Medical physics; Family medicine; Laser; Optics","score_opus":0.17536415432144775,"score_gpt":0.49475722817628426,"score_spread":0.3193930738548365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402103647","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12099106,0.015855514,0.001388673,0.01337471,0.00080533576,0.0005447496,0.7117608,0.0006919439,0.13458729],"genre_scores_gemma":[0.4670766,0.021873523,0.007968821,0.012975094,0.00037881522,0.0008446741,0.43293494,0.00023079148,0.055716723],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99507576,0.00017421335,0.00039786473,0.00026430128,0.003190919,0.0008968766],"domain_scores_gemma":[0.9835344,0.0009869648,0.0016043907,0.00016130874,0.012339678,0.0013732049],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015150432,0.0005247161,0.00071568514,0.006917059,0.0021975196,0.0017018167,0.0015822276,0.00086224906,0.015173763],"category_scores_gemma":[0.012025908,0.00049399777,0.0014666296,0.01582774,0.00035296753,0.00058354734,0.00084865233,0.0016023429,0.0024363918],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043860552,0.00018074145,0.26283315,0.0017964543,0.00046997334,0.0001849082,0.00067054783,0.001264236,0.00032220402,0.002703379,0.6236533,0.105482616],"study_design_scores_gemma":[0.00010858727,0.000058617836,0.72873634,0.0012958813,0.00031562464,0.00021141532,0.0010283706,0.0012153517,0.00042444083,0.00028385757,0.2662161,0.00010532703],"about_ca_topic_score_codex":0.9942931,"about_ca_topic_score_gemma":0.9967687,"teacher_disagreement_score":0.045373727,"about_ca_system_score_codex":0.045373727,"about_ca_system_score_gemma":0.12725104,"threshold_uncertainty_score":0.32921094},"labels":[],"label_agreement":null},{"id":"W4402103654","doi":"10.1016/j.jaad.2024.07.386","title":"52238 Updated integrated safety analysis of ritlecitinib over 36 months in patients with alopecia areata (AA) from the ALLEGRO clinical trial program","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Biomedical Ethics and Regulation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Alopecia areata; Medicine; Dermatology; Clinical trial; Internal medicine","score_opus":0.026735798035042477,"score_gpt":0.37894207617104114,"score_spread":0.35220627813599864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402103654","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.80949557,0.046117757,0.0056650294,0.0053084916,0.0008297845,0.0029318274,0.08795464,0.0006314992,0.041065387],"genre_scores_gemma":[0.93904394,0.0051202714,0.0029249005,0.0037880817,0.0006431739,0.001407233,0.041331496,0.00015001712,0.0055908803],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9935149,0.0029058275,0.00069721433,0.000736797,0.0016978759,0.00044738615],"domain_scores_gemma":[0.9873471,0.0044760793,0.0042022113,0.0012208094,0.0021339175,0.0006198404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009800637,0.0004286062,0.001744511,0.0008014659,0.0004080859,0.0019232652,0.00064390834,0.00072273205,0.0075142607],"category_scores_gemma":[0.012792674,0.00029008975,0.0034090038,0.0014620974,0.00027503198,0.0012125162,0.0006540714,0.0019096197,0.0011880073],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2807633,0.0020572683,0.16810162,0.00685062,0.036837336,0.00048479513,0.00029955167,0.0056738383,0.0063080504,0.0015490795,0.06131713,0.4297574],"study_design_scores_gemma":[0.066877946,0.028522585,0.71833104,0.0017467597,0.049486194,0.0013417334,0.00015386644,0.003412135,0.00402989,0.0022374662,0.123661876,0.00019847204],"about_ca_topic_score_codex":0.0014627449,"about_ca_topic_score_gemma":0.0038134523,"teacher_disagreement_score":0.009800637,"about_ca_system_score_codex":0.0012034436,"about_ca_system_score_gemma":0.002126534,"threshold_uncertainty_score":0.051831365},"labels":[],"label_agreement":null},{"id":"W4402103671","doi":"10.1016/j.jaad.2024.07.354","title":"51349 Spesolimab for the prevention of generalized pustular psoriasis (GPP) flares in White/Caucasian patients: Results from the randomized, placebo-controlled Effisayil 2 study","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Generalized pustular psoriasis; Dermatology; Placebo; Psoriasis; Randomized controlled trial; Internal medicine; Pathology; Alternative medicine","score_opus":0.0147021214546543,"score_gpt":0.28329756275677676,"score_spread":0.26859544130212243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402103671","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98466057,0.00968369,0.0004623422,0.00062640087,0.0005575954,0.00096607994,0.00078333565,0.00012697473,0.0021330994],"genre_scores_gemma":[0.98496336,0.0061986605,0.0010334753,0.0019571013,0.0008170403,0.0009084378,0.0009524352,0.000031489843,0.0031381124],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9993881,0.00030158614,0.000042641317,0.00008931924,0.000055136516,0.00012313353],"domain_scores_gemma":[0.9995296,0.00011511537,0.00010741173,0.00003445674,0.000038177765,0.00017533256],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016183717,0.0015600236,0.0026885734,0.0005866077,0.0005127794,0.0010414376,0.0006423839,0.0017516711,0.004641582],"category_scores_gemma":[0.0009469651,0.00067756383,0.0022066599,0.00046518733,0.00083631143,0.0008729043,0.00033159112,0.0021016141,0.000715121],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.96021134,0.005565701,0.0010051469,0.00070747297,0.0019656846,0.00009148132,0.000044836514,0.00014615663,0.0068208557,0.00008241343,0.000853453,0.022505483],"study_design_scores_gemma":[0.92983174,0.05999492,0.007304571,0.000050007995,0.0011623715,0.000059970695,0.000034266668,0.00017563056,0.00055189634,0.00008080303,0.00073481654,0.000019080388],"about_ca_topic_score_codex":0.0009851726,"about_ca_topic_score_gemma":0.0019107605,"teacher_disagreement_score":0.004641582,"about_ca_system_score_codex":0.00033899496,"about_ca_system_score_gemma":0.0005313501,"threshold_uncertainty_score":0.015527666},"labels":[],"label_agreement":null},{"id":"W4402103711","doi":"10.1016/j.jaad.2024.07.052","title":"53767 A practical algorithm for the integration of skincare to improve patient outcomes and satisfaction with energy-based dermatologic procedures","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Body Image and Dysmorphia Studies","field":"Psychology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cosmedica","funders":"","keywords":"Medicine; Energy (signal processing); Algorithm; Patient satisfaction; Dermatology; Surgery; Statistics; Computer science","score_opus":0.019427297297996752,"score_gpt":0.34991123308559474,"score_spread":0.330483935787598,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402103711","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12517808,0.0018694315,0.62066835,0.046382826,0.0017245793,0.03690889,0.0027971934,0.02089443,0.14357623],"genre_scores_gemma":[0.08123549,0.0004770261,0.9008166,0.0012472537,0.00012952175,0.0051749325,0.0006571958,0.000218001,0.010043963],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974126,0.0010337671,0.00034381993,0.00023931061,0.00079658144,0.00017382065],"domain_scores_gemma":[0.99748045,0.00071314204,0.00026956506,0.00017617061,0.00089120615,0.00046944435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035492915,0.0013192232,0.0007069811,0.0028561647,0.0015393081,0.0025266886,0.0016536847,0.0016030371,0.041212145],"category_scores_gemma":[0.008543378,0.0004998554,0.0010743063,0.0010338253,0.00053755014,0.0017028092,0.0018581721,0.00228007,0.008338219],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057023915,0.0037197634,0.010593684,0.00024820166,0.000055541168,0.00026240604,0.0002569023,0.00216535,0.002150116,0.0042565423,0.048888024,0.92683333],"study_design_scores_gemma":[0.009963956,0.015612459,0.2896649,0.005233834,0.0010142777,0.007576669,0.005001244,0.1976429,0.0334953,0.085335106,0.3485465,0.00091298966],"about_ca_topic_score_codex":0.002563936,"about_ca_topic_score_gemma":0.009242299,"teacher_disagreement_score":0.041212145,"about_ca_system_score_codex":0.0019318305,"about_ca_system_score_gemma":0.0055521703,"threshold_uncertainty_score":0.13786834},"labels":[],"label_agreement":null},{"id":"W4402103750","doi":"10.1016/j.jaad.2024.07.160","title":"50865 Efficacy of Step-up Abrocitinib Treatment in Combination With Topical Medicated Therapy for Treating Atopic Dermatitis Flares: A Post Hoc Analysis of the JADE REGIMEN Trial","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; SKiN Health; Queen's University","funders":"","keywords":"Medicine; Atopic dermatitis; JADE (particle detector); Dermatology; Post-hoc analysis; Regimen; Post hoc; Surgery; Internal medicine","score_opus":0.01707273910249197,"score_gpt":0.3347734183579437,"score_spread":0.31770067925545176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402103750","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9874858,0.0054766876,0.0004583587,0.00044974644,0.00056527404,0.0004735591,0.0013331857,0.00011570933,0.0036416939],"genre_scores_gemma":[0.9921462,0.0016378007,0.0005437035,0.0006153919,0.00034123255,0.00038201277,0.0012662155,0.00003179131,0.003035728],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99908185,0.000516593,0.000044683737,0.00014782406,0.000051996736,0.00015707122],"domain_scores_gemma":[0.99905914,0.00043506708,0.00014328283,0.00011336064,0.00006260841,0.00018656158],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017588363,0.0015818472,0.004502672,0.00027725377,0.00036835764,0.001577908,0.00081837876,0.0008822116,0.0061684214],"category_scores_gemma":[0.0015448234,0.0005044987,0.0036278593,0.0003233995,0.00064454536,0.0011422113,0.00042856782,0.0038767608,0.0010495011],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9728003,0.0016483963,0.0014499228,0.0005333037,0.0062475735,0.0000450382,0.00003458927,0.00086076645,0.002204615,0.00014846139,0.0011711436,0.012855789],"study_design_scores_gemma":[0.85479945,0.108044416,0.019556655,0.00011102106,0.010947375,0.00012260138,0.00011120501,0.002579795,0.0010076374,0.00047785623,0.0021820634,0.000060007827],"about_ca_topic_score_codex":0.00058185816,"about_ca_topic_score_gemma":0.0018866092,"teacher_disagreement_score":0.0061684214,"about_ca_system_score_codex":0.00054697046,"about_ca_system_score_gemma":0.0006237502,"threshold_uncertainty_score":0.020635426},"labels":[],"label_agreement":null},{"id":"W4402103762","doi":"10.1016/j.jaad.2024.07.195","title":"53225 Gammopathic Dermopathy of MGUS: Unraveling the Mysterious Gamut of Unrelated Scenarios","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"","keywords":"Medicine; Gamut; Dermatology; Artificial intelligence","score_opus":0.02304565812086819,"score_gpt":0.34025031215895263,"score_spread":0.31720465403808445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402103762","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.23622078,0.41895172,0.027794702,0.2322119,0.0076726945,0.0001984931,0.0004499127,0.0006145069,0.07588543],"genre_scores_gemma":[0.79205316,0.12652151,0.014949651,0.03466194,0.027727814,0.00007179643,0.00023272318,0.00010612525,0.0036752569],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9989895,0.00035063727,0.000117798205,0.0001369041,0.0002535452,0.0001515912],"domain_scores_gemma":[0.99724543,0.0017109924,0.00027916496,0.000217462,0.0002824503,0.00026452745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002312789,0.0009570563,0.001181399,0.0019740297,0.0013988147,0.0030285104,0.0014011007,0.0038259828,0.0033455975],"category_scores_gemma":[0.008102765,0.0005742307,0.00050801167,0.000785566,0.0040875105,0.011601157,0.0025065837,0.00480787,0.000950927],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013751448,0.00040206272,0.0749082,0.0017923849,0.00026547693,0.30160612,0.0024509989,0.0019634685,0.01012752,0.17206997,0.068223745,0.36481494],"study_design_scores_gemma":[0.00025397475,0.00031682878,0.022080673,0.003364098,0.00031486124,0.56558114,0.004610599,0.00941984,0.0017572122,0.24846439,0.14359343,0.0002429878],"about_ca_topic_score_codex":0.0010023806,"about_ca_topic_score_gemma":0.0015627994,"teacher_disagreement_score":0.0038259828,"about_ca_system_score_codex":0.0010069098,"about_ca_system_score_gemma":0.000946378,"threshold_uncertainty_score":0.01223135},"labels":[],"label_agreement":null},{"id":"W4402103798","doi":"10.1016/j.jaad.2024.07.334","title":"51999 Risk of malignancy associated with biologic use in patients with previous cancer: a systematic review","year":2024,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; McGill University Health Centre; University of Toronto; Dalhousie University; University of Ottawa; Queen's University; McMaster University","funders":"","keywords":"Medicine; Malignancy; Oncology; Systematic review; Cancer; Internal medicine; MEDLINE; Dermatology","score_opus":0.03467997377791906,"score_gpt":0.2892051319544645,"score_spread":0.2545251581765455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402103798","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015310398,0.99747604,0.00006884878,0.00010670719,0.00007031089,0.00006215112,0.0005144219,0.000004949308,0.00016548709],"genre_scores_gemma":[0.03553924,0.96306884,0.00028880307,0.00048112075,0.00008898074,0.000101603204,0.0002761964,0.000004647873,0.0001505458],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9981198,0.00053029985,0.00069950195,0.00026043702,0.0002990111,0.00009098119],"domain_scores_gemma":[0.9916468,0.0057358677,0.0018969193,0.00013940092,0.0004410049,0.00013990888],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024306942,0.00078406575,0.0048324224,0.0036260139,0.0002901199,0.0015529749,0.00091791106,0.0015118993,0.0064684246],"category_scores_gemma":[0.015322533,0.000762036,0.008784048,0.0051649474,0.0005260286,0.0009754262,0.0010187338,0.001156239,0.0003627446],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007077465,0.000027513874,0.006435691,0.89857346,0.057775624,0.00012611465,0.00009667536,0.00016496287,0.00020299101,0.00019287491,0.002466682,0.033229683],"study_design_scores_gemma":[0.0011722341,0.00040298857,0.029532464,0.45837942,0.4887315,0.00060630264,0.00024292266,0.00016504285,0.00018391792,0.00042074564,0.02007795,0.00008454941],"about_ca_topic_score_codex":0.012453424,"about_ca_topic_score_gemma":0.035877354,"teacher_disagreement_score":0.012453424,"about_ca_system_score_codex":0.0014588645,"about_ca_system_score_gemma":0.0036893198,"threshold_uncertainty_score":0.024761915},"labels":[],"label_agreement":null},{"id":"W4402103802","doi":"10.1016/j.jaad.2024.07.236","title":"54849 Leaving against medical advice among hidradenitis suppurativa patients: A retrospective cohort study","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Medicine; Hidradenitis suppurativa; Retrospective cohort study; Cohort; Dermatology; Against medical advice; Cohort study; Advice (programming); Family medicine; Surgery; Pediatrics; Internal medicine; Disease","score_opus":0.0072795457725221705,"score_gpt":0.30162896857566757,"score_spread":0.2943494228031454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402103802","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982186,0.00040784734,0.00006710311,0.000042472693,0.000023100198,0.000017165446,0.00066780136,0.0000032502844,0.00055268034],"genre_scores_gemma":[0.99851483,0.00023831878,0.0000766118,0.00009524305,0.000034314056,0.000025400239,0.0006359047,0.0000050918734,0.00037439013],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99932325,0.00009995461,0.000072859926,0.0002452056,0.00009058144,0.00016818984],"domain_scores_gemma":[0.9987295,0.00016797149,0.00054720865,0.00016915236,0.0001181614,0.00026800483],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040793425,0.0004340492,0.00060323573,0.0010231809,0.0011035069,0.0011044103,0.00053182663,0.00095394655,0.0044093197],"category_scores_gemma":[0.0013931486,0.00092109956,0.0009439627,0.00207534,0.00036795996,0.0010294474,0.0005192838,0.0012782977,0.00095893844],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017403119,0.00009549792,0.99845505,0.000012856403,0.000096002615,0.0002410623,0.00008653903,0.000009309689,0.00021301446,0.000015805701,0.00013313892,0.00046772163],"study_design_scores_gemma":[0.00002623298,0.00019972943,0.99781585,0.000015628555,0.000109269684,0.0007569179,0.0005631248,0.00008040009,0.000035024717,0.000025101508,0.0003621382,0.000010560559],"about_ca_topic_score_codex":0.0073873047,"about_ca_topic_score_gemma":0.0076268814,"teacher_disagreement_score":0.0073873047,"about_ca_system_score_codex":0.00045235857,"about_ca_system_score_gemma":0.0005848235,"threshold_uncertainty_score":0.0147506},"labels":[],"label_agreement":null},{"id":"W4402103808","doi":"10.1016/j.jaad.2024.07.027","title":"54010 DISCRN: (D)ifferentiating (I)mmune (S)ignatures in (C)utaneous T-Cell Lymphoma and Atopic D(e)rmatitis Through Integrative Single-Cell (RN)A Sequencing Analysis","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"","keywords":"Medicine; Lymphoma; Internal medicine","score_opus":0.013947217648198753,"score_gpt":0.28524804908997664,"score_spread":0.2713008314417779,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402103808","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7383011,0.003249843,0.029198235,0.0049657505,0.0042936765,0.00071569055,0.05876155,0.002579478,0.15793462],"genre_scores_gemma":[0.85256,0.0011486942,0.027404087,0.005341374,0.00030791262,0.00036714732,0.037987296,0.0010861412,0.073797345],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99929774,0.00008642873,0.000058117435,0.00024219895,0.00020450082,0.00011090051],"domain_scores_gemma":[0.99957055,0.000106338586,0.00004692252,0.000059870756,0.00011003697,0.0001062736],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065510883,0.0005417257,0.0003010879,0.0010897763,0.0007232477,0.0007717487,0.00048183248,0.0013579677,0.034064006],"category_scores_gemma":[0.0009570841,0.00023975405,0.00038868628,0.0005693818,0.00049414847,0.00027421405,0.00041605582,0.001097812,0.009713768],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002799883,0.0006799481,0.052078098,0.0004774497,0.00021821685,0.005590898,0.00070933107,0.0011890394,0.6547469,0.0066845883,0.10782069,0.1670049],"study_design_scores_gemma":[0.0005775049,0.001142941,0.12255754,0.00035477267,0.0003569295,0.014723737,0.0009959143,0.009361701,0.34949997,0.0027497488,0.49757016,0.000109064385],"about_ca_topic_score_codex":0.0031558282,"about_ca_topic_score_gemma":0.011116041,"teacher_disagreement_score":0.034064006,"about_ca_system_score_codex":0.00076757395,"about_ca_system_score_gemma":0.0008259266,"threshold_uncertainty_score":0.11395544},"labels":[],"label_agreement":null},{"id":"W4402103819","doi":"10.1016/j.jaad.2024.07.153","title":"52741 Efficacy of Abrocitinib Versus Dupilumab on Dermatitis in the Head-and-Neck Region of Patients With Moderate-To-Severe Atopic Dermatitis: A Post Hoc Analysis of the Phase 3 JADE DARE Study","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; SKiN Health; University of British Columbia; Queen's University","funders":"","keywords":"Medicine; Dupilumab; Atopic dermatitis; Dermatology; Post-hoc analysis; Head and neck; JADE (particle detector); Post hoc; Surgery; Internal medicine","score_opus":0.017170823375489162,"score_gpt":0.32645614856961025,"score_spread":0.3092853251941211,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402103819","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946808,0.002427174,0.00018450989,0.00021027408,0.00020540974,0.0002984786,0.0007582887,0.000043272954,0.0011917577],"genre_scores_gemma":[0.9960334,0.0008590294,0.00030913384,0.00031003967,0.00019078123,0.00024079018,0.0008419754,0.00002096826,0.0011939337],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99879587,0.0006907726,0.00005314377,0.00015398586,0.0000794895,0.00022669429],"domain_scores_gemma":[0.9986669,0.00063023606,0.00022828161,0.00012620792,0.00008680126,0.00026155947],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003123166,0.0015836435,0.004102872,0.00037662443,0.0004236153,0.0014946046,0.0008051555,0.00086630735,0.0036909555],"category_scores_gemma":[0.0017475464,0.00056667964,0.004611005,0.0003361039,0.00071314874,0.0011530475,0.000380026,0.003452303,0.0006981116],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9573259,0.0050634462,0.0039259293,0.00046340132,0.0047867564,0.00007974298,0.000060585306,0.0013543378,0.005070731,0.00009463115,0.001152851,0.020621745],"study_design_scores_gemma":[0.6403265,0.30023992,0.04232688,0.00007043308,0.008101535,0.00024168199,0.00015065612,0.003030194,0.0026164223,0.00026654478,0.0025421877,0.00008710407],"about_ca_topic_score_codex":0.0006846276,"about_ca_topic_score_gemma":0.0024459031,"teacher_disagreement_score":0.004102872,"about_ca_system_score_codex":0.0007352361,"about_ca_system_score_gemma":0.00094729953,"threshold_uncertainty_score":0.016517043},"labels":[],"label_agreement":null},{"id":"W4402103827","doi":"10.1016/j.jaad.2024.07.151","title":"51454 Efficacy and safety of apremilast in pediatric patients with moderate-to-severe plaque psoriasis: 52-week results from the SPROUT randomized controlled trial","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Stollery Children's Hospital; University of Alberta","funders":"","keywords":"Medicine; Apremilast; Plaque psoriasis; Psoriasis; Randomized controlled trial; Dermatology; Internal medicine; Psoriatic arthritis","score_opus":0.009500319463457446,"score_gpt":0.23983626522577003,"score_spread":0.2303359457623126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402103827","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9830201,0.011265061,0.00058679463,0.0005904037,0.0003370411,0.0010182246,0.0011527789,0.00014638617,0.0018831874],"genre_scores_gemma":[0.9868255,0.005634619,0.0013696983,0.0012155169,0.00043461536,0.0011811919,0.0011330723,0.00003627628,0.0021696312],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9992488,0.00039705858,0.00006207902,0.00012810701,0.00007679017,0.0000871005],"domain_scores_gemma":[0.9991327,0.0002821575,0.00027783366,0.00006791201,0.000056483404,0.00018290608],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012921774,0.0010742295,0.003356181,0.00025048965,0.000319182,0.0008925905,0.00057778903,0.0015449543,0.0050351196],"category_scores_gemma":[0.0014653403,0.00058973185,0.0021684873,0.00030041466,0.0007078335,0.00075750984,0.00028483765,0.0025012195,0.00073595985],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9618367,0.0035102048,0.0018921187,0.0011635487,0.0021538148,0.00009773765,0.000047074536,0.00040550574,0.003492799,0.00015129388,0.0012629635,0.023986349],"study_design_scores_gemma":[0.9352938,0.054422025,0.00696012,0.00009019824,0.0014054419,0.0000950674,0.000029364855,0.00041794844,0.0005607538,0.00008773593,0.00061605,0.000021581061],"about_ca_topic_score_codex":0.0007107757,"about_ca_topic_score_gemma":0.0012328529,"teacher_disagreement_score":0.0050351196,"about_ca_system_score_codex":0.00042460987,"about_ca_system_score_gemma":0.0006197639,"threshold_uncertainty_score":0.016844213},"labels":[],"label_agreement":null},{"id":"W4402103833","doi":"10.1016/j.jaad.2024.07.158","title":"50251 Efficacy of Risankizumab Versus Apremilast Among Patients with Scalp or Nail Psoriasis from the Phase 4 IMMpulse Study","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Probity Medical Research; University of British Columbia","funders":"","keywords":"Medicine; Apremilast; Dermatology; Scalp; Psoriasis; Nail (fastener)","score_opus":0.018038362342502633,"score_gpt":0.2926226818215649,"score_spread":0.2745843194790623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402103833","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9872054,0.0062724524,0.00029628573,0.00071934256,0.00024273677,0.00042678043,0.0014029978,0.00009769869,0.0033363374],"genre_scores_gemma":[0.9921659,0.0018906564,0.0004654018,0.0011282963,0.00025970247,0.00031831613,0.0018312153,0.000024336961,0.0019160514],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99956423,0.00020349667,0.000021179658,0.000073381096,0.000045058307,0.00009262847],"domain_scores_gemma":[0.99961936,0.00011198919,0.00006302331,0.00003364309,0.000025208421,0.00014671957],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013645744,0.00086231396,0.001671998,0.00023327037,0.00030048855,0.0010304368,0.0005567019,0.00080091925,0.003788919],"category_scores_gemma":[0.0007866545,0.00044759904,0.0018847567,0.00022346474,0.00048527212,0.00070105813,0.0002649922,0.0027004865,0.0008689438],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8280718,0.010146578,0.009481013,0.0010321309,0.0037885967,0.00023670286,0.00012970308,0.0021732543,0.021723475,0.00040273805,0.0064592673,0.11635469],"study_design_scores_gemma":[0.6997627,0.23921606,0.04556409,0.00012168258,0.0037920894,0.0004357695,0.000109485234,0.001820782,0.003060128,0.0005971324,0.005446774,0.00007339396],"about_ca_topic_score_codex":0.00052032457,"about_ca_topic_score_gemma":0.0014078424,"teacher_disagreement_score":0.003788919,"about_ca_system_score_codex":0.0005795383,"about_ca_system_score_gemma":0.00060915947,"threshold_uncertainty_score":0.012675166},"labels":[],"label_agreement":null},{"id":"W4402103865","doi":"10.1016/j.jaad.2024.07.015","title":"51363 Growth Analysis in Children Aged Less Than 12 Years with Moderate-to-Severe Atopic Dermatitis","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital","funders":"","keywords":"Medicine; Atopic dermatitis; Dermatology; Pediatrics","score_opus":0.009378769736083184,"score_gpt":0.272824998005247,"score_spread":0.2634462282691638,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402103865","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985727,0.00013212519,0.00004727037,0.000022895501,0.0000048675056,0.0000044154694,0.0005955653,0.000006559946,0.00061366125],"genre_scores_gemma":[0.9989367,0.00007851135,0.00006352703,0.000013577408,0.000004748207,0.000005285452,0.0005818241,0.0000047969806,0.00031101366],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997222,0.000064392334,0.000023537781,0.000050567964,0.00006184748,0.000077336925],"domain_scores_gemma":[0.9994986,0.00010901747,0.00015479708,0.000026403422,0.000085254374,0.00012592945],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027147046,0.0003889832,0.00041325958,0.0013568953,0.00052371755,0.00047230485,0.00026085484,0.00031910563,0.0015997955],"category_scores_gemma":[0.0011776384,0.00021580656,0.0005856535,0.0011475157,0.00028210346,0.0002766763,0.000439159,0.00050914485,0.00032346457],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037481697,0.00003962966,0.99722606,0.0000071139193,0.0000141438595,0.00032706853,0.00006385039,0.000051319472,0.0006756908,0.0000130240205,0.00008568909,0.0011215016],"study_design_scores_gemma":[0.0000029632704,0.00012862775,0.99913603,0.0000021643723,0.000008321786,0.00034185778,0.000112733156,0.000060903258,0.00009141276,0.0000056144204,0.00010763754,0.0000017959146],"about_ca_topic_score_codex":0.03176096,"about_ca_topic_score_gemma":0.019910641,"teacher_disagreement_score":0.03176096,"about_ca_system_score_codex":0.00048968487,"about_ca_system_score_gemma":0.00048312644,"threshold_uncertainty_score":0.063152194},"labels":[],"label_agreement":null},{"id":"W4402103868","doi":"10.1016/j.jaad.2024.07.239","title":"50351 Lebrikizumab maintains clinically meaningful outcomes with treatment administered every 4 weeks in adult and adolescent patients with moderate-to-severe atopic dermatitis","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Atopic dermatitis; Dermatology; Pediatrics","score_opus":0.012682936146004381,"score_gpt":0.2991372076006418,"score_spread":0.2864542714546374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402103868","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99728143,0.0015300749,0.00006367242,0.00012757903,0.000020552487,0.000019249268,0.00008534511,0.000010201246,0.0008618758],"genre_scores_gemma":[0.9992262,0.00031682858,0.00007547446,0.00007704407,0.000016093489,0.0000074031846,0.00008767022,0.0000013369885,0.00019193364],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9998356,0.00006489335,0.000013037818,0.000021906153,0.000022081524,0.00004257669],"domain_scores_gemma":[0.9996942,0.000082789935,0.00008664661,0.00001559351,0.000025068093,0.000095706026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039072192,0.00011981248,0.00040862738,0.000077998266,0.00014548129,0.00035879476,0.00012529915,0.00019208294,0.0012869616],"category_scores_gemma":[0.00086883333,0.000059444348,0.00032937338,0.00010937063,0.00012266429,0.00028840124,0.00011202795,0.0005481244,0.00016910104],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07075837,0.007355875,0.4419778,0.00042506264,0.0009971941,0.00087331387,0.00048568312,0.0010560722,0.02418386,0.0003418627,0.0046083783,0.44693658],"study_design_scores_gemma":[0.0075458693,0.0648554,0.9128069,0.00013918879,0.00072380115,0.0015471979,0.00056759734,0.0026563457,0.0032044747,0.00022572307,0.0057080872,0.000019386609],"about_ca_topic_score_codex":0.001026634,"about_ca_topic_score_gemma":0.0023743787,"teacher_disagreement_score":0.0012869616,"about_ca_system_score_codex":0.00027648167,"about_ca_system_score_gemma":0.00032520105,"threshold_uncertainty_score":0.004305303},"labels":[],"label_agreement":null},{"id":"W4402103887","doi":"10.1016/j.jaad.2024.07.043","title":"49702 A longitudinal cohort study of squalene epoxidase gene mutations in U.S. onychomycosis patients from 2022 to 2023 – Implications for terbinafine resistance","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada); University of Toronto","funders":"","keywords":"Squalene monooxygenase; Medicine; Terbinafine; Gene; Cohort; Squalene; Genetics; Internal medicine; Dermatology; Antifungal; Biology; Itraconazole; Biochemistry","score_opus":0.020519264545476017,"score_gpt":0.35061236924984057,"score_spread":0.33009310470436454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402103887","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99845326,0.000113853275,0.00004876659,0.00005561618,0.000014847417,0.0000060322536,0.0008179288,0.0000031451518,0.00048649652],"genre_scores_gemma":[0.9986364,0.00006563453,0.00004155002,0.00005466791,0.000009915571,0.000007210059,0.0007988393,0.0000030738195,0.00038275216],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995732,0.0000886979,0.00003825622,0.00012858097,0.00006191002,0.00010932786],"domain_scores_gemma":[0.99929714,0.00006293616,0.00019585334,0.00008738445,0.00015447715,0.00020221999],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043547052,0.00035682824,0.00029155263,0.00071069715,0.0009326111,0.00082672224,0.00038191417,0.00060369784,0.0023235672],"category_scores_gemma":[0.0009991575,0.0003906586,0.0005062912,0.0013347549,0.00020694174,0.0004656474,0.00042558732,0.0008252764,0.0005391694],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028572994,0.00008932664,0.9971174,0.0000033436384,0.000112537375,0.00022458321,0.00009193639,0.000038262486,0.0005901369,0.000032856326,0.00038815007,0.0010259098],"study_design_scores_gemma":[0.00002005984,0.000107611915,0.9987124,0.0000055871974,0.000054980246,0.00029899526,0.0002017891,0.00014717912,0.00006655688,0.00002484562,0.0003540943,0.0000058890682],"about_ca_topic_score_codex":0.034568362,"about_ca_topic_score_gemma":0.027935153,"teacher_disagreement_score":0.034568362,"about_ca_system_score_codex":0.00037705805,"about_ca_system_score_gemma":0.0005482106,"threshold_uncertainty_score":0.06873435},"labels":[],"label_agreement":null},{"id":"W4402103895","doi":"10.1016/j.jaad.2024.07.246","title":"53833 Long-term Safety and Efficacy of Risankizumab for the Treatment of Moderate-to-Severe Plaque Psoriasis: Interim Analysis of Results From the LIMMitless Open-label Extension Trial For up to 6 Years of Follow-up","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; University of Toronto","funders":"Amgen","keywords":"Medicine; Open label; Interim; Plaque psoriasis; Interim analysis; Term (time); Psoriasis; Adverse effect; Clinical trial; Dermatology; Surgery; Internal medicine","score_opus":0.052514300129946345,"score_gpt":0.3445210261402866,"score_spread":0.2920067260103403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402103895","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9786375,0.0070470725,0.001384087,0.0005730308,0.00039177202,0.00073154195,0.005818708,0.00023869352,0.005177648],"genre_scores_gemma":[0.9882984,0.0009577271,0.0008686493,0.00078996515,0.0002827529,0.0007734589,0.004908302,0.000047980404,0.003072751],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9977685,0.0010513333,0.00013974715,0.00029852585,0.00027634707,0.0004655765],"domain_scores_gemma":[0.9973471,0.0009024274,0.0006215009,0.00056321814,0.0002500202,0.0003156892],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006491267,0.0012637175,0.0039361925,0.00037869636,0.00060293137,0.0020629694,0.0008400481,0.0016455521,0.00515701],"category_scores_gemma":[0.0034970006,0.000561782,0.0049227695,0.00048012307,0.00090400386,0.0013630139,0.0004838311,0.0037389302,0.001771775],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.94340783,0.0032846634,0.006439506,0.00047267246,0.0040030046,0.00009488594,0.000056744524,0.0014261825,0.0047046635,0.00016583805,0.002723202,0.0332207],"study_design_scores_gemma":[0.65288377,0.22441456,0.09633638,0.00017628985,0.012142594,0.00035806865,0.00009242897,0.0030718693,0.0043839267,0.0010442712,0.004959436,0.0001363566],"about_ca_topic_score_codex":0.00052820874,"about_ca_topic_score_gemma":0.00090865063,"teacher_disagreement_score":0.006491267,"about_ca_system_score_codex":0.0006126267,"about_ca_system_score_gemma":0.001020987,"threshold_uncertainty_score":0.034329534},"labels":[],"label_agreement":null},{"id":"W4402103927","doi":"10.1016/j.jaad.2024.07.337","title":"52676 Safety and efficacy over one year of spesolimab treatment in patients with hidradenitis suppurativa (HS): Interim analysis of an open-label extension (OLE) study","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"","keywords":"Medicine; Hidradenitis suppurativa; Interim analysis; Interim; Open label; Dermatology; Extension (predicate logic); Surgery; Internal medicine; Randomized controlled trial","score_opus":0.028044636216964354,"score_gpt":0.3532672199971638,"score_spread":0.32522258378019947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402103927","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939567,0.0027968523,0.00040691902,0.00013887751,0.00012225896,0.00034616678,0.0011177118,0.000058194782,0.0010563558],"genre_scores_gemma":[0.99447614,0.0008020787,0.00049815833,0.00036190895,0.00018454723,0.00039504253,0.0017373494,0.00001703478,0.0015277758],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99876803,0.0005732895,0.000084515705,0.00015379167,0.00014326377,0.00027704737],"domain_scores_gemma":[0.9980044,0.0006385552,0.0005505312,0.00030499516,0.00016443827,0.000337229],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038277043,0.0010604984,0.0030425612,0.0004819087,0.00040373008,0.0011938108,0.00055136945,0.001150134,0.0033991362],"category_scores_gemma":[0.0020513427,0.00041014003,0.0031348208,0.0004686025,0.00073811266,0.0010731284,0.0003503449,0.0026838558,0.0008567619],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9235348,0.009006396,0.009135768,0.0004507415,0.00227476,0.00011126523,0.0000953468,0.0011796433,0.006891812,0.0000896962,0.0008587401,0.04637105],"study_design_scores_gemma":[0.358348,0.5418371,0.08614477,0.000105391744,0.004700946,0.0002873395,0.00013201147,0.0018192971,0.0039508375,0.00027223642,0.0023077582,0.00009425045],"about_ca_topic_score_codex":0.0003040162,"about_ca_topic_score_gemma":0.00046821425,"teacher_disagreement_score":0.0038277043,"about_ca_system_score_codex":0.00038889973,"about_ca_system_score_gemma":0.0006524377,"threshold_uncertainty_score":0.020243108},"labels":[],"label_agreement":null},{"id":"W4402103959","doi":"10.1016/j.jaad.2024.07.255","title":"50916 Markers of Type 2 Inflammation and Immunosenescence are Upregulated in Localized Scleroderma","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University Health Centre; University of Alberta; McGill University","funders":"","keywords":"Medicine; Immunosenescence; Scleroderma (fungus); Inflammation; Immunology; Downregulation and upregulation; Dermatology; Immune system; Genetics; Gene","score_opus":0.014229137900499443,"score_gpt":0.2867848491181483,"score_spread":0.2725557112176488,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402103959","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99490464,0.0013112277,0.00035860974,0.00005435253,0.000031194002,0.000010531395,0.00041249834,0.000043713862,0.0028732903],"genre_scores_gemma":[0.994716,0.00042767488,0.00042050568,0.000067356304,0.000037676702,0.000026342217,0.00071494386,0.00001234861,0.0035771779],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99975806,0.00004148094,0.000019518115,0.000034610694,0.000078543926,0.000067809124],"domain_scores_gemma":[0.99981266,0.000026632326,0.000052722706,0.000011447137,0.000032556007,0.000064060405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012591286,0.00023651075,0.00031629,0.0009095823,0.00032816414,0.0006459841,0.00011035539,0.00036269915,0.0058644265],"category_scores_gemma":[0.00024062383,0.00021261694,0.00018856017,0.0004922605,0.00021171654,0.00019309604,0.00029408245,0.0003864928,0.0012009329],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013587769,0.000100758414,0.01771569,0.00009154048,0.000034705008,0.00073680055,0.00008550978,0.000044952838,0.9742605,0.00008635618,0.0003630982,0.0051213456],"study_design_scores_gemma":[0.00008831015,0.0006198256,0.86113226,0.000027126665,0.00008015373,0.003094192,0.00046443383,0.00047013548,0.1297523,0.0002353626,0.004019183,0.000016806793],"about_ca_topic_score_codex":0.00039450527,"about_ca_topic_score_gemma":0.00055484095,"teacher_disagreement_score":0.0058644265,"about_ca_system_score_codex":0.00013727503,"about_ca_system_score_gemma":0.000103869665,"threshold_uncertainty_score":0.019618392},"labels":[],"label_agreement":null},{"id":"W4402103961","doi":"10.1016/j.jaad.2024.07.248","title":"52680 Long-Term Safety Data for Dupilumab in a 5-Year Open-Label Extension Study of Adults With Moderate-to-Severe Atopic Dermatitis","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"Amgen","keywords":"Dupilumab; Medicine; Atopic dermatitis; Open label; Dermatology; Term (time); Adverse effect; Internal medicine","score_opus":0.04048340952969717,"score_gpt":0.3611816546714925,"score_spread":0.32069824514179535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402103961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99323964,0.003871389,0.00020968587,0.00017834136,0.000101938866,0.00025462286,0.0009891682,0.000040638875,0.001114529],"genre_scores_gemma":[0.9955819,0.0011187826,0.0002758822,0.00039637095,0.0001421693,0.00018620894,0.001271502,0.000009734613,0.0010174933],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99941385,0.00026023807,0.000040814044,0.00009430206,0.000073269715,0.00011750325],"domain_scores_gemma":[0.9990864,0.00027543306,0.0001926825,0.00007611528,0.00010615873,0.0002633005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018708301,0.0007507763,0.0015504682,0.00028542077,0.0004047349,0.00086709106,0.00038044518,0.0008145603,0.0025642859],"category_scores_gemma":[0.0012631393,0.00029280334,0.0015301511,0.0002619542,0.0004530574,0.00078416814,0.00023882343,0.001955559,0.00067324284],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8150655,0.012085353,0.03256539,0.0010847264,0.0027159997,0.00055059243,0.00029196878,0.00088001206,0.026026608,0.00018237552,0.0034631193,0.1050884],"study_design_scores_gemma":[0.3821183,0.38724735,0.21121629,0.00020321406,0.00398023,0.0011759889,0.00024158772,0.0023690243,0.004090384,0.00021948907,0.00703288,0.000105138206],"about_ca_topic_score_codex":0.0007710996,"about_ca_topic_score_gemma":0.0017020159,"teacher_disagreement_score":0.0025642859,"about_ca_system_score_codex":0.00042760518,"about_ca_system_score_gemma":0.00053311733,"threshold_uncertainty_score":0.009894013},"labels":[],"label_agreement":null},{"id":"W4402103969","doi":"10.1016/j.jaad.2024.07.118","title":"52766 Comparative effectiveness of biologics across subgroups of patients with moderate-to-severe plaque psoriasis: Results at Months 6 and 12 from the PSoHO study in real-world settings","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Plaque psoriasis; Psoriasis; Dermatology; Comparative effectiveness research; Internal medicine; Alternative medicine; Pathology","score_opus":0.020455203739226772,"score_gpt":0.2988374757253141,"score_spread":0.27838227198608734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402103969","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987122,0.0006482411,0.000041189836,0.00003594043,0.000009187549,0.000041227566,0.0001794908,0.0000024318408,0.0003300926],"genre_scores_gemma":[0.99903286,0.00023588372,0.00013003947,0.0000508804,0.000030447685,0.000038427348,0.00031913604,0.0000022372521,0.00016011504],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9978676,0.0014579061,0.00013302684,0.00020960018,0.00013468454,0.00019727707],"domain_scores_gemma":[0.99709344,0.0014602308,0.0006633265,0.000221918,0.00015741057,0.0004035995],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002645076,0.00057670486,0.0014709837,0.00048712225,0.00037444796,0.00073599356,0.00035607777,0.00083916646,0.0028454724],"category_scores_gemma":[0.0031851456,0.00024716192,0.001956299,0.00059130695,0.0006066007,0.0008577822,0.0004267618,0.00083859725,0.00033302564],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8421581,0.008872784,0.10250191,0.00043741215,0.0026109507,0.0001492982,0.00032828178,0.000743474,0.0041169142,0.00011379454,0.00032967128,0.037637413],"study_design_scores_gemma":[0.114294425,0.3230752,0.55206096,0.00009199088,0.004386997,0.00031746677,0.0009940398,0.0014251115,0.0018380455,0.00022859122,0.0011777972,0.0001093703],"about_ca_topic_score_codex":0.0013367395,"about_ca_topic_score_gemma":0.002840883,"teacher_disagreement_score":0.0028454724,"about_ca_system_score_codex":0.00049428956,"about_ca_system_score_gemma":0.00047416944,"threshold_uncertainty_score":0.013988674},"labels":[],"label_agreement":null},{"id":"W4402103991","doi":"10.1016/j.jaad.2024.07.041","title":"53188 A Global Analysis of Cutaneous Lymphomatoid Reactions after COVID-19 Vaccination","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Autoimmune Bullous Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"","keywords":"Medicine; Coronavirus disease 2019 (COVID-19); Lymphomatoid papulosis; 2019-20 coronavirus outbreak; Dermatology; Vaccination; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Virology; Immunology; Pathology; Mycosis fungoides; Disease; Outbreak","score_opus":0.012572144079728878,"score_gpt":0.345014786595886,"score_spread":0.3324426425161571,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402103991","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962184,0.00049414585,0.00022480653,0.000018801076,0.000008906113,0.000027883052,0.0008843833,0.000017618016,0.0021051667],"genre_scores_gemma":[0.99825877,0.000096664335,0.000105489016,0.00002716939,0.000010299501,0.000011628467,0.0009703865,0.0000102997865,0.0005092616],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99940073,0.00015955107,0.00005103835,0.00013704943,0.000104355015,0.0001472689],"domain_scores_gemma":[0.9992447,0.00016966043,0.00025622212,0.00007518133,0.00013276323,0.00012145371],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006564316,0.00033574598,0.0004693139,0.0010273287,0.00027416018,0.00059182424,0.00017383878,0.00031206434,0.002867494],"category_scores_gemma":[0.0006753908,0.00013912904,0.0006014549,0.0009794082,0.00020330133,0.00032553668,0.00038072368,0.00036245305,0.0007092171],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031901503,0.00015927243,0.95437014,0.00012942225,0.00040197454,0.000686241,0.00017408312,0.00022610379,0.020806469,0.00004892053,0.00041729913,0.019389952],"study_design_scores_gemma":[0.000011122303,0.00041833802,0.9968605,0.0000067034016,0.00010585657,0.00074392086,0.00010822715,0.0000972992,0.0008093835,0.000016045284,0.00081943325,0.0000031402842],"about_ca_topic_score_codex":0.00079037383,"about_ca_topic_score_gemma":0.0008243069,"teacher_disagreement_score":0.002867494,"about_ca_system_score_codex":0.00024185967,"about_ca_system_score_gemma":0.00016273269,"threshold_uncertainty_score":0.009592712},"labels":[],"label_agreement":null},{"id":"W4402104003","doi":"10.1016/j.jaad.2024.07.060","title":"54494 A systematic review and meta-analysis exploring the risk of infections with janus kinase inhibitor treatment for plaque psoriasis","year":2024,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; McMaster University; University of Toronto","funders":"","keywords":"Medicine; Plaque psoriasis; Janus kinase; Dermatology; Psoriasis; Janus kinase inhibitor; Meta-analysis; Tofacitinib; Internal medicine","score_opus":0.08442853812902106,"score_gpt":0.33801477917347983,"score_spread":0.25358624104445876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402104003","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003853521,0.9947798,0.00034229073,0.00012053996,0.00016956002,0.00010752604,0.0003727744,0.000017689044,0.00023624381],"genre_scores_gemma":[0.12089287,0.87519413,0.0012701771,0.0009693516,0.00029249684,0.00027368846,0.00057247735,0.00002198535,0.00051278435],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99698204,0.001192084,0.0008903884,0.0004252193,0.00034084893,0.00016932502],"domain_scores_gemma":[0.9945933,0.0038602997,0.00091934006,0.0001574656,0.00037295482,0.00009652742],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004179282,0.0021048107,0.012212349,0.002833323,0.00049944385,0.0021074885,0.0013521075,0.0019035573,0.005491636],"category_scores_gemma":[0.012413704,0.0010942614,0.024566978,0.0041004084,0.0004772809,0.001199705,0.0011458134,0.0019661842,0.00048424405],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043332605,0.00005225788,0.003660213,0.4122345,0.5507566,0.00023397115,0.00008920923,0.0004213996,0.0005408469,0.00013909464,0.0013245993,0.026214058],"study_design_scores_gemma":[0.0011608321,0.0002611374,0.003692973,0.02026354,0.97208875,0.00009905468,0.000037250335,0.000112460424,0.000105036284,0.00013722027,0.0020130554,0.00002870678],"about_ca_topic_score_codex":0.0065613547,"about_ca_topic_score_gemma":0.01551824,"teacher_disagreement_score":0.012212349,"about_ca_system_score_codex":0.0011163215,"about_ca_system_score_gemma":0.0023161694,"threshold_uncertainty_score":0.022102416},"labels":[],"label_agreement":null},{"id":"W4402104020","doi":"10.1016/j.jaad.2024.07.152","title":"52715 Efficacy and safety of delgocitinib cream in adults with moderate to severe chronic hand eczema: pooled results of the Phase 3 DELTA-1 and -2 trials","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Contact Dermatitis and Allergies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Queen's University; SKiN Health; Innovaderm (Canada)","funders":"","keywords":"Medicine; Dermatology; Hand eczema; Pooled analysis; Pediatrics; Internal medicine; Allergy; Immunology; Meta-analysis; Contact dermatitis","score_opus":0.01847754404746727,"score_gpt":0.3253300007962851,"score_spread":0.30685245674881784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402104020","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.72293,0.26091307,0.001215665,0.0012168104,0.00084101124,0.0009417545,0.0038491231,0.00018210994,0.007910461],"genre_scores_gemma":[0.96781635,0.026556576,0.00048631543,0.0010353097,0.00041771156,0.0002897257,0.0019174496,0.000022009019,0.001458497],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9990845,0.00044975925,0.00010185077,0.00013930141,0.000114125454,0.00011053856],"domain_scores_gemma":[0.99891496,0.0005088922,0.0002952002,0.00006377794,0.000117629104,0.00009950422],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030974578,0.0010018441,0.0036364186,0.00046364873,0.00021012958,0.0011417565,0.00042354668,0.0008501876,0.002738124],"category_scores_gemma":[0.0023653384,0.00040742938,0.004474024,0.00052666705,0.00033079798,0.0008575252,0.00033827132,0.0017395531,0.00044636533],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.68058676,0.0012942267,0.011716951,0.013626871,0.07354322,0.00019772824,0.00011778855,0.0026560077,0.007014706,0.00026608675,0.0074448916,0.20153478],"study_design_scores_gemma":[0.7032459,0.069866136,0.093169175,0.0020302376,0.11041722,0.0008585461,0.00023713436,0.0028644581,0.002920691,0.00082442904,0.013391453,0.00017466923],"about_ca_topic_score_codex":0.0008325477,"about_ca_topic_score_gemma":0.0035715948,"teacher_disagreement_score":0.0036364186,"about_ca_system_score_codex":0.00054068293,"about_ca_system_score_gemma":0.00045412907,"threshold_uncertainty_score":0.016381145},"labels":[],"label_agreement":null},{"id":"W4402104023","doi":"10.1016/j.jaad.2024.07.016","title":"54414 Effect of maternal hidradenitis suppurativa on offspring outcomes","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut National de Santé Publique du Québec; Montreal General Hospital; McGill University Health Centre","funders":"","keywords":"Hidradenitis suppurativa; Medicine; Offspring; Dermatology; Pregnancy; Internal medicine; Disease; Genetics","score_opus":0.011569652138134014,"score_gpt":0.32949462034701743,"score_spread":0.31792496820888344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402104023","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99646664,0.0009978778,0.00006532973,0.00017924409,0.000037170306,0.000005270955,0.00051254604,0.0000096911745,0.0017261745],"genre_scores_gemma":[0.99754375,0.0005348076,0.00010003634,0.000044575012,0.000020721262,0.000012581992,0.00021123556,0.0000041722174,0.0015280389],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995858,0.00018445449,0.000015962238,0.00004642772,0.000046398236,0.000121022786],"domain_scores_gemma":[0.99825484,0.0006602422,0.000465509,0.00016296812,0.00005569365,0.00040072785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005975466,0.00029337732,0.0003041655,0.00028868185,0.00027496906,0.00041070385,0.00036106422,0.00047926023,0.0058100657],"category_scores_gemma":[0.0021594781,0.00017517341,0.0006295168,0.00020082906,0.00025196536,0.00022978983,0.00037141412,0.0010450298,0.0002327847],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03132477,0.003238591,0.9102669,0.00017612708,0.00176522,0.0018348751,0.00024890207,0.00042070058,0.0095784385,0.0008061345,0.000991542,0.039347745],"study_design_scores_gemma":[0.00026046377,0.00402631,0.9918189,0.000044453598,0.0005628888,0.00038261272,0.00016432273,0.00031148436,0.0013705443,0.00021449983,0.0008255549,0.00001795968],"about_ca_topic_score_codex":0.0033168383,"about_ca_topic_score_gemma":0.003608049,"teacher_disagreement_score":0.0058100657,"about_ca_system_score_codex":0.00036059367,"about_ca_system_score_gemma":0.0005639083,"threshold_uncertainty_score":0.019436538},"labels":[],"label_agreement":null},{"id":"W4402104070","doi":"10.1016/j.jaad.2024.07.102","title":"52661 Bimekizumab 4-year maintenance of responses in Week 16 responders with moderate to severe plaque psoriasis: Results from the BE BRIGHT open label extension phase 3 trial","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Plaque psoriasis; Open label; Psoriasis; Dermatology; Clinical trial; Internal medicine; Surgery","score_opus":0.048074770986853956,"score_gpt":0.32704431435357145,"score_spread":0.2789695433667175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402104070","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889318,0.0047348947,0.00037603092,0.00079790404,0.00029772776,0.0007608479,0.0012519467,0.00017755466,0.0026713952],"genre_scores_gemma":[0.98525083,0.0025043047,0.00088792725,0.0015505609,0.00036199816,0.0011894477,0.0020820661,0.000058719335,0.006114137],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99941444,0.00021711909,0.000020786232,0.00007464508,0.000054175565,0.00021881361],"domain_scores_gemma":[0.9992955,0.00013762014,0.00016649197,0.00007218716,0.000036720463,0.0002914819],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018869101,0.0013116859,0.0027738952,0.00032449586,0.0004290927,0.0013396274,0.0008009032,0.0013346246,0.0060658217],"category_scores_gemma":[0.00090388756,0.00051576836,0.0019893574,0.00030552948,0.0008153901,0.0011342186,0.00034404884,0.004354811,0.002009709],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8919322,0.014048798,0.0018943517,0.0006706053,0.0009779332,0.00011134201,0.00013415662,0.0010507778,0.010996972,0.00022811975,0.0052979123,0.0726569],"study_design_scores_gemma":[0.80219877,0.18134367,0.011504507,0.000071723014,0.00050282,0.00015888941,0.00005594547,0.0006985716,0.0010053988,0.00025542514,0.0021657927,0.000038474493],"about_ca_topic_score_codex":0.000840687,"about_ca_topic_score_gemma":0.0015926197,"teacher_disagreement_score":0.0060658217,"about_ca_system_score_codex":0.0006829694,"about_ca_system_score_gemma":0.00088787643,"threshold_uncertainty_score":0.020292163},"labels":[],"label_agreement":null},{"id":"W4402104084","doi":"10.1016/j.jaad.2024.07.165","title":"50555 Equitable Healing: Are Phototherapy Recommendations Equitable for Cutaneous T-Cell Lymphoma Patients of Diverse Skin Types?","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"","keywords":"Medicine; Dermatology; Lymphoma; Cutaneous T-cell lymphoma; Mycosis fungoides; Pathology","score_opus":0.031088004012289783,"score_gpt":0.35963134862314433,"score_spread":0.32854334461085455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402104084","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.051480927,0.019419385,0.0020881954,0.8549281,0.004397096,0.00011010162,0.00021047103,0.00008169651,0.06728397],"genre_scores_gemma":[0.6700391,0.021332998,0.012552564,0.27713582,0.008548359,0.0003430751,0.0003894534,0.00015394289,0.009504543],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9907645,0.005969179,0.00079711113,0.00030307527,0.0016101788,0.00055591704],"domain_scores_gemma":[0.9691505,0.014410258,0.004766696,0.0014710152,0.0058939005,0.0043076575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011983282,0.00016919765,0.0005031516,0.0005751591,0.0018140975,0.002756221,0.00084597623,0.0031118132,0.01672508],"category_scores_gemma":[0.09339168,0.0001856255,0.00050500676,0.0006302482,0.0013257476,0.00302755,0.0019530896,0.0038906366,0.0016059298],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00069470145,0.00069177465,0.034984253,0.00055749755,0.00022726317,0.0005590005,0.0010063909,0.00046819024,0.00049249496,0.009308459,0.19144572,0.7595642],"study_design_scores_gemma":[0.0012327955,0.0011271335,0.10534372,0.009161656,0.00089623407,0.0028157707,0.008668793,0.0014152374,0.0007692612,0.03618882,0.8321773,0.00020326846],"about_ca_topic_score_codex":0.0029999274,"about_ca_topic_score_gemma":0.00954526,"teacher_disagreement_score":0.01672508,"about_ca_system_score_codex":0.0019419204,"about_ca_system_score_gemma":0.0056218035,"threshold_uncertainty_score":0.0633744},"labels":[],"label_agreement":null},{"id":"W4402104141","doi":"10.1016/j.jaad.2024.07.507","title":"54621 Applying Mendelian randomization to infer causality within the atopic triad","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Medicine; Mendelian randomization; Triad (sociology); Causality (physics); Randomization; Mendelian inheritance; Dermatology; Clinical trial; Internal medicine; Genetics","score_opus":0.022054125647429364,"score_gpt":0.34306846416846526,"score_spread":0.3210143385210359,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402104141","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2912397,0.0028112207,0.6912482,0.0023340795,0.0013940057,0.002402378,0.0016847255,0.0015292668,0.0053563956],"genre_scores_gemma":[0.7732149,0.0006752294,0.21913983,0.00096198625,0.00034274123,0.0025645986,0.0006602392,0.00018500687,0.0022555005],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.7980896,0.18323143,0.0032714815,0.010291283,0.003676865,0.0014393387],"domain_scores_gemma":[0.84575856,0.13653317,0.0043163286,0.012024601,0.00086526317,0.0005021355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.07648841,0.0018309322,0.0034784735,0.003997314,0.0012432537,0.0018806179,0.0025309513,0.0021844108,0.009411993],"category_scores_gemma":[0.16009803,0.0013020806,0.0037862218,0.0029390668,0.0020990546,0.0016822073,0.0020046504,0.0027334993,0.00064693444],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.037106507,0.002357014,0.34403765,0.0025129458,0.052529342,0.014477086,0.0027754141,0.028960347,0.008979159,0.1789173,0.011680071,0.3156671],"study_design_scores_gemma":[0.027699547,0.008779314,0.0910333,0.0007741036,0.029867806,0.00982679,0.00076979003,0.42670056,0.0057648835,0.37926415,0.019123737,0.00039603518],"about_ca_topic_score_codex":0.0041344864,"about_ca_topic_score_gemma":0.0033626405,"teacher_disagreement_score":0.07648841,"about_ca_system_score_codex":0.0008084837,"about_ca_system_score_gemma":0.0023100523,"threshold_uncertainty_score":0.40451425},"labels":[],"label_agreement":null},{"id":"W4402104154","doi":"10.1016/j.jaad.2024.07.880","title":"52626 Granuloma Faciale: Most effect to the least effect treatment options","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Autoimmune and Inflammatory Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Capital District Health Authority","funders":"","keywords":"Medicine; Granuloma; Dermatology; Pathology","score_opus":0.009208717007067107,"score_gpt":0.314531410973503,"score_spread":0.3053226939664359,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402104154","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22376405,0.49385005,0.008996714,0.12502807,0.008044603,0.00023986578,0.00041917482,0.0006112309,0.1390463],"genre_scores_gemma":[0.7858654,0.12196304,0.0072385734,0.047921102,0.011572444,0.00008912989,0.0002576296,0.00010214574,0.02499056],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996332,0.000109070104,0.000032069882,0.00004959309,0.00009929686,0.00007684901],"domain_scores_gemma":[0.99958163,0.00016683641,0.00007840778,0.000016437687,0.000040283383,0.00011638721],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074276194,0.00040326235,0.00087928906,0.0006662088,0.0005906617,0.0010246559,0.00028120523,0.0010070954,0.0069615473],"category_scores_gemma":[0.0010201338,0.00010192934,0.0004208983,0.0002578232,0.0007168821,0.001017854,0.00047141293,0.001709827,0.0014047079],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002012935,0.00046545864,0.010414818,0.0015298334,0.00020355861,0.008630323,0.00010124168,0.00042563936,0.009144912,0.0067855725,0.034677096,0.9256086],"study_design_scores_gemma":[0.0035298355,0.0072064395,0.06957562,0.010215579,0.0014623809,0.19116561,0.00199013,0.0030805485,0.010493364,0.03884912,0.6621707,0.00026053403],"about_ca_topic_score_codex":0.00032102098,"about_ca_topic_score_gemma":0.001531773,"teacher_disagreement_score":0.0069615473,"about_ca_system_score_codex":0.0003812454,"about_ca_system_score_gemma":0.00038889472,"threshold_uncertainty_score":0.023288727},"labels":[],"label_agreement":null},{"id":"W4402104157","doi":"10.1016/j.jaad.2024.07.641","title":"53844 Clusters with Luster: Application of Unsupervised Machine Learning Pipeline and Subgroup Analysis for CTCL Patients Prior to Diagnosis","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"","keywords":"Medicine; Pipeline (software); Artificial intelligence; Machine learning; Dermatology; Computer science; Programming language","score_opus":0.00886400238795033,"score_gpt":0.3173145537476634,"score_spread":0.30845055135971305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402104157","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.44486183,0.0023120672,0.1363761,0.0021775477,0.0011390584,0.0018994112,0.27498302,0.126654,0.009596994],"genre_scores_gemma":[0.5058012,0.0005280573,0.22811075,0.00057719444,0.0004123367,0.002743128,0.23614287,0.012380576,0.01330385],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9992599,0.00009285831,0.00007754039,0.00031167912,0.00011152034,0.00014647111],"domain_scores_gemma":[0.99904066,0.00036456427,0.00007844393,0.00020000932,0.00021503099,0.00010120091],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013375182,0.0016420096,0.0016365492,0.0028294122,0.0012626082,0.0017861768,0.0016046835,0.0008209872,0.021359108],"category_scores_gemma":[0.0055706725,0.000564763,0.0023191376,0.001796032,0.00026111215,0.0005981503,0.001518949,0.0012394388,0.008978714],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009140269,0.0010491095,0.19503199,0.0014243776,0.002811375,0.0014021281,0.0015306836,0.009590089,0.041471045,0.0030295297,0.29269215,0.44082728],"study_design_scores_gemma":[0.0034192975,0.0017705101,0.29599673,0.00043046832,0.0036073413,0.002716073,0.0021034314,0.2901444,0.07809739,0.028351901,0.2926796,0.0006827917],"about_ca_topic_score_codex":0.011844181,"about_ca_topic_score_gemma":0.020282183,"teacher_disagreement_score":0.021359108,"about_ca_system_score_codex":0.0006754224,"about_ca_system_score_gemma":0.0026424583,"threshold_uncertainty_score":0.07145333},"labels":[],"label_agreement":null},{"id":"W4402104163","doi":"10.1016/j.jaad.2024.07.873","title":"51782 Generalized pustular psoriasis (GPP) continues to adversely impact quality of life between flares, as per Dermatology Life Quality Index scores: Baseline data from the Effisayil 2 trial","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Dermatology Life Quality Index; Quality of life (healthcare); Psoriasis; Dermatology; Psoriasis Area and Severity Index; Index (typography); Generalized pustular psoriasis; Baseline (sea)","score_opus":0.0769125939771212,"score_gpt":0.38047616063847883,"score_spread":0.30356356666135764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402104163","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90510535,0.057755757,0.00046532584,0.0045280186,0.00153013,0.00069641526,0.0050952216,0.00036425836,0.024459496],"genre_scores_gemma":[0.9678687,0.013885295,0.0005895557,0.0046608085,0.00082654203,0.0005549837,0.003944099,0.000039240247,0.0076306616],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9996131,0.00017112056,0.000021178066,0.000050618222,0.000051074225,0.00009279605],"domain_scores_gemma":[0.99969614,0.000093606046,0.00006203607,0.00002353892,0.000023696019,0.00010098193],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000880373,0.0006595989,0.0020489888,0.00021570208,0.00030365383,0.0010041225,0.0004342162,0.0011173275,0.013158897],"category_scores_gemma":[0.0009141746,0.00025431905,0.0013903143,0.00040212067,0.0004149778,0.00076811836,0.0002940477,0.0023578429,0.0017837682],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7078454,0.003052798,0.008280397,0.005281084,0.0076991054,0.00029330028,0.000100654324,0.0007622936,0.007947464,0.0008996926,0.029733224,0.22810449],"study_design_scores_gemma":[0.8755631,0.057199523,0.044054896,0.0006524797,0.0039436086,0.00038088582,0.000119091885,0.0006267056,0.00082219177,0.000908408,0.015674517,0.000054585526],"about_ca_topic_score_codex":0.0005977087,"about_ca_topic_score_gemma":0.002110211,"teacher_disagreement_score":0.013158897,"about_ca_system_score_codex":0.00032306052,"about_ca_system_score_gemma":0.00037105332,"threshold_uncertainty_score":0.04402089},"labels":[],"label_agreement":null},{"id":"W4402104183","doi":"10.1016/j.jaad.2024.07.748","title":"51600 Dupilumab Shows Improvements in Adult Patients With Prurigo Nodularis Regardless of Their Body Mass Index","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Prurigo nodularis; Dupilumab; Medicine; Dermatology; Body mass index; Atopic dermatitis; Pathology","score_opus":0.00583019262431405,"score_gpt":0.2620456156091702,"score_spread":0.25621542298485617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402104183","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96577525,0.022357414,0.0003128216,0.0007601043,0.00025748598,0.00009281764,0.0007543708,0.00020006992,0.009489695],"genre_scores_gemma":[0.99296373,0.0034516049,0.00037050009,0.00056516577,0.00011465993,0.00002656131,0.00062305434,0.00000936364,0.0018753893],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99988115,0.00002550911,0.000009679941,0.00001831967,0.000022504906,0.000042783977],"domain_scores_gemma":[0.99983394,0.000041031293,0.00003533632,0.000010870199,0.000024558312,0.000054290747],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021482629,0.00034344092,0.0005334281,0.00012967645,0.00012507533,0.00023498297,0.00013556486,0.0002409257,0.0028869582],"category_scores_gemma":[0.00037689164,0.0000918674,0.0003983923,0.000121585814,0.00007715081,0.00021783584,0.000087107626,0.00060899754,0.00061962986],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.074339435,0.004644819,0.05402262,0.0015312489,0.0015047994,0.0011521556,0.00011887005,0.00073558115,0.09544217,0.00016819572,0.015443737,0.7508963],"study_design_scores_gemma":[0.0219471,0.09605278,0.80975556,0.00035301602,0.0023390013,0.0082487315,0.00024267483,0.0024195302,0.0232673,0.00020328032,0.035095885,0.00007519916],"about_ca_topic_score_codex":0.00069982186,"about_ca_topic_score_gemma":0.0023667319,"teacher_disagreement_score":0.0028869582,"about_ca_system_score_codex":0.00017166694,"about_ca_system_score_gemma":0.00014928934,"threshold_uncertainty_score":0.0096578},"labels":[],"label_agreement":null},{"id":"W4402104193","doi":"10.1016/j.jaad.2024.07.1077","title":"51524 Oral tranexamic acid treatment longer than 6 months for melasma patients: a retrospective case series","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatologic Treatments and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Tranexamic acid; Melasma; Dermatology; Series (stratigraphy); Retrospective cohort study; Surgery; Blood loss","score_opus":0.025259814525703275,"score_gpt":0.34925510485549005,"score_spread":0.3239952903297868,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402104193","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936761,0.00266823,0.0005453795,0.00021854378,0.00006733313,0.00003307908,0.00010671419,0.000018582688,0.0026661062],"genre_scores_gemma":[0.9983431,0.00067132246,0.00019981497,0.00014117385,0.000112163245,0.000010918806,0.0001381816,0.000008919024,0.00037440663],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.999476,0.00006214107,0.000116914096,0.00010614555,0.000077476805,0.00016141548],"domain_scores_gemma":[0.99849176,0.00034630013,0.0006208867,0.00015751185,0.00009581415,0.00028771214],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023697504,0.00066090806,0.00064296485,0.001369362,0.0015267122,0.001234405,0.0005523147,0.001601947,0.0035463667],"category_scores_gemma":[0.0016383358,0.00062222726,0.0008958943,0.0010751468,0.0009840427,0.0011713621,0.0007270995,0.00095225975,0.0009915592],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002508768,0.00016438284,0.23786382,0.00006944428,0.00007785153,0.7543472,0.00034351012,0.00008065102,0.002290484,0.00020136939,0.0003732021,0.0039372877],"study_design_scores_gemma":[0.000017251681,0.00014563167,0.042186085,0.000024513667,0.000079589576,0.95513797,0.00062950456,0.00015685702,0.0004531754,0.0000774114,0.0010685759,0.000023437526],"about_ca_topic_score_codex":0.0010747127,"about_ca_topic_score_gemma":0.0011732376,"teacher_disagreement_score":0.0035463667,"about_ca_system_score_codex":0.0005619491,"about_ca_system_score_gemma":0.00067906163,"threshold_uncertainty_score":0.011863768},"labels":[],"label_agreement":null},{"id":"W4402104197","doi":"10.1016/j.jaad.2024.07.1258","title":"53133 Stability of long-term therapeutic responses to tralokinumab in adults with moderate-to-severe atopic dermatitis","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health; Queen's University; University of British Columbia","funders":"","keywords":"Medicine; Atopic dermatitis; Dermatology; Term (time)","score_opus":0.017950386713319853,"score_gpt":0.31307203700462427,"score_spread":0.29512165029130444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402104197","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980357,0.0008958029,0.00006378144,0.000052337695,0.000011609516,0.000007365895,0.00021123617,0.000008199894,0.0007138392],"genre_scores_gemma":[0.9994968,0.00009528981,0.00003073361,0.00003037593,0.000011648375,0.000004475393,0.00015941048,0.0000014567532,0.0001698062],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99965036,0.00007022626,0.000050832867,0.00007188067,0.000079145146,0.000077546356],"domain_scores_gemma":[0.99908197,0.00023213911,0.00038336063,0.000049374623,0.00014398032,0.000109187466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061902957,0.0001721968,0.00041806194,0.00031853968,0.00023740315,0.0005929563,0.00014578749,0.000286716,0.001336875],"category_scores_gemma":[0.0020018143,0.00008479843,0.00037791845,0.00034513784,0.00012616705,0.00035043943,0.00018508927,0.00044955427,0.00033475633],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007175371,0.00027907753,0.9295868,0.00010832166,0.00029659466,0.00089328573,0.0002938073,0.00027079837,0.01086942,0.000074337644,0.0007998622,0.04935236],"study_design_scores_gemma":[0.000039439437,0.0011463732,0.9957377,0.000014052511,0.00010819023,0.0007732866,0.00013481425,0.0003147364,0.0009398583,0.000024149116,0.0007591545,0.0000081327835],"about_ca_topic_score_codex":0.0013668174,"about_ca_topic_score_gemma":0.001552892,"teacher_disagreement_score":0.0013668174,"about_ca_system_score_codex":0.0003772457,"about_ca_system_score_gemma":0.00017241301,"threshold_uncertainty_score":0.0044722557},"labels":[],"label_agreement":null},{"id":"W4402104206","doi":"10.1016/j.jaad.2024.07.546","title":"54658 Association of country-level atopic dermatitis disease burden and socio-demographic index with topical calcineurin inhibitor utilization","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Calcineurin; Atopic dermatitis; Dermatology; Disease; Index (typography); Burden of disease; Association (psychology); Disease burden; Internal medicine","score_opus":0.01564326365194903,"score_gpt":0.29545202130110115,"score_spread":0.27980875764915214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402104206","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938099,0.0007075787,0.00017207506,0.00019722916,0.000044939137,0.000005735786,0.002188047,0.000025828731,0.0028487712],"genre_scores_gemma":[0.9983425,0.00013852166,0.00007290492,0.000046979247,0.00002954313,0.0000046695945,0.0005909125,0.0000053480926,0.00076861057],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996685,0.00007372498,0.00003942888,0.000074050804,0.000042938445,0.000101417776],"domain_scores_gemma":[0.9979317,0.0005685059,0.0008285567,0.0001760081,0.00017215255,0.00032301605],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036565642,0.00020754423,0.00027099464,0.0007107689,0.00028675428,0.0006357321,0.0003127777,0.00039240895,0.014113103],"category_scores_gemma":[0.002290574,0.00025987605,0.00092649466,0.0011116449,0.00019091526,0.00041605879,0.00036410431,0.0007514681,0.0011130791],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000111116635,0.000028671051,0.99840564,0.000007633166,0.00012052605,0.000041577718,0.000011578718,0.00003994671,0.0001028461,0.000019412186,0.00023687164,0.000874283],"study_design_scores_gemma":[0.0000052336377,0.00004497868,0.9988955,0.00000803631,0.00006301889,0.00017147145,0.00008453141,0.00032499805,0.00003154966,0.00002191705,0.00034494622,0.0000037260957],"about_ca_topic_score_codex":0.009018174,"about_ca_topic_score_gemma":0.008660526,"teacher_disagreement_score":0.014113103,"about_ca_system_score_codex":0.00020640338,"about_ca_system_score_gemma":0.00040266293,"threshold_uncertainty_score":0.047213018},"labels":[],"label_agreement":null},{"id":"W4402104210","doi":"10.1016/j.jaad.2024.07.1145","title":"52846 Proportion of the US psoriasis population impacted by common warnings for moderate-to-severe plaque psoriasis treatment","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Plaque psoriasis; Medicine; Psoriasis; Dermatology; Population; Environmental health","score_opus":0.014926408223219252,"score_gpt":0.2871291933056586,"score_spread":0.27220278508243934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402104210","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9606808,0.0015145537,0.0004781233,0.0015861128,0.00021336468,0.000055506465,0.016225213,0.00011512148,0.019131187],"genre_scores_gemma":[0.9865479,0.00091580115,0.0002473699,0.0016032633,0.00012929853,0.000046481193,0.005274298,0.000020464026,0.0052151135],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997156,0.00007593366,0.000023019978,0.000047282156,0.000085782835,0.000052326195],"domain_scores_gemma":[0.9996112,0.000047710404,0.00016606464,0.000022728225,0.000078317054,0.00007394438],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013862595,0.0001279584,0.00016821976,0.0004932992,0.00021285872,0.0002654514,0.00016733524,0.00030445217,0.013920073],"category_scores_gemma":[0.0011354267,0.00011874731,0.00033275684,0.0009752728,0.000091316186,0.00021186596,0.0002325245,0.0004232742,0.0019013481],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015786182,0.00007857892,0.97053146,0.000046660352,0.00006874252,0.00018133501,0.00006273868,0.00007236124,0.00113996,0.000120642726,0.013181589,0.014358009],"study_design_scores_gemma":[0.000008761778,0.000039885217,0.9941591,0.000024174262,0.000023502538,0.000420954,0.00020041694,0.00017875773,0.00009108701,0.000045000008,0.0048042485,0.0000040582513],"about_ca_topic_score_codex":0.013515699,"about_ca_topic_score_gemma":0.010832348,"teacher_disagreement_score":0.013920073,"about_ca_system_score_codex":0.00017049634,"about_ca_system_score_gemma":0.00028060557,"threshold_uncertainty_score":0.04656726},"labels":[],"label_agreement":null},{"id":"W4402104217","doi":"10.1016/j.jaad.2024.07.1250","title":"54244 Skin Tone Depiction in Google Image Search Results for Vitiligo","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"melanin and skin pigmentation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Vitiligo; Medicine; Depiction; Tone (literature); Dermatology; Artificial intelligence; Visual arts; Literature; Computer science","score_opus":0.01410549020019311,"score_gpt":0.3555622791337517,"score_spread":0.3414567889335586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402104217","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.26344645,0.024732297,0.0011491271,0.004550058,0.0020059587,0.0003105195,0.59634966,0.005572065,0.10188388],"genre_scores_gemma":[0.60310775,0.0142972,0.0041606748,0.0019369723,0.0011717047,0.00016477804,0.32144734,0.0012124155,0.052501053],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99977475,0.000021670876,0.000030974938,0.000025845136,0.0000880369,0.000058707665],"domain_scores_gemma":[0.99929607,0.00029398233,0.00012667969,0.00002786031,0.00014514053,0.00011031679],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011670759,0.0009488766,0.00045497876,0.0069634365,0.0005434805,0.0013395203,0.00025726508,0.00076491863,0.049581517],"category_scores_gemma":[0.0014660542,0.00010502199,0.00067217567,0.0037487599,0.00021064452,0.001116194,0.0010257185,0.00032392528,0.013248668],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010781001,0.00013929103,0.06925476,0.009303257,0.0002701239,0.005639364,0.0017368286,0.0007484075,0.0064237937,0.0016931634,0.82250255,0.081210315],"study_design_scores_gemma":[0.000107989974,0.00028399087,0.2823751,0.0036486597,0.0005717013,0.013161102,0.005353677,0.0036627897,0.005534901,0.0014222929,0.68372923,0.00014859773],"about_ca_topic_score_codex":0.019413453,"about_ca_topic_score_gemma":0.04005309,"teacher_disagreement_score":0.049581517,"about_ca_system_score_codex":0.00046011945,"about_ca_system_score_gemma":0.00035065497,"threshold_uncertainty_score":0.16586667},"labels":[],"label_agreement":null},{"id":"W4402104219","doi":"10.1016/j.jaad.2024.07.1262","title":"53753 StrataCTX® Gel Dressing as a Steroid-Sparing Supportive Therapy for CTCL-induced Pruritus","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Autoimmune Bullous Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"","keywords":"Medicine; Dermatology; Surgery","score_opus":0.032063632540254,"score_gpt":0.3688744693425066,"score_spread":0.3368108368022526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402104219","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95331925,0.032835655,0.0022271012,0.0007022563,0.0005682388,0.00018783238,0.00012479194,0.00030067126,0.009734185],"genre_scores_gemma":[0.99275583,0.0039411853,0.00091053435,0.00021987846,0.000092358496,0.000027936501,0.00006689269,0.000009745102,0.0019756497],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9999385,0.000011315402,0.000004844892,0.0000076373935,0.000023131703,0.000014537109],"domain_scores_gemma":[0.9999697,0.000007094414,0.0000047454537,0.000002815409,0.000002977717,0.000012615081],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000107478925,0.00013348517,0.00034196873,0.00020082295,0.00019756366,0.00017359148,0.00015785731,0.00020329378,0.0022411805],"category_scores_gemma":[0.00012416922,0.000059468326,0.0002679706,0.00012583485,0.000087306966,0.00012056741,0.00011059926,0.0005730816,0.00032881805],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0104898205,0.0039605503,0.0039020863,0.0018347092,0.0002606632,0.010781786,0.0002168571,0.0004969237,0.3307463,0.00083072204,0.00729672,0.6291829],"study_design_scores_gemma":[0.016178064,0.12826595,0.2544271,0.0012202646,0.0021191323,0.119699374,0.00047427852,0.01744028,0.2932533,0.0012103418,0.1655282,0.00018377318],"about_ca_topic_score_codex":0.00033903582,"about_ca_topic_score_gemma":0.000895843,"teacher_disagreement_score":0.0022411805,"about_ca_system_score_codex":0.00011374822,"about_ca_system_score_gemma":0.00015884524,"threshold_uncertainty_score":0.007497549},"labels":[],"label_agreement":null},{"id":"W4402104221","doi":"10.1016/j.jaad.2024.07.1168","title":"53838 Real-world drug survival of risankizumab at a tertiary care psoriasis clinic in Toronto, Canada","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Tertiary care; Psoriasis; Drug; Family medicine; Dermatology; Pharmacology","score_opus":0.01150235615120707,"score_gpt":0.28798463942477204,"score_spread":0.27648228327356494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402104221","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97516984,0.0013868391,0.00023306659,0.0050750654,0.000108794884,0.00016012734,0.006741793,0.00005430976,0.011070229],"genre_scores_gemma":[0.99405175,0.00045496895,0.00020231036,0.0010285,0.00006924301,0.000020791571,0.0012872255,0.000018102142,0.0028671336],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984047,0.00014192192,0.000090671645,0.00018573289,0.00041083823,0.00076617557],"domain_scores_gemma":[0.9954839,0.00023872966,0.00066693604,0.00007769229,0.0013239242,0.0022089342],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036010446,0.0002919952,0.0005400929,0.0006014136,0.0031837153,0.0020821316,0.0011307993,0.00090654887,0.0061996467],"category_scores_gemma":[0.0018981718,0.00042666844,0.00050400174,0.0015818261,0.00075612613,0.0005135121,0.00088066753,0.0016884297,0.0007520194],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004100207,0.0002670125,0.97080797,0.00012864512,0.00011981897,0.003462293,0.0016348521,0.00043233036,0.0006146171,0.00028015758,0.011819976,0.01002217],"study_design_scores_gemma":[0.000051769995,0.00022024868,0.98893446,0.000108762026,0.000068124915,0.0008939493,0.0043269107,0.00082547625,0.00014287666,0.00005208813,0.0043282355,0.00004709326],"about_ca_topic_score_codex":0.9666868,"about_ca_topic_score_gemma":0.9821003,"teacher_disagreement_score":0.9666868,"about_ca_system_score_codex":0.04195393,"about_ca_system_score_gemma":0.03524113,"threshold_uncertainty_score":0.30439848},"labels":[],"label_agreement":null},{"id":"W4402104227","doi":"10.1016/j.jaad.2024.07.572","title":"52675 Bimekizumab efficacy across subgroups of patients with moderate to severe plaque psoriasis: Pooled analysis from up to 3 years of treatment in 5 phase 3/3b clinical trials","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Dermatrials Research","funders":"","keywords":"Medicine; Plaque psoriasis; Psoriasis; Internal medicine; Clinical trial; Pooled analysis; Dermatology; Meta-analysis","score_opus":0.04094490572478248,"score_gpt":0.377095401805439,"score_spread":0.3361504960806565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402104227","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7146151,0.26757613,0.0045311786,0.0006605135,0.0009871176,0.00092752074,0.006137265,0.0002780139,0.0042871907],"genre_scores_gemma":[0.97845435,0.014406437,0.0010774966,0.00073723926,0.0004252084,0.00047828807,0.0034502307,0.00006590402,0.00090485875],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99141055,0.005169898,0.00089934806,0.0013267555,0.0006294409,0.0005639983],"domain_scores_gemma":[0.9925358,0.004021982,0.0018031496,0.00081490865,0.00049471366,0.0003294595],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014368351,0.0024226578,0.010201039,0.001259675,0.0004877651,0.0022386708,0.0010064968,0.0019244282,0.0024976043],"category_scores_gemma":[0.009832391,0.0012455145,0.022663206,0.0016673123,0.0006794743,0.001844452,0.0012523476,0.0023308052,0.00037587606],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4518117,0.0003358166,0.04167501,0.007684057,0.45088366,0.00020924497,0.00013932488,0.0030434746,0.0032718438,0.00018948397,0.0026420185,0.038114376],"study_design_scores_gemma":[0.12609494,0.025239937,0.1827707,0.0010216823,0.6539279,0.00044666932,0.00023242661,0.0024306006,0.001220026,0.0009814881,0.005418091,0.00021548512],"about_ca_topic_score_codex":0.001338031,"about_ca_topic_score_gemma":0.0035926448,"teacher_disagreement_score":0.014368351,"about_ca_system_score_codex":0.00070151896,"about_ca_system_score_gemma":0.0008913254,"threshold_uncertainty_score":0.075988054},"labels":[],"label_agreement":null},{"id":"W4402104236","doi":"10.1016/j.jaad.2024.07.1064","title":"54399 Omalizumab as an emerging treatment for severe refractory cutaneous mastocytosis: A systematic review of the adult and paediatric literature","year":2024,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Mast cells and histamine","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Omalizumab; Medicine; Dermatology; Refractory (planetary science); Cutaneous Mastocytosis; MEDLINE; Intensive care medicine; Immunoglobulin E; Systemic mastocytosis; Immunology; Mast cell","score_opus":0.01578791533229765,"score_gpt":0.31486648583365884,"score_spread":0.29907857050136116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402104236","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018937091,0.99949205,0.000022438126,0.000076434655,0.000041943815,0.000012996128,0.000075326476,0.0000019254448,0.000087502405],"genre_scores_gemma":[0.0015216917,0.99802893,0.00010124275,0.00019845975,0.000037551137,0.00001345346,0.000053042175,9.620463e-7,0.00004466965],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99911505,0.00017334822,0.00036622895,0.0001227371,0.00018124859,0.00004135081],"domain_scores_gemma":[0.9970095,0.0018807575,0.00076921296,0.000032678035,0.00023345088,0.00007433661],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015721396,0.00071478303,0.0038885046,0.0047545633,0.00027693756,0.0013436248,0.0010897715,0.0011275923,0.0046433443],"category_scores_gemma":[0.004381217,0.0003829565,0.0029757002,0.0045418735,0.0004107477,0.0012337697,0.0008829197,0.00088223006,0.00037958025],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055097986,0.000041507585,0.00090240955,0.6915113,0.0046714945,0.00033034038,0.00013580175,0.00020009805,0.00081393606,0.000440323,0.00932419,0.29107767],"study_design_scores_gemma":[0.0006822373,0.00064803794,0.010498586,0.6602283,0.0647902,0.003181121,0.00044556332,0.00021193431,0.00056977005,0.0006950013,0.25793624,0.00011303928],"about_ca_topic_score_codex":0.0027199273,"about_ca_topic_score_gemma":0.009391543,"teacher_disagreement_score":0.0047545633,"about_ca_system_score_codex":0.0007911583,"about_ca_system_score_gemma":0.003008352,"threshold_uncertainty_score":0.0155335665},"labels":[],"label_agreement":null},{"id":"W4402104239","doi":"10.1016/j.jaad.2024.07.1181","title":"52876 Relationships Among Abrocitinib Treatment, Itch, Skin Clearance, Anxiety, and Depression: A Mediation Modeling Analysis","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada); Probity Medical Research; SKiN Health; Queen's University; University of Alberta","funders":"","keywords":"Medicine; Anxiety; Depression (economics); Mediation; Dermatology; Clinical psychology; Psychiatry","score_opus":0.023296933604207846,"score_gpt":0.28211666060480134,"score_spread":0.25881972700059347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402104239","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9780196,0.0018863615,0.010891202,0.0016949266,0.00051145925,0.0006373405,0.0034937651,0.00025408616,0.0026112685],"genre_scores_gemma":[0.9854997,0.00054936926,0.004963827,0.00028845802,0.0001654541,0.001294207,0.0008544345,0.00004862486,0.0063359807],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9926708,0.005035381,0.0002898032,0.00075426017,0.0004083623,0.0008413537],"domain_scores_gemma":[0.9907987,0.007332319,0.00047631562,0.000610878,0.0004239913,0.0003577502],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008128864,0.0025237398,0.0018744156,0.0010484478,0.0010976404,0.0016520598,0.0034068336,0.0019321046,0.019222897],"category_scores_gemma":[0.010235521,0.0013141431,0.0059676166,0.00093198044,0.0006005029,0.0011380737,0.0018978394,0.0050436193,0.001837263],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.036155026,0.01070218,0.831081,0.0009621322,0.043352492,0.0016106052,0.0019947004,0.0122758215,0.004017289,0.0046967715,0.00785193,0.0453001],"study_design_scores_gemma":[0.013847484,0.028695052,0.5685698,0.0009771383,0.08616757,0.0022920417,0.0044326433,0.26652876,0.004316292,0.008565624,0.015177446,0.0004301326],"about_ca_topic_score_codex":0.017483605,"about_ca_topic_score_gemma":0.009238039,"teacher_disagreement_score":0.019222897,"about_ca_system_score_codex":0.0007449761,"about_ca_system_score_gemma":0.003412549,"threshold_uncertainty_score":0.064306974},"labels":[],"label_agreement":null},{"id":"W4402104274","doi":"10.1016/j.jaad.2024.07.1256","title":"51856 Spesolimab rapidly improves quality of life in patients with generalized pustular psoriasis, as per Dermatology Life Quality Index scores: Data from the Effisayil 2 trial","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Dermatology Life Quality Index; Dermatology; Psoriasis; Quality of life (healthcare); Generalized pustular psoriasis; Psoriasis Area and Severity Index; Index (typography)","score_opus":0.03684672638143557,"score_gpt":0.319830949425381,"score_spread":0.28298422304394544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402104274","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96260744,0.023562973,0.00051928294,0.0015146385,0.0005110134,0.0004331454,0.0019311955,0.0002583582,0.008661905],"genre_scores_gemma":[0.9861367,0.0057763206,0.00053944887,0.001886542,0.00038998175,0.00027491685,0.0021767344,0.000022026143,0.002797514],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99960905,0.00018765256,0.00002233381,0.000048175792,0.00005015532,0.00008265572],"domain_scores_gemma":[0.9995912,0.000114002054,0.000118674136,0.0000331738,0.000025530575,0.00011752209],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010399419,0.0010369582,0.0019169479,0.00025862953,0.00020072071,0.0008083994,0.0004255232,0.00074628746,0.003389479],"category_scores_gemma":[0.0008240027,0.00025700498,0.0014562169,0.0003291483,0.00037866965,0.0006010993,0.00023536842,0.001959606,0.00066877116],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.72720855,0.0042497134,0.008801007,0.0028038148,0.0059682718,0.00030737385,0.00008784206,0.0024778587,0.012167613,0.00053772127,0.014704159,0.22068608],"study_design_scores_gemma":[0.8525416,0.07972874,0.05584131,0.00020310936,0.002309066,0.0005005625,0.000074702584,0.0016702168,0.0011385924,0.0006811105,0.005248287,0.00006272126],"about_ca_topic_score_codex":0.0004566518,"about_ca_topic_score_gemma":0.0013274938,"teacher_disagreement_score":0.003389479,"about_ca_system_score_codex":0.00037263628,"about_ca_system_score_gemma":0.000333507,"threshold_uncertainty_score":0.011338949},"labels":[],"label_agreement":null},{"id":"W4402104283","doi":"10.1016/j.jaad.2024.07.745","title":"53474 Dupilumab Improves Self-Perception and Relationships among Patients with Chronic Spontaneous Urticaria Uncontrolled by H1 Antihistamines","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Urticaria and Related Conditions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Dupilumab; Medicine; Chronic urticaria; Dermatology; Atopic dermatitis","score_opus":0.004721645615990237,"score_gpt":0.23213693544978234,"score_spread":0.2274152898337921,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402104283","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981199,0.0005510141,0.000031893942,0.00009176091,0.00002219981,0.000011527307,0.00004609265,0.0000089421,0.0011166664],"genre_scores_gemma":[0.9993882,0.00013834167,0.00004545015,0.00005902719,0.000016561618,0.000004616344,0.000049380338,7.111155e-7,0.00029766242],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999877,0.000043849042,0.000009484259,0.000013264791,0.000023361923,0.000033040524],"domain_scores_gemma":[0.99976224,0.00006369047,0.00005634758,0.000010189105,0.000029736615,0.000077761215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019240408,0.00018959913,0.0002920662,0.0001189301,0.0002699181,0.00027755927,0.000099817844,0.00012878809,0.0019345989],"category_scores_gemma":[0.00073554344,0.00006380662,0.0002316957,0.00010293198,0.000066659544,0.00018625578,0.00012089286,0.0003625614,0.00017148732],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014919072,0.0091229165,0.60583407,0.00034515574,0.00091309455,0.00088114786,0.0007013238,0.00032654018,0.01512046,0.00009339335,0.0041887145,0.3475541],"study_design_scores_gemma":[0.00064103294,0.0065093497,0.9883654,0.0000232067,0.00019940046,0.0007414599,0.0004154163,0.0008071423,0.00075385335,0.000038346676,0.0014960199,0.000009357363],"about_ca_topic_score_codex":0.0013092965,"about_ca_topic_score_gemma":0.002882043,"teacher_disagreement_score":0.0019345989,"about_ca_system_score_codex":0.00016528879,"about_ca_system_score_gemma":0.00013527367,"threshold_uncertainty_score":0.0064718127},"labels":[],"label_agreement":null},{"id":"W4402104290","doi":"10.1016/j.jaad.2024.07.777","title":"52826 Efficacy and safety of tildrakizumab for the treatment of moderate-to-severe plaque psoriasis of the scalp: Week 52 results of a multicenter, randomized, double-blind, placebo-controlled clinical study","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Medicine; Scalp; Dermatology; Placebo; Psoriasis; Plaque psoriasis; Multicenter study; Double blind; Clinical trial; Pilot trial; Randomized controlled trial; Surgery; Internal medicine; Pathology","score_opus":0.039577097497548536,"score_gpt":0.34175244887346773,"score_spread":0.3021753513759192,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402104290","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98926765,0.0051217033,0.00064597913,0.00035140157,0.00029073303,0.0015745977,0.0006355955,0.00017784513,0.0019345351],"genre_scores_gemma":[0.99017525,0.0026792616,0.0008781539,0.0009825767,0.0005606012,0.0010915077,0.00075800385,0.000043079446,0.0028316095],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9992254,0.000386907,0.00006106557,0.00011525002,0.00008107707,0.0001302701],"domain_scores_gemma":[0.999265,0.00021849066,0.00015453671,0.00006541412,0.000060115715,0.0002364548],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017396425,0.0013443372,0.003977437,0.0006064978,0.00048134173,0.0009338782,0.0008526674,0.0023669738,0.005541567],"category_scores_gemma":[0.0012307332,0.00081959506,0.001454984,0.000421108,0.001080832,0.0009324574,0.00024382587,0.0022855764,0.0013931454],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9232234,0.017716756,0.0008495164,0.0007851903,0.0007766719,0.00009998677,0.000055796896,0.00034417456,0.026405549,0.00007098743,0.00085617474,0.028815784],"study_design_scores_gemma":[0.8688563,0.12346929,0.004871035,0.000031364038,0.000456427,0.000054258966,0.000017506098,0.00034291414,0.0013847653,0.000046600417,0.00044539533,0.000024049616],"about_ca_topic_score_codex":0.00060661515,"about_ca_topic_score_gemma":0.0009603318,"teacher_disagreement_score":0.005541567,"about_ca_system_score_codex":0.00035298654,"about_ca_system_score_gemma":0.0005672681,"threshold_uncertainty_score":0.018538356},"labels":[],"label_agreement":null},{"id":"W4402104294","doi":"10.1016/j.jaad.2024.07.916","title":"53118 IL-1β Inhibitors for the Treatment of Hidradenitis Suppurativa: A Systematic Review","year":2024,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital; McMaster University; University of Toronto","funders":"","keywords":"Hidradenitis suppurativa; Medicine; Dermatology; Internal medicine; Disease","score_opus":0.04979754136028241,"score_gpt":0.40066921220149004,"score_spread":0.35087167084120763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402104294","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003359664,0.99906117,0.000055907185,0.000074472606,0.00008562863,0.00009502209,0.00013669798,0.000004462266,0.00015068792],"genre_scores_gemma":[0.0050312825,0.9940602,0.00018960546,0.0003529117,0.000058372214,0.00010207458,0.00008634649,0.0000021732194,0.00011703331],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9983032,0.0005021413,0.0005862858,0.00019997894,0.00030488375,0.0001035038],"domain_scores_gemma":[0.99573106,0.0028253812,0.0009552213,0.000052938674,0.00033546807,0.00010004263],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025864474,0.0014588402,0.009059677,0.0040661115,0.0005518216,0.002137908,0.0015642324,0.0019492696,0.00797214],"category_scores_gemma":[0.009732978,0.0007691709,0.008216106,0.004636392,0.0006071317,0.0014463121,0.0011181175,0.0015454163,0.000557351],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006305529,0.000035583285,0.00034363102,0.94041944,0.019259868,0.000095328025,0.0000667636,0.00010287717,0.00020563263,0.00014610127,0.0020346784,0.036659535],"study_design_scores_gemma":[0.002167439,0.0005399303,0.004364586,0.6687064,0.29395384,0.0003896791,0.00021227276,0.00014658314,0.0002591197,0.00039627834,0.028786229,0.00007755575],"about_ca_topic_score_codex":0.009209893,"about_ca_topic_score_gemma":0.027240274,"teacher_disagreement_score":0.009209893,"about_ca_system_score_codex":0.0017823176,"about_ca_system_score_gemma":0.004460689,"threshold_uncertainty_score":0.026669502},"labels":[],"label_agreement":null},{"id":"W4402104362","doi":"10.1016/j.jaad.2024.07.952","title":"52284 Influence of Biological Sex on Clinical Manifestation in Moderate-to-Severe Atopic Dermatitis and on Dupilumab Treatment Effectiveness","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"Regeneron Pharmaceuticals; Sanofi","keywords":"Dupilumab; Medicine; Atopic dermatitis; Dermatology","score_opus":0.03205797531677393,"score_gpt":0.3744087618394168,"score_spread":0.34235078652264284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402104362","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948271,0.0019226201,0.000050782495,0.000097449636,0.00004131991,0.000009177757,0.00021327402,0.0000061277788,0.0028321284],"genre_scores_gemma":[0.9992441,0.00013096613,0.000020912295,0.00003195689,0.000022097458,0.00000293406,0.000078475096,0.0000036319645,0.00046495334],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999283,0.00032024505,0.000057746423,0.000082373284,0.00011707482,0.00013946682],"domain_scores_gemma":[0.99796677,0.0010513536,0.0003884622,0.00010596151,0.000120864795,0.00036669293],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007996286,0.00021523407,0.00051987864,0.00031718446,0.00021881735,0.00058930594,0.00020020311,0.00028961638,0.004147126],"category_scores_gemma":[0.0029131728,0.000090908965,0.0008289558,0.00032179593,0.00026186006,0.00032912698,0.00021494595,0.0005196993,0.00041094705],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03851879,0.0009893499,0.8857211,0.00015478612,0.0012995859,0.0007522133,0.00017197811,0.00026476907,0.010390443,0.00018188533,0.00047828179,0.06107673],"study_design_scores_gemma":[0.00019135703,0.0025187088,0.9948591,0.000017009417,0.00027901455,0.00049411884,0.00010226929,0.00023520131,0.00048902776,0.00006212809,0.000741651,0.00001037738],"about_ca_topic_score_codex":0.00074486894,"about_ca_topic_score_gemma":0.0011328845,"teacher_disagreement_score":0.004147126,"about_ca_system_score_codex":0.00024823743,"about_ca_system_score_gemma":0.00024863085,"threshold_uncertainty_score":0.013873458},"labels":[],"label_agreement":null},{"id":"W4402104371","doi":"10.1016/j.jaad.2024.07.910","title":"54495 IBD Presentation in Patients with Neutrophilic Dermatoses on IL-17 Inhibitors: A Systematic Review","year":2024,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Autoimmune and Inflammatory Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"","keywords":"Medicine; Dermatology; Presentation (obstetrics); Systematic review; MEDLINE; Surgery","score_opus":0.016177937214104265,"score_gpt":0.3275991122140312,"score_spread":0.31142117499992694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402104371","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010778448,0.99802846,0.000054506345,0.000117684875,0.00007827311,0.000091524584,0.0003911797,0.0000058210776,0.0001546987],"genre_scores_gemma":[0.014977769,0.9834862,0.0002822313,0.00069599145,0.00007556544,0.00012330526,0.00022861589,0.0000040878963,0.00012631269],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9979857,0.00042876613,0.00096764474,0.0002516205,0.00025359908,0.000112565045],"domain_scores_gemma":[0.9941089,0.0034846682,0.0018190598,0.00007010094,0.00039789992,0.000119268014],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019660064,0.0013191968,0.0073199226,0.0068153576,0.00038494822,0.0018797428,0.0011814293,0.0016097587,0.007840547],"category_scores_gemma":[0.009073107,0.0009002738,0.0077147475,0.0065209637,0.0005823291,0.001715423,0.0015466816,0.0010694972,0.00042881342],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046607564,0.000025626316,0.002020174,0.9453988,0.021280374,0.00016181846,0.00013488616,0.000066564826,0.0002469021,0.00009869818,0.002356406,0.0277435],"study_design_scores_gemma":[0.0012546148,0.00033211833,0.011898495,0.67662495,0.2836495,0.00089424726,0.0003664031,0.0000814708,0.00017418186,0.00021056097,0.024424491,0.000088966095],"about_ca_topic_score_codex":0.005934404,"about_ca_topic_score_gemma":0.024552412,"teacher_disagreement_score":0.007840547,"about_ca_system_score_codex":0.0014490894,"about_ca_system_score_gemma":0.003673104,"threshold_uncertainty_score":0.026229262},"labels":[],"label_agreement":null},{"id":"W4402104389","doi":"10.1016/j.jaad.2024.07.921","title":"52853 Impact of Baseline Disease Severity on the Long-Term Efficacy of Abrocitinib Treatment in Patients With Moderate-To-Severe Atopic Dermatitis: Interim Analysis of the Long-Term Extension JADE EXTEND Study","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health; Queen's University","funders":"","keywords":"Eczema Area and Severity Index; Medicine; Atopic dermatitis; Internal medicine; Clinical endpoint; Body surface area; Severity of illness; Pediatrics; Gastroenterology; Clinical trial; Dermatology","score_opus":0.018769511414954393,"score_gpt":0.3396118612340353,"score_spread":0.3208423498190809,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402104389","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98794365,0.006961028,0.0005057356,0.00016452547,0.0001228102,0.00010706397,0.001984485,0.00003833792,0.002172248],"genre_scores_gemma":[0.99545896,0.0006483856,0.00022101104,0.00021328192,0.000115808296,0.00010119309,0.0022467126,0.000010404603,0.0009842879],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9984243,0.0007497263,0.00012229121,0.0002002473,0.00023447901,0.00026909032],"domain_scores_gemma":[0.99758255,0.000882058,0.00068865024,0.00046688132,0.00015591714,0.00022393219],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0050574616,0.0007091948,0.0027183741,0.00027088975,0.00033162432,0.0014896961,0.00046127135,0.00062839995,0.0023948892],"category_scores_gemma":[0.0026361546,0.00026685593,0.0039414437,0.00040591048,0.00034102137,0.0010377736,0.00042731361,0.0019560785,0.00040493155],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.66768646,0.00272323,0.21015361,0.00095364905,0.024948338,0.00032528705,0.00013855883,0.003515803,0.006696929,0.0003696562,0.0030144388,0.07947404],"study_design_scores_gemma":[0.0605142,0.076695845,0.823542,0.00022151138,0.026268253,0.00053261203,0.00018583632,0.0038623025,0.0026312477,0.0007278666,0.004690785,0.0001275276],"about_ca_topic_score_codex":0.00036644225,"about_ca_topic_score_gemma":0.0009332884,"teacher_disagreement_score":0.0050574616,"about_ca_system_score_codex":0.00031168494,"about_ca_system_score_gemma":0.00044747794,"threshold_uncertainty_score":0.02674675},"labels":[],"label_agreement":null},{"id":"W4402104390","doi":"10.1016/j.jaad.2024.07.557","title":"54311 Autoimmune co-morbidities associated with vitiligo: A United States population-based case-control analysis using the All of Us research program","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"melanin and skin pigmentation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Vitiligo; Medicine; Population; Dermatology; Environmental health","score_opus":0.03532330679650186,"score_gpt":0.38952997256820243,"score_spread":0.35420666577170057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402104390","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985292,0.0002077734,0.00026428036,0.000023914605,0.000014068837,0.000026824497,0.0006000506,0.000009031902,0.00032482305],"genre_scores_gemma":[0.9985121,0.00010035113,0.00022650976,0.000027468217,0.000019784464,0.00003052832,0.00073708827,0.0000068827703,0.00033932828],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99834704,0.00063054694,0.00013750566,0.0005206839,0.00018602156,0.000178297],"domain_scores_gemma":[0.99817824,0.00040539447,0.0005667255,0.0003498277,0.00021446378,0.00028537482],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014459622,0.0009955936,0.00072833913,0.002002992,0.0013786239,0.0011923505,0.00091764826,0.00086841657,0.0030789913],"category_scores_gemma":[0.0022624303,0.0011842737,0.0014187408,0.0026251487,0.0005319656,0.000608271,0.0006899215,0.0012336576,0.00041496436],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009572666,0.0002747852,0.99587184,0.000011898528,0.0005935355,0.00024111303,0.00007511078,0.00006564593,0.0008057892,0.000043709817,0.00021033782,0.00084900646],"study_design_scores_gemma":[0.000081215585,0.00021268391,0.9982357,0.0000052679598,0.00032709131,0.0003864919,0.00011573596,0.00034013297,0.00008375697,0.000018959041,0.00018551257,0.00000736416],"about_ca_topic_score_codex":0.018859025,"about_ca_topic_score_gemma":0.01500108,"teacher_disagreement_score":0.018859025,"about_ca_system_score_codex":0.00048587736,"about_ca_system_score_gemma":0.00046501955,"threshold_uncertainty_score":0.037498534},"labels":[],"label_agreement":null},{"id":"W4402104411","doi":"10.1016/j.jaad.2024.07.1234","title":"51582 Simultaneous Genital Skin Clearance and Patient Reported Outcome Responses at Weeks 24 and 52 in Patients with Moderate-to-Severe Genital Psoriasis Treated with Ixekizumab: an analysis of the Phase 3 Clinical Trial IXORA-Q","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; SKiN Health; Queen's University","funders":"","keywords":"Medicine; Ixekizumab; Psoriasis; Sex organ; Dermatology; Psoriatic arthritis","score_opus":0.027475813929519508,"score_gpt":0.3195392359290998,"score_spread":0.29206342199958024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402104411","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975836,0.0009004971,0.00013686772,0.000119367774,0.0000461514,0.00015840166,0.00043071568,0.00002846406,0.000595903],"genre_scores_gemma":[0.9978459,0.00031236745,0.0001987965,0.00017859574,0.00006316104,0.00013304349,0.00063290313,0.000007979572,0.0006272611],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9993339,0.00033556877,0.00003128946,0.000106233136,0.00006897142,0.00012394521],"domain_scores_gemma":[0.9992079,0.00024469141,0.00023936943,0.00006732879,0.00003324696,0.00020743374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019151006,0.0006635256,0.0015212985,0.00022879597,0.00023914975,0.0008081618,0.00040246182,0.00070110324,0.0027767892],"category_scores_gemma":[0.0012517871,0.0003709801,0.0011851296,0.00023990637,0.00046078357,0.00063738105,0.00024276995,0.0019230959,0.0004615128],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8373915,0.012068894,0.036239307,0.00038056236,0.0023005633,0.0001688526,0.00013384769,0.0018583434,0.026478272,0.00016089961,0.0024358823,0.08038315],"study_design_scores_gemma":[0.41006225,0.38778362,0.18828619,0.00005315924,0.0016526885,0.0006235911,0.00010032062,0.0032668961,0.00528032,0.00029491915,0.0025119665,0.000084056046],"about_ca_topic_score_codex":0.00042724068,"about_ca_topic_score_gemma":0.0007544247,"teacher_disagreement_score":0.0027767892,"about_ca_system_score_codex":0.0004595411,"about_ca_system_score_gemma":0.00059272547,"threshold_uncertainty_score":0.01012814},"labels":[],"label_agreement":null},{"id":"W4402104414","doi":"10.1016/j.jaad.2024.07.1187","title":"50793 Response to therapy in skin of colour participants with moderate-to-severe psoriasis and atopic dermatitis: a systematic review","year":2024,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Université Laval; Queen's University","funders":"","keywords":"Medicine; Atopic dermatitis; Dermatology; Psoriasis","score_opus":0.036899782706698823,"score_gpt":0.33328899403685036,"score_spread":0.29638921133015156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402104414","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0021840888,0.9965617,0.0000848626,0.00012859373,0.00011123768,0.00017616924,0.0005382446,0.000010125441,0.00020496124],"genre_scores_gemma":[0.042205732,0.9554034,0.000528716,0.0009374455,0.00009224282,0.00028141824,0.0003251999,0.00000791587,0.00021799203],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9970782,0.0008686536,0.0011923036,0.00035221878,0.00036650256,0.00014225226],"domain_scores_gemma":[0.9934411,0.0037769713,0.0020861996,0.00011822045,0.00042799933,0.00014943154],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030863904,0.0011348088,0.0089412,0.0040867673,0.00037265866,0.0018552665,0.0013818278,0.001749882,0.0075455806],"category_scores_gemma":[0.012776907,0.00093475997,0.009682677,0.004186774,0.00066580035,0.0013383585,0.0015437779,0.0012541709,0.0003977121],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008197714,0.000025819236,0.0014852319,0.93768954,0.038059413,0.00009118349,0.0001373936,0.000069125315,0.00022194565,0.00008548049,0.0012450606,0.020070061],"study_design_scores_gemma":[0.0025274449,0.0006218195,0.014083906,0.47853214,0.4851776,0.0004343849,0.00035792287,0.000109422705,0.00018852847,0.00020756514,0.017675588,0.00008361446],"about_ca_topic_score_codex":0.009671541,"about_ca_topic_score_gemma":0.034950294,"teacher_disagreement_score":0.009671541,"about_ca_system_score_codex":0.0018557009,"about_ca_system_score_gemma":0.0031654206,"threshold_uncertainty_score":0.025242507},"labels":[],"label_agreement":null},{"id":"W4402104415","doi":"10.1016/j.jaad.2024.07.448","title":"54070 A Review of Intense Pulse Light (IPL) in the Treatment of Ocular Rosacea","year":2024,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Vancouver General Hospital; University of Toronto; McMaster University","funders":"","keywords":"Medicine; Rosacea; Intense pulsed light; Dermatology; Optometry; Pulse (music); Ophthalmology; Optics","score_opus":0.03638463901562694,"score_gpt":0.3956499269682089,"score_spread":0.35926528795258195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402104415","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000057291105,0.99912435,0.000045243953,0.00007246081,0.00017926905,0.000006349726,0.000020156614,0.0000038484136,0.00049099274],"genre_scores_gemma":[0.00027576668,0.99890196,0.00011144627,0.0001566425,0.00015247434,0.0000058335895,0.000029424988,9.378481e-7,0.0003655711],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997594,0.00003672714,0.00005529615,0.00004264569,0.00008770136,0.00001826859],"domain_scores_gemma":[0.99954945,0.00023035577,0.00007706502,0.00000890852,0.000098122066,0.000036078163],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006664206,0.0009879345,0.001951813,0.0033605206,0.00033436654,0.0010656969,0.0009770218,0.0010660416,0.008757028],"category_scores_gemma":[0.00106683,0.0003662764,0.0009580279,0.003164124,0.00037529168,0.0012314814,0.00069677294,0.0018811857,0.0025998224],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017224609,0.00011097683,0.000117926415,0.061899308,0.00021092664,0.00015516502,0.000058272402,0.00018271159,0.001488412,0.0010564879,0.033937797,0.90060973],"study_design_scores_gemma":[0.00012306638,0.00035679934,0.0014756258,0.017634263,0.0009511832,0.0014128359,0.000071487346,0.000111332076,0.00046596534,0.0007708546,0.9765835,0.000043184707],"about_ca_topic_score_codex":0.0020798014,"about_ca_topic_score_gemma":0.003924721,"teacher_disagreement_score":0.008757028,"about_ca_system_score_codex":0.0004526402,"about_ca_system_score_gemma":0.00104937,"threshold_uncertainty_score":0.029295146},"labels":[],"label_agreement":null},{"id":"W4402104433","doi":"10.1016/j.jaad.2024.07.1183","title":"52636 Remibrutinib improves hive severity in patients with chronic spontaneous urticaria: 52-week results from a Phase 2b extension study","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Urticaria and Related Conditions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Chronic urticaria; Extension (predicate logic); Dermatology","score_opus":0.010609964984862968,"score_gpt":0.2906173983531178,"score_spread":0.28000743336825484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402104433","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99093086,0.0048794225,0.0004526066,0.00047104724,0.00014999553,0.00071907893,0.00076640036,0.0001505177,0.0014801932],"genre_scores_gemma":[0.9900075,0.0029369057,0.0010740843,0.0010668582,0.0002293249,0.0008006039,0.0012602747,0.000040225616,0.0025841505],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9995728,0.00016413817,0.000022488011,0.00005734044,0.000043217336,0.00013991125],"domain_scores_gemma":[0.99942636,0.00012538339,0.00011045087,0.000062593805,0.000054073287,0.00022111494],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017801548,0.0015910714,0.0022335078,0.00031611396,0.00043367472,0.0009221718,0.00063471106,0.0012064289,0.004228243],"category_scores_gemma":[0.000864133,0.00044317008,0.00196157,0.00025529225,0.0005316483,0.00081116916,0.00028140692,0.0028910858,0.00100951],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.59940004,0.06755546,0.006935012,0.0021629771,0.003560857,0.0005002334,0.00045353363,0.0025904526,0.059788633,0.00026146616,0.007823877,0.24896756],"study_design_scores_gemma":[0.64526993,0.3043647,0.041176975,0.00013522308,0.0010252304,0.00043555442,0.00012791752,0.0013543145,0.002735103,0.00019094186,0.0031155276,0.00006853681],"about_ca_topic_score_codex":0.0009222856,"about_ca_topic_score_gemma":0.0020278117,"teacher_disagreement_score":0.004228243,"about_ca_system_score_codex":0.00045485393,"about_ca_system_score_gemma":0.0005747133,"threshold_uncertainty_score":0.014144838},"labels":[],"label_agreement":null},{"id":"W4402104460","doi":"10.1016/j.jaad.2024.07.1218","title":"51675 Safety and efficacy of risankizumab in adult patients with moderate-to-severe plaque psoriasis with non-pustular palmoplantar involvement: changes in PPASI and PASI from Phase 3b IMMprint trial","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"","keywords":"Medicine; Plaque psoriasis; Dermatology; Psoriasis","score_opus":0.008949594487291372,"score_gpt":0.24881062640019588,"score_spread":0.2398610319129045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402104460","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9778217,0.0103593115,0.0003840624,0.0011418702,0.00039106482,0.0005639158,0.0022712636,0.00021932313,0.006847511],"genre_scores_gemma":[0.9881754,0.0026162933,0.00046568844,0.0018528454,0.00027236374,0.0002918349,0.0029510623,0.000025304604,0.0033491876],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9996618,0.00012739055,0.000024991039,0.000048674476,0.00005230731,0.00008478785],"domain_scores_gemma":[0.99963546,0.00009406676,0.00008121669,0.000026676662,0.00003639066,0.0001262041],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010318196,0.00076837564,0.0015548348,0.00023109493,0.00025417432,0.0009477811,0.00041289395,0.001008934,0.0040060217],"category_scores_gemma":[0.0008385897,0.00035623106,0.0015278792,0.00020688926,0.000417712,0.0005367834,0.00018609795,0.0022056892,0.0014420102],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7383832,0.006942847,0.014831976,0.001444126,0.003170388,0.00040006972,0.0001690851,0.0023753184,0.023637392,0.0006519104,0.015182063,0.19281167],"study_design_scores_gemma":[0.69483477,0.2313045,0.052238625,0.00019473334,0.0021829898,0.0009618699,0.00009630269,0.0026079642,0.003877859,0.0005977583,0.011013395,0.000089196066],"about_ca_topic_score_codex":0.0004518851,"about_ca_topic_score_gemma":0.0013421836,"teacher_disagreement_score":0.0040060217,"about_ca_system_score_codex":0.0005664212,"about_ca_system_score_gemma":0.0006181128,"threshold_uncertainty_score":0.013401508},"labels":[],"label_agreement":null},{"id":"W4402104479","doi":"10.1016/j.jaad.2024.07.993","title":"53822 Longitudinal evaluation of the psoriasis epidemiology screening tool (PEST) in patients with moderate to severe psoriasis: Results from the PURE Registry","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Trent University; University of Ottawa; Probity Medical Research; Queen's University; Novartis (Canada); University of British Columbia","funders":"","keywords":"Medicine; Psoriasis; Epidemiology; Dermatology; Internal medicine","score_opus":0.04261913830304342,"score_gpt":0.30112543028913374,"score_spread":0.2585062919860903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402104479","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99645597,0.000169689,0.00014179359,0.000035012963,0.000008375212,0.00002092371,0.002666584,0.000011254335,0.0004903667],"genre_scores_gemma":[0.9941332,0.00015077056,0.00017667121,0.000063939835,0.000021876662,0.00004518654,0.0050065797,0.000009158779,0.00039262517],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99809355,0.00081687653,0.00018118868,0.00039377858,0.00031218288,0.00020242516],"domain_scores_gemma":[0.99699855,0.00052603224,0.0010799308,0.000497812,0.0005142605,0.0003834554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002545984,0.00043616057,0.0005883704,0.00094909506,0.00055154687,0.0009185405,0.00046581254,0.0004975378,0.0016646739],"category_scores_gemma":[0.004299349,0.0005406167,0.00077448523,0.0016306798,0.00022295439,0.0008714583,0.0008805114,0.000706747,0.0007829615],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005595582,0.000110386645,0.99771035,0.000007635295,0.0001023447,0.00002556159,0.00003476174,0.000022813509,0.00015279828,0.0000105846275,0.00020163681,0.0010615897],"study_design_scores_gemma":[0.000061737104,0.00021908275,0.99909985,0.0000039296774,0.00008203311,0.00008699273,0.00007695671,0.00010065843,0.000064461885,0.000011386015,0.00018835874,0.000004729539],"about_ca_topic_score_codex":0.006561153,"about_ca_topic_score_gemma":0.0052052974,"teacher_disagreement_score":0.006561153,"about_ca_system_score_codex":0.0003261098,"about_ca_system_score_gemma":0.000613184,"threshold_uncertainty_score":0.01346463},"labels":[],"label_agreement":null},{"id":"W4402104481","doi":"10.1016/j.jaad.2024.07.457","title":"54390 A Systematic Review on Treatment Outcomes of Striae","year":2024,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Dermatologic Treatments and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health; Université de Montréal; University of British Columbia; McGill University","funders":"","keywords":"Medicine; MEDLINE; Dermatology; Intensive care medicine","score_opus":0.09575722889740514,"score_gpt":0.4694030617768833,"score_spread":0.37364583287947817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402104481","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017261724,0.99695396,0.000115144845,0.00012674827,0.00012952999,0.00018725786,0.00042049086,0.0000072525463,0.00033327925],"genre_scores_gemma":[0.041343495,0.95629543,0.00058171223,0.0007871797,0.000118023425,0.00028164932,0.0003504203,0.000007716399,0.00023427549],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99472815,0.0021717036,0.0016262712,0.0005383742,0.0007342002,0.00020128426],"domain_scores_gemma":[0.9882705,0.008806392,0.0019207542,0.00017077701,0.0006781425,0.00015347822],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004557695,0.0013335058,0.008501944,0.003837907,0.00053981785,0.002126791,0.0013779674,0.0017250247,0.009413185],"category_scores_gemma":[0.025100065,0.00090429635,0.012564712,0.0047627906,0.0007980642,0.0016150476,0.0014991574,0.0021695266,0.00055090006],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010025933,0.000035861915,0.001538354,0.90509385,0.05870809,0.00007112005,0.00011326323,0.00009628848,0.00012317998,0.00015631772,0.0015803927,0.031480778],"study_design_scores_gemma":[0.002544443,0.00051879784,0.009730652,0.50725746,0.4673636,0.00027484566,0.00026309828,0.00011575789,0.00013926935,0.00038121152,0.011347363,0.0000634736],"about_ca_topic_score_codex":0.010067142,"about_ca_topic_score_gemma":0.033439137,"teacher_disagreement_score":0.010067142,"about_ca_system_score_codex":0.0020039892,"about_ca_system_score_gemma":0.0047848336,"threshold_uncertainty_score":0.031490207},"labels":[],"label_agreement":null},{"id":"W4402104590","doi":"10.1016/j.jaad.2024.07.665","title":"54146 Constructive Interference: Exploring the potential of a novel, tri-modal therapeutic to address complex inflammatory skin disease","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Advancements in Transdermal Drug Delivery","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Constructive; Modal; Interference (communication); Disease; Pathology; Telecommunications; Computer science","score_opus":0.12798685871901636,"score_gpt":0.434015385525252,"score_spread":0.3060285268062356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402104590","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84747344,0.024452098,0.07219964,0.0014348571,0.0011461651,0.00043714434,0.00047478275,0.00061375776,0.051768135],"genre_scores_gemma":[0.94925445,0.007069085,0.027402708,0.0011960368,0.0001442933,0.00017120814,0.00020353936,0.00004605465,0.01451268],"study_design_codex":"bench_or_experimental","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9998661,0.000024329434,0.000004310616,0.000028281644,0.00004251051,0.000034435092],"domain_scores_gemma":[0.9999492,0.000014054517,0.00001020521,0.000006265997,0.000007229617,0.00001290591],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002510034,0.00040414868,0.00025697067,0.000216756,0.00019982665,0.0004369954,0.00031787375,0.0005416674,0.004699106],"category_scores_gemma":[0.00015368793,0.00011805375,0.00030961298,0.00014009325,0.00028699086,0.00028510473,0.00036107423,0.00065565604,0.00082392845],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022994952,0.000118462165,0.00013452936,0.00015841848,0.000015300091,0.0001095714,0.000027887954,0.0004554753,0.9765636,0.001544498,0.00055905397,0.020083396],"study_design_scores_gemma":[0.00007881402,0.002355727,0.0010218719,0.000034873057,0.000067056564,0.0006967777,0.000055248987,0.004723234,0.9680655,0.0007422934,0.022135766,0.000022890514],"about_ca_topic_score_codex":0.0002057024,"about_ca_topic_score_gemma":0.00046082327,"teacher_disagreement_score":0.004699106,"about_ca_system_score_codex":0.00017262717,"about_ca_system_score_gemma":0.0002448836,"threshold_uncertainty_score":0.01572007},"labels":[],"label_agreement":null},{"id":"W4402104611","doi":"10.1016/j.jaad.2024.07.1409","title":"54512 Use of therapeutic drug monitoring to assess drug levels and antibody development in patients with Hidradenitis Suppurativa on Infliximab therapy","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"","keywords":"Medicine; Hidradenitis suppurativa; Infliximab; Drug; Therapeutic drug monitoring; Antibody therapy; Dermatology; Pharmacology; Antibody; Internal medicine; Immunology; Tumor necrosis factor alpha; Monoclonal antibody; Disease","score_opus":0.04864222974841178,"score_gpt":0.34837521496198337,"score_spread":0.2997329852135716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402104611","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98014176,0.006192577,0.00036483453,0.0005701328,0.000104506806,0.00003188688,0.0002499523,0.00002477633,0.012319532],"genre_scores_gemma":[0.9980179,0.0007162493,0.00032410424,0.00030018657,0.000085601554,0.000010258633,0.00013552098,0.0000043928526,0.00040569712],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990883,0.00029502908,0.00015418908,0.00009265839,0.0002593294,0.0001105371],"domain_scores_gemma":[0.9976987,0.0010024931,0.0006486,0.00009226499,0.00030567386,0.0002522429],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000740633,0.00042524704,0.0005914343,0.00091005,0.00043584363,0.0007008741,0.0002503321,0.0005998882,0.0015194756],"category_scores_gemma":[0.0036916814,0.00017079801,0.00045311378,0.00082150754,0.00019983276,0.00054343446,0.00018801026,0.0006921966,0.000325845],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036471355,0.00010916137,0.98102987,0.000038742994,0.000074909396,0.0012612224,0.00006268628,0.000054048483,0.0012224811,0.000032576,0.0003103144,0.015439329],"study_design_scores_gemma":[0.000035290934,0.000780964,0.98844403,0.00006756729,0.0001675891,0.006622872,0.00014569644,0.00069652346,0.0009959028,0.000045427303,0.0019866407,0.000011547789],"about_ca_topic_score_codex":0.0014000635,"about_ca_topic_score_gemma":0.0020273996,"teacher_disagreement_score":0.0015194756,"about_ca_system_score_codex":0.0003095557,"about_ca_system_score_gemma":0.00030720836,"threshold_uncertainty_score":0.0050831437},"labels":[],"label_agreement":null},{"id":"W4402104619","doi":"10.1016/j.jaad.2024.07.1366","title":"51817 Transcriptional age acceleration is associated with clinical features of atopic dermatitis and psoriasis","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McGill University; McGill University Health Centre","funders":"","keywords":"Medicine; Atopic dermatitis; Psoriasis; Dermatology","score_opus":0.028242488529244113,"score_gpt":0.34473109636894633,"score_spread":0.31648860783970223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402104619","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998211,0.00023148506,0.00022763252,0.000049916227,0.000020368849,0.0000047211242,0.00018981592,0.000016694032,0.0010483022],"genre_scores_gemma":[0.9987575,0.00008128075,0.00015803818,0.0000364724,0.000029405473,0.0000051782513,0.0002444277,0.000008403688,0.00067937194],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997743,0.000056141747,0.000025812238,0.00005508717,0.000052522955,0.000036095433],"domain_scores_gemma":[0.99904126,0.0002192808,0.00047624033,0.00005757904,0.000069114554,0.00013653345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015877785,0.00031395597,0.00034619798,0.00091263157,0.00024855905,0.00042114974,0.00021737958,0.00047795274,0.004638076],"category_scores_gemma":[0.00080086733,0.0001631836,0.00036779183,0.0006886202,0.00029012377,0.00019847619,0.00021631687,0.00045335034,0.00077424396],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045377617,0.00042227423,0.8210403,0.000092197464,0.0002142993,0.0065991716,0.0001851312,0.00018139849,0.15326369,0.000361849,0.00067756133,0.012424446],"study_design_scores_gemma":[0.00002422078,0.00020100723,0.98960423,0.000010557305,0.000054118933,0.005894986,0.00009861945,0.00038312975,0.0028092163,0.00018298811,0.0007274617,0.000009525676],"about_ca_topic_score_codex":0.0003341269,"about_ca_topic_score_gemma":0.00030874668,"teacher_disagreement_score":0.004638076,"about_ca_system_score_codex":0.00011988563,"about_ca_system_score_gemma":0.00009298247,"threshold_uncertainty_score":0.0155159235},"labels":[],"label_agreement":null},{"id":"W4402104623","doi":"10.1016/j.jaad.2024.07.1327","title":"51212 The Registry of Psoriasis Health Outcomes (RePhlect): Characteristics of Early Adopters of Deucravacitinib in the North American Region","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; University of Toronto","funders":"","keywords":"Medicine; Psoriasis; Dermatology; Early adopter; Family medicine; Marketing","score_opus":0.05337937166996482,"score_gpt":0.39190870668943495,"score_spread":0.33852933501947013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402104623","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948972,0.00011370524,0.00006440123,0.00008401916,0.000008326254,0.000021655542,0.00354355,0.0000053943327,0.0012618348],"genre_scores_gemma":[0.9958252,0.000116047064,0.00009511557,0.00014403116,0.000018539236,0.000036679976,0.002709746,0.0000076931165,0.0010468628],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993543,0.0001260831,0.00007300854,0.00014986782,0.00015590462,0.00014080657],"domain_scores_gemma":[0.9964734,0.00045538123,0.0019035826,0.00021301543,0.00031444582,0.000640205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005447561,0.00019382023,0.00028806544,0.0010706792,0.0004371356,0.0007123744,0.000468636,0.000373401,0.003957884],"category_scores_gemma":[0.0019498791,0.00025486085,0.00034119567,0.0018404243,0.00020210208,0.00062719197,0.00040149558,0.0007551087,0.00070434384],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000078457335,0.00006838701,0.9983455,0.0000050654194,0.000018770235,0.00004598074,0.000046182457,0.000014887044,0.00017508343,0.000014154228,0.00033132,0.00085620594],"study_design_scores_gemma":[0.00000899728,0.00006457501,0.99899083,0.0000060401994,0.000014597009,0.0001645371,0.00024433652,0.000058874215,0.00006069763,0.00000771998,0.00037542137,0.0000033583815],"about_ca_topic_score_codex":0.020499539,"about_ca_topic_score_gemma":0.02613379,"teacher_disagreement_score":0.020499539,"about_ca_system_score_codex":0.0004037603,"about_ca_system_score_gemma":0.0007681084,"threshold_uncertainty_score":0.040760398},"labels":[],"label_agreement":null},{"id":"W4402104966","doi":"10.1016/j.jaad.2024.07.1162","title":"53040 Rates of Viral Non-Respiratory Infections in Patients with Moderate-to-Severe Atopic Dermatitis in the US: A Retrospective Study of Administrative Claims","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Atopic dermatitis; Retrospective cohort study; Dermatology; Intensive care medicine; Internal medicine","score_opus":0.01837687608659767,"score_gpt":0.33443047607387,"score_spread":0.31605359998727234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402104966","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969311,0.0001867339,0.000072792194,0.000026701231,0.000004950417,0.0000069747584,0.0021990559,0.0000057075267,0.0005659161],"genre_scores_gemma":[0.99832135,0.00007635321,0.000039220253,0.000030031117,0.000006232418,0.000006955199,0.0013640696,0.0000024922886,0.00015337876],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99886864,0.00026197435,0.0002040299,0.00023192338,0.00025013028,0.00018331189],"domain_scores_gemma":[0.99724376,0.0004205118,0.0014157579,0.00030675167,0.0003499968,0.00026322974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006757054,0.00026710972,0.00035668744,0.001360665,0.0005611521,0.00090415776,0.00051184866,0.00047146797,0.0017861761],"category_scores_gemma":[0.0025160941,0.00045896406,0.0006349785,0.0027832175,0.00031826977,0.00071172294,0.0005853483,0.00054942555,0.00043878448],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042656775,0.000017804829,0.9994824,0.0000032177118,0.000030442336,0.000029319584,0.000029135506,0.000009768652,0.000060820166,0.000011226676,0.000070041184,0.00021306612],"study_design_scores_gemma":[0.0000023394186,0.00002757028,0.9994266,0.0000027033323,0.000014911113,0.00017112795,0.00012772597,0.000078929144,0.000033912023,0.000008085119,0.000103620674,0.0000024877986],"about_ca_topic_score_codex":0.023421848,"about_ca_topic_score_gemma":0.018881379,"teacher_disagreement_score":0.023421848,"about_ca_system_score_codex":0.0005883796,"about_ca_system_score_gemma":0.0005468274,"threshold_uncertainty_score":0.046571076},"labels":[],"label_agreement":null},{"id":"W4402104970","doi":"10.1016/j.jaad.2024.07.594","title":"54713 Burden of inpatient and emergency department care for atopic dermatitis in Canada, 2016-2021","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre; Université de Montréal","funders":"","keywords":"Medicine; Atopic dermatitis; Emergency department; Medical emergency; Emergency medicine; Dermatology; Psychiatry","score_opus":0.008543413497094105,"score_gpt":0.28418852268916833,"score_spread":0.27564510919207424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402104970","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7681431,0.010715272,0.0003866263,0.0109098945,0.0005949024,0.00028569764,0.17680593,0.00017866657,0.031979837],"genre_scores_gemma":[0.9499818,0.0073476834,0.0006148397,0.0021930763,0.00014207646,0.00008763935,0.029865628,0.000041376665,0.009725849],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99858,0.00005198529,0.000097558914,0.00011489221,0.00053365703,0.0006218642],"domain_scores_gemma":[0.99715614,0.00005389111,0.00046870223,0.00003228609,0.001384369,0.00090464856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032237874,0.00040233604,0.0005133391,0.0018711061,0.0022563708,0.0016755308,0.0013080973,0.00086516445,0.0069992933],"category_scores_gemma":[0.0020885775,0.0004331116,0.0013843173,0.005072232,0.00051086163,0.0005336237,0.0011592717,0.0019831378,0.000744655],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015528862,0.00009661327,0.94467187,0.00024293114,0.00022839318,0.0003683217,0.00030811314,0.00045069488,0.00020373582,0.0007902182,0.03919209,0.01329169],"study_design_scores_gemma":[0.000022878741,0.000020385658,0.99054104,0.0002591632,0.00006774714,0.00023880151,0.0013199177,0.0005515922,0.000051410392,0.00006977505,0.006837447,0.000019872541],"about_ca_topic_score_codex":0.9973863,"about_ca_topic_score_gemma":0.9985713,"teacher_disagreement_score":0.051332552,"about_ca_system_score_codex":0.051332552,"about_ca_system_score_gemma":0.08663203,"threshold_uncertainty_score":0.37244546},"labels":[],"label_agreement":null},{"id":"W4402104975","doi":"10.1016/j.jaad.2024.07.1116","title":"53863 Pooled efficacy, patient-reported outcomes, and safety of roflumilast cream 0.15% from the INTEGUMENT-1 and INTEGUMENT-2 phase 3 clinical trials of adults and children with atopic dermatitis","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Probity Medical Research; University of Calgary","funders":"","keywords":"Medicine; Integument; Atopic dermatitis; Roflumilast; Dermatology; Diaper Dermatitis; Internal medicine; Anatomy","score_opus":0.022811265429784778,"score_gpt":0.36470050138844995,"score_spread":0.34188923595866516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402104975","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9064578,0.07554583,0.0011861437,0.0008876422,0.000688709,0.0019335246,0.0080653615,0.00013567034,0.0050992956],"genre_scores_gemma":[0.9790948,0.011684027,0.00076679327,0.0009576428,0.00043607355,0.001285292,0.0039507914,0.000022853545,0.0018018011],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99731797,0.0016816118,0.0003572176,0.00023763847,0.00020304925,0.00020240813],"domain_scores_gemma":[0.99796814,0.0009054418,0.0006111674,0.00016793501,0.0001650049,0.00018227262],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0066494416,0.0012682206,0.0034814568,0.00062233757,0.0002575731,0.0012366793,0.0005488524,0.0009798113,0.00381511],"category_scores_gemma":[0.0037397542,0.0005218516,0.0065430487,0.00061921956,0.00049267354,0.0009415702,0.0004835791,0.0018015363,0.0005404457],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8902783,0.0013028604,0.007400199,0.003906107,0.044973414,0.0001155942,0.00007844712,0.0012418265,0.004700433,0.00016041045,0.0036096883,0.042232733],"study_design_scores_gemma":[0.8104142,0.07265459,0.052953765,0.00063230156,0.05504582,0.0003380063,0.00010788196,0.0012120631,0.0017715282,0.00035267128,0.004436711,0.0000804655],"about_ca_topic_score_codex":0.0009280506,"about_ca_topic_score_gemma":0.0029680808,"teacher_disagreement_score":0.0066494416,"about_ca_system_score_codex":0.0005573401,"about_ca_system_score_gemma":0.0008045369,"threshold_uncertainty_score":0.035165966},"labels":[],"label_agreement":null},{"id":"W4402105003","doi":"10.1016/j.jaad.2024.07.1331","title":"54537 The Risk of Infections with Janus Kinase Inhibitor Treatment for Atopic Dermatitis: A Systematic Review and Meta-Analysis","year":2024,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; University of Toronto","funders":"","keywords":"Medicine; Atopic dermatitis; Meta-analysis; Dermatology; Janus kinase inhibitor; Janus kinase; Skin barrier; Tofacitinib; MEDLINE; Immunology; Internal medicine","score_opus":0.04704565825114223,"score_gpt":0.3731078876161815,"score_spread":0.3260622293650393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402105003","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008285823,0.99021953,0.00037014516,0.00011916018,0.00016418265,0.00013022023,0.00045239404,0.000024437246,0.00023422703],"genre_scores_gemma":[0.27728322,0.7175077,0.0018686984,0.001341285,0.00034558083,0.00038872004,0.00061155827,0.000036825444,0.00061633775],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9964295,0.0013239204,0.0011330401,0.0005292534,0.00038864822,0.00019556175],"domain_scores_gemma":[0.9923494,0.005211947,0.0016255585,0.00024750346,0.0004342117,0.00013143958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004808404,0.0021367355,0.012034687,0.002728878,0.00048355904,0.0022076366,0.0016517855,0.002192443,0.006063833],"category_scores_gemma":[0.01321399,0.0015419965,0.029343273,0.0035938998,0.0006346684,0.0014258864,0.001402328,0.0020016027,0.00045750753],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033286677,0.00004594268,0.00680041,0.30779272,0.6679187,0.00020250631,0.000096942844,0.00031260648,0.00037992428,0.000091358794,0.0007800962,0.012250147],"study_design_scores_gemma":[0.0009197925,0.00020144631,0.0050509362,0.012531913,0.9797545,0.00009736412,0.00004535173,0.00011911692,0.00007388094,0.00008133106,0.0010977255,0.00002656393],"about_ca_topic_score_codex":0.0056662373,"about_ca_topic_score_gemma":0.01740888,"teacher_disagreement_score":0.012034687,"about_ca_system_score_codex":0.0011481171,"about_ca_system_score_gemma":0.0018086642,"threshold_uncertainty_score":0.025429606},"labels":[],"label_agreement":null},{"id":"W4402105014","doi":"10.1016/j.jaad.2024.07.1085","title":"54058 Pain, satisfaction and quality of life associated with field therapies for actinic keratosis: A systematic review","year":2024,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Actinic keratosis; Dermatology; Quality of life (healthcare); Internal medicine; Nursing","score_opus":0.06985654210927213,"score_gpt":0.4082809456219078,"score_spread":0.3384244035126357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402105014","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0034250445,0.9951507,0.0001109744,0.00012852241,0.00010227664,0.00025221947,0.0005731618,0.000009329225,0.0002477155],"genre_scores_gemma":[0.06464361,0.93262213,0.0007189997,0.0007986638,0.00009874077,0.0005498622,0.0003047405,0.0000089033465,0.0002543115],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9963832,0.0012760368,0.0013325763,0.00037102646,0.00048046387,0.00015667503],"domain_scores_gemma":[0.9892117,0.0074560056,0.002450297,0.00016404699,0.00054551434,0.00017241397],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004215922,0.0012985088,0.008082559,0.0048536435,0.00055732415,0.0023840328,0.0011326008,0.0017480447,0.008346348],"category_scores_gemma":[0.020384094,0.0010931419,0.012390154,0.006215867,0.00083483564,0.0015271853,0.0018237457,0.0016213793,0.00037607786],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005483355,0.000031415493,0.0028978758,0.91481394,0.06382297,0.00008602833,0.00014958277,0.00008192497,0.00013198292,0.000109917084,0.0009892533,0.016336806],"study_design_scores_gemma":[0.0020918036,0.00049080356,0.021381509,0.43314135,0.530828,0.00034405375,0.00048474167,0.00015873867,0.00013418455,0.00026379465,0.010593004,0.000088138295],"about_ca_topic_score_codex":0.013954091,"about_ca_topic_score_gemma":0.052470587,"teacher_disagreement_score":0.013954091,"about_ca_system_score_codex":0.0025298777,"about_ca_system_score_gemma":0.004565793,"threshold_uncertainty_score":0.027921319},"labels":[],"label_agreement":null},{"id":"W4402105023","doi":"10.1016/j.jaad.2024.07.1239","title":"54567 Skin Cancer Among People with Intellectual Disabilities: a Scoping Review and Recommendations for More Effective Detection and Prevention","year":2024,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"","keywords":"Medicine; Skin cancer; Cancer; Family medicine; Gerontology; Internal medicine","score_opus":0.027674305271962848,"score_gpt":0.3923719759012265,"score_spread":0.36469767062926367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402105023","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008852187,0.9990194,0.000046978428,0.00033704969,0.00014487289,0.00005769684,0.00009469327,0.0000039332413,0.00020691058],"genre_scores_gemma":[0.000769875,0.9984225,0.00022707727,0.00032419144,0.000040145787,0.000049404283,0.00005520952,0.00000116406,0.00011038603],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99727964,0.0007244269,0.0010486317,0.00021227686,0.0005969288,0.00013805955],"domain_scores_gemma":[0.9918767,0.004633356,0.0020140035,0.000102666316,0.0011928387,0.00018043623],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006686634,0.001385276,0.0056552277,0.009912799,0.00063055253,0.002991833,0.0014799146,0.0024173993,0.0076796017],"category_scores_gemma":[0.013692504,0.0009943272,0.0051173377,0.0076968665,0.0006514557,0.0022500975,0.0019059179,0.0017475229,0.0007681495],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014970437,0.000053503045,0.00062982505,0.71651286,0.003390089,0.000131504,0.00020982859,0.00017476962,0.00033390935,0.00060854113,0.012199911,0.2656055],"study_design_scores_gemma":[0.00011722463,0.000099878154,0.0020256736,0.8944761,0.016933767,0.00026145438,0.0002619111,0.00008413392,0.00013330397,0.000407505,0.08516722,0.000031853822],"about_ca_topic_score_codex":0.020323452,"about_ca_topic_score_gemma":0.051568918,"teacher_disagreement_score":0.020323452,"about_ca_system_score_codex":0.0030005947,"about_ca_system_score_gemma":0.011156822,"threshold_uncertainty_score":0.04041034},"labels":[],"label_agreement":null},{"id":"W4402105816","doi":"10.1016/j.jaad.2024.07.968","title":"51537 Investigation of the Microbiome in Scalp Biopsies of Different Forms of Alopecia","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Scalp; Microbiome; Dermatology; Scarring alopecia; Pathology; Bioinformatics; Biology","score_opus":0.01108761999586649,"score_gpt":0.2813763004956241,"score_spread":0.2702886804997576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402105816","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960055,0.00085851486,0.00036750402,0.0000584546,0.00002513564,0.000049683924,0.00028919926,0.00001058934,0.0023353926],"genre_scores_gemma":[0.9972639,0.0005749654,0.0009174647,0.00013741596,0.000021506687,0.00002512802,0.000364193,0.000009373953,0.0006859151],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997049,0.00006678804,0.000021964242,0.00004790601,0.0000908358,0.00006758872],"domain_scores_gemma":[0.9998016,0.000038439834,0.000033875447,0.000012967215,0.00005954382,0.00005362203],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002029974,0.00023551367,0.00018553862,0.0010197943,0.0005164896,0.0004420204,0.000111782414,0.0003851213,0.001896557],"category_scores_gemma":[0.0005333887,0.00016547139,0.00020086966,0.00040373855,0.00021996448,0.00023263782,0.00031334537,0.00024678212,0.0003597941],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017949779,0.0003020383,0.5173115,0.0002173294,0.00015472223,0.017700315,0.0015691755,0.000087807086,0.43272558,0.00014949341,0.0007172004,0.027269876],"study_design_scores_gemma":[0.00002891851,0.0007137977,0.9448194,0.00007846119,0.000111669935,0.023359999,0.0030002175,0.00042789464,0.023413911,0.00009893087,0.0039339997,0.000012833576],"about_ca_topic_score_codex":0.0013988261,"about_ca_topic_score_gemma":0.002545248,"teacher_disagreement_score":0.001896557,"about_ca_system_score_codex":0.00015907669,"about_ca_system_score_gemma":0.00016386375,"threshold_uncertainty_score":0.0063446164},"labels":[],"label_agreement":null},{"id":"W4402105952","doi":"10.1016/j.jaad.2024.07.429","title":"54309 A multicenter, intra-individual (left-right arm), randomized-controlled trial evaluating the safety and efficacy of using a dermocosmetic emollient versus a topical antimicrobial as adjunctive therapies for post-procedural wounds in dermatology","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Wound Healing and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal College of Physicians and Surgeons of Canada; Lynde Centre for Dermatology; University of Toronto","funders":"","keywords":"Medicine; Randomized controlled trial; Surgery; Clinical trial; Internal medicine","score_opus":0.03224445306673461,"score_gpt":0.3805770676272638,"score_spread":0.34833261456052916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402105952","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9853081,0.004067257,0.0012548678,0.0007506097,0.0010525458,0.0036579228,0.0010569384,0.00012358329,0.0027282452],"genre_scores_gemma":[0.9869486,0.001454643,0.002671966,0.0014018946,0.000857629,0.0031526226,0.0007312615,0.000028321912,0.0027530554],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9979152,0.0012889605,0.00014659409,0.00036988765,0.000084840125,0.00019450403],"domain_scores_gemma":[0.99820507,0.0007695282,0.00036695597,0.0001769871,0.00012348082,0.0003578806],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002557931,0.0015418909,0.003831497,0.00037487244,0.0006293584,0.00116238,0.0007520141,0.0023714213,0.011381318],"category_scores_gemma":[0.0032709672,0.0007964506,0.0021612963,0.000451438,0.0014165875,0.0012929364,0.00048120803,0.00300444,0.0013570756],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9923759,0.0023759124,0.0002690589,0.00022778507,0.00061002385,0.000013276396,0.000013722938,0.00006725548,0.001173493,0.000059574264,0.00022967038,0.0025841517],"study_design_scores_gemma":[0.9541287,0.043812774,0.000974633,0.000024633993,0.0004946633,0.00000962942,0.000010946906,0.00016548003,0.00014218819,0.00006348348,0.00016327317,0.000009519676],"about_ca_topic_score_codex":0.0008666629,"about_ca_topic_score_gemma":0.001865204,"teacher_disagreement_score":0.011381318,"about_ca_system_score_codex":0.00054250495,"about_ca_system_score_gemma":0.0009512664,"threshold_uncertainty_score":0.038074315},"labels":[],"label_agreement":null},{"id":"W4402106003","doi":"10.1016/j.jaad.2024.07.1308","title":"51752 The global prevalence and incidence of cutaneous malignancy following renal transplant in adults: A systematic review and meta-analysis","year":2024,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; University of Ottawa; Dalhousie University","funders":"","keywords":"Medicine; Incidence (geometry); Renal transplant; Meta-analysis; Malignancy; Systematic review; Dermatology; MEDLINE; Internal medicine; Transplantation","score_opus":0.032792210901837766,"score_gpt":0.36751311288019767,"score_spread":0.3347209019783599,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402106003","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0060140346,0.9923292,0.00030712067,0.00010827678,0.00012737904,0.00012545015,0.00072518515,0.000017142758,0.0002462774],"genre_scores_gemma":[0.1387236,0.85723716,0.0013284384,0.00095283985,0.00021039385,0.00036579368,0.00070702634,0.000021878677,0.0004528832],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9968286,0.00096780487,0.0012285569,0.00048007697,0.000355016,0.00013978124],"domain_scores_gemma":[0.9935673,0.004373745,0.0012893243,0.00022561298,0.000438066,0.000105828025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041737864,0.0016547013,0.009039024,0.0036513691,0.0004572874,0.0020405,0.001309809,0.0016498144,0.0056170686],"category_scores_gemma":[0.014290241,0.0013416741,0.023784772,0.0052025844,0.0005376937,0.0014257602,0.0013516035,0.0015365792,0.0005071558],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014088542,0.00003358918,0.011872956,0.45448616,0.5147555,0.00016210887,0.000111075984,0.00026818222,0.0002820577,0.00009672913,0.0010242553,0.0154985655],"study_design_scores_gemma":[0.00055521395,0.0001456961,0.008987037,0.024719855,0.96311206,0.00013576525,0.00006606027,0.000081140526,0.00008438357,0.00009816618,0.001983908,0.000030740863],"about_ca_topic_score_codex":0.00812107,"about_ca_topic_score_gemma":0.02566932,"teacher_disagreement_score":0.009039024,"about_ca_system_score_codex":0.0012035439,"about_ca_system_score_gemma":0.0021487654,"threshold_uncertainty_score":0.022073328},"labels":[],"label_agreement":null},{"id":"W4402106351","doi":"10.1016/j.jaad.2024.07.823","title":"50982 Evaluating the Clinical Utility of Sulfasalazine in the Treatment of Pyoderma Gangrenosum: A Systematic Review","year":2024,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Autoimmune and Inflammatory Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Women's College Hospital; University of Toronto","funders":"","keywords":"Medicine; Pyoderma gangrenosum; Sulfasalazine; Dermatology; Intensive care medicine; Surgery; Pathology; Disease; Ulcerative colitis","score_opus":0.1463473353979281,"score_gpt":0.49856003552134986,"score_spread":0.35221270012342176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402106351","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011165686,0.99790025,0.000113670474,0.00010659814,0.000113913884,0.00018426309,0.0002526025,0.000007798659,0.00020432293],"genre_scores_gemma":[0.011333192,0.98738086,0.00031590817,0.00045918452,0.000071377784,0.00012595378,0.00016287572,0.000004005414,0.00014673172],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99796826,0.0006240772,0.00075717753,0.00021069519,0.00034801892,0.00009175984],"domain_scores_gemma":[0.9934423,0.0044829133,0.0013779779,0.00008625719,0.00049154874,0.00011896104],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032593096,0.001295715,0.008136221,0.0038499392,0.00045002246,0.0018774279,0.0016376831,0.0016204525,0.006393084],"category_scores_gemma":[0.011790982,0.0007620582,0.008631671,0.0044582733,0.00069678057,0.001396818,0.0011360743,0.0012165838,0.00046959272],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010284899,0.000033614604,0.00060905324,0.93231833,0.027025528,0.000114544506,0.000084741965,0.00012360599,0.00037838044,0.00011661036,0.0015316169,0.03663551],"study_design_scores_gemma":[0.0029457752,0.0008422644,0.0063599623,0.516288,0.45149988,0.0004211037,0.00022884064,0.00019178615,0.00039456887,0.00028998146,0.020452587,0.00008527619],"about_ca_topic_score_codex":0.008888797,"about_ca_topic_score_gemma":0.027452888,"teacher_disagreement_score":0.008888797,"about_ca_system_score_codex":0.0017342113,"about_ca_system_score_gemma":0.0043582874,"threshold_uncertainty_score":0.021386981},"labels":[],"label_agreement":null},{"id":"W4402106390","doi":"10.1016/j.jaad.2024.07.1131","title":"50376 Prevalence and Clinical Correlates of Apathy in Psoriatic Disease","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Hereditary Neurological Disorders","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Alberta","funders":"","keywords":"Medicine; Apathy; Dermatology; Epidemiology; Disease; Internal medicine","score_opus":0.030915832111147123,"score_gpt":0.34577194889930857,"score_spread":0.31485611678816144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402106390","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99815327,0.0003014035,0.000028034918,0.00003081389,0.000004845429,0.00000495529,0.00016223562,0.0000030459762,0.0013114314],"genre_scores_gemma":[0.99962616,0.000086066124,0.000029970908,0.000012420151,0.000010020058,0.000002348009,0.00009612997,9.0004136e-7,0.00013591204],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99961084,0.00008232506,0.000068707144,0.00006259922,0.00010998056,0.000065517685],"domain_scores_gemma":[0.9985091,0.00027301503,0.00069100445,0.000050852756,0.00019499952,0.00028099163],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026124634,0.00022416808,0.00028942674,0.0018756177,0.0006285,0.0007533492,0.00028333472,0.00045888446,0.0047559673],"category_scores_gemma":[0.0024383236,0.00024899264,0.00022201063,0.0015245025,0.00033397437,0.00051062426,0.00045066688,0.00042306428,0.00057174684],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011021994,0.000049818507,0.9976801,0.00000804221,0.000016546293,0.00029752144,0.000052289368,0.00000938555,0.0004449762,0.000013975364,0.000045287867,0.0012718199],"study_design_scores_gemma":[0.0000032764165,0.000057241836,0.99823844,0.0000037466416,0.000008817317,0.0013744718,0.00015571553,0.000042097337,0.000034654226,0.000018722136,0.000060297913,0.0000023938428],"about_ca_topic_score_codex":0.0029257038,"about_ca_topic_score_gemma":0.0030598466,"teacher_disagreement_score":0.0047559673,"about_ca_system_score_codex":0.00020513692,"about_ca_system_score_gemma":0.00022118914,"threshold_uncertainty_score":0.015910327},"labels":[],"label_agreement":null},{"id":"W4402106411","doi":"10.1016/j.jaad.2024.07.1002","title":"52018 Low-dose oral isotretinoin therapy for rosacea: a systematic review and meta-analysis","year":2024,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Rosacea; Isotretinoin; Meta-analysis; Dermatology; Internal medicine; Acne","score_opus":0.07966789602694534,"score_gpt":0.4251194182027884,"score_spread":0.3454515221758431,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402106411","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004516868,0.99389404,0.00033448148,0.00013581135,0.00015398985,0.0002775142,0.00038734963,0.00002233304,0.00027763812],"genre_scores_gemma":[0.13478218,0.85967475,0.0018060533,0.0014107035,0.00020026306,0.0007013623,0.0005938218,0.00002991041,0.00080096064],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9969313,0.001076551,0.0010465973,0.00040330552,0.00035708013,0.00018505297],"domain_scores_gemma":[0.99579924,0.002510354,0.0010875266,0.00014861012,0.00033838395,0.000115794195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004959324,0.002381281,0.015284844,0.0035026113,0.0005821835,0.0025997618,0.0018051484,0.0023587572,0.007892925],"category_scores_gemma":[0.011318657,0.0013888282,0.02342488,0.0043056346,0.0006808615,0.0019418242,0.001629924,0.0021343792,0.0006215548],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033268535,0.000056683184,0.0021237026,0.5344022,0.44343737,0.00016068178,0.00011547655,0.00024485303,0.00042505583,0.000106138454,0.0008681423,0.014732845],"study_design_scores_gemma":[0.0016898419,0.00024383634,0.0028249181,0.026058037,0.96673,0.00008856993,0.00006149129,0.00008262793,0.00009663574,0.000106563624,0.0019871688,0.000030305531],"about_ca_topic_score_codex":0.0068678875,"about_ca_topic_score_gemma":0.026549578,"teacher_disagreement_score":0.015284844,"about_ca_system_score_codex":0.0018326507,"about_ca_system_score_gemma":0.0026616089,"threshold_uncertainty_score":0.0264045},"labels":[],"label_agreement":null},{"id":"W4402106544","doi":"10.1016/j.jaad.2024.07.549","title":"50526 Association of Vitiligo and Mental Health Outcomes: A Systematic Review and Meta-Analysis","year":2024,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"melanin and skin pigmentation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hamilton Health Sciences; Memorial University of Newfoundland","funders":"","keywords":"Medicine; Vitiligo; Meta-analysis; Association (psychology); Systematic review; Mental health; MEDLINE; Psychiatry; Dermatology; Internal medicine; Psychotherapist","score_opus":0.03538537526780097,"score_gpt":0.39384626106678344,"score_spread":0.3584608857989825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402106544","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004728737,0.9939121,0.0002937047,0.00013290539,0.000110754074,0.00013051974,0.0004985616,0.000019135045,0.00017355387],"genre_scores_gemma":[0.14574018,0.84917873,0.0019262168,0.0011557097,0.00026633925,0.0004717733,0.0007367979,0.000023109222,0.00050117815],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9975255,0.0008768421,0.0007726947,0.00038623222,0.00028277977,0.00015593857],"domain_scores_gemma":[0.9935169,0.004486633,0.0012770245,0.00020985644,0.00039151308,0.00011810878],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0048608924,0.0019976252,0.011840963,0.0030782833,0.00047784814,0.0021281394,0.0018006465,0.0020757872,0.0064343093],"category_scores_gemma":[0.012966675,0.0013393456,0.020799158,0.004511919,0.0005773908,0.001283926,0.0016026258,0.0014871527,0.00045064517],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020562292,0.000060636696,0.007941344,0.43135965,0.5365602,0.00021547636,0.000105872656,0.00034642394,0.00036502234,0.00014325936,0.0012379414,0.019607918],"study_design_scores_gemma":[0.0008873687,0.00017777974,0.006965688,0.019833846,0.9695207,0.00011654967,0.000052040992,0.00011675726,0.00007423469,0.00012562523,0.002096381,0.00003306429],"about_ca_topic_score_codex":0.007225841,"about_ca_topic_score_gemma":0.02503458,"teacher_disagreement_score":0.011840963,"about_ca_system_score_codex":0.0012234034,"about_ca_system_score_gemma":0.0025137211,"threshold_uncertainty_score":0.025707185},"labels":[],"label_agreement":null},{"id":"W4402106691","doi":"10.1016/j.jaad.2024.07.1011","title":"54168 Maximum-Use Trials of Ruxolitinib Cream in Adults, Adolescents, and Children Aged 2 to <12 Years With Atopic Dermatitis: Consistency of Safety, Pharmacokinetics, and Efficacy","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Transgenic Plants and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"","keywords":"Medicine; Atopic dermatitis; Ruxolitinib; Consistency (knowledge bases); Pharmacokinetics; Dermatology; Internal medicine","score_opus":0.012463370692972313,"score_gpt":0.2874595545873586,"score_spread":0.2749961838943863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402106691","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9807482,0.01147964,0.0003989995,0.00059725,0.0002427113,0.0008987409,0.001750447,0.00006304106,0.0038210202],"genre_scores_gemma":[0.99246573,0.0027170111,0.0006429098,0.0004324192,0.00016918608,0.0006321602,0.0010878274,0.000016908323,0.0018357779],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9986014,0.00086116215,0.00012549154,0.00013824068,0.00013476405,0.00013900586],"domain_scores_gemma":[0.9989569,0.0003898286,0.00024448836,0.00010184156,0.00012044478,0.00018649874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002560603,0.00071201124,0.001713899,0.000312056,0.00040219413,0.00073094066,0.00051350845,0.0010582166,0.005507357],"category_scores_gemma":[0.002625431,0.0004060318,0.0014807816,0.00026734054,0.0004107395,0.0009806326,0.0003562273,0.0020775876,0.00088333496],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.79547435,0.011213161,0.01553547,0.0013707752,0.004735712,0.00016140376,0.00028380268,0.00071413576,0.013981054,0.00034605036,0.004687467,0.15149659],"study_design_scores_gemma":[0.5736448,0.32891062,0.0741238,0.00042630365,0.0029615844,0.0005350775,0.0002515345,0.0009827822,0.005464662,0.00042410905,0.012197468,0.0000771601],"about_ca_topic_score_codex":0.00066473614,"about_ca_topic_score_gemma":0.002675533,"teacher_disagreement_score":0.005507357,"about_ca_system_score_codex":0.0005433207,"about_ca_system_score_gemma":0.00043487854,"threshold_uncertainty_score":0.018423915},"labels":[],"label_agreement":null},{"id":"W4402106693","doi":"10.1016/j.jaad.2024.07.773","title":"53652 Efficacy and safety of eblasakimab in adults with severe atopic dermatitis: a posthoc analysis of the Phase 2b TREK-AD trial","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; SKiN Health; Queen's University","funders":"","keywords":"Medicine; Atopic dermatitis; Dermatology","score_opus":0.009311971219199354,"score_gpt":0.3112447132870322,"score_spread":0.3019327420678328,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402106693","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930392,0.003144418,0.00035791498,0.0002087882,0.00011232877,0.00047630156,0.0011441931,0.00005088395,0.0014660268],"genre_scores_gemma":[0.9956065,0.0008959004,0.00036734613,0.00030456428,0.00015116764,0.00041046503,0.00087007973,0.000017665643,0.0013763156],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9987179,0.00073176075,0.00007799637,0.00016671579,0.000105914834,0.00019964803],"domain_scores_gemma":[0.99911803,0.00032865079,0.00021182715,0.000104591876,0.000065386164,0.00017143963],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002217375,0.0009836156,0.002470628,0.00025196056,0.00031425696,0.00085579144,0.00036174417,0.0006980637,0.004354087],"category_scores_gemma":[0.0016356426,0.000324391,0.0020025966,0.00031748397,0.0004725199,0.0008197587,0.00027803495,0.0018593674,0.00073080976],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.95897114,0.002909486,0.00314078,0.0003262901,0.002137361,0.000058639445,0.00004187812,0.00044002474,0.005164417,0.000077621844,0.00077704096,0.025955228],"study_design_scores_gemma":[0.74236417,0.20242813,0.044667866,0.00007740337,0.0039887754,0.00019561821,0.00006851917,0.0010809556,0.0024618804,0.0002832167,0.0023310895,0.00005229962],"about_ca_topic_score_codex":0.00041458773,"about_ca_topic_score_gemma":0.0009771967,"teacher_disagreement_score":0.004354087,"about_ca_system_score_codex":0.00044828502,"about_ca_system_score_gemma":0.0006888342,"threshold_uncertainty_score":0.014565885},"labels":[],"label_agreement":null},{"id":"W4402106714","doi":"10.1016/j.jaad.2024.07.1217","title":"51652 Safety and efficacy of risankizumab in adult patients with moderate to severe plaque psoriasis with non-pustular palmoplantar involvement: change in DLQI and achievement of DLQI 0/1 results from the Phase 3b IMMprint trial","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"","keywords":"Medicine; Dermatology","score_opus":0.014224999667186742,"score_gpt":0.26278382014051127,"score_spread":0.24855882047332453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402106714","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98549366,0.0069868024,0.00029205502,0.0008236066,0.0002832876,0.00037699565,0.0013947403,0.00015968322,0.004189184],"genre_scores_gemma":[0.99291176,0.0015623678,0.0002850226,0.0012270911,0.00021854547,0.00021746663,0.0015202191,0.000015796617,0.0020417874],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99962044,0.00015767111,0.000028218448,0.000057624955,0.00005210928,0.00008389884],"domain_scores_gemma":[0.99960226,0.000091957154,0.00011219359,0.000029210116,0.000033084754,0.00013118285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011194657,0.00082077837,0.0016107722,0.00022382489,0.00026268876,0.0009681295,0.00038789448,0.001040482,0.0029683837],"category_scores_gemma":[0.0008190235,0.00039348478,0.0014579848,0.00022959031,0.0004763862,0.0005753932,0.00020733003,0.0020962728,0.0011289079],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8218602,0.006985857,0.019455401,0.0011058508,0.0030142055,0.00032582428,0.00014051607,0.0019075379,0.018601527,0.00047558217,0.008803752,0.117323734],"study_design_scores_gemma":[0.72733295,0.19376014,0.06458212,0.00013031339,0.0018361763,0.00070825405,0.00009164514,0.0023206903,0.0024886348,0.0005114583,0.0061550555,0.00008261071],"about_ca_topic_score_codex":0.00045480795,"about_ca_topic_score_gemma":0.0010650925,"teacher_disagreement_score":0.0029683837,"about_ca_system_score_codex":0.0004711919,"about_ca_system_score_gemma":0.00052626483,"threshold_uncertainty_score":0.009930193},"labels":[],"label_agreement":null},{"id":"W4402106721","doi":"10.1016/j.jaad.2024.07.657","title":"50250 Comparing the Effect of Risankizumab versus Apremilast on Psoriasis Symptoms, Treatment Satisfaction, and Health-Related Quality of Life from the Phase 4 IMMpulse Study","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Probity Medical Research; Dermatrials Research","funders":"","keywords":"Apremilast; Medicine; Psoriasis; Quality of life (healthcare); Dermatology; Nursing","score_opus":0.04434144673981586,"score_gpt":0.35219063475214474,"score_spread":0.30784918801232886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402106721","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896046,0.004050533,0.00039207493,0.00041300736,0.00029137285,0.0007165728,0.0020816303,0.000056741334,0.002393514],"genre_scores_gemma":[0.9919552,0.0012685877,0.0008347453,0.00084900606,0.0003931183,0.0005679394,0.0024342078,0.000021168778,0.0016760903],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99890995,0.0006539182,0.000061653715,0.00013432727,0.000109968765,0.00013019769],"domain_scores_gemma":[0.99888366,0.0005337193,0.00018419331,0.00009933565,0.000061517596,0.00023754078],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027310096,0.0010362624,0.0020290667,0.00029897032,0.0003232882,0.00088128657,0.000735,0.0012563923,0.0056908266],"category_scores_gemma":[0.0016848504,0.00052245264,0.0035391976,0.00030370825,0.00070875697,0.00071625726,0.00040443696,0.00303081,0.00087509747],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9572875,0.007331452,0.0018405367,0.00035933434,0.0024508648,0.000034853183,0.00003059245,0.0006048678,0.0048378445,0.000101373276,0.0010370079,0.024083598],"study_design_scores_gemma":[0.6603168,0.31514782,0.01722545,0.000050577175,0.0029765689,0.000085035674,0.000044476223,0.0010113362,0.0017778472,0.00021213866,0.0011147734,0.000037062633],"about_ca_topic_score_codex":0.0007123645,"about_ca_topic_score_gemma":0.001360071,"teacher_disagreement_score":0.0056908266,"about_ca_system_score_codex":0.00055493036,"about_ca_system_score_gemma":0.0005422904,"threshold_uncertainty_score":0.019037664},"labels":[],"label_agreement":null},{"id":"W4402106759","doi":"10.1016/j.jaad.2024.07.743","title":"53693 Dupilumab Improves Emotional Burden in Patients with Chronic Spontaneous Urticaria Uncontrolled by H1 Antihistamines","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Urticaria and Related Conditions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Dupilumab; Medicine; Dermatology; Chronic urticaria; Atopic dermatitis","score_opus":0.0033415541142787063,"score_gpt":0.23894912492533577,"score_spread":0.23560757081105707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402106759","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887171,0.0060264915,0.00014345685,0.0005430739,0.00014863504,0.00004968528,0.00011838674,0.000041315732,0.004211874],"genre_scores_gemma":[0.99764305,0.0011520823,0.00014288012,0.00026789666,0.00007689258,0.000018328325,0.000100755424,0.000002728287,0.00059523707],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9999058,0.0000311009,0.000007821506,0.000007917825,0.000014419425,0.00003289662],"domain_scores_gemma":[0.9998921,0.000026749141,0.000026407595,0.0000049223627,0.000013022996,0.00003672739],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018131176,0.00027959744,0.00041353327,0.00010268611,0.00022388954,0.00023814471,0.00013038257,0.00013173437,0.0020442505],"category_scores_gemma":[0.00040263988,0.000069976784,0.0002990607,0.00009429217,0.000084855856,0.00016868894,0.00013478388,0.00041459248,0.00021410729],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.052979868,0.006990049,0.094436385,0.0016176264,0.0021415153,0.0027796514,0.00032241858,0.0008364079,0.042660546,0.000256785,0.012312363,0.7826663],"study_design_scores_gemma":[0.016506612,0.040259816,0.9066953,0.0003075252,0.0018277124,0.006485478,0.0006689744,0.0040616025,0.0050410544,0.00038856536,0.017697804,0.00005962839],"about_ca_topic_score_codex":0.00064427604,"about_ca_topic_score_gemma":0.002496539,"teacher_disagreement_score":0.0020442505,"about_ca_system_score_codex":0.00016776276,"about_ca_system_score_gemma":0.00016107697,"threshold_uncertainty_score":0.006838739},"labels":[],"label_agreement":null},{"id":"W4402106889","doi":"10.1016/j.jaad.2024.07.605","title":"54148 Characteristics of Real-world Patients With Psoriasis Prescribed Guselkumab or Interleukin-17 Inhibitors: Data From the Psoriasis Longitudinal Assessment and Registry (PSOLAR)","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Psoriasis; Dermatology; Interleukin 17; Interleukin; Longitudinal data; Internal medicine; Immunology; Cytokine; Data mining","score_opus":0.032508828523076315,"score_gpt":0.3090880432453111,"score_spread":0.2765792147222348,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402106889","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98970246,0.00031669566,0.00014423778,0.0000526537,0.000010891423,0.000022041646,0.008925556,0.000010629885,0.0008148867],"genre_scores_gemma":[0.9898375,0.00015469691,0.00012060176,0.00012048003,0.00002374076,0.00005529719,0.009187582,0.000008795198,0.00049132196],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99944836,0.00011056417,0.00008958439,0.00017130768,0.00007883984,0.00010127426],"domain_scores_gemma":[0.9985869,0.00023356215,0.0007445042,0.00011974872,0.000115342686,0.00019996671],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003544242,0.00024922966,0.0005386791,0.00092534866,0.0003378367,0.0005524397,0.00036804486,0.0005128828,0.0036803617],"category_scores_gemma":[0.0014648527,0.0002863087,0.00039802596,0.0019791743,0.00021525152,0.00058109604,0.00031838755,0.0004920911,0.000995056],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030079522,0.000056404995,0.99781895,0.000016258771,0.00005248671,0.00008711991,0.000037558064,0.00003689786,0.00018442316,0.000017069737,0.0004948949,0.0008971458],"study_design_scores_gemma":[0.00003359318,0.00013377827,0.99859065,0.0000056511985,0.000027747845,0.0003485932,0.00012642282,0.00009424361,0.000038407707,0.00001289264,0.00058201986,0.0000059648437],"about_ca_topic_score_codex":0.004438356,"about_ca_topic_score_gemma":0.0030150786,"teacher_disagreement_score":0.004438356,"about_ca_system_score_codex":0.00034739778,"about_ca_system_score_gemma":0.00029190417,"threshold_uncertainty_score":0.012311995},"labels":[],"label_agreement":null},{"id":"W4402106923","doi":"10.1016/j.jaad.2024.07.927","title":"51876 Impact of Long-Term Abrocitinib Treatment on Patient-Reported Outcomes and Quality of Life for Approximately 2 Years in Patients With Moderate-to-Severe Atopic Dermatitis: An Interim Analysis of JADE EXTEND, a Long-Term Extension Study","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; SKiN Health; Queen's University","funders":"","keywords":"Medicine; Atopic dermatitis; JADE (particle detector); Quality of life (healthcare); Interim analysis; Interim; Term (time); Dermatology; Surgery; Randomized controlled trial; Nursing","score_opus":0.0404592709399291,"score_gpt":0.3844992124744943,"score_spread":0.3440399415345652,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402106923","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929073,0.004399459,0.00017716136,0.00012295683,0.00006937223,0.00008285581,0.0013611781,0.000014682929,0.0008649897],"genre_scores_gemma":[0.99515015,0.00081747986,0.0002017368,0.00024580097,0.00009709864,0.0001381767,0.0026486625,0.000005572251,0.00069546606],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99877244,0.00051961775,0.00011234243,0.00016985834,0.00017419877,0.0002514366],"domain_scores_gemma":[0.99799216,0.0005540131,0.00066847843,0.00027985664,0.00017312501,0.0003323472],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003518537,0.0006906396,0.0020520692,0.00034378062,0.0004298585,0.0013757083,0.0005109948,0.0007078103,0.0018760407],"category_scores_gemma":[0.002286515,0.00024958042,0.0046811183,0.0005057202,0.00037684405,0.0009321118,0.0005399411,0.0019579942,0.00038954927],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.57017976,0.0070263813,0.30809382,0.0010422107,0.020016331,0.00038999782,0.00020345132,0.0029269091,0.0041100555,0.00023420542,0.002567549,0.08320928],"study_design_scores_gemma":[0.050627537,0.096608385,0.82616895,0.00021628835,0.018841377,0.00043040604,0.0002607254,0.0021520108,0.0013595823,0.000266873,0.0029575143,0.000110448644],"about_ca_topic_score_codex":0.00078839064,"about_ca_topic_score_gemma":0.0016246329,"teacher_disagreement_score":0.003518537,"about_ca_system_score_codex":0.00050770794,"about_ca_system_score_gemma":0.0006265694,"threshold_uncertainty_score":0.018608034},"labels":[],"label_agreement":null},{"id":"W4402106939","doi":"10.1016/j.jaad.2024.07.1099","title":"53817 Patient-reported outcomes with roflumilast foam 0.3% in patients with scalp and body psoriasis in the phase 3 ARRECTOR trial","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Probity Medical Research; Queen's University","funders":"","keywords":"Medicine; Scalp; Psoriasis; Dermatology; Roflumilast; Clinical trial; Pathology; Internal medicine; Surgery","score_opus":0.011292007441371238,"score_gpt":0.27422218211305005,"score_spread":0.2629301746716788,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402106939","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9458621,0.03277397,0.0007078408,0.0019533536,0.0007191869,0.0009676374,0.003955926,0.0003061245,0.012753881],"genre_scores_gemma":[0.9839482,0.006142182,0.0005651647,0.0019425707,0.0004663948,0.0008448646,0.0024472778,0.000039658,0.0036038032],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99950457,0.00025280213,0.000025219231,0.000056287197,0.000047864356,0.00011312342],"domain_scores_gemma":[0.99953246,0.00016455253,0.00011689227,0.00004427309,0.00004993181,0.00009191812],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013261826,0.0007242116,0.0014761406,0.00017423721,0.0002690107,0.00093859923,0.00047721365,0.0010923513,0.0055810898],"category_scores_gemma":[0.001101428,0.00025232576,0.0016567358,0.00025884513,0.00035214407,0.00074815203,0.00021407343,0.002639803,0.0012600332],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8685217,0.003065968,0.0048738816,0.0019414843,0.0040332475,0.0001816889,0.00008531568,0.0010389826,0.007621089,0.00055254647,0.011137413,0.09694676],"study_design_scores_gemma":[0.8460038,0.105695784,0.030199887,0.00039615028,0.00448629,0.0004767035,0.00012914182,0.0013219923,0.0015530004,0.0009812189,0.008671168,0.00008493026],"about_ca_topic_score_codex":0.0006458145,"about_ca_topic_score_gemma":0.0014100168,"teacher_disagreement_score":0.0055810898,"about_ca_system_score_codex":0.00034399636,"about_ca_system_score_gemma":0.00037961535,"threshold_uncertainty_score":0.018670559},"labels":[],"label_agreement":null},{"id":"W4402107048","doi":"10.1016/j.jaad.2024.07.1274","title":"53695 Systemic exposure and safety profile of delgocitinib cream in adults with moderate to severe chronic hand eczema in the Phase 3 DELTA-2 trial","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada); Probity Medical Research; Queen's University","funders":"","keywords":"Medicine; Cmax; Adverse effect; Pharmacokinetics; Janus kinase inhibitor; Clinical trial; Gastroenterology; Internal medicine; Janus kinase; Receptor","score_opus":0.028940941439967883,"score_gpt":0.3701049396946619,"score_spread":0.341163998254694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402107048","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.987039,0.0060667815,0.0003146228,0.0006463292,0.00016613187,0.00047478027,0.0011103611,0.00008584461,0.0040959683],"genre_scores_gemma":[0.99328727,0.0018107035,0.00029149008,0.0007725174,0.00010468425,0.00029796807,0.0009430815,0.000013330031,0.0024789844],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99979204,0.0000739883,0.000011797758,0.000032897522,0.000027412221,0.00006190461],"domain_scores_gemma":[0.999819,0.00004909484,0.000041421485,0.000011508628,0.000021660615,0.000057222784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006783091,0.00056661916,0.0010009897,0.00012978927,0.00018748897,0.00060157984,0.00027373157,0.0005283975,0.004397419],"category_scores_gemma":[0.0005543803,0.00019724615,0.0009448059,0.00013770741,0.0002306824,0.0004866644,0.00015953377,0.0017774218,0.0007729616],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6745495,0.009786186,0.01238243,0.001874322,0.0033724415,0.00043980274,0.00020120107,0.0024812103,0.030831799,0.00053986575,0.012248194,0.25129315],"study_design_scores_gemma":[0.65335345,0.25184143,0.0667566,0.0002871034,0.0026621197,0.001111763,0.00021608014,0.0034555353,0.005714797,0.00063257484,0.013889698,0.00007890828],"about_ca_topic_score_codex":0.00052646355,"about_ca_topic_score_gemma":0.0018907451,"teacher_disagreement_score":0.004397419,"about_ca_system_score_codex":0.0004040306,"about_ca_system_score_gemma":0.00039387718,"threshold_uncertainty_score":0.014710844},"labels":[],"label_agreement":null},{"id":"W4402107556","doi":"10.1016/j.jaad.2024.07.454","title":"54116 A Systematic Review of Clinical Features and Treatment Outcomes of Xanthoma Disseminatum","year":2024,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; McGill University; Université de Montréal","funders":"","keywords":"Medicine; Dermatology","score_opus":0.07158487236621121,"score_gpt":0.503458867665933,"score_spread":0.43187399529972176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402107556","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0021326689,0.9964497,0.00011590399,0.00010855357,0.00008455724,0.0002263137,0.0006305706,0.000007839947,0.00024390101],"genre_scores_gemma":[0.031959087,0.9659851,0.00052146823,0.0005307149,0.00007104958,0.00030760127,0.00043860002,0.0000074031964,0.00017899548],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9963515,0.0010798079,0.0015501323,0.00040384202,0.00047354586,0.00014114249],"domain_scores_gemma":[0.99091303,0.0059990813,0.0021594982,0.000150158,0.0006447959,0.0001333994],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038633377,0.0011782276,0.008740615,0.0051411577,0.0005250741,0.001964167,0.0015295678,0.0012440812,0.0063888836],"category_scores_gemma":[0.017398762,0.0008334856,0.009859469,0.006788546,0.00072044006,0.0016370852,0.0015296151,0.0011064337,0.00040249768],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007101762,0.000022045146,0.0017701834,0.92916286,0.04020149,0.00010725299,0.00012613759,0.00007897698,0.00019973678,0.000104968996,0.0012957468,0.026220363],"study_design_scores_gemma":[0.0014617279,0.00049013423,0.011864915,0.4840728,0.4878283,0.00047184635,0.00026743492,0.000087951215,0.00018169668,0.00026403528,0.01293646,0.00007266464],"about_ca_topic_score_codex":0.008315094,"about_ca_topic_score_gemma":0.027625551,"teacher_disagreement_score":0.008740615,"about_ca_system_score_codex":0.001799536,"about_ca_system_score_gemma":0.005060882,"threshold_uncertainty_score":0.021372914},"labels":[],"label_agreement":null},{"id":"W4402107731","doi":"10.1016/j.jaad.2024.07.577","title":"52671 Bimekizumab safety and tolerability in moderate to severe plaque psoriasis: Pooled analysis from up to 4 years of treatment in 5 phase 3/3b clinical trials","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Queen's University","funders":"","keywords":"Medicine; Tolerability; Plaque psoriasis; Clinical trial; Dermatology; Psoriasis; Pooled analysis; Adverse effect; Internal medicine; Meta-analysis","score_opus":0.05068970887569089,"score_gpt":0.384595949770265,"score_spread":0.3339062408945741,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402107731","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6391649,0.34203294,0.0043591703,0.00075774326,0.00096696784,0.0010869595,0.006305771,0.00035394254,0.004971615],"genre_scores_gemma":[0.9682925,0.023911137,0.0010442379,0.0009126934,0.0005924007,0.000585316,0.0033933076,0.000083464205,0.0011850083],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99379575,0.0035871977,0.0006296689,0.0009602091,0.00057440146,0.0004527098],"domain_scores_gemma":[0.9932058,0.0033121111,0.0019247266,0.0006719792,0.0005278047,0.00035764658],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014011886,0.002269434,0.009361345,0.0011672387,0.0004501186,0.0023203017,0.00097280944,0.0019097169,0.0031885644],"category_scores_gemma":[0.008879048,0.0011227155,0.02058559,0.0015191371,0.0007005986,0.0017183111,0.0010057756,0.0027770412,0.000492462],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5870293,0.000496261,0.021201994,0.011521514,0.31647465,0.00023943515,0.00013852249,0.0038707715,0.0036579676,0.00020053815,0.0033104517,0.051858604],"study_design_scores_gemma":[0.23496133,0.045664515,0.14003006,0.0015946093,0.5638454,0.00070859224,0.00021840773,0.0028208361,0.0015215441,0.0010251703,0.0073478585,0.00026165484],"about_ca_topic_score_codex":0.0011113326,"about_ca_topic_score_gemma":0.0026551664,"teacher_disagreement_score":0.014011886,"about_ca_system_score_codex":0.0008290163,"about_ca_system_score_gemma":0.0009583932,"threshold_uncertainty_score":0.07410282},"labels":[],"label_agreement":null},{"id":"W4402107868","doi":"10.1016/j.jaad.2024.07.570","title":"52797 Bimekizumab and secukinumab comparative effectiveness in hidradenitis suppurativa: Indirect treatment comparisons at Week 16 and 1 Year","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"","keywords":"Hidradenitis suppurativa; Medicine; Secukinumab; Dermatology; Internal medicine; Psoriasis; Disease","score_opus":0.03481026476026697,"score_gpt":0.34170812534546735,"score_spread":0.3068978605852004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402107868","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96933115,0.0240036,0.00036262572,0.00021681555,0.00040099255,0.00037584183,0.0017960377,0.000028214088,0.0034847078],"genre_scores_gemma":[0.9931733,0.00358158,0.0005685644,0.0001199525,0.00021665935,0.00028736112,0.0006965204,0.000009700899,0.0013463562],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9922254,0.0059763757,0.00046080555,0.00041480313,0.00050609896,0.0004164546],"domain_scores_gemma":[0.99192154,0.00544912,0.0015167621,0.0003995503,0.00029844194,0.00041457685],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0055625895,0.0018256641,0.005066234,0.0011648517,0.0003019978,0.001511697,0.0010662676,0.0015376697,0.009473051],"category_scores_gemma":[0.0062592127,0.0009465056,0.0076673655,0.0010899798,0.00086908625,0.0018633576,0.00089074555,0.002956334,0.0007562329],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9439398,0.0022038743,0.007413397,0.0019160799,0.017332086,0.000045961053,0.0001087576,0.0009580061,0.00084815413,0.00023145575,0.00029106956,0.024711363],"study_design_scores_gemma":[0.52446616,0.30083868,0.10651547,0.0010199423,0.055830967,0.00030046445,0.00053518417,0.0038698895,0.0028123371,0.0006849561,0.0029437786,0.00018218739],"about_ca_topic_score_codex":0.002160878,"about_ca_topic_score_gemma":0.00335032,"teacher_disagreement_score":0.009473051,"about_ca_system_score_codex":0.0012308576,"about_ca_system_score_gemma":0.00087306654,"threshold_uncertainty_score":0.031690538},"labels":[],"label_agreement":null},{"id":"W4402108893","doi":"10.1016/j.jaad.2024.07.751","title":"53713 Dupilumab Treatment Provides Long-Term Disease Control in Pediatric Patients With Moderate-to-Severe Atopic Dermatitis Over 1 Year","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital","funders":"","keywords":"Dupilumab; Medicine; Atopic dermatitis; Dermatology; Term (time); Pediatrics","score_opus":0.007305319705724159,"score_gpt":0.27171508783712606,"score_spread":0.2644097681314019,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402108893","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98761135,0.008996553,0.00025927197,0.00033854775,0.000054068652,0.000022010749,0.00025645475,0.000063092564,0.002398734],"genre_scores_gemma":[0.99704933,0.0017101478,0.00032327508,0.00014949263,0.000033965393,0.000011323984,0.00023094835,0.000007277026,0.00048427255],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9998808,0.00003117584,0.000008958133,0.000019332303,0.000020026582,0.000039703835],"domain_scores_gemma":[0.99981016,0.000051287945,0.000049958162,0.000008884317,0.000016147258,0.000063710286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021208444,0.00019858635,0.0005630192,0.00008349246,0.00018106228,0.00027871385,0.0001485083,0.0002064772,0.001534823],"category_scores_gemma":[0.00041370734,0.00006978507,0.000402202,0.00011204771,0.00008813627,0.00023671424,0.00009946002,0.0005462296,0.0002237342],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.035881802,0.0046380837,0.17726812,0.0011797615,0.0013040003,0.004717111,0.00044911617,0.0014784886,0.057767853,0.0005731151,0.01344092,0.70130163],"study_design_scores_gemma":[0.0051904838,0.046273187,0.8833299,0.0003426786,0.0018252127,0.017722873,0.0005785617,0.003710913,0.015586441,0.00027756678,0.025116924,0.000045201643],"about_ca_topic_score_codex":0.0010567347,"about_ca_topic_score_gemma":0.0042069475,"teacher_disagreement_score":0.001534823,"about_ca_system_score_codex":0.00024533275,"about_ca_system_score_gemma":0.0002808454,"threshold_uncertainty_score":0.0051344633},"labels":[],"label_agreement":null},{"id":"W4402109144","doi":"10.1016/j.jaad.2024.07.762","title":"49513 Effectiveness and Persistence of Brodalumab in Patients with Plaque Psoriasis in the Canadian Real-World Setting: 3-Month Follow-up Results from the CARE Study","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Memorial University of Newfoundland; University of Calgary; Vancouver Coastal Health Research Institute; Ontario Tech University; Vancouver Coastal Health; Lakeridge Health; Queen's University; University of British Columbia; Guenther Dermatology Research Centre; Health Canada; University of Manitoba; Bausch Health (Canada)","funders":"","keywords":"Medicine; Persistence (discontinuity); Plaque psoriasis; Psoriasis; Dermatology; Intensive care medicine","score_opus":0.012580726689783444,"score_gpt":0.2546101748891541,"score_spread":0.24202944819937067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402109144","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966053,0.0014046204,0.000019999392,0.00013765063,0.000011126795,0.000035381996,0.0007917124,0.000005020886,0.0009891428],"genre_scores_gemma":[0.9985032,0.00043652413,0.000058389323,0.000107637614,0.000013564825,0.000008768648,0.0006624007,0.0000019585063,0.00020763547],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986621,0.00018723197,0.000069547306,0.00016532652,0.0005285219,0.00038719928],"domain_scores_gemma":[0.9975981,0.00035353212,0.0005546829,0.00011525232,0.00089726073,0.00048115547],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014977305,0.00038903917,0.0008274134,0.000570655,0.0014449774,0.0013195311,0.00076421804,0.0006666512,0.0010261402],"category_scores_gemma":[0.0032037362,0.00024301127,0.00095470843,0.0016668418,0.0006495069,0.00047682598,0.00031964332,0.0008790173,0.00017467105],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007926557,0.0010531972,0.96490777,0.00015465805,0.00070536236,0.00016013085,0.00039507385,0.00019742412,0.0009811056,0.000058950493,0.0011144478,0.02234523],"study_design_scores_gemma":[0.00026792966,0.0007808706,0.99772125,0.000017582077,0.00026111925,0.000055454268,0.00020370151,0.00016473657,0.00009557882,0.000010388157,0.00040387287,0.000017421311],"about_ca_topic_score_codex":0.6777561,"about_ca_topic_score_gemma":0.72405785,"teacher_disagreement_score":0.32224393,"about_ca_system_score_codex":0.006974914,"about_ca_system_score_gemma":0.0069520795,"threshold_uncertainty_score":0.64828336},"labels":[],"label_agreement":null},{"id":"W4402109336","doi":"10.1016/j.jaad.2024.07.1101","title":"51620 Patterns in the risk factors, triggers, and management of chronic hand eczema in pediatric and adolescent populations: A systematic review","year":2024,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Contact Dermatitis and Allergies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Queen's University","funders":"","keywords":"Medicine; Hand eczema; Environmental health; Family medicine; Pediatrics; Allergy; Immunology; Contact dermatitis","score_opus":0.03949823600364085,"score_gpt":0.35594975728179273,"score_spread":0.3164515212781519,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402109336","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014700977,0.9979049,0.000054013522,0.00006537407,0.00004448632,0.00007357442,0.00029332654,0.000003859633,0.00009044175],"genre_scores_gemma":[0.014520712,0.98456925,0.00025039536,0.00025655047,0.000040779352,0.000107931926,0.00017920564,0.0000022591,0.00007284919],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9980506,0.00045902416,0.00081138796,0.00026891704,0.00031319403,0.0000968818],"domain_scores_gemma":[0.9918126,0.005702706,0.0018294671,0.00009895373,0.00043567974,0.00012061673],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026438308,0.001093447,0.0063367686,0.004092077,0.00042697217,0.0017113009,0.001222635,0.0015439587,0.0049973927],"category_scores_gemma":[0.013332787,0.00085520936,0.007766013,0.0056553236,0.0005385782,0.0013779124,0.0012219952,0.0009923503,0.00034406193],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000454335,0.00004037909,0.005449029,0.9143692,0.032606497,0.00013976557,0.00017045884,0.00010718978,0.00019609704,0.00012549563,0.0016624684,0.044679083],"study_design_scores_gemma":[0.0008118194,0.00035749792,0.028622884,0.58705586,0.36561593,0.0006568045,0.0004228047,0.00013035299,0.00018379265,0.0002612945,0.015798904,0.000082033956],"about_ca_topic_score_codex":0.011482201,"about_ca_topic_score_gemma":0.037578195,"teacher_disagreement_score":0.011482201,"about_ca_system_score_codex":0.0013249492,"about_ca_system_score_gemma":0.004456623,"threshold_uncertainty_score":0.022830725},"labels":[],"label_agreement":null},{"id":"W4402109363","doi":"10.1016/j.jaad.2024.07.692","title":"50457 Defining Atopic Dermatitis Flare From The Patient Perspective: A Modified Delphi Study","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"North York General Hospital; Public Health Ontario; University of Toronto; Women's College Hospital","funders":"","keywords":"Medicine; Atopic dermatitis; Perspective (graphical); Flare; Dermatology; Delphi; Delphi method; Artificial intelligence","score_opus":0.017988016143810244,"score_gpt":0.3225204671406739,"score_spread":0.30453245099686366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402109363","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897518,0.00016678986,0.00052278925,0.00020569144,0.000017424894,0.0007411876,0.00015635038,0.0000028464299,0.00843509],"genre_scores_gemma":[0.9972421,0.0001370239,0.0007896371,0.0002620266,0.000013153058,0.0008300706,0.000114125185,0.0000031471538,0.0006087251],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.9952495,0.0034020033,0.00030801806,0.00016134598,0.00041854772,0.00046056346],"domain_scores_gemma":[0.9965322,0.0020213819,0.00023892523,0.00016494749,0.0008000059,0.00024255007],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0054724785,0.00022208494,0.00027494837,0.0007615486,0.000658533,0.0007140103,0.0002664395,0.0004261741,0.003808027],"category_scores_gemma":[0.0077880383,0.00011808032,0.0005038679,0.0004912995,0.0005122428,0.0006683647,0.0017276519,0.000556808,0.0005622389],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041867886,0.0021092668,0.67430985,0.0011109322,0.00029018286,0.0036008656,0.08589369,0.00087152503,0.010889705,0.0035064393,0.0060806205,0.20715009],"study_design_scores_gemma":[0.00054777757,0.0072539607,0.8346441,0.000806317,0.0003259291,0.008440066,0.11054803,0.0022485226,0.0040441,0.0015333717,0.029468954,0.00013889819],"about_ca_topic_score_codex":0.0010007952,"about_ca_topic_score_gemma":0.0015065165,"teacher_disagreement_score":0.0054724785,"about_ca_system_score_codex":0.0007214122,"about_ca_system_score_gemma":0.0006830244,"threshold_uncertainty_score":0.028941572},"labels":[],"label_agreement":null},{"id":"W4402109598","doi":"10.1016/j.jaad.2024.07.774","title":"53583 Efficacy and Safety of Imiquimod Monotherapy in Lentigo Maligna: A Systematic Review and Meta-analysis","year":2024,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Synthesis of Organic Compounds","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Medicine; Lentigo maligna; Imiquimod; Dermatology; Meta-analysis; Internal medicine; Melanoma","score_opus":0.06497962822647287,"score_gpt":0.3917220816839436,"score_spread":0.32674245345747077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402109598","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008448586,0.9900726,0.00032662528,0.00012312522,0.0001500813,0.00019429096,0.0004058714,0.000020088124,0.00025880014],"genre_scores_gemma":[0.21724576,0.7779481,0.0014878283,0.0012593673,0.0002562858,0.00050200487,0.0006276605,0.000024218612,0.00064877456],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99734217,0.0009849713,0.00084923836,0.00035848524,0.00031653716,0.00014867495],"domain_scores_gemma":[0.99571913,0.0027161771,0.0010036639,0.00014893482,0.00032398588,0.00008808433],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0048032543,0.0019810174,0.0129051395,0.0025051618,0.00040810695,0.0021080642,0.0015454289,0.0018578256,0.0047085667],"category_scores_gemma":[0.009442995,0.0011748972,0.023091743,0.0034594922,0.00058623124,0.0012842036,0.0011662907,0.0015636531,0.0004067138],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005203803,0.000067424015,0.0042939177,0.37182173,0.5996017,0.00016602741,0.00009953283,0.0004113558,0.0005755557,0.00010119691,0.00078511896,0.016872618],"study_design_scores_gemma":[0.0015531573,0.00030609293,0.0035067215,0.011493498,0.98125756,0.00007033962,0.00004373426,0.0001259647,0.00010048185,0.000082295766,0.0014346847,0.000025399588],"about_ca_topic_score_codex":0.004608172,"about_ca_topic_score_gemma":0.016243914,"teacher_disagreement_score":0.0129051395,"about_ca_system_score_codex":0.001494799,"about_ca_system_score_gemma":0.0018340531,"threshold_uncertainty_score":0.025402367},"labels":[],"label_agreement":null},{"id":"W4402109850","doi":"10.1016/j.jaad.2024.07.1089","title":"54151 Patient Demographics and Treatment Strategies Observed in The Follicular Occlusion Triad and Tetrad","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Medicine; Tetrad; Demographics; Triad (sociology); Follicular phase; Internal medicine; Demography; Genetics","score_opus":0.02210611968412907,"score_gpt":0.3021502986891268,"score_spread":0.28004417900499773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402109850","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9865524,0.00058657257,0.0003223506,0.0005012479,0.00004669641,0.000038650636,0.0006810408,0.000017172833,0.011253867],"genre_scores_gemma":[0.99775547,0.00021805702,0.00023775834,0.0002909037,0.00004394695,0.000023899767,0.0006126462,0.000009808425,0.0008076155],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995371,0.000045742192,0.00006819975,0.00007587227,0.00009069021,0.00018243039],"domain_scores_gemma":[0.999337,0.00016147309,0.00017259565,0.00002244813,0.000057822504,0.0002486762],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025018962,0.00021477549,0.00039502367,0.0006609641,0.00075338985,0.00049937796,0.00020429857,0.00044479783,0.004848542],"category_scores_gemma":[0.0021059308,0.00012157943,0.00028444335,0.0006662326,0.0003011364,0.00044683064,0.00037450434,0.00079121254,0.00058144704],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004340385,0.00028193035,0.9484986,0.0000216816,0.00003823883,0.03152695,0.00040598685,0.00023872736,0.0011609708,0.0005112712,0.0022788548,0.014602674],"study_design_scores_gemma":[0.00005837157,0.000679225,0.81075007,0.000097585114,0.00006488969,0.1776666,0.0028053552,0.0008626903,0.00052906066,0.0007569697,0.0056845625,0.000044602453],"about_ca_topic_score_codex":0.0020949265,"about_ca_topic_score_gemma":0.0029659702,"teacher_disagreement_score":0.004848542,"about_ca_system_score_codex":0.00047335544,"about_ca_system_score_gemma":0.0007531526,"threshold_uncertainty_score":0.016219974},"labels":[],"label_agreement":null},{"id":"W4402110270","doi":"10.1016/j.jaad.2024.07.1324","title":"50004 The Psychosocial Implications of Acne in Patients with Skin of Colour","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of British Columbia","funders":"","keywords":"Medicine; Psychosocial; Dermatology; Acne; Psychiatry","score_opus":0.00752876746983532,"score_gpt":0.3079682831558129,"score_spread":0.3004395156859776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402110270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.973291,0.0036572956,0.000040698433,0.0031702472,0.0001852404,0.000026297592,0.00020448315,0.0000038907724,0.01942093],"genre_scores_gemma":[0.99704343,0.0011724632,0.000051454732,0.00051391026,0.00012187519,0.00000749611,0.000054914544,0.0000012130017,0.0010332529],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997025,0.00015134348,0.000018393433,0.000011037697,0.000047892925,0.00006878715],"domain_scores_gemma":[0.9988456,0.00044072216,0.00023253902,0.000016074568,0.00009806195,0.0003669945],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033760763,0.000135466,0.0001655975,0.0005263815,0.00075041904,0.00059869816,0.00011667076,0.0004209053,0.012771067],"category_scores_gemma":[0.0024914036,0.00007299822,0.00028950843,0.00052133255,0.0002912187,0.0003762853,0.00037594986,0.0005816363,0.00053404726],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003312717,0.00029989402,0.96180826,0.000099342906,0.00006718428,0.0027347035,0.0005928781,0.000048508435,0.00042262668,0.00016848638,0.002587213,0.030839648],"study_design_scores_gemma":[0.000022135468,0.00022953775,0.99092543,0.00007315493,0.000038801227,0.0029942237,0.0025813542,0.000054132463,0.000044919303,0.00011691552,0.002913043,0.000006440431],"about_ca_topic_score_codex":0.0022011108,"about_ca_topic_score_gemma":0.0056672366,"teacher_disagreement_score":0.012771067,"about_ca_system_score_codex":0.00032100047,"about_ca_system_score_gemma":0.0003725949,"threshold_uncertainty_score":0.042723477},"labels":[],"label_agreement":null},{"id":"W4402110375","doi":"10.1016/j.jaad.2024.07.771","title":"54540 Efficacy and benefits of a dermocosmetic cream containing Sphingobioma and Neurosensine in subjects with rosacea associated with erythema and sensitive skin","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Windsor Clinical Research; Western University","funders":"","keywords":"Medicine; Rosacea; Dermatology; Erythema; Sensitive skin; Acne","score_opus":0.011202986512463485,"score_gpt":0.26762940626101817,"score_spread":0.2564264197485547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402110375","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99697673,0.0015044841,0.00005234283,0.000084886604,0.000056115292,0.000077646095,0.00006724979,0.000007976881,0.0011726324],"genre_scores_gemma":[0.99794596,0.000618029,0.00012629517,0.00009122398,0.00008076718,0.000026467655,0.000083527135,0.0000017835271,0.0010259625],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99986994,0.000048906953,0.000013800708,0.000015215159,0.000023125198,0.000028986942],"domain_scores_gemma":[0.9998443,0.000053461383,0.000016375796,0.000007797461,0.000018021452,0.000060021976],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004016106,0.00032914328,0.00062909926,0.00032594506,0.00040953484,0.00019977428,0.0001692861,0.0004531162,0.002887491],"category_scores_gemma":[0.0005011346,0.00018334595,0.00041997485,0.00013920534,0.0002467113,0.00026577304,0.00014208391,0.0005822218,0.00035374635],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.52690816,0.04189601,0.03621466,0.0008247513,0.00076782284,0.0019368815,0.00036908628,0.0005804236,0.26431248,0.000163024,0.001111453,0.12491525],"study_design_scores_gemma":[0.054208487,0.49085242,0.4127045,0.00011664064,0.0020125145,0.0012993622,0.0006978807,0.0017417882,0.032240886,0.00013515823,0.003930449,0.000059893733],"about_ca_topic_score_codex":0.0019591611,"about_ca_topic_score_gemma":0.0028222627,"teacher_disagreement_score":0.002887491,"about_ca_system_score_codex":0.00017152297,"about_ca_system_score_gemma":0.0002201932,"threshold_uncertainty_score":0.009659588},"labels":[],"label_agreement":null},{"id":"W4402110565","doi":"10.1016/j.jaad.2024.07.1390","title":"53370 Understanding Burdens and Barriers to Dermatological Management, and Potential for Virtual Care in Northern and Rural Canadian Indigenous Communities: A National Healthcare Practitioner Cross-Sectional Survey Analysis","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Telemedicine and Telehealth Implementation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Dalhousie University; Saskatchewan Health Authority; McGill University; University of Calgary; University of Saskatchewan","funders":"","keywords":"Medicine; Indigenous; Cross-sectional study; Health care; Nursing; Family medicine","score_opus":0.04432229362628166,"score_gpt":0.38505443463228844,"score_spread":0.3407321410060068,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402110565","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99746716,0.00013042589,0.00004228877,0.00020379825,0.000004990418,0.0000652011,0.00041578925,0.0000023184168,0.001668012],"genre_scores_gemma":[0.997926,0.00027812444,0.00022088113,0.00021043545,0.000004654657,0.000053460066,0.00025836824,0.000002855567,0.001045237],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998478,0.00018302223,0.0000881288,0.00011778729,0.00045915353,0.0006738758],"domain_scores_gemma":[0.99770457,0.000255866,0.00046523774,0.000056509114,0.00084163377,0.0006761682],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013662408,0.0003260103,0.00039551052,0.0012179862,0.0053758053,0.0017859567,0.0012457655,0.000549415,0.0027591179],"category_scores_gemma":[0.003991857,0.0005485772,0.0006318044,0.0028971597,0.0008939085,0.00072023616,0.0015077594,0.0011431566,0.00023772093],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029650859,0.00018780783,0.9765326,0.000071714276,0.000040229366,0.00011226557,0.01700836,0.00004048859,0.00014915482,0.000108433516,0.0008519941,0.0048673176],"study_design_scores_gemma":[0.000003715882,0.000037954476,0.9583662,0.00006335735,0.000023237402,0.000056074525,0.040516123,0.00011672398,0.000030494662,0.000023795108,0.0007497986,0.00001245266],"about_ca_topic_score_codex":0.9820379,"about_ca_topic_score_gemma":0.99187803,"teacher_disagreement_score":0.017962098,"about_ca_system_score_codex":0.013634193,"about_ca_system_score_gemma":0.030432949,"threshold_uncertainty_score":0.098923445},"labels":[],"label_agreement":null},{"id":"W4402110715","doi":"10.1016/j.jaad.2024.07.679","title":"52091 Current Practices of Allergy Testing in Adults with Atopic Dermatitis in Canada: A National Survey","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Probity Medical Research; Canadian Arthritis Patient Alliance; SKiN Health; Innovative Medicines Canada; Ottawa Hospital; Women's College Hospital","funders":"","keywords":"Medicine; Atopic dermatitis; Dermatology; Allergy; Family medicine; Immunology","score_opus":0.03581950030413848,"score_gpt":0.33620093378389737,"score_spread":0.3003814334797589,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402110715","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.971557,0.0019023801,0.00014546873,0.00091075513,0.00003396107,0.00009283161,0.01873464,0.000034658842,0.006588299],"genre_scores_gemma":[0.99251926,0.0011768844,0.00027557043,0.0005688526,0.000013673981,0.000032288943,0.0033998643,0.00000969869,0.0020038493],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99855703,0.00009514203,0.00016876838,0.00022697622,0.00061083096,0.0003412567],"domain_scores_gemma":[0.99602294,0.00020347387,0.00087254477,0.000084515224,0.0018931741,0.0009232689],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047615377,0.00029491438,0.00044141532,0.001464251,0.0016603613,0.0009575484,0.0012140133,0.00080180616,0.0029176387],"category_scores_gemma":[0.0023213197,0.00043950888,0.0005694016,0.0049240263,0.0004660226,0.00049435085,0.0006317974,0.00088570704,0.00049642735],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021276279,0.00003381437,0.996445,0.00002883824,0.000028857829,0.00004727061,0.00020059846,0.000041540097,0.00006673615,0.00002430082,0.0012697579,0.0017919757],"study_design_scores_gemma":[0.000003805666,0.000014171639,0.99838364,0.000026447113,0.00001442089,0.00007279544,0.00059614354,0.00012934873,0.000024539322,0.0000058810797,0.000722776,0.0000060377033],"about_ca_topic_score_codex":0.99016714,"about_ca_topic_score_gemma":0.99368215,"teacher_disagreement_score":0.015302848,"about_ca_system_score_codex":0.015302848,"about_ca_system_score_gemma":0.0183954,"threshold_uncertainty_score":0.11103046},"labels":[],"label_agreement":null},{"id":"W4402110788","doi":"10.1016/j.jaad.2024.07.1411","title":"51087 UtahDERM: Implementing a Digital Dermatology Education Platform","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Social Media in Health Education","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Dermatology; Medical physics","score_opus":0.05865584836976062,"score_gpt":0.4351507973164239,"score_spread":0.3764949489466633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402110788","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09546211,0.0037355612,0.086909674,0.07604748,0.008251466,0.0057521733,0.011929336,0.16656938,0.5453429],"genre_scores_gemma":[0.19739142,0.003850125,0.39575076,0.01998212,0.0047959834,0.0031434924,0.015736716,0.009971872,0.34937745],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.997131,0.0007861118,0.00019213767,0.0003350798,0.0013095948,0.00024608787],"domain_scores_gemma":[0.98156804,0.004382903,0.0010843342,0.0026925525,0.004895001,0.005377256],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008298499,0.00039936724,0.00024936086,0.0017761828,0.0015380124,0.0033955376,0.0021195242,0.0012474718,0.11058783],"category_scores_gemma":[0.017625075,0.00043525719,0.00038994217,0.00090459635,0.00059977133,0.0042863926,0.005408346,0.0012104448,0.046648353],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015882438,0.00037848056,0.0057309135,0.00021403006,0.00001087309,0.00043416087,0.0005267153,0.0001893087,0.0029628698,0.0016284988,0.611273,0.37649235],"study_design_scores_gemma":[0.000082140294,0.00022650765,0.0076411236,0.0002760627,0.0000123150585,0.00044909716,0.00040945393,0.0015468488,0.0019317577,0.0013236352,0.98606455,0.000036580015],"about_ca_topic_score_codex":0.001920173,"about_ca_topic_score_gemma":0.006971074,"teacher_disagreement_score":0.11058783,"about_ca_system_score_codex":0.0009818536,"about_ca_system_score_gemma":0.005242896,"threshold_uncertainty_score":0.36995316},"labels":[],"label_agreement":null},{"id":"W4402110804","doi":"10.1016/j.jaad.2024.07.750","title":"51573 Dupilumab Treatment for up to 5 Years Improves Eczema Area and Severity Index Score Across all Anatomical Regions in Adults With Moderate-to-Severe Atopic Dermatitis","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"","keywords":"Dupilumab; Medicine; Atopic dermatitis; Eczema Area and Severity Index; Dermatology; Severity of illness; Index (typography); Internal medicine","score_opus":0.018971181730796965,"score_gpt":0.3196310531711289,"score_spread":0.3006598714403319,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402110804","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9882081,0.006227084,0.00013592526,0.00024227786,0.00012092774,0.000057240773,0.0004250811,0.000100655074,0.0044826902],"genre_scores_gemma":[0.99639505,0.001143151,0.00031656548,0.00031802183,0.000055100714,0.00002241545,0.00043775552,0.000005817462,0.0013061059],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9998609,0.00002676183,0.000013502394,0.000025886759,0.000031937907,0.000041045707],"domain_scores_gemma":[0.9998741,0.000023043136,0.000031191696,0.000008221221,0.000026140171,0.000037300466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025125456,0.00030415246,0.0007839033,0.00016959873,0.00019881711,0.0003060341,0.0001802458,0.00021687405,0.0027498822],"category_scores_gemma":[0.00037679536,0.00010607254,0.00045560504,0.00014319908,0.0000729564,0.00025526964,0.00013105117,0.00042588075,0.0004603125],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.040904112,0.006699977,0.18935084,0.000953978,0.001784102,0.000735038,0.00020822382,0.0007213719,0.04189314,0.00016772535,0.015060405,0.7015211],"study_design_scores_gemma":[0.00465395,0.02402833,0.95454085,0.00015365191,0.0012737864,0.0016123244,0.00025926277,0.0015341684,0.0036939168,0.00013473496,0.008085387,0.000029747918],"about_ca_topic_score_codex":0.0017759046,"about_ca_topic_score_gemma":0.0064537227,"teacher_disagreement_score":0.0027498822,"about_ca_system_score_codex":0.00021868176,"about_ca_system_score_gemma":0.000183027,"threshold_uncertainty_score":0.009199321},"labels":[],"label_agreement":null},{"id":"W4402110831","doi":"10.1016/j.jaad.2024.07.947","title":"52697 Incidence of Injection-Site Reactions With Dupilumab Treatment in a 5-Year Open-Label Extension Study of Adults With Moderate-to-Severe Atopic Dermatitis","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"","keywords":"Dupilumab; Medicine; Atopic dermatitis; Incidence (geometry); Dermatology; Open label; Surgery; Randomized controlled trial","score_opus":0.019155685741694913,"score_gpt":0.322080426439719,"score_spread":0.3029247406980241,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402110831","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979995,0.0010993378,0.00006822582,0.000019783456,0.000029310864,0.00011793953,0.00026183628,0.000007895979,0.00039627182],"genre_scores_gemma":[0.9987783,0.00027437272,0.00009734628,0.000058709422,0.000052177817,0.00007534766,0.00032524945,0.0000020455811,0.00033649118],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9990627,0.000396778,0.00007876629,0.00018688705,0.00015679075,0.0001181198],"domain_scores_gemma":[0.99873406,0.00037438786,0.00044469244,0.000094313255,0.00010432798,0.0002482765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017319352,0.0006683051,0.0012799577,0.0004060322,0.00035349943,0.00082703825,0.00038999756,0.00080373656,0.0018272601],"category_scores_gemma":[0.00138151,0.00034007983,0.0015303976,0.00040262647,0.0003592493,0.00074742123,0.00027479348,0.0012929228,0.00031160648],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6053123,0.011396009,0.32334858,0.00079992507,0.0035301049,0.0004426456,0.0002714925,0.0005816189,0.009660702,0.00010199336,0.00067661505,0.043878037],"study_design_scores_gemma":[0.037123114,0.13303068,0.82371134,0.00006317287,0.00216808,0.0004479292,0.00013478742,0.0011857698,0.0010298482,0.000046815276,0.0010076389,0.000050770126],"about_ca_topic_score_codex":0.0008138795,"about_ca_topic_score_gemma":0.00105655,"teacher_disagreement_score":0.0018272601,"about_ca_system_score_codex":0.00036114082,"about_ca_system_score_gemma":0.00033600858,"threshold_uncertainty_score":0.009159446},"labels":[],"label_agreement":null},{"id":"W4402111034","doi":"10.1016/j.jaad.2024.07.576","title":"52687 Bimekizumab improvement in three Dermatology Life Quality Index (DLQI) items capturing aspects most burdensome to patients with moderate to severe plaque psoriasis","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; University of Toronto","funders":"","keywords":"Dermatology Life Quality Index; Medicine; Dermatology; Psoriasis; Plaque psoriasis; Psoriasis Area and Severity Index; Quality of life (healthcare); Index (typography); World Wide Web","score_opus":0.014524148749033659,"score_gpt":0.26530608994801835,"score_spread":0.25078194119898467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402111034","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96228105,0.0036079683,0.00085884857,0.0011046185,0.00035358648,0.00025018028,0.0042151283,0.00014474423,0.027183989],"genre_scores_gemma":[0.99078465,0.0005134777,0.0014289109,0.0005322125,0.00009667038,0.00009866884,0.0023792936,0.00001004672,0.004156027],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99947554,0.00017491158,0.000059718288,0.000051297386,0.00013847655,0.00010015449],"domain_scores_gemma":[0.99937904,0.00011838594,0.000219205,0.000028564253,0.00014934532,0.000105395],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076187524,0.00019048432,0.00041896058,0.0002739718,0.00017944258,0.00035116382,0.00016695895,0.00016578108,0.009010247],"category_scores_gemma":[0.0015081842,0.00006749035,0.00041356718,0.00029228235,0.00007138912,0.00015731786,0.0002607745,0.0005023681,0.0010980839],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012029268,0.0019863409,0.5597525,0.0004968751,0.0009599606,0.00024695892,0.00010468508,0.0008232831,0.00945031,0.0003040952,0.03101662,0.38282907],"study_design_scores_gemma":[0.001700295,0.0034844896,0.9768553,0.000068740235,0.00039993078,0.0008177134,0.00010182039,0.0013512643,0.0023318203,0.00015237909,0.012711792,0.000024400937],"about_ca_topic_score_codex":0.00142977,"about_ca_topic_score_gemma":0.0029782718,"teacher_disagreement_score":0.009010247,"about_ca_system_score_codex":0.00036789334,"about_ca_system_score_gemma":0.00029574838,"threshold_uncertainty_score":0.030142307},"labels":[],"label_agreement":null},{"id":"W4402552331","doi":"10.1016/j.jaad.2024.08.062","title":"Development of an Objective Structured Assessment of Technical Skills for Sclerotherapy","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Healthcare Systems and Public Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Feinberg School of Medicine; School of Medicine, Stanford University; York University; Weill Cornell Medical College; Seattle Children's Research Institute; University of Washington; West Virginia University; Tulane University; Cleveland Clinic; Northwestern University; Louisiana State University; NYU Langone Medical Center; Park Nicollet Foundation; University of Southern California; Yale University; Loma Linda University","keywords":"Medicine; Sclerotherapy; Medical physics; Surgery","score_opus":0.027722025924746485,"score_gpt":0.42970899724820166,"score_spread":0.4019869713234552,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402552331","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89600456,0.00026897658,0.053737763,0.0009173649,0.00023629093,0.024710592,0.0019458175,0.00047767785,0.021701012],"genre_scores_gemma":[0.6961457,0.00061704055,0.2654965,0.0005347313,0.00007107219,0.024521777,0.0036769127,0.00008639793,0.008849967],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9943873,0.0017255913,0.00095346844,0.00030268397,0.0023361593,0.0002947618],"domain_scores_gemma":[0.985932,0.0039068004,0.0015721488,0.0005864693,0.0072025354,0.0008001924],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007708263,0.00060561806,0.0007204826,0.0015520887,0.0005495153,0.00085722323,0.00090181956,0.00057469227,0.0016268782],"category_scores_gemma":[0.01364904,0.00037668724,0.001091332,0.00042769464,0.00041381622,0.0009533545,0.00152041,0.0010901536,0.00065528805],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012305345,0.016924635,0.43225297,0.0009230929,0.00020198258,0.00062159146,0.0053634513,0.004507707,0.01853967,0.0015575417,0.011870864,0.506006],"study_design_scores_gemma":[0.0006501983,0.012650456,0.9147476,0.00073838443,0.00016076394,0.0009871578,0.0044295276,0.018571598,0.024105823,0.0011763688,0.021565327,0.00021667138],"about_ca_topic_score_codex":0.0031857633,"about_ca_topic_score_gemma":0.009062485,"teacher_disagreement_score":0.007708263,"about_ca_system_score_codex":0.0013191949,"about_ca_system_score_gemma":0.006679237,"threshold_uncertainty_score":0.040765703},"labels":[],"label_agreement":null},{"id":"W4402570269","doi":"10.1016/j.jaad.2024.08.066","title":"Systemic Janus kinase inhibitor treatment for vitiligo: An evidence-based review","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"melanin and skin pigmentation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Sunnybrook Health Science Centre; Women's College Hospital; Calgary Laboratory Services; University of Toronto","funders":"","keywords":"Medicine; Vitiligo; Janus kinase; Dermatology; Janus kinase inhibitor; Internal medicine","score_opus":0.037670493167077546,"score_gpt":0.3614528513842564,"score_spread":0.3237823582171789,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402570269","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009002799,0.99945444,0.000040368162,0.0001574963,0.000101244936,0.000005581237,0.0000128533275,0.0000023900072,0.00013558655],"genre_scores_gemma":[0.0013774539,0.9978459,0.00013717604,0.00036384573,0.00014760008,0.000008666874,0.000023262452,8.2204235e-7,0.00009521429],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9996928,0.000058352718,0.00009409163,0.000053116823,0.00008008539,0.000021495856],"domain_scores_gemma":[0.9988636,0.00073077745,0.0002162264,0.000011773241,0.0001352638,0.00004236607],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010909967,0.0006682612,0.002954083,0.0015694764,0.0002506103,0.0011093244,0.0013394335,0.0011780574,0.0029241797],"category_scores_gemma":[0.0017392683,0.00035632413,0.0014574393,0.001351236,0.00036612048,0.0011412895,0.00046928664,0.0018399014,0.0006075198],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00075978145,0.00014457607,0.00036540738,0.11271665,0.0016387156,0.00036796264,0.000049629212,0.00035622166,0.0012517824,0.0011265951,0.028181197,0.8530414],"study_design_scores_gemma":[0.0021054663,0.0015109412,0.006843909,0.112919286,0.020655101,0.005886552,0.00026003143,0.00068035355,0.0014344731,0.0029305306,0.8446327,0.00014072545],"about_ca_topic_score_codex":0.000773109,"about_ca_topic_score_gemma":0.002454341,"teacher_disagreement_score":0.002954083,"about_ca_system_score_codex":0.0004912012,"about_ca_system_score_gemma":0.0010755443,"threshold_uncertainty_score":0.009782314},"labels":[],"label_agreement":null},{"id":"W4402676643","doi":"10.1016/j.jaad.2024.09.022","title":"Gastrointestinal adverse events associated with use of biologic therapies available for psoriasis: A systematic review of pharmacovigilance studies","year":2024,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Western University; Women's College Hospital; University of Toronto","funders":"","keywords":"Medicine; Pharmacovigilance; Psoriasis; Adverse effect; Dermatology; Intensive care medicine; MEDLINE; Pharmacology","score_opus":0.2809996016138696,"score_gpt":0.5092898253715773,"score_spread":0.2282902237577077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402676643","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0022734432,0.99710923,0.0000808284,0.00007203185,0.000029200773,0.000050994462,0.00029206526,0.0000048077472,0.00008747005],"genre_scores_gemma":[0.03277704,0.96572024,0.0005691294,0.0003876472,0.000054718,0.000078650824,0.00033449449,0.0000042159963,0.000073873],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99649733,0.0008006709,0.0015734325,0.00045799275,0.0005703175,0.000100308556],"domain_scores_gemma":[0.9857429,0.0089671705,0.0042942376,0.00018481935,0.00067141885,0.00013939168],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003793324,0.0010136927,0.005535863,0.0052533415,0.00031903625,0.0013984918,0.0011109393,0.0012269486,0.0026510616],"category_scores_gemma":[0.01379824,0.00063484994,0.008967155,0.0059894663,0.00046452464,0.0010983156,0.0012544218,0.00090726995,0.00013016567],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00094893307,0.00003965074,0.0069813468,0.8473012,0.07196451,0.00021872102,0.00015439882,0.00022447998,0.00044148596,0.00014531412,0.0015677351,0.070012175],"study_design_scores_gemma":[0.0013420768,0.0005909654,0.052280184,0.3568593,0.5616145,0.0016496206,0.00042793842,0.0002903422,0.0005027696,0.0005195231,0.023777785,0.00014495647],"about_ca_topic_score_codex":0.004392405,"about_ca_topic_score_gemma":0.015786465,"teacher_disagreement_score":0.005535863,"about_ca_system_score_codex":0.0010732358,"about_ca_system_score_gemma":0.0022252991,"threshold_uncertainty_score":0.020061255},"labels":[],"label_agreement":null},{"id":"W4402700696","doi":"10.1016/j.jaad.2024.08.076","title":"Pediatric Bier anemic spots, cyanosis and urticaria-like eruption syndrome in 42 patients: A peek into dysautonomia","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Endoplasmic Reticulum Stress and Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"H2020 European Research Council","keywords":"Medicine; Dysautonomia; Familial dysautonomia; Peek; Surgery; Internal medicine","score_opus":0.004033183318426324,"score_gpt":0.2518203507477016,"score_spread":0.24778716742927526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402700696","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99717295,0.00030372417,0.0002895794,0.00009707181,0.000015943462,0.000017108916,0.000065166954,0.000020996213,0.0020175118],"genre_scores_gemma":[0.9992995,0.00013414814,0.00013518055,0.000046318244,0.000023411218,0.000007043428,0.000039958384,0.0000076223087,0.00030670234],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.99955636,0.000052764914,0.000058210364,0.00011487061,0.00008924538,0.00012843176],"domain_scores_gemma":[0.9995372,0.00013450651,0.00009562431,0.000027530581,0.0000394436,0.00016569153],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026248622,0.0013070039,0.00049802125,0.0013354466,0.001105515,0.0006673587,0.0003438575,0.00081364025,0.003112618],"category_scores_gemma":[0.0012776252,0.00072804175,0.00039402023,0.0006896868,0.0007091197,0.0007549213,0.0006713642,0.0006969324,0.0004601118],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003916029,0.00020869309,0.3792203,0.000053654203,0.0000517798,0.6003889,0.0013709778,0.00022998906,0.01080889,0.0004117944,0.0004596324,0.0064038993],"study_design_scores_gemma":[0.00004981485,0.00037765436,0.34326503,0.000021384843,0.000078071746,0.65117717,0.0009175732,0.00054720853,0.0023744563,0.0002198406,0.00094517064,0.00002666875],"about_ca_topic_score_codex":0.001230895,"about_ca_topic_score_gemma":0.00097227196,"teacher_disagreement_score":0.003112618,"about_ca_system_score_codex":0.000306997,"about_ca_system_score_gemma":0.00030617564,"threshold_uncertainty_score":0.010412753},"labels":[],"label_agreement":null},{"id":"W4403001201","doi":"10.1016/j.jaad.2024.09.041","title":"Response to Ong et al, “Hair-raising costs: Evaluating botulinum toxin treatment for androgenetic alopecia”","year":2024,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Grand River Hospital","funders":"","keywords":"Medicine; Dermatology; Botulinum toxin; Surgery","score_opus":0.051913301493088045,"score_gpt":0.4039397774512743,"score_spread":0.35202647595818626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403001201","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009158656,0.0008322415,0.000064630476,0.9832986,0.01164709,0.00003042931,0.00011252282,0.000027884176,0.0030706574],"genre_scores_gemma":[0.005316656,0.0007902037,0.00021171715,0.9675378,0.021279126,0.00005027232,0.00006513867,0.000019707624,0.004729395],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979017,0.0005737023,0.00029278087,0.00031275666,0.0005225474,0.000396563],"domain_scores_gemma":[0.995275,0.0021358281,0.00047652156,0.000104797255,0.0011180784,0.00088970567],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017836859,0.0009197591,0.0011976851,0.0008573863,0.0028935103,0.002867441,0.0016432351,0.0427356,0.007987088],"category_scores_gemma":[0.018467251,0.00057767425,0.0014877943,0.0008308926,0.0012538114,0.0019856102,0.00094700756,0.024211349,0.0038746954],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027651645,0.0001274344,0.0021366896,0.0000897953,0.000041903902,0.008311987,0.00012489858,0.00014612544,0.00030203632,0.0010716193,0.97944516,0.007925803],"study_design_scores_gemma":[0.001043987,0.00042047907,0.0063758516,0.0008069845,0.00021157072,0.01464828,0.0012314859,0.0017891871,0.00068371336,0.007005412,0.9656357,0.0001472525],"about_ca_topic_score_codex":0.007885431,"about_ca_topic_score_gemma":0.014619832,"teacher_disagreement_score":0.0427356,"about_ca_system_score_codex":0.0046142805,"about_ca_system_score_gemma":0.0039616264,"threshold_uncertainty_score":0.033479095},"labels":[],"label_agreement":null},{"id":"W4403044799","doi":"10.1016/j.jaad.2024.07.1492","title":"Prevalence and risk factors of interstitial lung disease in dermatomyositis: A retrospective study","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Inflammatory Myopathies and Dermatomyositis","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Toronto; Hamilton Health Sciences","funders":"","keywords":"Medicine; Dermatomyositis; Interstitial lung disease; Retrospective cohort study; Disease; Lung disease; Dermatology; Lung; Internal medicine","score_opus":0.007219049887209405,"score_gpt":0.29446984870208476,"score_spread":0.28725079881487536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403044799","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995906,0.002607905,0.00011105301,0.00042892178,0.00004415779,0.000012336858,0.00055064505,0.0000046157493,0.00033434722],"genre_scores_gemma":[0.9981719,0.00077380106,0.00012908311,0.0002466438,0.00019520137,0.00001134701,0.00035056102,0.000002225484,0.00011919489],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99927527,0.00019948283,0.00018169632,0.00014979053,0.000116738884,0.00007705072],"domain_scores_gemma":[0.99698454,0.0009864602,0.0011823014,0.00017233344,0.0003510389,0.0003232695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010561812,0.00021258391,0.00041624345,0.00081912463,0.0002927707,0.0005578543,0.0004513046,0.00063930993,0.0016325115],"category_scores_gemma":[0.003448835,0.00030325892,0.00028436363,0.0014418194,0.00024753102,0.0006189118,0.00029502547,0.0005323396,0.00023188886],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004974211,0.000024905838,0.99812907,0.000027802946,0.000041483476,0.00028907997,0.000041088715,0.000009377263,0.0000736526,0.00001272988,0.00032447965,0.0009766442],"study_design_scores_gemma":[0.0000134930315,0.0001415918,0.99492306,0.00004681731,0.000088438974,0.0033081083,0.0002849688,0.00024535804,0.00006487065,0.000031892698,0.00084083225,0.000010605458],"about_ca_topic_score_codex":0.0014887977,"about_ca_topic_score_gemma":0.0013882568,"teacher_disagreement_score":0.0016325115,"about_ca_system_score_codex":0.00016432139,"about_ca_system_score_gemma":0.00022078458,"threshold_uncertainty_score":0.0055856705},"labels":[],"label_agreement":null},{"id":"W4403150659","doi":"10.1016/j.jaad.2024.09.048","title":"Hand eczema—Part 1: Epidemiology, pathogenesis, diagnosis, and work-up","year":2024,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Contact Dermatitis and Allergies","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Innovaderm (Canada)","funders":"","keywords":"Medicine; Epidemiology; Pathogenesis; Dermatology; Pathology","score_opus":0.07712894003050594,"score_gpt":0.3898101754194533,"score_spread":0.3126812353889473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403150659","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000051484636,0.99958855,0.000038192324,0.00009531683,0.000100326324,0.0000037880925,0.000011007238,0.0000021171718,0.00010911392],"genre_scores_gemma":[0.00043851943,0.9988961,0.0000883134,0.000119502496,0.00030942893,0.0000047864123,0.000024783141,6.251151e-7,0.00011786449],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99938345,0.00011655461,0.00013440709,0.00010924843,0.00021291504,0.00004341891],"domain_scores_gemma":[0.99882084,0.00056782627,0.0002864215,0.00002303287,0.00023952922,0.00006220381],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010368273,0.001641336,0.0030056657,0.0034879956,0.00025775586,0.0014566906,0.0013606742,0.0013675628,0.0032609876],"category_scores_gemma":[0.001679438,0.00055106345,0.0012058102,0.003261575,0.0006866156,0.0017390596,0.0007955385,0.0020798973,0.0013744025],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001624523,0.00014588707,0.0012798804,0.04923705,0.00040353113,0.00021955307,0.000063197396,0.00048641575,0.0012242334,0.0009694926,0.037425254,0.9083831],"study_design_scores_gemma":[0.00017723531,0.0005173464,0.023304533,0.05253275,0.002357003,0.009086784,0.00033157307,0.00059628225,0.0007130884,0.0031939785,0.9070547,0.00013470615],"about_ca_topic_score_codex":0.0029425554,"about_ca_topic_score_gemma":0.005047679,"teacher_disagreement_score":0.0034879956,"about_ca_system_score_codex":0.0009218376,"about_ca_system_score_gemma":0.0015495613,"threshold_uncertainty_score":0.01090914},"labels":[],"label_agreement":null},{"id":"W4403154445","doi":"10.1016/j.jaad.2024.09.049","title":"Hand eczema—Part 2: Prevention, management, and treatment","year":2024,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Contact Dermatitis and Allergies","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Innovaderm (Canada)","funders":"","keywords":"Medicine; Dermatology; MEDLINE","score_opus":0.04614757969202977,"score_gpt":0.3759904598324948,"score_spread":0.32984288014046503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403154445","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000056312794,0.9994967,0.000033647946,0.00008002388,0.000111227455,0.000006974606,0.000010775204,0.0000028561392,0.00020138462],"genre_scores_gemma":[0.00044199897,0.99890506,0.000103509126,0.00012507608,0.00018495663,0.000008190765,0.000019115007,7.179679e-7,0.00021142863],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99956745,0.00007838828,0.00007654817,0.000067646295,0.00017313982,0.000036815924],"domain_scores_gemma":[0.9994498,0.00025588885,0.00012538082,0.00001206281,0.00011674814,0.000040121882],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00086539827,0.0014557429,0.002687602,0.0027954185,0.00027295158,0.0012609204,0.0011133039,0.0013164569,0.004649389],"category_scores_gemma":[0.0011278711,0.00040685944,0.0011239921,0.002007971,0.00047510513,0.001127364,0.0006221899,0.0020709806,0.001419593],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012634548,0.00017947143,0.00022747912,0.03504223,0.0002449556,0.000080078564,0.000033131473,0.00032394077,0.000903612,0.0008268537,0.023932206,0.9380796],"study_design_scores_gemma":[0.00027214497,0.0005645044,0.006621353,0.036347628,0.0013737245,0.0027386057,0.00014502858,0.0004512604,0.0007010172,0.0018986112,0.9488134,0.000072878436],"about_ca_topic_score_codex":0.0026433168,"about_ca_topic_score_gemma":0.0047602034,"teacher_disagreement_score":0.004649389,"about_ca_system_score_codex":0.0006819206,"about_ca_system_score_gemma":0.0011940122,"threshold_uncertainty_score":0.015553772},"labels":[],"label_agreement":null},{"id":"W4403266005","doi":"10.1016/j.jaad.2024.09.046","title":"Real-world treatment outcomes of systemic treatments for moderate-to-severe atopic dermatitis in children aged less than 12 years: 2-year results from PEDIatric STudy in Atopic Dermatitis","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"Regeneron Pharmaceuticals; Sanofi","keywords":"Medicine; Atopic dermatitis; Dermatology; Pediatrics","score_opus":0.022026746284921427,"score_gpt":0.31884534021854993,"score_spread":0.2968185939336285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403266005","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99635965,0.0011033228,0.00008307883,0.000048095448,0.000008248258,0.00006297014,0.0020725662,0.0000053291033,0.00025684232],"genre_scores_gemma":[0.9956867,0.00038937913,0.000229635,0.00006042543,0.000022846145,0.00010118795,0.0034048173,0.0000042395136,0.00010072321],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99682873,0.0014650313,0.00038897328,0.0004717717,0.0005533889,0.0002920842],"domain_scores_gemma":[0.9929127,0.0011168913,0.0042559532,0.0004740283,0.00063521863,0.0006051797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0045682727,0.0005124633,0.00090260105,0.00075642637,0.00043833192,0.0007195741,0.00047400748,0.0006297196,0.00076515303],"category_scores_gemma":[0.0045144535,0.0002737906,0.0020003733,0.0011109314,0.0003458635,0.0008481422,0.0007277483,0.00093680125,0.00016638523],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005857465,0.00046808622,0.9861011,0.00014727117,0.0010396347,0.0000617493,0.00018168749,0.00018531336,0.00023306519,0.000017836654,0.00046710204,0.0052395957],"study_design_scores_gemma":[0.0004475436,0.0024987655,0.99566466,0.000021958958,0.00046772318,0.00015647338,0.00014033836,0.00010417053,0.0001293463,0.000007518555,0.0003517986,0.000009780053],"about_ca_topic_score_codex":0.0044164346,"about_ca_topic_score_gemma":0.005079008,"teacher_disagreement_score":0.0045682727,"about_ca_system_score_codex":0.00078507396,"about_ca_system_score_gemma":0.000540407,"threshold_uncertainty_score":0.02415967},"labels":[],"label_agreement":null},{"id":"W4403500339","doi":"10.1016/j.jaad.2024.09.064","title":"Sustained hair regrowth with continued ritlecitinib treatment through week 48 in patients with alopecia areata with or without early target responses: Post hoc analysis of the ALLEGRO phase 2b/3 trial","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Pfizer","keywords":"Alopecia areata; Medicine; Post-hoc analysis; Dermatology; Post hoc; Hair growth; Hair loss; Internal medicine; Physiology","score_opus":0.01568490326520126,"score_gpt":0.3174311889314136,"score_spread":0.3017462856662123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403500339","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99390393,0.0033988473,0.00029094014,0.00023453601,0.00005706551,0.00054431293,0.0005692443,0.000074676085,0.0009263839],"genre_scores_gemma":[0.99727064,0.00060504535,0.00036362786,0.00016882348,0.00006866812,0.00046153265,0.00051875826,0.000013699639,0.0005291727],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9988317,0.000683057,0.00006432246,0.00016234822,0.00010220735,0.00015644294],"domain_scores_gemma":[0.9984162,0.00054227235,0.00045852823,0.00015426106,0.000106077496,0.00032266814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0039403993,0.0007366704,0.002059213,0.0002652604,0.00028199077,0.0008357044,0.00052023504,0.0005702771,0.003352061],"category_scores_gemma":[0.0017944571,0.00025530736,0.0031120218,0.000254838,0.0004022572,0.0009184395,0.00029746883,0.0019167555,0.00056816067],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.89304554,0.005647233,0.01472096,0.001049403,0.005466644,0.00010559842,0.00014152519,0.0017025745,0.009022051,0.00006943533,0.0019438494,0.067085244],"study_design_scores_gemma":[0.5115918,0.37684008,0.095873944,0.00011331231,0.005724364,0.00037000215,0.0000936001,0.0028288206,0.0030294203,0.00027463835,0.0032015613,0.00005848871],"about_ca_topic_score_codex":0.0004649754,"about_ca_topic_score_gemma":0.001975743,"teacher_disagreement_score":0.0039403993,"about_ca_system_score_codex":0.00060120126,"about_ca_system_score_gemma":0.0009133853,"threshold_uncertainty_score":0.020839095},"labels":[],"label_agreement":null},{"id":"W4403695529","doi":"10.1016/j.jaad.2024.09.066","title":"A retrospective multicenter cohort study of differences in clinical characteristics of Infantile Hemangiomas in preterm and term infants: Prematurity increases risk of permanent cutaneous sequelae","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Vascular Malformations and Hemangiomas","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Pediatric Dermatology Research Alliance","keywords":"Medicine; Retrospective cohort study; Pediatrics; Cohort study; Cohort; Multicenter study; Surgery; Internal medicine; Randomized controlled trial","score_opus":0.012964476277886817,"score_gpt":0.3172832230146749,"score_spread":0.30431874673678805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403695529","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994344,0.00009647693,0.000053859567,0.000013797855,0.000005077438,0.000006046669,0.00024767604,0.0000022028846,0.00014037605],"genre_scores_gemma":[0.9994362,0.00005152821,0.000055911747,0.00001811018,0.000008771544,0.000011285358,0.00029263351,0.0000038044575,0.000121818186],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99919945,0.00019181157,0.00008415497,0.00026412503,0.000095910684,0.00016458605],"domain_scores_gemma":[0.9979235,0.00026635258,0.00081936567,0.00032543726,0.0002519506,0.00041337372],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070918596,0.0005196178,0.00061319215,0.0009395866,0.00082649896,0.0008500285,0.0006079415,0.0008533961,0.0020307929],"category_scores_gemma":[0.002537594,0.0006485482,0.00075415586,0.0014124062,0.00034153866,0.0008214786,0.0006525827,0.0009811644,0.00035957788],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030739006,0.000051711457,0.9985209,0.0000046903406,0.00007356587,0.00019585673,0.00008426047,0.000011226301,0.00030579275,0.00001389233,0.000057533358,0.00037324164],"study_design_scores_gemma":[0.000013135694,0.00021922868,0.998538,0.00000332639,0.000047644593,0.0006080722,0.0003391522,0.000076082564,0.00005193078,0.000011851954,0.00008614865,0.0000053522167],"about_ca_topic_score_codex":0.0067303455,"about_ca_topic_score_gemma":0.0045679286,"teacher_disagreement_score":0.0067303455,"about_ca_system_score_codex":0.0004170376,"about_ca_system_score_gemma":0.0004736351,"threshold_uncertainty_score":0.013382375},"labels":[],"label_agreement":null},{"id":"W4403860155","doi":"10.1016/j.jaad.2024.09.040","title":"US Food and Drug Administration recalls of cosmetic and personal products from 2011 to 2023: A cross-sectional study","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Pharmaceutical industry and healthcare","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Food and drug administration; Cross-sectional study; Drug; Environmental health; Pharmacology; Pathology","score_opus":0.2506028828390506,"score_gpt":0.5316822916769813,"score_spread":0.28107940883793076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403860155","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992516,0.00030516728,0.00009984722,0.00009590124,0.000022323182,0.000036935016,0.006032047,0.0000095919295,0.0008821803],"genre_scores_gemma":[0.9930895,0.0003008294,0.000119945355,0.00018017027,0.00001771671,0.000053282616,0.005287475,0.0000060814655,0.0009450444],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991431,0.00016379419,0.00016880126,0.0001771458,0.00017198271,0.00017513592],"domain_scores_gemma":[0.99665076,0.0003650164,0.001875889,0.00023022328,0.00056470773,0.0003133949],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009357874,0.00046641016,0.00044741522,0.0013523832,0.000706169,0.0009844092,0.0007942292,0.001388971,0.002119014],"category_scores_gemma":[0.002469519,0.0009357714,0.0010685159,0.002612937,0.0003325193,0.0011086784,0.0008697722,0.0014596538,0.00095335185],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000090248664,0.00008296157,0.99890566,0.000010872614,0.00007992242,0.000038104332,0.00008058168,0.000023785466,0.00006470765,0.000005018108,0.0002097734,0.0004083122],"study_design_scores_gemma":[0.000003362187,0.000063996245,0.9992143,0.000007834956,0.000029812578,0.0000915693,0.00025937622,0.00006420703,0.000029467694,0.0000033699876,0.00022816814,0.000004347866],"about_ca_topic_score_codex":0.083965175,"about_ca_topic_score_gemma":0.09689035,"teacher_disagreement_score":0.083965175,"about_ca_system_score_codex":0.0010951604,"about_ca_system_score_gemma":0.0008908873,"threshold_uncertainty_score":0.16695291},"labels":[],"label_agreement":null},{"id":"W4404169234","doi":"10.1016/j.jaad.2024.10.064","title":"Reduction of masseter muscle prominence after treatment with onabotulinumtoxinA: Primary results from a randomized phase 2 study","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Botulinum Toxin and Related Neurological Disorders","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Positive Living Society of British Columbia","funders":"Allergan; AbbVie; Allergan Aesthetics","keywords":"Medicine; Masseter muscle; Reduction (mathematics); Randomized controlled trial; Dentistry; Physical therapy; Surgery","score_opus":0.014879580517499939,"score_gpt":0.3060465905366975,"score_spread":0.2911670100191976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404169234","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9757304,0.0069813845,0.001174563,0.00060326204,0.00046273207,0.011856599,0.0014574785,0.00017906181,0.0015545074],"genre_scores_gemma":[0.96695775,0.00715534,0.0035464258,0.0015142807,0.0010350095,0.015510493,0.0017037356,0.00005672731,0.0025201896],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.998575,0.00082217914,0.00010464634,0.00018948915,0.00014282684,0.00016588315],"domain_scores_gemma":[0.99805045,0.0006263617,0.0006496819,0.00018692751,0.00015093395,0.00033557578],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004047291,0.0019664995,0.0035612178,0.00054756616,0.00047763955,0.001027063,0.0011453857,0.0017944853,0.00804431],"category_scores_gemma":[0.0029320258,0.0008612194,0.0022782234,0.00046184266,0.0011351635,0.000944967,0.0003971616,0.0018692554,0.00089014316],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.95105666,0.01718184,0.0009037268,0.0014288442,0.0014942242,0.00007319384,0.00007678216,0.00016474459,0.006050266,0.00004908948,0.0007648483,0.02075571],"study_design_scores_gemma":[0.8935934,0.10264035,0.0021688105,0.000048212587,0.0005555141,0.000041749034,0.000014706743,0.00010393212,0.00041638935,0.000040749845,0.00036823459,0.00000793041],"about_ca_topic_score_codex":0.00061466027,"about_ca_topic_score_gemma":0.0015815604,"teacher_disagreement_score":0.00804431,"about_ca_system_score_codex":0.0008098539,"about_ca_system_score_gemma":0.0015639769,"threshold_uncertainty_score":0.026910901},"labels":[],"label_agreement":null},{"id":"W4404368241","doi":"10.1016/j.jaad.2024.10.076","title":"FRONTIER-2: A phase 2b, long-term extension, dose-ranging study of oral JNJ-77242113 for the treatment of moderate-to-severe plaque psoriasis","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"Cilag; Galderma; Janssen Research and Development; Pfizer Pharmaceuticals; LEO Pharma; Bausch Health; Basilea Pharmaceutica; Glenmark Pharmaceuticals; Actelion Pharmaceuticals; Pfizer; Biogen; Incyte; IC Design Education Center; Kiniksa Pharmaceuticals; Regeneron Pharmaceuticals; Mylan; Castle Biosciences; Dermira; Celgene; Valeant Pharmaceuticals International; Sanofi; Amgen; Eli Lilly and Company; Bristol-Myers Squibb; GlaxoSmithKline","keywords":"Medicine; Plaque psoriasis; Term (time); Dose-ranging study; Dermatology; Psoriasis; Extension (predicate logic); Internal medicine; Pathology","score_opus":0.03348407815273174,"score_gpt":0.3308613464931109,"score_spread":0.29737726834037914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404368241","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923919,0.0024994437,0.00049217197,0.00036588826,0.000083043495,0.0014407969,0.00083743833,0.00010516791,0.001784187],"genre_scores_gemma":[0.9857757,0.00268408,0.0019430621,0.0008988304,0.00017422612,0.0015443185,0.0021912914,0.000040315026,0.0047481926],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997638,0.000087592496,0.0000095657515,0.000036499503,0.000045976292,0.000056644054],"domain_scores_gemma":[0.99965906,0.000053714946,0.00008129665,0.000018554752,0.000024352457,0.00016305594],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013705734,0.0013286131,0.00087756896,0.00036035586,0.0002999719,0.0006659958,0.0007642388,0.0007978354,0.004665422],"category_scores_gemma":[0.00043117767,0.0003928525,0.000655175,0.00021842193,0.0005839284,0.000570593,0.00032136147,0.0023295882,0.0009448909],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.41962537,0.13737299,0.009271151,0.0024727406,0.0012545421,0.00064499263,0.00043953778,0.0025197312,0.22616284,0.000643165,0.010037632,0.18955532],"study_design_scores_gemma":[0.56015396,0.3961386,0.026037684,0.00010301529,0.00046951903,0.0007672129,0.000079336656,0.0009388581,0.010110429,0.0001754374,0.0049809003,0.000045080636],"about_ca_topic_score_codex":0.000814867,"about_ca_topic_score_gemma":0.0021963909,"teacher_disagreement_score":0.004665422,"about_ca_system_score_codex":0.000538561,"about_ca_system_score_gemma":0.0012222554,"threshold_uncertainty_score":0.015607417},"labels":[],"label_agreement":null},{"id":"W4404636009","doi":"10.1016/j.jaad.2024.09.083","title":"Response to Tang et al, “Insufficient evidence for association between dermatology follow-up and melanoma survival”","year":2024,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; Women's College Hospital; University of Toronto; Queen's University","funders":"","keywords":"Medicine; Dermatology; Melanoma; Association (psychology); MEDLINE","score_opus":0.04432748158051437,"score_gpt":0.35404769669274216,"score_spread":0.3097202151122278,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404636009","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00032487727,0.00058923464,0.0000388731,0.98212814,0.01580836,0.000011278966,0.00012525935,0.000019795521,0.00095417554],"genre_scores_gemma":[0.00201666,0.0004190191,0.00010069347,0.974872,0.020275394,0.000027770386,0.000054579377,0.000013441245,0.0022203738],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99644357,0.000974342,0.000558285,0.0005415569,0.00088065275,0.0006015925],"domain_scores_gemma":[0.9853194,0.0072475583,0.0015183641,0.00039485111,0.003364673,0.0021552355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004297021,0.00080294313,0.0018162904,0.0012868146,0.0037962408,0.0036481267,0.0021500916,0.045367427,0.0076013934],"category_scores_gemma":[0.03223025,0.0009112909,0.0013955673,0.0011474201,0.0017064599,0.0024086358,0.0015740097,0.031173551,0.007091985],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006015944,0.000023254881,0.0011515351,0.00004487483,0.000021654321,0.0006428534,0.00006519797,0.000027817907,0.000077861754,0.00033754096,0.99387854,0.0036687509],"study_design_scores_gemma":[0.00035234957,0.00015751107,0.0073939045,0.0010413134,0.00019590402,0.0033212192,0.0013181946,0.00071671704,0.00042565764,0.0049091247,0.98004216,0.00012592114],"about_ca_topic_score_codex":0.010106999,"about_ca_topic_score_gemma":0.01967871,"teacher_disagreement_score":0.045367427,"about_ca_system_score_codex":0.0051116627,"about_ca_system_score_gemma":0.005842713,"threshold_uncertainty_score":0.037087917},"labels":[],"label_agreement":null},{"id":"W4404800889","doi":"10.1016/j.jaad.2024.10.107","title":"Risk factors and temporal associations of progression of the atopic march in children with early-onset atopic dermatitis","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"Pfizer","keywords":"Medicine; Atopic dermatitis; Dermatology; Atopy; Allergy; Immunology","score_opus":0.011353393450278403,"score_gpt":0.3076284360803613,"score_spread":0.29627504263008286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404800889","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980646,0.0006186181,0.00006508864,0.0000548013,0.000010078199,0.000004323255,0.00026078147,0.0000075141634,0.00091418985],"genre_scores_gemma":[0.99936706,0.00017949445,0.000054797667,0.000007841581,0.000012420353,0.0000034940956,0.00016119437,0.0000025789607,0.0002111735],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99956924,0.00009746073,0.00005548635,0.00008592107,0.00007226522,0.00011969289],"domain_scores_gemma":[0.99785054,0.00040301422,0.0010473276,0.00012602539,0.00017613331,0.00039694415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042773338,0.00033470333,0.0003458396,0.00096899376,0.0004550046,0.0007671074,0.00045952687,0.00057699106,0.002696765],"category_scores_gemma":[0.0023845478,0.00031488616,0.000617534,0.0012903363,0.00029173252,0.00061535806,0.0005143831,0.0013551919,0.00028975666],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026960787,0.000044827804,0.9981165,0.000008658509,0.00003063204,0.00023943816,0.00006174014,0.000026700622,0.00026554923,0.00003163984,0.00004749911,0.0008572231],"study_design_scores_gemma":[0.0000028886693,0.000065546665,0.99879956,0.000005020313,0.000020049352,0.0006672284,0.00018203605,0.000075573946,0.000058529873,0.00002130968,0.00009940992,0.000002823864],"about_ca_topic_score_codex":0.0061669135,"about_ca_topic_score_gemma":0.0058386596,"teacher_disagreement_score":0.0061669135,"about_ca_system_score_codex":0.00031301158,"about_ca_system_score_gemma":0.00046515453,"threshold_uncertainty_score":0.012262046},"labels":[],"label_agreement":null},{"id":"W4404960032","doi":"10.1016/j.jaad.2024.09.086","title":"Long-term evolution of prepubertal-onset anogenital lichen sclerosus: A 35-year retrospective and cross-sectional study from a single tertiary care maternal and pediatric center","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Genital Health and Disease","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Lichen sclerosus; Tertiary care; Cross-sectional study; Retrospective cohort study; Center (category theory); Pediatrics; Term (time); Dermatology; Family medicine; Surgery","score_opus":0.011748622377059644,"score_gpt":0.31057997775339097,"score_spread":0.2988313553763313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404960032","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99953985,0.00011637579,0.000023509352,0.000014027944,0.0000023090186,0.0000031527334,0.00014218305,0.0000015673626,0.00015709826],"genre_scores_gemma":[0.9996275,0.00007395369,0.000025100624,0.000016859494,0.000004739633,0.0000033462043,0.00018262862,0.000001228354,0.000064670545],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99936813,0.00015798287,0.00009328682,0.00014613508,0.00008470968,0.00014978243],"domain_scores_gemma":[0.99803466,0.0003167349,0.00079181796,0.0001188353,0.0002520748,0.0004859453],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005521749,0.00034818146,0.00040057002,0.0013914447,0.0010134402,0.0009232448,0.0004722297,0.0007122393,0.0012373368],"category_scores_gemma":[0.0015629237,0.0005068439,0.0005418243,0.0013543707,0.0005278146,0.0010377186,0.0007835474,0.0007859374,0.0002734363],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003407275,0.000040183062,0.99921036,0.0000028164604,0.000019990703,0.0002480843,0.000094480696,0.000008147406,0.00011041047,0.000006137498,0.00002273023,0.00020252993],"study_design_scores_gemma":[0.0000015095357,0.0001078001,0.9983973,0.0000031195639,0.000017809803,0.00077090063,0.0005777973,0.000035927904,0.000024497382,0.0000041882868,0.000055858847,0.000003355922],"about_ca_topic_score_codex":0.010581436,"about_ca_topic_score_gemma":0.011557191,"teacher_disagreement_score":0.010581436,"about_ca_system_score_codex":0.0005182847,"about_ca_system_score_gemma":0.0005401583,"threshold_uncertainty_score":0.021039665},"labels":[],"label_agreement":null},{"id":"W4405150469","doi":"10.1016/j.jaad.2024.11.057","title":"Cost-utility analysis of clinic-based deroofing versus local excision for hidradenitis suppurativa","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Public Health Agency of Canada; Women's College Hospital; University of Toronto","funders":"Public Health Agency; Public Health Agency of Canada","keywords":"Hidradenitis suppurativa; Medicine; Dermatology; Surgery; Internal medicine; Disease","score_opus":0.07617986358102784,"score_gpt":0.42013174831042277,"score_spread":0.3439518847293949,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405150469","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9531933,0.005910259,0.022928827,0.002117916,0.00009664334,0.0011424228,0.0048651625,0.000114648334,0.009630789],"genre_scores_gemma":[0.99500316,0.0004779518,0.0029940768,0.00010653913,0.000011773462,0.0002134119,0.0006415844,0.00000677661,0.0005447408],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9980235,0.0014432105,0.000062005085,0.00016066707,0.00014065234,0.00017007365],"domain_scores_gemma":[0.99279344,0.0060544326,0.00051059725,0.000116901785,0.00026838543,0.00025632192],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004612043,0.00079366635,0.0014842057,0.0011567853,0.00025663228,0.0013751823,0.0010261729,0.0008969974,0.005181246],"category_scores_gemma":[0.0132125355,0.00042266076,0.0033680673,0.0009808261,0.00036619083,0.000812791,0.000801616,0.0010684788,0.00018698211],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007723807,0.0005084326,0.01648936,0.0007825696,0.0018488944,0.00021890439,0.000056427652,0.9448234,0.0005601908,0.005403887,0.0014419308,0.020142209],"study_design_scores_gemma":[0.0013934165,0.0043311804,0.014749956,0.00048295484,0.0029446871,0.00032799834,0.00016416832,0.9684834,0.00059461314,0.005196626,0.0012532327,0.00007781773],"about_ca_topic_score_codex":0.011619865,"about_ca_topic_score_gemma":0.0073377886,"teacher_disagreement_score":0.011619865,"about_ca_system_score_codex":0.00594005,"about_ca_system_score_gemma":0.0030805904,"threshold_uncertainty_score":0.04309827},"labels":[],"label_agreement":null},{"id":"W4405635432","doi":"10.1016/j.jaad.2024.11.065","title":"Risk of Candida and overall fungal infections with interleukin-17 inhibitors in the treatment of hidradenitis suppurativa: A systematic review and meta-analysis","year":2024,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McMaster University","funders":"","keywords":"Hidradenitis suppurativa; Medicine; Meta-analysis; Dermatology; Internal medicine; Disease","score_opus":0.03639534485276472,"score_gpt":0.3588279827944944,"score_spread":0.32243263794172966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405635432","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005362424,0.99400145,0.00016742518,0.00005660403,0.00008629125,0.00004929211,0.00015899401,0.000007702549,0.000109818444],"genre_scores_gemma":[0.14210556,0.85550666,0.0008359733,0.00053303665,0.00023164191,0.00019166576,0.00032309027,0.000012087971,0.0002603449],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9973097,0.0009776034,0.0008289133,0.00039340032,0.00034092777,0.0001494333],"domain_scores_gemma":[0.9937691,0.0045354837,0.0010684502,0.00015155421,0.0003598571,0.00011549775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003870003,0.0019753615,0.012934461,0.002614394,0.00046985399,0.0022501766,0.0013750402,0.0020208855,0.0028294607],"category_scores_gemma":[0.010691075,0.0011648168,0.027473094,0.0036528686,0.00052503933,0.0011328447,0.0011409384,0.0021345254,0.00020108485],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0057129753,0.0000831725,0.0072400416,0.3192551,0.643706,0.00017690953,0.00009874266,0.0005600911,0.0003759657,0.000106693195,0.0006723539,0.02201197],"study_design_scores_gemma":[0.000901686,0.00029369796,0.006296161,0.013251924,0.9775253,0.000114534996,0.000056347315,0.00017040683,0.00010553854,0.000108923996,0.0011430427,0.000032519863],"about_ca_topic_score_codex":0.0061933426,"about_ca_topic_score_gemma":0.0140828015,"teacher_disagreement_score":0.012934461,"about_ca_system_score_codex":0.001210687,"about_ca_system_score_gemma":0.0016655853,"threshold_uncertainty_score":0.020466745},"labels":[],"label_agreement":null},{"id":"W4405695730","doi":"10.1016/j.jaad.2024.12.018","title":"Efficacy and safety of tildrakizumab for the treatment of moderate-to-severe plaque psoriasis of the scalp: Week 52 results from a phase 3b, randomized, double-blind, placebo-controlled trial","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"Sun Pharma; Amgen","keywords":"Medicine; Scalp; Randomized controlled trial; Placebo; Double blind; Dermatology; Psoriasis; Adverse effect; Surgery; Internal medicine; Pathology; Alternative medicine","score_opus":0.02970217914875858,"score_gpt":0.31243469179696925,"score_spread":0.2827325126482107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405695730","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97175074,0.015141221,0.0010408022,0.0009451123,0.00035238452,0.004684327,0.0016073132,0.0002673358,0.0042107226],"genre_scores_gemma":[0.9859897,0.0041235685,0.001226162,0.0012910201,0.00029235394,0.0032599822,0.0012474214,0.00004084555,0.0025289545],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9990576,0.00045937096,0.000081434526,0.00016959356,0.00011517957,0.00011677814],"domain_scores_gemma":[0.99906033,0.00019311531,0.0003656999,0.00008476981,0.00007442838,0.00022164526],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023646161,0.0011079621,0.001990008,0.000275319,0.00039569134,0.0009966053,0.0006881888,0.0014468073,0.0068687694],"category_scores_gemma":[0.0015920192,0.00044459244,0.0018677055,0.00027032217,0.0006081635,0.0006771523,0.00026023135,0.0022166185,0.0011940718],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9159862,0.010208053,0.0020225393,0.0022489566,0.0020710179,0.000105490486,0.00010297862,0.00039254193,0.018180497,0.00010421755,0.0026442774,0.045933284],"study_design_scores_gemma":[0.9317736,0.055310767,0.009024463,0.00013526628,0.00088849245,0.00012445495,0.000016175558,0.00029947524,0.0011511112,0.00011310925,0.0011427427,0.000020368181],"about_ca_topic_score_codex":0.00044263367,"about_ca_topic_score_gemma":0.0011619146,"teacher_disagreement_score":0.0068687694,"about_ca_system_score_codex":0.0005581822,"about_ca_system_score_gemma":0.00075472525,"threshold_uncertainty_score":0.022978365},"labels":[],"label_agreement":null},{"id":"W4405738575","doi":"10.1016/j.jaad.2024.11.071","title":"North American clinical practice guidelines for the medical management of hidradenitis suppurativa in special patient populations","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Women's College Hospital; University of Calgary; Centre hospitalier de l'Université Laval; University of British Columbia; Hospital for Sick Children; Ottawa Hospital; University of Ottawa; Memorial University of Newfoundland; University of Toronto; Sunnybrook Hospital; Sunnybrook Health Science Centre","funders":"","keywords":"Hidradenitis suppurativa; Medicine; Dermatology; Clinical Practice; MEDLINE; Family medicine; Internal medicine; Disease","score_opus":0.0986742628302681,"score_gpt":0.474273538065497,"score_spread":0.3755992752352289,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405738575","genre_codex":"review","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009060896,0.4302938,0.050477363,0.228859,0.02058275,0.007947973,0.0073456853,0.0025142054,0.24291828],"genre_scores_gemma":[0.08139987,0.33588982,0.38584682,0.10649412,0.013721285,0.017000604,0.017546328,0.00066092896,0.041440126],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9915799,0.0031288122,0.0025600458,0.0002819026,0.0020648004,0.0003845443],"domain_scores_gemma":[0.95356256,0.014473627,0.0070577385,0.0006888262,0.02219841,0.0020188948],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007555117,0.0009840201,0.0015550479,0.0046982053,0.0019431101,0.0024576038,0.0027413082,0.005058587,0.010833349],"category_scores_gemma":[0.03599869,0.0006365678,0.0024760915,0.0041149836,0.0011911058,0.0014999099,0.0013783744,0.005495148,0.004257137],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020422418,0.0007477588,0.005636709,0.004693167,0.00019212002,0.00078698364,0.00052838126,0.0013096494,0.0008131333,0.004726195,0.67174613,0.30861554],"study_design_scores_gemma":[0.0008731816,0.00027389676,0.03086925,0.031809177,0.0004212251,0.0045044217,0.0009867554,0.0023182498,0.0006307371,0.008282039,0.91884035,0.00019058121],"about_ca_topic_score_codex":0.017614974,"about_ca_topic_score_gemma":0.039169338,"teacher_disagreement_score":0.017614974,"about_ca_system_score_codex":0.0026827175,"about_ca_system_score_gemma":0.011429659,"threshold_uncertainty_score":0.039955735},"labels":[],"label_agreement":null},{"id":"W4405835719","doi":"10.1016/j.jaad.2024.12.026","title":"The efficacy of longer-term lebrikizumab treatment in patients with moderate-to-severe atopic dermatitis who did not meet protocol-defined response criteria at week 16 in 2 randomized controlled clinical trials","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; University of British Columbia","funders":"","keywords":"Medicine; Atopic dermatitis; Randomized controlled trial; Protocol (science); Clinical trial; Dermatology; Surgery; Internal medicine; Alternative medicine; Pathology","score_opus":0.03445861244870212,"score_gpt":0.39352145412648143,"score_spread":0.3590628416777793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405835719","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91774535,0.07341384,0.001093402,0.0017936263,0.0013607879,0.0018241701,0.00058859074,0.00009439437,0.0020859037],"genre_scores_gemma":[0.98720735,0.0069545433,0.000996957,0.0013238271,0.0004686569,0.0016034478,0.00043949054,0.000013209742,0.000992564],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99755657,0.0014496114,0.00029178415,0.0003339817,0.00013963728,0.00022840522],"domain_scores_gemma":[0.9975799,0.0012222689,0.000587539,0.00015980152,0.00012905234,0.0003215163],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0052491515,0.0011743925,0.0049169175,0.00041449373,0.0005245199,0.001445656,0.0009894101,0.0027549788,0.0037181424],"category_scores_gemma":[0.004464727,0.0006134897,0.004543154,0.0004802819,0.0013341379,0.0020435445,0.0004926271,0.0041858857,0.00038612325],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.96409655,0.0016480536,0.0011755284,0.0029710692,0.0043608337,0.000054677806,0.00009429458,0.00037911706,0.0013390732,0.00013889343,0.0005165025,0.023225347],"study_design_scores_gemma":[0.9456698,0.045288894,0.0039652777,0.00026858837,0.0028194648,0.00004929928,0.00005601272,0.00041506696,0.0002837703,0.00023085656,0.0009233699,0.000029623025],"about_ca_topic_score_codex":0.0007623291,"about_ca_topic_score_gemma":0.0018729094,"teacher_disagreement_score":0.0052491515,"about_ca_system_score_codex":0.001055183,"about_ca_system_score_gemma":0.0009480254,"threshold_uncertainty_score":0.027760506},"labels":[],"label_agreement":null},{"id":"W4406410756","doi":"10.1016/j.jaad.2024.11.077","title":"Safety of beta blockers for the treatment of PHACE syndrome: A systematic review","year":2025,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Diverse Scientific and Economic Studies","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; BETA (programming language); MEDLINE; Intensive care medicine","score_opus":0.05264881151592456,"score_gpt":0.3142917156578312,"score_spread":0.26164290414190666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406410756","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009772967,0.99836737,0.00009358911,0.00011700748,0.00007246967,0.00007483517,0.00017316714,0.000004162248,0.000120074],"genre_scores_gemma":[0.022078479,0.9765379,0.00031628355,0.00056981883,0.00012654606,0.000101491765,0.00017399437,0.0000033371684,0.000092152324],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99679404,0.000994404,0.0012034534,0.00033916044,0.0005576236,0.000111304784],"domain_scores_gemma":[0.9880244,0.008356705,0.0026094452,0.00015909135,0.00068764243,0.00016270528],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0039010379,0.0010460194,0.007837295,0.0028017343,0.00037331256,0.0017129701,0.0015322698,0.0019124829,0.0037198367],"category_scores_gemma":[0.018601838,0.0006242888,0.008358869,0.0029107,0.0006488251,0.0012152229,0.00093382125,0.0014069384,0.00024275582],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017946406,0.000044082393,0.001511925,0.8834733,0.059369996,0.00011898298,0.00008804006,0.00021272755,0.00025822845,0.00020696373,0.0020162347,0.050904956],"study_design_scores_gemma":[0.0029374259,0.0008900772,0.010123764,0.48277608,0.48325104,0.00052439614,0.00020615844,0.00025071288,0.00032749027,0.00063129014,0.017986907,0.00009457886],"about_ca_topic_score_codex":0.0051030903,"about_ca_topic_score_gemma":0.01313202,"teacher_disagreement_score":0.007837295,"about_ca_system_score_codex":0.0015078117,"about_ca_system_score_gemma":0.0037540153,"threshold_uncertainty_score":0.020630896},"labels":[],"label_agreement":null},{"id":"W4406620870","doi":"10.1016/j.jaad.2024.12.034","title":"Real-world experience of bimekizumab for plaque psoriasis in adult patients with prior exposure to interleukin-17 inhibitors: A 52-week multicenter retrospective review","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; Women's College Hospital; Dermatrials Research; Probity Medical Research; SKiN Health; University of Calgary; University of Toronto","funders":"Women's College Hospital","keywords":"Medicine; Plaque psoriasis; Psoriasis; Multicenter study; Interleukin; Retrospective cohort study; Dermatology; Interleukin 17; Internal medicine; Cytokine; Randomized controlled trial","score_opus":0.00941404489685831,"score_gpt":0.28059734968477007,"score_spread":0.27118330478791175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406620870","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9793931,0.019219944,0.00022932905,0.00011847118,0.000017450602,0.000033372984,0.00040828905,0.0000029346347,0.00057710777],"genre_scores_gemma":[0.9936027,0.005570459,0.000163366,0.00013538003,0.00003751349,0.000020008052,0.0003903819,0.0000035041478,0.000076657896],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99860364,0.00036115508,0.000349391,0.0003318051,0.00023365587,0.00012030279],"domain_scores_gemma":[0.996119,0.0010946618,0.0020369745,0.0002055432,0.00033358246,0.0002102765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016387859,0.0001897431,0.00064048666,0.000616474,0.00032531022,0.0010466404,0.00034298285,0.00051497057,0.0008534192],"category_scores_gemma":[0.004020316,0.00025322204,0.0007471378,0.0010697921,0.00042691152,0.0006275908,0.00044653282,0.00045123644,0.00018463505],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008454078,0.0001443255,0.9782696,0.00073045347,0.0007486195,0.0027265006,0.00062594644,0.000088463006,0.0006952168,0.0001076511,0.00049726834,0.01452066],"study_design_scores_gemma":[0.00012811122,0.0012007891,0.96437466,0.00049894414,0.0013374147,0.02354738,0.0026815108,0.00022310927,0.0005331109,0.00006751644,0.005368599,0.000038849743],"about_ca_topic_score_codex":0.001168202,"about_ca_topic_score_gemma":0.0012667364,"teacher_disagreement_score":0.0016387859,"about_ca_system_score_codex":0.0005498344,"about_ca_system_score_gemma":0.0005649032,"threshold_uncertainty_score":0.008666813},"labels":[],"label_agreement":null},{"id":"W4406682209","doi":"10.1016/j.jaad.2025.01.029","title":"A call to action: The need to update population descriptors in dermatology research studies with the use of an inclusive skin classification system","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Sex and Gender in Healthcare","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"","keywords":"Medicine; Dermatology; Call to action; Action (physics); Population; Environmental health; Advertising","score_opus":0.2214966673969795,"score_gpt":0.483671342090271,"score_spread":0.2621746746932915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406682209","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018830054,0.01373361,0.009040343,0.9430889,0.029668748,0.00036880284,0.00036290527,0.00032448972,0.001529244],"genre_scores_gemma":[0.023706118,0.013029562,0.13819298,0.79383826,0.025583137,0.0021315888,0.00085180526,0.00043963038,0.0022269473],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.59496063,0.22586921,0.0963065,0.012840925,0.06516885,0.0048538796],"domain_scores_gemma":[0.11630529,0.6038523,0.032113917,0.03855719,0.19248189,0.016689446],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.50485915,0.0025574933,0.01298878,0.012674021,0.009886169,0.029772053,0.018029166,0.042109627,0.0077378326],"category_scores_gemma":[0.627647,0.003656685,0.007594375,0.0094876755,0.02820462,0.048109643,0.016162893,0.078541845,0.003751236],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005115557,0.000752248,0.021761207,0.008089006,0.0011124515,0.00054145977,0.016403118,0.0008140896,0.0011369823,0.030816516,0.6972026,0.22085875],"study_design_scores_gemma":[0.0005778052,0.00069907575,0.029837957,0.038948726,0.0013754359,0.00195439,0.03218875,0.0030434248,0.0010586354,0.054701302,0.8336946,0.0019199931],"about_ca_topic_score_codex":0.050744135,"about_ca_topic_score_gemma":0.084070325,"teacher_disagreement_score":0.49514085,"about_ca_system_score_codex":0.01591211,"about_ca_system_score_gemma":0.06307164,"threshold_uncertainty_score":0.6105969},"labels":[],"label_agreement":null},{"id":"W4406693435","doi":"10.1016/j.jaad.2024.11.079","title":"Dupilumab treatment restores lesional and nonlesional skin barrier function in adults and adolescents with atopic dermatitis irrespective of the filaggrin genotype: Results from an open-label, healthy-control–matched, phase 4 clinical study (BALISTAD)","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"Regeneron Pharmaceuticals; Sanofi","keywords":"Medicine; Atopic dermatitis; Filaggrin; Dermatology; Open label; Dupilumab; Skin barrier; Genotype; Randomized controlled trial; Surgery","score_opus":0.024837628024597068,"score_gpt":0.37862234941935347,"score_spread":0.3537847213947564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406693435","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984086,0.0010143648,0.000057153564,0.000043076197,0.000027220569,0.00008705516,0.00010072472,0.000015723437,0.00024611596],"genre_scores_gemma":[0.9981988,0.0007354856,0.00025112473,0.00015445518,0.000039821105,0.000086591106,0.0002224636,0.000005377085,0.00030580637],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99974936,0.00009143852,0.000018042954,0.000049042003,0.0000346604,0.00005744658],"domain_scores_gemma":[0.9997563,0.000053083735,0.00005299855,0.00001845374,0.000021448319,0.00009765073],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070302206,0.0005770277,0.0012283763,0.00025598056,0.00028697908,0.0005176012,0.0004008588,0.00049076264,0.0012356626],"category_scores_gemma":[0.00045069435,0.0002261002,0.0005648354,0.00016974514,0.00038518902,0.00041501675,0.0001751061,0.0010013713,0.00022869892],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5570079,0.05645371,0.03603629,0.0016214552,0.0033537885,0.0007285583,0.00060697336,0.0008202619,0.09256423,0.0001714568,0.002932237,0.2477031],"study_design_scores_gemma":[0.2266336,0.49102798,0.26334444,0.00012015881,0.0021883221,0.0015361329,0.00041034995,0.0016436931,0.00915808,0.00015490603,0.0037210651,0.000061301675],"about_ca_topic_score_codex":0.00079085596,"about_ca_topic_score_gemma":0.0022639073,"teacher_disagreement_score":0.0012356626,"about_ca_system_score_codex":0.00035718307,"about_ca_system_score_gemma":0.00038042144,"threshold_uncertainty_score":0.0041337013},"labels":[],"label_agreement":null},{"id":"W4406873098","doi":"10.1016/j.jaad.2025.01.051","title":"Real-world experience of tralokinumab for atopic dermatitis: A 16-week multicenter retrospective study","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Calgary; University of Alberta Hospital; University of Alberta; SKiN Health; Calgary Laboratory Services; University of Manitoba; University of Toronto","funders":"","keywords":"Medicine; Atopic dermatitis; Multicenter study; Retrospective cohort study; Dermatology; Surgery","score_opus":0.01787948283214485,"score_gpt":0.3503615032673751,"score_spread":0.33248202043523023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406873098","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981488,0.0009046808,0.00021342222,0.0000528446,0.000014085142,0.00004565223,0.0002802227,0.0000029906744,0.00033734858],"genre_scores_gemma":[0.9987658,0.00033812723,0.00016622497,0.00008331552,0.000041936168,0.000032231004,0.00044253774,0.0000060050934,0.0001238119],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973961,0.00086468155,0.00044420265,0.00067287765,0.00037301664,0.0002491758],"domain_scores_gemma":[0.994693,0.0011595897,0.0021982952,0.00072056614,0.0005146688,0.0007138951],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003213984,0.0005429237,0.0008334801,0.0006322658,0.0006222086,0.0013662435,0.00051935436,0.0007245761,0.0016648268],"category_scores_gemma":[0.005683034,0.00041693862,0.0009908109,0.0008854695,0.00071555015,0.0010449911,0.00074969535,0.00075240614,0.0005737957],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024293067,0.0005264359,0.98941296,0.000093382165,0.00037262993,0.001811004,0.0006283188,0.00012527918,0.00059213204,0.000046504818,0.00028382087,0.003678273],"study_design_scores_gemma":[0.00042473097,0.005961859,0.97400224,0.00010567158,0.00065208843,0.012319117,0.0018170499,0.00071495003,0.00049602316,0.00007191312,0.0033413284,0.00009315787],"about_ca_topic_score_codex":0.0011212699,"about_ca_topic_score_gemma":0.00097516045,"teacher_disagreement_score":0.003213984,"about_ca_system_score_codex":0.0007398983,"about_ca_system_score_gemma":0.00053426746,"threshold_uncertainty_score":0.016997397},"labels":[],"label_agreement":null},{"id":"W4406874468","doi":"10.1016/j.jaad.2025.01.057","title":"Comparative analyses of hidradenitis suppurativa surgical methods: A systematic review and meta-analysis","year":2025,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Queen's University; University of Toronto; Women's College Hospital; McGill University Health Centre","funders":"","keywords":"Hidradenitis suppurativa; Medicine; Meta-analysis; Dermatology; MEDLINE; Pathology; Disease","score_opus":0.2110392287549769,"score_gpt":0.5396393407368972,"score_spread":0.3286001119819203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406874468","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005401194,0.99359095,0.0003288854,0.00006113623,0.000099633675,0.00016272686,0.00021700443,0.000010694348,0.00012778597],"genre_scores_gemma":[0.170783,0.8241446,0.0025867403,0.0007363868,0.00020935005,0.00062829885,0.0005284826,0.00002686764,0.00035626456],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9940258,0.002571817,0.0018702437,0.000693911,0.0005843768,0.0002537486],"domain_scores_gemma":[0.9896774,0.007474905,0.0017661507,0.00033044786,0.00060689147,0.00014422533],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009129338,0.0025756448,0.018018732,0.0038586978,0.0005259093,0.0028908893,0.001999713,0.0022892207,0.004731083],"category_scores_gemma":[0.018745877,0.0014778874,0.029196255,0.005238961,0.0007891606,0.0020248997,0.0015581116,0.0021147914,0.000322865],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037281346,0.000051975487,0.0028173712,0.34554565,0.63600504,0.000099629804,0.00010076586,0.0002325786,0.0002257299,0.00010002919,0.00035821486,0.010734775],"study_design_scores_gemma":[0.0012752902,0.00023417319,0.0031296725,0.012296688,0.9816921,0.00007376263,0.00006606745,0.00008501265,0.00006546648,0.00012616404,0.0009323974,0.000023221424],"about_ca_topic_score_codex":0.004523974,"about_ca_topic_score_gemma":0.014000039,"teacher_disagreement_score":0.018018732,"about_ca_system_score_codex":0.0017532053,"about_ca_system_score_gemma":0.0021801973,"threshold_uncertainty_score":0.048281074},"labels":[],"label_agreement":null},{"id":"W4407098540","doi":"10.1016/j.jaad.2025.01.078","title":"Updated expert opinion guidelines regarding the effects of immunosuppressive agents on patch testing","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Viral Infections and Immunology Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Expert opinion; Patch testing; MEDLINE; Intensive care medicine; Medical physics; Immunology","score_opus":0.05075914003876709,"score_gpt":0.4159812205980983,"score_spread":0.3652220805593312,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407098540","genre_codex":"review","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012333904,0.78891426,0.0064240373,0.1253739,0.02631148,0.00048384495,0.002536638,0.00041042242,0.048311967],"genre_scores_gemma":[0.016556976,0.70008814,0.02674848,0.17116983,0.046682306,0.0010441319,0.005674846,0.00019441714,0.03184083],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9951138,0.001613917,0.0010317948,0.00028526323,0.0016722768,0.00028292698],"domain_scores_gemma":[0.981028,0.008402579,0.002015427,0.00031950753,0.007511458,0.0007229132],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00509374,0.0009808644,0.0024943312,0.00268017,0.00066326704,0.0021879287,0.002925078,0.005787889,0.013053253],"category_scores_gemma":[0.020949047,0.00047162082,0.00358611,0.0013525506,0.0006553268,0.0018547331,0.0008962845,0.0056406646,0.005942323],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024398863,0.00013061003,0.0005529288,0.006934239,0.00028946635,0.0006915668,0.00009406618,0.00032221092,0.0006001951,0.0020135208,0.59033495,0.39779225],"study_design_scores_gemma":[0.00029537422,0.00010804376,0.0019652338,0.02053374,0.00086376374,0.0019209766,0.0000774771,0.0002182854,0.0003407377,0.0029065844,0.9707146,0.000055173034],"about_ca_topic_score_codex":0.0063205487,"about_ca_topic_score_gemma":0.013857711,"teacher_disagreement_score":0.013053253,"about_ca_system_score_codex":0.0016451144,"about_ca_system_score_gemma":0.0030852156,"threshold_uncertainty_score":0.043667555},"labels":[],"label_agreement":null},{"id":"W4407115483","doi":"10.1016/j.jaad.2024.12.046","title":"Improvements in moderate-to-severe hidradenitis suppurativa with upadacitinib: Results from a phase 2, randomized, placebo-controlled study","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; University of Calgary","funders":"Montana Water Center, Montana State University; AbbVie","keywords":"Medicine; Hidradenitis suppurativa; Placebo; Dermatology; Randomized controlled trial; Internal medicine; Pathology","score_opus":0.012333139018554018,"score_gpt":0.32836215151356585,"score_spread":0.3160290124950118,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407115483","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97817254,0.013953719,0.0007556413,0.00040832406,0.00032079246,0.0036710687,0.0011911364,0.00013022307,0.001396614],"genre_scores_gemma":[0.98923475,0.0049631004,0.0011705027,0.00071386795,0.00025574042,0.0017726766,0.0011567491,0.000018101131,0.0007143931],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9990571,0.00046918928,0.00009829284,0.00013025623,0.00011641236,0.00012888588],"domain_scores_gemma":[0.99874663,0.0003469191,0.00041761776,0.00010414916,0.0001356779,0.00024887535],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030102204,0.0010523549,0.0025381963,0.00033902438,0.00031443406,0.00082692713,0.0007284703,0.0010687414,0.004093202],"category_scores_gemma":[0.0022323085,0.00042621844,0.0019930843,0.00040837194,0.00060796813,0.00060979935,0.00032210498,0.0015338004,0.00035962928],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.90580136,0.012579835,0.0020696647,0.003158653,0.003452326,0.00011374172,0.00008439051,0.00040374577,0.012059907,0.00006951671,0.0014672007,0.05873967],"study_design_scores_gemma":[0.84917146,0.13435741,0.011667958,0.00013354792,0.0019182112,0.00014425535,0.000036941357,0.00030304887,0.0012660093,0.0000615578,0.0009148862,0.000024734976],"about_ca_topic_score_codex":0.00043451242,"about_ca_topic_score_gemma":0.0012247744,"teacher_disagreement_score":0.004093202,"about_ca_system_score_codex":0.00045223284,"about_ca_system_score_gemma":0.0007935839,"threshold_uncertainty_score":0.015919745},"labels":[],"label_agreement":null},{"id":"W4407186570","doi":"10.1016/j.jaad.2025.02.002","title":"An international multicenter, retrospective cohort study of 203 patients with pediatric androgenetic alopecia","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"National Institutes of Health","keywords":"Medicine; Retrospective cohort study; Multicenter study; Dermatology; Cohort study; MEDLINE; Pediatrics; Internal medicine; Randomized controlled trial","score_opus":0.0046066390736368085,"score_gpt":0.28900835630058397,"score_spread":0.2844017172269472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407186570","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99942684,0.000083728504,0.000046221194,0.000011975856,0.0000036986316,0.000008528773,0.000216878,0.0000019647125,0.0002002739],"genre_scores_gemma":[0.9991709,0.0000917614,0.000078232035,0.000033186392,0.000008593021,0.0000145162285,0.0005191711,0.0000034980708,0.000080173304],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993475,0.00013714386,0.00006552142,0.0002384527,0.00007815979,0.00013326453],"domain_scores_gemma":[0.99893695,0.00017675558,0.00041803965,0.00013344195,0.00011361897,0.00022112177],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057366805,0.0005727398,0.00063027523,0.0009178301,0.0010460927,0.0010746855,0.00053692365,0.00060346146,0.0018793286],"category_scores_gemma":[0.0013622638,0.0006674032,0.0006846648,0.0015445153,0.00048588772,0.0010077519,0.00062506367,0.00076720247,0.00047816415],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012012285,0.0000612557,0.99858594,0.0000041957474,0.000048099686,0.00038211187,0.0001036405,0.000013562987,0.00021503768,0.000015236367,0.00006794843,0.00038281144],"study_design_scores_gemma":[0.000037003643,0.00025789518,0.99609417,0.000007685126,0.00006769005,0.0021259938,0.00091798615,0.00012507265,0.000078660196,0.000019457455,0.00026080207,0.0000076005185],"about_ca_topic_score_codex":0.0064945985,"about_ca_topic_score_gemma":0.00615333,"teacher_disagreement_score":0.0064945985,"about_ca_system_score_codex":0.00053589087,"about_ca_system_score_gemma":0.0006143651,"threshold_uncertainty_score":0.012913644},"labels":[],"label_agreement":null},{"id":"W4407187386","doi":"10.1016/j.jaad.2025.02.006","title":"Usefulness of rituximab for the treatment of systemic sclerosis-associated interstitial lung disease: Further analysis of the DESIRES trial","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Rituximab; Interstitial lung disease; Lung; Disease; Systemic disease; Lung disease; Internal medicine; Oncology; Dermatology; Lymphoma","score_opus":0.038619059582506096,"score_gpt":0.3250503427802029,"score_spread":0.2864312831976968,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407187386","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95688295,0.026659718,0.001401144,0.0024801916,0.0003243463,0.0011210328,0.003543757,0.000052960222,0.0075339195],"genre_scores_gemma":[0.98721176,0.0041963374,0.0010614982,0.0014470551,0.0006877449,0.000680149,0.0030118593,0.000019533605,0.0016840298],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99313265,0.005517671,0.00039917877,0.00033562732,0.0003780964,0.00023675879],"domain_scores_gemma":[0.9926968,0.004780476,0.00088036875,0.0006082512,0.000364768,0.0006693431],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01096559,0.00073029177,0.0020351124,0.00023409072,0.0002909481,0.0015019765,0.0005643078,0.0011063652,0.003919261],"category_scores_gemma":[0.010224418,0.0001757139,0.0029544327,0.0004193,0.0005152733,0.0013062323,0.00071528804,0.0013595995,0.0004575551],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9049607,0.0011334424,0.020026952,0.0015971926,0.011416239,0.00015849718,0.00016444831,0.0011525587,0.002836997,0.0009566235,0.0021608407,0.053435516],"study_design_scores_gemma":[0.64146703,0.12408371,0.16738774,0.0008616981,0.032547988,0.00046256607,0.0003923361,0.0037951819,0.003039064,0.002832202,0.022930333,0.00020012348],"about_ca_topic_score_codex":0.000348053,"about_ca_topic_score_gemma":0.00083002215,"teacher_disagreement_score":0.01096559,"about_ca_system_score_codex":0.00047742022,"about_ca_system_score_gemma":0.00080300815,"threshold_uncertainty_score":0.05799228},"labels":[],"label_agreement":null},{"id":"W4407588454","doi":"10.1016/j.jaad.2024.11.083","title":"Response to Potestio et al., “Comment on Real-world experience of bimekizumab for plaque psoriasis in adult patients with prior exposure to interleukin-17 inhibitors: A 16-week multicenter retrospective review”","year":2025,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; Women's College Hospital; Dermatrials Research; Probity Medical Research; SKiN Health; University of Calgary; University of Toronto","funders":"Women's College Hospital","keywords":"Medicine; Plaque psoriasis; Psoriasis; Multicenter study; Dermatology; Interleukin; Interleukin 17; Internal medicine; Cytokine; Randomized controlled trial","score_opus":0.0120106946450387,"score_gpt":0.2884723279994982,"score_spread":0.2764616333544595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407588454","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007172108,0.00077198196,0.000080274905,0.98406965,0.012948895,0.000014226761,0.00025451943,0.0000638956,0.0010793824],"genre_scores_gemma":[0.003407823,0.0004793245,0.00011296292,0.9808889,0.013117727,0.00003200347,0.00007178306,0.000024353321,0.0018651482],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973552,0.00076473074,0.0004496962,0.0003952614,0.0006924733,0.00034276413],"domain_scores_gemma":[0.99197173,0.0037392585,0.001045052,0.00021991381,0.0020723576,0.0009516676],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036939709,0.00070702855,0.0013254572,0.00086569967,0.0020399021,0.0025058803,0.0018004536,0.026015032,0.006072328],"category_scores_gemma":[0.022788906,0.00064358686,0.0011685443,0.000979291,0.0015672162,0.0023370476,0.0009270108,0.019177264,0.006880906],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000856636,0.000022569535,0.0010466047,0.000045198143,0.000017189494,0.0010154442,0.00007759488,0.000033821743,0.0001011644,0.00025646674,0.9946426,0.0026557033],"study_design_scores_gemma":[0.00045192314,0.00026630965,0.006565155,0.000714333,0.00014329453,0.007468551,0.0009977169,0.0007443822,0.0009193314,0.0041724057,0.9773955,0.00016116092],"about_ca_topic_score_codex":0.0059676557,"about_ca_topic_score_gemma":0.007036654,"teacher_disagreement_score":0.026015032,"about_ca_system_score_codex":0.0030562836,"about_ca_system_score_gemma":0.0031529283,"threshold_uncertainty_score":0.022175014},"labels":[],"label_agreement":null},{"id":"W4407722455","doi":"10.1016/j.jaad.2025.02.032","title":"Assessing the diagnostic metrics of cutaneous leiomyomas in hereditary leiomyomatosis and renal cell cancer syndrome: An observational study","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Urologic and reproductive health conditions","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University; Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Leiomyomatosis; Observational study; Leiomyoma; Pathology; Dermatology","score_opus":0.07531074449420036,"score_gpt":0.4124498378126121,"score_spread":0.33713909331841174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407722455","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99852043,0.00036532222,0.00020297442,0.00004672469,0.000007281413,0.000016624695,0.0006245202,0.0000025459735,0.00021357316],"genre_scores_gemma":[0.9990489,0.00010636988,0.00019975875,0.000038597467,0.000011634864,0.000018514518,0.00052014785,0.0000028365869,0.000053117503],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99727386,0.0008252647,0.00043942983,0.00072066794,0.00048234916,0.00025850147],"domain_scores_gemma":[0.99262404,0.0017103128,0.0033923655,0.0007193459,0.0007893005,0.00076463155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029279622,0.00035005144,0.0005429837,0.0008613524,0.00061940344,0.00083460385,0.0009918961,0.00090503116,0.0011854741],"category_scores_gemma":[0.009389729,0.0004876658,0.0010878304,0.0013154217,0.00042426414,0.00090523,0.00090426544,0.0011923857,0.00020499516],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006957681,0.000026949068,0.99940026,0.000008585745,0.00009090967,0.000032989512,0.00004979202,0.000011573519,0.000048094265,0.000014198088,0.000048978614,0.00019809061],"study_design_scores_gemma":[0.000013480229,0.0001722329,0.99815863,0.000013231113,0.00011908377,0.0004713058,0.00033866047,0.000397994,0.000041354193,0.000040128136,0.00022459036,0.0000093601],"about_ca_topic_score_codex":0.0069421222,"about_ca_topic_score_gemma":0.007193478,"teacher_disagreement_score":0.0069421222,"about_ca_system_score_codex":0.00060962094,"about_ca_system_score_gemma":0.0005844351,"threshold_uncertainty_score":0.015484691},"labels":[],"label_agreement":null},{"id":"W4407821974","doi":"10.1016/j.jaad.2025.02.045","title":"Pneumocystis jirovecii pneumonia prophylaxis in patients with chronic inflammatory skin diseases: Systematic review and meta-analysis","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Pneumocystis jirovecii pneumonia detection and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Alberta Innovates; Scoliosis Research Society","keywords":"Medicine; Meta-analysis; Pneumonia; Pneumocystis jirovecii; Dermatology; Pneumocystis pneumonia; Immunology; Intensive care medicine; Internal medicine","score_opus":0.006504266738369177,"score_gpt":0.26804349879957073,"score_spread":0.26153923206120155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407821974","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0076897084,0.9905128,0.0002437773,0.00014651452,0.00010109044,0.00012557319,0.0008888467,0.000013566121,0.00027818343],"genre_scores_gemma":[0.22049373,0.77493393,0.0011107562,0.00086677255,0.00026843578,0.00059968163,0.0013163456,0.000019462064,0.0003908559],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9966342,0.001228059,0.0011078137,0.0004657378,0.00038602718,0.00017831118],"domain_scores_gemma":[0.9896947,0.007339647,0.0016577907,0.00028587115,0.00085554953,0.00016643132],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004959098,0.001463924,0.010625303,0.0028608483,0.0004811083,0.0016994519,0.001339366,0.001524176,0.0037882423],"category_scores_gemma":[0.017007394,0.000803014,0.019603029,0.0046125706,0.00039142466,0.0011341382,0.00088694127,0.0012980347,0.00023631485],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033435302,0.000052172632,0.0123207625,0.51224756,0.44894806,0.00017798453,0.000100283614,0.00055026426,0.00034547897,0.00015637281,0.001930221,0.019827293],"study_design_scores_gemma":[0.0007716674,0.00024773905,0.011910413,0.032575686,0.9508316,0.00016615658,0.00005328114,0.00020632346,0.00013194341,0.00016580391,0.00290614,0.00003327206],"about_ca_topic_score_codex":0.0053389543,"about_ca_topic_score_gemma":0.01533045,"teacher_disagreement_score":0.010625303,"about_ca_system_score_codex":0.0011881165,"about_ca_system_score_gemma":0.0019497316,"threshold_uncertainty_score":0.02622652},"labels":[],"label_agreement":null},{"id":"W4408053182","doi":"10.1016/j.jaad.2025.02.072","title":"Reported psychiatric adverse events among isotretinoin users: Monitoring priorities from a 20-year FDA Adverse Event Reporting System database study","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"National Natural Science Foundation of China","keywords":"Medicine; Isotretinoin; Adverse Event Reporting System; Adverse effect; MEDLINE; Database; Psychiatry; Emergency medicine; Medical emergency; Dermatology; Internal medicine","score_opus":0.02015912952230271,"score_gpt":0.3386777166133881,"score_spread":0.3185185870910854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408053182","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992502,0.0007235242,0.00021781765,0.000357371,0.00001234008,0.00007762492,0.005078206,0.000008984752,0.0010220817],"genre_scores_gemma":[0.99498796,0.0004192576,0.00030041186,0.00022377599,0.000021807136,0.000044171684,0.0038014916,0.000005516137,0.00019555686],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99634475,0.0011852896,0.0010310878,0.00038850494,0.0007988034,0.00025166097],"domain_scores_gemma":[0.98519355,0.0023597314,0.008826502,0.00036423578,0.0024816925,0.00077427557],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031897451,0.00024849648,0.0004266843,0.0017749497,0.00046604595,0.0011193634,0.0004881195,0.0005338081,0.00075746106],"category_scores_gemma":[0.00881435,0.00020932312,0.0009049955,0.0032063595,0.00015657693,0.00095955766,0.0008832226,0.0005984468,0.00018218378],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019843256,0.00004405159,0.9972481,0.000028283312,0.0000916645,0.000043696607,0.000067796005,0.000026171638,0.00009334201,0.0000117819545,0.00029242926,0.0018542734],"study_design_scores_gemma":[0.000012396448,0.000054837812,0.9990277,0.000009940044,0.00007796566,0.00008677963,0.00019597316,0.00020239581,0.00006589568,0.000006717315,0.0002539554,0.0000053638014],"about_ca_topic_score_codex":0.017449515,"about_ca_topic_score_gemma":0.027943097,"teacher_disagreement_score":0.017449515,"about_ca_system_score_codex":0.00086723943,"about_ca_system_score_gemma":0.00094731123,"threshold_uncertainty_score":0.034695923},"labels":[],"label_agreement":null},{"id":"W4408274595","doi":"10.1016/j.jaad.2025.03.009","title":"Disease severity and pruritus treatment outcomes in prurigo nodularis: A systematic review of randomized-controlled trials","year":2025,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Western University; Women's College Hospital; University of Toronto","funders":"","keywords":"Medicine; Prurigo nodularis; Randomized controlled trial; Dermatology; Disease; MEDLINE; Surgery; Internal medicine","score_opus":0.02798422911132209,"score_gpt":0.3939681653761733,"score_spread":0.3659839362648512,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408274595","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00062961556,0.998588,0.00007158452,0.00008883742,0.00006204034,0.00018175744,0.00023179897,0.000005550533,0.00014069017],"genre_scores_gemma":[0.013816547,0.9846971,0.0003701968,0.00035761157,0.000068909845,0.00034819034,0.00023474466,0.000004752471,0.00010195127],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9943797,0.0019501852,0.002117346,0.0005004529,0.00088987773,0.00016244919],"domain_scores_gemma":[0.9803766,0.014205199,0.0036067995,0.00025147037,0.0013333329,0.0002265409],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007085467,0.0015772554,0.010897463,0.0048809038,0.00048976653,0.0020119462,0.0014818127,0.0013701584,0.0067307567],"category_scores_gemma":[0.030133933,0.0008256272,0.009961744,0.0058109807,0.0007324182,0.0013603282,0.0011327632,0.0013906593,0.00030563],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008376092,0.00002269078,0.0006728277,0.9358757,0.027368695,0.00004292509,0.00006953616,0.00010666874,0.00011884877,0.00014056714,0.0013064623,0.033437524],"study_design_scores_gemma":[0.0022643069,0.0005803866,0.0069744927,0.5972879,0.37390313,0.0003389639,0.00018732627,0.00013182838,0.00022339191,0.0005678072,0.017477803,0.00006275996],"about_ca_topic_score_codex":0.005306011,"about_ca_topic_score_gemma":0.0147287315,"teacher_disagreement_score":0.010897463,"about_ca_system_score_codex":0.0025274483,"about_ca_system_score_gemma":0.0048532123,"threshold_uncertainty_score":0.03747201},"labels":[],"label_agreement":null},{"id":"W4408328765","doi":"10.1016/j.jaad.2025.03.008","title":"Long-term safety and efficacy of delgocitinib cream for up to 52 weeks in adults with Chronic Hand Eczema: Results of the phase 3 open-label extension DELTA 3 trial following the DELTA 1 and 2 trials","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Contact Dermatitis and Allergies","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada); Queen's University; Probity Medical Research","funders":"Manchester Biomedical Research Centre; LEO Pharma; National Institute for Health and Care Research","keywords":"Medicine; Open label; Term (time); Clinical trial; Extension (predicate logic); Dermatology; Pediatrics; Surgery; Internal medicine","score_opus":0.03851447355711272,"score_gpt":0.38342482527772603,"score_spread":0.3449103517206133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408328765","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928911,0.0041788137,0.00021571117,0.00024613968,0.000054120686,0.0005664464,0.0007187123,0.000033565928,0.0010954173],"genre_scores_gemma":[0.99569607,0.0011863884,0.00038395385,0.00039120027,0.00008080573,0.00048103658,0.0009100564,0.000008261062,0.00086215674],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9995788,0.00015775494,0.0000357392,0.000074064636,0.0000680302,0.00008565731],"domain_scores_gemma":[0.9988896,0.00023735606,0.00036561038,0.00007990796,0.00012249169,0.00030499598],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021788492,0.00059123425,0.0011327281,0.00018404202,0.0003760486,0.0006606514,0.00038646001,0.0009210852,0.002405052],"category_scores_gemma":[0.0012398768,0.00022150888,0.0009648684,0.00018150253,0.00039382195,0.0006452116,0.00023503607,0.0021820082,0.00054533227],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7407415,0.032797743,0.019045543,0.0013152852,0.0017371617,0.00033232043,0.00036270687,0.0015219159,0.03239357,0.00012626634,0.0051998263,0.16442606],"study_design_scores_gemma":[0.3997767,0.5205503,0.0665241,0.00017474043,0.0012291723,0.00074166484,0.00012707559,0.0014643136,0.0052061127,0.00016015339,0.003999246,0.000046387617],"about_ca_topic_score_codex":0.0006752763,"about_ca_topic_score_gemma":0.0021105723,"teacher_disagreement_score":0.002405052,"about_ca_system_score_codex":0.0005732936,"about_ca_system_score_gemma":0.000692882,"threshold_uncertainty_score":0.011523008},"labels":[],"label_agreement":null},{"id":"W4408433355","doi":"10.1016/j.jaad.2025.03.019","title":"Ruxolitinib versus roflumilast: A meta-analysis of the comparative efficacy of two topical therapies for atopic dermatitis","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Ottawa","funders":"","keywords":"Medicine; Roflumilast; Ruxolitinib; Atopic dermatitis; Dupilumab; Meta-analysis; Dermatology; Internal medicine","score_opus":0.0766898826600756,"score_gpt":0.408527506864411,"score_spread":0.33183762420433544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408433355","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.363505,0.6273683,0.0029744236,0.0008212228,0.0014573126,0.0003642298,0.0016605032,0.00015803668,0.0016909598],"genre_scores_gemma":[0.9682472,0.028246142,0.0011951711,0.0006816494,0.00033226423,0.00016294548,0.00060798373,0.00004725857,0.00047930764],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98866814,0.007416562,0.0012989842,0.0015317004,0.0006987394,0.00038580803],"domain_scores_gemma":[0.98731637,0.009387315,0.0016310157,0.0008947992,0.00044393798,0.00032655953],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012625882,0.0027378467,0.0134289125,0.0013143177,0.0006111422,0.0027774163,0.0019294277,0.002463465,0.0030962052],"category_scores_gemma":[0.017192855,0.0014510467,0.031364672,0.0016329242,0.0010596799,0.0018414679,0.0011780462,0.003735099,0.0003598622],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.111663744,0.00008992179,0.0060331672,0.013339392,0.86203915,0.00009018407,0.00006337289,0.0006695896,0.0006365965,0.00010861254,0.00027126464,0.0049949978],"study_design_scores_gemma":[0.016584562,0.0017676151,0.006836554,0.00057330873,0.9725748,0.00006429582,0.000060989867,0.00052959844,0.00021157842,0.00023640697,0.00052923895,0.000031172513],"about_ca_topic_score_codex":0.0032978551,"about_ca_topic_score_gemma":0.005796901,"teacher_disagreement_score":0.0134289125,"about_ca_system_score_codex":0.0013097603,"about_ca_system_score_gemma":0.00071201666,"threshold_uncertainty_score":0.06677288},"labels":[],"label_agreement":null},{"id":"W4408902738","doi":"10.1016/j.jaad.2025.03.056","title":"Current therapeutic options for adult patients with urticarial vasculitis: A scoping review","year":2025,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Urticaria and Related Conditions","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Sacré-Cœur de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Dermatology; Vasculitis; Intensive care medicine; Pathology; Disease","score_opus":0.028592591544620797,"score_gpt":0.38674037001668576,"score_spread":0.35814777847206497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408902738","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006592897,0.9996401,0.00002672221,0.00007204161,0.000044040506,0.0000074735844,0.00001644845,0.0000019484264,0.00012526318],"genre_scores_gemma":[0.0007118634,0.9988739,0.000116083065,0.00016839565,0.000042913114,0.0000099592835,0.000021033373,6.5534783e-7,0.000055108358],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99932826,0.00016010848,0.00022876506,0.00007789108,0.00016266781,0.00004244079],"domain_scores_gemma":[0.9977228,0.0016419971,0.00038957433,0.000022502118,0.00018102156,0.000042108106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015917359,0.0008836561,0.0034312718,0.0037178847,0.00037107826,0.0018787582,0.0011798487,0.0016354945,0.0044950154],"category_scores_gemma":[0.0038939274,0.0004956774,0.0023678343,0.0032124112,0.00043897296,0.001708709,0.0008681315,0.001338275,0.00055847276],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022922328,0.000082903774,0.0005922536,0.36351138,0.0018618321,0.0002781668,0.00017927377,0.00026213683,0.0005038016,0.00074674765,0.013460416,0.6182918],"study_design_scores_gemma":[0.0003341718,0.0002809121,0.004003818,0.59245926,0.016781412,0.0026057502,0.0005595522,0.00026397343,0.00038279864,0.0013755672,0.38087362,0.00007913046],"about_ca_topic_score_codex":0.0023804868,"about_ca_topic_score_gemma":0.006283101,"teacher_disagreement_score":0.0044950154,"about_ca_system_score_codex":0.0006840087,"about_ca_system_score_gemma":0.0018585915,"threshold_uncertainty_score":0.015037358},"labels":[],"label_agreement":null},{"id":"W4409201864","doi":"10.1016/j.jaad.2025.04.006","title":"Minoxidil toxicosis in cats and dogs: A scoping review and call to action","year":2025,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Rabbits: Nutrition, Reproduction, Health","field":"Agricultural and Biological Sciences","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health; Hospital for Sick Children; University of Guelph; University of Ottawa; Western University; Women's College Hospital; McMaster University; SickKids Foundation; University of Toronto","funders":"Pfizer","keywords":"Medicine; CATS; Call to action; Action (physics); Minoxidil; Dermatology; Internal medicine; Advertising","score_opus":0.05908878396766406,"score_gpt":0.3785350688960842,"score_spread":0.31944628492842014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409201864","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000071410206,0.9994326,0.000024471412,0.00022403471,0.0001281995,0.000010029628,0.000024211813,0.000003226321,0.00008190047],"genre_scores_gemma":[0.0007138954,0.99837565,0.00017448097,0.00050534087,0.00009201791,0.00001216732,0.000031897092,0.0000011507515,0.000093390176],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9986853,0.00022435233,0.00054524094,0.00014101187,0.0003239371,0.00008012677],"domain_scores_gemma":[0.9950749,0.0022967411,0.0016668253,0.000075027274,0.00072968286,0.00015675668],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037553261,0.0011684551,0.006084003,0.006592726,0.00041492342,0.002857883,0.0016331527,0.003177831,0.003284152],"category_scores_gemma":[0.0046653952,0.00070887455,0.003563132,0.004464962,0.0007926645,0.0026948801,0.0013923933,0.001801401,0.0005223077],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031984993,0.000100766345,0.0008610893,0.4068302,0.0026981728,0.0007336514,0.00029361117,0.00027503152,0.001407078,0.001055847,0.03710432,0.54832035],"study_design_scores_gemma":[0.00020505225,0.0003396219,0.003908631,0.48875514,0.014295331,0.0029521994,0.0006877216,0.00019700981,0.00047803562,0.0010647776,0.48701218,0.000104337065],"about_ca_topic_score_codex":0.005936236,"about_ca_topic_score_gemma":0.022148013,"teacher_disagreement_score":0.006592726,"about_ca_system_score_codex":0.001989116,"about_ca_system_score_gemma":0.005393311,"threshold_uncertainty_score":0.019860327},"labels":[],"label_agreement":null},{"id":"W4409276499","doi":"10.1016/j.jaad.2025.04.007","title":"Comparative effects of biologics and small molecule inhibitors on cutaneous disease activity in lupus erythematosus: A systematic review and network meta-analysis","year":2025,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Ottawa; BC Children's Hospital; McMaster University; Western University","funders":"","keywords":"Medicine; Meta-analysis; Systemic lupus erythematosus; Lupus erythematosus; Dermatology; MEDLINE; Disease; Immunology; Internal medicine; Antibody; Biochemistry","score_opus":0.06305850422179628,"score_gpt":0.3835449081559002,"score_spread":0.32048640393410394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409276499","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009429286,0.9888248,0.00056693895,0.0001315586,0.00016499287,0.00013593731,0.0005014599,0.000028352679,0.00021667583],"genre_scores_gemma":[0.31097808,0.68307066,0.0024869114,0.0011812681,0.0003098778,0.00046429218,0.0008902367,0.000047624337,0.0005710287],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99460983,0.0024817754,0.0013926683,0.0007541283,0.00050637726,0.000255194],"domain_scores_gemma":[0.9899158,0.0075521446,0.0015261106,0.00033080872,0.00050099904,0.00017416658],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0072233193,0.0024993024,0.017423494,0.0032544998,0.0005008703,0.0027299514,0.002067303,0.002275286,0.0044890726],"category_scores_gemma":[0.016091969,0.0014885043,0.03104551,0.0048134793,0.000719303,0.0017636075,0.0018088493,0.0024389613,0.00036973448],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037995905,0.000030253797,0.003924512,0.16479881,0.81880724,0.00008562664,0.000064167056,0.0003581319,0.00022625545,0.00008139054,0.00040962108,0.0074144406],"study_design_scores_gemma":[0.00089721085,0.00013092248,0.0028217256,0.005000517,0.9901766,0.00004031291,0.00003076922,0.00009760987,0.000044883178,0.000105574756,0.0006367309,0.000017150494],"about_ca_topic_score_codex":0.00685135,"about_ca_topic_score_gemma":0.017945146,"teacher_disagreement_score":0.017423494,"about_ca_system_score_codex":0.0017891881,"about_ca_system_score_gemma":0.0018506884,"threshold_uncertainty_score":0.038201034},"labels":[],"label_agreement":null},{"id":"W4409417341","doi":"10.1016/j.jaad.2025.04.021","title":"Skincare ingredients recommended by cosmetic dermatologists: A Delphi consensus study","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto and Region Conservation Authority; ITS Electronics (Canada)","funders":"","keywords":"Medicine; Dermatology; Delphi method; MEDLINE; Family medicine","score_opus":0.014493152632869915,"score_gpt":0.3498235638977472,"score_spread":0.3353304112648773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409417341","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.962368,0.0033418832,0.004336121,0.004408084,0.00037173723,0.008002686,0.0007756733,0.000019257179,0.016376473],"genre_scores_gemma":[0.9745892,0.0021682694,0.0110503,0.0029089446,0.000117514945,0.0075926776,0.00069063617,0.000020806774,0.0008616543],"study_design_codex":"design_other","study_design_gemma":"qualitative","domain_scores_codex":[0.9551301,0.029761497,0.0066083176,0.0014433046,0.00501827,0.0020384695],"domain_scores_gemma":[0.8994933,0.06815322,0.004818007,0.002388562,0.023205059,0.001941826],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.07454133,0.00053005613,0.0010215972,0.0018589179,0.002721116,0.0014465145,0.001269084,0.0019457883,0.0033261217],"category_scores_gemma":[0.07345819,0.00049279473,0.0018026968,0.0012507478,0.0013867161,0.0016399169,0.0039701196,0.0020720046,0.0005588053],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008989543,0.0054023825,0.32609424,0.021374494,0.0026397218,0.002502081,0.24987504,0.0015471929,0.014357827,0.0054540304,0.025328374,0.33643508],"study_design_scores_gemma":[0.005710523,0.007650657,0.40044993,0.02963189,0.0043626092,0.0045067505,0.4200381,0.0064279637,0.008548355,0.004584873,0.10730531,0.0007831161],"about_ca_topic_score_codex":0.0018507871,"about_ca_topic_score_gemma":0.0045446553,"teacher_disagreement_score":0.07454133,"about_ca_system_score_codex":0.0030540992,"about_ca_system_score_gemma":0.007788016,"threshold_uncertainty_score":0.39421695},"labels":[],"label_agreement":null},{"id":"W4409764043","doi":"10.1016/j.jaad.2025.03.094","title":"Response to response to Metko et al, “prevalence and risk factors of interstitial lung disease in dermatomyositis: A retrospective study”","year":2025,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Inflammatory Myopathies and Dermatomyositis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Health Sciences","funders":"","keywords":"Medicine; Dermatomyositis; Interstitial lung disease; Retrospective cohort study; Dermatology; Disease; Lung disease; Lung; Internal medicine","score_opus":0.008845704470273741,"score_gpt":0.31648216857029543,"score_spread":0.3076364641000217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409764043","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009248091,0.0008635707,0.00019583807,0.95564836,0.028496157,0.000074020354,0.0005995872,0.00005987615,0.0048144846],"genre_scores_gemma":[0.031083763,0.0008271326,0.0003226305,0.91958874,0.03987213,0.00012041993,0.00037029726,0.000037355334,0.0077774273],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99684,0.00089567347,0.00071522046,0.00045107634,0.00059574994,0.0005023195],"domain_scores_gemma":[0.99057907,0.0037882978,0.00096661714,0.0004103377,0.002999146,0.0012564473],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028391276,0.00068847224,0.0010322768,0.0010455338,0.0023312045,0.0024299775,0.0015091369,0.017145215,0.004125755],"category_scores_gemma":[0.01942161,0.00044539565,0.0012031221,0.0010279072,0.00081943534,0.0013915309,0.00078988436,0.010818214,0.0031175194],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005325866,0.00034722648,0.029338136,0.00016983865,0.00015791015,0.017038317,0.00041915753,0.00019347649,0.000872579,0.0007339888,0.9405475,0.009649183],"study_design_scores_gemma":[0.001365762,0.0011877539,0.09021847,0.0017184571,0.00058624556,0.03926942,0.005050894,0.0035395653,0.0025113332,0.004538144,0.8495902,0.00042374968],"about_ca_topic_score_codex":0.0049186912,"about_ca_topic_score_gemma":0.0066821487,"teacher_disagreement_score":0.017145215,"about_ca_system_score_codex":0.003114687,"about_ca_system_score_gemma":0.0024500475,"threshold_uncertainty_score":0.022598743},"labels":[],"label_agreement":null},{"id":"W4409777208","doi":"10.1016/j.jaad.2025.04.038","title":"Bimekizumab durability of efficacy through 196 weeks and safety through 4 years in patients with moderate to severe plaque psoriasis: Results from the BE BRIGHT open-label extension trial","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Sanofi Genzyme; Union Chimique Belge; Sanofi; UCB; Bright Research Group","keywords":"Medicine; Open label; Psoriasis; Dermatology; Plaque psoriasis; Extension (predicate logic); Clinical trial; Surgery; Internal medicine","score_opus":0.02517035636229951,"score_gpt":0.2934647518648225,"score_spread":0.268294395502523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409777208","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918283,0.005189275,0.00021447404,0.0002359235,0.00005260521,0.0004141143,0.00061318034,0.000024067293,0.0014280609],"genre_scores_gemma":[0.99484754,0.0015851978,0.0004887761,0.00046129685,0.00014318289,0.00048257312,0.0012237298,0.000009737466,0.00075804774],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99896836,0.0005643468,0.000066215296,0.00010218595,0.00015392802,0.00014497053],"domain_scores_gemma":[0.9982773,0.00041389925,0.00050707767,0.00015577357,0.00015073434,0.0004951291],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041200635,0.0005146224,0.0014399204,0.00021505069,0.0003426235,0.0010212673,0.00046108343,0.0008327164,0.0023096192],"category_scores_gemma":[0.0024631054,0.0003252916,0.001812564,0.00027319242,0.0004180018,0.00065852323,0.00042265252,0.0020387832,0.00045291518],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.863311,0.0121364435,0.027186679,0.0011139788,0.00273005,0.00015376095,0.00028370434,0.00073524844,0.009086608,0.00019190137,0.0033614105,0.07970921],"study_design_scores_gemma":[0.6133148,0.22642003,0.14650398,0.00028574013,0.0033207692,0.0006185838,0.00015079866,0.001270039,0.0025753966,0.0004728117,0.0049963947,0.00007063747],"about_ca_topic_score_codex":0.00037410794,"about_ca_topic_score_gemma":0.00060133165,"teacher_disagreement_score":0.0041200635,"about_ca_system_score_codex":0.00038503445,"about_ca_system_score_gemma":0.0008672415,"threshold_uncertainty_score":0.021789253},"labels":[],"label_agreement":null},{"id":"W4409777221","doi":"10.1016/j.jaad.2025.04.041","title":"Effectiveness and safety of ruxolitinib cream in Chinese patients with nonsegmental vitiligo","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"melanin and skin pigmentation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital","funders":"","keywords":"Medicine; Vitiligo; Ruxolitinib; Dermatology; Traditional medicine; Internal medicine; Myelofibrosis","score_opus":0.0025610206050910565,"score_gpt":0.2683153921543862,"score_spread":0.26575437154929515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409777221","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949521,0.0041596643,0.000023499717,0.00012687469,0.000016039128,0.000016294456,0.000036224345,0.0000036806464,0.00066566817],"genre_scores_gemma":[0.99855787,0.0010650371,0.000033658875,0.000096961085,0.00002559768,0.000008240175,0.000048604776,6.226714e-7,0.00016342232],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9998828,0.000035443896,0.000012040195,0.000020505411,0.000025185984,0.000024019366],"domain_scores_gemma":[0.99985886,0.000058416867,0.00003404704,0.000005344954,0.000013506526,0.000029792885],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021770566,0.00015986634,0.00068405236,0.00023133236,0.0002596487,0.00024104978,0.00013177696,0.00019413744,0.0009397868],"category_scores_gemma":[0.0005326419,0.0000763101,0.00033926184,0.0002598795,0.0001298394,0.00020555379,0.00008975822,0.0003648037,0.00008961044],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06785978,0.003988622,0.46223605,0.0013825498,0.002362679,0.0023320264,0.0006314773,0.0013396668,0.035256807,0.0003898872,0.0024448447,0.41977566],"study_design_scores_gemma":[0.011870575,0.026806861,0.9377562,0.00018709271,0.004599016,0.002660283,0.0007613788,0.003791613,0.00561082,0.00029702258,0.005585751,0.00007333653],"about_ca_topic_score_codex":0.0015024722,"about_ca_topic_score_gemma":0.0030797983,"teacher_disagreement_score":0.0015024722,"about_ca_system_score_codex":0.0003786426,"about_ca_system_score_gemma":0.00037947609,"threshold_uncertainty_score":0.0031439066},"labels":[],"label_agreement":null},{"id":"W4410193745","doi":"10.1016/j.jaad.2025.03.099","title":"Transected squamous cell carcinoma in situ specimens referred for Mohs micrographic surgery: A retrospective chart review","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"","keywords":"Medicine; Mohs surgery; Basal cell; Dermatology; Chart; Retrospective cohort study; In situ; Carcinoma in situ; Carcinoma; Surgery; Pathology","score_opus":0.019303213529680865,"score_gpt":0.3120241502587776,"score_spread":0.29272093672909677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410193745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99238175,0.0021624092,0.00043303674,0.000044233646,0.000026684407,0.00023463978,0.0024785844,0.000018137374,0.002220539],"genre_scores_gemma":[0.99556583,0.0011404745,0.00042501756,0.00005925368,0.00002128696,0.00007614827,0.0022090885,0.000009723377,0.0004931823],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99918836,0.000107173524,0.00021365244,0.0001912996,0.00019322278,0.00010624441],"domain_scores_gemma":[0.9951441,0.0012993274,0.0013909449,0.00056320813,0.0011886955,0.00041374034],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070018845,0.00026591343,0.0003111256,0.0032948754,0.00060351606,0.0007298058,0.0003667301,0.0002892728,0.002538328],"category_scores_gemma":[0.0022613788,0.00030690187,0.0002754159,0.0022175626,0.0005296347,0.0005632497,0.00051345926,0.00028615072,0.0005784613],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029024505,0.0000845011,0.97869074,0.00019892683,0.00003789636,0.009308037,0.00076358,0.00002753595,0.004803748,0.00010119285,0.00044354293,0.005249936],"study_design_scores_gemma":[0.000017763721,0.0004962997,0.962759,0.000103768885,0.00014453479,0.024121521,0.0028855978,0.000111438545,0.004532761,0.000029178613,0.0047808425,0.00001737605],"about_ca_topic_score_codex":0.004196463,"about_ca_topic_score_gemma":0.005113637,"teacher_disagreement_score":0.004196463,"about_ca_system_score_codex":0.0006041509,"about_ca_system_score_gemma":0.0013655787,"threshold_uncertainty_score":0.008491516},"labels":[],"label_agreement":null},{"id":"W4410352220","doi":"10.1016/j.jaad.2025.05.1385","title":"Efficacy and safety of ruxolitinib cream in children aged 2 to 11 years with atopic dermatitis: Results from TRuE-AD3, a phase 3, randomized double-blind study","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Heritage Medical Research Clinic","funders":"Incyte","keywords":"Medicine; Atopic dermatitis; Ruxolitinib; Double blind; Dermatology; Randomized controlled trial; Internal medicine; Alternative medicine; Pathology; Placebo; Bone marrow","score_opus":0.014490924291335677,"score_gpt":0.33294974725685866,"score_spread":0.31845882296552297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410352220","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99376315,0.0037852642,0.00020175862,0.00010863155,0.000050660983,0.0009397491,0.0005876118,0.000027778837,0.00053536484],"genre_scores_gemma":[0.9933478,0.0027063899,0.0010228162,0.00040301777,0.00010371101,0.0010603421,0.0008235039,0.000011426248,0.0005209],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9993305,0.00032268098,0.00006620924,0.0001010578,0.00009285425,0.00008669904],"domain_scores_gemma":[0.99906677,0.00027761565,0.0003048424,0.00005590803,0.00007468411,0.00022015117],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019673626,0.0007770457,0.001897926,0.00019267817,0.00035073055,0.0005947012,0.0005479849,0.0008961936,0.002405146],"category_scores_gemma":[0.001112522,0.0004075875,0.0015505502,0.00023598659,0.0005683667,0.0005302641,0.00025193486,0.0016131089,0.0003780754],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8462933,0.03094806,0.021565797,0.0024160536,0.0025744182,0.0004102296,0.0002546665,0.0006149613,0.020262271,0.000109162254,0.0018691829,0.07268192],"study_design_scores_gemma":[0.64759344,0.28492248,0.05972398,0.00012640866,0.0015098025,0.0005706117,0.000083818224,0.0005000275,0.0030630808,0.00006236504,0.0018145314,0.000029554381],"about_ca_topic_score_codex":0.0009054741,"about_ca_topic_score_gemma":0.0027366178,"teacher_disagreement_score":0.002405146,"about_ca_system_score_codex":0.0006894105,"about_ca_system_score_gemma":0.0010766719,"threshold_uncertainty_score":0.010404468},"labels":[],"label_agreement":null},{"id":"W4410415961","doi":"10.1016/j.jaad.2025.05.1382","title":"Combination of carbon dioxide laser and triamcinolone acetonide for keloid and hypertrophic scar treatment: A systematic review","year":2025,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Dermatologic Treatments and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health; Quest University Canada; University of British Columbia; McMaster University","funders":"","keywords":"Medicine; Keloid; Triamcinolone acetonide; Carbon dioxide laser; Dermatology; Hypertrophic scar; Ophthalmology; Laser; Surgery; Laser surgery; Optics","score_opus":0.041898611688513596,"score_gpt":0.38546649389409626,"score_spread":0.34356788220558265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410415961","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001345143,0.9978835,0.00009209024,0.000078899924,0.00008023809,0.00016049111,0.00015308007,0.0000074506825,0.00019913264],"genre_scores_gemma":[0.018822318,0.9795624,0.0005310392,0.00052299467,0.00006354383,0.00017501881,0.00012378069,0.0000051222646,0.00019371873],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99832577,0.00049444364,0.00059935567,0.00019017623,0.0003074898,0.000082795515],"domain_scores_gemma":[0.9961767,0.0023451077,0.0010536447,0.000051400784,0.00028387955,0.000089219735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002138375,0.0011557076,0.007922508,0.0032384526,0.0003778149,0.0015950127,0.0017342444,0.0016160413,0.006162508],"category_scores_gemma":[0.007377689,0.00073777966,0.007489284,0.003927604,0.0005423767,0.0014630452,0.00089258834,0.0012347855,0.00035234084],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014539672,0.00006179855,0.0005294459,0.9233011,0.031962954,0.00009977838,0.00009708388,0.00011929932,0.00031940226,0.00010128628,0.0015044585,0.040449403],"study_design_scores_gemma":[0.004558536,0.0014141226,0.007746673,0.42587554,0.53489685,0.0006583906,0.0003689,0.0002513974,0.0003883804,0.00031438077,0.023425868,0.00010088685],"about_ca_topic_score_codex":0.00733407,"about_ca_topic_score_gemma":0.027595473,"teacher_disagreement_score":0.007922508,"about_ca_system_score_codex":0.0016028007,"about_ca_system_score_gemma":0.0032946952,"threshold_uncertainty_score":0.020615578},"labels":[],"label_agreement":null},{"id":"W4410422160","doi":"10.1016/j.jaad.2025.05.1395","title":"The impact of lifestyle factors on cardiometabolic comorbidities and mortality of psoriatic diseases: A multistate model analysis","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"National Key Research and Development Program of China; Natural Science Foundation of Hunan Province; National Natural Science Foundation of China-Guangdong Joint Fund; National Natural Science Foundation of China","keywords":"Medicine; Comorbidity; Environmental health; Internal medicine","score_opus":0.017644009180269826,"score_gpt":0.36025834114367017,"score_spread":0.34261433196340035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410422160","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956774,0.000618717,0.0022067314,0.00023043975,0.00010194426,0.00004347602,0.0008094046,0.00005066412,0.00026121334],"genre_scores_gemma":[0.99650276,0.00026267668,0.0009057701,0.000051240746,0.000074185395,0.0000894886,0.001219051,0.000017741373,0.0008771523],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99447745,0.0036779558,0.00024024764,0.0007325536,0.00023345725,0.00063831906],"domain_scores_gemma":[0.99230766,0.0046236166,0.0006521886,0.0012107921,0.00040415063,0.00080157863],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011500683,0.0025994724,0.0028910171,0.0012055074,0.0012320986,0.0025287492,0.0024808946,0.0018591912,0.0046886667],"category_scores_gemma":[0.0066234227,0.002065252,0.010676635,0.0011877262,0.0008790411,0.0017919581,0.0027289456,0.0033955537,0.0005311921],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022774769,0.0023798177,0.9179904,0.00017638401,0.03159086,0.0003638571,0.00033951586,0.015772227,0.0009872742,0.0008336524,0.0012452049,0.00554591],"study_design_scores_gemma":[0.0012267638,0.0062880972,0.79844725,0.00008101743,0.019123858,0.0004466225,0.0008910002,0.17010483,0.00050660915,0.0016769479,0.0010365642,0.00017046423],"about_ca_topic_score_codex":0.019184941,"about_ca_topic_score_gemma":0.012596443,"teacher_disagreement_score":0.019184941,"about_ca_system_score_codex":0.00078240776,"about_ca_system_score_gemma":0.0024174706,"threshold_uncertainty_score":0.06082219},"labels":[],"label_agreement":null},{"id":"W4410422177","doi":"10.1016/j.jaad.2025.05.1391","title":"Skin clearance, duration of treatment-free interval, and safety of tapinarof cream 1% once daily: Results from ADORING 3, a 48-week phase 3 open-label extension trial in adults and children down to 2 years of age with atopic dermatitis","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"","keywords":"Medicine; Open label; Confidence interval; Duration (music); Interval (graph theory); Extension (predicate logic); Phase (matter); Clinical trial; Randomized controlled trial; Surgery; Internal medicine; Combinatorics; Mathematics","score_opus":0.01729761670407963,"score_gpt":0.3214463128655334,"score_spread":0.30414869616145374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410422177","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99627906,0.001984624,0.00020234022,0.000060584494,0.000016685255,0.00038453037,0.00048729993,0.000025464162,0.0005593758],"genre_scores_gemma":[0.9969919,0.0008697082,0.00041450618,0.00013765245,0.000059028072,0.00030648505,0.00086263387,0.000010385216,0.0003476151],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99929607,0.00031249312,0.0000664301,0.00009661687,0.00012582674,0.000102510974],"domain_scores_gemma":[0.9981331,0.0005351381,0.00061304966,0.00012705657,0.00012496559,0.00046674575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023611865,0.00068259204,0.001038862,0.00024069587,0.00026210083,0.0005092189,0.00037095055,0.0006689111,0.002266484],"category_scores_gemma":[0.0015730117,0.00023202642,0.0011232365,0.00025721604,0.00040726317,0.0006066852,0.00020061298,0.0015842007,0.00030357885],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7080075,0.040396243,0.032433044,0.0012208684,0.001588977,0.00024149832,0.00042804945,0.0012635103,0.035043094,0.0001236952,0.0027246885,0.17652883],"study_design_scores_gemma":[0.31940657,0.5531608,0.11747182,0.000078556346,0.0009926173,0.00067227264,0.00008633908,0.0011849134,0.0050351135,0.00012186334,0.0017450309,0.000044185927],"about_ca_topic_score_codex":0.00056346477,"about_ca_topic_score_gemma":0.001039618,"teacher_disagreement_score":0.0023611865,"about_ca_system_score_codex":0.0003953505,"about_ca_system_score_gemma":0.00052034267,"threshold_uncertainty_score":0.012487352},"labels":[],"label_agreement":null},{"id":"W4410707514","doi":"10.1016/j.jaad.2025.05.1418","title":"Predictors of drug survival of biologics in hidradenitis suppurativa: A systematic review and meta-analysis","year":2025,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Children's Hospital; McMaster University; Western University","funders":"Janssen Pharmaceuticals; AbbVie","keywords":"Medicine; Hidradenitis suppurativa; Meta-analysis; Dermatology; MEDLINE; Drug; Internal medicine; Pharmacology; Disease","score_opus":0.052763059425542505,"score_gpt":0.37797650529183047,"score_spread":0.325213445866288,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410707514","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0069393595,0.9921163,0.00024847305,0.000082575396,0.00009483002,0.00007326331,0.00029014776,0.000012427361,0.000142771],"genre_scores_gemma":[0.2041181,0.79210186,0.0014578939,0.00079014275,0.0002392572,0.00028249598,0.0006087882,0.00001962733,0.00038177735],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99736124,0.0009641275,0.00082739786,0.00040320557,0.00028383464,0.00016021845],"domain_scores_gemma":[0.9929575,0.0049825357,0.0013149271,0.00022800574,0.0003815855,0.00013540468],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004400911,0.0018304294,0.012312123,0.0024493423,0.00045139084,0.00226358,0.0015135839,0.0018352598,0.0036521968],"category_scores_gemma":[0.010841763,0.0011775088,0.027301425,0.0040908796,0.0005580997,0.0014543531,0.0013252741,0.002167629,0.00031084692],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004883558,0.000071512215,0.011518072,0.3031484,0.65710986,0.00015779094,0.000109121334,0.00053223735,0.0003323577,0.00011350601,0.00079877867,0.021224866],"study_design_scores_gemma":[0.0008914181,0.00024943115,0.007597513,0.01230513,0.97706705,0.00008412487,0.000056805573,0.00017194025,0.00008004143,0.00014164367,0.0013244163,0.000030581687],"about_ca_topic_score_codex":0.005227683,"about_ca_topic_score_gemma":0.014644782,"teacher_disagreement_score":0.012312123,"about_ca_system_score_codex":0.0011751199,"about_ca_system_score_gemma":0.0017753071,"threshold_uncertainty_score":0.023274481},"labels":[],"label_agreement":null},{"id":"W4410711514","doi":"10.1016/j.jaad.2025.05.1412","title":"The association between bariatric surgery and improvement in psoriasis: A systematic review","year":2025,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dermatrials Research; Queen's University; McMaster University","funders":"","keywords":"Medicine; Psoriasis; Dermatology; MEDLINE; Association (psychology); Surgery; General surgery","score_opus":0.02028919796348273,"score_gpt":0.2997666705720775,"score_spread":0.2794774726085948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410711514","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010410432,0.9983961,0.0000499909,0.00010076784,0.000065636705,0.00003416937,0.00023067615,0.0000041700796,0.00007746265],"genre_scores_gemma":[0.022296932,0.9765192,0.000266792,0.00049325096,0.00009472404,0.0000649406,0.00019521434,0.0000038588755,0.000065000764],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99778974,0.00057367916,0.0008898266,0.0003240456,0.0003196851,0.00010302564],"domain_scores_gemma":[0.98904294,0.00793986,0.00210263,0.00016670952,0.00057604833,0.00017181554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030858712,0.00094007957,0.0072174096,0.0036362095,0.0003312786,0.0016639623,0.0015479473,0.0017463454,0.004281734],"category_scores_gemma":[0.013904786,0.00089783664,0.007803973,0.0051891194,0.0006038823,0.0013458553,0.0011801218,0.0013480233,0.00028991528],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00082479237,0.00003479923,0.004467626,0.8809621,0.07211296,0.00015519967,0.00013096785,0.00014489658,0.00023673003,0.00014325029,0.0024410575,0.03834562],"study_design_scores_gemma":[0.0015011489,0.0004244498,0.030640554,0.3321864,0.6172056,0.0005950511,0.00030649683,0.00017618922,0.0002012315,0.00044095243,0.016210426,0.00011150905],"about_ca_topic_score_codex":0.007671274,"about_ca_topic_score_gemma":0.026207112,"teacher_disagreement_score":0.007671274,"about_ca_system_score_codex":0.0011436015,"about_ca_system_score_gemma":0.0033643476,"threshold_uncertainty_score":0.016319811},"labels":[],"label_agreement":null},{"id":"W4410876696","doi":"10.1016/j.jaad.2025.05.1430","title":"Clinical presentations and outcomes of cutaneous metastases from prostate cancer: A systematic review","year":2025,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Cancer Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Université de Sherbrooke; McGill University Health Centre","funders":"McGill University","keywords":"Medicine; Prostate cancer; Oncology; MEDLINE; Dermatology; Internal medicine; Cancer","score_opus":0.04847407595966692,"score_gpt":0.4616827047009094,"score_spread":0.4132086287412425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410876696","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002480379,0.9968683,0.000045348566,0.000073545954,0.000036552963,0.00004258227,0.00033872703,0.0000027602534,0.000111857924],"genre_scores_gemma":[0.055083346,0.9436235,0.00027889558,0.00042469226,0.000076392316,0.00009250243,0.0003278217,0.000003582278,0.00008931166],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99784267,0.00059099327,0.0008190095,0.00030855832,0.00033605398,0.00010268326],"domain_scores_gemma":[0.99132746,0.0058575226,0.002089904,0.00010629629,0.0004924395,0.0001263268],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019167756,0.0008173301,0.004529163,0.0031901638,0.00031066706,0.0013816212,0.001137599,0.0012409833,0.003723286],"category_scores_gemma":[0.01462704,0.0007389164,0.007876218,0.005086652,0.0005075125,0.0012900339,0.0011482615,0.0010960381,0.00021058589],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007585007,0.0000407688,0.015592134,0.8654231,0.06820334,0.00018590927,0.00020567585,0.00021900474,0.00017940738,0.00016234156,0.0028558783,0.04617393],"study_design_scores_gemma":[0.0010585097,0.0004314483,0.06853809,0.4450628,0.4642765,0.0014514534,0.00067765656,0.00022434279,0.00019617246,0.00056265946,0.01737932,0.00014112492],"about_ca_topic_score_codex":0.008566868,"about_ca_topic_score_gemma":0.028915092,"teacher_disagreement_score":0.008566868,"about_ca_system_score_codex":0.0012560065,"about_ca_system_score_gemma":0.0023083142,"threshold_uncertainty_score":0.017033994},"labels":[],"label_agreement":null},{"id":"W4411022889","doi":"10.1016/j.jaad.2025.05.1435","title":"Association between body location of itch and stress in patients with chronic pruritus","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Medicine; Dermatology; Association (psychology)","score_opus":0.004956468305115962,"score_gpt":0.2775458829706993,"score_spread":0.27258941466558334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411022889","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99850106,0.000432711,0.000037262926,0.00008311641,0.00001476072,0.000004212478,0.00013441502,0.0000024689502,0.000789985],"genre_scores_gemma":[0.9996977,0.000084018626,0.00002417513,0.000020899037,0.000019364094,0.0000022140434,0.000075315176,6.5857284e-7,0.00007584307],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997173,0.00008340443,0.00003706574,0.000041801544,0.000044752687,0.00007559514],"domain_scores_gemma":[0.99848986,0.00035769687,0.00074457884,0.00005164607,0.00008293858,0.00027329059],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022957346,0.00026393545,0.00033192668,0.00082135847,0.00043047583,0.00053380145,0.00023410704,0.0006055705,0.0032040104],"category_scores_gemma":[0.0017989863,0.00020208511,0.00049638667,0.0008074321,0.00029406033,0.0004234538,0.00040607306,0.0007123689,0.00023098566],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011191628,0.000028526365,0.99871325,0.000010509266,0.000032856355,0.00024099568,0.000037914033,0.000015062129,0.00022407253,0.000007516309,0.00003130726,0.000546112],"study_design_scores_gemma":[0.0000029127195,0.00006185726,0.9990815,0.0000038928943,0.000011956267,0.0005826481,0.0001424048,0.000047527075,0.00001364911,0.0000093152275,0.00003998866,0.0000023093598],"about_ca_topic_score_codex":0.001863872,"about_ca_topic_score_gemma":0.0027243283,"teacher_disagreement_score":0.0032040104,"about_ca_system_score_codex":0.00019509271,"about_ca_system_score_gemma":0.00017070163,"threshold_uncertainty_score":0.010718524},"labels":[],"label_agreement":null},{"id":"W4411306914","doi":"10.1016/j.jaad.2025.06.028","title":"Response to Chen et al., “Comment on “Assessing the diagnostic metrics of cutaneous leiomyomas in hereditary leiomyomatosis and renal cell cancer syndrome: An observational study””","year":2025,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Renal and related cancers","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre; McGill University","funders":"","keywords":"Medicine; Leiomyomatosis; Pathology; Observational study; Cancer; Gynecology; Leiomyoma; Internal medicine","score_opus":0.02978128547016528,"score_gpt":0.3429714789262754,"score_spread":0.3131901934561101,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411306914","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004158358,0.0005217334,0.00006493367,0.98432666,0.013482162,0.00001470267,0.00027033826,0.000046618658,0.0008570065],"genre_scores_gemma":[0.0015753066,0.00022948015,0.00009246052,0.9862547,0.009618639,0.000037635924,0.000057059406,0.00001657963,0.0021181973],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966139,0.0008883187,0.000510966,0.00056863297,0.0009021098,0.0005160135],"domain_scores_gemma":[0.98573154,0.008179079,0.0009794357,0.0003363091,0.0030460968,0.0017275995],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0052150153,0.00075518433,0.0014575334,0.0009105045,0.0033145896,0.002627997,0.0020996782,0.035005916,0.007417383],"category_scores_gemma":[0.031949136,0.0008103993,0.0012569526,0.001029676,0.001770202,0.0022594365,0.0012275997,0.028513994,0.007419658],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005591765,0.000014187739,0.0007451404,0.000023768876,0.000009284903,0.0003550441,0.00005582334,0.000018738552,0.00006766378,0.00024918182,0.9964276,0.0019776397],"study_design_scores_gemma":[0.00040299172,0.00017431186,0.009264138,0.0006909198,0.00010238796,0.0022700736,0.0010429648,0.00067054277,0.00087658665,0.004969779,0.9793401,0.00019520942],"about_ca_topic_score_codex":0.01449742,"about_ca_topic_score_gemma":0.02203559,"teacher_disagreement_score":0.035005916,"about_ca_system_score_codex":0.003452132,"about_ca_system_score_gemma":0.0053773555,"threshold_uncertainty_score":0.028826118},"labels":[],"label_agreement":null},{"id":"W4411334468","doi":"10.1016/j.jaad.2025.05.1456","title":"Tattoo inks and carcinogenic risk: Current evidence and regulatory gaps","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Tattoo and Body Piercing Complications","field":"Social Sciences","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McGill University Health Centre","funders":"","keywords":"Medicine; Current (fluid); Carcinogen; Environmental health; Genetics","score_opus":0.02970496303628146,"score_gpt":0.37683934376959566,"score_spread":0.3471343807333142,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411334468","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007208315,0.94894505,0.00069100276,0.033297665,0.0012927939,0.00003887901,0.00044038153,0.00002055712,0.008065327],"genre_scores_gemma":[0.105285525,0.8731028,0.0017230728,0.014357046,0.0042314082,0.00009521413,0.0004755908,0.000020390009,0.00070899253],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9910945,0.003518414,0.001351511,0.0013757193,0.002266277,0.00039355262],"domain_scores_gemma":[0.88255095,0.09285206,0.012943004,0.0019065533,0.0085385265,0.0012088785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020942183,0.00089840364,0.0025147554,0.002271815,0.00088123535,0.00719022,0.0026376734,0.006516544,0.009243701],"category_scores_gemma":[0.048001774,0.0007055037,0.0018291571,0.0034502856,0.005468419,0.0039870995,0.0016637556,0.0046437015,0.0010044947],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004537268,0.0018941332,0.06222257,0.039083373,0.0025432198,0.0003760955,0.0010840179,0.0013172985,0.0015706675,0.041116767,0.029936906,0.81431764],"study_design_scores_gemma":[0.0014042291,0.0033708357,0.10884595,0.12456609,0.0084657995,0.0020138856,0.0064644725,0.001490225,0.0038702593,0.09457144,0.64464694,0.0002899279],"about_ca_topic_score_codex":0.007422057,"about_ca_topic_score_gemma":0.007856592,"teacher_disagreement_score":0.020942183,"about_ca_system_score_codex":0.0020768226,"about_ca_system_score_gemma":0.0073703555,"threshold_uncertainty_score":0.11075419},"labels":[],"label_agreement":null},{"id":"W4411370152","doi":"10.1016/j.jaad.2025.05.1386","title":"Focused update: Guidelines of care for the management of atopic dermatitis in adults","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"American Academy of Dermatology","keywords":"Medicine; Atopic dermatitis; Dermatology; MEDLINE; Skin care; Family medicine; Nursing","score_opus":0.014424952664098082,"score_gpt":0.3354622603990493,"score_spread":0.3210373077349512,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411370152","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0034507352,0.7069338,0.0061377273,0.1711581,0.060572,0.0009671862,0.0071120807,0.0011059173,0.042562433],"genre_scores_gemma":[0.016256697,0.6950788,0.052535314,0.14845526,0.047247794,0.0014271333,0.018011697,0.00031068103,0.020676654],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99645776,0.001121125,0.0008347025,0.00017293038,0.0011701039,0.00024338765],"domain_scores_gemma":[0.9853233,0.004225747,0.0022966238,0.0002468139,0.0067022326,0.001205349],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038628355,0.0012286701,0.0022278256,0.0041350164,0.00059900037,0.0023364127,0.0028208538,0.0051721428,0.0067492076],"category_scores_gemma":[0.019300964,0.0005098245,0.0024959669,0.0029120357,0.00051789137,0.0017873105,0.0012369857,0.0062803305,0.0043718484],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011054206,0.00014927129,0.0012498965,0.0028455474,0.0001282703,0.0001786257,0.000040543164,0.00026794447,0.0001886257,0.0004594802,0.7833586,0.21102265],"study_design_scores_gemma":[0.00027318887,0.00013021303,0.008366629,0.017244,0.0005954626,0.0013014034,0.000098734694,0.00050293433,0.00017121338,0.00071355375,0.97053546,0.000067266454],"about_ca_topic_score_codex":0.012607058,"about_ca_topic_score_gemma":0.031941555,"teacher_disagreement_score":0.012607058,"about_ca_system_score_codex":0.0023870459,"about_ca_system_score_gemma":0.0073074177,"threshold_uncertainty_score":0.025067389},"labels":[],"label_agreement":null},{"id":"W4411440341","doi":"10.1016/j.jaad.2025.06.045","title":"Wound Care – Part II: Tissue-engineered skin substitutes & other advanced wound therapies","year":2025,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Wound Healing and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Calgary","funders":"","keywords":"Medicine; Wound healing; Regeneration (biology); Tissue engineering; Wound care; Tissue repair; Surgery; Dermatology; Biomedical engineering; Biology; Cell biology","score_opus":0.035686371197079396,"score_gpt":0.38595627900161333,"score_spread":0.35026990780453393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411440341","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000111695255,0.99794215,0.00009550266,0.00009660815,0.00040771847,0.000017234233,0.00003035287,0.0000056202875,0.0012931257],"genre_scores_gemma":[0.0005269416,0.9971699,0.00023477098,0.00021864579,0.00032081155,0.000016340033,0.00006679451,0.0000026009984,0.0014432316],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99972063,0.0000386288,0.000046512207,0.0000424135,0.000124525,0.000027241007],"domain_scores_gemma":[0.99960846,0.00016783927,0.00008950241,0.000011539876,0.00008807473,0.000034628],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057289185,0.0011034149,0.0014794166,0.003632373,0.00023192733,0.0011757571,0.0007108434,0.00087875593,0.007286639],"category_scores_gemma":[0.00074596715,0.00028771575,0.00071790355,0.0028269363,0.0004489661,0.0012696449,0.00065965235,0.0015763494,0.0029158068],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007217024,0.00016651739,0.000076737975,0.019302849,0.00010089441,0.00006547199,0.00002395303,0.00023503239,0.0020285526,0.001601312,0.037146207,0.93918025],"study_design_scores_gemma":[0.000044333323,0.00017748286,0.00084483274,0.007131401,0.00017791144,0.00072187977,0.000034728233,0.0001224603,0.00077842956,0.0007828947,0.98916465,0.000018903738],"about_ca_topic_score_codex":0.0013101046,"about_ca_topic_score_gemma":0.0026699505,"teacher_disagreement_score":0.007286639,"about_ca_system_score_codex":0.00048263368,"about_ca_system_score_gemma":0.0008336119,"threshold_uncertainty_score":0.024376214},"labels":[],"label_agreement":null},{"id":"W4411443142","doi":"10.1016/j.jaad.2025.06.044","title":"Increased prevalence of renal cysts in hereditary leiomyomatosis and renal cell cancer: A cross-sectional magnetic resonance imaging-based study","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University; McGill University Health Centre","funders":"","keywords":"Medicine; Leiomyomatosis; Cross-sectional study; Pathology; Radiology; Leiomyoma","score_opus":0.011949926979883119,"score_gpt":0.30682976405469825,"score_spread":0.29487983707481513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411443142","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99945456,0.000120896395,0.000049595816,0.000020434174,0.0000032396806,0.000003111728,0.00009382122,0.000002713031,0.00025160305],"genre_scores_gemma":[0.99970585,0.000055669705,0.000040336097,0.000017512488,0.0000067987303,0.0000031167463,0.000077902536,0.0000017474993,0.000091069036],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994248,0.00018864854,0.000058975107,0.00017176005,0.00007881181,0.00007693448],"domain_scores_gemma":[0.9981627,0.0003484162,0.00067989976,0.00015389762,0.00021185177,0.00044335853],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066996884,0.00036392245,0.00038459038,0.001212,0.00060905557,0.00069579156,0.00042833135,0.0008571252,0.0023576824],"category_scores_gemma":[0.0019457531,0.0006862705,0.00055399997,0.0010364223,0.00049288565,0.00082895154,0.0005138208,0.0005846987,0.0003311978],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044584656,0.00004555989,0.99920696,0.00000302548,0.00004195981,0.00009405963,0.00006368205,0.000009005614,0.00026396688,0.000006124959,0.000018986591,0.00020203655],"study_design_scores_gemma":[0.0000020677128,0.000063255444,0.9992698,0.0000015344732,0.00002288351,0.00038046768,0.00014472965,0.000050588867,0.000025873824,0.0000051166426,0.000031456428,0.0000022051406],"about_ca_topic_score_codex":0.004441121,"about_ca_topic_score_gemma":0.0038899474,"teacher_disagreement_score":0.004441121,"about_ca_system_score_codex":0.00024226749,"about_ca_system_score_gemma":0.0002229869,"threshold_uncertainty_score":0.008830547},"labels":[],"label_agreement":null},{"id":"W4411488589","doi":"10.1016/j.jaad.2025.02.103","title":"Wound Care – Part I: A practical approach to local wound care and dressing selection","year":2025,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Pressure Ulcer Prevention and Management","field":"Health Professions","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Calgary","funders":"","keywords":"Medicine; Wound care; Selection (genetic algorithm); Wound dressing; Intensive care medicine; Wound healing; Surgery; Artificial intelligence","score_opus":0.07843623817578152,"score_gpt":0.48219911512996017,"score_spread":0.4037628769541787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411488589","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021265906,0.992144,0.001043049,0.002515198,0.0007940766,0.00009916935,0.00004430587,0.000020403095,0.0031271442],"genre_scores_gemma":[0.0017937921,0.9895923,0.003488629,0.0022120907,0.00093056756,0.00010016439,0.00006906266,0.000006598366,0.0018067925],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99844956,0.00048394638,0.00028580817,0.00012370425,0.00058326445,0.0000737846],"domain_scores_gemma":[0.99793684,0.000974227,0.0004166832,0.000049212507,0.00052199204,0.00010102471],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026665574,0.0010298182,0.0015757199,0.003039502,0.0004884697,0.0018171681,0.0012248206,0.0018407791,0.005417511],"category_scores_gemma":[0.0035475162,0.00045074458,0.0010563678,0.0023126977,0.00096814334,0.0018541269,0.0011376571,0.0026756998,0.002611937],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042742424,0.0001868781,0.00030961918,0.02358185,0.00010003559,0.00005580429,0.00009248022,0.00015211478,0.0005872783,0.0028032716,0.048011903,0.92407596],"study_design_scores_gemma":[0.000061093895,0.00028263006,0.00622005,0.043073352,0.0002527239,0.0018853968,0.0002509213,0.0002077443,0.0005676863,0.003248326,0.94390124,0.00004877868],"about_ca_topic_score_codex":0.0032567498,"about_ca_topic_score_gemma":0.008434848,"teacher_disagreement_score":0.005417511,"about_ca_system_score_codex":0.0015516505,"about_ca_system_score_gemma":0.0033331143,"threshold_uncertainty_score":0.018123329},"labels":[],"label_agreement":null},{"id":"W4411991532","doi":"10.1016/j.jaad.2025.06.065","title":"Topical ruxolitinib vs topical roflumilast for itch reduction in atopic dermatitis: A comparative meta-analysis","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; University of Alberta; University of Ottawa; McMaster University","funders":"","keywords":"Medicine; Ruxolitinib; Roflumilast; Atopic dermatitis; Dermatology; Meta-analysis; Dupilumab; Internal medicine; Myelofibrosis","score_opus":0.05600985807728318,"score_gpt":0.3870084185475585,"score_spread":0.3309985604702753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411991532","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3043071,0.6857772,0.0031350667,0.0006718132,0.0014136466,0.0007659123,0.0017097386,0.00019284814,0.002026718],"genre_scores_gemma":[0.9506391,0.044990115,0.0014827998,0.0008738245,0.00033075086,0.00029130137,0.00051722495,0.000047400197,0.0008273307],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99441826,0.0032122976,0.000799295,0.00088662666,0.0003722711,0.00031131465],"domain_scores_gemma":[0.99405473,0.0036628314,0.0011814771,0.00051882066,0.00035766856,0.00022456808],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007942077,0.002904457,0.011186056,0.0013076725,0.00060750445,0.0024059445,0.001777789,0.0022163033,0.0055082655],"category_scores_gemma":[0.01173441,0.0016126367,0.02934539,0.0016671402,0.0009711375,0.0015569549,0.001254156,0.0029102697,0.00054678257],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09435655,0.00017274285,0.0044232393,0.026529701,0.8664497,0.00010392061,0.00008581234,0.00044227813,0.0006830724,0.0001132696,0.00033199662,0.006307776],"study_design_scores_gemma":[0.0195757,0.0019496803,0.0044360617,0.0009667484,0.97188693,0.0000554316,0.0000545386,0.00024546572,0.00013448129,0.0001730815,0.0004944383,0.000027350547],"about_ca_topic_score_codex":0.0044321697,"about_ca_topic_score_gemma":0.009858576,"teacher_disagreement_score":0.011186056,"about_ca_system_score_codex":0.0015279358,"about_ca_system_score_gemma":0.00090431364,"threshold_uncertainty_score":0.04200226},"labels":[],"label_agreement":null},{"id":"W4412454865","doi":"10.1016/j.jaad.2025.07.017","title":"Paradigm shift in the management of infantile hemangiomas in the beta-blocker era: A retrospective cohort study","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Vascular Malformations and Hemangiomas","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Pediatric Dermatology Research Alliance","keywords":"Medicine; Retrospective cohort study; Beta blocker; Cohort; Pediatrics; Internal medicine","score_opus":0.010097845781712108,"score_gpt":0.30712974184423725,"score_spread":0.2970318960625251,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412454865","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972082,0.0015549328,0.0002049618,0.00021256733,0.000034957084,0.000008827274,0.00024533126,0.000002969457,0.0005272164],"genre_scores_gemma":[0.9991781,0.00033393074,0.00008562281,0.0001193781,0.000028072534,0.0000075273556,0.00016888815,0.000004206756,0.000074151045],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99864405,0.00032770014,0.00015574017,0.0004001761,0.00019051647,0.00028186734],"domain_scores_gemma":[0.998221,0.0003047639,0.0008699424,0.00017403685,0.00017894356,0.0002512623],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009996755,0.00019813601,0.0004333986,0.00047324583,0.0005731193,0.0010508667,0.0003803781,0.0005232398,0.0013168713],"category_scores_gemma":[0.003219202,0.00023888107,0.00055535446,0.0009581736,0.0002328828,0.0006709168,0.00038850197,0.0009084936,0.0001720691],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021276395,0.00005313907,0.9966562,0.0000146998345,0.00013832276,0.00029945982,0.00013914201,0.000034809924,0.00024965528,0.00009630357,0.00024091662,0.0018645973],"study_design_scores_gemma":[0.000026982747,0.00029495338,0.9938245,0.000046069086,0.00018916572,0.0026368063,0.001207401,0.000375485,0.00012359864,0.0002046971,0.0010516802,0.000018648456],"about_ca_topic_score_codex":0.0026474723,"about_ca_topic_score_gemma":0.0030235685,"teacher_disagreement_score":0.0026474723,"about_ca_system_score_codex":0.0004915981,"about_ca_system_score_gemma":0.00084621366,"threshold_uncertainty_score":0.0052868724},"labels":[],"label_agreement":null},{"id":"W4412454913","doi":"10.1016/j.jaad.2025.07.013","title":"Highly selective, allosteric inhibition of TYK2 with oral ESK-001 in patients with moderate-to-severe plaque psoriasis: Results from STRIDE, a 12-week, randomized, double-blinded, placebo-controlled, dose-ranging phase 2 study","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Medicine; Plaque psoriasis; Placebo; Dose-ranging study; STRIDE; Dermatology; Psoriasis; Randomized controlled trial; Internal medicine; Pathology; Double blind; Physical medicine and rehabilitation","score_opus":0.014979457793060856,"score_gpt":0.26939739043571403,"score_spread":0.25441793264265317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412454913","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934668,0.0036758583,0.00038925104,0.00023598262,0.000051879157,0.0006889635,0.00029156587,0.00005899031,0.0011407621],"genre_scores_gemma":[0.9938294,0.00230688,0.0010350295,0.0005431345,0.00010313376,0.00071591674,0.0006186455,0.00001595107,0.00083176675],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.999485,0.00024908144,0.00004747863,0.00007212234,0.00008906591,0.00005722713],"domain_scores_gemma":[0.9994973,0.00011369636,0.00014451542,0.000046359677,0.00003902763,0.00015900229],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023838175,0.00085980335,0.0015049034,0.00024816833,0.00023783224,0.00069459964,0.0005588103,0.00063501997,0.0023647984],"category_scores_gemma":[0.0008357199,0.00045704053,0.0013377743,0.00024453292,0.0005871777,0.00068272994,0.00028061788,0.0022476867,0.00048782481],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6441469,0.054547142,0.011476803,0.0022967039,0.0031603,0.00030148675,0.00043137948,0.001753342,0.1161249,0.00029289845,0.0031959398,0.1622723],"study_design_scores_gemma":[0.6217148,0.3328353,0.033279344,0.00009509445,0.0011473196,0.0004466282,0.000079386744,0.0010542427,0.0064080707,0.00017584741,0.0027221863,0.00004190435],"about_ca_topic_score_codex":0.00022912343,"about_ca_topic_score_gemma":0.0008255344,"teacher_disagreement_score":0.0023838175,"about_ca_system_score_codex":0.00034479288,"about_ca_system_score_gemma":0.00063784077,"threshold_uncertainty_score":0.012606978},"labels":[],"label_agreement":null},{"id":"W4412465017","doi":"10.1016/j.jaad.2025.07.014","title":"Novel application of punch excision therapy in the treatment of keloids: A systematic review","year":2025,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Dermatologic Treatments and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Ottawa","funders":"","keywords":"Medicine; Keloid; Dermatology; MEDLINE; Surgery","score_opus":0.06463956115118104,"score_gpt":0.4421992276117579,"score_spread":0.37755966646057687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412465017","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006046876,0.9989207,0.00006671567,0.00006198772,0.000054144875,0.000075766926,0.00010834249,0.0000028540412,0.000104804836],"genre_scores_gemma":[0.007861979,0.991322,0.0002780578,0.00027482014,0.00005064123,0.00007012771,0.00008063209,0.0000021354795,0.000059704496],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99771166,0.0006576618,0.00082128897,0.00026322293,0.0004579277,0.000088253604],"domain_scores_gemma":[0.99174553,0.0060397736,0.0014455835,0.00010433026,0.0005535274,0.00011135721],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031644097,0.0011672948,0.007121496,0.0036099348,0.00046213705,0.0019760733,0.0018017285,0.0018732017,0.0049025808],"category_scores_gemma":[0.013798648,0.0006766165,0.0082218,0.0043875556,0.00068324734,0.0017190449,0.0009565924,0.0013114492,0.00033314695],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008083317,0.000046575627,0.00075481454,0.9155142,0.0214033,0.00008937084,0.00010840513,0.00013585825,0.00024175252,0.00014778232,0.0015042956,0.059245348],"study_design_scores_gemma":[0.0017756423,0.000799416,0.0079001775,0.6352799,0.32793865,0.0006621086,0.0003981446,0.00021588833,0.00035574593,0.00050518115,0.024065109,0.00010398125],"about_ca_topic_score_codex":0.006442588,"about_ca_topic_score_gemma":0.024137095,"teacher_disagreement_score":0.007121496,"about_ca_system_score_codex":0.0014372414,"about_ca_system_score_gemma":0.0042077904,"threshold_uncertainty_score":0.016735196},"labels":[],"label_agreement":null},{"id":"W4412465320","doi":"10.1016/j.jaad.2025.07.020","title":"Medico-legal risks associated with laser therapy: A cross-sectional descriptive analysis of closed cases over a 10-year period in Canada","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Medical Malpractice and Liability Issues","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Medical Protective Association; Canadian Medical Association; Vancouver Coastal Health; Vancouver Coastal Health Research Institute; University of British Columbia","funders":"Institute of Musculoskeletal Health and Arthritis; Canadian Institutes of Health Research; Canadian Dermatology Foundation; Michael Smith Health Research BC; Lotte and John Hecht Memorial Foundation; University of British Columbia","keywords":"Medicine; Cross-sectional study; Descriptive statistics; Laser therapy; Family medicine; Laser; Statistics; Pathology","score_opus":0.06009309020162526,"score_gpt":0.43517842314840915,"score_spread":0.3750853329467839,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412465320","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967996,0.00046387606,0.000049129572,0.00022241505,0.000007176839,0.000042546493,0.0012411387,0.0000048949446,0.001169235],"genre_scores_gemma":[0.99810874,0.0005334782,0.00006173359,0.0000949728,0.0000072339017,0.000015306563,0.00072533067,0.000003544198,0.00044964708],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99770975,0.00016597351,0.00020190339,0.0002258465,0.0008927088,0.0008037579],"domain_scores_gemma":[0.9904079,0.00068969023,0.004227259,0.00014026774,0.002584732,0.0019502006],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000746974,0.00035920786,0.000457438,0.0033100385,0.0031571817,0.0019137546,0.0020493856,0.0011690652,0.0019772903],"category_scores_gemma":[0.005199081,0.00076368626,0.0008632487,0.0063405917,0.0015411209,0.0009231046,0.0019393094,0.001745359,0.00022513926],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044707893,0.000063294276,0.99759907,0.000015825939,0.000030455994,0.00016244753,0.0007887955,0.00003679472,0.000060918577,0.000046740824,0.0002656456,0.0008853472],"study_design_scores_gemma":[0.000001735501,0.000022933064,0.9971756,0.00001364014,0.000010763446,0.00012107896,0.0023489997,0.00007927787,0.000018918146,0.000008235134,0.00019212683,0.0000067365495],"about_ca_topic_score_codex":0.96724516,"about_ca_topic_score_gemma":0.97885543,"teacher_disagreement_score":0.03275484,"about_ca_system_score_codex":0.023665827,"about_ca_system_score_gemma":0.025909118,"threshold_uncertainty_score":0.1717084},"labels":[],"label_agreement":null},{"id":"W4412555606","doi":"10.1016/j.jaad.2025.07.035","title":"Body politics","year":2025,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Historical Gender and Feminism Studies","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"","keywords":"Medicine; Politics; Law","score_opus":0.027409067838720352,"score_gpt":0.3492204269745607,"score_spread":0.32181135913584036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412555606","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016506868,0.0055031553,0.0003327095,0.5868133,0.02622854,0.00005035119,0.00015536023,0.00006446713,0.37920144],"genre_scores_gemma":[0.0119967135,0.001018021,0.00016641997,0.47793528,0.009273268,0.000057761597,0.000054535245,0.000035597528,0.4994624],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99795544,0.0003900548,0.00010510414,0.00040258272,0.0006246179,0.0005223459],"domain_scores_gemma":[0.9979406,0.000832172,0.0000866547,0.00016354636,0.0004652391,0.0005118433],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018053029,0.0003926969,0.0005138147,0.00056811626,0.010579684,0.007421899,0.0010709924,0.03182719,0.05341711],"category_scores_gemma":[0.007204752,0.0005335606,0.0007141253,0.00035415567,0.0036626519,0.0028170352,0.002989709,0.0231932,0.022614503],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027902866,0.000042150517,0.0004549546,0.000030487337,0.000005920265,0.00037263834,0.00048959313,0.000024656245,0.00020751248,0.07530271,0.9086394,0.014402073],"study_design_scores_gemma":[0.0000109430475,0.000007717833,0.0005043477,0.000078580655,0.0000035416592,0.00010725654,0.00034024677,0.000028495659,0.0000721861,0.007827053,0.99101275,0.000006865784],"about_ca_topic_score_codex":0.020751702,"about_ca_topic_score_gemma":0.06904496,"teacher_disagreement_score":0.05341711,"about_ca_system_score_codex":0.0046048095,"about_ca_system_score_gemma":0.006315678,"threshold_uncertainty_score":0.17869806},"labels":[],"label_agreement":null},{"id":"W4413407654","doi":"10.1016/j.jaad.2025.08.031","title":"Red light photodynamic therapy with 10% aminolevulinic acid gel showed efficacy for treatment of superficial basal cell carcinoma in a randomized, vehicle controlled, double-blind, multicenter phase III study","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bell (Canada)","funders":"Biofrontera","keywords":"Medicine; Photodynamic therapy; Double blind; Basal cell carcinoma; Red light; Multicenter study; Randomized controlled trial; Double blind study; Basal cell; Dermatology; Pathology","score_opus":0.02589014983248519,"score_gpt":0.35196673066922923,"score_spread":0.32607658083674407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413407654","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904739,0.004202532,0.0009784756,0.00035677516,0.0001854915,0.0025599892,0.00041412146,0.00007884539,0.0007498903],"genre_scores_gemma":[0.9921645,0.002344008,0.0016114825,0.00052653643,0.00013545316,0.0018815881,0.00044324266,0.000026113623,0.0008672437],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9989827,0.0005934927,0.00006206332,0.0001487966,0.000108993,0.000103990445],"domain_scores_gemma":[0.9988273,0.00034607886,0.00033845357,0.00010368166,0.00013184869,0.0002527142],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031225397,0.0009667221,0.0017837979,0.00032425404,0.00033218408,0.0008946446,0.0007466118,0.0012066144,0.0030216288],"category_scores_gemma":[0.001323802,0.0005617595,0.0016685582,0.00033515008,0.0008114695,0.0006159883,0.00019135795,0.0019366485,0.0005382949],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.83705324,0.050959,0.002363336,0.0016032306,0.0023610326,0.000111870446,0.00020970548,0.0005833908,0.057852115,0.0001451131,0.0014890404,0.04526894],"study_design_scores_gemma":[0.65472764,0.33193982,0.0053025293,0.000074409574,0.001170185,0.00008060663,0.000036364418,0.00058714725,0.0050213374,0.00007684814,0.0009630344,0.000020098068],"about_ca_topic_score_codex":0.0005552102,"about_ca_topic_score_gemma":0.0010935153,"teacher_disagreement_score":0.0031225397,"about_ca_system_score_codex":0.0006374269,"about_ca_system_score_gemma":0.0013151084,"threshold_uncertainty_score":0.016513765},"labels":[],"label_agreement":null},{"id":"W4413427106","doi":"10.1016/j.jaad.2025.08.047","title":"The burden of alopecia areata among United States, 2000-2021: A systematic analysis for the Global Burden of Disease Study 2021","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute for Information and Communications Technology Promotion; Bill and Melinda Gates Foundation; Ministry of Science and ICT, South Korea; National Health and Medical Research Council; Information Technology Research Centre; Queensland Health","keywords":"Medicine; Alopecia areata; Dermatology; Burden of disease; Disease; Disease burden; Internal medicine","score_opus":0.010561837946145219,"score_gpt":0.3094853294505445,"score_spread":0.2989234915043993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413427106","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.50903004,0.39857158,0.0009508376,0.0009802699,0.00028607892,0.00021902357,0.08831678,0.00009141879,0.0015539941],"genre_scores_gemma":[0.8937231,0.086646855,0.0008750959,0.00059756765,0.00013933345,0.00029821944,0.017335184,0.000019580917,0.00036508273],"study_design_codex":"observational","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9981036,0.0004851148,0.0004663502,0.0004900093,0.00031439876,0.00014061964],"domain_scores_gemma":[0.99719834,0.00076873193,0.0011549414,0.00020646371,0.0005333295,0.00013823879],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018667111,0.00075322075,0.0020172996,0.004153377,0.00039450527,0.0008762137,0.0005839154,0.0008183327,0.0008582093],"category_scores_gemma":[0.005712333,0.00074453856,0.008231098,0.00676394,0.00033703042,0.0007118528,0.0011535507,0.00068770495,0.0001426832],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013077545,0.000040904855,0.9054143,0.01610389,0.05024681,0.0001764095,0.00032758716,0.000686604,0.00034412788,0.0001498924,0.006438249,0.018763535],"study_design_scores_gemma":[0.00034232027,0.00014738858,0.94950294,0.0045554973,0.039555535,0.00035136816,0.00034857113,0.00043659844,0.00010728097,0.00014010342,0.004470753,0.000041561245],"about_ca_topic_score_codex":0.07106015,"about_ca_topic_score_gemma":0.12502186,"teacher_disagreement_score":0.07106015,"about_ca_system_score_codex":0.0011244366,"about_ca_system_score_gemma":0.0021693883,"threshold_uncertainty_score":0.14129305},"labels":[],"label_agreement":null},{"id":"W4413754560","doi":"10.1016/j.jaad.2025.07.061","title":"Response to Chu et al’s “Atopic dermatitis (eczema) guidelines: 2023 American Academy of Allergy, Asthma and Immunology/American College of Allergy, Asthma and Immunology Joint Task Force on Practice Parameters GRADE− and Institute of Medicine−based recommendations”","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"","keywords":"Medicine; Allergy; Asthma; Atopic dermatitis; Immunology; Task force; Dermatology","score_opus":0.02687141408772909,"score_gpt":0.3548123396943497,"score_spread":0.32794092560662064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413754560","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00025491734,0.0005212193,0.000125661,0.9600424,0.037167408,0.00004249101,0.0003926217,0.00004958912,0.0014036564],"genre_scores_gemma":[0.0010065505,0.0004906502,0.00022593734,0.97484857,0.02035589,0.00007184641,0.0002253387,0.000019187137,0.0027561355],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99411386,0.0012748303,0.0012531009,0.0005450996,0.0018854379,0.00092768617],"domain_scores_gemma":[0.9716403,0.009769564,0.003020445,0.0005118897,0.011253367,0.003804491],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006673001,0.00081452343,0.0017028708,0.0013360649,0.0027779934,0.0032471207,0.00210976,0.032186627,0.016750239],"category_scores_gemma":[0.041519992,0.0008830673,0.0024552622,0.0010159396,0.0015076968,0.0026872326,0.0028916153,0.0251956,0.011199434],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035925696,0.00001718583,0.00030335775,0.00007436996,0.000011747122,0.0001280127,0.00003190803,0.000028345914,0.00004464085,0.00019553851,0.99596345,0.003165465],"study_design_scores_gemma":[0.0002378574,0.000081374455,0.0030733459,0.0010862693,0.00007096991,0.0006963723,0.0006062484,0.00030895465,0.00021150775,0.0012673181,0.9922913,0.00006850077],"about_ca_topic_score_codex":0.0068601477,"about_ca_topic_score_gemma":0.017461168,"teacher_disagreement_score":0.032186627,"about_ca_system_score_codex":0.0046972353,"about_ca_system_score_gemma":0.008405149,"threshold_uncertainty_score":0.05603516},"labels":[],"label_agreement":null},{"id":"W4413815245","doi":"10.1016/j.jaad.2025.08.070","title":"Response to: “Response to Bissonnette et al. Dupilumab treatment restores lesional and nonlesional skin barrier function in adults and adolescents with atopic dermatitis irrespective of the filaggrin genotype: Results from an open-label, healthy control–matched, phase 4 clinical study (BALISTAD)”","year":2025,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"Regeneron Pharmaceuticals; Sanofi","keywords":"Dupilumab; Medicine; Filaggrin; Atopic dermatitis; Dermatology; Genotype","score_opus":0.02626856573244947,"score_gpt":0.38296885530616054,"score_spread":0.3567002895737111,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413815245","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0027624997,0.0007555056,0.00011560326,0.97707486,0.01239814,0.00007122491,0.00045692726,0.00010859962,0.00625669],"genre_scores_gemma":[0.011444011,0.00056825246,0.00021924135,0.9618626,0.015369874,0.00007470659,0.00025244782,0.000038891823,0.010169985],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986971,0.00033081998,0.00015798793,0.00021934956,0.00031850956,0.00027628843],"domain_scores_gemma":[0.99782604,0.0008273427,0.00020534165,0.00006649914,0.00056524965,0.0005095708],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014441335,0.0006753326,0.0010113757,0.00052440964,0.0023637782,0.0018778882,0.0010848566,0.021872496,0.009893826],"category_scores_gemma":[0.0077852574,0.0003603902,0.00092499785,0.00050447776,0.0009947427,0.0014554663,0.00060078857,0.012544129,0.007461866],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003541735,0.0001170755,0.0016625072,0.000062509076,0.000034566845,0.0038936469,0.00008565516,0.00008430782,0.00032568182,0.0006131937,0.9857253,0.007041365],"study_design_scores_gemma":[0.0014745803,0.00067543075,0.010122467,0.0005074098,0.00015389059,0.009894582,0.0007892152,0.0017552421,0.0009975092,0.004985121,0.9684956,0.00014884326],"about_ca_topic_score_codex":0.0054348093,"about_ca_topic_score_gemma":0.008958942,"teacher_disagreement_score":0.021872496,"about_ca_system_score_codex":0.0030194318,"about_ca_system_score_gemma":0.0022702082,"threshold_uncertainty_score":0.03309816},"labels":[],"label_agreement":null},{"id":"W4413869784","doi":"10.1016/j.jaad.2025.08.106","title":"Adverse events of topical treatments for rosacea: A systematic review of randomized controlled trials","year":2025,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto; University of Ottawa","funders":"","keywords":"Medicine; Rosacea; Randomized controlled trial; Adverse effect; Dermatology; MEDLINE; Surgery; Internal medicine; Acne","score_opus":0.038514874222773984,"score_gpt":0.4218697504631301,"score_spread":0.3833548762403561,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413869784","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018302666,0.9970638,0.00018244814,0.00009500302,0.00008546559,0.0003235783,0.00027152646,0.0000104685805,0.00013745562],"genre_scores_gemma":[0.038112395,0.95905024,0.0010816347,0.0006936144,0.00010724535,0.0005105632,0.00027190463,0.0000100537245,0.00016234742],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99287343,0.002565145,0.0026620037,0.0007162476,0.000979337,0.00020385263],"domain_scores_gemma":[0.97746414,0.015598996,0.005394996,0.0003242154,0.0009638501,0.00025372353],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008708379,0.0018184859,0.012204941,0.0037343754,0.0005007536,0.0021500243,0.0019789473,0.0019345906,0.005889617],"category_scores_gemma":[0.029742338,0.0010982308,0.012816387,0.0039575174,0.00100639,0.0018303955,0.0014847704,0.0019903015,0.00023857696],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002315519,0.000032056243,0.00088053045,0.9019441,0.07025979,0.000069826754,0.00008586545,0.00012591683,0.00017892806,0.000096093594,0.0008177936,0.023193574],"study_design_scores_gemma":[0.006649789,0.0009414233,0.008525283,0.32931733,0.6431866,0.0003846142,0.00022333013,0.00018575646,0.00028791552,0.00046277881,0.009750553,0.0000845964],"about_ca_topic_score_codex":0.0044267843,"about_ca_topic_score_gemma":0.014686221,"teacher_disagreement_score":0.012204941,"about_ca_system_score_codex":0.0021957783,"about_ca_system_score_gemma":0.0034898475,"threshold_uncertainty_score":0.04605484},"labels":[],"label_agreement":null},{"id":"W4413870586","doi":"10.1016/j.jaad.2025.05.886","title":"63006 Impact of Atopic Eczema on Life Choices and Destiny: A Global Study","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Windsor Clinical Research","funders":"","keywords":"Medicine; Destiny (ISS module); Dermatology","score_opus":0.01563370997363361,"score_gpt":0.37476315605091465,"score_spread":0.35912944607728103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413870586","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99394023,0.0012715088,0.000051105035,0.000330101,0.000018985604,0.000010276326,0.0014941349,0.00000276086,0.0028809542],"genre_scores_gemma":[0.9983169,0.00062193075,0.000032567124,0.00008623346,0.000019377558,0.0000053402287,0.0005030431,0.0000026144162,0.0004120239],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995165,0.00017103189,0.000042815795,0.00007082334,0.000057032517,0.0001417577],"domain_scores_gemma":[0.9980034,0.00032817957,0.0009201804,0.00010469463,0.0001445807,0.0004990697],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063918775,0.0003414822,0.00030111775,0.001017014,0.00057434535,0.00092783617,0.00032101243,0.0006442481,0.0039239135],"category_scores_gemma":[0.001662815,0.00027905338,0.0013303326,0.0030580943,0.00071988825,0.0009651856,0.0012463429,0.0010376103,0.00043226522],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007117289,0.000050958974,0.99714065,0.000028334149,0.00012770123,0.00008449492,0.0002832684,0.000037701502,0.00003640471,0.000058437345,0.00015129246,0.0019296054],"study_design_scores_gemma":[0.0000034016093,0.000051499053,0.99852777,0.000016455268,0.000045479665,0.00008397242,0.00079983857,0.000024400177,0.00000965802,0.000027927066,0.0004059303,0.000003687412],"about_ca_topic_score_codex":0.020568075,"about_ca_topic_score_gemma":0.029779768,"teacher_disagreement_score":0.020568075,"about_ca_system_score_codex":0.00036376517,"about_ca_system_score_gemma":0.0004423245,"threshold_uncertainty_score":0.040896714},"labels":[],"label_agreement":null},{"id":"W4413870593","doi":"10.1016/j.jaad.2025.05.1192","title":"63736 SPECTREM: Guselkumab Demonstrates Consistent Significant Clearance Across the Full Range of Low Body Surface Area, Moderate Psoriasis With Special Sites Involvement","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health; Dalhousie University; Probity Medical Research; University of Toronto","funders":"","keywords":"Medicine; Psoriasis; Body surface area; Dermatology; Internal medicine","score_opus":0.016471736223666805,"score_gpt":0.2625292127327814,"score_spread":0.2460574765091146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413870593","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9599751,0.005176938,0.0035196953,0.0013907852,0.00022252624,0.00011487051,0.001119535,0.0008893914,0.02759107],"genre_scores_gemma":[0.98923033,0.0005506184,0.0016365645,0.00032137675,0.00004864267,0.000033324788,0.0010180696,0.000057141024,0.0071039787],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99977106,0.00004103043,0.000012778151,0.000035579116,0.000079837555,0.00005974108],"domain_scores_gemma":[0.99990284,0.000020851858,0.000013796399,0.000015522037,0.00001743373,0.000029511042],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026472806,0.00032879892,0.0003500072,0.00027625743,0.00024101393,0.00038837275,0.0002444956,0.0006175496,0.006918644],"category_scores_gemma":[0.0003506005,0.00010737936,0.00018455689,0.00020734743,0.00023308562,0.0002688317,0.00016803652,0.00088630803,0.002148069],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040129623,0.0010027102,0.007091255,0.00020132156,0.00008117689,0.0019346095,0.00006623861,0.00022572525,0.8450487,0.0005860214,0.008718396,0.13103078],"study_design_scores_gemma":[0.0013931306,0.013338821,0.17423974,0.00009329643,0.00019351114,0.035460174,0.000147336,0.0036572937,0.6746597,0.0010960173,0.09565979,0.00006112411],"about_ca_topic_score_codex":0.00051320286,"about_ca_topic_score_gemma":0.0006258842,"teacher_disagreement_score":0.006918644,"about_ca_system_score_codex":0.00024221,"about_ca_system_score_gemma":0.00020594358,"threshold_uncertainty_score":0.02314514},"labels":[],"label_agreement":null},{"id":"W4413870621","doi":"10.1016/j.jaad.2025.05.1259","title":"62714 The impact of individual, group, and mixed mentorship models on resident wellness","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Healthcare professionals’ stress and burnout","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Calgary","funders":"","keywords":"Medicine; Mentorship; Group (periodic table); Medical education","score_opus":0.06620041221949234,"score_gpt":0.45377969864004947,"score_spread":0.3875792864205571,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413870621","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979366,0.00019742038,0.000057792713,0.0003108914,0.00004592274,0.000017759958,0.000019815705,0.0000043670157,0.0014095207],"genre_scores_gemma":[0.9988918,0.00011419902,0.0001519182,0.000057717316,0.000022199483,0.000022507395,0.000018220648,0.000002311367,0.0007192321],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9982318,0.00095351227,0.00007499504,0.00008215317,0.00025749064,0.00040007939],"domain_scores_gemma":[0.99058783,0.0038824466,0.00089460093,0.00034994326,0.0006228756,0.0036622677],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034518647,0.00020956117,0.00029191337,0.0002863636,0.00078217435,0.0012458088,0.00061083795,0.00039486025,0.008101819],"category_scores_gemma":[0.011709155,0.00010870622,0.00069611025,0.00021061378,0.00040415904,0.0008361612,0.001304893,0.0006182121,0.00043948856],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022109507,0.033682674,0.40358624,0.00052061386,0.0013713491,0.0003280211,0.0059628002,0.001800529,0.002938938,0.0010860064,0.004728243,0.5218851],"study_design_scores_gemma":[0.0020912297,0.04990891,0.9122444,0.00053527334,0.0009497883,0.00034738416,0.01926004,0.0044283373,0.0025621294,0.0012537099,0.006322358,0.00009646822],"about_ca_topic_score_codex":0.0020962718,"about_ca_topic_score_gemma":0.0094597805,"teacher_disagreement_score":0.008101819,"about_ca_system_score_codex":0.0008444549,"about_ca_system_score_gemma":0.002422597,"threshold_uncertainty_score":0.027103305},"labels":[],"label_agreement":null},{"id":"W4413870637","doi":"10.1016/j.jaad.2025.05.1255","title":"64857 The impact of continuous secukinumab treatment through week 104 on efficacy outcomes in patients with moderate to severe hidradenitis suppurativa: A post hoc analysis of the SUNSHINE and SUNRISE core and extension trials","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Barrie Urology Group","funders":"","keywords":"Medicine; Hidradenitis suppurativa; Secukinumab; Post-hoc analysis; Post hoc; Dermatology; Internal medicine; Disease; Psoriasis","score_opus":0.028263941607460166,"score_gpt":0.35799831075538563,"score_spread":0.3297343691479255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413870637","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896187,0.005845087,0.00054643303,0.00030691837,0.00048091562,0.0006463495,0.00087443413,0.00007167067,0.0016094345],"genre_scores_gemma":[0.99505615,0.0011113718,0.0004961863,0.00025870037,0.00028918026,0.0004521097,0.0005562073,0.000021191541,0.0017588992],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9963336,0.0024987087,0.00022542791,0.00034116075,0.00015343436,0.00044767733],"domain_scores_gemma":[0.9955604,0.0028548697,0.00056358724,0.00036195386,0.00021876034,0.00044037704],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0062875026,0.0019515927,0.00585702,0.00046957727,0.00042459593,0.0015907336,0.0008194681,0.0011631161,0.0056793466],"category_scores_gemma":[0.004957736,0.00068994384,0.008091116,0.0004465594,0.00090953894,0.0015733091,0.000732548,0.0038976283,0.0006215842],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97613543,0.0011226288,0.0017831884,0.00057061424,0.008761982,0.000028666427,0.000042640208,0.0006178408,0.001119807,0.00006299747,0.00041089812,0.009343334],"study_design_scores_gemma":[0.7149958,0.22042014,0.032745693,0.00021846112,0.024950411,0.0000755856,0.000142988,0.0025954307,0.0014870543,0.00045650944,0.0018279502,0.00008395505],"about_ca_topic_score_codex":0.00082023605,"about_ca_topic_score_gemma":0.0019130481,"teacher_disagreement_score":0.0062875026,"about_ca_system_score_codex":0.00057478424,"about_ca_system_score_gemma":0.0010825543,"threshold_uncertainty_score":0.03325188},"labels":[],"label_agreement":null},{"id":"W4413870645","doi":"10.1016/j.jaad.2025.05.1115","title":"62400 Rapid Itch Relief with Upadacitinib vs Dupilumab in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: Results from the Phase 3b/4 Level Up Study","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Utilities Corporation","funders":"","keywords":"Dupilumab; Medicine; Atopic dermatitis; Dermatology","score_opus":0.015787605422378993,"score_gpt":0.3029897727319811,"score_spread":0.2872021673096021,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413870645","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9840352,0.010816771,0.0002431212,0.0005788403,0.00023180942,0.00076968555,0.0010180505,0.00007220022,0.0022343593],"genre_scores_gemma":[0.9880922,0.00551395,0.0006654249,0.0013371836,0.00027312708,0.00068823254,0.0015206699,0.000022126005,0.0018870551],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9995443,0.0001703073,0.000030131545,0.000069851594,0.00006845523,0.000116868905],"domain_scores_gemma":[0.9994087,0.0001543589,0.00011173978,0.00003875698,0.000059152262,0.0002272992],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012301983,0.00093627383,0.002480655,0.00027947378,0.00040109293,0.0012899319,0.0005483227,0.0010197223,0.0037342936],"category_scores_gemma":[0.0009024324,0.00040223074,0.0025236593,0.0003460447,0.0005893905,0.0009828873,0.00029969178,0.0030993654,0.0008527726],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7922568,0.022199955,0.008240503,0.0021126894,0.0054054447,0.00020174106,0.00022242535,0.00100397,0.010087159,0.00026102253,0.0053287484,0.15267955],"study_design_scores_gemma":[0.7645578,0.18970801,0.03517658,0.00023369127,0.0036556385,0.00028240317,0.0001505501,0.00094143103,0.0011416221,0.00027698115,0.0038229376,0.00005236463],"about_ca_topic_score_codex":0.001276122,"about_ca_topic_score_gemma":0.0035502748,"teacher_disagreement_score":0.0037342936,"about_ca_system_score_codex":0.00078529504,"about_ca_system_score_gemma":0.0006932502,"threshold_uncertainty_score":0.012492418},"labels":[],"label_agreement":null},{"id":"W4413870649","doi":"10.1016/j.jaad.2025.05.817","title":"61634 Exploring Demographic Representation in Cutaneous Oncological Clinical Trials","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Dermatology; Representation (politics); Clinical trial; Internal medicine","score_opus":0.11260487344213821,"score_gpt":0.4426303103108215,"score_spread":0.3300254368686833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413870649","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98192364,0.0021750713,0.002047824,0.0025879282,0.00010537857,0.00032745767,0.0019111151,0.000016267251,0.008905383],"genre_scores_gemma":[0.9970266,0.00031088857,0.00052198715,0.00088253384,0.00011235963,0.00025812406,0.00041619976,0.000009008804,0.00046221953],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9744452,0.019465813,0.002104679,0.0011151916,0.0017985771,0.0010705937],"domain_scores_gemma":[0.9141578,0.054187316,0.02257934,0.003179817,0.0024553859,0.003440393],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.013538083,0.00012313412,0.00038137333,0.0009591842,0.00065073586,0.0010694966,0.00046578728,0.0006644356,0.008911198],"category_scores_gemma":[0.08763389,0.00016797005,0.00053279806,0.0019899455,0.00051071506,0.0011377747,0.0009585945,0.0008956028,0.00086793344],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003068556,0.00026842422,0.9702669,0.000156816,0.0004488663,0.00010182107,0.00031047052,0.0002261355,0.00025669858,0.0007482918,0.0023853325,0.02176173],"study_design_scores_gemma":[0.00051886827,0.002495976,0.9789464,0.00025395976,0.0006637271,0.0005918639,0.001113238,0.0027482861,0.00052975863,0.002431126,0.00967727,0.000029606488],"about_ca_topic_score_codex":0.00091713166,"about_ca_topic_score_gemma":0.00160657,"teacher_disagreement_score":0.98646194,"about_ca_system_score_codex":0.0004472555,"about_ca_system_score_gemma":0.001090833,"threshold_uncertainty_score":0.07159704},"labels":[],"label_agreement":null},{"id":"W4413870661","doi":"10.1016/j.jaad.2025.05.292","title":"61380 Predictors of wound healing after surgical deroofing in Hidradenitis Suppurativa","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"","keywords":"Hidradenitis suppurativa; Medicine; Wound healing; Dermatology; Surgery; Pathology; Disease","score_opus":0.010625278584000268,"score_gpt":0.31563789178810997,"score_spread":0.3050126132041097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413870661","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984522,0.000347342,0.00006169226,0.00008092514,0.000029407813,0.000006443758,0.00020192591,0.0000033294746,0.0008167345],"genre_scores_gemma":[0.99927956,0.00011990117,0.00007055338,0.000018687582,0.00003664138,0.0000042638862,0.00017947995,0.0000019901206,0.00028887545],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997335,0.00007635483,0.000039754508,0.000022823717,0.000051708525,0.000075746975],"domain_scores_gemma":[0.9965569,0.0011032944,0.0012855089,0.0001032341,0.00025374247,0.00069728855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046449478,0.0002007793,0.0002506729,0.00058789086,0.00038419262,0.00058684783,0.0002403205,0.00040436737,0.0046436265],"category_scores_gemma":[0.0034600117,0.00013597254,0.0004421818,0.00079459866,0.0002688463,0.00038061786,0.00033927753,0.00072323706,0.0005368899],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022240612,0.00006099922,0.99799985,0.000008510507,0.00002081104,0.00012774242,0.000016879481,0.00002139031,0.00011076006,0.000010113302,0.000066940825,0.0013336027],"study_design_scores_gemma":[0.00000719158,0.00017222107,0.998787,0.000009366082,0.00002172991,0.00034832605,0.00017422972,0.00017511408,0.00008111867,0.000019665515,0.00020058098,0.0000035187581],"about_ca_topic_score_codex":0.0015225295,"about_ca_topic_score_gemma":0.0017151362,"teacher_disagreement_score":0.0046436265,"about_ca_system_score_codex":0.00017252319,"about_ca_system_score_gemma":0.00033865933,"threshold_uncertainty_score":0.015534461},"labels":[],"label_agreement":null},{"id":"W4413870668","doi":"10.1016/j.jaad.2025.05.1247","title":"62388 The evaluation of adequate clinical response to systemic therapy as measured by the Merit-based Incentive Payment System (MIPS) #410 psoriasis quality measure in patients treated with deucravacitinib: a RePhlect 6-month follow-up study","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Probity Medical Research; SKiN Health; Queen's University","funders":"","keywords":"Medicine; Psoriasis; Measure (data warehouse); Systemic therapy; Payment; Quality (philosophy); Incentive; Quality of life (healthcare); Medical physics; Intensive care medicine; Dermatology; Internal medicine; Cancer; Data mining; Nursing; Breast cancer; Finance","score_opus":0.2270380083185659,"score_gpt":0.4649514367566329,"score_spread":0.237913428438067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413870668","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99784505,0.00046942788,0.000110480534,0.000111306595,0.000016402464,0.000060543476,0.0008012432,0.0000032489784,0.0005823198],"genre_scores_gemma":[0.9987006,0.000102666825,0.00012007056,0.00003971298,0.00002083189,0.000041778312,0.0007892204,0.0000011785053,0.0001837925],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99819046,0.0010522634,0.00016288896,0.00017578513,0.00027565018,0.00014285724],"domain_scores_gemma":[0.99408334,0.0016715459,0.0027162211,0.0003533554,0.00056361954,0.00061191345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0042144973,0.00023789509,0.0006557391,0.0005840954,0.0003179562,0.00082783104,0.0003519603,0.00054712687,0.0017766022],"category_scores_gemma":[0.007698306,0.00017970712,0.0014595337,0.0009584333,0.00027573275,0.00077750266,0.00044596408,0.0008564836,0.0003028065],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.050306328,0.0027460265,0.9079177,0.00020036506,0.00156525,0.000065515815,0.00009747409,0.00057160185,0.00041087036,0.00019641583,0.0012215007,0.034700967],"study_design_scores_gemma":[0.0036564239,0.008266269,0.9837141,0.000048534774,0.00080936425,0.00010914337,0.000078630415,0.0021237424,0.00021003436,0.00010897135,0.00084941264,0.000025393381],"about_ca_topic_score_codex":0.002310349,"about_ca_topic_score_gemma":0.0019958415,"teacher_disagreement_score":0.0042144973,"about_ca_system_score_codex":0.0011869124,"about_ca_system_score_gemma":0.00071875105,"threshold_uncertainty_score":0.02228862},"labels":[],"label_agreement":null},{"id":"W4413870680","doi":"10.1016/j.jaad.2025.05.1248","title":"62820 The Evolution of Sunscreen from Ancient Egypt to Modern Day: A historical perspective","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Ancient Egypt and Archaeology","field":"Arts and Humanities","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Medicine; Perspective (graphical); Visual arts","score_opus":0.018245751595736156,"score_gpt":0.27182373003900995,"score_spread":0.2535779784432738,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413870680","genre_codex":"other","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3324588,0.24410106,0.0026175377,0.035233602,0.0015523818,0.00005745892,0.00034629385,0.00005816024,0.3835746],"genre_scores_gemma":[0.8639681,0.0919956,0.0012406085,0.002978193,0.0007947883,0.000017117212,0.00008934153,0.00004793495,0.038868364],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99961424,0.00010266897,0.000029067325,0.00008762183,0.00006555929,0.00010086038],"domain_scores_gemma":[0.9993412,0.00021781595,0.00012893937,0.000034604116,0.00021498391,0.00006248357],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015106242,0.00036618227,0.00026033382,0.002513959,0.0030287995,0.0030163056,0.00048568982,0.0013114406,0.011291678],"category_scores_gemma":[0.0017850583,0.00030591773,0.00012295718,0.0023704558,0.010070055,0.002532807,0.0016352618,0.002025051,0.00068539404],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045257376,0.00019977719,0.015905576,0.0017274459,0.0000718744,0.002521428,0.13120571,0.0008060252,0.0049814726,0.5941235,0.011239357,0.2367652],"study_design_scores_gemma":[0.000028641189,0.00015903937,0.03839359,0.001973194,0.000054942415,0.0021300917,0.039224263,0.00024801036,0.0026070168,0.023849366,0.8912645,0.00006732995],"about_ca_topic_score_codex":0.020586777,"about_ca_topic_score_gemma":0.037373085,"teacher_disagreement_score":0.020586777,"about_ca_system_score_codex":0.0062632565,"about_ca_system_score_gemma":0.002337024,"threshold_uncertainty_score":0.045443296},"labels":[],"label_agreement":null},{"id":"W4413870707","doi":"10.1016/j.jaad.2025.05.1158","title":"62151 Roflumilast Foam 0.3% in Patients With Scalp and Body Psoriasis: Improvements in Patient-Reported Outcomes","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dupuytren's Contracture and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Western University; SKiN Health","funders":"","keywords":"Medicine; Roflumilast; Scalp; Psoriasis; Dermatology; Intensive care medicine; Internal medicine","score_opus":0.004646647158898283,"score_gpt":0.27206280695303264,"score_spread":0.26741615979413436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413870707","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9828383,0.010726257,0.00017894262,0.00038797,0.00010123091,0.000057605856,0.0002171656,0.000070117654,0.0054224445],"genre_scores_gemma":[0.99670744,0.0019940296,0.00016222805,0.00015830931,0.00005780526,0.00001978558,0.00015120754,0.0000036812232,0.0007454822],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9999101,0.0000251312,0.000007397859,0.0000112736125,0.000020427855,0.000025701125],"domain_scores_gemma":[0.99989784,0.00003221704,0.000031102933,0.0000045099423,0.000008893473,0.0000253909],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016499856,0.00019310837,0.00047232397,0.00014388756,0.00010787908,0.00018928376,0.00010918046,0.0001990544,0.002816589],"category_scores_gemma":[0.0004109224,0.00005830639,0.0002946058,0.00014399202,0.000071682385,0.00017386745,0.000076617805,0.00042710712,0.0003031095],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09583233,0.006839244,0.03924559,0.0012058485,0.0009310943,0.0013020973,0.00017765551,0.00055819616,0.043264575,0.0002156387,0.006466753,0.8039609],"study_design_scores_gemma":[0.04851515,0.16362546,0.7450865,0.00065931375,0.0028663166,0.0071940264,0.0006963439,0.004252753,0.011464167,0.00048388328,0.01505225,0.000103736325],"about_ca_topic_score_codex":0.00090901525,"about_ca_topic_score_gemma":0.0015351628,"teacher_disagreement_score":0.002816589,"about_ca_system_score_codex":0.00012473398,"about_ca_system_score_gemma":0.00015294105,"threshold_uncertainty_score":0.009422421},"labels":[],"label_agreement":null},{"id":"W4413870708","doi":"10.1016/j.jaad.2025.05.1131","title":"63307 Real-World Prevalence of Psychiatric and Sleep Disorders Among Adult Patients With Prurigo Nodularis and Prurigo Nodularis Patients Initiating Dupilumab in the US","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; University of Saskatchewan","funders":"","keywords":"Prurigo nodularis; Dupilumab; Medicine; Dermatology; Prurigo; Young adult; Psychiatry; Atopic dermatitis; Gerontology","score_opus":0.0032816733462720433,"score_gpt":0.25536819879294176,"score_spread":0.2520865254466697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413870708","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973732,0.00026499035,0.000024318124,0.000079594894,0.0000082835995,0.000007774333,0.0015449987,0.0000052708874,0.0006915305],"genre_scores_gemma":[0.9987785,0.000159196,0.000029981727,0.00009258603,0.000013535596,0.000008195907,0.00078473624,0.0000015818913,0.00013155905],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99953365,0.00008727153,0.000076400014,0.00010223939,0.00008885695,0.000111584515],"domain_scores_gemma":[0.9990451,0.00012390039,0.0004871443,0.00004006802,0.00009272315,0.00021102454],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024596442,0.00022149704,0.00032356972,0.0008244715,0.00050148467,0.0007623335,0.0003188602,0.000490217,0.0024251346],"category_scores_gemma":[0.0010051462,0.00027477436,0.0005099168,0.0015415692,0.00026962152,0.0005295983,0.00039227825,0.0006311027,0.00039437442],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049642716,0.000028403992,0.99891436,0.000009076903,0.000031319276,0.00011279461,0.000038708935,0.000012109816,0.000063167136,0.000007999414,0.00018460203,0.0005478549],"study_design_scores_gemma":[0.0000058283563,0.000044544486,0.9988838,0.000008553406,0.000021488087,0.0005032013,0.00027535617,0.000059340928,0.000017296836,0.0000085333295,0.00016809392,0.000003897421],"about_ca_topic_score_codex":0.022922155,"about_ca_topic_score_gemma":0.02812794,"teacher_disagreement_score":0.022922155,"about_ca_system_score_codex":0.00059216534,"about_ca_system_score_gemma":0.0004997789,"threshold_uncertainty_score":0.045577466},"labels":[],"label_agreement":null},{"id":"W4413870743","doi":"10.1016/j.jaad.2025.05.038","title":"62310 A Machine Learning Model for Early Detection of Mycosis Fungoides: Distinguishing CTCL from Benign Dermatoses","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"","keywords":"Mycosis fungoides; Medicine; Dermatology; Pathology; Lymphoma","score_opus":0.022764837111875616,"score_gpt":0.34121133719246677,"score_spread":0.31844650008059117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413870743","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7584815,0.0025556963,0.22676827,0.001967515,0.00057148305,0.00023199503,0.00197252,0.00186233,0.005588724],"genre_scores_gemma":[0.9798386,0.00021260865,0.015979948,0.00013531573,0.00008856122,0.00007003612,0.00088008854,0.00001465632,0.0027801553],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9998055,0.000039492843,0.000018414741,0.000057154928,0.00003930689,0.0000400729],"domain_scores_gemma":[0.9994579,0.00029932606,0.000043548007,0.000020613175,0.00014569702,0.000032841086],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006845702,0.0004981129,0.0006366434,0.0009101472,0.0003131208,0.00071626756,0.0005225049,0.00078838866,0.0017048579],"category_scores_gemma":[0.0016275567,0.0001574028,0.0005065017,0.00032150367,0.00012832068,0.00033426585,0.0003278677,0.00078438036,0.00075961807],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012428863,0.0012538612,0.08126894,0.00014970098,0.00021898918,0.0005373872,0.00006793744,0.2947909,0.017311608,0.0014982395,0.009942754,0.5917168],"study_design_scores_gemma":[0.000014230179,0.00008143414,0.0031661594,0.0000094794505,0.000021759895,0.000059893526,0.0000056092217,0.9952024,0.0007930846,0.00030138638,0.0003384909,0.000006118555],"about_ca_topic_score_codex":0.0067196377,"about_ca_topic_score_gemma":0.0052552135,"teacher_disagreement_score":0.0067196377,"about_ca_system_score_codex":0.00042185432,"about_ca_system_score_gemma":0.0007272183,"threshold_uncertainty_score":0.013361096},"labels":[],"label_agreement":null},{"id":"W4413870751","doi":"10.1016/j.jaad.2025.05.754","title":"63485 Efficacy of Abrocitinib in Patients Based on Prior Biologic Treatment History: A Post Hoc Analysis of JADE MONO-1, JADE MONO-2, and JADE REGIMEN","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; SKiN Health; Queen's University","funders":"","keywords":"JADE (particle detector); Medicine; Post-hoc analysis; Post hoc; Regimen; Internal medicine","score_opus":0.015070026671562164,"score_gpt":0.30792999118227965,"score_spread":0.2928599645107175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413870751","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99535465,0.0010314994,0.00042085492,0.00012882195,0.0002244932,0.00014553487,0.0010077157,0.00004031745,0.0016461038],"genre_scores_gemma":[0.99536175,0.00027179497,0.00033672393,0.00023018704,0.00021249552,0.00021630754,0.001172207,0.00003094837,0.0021675688],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9965096,0.0017609511,0.00019124051,0.0006064896,0.0002849369,0.0006467451],"domain_scores_gemma":[0.99584323,0.002651817,0.00039893197,0.0004626518,0.0001985993,0.0004447703],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004225321,0.0013940836,0.005019204,0.00050812116,0.0004719986,0.001746323,0.0010600373,0.0011129974,0.005724639],"category_scores_gemma":[0.004380261,0.00049383723,0.007213393,0.00043752164,0.0006352839,0.0017419221,0.0007481716,0.0032157856,0.0006459062],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8777471,0.0026545543,0.06466759,0.000450677,0.02241694,0.00036883933,0.00016759068,0.0024363857,0.007109666,0.0002829551,0.0024544457,0.019243347],"study_design_scores_gemma":[0.118963644,0.25583285,0.54209495,0.0001935986,0.042865016,0.0006942918,0.00073977845,0.021937424,0.007338167,0.0013411482,0.0076694153,0.0003296557],"about_ca_topic_score_codex":0.0010751924,"about_ca_topic_score_gemma":0.0022783102,"teacher_disagreement_score":0.005724639,"about_ca_system_score_codex":0.00069299096,"about_ca_system_score_gemma":0.0011049106,"threshold_uncertainty_score":0.02234596},"labels":[],"label_agreement":null},{"id":"W4413870758","doi":"10.1016/j.jaad.2025.05.709","title":"63413 Dupilumab Treatment Improves Skin Barrier Function in Adolescent and Adult Patients With Atopic Dermatitis: Results From the BALISTAD and BALISTAD-CN Studies","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"","keywords":"Dupilumab; Medicine; Atopic dermatitis; Dermatology; Skin barrier","score_opus":0.009836297278071261,"score_gpt":0.2811379574339535,"score_spread":0.2713016601558822,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413870758","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921556,0.006493538,0.000048897557,0.00011303939,0.000028830005,0.000040342737,0.00015405336,0.000007207384,0.00095854397],"genre_scores_gemma":[0.9952998,0.003669779,0.00018316488,0.0002060724,0.000041707503,0.00002426012,0.00018167225,0.0000023126868,0.00039120592],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99981207,0.000079578116,0.000016134683,0.00002414598,0.000038515904,0.000029695644],"domain_scores_gemma":[0.9995813,0.0001419376,0.00010309493,0.000020977628,0.000051164003,0.00010157251],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000634793,0.00027459627,0.00057453505,0.00015896464,0.0001898687,0.00037475472,0.00015445966,0.0002447825,0.0011345255],"category_scores_gemma":[0.0005875295,0.00009989097,0.0005622221,0.00016990998,0.00016855983,0.00024606715,0.00011409191,0.0005997019,0.00014334281],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1473914,0.014643729,0.24226566,0.0025175903,0.0053226324,0.00087859586,0.00062336307,0.0005569711,0.059591018,0.0002201019,0.0040160846,0.5219729],"study_design_scores_gemma":[0.024421915,0.13510013,0.8110851,0.00033388153,0.0045107873,0.0020938404,0.0004666001,0.00083194143,0.009981921,0.00012814315,0.011002734,0.000042985455],"about_ca_topic_score_codex":0.001079354,"about_ca_topic_score_gemma":0.0034159233,"teacher_disagreement_score":0.0011345255,"about_ca_system_score_codex":0.00027641444,"about_ca_system_score_gemma":0.00031809506,"threshold_uncertainty_score":0.0037953258},"labels":[],"label_agreement":null},{"id":"W4413870770","doi":"10.1016/j.jaad.2025.05.1165","title":"65106 Safety profile of Rezpegaldesleukin, A Selective Regulatory T-Cell-Inducing Interleukin-2 Conjugate, versus Placebo Based on Aggregate Safety Evaluation of 746 Subjects Enrolled Across 9 Studies","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Placebo; Conjugate; Interleukin; Safety profile; Internal medicine; Pharmacology; Oncology; Cytokine; Adverse effect; Pathology; Alternative medicine","score_opus":0.03453460692454409,"score_gpt":0.37269818288710704,"score_spread":0.33816357596256297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413870770","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99552226,0.0026339355,0.00045457017,0.00007049311,0.000042993386,0.0002033136,0.00029599143,0.000030635343,0.0007459171],"genre_scores_gemma":[0.99829155,0.00048726084,0.0002130901,0.00009492916,0.000049067217,0.00008021733,0.00029508662,0.0000037003929,0.00048514231],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9990609,0.000503862,0.00008700096,0.00015797166,0.00012669832,0.000063527485],"domain_scores_gemma":[0.999491,0.00018118213,0.00017020015,0.00004620446,0.00005394003,0.000057504847],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020299589,0.0004918079,0.0010425444,0.00030217838,0.0002125675,0.0005744973,0.00024518638,0.0006757736,0.001844594],"category_scores_gemma":[0.001165037,0.0002682958,0.00091332436,0.00025602573,0.00039222103,0.00046155349,0.00016061703,0.00071514247,0.0003368362],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7597481,0.006597451,0.023467658,0.0009017642,0.004489701,0.00022688137,0.00020944928,0.0011338708,0.0834566,0.00027812537,0.00091751135,0.118572816],"study_design_scores_gemma":[0.16560532,0.67933357,0.11825427,0.00012225623,0.0061509106,0.0005490563,0.00016996193,0.002139293,0.022800526,0.0003845118,0.0044285012,0.00006185697],"about_ca_topic_score_codex":0.00016409249,"about_ca_topic_score_gemma":0.00023562305,"teacher_disagreement_score":0.0020299589,"about_ca_system_score_codex":0.00024140075,"about_ca_system_score_gemma":0.000237503,"threshold_uncertainty_score":0.010735571},"labels":[],"label_agreement":null},{"id":"W4413870772","doi":"10.1016/j.jaad.2025.05.756","title":"60746 Efficacy of Apremilast for the Treatment of Japanese Patients With Palmoplantar Pustulosis: 52-Week Exploratory Endpoints From a Phase 3, Randomized, Placebo-controlled Study","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Oral Health Pathology and Treatment","field":"Dentistry","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"","keywords":"Medicine; Palmoplantar pustulosis; Apremilast; Placebo; Dermatology; Randomized controlled trial; Clinical endpoint; Psoriasis; Internal medicine; Alternative medicine; Pathology; Psoriatic arthritis","score_opus":0.019878204353532877,"score_gpt":0.33832184151307654,"score_spread":0.31844363715954366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413870772","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98455185,0.010344118,0.00049342413,0.0004378628,0.00034290733,0.0018088284,0.00034672086,0.00010546793,0.0015688777],"genre_scores_gemma":[0.98665804,0.006182246,0.0014053426,0.0013540753,0.0006015289,0.0015193268,0.00048200897,0.000019858548,0.0017776523],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9995585,0.00021897085,0.000043997028,0.00005491804,0.000049809452,0.00007385013],"domain_scores_gemma":[0.99948466,0.00013554217,0.00011365199,0.000033282184,0.000051678893,0.00018114454],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015190346,0.0012406163,0.0035372474,0.00048998697,0.00063345407,0.0007559396,0.000572304,0.0015557514,0.0041322606],"category_scores_gemma":[0.0009054314,0.0006357575,0.0017869524,0.00041779896,0.0010058101,0.0009458091,0.00025683202,0.0022754062,0.00061849115],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.89875174,0.020771714,0.0013706959,0.0025393716,0.0017851655,0.00019251455,0.00014660925,0.0004632737,0.019346956,0.00014410756,0.001167862,0.05332002],"study_design_scores_gemma":[0.78779113,0.20379516,0.005052967,0.00007469632,0.00096632465,0.00009171311,0.00005875698,0.0004179145,0.00089322915,0.00007302515,0.00075358053,0.00003156856],"about_ca_topic_score_codex":0.00060298597,"about_ca_topic_score_gemma":0.0016535675,"teacher_disagreement_score":0.0041322606,"about_ca_system_score_codex":0.00032176153,"about_ca_system_score_gemma":0.00083850574,"threshold_uncertainty_score":0.013823807},"labels":[],"label_agreement":null},{"id":"W4413870773","doi":"10.1016/j.jaad.2025.05.838","title":"64838 Fractional Microneedle Radiofrequency (RF) with Split-Neck Application of Vitamin C, E, and Ferulic Acid Serum vs. Placebo for Neck Skin Rejuvenation: A Placebo-Controlled Trial","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Skin Protection and Aging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Placebo; Ferulic acid; Rejuvenation; Vitamin C; Ascorbic acid; Internal medicine; Surgery; Pathology; Food science","score_opus":0.0077302204049673135,"score_gpt":0.2886522809581293,"score_spread":0.280922060553162,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413870773","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9448114,0.03613597,0.0014616395,0.001431483,0.0025764764,0.00629991,0.0016631706,0.00032333302,0.0052964976],"genre_scores_gemma":[0.9659381,0.01377466,0.0019494207,0.0016914296,0.0014384803,0.0056208624,0.00080883777,0.000033667457,0.008744609],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99960464,0.0001511648,0.000041827378,0.000096058524,0.000035742065,0.00007053314],"domain_scores_gemma":[0.999498,0.00019707282,0.00009786471,0.000035805257,0.00005321629,0.00011804106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009947176,0.001601616,0.0038484747,0.00047885202,0.00047718568,0.0007767669,0.0007681323,0.0025069867,0.0100388685],"category_scores_gemma":[0.0011778135,0.00055805,0.002006332,0.00046029908,0.0009217299,0.00082219404,0.0002845261,0.0024914427,0.0012900112],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98041016,0.0027456095,0.00010127168,0.0013855234,0.000848142,0.000028141098,0.000020332622,0.00006778742,0.0025353404,0.00007064902,0.00049791124,0.011289025],"study_design_scores_gemma":[0.9603491,0.03745167,0.0005635777,0.00007468969,0.00057970214,0.000016299942,0.000014279078,0.00011752254,0.0002996219,0.00007020048,0.00045386993,0.000009436885],"about_ca_topic_score_codex":0.0011610665,"about_ca_topic_score_gemma":0.0017787175,"teacher_disagreement_score":0.0100388685,"about_ca_system_score_codex":0.0004943098,"about_ca_system_score_gemma":0.0006697474,"threshold_uncertainty_score":0.033583403},"labels":[],"label_agreement":null},{"id":"W4413870775","doi":"10.1016/j.jaad.2025.05.489","title":"60859 Apremilast efficacy in patients with early oligoarticular psoriatic arthritis (PsA) affecting weight-bearing joints by body mass index (BMI): Results from the randomized, double-blind, placebo-controlled FOREMOST study","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"","keywords":"Medicine; Psoriatic arthritis; Body mass index; Apremilast; Placebo; Double blind; Arthritis; Internal medicine; Dermatology; Pathology","score_opus":0.008387885612804047,"score_gpt":0.26766191609201684,"score_spread":0.25927403047921277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413870775","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9714868,0.023693228,0.00034605464,0.00058560097,0.0004753761,0.0005433793,0.0008004805,0.00015968377,0.0019093181],"genre_scores_gemma":[0.98435634,0.009767513,0.0007252351,0.0011087407,0.00055887474,0.00038699273,0.0007549005,0.000017161492,0.0023241234],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99964607,0.00018748526,0.000037811875,0.000045847064,0.00003755435,0.000045315308],"domain_scores_gemma":[0.9995278,0.00014979494,0.00010988503,0.000027901422,0.000034369186,0.00015036859],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010229256,0.0008919435,0.0027277297,0.00038520517,0.0003416134,0.000620005,0.00041015117,0.0011905523,0.0042965924],"category_scores_gemma":[0.00083780015,0.000522074,0.001196807,0.00035344937,0.00055069797,0.0006715782,0.00023682576,0.0014827739,0.0007300701],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9405999,0.0058589582,0.0012205214,0.0016141725,0.0016013276,0.00007924346,0.000042608583,0.00023613026,0.010606394,0.00008139218,0.00096960185,0.03708967],"study_design_scores_gemma":[0.90363693,0.08320986,0.010319153,0.00006263298,0.0009130886,0.0000998662,0.000026759923,0.00027144945,0.0007157861,0.000073566385,0.0006511939,0.000019705896],"about_ca_topic_score_codex":0.00044449157,"about_ca_topic_score_gemma":0.0010394744,"teacher_disagreement_score":0.0042965924,"about_ca_system_score_codex":0.00020342135,"about_ca_system_score_gemma":0.00039669656,"threshold_uncertainty_score":0.014373541},"labels":[],"label_agreement":null},{"id":"W4413870807","doi":"10.1016/j.jaad.2025.05.1122","title":"62697 Real-world effectiveness of deucravacitinib in patients with plaque psoriasis: a 6-month analysis of skin clearance from the RePhlect Registry","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Probity Medical Research; SKiN Health; Queen's University","funders":"","keywords":"Medicine; Plaque psoriasis; Psoriasis; Dermatology","score_opus":0.006789472635826107,"score_gpt":0.2592353245623932,"score_spread":0.25244585192656704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413870807","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945148,0.0023275476,0.00011604433,0.00009862127,0.000025971536,0.000039056333,0.0020141718,0.000015995229,0.0008477573],"genre_scores_gemma":[0.99604553,0.00044414485,0.00010294249,0.00008380562,0.000049242688,0.000028882845,0.0030386636,0.0000067918395,0.00019990646],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967288,0.0013462408,0.00038630835,0.0005606997,0.0006449276,0.0003330388],"domain_scores_gemma":[0.99473226,0.0015478662,0.0024457774,0.0005099047,0.00038776596,0.00037649143],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003265704,0.00029751137,0.0012807852,0.00068022136,0.00033282567,0.0013159642,0.00039619865,0.00059673475,0.0011509834],"category_scores_gemma":[0.005180868,0.0002046536,0.0015589737,0.0011472102,0.0003329209,0.0011347877,0.00047998372,0.0009476818,0.00051068637],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023314927,0.00079601485,0.9361624,0.00029889558,0.002763208,0.00022371027,0.000116962925,0.0009636853,0.00080380053,0.00010695897,0.0017210606,0.03272831],"study_design_scores_gemma":[0.0011325824,0.0042050495,0.98879725,0.000046001358,0.0011655127,0.00043190402,0.00015435876,0.0012310573,0.00033274083,0.000058668935,0.0024085667,0.00003625923],"about_ca_topic_score_codex":0.001622407,"about_ca_topic_score_gemma":0.0021025513,"teacher_disagreement_score":0.003265704,"about_ca_system_score_codex":0.00072624383,"about_ca_system_score_gemma":0.00056988944,"threshold_uncertainty_score":0.017270923},"labels":[],"label_agreement":null},{"id":"W4413870809","doi":"10.1016/j.jaad.2025.05.972","title":"62152 Long-term safety and tolerability of bimekizumab in patients with axial spondyloarthritis and psoriatic arthritis: Updated results from phase 2b/3 studies and their open-label extensions","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Psoriatic arthritis; Tolerability; Axial spondyloarthritis; Dermatology; Open label; Term (time); Psoriasis; Arthritis; Internal medicine; Adverse effect; Sacroiliitis","score_opus":0.02042594686398782,"score_gpt":0.3318206940391707,"score_spread":0.3113947471751829,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413870809","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8780058,0.102228455,0.001928465,0.0013991228,0.0007467718,0.0013852121,0.006226289,0.00021920384,0.007860629],"genre_scores_gemma":[0.9540345,0.024399351,0.0031976893,0.003455857,0.0008686693,0.0011121539,0.009052559,0.000063402375,0.0038157098],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99880743,0.00055459404,0.00014156706,0.0001171474,0.00026343565,0.00011584399],"domain_scores_gemma":[0.9983557,0.00056617433,0.0005799865,0.000110613946,0.00022046283,0.00016718224],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0043477807,0.0007793705,0.0022268507,0.00051365874,0.0002876576,0.001348352,0.0005335626,0.0010540045,0.0034061247],"category_scores_gemma":[0.002581378,0.00043318034,0.0026217515,0.00065308285,0.00039101293,0.0009183532,0.00032771984,0.0020652344,0.0009136969],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.42971143,0.009162996,0.026584629,0.0062161773,0.010376962,0.00038407062,0.00028365193,0.002001498,0.033016004,0.0002811088,0.01284809,0.46913335],"study_design_scores_gemma":[0.48840502,0.25568002,0.187504,0.0011954128,0.014503148,0.0016284217,0.00025265507,0.0024379932,0.010462572,0.0007396998,0.036980417,0.00021070377],"about_ca_topic_score_codex":0.00061197253,"about_ca_topic_score_gemma":0.0017204857,"teacher_disagreement_score":0.0043477807,"about_ca_system_score_codex":0.00056056643,"about_ca_system_score_gemma":0.0007930282,"threshold_uncertainty_score":0.022993565},"labels":[],"label_agreement":null},{"id":"W4413870841","doi":"10.1016/j.jaad.2025.05.815","title":"62742 Exploring and assessing the environmental, occupational, socioeconomic characteristics and risk factors of atopic dermatitis","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Delphi Technique in Research","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University","funders":"","keywords":"Medicine; Atopic dermatitis; Socioeconomic status; Dermatology; Environmental health; Occupational exposure; Population","score_opus":0.07694631046982507,"score_gpt":0.4140057367440594,"score_spread":0.3370594262742343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413870841","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9751074,0.00032483306,0.00091341144,0.00040112218,0.00002459213,0.00025859202,0.00013375898,0.0000043367013,0.022831846],"genre_scores_gemma":[0.9915587,0.0006368215,0.0024633238,0.00021404187,0.000020320103,0.00022532615,0.00010042307,0.0000025724835,0.0047785966],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986266,0.0008699295,0.000116463,0.000032014625,0.00022872219,0.00012635226],"domain_scores_gemma":[0.99845624,0.0009265476,0.00012858657,0.000042012503,0.00035024327,0.000096369644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032992458,0.000097262026,0.00015918353,0.0007477511,0.00055963814,0.00056308624,0.00012442215,0.000268282,0.009000897],"category_scores_gemma":[0.005269001,0.0001006157,0.0001836884,0.00064037193,0.00020090528,0.00033543262,0.00064522633,0.00028504632,0.000984793],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002593601,0.000689215,0.8329858,0.00025765016,0.000041873085,0.00063096517,0.0075042783,0.00013352929,0.0040109092,0.0008501539,0.0026173727,0.15001886],"study_design_scores_gemma":[0.0000382313,0.000689305,0.9580181,0.00022282614,0.000040800067,0.0010800749,0.021615138,0.00031874387,0.0011547551,0.0005280815,0.016277207,0.000016632493],"about_ca_topic_score_codex":0.0020127755,"about_ca_topic_score_gemma":0.0038633086,"teacher_disagreement_score":0.009000897,"about_ca_system_score_codex":0.00015937487,"about_ca_system_score_gemma":0.00081233215,"threshold_uncertainty_score":0.030111015},"labels":[],"label_agreement":null},{"id":"W4413870850","doi":"10.1016/j.jaad.2025.05.857","title":"63549 Guselkumab for the treatment of moderate-to-severe plaque psoriasis in pediatric patients: results of a phase 3, randomized, placebo-controlled study","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; SKiN Health; University of Calgary","funders":"","keywords":"Medicine; Plaque psoriasis; Dermatology; Placebo; Psoriasis; Randomized controlled trial; Internal medicine; Alternative medicine; Pathology","score_opus":0.013769705088917773,"score_gpt":0.2986567653505907,"score_spread":0.28488706026167293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413870850","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98220646,0.013271855,0.0006558963,0.00042847707,0.00024832916,0.0013005041,0.00061083987,0.000095321884,0.001182285],"genre_scores_gemma":[0.9788807,0.013891359,0.0018105925,0.0013306212,0.00045172437,0.001449654,0.00094088214,0.00004230482,0.001202147],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99936336,0.00031316787,0.00005286684,0.00008298993,0.000079206984,0.00010839545],"domain_scores_gemma":[0.99926704,0.00022307067,0.00015442182,0.000052943924,0.00005443333,0.00024807212],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015839451,0.0011127933,0.0038818554,0.00036868016,0.0004054327,0.00084316643,0.0007512262,0.0015780149,0.0030490276],"category_scores_gemma":[0.0010340391,0.0005637844,0.0021767963,0.0004801798,0.0009733439,0.00081071095,0.0002600927,0.0032243994,0.0005571184],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8550151,0.026297413,0.0033002533,0.001799532,0.0032226578,0.00030792019,0.00014310601,0.00062007585,0.020651234,0.00024211897,0.0014650337,0.08693539],"study_design_scores_gemma":[0.8321583,0.1523798,0.010753723,0.00011118052,0.0012953053,0.00019721984,0.000048324902,0.0003345088,0.0014889974,0.000106666324,0.0011006162,0.000025353313],"about_ca_topic_score_codex":0.0009828364,"about_ca_topic_score_gemma":0.0019992143,"teacher_disagreement_score":0.0038818554,"about_ca_system_score_codex":0.0005379764,"about_ca_system_score_gemma":0.0011281585,"threshold_uncertainty_score":0.010199964},"labels":[],"label_agreement":null},{"id":"W4413870882","doi":"10.1016/j.jaad.2025.05.834","title":"64510 Flare burden in generalized pustular psoriasis (GPP): analysis of pre-trial historical experience of patients enrolled in EFFISAYIL® 2","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Generalized pustular psoriasis; Flare; Psoriasis; Pustular psoriasis; Dermatology","score_opus":0.01133503957624771,"score_gpt":0.2836634516875507,"score_spread":0.272328412111303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413870882","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988444,0.00038591982,0.000056851015,0.000019481466,0.0000052289643,0.000020581201,0.00014067904,0.0000033562467,0.00052345206],"genre_scores_gemma":[0.99930215,0.000094284325,0.0000420109,0.000033061515,0.000015497024,0.0000112109055,0.0003043573,0.0000018721281,0.0001954623],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990415,0.0005211828,0.00005298354,0.00012790074,0.00011755843,0.00013882318],"domain_scores_gemma":[0.99828184,0.00074995396,0.00039632234,0.00015375037,0.00009148594,0.00032672545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021371567,0.00026222007,0.00047797733,0.0002952551,0.0003198253,0.00060235616,0.0002384396,0.00037582783,0.0017098237],"category_scores_gemma":[0.0031958171,0.00013092501,0.00048348046,0.00034325468,0.00039260613,0.0005674284,0.00032348276,0.0006717117,0.00030009204],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.28968844,0.004910273,0.5922901,0.00032344335,0.0015944097,0.0006468476,0.0005600663,0.0012098501,0.01588565,0.00040860777,0.0014569679,0.09102539],"study_design_scores_gemma":[0.0061708055,0.07688957,0.9117948,0.000027403237,0.0005266743,0.0006557416,0.00018210805,0.00073507085,0.0012559902,0.00017426857,0.0015560568,0.00003147846],"about_ca_topic_score_codex":0.0005028814,"about_ca_topic_score_gemma":0.0006889323,"teacher_disagreement_score":0.0021371567,"about_ca_system_score_codex":0.00036468776,"about_ca_system_score_gemma":0.0002224416,"threshold_uncertainty_score":0.011302471},"labels":[],"label_agreement":null},{"id":"W4413870889","doi":"10.1016/j.jaad.2025.05.978","title":"64412 Maintenance of Clinical Efficacy in Response to Upadacitinib Treatment in Adult Patients with Moderate-to-Severe Hidradenitis Suppurativa","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Health Sciences","funders":"","keywords":"Medicine; Hidradenitis suppurativa; Dermatology; Internal medicine; Disease","score_opus":0.017955352237489126,"score_gpt":0.3565449045622335,"score_spread":0.33858955232474436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413870889","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927228,0.004839494,0.00009939162,0.00018354425,0.000042842243,0.000054962704,0.00034958337,0.000020971578,0.0016863598],"genre_scores_gemma":[0.99838555,0.0006648848,0.00013076952,0.00009797408,0.000034749086,0.000020859905,0.00046896533,0.0000019014644,0.00019434866],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99973613,0.00007468471,0.000041932337,0.000033382534,0.000046608042,0.000067285015],"domain_scores_gemma":[0.9995036,0.00013665266,0.00013903368,0.000025744142,0.000059748112,0.00013518574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063590176,0.00020283277,0.0007793037,0.00024204538,0.00021212347,0.00039602077,0.00014145572,0.00021494244,0.001131945],"category_scores_gemma":[0.0010511787,0.000078786776,0.0004413198,0.00033304974,0.00012568291,0.00030141763,0.00015126173,0.00049621233,0.00018944447],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1143892,0.002440694,0.48790243,0.0010339916,0.0014414322,0.0018940602,0.0002547003,0.0012392313,0.032576494,0.00019802302,0.004551132,0.35207856],"study_design_scores_gemma":[0.004445655,0.032574072,0.94758373,0.0001896931,0.00082437677,0.0028885119,0.0002314712,0.0019094902,0.003941544,0.00011590013,0.005258247,0.000037321093],"about_ca_topic_score_codex":0.0005850142,"about_ca_topic_score_gemma":0.0012763481,"teacher_disagreement_score":0.001131945,"about_ca_system_score_codex":0.00030911216,"about_ca_system_score_gemma":0.0003161251,"threshold_uncertainty_score":0.0037867427},"labels":[],"label_agreement":null},{"id":"W4413870934","doi":"10.1016/j.jaad.2025.05.1169","title":"64876 Scratching the Surface: a Cross-Sectional Study of Itch and Quality of Life","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"","keywords":"Scratching; Medicine; Cross-sectional study; Quality of life (healthcare); Quality (philosophy); Pathology; Nursing; Composite material","score_opus":0.03665401774397857,"score_gpt":0.39589554682376804,"score_spread":0.35924152907978946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413870934","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992255,0.00013781933,0.00003144598,0.000035718665,0.000011456791,0.000011204145,0.00019030589,0.0000016029686,0.00035499423],"genre_scores_gemma":[0.999038,0.00012055443,0.000054685563,0.00008254746,0.000014924019,0.0000149238485,0.0002653218,0.0000017168965,0.00040744417],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994574,0.00018220182,0.000058415808,0.00008226196,0.00009731387,0.00012238647],"domain_scores_gemma":[0.99845636,0.0002446947,0.00059187773,0.00010949812,0.00015580449,0.00044178823],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007744653,0.00039645156,0.00045374222,0.0008032546,0.0007724318,0.00076566724,0.00035802682,0.0009544338,0.0026596414],"category_scores_gemma":[0.0017260909,0.00073754456,0.00083693163,0.0012315231,0.00030950524,0.00088843744,0.0005120553,0.00138207,0.00068727747],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000111991954,0.00030530285,0.9986368,0.0000083216655,0.000088713576,0.000060318696,0.000109294626,0.000011906647,0.0001257418,0.000007360075,0.000060040693,0.00047431682],"study_design_scores_gemma":[0.0000068872314,0.00023445053,0.9992155,0.000004430523,0.000026377018,0.00008994031,0.0002944235,0.00003275902,0.000013439468,0.0000058321934,0.00007264615,0.0000032461542],"about_ca_topic_score_codex":0.0062538707,"about_ca_topic_score_gemma":0.00996858,"teacher_disagreement_score":0.0062538707,"about_ca_system_score_codex":0.00032641026,"about_ca_system_score_gemma":0.0003362449,"threshold_uncertainty_score":0.012434959},"labels":[],"label_agreement":null},{"id":"W4413870938","doi":"10.1016/j.jaad.2025.05.1284","title":"60766 The Therapeutic Applications of Exosomes in Dermatology and Cutaneous Medical Aesthetics: A Comprehensive Systematic Review","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"","keywords":"Medicine; Microvesicles; Dermatology","score_opus":0.0070447023951959765,"score_gpt":0.3023427807264633,"score_spread":0.2952980783312673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413870938","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00078400783,0.99831307,0.00008512013,0.00017617564,0.00005123098,0.000049355447,0.0003573819,0.000003228607,0.00018044523],"genre_scores_gemma":[0.0078051207,0.9910166,0.00030842394,0.0004539331,0.000059408467,0.00006930488,0.00020850624,0.0000023824769,0.000076220036],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99810636,0.000543114,0.0006961753,0.00022357765,0.000348769,0.0000820015],"domain_scores_gemma":[0.9897531,0.0076651475,0.0017542393,0.0001394179,0.0005695766,0.000118537915],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033945986,0.0006995525,0.0036056617,0.0046783974,0.00027282775,0.0014252843,0.0009032084,0.001169033,0.004165819],"category_scores_gemma":[0.013150311,0.00046915378,0.004706889,0.0050256946,0.00046513815,0.0014107339,0.0012208959,0.0007402114,0.00034807477],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004876982,0.00004189888,0.0032532492,0.7920361,0.016746838,0.00013584031,0.00019417997,0.00020705962,0.00056725903,0.00054539973,0.005623684,0.18016078],"study_design_scores_gemma":[0.0007645115,0.00044991134,0.019905347,0.7453386,0.14361547,0.00074907456,0.00047551634,0.00021064992,0.00041807568,0.00090017373,0.087055214,0.00011737075],"about_ca_topic_score_codex":0.0027430425,"about_ca_topic_score_gemma":0.010705018,"teacher_disagreement_score":0.0046783974,"about_ca_system_score_codex":0.0007748078,"about_ca_system_score_gemma":0.00389118,"threshold_uncertainty_score":0.017952621},"labels":[],"label_agreement":null},{"id":"W4413870954","doi":"10.1016/j.jaad.2025.05.392","title":"63438 VISIBLE Cohort B: Guselkumab Demonstrated Scalp Clearance and Improved Health-Related Quality of Life Through Week 48 in Participants With Moderate-to-Severe Scalp Psoriasis Across All Skin Tones","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Body Image and Dysmorphia Studies","field":"Psychology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Scalp; Dermatology; Psoriasis; Cohort; Quality of life (healthcare); Cohort study; Internal medicine","score_opus":0.0459251179344522,"score_gpt":0.3901948829515553,"score_spread":0.3442697650171031,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413870954","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959015,0.00059630745,0.00018051355,0.00015753323,0.000060779028,0.0001046703,0.0012862484,0.000019459612,0.0016929264],"genre_scores_gemma":[0.99546826,0.00031258215,0.00017433344,0.00023747499,0.00004113526,0.000067409565,0.0010949789,0.000010017759,0.0025937941],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99978215,0.000045276938,0.000013123494,0.00004192119,0.00005281721,0.000064772146],"domain_scores_gemma":[0.99958986,0.00005130697,0.000077161094,0.000046995036,0.000088530534,0.00014605909],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007437876,0.00029501872,0.00037813414,0.00021033744,0.00039308364,0.00062557973,0.0002024085,0.00035880928,0.005544054],"category_scores_gemma":[0.0007551861,0.00015927492,0.00074021035,0.00016687969,0.00018900134,0.0003722883,0.00031345713,0.0009978494,0.0006457788],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18204404,0.015500693,0.5323868,0.00074738654,0.0044108066,0.0005298842,0.00088501157,0.0002410482,0.095145665,0.00025273152,0.014799129,0.15305682],"study_design_scores_gemma":[0.0036968517,0.022204122,0.9635597,0.00006965588,0.0009268401,0.00028590823,0.0004056176,0.00013539226,0.0034294296,0.000079558165,0.0051799957,0.000027083744],"about_ca_topic_score_codex":0.0042078206,"about_ca_topic_score_gemma":0.0069906027,"teacher_disagreement_score":0.005544054,"about_ca_system_score_codex":0.00024698197,"about_ca_system_score_gemma":0.0005991651,"threshold_uncertainty_score":0.01854676},"labels":[],"label_agreement":null},{"id":"W4413870982","doi":"10.1016/j.jaad.2025.05.650","title":"63417 Delayed biologic initiation is associated with increased healthcare resource use in patients diagnosed with hidradenitis suppurativa","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Hidradenitis suppurativa; Medicine; Dermatology; Health care; Resource use; Intensive care medicine; Internal medicine; Disease; Environmental resource management","score_opus":0.015955350253355635,"score_gpt":0.2899697303190907,"score_spread":0.27401438006573503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413870982","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995223,0.0021680368,0.00006287072,0.00029565138,0.000058450525,0.0000069791295,0.0004750576,0.0000071218524,0.0017028017],"genre_scores_gemma":[0.99890924,0.00036977316,0.00007383342,0.00011778401,0.00005837597,0.0000037844643,0.00025321744,0.0000031380832,0.0002109011],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99939215,0.00017244574,0.00008418172,0.0000791349,0.00012843675,0.0001435429],"domain_scores_gemma":[0.9951261,0.001487402,0.0023289402,0.00015029205,0.00020722846,0.00069996394],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036453706,0.00023299185,0.00047316804,0.0006280916,0.000408517,0.0010264633,0.00030658662,0.00052722986,0.0047850264],"category_scores_gemma":[0.0047529256,0.00024821446,0.00077497953,0.0012637133,0.00020457321,0.00046659537,0.00034418728,0.0013170369,0.00030383078],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015091471,0.000054879038,0.9977519,0.000016285921,0.00006147333,0.00015314968,0.000022171002,0.000016564947,0.00011503782,0.00001199784,0.000103939215,0.0015416533],"study_design_scores_gemma":[0.000010785309,0.00007099173,0.9987924,0.000021248565,0.000055264954,0.00046951967,0.00014585073,0.0001524726,0.000035455658,0.000022986924,0.00021878924,0.0000040302607],"about_ca_topic_score_codex":0.004568106,"about_ca_topic_score_gemma":0.006146691,"teacher_disagreement_score":0.0047850264,"about_ca_system_score_codex":0.00030444664,"about_ca_system_score_gemma":0.0004985815,"threshold_uncertainty_score":0.016007543},"labels":[],"label_agreement":null},{"id":"W4413870983","doi":"10.1016/j.jaad.2025.05.588","title":"61393 Clinical benefit of an ultra-concentrated tri-acid complex dermocosmetic serum in adult subjects with mild to moderate acne across all skin phototypes","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Windsor Clinical Research; Western University","funders":"","keywords":"Medicine; Acne; Dermatology","score_opus":0.027752885436808615,"score_gpt":0.37843119003415937,"score_spread":0.3506783045973508,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413870983","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968477,0.0013383689,0.00013356746,0.00015302007,0.000065450775,0.00006844186,0.00010064581,0.00003800593,0.0012547938],"genre_scores_gemma":[0.9985234,0.000280035,0.00010892408,0.0001437613,0.00007929045,0.0000137886445,0.00012222453,0.000002441144,0.00072610937],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9999013,0.00003398373,0.000008375447,0.000014381661,0.000017034336,0.000024932031],"domain_scores_gemma":[0.99978465,0.000053253378,0.000022506169,0.000008574929,0.000021040447,0.000109862245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027207885,0.00035537238,0.0005699478,0.00020355424,0.00028006194,0.00027217614,0.00010934738,0.00040693465,0.002346559],"category_scores_gemma":[0.0005107494,0.00010402826,0.00027149115,0.00013531753,0.00017310982,0.00017223899,0.00012071823,0.0005592294,0.00032422467],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.55598116,0.019309744,0.08598259,0.000386419,0.00049783214,0.0028441523,0.0002693236,0.0005093372,0.18364677,0.00014606355,0.0035313945,0.14689524],"study_design_scores_gemma":[0.03366603,0.40229508,0.52788144,0.00007068199,0.0008920606,0.003798182,0.0003924694,0.002195906,0.024465077,0.00009859113,0.0042006057,0.0000438985],"about_ca_topic_score_codex":0.0011202776,"about_ca_topic_score_gemma":0.001993868,"teacher_disagreement_score":0.002346559,"about_ca_system_score_codex":0.00016272912,"about_ca_system_score_gemma":0.00023062235,"threshold_uncertainty_score":0.007849991},"labels":[],"label_agreement":null},{"id":"W4413870989","doi":"10.1016/j.jaad.2025.05.1285","title":"63205 The Transcriptional Landscape Analysis of High-Risk Aggressive Basal Cell Carcinoma Identifies Subtype-Specific Biomarkers and Cancer Promotion Pathways","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Université Laval; Centre hospitalier de l'Université Laval; McGill University Health Centre; Centre Hospitalier de l’Université de Montréal; McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Basal cell carcinoma; Cancer; Basal (medicine); Cancer research; Oncology; Basal cell; Internal medicine; Bioinformatics; Biology","score_opus":0.015469242701182316,"score_gpt":0.2791355161818344,"score_spread":0.2636662734806521,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413870989","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99552166,0.00091224763,0.00039846386,0.00008865217,0.000009689273,0.00001238171,0.001530739,0.000014886603,0.0015112716],"genre_scores_gemma":[0.99706596,0.00025131743,0.00024234902,0.000078459445,0.0000072332255,0.0000131835095,0.0010287341,0.000006841172,0.0013058884],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99975544,0.000045643275,0.0000120327495,0.00005794041,0.00006117457,0.000067756715],"domain_scores_gemma":[0.9998361,0.000042204458,0.000039813756,0.000019937002,0.00003467723,0.000027206142],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002848575,0.00014212605,0.00033161548,0.00060573267,0.0003723458,0.0009199691,0.00012779694,0.00021079299,0.0034412162],"category_scores_gemma":[0.000391042,0.00011603424,0.00035258412,0.0007160147,0.00019691767,0.00014865395,0.00022187435,0.00027162553,0.00059287436],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018304099,0.0002244245,0.6980744,0.00021423845,0.0004022927,0.00024137608,0.00041225462,0.00046077208,0.2660033,0.00051248656,0.001428573,0.030195395],"study_design_scores_gemma":[0.000018762448,0.00029057785,0.98089266,0.000017215289,0.00014235769,0.0003561188,0.0006140959,0.00063984917,0.013824032,0.00033457362,0.002861644,0.000008015379],"about_ca_topic_score_codex":0.003083173,"about_ca_topic_score_gemma":0.006308871,"teacher_disagreement_score":0.0034412162,"about_ca_system_score_codex":0.00030480532,"about_ca_system_score_gemma":0.0003169342,"threshold_uncertainty_score":0.0115119815},"labels":[],"label_agreement":null},{"id":"W4413871026","doi":"10.1016/j.jaad.2025.05.1297","title":"62897 Time-Interval Incidence Rates of Adverse Events in Patients With Moderate-to-Severe Atopic Dermatitis Treated With Abrocitinib","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; SKiN Health; Queen's University","funders":"","keywords":"Medicine; Atopic dermatitis; Incidence (geometry); Dermatology; Adverse effect; Interval (graph theory); Confidence interval; Internal medicine","score_opus":0.006572408375374025,"score_gpt":0.2811076195135922,"score_spread":0.27453521113821816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413871026","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995513,0.0015556267,0.00012332418,0.000039615534,0.000018886749,0.000010777758,0.0009189927,0.000010447177,0.0018092958],"genre_scores_gemma":[0.99876714,0.00024406596,0.00003968969,0.000029421633,0.000021196498,0.00000565286,0.0006208456,0.0000019793433,0.00027006186],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99962366,0.000078977384,0.00006954459,0.00006907832,0.000092049144,0.00006669566],"domain_scores_gemma":[0.9988518,0.00028268358,0.0006271819,0.00004067688,0.000084160354,0.00011346527],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042128706,0.0001451879,0.00035519776,0.00038164738,0.00011131621,0.00038333345,0.00013222858,0.00021779702,0.0021022803],"category_scores_gemma":[0.0014119215,0.00011101123,0.00083464757,0.0005012328,0.00006863512,0.00025243618,0.00016451532,0.00043370802,0.00021766932],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033268777,0.000106892905,0.9852201,0.00006479223,0.0004709839,0.0002546681,0.000025352923,0.00023189407,0.0009917078,0.000059204507,0.00043746582,0.008809966],"study_design_scores_gemma":[0.00006546719,0.00035000866,0.9978873,0.000007215019,0.00015089028,0.00052808115,0.000036201232,0.00044537283,0.00010804663,0.000028018974,0.00038770094,0.000005698087],"about_ca_topic_score_codex":0.0015613389,"about_ca_topic_score_gemma":0.0017201746,"teacher_disagreement_score":0.0021022803,"about_ca_system_score_codex":0.00018187812,"about_ca_system_score_gemma":0.00017306229,"threshold_uncertainty_score":0.0070328712},"labels":[],"label_agreement":null},{"id":"W4413871050","doi":"10.1016/j.jaad.2025.05.307","title":"64220 Punch Excision Therapy for the Treatment of Keloids: A Systematic Review","year":2025,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Dermatologic Treatments and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health; University of British Columbia; University of Ottawa","funders":"","keywords":"Medicine; Keloid; Dermatology; Surgery","score_opus":0.07865950039219366,"score_gpt":0.46054547819533653,"score_spread":0.3818859778031429,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413871050","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007927222,0.998429,0.000079613754,0.00008379837,0.00007811656,0.00014325502,0.00019603153,0.0000051616257,0.00019233309],"genre_scores_gemma":[0.010157085,0.9887326,0.00026312942,0.00038491658,0.000061923936,0.00013272431,0.00013626249,0.000003109154,0.00012822033],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99762326,0.0007676383,0.00081855454,0.00025637398,0.0004226019,0.00011155664],"domain_scores_gemma":[0.9934009,0.004707665,0.0012307088,0.0000898684,0.00046628073,0.000104584455],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026619786,0.0013279654,0.007318073,0.0037087025,0.0005712907,0.0017945383,0.0015362749,0.0017578588,0.007536555],"category_scores_gemma":[0.012652773,0.00076711655,0.0073034074,0.004605651,0.0007079786,0.0016561821,0.0010653645,0.0012260245,0.000599573],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065644627,0.000038711845,0.0006640126,0.94004035,0.01811444,0.000112027985,0.00010006447,0.000083368126,0.00023713002,0.00011721179,0.0019591616,0.037877034],"study_design_scores_gemma":[0.001998901,0.0006479809,0.006848803,0.69442415,0.2750979,0.0006101393,0.0003405057,0.00012918853,0.00030802173,0.00035948696,0.019151336,0.00008349841],"about_ca_topic_score_codex":0.008567743,"about_ca_topic_score_gemma":0.030124832,"teacher_disagreement_score":0.008567743,"about_ca_system_score_codex":0.0017314621,"about_ca_system_score_gemma":0.004325807,"threshold_uncertainty_score":0.025212288},"labels":[],"label_agreement":null},{"id":"W4413871080","doi":"10.1016/j.jaad.2025.05.1130","title":"63337 Real-World Prevalence of Comorbidities Among Adult Patients With Prurigo Nodularis With and Without Type 2 Inflammatory Diseases in the US","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Medicine and Dermatology Studies History","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Prurigo nodularis; Dermatology; Comorbidity; Internal medicine","score_opus":0.006547816427726337,"score_gpt":0.2718679779807221,"score_spread":0.26532016155299576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413871080","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962394,0.00026773644,0.00004028327,0.00007012013,0.000008691503,0.000006129787,0.002522156,0.000005857144,0.00083965],"genre_scores_gemma":[0.9983884,0.0001574083,0.00003531166,0.00006218418,0.00001307035,0.000006572548,0.001194397,0.0000016946316,0.00014088287],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99964774,0.00007236855,0.000060156864,0.00007989321,0.000060048416,0.00007981545],"domain_scores_gemma":[0.99920875,0.00010213016,0.0004202695,0.000044686345,0.00007440161,0.00014975996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024534375,0.00020662785,0.00027979238,0.0008716418,0.0003364341,0.00059505104,0.00023009809,0.00042572184,0.002811789],"category_scores_gemma":[0.0011666068,0.00023402534,0.0004287339,0.0017609659,0.00021729918,0.0005348305,0.0004367734,0.0004938462,0.00045514904],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003193183,0.000017486658,0.999199,0.000006960955,0.000025640802,0.00005709379,0.000026695852,0.0000119410815,0.000047864778,0.000009017522,0.00015208698,0.0004143816],"study_design_scores_gemma":[0.0000026238624,0.00002178764,0.99929404,0.0000054208185,0.000012337484,0.00024432075,0.00019162074,0.0000628999,0.000009932743,0.000009165974,0.00014334386,0.0000024529897],"about_ca_topic_score_codex":0.019886661,"about_ca_topic_score_gemma":0.019347452,"teacher_disagreement_score":0.019886661,"about_ca_system_score_codex":0.0003535085,"about_ca_system_score_gemma":0.00033572776,"threshold_uncertainty_score":0.03954184},"labels":[],"label_agreement":null},{"id":"W4413871093","doi":"10.1016/j.jaad.2025.05.968","title":"63305 Long-term efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata (AA): 3-year results from the ALLEGRO-LT phase 3, open-label study","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Alopecia areata; Dermatology; Open label; Term (time); Pediatrics; Adverse effect; Internal medicine","score_opus":0.01870791245709116,"score_gpt":0.34047695687339924,"score_spread":0.3217690444163081,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413871093","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98644596,0.010420544,0.0002389013,0.00024524328,0.00007340968,0.00020777612,0.00077405194,0.00009601621,0.0014981189],"genre_scores_gemma":[0.9933513,0.0030586177,0.00039111904,0.0005532774,0.00010569489,0.00018825446,0.00120625,0.000013483091,0.0011320558],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996668,0.00011756405,0.000026699667,0.000053477994,0.000056057175,0.00007946737],"domain_scores_gemma":[0.99953747,0.00013414068,0.0001200438,0.000030156896,0.00003637408,0.00014198122],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010899606,0.00056241715,0.001743568,0.00021830013,0.00031974973,0.0006976507,0.00034494014,0.00079893693,0.0018199213],"category_scores_gemma":[0.0005663057,0.00023163781,0.0014287852,0.00025055557,0.0003943667,0.00068789505,0.00017353753,0.0016771323,0.0007841886],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.44805494,0.02366882,0.04371962,0.0026087943,0.0053753667,0.00063279783,0.00040090687,0.0029521254,0.033599053,0.00037263628,0.009647079,0.42896786],"study_design_scores_gemma":[0.33070856,0.39245617,0.25187114,0.00032074342,0.0038286068,0.0016325045,0.0002575866,0.003408788,0.0048731966,0.000340516,0.010178132,0.00012413632],"about_ca_topic_score_codex":0.0007220409,"about_ca_topic_score_gemma":0.0022811594,"teacher_disagreement_score":0.0018199213,"about_ca_system_score_codex":0.00041345894,"about_ca_system_score_gemma":0.00050350494,"threshold_uncertainty_score":0.006088197},"labels":[],"label_agreement":null},{"id":"W4413871102","doi":"10.1016/j.jaad.2025.05.985","title":"61609 Medico-legal Complaints Against Dermatologists: Data From the Canadian Medical Protective Association, 2013 – 2022","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Medical Malpractice and Liability Issues","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Medical Protective Association; University of Toronto; University of Calgary","funders":"","keywords":"Medicine; Family medicine; Dermatology; Association (psychology); MEDLINE; Law","score_opus":0.05076628220728405,"score_gpt":0.43320509292346954,"score_spread":0.38243881071618546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413871102","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2632269,0.004440243,0.00021759461,0.0028960498,0.0002662295,0.00078031985,0.6746962,0.00014654716,0.053329937],"genre_scores_gemma":[0.5796814,0.009180366,0.0010578327,0.005585895,0.00030301177,0.0008283513,0.35991046,0.00010155276,0.043351136],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9934876,0.00015219278,0.00060501724,0.00030741823,0.0042938143,0.0011539618],"domain_scores_gemma":[0.9826681,0.0010617642,0.0033768197,0.00026955098,0.010483505,0.0021402866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015914235,0.0007398063,0.00065663655,0.011323957,0.0038974336,0.0022171976,0.0021953085,0.0018190382,0.011943214],"category_scores_gemma":[0.011759858,0.0008934912,0.0014075803,0.01994543,0.0007135525,0.0008088228,0.0017268889,0.0018672957,0.0035704887],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000528374,0.00033853995,0.7475223,0.00080625445,0.00027219823,0.00049660035,0.0007435743,0.00029374272,0.00015649047,0.0003943606,0.22585055,0.02259707],"study_design_scores_gemma":[0.000033814813,0.000020814765,0.9841325,0.00017354368,0.000060548806,0.00012412725,0.0006677946,0.00015404426,0.00005986429,0.000027559629,0.014519435,0.000025860609],"about_ca_topic_score_codex":0.9872306,"about_ca_topic_score_gemma":0.993148,"teacher_disagreement_score":0.977735,"about_ca_system_score_codex":0.022265015,"about_ca_system_score_gemma":0.065074146,"threshold_uncertainty_score":0.16154474},"labels":[],"label_agreement":null},{"id":"W4413871103","doi":"10.1016/j.jaad.2025.05.1184","title":"62193 SKIN Disclosure: Recommendations for Breaking Bad News Based on Survey of Dermatologist Experiences","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Social Media in Health Education","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"","keywords":"Medicine; Dermatology; MEDLINE; Family medicine; Law","score_opus":0.1034431473716615,"score_gpt":0.4638592720447408,"score_spread":0.3604161246730793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413871103","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.39145792,0.0068997853,0.010004485,0.41422573,0.006441079,0.0073811,0.013877694,0.0013616051,0.14835063],"genre_scores_gemma":[0.79187626,0.010830741,0.07520546,0.05533766,0.0038917451,0.007679263,0.011617246,0.0003638023,0.04319769],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.9928625,0.0034628515,0.0014647053,0.00019384187,0.0015060753,0.0005100375],"domain_scores_gemma":[0.9431304,0.025911922,0.0077515356,0.0011803843,0.015007261,0.0070186015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012871306,0.00030457266,0.00040451178,0.0029257203,0.0022042328,0.0020302914,0.0011726147,0.0025294637,0.013970534],"category_scores_gemma":[0.06814072,0.00037429843,0.00080465805,0.0020613482,0.00038780776,0.001754586,0.0014526525,0.0023151152,0.0043291193],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033435252,0.0015173496,0.5110484,0.0009516191,0.00007072463,0.0002914809,0.0021855002,0.00018790046,0.0004924854,0.00053844013,0.28671315,0.19566856],"study_design_scores_gemma":[0.00045980632,0.00094353827,0.8201064,0.0038875975,0.00046106346,0.00040261773,0.021766031,0.001757179,0.0013586757,0.0016805627,0.14703304,0.0001434754],"about_ca_topic_score_codex":0.009649447,"about_ca_topic_score_gemma":0.024664793,"teacher_disagreement_score":0.013970534,"about_ca_system_score_codex":0.001246664,"about_ca_system_score_gemma":0.0062653255,"threshold_uncertainty_score":0.06807083},"labels":[],"label_agreement":null},{"id":"W4413871122","doi":"10.1016/j.jaad.2025.05.966","title":"64587 Longitudinal Psychological Impact of Psoriasis: A Comparative Study between Adults and Children","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Western University","funders":"","keywords":"Medicine; Psoriasis; Longitudinal study; Clinical psychology; Dermatology; Pathology","score_opus":0.029771633809812764,"score_gpt":0.36033988368432934,"score_spread":0.3305682498745166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413871122","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99963474,0.00007248711,0.000009042368,0.000011171746,0.000002978088,0.0000039194492,0.00009027415,5.327617e-7,0.00017491775],"genre_scores_gemma":[0.9993699,0.00013601566,0.000020650396,0.00002335315,0.0000065843637,0.000009075311,0.00022407727,0.0000012218228,0.00020922381],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994753,0.0001425498,0.000040265004,0.00007989999,0.000085347725,0.0001766499],"domain_scores_gemma":[0.99856526,0.00018118703,0.0004451591,0.0000640997,0.00018291833,0.0005613258],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006702033,0.00028471195,0.00044506456,0.0010544845,0.00090301526,0.0008036282,0.00030292402,0.0005577519,0.0014658825],"category_scores_gemma":[0.0021148035,0.0003145618,0.0005105535,0.0014950928,0.00041659913,0.00072611036,0.0007089616,0.00081517524,0.00042734967],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019724769,0.0001592762,0.9981073,0.0000047108383,0.000023995932,0.00011883465,0.00035482855,0.000009312733,0.000115741495,0.000010561568,0.00002893725,0.0008693511],"study_design_scores_gemma":[0.0000051691704,0.0003474875,0.99850476,0.000003545415,0.00001237377,0.00016218213,0.0008395748,0.000012373794,0.000022064416,0.000005470933,0.00008246502,0.0000025481347],"about_ca_topic_score_codex":0.014049902,"about_ca_topic_score_gemma":0.013793891,"teacher_disagreement_score":0.014049902,"about_ca_system_score_codex":0.0005118255,"about_ca_system_score_gemma":0.00055343,"threshold_uncertainty_score":0.02793622},"labels":[],"label_agreement":null},{"id":"W4413871154","doi":"10.1016/j.jaad.2025.05.1100","title":"64278 Pyoderma gangrenosum associated with IgA monoclonal gammopathy demonstrate IgA and C5a expression","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Autoimmune and Inflammatory Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health; University of British Columbia","funders":"","keywords":"Pyoderma gangrenosum; Medicine; Monoclonal gammopathy; Immunoglobulin A; Paraproteinemias; Monoclonal; Dermatology; Gammopathy; Immunology; Immunopathology; Monoclonal gammopathy of undetermined significance; Monoclonal antibody; Pathology; Antibody; Immunoglobulin G","score_opus":0.007585256751454021,"score_gpt":0.27089999417591,"score_spread":0.263314737424456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413871154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97923595,0.00094031426,0.0007060439,0.000117905896,0.0000318824,0.000028106939,0.00012767075,0.00004971364,0.018762395],"genre_scores_gemma":[0.99795914,0.00016931116,0.0005066577,0.000046567675,0.0000257177,0.000007262573,0.00011277114,0.000008220507,0.0011642963],"study_design_codex":"bench_or_experimental","study_design_gemma":"case_report","domain_scores_codex":[0.9997727,0.000030160083,0.000024862678,0.000024641029,0.000048996822,0.000098601806],"domain_scores_gemma":[0.9997094,0.000092512666,0.00005848127,0.000034174212,0.00004429681,0.000061016483],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019244042,0.00054963003,0.00022709163,0.0013384612,0.00038223996,0.0004676259,0.0003017503,0.00064079865,0.005068395],"category_scores_gemma":[0.00061830576,0.00029637362,0.00025468375,0.00059971935,0.000360779,0.00030857892,0.0004952595,0.00035380488,0.001216231],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021459204,0.00037279897,0.1538538,0.0004055667,0.00016745822,0.36043686,0.00054455525,0.00034964606,0.4526477,0.0019625518,0.0016304182,0.025482802],"study_design_scores_gemma":[0.00014962238,0.00063684164,0.4075535,0.000094640185,0.00023072927,0.48846677,0.0006866735,0.002843875,0.08851476,0.0011287926,0.009661712,0.00003201271],"about_ca_topic_score_codex":0.0013146788,"about_ca_topic_score_gemma":0.0010580532,"teacher_disagreement_score":0.005068395,"about_ca_system_score_codex":0.00019020101,"about_ca_system_score_gemma":0.0001294232,"threshold_uncertainty_score":0.016955435},"labels":[],"label_agreement":null},{"id":"W4413871179","doi":"10.1016/j.jaad.2025.05.1113","title":"59674 Randomized Phase 3 trial of spesolimab in patients with ulcerative pyoderma gangrenosum: A study protocol","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Autoimmune and Inflammatory Disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Boehringer Ingelheim (Canada)","funders":"","keywords":"Medicine; Pyoderma gangrenosum; Dermatology; Randomized controlled trial; Protocol (science); Surgery; Internal medicine; Pathology; Disease; Alternative medicine","score_opus":0.009000177000796068,"score_gpt":0.3464731479822631,"score_spread":0.337472970981467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413871179","genre_codex":"protocol","genre_gemma":"protocol","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"protocol","genre_consensus":"protocol","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.35773116,0.012275656,0.010301514,0.0063134395,0.004516896,0.5386667,0.030869724,0.0018467208,0.037478253],"genre_scores_gemma":[0.41718084,0.00561798,0.01361754,0.011399054,0.001451598,0.5087822,0.011277786,0.00021010764,0.030462882],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9985551,0.0007486484,0.00010045945,0.00019302097,0.00011545655,0.00028721557],"domain_scores_gemma":[0.9990465,0.00023292852,0.00020187162,0.000093778704,0.0000925136,0.00033237075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030385312,0.003097928,0.003744417,0.00075710134,0.0010416028,0.0015732829,0.0014137534,0.0029170325,0.03867991],"category_scores_gemma":[0.002497443,0.0012779149,0.0026935223,0.00068044476,0.0014064561,0.0010054073,0.00083724514,0.004320811,0.0057144407],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97356445,0.0029090592,0.00030683694,0.0014480122,0.0008975752,0.000071199436,0.000041268107,0.00045838236,0.0014791614,0.00042396793,0.006337862,0.01206216],"study_design_scores_gemma":[0.9910289,0.006105487,0.0004151034,0.00004984897,0.00020575011,0.000012822876,0.000005974143,0.00012160322,0.000077519166,0.00015456777,0.0018139377,0.000008439632],"about_ca_topic_score_codex":0.001531714,"about_ca_topic_score_gemma":0.0042162584,"teacher_disagreement_score":0.03867991,"about_ca_system_score_codex":0.0014087342,"about_ca_system_score_gemma":0.003997042,"threshold_uncertainty_score":0.12939715},"labels":[],"label_agreement":null},{"id":"W4413871197","doi":"10.1016/j.jaad.2025.05.311","title":"63281 Real-World Comorbidities of Adult Patients With Prurigo Nodularis Initiating Dupilumab in the US","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Dupilumab; Prurigo nodularis; Medicine; Dermatology; Rescue therapy; Atopic dermatitis; Internal medicine","score_opus":0.00920490195612543,"score_gpt":0.2975111947741048,"score_spread":0.28830629281797937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413871197","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952865,0.0007578317,0.00004457436,0.0003159992,0.000022406814,0.00000868932,0.0013177728,0.0000073824676,0.0022388797],"genre_scores_gemma":[0.9986834,0.00027096586,0.000043725293,0.00016981112,0.000034706325,0.00000502562,0.000658308,0.0000015313366,0.00013251604],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99959856,0.00007536504,0.00005556953,0.000071454975,0.00007978139,0.00011922179],"domain_scores_gemma":[0.99913174,0.00014252431,0.00041588917,0.000031236206,0.00007773145,0.0002008679],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022359323,0.00018080366,0.0002595665,0.0004982271,0.00042209684,0.0006511891,0.00018611501,0.00036369462,0.0024084249],"category_scores_gemma":[0.0013409135,0.0001299256,0.00029448,0.0011137605,0.00017236057,0.00038325269,0.00034909113,0.00056517683,0.00022456342],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017493956,0.000044353976,0.99567944,0.00001733804,0.00004570967,0.00059580134,0.00004466955,0.00004399312,0.00013362344,0.000038076647,0.00062908046,0.0025530674],"study_design_scores_gemma":[0.000018553952,0.00008289501,0.9959163,0.000025999678,0.000056743967,0.0022472453,0.00036194499,0.00021649369,0.000044446053,0.00005128669,0.00097102154,0.000007001083],"about_ca_topic_score_codex":0.013732211,"about_ca_topic_score_gemma":0.020819902,"teacher_disagreement_score":0.013732211,"about_ca_system_score_codex":0.0005105238,"about_ca_system_score_gemma":0.0005431908,"threshold_uncertainty_score":0.02730459},"labels":[],"label_agreement":null},{"id":"W4413871205","doi":"10.1016/j.jaad.2025.05.1036","title":"60920 Outcomes of Upadacitinib following Dupilumab for Dupilumab-Associated Facial and Neck Erythema: A Systematic Review","year":2025,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Autoimmune Bullous Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Western University","funders":"","keywords":"Dupilumab; Medicine; Dermatology; Erythema; Atopic dermatitis","score_opus":0.024094550908804992,"score_gpt":0.37019974489237556,"score_spread":0.3461051939835706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413871205","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018451237,0.9972838,0.000066811706,0.00008926269,0.00008554838,0.00009910187,0.00033231376,0.000006138941,0.0001919206],"genre_scores_gemma":[0.03366049,0.9647413,0.000285782,0.0005863701,0.000080394406,0.00015747712,0.0002973423,0.00000624808,0.00018457494],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9981207,0.0005286476,0.00070099515,0.0002492753,0.0002830508,0.000117347416],"domain_scores_gemma":[0.9946456,0.0031448328,0.0016270615,0.000083403706,0.00038688304,0.00011227339],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002835447,0.0011572907,0.008272435,0.0031747615,0.00037073263,0.0019336509,0.0013072254,0.0014526332,0.0061257705],"category_scores_gemma":[0.010041684,0.00084047235,0.0110614095,0.003891511,0.00055409875,0.0014279098,0.0012873062,0.0015217635,0.00041307523],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018245912,0.000040589723,0.0022386666,0.88913864,0.06825289,0.0001276654,0.00010412067,0.00016122527,0.00026760285,0.00015064179,0.0021724114,0.03552087],"study_design_scores_gemma":[0.0030406762,0.0008123958,0.012134887,0.3459969,0.61817765,0.00043466003,0.00026342404,0.00018364811,0.00024520356,0.00030904188,0.018307438,0.000094080126],"about_ca_topic_score_codex":0.0069106156,"about_ca_topic_score_gemma":0.024734136,"teacher_disagreement_score":0.008272435,"about_ca_system_score_codex":0.0019104114,"about_ca_system_score_gemma":0.0032102128,"threshold_uncertainty_score":0.020492792},"labels":[],"label_agreement":null},{"id":"W4413871244","doi":"10.1016/j.jaad.2025.05.313","title":"62396 Real-world effectiveness of deucravacitinib in patients with plaque psoriasis: a 6-month analysis of skin pain, itch, and fatigue from the RePhlect Registry","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health; Queen's University; Probity Medical Research; University of Toronto","funders":"","keywords":"Medicine; Plaque psoriasis; Dermatology; Psoriasis","score_opus":0.008740750792603981,"score_gpt":0.2625338765884431,"score_spread":0.2537931257958391,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413871244","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913502,0.003515189,0.00011459693,0.00012348579,0.000033004446,0.00006536882,0.0039188373,0.000018898063,0.0008604259],"genre_scores_gemma":[0.9908627,0.0010525705,0.00017757557,0.00016561936,0.0000891729,0.00007255094,0.0072623254,0.000008998169,0.0003084375],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99768794,0.00089498144,0.00032397456,0.00043319873,0.00044044064,0.00021955588],"domain_scores_gemma":[0.99640024,0.00097235915,0.0016990784,0.00036384462,0.00023626784,0.00032823975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025831403,0.0003708192,0.0015581072,0.0005972594,0.00028642776,0.0010713353,0.00044140985,0.00067470473,0.0012961766],"category_scores_gemma":[0.0034256768,0.0002708288,0.0018156032,0.001302429,0.00035329105,0.00089118705,0.00045465317,0.00094085466,0.0005340595],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.038188387,0.0009135044,0.9185701,0.0005238101,0.0049145333,0.00027347327,0.000088180605,0.0009808156,0.0011111597,0.00009787362,0.00235076,0.03198744],"study_design_scores_gemma":[0.0036765952,0.0050874082,0.98454535,0.0000661818,0.002101523,0.0004881111,0.00011241885,0.00084953714,0.0003023865,0.000060484275,0.0026672909,0.000042603187],"about_ca_topic_score_codex":0.0014721291,"about_ca_topic_score_gemma":0.0024439946,"teacher_disagreement_score":0.0025831403,"about_ca_system_score_codex":0.0006138009,"about_ca_system_score_gemma":0.0005577631,"threshold_uncertainty_score":0.013661146},"labels":[],"label_agreement":null},{"id":"W4413871270","doi":"10.1016/j.jaad.2025.05.556","title":"62934 Body Mass Index and Weight as Cardiometabolic Outcomes in Pediatric Patients With Moderate-to-Severe Plaque Psoriasis Treated With Apremilast: 16-Week Results From the SPROUT Randomized Controlled Trial","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Apremilast; Plaque psoriasis; Body mass index; Randomized controlled trial; Psoriasis; Psoriasis Area and Severity Index; Internal medicine; Dermatology","score_opus":0.0059502749653910355,"score_gpt":0.23229439759222614,"score_spread":0.22634412262683512,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413871270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9749572,0.017947547,0.00052421197,0.0010122159,0.00092550233,0.0011565658,0.0015359313,0.00015489604,0.0017858674],"genre_scores_gemma":[0.9799897,0.009005197,0.0014356987,0.0016965586,0.0010894588,0.0019228893,0.0016209314,0.000036275836,0.0032033164],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99946314,0.00026212202,0.000046719768,0.00011061949,0.000044001095,0.000073460775],"domain_scores_gemma":[0.99918944,0.0002421152,0.00024204017,0.00006257515,0.000054512635,0.00020930856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012233894,0.0015707675,0.0044589085,0.0003508317,0.0003857827,0.0012298849,0.00080626726,0.0019422143,0.0061567165],"category_scores_gemma":[0.00150291,0.0007464713,0.0030963612,0.0004411541,0.00079422764,0.0009439978,0.0004613795,0.0033640394,0.00069798157],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9814548,0.0021778736,0.001751876,0.0010465793,0.0034475222,0.00005062537,0.000026088403,0.00021757955,0.00085927936,0.000088257024,0.00078703446,0.008092623],"study_design_scores_gemma":[0.9758959,0.01642394,0.004521695,0.00008207973,0.002280672,0.00002689791,0.000021785729,0.00023513086,0.00012229086,0.00007662706,0.00030023317,0.000012739865],"about_ca_topic_score_codex":0.0016633217,"about_ca_topic_score_gemma":0.0024036316,"teacher_disagreement_score":0.0061567165,"about_ca_system_score_codex":0.00048389216,"about_ca_system_score_gemma":0.00070587464,"threshold_uncertainty_score":0.020596266},"labels":[],"label_agreement":null},{"id":"W4413871295","doi":"10.1016/j.jaad.2025.05.542","title":"61888 Bimekizumab efficacy by disease duration in moderate to severe hidradenitis suppurativa: 2-year phase 3 results from BE HEARD EXT","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Oakville-Trafalgar Memorial Hospital; Queen's University","funders":"","keywords":"Hidradenitis suppurativa; Medicine; Dermatology; Duration (music); Internal medicine; Disease","score_opus":0.0176826088443445,"score_gpt":0.34016107057901035,"score_spread":0.3224784617346659,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413871295","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95983714,0.02507731,0.0006090012,0.0020684784,0.0005902386,0.0027544622,0.0032170143,0.00017309588,0.005673328],"genre_scores_gemma":[0.95796335,0.01400805,0.0022181133,0.005476204,0.0009595326,0.0032399688,0.005069486,0.00008415424,0.0109812375],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99940526,0.00020818863,0.00004761295,0.00007490839,0.00008871108,0.00017520678],"domain_scores_gemma":[0.9992354,0.00017786743,0.00014564238,0.000049734306,0.000063729014,0.00032761847],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002315125,0.0010365142,0.0024316947,0.00043537194,0.0005823086,0.0010877294,0.00076436735,0.0014256496,0.0057003833],"category_scores_gemma":[0.0008784638,0.000477809,0.0024162384,0.00035361585,0.00058853754,0.0009157459,0.00042752505,0.0029224283,0.0012855668],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.58576274,0.04415934,0.008238784,0.0023717948,0.0022939078,0.00021453561,0.00026505007,0.0016826115,0.030164918,0.00037092195,0.017117482,0.30735794],"study_design_scores_gemma":[0.65028304,0.30586132,0.030118486,0.00018385742,0.0011848237,0.00025811256,0.00009157009,0.00066801347,0.0026345463,0.00024515923,0.008419618,0.00005157134],"about_ca_topic_score_codex":0.0009246344,"about_ca_topic_score_gemma":0.0024891023,"teacher_disagreement_score":0.0057003833,"about_ca_system_score_codex":0.00062832603,"about_ca_system_score_gemma":0.0010193815,"threshold_uncertainty_score":0.019069672},"labels":[],"label_agreement":null},{"id":"W4413871392","doi":"10.1016/j.jaad.2025.05.612","title":"61900 Comparing Clinicians’ Assessments of Wound Tissue Types to an AI Model: Implications for Wound Care Practice","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Pressure Ulcer Prevention and Management","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Wound care; Intensive care medicine; Wound healing; Surgery","score_opus":0.09498818318805058,"score_gpt":0.5611940644430022,"score_spread":0.46620588125495166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413871392","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.977594,0.0010891665,0.0037522835,0.002964176,0.00064694457,0.00037536307,0.0004441454,0.000029617571,0.013104396],"genre_scores_gemma":[0.99529004,0.0001804459,0.0027779178,0.0007285992,0.00009951361,0.00024208307,0.0002133564,0.00001469868,0.0004533501],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.94917375,0.03489349,0.00457136,0.0019866948,0.008156919,0.0012177447],"domain_scores_gemma":[0.77049804,0.17878678,0.018876089,0.00476085,0.023099793,0.003978435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.047777105,0.00030044903,0.0005443059,0.0020053077,0.0011073189,0.0037810237,0.0013596371,0.000987558,0.0052299057],"category_scores_gemma":[0.26141152,0.00029641174,0.000994009,0.0020530869,0.001407065,0.0035372574,0.0020590052,0.0015899567,0.00076880923],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001579965,0.0012423571,0.93429863,0.0003453041,0.00047430128,0.00006451515,0.0037095984,0.00036678344,0.0003822852,0.0013886988,0.0030148753,0.053132564],"study_design_scores_gemma":[0.0003392248,0.0029792811,0.96254647,0.0007202844,0.00034598616,0.00022022043,0.016970003,0.004349585,0.00073466974,0.0051604058,0.005559351,0.00007454001],"about_ca_topic_score_codex":0.0045493995,"about_ca_topic_score_gemma":0.008820455,"teacher_disagreement_score":0.047777105,"about_ca_system_score_codex":0.0022097162,"about_ca_system_score_gemma":0.0021082668,"threshold_uncertainty_score":0.2526725},"labels":[],"label_agreement":null},{"id":"W4413871446","doi":"10.1016/j.jaad.2025.05.544","title":"62020 Bimekizumab efficacy in patients with plaque psoriasis: A post hoc stratification by weight over 4 years in BE BRIGHT","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Queen's University","funders":"","keywords":"Medicine; Plaque psoriasis; Post-hoc analysis; Psoriasis; Post hoc; Stratification (seeds); Dermatology; Internal medicine","score_opus":0.005397165505638845,"score_gpt":0.2401147297499204,"score_spread":0.23471756424428156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413871446","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975158,0.00071687275,0.00014718219,0.00009885048,0.000092533555,0.000114089686,0.00036864038,0.000013070315,0.000933016],"genre_scores_gemma":[0.9973508,0.00021312514,0.00014675982,0.00012676873,0.00008155865,0.00011843459,0.0007671448,0.000007781264,0.0011876702],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9987577,0.0005783075,0.000057346268,0.0001906383,0.000114784074,0.00030120573],"domain_scores_gemma":[0.9993037,0.00018235753,0.00011636883,0.000081230944,0.000084112886,0.00023216916],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017143486,0.00070165936,0.0019511703,0.00036812696,0.0006293941,0.0012514675,0.00043330053,0.0006796123,0.0032328335],"category_scores_gemma":[0.0014787898,0.00038572936,0.002636705,0.00048548638,0.0003980679,0.0008888969,0.00061656564,0.0015059945,0.000494002],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7670624,0.0043971627,0.19492301,0.00022261695,0.0048364494,0.00020233387,0.0001618983,0.00041606885,0.004136641,0.00016460018,0.001712029,0.021764804],"study_design_scores_gemma":[0.05542315,0.10929683,0.81687653,0.000097137745,0.008101616,0.00020703534,0.0006437021,0.0027653447,0.0012192258,0.00045852186,0.004815815,0.00009512167],"about_ca_topic_score_codex":0.0022782334,"about_ca_topic_score_gemma":0.0040303394,"teacher_disagreement_score":0.0032328335,"about_ca_system_score_codex":0.0005478744,"about_ca_system_score_gemma":0.0008700084,"threshold_uncertainty_score":0.010814905},"labels":[],"label_agreement":null},{"id":"W4413871484","doi":"10.1016/j.jaad.2025.05.536","title":"63116 Beyond Sunless Tanning: A Systematic Review of Dihydroxyacetone in Dermatology","year":2025,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Dermatologic Treatments and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Université de Sherbrooke; Université de Montréal","funders":"","keywords":"Dihydroxyacetone; Medicine; Dermatology","score_opus":0.035413757355656675,"score_gpt":0.4225742173482168,"score_spread":0.38716045999256016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413871484","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006250363,0.9988563,0.000045270226,0.00008189252,0.000062087376,0.000067497866,0.00013626962,0.0000039026763,0.00012171628],"genre_scores_gemma":[0.013942941,0.9848467,0.0002806281,0.0005843704,0.00006404369,0.000070215865,0.000095193514,0.00000404131,0.00011191416],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9974139,0.000958625,0.00086389825,0.00026840944,0.00038050348,0.0001146339],"domain_scores_gemma":[0.992938,0.0047164974,0.0016691902,0.000100729194,0.00042864142,0.00014692929],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003475498,0.0011163529,0.008198748,0.0039229947,0.00038753005,0.0022368599,0.0013888129,0.0015714212,0.0071827415],"category_scores_gemma":[0.012477801,0.0008617259,0.0074090506,0.0051018293,0.000698686,0.0016868269,0.0014684869,0.0013716011,0.00035708825],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007043653,0.000026685822,0.00068298983,0.936762,0.022984887,0.0000908559,0.000094253635,0.00009278546,0.00024420224,0.00014315824,0.0014080516,0.036765646],"study_design_scores_gemma":[0.0023707282,0.00068150734,0.009011555,0.61224633,0.34409162,0.0003876594,0.00032921258,0.0001634713,0.00025559717,0.00043683322,0.029937407,0.000088064124],"about_ca_topic_score_codex":0.009580823,"about_ca_topic_score_gemma":0.042918477,"teacher_disagreement_score":0.009580823,"about_ca_system_score_codex":0.0017218795,"about_ca_system_score_gemma":0.0045960904,"threshold_uncertainty_score":0.024028659},"labels":[],"label_agreement":null},{"id":"W4413871655","doi":"10.1016/j.jaad.2025.05.543","title":"63285 Bimekizumab efficacy by patient subgroups in moderate to severe hidradenitis suppurativa: 2-year phase 3 results from BE HEARD EXT","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"","keywords":"Hidradenitis suppurativa; Medicine; Dermatology; Internal medicine","score_opus":0.016147905965179638,"score_gpt":0.3255160629159564,"score_spread":0.3093681569507768,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413871655","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9711483,0.015803209,0.00059281447,0.0018355914,0.00050199503,0.0027766433,0.0031194875,0.00013761487,0.0040843138],"genre_scores_gemma":[0.9717416,0.0077088815,0.0020011314,0.004726478,0.00073013065,0.0029600342,0.0044657644,0.000071163915,0.0055947863],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9992204,0.00031789695,0.000055187757,0.000098047305,0.000104189814,0.0002043045],"domain_scores_gemma":[0.9990845,0.0002321802,0.0001677798,0.00005941866,0.000080785256,0.0003753216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003032616,0.0010763505,0.002613975,0.0003808015,0.0006644717,0.0011924062,0.00073682057,0.0013014786,0.00448281],"category_scores_gemma":[0.0013031543,0.00042838152,0.0029913497,0.00041105383,0.0005762917,0.0008600086,0.0004553328,0.0030018475,0.0010250029],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.68141234,0.040974524,0.012022429,0.0017612433,0.0036293117,0.00018258645,0.00032603208,0.0016171953,0.022580069,0.00026866782,0.013981815,0.22124375],"study_design_scores_gemma":[0.65775836,0.2864141,0.043449223,0.00015798585,0.0019307485,0.00020901838,0.00014933739,0.0007209209,0.002148628,0.0002951778,0.0067124204,0.000054154756],"about_ca_topic_score_codex":0.0011550946,"about_ca_topic_score_gemma":0.0033509443,"teacher_disagreement_score":0.00448281,"about_ca_system_score_codex":0.0006978073,"about_ca_system_score_gemma":0.0012635569,"threshold_uncertainty_score":0.01603818},"labels":[],"label_agreement":null},{"id":"W4413871680","doi":"10.1016/j.jaad.2025.05.541","title":"62275 Bimekizumab efficacy and safety through 5 years in patients with moderate to severe plaque psoriasis in the US and Canada","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Probity Medical Research; Dermatrials Research","funders":"","keywords":"Medicine; Plaque psoriasis; Dermatology; Psoriasis","score_opus":0.006009678061953932,"score_gpt":0.23114932568880706,"score_spread":0.22513964762685312,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413871680","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98287785,0.005857322,0.00009270082,0.0012405599,0.00005407985,0.00006788751,0.0026377072,0.000015427682,0.0071563455],"genre_scores_gemma":[0.99574536,0.001212805,0.00008388694,0.0003580538,0.00001980339,0.000011221604,0.0009769278,0.000003991285,0.0015878938],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993843,0.00005787539,0.000028977309,0.00007425949,0.00022713393,0.00022740377],"domain_scores_gemma":[0.9990539,0.000060402963,0.00012547539,0.000017090488,0.00045637594,0.0002867379],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055984326,0.00016455252,0.0004883454,0.00037160184,0.0009807396,0.0007624741,0.0005124704,0.00033051614,0.0013825564],"category_scores_gemma":[0.0013236053,0.000121078374,0.0005383144,0.0010347308,0.00033157974,0.0002217428,0.00024564547,0.0007817854,0.00018112134],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013035232,0.0008814247,0.85992724,0.00027317583,0.0006628188,0.00054572214,0.0006205662,0.0011648163,0.0030670287,0.00069011044,0.011257957,0.10787382],"study_design_scores_gemma":[0.0010458402,0.0012142875,0.9883577,0.00010273412,0.00042204576,0.00028805214,0.0005872723,0.0007006637,0.0003287109,0.00012487531,0.0067963554,0.000031551746],"about_ca_topic_score_codex":0.92308754,"about_ca_topic_score_gemma":0.96119815,"teacher_disagreement_score":0.07691246,"about_ca_system_score_codex":0.014080359,"about_ca_system_score_gemma":0.017249638,"threshold_uncertainty_score":0.1547308},"labels":[],"label_agreement":null},{"id":"W4413872134","doi":"10.1016/j.jaad.2025.05.1163","title":"60412 Safety and efficacy of topical zabalafin as a uniquely singular approach to comprehensive and effective AD management and with or without concurrent Staphylococcus aureus (SA) or MRSA infection","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Stephen's University","funders":"","keywords":"Medicine; Staphylococcus aureus; Methicillin-resistant Staphylococcus aureus; Intensive care medicine; Bacteria","score_opus":0.013040428684346846,"score_gpt":0.3270033784931455,"score_spread":0.31396294980879863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413872134","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933889,0.0037061577,0.00020763834,0.00016303905,0.000094880794,0.000076467135,0.00015373438,0.000021790951,0.002187383],"genre_scores_gemma":[0.9980869,0.000929124,0.00019579925,0.00009627935,0.000043269058,0.000020662908,0.00009926796,0.0000026379723,0.0005259573],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99981827,0.000068887675,0.00001365278,0.000027170136,0.00003874699,0.00003328307],"domain_scores_gemma":[0.99977237,0.00006024182,0.000054648786,0.0000271045,0.000026870755,0.00005875833],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003209772,0.00014994275,0.00043895177,0.00016450827,0.00020164435,0.00036791243,0.00013909375,0.00030430997,0.0020325137],"category_scores_gemma":[0.00069974316,0.000072266055,0.0002508955,0.00013465888,0.00025570346,0.00032693596,0.00011153561,0.000672209,0.0003608731],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.27717108,0.01886655,0.018567925,0.0010088056,0.0007553537,0.00072669616,0.00020616721,0.0008562912,0.22049722,0.0008863468,0.0027737261,0.4576839],"study_design_scores_gemma":[0.042131875,0.67742616,0.15684773,0.00040054432,0.0015354564,0.0047317133,0.0005525287,0.0049838447,0.08581384,0.0009085747,0.024569008,0.00009872079],"about_ca_topic_score_codex":0.0005172648,"about_ca_topic_score_gemma":0.00082154595,"teacher_disagreement_score":0.0020325137,"about_ca_system_score_codex":0.00017630986,"about_ca_system_score_gemma":0.000450567,"threshold_uncertainty_score":0.0067994595},"labels":[],"label_agreement":null},{"id":"W4413872793","doi":"10.1016/j.jaad.2025.05.1082","title":"63750 Prevalence and Management of Skin Cancer in Nursing Homes: A Scoping Review","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Skin Protection and Aging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"","keywords":"Medicine; Skin cancer; Nursing; Gerontology; Family medicine; Environmental health; Cancer; Internal medicine","score_opus":0.015625829729801866,"score_gpt":0.39621367714657973,"score_spread":0.38058784741677787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413872793","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011683312,0.9980763,0.0000321421,0.00021763821,0.00006520348,0.000034338067,0.00009977164,0.000001975239,0.00030420988],"genre_scores_gemma":[0.010393591,0.9889023,0.00015688727,0.0002833472,0.000050144565,0.000050952494,0.000107233696,0.0000014558407,0.000054106808],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9958093,0.0010848116,0.001686138,0.00045438262,0.0008030988,0.00016222322],"domain_scores_gemma":[0.97544426,0.018941803,0.0036103174,0.00019447051,0.0016053002,0.00020389182],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006387567,0.0006839145,0.0027724074,0.0068080663,0.00059596286,0.0027908005,0.001169165,0.002110676,0.0028120659],"category_scores_gemma":[0.030500928,0.0009549059,0.0040045893,0.007790338,0.0007909253,0.0020959417,0.0011761984,0.0011191352,0.0002972803],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003043405,0.00016151807,0.018297672,0.6479479,0.009264096,0.00028021084,0.00088023586,0.00028002838,0.00029667318,0.0006188657,0.0065098153,0.31515864],"study_design_scores_gemma":[0.000058356967,0.0001502315,0.026708707,0.92650515,0.018199015,0.0005936982,0.0009054358,0.00010064466,0.00013273468,0.0002302457,0.026374234,0.00004165433],"about_ca_topic_score_codex":0.021674128,"about_ca_topic_score_gemma":0.042112533,"teacher_disagreement_score":0.021674128,"about_ca_system_score_codex":0.0023001288,"about_ca_system_score_gemma":0.0071041835,"threshold_uncertainty_score":0.043095946},"labels":[],"label_agreement":null},{"id":"W4413873664","doi":"10.1016/j.jaad.2025.05.1200","title":"60290 Stratification of the Continuum of Skin Immune-Mediated and Inflammatory Diseases via an AI Foundation Model","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"L'Alliance Boviteq","funders":"","keywords":"Medicine; Stratification (seeds); Foundation (evidence); Immune system; Risk stratification; Immunology; Internal medicine","score_opus":0.009298654058877353,"score_gpt":0.2925444393112356,"score_spread":0.2832457852523582,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413873664","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7213666,0.0020673883,0.08881087,0.011068376,0.0006835605,0.00024559168,0.00057976856,0.0003243409,0.17485364],"genre_scores_gemma":[0.97051764,0.0006251204,0.01327721,0.0005369908,0.00013233989,0.000091259186,0.00013112578,0.000027853723,0.014660499],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9997706,0.000074870055,0.000007687669,0.000037297174,0.00006259925,0.00004691705],"domain_scores_gemma":[0.9995493,0.00009012132,0.00009826308,0.00005054678,0.00006370508,0.00014797448],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053869735,0.00039474812,0.0002654466,0.0012349843,0.000605752,0.0013748772,0.0003930488,0.00037750418,0.0058895326],"category_scores_gemma":[0.00083201565,0.000107808424,0.00036398077,0.00038717611,0.0011528165,0.0010453311,0.0010024188,0.0012913493,0.0005838082],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010704196,0.0012313095,0.037487075,0.00019452542,0.0001058985,0.001102286,0.0008146504,0.004411346,0.08585933,0.75143874,0.006220472,0.110063955],"study_design_scores_gemma":[0.00063009665,0.003420287,0.11829062,0.00035461143,0.0003422174,0.005589272,0.0034580885,0.092554405,0.021162407,0.67155474,0.0824914,0.00015181999],"about_ca_topic_score_codex":0.0018489558,"about_ca_topic_score_gemma":0.0016211678,"teacher_disagreement_score":0.0058895326,"about_ca_system_score_codex":0.0007140539,"about_ca_system_score_gemma":0.00081767683,"threshold_uncertainty_score":0.019702435},"labels":[],"label_agreement":null},{"id":"W4413873989","doi":"10.1016/j.jaad.2025.05.232","title":"64495 Inflammatory eye disease in patients with hidradenitis suppurativa: a systematic review","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Queen's University","funders":"","keywords":"Hidradenitis suppurativa; Medicine; Dermatology; Disease; Pathology","score_opus":0.004732640542393404,"score_gpt":0.27875131987404594,"score_spread":0.2740186793316525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413873989","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0026623532,0.9960389,0.00006661582,0.00016650629,0.00010837045,0.00016025068,0.0006197983,0.00000546511,0.00017174147],"genre_scores_gemma":[0.079770714,0.916762,0.00064002397,0.0015207194,0.00016425579,0.0004584583,0.00049488165,0.000007232191,0.00018169914],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9939839,0.0015668735,0.0029441484,0.00066404283,0.0005899657,0.00025096792],"domain_scores_gemma":[0.9837217,0.010467118,0.004376522,0.00025666985,0.0008939763,0.000284067],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004147317,0.0012084375,0.0077346303,0.0069055255,0.0005207696,0.00200549,0.0012462254,0.0021990603,0.0060195513],"category_scores_gemma":[0.021300195,0.001152762,0.010403518,0.0063501494,0.000765456,0.002071491,0.00165517,0.0011610842,0.0003501025],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006035139,0.0000309584,0.008748047,0.91992253,0.054928258,0.00017325403,0.00018862265,0.00005688633,0.00019554204,0.00008507022,0.0013738165,0.013693385],"study_design_scores_gemma":[0.0017239464,0.00048088285,0.031150017,0.5351288,0.41774592,0.0007150928,0.0004705189,0.000096175194,0.00015150118,0.00017900503,0.012065505,0.000092595015],"about_ca_topic_score_codex":0.009585485,"about_ca_topic_score_gemma":0.037455875,"teacher_disagreement_score":0.009585485,"about_ca_system_score_codex":0.0019942324,"about_ca_system_score_gemma":0.004763939,"threshold_uncertainty_score":0.021933377},"labels":[],"label_agreement":null},{"id":"W4413875724","doi":"10.1016/j.jaad.2025.05.165","title":"62986 Efficacy and safety of apremilast in pediatric patients with moderate-to-severe plaque psoriasis: 2-year results from the SPROUT extension trial","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Stollery Children's Hospital; University of Alberta","funders":"","keywords":"Medicine; Apremilast; Psoriasis; Dermatology; Plaque psoriasis; Internal medicine; Psoriatic arthritis","score_opus":0.01031342340016822,"score_gpt":0.2454803991084882,"score_spread":0.23516697570832,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413875724","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9853217,0.010401592,0.0002664555,0.00042292094,0.00014299012,0.00026572138,0.0011458617,0.000071909,0.0019608347],"genre_scores_gemma":[0.9853389,0.007806474,0.0008287088,0.00089424953,0.00035053864,0.00047284173,0.0020249137,0.000034964767,0.0022484658],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99954,0.00021332932,0.000033462322,0.00007173549,0.00007390372,0.00006759137],"domain_scores_gemma":[0.99932814,0.00016859069,0.0002075153,0.000051492825,0.000052633615,0.00019167828],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010934799,0.0008457071,0.002406802,0.00021068811,0.0002596888,0.00078541966,0.00037862814,0.00103324,0.0021768794],"category_scores_gemma":[0.00095720316,0.00031422428,0.0015521419,0.00028420915,0.00043549752,0.00064972206,0.00021910398,0.002290052,0.000578758],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7938787,0.011697861,0.016887452,0.0015993214,0.003479771,0.00066594774,0.00022055041,0.0015964801,0.0160456,0.00042584896,0.005351865,0.14815058],"study_design_scores_gemma":[0.6692837,0.23714598,0.079071745,0.00025072595,0.0028956388,0.0010247297,0.00012969118,0.0012053649,0.002698485,0.00033912322,0.0058943676,0.00006043861],"about_ca_topic_score_codex":0.00050698133,"about_ca_topic_score_gemma":0.0009504039,"teacher_disagreement_score":0.002406802,"about_ca_system_score_codex":0.00031990706,"about_ca_system_score_gemma":0.0005639612,"threshold_uncertainty_score":0.0072823763},"labels":[],"label_agreement":null},{"id":"W4413875738","doi":"10.1016/j.jaad.2025.05.252","title":"61148 Local Recurrence Rates of Head and Neck Non-Melanomas: A Systematic Review and Meta-Analysis of Wide Local Excision Versus Mohs Micrographic Surgery","year":2025,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Medicine; Head and neck; Meta-analysis; Wide local excision; Mohs surgery; Surgery; Dermatology; Pathology","score_opus":0.07307457489623974,"score_gpt":0.40245880721539284,"score_spread":0.3293842323191531,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413875738","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009392087,0.98915344,0.00030388872,0.00011194922,0.00014222076,0.00012664235,0.00051155715,0.00001873246,0.00023950673],"genre_scores_gemma":[0.27538213,0.7197529,0.0014330745,0.0013414692,0.00024788963,0.00039519297,0.0007396321,0.000035349625,0.0006723684],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99636817,0.0015128581,0.0011245062,0.000513036,0.00031830606,0.00016314126],"domain_scores_gemma":[0.9933442,0.004577855,0.001302087,0.000228452,0.00042373664,0.00012375506],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0047920463,0.0016626931,0.010328099,0.0025991818,0.00044774095,0.001883461,0.0013404181,0.0016872856,0.004832486],"category_scores_gemma":[0.014322267,0.0012060008,0.022298329,0.0036643038,0.0006195449,0.0013605743,0.0012533559,0.0016374843,0.00045083574],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035484217,0.000033384506,0.0070110834,0.42026323,0.55314285,0.00015625224,0.0001425072,0.00024144388,0.00048648877,0.0000857751,0.0008660042,0.014022628],"study_design_scores_gemma":[0.0012413942,0.00027085948,0.007096904,0.018025868,0.97109264,0.00010511244,0.00007923679,0.000071766844,0.00010241611,0.00009683892,0.0017886846,0.000028314136],"about_ca_topic_score_codex":0.006438453,"about_ca_topic_score_gemma":0.022833027,"teacher_disagreement_score":0.010328099,"about_ca_system_score_codex":0.0012300946,"about_ca_system_score_gemma":0.001618337,"threshold_uncertainty_score":0.02534306},"labels":[],"label_agreement":null},{"id":"W4413878340","doi":"10.1016/j.jaad.2025.05.1236","title":"61257 The Clinical and Molecular Response of Pyoderma Gangrenosum to Interleukin 23 Blockade: Result from a proof-of-concept open-label clinical trial","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Autoimmune and Inflammatory Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"","keywords":"Pyoderma gangrenosum; Medicine; Proof of concept; Open label; Blockade; Dermatology; Clinical trial; Interleukin; Immunology; Cytokine; Internal medicine","score_opus":0.05901281737293329,"score_gpt":0.43286397167652996,"score_spread":0.37385115430359667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413878340","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97322625,0.01246802,0.0018285383,0.0015487813,0.0009943572,0.0034474193,0.0016471337,0.0001676503,0.0046718414],"genre_scores_gemma":[0.98242885,0.004716555,0.0026395437,0.0023866019,0.00073700777,0.002193367,0.0012599251,0.00004125501,0.0035969538],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99910885,0.00045599948,0.00004288123,0.0001230571,0.00010148975,0.0001677786],"domain_scores_gemma":[0.9990274,0.00038510768,0.000186418,0.00007558636,0.000071990995,0.00025361672],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026971085,0.001241895,0.0019605705,0.00027645478,0.00039953558,0.001729021,0.0005800668,0.0018883446,0.0064262026],"category_scores_gemma":[0.0016717424,0.00039150732,0.0019861546,0.000261028,0.0012949797,0.0009535235,0.0002821952,0.0041755014,0.0013932529],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8225907,0.03261524,0.0015046479,0.0017857199,0.0021387571,0.00023165475,0.00015867132,0.000906027,0.032902077,0.00057189405,0.0043465374,0.10024808],"study_design_scores_gemma":[0.5923215,0.3927234,0.004624668,0.00015416072,0.00093402015,0.00018886312,0.00007650792,0.0006494119,0.0035651834,0.0005480411,0.0041632494,0.00005101875],"about_ca_topic_score_codex":0.00035591688,"about_ca_topic_score_gemma":0.00076268153,"teacher_disagreement_score":0.0064262026,"about_ca_system_score_codex":0.00066583906,"about_ca_system_score_gemma":0.0009630917,"threshold_uncertainty_score":0.021497846},"labels":[],"label_agreement":null},{"id":"W4413881706","doi":"10.1016/j.jaad.2025.05.1331","title":"62512 U.S. Food and Drug Administration recalls of cosmetic and personal products from 2011 to 2023: A cross-sectional study","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Pharmaceutical industry and healthcare","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Food and drug administration; Cross-sectional study; Environmental health; Drug; Pharmacology; Pathology","score_opus":0.22033305002181547,"score_gpt":0.5301229757087259,"score_spread":0.30978992568691044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413881706","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9884975,0.0003989168,0.00011460832,0.00009476162,0.000024060239,0.000051865693,0.008796599,0.000008924432,0.002012905],"genre_scores_gemma":[0.9909253,0.00039473176,0.00013545425,0.00031386057,0.000025479587,0.00006866124,0.0065323925,0.0000063922425,0.0015977203],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993135,0.00015826344,0.00011276028,0.00016780704,0.00014190987,0.00010577181],"domain_scores_gemma":[0.997584,0.00039301906,0.0011622958,0.00020657862,0.00045725517,0.00019685025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081846456,0.00035143257,0.00031594918,0.0009616906,0.0006747279,0.0008522475,0.0005152647,0.0009768825,0.0035770414],"category_scores_gemma":[0.002090536,0.00081077084,0.0005237083,0.0021430391,0.00023308696,0.0007594541,0.0005507085,0.0009513837,0.0016783001],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000095244126,0.00010222082,0.9983386,0.000015299069,0.00006608911,0.00003940896,0.00007987255,0.00002106567,0.000096111864,0.000007751919,0.00041740295,0.00072099577],"study_design_scores_gemma":[0.000005867875,0.00007060081,0.9990552,0.000011637258,0.000030651932,0.000093985625,0.00023579228,0.00006213043,0.00004062135,0.0000036055424,0.00038522788,0.0000045634783],"about_ca_topic_score_codex":0.06284382,"about_ca_topic_score_gemma":0.07892755,"teacher_disagreement_score":0.06284382,"about_ca_system_score_codex":0.0007680291,"about_ca_system_score_gemma":0.0005813853,"threshold_uncertainty_score":0.12495607},"labels":[],"label_agreement":null},{"id":"W4413881718","doi":"10.1016/j.jaad.2025.05.1286","title":"64787 The Use of a Novel Tri-Modal Therapeutic to Resolve Pruritus and Inflammation in Murine Models of Atopic Dermatitis","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"","keywords":"Medicine; Atopic dermatitis; Dermatology; Inflammation; Immunology","score_opus":0.03879061067374455,"score_gpt":0.32149353897855376,"score_spread":0.2827029283048092,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413881718","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9740785,0.0059064333,0.0069417506,0.0008089228,0.00061724696,0.00029229917,0.00059330545,0.0003219175,0.010439567],"genre_scores_gemma":[0.9841074,0.0026128397,0.006120641,0.00025306822,0.00007578889,0.00019568323,0.0003625692,0.00002582751,0.006246311],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998272,0.000028187433,0.000010312673,0.000025703552,0.00004981733,0.000058793164],"domain_scores_gemma":[0.99993825,0.000010034559,0.000010178116,0.0000075943663,0.000007855279,0.00002611872],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002449581,0.0003917244,0.0003842569,0.0005940795,0.00034396374,0.00042408583,0.00026075068,0.0007362601,0.0031858222],"category_scores_gemma":[0.00009752309,0.00013922153,0.00038743808,0.00019891837,0.00035903085,0.00043320635,0.00016678011,0.0018746885,0.0006724432],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013239607,0.00086259877,0.0001259843,0.000116735544,0.00002198533,0.00010991364,0.000031850752,0.0002688965,0.9832586,0.0005404506,0.00038736788,0.012951711],"study_design_scores_gemma":[0.0007729086,0.0123376595,0.0033698694,0.00006200237,0.0001036334,0.0008867528,0.00012845792,0.0030881339,0.96696424,0.00045414732,0.011807235,0.000024924826],"about_ca_topic_score_codex":0.0003840103,"about_ca_topic_score_gemma":0.00083827495,"teacher_disagreement_score":0.0031858222,"about_ca_system_score_codex":0.00020123985,"about_ca_system_score_gemma":0.00034824584,"threshold_uncertainty_score":0.0106576085},"labels":[],"label_agreement":null},{"id":"W4413881753","doi":"10.1016/j.jaad.2025.05.467","title":"63919 AI-ENABLED MAUDE DATABASE ANALYSIS OF DELAYED COMPLICATIONS WITH HYALURONIC ACID FILLERS REVEALS TECHNOLOGY-BASED DIFFERENCES","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Facial Rejuvenation and Surgery Techniques","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Hyaluronic acid; Database; Anatomy; Computer science","score_opus":0.014969293633603997,"score_gpt":0.3285960631692827,"score_spread":0.3136267695356787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413881753","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.79332983,0.0025540837,0.0031345333,0.00051209563,0.00007878544,0.00011763607,0.19058721,0.0010531383,0.008632632],"genre_scores_gemma":[0.8729129,0.0006850081,0.0037862966,0.00029284135,0.000043293778,0.00012319037,0.120480694,0.00014777292,0.0015279701],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980141,0.0002949281,0.0004245612,0.00045550615,0.00063935324,0.00017143374],"domain_scores_gemma":[0.9907252,0.0048263506,0.0018259509,0.0010320875,0.0013406913,0.0002496154],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016116573,0.00024592128,0.0003896358,0.0028257323,0.0002312585,0.001318128,0.000650935,0.00036046407,0.003309905],"category_scores_gemma":[0.012287336,0.0001425816,0.0008962956,0.0023387058,0.000144988,0.0006500416,0.0006813935,0.00035866364,0.0013886429],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025532471,0.00020850943,0.8980718,0.000754543,0.0011853942,0.00042178808,0.0003205907,0.001408793,0.0029416366,0.0019004319,0.018686727,0.07154651],"study_design_scores_gemma":[0.0002315572,0.0004679159,0.92273635,0.00027484205,0.0010809975,0.0017899448,0.00084100413,0.009975382,0.005284466,0.0010476568,0.056186542,0.000083169616],"about_ca_topic_score_codex":0.011208118,"about_ca_topic_score_gemma":0.01246386,"teacher_disagreement_score":0.011208118,"about_ca_system_score_codex":0.0004397771,"about_ca_system_score_gemma":0.00082293357,"threshold_uncertainty_score":0.02228576},"labels":[],"label_agreement":null},{"id":"W4413881798","doi":"10.1016/j.jaad.2025.05.1062","title":"63633 PGA score versus ENLIST severity scale for erythema nodosum leprosum: A clinically-supported comparison","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Leprosy Research and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"","keywords":"Medicine; Dermatology; Erythema nodosum; Scale (ratio); Internal medicine; Cartography; Disease","score_opus":0.0563555861732234,"score_gpt":0.4284695894451645,"score_spread":0.3721140032719411,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413881798","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99281937,0.0027337861,0.00028433802,0.00019855787,0.00043677524,0.00023672024,0.0006897261,0.000012111599,0.002588574],"genre_scores_gemma":[0.99720323,0.00045997193,0.0002177051,0.00013361,0.00025756483,0.00019049176,0.00066992536,0.0000061632923,0.00086127163],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99681705,0.0018689862,0.00023970845,0.0004090542,0.00043149947,0.00023382355],"domain_scores_gemma":[0.9917447,0.005558985,0.0009966631,0.00027242964,0.00056829833,0.0008589568],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004281177,0.0012146519,0.002386897,0.0011760971,0.0004235182,0.0012118915,0.0018147081,0.0020473269,0.0077324864],"category_scores_gemma":[0.006048915,0.0004961582,0.002236748,0.0007002418,0.00091912714,0.002710638,0.0010532737,0.002075814,0.0011686244],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8214946,0.005691609,0.141723,0.00088702573,0.007263581,0.00023522488,0.00038920337,0.00063752785,0.0021436913,0.00054637936,0.001041376,0.017946914],"study_design_scores_gemma":[0.15079191,0.25507858,0.5708517,0.00031744462,0.008148797,0.000559782,0.0020261214,0.0059287716,0.0011302101,0.0015545045,0.0034044904,0.00020767347],"about_ca_topic_score_codex":0.00065474404,"about_ca_topic_score_gemma":0.001072483,"teacher_disagreement_score":0.0077324864,"about_ca_system_score_codex":0.000729177,"about_ca_system_score_gemma":0.00047019517,"threshold_uncertainty_score":0.0258677},"labels":[],"label_agreement":null},{"id":"W4413881814","doi":"10.1016/j.jaad.2025.05.469","title":"62188 Amlitelimab Reduces Th2-, Th1-, and Th17/22-Related Cytokines and Chemokines in Adults With Moderate-to-Severe Atopic Dermatitis): Results From an Exploratory Analysis of the Phase 2b STREAM-AD Study","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lynde Centre for Dermatology","funders":"","keywords":"Medicine; Atopic dermatitis; Chemokine; Exploratory analysis; Dermatology; Immunology; Inflammation; Data science","score_opus":0.010440328775363704,"score_gpt":0.3065078898565411,"score_spread":0.2960675610811774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413881814","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974783,0.0011060716,0.00010643912,0.00007620191,0.000018669096,0.00020878679,0.00047019942,0.00001457812,0.0005208757],"genre_scores_gemma":[0.9972077,0.0004284239,0.00034792884,0.00017540368,0.00005788962,0.00017087116,0.0007892903,0.000007356043,0.00081508356],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99935037,0.0003109799,0.000042941032,0.00009502603,0.000091111266,0.00010961561],"domain_scores_gemma":[0.999521,0.00013511037,0.00011181746,0.00005107234,0.00005241214,0.00012861105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017182924,0.0006343077,0.00086300203,0.00028548556,0.0003077692,0.00081945286,0.00029054648,0.0004354732,0.0027314266],"category_scores_gemma":[0.0009142891,0.00025619933,0.001051954,0.00022288362,0.00035855646,0.00051301625,0.00034268657,0.00077036367,0.00049195933],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6180479,0.02771294,0.14271164,0.0008130026,0.004610205,0.00029776865,0.00027006623,0.0008154579,0.062351923,0.00024239816,0.0033498623,0.13877688],"study_design_scores_gemma":[0.15214282,0.3219481,0.5034044,0.00009677089,0.0035056386,0.0006635871,0.00030382044,0.0010408913,0.01015574,0.000292486,0.0063898647,0.00005587023],"about_ca_topic_score_codex":0.00036091314,"about_ca_topic_score_gemma":0.0010096759,"teacher_disagreement_score":0.0027314266,"about_ca_system_score_codex":0.00026202414,"about_ca_system_score_gemma":0.0004993727,"threshold_uncertainty_score":0.009137511},"labels":[],"label_agreement":null},{"id":"W4413881821","doi":"10.1016/j.jaad.2025.05.552","title":"60857 Biologics in lichen planus: A systematic review","year":2025,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Oral Health Pathology and Treatment","field":"Dentistry","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University; Queen's University; Université Laval","funders":"","keywords":"Medicine; Dermatology; Lichen","score_opus":0.053304122121080724,"score_gpt":0.43499439166272735,"score_spread":0.38169026954164664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413881821","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00095624634,0.9982736,0.0000649675,0.00010905657,0.00007343124,0.00011533421,0.00024518874,0.0000061720793,0.00015598588],"genre_scores_gemma":[0.021486824,0.9769842,0.00038538603,0.0006216559,0.00006659142,0.00015709357,0.0001446215,0.0000040461623,0.00014962509],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9968149,0.0010069566,0.0011848282,0.00033562223,0.0004939707,0.00016374292],"domain_scores_gemma":[0.9930675,0.004132987,0.0020502917,0.000115630384,0.00047032742,0.00016328004],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003470425,0.0012920297,0.007872992,0.0066610607,0.0005532657,0.0020347948,0.0015280495,0.0021074864,0.008285155],"category_scores_gemma":[0.011628488,0.0010866931,0.00831064,0.0062773162,0.0008448968,0.0018889398,0.0016803761,0.0012492489,0.0004783857],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005146028,0.000031534924,0.0012686265,0.9424572,0.027573755,0.00014449636,0.00012877732,0.00008232322,0.00022829711,0.00013771959,0.0017293108,0.025703281],"study_design_scores_gemma":[0.0017686103,0.00045185644,0.0084804725,0.62238294,0.34331444,0.0005862175,0.00038875954,0.00011781872,0.00020787209,0.00029886485,0.021929936,0.00007220042],"about_ca_topic_score_codex":0.008242063,"about_ca_topic_score_gemma":0.035273205,"teacher_disagreement_score":0.008285155,"about_ca_system_score_codex":0.0020887095,"about_ca_system_score_gemma":0.004497904,"threshold_uncertainty_score":0.027716637},"labels":[],"label_agreement":null},{"id":"W4413883973","doi":"10.1016/j.jaad.2025.08.094","title":"Beyond Fitzpatrick skin types: A Delphi consensus on key considerations for a universal skin typing classification","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"L'Oreal USA; Bristol-Myers Squibb","keywords":"Medicine; Typing; Delphi; Dermatology; Delphi method; MEDLINE; Artificial intelligence; Genetics; Computer science","score_opus":0.025331697636887827,"score_gpt":0.3137769150967029,"score_spread":0.2884452174598151,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413883973","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1075952,0.02176387,0.14416037,0.6523066,0.016139936,0.0058014276,0.0005397655,0.00029716338,0.051395677],"genre_scores_gemma":[0.6208109,0.014421433,0.25407752,0.09450161,0.0037830973,0.0064736847,0.00072787015,0.00038586283,0.004818047],"study_design_codex":"design_other","study_design_gemma":"qualitative","domain_scores_codex":[0.8989933,0.059657436,0.018076919,0.0035297598,0.014590605,0.0051519363],"domain_scores_gemma":[0.88290143,0.06292733,0.0049308026,0.006702042,0.034198035,0.008340413],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.18648453,0.0005985168,0.0014346623,0.0029620584,0.005177001,0.0062749046,0.004181164,0.0043617794,0.002524105],"category_scores_gemma":[0.15591615,0.0006872107,0.0017504784,0.0019219659,0.00812026,0.008548379,0.010367487,0.011303773,0.0007266042],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056584633,0.00034163662,0.024575207,0.00556892,0.00022193482,0.0023392495,0.08384301,0.0017166313,0.008738294,0.119038455,0.16524497,0.58780587],"study_design_scores_gemma":[0.00032895213,0.00053349766,0.038530946,0.040461004,0.0002960887,0.0076824473,0.14964274,0.008052226,0.00257713,0.26464832,0.4866318,0.0006148431],"about_ca_topic_score_codex":0.005267994,"about_ca_topic_score_gemma":0.006847182,"teacher_disagreement_score":0.18648453,"about_ca_system_score_codex":0.0070142196,"about_ca_system_score_gemma":0.028584018,"threshold_uncertainty_score":0.9862363},"labels":[],"label_agreement":null},{"id":"W4413893419","doi":"10.1016/j.jaad.2025.05.198","title":"61055 False positive PET scan of hereditary leiomyomatosis and renal cell cancer suggesting cutaneous metastasis","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"","keywords":"Medicine; Leiomyomatosis; Metastasis; Cancer; Pathology; Dermatology; Oncology; Internal medicine; Leiomyoma","score_opus":0.012845449835227923,"score_gpt":0.2983851670984343,"score_spread":0.28553971726320637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413893419","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93594265,0.007627387,0.00258362,0.007422441,0.00080900756,0.00012439539,0.00063944265,0.0003529969,0.04449807],"genre_scores_gemma":[0.99495584,0.0006872406,0.00089317525,0.0009624771,0.00033695623,0.000012205241,0.00018859812,0.000021698641,0.0019417501],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9996792,0.00005125864,0.000042748703,0.00007349257,0.00005941379,0.000093844355],"domain_scores_gemma":[0.99922156,0.00027525943,0.00006297492,0.00006708129,0.0001137011,0.00025929694],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046381316,0.00086008274,0.0004965686,0.0018979135,0.00092388765,0.0007780753,0.0007294512,0.0028906185,0.0070854235],"category_scores_gemma":[0.0020462146,0.0004436063,0.00089180586,0.0004775713,0.00056905026,0.0007060169,0.000403933,0.0011471376,0.0013873654],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037880242,0.00010474457,0.046943035,0.000072402094,0.00004262555,0.9352978,0.000116637246,0.00018441945,0.0074990904,0.00031426456,0.0022439973,0.0068021836],"study_design_scores_gemma":[0.00007095687,0.00033615757,0.05964438,0.00006676801,0.00018525473,0.92638654,0.00012497375,0.0027086097,0.0062236143,0.00036737995,0.0038593528,0.000026035255],"about_ca_topic_score_codex":0.0035949722,"about_ca_topic_score_gemma":0.0042872876,"teacher_disagreement_score":0.0070854235,"about_ca_system_score_codex":0.00084427546,"about_ca_system_score_gemma":0.00040933012,"threshold_uncertainty_score":0.023703039},"labels":[],"label_agreement":null},{"id":"W4413893437","doi":"10.1016/j.jaad.2025.05.164","title":"59589 Efficacy and Safety of Apremilast for the Treatment of Japanese Patients With Palmoplantar Pustulosis: 52-week Results From a Phase 3, Randomized, Placebo-controlled Study","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Oral Health Pathology and Treatment","field":"Dentistry","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"","keywords":"Medicine; Palmoplantar pustulosis; Apremilast; Dermatology; Placebo; Randomized controlled trial; Internal medicine; Psoriasis; Alternative medicine; Pathology; Psoriatic arthritis","score_opus":0.015731578694463202,"score_gpt":0.3323398910805859,"score_spread":0.31660831238612275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413893437","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9848947,0.010809443,0.00046117097,0.0003710783,0.00033798118,0.0012620495,0.00030865122,0.00008808672,0.0014668329],"genre_scores_gemma":[0.98761463,0.0062895548,0.0012007374,0.0012037966,0.00058380805,0.0009474866,0.00043365013,0.000020130921,0.0017061739],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99956495,0.00020152153,0.000050017647,0.00006739853,0.0000507684,0.00006535517],"domain_scores_gemma":[0.9994832,0.0001523537,0.000110996545,0.000035158573,0.000045255674,0.00017285137],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012553756,0.0010160626,0.0035634418,0.0004523786,0.00061614095,0.00070094725,0.0006531865,0.0016383575,0.0048456145],"category_scores_gemma":[0.00090419425,0.0007209926,0.0016881926,0.0003774763,0.001025187,0.0009314021,0.00024460148,0.002169442,0.00072621787],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.89679605,0.019453779,0.0013810378,0.0024402305,0.0017078555,0.00023254394,0.00013281745,0.00032059892,0.02086198,0.00012296501,0.00096583884,0.055584338],"study_design_scores_gemma":[0.83378047,0.15646261,0.0065218313,0.00007092024,0.0009560825,0.00012105427,0.000052652304,0.0003903771,0.00086504314,0.00006097851,0.00068635965,0.000031637104],"about_ca_topic_score_codex":0.000593399,"about_ca_topic_score_gemma":0.0014466351,"teacher_disagreement_score":0.0048456145,"about_ca_system_score_codex":0.0002744191,"about_ca_system_score_gemma":0.0006375178,"threshold_uncertainty_score":0.016210198},"labels":[],"label_agreement":null},{"id":"W4413895241","doi":"10.1016/j.jaad.2025.05.218","title":"60170 Impact of digital wound care: A pilot study at Giishkaandago’Ikwe Health Services","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Mobile Health and mHealth Applications","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Wound care; Health care; Intensive care medicine","score_opus":0.036146781631933224,"score_gpt":0.4708390522388403,"score_spread":0.43469227060690707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413895241","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983877,0.000021432546,0.000023843495,0.00012823462,0.000009109326,0.00026784156,0.000089833324,0.0000025062384,0.0010694375],"genre_scores_gemma":[0.9962555,0.00016432305,0.00028762082,0.00053918053,0.000024070898,0.00044447032,0.00018125406,0.0000051691127,0.002098279],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99857247,0.00042860233,0.000052027648,0.000090146576,0.00022740483,0.00062942534],"domain_scores_gemma":[0.99770147,0.0005819526,0.00019674937,0.00009061279,0.00034253474,0.001086762],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019825227,0.00042109392,0.0003654644,0.0007707888,0.004288139,0.001477753,0.0006768513,0.00067520584,0.009282947],"category_scores_gemma":[0.0027429066,0.0004391251,0.0005385328,0.0008016481,0.0010506376,0.00095586665,0.0018265193,0.0018664605,0.00097259635],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038699806,0.11168859,0.650724,0.0007292917,0.00016070435,0.0069372165,0.11909753,0.0002601709,0.008740699,0.0008453617,0.0058851927,0.09106135],"study_design_scores_gemma":[0.00073515787,0.030361168,0.7149812,0.00017794462,0.00014863533,0.00090744515,0.24488302,0.000354951,0.0013353573,0.00020783467,0.0058241743,0.00008314881],"about_ca_topic_score_codex":0.040981155,"about_ca_topic_score_gemma":0.10336973,"teacher_disagreement_score":0.040981155,"about_ca_system_score_codex":0.0025626533,"about_ca_system_score_gemma":0.0063768807,"threshold_uncertainty_score":0.08148521},"labels":[],"label_agreement":null},{"id":"W4413897076","doi":"10.1016/j.jaad.2025.05.537","title":"63312 Bimekizumab 3-year efficacy in patients with psoriasis and risk factors for progression to psoriatic arthritis or screening positive for psoriatic arthritis: Long-term results from BE BRIGHT and BE RADIANT","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Psoriatic arthritis; Psoriasis; Dermatology; Arthritis; Internal medicine","score_opus":0.012250122327350637,"score_gpt":0.27517079298144587,"score_spread":0.26292067065409525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413897076","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918887,0.005720226,0.000075974756,0.00031274307,0.00012018964,0.00007242755,0.00036033173,0.000023944875,0.0014255882],"genre_scores_gemma":[0.9945074,0.0019325486,0.0001206141,0.00039431942,0.00017685135,0.00006553036,0.00084289873,0.00000639135,0.0019533709],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9996662,0.00010777829,0.00002064994,0.000048426653,0.00005408337,0.000102865226],"domain_scores_gemma":[0.99962103,0.000062979554,0.000078497505,0.00003000762,0.000033065913,0.00017442594],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010571349,0.00047939087,0.0014052894,0.00027142387,0.0003560993,0.0006073982,0.0003177226,0.0006607638,0.0021761565],"category_scores_gemma":[0.0006064533,0.00023828597,0.0014068371,0.000260571,0.00030636718,0.0004741722,0.00022509761,0.00145247,0.00055594236],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6529487,0.02115704,0.058349542,0.0006205789,0.0026891988,0.00037963816,0.0001789363,0.0013176269,0.018398209,0.00018433997,0.0056386865,0.23813754],"study_design_scores_gemma":[0.23983882,0.3389076,0.40546247,0.0001528118,0.0031568245,0.00072311447,0.00017986479,0.001952532,0.003338194,0.00027288633,0.005929504,0.00008545788],"about_ca_topic_score_codex":0.0014676446,"about_ca_topic_score_gemma":0.00230252,"teacher_disagreement_score":0.0021761565,"about_ca_system_score_codex":0.0004503967,"about_ca_system_score_gemma":0.0006449666,"threshold_uncertainty_score":0.007279992},"labels":[],"label_agreement":null},{"id":"W4413898258","doi":"10.1016/j.jaad.2025.05.927","title":"61877 Integrated Interval Analysis of Clinical Trial Data to Evaluate the Long-Term Safety of Risankizumab in Patients With Psoriatic Disease","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; University of Toronto","funders":"","keywords":"Medicine; Clinical trial; Disease; Term (time); Confidence interval; Dermatology; Intensive care medicine; Internal medicine","score_opus":0.29120638878328853,"score_gpt":0.5069010498670402,"score_spread":0.21569466108375168,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413898258","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9325012,0.019998575,0.031011831,0.0008953491,0.00046117508,0.0012551368,0.008565227,0.00044395332,0.004867499],"genre_scores_gemma":[0.98515,0.0009853129,0.0072248904,0.0002210579,0.00016034294,0.0004640938,0.0051899445,0.000040841984,0.00056358153],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9646105,0.029526591,0.0019349363,0.0014392259,0.0019682865,0.0005203844],"domain_scores_gemma":[0.90419036,0.07665206,0.009840685,0.005726707,0.0021601391,0.0014299437],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.043837123,0.00068833213,0.0027218575,0.0015181914,0.00017798037,0.0012624923,0.0007555457,0.0006816218,0.005698438],"category_scores_gemma":[0.07078527,0.00033307896,0.003518941,0.0016948171,0.00034401898,0.0010491752,0.00096368045,0.0017099077,0.00037001516],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.46795186,0.002219963,0.16765808,0.0035658118,0.07371822,0.00024482678,0.00014867066,0.025355607,0.002570802,0.0038966704,0.0059292037,0.24674025],"study_design_scores_gemma":[0.121411815,0.09498367,0.3554025,0.0013815247,0.09905563,0.0008681975,0.0002101029,0.28971884,0.005488902,0.013307055,0.017902156,0.00026966608],"about_ca_topic_score_codex":0.00061693834,"about_ca_topic_score_gemma":0.00083115435,"teacher_disagreement_score":0.043837123,"about_ca_system_score_codex":0.0005342909,"about_ca_system_score_gemma":0.0012172497,"threshold_uncertainty_score":0.2318356},"labels":[],"label_agreement":null},{"id":"W4413971979","doi":"10.1016/j.jaad.2025.08.041","title":"Establishment of standardized definitions and a core set of outcome characteristics following hidradenitis suppurativa surgery developed by an expert Delphi consensus","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity; University of Toronto","funders":"Novartis Pharma; LEO Pharma; Pfizer; Incyte; InflaRx; Gemeinsame Bundesausschuss; Coloplast; Cilag; Insmed; Hidradenitis Suppurativa Foundation; Celltrion; Strong; Heising-Simons Foundation; UCB Pharma; Sun Pharma; Regeneron Pharmaceuticals; Galderma; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; CSL Behring; Sanofi; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Celgene","keywords":"Hidradenitis suppurativa; Medicine; Delphi method; Delphi; Core (optical fiber); Outcome (game theory); Set (abstract data type); MEDLINE; Surgery; Intensive care medicine; Medical physics; Internal medicine; Disease; Artificial intelligence","score_opus":0.07262331103970165,"score_gpt":0.3705035138551058,"score_spread":0.29788020281540417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413971979","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2530526,0.0026391875,0.5774971,0.00828861,0.0009941556,0.11620657,0.005607204,0.00043615486,0.03527839],"genre_scores_gemma":[0.33235008,0.0013555031,0.51469296,0.0013709216,0.00020492356,0.14232394,0.0061627496,0.00016256692,0.0013763725],"study_design_codex":"design_other","study_design_gemma":"qualitative","domain_scores_codex":[0.8738432,0.06380977,0.04145832,0.0036899638,0.013659286,0.0035395182],"domain_scores_gemma":[0.83596355,0.074448794,0.01677793,0.011943806,0.05893998,0.0019260412],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.1936033,0.0013155657,0.002727159,0.009756703,0.0023781802,0.0034950834,0.0030731482,0.0020809844,0.0028651308],"category_scores_gemma":[0.18701734,0.0008632923,0.0042277155,0.004846789,0.0038424141,0.0039849584,0.0060169273,0.0037436436,0.0006990557],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023419764,0.0017728974,0.10774889,0.02852803,0.0014697149,0.0011142149,0.0769915,0.015197413,0.01612845,0.14409472,0.034690686,0.56992155],"study_design_scores_gemma":[0.0025532935,0.006014546,0.32113272,0.044692867,0.0033721626,0.0029408962,0.08862045,0.06498132,0.030164158,0.20048113,0.23377633,0.001270117],"about_ca_topic_score_codex":0.0032074293,"about_ca_topic_score_gemma":0.00376794,"teacher_disagreement_score":0.8063967,"about_ca_system_score_codex":0.009066575,"about_ca_system_score_gemma":0.02278336,"threshold_uncertainty_score":0.99443066},"labels":[],"label_agreement":null},{"id":"W4414002075","doi":"10.1016/j.jaad.2025.08.076","title":"The efficacy and tolerability of low-dose naltrexone in the treatment of lichen planopilaris and frontal fibrosing alopecia: A systematic review","year":2025,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Toronto; University of Ottawa","funders":"","keywords":"Medicine; Scarring alopecia; Dermatology; Naltrexone; Scalp; Internal medicine; Opioid","score_opus":0.019666641068195743,"score_gpt":0.3513139452193114,"score_spread":0.33164730415111565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414002075","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018711225,0.9976814,0.000059128917,0.00006393641,0.000052903237,0.000058974052,0.0000985945,0.000004279528,0.00010955607],"genre_scores_gemma":[0.03282776,0.9660985,0.0002889856,0.00041587465,0.00006655854,0.00007384324,0.000108456356,0.0000031156276,0.00011692086],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99869245,0.00042034686,0.00045161322,0.00015170156,0.0002290693,0.00005483996],"domain_scores_gemma":[0.9946025,0.0038254005,0.001121683,0.0000656287,0.0002937176,0.00009110122],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002543135,0.00078302494,0.005853142,0.0019654424,0.0002722649,0.0013483667,0.0013233337,0.0012638242,0.0033413314],"category_scores_gemma":[0.008592096,0.0005317965,0.006180752,0.0021097711,0.0005998485,0.0010800184,0.00070965115,0.0010473916,0.00019092763],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021689755,0.00007165607,0.001023408,0.8794118,0.036809474,0.0001264762,0.00013434976,0.00020276014,0.00046561417,0.00015103677,0.0015176847,0.07791674],"study_design_scores_gemma":[0.0056524463,0.0022369593,0.017259222,0.42458147,0.51880926,0.000986111,0.0005245079,0.0004386243,0.0006676623,0.00056492985,0.028134175,0.00014467162],"about_ca_topic_score_codex":0.0053875945,"about_ca_topic_score_gemma":0.018870734,"teacher_disagreement_score":0.005853142,"about_ca_system_score_codex":0.0012757678,"about_ca_system_score_gemma":0.0020871407,"threshold_uncertainty_score":0.01344955},"labels":[],"label_agreement":null},{"id":"W4414267314","doi":"10.1016/j.jaad.2025.08.117","title":"Efficacy of ruxolitinib cream at different body sites in Chinese patients with nonsegmental vitiligo","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"melanin and skin pigmentation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Anhui Medical University; Ministry of Education","keywords":"Ruxolitinib; Vitiligo; MEDLINE; Pigmentation disorder; Depigmentation","score_opus":0.004279820116921357,"score_gpt":0.2767942734682006,"score_spread":0.2725144533512793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414267314","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99846834,0.0011178618,0.000014132741,0.00004191264,0.0000065596487,0.000007922126,0.000020810963,0.0000021409935,0.00032028774],"genre_scores_gemma":[0.9994254,0.00034983194,0.000021527316,0.000042513904,0.000009300777,0.0000046236096,0.00003525629,5.182987e-7,0.00011106],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99990046,0.000024236595,0.000009668835,0.000020314787,0.000019815792,0.000025526566],"domain_scores_gemma":[0.99988425,0.00004265989,0.000026815287,0.000005421305,0.0000111500085,0.000029659126],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022384943,0.00021964866,0.0006915488,0.00026293556,0.00026578215,0.00020947504,0.00016774869,0.00021022858,0.0007580045],"category_scores_gemma":[0.00039638334,0.000104839884,0.00041698574,0.00031067152,0.00016009362,0.00018230663,0.000097636046,0.00030783255,0.00007351103],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.038118187,0.002869395,0.77672464,0.000588699,0.0014580463,0.0020572871,0.00062929175,0.0014097558,0.03797005,0.00021451124,0.0010581834,0.1369021],"study_design_scores_gemma":[0.002716336,0.0067246533,0.98269284,0.000035153018,0.0015483608,0.00084174203,0.0003096927,0.0017092744,0.0022748774,0.00009272129,0.0010241987,0.000030113684],"about_ca_topic_score_codex":0.0028385671,"about_ca_topic_score_gemma":0.0050705024,"teacher_disagreement_score":0.0028385671,"about_ca_system_score_codex":0.00039268046,"about_ca_system_score_gemma":0.00032633156,"threshold_uncertainty_score":0.005644083},"labels":[],"label_agreement":null},{"id":"W4414578730","doi":"10.1016/j.jaad.2025.08.123","title":"A forty-year review of Canadian medico-legal cases involving skin cancer","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Medical Malpractice and Liability Issues","field":"Health Professions","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; McGill University; McGill University Health Centre","funders":"","keywords":"Skin cancer; MEDLINE; Cancer; Neoplasm staging","score_opus":0.052209822676182856,"score_gpt":0.4632172949502245,"score_spread":0.41100747227404166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414578730","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.075018905,0.8348378,0.00033898908,0.020047752,0.0030200745,0.00028238422,0.003102196,0.00007747613,0.06327445],"genre_scores_gemma":[0.2106013,0.75462306,0.0011280345,0.015044225,0.0013531747,0.00007665993,0.004277936,0.000045444503,0.012850201],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99530953,0.00030149295,0.00061649265,0.0002360002,0.0029116247,0.0006247562],"domain_scores_gemma":[0.97434694,0.005263568,0.0038793224,0.00033290064,0.014414319,0.0017628667],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025778275,0.0005513219,0.00040334542,0.02089134,0.005090483,0.002767443,0.0017822881,0.0021184264,0.0037543077],"category_scores_gemma":[0.011633537,0.0004541189,0.00062554044,0.022102393,0.0025040288,0.001083466,0.0014476817,0.00095386984,0.0005825259],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020484145,0.00021780693,0.11538201,0.011563178,0.00024573648,0.019497192,0.011174075,0.0002408793,0.0011806961,0.0039293757,0.39334616,0.4430181],"study_design_scores_gemma":[0.0000149201205,0.00007068158,0.23685233,0.011044229,0.00031997866,0.021172054,0.010925115,0.00007728327,0.00031917726,0.00020891133,0.71890515,0.00009013529],"about_ca_topic_score_codex":0.7256454,"about_ca_topic_score_gemma":0.913766,"teacher_disagreement_score":0.27435458,"about_ca_system_score_codex":0.025992615,"about_ca_system_score_gemma":0.060374014,"threshold_uncertainty_score":0.55194056},"labels":[],"label_agreement":null},{"id":"W4414687313","doi":"10.1016/j.jaad.2025.09.072","title":"The efficacy and tolerability of off-label dupilumab in acantholytic dyskeratotic disorders","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Biomedical Research and Pathophysiology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital; Centre Hospitalier de l’Université de Montréal; University of British Columbia; McGill University Health Centre","funders":"","keywords":"Dupilumab; Tolerability; Monoclonal; Immunopathology; MEDLINE","score_opus":0.01342506816149609,"score_gpt":0.3525930777111358,"score_spread":0.3391680095496397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414687313","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888188,0.007338122,0.00018985978,0.00028633297,0.00007817471,0.000031155414,0.00026459055,0.000021407943,0.00297153],"genre_scores_gemma":[0.99821657,0.0007449357,0.00011425642,0.0001561791,0.000059615377,0.000010569868,0.0002018927,0.000006080994,0.0004897688],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99956435,0.00015020066,0.000033606284,0.000056934874,0.000098266435,0.000096586424],"domain_scores_gemma":[0.99931455,0.00030699142,0.00011526481,0.000049950875,0.00008906176,0.0001241233],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008190391,0.00023393278,0.00060125225,0.00022851473,0.00028635756,0.00081270066,0.00024087747,0.00041423633,0.001920215],"category_scores_gemma":[0.0013562131,0.00013035187,0.00063181255,0.00014458528,0.00031890246,0.00059548137,0.00014784058,0.0010095335,0.00031919082],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11154495,0.0065982454,0.08143859,0.0011989254,0.001208731,0.0013077508,0.0004092416,0.001997792,0.070898965,0.00071636075,0.0052320412,0.71744835],"study_design_scores_gemma":[0.020350879,0.2038697,0.6640428,0.0005293071,0.0038972443,0.011725611,0.0013670024,0.012479116,0.051286295,0.001693718,0.028561326,0.00019700525],"about_ca_topic_score_codex":0.0007632348,"about_ca_topic_score_gemma":0.0016456664,"teacher_disagreement_score":0.001920215,"about_ca_system_score_codex":0.0007868779,"about_ca_system_score_gemma":0.00028138142,"threshold_uncertainty_score":0.0064237714},"labels":[],"label_agreement":null},{"id":"W4414700042","doi":"10.1016/j.jaad.2025.09.089","title":"Artificial intelligence chatbots for atopic dermatitis: Accuracy, readability, and concordance with American Academy of Dermatology guidelines","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Social Media in Health Education","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McGill University; McGill University Health Centre; Université de Montréal","funders":"","keywords":"Concordance; MEDLINE; Teledermatology; Applications of artificial intelligence","score_opus":0.1093431844385445,"score_gpt":0.465895583389321,"score_spread":0.3565523989507765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414700042","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97964627,0.0026281537,0.0036067741,0.0013798266,0.0002801231,0.00033934618,0.003259518,0.0007141429,0.008145873],"genre_scores_gemma":[0.9894651,0.00070074905,0.0053295884,0.0003759181,0.00009724659,0.00020455375,0.0023435939,0.000071708215,0.0014115043],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9914914,0.0042661116,0.0015436406,0.0006625804,0.0017679136,0.00026836927],"domain_scores_gemma":[0.87853914,0.09748811,0.008828409,0.0037388252,0.009672674,0.0017328802],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0101829,0.0003541148,0.0005720606,0.0035511116,0.00055294094,0.0014491162,0.00063619943,0.0008488254,0.0040977355],"category_scores_gemma":[0.09776172,0.00020519561,0.00065185816,0.0009739107,0.00030168498,0.0019501194,0.0012493363,0.00094931613,0.0012883039],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022981695,0.0013489876,0.76842445,0.0017112009,0.0004988458,0.0006252035,0.0037676988,0.0013415719,0.0021131902,0.0005614478,0.024445083,0.19286405],"study_design_scores_gemma":[0.00036907193,0.0015863063,0.9203652,0.0023772183,0.00097637734,0.0033989495,0.0037933972,0.0408151,0.0066413316,0.0023982658,0.017113173,0.0001655869],"about_ca_topic_score_codex":0.0018398943,"about_ca_topic_score_gemma":0.0032760983,"teacher_disagreement_score":0.0101829,"about_ca_system_score_codex":0.00048787222,"about_ca_system_score_gemma":0.0005718019,"threshold_uncertainty_score":0.053852975},"labels":[],"label_agreement":null},{"id":"W4414866676","doi":"10.1016/j.jaad.2025.10.005","title":"Safety and efficacy of envudeucitinib, a highly selective, oral allosteric TYK2 inhibitor, in patients with moderate-to-severe plaque psoriasis: Results from the 52-week open-label extension period of the phase 2 STRIDE study","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Plaque psoriasis; STRIDE; Allosteric regulation; Adverse effect; Psoriasis; Phases of clinical research","score_opus":0.01926189088015886,"score_gpt":0.2876578508778589,"score_spread":0.26839595999770005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414866676","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974558,0.0012762075,0.00017485234,0.000075061835,0.000009424694,0.0001193024,0.00028180348,0.000024249892,0.00058346265],"genre_scores_gemma":[0.9983095,0.00037372333,0.00025511158,0.00011076316,0.000023356684,0.00006811995,0.00058671454,0.000005305964,0.00026740233],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9994068,0.00025574464,0.00005149393,0.000098489516,0.000118521864,0.00006899289],"domain_scores_gemma":[0.9991684,0.00021633446,0.00024113954,0.000075098054,0.00008589104,0.0002131083],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002165109,0.0004046668,0.0011799302,0.000174031,0.00023957879,0.000582476,0.00029435568,0.0005204186,0.001103181],"category_scores_gemma":[0.0012696716,0.00020606791,0.0008934759,0.0001806758,0.00028821378,0.0005349778,0.00023492114,0.0013011959,0.00026387407],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.39499792,0.02820416,0.10123583,0.001222972,0.003065896,0.0007383963,0.00076545717,0.0044223065,0.13148314,0.00018540483,0.0051155584,0.32856292],"study_design_scores_gemma":[0.13884288,0.38708064,0.43948093,0.000087200635,0.0015707817,0.0026560426,0.000202636,0.005080815,0.018072063,0.00018012356,0.0066522793,0.00009354023],"about_ca_topic_score_codex":0.00033152252,"about_ca_topic_score_gemma":0.00085276854,"teacher_disagreement_score":0.002165109,"about_ca_system_score_codex":0.00043046148,"about_ca_system_score_gemma":0.0005184218,"threshold_uncertainty_score":0.01145035},"labels":[],"label_agreement":null},{"id":"W4415071690","doi":"10.1016/j.jaad.2025.10.028","title":"Modern definitions of periungual pigmentation (Hutchinson sign): Results of an expert opinion consensus conference","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"melanin and skin pigmentation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Leonard M. Miller School of Medicine, University of Miami; Samsung; Centre Hospitalier Universitaire de Bordeaux; Università di Bologna; Seoul National University; Tel Aviv University; Emory University; Sungkyunkwan University; Faculty of Medicine and Health, University of Sydney; College of Medicine, Seoul National University; School of Medicine, Emory University; Université Hassan II de Casablanca; Faculdade de Medicina do ABC; Leonard M. Miller School of Medicine; Radboud Universiteit; University of Miami; York University; National and Kapodistrian University of Athens; Inselspital, Universitätsspital Bern; Radboud Universitair Medisch Centrum; Brown University","keywords":"Expert opinion; Consensus conference; Second opinion; MEDLINE; Alternative medicine","score_opus":0.03170510396754634,"score_gpt":0.3448214519169923,"score_spread":0.313116347949446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415071690","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.030469218,0.5629585,0.03001447,0.3055389,0.040994234,0.0038059861,0.0023287092,0.00021185158,0.023678118],"genre_scores_gemma":[0.29433647,0.40618476,0.15263702,0.106870875,0.020886535,0.0052210037,0.007899181,0.0003604434,0.0056037293],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9460599,0.022786552,0.014176713,0.0035285752,0.011770569,0.0016778315],"domain_scores_gemma":[0.8551842,0.06828076,0.0072302804,0.0029398664,0.061777268,0.0045876275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.15665135,0.0016489092,0.0029734462,0.0058744596,0.0020952786,0.004922366,0.008479385,0.008762038,0.002943991],"category_scores_gemma":[0.1174045,0.0010755688,0.00488379,0.0033371372,0.0023620527,0.0057008048,0.0054306583,0.008430387,0.0010953007],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015873213,0.00057716307,0.008924115,0.030529752,0.0029092373,0.0014116446,0.00504676,0.0023001092,0.003407608,0.010354525,0.24385376,0.68909806],"study_design_scores_gemma":[0.0016666069,0.0007457296,0.024309063,0.14087552,0.0072011803,0.003509383,0.009323128,0.0045366287,0.0038192172,0.022229467,0.78108925,0.0006948201],"about_ca_topic_score_codex":0.00510356,"about_ca_topic_score_gemma":0.007309339,"teacher_disagreement_score":0.15665135,"about_ca_system_score_codex":0.00651727,"about_ca_system_score_gemma":0.014913969,"threshold_uncertainty_score":0.8284614},"labels":[],"label_agreement":null},{"id":"W4415141911","doi":"10.1016/j.jaad.2025.10.039","title":"Defining Mohs micrographic surgery workforce: A cross-sectional analysis of Centers for Medicare and Medicaid Services Current Procedural Terminology Code 17311 billing from 2015 to 2020","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"","keywords":"Current Procedural Terminology; Terminology; Medicaid; Mohs surgery; Population; Reimbursement","score_opus":0.02167437687948478,"score_gpt":0.3707989461209992,"score_spread":0.3491245692415144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415141911","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943007,0.00024949154,0.000097535354,0.00028348577,0.00002275754,0.00002364995,0.0043310784,0.000005071631,0.0006862251],"genre_scores_gemma":[0.9960769,0.00013340372,0.00007238434,0.00017025991,0.000010797889,0.000025099856,0.0031551016,0.0000042407137,0.0003518708],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984309,0.00026317063,0.00024732758,0.00028805537,0.0003207327,0.000449718],"domain_scores_gemma":[0.9937826,0.0006645849,0.003663963,0.00022266748,0.0007718287,0.0008944033],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002180877,0.0003068299,0.0002595712,0.0017310064,0.00062682864,0.000939549,0.0010405118,0.00089924847,0.0023211718],"category_scores_gemma":[0.0051165004,0.00046342166,0.0010014623,0.0022728387,0.00040191624,0.0019011969,0.00164439,0.0012601706,0.0005117057],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013145056,0.000030434408,0.99924505,0.0000041728454,0.000023686933,0.000007703476,0.00008074801,0.00001892843,0.000018855713,0.000015107967,0.00024857197,0.00029358437],"study_design_scores_gemma":[9.888711e-7,0.00002904302,0.9989918,0.000009601342,0.000008746157,0.000033199118,0.0005347556,0.000084014566,0.000017170241,0.00000848174,0.00027975652,0.0000025401796],"about_ca_topic_score_codex":0.03898478,"about_ca_topic_score_gemma":0.053872474,"teacher_disagreement_score":0.03898478,"about_ca_system_score_codex":0.001043134,"about_ca_system_score_gemma":0.00171037,"threshold_uncertainty_score":0.07751572},"labels":[],"label_agreement":null},{"id":"W4415279767","doi":"10.1016/j.jaad.2025.10.042","title":"Response to Veenstra et al’s “Benzoyl peroxide acne treatment shows no significant association with benzene-related cancers: A multicenter retrospective analysis” on statistical design","year":2025,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Multicenter study; Retrospective cohort study; Acne; Statistical analysis; Double blind study; MEDLINE; Association (psychology); Severity of illness","score_opus":0.009163806686486888,"score_gpt":0.2883420320222829,"score_spread":0.27917822533579606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415279767","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0037129195,0.00034917876,0.00031243428,0.97733736,0.016343327,0.000051525727,0.00032955824,0.000042006133,0.0015215928],"genre_scores_gemma":[0.01787791,0.00042505507,0.0006595243,0.94139075,0.03578574,0.000109165,0.0001624258,0.00004296556,0.0035464964],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99258,0.0026220728,0.0015660488,0.00091746857,0.001529786,0.00078459905],"domain_scores_gemma":[0.96839964,0.01794832,0.0029158406,0.0012943,0.007143561,0.0022983411],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.00831535,0.0006415454,0.0014833861,0.0012397086,0.0022007925,0.0028475176,0.0015968515,0.0176982,0.0047306116],"category_scores_gemma":[0.048237298,0.0006015294,0.0011348856,0.0014928166,0.0013026344,0.0015755196,0.0009168267,0.013334329,0.003991044],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007146693,0.00020557581,0.01877187,0.00011955607,0.00019411104,0.0064680087,0.0003182439,0.00020459182,0.00076947006,0.0012838205,0.95088,0.020070137],"study_design_scores_gemma":[0.0013525173,0.0010774856,0.029664036,0.00094362284,0.0006917565,0.017946893,0.0028589151,0.004473104,0.0026894545,0.013713811,0.9242714,0.00031701033],"about_ca_topic_score_codex":0.0036784809,"about_ca_topic_score_gemma":0.006716579,"teacher_disagreement_score":0.9916847,"about_ca_system_score_codex":0.0031044655,"about_ca_system_score_gemma":0.0023648727,"threshold_uncertainty_score":0.043976307},"labels":[],"label_agreement":null},{"id":"W4415601184","doi":"10.1016/j.jaad.2025.09.110","title":"Comment on “Patient-reported quality of life and aesthetic satisfaction continues to improve for 1-year after Mohs surgery: A multicenter prospective cohort study”","year":2025,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"","keywords":"Prospective cohort study; Quality of life (healthcare); Patient satisfaction; Cohort; Multicenter study; MEDLINE","score_opus":0.01894381868723145,"score_gpt":0.3287247303047739,"score_spread":0.30978091161754245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415601184","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0031212121,0.00041554475,0.00008403938,0.9730628,0.020796115,0.00002047305,0.00039241285,0.00004650626,0.0020608658],"genre_scores_gemma":[0.0074827853,0.0003100416,0.00014550952,0.97265846,0.01538556,0.000050538285,0.0001269986,0.000015714939,0.0038243742],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.996414,0.000887304,0.0006367444,0.0005029723,0.0008265253,0.00073241803],"domain_scores_gemma":[0.98736304,0.006615023,0.0016239283,0.0004531319,0.0025721823,0.0013726181],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004099982,0.00067317224,0.0014315771,0.00085110805,0.0033735007,0.002706636,0.0015852058,0.030100524,0.004863592],"category_scores_gemma":[0.024802536,0.00063910184,0.0011893269,0.0012983023,0.0015558966,0.0018146235,0.0011053918,0.018455042,0.005458084],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013910925,0.00006100344,0.006523024,0.000056869325,0.000034680837,0.0014894983,0.00024375117,0.00004129605,0.00017633625,0.00061255525,0.9853081,0.0053137764],"study_design_scores_gemma":[0.00050159195,0.0003604214,0.03066585,0.0009000539,0.00026648812,0.0043497477,0.0028643522,0.001144921,0.0009460727,0.004185073,0.95358986,0.00022562481],"about_ca_topic_score_codex":0.015721202,"about_ca_topic_score_gemma":0.020430205,"teacher_disagreement_score":0.030100524,"about_ca_system_score_codex":0.0039124405,"about_ca_system_score_gemma":0.004531025,"threshold_uncertainty_score":0.031259418},"labels":[],"label_agreement":null},{"id":"W4415679158","doi":"10.1016/j.jaad.2025.10.112","title":"Response to Childs et al., “The four ‘D’s of psoriasis disparities in patients with skin of color: A Letter to the Editor”","year":2025,"lang":"en","type":"letter","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia; University of Toronto","funders":"","keywords":"Psoriasis; MEDLINE; Severity of illness; Immunopathology","score_opus":0.008155249931565807,"score_gpt":0.2466855314604971,"score_spread":0.2385302815289313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415679158","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003304269,0.00094881793,0.00003733092,0.97713757,0.020122113,0.000007887606,0.000074341224,0.000027125043,0.0013144307],"genre_scores_gemma":[0.0026677104,0.0005990102,0.000075788776,0.972114,0.020959126,0.000019931678,0.000033032018,0.000017751625,0.003513659],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981323,0.00070584676,0.00016995776,0.0002445054,0.00043626814,0.00031109297],"domain_scores_gemma":[0.99401677,0.0030296082,0.00042040469,0.00013503239,0.0014019891,0.0009961025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028678349,0.0008107859,0.0012306144,0.00061361806,0.0037345898,0.0029696897,0.0015265819,0.029230835,0.008435251],"category_scores_gemma":[0.018579306,0.00059800415,0.00096430496,0.000565829,0.0014907037,0.0023760723,0.000980934,0.022386244,0.005994738],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044970395,0.000014178376,0.0003427957,0.000017670282,0.0000059420986,0.0003357656,0.000052752963,0.000014575432,0.00004259003,0.00029905463,0.99654335,0.002286288],"study_design_scores_gemma":[0.0002197587,0.00008582802,0.0027642287,0.00038071047,0.00004342842,0.0024093355,0.00084168,0.00034177574,0.0003418163,0.0031177439,0.98937476,0.000078886216],"about_ca_topic_score_codex":0.008360612,"about_ca_topic_score_gemma":0.011513255,"teacher_disagreement_score":0.029230835,"about_ca_system_score_codex":0.0030189538,"about_ca_system_score_gemma":0.0037811175,"threshold_uncertainty_score":0.028218746},"labels":[],"label_agreement":null},{"id":"W4415985943","doi":"10.1016/j.jaad.2025.11.005","title":"Five-year real-world drug survival of dupilumab in patients with atopic dermatitis: A multicenter retrospective study","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health; University of Calgary; Women's College Hospital; Calgary Laboratory Services; University of Toronto","funders":"","keywords":"Dupilumab; Retrospective cohort study; Multicenter study; Drug; Overall survival; Survival analysis; MEDLINE","score_opus":0.006202871584125317,"score_gpt":0.28893098782603266,"score_spread":0.28272811624190736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415985943","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99900216,0.00048389155,0.000039317016,0.000017770377,0.0000053313624,0.000005537768,0.0002780635,0.0000019745105,0.00016594605],"genre_scores_gemma":[0.9993351,0.000121704266,0.00002872844,0.000021238064,0.000012208608,0.000004925353,0.00042624728,0.0000013758137,0.000048497626],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99907506,0.00021787552,0.00012947177,0.0003060515,0.000099938356,0.00017163366],"domain_scores_gemma":[0.9976386,0.00036115618,0.0011471469,0.00026042864,0.00022046737,0.00037217693],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010149939,0.00044692546,0.0007084382,0.0009424817,0.00053962774,0.0011442063,0.00050140626,0.0007671911,0.0009557538],"category_scores_gemma":[0.0017869243,0.0002894811,0.0012292033,0.001384997,0.00053444627,0.0010764935,0.00058960036,0.0006169148,0.00024324167],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011593744,0.000068298476,0.9967307,0.000018345629,0.0002887209,0.00021172405,0.0000637162,0.00006783434,0.0001713379,0.000020707175,0.000075394535,0.0011239212],"study_design_scores_gemma":[0.000060143804,0.000659521,0.99687296,0.000010629426,0.00036621542,0.0008561555,0.0003186353,0.00033565794,0.000116440024,0.000027722896,0.00035759373,0.000018322613],"about_ca_topic_score_codex":0.003120756,"about_ca_topic_score_gemma":0.002419653,"teacher_disagreement_score":0.003120756,"about_ca_system_score_codex":0.0008013452,"about_ca_system_score_gemma":0.0003977506,"threshold_uncertainty_score":0.0062051415},"labels":[],"label_agreement":null},{"id":"W4416356101","doi":"10.1016/j.jaad.2025.10.149","title":"Efficacy and safety of ruxolitinib cream in patients with mild to moderate hidradenitis suppurativa: Results from a randomized, double-blind, vehicle-controlled phase 2 study","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"Incyte","keywords":"Ruxolitinib; Phases of clinical research; Clinical trial; Adverse effect; Janus kinase inhibitor; Open label","score_opus":0.017798340440165705,"score_gpt":0.33000756156174316,"score_spread":0.31220922112157745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416356101","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9870703,0.006651236,0.000762805,0.00037072806,0.00015568442,0.0031722982,0.0006686776,0.000085276806,0.00106298],"genre_scores_gemma":[0.9905551,0.002642097,0.001585234,0.00074320106,0.00023920425,0.002724482,0.0006874548,0.000015549256,0.00080770865],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99929106,0.00037838245,0.00007175552,0.00009877467,0.00008013126,0.00007988572],"domain_scores_gemma":[0.9989681,0.00031958224,0.0003209916,0.0000731433,0.000090117464,0.00022802448],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024321864,0.00081407296,0.002115022,0.00026649286,0.00030462752,0.0006995595,0.0006033803,0.0010522692,0.003931661],"category_scores_gemma":[0.0016353747,0.00042178854,0.0014611008,0.00025366255,0.0005168392,0.0007149684,0.0002290435,0.0015433009,0.000568129],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8496131,0.031034937,0.0036777926,0.0025440888,0.0020782168,0.00015443229,0.00017646697,0.0005402596,0.027276315,0.0001203919,0.0016384302,0.08114557],"study_design_scores_gemma":[0.812406,0.17628118,0.008053322,0.00007033872,0.0005626284,0.00012301873,0.000024412628,0.00040796897,0.0011283812,0.000054055272,0.00087206403,0.00001672572],"about_ca_topic_score_codex":0.00025866504,"about_ca_topic_score_gemma":0.00073570566,"teacher_disagreement_score":0.003931661,"about_ca_system_score_codex":0.00042423522,"about_ca_system_score_gemma":0.0007923261,"threshold_uncertainty_score":0.013152778},"labels":[],"label_agreement":null},{"id":"W4416356395","doi":"10.1016/j.jaad.2025.09.112","title":"Prevalence of sleep disturbance and psychologic comorbidities in college students with common skin diseases: A nationwide cross-sectional study","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"Hunan Provincial Innovation Foundation for Postgraduate; Central South University; National Natural Science Foundation of China","keywords":"Sleep disorder; Sleep (system call); Comorbidity; Disturbance (geology); MEDLINE; Severity of illness","score_opus":0.012734630200535661,"score_gpt":0.35959745541724364,"score_spread":0.34686282521670797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416356395","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992162,0.00008804605,0.00003861638,0.000024861023,0.0000063556904,0.000010647798,0.00035387516,0.0000025042332,0.00025891876],"genre_scores_gemma":[0.9993825,0.000060943326,0.000045385914,0.000041475563,0.000006672967,0.000008544808,0.00033114525,0.000001115737,0.00012216624],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994873,0.00012197624,0.00007545963,0.00012617698,0.00008600921,0.00010311434],"domain_scores_gemma":[0.998747,0.00015221025,0.00045429415,0.00008917737,0.00016825885,0.00038898026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005514378,0.0002971519,0.00043813518,0.00091098004,0.00066055916,0.0007657639,0.00042762267,0.0007651392,0.0015146105],"category_scores_gemma":[0.0011741907,0.0005731988,0.0006791658,0.0013805315,0.00033893564,0.0007172005,0.00057284656,0.00077548117,0.00033762146],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002565382,0.00006696084,0.99951756,0.0000033606489,0.00003652536,0.000018203606,0.000034256005,0.0000053591893,0.000086597836,0.0000025675859,0.000031265106,0.0001717308],"study_design_scores_gemma":[0.0000018016033,0.000033428616,0.99967754,0.0000012920597,0.000010285153,0.000035995003,0.00017167427,0.00003185282,0.000007647601,0.0000018560768,0.000025119794,0.0000013927739],"about_ca_topic_score_codex":0.021991897,"about_ca_topic_score_gemma":0.029255321,"teacher_disagreement_score":0.021991897,"about_ca_system_score_codex":0.00042687735,"about_ca_system_score_gemma":0.0004638322,"threshold_uncertainty_score":0.043727815},"labels":[],"label_agreement":null},{"id":"W4416757605","doi":"10.1016/j.jaad.2025.11.070","title":"Efficacy and safety of deuruxolitinib, an oral selective Janus kinase 1/2 inhibitor, in adults with alopecia areata: Results from the THRIVE-AA2 Phase 3, randomized, double-blind, controlled trial","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Red Deer Regional Hospital; Red Deer Polytechnic","funders":"Sun Pharma; Concert Pharmaceuticals","keywords":"Randomized controlled trial; Safety profile; Janus kinase inhibitor; Janus kinase; Clinical trial; Phases of clinical research; Adverse effect","score_opus":0.01673547740199586,"score_gpt":0.3291126137284758,"score_spread":0.3123771363264799,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416757605","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9738322,0.01946425,0.0003676071,0.00090890017,0.00024055887,0.0013624508,0.001378839,0.00007845523,0.0023666883],"genre_scores_gemma":[0.99124837,0.0039886087,0.0006062327,0.0009953048,0.0003643013,0.0009333653,0.0011513017,0.000010643545,0.00070188806],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99931467,0.0003709329,0.00007171399,0.000106957326,0.000068260895,0.000067513],"domain_scores_gemma":[0.9987558,0.00035714766,0.00044325093,0.000059089496,0.000089750145,0.00029489349],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021943382,0.0008351965,0.0018362209,0.00022730113,0.00037389415,0.00084346376,0.0005299084,0.0011686188,0.0035589936],"category_scores_gemma":[0.0016539713,0.00032855515,0.0016787883,0.00026658105,0.0005851533,0.000695709,0.00021818318,0.0017161466,0.0005065857],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.92070895,0.006934224,0.006166988,0.0020631326,0.0031879547,0.00012372748,0.00013637412,0.000510125,0.007981566,0.00015465153,0.0030225709,0.049009647],"study_design_scores_gemma":[0.9106157,0.07149629,0.013591851,0.00009978366,0.0013934922,0.00018056446,0.000034503588,0.00048719964,0.0007002423,0.00012835921,0.0012536473,0.00001835823],"about_ca_topic_score_codex":0.0004174037,"about_ca_topic_score_gemma":0.0012735327,"teacher_disagreement_score":0.0035589936,"about_ca_system_score_codex":0.00046542843,"about_ca_system_score_gemma":0.0006414357,"threshold_uncertainty_score":0.011906028},"labels":[],"label_agreement":null},{"id":"W4416919595","doi":"10.1016/j.jaad.2025.11.093","title":"The Mohs advancing and improving quality (MohsAIQ) national database registry: A new database of Mohs surgery cases performed in the United States","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"","keywords":"National database; Mohs surgery; Quality (philosophy); MEDLINE; National library; Documentation","score_opus":0.038770443143059725,"score_gpt":0.3760372784038508,"score_spread":0.3372668352607911,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416919595","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6859592,0.0017574214,0.0014103539,0.00065052725,0.00008204345,0.00061469834,0.30269834,0.00014616847,0.006681236],"genre_scores_gemma":[0.74932986,0.001463361,0.00512751,0.00086129084,0.00015744605,0.000778395,0.2406609,0.00007886569,0.0015422382],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979242,0.00031784418,0.00055371766,0.00048838067,0.00052307826,0.0001926681],"domain_scores_gemma":[0.9867872,0.0015214513,0.0060195345,0.0010732807,0.0033253776,0.001273097],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017065541,0.00037009257,0.0008667995,0.004608076,0.00060759916,0.0012545137,0.0012153069,0.0004557323,0.0025119437],"category_scores_gemma":[0.005821891,0.00050885545,0.00061598624,0.0075600673,0.0002605198,0.0017153199,0.0015052124,0.00071084715,0.0008313658],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022716487,0.00016128786,0.97560704,0.00019398244,0.00021193105,0.00011416719,0.00020016778,0.0001202644,0.00046670053,0.0002389584,0.014778131,0.0076801777],"study_design_scores_gemma":[0.00006892295,0.000053892527,0.99430966,0.00007507159,0.00009679096,0.00023302152,0.00028734445,0.00034946308,0.00019896783,0.000051998493,0.0042608967,0.000013902763],"about_ca_topic_score_codex":0.04608739,"about_ca_topic_score_gemma":0.08413064,"teacher_disagreement_score":0.04608739,"about_ca_system_score_codex":0.0017181957,"about_ca_system_score_gemma":0.0037656962,"threshold_uncertainty_score":0.09163827},"labels":[],"label_agreement":null},{"id":"W4416972343","doi":"10.1016/j.jaad.2025.12.008","title":"Response to Zheng et al: “Advances and challenges in diagnostic strategies for HLRCC—A Letter to the Editor regarding the study by Ouchene et al on HLRCC”","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Esophageal Cancer Research and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University; Université de Montréal; McGill University Health Centre","funders":"","keywords":"Letter to the editor; MEDLINE; Alternative medicine; Evidence-based medicine","score_opus":0.03802520122085151,"score_gpt":0.4026197145119428,"score_spread":0.36459451329109127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416972343","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017947244,0.0019577492,0.00007407856,0.9416504,0.055582568,0.0000084611065,0.000056056473,0.000024743265,0.0004664248],"genre_scores_gemma":[0.0017915419,0.0014197933,0.00012723122,0.89399946,0.101536065,0.000021983698,0.00003590789,0.000017480294,0.0010505264],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9942205,0.0016395682,0.0011089981,0.0007776389,0.0014927442,0.00076054264],"domain_scores_gemma":[0.9699921,0.014217658,0.0031303081,0.00072384544,0.00891365,0.0030224696],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0064594056,0.0011385672,0.002513336,0.0014835311,0.0031458298,0.004479802,0.0033062228,0.038006343,0.00673958],"category_scores_gemma":[0.04868177,0.00095083966,0.0016477344,0.0014009819,0.0029201868,0.0036947413,0.0020093455,0.034720127,0.005086802],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004292906,0.000015304098,0.0004900708,0.00007571337,0.000016095802,0.00049890066,0.000058492915,0.000028962804,0.000060038947,0.00036720783,0.9947326,0.0036137297],"study_design_scores_gemma":[0.00017663797,0.00008262055,0.002088698,0.00080084516,0.00009622563,0.0025331727,0.0007695441,0.00031899803,0.0003685574,0.0024723536,0.9901675,0.00012480306],"about_ca_topic_score_codex":0.004457175,"about_ca_topic_score_gemma":0.007096828,"teacher_disagreement_score":0.038006343,"about_ca_system_score_codex":0.0037052298,"about_ca_system_score_gemma":0.005207058,"threshold_uncertainty_score":0.03416097},"labels":[],"label_agreement":null},{"id":"W4417066371","doi":"10.1016/j.jaad.2025.12.010","title":"Validation of the Physician Global Assessment × Maximum Diameter (PGAMAX) as a severity assessment tool for pyoderma gangrenosum","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Autoimmune and Inflammatory Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"Ohio State University","keywords":"Pyoderma gangrenosum; MEDLINE; Severity of illness; Risk assessment; Global health","score_opus":0.009584955493197067,"score_gpt":0.3414839243281099,"score_spread":0.3318989688349129,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417066371","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99112695,0.00067038595,0.004184747,0.00020622528,0.0002579348,0.0005061992,0.00040102124,0.00003610067,0.0026104248],"genre_scores_gemma":[0.9943453,0.00015524721,0.0041621756,0.00014522488,0.00006751909,0.00030994695,0.00040197957,0.000015283149,0.00039725887],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.98667604,0.006442552,0.0014110778,0.001245488,0.0037477466,0.00047708774],"domain_scores_gemma":[0.9788961,0.011111275,0.0027323295,0.0012254984,0.0051879906,0.0008467624],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02347763,0.0009384669,0.00090514455,0.0018020784,0.0007120319,0.0019598028,0.0010439657,0.0013189556,0.000959987],"category_scores_gemma":[0.029636916,0.0004609138,0.0014503691,0.0008769935,0.001153525,0.001488454,0.001526164,0.0011451697,0.0004815095],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013621141,0.0009276506,0.97059804,0.00017138044,0.00044342657,0.000120653545,0.0010666252,0.0010078261,0.003126195,0.00033220445,0.00071029115,0.02013344],"study_design_scores_gemma":[0.00035242378,0.0033836495,0.9768769,0.0002085831,0.0003611648,0.0005114613,0.000908199,0.012027943,0.002220259,0.00036169804,0.0027293565,0.00005847779],"about_ca_topic_score_codex":0.0012735558,"about_ca_topic_score_gemma":0.0017477792,"teacher_disagreement_score":0.02347763,"about_ca_system_score_codex":0.0005167713,"about_ca_system_score_gemma":0.0011025796,"threshold_uncertainty_score":0.12416303},"labels":[],"label_agreement":null},{"id":"W4417436532","doi":"10.1016/j.jaad.2025.12.052","title":"Exosomes and extracellular vesicles as biomarkers in dermatology and systemic inflammatory diseases: Emerging clinical applications","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Microvesicles; Extracellular vesicles; Exosome; Inflammation; Extracellular; Systemic disease","score_opus":0.0072811939150967,"score_gpt":0.3111992716293958,"score_spread":0.30391807771429913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417436532","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008792188,0.9739527,0.0040365355,0.009271681,0.0013643203,0.000025733834,0.00010768094,0.000047199832,0.0024019538],"genre_scores_gemma":[0.23470199,0.73265105,0.0135655105,0.0069391374,0.008183865,0.00014938369,0.00026409375,0.000036883135,0.0035081005],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99878985,0.00055404473,0.000105433166,0.00016656157,0.00028512138,0.00009887089],"domain_scores_gemma":[0.99515104,0.0029099605,0.0005866395,0.00018554491,0.0007702058,0.00039663212],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0050216382,0.0007420742,0.0017150611,0.0015705925,0.00039708646,0.004715517,0.0007340963,0.0030950324,0.0021366247],"category_scores_gemma":[0.0047106654,0.00032832686,0.00058873784,0.0014882805,0.001802473,0.0037741833,0.0015280996,0.0025235214,0.00061146996],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002301593,0.00046072574,0.023885623,0.0036288563,0.00030354195,0.0013775575,0.000554216,0.00091677037,0.028007945,0.05568923,0.028972851,0.85390127],"study_design_scores_gemma":[0.0006604151,0.0037650769,0.03856445,0.005960379,0.0006824572,0.009822329,0.0025425928,0.009047921,0.028366871,0.10820794,0.7920464,0.00033309666],"about_ca_topic_score_codex":0.00024229474,"about_ca_topic_score_gemma":0.00042831604,"teacher_disagreement_score":0.0050216382,"about_ca_system_score_codex":0.0007406687,"about_ca_system_score_gemma":0.0011615128,"threshold_uncertainty_score":0.026557267},"labels":[],"label_agreement":null},{"id":"W7117150585","doi":"10.1016/j.jaad.2025.12.066","title":"Biologic therapy and risk of paradoxical eczema in psoriasis: A propensity-matched cohort analysis of tumor necrosis factor-α and interleukin 17 inhibitors using TriNetX","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Interleukin 17; Tumor necrosis factor alpha; Immunopathology; Interleukin; Cohort; Cohort study; Necrosis","score_opus":0.0256706818352078,"score_gpt":0.28643143368582524,"score_spread":0.2607607518506174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7117150585","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99867684,0.0003795778,0.0003125432,0.00002126362,0.000023169989,0.000010752688,0.00030267777,0.000009106597,0.0002639076],"genre_scores_gemma":[0.9991886,0.000091445385,0.000118235555,0.00001794281,0.000017876606,0.000007793404,0.00024819176,0.0000054200495,0.0003046267],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991314,0.00022997281,0.00008104687,0.0003157332,0.0001032754,0.0001386241],"domain_scores_gemma":[0.998735,0.00019430436,0.00042798294,0.00035243246,0.00008350489,0.00020682585],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00091373443,0.00048509156,0.00072532153,0.00053684687,0.0004573715,0.0011253121,0.00055211835,0.00069250574,0.0025351332],"category_scores_gemma":[0.0013995516,0.00064841466,0.0020402614,0.00094626757,0.00028253035,0.00062432094,0.00057248195,0.0011726052,0.0003236509],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00683486,0.00021548703,0.9843556,0.000029694145,0.002618013,0.00022349037,0.0000662493,0.00022497507,0.0020593689,0.00009553027,0.0002947421,0.002981752],"study_design_scores_gemma":[0.00035621598,0.0010871644,0.99332243,0.000011263648,0.001510343,0.00055386266,0.0001806272,0.0019503115,0.00034006982,0.00012425863,0.0005406812,0.00002284055],"about_ca_topic_score_codex":0.0026138767,"about_ca_topic_score_gemma":0.0023521518,"teacher_disagreement_score":0.0026138767,"about_ca_system_score_codex":0.00027274713,"about_ca_system_score_gemma":0.00032402753,"threshold_uncertainty_score":0.008480847},"labels":[],"label_agreement":null},{"id":"W7117316219","doi":"10.1016/j.jaad.2025.12.079","title":"Dupilumab treatment improves health-related quality of life in patients with moderate-to-severe atopic dermatitis primarily affecting the hands (atopic hand eczema): Results from a randomized placebo-controlled trial","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Regeneron Pharmaceuticals; Sanofi","keywords":"Dupilumab; Atopic dermatitis; Randomized controlled trial; Quality of life (healthcare); MEDLINE; Randomization; Atopy","score_opus":0.012128738482371695,"score_gpt":0.2963015256507871,"score_spread":0.28417278716841543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7117316219","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9759483,0.020110367,0.0002836837,0.00047182225,0.0005167568,0.00067313097,0.00046280512,0.000060741655,0.0014724106],"genre_scores_gemma":[0.99136955,0.0055565746,0.0003973179,0.00068156194,0.00036969504,0.0003875487,0.0004487693,0.000006696394,0.0007823922],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9995092,0.0002268971,0.000046679746,0.00008722812,0.00004232301,0.00008765107],"domain_scores_gemma":[0.9993598,0.0002462675,0.00016288251,0.000037644124,0.000041631465,0.00015190388],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010535964,0.0011979657,0.0030404027,0.0003222693,0.00038495628,0.0009450034,0.0006834457,0.0013898879,0.0034891113],"category_scores_gemma":[0.0012572741,0.00047220514,0.0025942137,0.0003914881,0.00087791693,0.0006152174,0.00027828262,0.0019103687,0.00040336754],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9603799,0.004016897,0.0018019739,0.0021877524,0.0041421847,0.000082171166,0.00004667176,0.00018418946,0.002150568,0.00006436073,0.0006475276,0.024295714],"study_design_scores_gemma":[0.95005625,0.03813593,0.0080050705,0.000099674755,0.0025317413,0.00007173869,0.000037616945,0.00025747294,0.0002757809,0.000080157544,0.00043033506,0.000018338947],"about_ca_topic_score_codex":0.0009651635,"about_ca_topic_score_gemma":0.002186809,"teacher_disagreement_score":0.0034891113,"about_ca_system_score_codex":0.00052583887,"about_ca_system_score_gemma":0.00041992543,"threshold_uncertainty_score":0.011672199},"labels":[],"label_agreement":null},{"id":"W7117320251","doi":"10.1016/j.jaad.2025.12.078","title":"Assessing and predicting cutaneous leiomyoma severity in hereditary leiomyomatosis and renal cell cancer syndrome: An observational study","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University; Université de Montréal; McGill University Health Centre","funders":"","keywords":"Leiomyomatosis; Observational study; Leiomyoma; MEDLINE; Kidney cancer; Cell; Cancer","score_opus":0.05676837255858766,"score_gpt":0.3647437478334322,"score_spread":0.30797537527484453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7117320251","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99945396,0.000120172364,0.00008554498,0.000022680333,0.000006738497,0.00000832954,0.00018451584,0.0000015109129,0.00011638067],"genre_scores_gemma":[0.99940336,0.00007332955,0.00009495959,0.000026716136,0.000012127882,0.000012559453,0.00028338074,0.000001695138,0.000091807255],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99851066,0.000547166,0.00017055387,0.0004063876,0.00016061647,0.00020460416],"domain_scores_gemma":[0.9956874,0.0010198327,0.001643709,0.0005671061,0.0003314956,0.0007503591],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015977868,0.00075399387,0.0008511438,0.0006509213,0.0010132963,0.0011428833,0.000838694,0.0015017964,0.0015541575],"category_scores_gemma":[0.0047323,0.00096813694,0.0015174355,0.0013684989,0.0007418741,0.0011644968,0.0010036086,0.0018293896,0.0002865818],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041762745,0.00018309055,0.99854314,0.00000888012,0.00021577846,0.000083867824,0.000080319696,0.000028472316,0.00012588529,0.000018032533,0.000047342597,0.00024743535],"study_design_scores_gemma":[0.00008049366,0.00052959064,0.9977812,0.000009391784,0.00021881738,0.00039467955,0.0003841277,0.0003652618,0.000043132222,0.000051894393,0.0001264306,0.0000150095175],"about_ca_topic_score_codex":0.009708752,"about_ca_topic_score_gemma":0.00869278,"teacher_disagreement_score":0.009708752,"about_ca_system_score_codex":0.0006449727,"about_ca_system_score_gemma":0.0007796127,"threshold_uncertainty_score":0.019304514},"labels":[],"label_agreement":null},{"id":"W7117768649","doi":"10.1016/j.jaad.2025.12.090","title":"Response to Ma et al., “Response to McMullen et al., Minoxidil toxicosis in cats and dogs: A scoping review and call to action”","year":2025,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Skin and Cellular Biology Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Hospital for Sick Children; University of Guelph; University of Ottawa; Western University; Women's College Hospital; McMaster University; SickKids Foundation; University of Toronto","funders":"","keywords":"Minoxidil; CATS; MEDLINE; Carnivora","score_opus":0.022225673217015227,"score_gpt":0.3910505161255408,"score_spread":0.3688248429085256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7117768649","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00022078355,0.003077561,0.00019732994,0.9109635,0.0830348,0.00012987765,0.0009356994,0.00014123532,0.0012991624],"genre_scores_gemma":[0.00095535605,0.0026504763,0.00033225896,0.941995,0.04676887,0.00018809817,0.0003222077,0.00004620494,0.006741546],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965837,0.0008595689,0.00070773595,0.00041127013,0.0011009518,0.00033674508],"domain_scores_gemma":[0.98217106,0.006577227,0.0019333306,0.00037002302,0.006890975,0.002057417],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006022605,0.001280154,0.0025034547,0.0016063253,0.002031193,0.003556946,0.0027022401,0.029003717,0.022808025],"category_scores_gemma":[0.04260332,0.00088585855,0.002639007,0.0010089658,0.0017388874,0.003648815,0.00356863,0.022011027,0.013382514],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000055350578,0.000012938042,0.000112099944,0.00028092056,0.000016023469,0.00013312908,0.000030366542,0.000021964948,0.00007632445,0.00008881521,0.9955166,0.0036553775],"study_design_scores_gemma":[0.0001504327,0.0000707484,0.0011554295,0.0016150645,0.000060849445,0.0006807003,0.00039929335,0.00014845908,0.00019501665,0.0008037395,0.9946572,0.00006285152],"about_ca_topic_score_codex":0.0051431917,"about_ca_topic_score_gemma":0.0102934195,"teacher_disagreement_score":0.029003717,"about_ca_system_score_codex":0.0035066346,"about_ca_system_score_gemma":0.005023807,"threshold_uncertainty_score":0.07630044},"labels":[],"label_agreement":null},{"id":"W76367842","doi":"10.1016/j.jaad.2014.08.038","title":"Guidelines of care for the management of atopic dermatitis","year":2014,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":324,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health; Quest University Canada; University of British Columbia","funders":"Chugai Pharmaceutical; National Institutes of Health; Astellas Pharma; LEO Pharma; Galderma; Dermira; Regeneron Pharmaceuticals; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Celgene; Valeant Pharmaceuticals International; Sanofi; Amgen; Pfizer; GlaxoSmithKline","keywords":"Medicine; Atopic dermatitis; Dermatology; MEDLINE","score_opus":0.02141403959256145,"score_gpt":0.34237505895062886,"score_spread":0.3209610193580674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W76367842","genre_codex":"review","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009828572,0.3396917,0.059534393,0.3311117,0.022988742,0.0041313036,0.0038412237,0.0015432762,0.22732908],"genre_scores_gemma":[0.08286736,0.3260158,0.38762665,0.1167581,0.015125573,0.007801649,0.012562118,0.0004515737,0.050791197],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.994803,0.0018964519,0.0013515227,0.00015492692,0.0014520993,0.0003419242],"domain_scores_gemma":[0.98933196,0.002250897,0.0012573589,0.00020932793,0.0060034054,0.00094705867],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004148897,0.0011646848,0.0014462611,0.003456868,0.0016257246,0.0021952824,0.0035822557,0.005520674,0.00539217],"category_scores_gemma":[0.014274794,0.0004228056,0.0024264236,0.0015615856,0.00081509334,0.0011770306,0.0015090312,0.006990917,0.0030174488],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013400866,0.00064115465,0.005911085,0.0023775136,0.00017129412,0.0018662384,0.00046266796,0.0017484761,0.0010573309,0.0100822495,0.58540934,0.3901386],"study_design_scores_gemma":[0.000349582,0.00028028435,0.016984032,0.024247605,0.00036055478,0.0058730124,0.00063932413,0.0016397998,0.0007741756,0.013106319,0.935622,0.00012333541],"about_ca_topic_score_codex":0.014236278,"about_ca_topic_score_gemma":0.034023236,"teacher_disagreement_score":0.014236278,"about_ca_system_score_codex":0.0025158871,"about_ca_system_score_gemma":0.009329636,"threshold_uncertainty_score":0.028306842},"labels":[],"label_agreement":null}]}